compound_number,pubchem_id,chembl_id,chemspider_id,canonical_smiles,iupac_name,inchi,inchikey,biochemical_tests,cellular_tests,pk_tests,cytotoxicity_tests,ppi_family,best_activity,diseases,mmoa,error
1,24801007,259033,23326307,CC(C)C(=O)c1cc(C(=O)c2ccc(Oc3ccccc3)cc2)c(O)c(O)c1O,"2-methyl-1-[2,3,4-trihydroxy-5-(4-phenoxybenzoyl)phenyl]propan-1-one","InChI=1S/C23H20O6/c1-13(2)19(24)17-12-18(22(27)23(28)21(17)26)20(25)14-8-10-16(11-9-14)29-15-6-4-3-5-7-15/h3-13,26-28H,1-2H3",CVVQMBDTMYUWTR-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,5.59,cancer,Inhibition,
2,11156875,106518,9331983,NC(=N)N[C@H](C1CCCCC1)C(=O)NCC(=O)N1CCC(CC1)c1cc(n[nH]1)-c1ccc(Cl)cc1Cl,"(2R)-2-cyclohexyl-2-(diaminomethylideneamino)-N-[2-[4-[3-(2,4-dichlorophenyl)-1H-pyrazol-5-yl]piperidin-1-yl]-2-oxoethyl]acetamide","InChI=1S/C25H33Cl2N7O2/c26-17-6-7-18(19(27)12-17)21-13-20(32-33-21)15-8-10-34(11-9-15)22(35)14-30-24(36)23(31-25(28)29)16-4-2-1-3-5-16/h6-7,12-13,15-16,23H,1-5,8-11,14H2,(H,30,36)(H,32,33)(H4,28,29,31)/t23-/m1/s1",CRBHPAAKAZMYPT-HSZRJFAPSA-N,1,0,0,0,IL2 / IL2R,5.00,immune system disease,Inhibition,
3,168318339,,,Cn1ncc2c1nc(-c1ccccc1)c1c2[nH]n(-c2ccc(Cl)cc2)c1=O,,"InChI=1S/C20H14ClN5O/c1-25-19-15(11-22-25)18-16(17(23-19)12-5-3-2-4-6-12)20(27)26(24-18)14-9-7-13(21)8-10-14/h2-11,24H,1H3",JVMVERZOOQABAE-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,5.74,cancer,Inhibition,
4,1210966,268669,23108025,OC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1ccccc1Br,(2S)-2-[(2-bromobenzoyl)amino]-3-(1H-indol-3-yl)propanoic acid,"InChI=1S/C18H15BrN2O3/c19-14-7-3-1-6-13(14)17(22)21-16(18(23)24)9-11-10-20-15-8-4-2-5-12(11)15/h1-8,10,16,20H,9H2,(H,21,22)(H,23,24)/t16-/m0/s1",PYLJGABTKOZRCY-INIZCTEOSA-N,1,0,0,0,LFA / ICAM,5.76,immune system disease,Inhibition,
5,168318344,,24635343,CNC(=O)c1ccc(O[C@H](C)C(=O)N2CCN(C[C@H]2C)C(=O)c2ccccc2)cc1,4-[1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-1-oxopropan-2-yl]oxy-N-methylbenzamide,"InChI=1S/C23H27N3O4/c1-16-15-25(23(29)19-7-5-4-6-8-19)13-14-26(16)22(28)17(2)30-20-11-9-18(10-12-20)21(27)24-3/h4-12,16-17H,13-15H2,1-3H3,(H,24,27)/t16-,17-/m1/s1",GTKRGUHTQKGJJW-IAGOWNOFSA-N,0,1,0,0,CD4 / gp120,5.59,HIV infectious disease,Inhibition,
6,1045147,3222135,896872,CCOC(=O)c1cnn(c1NC(=O)c1cc2nc(cc(n2n1)C(F)(F)Cl)-c1ccco1)-c1ccccc1,"ethyl 5-[[7-[chloro(difluoro)methyl]-5-(furan-2-yl)pyrazolo[1,5-a]pyrimidine-2-carbonyl]amino]-1-phenylpyrazole-4-carboxylate","InChI=1S/C24H17ClF2N6O4/c1-2-36-23(35)15-13-28-32(14-7-4-3-5-8-14)21(15)30-22(34)17-12-20-29-16(18-9-6-10-37-18)11-19(24(25,26)27)33(20)31-17/h3-13H,2H2,1H3,(H,30,34)",YPPNLSKYXDXQGD-UHFFFAOYSA-N,1,0,0,0,Myc / Max,4.57,cancer,Inhibition,
7,168318351,,,Cc1cc2CN(CCc2c(C)c1C(=O)N[C@@H](CNC(=O)c1cccs1)C(O)=O)C(=O)c1ccc(Cl)cc1,,"InChI=1S/C27H26ClN3O5S/c1-15-12-18-14-31(26(34)17-5-7-19(28)8-6-17)10-9-20(18)16(2)23(15)25(33)30-21(27(35)36)13-29-24(32)22-4-3-11-37-22/h3-8,11-12,21H,9-10,13-14H2,1-2H3,(H,29,32)(H,30,33)(H,35,36)/t21-/m0/s1",YATCZKNVHQPYSO-NRFANRHFSA-N,0,1,0,0,LFA / ICAM,7.66,immune system disease,Inhibition,
8,44549629,,,CN1c2ncnn2[C@H](C2=C1c1ccccc1O[C@@H]2c1ccc(Br)cc1)c1ccc(cc1)C#N,,"InChI=1S/C26H18BrN5O/c1-31-24-20-4-2-3-5-21(20)33-25(18-10-12-19(27)13-11-18)22(24)23(32-26(31)29-15-30-32)17-8-6-16(14-28)7-9-17/h2-13,15,23,25H,1H3/t23-,25+/m0/s1",LRJDBZGHSHPPKN-UKILVPOCSA-N,1,0,0,0,MDM2-Like / P53,5.23,cancer,Inhibition,
9,23646344,180851,23246988,C[C@H](N)C(=O)Nc1ccc2c(C)cc(C)nc2n1,"(2S)-2-amino-N-(5,7-dimethyl-1,8-naphthyridin-2-yl)propanamide","InChI=1S/C13H16N4O/c1-7-6-8(2)15-12-10(7)4-5-11(16-12)17-13(18)9(3)14/h4-6,9H,14H2,1-3H3,(H,15,16,17,18)/t9-/m0/s1",NEVIWLQURZYMJU-VIFPVBQESA-N,1,0,0,0,XIAP / Smac,4.70,cancer,Inhibition,
10,45138849,,,CN[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2c1ncccn1)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(2S,3R)-1-[(3aR,6S,6aR)-6-(6-fluoro-1H-indol-3-yl)-4-pyrimidin-2-yl-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-3-hydroxy-1-oxobutan-2-yl]-2-(methylamino)propanamide","InChI=1S/C26H32FN7O3/c1-14(28-3)24(36)32-22(15(2)35)25(37)33-10-7-21-23(33)19(13-34(21)26-29-8-4-9-30-26)18-12-31-20-11-16(27)5-6-17(18)20/h4-6,8-9,11-12,14-15,19,21-23,28,31,35H,7,10,13H2,1-3H3,(H,32,36)/t14-,15+,19+,21+,22-,23+/m0/s1",BSULVKBAPZHEJF-ZKQQCHMPSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
11,44176181,212747,23271769,CN(C)CCCN1c2ccc(I)cc2C(=O)N(Cc2ccc(Cl)cc2N)[C@@H](c2ccc(Cl)cc2)C1=O,"4-[(2-amino-4-chlorophenyl)methyl]-3-(4-chlorophenyl)-1-[3-(dimethylamino)propyl]-7-iodo-3H-1,4-benzodiazepine-2,5-dione","InChI=1S/C27H27Cl2IN4O2/c1-32(2)12-3-13-33-24-11-10-21(30)15-22(24)26(35)34(16-18-6-9-20(29)14-23(18)31)25(27(33)36)17-4-7-19(28)8-5-17/h4-11,14-15,25H,3,12-13,16,31H2,1-2H3/t25-/m0/s1",CUXYJJOQGJZCMF-VWLOTQADSA-N,1,0,0,0,MDM2-Like / P53,4.91,cancer,Inhibition,
12,58531371,,,Oc1c(Cl)cc(Cl)cc1S(=O)(=O)N(Cc1ccc(F)cc1)Cc1ccc(CN(Cc2ccc(F)cc2)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)cc1,"3,5-dichloro-N-[[4-[[(3,5-dichloro-2-hydroxyphenyl)sulfonyl-[(4-fluorophenyl)methyl]amino]methyl]phenyl]methyl]-N-[(4-fluorophenyl)methyl]-2-hydroxybenzenesulfonamide","InChI=1S/C34H26Cl4F2N2O6S2/c35-25-13-29(37)33(43)31(15-25)49(45,46)41(19-23-5-9-27(39)10-6-23)17-21-1-2-22(4-3-21)18-42(20-24-7-11-28(40)12-8-24)50(47,48)32-16-26(36)14-30(38)34(32)44/h1-16,43-44H,17-20H2",UTRDJZHGWZOLRH-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,8.00,cancer,Inhibition,
13,20791246,495004,19627883,Fc1ccc(C#N)c2[nH]cc(C(=O)C(=O)N3CCN(CC3)C(=O)c3ccccc3)c12,3-[2-(4-benzoylpiperazin-1-yl)-2-oxoacetyl]-4-fluoro-1H-indole-7-carbonitrile,"InChI=1S/C22H17FN4O3/c23-17-7-6-15(12-24)19-18(17)16(13-25-19)20(28)22(30)27-10-8-26(9-11-27)21(29)14-4-2-1-3-5-14/h1-7,13,25H,8-11H2",DYQVCZDEOGDGHY-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,8.72,HIV infectious disease,Inhibition,
14,44390637,359740,23246659,CCc1ccc2NC(=O)[C@@H](N([C@H](C(O)=O)c3ccc(Cl)cc3)C(=O)c2c1)c1ccc(Cl)cc1,"2-(4-chlorophenyl)-2-[3-(4-chlorophenyl)-7-ethyl-2,5-dioxo-1,3-dihydro-1,4-benzodiazepin-4-yl]acetic acid","InChI=1S/C25H20Cl2N2O4/c1-2-14-3-12-20-19(13-14)24(31)29(22(25(32)33)16-6-10-18(27)11-7-16)21(23(30)28-20)15-4-8-17(26)9-5-15/h3-13,21-22H,2H2,1H3,(H,28,30)(H,32,33)/t21-,22-/m0/s1",YIEASSPQFWICET-VXKWHMMOSA-N,1,0,0,0,MDM2-Like / P53,5.82,cancer,Inhibition,
15,87251440,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2ccccc2-c2cccc(Cl)c2)CC1,,"InChI=1S/C44H49ClF3N7O4S3/c1-53(2)21-17-34(29-60-36-12-4-3-5-13-36)51-40-16-15-37(26-42(40)61(56,57)44(46,47)48)62(58,59)52-43-39-20-24-55(28-41(39)49-30-50-43)35-18-22-54(23-19-35)27-32-9-6-7-14-38(32)31-10-8-11-33(45)25-31/h3-16,25-26,30,34-35,51H,17-24,27-29H2,1-2H3,(H,49,50,52)/t34-/m1/s1",SWCUWBBMUCSKHT-UUWRZZSWSA-N,1,0,0,0,BCL2-Like / BAX,7.31,cancer,Inhibition,
16,44390699,179890,23246722,OC(=O)[C@@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)Nc2cc(Cl)ccc2C1=O)c1ccc(Cl)cc1,"2-[8-chloro-3-(4-chlorophenyl)-2,5-dioxo-1,3-dihydro-1,4-benzodiazepin-4-yl]-2-(4-chlorophenyl)acetic acid","InChI=1S/C23H15Cl3N2O4/c24-14-5-1-12(2-6-14)19-21(29)27-18-11-16(26)9-10-17(18)22(30)28(19)20(23(31)32)13-3-7-15(25)8-4-13/h1-11,19-20H,(H,27,29)(H,31,32)/t19-,20-/m0/s1",BGVUXEXHNXDISI-PMACEKPBSA-N,1,0,0,0,MDM2-Like / P53,5.20,cancer,Inhibition,
17,46840523,,,CC(C)Oc1ccc(cc1F)-c1sc(nc1C(O)=O)-c1ccc2CCCN(C(=O)Nc3nc4ccccc4s3)c2c1,"2-[1-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-2H-quinolin-7-yl]-5-(3-fluoro-4-propan-2-yloxyphenyl)-1,3-thiazole-4-carboxylic acid","InChI=1S/C30H25FN4O4S2/c1-16(2)39-23-12-11-18(14-20(23)31)26-25(28(36)37)33-27(41-26)19-10-9-17-6-5-13-35(22(17)15-19)30(38)34-29-32-21-7-3-4-8-24(21)40-29/h3-4,7-12,14-16H,5-6,13H2,1-2H3,(H,36,37)(H,32,34,38)",RSSPYPZTSOSDNQ-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,9.15,cancer,Inhibition,
18,44305116,66645,23156002,OC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1cccnc1Cl,(2S)-2-[(2-chloropyridine-3-carbonyl)amino]-3-(1H-indol-3-yl)propanoic acid,"InChI=1S/C17H14ClN3O3/c18-15-12(5-3-7-19-15)16(22)21-14(17(23)24)8-10-9-20-13-6-2-1-4-11(10)13/h1-7,9,14,20H,8H2,(H,21,22)(H,23,24)/t14-/m0/s1",MPDJJMAOGCKNGY-AWEZNQCLSA-N,1,0,0,0,LFA / ICAM,5.92,immune system disease,Inhibition,
19,67175585,,,C[C@H](N)C(=O)N[C@@H](Cc1cccc(c1)C(N)=O)C(=O)N1C[C@H]([C@@H]1C(=O)N[C@@H]1CCc2ccccc12)c1ccccc1,,"InChI=1S/C32H35N5O4/c1-19(33)30(39)36-27(17-20-8-7-12-23(16-20)29(34)38)32(41)37-18-25(21-9-3-2-4-10-21)28(37)31(40)35-26-15-14-22-11-5-6-13-24(22)26/h2-13,16,19,25-28H,14-15,17-18,33H2,1H3,(H2,34,38)(H,35,40)(H,36,39)/t19-,25-,26+,27-,28+/m0/s1",POWYHOALPVWVMX-BWZPRNMBSA-N,1,0,0,0,XIAP / Smac,8.00,cancer,Inhibition,
20,10952496,104594,9127715,CC(C)C[C@@H](NC(N)=N)C(=O)NCC(=O)N1CCC(CC1)c1cc(nn1C)-c1ccc(OCc2ccc(cc2)C(O)=O)c(Cl)c1Cl,"4-[[2,3-dichloro-4-[5-[1-[2-[[(2R)-2-(diaminomethylideneamino)-4-methylpentanoyl]amino]acetyl]piperidin-4-yl]-1-methylpyrazol-3-yl]phenoxy]methyl]benzoic acid","InChI=1S/C32H39Cl2N7O5/c1-18(2)14-24(38-32(35)36)30(43)37-16-27(42)41-12-10-20(11-13-41)25-15-23(39-40(25)3)22-8-9-26(29(34)28(22)33)46-17-19-4-6-21(7-5-19)31(44)45/h4-9,15,18,20,24H,10-14,16-17H2,1-3H3,(H,37,43)(H,44,45)(H4,35,36,38)/t24-/m1/s1",WWIPZQVVSVLGCO-XMMPIXPASA-N,2,0,0,0,IL2 / IL2R,6.70,immune system disease,Inhibition,
21,44570040,501871,24711900,COC[C@@H]1Cc2ccccc2CN1C(=O)c1ccccc1-n1nc(cc1C)C(=O)N(c1ccccc1)c1ccccc1,"1-[2-[(3S)-3-(methoxymethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-5-methyl-N,N-diphenylpyrazole-3-carboxamide","InChI=1S/C35H32N4O3/c1-25-21-32(35(41)38(28-15-5-3-6-16-28)29-17-7-4-8-18-29)36-39(25)33-20-12-11-19-31(33)34(40)37-23-27-14-10-9-13-26(27)22-30(37)24-42-2/h3-21,30H,22-24H2,1-2H3/t30-/m0/s1",AVAAPAOVVKDHIA-PMERELPUSA-N,2,0,0,0,BCL2-Like / BAX,6.80,cancer,Inhibition,
22,44305032,293608,23155887,Nc1ccc(C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(O)=O)c(Cl)c1,(2S)-2-[(4-amino-2-chlorobenzoyl)amino]-3-(1H-indol-3-yl)propanoic acid,"InChI=1S/C18H16ClN3O3/c19-14-8-11(20)5-6-13(14)17(23)22-16(18(24)25)7-10-9-21-15-4-2-1-3-12(10)15/h1-6,8-9,16,21H,7,20H2,(H,22,23)(H,24,25)/t16-/m0/s1",JBIMMGGXACSHDI-INIZCTEOSA-N,1,0,0,0,LFA / ICAM,5.70,immune system disease,Inhibition,
23,67032159,,,COc1cccc(n1)-c1nc(C(O)=O)c(-c2ccc(F)c(Cl)c2)n1-c1cc(Cl)ccc1C,,"InChI=1S/C23H16Cl2FN3O3/c1-12-6-8-14(24)11-18(12)29-21(13-7-9-16(26)15(25)10-13)20(23(30)31)28-22(29)17-4-3-5-19(27-17)32-2/h3-11H,1-2H3,(H,30,31)",KONVKQXFIZORGX-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,8.17,cancer,Inhibition,
24,168318348,,,Cc1cc2CN(CCc2c(C)c1C(=O)N[C@@H](CNC(=O)c1cccs1)C(O)=O)C(=O)c1ccc2CCOc2c1,,"InChI=1S/C29H29N3O6S/c1-16-12-20-15-32(28(35)19-6-5-18-8-10-38-23(18)13-19)9-7-21(20)17(2)25(16)27(34)31-22(29(36)37)14-30-26(33)24-4-3-11-39-24/h3-6,11-13,22H,7-10,14-15H2,1-2H3,(H,30,33)(H,31,34)(H,36,37)/t22-/m0/s1",JNCBBXFRVFGSNI-QFIPXVFZSA-N,0,1,0,0,LFA / ICAM,7.89,immune system disease,Inhibition,
25,168318347,,,COc1c(Nc2ccnc3[C@@H](O)CCc23)ccc(NCCc2c[nH]c3c(cccc23)C(C)=C)c1F,"4-[3-fluoro-2-methoxy-4-[2-(7-prop-1-en-2-yl-1H-indol-3-yl)ethylamino]anilino]-6,7-dihydro-5H-cyclopenta[b]pyridin-7-ol","InChI=1S/C28H29FN4O2/c1-16(2)18-5-4-6-19-17(15-32-26(18)19)11-13-30-22-8-9-23(28(35-3)25(22)29)33-21-12-14-31-27-20(21)7-10-24(27)34/h4-6,8-9,12,14-15,24,30,32,34H,1,7,10-11,13H2,2-3H3,(H,31,33)/t24-/m0/s1",SDGNLJQANKDFMF-DEOSSOPVSA-N,1,1,0,0,MDM2-Like / P53,7.07,cancer,Inhibition,
26,44392055,434327,23248125,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1ccnc(c1)N1CCCCC1,2-piperidin-1-yl-4-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyridine,"InChI=1S/C26H27F3N2S/c1-18(2)21-8-4-5-9-23(21)32-24-11-10-19(16-22(24)26(27,28)29)20-12-13-30-25(17-20)31-14-6-3-7-15-31/h4-5,8-13,16-18H,3,6-7,14-15H2,1-2H3",IOBIQCAVWCTRDY-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,6.00,immune system disease,Inhibition,
27,44570080,480009,24698360,CCN(C(=O)c1cc(C)n(n1)-c1ccccc1C(=O)N1CCc2ccccc2C1)c1ccccc1,"1-[2-(3,4-dihydro-1H-isoquinoline-2-carbonyl)phenyl]-N-ethyl-5-methyl-N-phenylpyrazole-3-carboxamide","InChI=1S/C29H28N4O2/c1-3-32(24-13-5-4-6-14-24)29(35)26-19-21(2)33(30-26)27-16-10-9-15-25(27)28(34)31-18-17-22-11-7-8-12-23(22)20-31/h4-16,19H,3,17-18,20H2,1-2H3",DNHJKFTYIWNMAF-UHFFFAOYSA-N,1,0,0,0,BCL2-Like / BAX,5.72,cancer,Inhibition,
28,24875307,487705,24703532,FC(F)(F)c1c(Sc2ccccc2OCc2cccnc2)ccc(\C=C\C(=O)N2CCOCC2)c1C(F)(F)F,"(E)-1-morpholin-4-yl-3-[4-[2-(pyridin-3-ylmethoxy)phenyl]sulfanyl-2,3-bis(trifluoromethyl)phenyl]prop-2-en-1-one","InChI=1S/C27H22F6N2O3S/c28-26(29,30)24-19(8-10-23(36)35-12-14-37-15-13-35)7-9-22(25(24)27(31,32)33)39-21-6-2-1-5-20(21)38-17-18-4-3-11-34-16-18/h1-11,16H,12-15,17H2/b10-8+",ZRIKDHLPCRURPX-CSKARUKUSA-N,1,0,0,0,LFA / ICAM,8.60,immune system disease,Inhibition,
29,168318346,,,CCOc1cc(Nc2ccnc3[C@H](O)CCCc23)ccc1NCCc1c[nH]c2cc(OC)ccc12,"4-[3-ethoxy-4-[2-(6-methoxy-1H-indol-3-yl)ethylamino]anilino]-5,6,7,8-tetrahydroquinolin-8-ol","InChI=1S/C28H32N4O3/c1-3-35-27-15-19(32-23-12-14-30-28-22(23)5-4-6-26(28)33)7-10-24(27)29-13-11-18-17-31-25-16-20(34-2)8-9-21(18)25/h7-10,12,14-17,26,29,31,33H,3-6,11,13H2,1-2H3,(H,30,32)/t26-/m1/s1",UQZCXLZZFZIPMT-AREMUKBSSA-N,1,1,0,0,MDM2-Like / P53,7.00,cancer,Inhibition,
30,59555676,,,CC(=O)OCc1cc(Nc2ccc(NCCc3c[nH]c4ccccc34)cc2)ccn1,[4-[4-[2-(1H-indol-3-yl)ethylamino]anilino]pyridin-2-yl]methyl acetate,"InChI=1S/C24H24N4O2/c1-17(29)30-16-22-14-21(11-13-26-22)28-20-8-6-19(7-9-20)25-12-10-18-15-27-24-5-3-2-4-23(18)24/h2-9,11,13-15,25,27H,10,12,16H2,1H3,(H,26,28)",HNIBHRJQYPVYBO-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,6.00,cancer,Inhibition,
31,21906767,182384,10657276,CC(=O)N1CCN(CC1)c1cc(ccn1)-c1ccc(Sc2ccc3OCCOc3c2)c(c1)C(F)(F)F,"1-[4-[4-[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfanyl)-3-(trifluoromethyl)phenyl]pyridin-2-yl]piperazin-1-yl]ethanone","InChI=1S/C26H24F3N3O3S/c1-17(33)31-8-10-32(11-9-31)25-15-19(6-7-30-25)18-2-5-24(21(14-18)26(27,28)29)36-20-3-4-22-23(16-20)35-13-12-34-22/h2-7,14-16H,8-13H2,1H3",BVXBVMYTIQBMPV-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,6.88,immune system disease,Inhibition,
32,44237072,,,CC[C@H](NC)C(=O)N[C@H]1[C@@H](CNCc2ccccc2)CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7R,9aS)-N-benzhydryl-7-[(benzylamino)methyl]-6-[[(2S)-2-(methylamino)butanoyl]amino]-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C36H45N5O3/c1-3-30(37-2)34(42)40-33-28(24-38-23-25-13-7-4-8-14-25)19-20-29-21-22-31(41(29)36(33)44)35(43)39-32(26-15-9-5-10-16-26)27-17-11-6-12-18-27/h4-18,28-33,37-38H,3,19-24H2,1-2H3,(H,39,43)(H,40,42)/t28-,29+,30+,31+,33+/m1/s1",SJLRWHKVFCAJDF-PIXGQMGXSA-N,1,2,0,0,XIAP / Smac,6.96,cancer,Inhibition,
33,44390682,368244,23246705,OC(=O)[C@@H](N1[C@@H](c2ccc(Cl)nc2)C(=O)Nc2ccc(I)cc2C1=O)c1ccc(Cl)cc1,"2-(4-chlorophenyl)-2-[3-(6-chloropyridin-3-yl)-7-iodo-2,5-dioxo-1,3-dihydro-1,4-benzodiazepin-4-yl]acetic acid","InChI=1S/C22H14Cl2IN3O4/c23-13-4-1-11(2-5-13)19(22(31)32)28-18(12-3-8-17(24)26-10-12)20(29)27-16-7-6-14(25)9-15(16)21(28)30/h1-10,18-19H,(H,27,29)(H,31,32)/t18-,19-/m0/s1",GHHRPEIJMVCVMO-OALUTQOASA-N,1,0,0,0,MDM2-Like / P53,5.13,cancer,Inhibition,
34,44191638,554545,24622209,Cc1cc(C)c(CNC(=O)c2c(O)c(O)cc3c(O)c(c(C)cc23)-c2c(C)cc3c(C(=O)NCc4c(C)cc(C)cc4C)c(O)c(O)cc3c2O)c(C)c1,"2,3,5-trihydroxy-7-methyl-6-[1,6,7-trihydroxy-3-methyl-5-[(2,4,6-trimethylphenyl)methylcarbamoyl]naphthalen-2-yl]-N-[(2,4,6-trimethylphenyl)methyl]naphthalene-1-carboxamide","InChI=1S/C44H44N2O8/c1-19-9-21(3)31(22(4)10-19)17-45-43(53)37-27-13-25(7)35(39(49)29(27)15-33(47)41(37)51)36-26(8)14-28-30(40(36)50)16-34(48)42(52)38(28)44(54)46-18-32-23(5)11-20(2)12-24(32)6/h9-16,47-52H,17-18H2,1-8H3,(H,45,53)(H,46,54)",RBEVOAVIETWZMX-UHFFFAOYSA-N,3,0,0,0,BCL2-Like / BAX,6.15,cancer,Inhibition,
35,44237044,578239,24638880,CC[C@H](N)C(=O)N[C@H]1[C@@H](CN=[N+]=[N-])CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7R,9aS)-6-[[(2S)-2-aminobutanoyl]amino]-7-(azidomethyl)-N-benzhydryl-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C28H35N7O3/c1-2-22(29)26(36)33-25-20(17-31-34-30)13-14-21-15-16-23(35(21)28(25)38)27(37)32-24(18-9-5-3-6-10-18)19-11-7-4-8-12-19/h3-12,20-25H,2,13-17,29H2,1H3,(H,32,37)(H,33,36)/t20-,21+,22+,23+,25+/m1/s1",NEWAVIBWEBAKJU-FCRIMTMASA-N,2,0,0,0,XIAP / Smac,6.39,cancer,Inhibition,
36,71624427,2326745,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1,,"InChI=1S/C44H49ClF3N7O4S3/c1-53(2)22-18-34(29-60-36-9-4-3-5-10-36)51-40-17-16-37(26-42(40)61(56,57)44(46,47)48)62(58,59)52-43-39-21-25-55(28-41(39)49-30-50-43)35-19-23-54(24-20-35)27-32-8-6-7-11-38(32)31-12-14-33(45)15-13-31/h3-17,26,30,34-35,51H,18-25,27-29H2,1-2H3,(H,49,50,52)/t34-/m1/s1",ZLPUERMAGNHUAF-UUWRZZSWSA-N,1,0,0,0,BCL2-Like / BAX,7.70,cancer,Inhibition,
37,168318299,,8293396,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1cc(ncn1)N1CCC[C@@H](C1)C(O)=O,1-[6-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyrimidin-4-yl]piperidine-3-carboxylic acid,"InChI=1S/C26H26F3N3O2S/c1-16(2)19-7-3-4-8-22(19)35-23-10-9-17(12-20(23)26(27,28)29)21-13-24(31-15-30-21)32-11-5-6-18(14-32)25(33)34/h3-4,7-10,12-13,15-16,18H,5-6,11,14H2,1-2H3,(H,33,34)/t18-/m0/s1",MPHIYSGHFVGRGH-SFHVURJKSA-N,0,1,0,0,LFA / ICAM,6.92,immune system disease,Inhibition,
38,168318297,,,Cc1cc2CN(CCc2c(C)c1C(=O)N[C@@H](CNC(=O)C1CCCCC1)C(O)=O)C(=O)c1ccc(Cl)cc1,,"InChI=1S/C29H34ClN3O5/c1-17-14-21-16-33(28(36)20-8-10-22(30)11-9-20)13-12-23(21)18(2)25(17)27(35)32-24(29(37)38)15-31-26(34)19-6-4-3-5-7-19/h8-11,14,19,24H,3-7,12-13,15-16H2,1-2H3,(H,31,34)(H,32,35)(H,37,38)/t24-/m0/s1",YZAIMHYESCSCHY-DEOSSOPVSA-N,0,1,0,0,LFA / ICAM,6.27,immune system disease,Inhibition,
39,24737642,2431768,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1nc(cs1)C(=O)c1ccc(F)cc1,"(2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C26H33FN4O3S/c1-16(28-2)24(33)30-22(17-7-4-3-5-8-17)26(34)31-14-6-9-21(31)25-29-20(15-35-25)23(32)18-10-12-19(27)13-11-18/h10-13,15-17,21-22,28H,3-9,14H2,1-2H3,(H,30,33)/t16-,21-,22-/m0/s1",UFPFGVNKHCLJJO-SSKFGXFMSA-N,1,0,0,0,XIAP / Smac,6.00,cancer,Inhibition,
40,25113117,503454,24711379,Cc1c(Cl)c(nn1-c1ccccc1C(=O)N1Cc2ccccc2C[C@H]1CN)C(=O)N(c1ccccc1)c1ccccc1,"1-[2-[(3S)-3-(aminomethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-4-chloro-5-methyl-N,N-diphenylpyrazole-3-carboxamide","InChI=1S/C34H30ClN5O2/c1-23-31(35)32(34(42)39(26-14-4-2-5-15-26)27-16-6-3-7-17-27)37-40(23)30-19-11-10-18-29(30)33(41)38-22-25-13-9-8-12-24(25)20-28(38)21-36/h2-19,28H,20-22,36H2,1H3/t28-/m0/s1",MLZCQGFPFQDFLC-NDEPHWFRSA-N,2,0,0,0,BCL2-Like / BAX,7.52,cancer,Inhibition,
41,25173265,,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1cncc(Oc2ccc(F)cc2)c1,N-[1-cyclohexyl-2-[2-[5-(4-fluorophenoxy)pyridin-3-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide,"InChI=1S/C27H35FN4O3/c1-18(29-2)26(33)31-25(19-7-4-3-5-8-19)27(34)32-14-6-9-24(32)20-15-23(17-30-16-20)35-22-12-10-21(28)11-13-22/h10-13,15-19,24-25,29H,3-9,14H2,1-2H3,(H,31,33)/t18-,24-,25-/m0/s1",CLEDYXXBPZCGOA-WDNCENIBSA-N,1,0,0,0,XIAP / Smac,6.00,cancer,Inhibition,
42,168318295,,,CNC(=O)[C@@H]1C[C@@H](CN1C(=O)[C@@H]1C[C@@H](CN1C(=O)[C@H](Cn1cncn1)NC(=O)[C@H](C)N)c1ccccc1)c1ccccc1,"(2S,4R)-1-[(2S,4R)-1-[2-[[(2S)-2-aminopropanoyl]amino]-3-(1,2,4-triazol-1-yl)propanoyl]-4-phenylpyrrolidine-2-carbonyl]-N-methyl-4-phenylpyrrolidine-2-carboxamide","InChI=1S/C31H38N8O4/c1-20(32)28(40)36-25(17-37-19-34-18-35-37)30(42)39-16-24(22-11-7-4-8-12-22)14-27(39)31(43)38-15-23(13-26(38)29(41)33-2)21-9-5-3-6-10-21/h3-12,18-20,23-27H,13-17,32H2,1-2H3,(H,33,41)(H,36,40)/t20-,23-,24-,25-,26-,27-/m0/s1",WJZYPXYQPOMOTN-BCAOEVRMSA-N,1,0,0,0,XIAP / Smac,8.00,cancer,Inhibition,
43,44580069,521385,24719497,FC(F)(F)c1c(Sc2ccccc2OCc2ccccn2)ccc(\C=C\C(=O)N2CCOCC2)c1C(F)(F)F,"(E)-1-morpholin-4-yl-3-[4-[2-(pyridin-2-ylmethoxy)phenyl]sulfanyl-2,3-bis(trifluoromethyl)phenyl]prop-2-en-1-one","InChI=1S/C27H22F6N2O3S/c28-26(29,30)24-18(9-11-23(36)35-13-15-37-16-14-35)8-10-22(25(24)27(31,32)33)39-21-7-2-1-6-20(21)38-17-19-5-3-4-12-34-19/h1-12H,13-17H2/b11-9+",PKSKMDBFTLPBGD-PKNBQFBNSA-N,1,0,0,0,LFA / ICAM,8.01,immune system disease,Inhibition,
44,67954257,,,CCOC(=O)c1nc(-c2cccc(C)c2)n(c1-c1cccc(Cl)c1)-c1cc(Cl)ccc1C,,"InChI=1S/C26H22Cl2N2O2/c1-4-32-26(31)23-24(18-8-6-10-20(27)14-18)30(22-15-21(28)12-11-17(22)3)25(29-23)19-9-5-7-16(2)13-19/h5-15H,4H2,1-3H3",XHFIHYLBYMLITD-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,5.45,cancer,Inhibition,
45,44392026,368031,23248099,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1cc(ncn1)N1CC[C@@H](O)C1,1-[6-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyrimidin-4-yl]pyrrolidin-3-ol,"InChI=1S/C24H24F3N3OS/c1-15(2)18-5-3-4-6-21(18)32-22-8-7-16(11-19(22)24(25,26)27)20-12-23(29-14-28-20)30-10-9-17(31)13-30/h3-8,11-12,14-15,17,31H,9-10,13H2,1-2H3/t17-/m1/s1",VJRMETDTVGHPMG-QGZVFWFLSA-N,0,1,0,0,LFA / ICAM,6.80,immune system disease,Inhibition,
46,1874292,583427,4698299,Brc1ccc(cc1)[C@H]1Oc2ccccc2C2=C1[C@@H](c1ccc(Br)cc1)n1ncnc1N2,,"InChI=1S/C24H16Br2N4O/c25-16-9-5-14(6-10-16)22-20-21(29-24-27-13-28-30(22)24)18-3-1-2-4-19(18)31-23(20)15-7-11-17(26)12-8-15/h1-13,22-23H,(H,27,28,29)/t22-,23-/m1/s1",HNNGTASVWGJHBY-DHIUTWEWSA-N,1,0,0,0,MDM2-Like / P53,5.41,cancer,Inhibition,
47,46220961,1098760,24671201,CN1C(=O)N(C(=O)[C@]11CN(C[C@H]1c1ccc(cc1)C#N)c1cc(ncn1)C(O)=O)c1cc(Cl)cc(Cl)c1,"6-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl]pyrimidine-4-carboxylic acid","InChI=1S/C25H18Cl2N6O4/c1-31-24(37)33(18-7-16(26)6-17(27)8-18)23(36)25(31)12-32(21-9-20(22(34)35)29-13-30-21)11-19(25)15-4-2-14(10-28)3-5-15/h2-9,13,19H,11-12H2,1H3,(H,34,35)/t19-,25+/m0/s1",KNCARWQABJNUDQ-UQBPGWFLSA-N,1,0,0,0,LFA / ICAM,8.10,immune system disease,Inhibition,
48,168318113,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(Cc2ccc(cc2)S(C)(=O)=O)CC1,,"InChI=1S/C37H44N6O7S3/c1-40(2)20-19-30(27-51-32-7-5-4-6-8-32)38-35-18-17-34(25-36(35)43(45)46)53(49,50)39-37(44)29-11-13-31(14-12-29)42-23-21-41(22-24-42)26-28-9-15-33(16-10-28)52(3,47)48/h4-18,25,30,38H,19-24,26-27H2,1-3H3,(H,39,44)/t30-/m1/s1",IZSMBGOCWQYYAX-SSEXGKCCSA-N,2,0,0,0,BCL2-Like / BAX,9.00,cancer,Inhibition,
49,23646351,181711,23246952,C[C@H](N)C(=O)Nc1nc(c(s1)-c1ccccc1)-c1ccccc1,"(2S)-2-amino-N-(4,5-diphenyl-1,3-thiazol-2-yl)propanamide","InChI=1S/C18H17N3OS/c1-12(19)17(22)21-18-20-15(13-8-4-2-5-9-13)16(23-18)14-10-6-3-7-11-14/h2-12H,19H2,1H3,(H,20,21,22)/t12-/m0/s1",ACAHAYSKCDTFST-LBPRGKRZSA-N,1,0,0,0,XIAP / Smac,5.96,cancer,Inhibition,
50,168318291,,26361830,CN(C)CCC[C@](O)(c1ccccc1)c1cccc(OCc2cccc(c2)-c2ccc(cc2)C(O)=O)c1,4-[3-[[3-[4-(dimethylamino)-1-hydroxy-1-phenylbutyl]phenoxy]methyl]phenyl]benzoic acid,"InChI=1S/C32H33NO4/c1-33(2)20-8-19-32(36,28-11-4-3-5-12-28)29-13-7-14-30(22-29)37-23-24-9-6-10-27(21-24)25-15-17-26(18-16-25)31(34)35/h3-7,9-18,21-22,36H,8,19-20,23H2,1-2H3,(H,34,35)/t32-/m0/s1",ZEADEHHKYWFCSR-YTTGMZPUSA-N,1,0,0,0,BCL2-Like / BAX,4.70,cancer,Inhibition,
51,44237066,574704,24638453,CC[C@H](NC)C(=O)N[C@H]1[C@@H](CCN)CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7R,9aS)-7-(2-aminoethyl)-N-benzhydryl-6-[[(2S)-2-(methylamino)butanoyl]amino]-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C30H41N5O3/c1-3-24(32-2)28(36)34-27-22(18-19-31)14-15-23-16-17-25(35(23)30(27)38)29(37)33-26(20-10-6-4-7-11-20)21-12-8-5-9-13-21/h4-13,22-27,32H,3,14-19,31H2,1-2H3,(H,33,37)(H,34,36)/t22-,23+,24+,25+,27+/m1/s1",NTMBSFPXIRJHSX-HOIWYFOJSA-N,2,1,0,0,XIAP / Smac,6.85,cancer,Inhibition,
52,58007331,,,CC(C)C1=C(SC2=N[C@](C)([C@H](N12)c1ccc(Cl)cc1)c1ccc(Cl)cc1)C(=O)N1CCC[C@H]1C(=O)N1CCN(CC(F)F)CC1,"[(2S)-1-[(5R,6S)-5,6-bis(4-chlorophenyl)-6-methyl-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazole-2-carbonyl]pyrrolidin-2-yl]-[4-(2,2-difluoroethyl)piperazin-1-yl]methanone","InChI=1S/C33H37Cl2F2N5O2S/c1-20(2)27-28(31(44)41-14-4-5-25(41)30(43)40-17-15-39(16-18-40)19-26(36)37)45-32-38-33(3,22-8-12-24(35)13-9-22)29(42(27)32)21-6-10-23(34)11-7-21/h6-13,20,25-26,29H,4-5,14-19H2,1-3H3/t25-,29+,33-/m0/s1",SHTICDNHSXGIQJ-LHKFRKOXSA-N,1,0,0,0,MDM2-Like / P53,7.52,cancer,Inhibition,
53,23646349,179951,23246969,C[C@H](N)C(=O)Nc1nc(c(s1)C(C)(C)C)-c1ccccc1,"(2S)-2-amino-N-(5-tert-butyl-4-phenyl-1,3-thiazol-2-yl)propanamide","InChI=1S/C16H21N3OS/c1-10(17)14(20)19-15-18-12(11-8-6-5-7-9-11)13(21-15)16(2,3)4/h5-10H,17H2,1-4H3,(H,18,19,20)/t10-/m0/s1",YDKNXEHODDDSPQ-JTQLQIEISA-N,1,0,0,0,XIAP / Smac,5.32,cancer,Inhibition,
54,506247,492586,442078,COc1ccc(Cl)c2[nH]cc(C(=O)C(=O)N3CCN(CC3)C(=O)c3ccccc3)c12,"1-(4-benzoylpiperazin-1-yl)-2-(7-chloro-4-methoxy-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C22H20ClN3O4/c1-30-17-8-7-16(23)19-18(17)15(13-24-19)20(27)22(29)26-11-9-25(10-12-26)21(28)14-5-3-2-4-6-14/h2-8,13,24H,9-12H2,1H3",FCDQSRYKNBOBTQ-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,11.15,HIV infectious disease,Inhibition,
55,67031923,,,CN1CCN(Cc2ccc(Cl)cc2-c2c(nc(-c3ccccc3)n2-c2cccc(Cl)c2F)-c2nn[nH]n2)CC1,,"InChI=1S/C28H25Cl2FN8/c1-37-12-14-38(15-13-37)17-19-10-11-20(29)16-21(19)26-25(27-33-35-36-34-27)32-28(18-6-3-2-4-7-18)39(26)23-9-5-8-22(30)24(23)31/h2-11,16H,12-15,17H2,1H3,(H,33,34,35,36)",DPFVGTSSGVNUTP-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,6.82,cancer,Inhibition,
56,42601678,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCC(CC1)NC(=O)c1ccccc1Br,2-bromo-N-[1-[4-[[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonylcarbamoyl]phenyl]piperidin-4-yl]benzamide,"InChI=1S/C37H41BrN6O6S2/c1-42(2)21-18-28(25-51-30-8-4-3-5-9-30)39-34-17-16-31(24-35(34)44(47)48)52(49,50)41-36(45)26-12-14-29(15-13-26)43-22-19-27(20-23-43)40-37(46)32-10-6-7-11-33(32)38/h3-17,24,27-28,39H,18-23,25H2,1-2H3,(H,40,46)(H,41,45)/t28-/m1/s1",TYBKQXUYNXHALH-MUUNZHRXSA-N,1,0,0,0,BCL2-Like / BAX,5.30,cancer,Inhibition,
57,168318281,,,C[C@H]1C[C@H](CCN1CC1=C(CC(C)(C)CC1)c1ccc(Cl)cc1)N1CCc2c(C1)ncnc2NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(c1)S(=O)(=O)C(F)(F)F,,"InChI=1S/C49H61ClF3N7O5S3/c1-34-27-39(17-21-59(34)30-36-15-19-48(2,3)29-43(36)35-9-11-37(50)12-10-35)60-22-18-42-45(31-60)54-33-55-47(42)57-68(63,64)41-13-14-44(46(28-41)67(61,62)49(51,52)53)56-38(16-20-58-23-25-65-26-24-58)32-66-40-7-5-4-6-8-40/h4-14,28,33-34,38-39,56H,15-27,29-32H2,1-3H3,(H,54,55,57)/t34-,38+,39-/m0/s1",FVPJABXVEBVSTQ-ZFKVFEFPSA-N,1,0,0,0,BCL2-Like / BAX,6.69,cancer,Inhibition,
58,44176183,379487,23271888,CN1CCN(CCCCN2c3ccc(I)cc3C(=O)N(Cc3ccc(Cl)cc3N)[C@@H](c3ccc(Cl)cc3)C2=O)CC1,"4-[(2-amino-4-chlorophenyl)methyl]-3-(4-chlorophenyl)-7-iodo-1-[4-(4-methylpiperazin-1-yl)butyl]-3H-1,4-benzodiazepine-2,5-dione","InChI=1S/C31H34Cl2IN5O2/c1-36-14-16-37(17-15-36)12-2-3-13-38-28-11-10-25(34)19-26(28)30(40)39(20-22-6-9-24(33)18-27(22)35)29(31(38)41)21-4-7-23(32)8-5-21/h4-11,18-19,29H,2-3,12-17,20,35H2,1H3/t29-/m0/s1",MUHZTXDQFRVJAS-LJAQVGFWSA-N,1,0,0,0,MDM2-Like / P53,5.25,cancer,Inhibition,
59,44820626,1091044,24670318,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1nc(cs1)-c1cccc2ccccc12,"(2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-(4-naphthalen-1-yl-1,3-thiazol-2-yl)pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C29H36N4O2S/c1-19(30-2)27(34)32-26(21-11-4-3-5-12-21)29(35)33-17-9-16-25(33)28-31-24(18-36-28)23-15-8-13-20-10-6-7-14-22(20)23/h6-8,10,13-15,18-19,21,25-26,30H,3-5,9,11-12,16-17H2,1-2H3,(H,32,34)/t19-,25-,26-/m0/s1",OWHXKYSKEROHGU-CNVLFFCLSA-N,1,0,0,0,XIAP / Smac,7.17,cancer,Inhibition,
60,68402923,,,O[C@H]1Cc2nccc(Nc3ccc(NCCc4c[nH]c5ccccc45)cc3)c2C1,,"InChI=1S/C24H24N4O/c29-19-13-21-23(10-12-26-24(21)14-19)28-18-7-5-17(6-8-18)25-11-9-16-15-27-22-4-2-1-3-20(16)22/h1-8,10,12,15,19,25,27,29H,9,11,13-14H2,(H,26,28)/t19-/m1/s1",CHYGRNJVMTUORE-LJQANCHMSA-N,1,1,0,0,MDM2-Like / P53,7.10,cancer,Inhibition,
61,168318290,,26362571,CN(C)CCC[C@](O)(c1ccccc1)c1ccc(OCc2cccc(c2)-c2ccc(cc2)C(O)=O)cc1,4-[3-[[4-[4-(dimethylamino)-1-hydroxy-1-phenylbutyl]phenoxy]methyl]phenyl]benzoic acid,"InChI=1S/C32H33NO4/c1-33(2)21-7-20-32(36,28-10-4-3-5-11-28)29-16-18-30(19-17-29)37-23-24-8-6-9-27(22-24)25-12-14-26(15-13-25)31(34)35/h3-6,8-19,22,36H,7,20-21,23H2,1-2H3,(H,34,35)/t32-/m0/s1",WHAPPDCEEYUSOQ-YTTGMZPUSA-N,1,0,0,0,BCL2-Like / BAX,5.24,cancer,Inhibition,
62,45486361,569919,24634480,CNc1nc(NCc2ccc(cc2)-c2ccccc2C(=O)OC)c2ccccc2n1,methyl 2-[4-[[[2-(methylamino)quinazolin-4-yl]amino]methyl]phenyl]benzoate,"InChI=1S/C24H22N4O2/c1-25-24-27-21-10-6-5-9-20(21)22(28-24)26-15-16-11-13-17(14-12-16)18-7-3-4-8-19(18)23(29)30-2/h3-14H,15H2,1-2H3,(H2,25,26,27,28)",YRYOXLMVSKUYKY-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,6.34,cancer,Inhibition,
63,59452408,,,Cc1cccc2c(CCN3CC4(CCCCC4)Oc4cc(Nc5ccnc(CO)c5)ccc34)c[nH]c12,"[4-[[4-[2-(7-methyl-1H-indol-3-yl)ethyl]spiro[3H-1,4-benzoxazine-2,1'-cyclohexane]-7-yl]amino]pyridin-2-yl]methanol","InChI=1S/C30H34N4O2/c1-21-6-5-7-26-22(18-32-29(21)26)11-15-34-20-30(12-3-2-4-13-30)36-28-17-23(8-9-27(28)34)33-24-10-14-31-25(16-24)19-35/h5-10,14,16-18,32,35H,2-4,11-13,15,19-20H2,1H3,(H,31,33)",JQQAPMHYIQKYES-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,6.52,cancer,Inhibition,
64,44429172,437577,23291041,CCC\C(=C1\SC(=S)N(C1=O)[C@H](C(O)=O)Cc1ccccc1)c1ccccc1,"(2S)-2-[(5Z)-4-oxo-5-(1-phenylbutylidene)-2-sulfanylidene-1,3-thiazolidin-3-yl]-3-phenylpropanoic acid","InChI=1S/C22H21NO3S2/c1-2-9-17(16-12-7-4-8-13-16)19-20(24)23(22(27)28-19)18(21(25)26)14-15-10-5-3-6-11-15/h3-8,10-13,18H,2,9,14H2,1H3,(H,25,26)/b19-17-/t18-/m0/s1",KAOXISQJUWHXIJ-VZCCSQPZSA-N,2,0,0,0,BCL2-Like / BAX,4.92,cancer,Inhibition,
65,59555550,,,O[C@@H]1CCc2c1nccc2Nc1ccc(NCCc2c[nH]c3ccccc23)cc1,"4-[4-[2-(1H-indol-3-yl)ethylamino]anilino]-6,7-dihydro-5H-cyclopenta[b]pyridin-7-ol","InChI=1S/C24H24N4O/c29-23-10-9-20-22(12-14-26-24(20)23)28-18-7-5-17(6-8-18)25-13-11-16-15-27-21-4-2-1-3-19(16)21/h1-8,12,14-15,23,25,27,29H,9-11,13H2,(H,26,28)/t23-/m1/s1",FBBUTFVHJKFJIW-HSZRJFAPSA-N,2,1,0,0,MDM2-Like / P53,8.00,cancer,Inhibition,
66,506252,493838,442083,FC(F)(F)Oc1ccc(Br)c2[nH]cc(C(=O)C(=O)N3CCN(CC3)C(=O)c3ccccc3)c12,"1-(4-benzoylpiperazin-1-yl)-2-[7-bromo-4-(trifluoromethoxy)-1H-indol-3-yl]ethane-1,2-dione","InChI=1S/C22H17BrF3N3O4/c23-15-6-7-16(33-22(24,25)26)17-14(12-27-18(15)17)19(30)21(32)29-10-8-28(9-11-29)20(31)13-4-2-1-3-5-13/h1-7,12,27H,8-11H2",AAQNOENKTHJXFV-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,7.37,HIV infectious disease,Inhibition,
67,45138259,,,CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2C(C)=O)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(2S)-1-[(3aR,6S,6aR)-4-acetyl-6-(6-fluoro-1H-indol-3-yl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-1-oxobutan-2-yl]-2-(methylamino)propanamide","InChI=1S/C24H32FN5O3/c1-5-19(28-23(32)13(2)26-4)24(33)29-9-8-21-22(29)18(12-30(21)14(3)31)17-11-27-20-10-15(25)6-7-16(17)20/h6-7,10-11,13,18-19,21-22,26-27H,5,8-9,12H2,1-4H3,(H,28,32)/t13-,18+,19-,21+,22+/m0/s1",DUPPPHNZCVQSQO-NTFMPISFSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
68,24775146,,,CCOc1nc(C)ncc1C1=N[C@H]([C@H](N1C(=O)N1CCN(CC(=O)N(C)C)CC1)c1ccc(Cl)cc1)c1ccc(Cl)cc1,"2-[4-[(4S,5R)-4,5-bis(4-chlorophenyl)-2-(4-ethoxy-2-methylpyrimidin-5-yl)-4,5-dihydroimidazole-1-carbonyl]piperazin-1-yl]-N,N-dimethylacetamide","InChI=1S/C31H35Cl2N7O3/c1-5-43-30-25(18-34-20(2)35-30)29-36-27(21-6-10-23(32)11-7-21)28(22-8-12-24(33)13-9-22)40(29)31(42)39-16-14-38(15-17-39)19-26(41)37(3)4/h6-13,18,27-28H,5,14-17,19H2,1-4H3/t27-,28+/m0/s1",UBFZQXHKHIPGON-WUFINQPMSA-N,1,0,0,0,MDM2-Like / P53,6.17,cancer,Inhibition,
69,11767613,,9942298,CC(C)C[C@@H](NC(N)=N)C(=O)NCC(=O)N1CCC(CC1)c1cc(nn1C)-c1ccc(OCCc2ccc(cc2)C(O)=O)c(Cl)c1Cl,"4-[2-[2,3-dichloro-4-[5-[1-[2-[[(2R)-2-(diaminomethylideneamino)-4-methylpentanoyl]amino]acetyl]piperidin-4-yl]-1-methylpyrazol-3-yl]phenoxy]ethyl]benzoic acid","InChI=1S/C33H41Cl2N7O5/c1-19(2)16-25(39-33(36)37)31(44)38-18-28(43)42-13-10-21(11-14-42)26-17-24(40-41(26)3)23-8-9-27(30(35)29(23)34)47-15-12-20-4-6-22(7-5-20)32(45)46/h4-9,17,19,21,25H,10-16,18H2,1-3H3,(H,38,44)(H,45,46)(H4,36,37,39)/t25-/m1/s1",CZEAYXRBBPCEGX-RUZDIDTESA-N,1,0,0,0,IL2 / IL2R,5.74,immune system disease,Inhibition,
70,168318289,,24635142,CC[C@H]1CN(CCN1C(=O)C(=O)c1c[nH]c2cccc(F)c12)C(=O)c1ccccc1,"1-(4-benzoyl-2-ethylpiperazin-1-yl)-2-(4-fluoro-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C23H22FN3O3/c1-2-16-14-26(22(29)15-7-4-3-5-8-15)11-12-27(16)23(30)21(28)17-13-25-19-10-6-9-18(24)20(17)19/h3-10,13,16,25H,2,11-12,14H2,1H3/t16-/m0/s1",UOQQQRFMXIOQQJ-INIZCTEOSA-N,0,1,0,0,CD4 / gp120,8.15,HIV infectious disease,Inhibition,
71,168318287,,,C[C@@H](N)[C@H]1CCC[C@H](N1)C(=O)N1C[C@H](C[C@H]1C(=O)N1CC[C@@H](C1)c1ccccc1)c1ccccc1,"[(6R)-6-(1-aminoethyl)piperidin-2-yl]-[(2S,4R)-4-phenyl-2-[(3R)-3-phenylpyrrolidine-1-carbonyl]pyrrolidin-1-yl]methanone","InChI=1S/C29H38N4O2/c1-20(30)25-13-8-14-26(31-25)28(34)33-19-24(22-11-6-3-7-12-22)17-27(33)29(35)32-16-15-23(18-32)21-9-4-2-5-10-21/h2-7,9-12,20,23-27,31H,8,13-19,30H2,1H3/t20-,23+,24+,25-,26+,27+/m1/s1",QGKIOJRTXDLQKU-DLVVYKNMSA-N,1,0,0,0,XIAP / Smac,5.30,cancer,Inhibition,
72,53324559,1644119,26380392,Cc1ccc2c(cn(c2c1)S(C)(=O)=O)C(=O)NC[C@H](NC(=O)c1c(Cl)cc2CN(CCc2c1Cl)C(=O)c1ccc(Cl)cc1)C(O)=O,"(2S)-2-[[5,7-dichloro-2-(4-chlorobenzoyl)-3,4-dihydro-1H-isoquinoline-6-carbonyl]amino]-3-[(6-methyl-1-methylsulfonylindole-3-carbonyl)amino]propanoic acid","InChI=1S/C31H27Cl3N4O7S/c1-16-3-8-21-22(15-38(25(21)11-16)46(2,44)45)28(39)35-13-24(31(42)43)36-29(40)26-23(33)12-18-14-37(10-9-20(18)27(26)34)30(41)17-4-6-19(32)7-5-17/h3-8,11-12,15,24H,9-10,13-14H2,1-2H3,(H,35,39)(H,36,40)(H,42,43)/t24-/m0/s1",AIMBUGRSRLAWJW-DEOSSOPVSA-N,1,0,0,0,LFA / ICAM,7.41,immune system disease,Inhibition,
73,168318286,,23242419,CCOC(=O)[C@H]1CCCN(C1)c1ccccc1Sc1ccc(cc1C(F)(F)F)[C@@H]1C[C@H]1C(=O)NCCCN1CCCC1=O,ethyl 1-[2-[4-[2-[3-(2-oxopyrrolidin-1-yl)propylcarbamoyl]cyclopropyl]-2-(trifluoromethyl)phenyl]sulfanylphenyl]piperidine-3-carboxylate,"InChI=1S/C32H38F3N3O4S/c1-2-42-31(41)22-8-5-16-38(20-22)26-9-3-4-10-28(26)43-27-13-12-21(18-25(27)32(33,34)35)23-19-24(23)30(40)36-14-7-17-37-15-6-11-29(37)39/h3-4,9-10,12-13,18,22-24H,2,5-8,11,14-17,19-20H2,1H3,(H,36,40)/t22-,23-,24+/m0/s1",IOORAGVPEMUXSU-KMDXXIMOSA-N,0,1,0,0,LFA / ICAM,7.00,immune system disease,Inhibition,
74,168318285,,26363289,CN(C)CCC[C@](O)(c1ccccc1)c1cccc(OCc2ccc(cc2)-c2ccc(cc2)C(O)=O)c1,4-[4-[[3-[4-(dimethylamino)-1-hydroxy-1-phenylbutyl]phenoxy]methyl]phenyl]benzoic acid,"InChI=1S/C32H33NO4/c1-33(2)21-7-20-32(36,28-8-4-3-5-9-28)29-10-6-11-30(22-29)37-23-24-12-14-25(15-13-24)26-16-18-27(19-17-26)31(34)35/h3-6,8-19,22,36H,7,20-21,23H2,1-2H3,(H,34,35)/t32-/m0/s1",NHAWCIYWXIMWEF-YTTGMZPUSA-N,1,0,0,0,BCL2-Like / BAX,5.28,cancer,Inhibition,
75,16117550,182385,10657323,COCCCNc1nc(cs1)-c1ccc(Sc2ccccc2C(C)C)c(c1)C(F)(F)F,"N-(3-methoxypropyl)-4-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]-1,3-thiazol-2-amine","InChI=1S/C23H25F3N2OS2/c1-15(2)17-7-4-5-8-20(17)31-21-10-9-16(13-18(21)23(24,25)26)19-14-30-22(28-19)27-11-6-12-29-3/h4-5,7-10,13-15H,6,11-12H2,1-3H3,(H,27,28)",MDVVBJFUHZPIGB-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,4.98,immune system disease,Inhibition,
76,168318284,,,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(C(=O)Nc3ccc(CCO)cc3)c(F)c2)c1=O,,"InChI=1S/C30H22F4N6O3/c1-39-27-22(15-35-39)26-24(25(37-27)17-3-2-4-18(13-17)30(32,33)34)29(43)40(38-26)20-9-10-21(23(31)14-20)28(42)36-19-7-5-16(6-8-19)11-12-41/h2-10,13-15,38,41H,11-12H2,1H3,(H,36,42)",ZOZXUGMEIQJOIS-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.19,cancer,Inhibition,
77,46224084,1097384,24679707,CN1C(=O)N(C(=O)[C@]11CN(C[C@H]1c1ccc(cc1)C#N)c1ccccn1)c1cc(Cl)cc(Cl)c1,"4-[3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-7-pyridin-2-yl-1,3,7-triazaspiro[4.4]nonan-9-yl]benzonitrile","InChI=1S/C25H19Cl2N5O2/c1-30-24(34)32(20-11-18(26)10-19(27)12-20)23(33)25(30)15-31(22-4-2-3-9-29-22)14-21(25)17-7-5-16(13-28)6-8-17/h2-12,21H,14-15H2,1H3/t21-,25+/m0/s1",OERBTZBYLXYWQC-SQJMNOBHSA-N,1,0,0,0,LFA / ICAM,7.96,immune system disease,Inhibition,
78,71720436,2322022,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1nc(nc2CN(CCc12)C1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1)C(F)(F)F,,"InChI=1S/C45H48ClF6N7O4S3/c1-57(2)22-18-33(29-64-35-9-4-3-5-10-35)53-39-17-16-36(26-41(39)65(60,61)45(50,51)52)66(62,63)56-42-38-21-25-59(28-40(38)54-43(55-42)44(47,48)49)34-19-23-58(24-20-34)27-31-8-6-7-11-37(31)30-12-14-32(46)15-13-30/h3-17,26,33-34,53H,18-25,27-29H2,1-2H3,(H,54,55,56)/t33-/m1/s1",GEYWUOQZYZEPCE-MGBGTMOVSA-N,1,0,0,0,BCL2-Like / BAX,7.38,cancer,Inhibition,
79,11856773,,10031244,CCOc1cc(Cl)c(cc1C1=N[C@H]([C@H](N1C(=O)N1CCN(CC(=O)N2CCOCC2)CC1)c1ccc(Cl)cc1)c1ccc(Cl)cc1)S(N)(=O)=O,"5-[(4S,5R)-4,5-bis(4-chlorophenyl)-1-[4-(2-morpholin-4-yl-2-oxoethyl)piperazine-1-carbonyl]-4,5-dihydroimidazol-2-yl]-2-chloro-4-ethoxybenzenesulfonamide","InChI=1S/C34H37Cl3N6O6S/c1-2-49-28-20-27(37)29(50(38,46)47)19-26(28)33-39-31(22-3-7-24(35)8-4-22)32(23-5-9-25(36)10-6-23)43(33)34(45)42-13-11-40(12-14-42)21-30(44)41-15-17-48-18-16-41/h3-10,19-20,31-32H,2,11-18,21H2,1H3,(H2,38,46,47)/t31-,32+/m0/s1",GSNCDUDXCDSSAU-AJQTZOPKSA-N,1,0,0,0,MDM2-Like / P53,8.05,cancer,Inhibition,
80,21060012,209201,19859828,C[C@@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)N(CCN2CCOCC2)c2ccc(I)cc2C1=O)c1ccc(Cl)cc1,"(3R)-3-(4-chlorophenyl)-4-[(1R)-1-(4-chlorophenyl)ethyl]-7-iodo-1-(2-morpholin-4-ylethyl)-3H-1,4-benzodiazepine-2,5-dione","InChI=1S/C29H28Cl2IN3O3/c1-19(20-2-6-22(30)7-3-20)35-27(21-4-8-23(31)9-5-21)29(37)34(13-12-33-14-16-38-17-15-33)26-11-10-24(32)18-25(26)28(35)36/h2-11,18-19,27H,12-17H2,1H3/t19-,27+/m1/s1",ATPRYWVAPFXDLB-WINIVTDRSA-N,1,0,0,0,MDM2-Like / P53,5.57,cancer,Inhibition,
81,168318283,,,FC(F)(F)c1ccc(O[C@]2(CCCN(C2)C(=O)c2cnccc2C(F)(F)F)C(=O)N2CCN(CC2)c2ccccc2NC(=O)C[C@@H]2NC(=O)NC2=O)cc1,"2-(2,5-dioxoimidazolidin-4-yl)-N-[2-[4-[3-[4-(trifluoromethyl)phenoxy]-1-[4-(trifluoromethyl)pyridine-3-carbonyl]piperidine-3-carbonyl]piperazin-1-yl]phenyl]acetamide","InChI=1S/C35H33F6N7O6/c36-34(37,38)21-6-8-22(9-7-21)54-33(11-3-13-48(20-33)30(51)23-19-42-12-10-24(23)35(39,40)41)31(52)47-16-14-46(15-17-47)27-5-2-1-4-25(27)43-28(49)18-26-29(50)45-32(53)44-26/h1-2,4-10,12,19,26H,3,11,13-18,20H2,(H,43,49)(H2,44,45,50,53)/t26-,33-/m0/s1",IVMFHRPDIPCCAI-UBOZLPQGSA-N,1,0,0,0,MDM2-Like / P53,6.57,cancer,Inhibition,
82,168318282,,,CC[C@H](N)C(=O)N[C@@H]1CCC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,9aS)-6-[[(2S)-2-aminobutanoyl]amino]-N-benzhydryl-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C27H34N4O3/c1-2-21(28)25(32)29-22-15-9-14-20-16-17-23(31(20)27(22)34)26(33)30-24(18-10-5-3-6-11-18)19-12-7-4-8-13-19/h3-8,10-13,20-24H,2,9,14-17,28H2,1H3,(H,29,32)(H,30,33)/t20-,21-,22+,23-/m0/s1",XWYMWLGPGRAJLM-GPJHCHHRSA-N,1,0,0,0,XIAP / Smac,4.77,cancer,Inhibition,
83,44580638,501976,24710158,C[C@H]1CC[C@H](CC1)Oc1cccc(c1)Sc1ccc(\C=C\C(=O)N2CCOCC2)c(C(F)(F)F)c1C(F)(F)F,"(E)-3-[4-[3-(4-methylcyclohexyl)oxyphenyl]sulfanyl-2,3-bis(trifluoromethyl)phenyl]-1-morpholin-4-ylprop-2-en-1-one","InChI=1S/C28H29F6NO3S/c1-18-5-9-20(10-6-18)38-21-3-2-4-22(17-21)39-23-11-7-19(8-12-24(36)35-13-15-37-16-14-35)25(27(29,30)31)26(23)28(32,33)34/h2-4,7-8,11-12,17-18,20H,5-6,9-10,13-16H2,1H3/b12-8+/t18-,20+",YCBXYRIEXMXDKQ-RVZNYTPASA-N,1,0,0,0,LFA / ICAM,6.07,immune system disease,Inhibition,
84,44550016,,,CN1c2ncnn2[C@H](C2=C1c1cc(C)c(F)cc1O[C@@H]2c1ccc(Br)cc1)c1ccc(Br)cc1,,"InChI=1S/C26H19Br2FN4O/c1-14-11-19-21(12-20(14)29)34-25(16-5-9-18(28)10-6-16)22-23(15-3-7-17(27)8-4-15)33-26(30-13-31-33)32(2)24(19)22/h3-13,23,25H,1-2H3/t23-,25+/m0/s1",SPIVDVDFJKYYRU-UKILVPOCSA-N,1,0,0,0,MDM2-Like / P53,6.32,cancer,Inhibition,
85,44580772,500111,24708186,FC(F)(F)c1c(Sc2ccccc2OCc2ccccc2)ccc(\C=C\C(=O)N2CCOCC2)c1C(F)(F)F,"(E)-1-morpholin-4-yl-3-[4-(2-phenylmethoxyphenyl)sulfanyl-2,3-bis(trifluoromethyl)phenyl]prop-2-en-1-one","InChI=1S/C28H23F6NO3S/c29-27(30,31)25-20(11-13-24(36)35-14-16-37-17-15-35)10-12-23(26(25)28(32,33)34)39-22-9-5-4-8-21(22)38-18-19-6-2-1-3-7-19/h1-13H,14-18H2/b13-11+",WVKIRPXFXBGIEJ-ACCUITESSA-N,1,0,0,0,LFA / ICAM,7.62,immune system disease,Inhibition,
86,168318280,,,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(cc2)C(=O)NCc2ccc(O)c(O)c2)c1=O,,"InChI=1S/C29H21F3N6O4/c1-37-26-20(14-34-37)25-23(24(35-26)17-3-2-4-18(12-17)29(30,31)32)28(42)38(36-25)19-8-6-16(7-9-19)27(41)33-13-15-5-10-21(39)22(40)11-15/h2-12,14,36,39-40H,13H2,1H3,(H,33,41)",DBDSHOVUOCVWNP-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.44,cancer,Inhibition,
87,506223,524010,442054,Fc1ccc2c(c[nH]c2c1)C(=O)C(=O)N1CCN(CC1)C(=O)c1ccccc1,"1-(4-benzoylpiperazin-1-yl)-2-(6-fluoro-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C21H18FN3O3/c22-15-6-7-16-17(13-23-18(16)12-15)19(26)21(28)25-10-8-24(9-11-25)20(27)14-4-2-1-3-5-14/h1-7,12-13,23H,8-11H2",DPGSZXRFIARKKL-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,7.68,HIV infectious disease,Inhibition,
88,11952783,377614,23271924,C[C@@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)N(CCCCC(O)=O)c2ccc(I)cc2C1=O)c1ccc(Cl)cc1N,"5-[4-[1-(2-amino-4-chlorophenyl)ethyl]-3-(4-chlorophenyl)-7-iodo-2,5-dioxo-3H-1,4-benzodiazepin-1-yl]pentanoic acid","InChI=1S/C28H26Cl2IN3O4/c1-16(21-11-9-19(30)14-23(21)32)34-26(17-5-7-18(29)8-6-17)28(38)33(13-3-2-4-25(35)36)24-12-10-20(31)15-22(24)27(34)37/h5-12,14-16,26H,2-4,13,32H2,1H3,(H,35,36)/t16-,26+/m1/s1",SAGXSWWCECPDLO-DXPJPUQTSA-N,2,0,0,0,MDM2-Like / P53,6.60,cancer,Inhibition,
89,45138851,,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CC[C@H]2NC[C@@H]([C@@H]12)c1cn(Cc2ccccc2)c2cc(F)ccc12,"(2S)-N-[(1S)-2-[(3aR,6S,6aR)-6-(1-benzyl-6-fluoroindol-3-yl)-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,2-b]pyrrol-1-yl]-1-cyclohexyl-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C33H42FN5O2/c1-21(35-2)32(40)37-30(23-11-7-4-8-12-23)33(41)39-16-15-28-31(39)26(18-36-28)27-20-38(19-22-9-5-3-6-10-22)29-17-24(34)13-14-25(27)29/h3,5-6,9-10,13-14,17,20-21,23,26,28,30-31,35-36H,4,7-8,11-12,15-16,18-19H2,1-2H3,(H,37,40)/t21-,26+,28+,30-,31+/m0/s1",YGUSRFZFDFCZNV-LJFYZJGBSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
90,153215728,,17249028,Clc1ccc(cc1)[C@]1(OCCc2ccccn2)N(Cc2ccccc2)C(=O)c2ccccc12,2-benzyl-3-(4-chlorophenyl)-3-(2-pyridin-2-ylethoxy)isoindol-1-one,"InChI=1S/C28H23ClN2O2/c29-23-15-13-22(14-16-23)28(33-19-17-24-10-6-7-18-30-24)26-12-5-4-11-25(26)27(32)31(28)20-21-8-2-1-3-9-21/h1-16,18H,17,19-20H2/t28-/m1/s1",WMRBNNJTKWNKRQ-MUUNZHRXSA-N,2,0,0,0,MDM2-Like / P53,4.58,cancer,Inhibition,
91,23646334,362245,23246897,CC(C)[C@H](NC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(=O)Nc1ccccc1,(2S)-1-[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-3-methylbutanoyl]-N-phenylpyrrolidine-2-carboxamide,"InChI=1S/C19H28N4O3/c1-12(2)16(22-17(24)13(3)20)19(26)23-11-7-10-15(23)18(25)21-14-8-5-4-6-9-14/h4-6,8-9,12-13,15-16H,7,10-11,20H2,1-3H3,(H,21,25)(H,22,24)/t13-,15-,16-/m0/s1",JJITZNJGYINLAK-BPUTZDHNSA-N,1,0,0,0,XIAP / Smac,5.31,cancer,Inhibition,
92,59542064,4597515,,CN[C@H](Cc1ccccc1)C(=O)N[C@H]1[C@@H](CN)CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7R,9aS)-7-(aminomethyl)-N-benzhydryl-6-[[(2R)-2-(methylamino)-3-phenylpropanoyl]amino]-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C34H41N5O3/c1-36-28(21-23-11-5-2-6-12-23)32(40)38-31-26(22-35)17-18-27-19-20-29(39(27)34(31)42)33(41)37-30(24-13-7-3-8-14-24)25-15-9-4-10-16-25/h2-16,26-31,36H,17-22,35H2,1H3,(H,37,41)(H,38,40)/t26-,27+,28-,29+,31+/m1/s1",MRXDHUQLRGVINQ-IQLUAKAASA-N,1,0,0,0,XIAP / Smac,6.29,cancer,Inhibition,
93,24775525,,,CCOc1ccsc1C1=N[C@H]([C@H](N1C(=O)N1CCN(CC(=O)NC(C)(C)C)CC1)c1ccc(Cl)cc1)c1ccc(Cl)cc1,"2-[4-[(4S,5R)-4,5-bis(4-chlorophenyl)-2-(3-ethoxythiophen-2-yl)-4,5-dihydroimidazole-1-carbonyl]piperazin-1-yl]-N-tert-butylacetamide","InChI=1S/C32H37Cl2N5O3S/c1-5-42-25-14-19-43-29(25)30-35-27(21-6-10-23(33)11-7-21)28(22-8-12-24(34)13-9-22)39(30)31(41)38-17-15-37(16-18-38)20-26(40)36-32(2,3)4/h6-14,19,27-28H,5,15-18,20H2,1-4H3,(H,36,40)/t27-,28+/m0/s1",VWMPHUCGQIYXNE-WUFINQPMSA-N,1,0,0,0,MDM2-Like / P53,6.96,cancer,Inhibition,
94,168318279,,,NC(=O)[C@@H](Cc1c[nH]c2ccccc12)Nc1ccc(Nc2ccnc3ccccc23)cc1,3-(1H-indol-3-yl)-2-[4-(quinolin-4-ylamino)anilino]propanamide,"InChI=1S/C26H23N5O/c27-26(32)25(15-17-16-29-22-7-3-1-5-20(17)22)31-19-11-9-18(10-12-19)30-24-13-14-28-23-8-4-2-6-21(23)24/h1-14,16,25,29,31H,15H2,(H2,27,32)(H,28,30)/t25-/m1/s1",SEBZFJAEUWVCAO-RUZDIDTESA-N,1,1,0,0,MDM2-Like / P53,7.00,cancer,Inhibition,
95,44579162,515964,24716837,FC(F)(F)c1c(Sc2cccc(NC3CCCC3)c2)ccc(\C=C\C(=O)N2CCOCC2)c1C(F)(F)F,"(E)-3-[4-[3-(cyclopentylamino)phenyl]sulfanyl-2,3-bis(trifluoromethyl)phenyl]-1-morpholin-4-ylprop-2-en-1-one","InChI=1S/C26H26F6N2O2S/c27-25(28,29)23-17(9-11-22(35)34-12-14-36-15-13-34)8-10-21(24(23)26(30,31)32)37-20-7-3-6-19(16-20)33-18-4-1-2-5-18/h3,6-11,16,18,33H,1-2,4-5,12-15H2/b11-9+",LQONBFLCEHNJJY-PKNBQFBNSA-N,1,0,0,0,LFA / ICAM,7.35,immune system disease,Inhibition,
96,168318278,,,Cc1cccc2c(CCN3CCOc4cc(Nc5ccnc6[C@@H](O)CCc56)ccc34)c[nH]c12,"4-[[4-[2-(7-methyl-1H-indol-3-yl)ethyl]-2,3-dihydro-1,4-benzoxazin-7-yl]amino]-6,7-dihydro-5H-cyclopenta[b]pyridin-7-ol","InChI=1S/C27H28N4O2/c1-17-3-2-4-20-18(16-29-26(17)20)10-12-31-13-14-33-25-15-19(5-7-23(25)31)30-22-9-11-28-27-21(22)6-8-24(27)32/h2-5,7,9,11,15-16,24,29,32H,6,8,10,12-14H2,1H3,(H,28,30)/t24-/m0/s1",LHUUKEVVWTXXRE-DEOSSOPVSA-N,1,1,0,0,MDM2-Like / P53,5.54,cancer,Inhibition,
97,44237071,,,CCNC[C@H]1CC[C@H]2CC[C@H](N2C(=O)[C@H]1NC(=O)[C@H](CC)NC)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7R,9aS)-N-benzhydryl-7-(ethylaminomethyl)-6-[[(2S)-2-(methylamino)butanoyl]amino]-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C31H43N5O3/c1-4-25(32-3)29(37)35-28-23(20-33-5-2)16-17-24-18-19-26(36(24)31(28)39)30(38)34-27(21-12-8-6-9-13-21)22-14-10-7-11-15-22/h6-15,23-28,32-33H,4-5,16-20H2,1-3H3,(H,34,38)(H,35,37)/t23-,24+,25+,26+,28+/m1/s1",FKBBWFBAIPDVSK-VETGFMSWSA-N,1,1,0,0,XIAP / Smac,7.07,cancer,Inhibition,
98,46836648,3287300,,OC(=O)c1nc(sc1CCOc1ccccc1)N1CCc2cccc(C(=O)Nc3nc4ccccc4s3)c2C1,"2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-5-(2-phenoxyethyl)-1,3-thiazole-4-carboxylic acid","InChI=1S/C29H24N4O4S2/c34-26(32-28-30-22-11-4-5-12-23(22)38-28)20-10-6-7-18-13-15-33(17-21(18)20)29-31-25(27(35)36)24(39-29)14-16-37-19-8-2-1-3-9-19/h1-12H,13-17H2,(H,35,36)(H,30,32,34)",BRLWTVUGQTUPNI-UHFFFAOYSA-N,1,0,0,0,BCL2-Like / BAX,6.46,cancer,Inhibition,
99,168318277,,,OC[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)Nc1ccc(Nc2ccncc2)cc1,1-[2-(hydroxymethyl)pyrrolidin-1-yl]-3-(1H-indol-3-yl)-2-[4-(pyridin-4-ylamino)anilino]propan-1-one,"InChI=1S/C27H29N5O2/c33-18-23-4-3-15-32(23)27(34)26(16-19-17-29-25-6-2-1-5-24(19)25)31-21-9-7-20(8-10-21)30-22-11-13-28-14-12-22/h1-2,5-14,17,23,26,29,31,33H,3-4,15-16,18H2,(H,28,30)/t23-,26-/m0/s1",KLMSFYVWNGHTBP-OZXSUGGESA-N,1,0,0,0,MDM2-Like / P53,5.52,cancer,Inhibition,
100,168318268,,24634821,CNC(=O)c1ccc(O[C@H](C)C(=O)N2CCN(C[C@H]2C)C(=O)c2ccccc2)cc1C,"4-[1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-1-oxopropan-2-yl]oxy-N,2-dimethylbenzamide","InChI=1S/C24H29N3O4/c1-16-14-20(10-11-21(16)22(28)25-4)31-18(3)23(29)27-13-12-26(15-17(27)2)24(30)19-8-6-5-7-9-19/h5-11,14,17-18H,12-13,15H2,1-4H3,(H,25,28)/t17-,18-/m1/s1",OZGKVRXNNDLXIA-QZTJIDSGSA-N,0,1,0,0,CD4 / gp120,6.00,HIV infectious disease,Inhibition,
101,44579347,,24686812,CN1[C@H]2CC[C@@H]1C[C@H](C2)Nc1cccc(c1)Sc1ccc(\C=C\C(=O)N2CCOCC2)c(C(F)(F)F)c1C(F)(F)F,"(E)-3-[4-[3-[(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)amino]phenyl]sulfanyl-2,3-bis(trifluoromethyl)phenyl]-1-morpholin-4-ylprop-2-en-1-one","InChI=1S/C29H31F6N3O2S/c1-37-21-7-8-22(37)16-20(15-21)36-19-3-2-4-23(17-19)41-24-9-5-18(6-10-25(39)38-11-13-40-14-12-38)26(28(30,31)32)27(24)29(33,34)35/h2-6,9-10,17,20-22,36H,7-8,11-16H2,1H3/b10-6+/t20-,21-,22+",FEEFNAKFIFJCIA-BFQUWBQXSA-N,1,0,0,0,LFA / ICAM,9.03,immune system disease,Inhibition,
102,11151918,360545,9327026,CC(C)[C@H](NC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(=O)NCC1CC1,(2S)-1-[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-3-methylbutanoyl]-N-(cyclopropylmethyl)pyrrolidine-2-carboxamide,"InChI=1S/C17H30N4O3/c1-10(2)14(20-15(22)11(3)18)17(24)21-8-4-5-13(21)16(23)19-9-12-6-7-12/h10-14H,4-9,18H2,1-3H3,(H,19,23)(H,20,22)/t11-,13-,14-/m0/s1",AVVAGMSMAIELCX-UBHSHLNASA-N,1,0,0,0,XIAP / Smac,5.36,cancer,Inhibition,
103,59555616,,,COc1ccc2c(CCNc3ccc(Nc4ccncc4)cc3)c[nH]c2c1,"1-N-[2-(6-methoxy-1H-indol-3-yl)ethyl]-4-N-pyridin-4-ylbenzene-1,4-diamine","InChI=1S/C22H22N4O/c1-27-20-6-7-21-16(15-25-22(21)14-20)8-13-24-17-2-4-18(5-3-17)26-19-9-11-23-12-10-19/h2-7,9-12,14-15,24-25H,8,13H2,1H3,(H,23,26)",NBSJNXSEVPNASI-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,6.90,cancer,Inhibition,
104,58006975,,,CC(C)C1=C(SC2=N[C@](C)([C@H](N12)c1ccc(Cl)cc1)c1ccc(Cl)cc1)C(=O)N1CCC[C@H]1C(=O)N1CC[C@H](C1)N(C)C,"[(2S)-1-[(5R,6S)-5,6-bis(4-chlorophenyl)-6-methyl-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazole-2-carbonyl]pyrrolidin-2-yl]-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]methanone","InChI=1S/C33H39Cl2N5O2S/c1-20(2)27-28(31(42)39-17-6-7-26(39)30(41)38-18-16-25(19-38)37(4)5)43-32-36-33(3,22-10-14-24(35)15-11-22)29(40(27)32)21-8-12-23(34)13-9-21/h8-15,20,25-26,29H,6-7,16-19H2,1-5H3/t25-,26+,29-,33+/m1/s1",SBANPWTXZIIDBN-HOFLKKASSA-N,1,0,0,0,MDM2-Like / P53,7.74,cancer,Inhibition,
105,45487395,565434,24629667,CNC(=O)c1nccc2c(O[C@@H](C)C(=O)N3CCN(C[C@H]3C)C(=O)c3ccccc3)ccc(F)c12,5-[(2S)-1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-1-oxopropan-2-yl]oxy-8-fluoro-N-methylisoquinoline-1-carboxamide,"InChI=1S/C26H27FN4O4/c1-16-15-30(26(34)18-7-5-4-6-8-18)13-14-31(16)25(33)17(2)35-21-10-9-20(27)22-19(21)11-12-29-23(22)24(32)28-3/h4-12,16-17H,13-15H2,1-3H3,(H,28,32)/t16-,17+/m1/s1",ZNARIMRWAILYDS-SJORKVTESA-N,0,1,0,0,CD4 / gp120,7.51,HIV infectious disease,Inhibition,
106,46836927,,,CN(C)CC#Cc1ccc(OCCCc2ccc(nc2C(O)=O)N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)c(F)c1,"6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-[3-[4-[3-(dimethylamino)prop-1-ynyl]-2-fluorophenoxy]propyl]pyridine-2-carboxylic acid","InChI=1S/C37H34FN5O4S/c1-42(2)19-6-8-24-14-16-31(29(38)22-24)47-21-7-10-26-15-17-33(40-34(26)36(45)46)43-20-18-25-9-5-11-27(28(25)23-43)35(44)41-37-39-30-12-3-4-13-32(30)48-37/h3-5,9,11-17,22H,7,10,18-21,23H2,1-2H3,(H,45,46)(H,39,41,44)",CRQSCPOYMXTLQY-UHFFFAOYSA-N,1,0,0,0,BCL2-Like / BAX,6.57,cancer,Inhibition,
107,16109151,222069,17266564,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCC(CC1)=Cc1ccc(cc1)C(F)(F)F,N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonyl-4-[4-[[4-(trifluoromethyl)phenyl]methylidene]piperidin-1-yl]benzamide,"InChI=1S/C38H40F3N5O5S2/c1-44(2)21-20-31(26-52-33-6-4-3-5-7-33)42-35-17-16-34(25-36(35)46(48)49)53(50,51)43-37(47)29-10-14-32(15-11-29)45-22-18-28(19-23-45)24-27-8-12-30(13-9-27)38(39,40)41/h3-17,24-25,31,42H,18-23,26H2,1-2H3,(H,43,47)/t31-/m1/s1",FIFOMEJSIJQOII-WJOKGBTCSA-N,2,0,0,0,BCL2-Like / BAX,8.85,cancer,Inhibition,
108,12096650,,,Clc1cc(Cl)cc(c1)N1C(=O)[C@H]2C[C@H](CN2C1=O)OCc1ccc(Br)cc1,"(6S)-6-[(4-bromophenyl)methoxy]-2-(3,5-dichlorophenyl)-5,6,7,7a-tetrahydropyrrolo[1,2-c]imidazole-1,3-dione","InChI=1S/C19H15BrCl2N2O3/c20-12-3-1-11(2-4-12)10-27-16-8-17-18(25)24(19(26)23(17)9-16)15-6-13(21)5-14(22)7-15/h1-7,16-17H,8-10H2/t16-,17-/m1/s1",XYJWVMMIIYDEBE-IAGOWNOFSA-N,0,1,0,0,LFA / ICAM,6.56,immune system disease,Inhibition,
109,44391942,361628,23248029,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1coc(n1)N1CCN(CC1)C(C)=O,"1-[4-[4-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]-1,3-oxazol-2-yl]piperazin-1-yl]ethanone","InChI=1S/C25H26F3N3O2S/c1-16(2)19-6-4-5-7-22(19)34-23-9-8-18(14-20(23)25(26,27)28)21-15-33-24(29-21)31-12-10-30(11-13-31)17(3)32/h4-9,14-16H,10-13H2,1-3H3",MVRMZEXFMDYXCV-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,5.60,immune system disease,Inhibition,
110,68051292,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCC(CC1)=Cc1ccccc1,,"InChI=1S/C39H45F3N6O4S3/c1-47(2)21-19-30(26-53-32-11-7-4-8-12-32)45-35-18-17-33(24-37(35)54(49,50)39(40,41)42)55(51,52)46-38-34-20-22-48(25-36(34)43-27-44-38)31-15-13-29(14-16-31)23-28-9-5-3-6-10-28/h3-12,17-18,23-24,27,30-31,45H,13-16,19-22,25-26H2,1-2H3,(H,43,44,46)/t30-,31?/m1/s1",KDXMNAXJDGEAMV-PBBFAOSKSA-N,1,0,0,0,BCL2-Like / BAX,5.93,cancer,Inhibition,
111,71719220,2322021,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1nc(Cl)nc2CN(CCc12)C1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1,,"InChI=1S/C44H48Cl2F3N7O4S3/c1-54(2)22-18-33(29-61-35-9-4-3-5-10-35)50-39-17-16-36(26-41(39)62(57,58)44(47,48)49)63(59,60)53-42-38-21-25-56(28-40(38)51-43(46)52-42)34-19-23-55(24-20-34)27-31-8-6-7-11-37(31)30-12-14-32(45)15-13-30/h3-17,26,33-34,50H,18-25,27-29H2,1-2H3,(H,51,52,53)/t33-/m1/s1",YFPNPFXDGIEWEL-MGBGTMOVSA-N,1,0,0,0,BCL2-Like / BAX,7.51,cancer,Inhibition,
112,46221192,1094128,24668742,CN1C(=O)N(C(=O)[C@]11CN(C[C@H]1c1ccc(cc1)C#N)c1nc2cccc(C(O)=O)c2s1)c1cc(Cl)cc(Cl)c1,"2-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl]-1,3-benzothiazole-7-carboxylic acid","InChI=1S/C28H19Cl2N5O4S/c1-33-27(39)35(19-10-17(29)9-18(30)11-19)25(38)28(33)14-34(13-21(28)16-7-5-15(12-31)6-8-16)26-32-22-4-2-3-20(24(36)37)23(22)40-26/h2-11,21H,13-14H2,1H3,(H,36,37)/t21-,28+/m0/s1",VUXOQFRVHLWQSW-RBTNQOKQSA-N,1,0,0,0,LFA / ICAM,8.74,immune system disease,Inhibition,
113,168318329,,,Cn1ncc2c1nc(-c1cccc(Br)c1)c1c2[nH]n(-c2cccc(F)c2)c1=O,,"InChI=1S/C20H13BrFN5O/c1-26-19-15(10-23-26)18-16(17(24-19)11-4-2-5-12(21)8-11)20(28)27(25-18)14-7-3-6-13(22)9-14/h2-10,25H,1H3",YQTWQTNGIZDXFE-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.66,cancer,Inhibition,
114,44549894,,,CN1c2ncnn2[C@H](C2=C1c1ccc(F)cc1O[C@@H]2c1ccc(Br)cc1)c1ccc(Br)cc1,,"InChI=1S/C25H17Br2FN4O/c1-31-23-19-11-10-18(28)12-20(19)33-24(15-4-8-17(27)9-5-15)21(23)22(32-25(31)29-13-30-32)14-2-6-16(26)7-3-14/h2-13,22,24H,1H3/t22-,24+/m0/s1",AIOZGEABJSSJIO-LADGPHEKSA-N,1,0,0,0,MDM2-Like / P53,6.00,cancer,Inhibition,
115,168318343,,26362657,CN(C)CCC[C@](O)(c1ccccc1)c1ccc(OCCc2cccc(c2)-c2ccc(cc2)C(O)=O)cc1,4-[3-[2-[4-[4-(dimethylamino)-1-hydroxy-1-phenylbutyl]phenoxy]ethyl]phenyl]benzoic acid,"InChI=1S/C33H35NO4/c1-34(2)22-7-21-33(37,29-10-4-3-5-11-29)30-16-18-31(19-17-30)38-23-20-25-8-6-9-28(24-25)26-12-14-27(15-13-26)32(35)36/h3-6,8-19,24,37H,7,20-23H2,1-2H3,(H,35,36)/t33-/m0/s1",APSPXYQCUPNVKV-XIFFEERXSA-N,1,0,0,0,BCL2-Like / BAX,5.10,cancer,Inhibition,
116,168318342,,24635300,CC(C)[C@@H]1CN(CCN1C(=O)C(=O)c1c[nH]c2cccc(F)c12)C(=O)c1ccccc1,"1-(4-benzoyl-2-propan-2-ylpiperazin-1-yl)-2-(4-fluoro-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C24H24FN3O3/c1-15(2)20-14-27(23(30)16-7-4-3-5-8-16)11-12-28(20)24(31)22(29)17-13-26-19-10-6-9-18(25)21(17)19/h3-10,13,15,20,26H,11-12,14H2,1-2H3/t20-/m0/s1",UMIRVWYLVYLOHJ-FQEVSTJZSA-N,0,1,0,0,CD4 / gp120,6.33,HIV infectious disease,Inhibition,
117,168318341,,,O[C@H]1CCc2c1nccc2Nc1ccc2N(CCc3c[nH]c4ccccc34)CCOc2c1,"4-[[4-[2-(1H-indol-3-yl)ethyl]-2,3-dihydro-1,4-benzoxazin-7-yl]amino]-6,7-dihydro-5H-cyclopenta[b]pyridin-7-ol","InChI=1S/C26H26N4O2/c31-24-8-6-20-22(9-11-27-26(20)24)29-18-5-7-23-25(15-18)32-14-13-30(23)12-10-17-16-28-21-4-2-1-3-19(17)21/h1-5,7,9,11,15-16,24,28,31H,6,8,10,12-14H2,(H,27,29)/t24-/m0/s1",OICNNGQJJXUBER-DEOSSOPVSA-N,1,1,0,0,MDM2-Like / P53,7.00,cancer,Inhibition,
118,51355193,1689146,26392141,CC1(C)CCC(=C(CN2CCN(CC2)c2ccc3c(NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(c4)S(=O)(=O)C(F)(F)F)ncnc3c2)C1)c1ccc(Cl)cc1,"N-[7-[4-[[2-(4-chlorophenyl)-5,5-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]quinazolin-4-yl]-4-[[(2R)-4-morpholin-4-yl-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)benzenesulfonamide","InChI=1S/C48H55ClF3N7O5S3/c1-47(2)18-16-41(34-8-10-36(49)11-9-34)35(30-47)31-58-20-22-59(23-21-58)38-12-14-42-44(28-38)53-33-54-46(42)56-67(62,63)40-13-15-43(45(29-40)66(60,61)48(50,51)52)55-37(17-19-57-24-26-64-27-25-57)32-65-39-6-4-3-5-7-39/h3-15,28-29,33,37,55H,16-27,30-32H2,1-2H3,(H,53,54,56)/t37-/m1/s1",TVDUKEWRDIIDNF-DIPNUNPCSA-N,1,0,0,0,BCL2-Like / BAX,7.54,cancer,Inhibition,
119,168318340,,,CN(CCO)C(=O)[C@@H](Cc1c[nH]c2ccccc12)Nc1ccc(Nc2ccncc2)cc1,N-(2-hydroxyethyl)-3-(1H-indol-3-yl)-N-methyl-2-[4-(pyridin-4-ylamino)anilino]propanamide,"InChI=1S/C25H27N5O2/c1-30(14-15-31)25(32)24(16-18-17-27-23-5-3-2-4-22(18)23)29-20-8-6-19(7-9-20)28-21-10-12-26-13-11-21/h2-13,17,24,27,29,31H,14-16H2,1H3,(H,26,28)/t24-/m1/s1",DOHYOTCGUYLNSO-XMMPIXPASA-N,1,0,0,0,MDM2-Like / P53,5.52,cancer,Inhibition,
120,25138054,458358,24690581,CN[C@@H](C)C(=O)Nc1ccc(Oc2ccc(OC)cc2)c(c1)C(=O)NCc1csc(n1)-c1cccs1,"2-(4-methoxyphenoxy)-5-[[(2S)-2-(methylamino)propanoyl]amino]-N-[(2-thiophen-2-yl-1,3-thiazol-4-yl)methyl]benzamide","InChI=1S/C26H26N4O4S2/c1-16(27-2)24(31)29-17-6-11-22(34-20-9-7-19(33-3)8-10-20)21(13-17)25(32)28-14-18-15-36-26(30-18)23-5-4-12-35-23/h4-13,15-16,27H,14H2,1-3H3,(H,28,32)(H,29,31)/t16-/m0/s1",JRGQZQQTSQNVKL-INIZCTEOSA-N,1,0,0,0,XIAP / Smac,5.60,cancer,Inhibition,
121,46176079,,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1cc2ncnc(-c3ccccc3)c2[nH]1,"(2S)-N-[(1S)-1-cyclohexyl-2-oxo-2-[(2S)-2-(4-phenyl-5H-pyrrolo[3,2-d]pyrimidin-6-yl)pyrrolidin-1-yl]ethyl]-2-(methylamino)propanamide","InChI=1S/C28H36N6O2/c1-18(29-2)27(35)33-25(20-12-7-4-8-13-20)28(36)34-15-9-14-23(34)21-16-22-26(32-21)24(31-17-30-22)19-10-5-3-6-11-19/h3,5-6,10-11,16-18,20,23,25,29,32H,4,7-9,12-15H2,1-2H3,(H,33,35)/t18-,23-,25-/m0/s1",VRTPGJLBYIPJJQ-WYRQLCSISA-N,2,0,0,0,XIAP / Smac,7.10,cancer,Inhibition,
122,5755150,576541,17734902,CCOC(=O)[C@H](Cc1ccc(\N=C\c2cc(Br)ccc2O)cc1)N1C(=O)c2ccccc2C1=O,"ethyl 3-[4-[[(Z)-(3-bromo-6-oxocyclohexa-2,4-dien-1-ylidene)methyl]amino]phenyl]-2-(1,3-dioxoisoindol-2-yl)propanoate","InChI=1S/C26H21BrN2O5/c1-2-34-26(33)22(29-24(31)20-5-3-4-6-21(20)25(29)32)13-16-7-10-19(11-8-16)28-15-17-14-18(27)9-12-23(17)30/h3-12,14-15,22,30H,2,13H2,1H3/b28-15+/t22-/m0/s1",JRXHFARYLAYVTG-SQEMJAKJSA-N,0,1,0,0,CD4 / gp120,4.66,HIV infectious disease,Inhibition,
123,143180954,,,C[C@H](N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H]1CCCc2ccccc12)C(C)(C)C,"(2R)-1-[(2R)-2-[[(2S)-2-aminopropanoyl]amino]-3,3-dimethylbutanoyl]-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]pyrrolidine-2-carboxamide","InChI=1S/C24H36N4O3/c1-15(25)21(29)27-20(24(2,3)4)23(31)28-14-8-13-19(28)22(30)26-18-12-7-10-16-9-5-6-11-17(16)18/h5-6,9,11,15,18-20H,7-8,10,12-14,25H2,1-4H3,(H,26,30)(H,27,29)/t15-,18+,19-,20+/m0/s1",SLOODFCFHRMFEF-JOCLIGHLSA-N,1,1,0,0,XIAP / Smac,6.15,cancer,Inhibition,
124,168318335,,,C[C@H](N1CCC(CC1)N1CCc2c(C1)ncnc2NS(=O)(=O)c1ccc(N[C@H](CCN2CCN(C)CC2)CSc2ccccc2)c(c1)S(=O)(=O)C(F)(F)F)c1cc(F)ccc1-c1ccc(Cl)cc1,,"InChI=1S/C48H55ClF4N8O4S3/c1-33(43-28-36(50)12-14-41(43)34-8-10-35(49)11-9-34)60-21-17-38(18-22-60)61-23-19-42-45(30-61)54-32-55-47(42)57-68(64,65)40-13-15-44(46(29-40)67(62,63)48(51,52)53)56-37(31-66-39-6-4-3-5-7-39)16-20-59-26-24-58(2)25-27-59/h3-15,28-29,32-33,37-38,56H,16-27,30-31H2,1-2H3,(H,54,55,57)/t33-,37+/m0/s1",QMGQISZMOZNURR-DYKQPOOOSA-N,1,0,0,0,BCL2-Like / BAX,7.10,cancer,Inhibition,
125,168318337,,24641388,C[C@@H](Oc1cccc2c1cc[nH]c2=O)C(=O)N1CCN(C[C@H]1C)C(=O)c1ccccc1,5-[1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-1-oxopropan-2-yl]oxy-2H-isoquinolin-1-one,"InChI=1S/C24H25N3O4/c1-16-15-26(24(30)18-7-4-3-5-8-18)13-14-27(16)23(29)17(2)31-21-10-6-9-20-19(21)11-12-25-22(20)28/h3-12,16-17H,13-15H2,1-2H3,(H,25,28)/t16-,17-/m1/s1",YGOXZGSCGTYEBU-IAGOWNOFSA-N,0,1,0,0,CD4 / gp120,7.17,HIV infectious disease,Inhibition,
126,5760102,574376,4686639,CCOC(=O)C(=C/c1ccc(o1)-c1cccc(c1)N(=O)=O)\C(=O)c1ccccc1,ethyl 2-benzoyl-3-[5-(3-nitrophenyl)furan-2-yl]prop-2-enoate,"InChI=1S/C22H17NO6/c1-2-28-22(25)19(21(24)15-7-4-3-5-8-15)14-18-11-12-20(29-18)16-9-6-10-17(13-16)23(26)27/h3-14H,2H2,1H3/b19-14-",STHDWXNFQXMXMZ-RGEXLXHISA-N,0,1,0,0,CD4 / gp120,5.05,HIV infectious disease,Inhibition,
127,67032065,,,Nc1nnc(o1)-c1nc(C2CCCCC2)n(c1-c1ccc(F)c(Cl)c1)-c1c(CC(=O)Nc2cccc(F)c2)ccc(Cl)c1F,,"InChI=1S/C31H25Cl2F3N6O2/c32-21-11-9-18(14-24(43)38-20-8-4-7-19(34)15-20)27(25(21)36)42-28(17-10-12-23(35)22(33)13-17)26(30-40-41-31(37)44-30)39-29(42)16-5-2-1-3-6-16/h4,7-13,15-16H,1-3,5-6,14H2,(H2,37,41)(H,38,43)",RWYWCCRFKVBJBT-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,8.05,cancer,Inhibition,
128,69945341,,,Cc1ccc(cc1C)-c1nc(C(N)=O)c(-c2cccc(Cl)c2)n1-c1cc(Cl)ccc1C,,"InChI=1S/C25H21Cl2N3O/c1-14-7-9-18(11-16(14)3)25-29-22(24(28)31)23(17-5-4-6-19(26)12-17)30(25)21-13-20(27)10-8-15(21)2/h4-13H,1-3H3,(H2,28,31)",HQDXXKMWEXNZQE-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,6.02,cancer,Inhibition,
129,51354615,1689141,26393543,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1ncnc2cc(ccc12)N1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1,N-[7-[4-[[2-(4-chlorophenyl)phenyl]methyl]piperazin-1-yl]quinazolin-4-yl]-4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)benzenesulfonamide,"InChI=1S/C44H45ClF3N7O4S3/c1-53(2)21-20-34(29-60-36-9-4-3-5-10-36)51-40-19-17-37(27-42(40)61(56,57)44(46,47)48)62(58,59)52-43-39-18-16-35(26-41(39)49-30-50-43)55-24-22-54(23-25-55)28-32-8-6-7-11-38(32)31-12-14-33(45)15-13-31/h3-19,26-27,30,34,51H,20-25,28-29H2,1-2H3,(H,49,50,52)/t34-/m1/s1",HXYGJHGNMRUJCS-UUWRZZSWSA-N,1,0,0,0,BCL2-Like / BAX,8.22,cancer,Inhibition,
130,168318334,,23248018,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1cc(ncn1)N1CCC[C@H]1CO,[1-[6-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyrimidin-4-yl]pyrrolidin-2-yl]methanol,"InChI=1S/C25H26F3N3OS/c1-16(2)19-7-3-4-8-22(19)33-23-10-9-17(12-20(23)25(26,27)28)21-13-24(30-15-29-21)31-11-5-6-18(31)14-32/h3-4,7-10,12-13,15-16,18,32H,5-6,11,14H2,1-2H3/t18-/m0/s1",AVYYYDWRPGSZGL-SFHVURJKSA-N,0,1,0,0,LFA / ICAM,6.17,immune system disease,Inhibition,
131,44392011,183870,23248087,CCOC(=O)CN1CCN(CC1)c1cc(ncn1)-c1ccc(Sc2ccccc2C(C)C)c(c1)C(F)(F)F,ethyl 2-[4-[6-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyrimidin-4-yl]piperazin-1-yl]acetate,"InChI=1S/C28H31F3N4O2S/c1-4-37-27(36)17-34-11-13-35(14-12-34)26-16-23(32-18-33-26)20-9-10-25(22(15-20)28(29,30)31)38-24-8-6-5-7-21(24)19(2)3/h5-10,15-16,18-19H,4,11-14,17H2,1-3H3",GKTUFNINEUKFJG-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,6.38,immune system disease,Inhibition,
132,59555785,,,CS(=O)(=O)NCc1cc(Nc2ccc(NCCc3c[nH]c4ccccc34)cc2)ccn1,N-[[4-[4-[2-(1H-indol-3-yl)ethylamino]anilino]pyridin-2-yl]methyl]methanesulfonamide,"InChI=1S/C23H25N5O2S/c1-31(29,30)27-16-21-14-20(11-13-25-21)28-19-8-6-18(7-9-19)24-12-10-17-15-26-23-5-3-2-4-22(17)23/h2-9,11,13-15,24,26-27H,10,12,16H2,1H3,(H,25,28)",HEUXKLBXFGSLNF-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,5.70,cancer,Inhibition,
133,16109117,437146,17266530,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(CC1)C(=O)Nc1ccccc1,4-[4-[[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonylcarbamoyl]phenyl]-N-phenylpiperazine-1-carboxamide,"InChI=1S/C36H41N7O6S2/c1-40(2)20-19-29(26-50-31-11-7-4-8-12-31)37-33-18-17-32(25-34(33)43(46)47)51(48,49)39-35(44)27-13-15-30(16-14-27)41-21-23-42(24-22-41)36(45)38-28-9-5-3-6-10-28/h3-18,25,29,37H,19-24,26H2,1-2H3,(H,38,45)(H,39,44)/t29-/m1/s1",YXKBOKPOXNALDG-GDLZYMKVSA-N,2,0,0,0,BCL2-Like / BAX,8.60,cancer,Inhibition,
134,168318336,,,FC(F)(F)c1ccc(O[C@]2(CCCN(C2)C(=O)c2cnccc2C(F)(F)F)C(=O)N2CCN(CC2)c2ccccn2)cc1,[3-(4-pyridin-2-ylpiperazine-1-carbonyl)-3-[4-(trifluoromethyl)phenoxy]piperidin-1-yl]-[4-(trifluoromethyl)pyridin-3-yl]methanone,"InChI=1S/C29H27F6N5O3/c30-28(31,32)20-5-7-21(8-6-20)43-27(26(42)39-16-14-38(15-17-39)24-4-1-2-11-37-24)10-3-13-40(19-27)25(41)22-18-36-12-9-23(22)29(33,34)35/h1-2,4-9,11-12,18H,3,10,13-17,19H2/t27-/m0/s1",AQPOAKIXGJAWQW-MHZLTWQESA-N,1,0,0,0,MDM2-Like / P53,5.64,cancer,Inhibition,
135,58531435,,,CC(C)CN(Cc1cc(Cl)cc(CN(CC(C)C)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)c1)C(=O)c1ccc(SC(F)(F)F)cc1,"N-[[3-chloro-5-[[(3,5-dichloro-2-hydroxyphenyl)sulfonyl-(2-methylpropyl)amino]methyl]phenyl]methyl]-N-(2-methylpropyl)-4-(trifluoromethylsulfanyl)benzamide","InChI=1S/C30H32Cl3F3N2O4S2/c1-18(2)14-37(29(40)22-5-7-25(8-6-22)43-30(34,35)36)16-20-9-21(11-23(31)10-20)17-38(15-19(3)4)44(41,42)27-13-24(32)12-26(33)28(27)39/h5-13,18-19,39H,14-17H2,1-4H3",QVALIAVGZJQJEF-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,6.33,cancer,Inhibition,
136,91253032,,19174436,CC(C)c1ccccc1Sc1ccc([C@@H]2C[C@H]2C(=O)NCCCC(O)=O)c(Cl)c1Cl,"4-[[2-[2,3-dichloro-4-(2-propan-2-ylphenyl)sulfanylphenyl]cyclopropanecarbonyl]amino]butanoic acid","InChI=1S/C23H25Cl2NO3S/c1-13(2)14-6-3-4-7-18(14)30-19-10-9-15(21(24)22(19)25)16-12-17(16)23(29)26-11-5-8-20(27)28/h3-4,6-7,9-10,13,16-17H,5,8,11-12H2,1-2H3,(H,26,29)(H,27,28)/t16-,17+/m0/s1",OHELAVHWEMILBF-DLBZAZTESA-N,0,1,0,0,LFA / ICAM,8.15,immune system disease,Inhibition,
137,25096947,,,CN1CCN(CCNC(=O)c2[nH]c3cc(Cl)ccc3c2-c2c(ncn2Cc2ccc(Cl)cc2)-c2ccccc2)CC1,6-chloro-3-[3-[(4-chlorophenyl)methyl]-5-phenylimidazol-4-yl]-N-[2-(4-methylpiperazin-1-yl)ethyl]-1H-indole-2-carboxamide,"InChI=1S/C32H32Cl2N6O/c1-38-15-17-39(18-16-38)14-13-35-32(41)30-28(26-12-11-25(34)19-27(26)37-30)31-29(23-5-3-2-4-6-23)36-21-40(31)20-22-7-9-24(33)10-8-22/h2-12,19,21,37H,13-18,20H2,1H3,(H,35,41)",BEXXAAHGTRNYPN-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,6.52,cancer,Inhibition,
138,44237053,572851,24637584,CC[C@H](N)C(=O)N[C@H]1[C@@H](CN(CC)CC)CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7R,9aS)-6-[[(2S)-2-aminobutanoyl]amino]-N-benzhydryl-7-(diethylaminomethyl)-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C32H45N5O3/c1-4-26(33)30(38)35-29-24(21-36(5-2)6-3)17-18-25-19-20-27(37(25)32(29)40)31(39)34-28(22-13-9-7-10-14-22)23-15-11-8-12-16-23/h7-16,24-29H,4-6,17-21,33H2,1-3H3,(H,34,39)(H,35,38)/t24-,25+,26+,27+,29+/m1/s1",UIAACWOVDAQNKS-IYYUCAQOSA-N,1,0,0,0,XIAP / Smac,6.36,cancer,Inhibition,
139,11621362,499029,24709517,OC(=O)[C@H]1CC[C@@H](CC1)Oc1cccc(c1)Sc1ccc(\C=C\C(=O)N2CCOCC2)c(C(F)(F)F)c1C(F)(F)F,"4-[3-[4-[(E)-3-morpholin-4-yl-3-oxoprop-1-enyl]-2,3-bis(trifluoromethyl)phenyl]sulfanylphenoxy]cyclohexane-1-carboxylic acid","InChI=1S/C28H27F6NO5S/c29-27(30,31)24-17(7-11-23(36)35-12-14-39-15-13-35)6-10-22(25(24)28(32,33)34)41-21-3-1-2-20(16-21)40-19-8-4-18(5-9-19)26(37)38/h1-3,6-7,10-11,16,18-19H,4-5,8-9,12-15H2,(H,37,38)/b11-7+/t18-,19-",WBSXKVRTVMHGNY-GKWHILSKSA-N,1,0,0,0,LFA / ICAM,7.74,immune system disease,Inhibition,
140,44595109,,,Oc1c(Cl)cc(Cl)cc1S(=O)(=O)N(Cc1ccc(F)cc1)Cc1ccc(cc1)C(=O)N1CCN(CC1)c1cnccn1,"3,5-dichloro-N-[(4-fluorophenyl)methyl]-2-hydroxy-N-[[4-(4-pyrazin-2-ylpiperazine-1-carbonyl)phenyl]methyl]benzenesulfonamide","InChI=1S/C29H26Cl2FN5O4S/c30-23-15-25(31)28(38)26(16-23)42(40,41)37(19-21-3-7-24(32)8-4-21)18-20-1-5-22(6-2-20)29(39)36-13-11-35(12-14-36)27-17-33-9-10-34-27/h1-10,15-17,38H,11-14,18-19H2",MXHCHTYGBFEAAC-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,6.18,cancer,Inhibition,
141,21906806,426788,10657327,CC(C)N(C)c1cc(ncn1)-c1ccc(Sc2ccccc2C(C)C)c(c1)C(F)(F)F,N-methyl-N-propan-2-yl-6-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyrimidin-4-amine,"InChI=1S/C24H26F3N3S/c1-15(2)18-8-6-7-9-21(18)31-22-11-10-17(12-19(22)24(25,26)27)20-13-23(29-14-28-20)30(5)16(3)4/h6-16H,1-5H3",YYCCOHSORPUJOI-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,6.13,immune system disease,Inhibition,
142,45137133,,,CC(C)(C)C[C@@H]1N[C@H]([C@H](c2cccc(Cl)c2)[C@@]1(C#N)c1ccc(Cl)cc1)C(=O)NCC1(CO)CCC1,"(2R,3R,4R,5S)-3-(3-chlorophenyl)-4-(4-chlorophenyl)-4-cyano-5-(2,2-dimethylpropyl)-N-[[1-(hydroxymethyl)cyclobutyl]methyl]pyrrolidine-2-carboxamide","InChI=1S/C29H35Cl2N3O2/c1-27(2,3)15-23-29(16-32,20-8-10-21(30)11-9-20)24(19-6-4-7-22(31)14-19)25(34-23)26(36)33-17-28(18-35)12-5-13-28/h4,6-11,14,23-25,34-35H,5,12-13,15,17-18H2,1-3H3,(H,33,36)/t23-,24-,25+,29-/m0/s1",CCEUDGYCMAKDED-VYUAFQCHSA-N,1,0,0,0,MDM2-Like / P53,5.62,cancer,Inhibition,
143,51354616,1689142,26393138,FC(F)(F)S(=O)(=O)c1cc(ccc1N[C@H](CCN1CCOCC1)CSc1ccccc1)S(=O)(=O)Nc1ncnc2cc(ccc12)N1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1,N-[7-[4-[[2-(4-chlorophenyl)phenyl]methyl]piperazin-1-yl]quinazolin-4-yl]-4-[[(2R)-4-morpholin-4-yl-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)benzenesulfonamide,"InChI=1S/C46H47ClF3N7O5S3/c47-35-12-10-33(11-13-35)40-9-5-4-6-34(40)30-56-20-22-57(23-21-56)37-14-16-41-43(28-37)51-32-52-45(41)54-65(60,61)39-15-17-42(44(29-39)64(58,59)46(48,49)50)53-36(18-19-55-24-26-62-27-25-55)31-63-38-7-2-1-3-8-38/h1-17,28-29,32,36,53H,18-27,30-31H2,(H,51,52,54)/t36-/m1/s1",JYASJBDXOVFRBN-PSXMRANNSA-N,1,0,0,0,BCL2-Like / BAX,7.80,cancer,Inhibition,
144,168318052,,,CN(C)CC[C@H](CSc1ccccc1F)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2ccccc2-c2ccc(F)cc2)CC1,,"InChI=1S/C44H48F5N7O4S3/c1-54(2)21-17-33(28-61-41-10-6-5-9-38(41)46)52-39-16-15-35(25-42(39)62(57,58)44(47,48)49)63(59,60)53-43-37-20-24-56(27-40(37)50-29-51-43)34-18-22-55(23-19-34)26-31-7-3-4-8-36(31)30-11-13-32(45)14-12-30/h3-16,25,29,33-34,52H,17-24,26-28H2,1-2H3,(H,50,51,53)/t33-/m1/s1",LEMMXJBWFAULSB-MGBGTMOVSA-N,1,0,0,0,BCL2-Like / BAX,7.00,cancer,Inhibition,
145,46836866,,,CN1CCN(CC1)c1ccc(OCCCc2ccc(nc2C(O)=O)N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)cc1,"6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-[3-[4-(4-methylpiperazin-1-yl)phenoxy]propyl]pyridine-2-carboxylic acid","InChI=1S/C37H38N6O4S/c1-41-19-21-42(22-20-41)27-12-14-28(15-13-27)47-23-5-7-26-11-16-33(39-34(26)36(45)46)43-18-17-25-6-4-8-29(30(25)24-43)35(44)40-37-38-31-9-2-3-10-32(31)48-37/h2-4,6,8-16H,5,7,17-24H2,1H3,(H,45,46)(H,38,40,44)",SYKPKGRMZAUPCI-UHFFFAOYSA-N,1,0,0,0,BCL2-Like / BAX,6.24,cancer,Inhibition,
146,168318332,,,OC[C@H](O)CNC(=O)c1cc(Cl)c(O)c(c1)S(=O)(=O)N(Cc1ccc(F)cc1)Cc1cccc(c1)-c1ccc(Cl)cc1,,"InChI=1S/C30H27Cl2FN2O6S/c31-24-8-6-21(7-9-24)22-3-1-2-20(12-22)17-35(16-19-4-10-25(33)11-5-19)42(40,41)28-14-23(13-27(32)29(28)38)30(39)34-15-26(37)18-36/h1-14,26,36-38H,15-18H2,(H,34,39)/t26-/m1/s1",KFLWIFKKERBPQE-AREMUKBSSA-N,2,0,0,0,BCL2-Like / BAX,5.79,cancer,Inhibition,
147,24999802,,,CC(C)(C)C[C@H]1N[C@H]([C@H](c2ccc(F)c(Cl)c2)[C@@]11C(=O)Nc2cc(Cl)c(F)cc12)C(=O)NC[C@H](O)[C@H](O)CO,"(2'R,3S,3'R,5'R)-6-chloro-3'-(3-chloro-4-fluorophenyl)-5'-(2,2-dimethylpropyl)-5-fluoro-2-oxo-N-[(2S,3R)-2,3,4-trihydroxybutyl]spiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide","InChI=1S/C27H31Cl2F2N3O5/c1-26(2,3)9-21-27(13-7-17(31)15(29)8-18(13)33-25(27)39)22(12-4-5-16(30)14(28)6-12)23(34-21)24(38)32-10-19(36)20(37)11-35/h4-8,19-23,34-37H,9-11H2,1-3H3,(H,32,38)(H,33,39)/t19-,20+,21+,22-,23+,27-/m0/s1",FIYLHPMFZUVLCU-HDUIEKHKSA-N,1,3,0,0,MDM2-Like / P53,6.30,cancer,Inhibition,
148,45139137,,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1C[C@@H](O)[C@@H]2[C@H]1[C@H](CN2C(=O)OCc1ccccc1)c1c[nH]c2cc(F)ccc12,"benzyl (3S,3aR,6R,6aS)-4-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-3-(6-fluoro-1H-indol-3-yl)-6-hydroxy-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrole-1-carboxylate","InChI=1S/C34H42FN5O5/c1-20(36-2)32(42)38-29(22-11-7-4-8-12-22)33(43)39-18-28(41)31-30(39)26(25-16-37-27-15-23(35)13-14-24(25)27)17-40(31)34(44)45-19-21-9-5-3-6-10-21/h3,5-6,9-10,13-16,20,22,26,28-31,36-37,41H,4,7-8,11-12,17-19H2,1-2H3,(H,38,42)/t20-,26+,28+,29-,30+,31+/m0/s1",CUILELPBYISBOE-YHOHHSIDSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
149,59555830,,,Cc1cccc2c(Nc3ccc(NCCc4c[nH]c5ccccc45)cc3)ccnc12,"1-N-[2-(1H-indol-3-yl)ethyl]-4-N-(8-methylquinolin-4-yl)benzene-1,4-diamine","InChI=1S/C26H24N4/c1-18-5-4-7-23-25(14-16-28-26(18)23)30-21-11-9-20(10-12-21)27-15-13-19-17-29-24-8-3-2-6-22(19)24/h2-12,14,16-17,27,29H,13,15H2,1H3,(H,28,30)",JGFRZVMGUBXGKO-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,7.70,cancer,Inhibition,
150,46883993,1091485,24669421,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1nc2c(cccc2s1)-c1ccccc1F,"(2S)-N-[(1S)-1-cyclohexyl-2-[(2R)-2-[4-(2-fluorophenyl)-1,3-benzothiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C29H35FN4O2S/c1-18(31-2)27(35)32-25(19-10-4-3-5-11-19)29(36)34-17-9-15-23(34)28-33-26-21(13-8-16-24(26)37-28)20-12-6-7-14-22(20)30/h6-8,12-14,16,18-19,23,25,31H,3-5,9-11,15,17H2,1-2H3,(H,32,35)/t18-,23-,25-/m0/s1",LLIIEEJHMACKQN-WYRQLCSISA-N,1,0,0,0,XIAP / Smac,7.34,cancer,Inhibition,
151,168318333,,,C[C@H](N)C(=O)N[C@@H](C)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2C(C)=O)c1c[nH]c2cc(F)ccc12,,"InChI=1S/C22H28FN5O3/c1-11(24)21(30)26-12(2)22(31)27-7-6-19-20(27)17(10-28(19)13(3)29)16-9-25-18-8-14(23)4-5-15(16)18/h4-5,8-9,11-12,17,19-20,25H,6-7,10,24H2,1-3H3,(H,26,30)/t11-,12-,17+,19+,20+/m0/s1",BPYNPIYCDXZKTR-YPLLMFNKSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
152,22474691,,11407083,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(Cl)c(c2)C(O)=O)c1=O,"2-chloro-5-[6-methyl-3-oxo-4-[3-(trifluoromethyl)phenyl]-1H-dipyrazolo[4,3-b:4',5'-e]pyridin-2-yl]benzoic acid","InChI=1S/C22H13ClF3N5O3/c1-30-19-14(9-27-30)18-16(17(28-19)10-3-2-4-11(7-10)22(24,25)26)20(32)31(29-18)12-5-6-15(23)13(8-12)21(33)34/h2-9,29H,1H3,(H,33,34)",FJPLTDDJOOICKB-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,8.15,cancer,Inhibition,
153,44392067,182447,23248137,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1ccnc(c1)N1CCC(CC1)c1nn[nH]n1,4-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]-2-[4-(2H-tetrazol-5-yl)piperidin-1-yl]pyridine,"InChI=1S/C27H27F3N6S/c1-17(2)21-5-3-4-6-23(21)37-24-8-7-19(15-22(24)27(28,29)30)20-9-12-31-25(16-20)36-13-10-18(11-14-36)26-32-34-35-33-26/h3-9,12,15-18H,10-11,13-14H2,1-2H3,(H,32,33,34,35)",LAGKCZDXFAJYPU-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,7.29,immune system disease,Inhibition,
154,46884435,1091045,24678311,CN[C@@H](C)C(=O)N[C@@H](C1CCOCC1)C(=O)N1CCC[C@H]1c1nc(cs1)-c1cccc2ccccc12,"(2S)-2-(methylamino)-N-[(1S)-2-[(2S)-2-(4-naphthalen-1-yl-1,3-thiazol-2-yl)pyrrolidin-1-yl]-1-(oxan-4-yl)-2-oxoethyl]propanamide","InChI=1S/C28H34N4O3S/c1-18(29-2)26(33)31-25(20-12-15-35-16-13-20)28(34)32-14-6-11-24(32)27-30-23(17-36-27)22-10-5-8-19-7-3-4-9-21(19)22/h3-5,7-10,17-18,20,24-25,29H,6,11-16H2,1-2H3,(H,31,33)/t18-,24-,25-/m0/s1",YXGUDIMUDRFJGV-WDNCENIBSA-N,1,0,0,0,XIAP / Smac,7.46,cancer,Inhibition,
155,46221417,1098437,24671330,CN1C(=O)N(C(=O)[C@]11CN(C[C@H]1c1ccc(cc1)C#N)c1nc2ccc(cc2s1)C(O)=O)c1cc(Cl)cc(Cl)c1,"2-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl]-1,3-benzothiazole-6-carboxylic acid","InChI=1S/C28H19Cl2N5O4S/c1-33-27(39)35(20-10-18(29)9-19(30)11-20)25(38)28(33)14-34(13-21(28)16-4-2-15(12-31)3-5-16)26-32-22-7-6-17(24(36)37)8-23(22)40-26/h2-11,21H,13-14H2,1H3,(H,36,37)/t21-,28+/m0/s1",XEAGJVYARBZHQL-RBTNQOKQSA-N,1,0,0,0,LFA / ICAM,8.36,immune system disease,Inhibition,
156,44570049,513318,24716121,CCCCN(CCCC)C(=O)c1cc(C)n(n1)-c1ccccc1C(=O)N1CCc2ccccc2C1,"N,N-dibutyl-1-[2-(3,4-dihydro-1H-isoquinoline-2-carbonyl)phenyl]-5-methylpyrazole-3-carboxamide","InChI=1S/C29H36N4O2/c1-4-6-17-31(18-7-5-2)29(35)26-20-22(3)33(30-26)27-15-11-10-14-25(27)28(34)32-19-16-23-12-8-9-13-24(23)21-32/h8-15,20H,4-7,16-19,21H2,1-3H3",FMDKBLIVRUNPCH-UHFFFAOYSA-N,1,0,0,0,BCL2-Like / BAX,6.64,cancer,Inhibition,
157,44580242,443467,24685858,OC(=O)[C@H]1CC[C@@H](CC1)COc1cccc(c1)Sc1ccc(\C=C\C(=O)N2CCOCC2)c(C(F)(F)F)c1C(F)(F)F,"4-[[3-[4-[(E)-3-morpholin-4-yl-3-oxoprop-1-enyl]-2,3-bis(trifluoromethyl)phenyl]sulfanylphenoxy]methyl]cyclohexane-1-carboxylic acid","InChI=1S/C29H29F6NO5S/c30-28(31,32)25-19(9-11-24(37)36-12-14-40-15-13-36)8-10-23(26(25)29(33,34)35)42-22-3-1-2-21(16-22)41-17-18-4-6-20(7-5-18)27(38)39/h1-3,8-11,16,18,20H,4-7,12-15,17H2,(H,38,39)/b11-9+/t18-,20-",VHJSCKJBRABOFP-QFBLVHQRSA-N,1,0,0,0,LFA / ICAM,8.47,immune system disease,Inhibition,
158,168318331,,24634762,CCC[C@H]1CN(CCN1C(=O)C(=O)c1c[nH]c2cccc(F)c12)C(=O)c1ccccc1,"1-(4-benzoyl-2-propylpiperazin-1-yl)-2-(4-fluoro-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C24H24FN3O3/c1-2-7-17-15-27(23(30)16-8-4-3-5-9-16)12-13-28(17)24(31)22(29)18-14-26-20-11-6-10-19(25)21(18)20/h3-6,8-11,14,17,26H,2,7,12-13,15H2,1H3/t17-/m0/s1",ATGNIAKOMZKQIA-KRWDZBQOSA-N,0,1,0,0,CD4 / gp120,7.81,HIV infectious disease,Inhibition,
159,168318330,,,Cc1cccc2c(CCN3CC4(CCCCC4)Oc4cc(Nc5ccnc6[C@H](O)CCc56)ccc34)c[nH]c12,"4-[[4-[2-(7-methyl-1H-indol-3-yl)ethyl]spiro[3H-1,4-benzoxazine-2,1'-cyclohexane]-7-yl]amino]-6,7-dihydro-5H-cyclopenta[b]pyridin-7-ol","InChI=1S/C32H36N4O2/c1-21-6-5-7-24-22(19-34-30(21)24)13-17-36-20-32(14-3-2-4-15-32)38-29-18-23(8-10-27(29)36)35-26-12-16-33-31-25(26)9-11-28(31)37/h5-8,10,12,16,18-19,28,34,37H,2-4,9,11,13-15,17,20H2,1H3,(H,33,35)/t28-/m1/s1",YPEZRWNIRUBSIP-MUUNZHRXSA-N,1,1,0,0,MDM2-Like / P53,7.52,cancer,Inhibition,
160,53322789,1644118,26377659,Cc1ccc2n(cc(C(=O)NC[C@H](NC(=O)c3c(Cl)cc4CN(CCc4c3Cl)C(=O)c3ccc(Cl)cc3)C(O)=O)c2c1)S(C)(=O)=O,"(2S)-2-[[5,7-dichloro-2-(4-chlorobenzoyl)-3,4-dihydro-1H-isoquinoline-6-carbonyl]amino]-3-[(5-methyl-1-methylsulfonylindole-3-carbonyl)amino]propanoic acid","InChI=1S/C31H27Cl3N4O7S/c1-16-3-8-25-21(11-16)22(15-38(25)46(2,44)45)28(39)35-13-24(31(42)43)36-29(40)26-23(33)12-18-14-37(10-9-20(18)27(26)34)30(41)17-4-6-19(32)7-5-17/h3-8,11-12,15,24H,9-10,13-14H2,1-2H3,(H,35,39)(H,36,40)(H,42,43)/t24-/m0/s1",GWKUQIDUBUTSSN-DEOSSOPVSA-N,1,0,0,0,LFA / ICAM,7.59,immune system disease,Inhibition,
161,21906764,179875,10657270,COc1ccccc1Sc1ccc(cc1C(F)(F)F)-c1ccnc(c1)N1CCC(CC1)C(O)=O,1-[4-[4-(2-methoxyphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyridin-2-yl]piperidine-4-carboxylic acid,"InChI=1S/C25H23F3N2O3S/c1-33-20-4-2-3-5-22(20)34-21-7-6-17(14-19(21)25(26,27)28)18-8-11-29-23(15-18)30-12-9-16(10-13-30)24(31)32/h2-8,11,14-16H,9-10,12-13H2,1H3,(H,31,32)",CEEYZLMHLBHWRT-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,6.95,immune system disease,Inhibition,
162,44549490,,,CN1c2ncnn2[C@H](C2=C1c1ccccc1O[C@@H]2c1ccc(cc1)C#N)c1ccc(Br)cc1,,"InChI=1S/C26H18BrN5O/c1-31-24-20-4-2-3-5-21(20)33-25(18-8-6-16(14-28)7-9-18)22(24)23(32-26(31)29-15-30-32)17-10-12-19(27)13-11-17/h2-13,15,23,25H,1H3/t23-,25+/m0/s1",YPNWUQXFHFLNLP-UKILVPOCSA-N,1,0,0,0,MDM2-Like / P53,5.68,cancer,Inhibition,
163,25775499,7140,23108032,OC(=O)[C@H](Cc1c[nH]cn1)NC(=O)c1ccccc1Br,2-[(2-bromobenzoyl)amino]-3-(1H-imidazol-5-yl)propanoic acid,"InChI=1S/C13H12BrN3O3/c14-10-4-2-1-3-9(10)12(18)17-11(13(19)20)5-8-6-15-7-16-8/h1-4,6-7,11H,5H2,(H,15,16)(H,17,18)(H,19,20)/t11-/m0/s1",XYLAVJHBJRSVOB-NSHDSACASA-N,1,0,0,0,LFA / ICAM,6.12,immune system disease,Inhibition,
164,45138554,,,CN[C@@H](C)C(=O)N[C@@H]([C@@H](C)OC)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2C(C)=O)c1c[nH]c2ccc(F)cc12,"(2S)-N-[(2S,3R)-1-[(3aR,6S,6aR)-4-acetyl-6-(5-fluoro-1H-indol-3-yl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-3-methoxy-1-oxobutan-2-yl]-2-(methylamino)propanamide","InChI=1S/C25H34FN5O4/c1-13(27-4)24(33)29-22(14(2)35-5)25(34)30-9-8-21-23(30)19(12-31(21)15(3)32)18-11-28-20-7-6-16(26)10-17(18)20/h6-7,10-11,13-14,19,21-23,27-28H,8-9,12H2,1-5H3,(H,29,33)/t13-,14+,19+,21+,22-,23+/m0/s1",DSEMMSTVFNYAGH-ZPTGBFNDSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
165,66616639,,,Oc1c(Cl)cc(Cl)cc1S(=O)(=O)N(Cc1ccc(F)cc1)Cc1ccc(CNS(=O)(=O)c2cc(Cl)cc(Cl)c2)cc1,,"InChI=1S/C27H21Cl4FN2O5S2/c28-20-9-21(29)11-24(10-20)40(36,37)33-14-17-1-3-18(4-2-17)15-34(16-19-5-7-23(32)8-6-19)41(38,39)26-13-22(30)12-25(31)27(26)35/h1-13,33,35H,14-16H2",OTIKOEVECJUKND-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,6.64,cancer,Inhibition,
166,44549764,2347394,,COc1cccc2O[C@@H](C3=C(N(C)c4ncnn4[C@H]3c3ccc(Br)cc3)c12)c1ccc(Br)cc1,,"InChI=1S/C26H20Br2N4O2/c1-31-24-21-19(33-2)4-3-5-20(21)34-25(16-8-12-18(28)13-9-16)22(24)23(32-26(31)29-14-30-32)15-6-10-17(27)11-7-15/h3-14,23,25H,1-2H3/t23-,25+/m0/s1",CBAILBZVEPFBDC-UKILVPOCSA-N,1,0,0,0,MDM2-Like / P53,6.52,cancer,Inhibition,
167,67954213,,,CC1(C)CN(C1)C(=O)Cc1ccc(Cl)c(F)c1-n1c(nc(-c2nnc(N)o2)c1-c1ccc(F)c(Cl)c1)C1CCCCC1,,"InChI=1S/C30H30Cl2F2N6O2/c1-30(2)14-39(15-30)22(41)13-18-8-10-19(31)23(34)25(18)40-26(17-9-11-21(33)20(32)12-17)24(28-37-38-29(35)42-28)36-27(40)16-6-4-3-5-7-16/h8-12,16H,3-7,13-15H2,1-2H3,(H2,35,38)",ILXUOBZBJFBIHC-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,8.22,cancer,Inhibition,
168,46840791,,,OC(=O)c1csc(n1)-c1ccc2CCCN(C(=O)Nc3nc4ccccc4s3)c2c1,"2-[1-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-2H-quinolin-7-yl]-1,3-thiazole-4-carboxylic acid","InChI=1S/C21H16N4O3S2/c26-19(27)15-11-29-18(22-15)13-8-7-12-4-3-9-25(16(12)10-13)21(28)24-20-23-14-5-1-2-6-17(14)30-20/h1-2,5-8,10-11H,3-4,9H2,(H,26,27)(H,23,24,28)",MPBQJXNTYAFDCG-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,6.71,cancer,Inhibition,
169,44237043,573548,24638009,CC[C@H](NC)C(=O)N[C@H]1[C@@H](CN)CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7R,9aS)-7-(aminomethyl)-N-benzhydryl-6-[[(2S)-2-(methylamino)butanoyl]amino]-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C29H39N5O3/c1-3-23(31-2)27(35)33-26-21(18-30)14-15-22-16-17-24(34(22)29(26)37)28(36)32-25(19-10-6-4-7-11-19)20-12-8-5-9-13-20/h4-13,21-26,31H,3,14-18,30H2,1-2H3,(H,32,36)(H,33,35)/t21-,22+,23+,24+,26+/m1/s1",CTTRVUXCBAGJKN-VEGWMBEDSA-N,1,1,0,0,XIAP / Smac,7.00,cancer,Inhibition,
170,44390681,367821,23246704,OC(=O)[C@@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)Nc2ccc(I)cc2C1=O)c1cccc(Cl)c1,"2-(3-chlorophenyl)-2-[3-(4-chlorophenyl)-7-iodo-2,5-dioxo-1,3-dihydro-1,4-benzodiazepin-4-yl]acetic acid","InChI=1S/C23H15Cl2IN2O4/c24-14-6-4-12(5-7-14)19-21(29)27-18-9-8-16(26)11-17(18)22(30)28(19)20(23(31)32)13-2-1-3-15(25)10-13/h1-11,19-20H,(H,27,29)(H,31,32)/t19-,20-/m0/s1",MTACKLDUVMCJLI-PMACEKPBSA-N,1,0,0,0,MDM2-Like / P53,5.57,cancer,Inhibition,
171,51039626,,,CO[C@@]1(Cc2ccccc2Br)CC[C@@H](CC1)N1CCc2c(C1)ncnc2NS(=O)(=O)c1ccc(N[C@H](CCN(C)C)CSc2ccccc2)c(c1)S(=O)(=O)C(F)(F)F,"N-[7-[4-[(2-bromophenyl)methyl]-4-methoxycyclohexyl]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl]-4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)benzenesulfonamide","InChI=1S/C40H48BrF3N6O5S3/c1-49(2)21-17-29(26-56-31-10-5-4-6-11-31)47-35-14-13-32(23-37(35)57(51,52)40(42,43)44)58(53,54)48-38-33-18-22-50(25-36(33)45-27-46-38)30-15-19-39(55-3,20-16-30)24-28-9-7-8-12-34(28)41/h4-14,23,27,29-30,47H,15-22,24-26H2,1-3H3,(H,45,46,48)/t29-,30-,39-/m1/s1",MCCLLJNTOCQCIM-DCWNVBBBSA-N,1,0,0,0,BCL2-Like / BAX,6.51,cancer,Inhibition,
172,59555772,,,OCc1cc(Nc2ccc(NCCc3c[nH]c4ccccc34)cc2)c2ccccc2n1,[4-[4-[2-(1H-indol-3-yl)ethylamino]anilino]quinolin-2-yl]methanol,"InChI=1S/C26H24N4O/c31-17-21-15-26(23-6-2-4-8-25(23)30-21)29-20-11-9-19(10-12-20)27-14-13-18-16-28-24-7-3-1-5-22(18)24/h1-12,15-16,27-28,31H,13-14,17H2,(H,29,30)",QEZDSTNLYDQRAB-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,7.40,cancer,Inhibition,
173,168318326,,10793053,OC(=O)CCCCN1c2ccc(I)cc2C(=O)N([C@@H](C(O)=O)c2ccc(Cl)cc2)[C@@H](c2ccc(Cl)cc2)C1=O,"5-[4-[carboxy-(4-chlorophenyl)methyl]-3-(4-chlorophenyl)-7-iodo-2,5-dioxo-3H-1,4-benzodiazepin-1-yl]pentanoic acid","InChI=1S/C28H23Cl2IN2O6/c29-18-8-4-16(5-9-18)24-27(37)32(14-2-1-3-23(34)35)22-13-12-20(31)15-21(22)26(36)33(24)25(28(38)39)17-6-10-19(30)11-7-17/h4-13,15,24-25H,1-3,14H2,(H,34,35)(H,38,39)/t24-,25+/m0/s1",JFDPWVMFHFOLFW-LOSJGSFVSA-N,1,2,0,0,MDM2-Like / P53,6.29,cancer,Inhibition,
174,46836865,,,CN1CCN(CC1)c1ccc(OCCCc2sc(nc2C(O)=O)N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)c(F)c1,"2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-5-[3-[2-fluoro-4-(4-methylpiperazin-1-yl)phenoxy]propyl]-1,3-thiazole-4-carboxylic acid","InChI=1S/C35H35FN6O4S2/c1-40-15-17-41(18-16-40)23-11-12-28(26(36)20-23)46-19-5-10-30-31(33(44)45)38-35(48-30)42-14-13-22-6-4-7-24(25(22)21-42)32(43)39-34-37-27-8-2-3-9-29(27)47-34/h2-4,6-9,11-12,20H,5,10,13-19,21H2,1H3,(H,44,45)(H,37,39,43)",ACEUUKOOFDTVPH-UHFFFAOYSA-N,1,0,0,0,BCL2-Like / BAX,6.81,cancer,Inhibition,
175,5288251,429852,4450452,CC(C)C[C@@H](NC(N)=N)C(=O)NCC(=O)N1CCC(CC1)c1cc(nn1C)-c1ccc(OCc2ccc(o2)C(O)=O)c(Cl)c1Cl,"5-[[2,3-dichloro-4-[5-[1-[2-[[(2R)-2-(diaminomethylideneamino)-4-methylpentanoyl]amino]acetyl]piperidin-4-yl]-1-methylpyrazol-3-yl]phenoxy]methyl]furan-2-carboxylic acid","InChI=1S/C30H37Cl2N7O6/c1-16(2)12-21(36-30(33)34)28(41)35-14-25(40)39-10-8-17(9-11-39)22-13-20(37-38(22)3)19-5-7-23(27(32)26(19)31)44-15-18-4-6-24(45-18)29(42)43/h4-7,13,16-17,21H,8-12,14-15H2,1-3H3,(H,35,41)(H,42,43)(H4,33,34,36)/t21-/m1/s1",VNZHOIDQBPFEJU-OAQYLSRUSA-N,2,0,0,0,IL2 / IL2R,7.22,immune system disease,Inhibition,
176,44237051,584395,24641231,CC[C@H](N)C(=O)N[C@H]1[C@@H](CN(C)Cc2ccccc2)CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7R,9aS)-6-[[(2S)-2-aminobutanoyl]amino]-N-benzhydryl-7-[[benzyl(methyl)amino]methyl]-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C36H45N5O3/c1-3-30(37)34(42)39-33-28(24-40(2)23-25-13-7-4-8-14-25)19-20-29-21-22-31(41(29)36(33)44)35(43)38-32(26-15-9-5-10-16-26)27-17-11-6-12-18-27/h4-18,28-33H,3,19-24,37H2,1-2H3,(H,38,43)(H,39,42)/t28-,29+,30+,31+,33+/m1/s1",BWLSZCKRHLWKLH-PIXGQMGXSA-N,2,0,0,0,XIAP / Smac,6.50,cancer,Inhibition,
177,44390642,360484,23246664,OC(=O)[C@@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)Nc2ccc(cc2C1=O)C#N)c1ccc(Cl)cc1,"2-(4-chlorophenyl)-2-[3-(4-chlorophenyl)-7-cyano-2,5-dioxo-1,3-dihydro-1,4-benzodiazepin-4-yl]acetic acid","InChI=1S/C24H15Cl2N3O4/c25-16-6-2-14(3-7-16)20-22(30)28-19-10-1-13(12-27)11-18(19)23(31)29(20)21(24(32)33)15-4-8-17(26)9-5-15/h1-11,20-21H,(H,28,30)(H,32,33)/t20-,21-/m0/s1",DXRBQZVQIJSNDC-SFTDATJTSA-N,1,0,0,0,MDM2-Like / P53,4.83,cancer,Inhibition,
178,168318325,,,CC(C)(C)C[C@H]1N[C@H]([C@H](c2cccc(Cl)c2)[C@]11C(=O)Nc2cc(Cl)ccc12)C(=O)NCC[C@H](O)CO,"(2'R,3S,3'R,5'R)-6-chloro-3'-(3-chlorophenyl)-N-[(3S)-3,4-dihydroxybutyl]-5'-(2,2-dimethylpropyl)-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide","InChI=1S/C27H33Cl2N3O4/c1-26(2,3)13-21-27(19-8-7-17(29)12-20(19)31-25(27)36)22(15-5-4-6-16(28)11-15)23(32-21)24(35)30-10-9-18(34)14-33/h4-8,11-12,18,21-23,32-34H,9-10,13-14H2,1-3H3,(H,30,35)(H,31,36)/t18-,21+,22-,23+,27+/m0/s1",NAOQNYFVXDLIDP-OKWRDYKUSA-N,2,2,0,0,MDM2-Like / P53,8.40,cancer,Inhibition,
179,29037212,64871,23155882,OC(=O)[C@H](Cc1c[nH]cn1)NC(=O)c1c(Cl)cccc1Cl,"(2S)-2-[(2,6-dichlorobenzoyl)amino]-3-(1H-imidazol-5-yl)propanoic acid","InChI=1S/C13H11Cl2N3O3/c14-8-2-1-3-9(15)11(8)12(19)18-10(13(20)21)4-7-5-16-6-17-7/h1-3,5-6,10H,4H2,(H,16,17)(H,18,19)(H,20,21)/t10-/m0/s1",KLWCZYZPAXGKGD-JTQLQIEISA-N,1,0,0,0,LFA / ICAM,6.80,immune system disease,Inhibition,
180,58531696,,,CC(C)CCNC(=O)c1ccc(CN(Cc2ccc(F)cc2)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)cc1,"4-[[(3,5-dichloro-2-hydroxyphenyl)sulfonyl-[(4-fluorophenyl)methyl]amino]methyl]-N-(3-methylbutyl)benzamide","InChI=1S/C26H27Cl2FN2O4S/c1-17(2)11-12-30-26(33)20-7-3-18(4-8-20)15-31(16-19-5-9-22(29)10-6-19)36(34,35)24-14-21(27)13-23(28)25(24)32/h3-10,13-14,17,32H,11-12,15-16H2,1-2H3,(H,30,33)",ZNGZMFHBDCXQFN-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,6.31,cancer,Inhibition,
181,11399131,1222288,9574031,OC(=O)[C@H](CNC(=O)c1cccs1)NC(=O)c1c(Cl)cc2CN(CCc2c1Cl)C(=O)c1ccc2ccoc2c1,"(2S)-2-[[2-(1-benzofuran-6-carbonyl)-5,7-dichloro-3,4-dihydro-1H-isoquinoline-6-carbonyl]amino]-3-(thiophene-2-carbonylamino)propanoic acid","InChI=1S/C27H21Cl2N3O6S/c28-18-10-16-13-32(26(35)15-4-3-14-6-8-38-20(14)11-15)7-5-17(16)23(29)22(18)25(34)31-19(27(36)37)12-30-24(33)21-2-1-9-39-21/h1-4,6,8-11,19H,5,7,12-13H2,(H,30,33)(H,31,34)(H,36,37)/t19-/m0/s1",FOBMOHYBRJMHEY-IBGZPJMESA-N,1,0,0,0,LFA / ICAM,8.30,immune system disease,Inhibition,
182,168318324,,,CC(=O)Nc1ccccc1N1CCN(CC1)C(=O)[C@@]1(CCCN(C1)C(=O)c1cnccc1C(F)(F)F)Oc1ccc(Br)c(F)c1,N-[2-[4-[3-(4-bromo-3-fluorophenoxy)-1-[4-(trifluoromethyl)pyridine-3-carbonyl]piperidine-3-carbonyl]piperazin-1-yl]phenyl]acetamide,"InChI=1S/C31H30BrF4N5O4/c1-20(42)38-26-5-2-3-6-27(26)39-13-15-40(16-14-39)29(44)30(45-21-7-8-24(32)25(33)17-21)10-4-12-41(19-30)28(43)22-18-37-11-9-23(22)31(34,35)36/h2-3,5-9,11,17-18H,4,10,12-16,19H2,1H3,(H,38,42)/t30-/m0/s1",WJADICXXRRMDLG-PMERELPUSA-N,1,0,0,0,MDM2-Like / P53,6.29,cancer,Inhibition,
183,44390720,361575,23246743,CCc1ccc(cc1)[C@@H]1N([C@H](C(O)=O)c2ccccc2)C(=O)c2cc(I)ccc2NC1=O,"2-[3-(4-ethylphenyl)-7-iodo-2,5-dioxo-1,3-dihydro-1,4-benzodiazepin-4-yl]-2-phenylacetic acid","InChI=1S/C25H21IN2O4/c1-2-15-8-10-17(11-9-15)21-23(29)27-20-13-12-18(26)14-19(20)24(30)28(21)22(25(31)32)16-6-4-3-5-7-16/h3-14,21-22H,2H2,1H3,(H,27,29)(H,31,32)/t21-,22-/m0/s1",ZWLYHYSXVKYCIB-VXKWHMMOSA-N,1,0,0,0,MDM2-Like / P53,5.12,cancer,Inhibition,
184,67032054,,,CC(C)(C)Cc1nc(-c2nn[nH]n2)c(-c2ccc(F)c(Cl)c2)n1-c1cccc(Cl)c1F,,"InChI=1S/C21H18Cl2F2N6/c1-21(2,3)10-16-26-18(20-27-29-30-28-20)19(11-7-8-14(24)13(23)9-11)31(16)15-6-4-5-12(22)17(15)25/h4-9H,10H2,1-3H3,(H,27,28,29,30)",JTMLNMHDWBOKLF-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,6.79,cancer,Inhibition,
185,25138056,516172,24716457,CN[C@@H](C)C(=O)N[C@H]1Cc2ccccc2[C@H]2CC[C@H](N2C1=O)C(=O)N[C@@H]1CCCc2ccccc12,"(3S,6S,11bR)-6-[[(2S)-2-(methylamino)propanoyl]amino]-5-oxo-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,3,6,7,11b-hexahydropyrrolo[2,1-a][2]benzazepine-3-carboxamide","InChI=1S/C28H34N4O3/c1-17(29-2)26(33)31-23-16-19-9-4-6-12-21(19)24-14-15-25(32(24)28(23)35)27(34)30-22-13-7-10-18-8-3-5-11-20(18)22/h3-6,8-9,11-12,17,22-25,29H,7,10,13-16H2,1-2H3,(H,30,34)(H,31,33)/t17-,22+,23-,24+,25-/m0/s1",YKDUDNBQXZHFLC-MMXROVNTSA-N,1,1,0,0,XIAP / Smac,7.74,cancer,Inhibition,
186,44176189,383471,23271214,CN(C)CCNC(=O)[C@@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)Nc2ccc(I)cc2C1=O)c1ccc(Cl)cc1,"(2S)-2-(4-chlorophenyl)-2-[(3S)-3-(4-chlorophenyl)-7-iodo-2,5-dioxo-1,3-dihydro-1,4-benzodiazepin-4-yl]-N-[2-(dimethylamino)ethyl]acetamide","InChI=1S/C27H25Cl2IN4O3/c1-33(2)14-13-31-25(35)23(16-3-7-18(28)8-4-16)34-24(17-5-9-19(29)10-6-17)26(36)32-22-12-11-20(30)15-21(22)27(34)37/h3-12,15,23-24H,13-14H2,1-2H3,(H,31,35)(H,32,36)/t23-,24-/m0/s1",PUQZWAZCZZGVMG-ZEQRLZLVSA-N,1,0,0,0,MDM2-Like / P53,4.57,cancer,Inhibition,
187,21906786,183884,10657296,COc1ccccc1Sc1ccc(cc1C(F)(F)F)-c1ccnc(c1)N1CCC(CCO)CC1,2-[1-[4-[4-(2-methoxyphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyridin-2-yl]piperidin-4-yl]ethanol,"InChI=1S/C26H27F3N2O2S/c1-33-22-4-2-3-5-24(22)34-23-7-6-19(16-21(23)26(27,28)29)20-8-12-30-25(17-20)31-13-9-18(10-14-31)11-15-32/h2-8,12,16-18,32H,9-11,13-15H2,1H3",VMYQJXMFOGNDIJ-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,6.95,immune system disease,Inhibition,
188,67954678,,,Cc1ccc(Cl)cc1-n1c(cc(C(O)=O)c1-c1cccc(Cl)c1)-c1ccccc1,,"InChI=1S/C24H17Cl2NO2/c1-15-10-11-19(26)13-21(15)27-22(16-6-3-2-4-7-16)14-20(24(28)29)23(27)17-8-5-9-18(25)12-17/h2-14H,1H3,(H,28,29)",OQJJRHRRBNFMKE-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,6.82,cancer,Inhibition,
189,506231,523372,442062,COc1cccc2c(c[nH]c12)C(=O)C(=O)N1CCN(CC1)C(=O)c1ccccc1,"1-(4-benzoylpiperazin-1-yl)-2-(7-methoxy-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C22H21N3O4/c1-29-18-9-5-8-16-17(14-23-19(16)18)20(26)22(28)25-12-10-24(11-13-25)21(27)15-6-3-2-4-7-15/h2-9,14,23H,10-13H2,1H3",WLXUTNUITKXLOB-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,8.18,HIV infectious disease,Inhibition,
190,168318322,,,COC(=O)[C@H]1CN(CCN1C(=O)c1ccccc1)C(=O)C(=O)c1c[nH]c2cccc(F)c12,methyl (2S)-1-benzoyl-4-[2-(4-fluoro-1H-indol-3-yl)-2-oxoacetyl]piperazine-2-carboxylate,"InChI=1S/C23H20FN3O5/c1-32-23(31)18-13-26(10-11-27(18)21(29)14-6-3-2-4-7-14)22(30)20(28)15-12-25-17-9-5-8-16(24)19(15)17/h2-9,12,18,25H,10-11,13H2,1H3/t18-/m1/s1",ROVDUALZLLENAS-GOSISDBHSA-N,0,1,0,0,CD4 / gp120,8.51,HIV infectious disease,Inhibition,
191,168318320,,,O[C@H]1CCc2c1nccc2Nc1cc(F)c2N(CCc3c[nH]c4ccccc34)CCOc2c1,"4-[[5-fluoro-4-[2-(1H-indol-3-yl)ethyl]-2,3-dihydro-1,4-benzoxazin-7-yl]amino]-6,7-dihydro-5H-cyclopenta[b]pyridin-7-ol","InChI=1S/C26H25FN4O2/c27-20-13-17(30-22-7-9-28-25-19(22)5-6-23(25)32)14-24-26(20)31(11-12-33-24)10-8-16-15-29-21-4-2-1-3-18(16)21/h1-4,7,9,13-15,23,29,32H,5-6,8,10-12H2,(H,28,30)/t23-/m0/s1",PWTOQBIEJHSEPN-QHCPKHFHSA-N,1,1,0,0,MDM2-Like / P53,6.00,cancer,Inhibition,
192,168318319,,,C[C@@H]1CN(CCc2c[nH]c3ccccc23)c2ccc(Nc3ccnc(CO)c3)cc2O1,"[4-[[4-[2-(1H-indol-3-yl)ethyl]-2-methyl-2,3-dihydro-1,4-benzoxazin-7-yl]amino]pyridin-2-yl]methanol","InChI=1S/C25H26N4O2/c1-17-15-29(11-9-18-14-27-23-5-3-2-4-22(18)23)24-7-6-19(13-25(24)31-17)28-20-8-10-26-21(12-20)16-30/h2-8,10,12-14,17,27,30H,9,11,15-16H2,1H3,(H,26,28)/t17-/m1/s1",STZTUORGNFWVQZ-QGZVFWFLSA-N,1,0,0,0,MDM2-Like / P53,5.00,cancer,Inhibition,
193,168318317,,24632966,C[C@@H](Oc1cccc2oc(C)nc12)C(=O)N1CCN(C[C@H]1C)C(=O)c1ccccc1,"1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-[(2-methyl-1,3-benzoxazol-4-yl)oxy]propan-1-one","InChI=1S/C23H25N3O4/c1-15-14-25(23(28)18-8-5-4-6-9-18)12-13-26(15)22(27)16(2)29-19-10-7-11-20-21(19)24-17(3)30-20/h4-11,15-16H,12-14H2,1-3H3/t15-,16-/m1/s1",TZXNONTVDOLQHU-HZPDHXFCSA-N,0,1,0,0,CD4 / gp120,5.69,HIV infectious disease,Inhibition,
194,168318309,,,C[C@H](N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NC1c2ccccc2-c2ccccc12)C(C)(C)C,,"InChI=1S/C27H34N4O3/c1-16(28)24(32)30-23(27(2,3)4)26(34)31-15-9-14-21(31)25(33)29-22-19-12-7-5-10-17(19)18-11-6-8-13-20(18)22/h5-8,10-13,16,21-23H,9,14-15,28H2,1-4H3,(H,29,33)(H,30,32)/t16-,21-,23+/m0/s1",VPJNLGRNHZXZRC-JFJYTDJESA-N,1,0,0,0,XIAP / Smac,7.33,cancer,Inhibition,
195,44579294,520731,24717623,CN1CCC(CC1)Nc1cccc(Sc2ccc(\C=C\C(=O)N3CCOCC3)c(c2C(F)(F)F)C(F)(F)F)c1,"(E)-3-[4-[3-[(1-methylpiperidin-4-yl)amino]phenyl]sulfanyl-2,3-bis(trifluoromethyl)phenyl]-1-morpholin-4-ylprop-2-en-1-one","InChI=1S/C27H29F6N3O2S/c1-35-11-9-19(10-12-35)34-20-3-2-4-21(17-20)39-22-7-5-18(6-8-23(37)36-13-15-38-16-14-36)24(26(28,29)30)25(22)27(31,32)33/h2-8,17,19,34H,9-16H2,1H3/b8-6+",CAESXWPQYVXWFJ-SOFGYWHQSA-N,1,0,0,0,LFA / ICAM,9.30,immune system disease,Inhibition,
196,44549628,,,CN1c2ncnn2[C@H](C2=C1c1ccccc1O[C@@H]2c1ccc(Br)cc1)c1ccc(C)cc1,,"InChI=1S/C26H21BrN4O/c1-16-7-9-17(10-8-16)23-22-24(30(2)26-28-15-29-31(23)26)20-5-3-4-6-21(20)32-25(22)18-11-13-19(27)14-12-18/h3-15,23,25H,1-2H3/t23-,25+/m0/s1",XTOOFJKUOMSKAG-UKILVPOCSA-N,1,0,0,0,MDM2-Like / P53,5.32,cancer,Inhibition,
197,44570039,453380,24687743,Cc1cc(nn1-c1ccccc1C(=O)N1Cc2ccccc2C[C@H]1CN)C(=O)N(c1ccccc1)c1ccccc1,"1-[2-[(3S)-3-(aminomethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-5-methyl-N,N-diphenylpyrazole-3-carboxamide","InChI=1S/C34H31N5O2/c1-24-20-31(34(41)38(27-14-4-2-5-15-27)28-16-6-3-7-17-28)36-39(24)32-19-11-10-18-30(32)33(40)37-23-26-13-9-8-12-25(26)21-29(37)22-35/h2-20,29H,21-23,35H2,1H3/t29-/m0/s1",WXEKNTLHAOLXLP-LJAQVGFWSA-N,2,0,0,0,BCL2-Like / BAX,6.96,cancer,Inhibition,
198,168318316,,,CC[C@H](N)C(=C)N[C@H]1CC[C@H]2CC[C@H](N2C1=O)C(=O)NCc1ccccc1,,"InChI=1S/C21H30N4O2/c1-3-17(22)14(2)24-18-11-9-16-10-12-19(25(16)21(18)27)20(26)23-13-15-7-5-4-6-8-15/h4-8,16-19,24H,2-3,9-13,22H2,1H3,(H,23,26)/t16-,17-,18-,19-/m0/s1",ZEPNVGAPAQEBCH-VJANTYMQSA-N,1,0,0,0,XIAP / Smac,5.85,cancer,Inhibition,
199,168318315,,,CC[C@H](N)C(=O)N[C@H]1[C@@H](Cn2cc(nn2)[C@@H](O)CC)CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7R,9aS)-6-[[(2S)-2-aminobutanoyl]amino]-N-benzhydryl-7-[[4-[(1R)-1-hydroxypropyl]triazol-1-yl]methyl]-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C33H43N7O4/c1-3-25(34)31(42)36-30-23(19-39-20-26(37-38-39)28(41)4-2)15-16-24-17-18-27(40(24)33(30)44)32(43)35-29(21-11-7-5-8-12-21)22-13-9-6-10-14-22/h5-14,20,23-25,27-30,41H,3-4,15-19,34H2,1-2H3,(H,35,43)(H,36,42)/t23-,24+,25+,27+,28+,30+/m1/s1",BKDHFGCNNIXCGS-SOMXMSSDSA-N,1,0,0,0,XIAP / Smac,6.61,cancer,Inhibition,
200,168318314,,,FC(F)(F)c1ccc(O[C@@]2(CCCN(C2)C(=O)C2(CC2)c2ccc(Cl)cc2)C(=O)NCCc2ccccc2)cc1,1-[1-(4-chlorophenyl)cyclopropanecarbonyl]-N-(2-phenylethyl)-3-[4-(trifluoromethyl)phenoxy]piperidine-3-carboxamide,"InChI=1S/C31H30ClF3N2O3/c32-25-11-7-23(8-12-25)29(17-18-29)28(39)37-20-4-16-30(21-37,27(38)36-19-15-22-5-2-1-3-6-22)40-26-13-9-24(10-14-26)31(33,34)35/h1-3,5-14H,4,15-21H2,(H,36,38)/t30-/m1/s1",YPAQBCLUJBPATB-SSEXGKCCSA-N,1,0,0,0,MDM2-Like / P53,5.85,cancer,Inhibition,
201,58007280,2398239,,CC(C)C1=C(SC2=N[C@](C)([C@H](N12)c1ccc(Cl)cc1)c1ccc(Cl)cc1)C(=O)N1[C@H](C)CC[C@H]1C(=O)N1CCN(C)C(C)(C)C1,"[(2S,5R)-1-[(5R,6S)-5,6-bis(4-chlorophenyl)-6-methyl-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazole-2-carbonyl]-5-methylpyrrolidin-2-yl]-(3,3,4-trimethylpiperazin-1-yl)methanone","InChI=1S/C35H43Cl2N5O2S/c1-21(2)28-29(32(44)41-22(3)8-17-27(41)31(43)40-19-18-39(7)34(4,5)20-40)45-33-38-35(6,24-11-15-26(37)16-12-24)30(42(28)33)23-9-13-25(36)14-10-23/h9-16,21-22,27,30H,8,17-20H2,1-7H3/t22-,27+,30-,35+/m1/s1",LCCCYUDWOIWMBN-SSWZFYISSA-N,1,0,0,0,MDM2-Like / P53,7.72,cancer,Inhibition,
202,168318310,,,Cc1ccccc1C(=O)N1CCc2c(C)c(C(=O)N[C@@H](CNC(=O)c3cccs3)C(O)=O)c(C)cc2C1,,"InChI=1S/C28H29N3O5S/c1-16-7-4-5-8-20(16)27(34)31-11-10-21-18(3)24(17(2)13-19(21)15-31)26(33)30-22(28(35)36)14-29-25(32)23-9-6-12-37-23/h4-9,12-13,22H,10-11,14-15H2,1-3H3,(H,29,32)(H,30,33)(H,35,36)/t22-/m0/s1",CXORMCYWYORQIB-QFIPXVFZSA-N,0,1,0,0,LFA / ICAM,6.34,immune system disease,Inhibition,
203,44389239,178314,23245158,CNC(=O)[C@H](Cc1ccc2ccccc2c1)N1CCC(=O)N(Cc2ccccc2)[C@@H](CC(C)C)C1=O,"(2S)-2-[(3S)-4-benzyl-3-(2-methylpropyl)-2,5-dioxo-1,4-diazepan-1-yl]-N-methyl-3-naphthalen-2-ylpropanamide","InChI=1S/C30H35N3O3/c1-21(2)17-27-30(36)32(16-15-28(34)33(27)20-22-9-5-4-6-10-22)26(29(35)31-3)19-23-13-14-24-11-7-8-12-25(24)18-23/h4-14,18,21,26-27H,15-17,19-20H2,1-3H3,(H,31,35)/t26-,27-/m0/s1",GEVABPTUVMJNDH-SVBPBHIXSA-N,1,0,0,0,LFA / ICAM,5.55,immune system disease,Inhibition,
204,168318304,,,C[C@H](N)C(=O)Nc1nc(COCc2cccc3ccccc23)c(Cc2ccccc2)s1,,"InChI=1S/C25H25N3O2S/c1-17(26)24(29)28-25-27-22(23(31-25)14-18-8-3-2-4-9-18)16-30-15-20-12-7-11-19-10-5-6-13-21(19)20/h2-13,17H,14-16,26H2,1H3,(H,27,28,29)/t17-/m0/s1",APEYWYOETFXHMU-KRWDZBQOSA-N,1,0,0,0,XIAP / Smac,4.68,cancer,Inhibition,
205,16109089,376921,17266503,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(Cc2ccccc2)CC1,4-(4-benzylpiperazin-1-yl)-N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonylbenzamide,"InChI=1S/C36H42N6O5S2/c1-39(2)20-19-30(27-48-32-11-7-4-8-12-32)37-34-18-17-33(25-35(34)42(44)45)49(46,47)38-36(43)29-13-15-31(16-14-29)41-23-21-40(22-24-41)26-28-9-5-3-6-10-28/h3-18,25,30,37H,19-24,26-27H2,1-2H3,(H,38,43)/t30-/m1/s1",GVUHBRBKGLCYFC-SSEXGKCCSA-N,2,0,0,0,BCL2-Like / BAX,8.59,cancer,Inhibition,
206,11538758,,9713538,COc1cccc2c(Nc3ccc(NCCc4c[nH]c5ccccc45)cc3)ccnc12,"1-N-[2-(1H-indol-3-yl)ethyl]-4-N-(8-methoxyquinolin-4-yl)benzene-1,4-diamine","InChI=1S/C26H24N4O/c1-31-25-8-4-6-22-24(14-16-28-26(22)25)30-20-11-9-19(10-12-20)27-15-13-18-17-29-23-7-3-2-5-21(18)23/h2-12,14,16-17,27,29H,13,15H2,1H3,(H,28,30)",ASCMASMAJFAADA-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,8.00,cancer,Inhibition,
207,44580484,496314,24705831,FC(F)(F)c1c(Sc2ccccc2OC2CCCCC2)ccc(\C=C\C(=O)N2CCOCC2)c1C(F)(F)F,"(E)-3-[4-(2-cyclohexyloxyphenyl)sulfanyl-2,3-bis(trifluoromethyl)phenyl]-1-morpholin-4-ylprop-2-en-1-one","InChI=1S/C27H27F6NO3S/c28-26(29,30)24-18(11-13-23(35)34-14-16-36-17-15-34)10-12-22(25(24)27(31,32)33)38-21-9-5-4-8-20(21)37-19-6-2-1-3-7-19/h4-5,8-13,19H,1-3,6-7,14-17H2/b13-11+",QOPHPRIAHZKBGU-ACCUITESSA-N,1,0,0,0,LFA / ICAM,8.05,immune system disease,Inhibition,
208,168318307,,10657267,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1cc(ncn1)N1C[C@H](C)O[C@H](C)C1,"2,6-dimethyl-4-[6-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyrimidin-4-yl]morpholine","InChI=1S/C26H28F3N3OS/c1-16(2)20-7-5-6-8-23(20)34-24-10-9-19(11-21(24)26(27,28)29)22-12-25(31-15-30-22)32-13-17(3)33-18(4)14-32/h5-12,15-18H,13-14H2,1-4H3/t17-,18+",XXLJXHUHENVDCY-HDICACEKSA-N,0,1,0,0,LFA / ICAM,6.31,immune system disease,Inhibition,
209,45138263,,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2C(C)=O)c1c[nH]c2ccc(F)cc12,"(2S)-N-[(1S)-2-[(3aR,6S,6aR)-4-acetyl-6-(5-fluoro-1H-indol-3-yl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-1-cyclohexyl-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C28H38FN5O3/c1-16(30-3)27(36)32-25(18-7-5-4-6-8-18)28(37)33-12-11-24-26(33)22(15-34(24)17(2)35)21-14-31-23-10-9-19(29)13-20(21)23/h9-10,13-14,16,18,22,24-26,30-31H,4-8,11-12,15H2,1-3H3,(H,32,36)/t16-,22+,24+,25-,26+/m0/s1",HZWDCTNCVYXQNO-ONBGBDQZSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
210,44390636,181252,23246658,OC(=O)[C@@H](N1[C@@H](c2ccc(cc2)C(F)(F)F)C(=O)Nc2ccc(I)cc2C1=O)c1ccc(Cl)cc1,"2-(4-chlorophenyl)-2-[7-iodo-2,5-dioxo-3-[4-(trifluoromethyl)phenyl]-1,3-dihydro-1,4-benzodiazepin-4-yl]acetic acid","InChI=1S/C24H15ClF3IN2O4/c25-15-7-3-13(4-8-15)20(23(34)35)31-19(12-1-5-14(6-2-12)24(26,27)28)21(32)30-18-10-9-16(29)11-17(18)22(31)33/h1-11,19-20H,(H,30,32)(H,34,35)/t19-,20-/m0/s1",MTPCBUJQUKLCOM-PMACEKPBSA-N,1,0,0,0,MDM2-Like / P53,6.21,cancer,Inhibition,
211,46221191,1094127,24678944,CN1C(=O)N(C(=O)[C@]11CN(C[C@H]1c1ccc(cc1)C#N)c1nc2cc(ccc2o1)C(O)=O)c1cc(Cl)cc(Cl)c1,"2-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl]-1,3-benzoxazole-5-carboxylic acid","InChI=1S/C28H19Cl2N5O5/c1-33-27(39)35(20-10-18(29)9-19(30)11-20)25(38)28(33)14-34(13-21(28)16-4-2-15(12-31)3-5-16)26-32-22-8-17(24(36)37)6-7-23(22)40-26/h2-11,21H,13-14H2,1H3,(H,36,37)/t21-,28+/m0/s1",ADBMUKYDRHZIQJ-RBTNQOKQSA-N,1,0,0,0,LFA / ICAM,8.40,immune system disease,Inhibition,
212,168318250,,24635188,C[C@@H](Oc1cccc2[nH]nc(C)c12)C(=O)N1CCN(C[C@H]1C)C(=O)c1ccccc1,(2S)-1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-[(3-methyl-2H-indazol-4-yl)oxy]propan-1-one,"InChI=1S/C23H26N4O3/c1-15-14-26(23(29)18-8-5-4-6-9-18)12-13-27(15)22(28)17(3)30-20-11-7-10-19-21(20)16(2)24-25-19/h4-11,15,17H,12-14H2,1-3H3,(H,24,25)/t15-,17-/m1/s1",JHVGTAQPCZXVSX-NVXWUHKLSA-N,0,1,0,0,CD4 / gp120,7.80,HIV infectious disease,Inhibition,
213,168318249,,,CC(C)(C)S(=O)(=O)c1cc(ccc1N[C@H](CCN1CCOCC1)CSc1ccccc1)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(CC2=C(CC(C)(C)CC2)c2ccc(Cl)cc2)CC1,,"InChI=1S/C51H68ClN7O5S3/c1-50(2,3)66(60,61)48-31-43(15-16-46(48)55-40(18-23-57-27-29-64-30-28-57)35-65-42-9-7-6-8-10-42)67(62,63)56-49-44-21-26-59(34-47(44)53-36-54-49)41-19-24-58(25-20-41)33-38-17-22-51(4,5)32-45(38)37-11-13-39(52)14-12-37/h6-16,31,36,40-41,55H,17-30,32-35H2,1-5H3,(H,53,54,56)/t40-/m1/s1",DJSNNNJGIIDYTC-RRHRGVEJSA-N,1,0,0,0,BCL2-Like / BAX,7.39,cancer,Inhibition,
214,168318275,,,CC(C)(C)C[C@H]1N[C@H]([C@H](c2cccc(Cl)c2)[C@]11C(=O)Nc2cc(Cl)c(F)cc12)C(=O)NCC[C@H](O)CO,"(2'R,3S,3'R,5'R)-6-chloro-3'-(3-chlorophenyl)-N-[(3S)-3,4-dihydroxybutyl]-5'-(2,2-dimethylpropyl)-5-fluoro-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide","InChI=1S/C27H32Cl2FN3O4/c1-26(2,3)12-21-27(17-10-19(30)18(29)11-20(17)32-25(27)37)22(14-5-4-6-15(28)9-14)23(33-21)24(36)31-8-7-16(35)13-34/h4-6,9-11,16,21-23,33-35H,7-8,12-13H2,1-3H3,(H,31,36)(H,32,37)/t16-,21+,22-,23+,27+/m0/s1",UNXQGBMZYKHQCO-SARUBHRKSA-N,2,2,0,0,MDM2-Like / P53,7.88,cancer,Inhibition,
215,44191246,553474,24620139,Cc1cc2c(C(=O)NCCc3cccc(Cl)c3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)NCCc3cccc(Cl)c3)c(O)c(O)cc2c1O,"N-[2-(3-chlorophenyl)ethyl]-6-[5-[2-(3-chlorophenyl)ethylcarbamoyl]-1,6,7-trihydroxy-3-methylnaphthalen-2-yl]-2,3,5-trihydroxy-7-methylnaphthalene-1-carboxamide","InChI=1S/C40H34Cl2N2O8/c1-19-13-25-27(17-29(45)37(49)33(25)39(51)43-11-9-21-5-3-7-23(41)15-21)35(47)31(19)32-20(2)14-26-28(36(32)48)18-30(46)38(50)34(26)40(52)44-12-10-22-6-4-8-24(42)16-22/h3-8,13-18,45-50H,9-12H2,1-2H3,(H,43,51)(H,44,52)",FTGGNSWNSSLDSL-UHFFFAOYSA-N,3,0,0,0,BCL2-Like / BAX,5.49,cancer,Inhibition,
216,58006984,,,CO[C@H]1C[C@H](N(C1)C(=O)C1=C(C(C)C)N2[C@H](c3ccc(Cl)cc3)[C@@](C)(N=C2S1)c1ccc(Cl)cc1)C(=O)N1CCOCC1,"[(2S,4S)-1-[(5R,6S)-5,6-bis(4-chlorophenyl)-6-methyl-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazole-2-carbonyl]-4-methoxypyrrolidin-2-yl]-morpholin-4-ylmethanone","InChI=1S/C32H36Cl2N4O4S/c1-19(2)26-27(30(40)37-18-24(41-4)17-25(37)29(39)36-13-15-42-16-14-36)43-31-35-32(3,21-7-11-23(34)12-8-21)28(38(26)31)20-5-9-22(33)10-6-20/h5-12,19,24-25,28H,13-18H2,1-4H3/t24-,25-,28+,32-/m0/s1",NGRYFDAHLUATBD-KSHNBWNRSA-N,1,0,0,0,MDM2-Like / P53,6.87,cancer,Inhibition,
217,44176179,212568,23271758,Cc1cc(Cl)ccc1CN1[C@@H](c2ccc(Cl)cc2)C(=O)N(CCN2CCOCC2)c2ccc(I)cc2C1=O,"4-[(4-chloro-2-methylphenyl)methyl]-3-(4-chlorophenyl)-7-iodo-1-(2-morpholin-4-ylethyl)-3H-1,4-benzodiazepine-2,5-dione","InChI=1S/C29H28Cl2IN3O3/c1-19-16-23(31)7-4-21(19)18-35-27(20-2-5-22(30)6-3-20)29(37)34(11-10-33-12-14-38-15-13-33)26-9-8-24(32)17-25(26)28(35)36/h2-9,16-17,27H,10-15,18H2,1H3/t27-/m0/s1",BWJZWGVPPXHFLK-MHZLTWQESA-N,1,0,0,0,MDM2-Like / P53,4.72,cancer,Inhibition,
218,168318273,,,COc1cc(CNC(=O)c2cc(ccc2Cl)-n2[nH]c3c4cnn(C)c4nc(-c4cccc(c4)C(F)(F)F)c3c2=O)ccc1O,,"InChI=1S/C30H22ClF3N6O4/c1-39-27-20(14-36-39)26-24(25(37-27)16-4-3-5-17(11-16)30(32,33)34)29(43)40(38-26)18-7-8-21(31)19(12-18)28(42)35-13-15-6-9-22(41)23(10-15)44-2/h3-12,14,38,41H,13H2,1-2H3,(H,35,42)",IJFMOURLOBWRKH-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.26,cancer,Inhibition,
219,11176463,359812,9351555,CC(C)[C@H](NC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(=O)NCC1CCCCC1,(2S)-1-[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-3-methylbutanoyl]-N-(cyclohexylmethyl)pyrrolidine-2-carboxamide,"InChI=1S/C20H36N4O3/c1-13(2)17(23-18(25)14(3)21)20(27)24-11-7-10-16(24)19(26)22-12-15-8-5-4-6-9-15/h13-17H,4-12,21H2,1-3H3,(H,22,26)(H,23,25)/t14-,16-,17-/m0/s1",UETWNTWJPLMFAF-XIRDDKMYSA-N,1,0,0,0,XIAP / Smac,5.90,cancer,Inhibition,
220,10294628,,8470096,Cn1ncc2c1nc(-c1cccc(c1)N(=O)=O)c1c2[nH]n(-c2cccc(F)c2)c1=O,"2-(3-fluorophenyl)-6-methyl-4-(3-nitrophenyl)-1H-dipyrazolo[4,3-b:4',5'-e]pyridin-3-one","InChI=1S/C20H13FN6O3/c1-25-19-15(10-22-25)18-16(17(23-19)11-4-2-7-14(8-11)27(29)30)20(28)26(24-18)13-6-3-5-12(21)9-13/h2-10,24H,1H3",VCPPGYMUZGKKJO-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,8.40,cancer,Inhibition,
221,168318272,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(C)(C)C)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2cc(F)ccc2-c2ccc(Cl)cc2)CC1,,"InChI=1S/C47H57ClFN7O4S3/c1-47(2,3)62(57,58)45-28-40(16-18-43(45)52-37(19-23-54(4)5)31-61-39-9-7-6-8-10-39)63(59,60)53-46-42-22-26-56(30-44(42)50-32-51-46)38-20-24-55(25-21-38)29-34-27-36(49)15-17-41(34)33-11-13-35(48)14-12-33/h6-18,27-28,32,37-38,52H,19-26,29-31H2,1-5H3,(H,50,51,53)/t37-/m1/s1",IVAQTQSIBCSTCJ-DIPNUNPCSA-N,1,0,0,0,BCL2-Like / BAX,7.66,cancer,Inhibition,
222,45138260,,,CN[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2C(C)=O)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(2S)-1-[(3aR,6S,6aR)-4-acetyl-6-(6-fluoro-1H-indol-3-yl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-3-methyl-1-oxobutan-2-yl]-2-(methylamino)propanamide","InChI=1S/C25H34FN5O3/c1-13(2)22(29-24(33)14(3)27-5)25(34)30-9-8-21-23(30)19(12-31(21)15(4)32)18-11-28-20-10-16(26)6-7-17(18)20/h6-7,10-11,13-14,19,21-23,27-28H,8-9,12H2,1-5H3,(H,29,33)/t14-,19+,21+,22-,23+/m0/s1",BJWVLAYRNLEYTQ-HCLLECIRSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
223,21906803,362239,10657324,COc1ccccc1Sc1ccc(cc1C(F)(F)F)-c1ccnc(c1)N1CCC(CO)CC1,[1-[4-[4-(2-methoxyphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyridin-2-yl]piperidin-4-yl]methanol,"InChI=1S/C25H25F3N2O2S/c1-32-21-4-2-3-5-23(21)33-22-7-6-18(14-20(22)25(26,27)28)19-8-11-29-24(15-19)30-12-9-17(16-31)10-13-30/h2-8,11,14-15,17,31H,9-10,12-13,16H2,1H3",RLTHAIWBVZSQOO-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,7.10,immune system disease,Inhibition,
224,45137061,,,CO[C@H](C)[C@H](NC(=O)[C@H](C)N)C(=O)N1CC[C@H]2NC[C@@H]([C@@H]12)c1cn(Cc2ccccc2)c2cc(F)ccc12,"(2S)-N-[(2S,3R)-1-[(3aR,6S,6aR)-6-(1-benzyl-6-fluoroindol-3-yl)-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,2-b]pyrrol-1-yl]-3-methoxy-1-oxobutan-2-yl]-2-aminopropanamide","InChI=1S/C29H36FN5O3/c1-17(31)28(36)33-26(18(2)38-3)29(37)35-12-11-24-27(35)22(14-32-24)23-16-34(15-19-7-5-4-6-8-19)25-13-20(30)9-10-21(23)25/h4-10,13,16-18,22,24,26-27,32H,11-12,14-15,31H2,1-3H3,(H,33,36)/t17-,18+,22+,24+,26-,27+/m0/s1",LDUBECIZUPSFRT-BQDWDSRNSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
225,44570086,520607,24718492,CCN(CC)C(=O)c1nn(c(C)c1Br)-c1ccccc1C(=O)N1Cc2ccccc2C[C@H]1CO,"4-bromo-N,N-diethyl-1-[2-[(3S)-3-(hydroxymethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide","InChI=1S/C26H29BrN4O3/c1-4-29(5-2)26(34)24-23(27)17(3)31(28-24)22-13-9-8-12-21(22)25(33)30-15-19-11-7-6-10-18(19)14-20(30)16-32/h6-13,20,32H,4-5,14-16H2,1-3H3/t20-/m0/s1",MBRSVHOHDRQYGO-FQEVSTJZSA-N,1,0,0,0,BCL2-Like / BAX,5.44,cancer,Inhibition,
226,168318271,,,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(cc2)C(=O)NCCCO)c1=O,,"InChI=1S/C25H21F3N6O3/c1-33-22-18(13-30-33)21-19(20(31-22)15-4-2-5-16(12-15)25(26,27)28)24(37)34(32-21)17-8-6-14(7-9-17)23(36)29-10-3-11-35/h2,4-9,12-13,32,35H,3,10-11H2,1H3,(H,29,36)",JOIUZRRTKNSOEM-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.01,cancer,Inhibition,
227,21906780,181377,10657290,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1ccnc(c1)N1CCC(CO)CC1,[1-[4-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyridin-2-yl]piperidin-4-yl]methanol,"InChI=1S/C27H29F3N2OS/c1-18(2)22-5-3-4-6-24(22)34-25-8-7-20(15-23(25)27(28,29)30)21-9-12-31-26(16-21)32-13-10-19(17-33)11-14-32/h3-9,12,15-16,18-19,33H,10-11,13-14,17H2,1-2H3",ULOLQJYJZXDFCF-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,6.80,immune system disease,Inhibition,
228,168318269,,,COC1(CCN(CC1)c1ccc(cc1)C(=O)NS(=O)(=O)c1ccc(N[C@H](CCN(C)C)CSc2ccccc2)c(c1)N(=O)=O)c1ccc(cc1)-c1ccccc1,,"InChI=1S/C43H47N5O6S2/c1-46(2)27-24-36(31-55-38-12-8-5-9-13-38)44-40-23-22-39(30-41(40)48(50)51)56(52,53)45-42(49)34-16-20-37(21-17-34)47-28-25-43(54-3,26-29-47)35-18-14-33(15-19-35)32-10-6-4-7-11-32/h4-23,30,36,44H,24-29,31H2,1-3H3,(H,45,49)/t36-/m1/s1",DFMAYBTXVMUNDL-PSXMRANNSA-N,2,0,0,0,BCL2-Like / BAX,9.05,cancer,Inhibition,
229,10930456,106951,9105696,CC(C)C[C@@H](NC(N)=N)C(=O)NCC(=O)N1CCC(CC1)c1cc(nn1C)-c1ccc(OCc2ccc(CC(O)=O)cc2)c(Cl)c1Cl,"2-[4-[[2,3-dichloro-4-[5-[1-[2-[[(2R)-2-(diaminomethylideneamino)-4-methylpentanoyl]amino]acetyl]piperidin-4-yl]-1-methylpyrazol-3-yl]phenoxy]methyl]phenyl]acetic acid","InChI=1S/C33H41Cl2N7O5/c1-19(2)14-25(39-33(36)37)32(46)38-17-28(43)42-12-10-22(11-13-42)26-16-24(40-41(26)3)23-8-9-27(31(35)30(23)34)47-18-21-6-4-20(5-7-21)15-29(44)45/h4-9,16,19,22,25H,10-15,17-18H2,1-3H3,(H,38,46)(H,44,45)(H4,36,37,39)/t25-/m1/s1",RYQNKFRJJMROGZ-RUZDIDTESA-N,2,0,0,0,IL2 / IL2R,6.22,immune system disease,Inhibition,
230,168318379,,10657329,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1ccnc(c1)N1CC[C@H](O)C1,1-[4-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyridin-2-yl]pyrrolidin-3-ol,"InChI=1S/C25H25F3N2OS/c1-16(2)20-5-3-4-6-22(20)32-23-8-7-17(13-21(23)25(26,27)28)18-9-11-29-24(14-18)30-12-10-19(31)15-30/h3-9,11,13-14,16,19,31H,10,12,15H2,1-2H3/t19-/m0/s1",ASEPTZPIYTWOSV-IBGZPJMESA-N,0,1,0,0,LFA / ICAM,7.03,immune system disease,Inhibition,
231,44176185,379656,23271277,OC(=O)C[C@@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)Nc2ccc(I)cc2C1=O)c1ccc(Cl)cc1,"3-(4-chlorophenyl)-3-[3-(4-chlorophenyl)-7-iodo-2,5-dioxo-1,3-dihydro-1,4-benzodiazepin-4-yl]propanoic acid","InChI=1S/C24H17Cl2IN2O4/c25-15-5-1-13(2-6-15)20(12-21(30)31)29-22(14-3-7-16(26)8-4-14)23(32)28-19-10-9-17(27)11-18(19)24(29)33/h1-11,20,22H,12H2,(H,28,32)(H,30,31)/t20-,22+/m1/s1",UHDVYHWPJKKLPO-IRLDBZIGSA-N,1,2,0,0,MDM2-Like / P53,6.27,cancer,Inhibition,
232,44390666,369560,23246688,OC(=O)[C@@H](N1[C@@H](c2ccc(OC(F)(F)F)cc2)C(=O)Nc2ccc(I)cc2C1=O)c1ccc(Cl)cc1,"2-(4-chlorophenyl)-2-[7-iodo-2,5-dioxo-3-[4-(trifluoromethoxy)phenyl]-1,3-dihydro-1,4-benzodiazepin-4-yl]acetic acid","InChI=1S/C24H15ClF3IN2O5/c25-14-5-1-13(2-6-14)20(23(34)35)31-19(12-3-8-16(9-4-12)36-24(26,27)28)21(32)30-18-10-7-15(29)11-17(18)22(31)33/h1-11,19-20H,(H,30,32)(H,34,35)/t19-,20-/m0/s1",BJRDRKOWQXJANR-PMACEKPBSA-N,1,0,0,0,MDM2-Like / P53,6.12,cancer,Inhibition,
233,44176176,380178,23271767,Nc1cc(Cl)ccc1CN1[C@@H](c2ccc(Cl)cc2)C(=O)N(CCCN2CCOCC2)c2ccc(I)cc2C1=O,"4-[(2-amino-4-chlorophenyl)methyl]-3-(4-chlorophenyl)-7-iodo-1-(3-morpholin-4-ylpropyl)-3H-1,4-benzodiazepine-2,5-dione","InChI=1S/C29H29Cl2IN4O3/c30-21-5-2-19(3-6-21)27-29(38)35(11-1-10-34-12-14-39-15-13-34)26-9-8-23(32)17-24(26)28(37)36(27)18-20-4-7-22(31)16-25(20)33/h2-9,16-17,27H,1,10-15,18,33H2/t27-/m0/s1",DIRPNNUWQMTLTK-MHZLTWQESA-N,1,0,0,0,MDM2-Like / P53,5.44,cancer,Inhibition,
234,168318266,,,COC1(CCN(CC1)c1ccc(cc1)C(=O)NS(=O)(=O)c1ccc(N[C@H](CCN(C)C)CSc2ccccc2)c(c1)N(=O)=O)c1ccccc1F,,"InChI=1S/C37H42FN5O6S2/c1-41(2)22-19-28(26-50-30-9-5-4-6-10-30)39-34-18-17-31(25-35(34)43(45)46)51(47,48)40-36(44)27-13-15-29(16-14-27)42-23-20-37(49-3,21-24-42)32-11-7-8-12-33(32)38/h4-18,25,28,39H,19-24,26H2,1-3H3,(H,40,44)/t28-/m1/s1",FQNSMGGNFIDLLO-MUUNZHRXSA-N,2,0,0,0,BCL2-Like / BAX,9.05,cancer,Inhibition,
235,168315335,,9379955,CCOc1cc(ccc1C1=N[C@H]([C@@H](N1C(=O)N1CCC(CC1)NCC(=O)N(C)CCC#N)c1ccc(Cl)cc1)c1ccc(Cl)cc1)C(F)(F)F,"2-[[1-[4,5-bis(4-chlorophenyl)-2-[2-ethoxy-4-(trifluoromethyl)phenyl]-4,5-dihydroimidazole-1-carbonyl]piperidin-4-yl]amino]-N-(2-cyanoethyl)-N-methylacetamide","InChI=1S/C36H37Cl2F3N6O3/c1-3-50-30-21-25(36(39,40)41)9-14-29(30)34-44-32(23-5-10-26(37)11-6-23)33(24-7-12-27(38)13-8-24)47(34)35(49)46-19-15-28(16-20-46)43-22-31(48)45(2)18-4-17-42/h5-14,21,28,32-33,43H,3-4,15-16,18-20,22H2,1-2H3/t32-,33-/m0/s1",IQCPDPHGEWITPU-LQJZCPKCSA-N,1,0,0,0,MDM2-Like / P53,7.68,cancer,Inhibition,
236,44549488,,,CN1c2ncnn2[C@H](C2=C1c1ccccc1O[C@@H]2c1ccc(Cl)cc1)c1ccc(Br)cc1,,"InChI=1S/C25H18BrClN4O/c1-30-23-19-4-2-3-5-20(19)32-24(16-8-12-18(27)13-9-16)21(23)22(31-25(30)28-14-29-31)15-6-10-17(26)11-7-15/h2-14,22,24H,1H3/t22-,24+/m0/s1",PQGSGKGNJOWFEG-LADGPHEKSA-N,1,0,0,0,MDM2-Like / P53,6.05,cancer,Inhibition,
237,46883994,1090431,24669936,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1nc2c(cccc2s1)-c1cccc(F)c1,"(2S)-N-[(1S)-1-cyclohexyl-2-[(2R)-2-[4-(3-fluorophenyl)-1,3-benzothiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C29H35FN4O2S/c1-18(31-2)27(35)32-25(19-9-4-3-5-10-19)29(36)34-16-8-14-23(34)28-33-26-22(13-7-15-24(26)37-28)20-11-6-12-21(30)17-20/h6-7,11-13,15,17-19,23,25,31H,3-5,8-10,14,16H2,1-2H3,(H,32,35)/t18-,23-,25-/m0/s1",ZXIUVRCLHAZSCB-WYRQLCSISA-N,1,0,0,0,XIAP / Smac,7.31,cancer,Inhibition,
238,11017948,,9193132,COc1cc(COc2ccc(-c3cc(C4CCN(CC4)C(=O)CNC(=O)[C@@H](CC(C)C)NC(N)=N)n(C)n3)c(Cl)c2Cl)ccc1C(O)=O,"4-[[2,3-dichloro-4-[5-[1-[2-[[(2R)-2-(diaminomethylideneamino)-4-methylpentanoyl]amino]acetyl]piperidin-4-yl]-1-methylpyrazol-3-yl]phenoxy]methyl]-2-methoxybenzoic acid","InChI=1S/C33H41Cl2N7O6/c1-18(2)13-24(39-33(36)37)31(44)38-16-28(43)42-11-9-20(10-12-42)25-15-23(40-41(25)3)21-7-8-26(30(35)29(21)34)48-17-19-5-6-22(32(45)46)27(14-19)47-4/h5-8,14-15,18,20,24H,9-13,16-17H2,1-4H3,(H,38,44)(H,45,46)(H4,36,37,39)/t24-/m1/s1",COCRJQFFPPGHDF-XMMPIXPASA-N,1,0,0,0,IL2 / IL2R,6.52,immune system disease,Inhibition,
239,21906755,360677,10657259,COc1ccccc1Sc1ccc(cc1C(F)(F)F)-c1ccnc(c1)N1CCN(CC1)C=O,4-[4-[4-(2-methoxyphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyridin-2-yl]piperazine-1-carbaldehyde,"InChI=1S/C24H22F3N3O2S/c1-32-20-4-2-3-5-22(20)33-21-7-6-17(14-19(21)24(25,26)27)18-8-9-28-23(15-18)30-12-10-29(16-31)11-13-30/h2-9,14-16H,10-13H2,1H3",SUZAUKCYSQZDMS-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,6.73,immune system disease,Inhibition,
240,168318260,,,Cn1ncc2c1nc(-c1cccc(c1)C#N)c1c2[nH]n(-c2cccc(F)c2)c1=O,,"InChI=1S/C21H13FN6O/c1-27-20-16(11-24-27)19-17(18(25-20)13-5-2-4-12(8-13)10-23)21(29)28(26-19)15-7-3-6-14(22)9-15/h2-9,11,26H,1H3",MZBCNTIPBPFKKG-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.30,cancer,Inhibition,
241,45138558,,,CN[C@@H](C)C(=O)N[C@@H]([C@@H](C)OC)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2C(C)=O)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(2S,3R)-1-[(3aR,6S,6aR)-4-acetyl-6-(6-fluoro-1H-indol-3-yl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-3-methoxy-1-oxobutan-2-yl]-2-(methylamino)propanamide","InChI=1S/C25H34FN5O4/c1-13(27-4)24(33)29-22(14(2)35-5)25(34)30-9-8-21-23(30)19(12-31(21)15(3)32)18-11-28-20-10-16(26)6-7-17(18)20/h6-7,10-11,13-14,19,21-23,27-28H,8-9,12H2,1-5H3,(H,29,33)/t13-,14+,19+,21+,22-,23+/m0/s1",AIFHCXCKGHNBDU-ZPTGBFNDSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
242,12096157,,11591256,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2cccc(c2)C(O)=O)c1=O,"3-[6-methyl-3-oxo-4-[3-(trifluoromethyl)phenyl]-1H-dipyrazolo[4,3-b:4',5'-e]pyridin-2-yl]benzoic acid","InChI=1S/C22H14F3N5O3/c1-29-19-15(10-26-29)18-16(17(27-19)11-4-2-6-13(8-11)22(23,24)25)20(31)30(28-18)14-7-3-5-12(9-14)21(32)33/h2-10,28H,1H3,(H,32,33)",ZWRQPEWYISPCJH-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.32,cancer,Inhibition,
243,67036197,,,CC(C)(C)OC(=O)Cc1ccc(Cl)c(F)c1-n1c(nc(C(O)=O)c1-c1ccc(F)c(Cl)c1)C1CCCCC1,,"InChI=1S/C28H28Cl2F2N2O4/c1-28(2,3)38-21(35)14-17-9-11-18(29)22(32)24(17)34-25(16-10-12-20(31)19(30)13-16)23(27(36)37)33-26(34)15-7-5-4-6-8-15/h9-13,15H,4-8,14H2,1-3H3,(H,36,37)",DSHOMFHFLKCSNZ-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,8.82,cancer,Inhibition,
244,24968164,2315834,,CC(C)C1=C(SC2=N[C@](C)([C@H](N12)c1ccc(Cl)cc1)c1ccc(Cl)cc1)C(=O)N1CCNC(=O)C1,"4-[(5S,6R)-5,6-bis(4-chlorophenyl)-6-methyl-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazole-2-carbonyl]piperazin-2-one","InChI=1S/C26H26Cl2N4O2S/c1-15(2)21-22(24(34)31-13-12-29-20(33)14-31)35-25-30-26(3,17-6-10-19(28)11-7-17)23(32(21)25)16-4-8-18(27)9-5-16/h4-11,15,23H,12-14H2,1-3H3,(H,29,33)/t23-,26+/m1/s1",LRLCSDTXRWLHPZ-BVAGGSTKSA-N,1,0,0,0,MDM2-Like / P53,7.06,cancer,Inhibition,
245,44579160,475914,24697288,CN(C)c1cccc(Sc2ccc(\C=C\C(=O)N3CCOCC3)c(c2C(F)(F)F)C(F)(F)F)c1,"(E)-3-[4-[3-(dimethylamino)phenyl]sulfanyl-2,3-bis(trifluoromethyl)phenyl]-1-morpholin-4-ylprop-2-en-1-one","InChI=1S/C23H22F6N2O2S/c1-30(2)16-4-3-5-17(14-16)34-18-8-6-15(7-9-19(32)31-10-12-33-13-11-31)20(22(24,25)26)21(18)23(27,28)29/h3-9,14H,10-13H2,1-2H3/b9-7+",ZTKAYKYKKPDCAJ-VQHVLOKHSA-N,1,0,0,0,LFA / ICAM,7.64,immune system disease,Inhibition,
246,58007097,,,CC(C)CN(CC(=O)N1CCN(CC1)C(C)=O)C(=O)C1=C(C(C)C)N2[C@H](c3ccc(Cl)cc3)[C@@](C)(N=C2S1)c1ccc(Cl)cc1,"(5R,6S)-N-[2-(4-acetylpiperazin-1-yl)-2-oxoethyl]-5,6-bis(4-chlorophenyl)-6-methyl-N-(2-methylpropyl)-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazole-2-carboxamide","InChI=1S/C34H41Cl2N5O3S/c1-21(2)19-40(20-28(43)39-17-15-38(16-18-39)23(5)42)32(44)30-29(22(3)4)41-31(24-7-11-26(35)12-8-24)34(6,37-33(41)45-30)25-9-13-27(36)14-10-25/h7-14,21-22,31H,15-20H2,1-6H3/t31-,34+/m1/s1",SHAUOSYVPXCRBM-FJQKOURKSA-N,1,0,0,0,MDM2-Like / P53,7.74,cancer,Inhibition,
247,45139136,,,CN[C@@H](C)C(=O)N[C@@H](COC)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2c1ncccn1)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(2S)-1-[(3aR,6S,6aR)-6-(6-fluoro-1H-indol-3-yl)-4-pyrimidin-2-yl-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-3-methoxy-1-oxopropan-2-yl]-2-(methylamino)propanamide","InChI=1S/C26H32FN7O3/c1-15(28-2)24(35)32-21(14-37-3)25(36)33-10-7-22-23(33)19(13-34(22)26-29-8-4-9-30-26)18-12-31-20-11-16(27)5-6-17(18)20/h4-6,8-9,11-12,15,19,21-23,28,31H,7,10,13-14H2,1-3H3,(H,32,35)/t15-,19+,21-,22+,23+/m0/s1",NNRIFUQRJIMVER-CGLVNMBPSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
248,168318264,,,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(cc2)-c2ccccc2)c1=O,,"InChI=1S/C27H18F3N5O/c1-34-25-21(15-31-34)24-22(23(32-25)18-8-5-9-19(14-18)27(28,29)30)26(36)35(33-24)20-12-10-17(11-13-20)16-6-3-2-4-7-16/h2-15,33H,1H3",HDIHMXRUMDPQKQ-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.41,cancer,Inhibition,
249,94251175,,5012370,COc1ccc(cc1)[C@@H]1C2=C(N=c3s\c(=C/c4ccc(OCc5cccc(C(=O)O)c5)c(OC)c4)c(=O)n13)c1ccccc1CC2,,"InChI=1S/C37H30N2O6S/c1-43-27-14-11-25(12-15-27)34-29-16-13-24-7-3-4-9-28(24)33(29)38-37-39(34)35(40)32(46-37)20-22-10-17-30(31(19-22)44-2)45-21-23-6-5-8-26(18-23)36(41)42/h3-12,14-15,17-20,34H,13,16,21H2,1-2H3,(H,41,42)/b32-20-/t34-/m1/s1",GNFYUMDTXAXKFG-IKHSWBDUSA-N,2,0,0,0,BCL2-Like / BAX,4.76,cancer,Inhibition,
250,168318263,,,CC(C)C1=C(SC2=N[C@](C)([C@@H](N12)c1ccc(Cl)cc1)c1ccc(Cl)cc1)C(=O)NCC(N)=O,"N-(2-amino-2-oxoethyl)-5,6-bis(4-chlorophenyl)-6-methyl-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazole-2-carboxamide","InChI=1S/C24H24Cl2N4O2S/c1-13(2)19-20(22(32)28-12-18(27)31)33-23-29-24(3,15-6-10-17(26)11-7-15)21(30(19)23)14-4-8-16(25)9-5-14/h4-11,13,21H,12H2,1-3H3,(H2,27,31)(H,28,32)/t21-,24-/m0/s1",WSTLPNXJKMWFQZ-URXFXBBRSA-N,1,0,0,0,MDM2-Like / P53,7.29,cancer,Inhibition,
251,1874294,567426,24632508,Brc1ccc(cc1)[C@H]1Oc2ccccc2C2=C1[C@H](c1ccc(Br)cc1)n1ncnc1N2,,"InChI=1S/C24H16Br2N4O/c25-16-9-5-14(6-10-16)22-20-21(29-24-27-13-28-30(22)24)18-3-1-2-4-19(18)31-23(20)15-7-11-17(26)12-8-15/h1-13,22-23H,(H,27,28,29)/t22-,23+/m0/s1",HNNGTASVWGJHBY-XZOQPEGZSA-N,1,0,0,0,MDM2-Like / P53,5.91,cancer,Inhibition,
252,59452414,,,OCc1cc(Nc2cc(F)c3N(CCc4c[nH]c5ccccc45)CCOc3c2)ccn1,"[4-[[5-fluoro-4-[2-(1H-indol-3-yl)ethyl]-2,3-dihydro-1,4-benzoxazin-7-yl]amino]pyridin-2-yl]methanol","InChI=1S/C24H23FN4O2/c25-21-12-18(28-17-5-7-26-19(11-17)15-30)13-23-24(21)29(9-10-31-23)8-6-16-14-27-22-4-2-1-3-20(16)22/h1-5,7,11-14,27,30H,6,8-10,15H2,(H,26,28)",YYUHVSFHPFDNGR-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,5.00,cancer,Inhibition,
253,69891675,,,Clc1cc(Cl)cc(c1)N1C(=O)[C@@H]2C[C@@H](CN2C1=O)OCc1cccc(Br)c1,,"InChI=1S/C19H15BrCl2N2O3/c20-12-3-1-2-11(4-12)10-27-16-8-17-18(25)24(19(26)23(17)9-16)15-6-13(21)5-14(22)7-15/h1-7,16-17H,8-10H2/t16-,17-/m0/s1",JZZJIKPLQRKHRV-IRXDYDNUSA-N,0,1,0,0,LFA / ICAM,6.12,immune system disease,Inhibition,
254,1776172,,5019715,COc1ccccc1[C@@H]1C2=C(N=c3s\c(=C/c4cccc(OCC(O)=O)c4)c(=O)n13)c1ccccc1CC2,,"InChI=1S/C30H24N2O5S/c1-36-24-12-5-4-11-22(24)28-23-14-13-19-8-2-3-10-21(19)27(23)31-30-32(28)29(35)25(38-30)16-18-7-6-9-20(15-18)37-17-26(33)34/h2-12,15-16,28H,13-14,17H2,1H3,(H,33,34)/b25-16-/t28-/m1/s1",XCPQKGPAGJNOBL-NKYAOSOXSA-N,3,0,0,0,BCL2-Like / BAX,5.51,cancer,Inhibition,
255,168318261,,,COc1c(Nc2ccnc3[C@@H](O)CCc23)ccc(NCCc2c[nH]c3c(CO)cccc23)c1F,"4-[3-fluoro-4-[2-[7-(hydroxymethyl)-1H-indol-3-yl]ethylamino]-2-methoxyanilino]-6,7-dihydro-5H-cyclopenta[b]pyridin-7-ol","InChI=1S/C26H27FN4O3/c1-34-26-21(31-19-10-12-29-25-18(19)5-8-22(25)33)7-6-20(23(26)27)28-11-9-15-13-30-24-16(14-32)3-2-4-17(15)24/h2-4,6-7,10,12-13,22,28,30,32-33H,5,8-9,11,14H2,1H3,(H,29,31)/t22-/m0/s1",WYFMKEQCIHBTJO-QFIPXVFZSA-N,1,1,0,0,MDM2-Like / P53,6.04,cancer,Inhibition,
256,59555781,,,C(Cc1c[nH]c2ccccc12)Nc1ccc(Nc2ccnc3[nH]ccc23)cc1,"1-N-[2-(1H-indol-3-yl)ethyl]-4-N-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzene-1,4-diamine","InChI=1S/C23H21N5/c1-2-4-21-19(3-1)16(15-27-21)9-12-24-17-5-7-18(8-6-17)28-22-11-14-26-23-20(22)10-13-25-23/h1-8,10-11,13-15,24,27H,9,12H2,(H2,25,26,28)",RCMFPMSEJYQJGV-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,6.00,cancer,Inhibition,
257,67954308,,,Fc1ccc(cc1Cl)-c1c(nc(CC2CCCCC2)n1-c1cccc(Cl)c1F)-c1nn[nH]n1,,"InChI=1S/C23H20Cl2F2N6/c24-15-7-4-8-18(20(15)27)33-19(11-13-5-2-1-3-6-13)28-21(23-29-31-32-30-23)22(33)14-9-10-17(26)16(25)12-14/h4,7-10,12-13H,1-3,5-6,11H2,(H,29,30,31,32)",MQGGQLYFTURIRO-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,8.14,cancer,Inhibition,
258,168318259,,,COC(=O)c1cccc2c(CCNc3ccc(Nc4ccnc5[C@@H](O)CCc45)c(OC)c3F)c[nH]c12,"methyl 3-[2-[2-fluoro-4-[(7-hydroxy-6,7-dihydro-5H-cyclopenta[b]pyridin-4-yl)amino]-3-methoxyanilino]ethyl]-1H-indole-7-carboxylate","InChI=1S/C27H27FN4O4/c1-35-26-21(32-19-11-13-30-25-17(19)6-9-22(25)33)8-7-20(23(26)28)29-12-10-15-14-31-24-16(15)4-3-5-18(24)27(34)36-2/h3-5,7-8,11,13-14,22,29,31,33H,6,9-10,12H2,1-2H3,(H,30,32)/t22-/m0/s1",AJNIRMRAESTAJH-QFIPXVFZSA-N,1,1,0,0,MDM2-Like / P53,6.00,cancer,Inhibition,
259,45138994,,,C[C@H](N)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CC[C@H]2NC[C@@H]([C@@H]12)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(1S)-2-[(3aR,6S,6aR)-6-(6-fluoro-1H-indol-3-yl)-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,2-b]pyrrol-1-yl]-1-cyclohexyl-2-oxoethyl]-2-aminopropanamide","InChI=1S/C25H34FN5O2/c1-14(27)24(32)30-22(15-5-3-2-4-6-15)25(33)31-10-9-20-23(31)19(13-28-20)18-12-29-21-11-16(26)7-8-17(18)21/h7-8,11-12,14-15,19-20,22-23,28-29H,2-6,9-10,13,27H2,1H3,(H,30,32)/t14-,19+,20+,22-,23+/m0/s1",OGPBYLALTFSNEG-JREXFWJNSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
260,44390727,362794,23246750,CC(C)c1ccc(cc1)[C@@H]1N([C@H](C(O)=O)c2ccccc2)C(=O)c2cc(I)ccc2NC1=O,"2-[7-iodo-2,5-dioxo-3-(4-propan-2-ylphenyl)-1,3-dihydro-1,4-benzodiazepin-4-yl]-2-phenylacetic acid","InChI=1S/C26H23IN2O4/c1-15(2)16-8-10-18(11-9-16)22-24(30)28-21-13-12-19(27)14-20(21)25(31)29(22)23(26(32)33)17-6-4-3-5-7-17/h3-15,22-23H,1-2H3,(H,28,30)(H,32,33)/t22-,23-/m0/s1",JTTRNKYMICLIFV-GOTSBHOMSA-N,1,0,0,0,MDM2-Like / P53,4.74,cancer,Inhibition,
261,3738357,,2968450,FC(F)(F)c1cc(nc2cc(nn12)C(=O)NCc1cccs1)-c1cccs1,"5-thiophen-2-yl-N-(thiophen-2-ylmethyl)-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxamide","InChI=1S/C17H11F3N4OS2/c18-17(19,20)14-7-11(13-4-2-6-27-13)22-15-8-12(23-24(14)15)16(25)21-9-10-3-1-5-26-10/h1-8H,9H2,(H,21,25)",LNQURAJSNNFBJI-UHFFFAOYSA-N,1,0,0,0,Myc / Max,4.72,cancer,Inhibition,
262,45138556,,,CN[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2c1ncccn1)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(2S)-1-[(3aR,6S,6aR)-6-(6-fluoro-1H-indol-3-yl)-4-pyrimidin-2-yl-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-3-methyl-1-oxobutan-2-yl]-2-(methylamino)propanamide","InChI=1S/C27H34FN7O2/c1-15(2)23(33-25(36)16(3)29-4)26(37)34-11-8-22-24(34)20(14-35(22)27-30-9-5-10-31-27)19-13-32-21-12-17(28)6-7-18(19)21/h5-7,9-10,12-13,15-16,20,22-24,29,32H,8,11,14H2,1-4H3,(H,33,36)/t16-,20+,22+,23-,24+/m0/s1",WNEYOYVCKLLFFV-JZPZAOSGSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
263,168318257,,,Cc1cc2CN(CCc2c(C)c1C(=O)N[C@@H](CNC(=O)c1ccccc1)C(O)=O)C(=O)c1ccc(Cl)cc1,,"InChI=1S/C29H28ClN3O5/c1-17-14-21-16-33(28(36)20-8-10-22(30)11-9-20)13-12-23(21)18(2)25(17)27(35)32-24(29(37)38)15-31-26(34)19-6-4-3-5-7-19/h3-11,14,24H,12-13,15-16H2,1-2H3,(H,31,34)(H,32,35)(H,37,38)/t24-/m0/s1",VAWPASCNCNMKHW-DEOSSOPVSA-N,0,1,0,0,LFA / ICAM,7.54,immune system disease,Inhibition,
264,44305149,62651,23156050,Cc1cccc(Cl)c1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O,(2S)-2-[(2-chloro-6-methylbenzoyl)amino]-3-(1H-indol-3-yl)propanoic acid,"InChI=1S/C19H17ClN2O3/c1-11-5-4-7-14(20)17(11)18(23)22-16(19(24)25)9-12-10-21-15-8-3-2-6-13(12)15/h2-8,10,16,21H,9H2,1H3,(H,22,23)(H,24,25)/t16-/m0/s1",PMUGSFJFKNRORH-INIZCTEOSA-N,1,0,0,0,LFA / ICAM,6.19,immune system disease,Inhibition,
265,46701726,3342196,,CN1CCN(CCCNc2ncnc3n(ncc23)-c2ccc(OCCCc3sc(nc3C(O)=O)N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)cc2)CC1,"2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-5-[3-[4-[4-[3-(4-methylpiperazin-1-yl)propylamino]pyrazolo[3,4-d]pyrimidin-1-yl]phenoxy]propyl]-1,3-thiazole-4-carboxylic acid","InChI=1S/C43H45N11O4S2/c1-51-20-22-52(23-21-51)18-6-17-44-38-32-25-47-54(39(32)46-27-45-38)29-12-14-30(15-13-29)58-24-5-11-36-37(41(56)57)49-43(60-36)53-19-16-28-7-4-8-31(33(28)26-53)40(55)50-42-48-34-9-2-3-10-35(34)59-42/h2-4,7-10,12-15,25,27H,5-6,11,16-24,26H2,1H3,(H,56,57)(H,44,45,46)(H,48,50,55)",UYKNWWODISPUHU-UHFFFAOYSA-N,1,0,0,0,BCL2-Like / BAX,6.85,cancer,Inhibition,
266,25052265,,,COC(=O)c1cccc(c1)S(=O)(=O)N1[C@@H]([C@H](c2ccc(Cl)cc2)n2c1ccc(C(=O)N1CCN(CC(=O)N3CCOCC3)CC1)c2=O)c1ccc(Cl)cc1,"methyl 3-[[(2R,3S)-2,3-bis(4-chlorophenyl)-6-[4-(2-morpholin-4-yl-2-oxoethyl)piperazine-1-carbonyl]-5-oxo-2,3-dihydroimidazo[1,2-a]pyridin-1-yl]sulfonyl]benzoate","InChI=1S/C38H37Cl2N5O8S/c1-52-38(49)27-3-2-4-30(23-27)54(50,51)45-32-14-13-31(36(47)43-17-15-41(16-18-43)24-33(46)42-19-21-53-22-20-42)37(48)44(32)34(25-5-9-28(39)10-6-25)35(45)26-7-11-29(40)12-8-26/h2-14,23,34-35H,15-22,24H2,1H3/t34-,35+/m0/s1",UPSHSSACCRDPOP-OIDHKYIRSA-N,1,0,0,0,MDM2-Like / P53,6.33,cancer,Inhibition,
267,23646360,181796,23246954,C[C@H](N)C(=O)Nc1nc-2c(CCc3ccccc-23)s1,"(2S)-2-amino-N-(4,5-dihydrobenzo[e][1,3]benzothiazol-2-yl)propanamide","InChI=1S/C14H15N3OS/c1-8(15)13(18)17-14-16-12-10-5-3-2-4-9(10)6-7-11(12)19-14/h2-5,8H,6-7,15H2,1H3,(H,16,17,18)/t8-/m0/s1",DILLNEYKYRQUAB-QMMMGPOBSA-N,1,0,0,0,XIAP / Smac,5.25,cancer,Inhibition,
268,24754886,481422,24700386,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S)-N-benzhydryl-6-[[(2S)-2-(methylamino)propanoyl]amino]-5-oxo-2,3,6,7,8,9,10,10a-octahydro-1H-pyrrolo[1,2-a]azocine-3-carboxamide","InChI=1S/C28H36N4O3/c1-19(29-2)26(33)30-23-16-10-9-15-22-17-18-24(32(22)28(23)35)27(34)31-25(20-11-5-3-6-12-20)21-13-7-4-8-14-21/h3-8,11-14,19,22-25,29H,9-10,15-18H2,1-2H3,(H,30,33)(H,31,34)/t19-,22-,23-,24-/m0/s1",XBTLZUHJBOBKRG-HCUBDLJJSA-N,5,2,0,0,XIAP / Smac,7.59,cancer,Inhibition,
269,168318256,,,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(Cl)c(c2)C(=O)Nc2cccc(CO)c2)c1=O,,"InChI=1S/C29H20ClF3N6O3/c1-38-26-21(13-34-38)25-23(24(36-26)16-5-3-6-17(11-16)29(31,32)33)28(42)39(37-25)19-8-9-22(30)20(12-19)27(41)35-18-7-2-4-15(10-18)14-40/h2-13,37,40H,14H2,1H3,(H,35,41)",BUIIMESBGVYSOD-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.00,cancer,Inhibition,
270,44549891,1688305,26393692,CN1c2ncnn2[C@H](C2=C1c1cc(C)ccc1O[C@@H]2c1ccc(Br)cc1)c1ccc(Br)cc1,,"InChI=1S/C26H20Br2N4O/c1-15-3-12-21-20(13-15)24-22(25(33-21)17-6-10-19(28)11-7-17)23(16-4-8-18(27)9-5-16)32-26(31(24)2)29-14-30-32/h3-14,23,25H,1-2H3/t23-,25+/m0/s1",YVBPVLXAHZCKBM-UKILVPOCSA-N,1,0,0,0,MDM2-Like / P53,6.36,cancer,Inhibition,
271,25138063,520870,24718132,CC[C@H](N)C(=O)N[C@H]1CCCC[C@H]2CC[C@H](N2C1=O)C(=O)N[C@H](c1ccccc1)c1ccc2ccccc2c1,"(3S,6S,10aS)-6-[[(2S)-2-aminobutanoyl]amino]-N-[(R)-naphthalen-2-yl(phenyl)methyl]-5-oxo-2,3,6,7,8,9,10,10a-octahydro-1H-pyrrolo[1,2-a]azocine-3-carboxamide","InChI=1S/C32H38N4O3/c1-2-26(33)30(37)34-27-15-9-8-14-25-18-19-28(36(25)32(27)39)31(38)35-29(22-11-4-3-5-12-22)24-17-16-21-10-6-7-13-23(21)20-24/h3-7,10-13,16-17,20,25-29H,2,8-9,14-15,18-19,33H2,1H3,(H,34,37)(H,35,38)/t25-,26-,27-,28-,29+/m0/s1",MKYCFUQCPNJXDQ-MYHRABSESA-N,1,0,0,0,XIAP / Smac,6.12,cancer,Inhibition,
272,51042428,,,COc1ccc(c(CN2CCC(CC2)N2CCc3c(C2)ncnc3NS(=O)(=O)c2ccc(N[C@H](CCN(C)C)CSc3ccccc3)c(c2)S(=O)(=O)C(F)(F)F)c1)-c1ccc(Cl)cc1,"N-[7-[1-[[2-(4-chlorophenyl)-5-methoxyphenyl]methyl]piperidin-4-yl]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl]-4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)benzenesulfonamide","InChI=1S/C45H51ClF3N7O5S3/c1-54(2)21-17-34(29-62-37-7-5-4-6-8-37)52-41-16-14-38(26-43(41)63(57,58)45(47,48)49)64(59,60)53-44-40-20-24-56(28-42(40)50-30-51-44)35-18-22-55(23-19-35)27-32-25-36(61-3)13-15-39(32)31-9-11-33(46)12-10-31/h4-16,25-26,30,34-35,52H,17-24,27-29H2,1-3H3,(H,50,51,53)/t34-/m1/s1",SEIDCGVQBYNKNC-UUWRZZSWSA-N,1,0,0,0,BCL2-Like / BAX,7.47,cancer,Inhibition,
273,506221,493942,442052,Brc1ccc2[nH]cc(C(=O)C(=O)N3CCN(CC3)C(=O)c3ccccc3)c2c1,"1-(4-benzoylpiperazin-1-yl)-2-(5-bromo-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C21H18BrN3O3/c22-15-6-7-18-16(12-15)17(13-23-18)19(26)21(28)25-10-8-24(9-11-25)20(27)14-4-2-1-3-5-14/h1-7,12-13,23H,8-11H2",OLEQTQPSKHWASS-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,5.96,HIV infectious disease,Inhibition,
274,67954111,,,Cn1ccc2ccc(cc12)-c1nc(-c2nn[nH]n2)c(-c2ccc(F)c(Cl)c2)n1-c1cccc(Cl)c1F,,"InChI=1S/C25H15Cl2F2N7/c1-35-10-9-13-5-6-15(12-20(13)35)25-30-22(24-31-33-34-32-24)23(14-7-8-18(28)17(27)11-14)36(25)19-4-2-3-16(26)21(19)29/h2-12H,1H3,(H,31,32,33,34)",CKRVHNGANXERQS-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,8.13,cancer,Inhibition,
275,45137200,,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2Cc1ncc(C)s1)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(1S)-2-[(3aR,6S,6aR)-6-(6-fluoro-1H-indol-3-yl)-4-[(5-methyl-1,3-thiazol-2-yl)methyl]-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-1-cyclohexyl-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C31H41FN6O2S/c1-18-14-35-27(41-18)17-37-16-24(23-15-34-25-13-21(32)9-10-22(23)25)29-26(37)11-12-38(29)31(40)28(20-7-5-4-6-8-20)36-30(39)19(2)33-3/h9-10,13-15,19-20,24,26,28-29,33-34H,4-8,11-12,16-17H2,1-3H3,(H,36,39)/t19-,24+,26+,28-,29+/m0/s1",OIGOMRZKAWMDEY-UQCFCHBKSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
276,46883828,1092185,24670889,CN[C@@H](C)C(=O)N[C@@H](C1CCOCC1)C(=O)N1CCC[C@H]1c1nc(c(s1)C#CCO)-c1cccc2ccccc12,"(2S)-N-[(1S)-2-[(2S)-2-[5-(3-hydroxyprop-1-ynyl)-4-naphthalen-1-yl-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(oxan-4-yl)-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C31H36N4O4S/c1-20(32-2)29(37)33-27(22-14-18-39-19-15-22)31(38)35-16-6-12-25(35)30-34-28(26(40-30)13-7-17-36)24-11-5-9-21-8-3-4-10-23(21)24/h3-5,8-11,20,22,25,27,32,36H,6,12,14-19H2,1-2H3,(H,33,37)/t20-,25-,27-/m0/s1",CEVZTZIVXIOUAQ-OICBGKIFSA-N,1,0,0,0,XIAP / Smac,7.51,cancer,Inhibition,
277,44573758,492965,24705139,C\C=C\n1cc(C(=O)C(=O)N2CCN(CC2)C(=O)c2ccccc2)c2ccccc12,"1-(4-benzoylpiperazin-1-yl)-2-[1-[(E)-prop-1-enyl]indol-3-yl]ethane-1,2-dione","InChI=1S/C24H23N3O3/c1-2-12-27-17-20(19-10-6-7-11-21(19)27)22(28)24(30)26-15-13-25(14-16-26)23(29)18-8-4-3-5-9-18/h2-12,17H,13-16H2,1H3/b12-2+",RBKSLBLKMUKBOV-SWGQDTFXSA-N,0,1,0,0,CD4 / gp120,5.17,HIV infectious disease,Inhibition,
278,140459313,,,COC(=O)[C@H](Cc1ccc(cc1)C#Cc1ccccc1)NC(=O)CNC(=O)[C@H](NC(N)=N)C(C)(C)C,"methyl (2S)-2-[[2-[[(2S)-2-(diaminomethylideneamino)-3,3-dimethylbutanoyl]amino]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate","InChI=1S/C27H33N5O4/c1-27(2,3)23(32-26(28)29)24(34)30-17-22(33)31-21(25(35)36-4)16-20-14-12-19(13-15-20)11-10-18-8-6-5-7-9-18/h5-9,12-15,21,23H,16-17H2,1-4H3,(H,30,34)(H,31,33)(H4,28,29,32)/t21-,23-/m0/s1",JWVTXNFJOZMBPJ-GMAHTHKFSA-N,1,0,0,0,IL2 / IL2R,5.05,immune system disease,Inhibition,
279,506228,494349,442059,CCc1cccc2c(c[nH]c12)C(=O)C(=O)N1CCN(CC1)C(=O)c1ccccc1,"1-(4-benzoylpiperazin-1-yl)-2-(7-ethyl-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C23H23N3O3/c1-2-16-9-6-10-18-19(15-24-20(16)18)21(27)23(29)26-13-11-25(12-14-26)22(28)17-7-4-3-5-8-17/h3-10,15,24H,2,11-14H2,1H3",SOJNRYBLJMNPPN-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,7.62,HIV infectious disease,Inhibition,
280,46220746,1094115,24668191,CN1C(=O)N(C(=O)[C@]11CN(C[C@H]1c1ccc(cc1)C#N)c1cc(ccn1)C(O)=O)c1cc(Cl)cc(Cl)c1,"2-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl]pyridine-4-carboxylic acid","InChI=1S/C26H19Cl2N5O4/c1-31-25(37)33(20-10-18(27)9-19(28)11-20)24(36)26(31)14-32(22-8-17(23(34)35)6-7-30-22)13-21(26)16-4-2-15(12-29)3-5-16/h2-11,21H,13-14H2,1H3,(H,34,35)/t21-,26+/m0/s1",AVVRVUNGRRWPNF-HFZDXXHNSA-N,1,0,0,0,LFA / ICAM,8.44,immune system disease,Inhibition,
281,58531644,,,CC(C)CN(Cc1cc(Cl)cc(CN(CC(C)C)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)c1)C(=O)c1cccc(c1)S(=O)(=O)C(F)(F)F,"N-[[3-chloro-5-[[(3,5-dichloro-2-hydroxyphenyl)sulfonyl-(2-methylpropyl)amino]methyl]phenyl]methyl]-N-(2-methylpropyl)-3-(trifluoromethylsulfonyl)benzamide","InChI=1S/C30H32Cl3F3N2O6S2/c1-18(2)14-37(29(40)22-6-5-7-25(11-22)45(41,42)30(34,35)36)16-20-8-21(10-23(31)9-20)17-38(15-19(3)4)46(43,44)27-13-24(32)12-26(33)28(27)39/h5-13,18-19,39H,14-17H2,1-4H3",CZGXXZXSMNQLKU-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,6.50,cancer,Inhibition,
282,46221189,1095138,24669561,CN1C(=O)N(C(=O)[C@]11CN(C[C@H]1c1ccc(cc1)C#N)c1nc2cccc(C(O)=O)c2o1)c1cc(Cl)cc(Cl)c1,"2-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl]-1,3-benzoxazole-7-carboxylic acid","InChI=1S/C28H19Cl2N5O5/c1-33-27(39)35(19-10-17(29)9-18(30)11-19)25(38)28(33)14-34(13-21(28)16-7-5-15(12-31)6-8-16)26-32-22-4-2-3-20(24(36)37)23(22)40-26/h2-11,21H,13-14H2,1H3,(H,36,37)/t21-,28+/m0/s1",LDBCJZLJJWTVHF-RBTNQOKQSA-N,1,0,0,0,LFA / ICAM,8.32,immune system disease,Inhibition,
283,50996771,,,CC(C)(C)OC(=O)Cc1ccc(Cl)c(F)c1-n1c(nc(C(O)=O)c1-c1ccc(F)c(Cl)c1)C1CCCCCC1,1-[3-chloro-2-fluoro-6-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]phenyl]-5-(3-chloro-4-fluorophenyl)-2-cycloheptylimidazole-4-carboxylic acid,"InChI=1S/C29H30Cl2F2N2O4/c1-29(2,3)39-22(36)15-18-10-12-19(30)23(33)25(18)35-26(17-11-13-21(32)20(31)14-17)24(28(37)38)34-27(35)16-8-6-4-5-7-9-16/h10-14,16H,4-9,15H2,1-3H3,(H,37,38)",MSCKVRLDFNRJEN-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,9.00,cancer,Inhibition,
284,168318255,,,CCOc1cc(Nc2ccnc(c2)[C@H](C)O)ccc1NCCc1c[nH]c2cc(OC)ccc12,1-[4-[3-ethoxy-4-[2-(6-methoxy-1H-indol-3-yl)ethylamino]anilino]pyridin-2-yl]ethanol,"InChI=1S/C26H30N4O3/c1-4-33-26-14-19(30-20-10-12-28-24(13-20)17(2)31)5-8-23(26)27-11-9-18-16-29-25-15-21(32-3)6-7-22(18)25/h5-8,10,12-17,27,29,31H,4,9,11H2,1-3H3,(H,28,30)/t17-/m0/s1",QINUJAURWORMBP-KRWDZBQOSA-N,1,1,0,0,MDM2-Like / P53,6.10,cancer,Inhibition,
285,168318254,,,COc1cccc(CN2CCN(CC2)c2ccc(cc2)C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN(C)C)CSc3ccccc3)c(c2)N(=O)=O)c1,,"InChI=1S/C37H44N6O6S2/c1-40(2)19-18-30(27-50-33-10-5-4-6-11-33)38-35-17-16-34(25-36(35)43(45)46)51(47,48)39-37(44)29-12-14-31(15-13-29)42-22-20-41(21-23-42)26-28-8-7-9-32(24-28)49-3/h4-17,24-25,30,38H,18-23,26-27H2,1-3H3,(H,39,44)/t30-/m1/s1",MLRWWNYWQBGLIR-SSEXGKCCSA-N,2,0,0,0,BCL2-Like / BAX,9.30,cancer,Inhibition,
286,9846275,,8021989,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(Cl)cc2)c1=O,"2-(4-chlorophenyl)-6-methyl-4-[3-(trifluoromethyl)phenyl]-1H-dipyrazolo[4,3-b:4',5'-e]pyridin-3-one","InChI=1S/C21H13ClF3N5O/c1-29-19-15(10-26-29)18-16(20(31)30(28-18)14-7-5-13(22)6-8-14)17(27-19)11-3-2-4-12(9-11)21(23,24)25/h2-10,28H,1H3",RPACVNBASWYIPR-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.22,cancer,Inhibition,
287,57809304,,,CCOc1cc(NC(=O)C(C)(C)C)ccc1C1=N[C@H]([C@H](N1C(=O)N1CCNC(=O)C1)c1ccc(Cl)cc1)c1ccc(Cl)cc1,"N-[4-[(4S,5R)-4,5-bis(4-chlorophenyl)-1-(3-oxopiperazine-1-carbonyl)-4,5-dihydroimidazol-2-yl]-3-ethoxyphenyl]-2,2-dimethylpropanamide","InChI=1S/C33H35Cl2N5O4/c1-5-44-26-18-24(37-31(42)33(2,3)4)14-15-25(26)30-38-28(20-6-10-22(34)11-7-20)29(21-8-12-23(35)13-9-21)40(30)32(43)39-17-16-36-27(41)19-39/h6-15,18,28-29H,5,16-17,19H2,1-4H3,(H,36,41)(H,37,42)/t28-,29+/m0/s1",DTPBPJCWDDNTPF-URLMMPGGSA-N,1,0,0,0,MDM2-Like / P53,6.80,cancer,Inhibition,
288,168318252,,,O[C@H]1CCc2c1nccc2Nc1ccc2N(CCc3c[nH]c4ccccc34)C(=O)C(F)(F)Oc2c1,"2,2-difluoro-7-[(7-hydroxy-6,7-dihydro-5H-cyclopenta[b]pyridin-4-yl)amino]-4-[2-(1H-indol-3-yl)ethyl]-1,4-benzoxazin-3-one","InChI=1S/C26H22F2N4O3/c27-26(28)25(34)32(12-10-15-14-30-19-4-2-1-3-17(15)19)21-7-5-16(13-23(21)35-26)31-20-9-11-29-24-18(20)6-8-22(24)33/h1-5,7,9,11,13-14,22,30,33H,6,8,10,12H2,(H,29,31)/t22-/m0/s1",ZEDNSWQGKRIKJS-QFIPXVFZSA-N,1,0,0,0,MDM2-Like / P53,6.52,cancer,Inhibition,
289,17754765,2386350,24750956,CCOc1cc(ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@](C)(N1C(=O)N1CCN(CC(=O)N2CCOCC2)CC1)c1ccc(Cl)cc1)C(C)(C)C,"2-[4-[(4S,5R)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethylimidazole-1-carbonyl]piperazin-1-yl]-1-morpholin-4-ylethanone","InChI=1S/C40H49Cl2N5O4/c1-7-51-34-26-30(38(2,3)4)12-17-33(34)36-43-39(5,28-8-13-31(41)14-9-28)40(6,29-10-15-32(42)16-11-29)47(36)37(49)46-20-18-44(19-21-46)27-35(48)45-22-24-50-25-23-45/h8-17,26H,7,18-25,27H2,1-6H3/t39-,40+/m0/s1",DJZBZZRLUQDRII-IOLBBIBUSA-N,1,0,0,0,MDM2-Like / P53,7.72,cancer,Inhibition,
290,44818496,568851,24630510,CN(C)c1nc(NCc2ccc(NC(=O)c3ccc(F)cc3)cc2)c2ccc(C)cc2n1,N-[4-[[[2-(dimethylamino)-7-methylquinazolin-4-yl]amino]methyl]phenyl]-4-fluorobenzamide,"InChI=1S/C25H24FN5O/c1-16-4-13-21-22(14-16)29-25(31(2)3)30-23(21)27-15-17-5-11-20(12-6-17)28-24(32)18-7-9-19(26)10-8-18/h4-14H,15H2,1-3H3,(H,28,32)(H,27,29,30)",RGFXAEWWEUXTCN-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,6.34,cancer,Inhibition,
291,25025710,568853,24630682,CNc1nc(NCc2ccc(NC(=O)c3ccc(Cl)cc3)cc2)c2cc(C)ccc2n1,4-chloro-N-[4-[[[6-methyl-2-(methylamino)quinazolin-4-yl]amino]methyl]phenyl]benzamide,"InChI=1S/C24H22ClN5O/c1-15-3-12-21-20(13-15)22(30-24(26-2)29-21)27-14-16-4-10-19(11-5-16)28-23(31)17-6-8-18(25)9-7-17/h3-13H,14H2,1-2H3,(H,28,31)(H2,26,27,29,30)",RGPXAJSDCKQSRK-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,6.23,cancer,Inhibition,
292,50996416,,,Cc1ccc(cc1C)-c1nc(C(O)=O)c(-c2cccc(Cl)c2)n1-c1cc(Cl)ccc1C,"1-(5-chloro-2-methylphenyl)-5-(3-chlorophenyl)-2-(3,4-dimethylphenyl)imidazole-4-carboxylic acid","InChI=1S/C25H20Cl2N2O2/c1-14-7-9-18(11-16(14)3)24-28-22(25(30)31)23(17-5-4-6-19(26)12-17)29(24)21-13-20(27)10-8-15(21)2/h4-13H,1-3H3,(H,30,31)",PHCHYXZJSSQRHH-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,7.01,cancer,Inhibition,
293,44574953,467309,24692938,OC[C@@H]1[C@H]2Cn3c(cccc3=O)[C@H]2N(CC2CCCCC2)[C@H]1C(=O)N[C@@H]1CCN(Cc2ccccc2)C1,"(2R,3R,3aS,9bS)-N-[(3S)-1-benzylpyrrolidin-3-yl]-1-(cyclohexylmethyl)-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide","InChI=1S/C30H40N4O3/c35-20-25-24-19-33-26(12-7-13-27(33)36)28(24)34(17-22-10-5-2-6-11-22)29(25)30(37)31-23-14-15-32(18-23)16-21-8-3-1-4-9-21/h1,3-4,7-9,12-13,22-25,28-29,35H,2,5-6,10-11,14-20H2,(H,31,37)/t23-,24-,25-,28+,29-/m1/s1",HIGRFICTTRTBSR-JYXIKEANSA-N,1,0,0,0,BCL2-Like / BAX,5.11,cancer,Inhibition,
294,23647741,,,CN[C@@H](C)C(=O)N[C@H]1CCC[C@@H]2SC(C)(C)[C@H](N2C1=O)C(=O)Nc1cc(C)nn1-c1ccccc1,"(3R,6R,9aR)-2,2-dimethyl-6-[[(2S)-2-(methylamino)propanoyl]amino]-N-(5-methyl-2-phenylpyrazol-3-yl)-5-oxo-3,6,7,8,9,9a-hexahydro-[1,3]thiazolo[3,2-a]azepine-3-carboxamide","InChI=1S/C25H34N6O3S/c1-15-14-19(31(29-15)17-10-7-6-8-11-17)28-23(33)21-25(3,4)35-20-13-9-12-18(24(34)30(20)21)27-22(32)16(2)26-5/h6-8,10-11,14,16,18,20-21,26H,9,12-13H2,1-5H3,(H,27,32)(H,28,33)/t16-,18-,20-,21+/m0/s1",RBLGKKZTMVKMNE-BVPXEZJJSA-N,1,0,0,0,XIAP / Smac,5.63,cancer,Inhibition,
295,16741970,,20573267,C(Cc1c[nH]c2ncccc12)Nc1ccc(Nc2ccncc2)cc1,"4-N-pyridin-4-yl-1-N-[2-(1H-pyrrolo[2,3-b]pyridin-3-yl)ethyl]benzene-1,4-diamine","InChI=1S/C20H19N5/c1-2-19-15(14-24-20(19)23-10-1)7-13-22-16-3-5-17(6-4-16)25-18-8-11-21-12-9-18/h1-6,8-12,14,22H,7,13H2,(H,21,25)(H,23,24)",WUSPPSCYKHDCEC-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,5.52,cancer,Inhibition,
296,11570828,450871,24687699,OC(=O)[C@H]1CC[C@@H](CC1)CNc1cccc(c1)Sc1ccc(\C=C\C(=O)N2CCOCC2)c(C(F)(F)F)c1C(F)(F)F,"4-[[3-[4-[(E)-3-morpholin-4-yl-3-oxoprop-1-enyl]-2,3-bis(trifluoromethyl)phenyl]sulfanylanilino]methyl]cyclohexane-1-carboxylic acid","InChI=1S/C29H30F6N2O4S/c30-28(31,32)25-19(9-11-24(38)37-12-14-41-15-13-37)8-10-23(26(25)29(33,34)35)42-22-3-1-2-21(16-22)36-17-18-4-6-20(7-5-18)27(39)40/h1-3,8-11,16,18,20,36H,4-7,12-15,17H2,(H,39,40)/b11-9+/t18-,20-",DMEDNZSJTBCBCR-QFBLVHQRSA-N,1,0,0,0,LFA / ICAM,8.85,immune system disease,Inhibition,
297,44390698,180799,23246721,CC(C)(C)c1ccc(cc1)[C@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)Nc2ccc(I)cc2C1=O)C(O)=O,"2-(4-tert-butylphenyl)-2-[3-(4-chlorophenyl)-7-iodo-2,5-dioxo-1,3-dihydro-1,4-benzodiazepin-4-yl]acetic acid","InChI=1S/C27H24ClIN2O4/c1-27(2,3)17-8-4-16(5-9-17)23(26(34)35)31-22(15-6-10-18(28)11-7-15)24(32)30-21-13-12-19(29)14-20(21)25(31)33/h4-14,22-23H,1-3H3,(H,30,32)(H,34,35)/t22-,23-/m0/s1",ZZCIFFMKXWTSJV-GOTSBHOMSA-N,1,0,0,0,MDM2-Like / P53,5.64,cancer,Inhibition,
298,25108965,,,CN[C@@H](C)C(=O)Nc1ncc(-c2ccccc2)n(CC(=O)N[C@@H]2CCCc3ccccc23)c1=O,"(2S)-2-(methylamino)-N-[3-oxo-4-[2-oxo-2-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]amino]ethyl]-5-phenylpyrazin-2-yl]propanamide","InChI=1S/C26H29N5O3/c1-17(27-2)25(33)30-24-26(34)31(22(15-28-24)19-10-4-3-5-11-19)16-23(32)29-21-14-8-12-18-9-6-7-13-20(18)21/h3-7,9-11,13,15,17,21,27H,8,12,14,16H2,1-2H3,(H,29,32)(H,28,30,33)/t17-,21+/m0/s1",WCTBSPJRJYXYSQ-LAUBAEHRSA-N,1,0,0,0,XIAP / Smac,6.00,cancer,Inhibition,
299,168318246,,24635022,CC(C)C[C@H]1CN(CCN1C(=O)c1ccccc1)C(=O)C(=O)c1c[nH]c2cccc(F)c12,"1-[4-benzoyl-3-(2-methylpropyl)piperazin-1-yl]-2-(4-fluoro-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C25H26FN3O3/c1-16(2)13-18-15-28(11-12-29(18)24(31)17-7-4-3-5-8-17)25(32)23(30)19-14-27-21-10-6-9-20(26)22(19)21/h3-10,14,16,18,27H,11-13,15H2,1-2H3/t18-/m0/s1",WSCMWUHPGDJGCX-SFHVURJKSA-N,0,1,0,0,CD4 / gp120,6.52,HIV infectious disease,Inhibition,
300,168318247,,442121,C[C@H]1CN(CCN1C(=O)c1ccccc1)C(=O)C(=O)c1c[nH]c2cccc(F)c12,"1-(4-benzoyl-3-methylpiperazin-1-yl)-2-(4-fluoro-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C22H20FN3O3/c1-14-13-25(10-11-26(14)21(28)15-6-3-2-4-7-15)22(29)20(27)16-12-24-18-9-5-8-17(23)19(16)18/h2-9,12,14,24H,10-11,13H2,1H3/t14-/m0/s1",PNJPCIYMKXINDN-AWEZNQCLSA-N,0,1,0,0,CD4 / gp120,8.59,HIV infectious disease,Inhibition,
301,67954180,3260820,,Nc1nnc(o1)-c1nc(C2CCCCC2)n(c1-c1ccc(F)c(Cl)c1)-c1c(CC(=O)Nc2ccccc2)ccc(Cl)c1F,,"InChI=1S/C31H26Cl2F2N6O2/c32-21-13-11-19(16-24(42)37-20-9-5-2-6-10-20)27(25(21)35)41-28(18-12-14-23(34)22(33)15-18)26(30-39-40-31(36)43-30)38-29(41)17-7-3-1-4-8-17/h2,5-6,9-15,17H,1,3-4,7-8,16H2,(H2,36,40)(H,37,42)",LVTCZQLXJGEKOF-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,8.15,cancer,Inhibition,
302,168318239,,8068050,CC(C)c1ccccc1Sc1ccc([C@@H]2C[C@H]2C(=O)NCCCN2CCCC2=O)c(Cl)c1Cl,"2-[2,3-dichloro-4-(2-propan-2-ylphenyl)sulfanylphenyl]-N-[3-(2-oxopyrrolidin-1-yl)propyl]cyclopropane-1-carboxamide","InChI=1S/C26H30Cl2N2O2S/c1-16(2)17-7-3-4-8-21(17)33-22-11-10-18(24(27)25(22)28)19-15-20(19)26(32)29-12-6-14-30-13-5-9-23(30)31/h3-4,7-8,10-11,16,19-20H,5-6,9,12-15H2,1-2H3,(H,29,32)/t19-,20+/m0/s1",WCVPXAWSKHNQTH-VQTJNVASSA-N,0,1,0,0,LFA / ICAM,8.15,immune system disease,Inhibition,
303,168318235,,,COC1(CCN(CC1)c1ccc(cc1)C(=O)NS(=O)(=O)c1ccc(N[C@H](CCN(C)C)CSc2ccccc2)c(c1)N(=O)=O)C1CCCCC1,,"InChI=1S/C37H49N5O6S2/c1-40(2)23-20-30(27-49-32-12-8-5-9-13-32)38-34-19-18-33(26-35(34)42(44)45)50(46,47)39-36(43)28-14-16-31(17-15-28)41-24-21-37(48-3,22-25-41)29-10-6-4-7-11-29/h5,8-9,12-19,26,29-30,38H,4,6-7,10-11,20-25,27H2,1-3H3,(H,39,43)/t30-/m1/s1",UPFYBJZBOXFORE-SSEXGKCCSA-N,2,0,0,0,BCL2-Like / BAX,9.10,cancer,Inhibition,
304,24775527,,,CCOc1ccsc1C1=N[C@H]([C@H](N1C(=O)N1CCN(CC(=O)N(CCOC)CCOC)CC1)c1ccc(Cl)cc1)c1ccc(Cl)cc1,"2-[4-[(4S,5R)-4,5-bis(4-chlorophenyl)-2-(3-ethoxythiophen-2-yl)-4,5-dihydroimidazole-1-carbonyl]piperazin-1-yl]-N,N-bis(2-methoxyethyl)acetamide","InChI=1S/C34H41Cl2N5O5S/c1-4-46-28-13-22-47-32(28)33-37-30(24-5-9-26(35)10-6-24)31(25-7-11-27(36)12-8-25)41(33)34(43)40-16-14-38(15-17-40)23-29(42)39(18-20-44-2)19-21-45-3/h5-13,22,30-31H,4,14-21,23H2,1-3H3/t30-,31+/m0/s1",BMPLFFGITZVCDB-IOWSJCHKSA-N,1,0,0,0,MDM2-Like / P53,7.27,cancer,Inhibition,
305,168318147,,,C[C@H](N1CCC(CC1)N1CCc2c(C1)ncnc2NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(c1)S(=O)(=O)C(F)(F)F)c1cc(F)ccc1-c1ccc(Cl)cc1,,"InChI=1S/C47H52ClF4N7O5S3/c1-32(42-27-35(49)11-13-40(42)33-7-9-34(48)10-8-33)58-20-16-37(17-21-58)59-22-18-41-44(29-59)53-31-54-46(41)56-67(62,63)39-12-14-43(45(28-39)66(60,61)47(50,51)52)55-36(15-19-57-23-25-64-26-24-57)30-65-38-5-3-2-4-6-38/h2-14,27-28,31-32,36-37,55H,15-26,29-30H2,1H3,(H,53,54,56)/t32-,36+/m0/s1",QFFLMZYKGGAUPT-LBHUVFDKSA-N,1,0,0,0,BCL2-Like / BAX,7.08,cancer,Inhibition,
306,44251267,506763,24713380,OC[C@H]1[C@@H]2Cn3c(cccc3=O)[C@@H]2N(Cc2ccc(Cl)c(Cl)c2)[C@@H]1C(=O)N1CCC(Cc2ccccc2)CC1,"(2S,3S,3aR,9bR)-2-(4-benzylpiperidine-1-carbonyl)-1-[(3,4-dichlorophenyl)methyl]-3-(hydroxymethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one","InChI=1S/C31H33Cl2N3O3/c32-25-10-9-22(16-26(25)33)17-36-29-23(18-35-27(29)7-4-8-28(35)38)24(19-37)30(36)31(39)34-13-11-21(12-14-34)15-20-5-2-1-3-6-20/h1-10,16,21,23-24,29-30,37H,11-15,17-19H2/t23-,24-,29+,30-/m0/s1",HMQKUUULPUCLGV-FCLIQBFMSA-N,1,0,0,0,BCL2-Like / BAX,5.92,cancer,Inhibition,
307,44424320,1206152,25063861,OC(=O)[C@@H]1[C@@H]([C@@H](OC11C(=O)c2ccccc2C1=O)c1ccc(Cl)c(Cl)c1)C(=O)NCc1ccccc1,"(3'R,4'S,5'R)-4'-(benzylcarbamoyl)-5'-(3,4-dichlorophenyl)-1,3-dioxospiro[indene-2,2'-oxolane]-3'-carboxylic acid","InChI=1S/C27H19Cl2NO6/c28-18-11-10-15(12-19(18)29)22-20(25(33)30-13-14-6-2-1-3-7-14)21(26(34)35)27(36-22)23(31)16-8-4-5-9-17(16)24(27)32/h1-12,20-22H,13H2,(H,30,33)(H,34,35)/t20-,21-,22-/m0/s1",ZGIJVJFJJBVNIE-FKBYEOEOSA-N,1,0,0,0,E2 / E1,5.46,human papilloma virus infection,Inhibition,
308,168318245,,,O[C@H]1CCc2c1nccc2Nc1cc(c(NCCc2c[nH]c3ccccc23)c(c1)C(F)(F)F)C(F)(F)F,"4-[4-[2-(1H-indol-3-yl)ethylamino]-3,5-bis(trifluoromethyl)anilino]-6,7-dihydro-5H-cyclopenta[b]pyridin-7-ol","InChI=1S/C26H22F6N4O/c27-25(28,29)18-11-15(36-21-8-10-33-23-17(21)5-6-22(23)37)12-19(26(30,31)32)24(18)34-9-7-14-13-35-20-4-2-1-3-16(14)20/h1-4,8,10-13,22,34-35,37H,5-7,9H2,(H,33,36)/t22-/m0/s1",LSPZUTKLZSBKIG-QFIPXVFZSA-N,1,0,0,0,MDM2-Like / P53,6.52,cancer,Inhibition,
309,58531640,,,CN(C)c1ccc(CNC(=O)c2ccc(CN(Cc3ccc(F)cc3)S(=O)(=O)c3cc(Cl)cc(Cl)c3O)cc2)cc1,"4-[[(3,5-dichloro-2-hydroxyphenyl)sulfonyl-[(4-fluorophenyl)methyl]amino]methyl]-N-[[4-(dimethylamino)phenyl]methyl]benzamide","InChI=1S/C30H28Cl2FN3O4S/c1-35(2)26-13-7-20(8-14-26)17-34-30(38)23-9-3-21(4-10-23)18-36(19-22-5-11-25(33)12-6-22)41(39,40)28-16-24(31)15-27(32)29(28)37/h3-16,37H,17-19H2,1-2H3,(H,34,38)",LYPWDZVSBIMIRW-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,6.36,cancer,Inhibition,
310,44573797,522666,24719014,COc1cc2[nH]cc(C(=O)C(=O)N3CCN(CC3)C(=O)c3ccccc3)c2cc1OC,"1-(4-benzoylpiperazin-1-yl)-2-(5,6-dimethoxy-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C23H23N3O5/c1-30-19-12-16-17(14-24-18(16)13-20(19)31-2)21(27)23(29)26-10-8-25(9-11-26)22(28)15-6-4-3-5-7-15/h3-7,12-14,24H,8-11H2,1-2H3",LIDDHGJXWRAWTG-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,7.34,HIV infectious disease,Inhibition,
311,44392038,181569,23248110,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1cc(ncn1)N1CCN(CC1)c1ccccn1,4-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]-6-(4-pyridin-2-ylpiperazin-1-yl)pyrimidine,"InChI=1S/C29H28F3N5S/c1-20(2)22-7-3-4-8-25(22)38-26-11-10-21(17-23(26)29(30,31)32)24-18-28(35-19-34-24)37-15-13-36(14-16-37)27-9-5-6-12-33-27/h3-12,17-20H,13-16H2,1-2H3",DSFIFHBCIUBDGW-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,5.90,immune system disease,Inhibition,
312,23646337,361542,23246963,CC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NCc1ccccc1,(2S)-1-[(2S)-2-[[(2S)-2-aminobutanoyl]amino]-3-methylbutanoyl]-N-benzylpyrrolidine-2-carboxamide,"InChI=1S/C21H32N4O3/c1-4-16(22)19(26)24-18(14(2)3)21(28)25-12-8-11-17(25)20(27)23-13-15-9-6-5-7-10-15/h5-7,9-10,14,16-18H,4,8,11-13,22H2,1-3H3,(H,23,27)(H,24,26)/t16-,17-,18-/m0/s1",QLSCFXXQNWFPJE-BZSNNMDCSA-N,1,0,0,0,XIAP / Smac,7.09,cancer,Inhibition,
313,16656779,,17590060,CCOc1nc(ncc1C1=N[C@H]([C@H](N1C(=O)N1CCNC(=O)C1)c1ccc(Cl)cc1)c1ccc(Cl)cc1)C(C)(C)C,"4-[(4S,5R)-2-(2-tert-butyl-4-ethoxypyrimidin-5-yl)-4,5-bis(4-chlorophenyl)-4,5-dihydroimidazole-1-carbonyl]piperazin-2-one","InChI=1S/C30H32Cl2N6O3/c1-5-41-27-22(16-34-28(36-27)30(2,3)4)26-35-24(18-6-10-20(31)11-7-18)25(19-8-12-21(32)13-9-19)38(26)29(40)37-15-14-33-23(39)17-37/h6-13,16,24-25H,5,14-15,17H2,1-4H3,(H,33,39)/t24-,25+/m0/s1",XPZGWKIAYANWCX-LOSJGSFVSA-N,1,0,0,0,MDM2-Like / P53,7.34,cancer,Inhibition,
314,46884023,1092761,24670729,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1nc2c(cncc2s1)-c1ccccc1,"(2S)-N-[(1S)-1-cyclohexyl-2-oxo-2-[(2S)-2-(7-phenyl-[1,3]thiazolo[5,4-c]pyridin-2-yl)pyrrolidin-1-yl]ethyl]-2-(methylamino)propanamide","InChI=1S/C28H35N5O2S/c1-18(29-2)26(34)31-24(20-12-7-4-8-13-20)28(35)33-15-9-14-22(33)27-32-25-21(16-30-17-23(25)36-27)19-10-5-3-6-11-19/h3,5-6,10-11,16-18,20,22,24,29H,4,7-9,12-15H2,1-2H3,(H,31,34)/t18-,22-,24-/m0/s1",ULSNCAHGMVHVCJ-OEOAZWSVSA-N,1,0,0,0,XIAP / Smac,7.14,cancer,Inhibition,
315,16109156,385119,17266569,COc1ccccc1CN1CCN(CC1)c1ccc(cc1)C(=O)NS(=O)(=O)c1ccc(N[C@H](CCN(C)C)CSc2ccccc2)c(c1)N(=O)=O,N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonyl-4-[4-[(2-methoxyphenyl)methyl]piperazin-1-yl]benzamide,"InChI=1S/C37H44N6O6S2/c1-40(2)20-19-30(27-50-32-10-5-4-6-11-32)38-34-18-17-33(25-35(34)43(45)46)51(47,48)39-37(44)28-13-15-31(16-14-28)42-23-21-41(22-24-42)26-29-9-7-8-12-36(29)49-3/h4-18,25,30,38H,19-24,26-27H2,1-3H3,(H,39,44)/t30-/m1/s1",BMFIKSDWRTVGGF-SSEXGKCCSA-N,2,0,0,0,BCL2-Like / BAX,9.30,cancer,Inhibition,
316,67981072,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2ccccc2Br)CC1,,"InChI=1S/C38H45BrF3N7O4S3/c1-47(2)18-14-28(25-54-30-9-4-3-5-10-30)45-34-13-12-31(22-36(34)55(50,51)38(40,41)42)56(52,53)46-37-32-17-21-49(24-35(32)43-26-44-37)29-15-19-48(20-16-29)23-27-8-6-7-11-33(27)39/h3-13,22,26,28-29,45H,14-21,23-25H2,1-2H3,(H,43,44,46)/t28-/m1/s1",KKXQWLOSHVGUGR-MUUNZHRXSA-N,1,0,0,0,BCL2-Like / BAX,6.30,cancer,Inhibition,
317,59774797,,,COc1cccc(c1)[C@H]1NCC[C@@H](c2cccc(Cl)c2)[C@]11C(=O)Nc2cc(Cl)ccc12,"(2'R,3R,4'S)-6-chloro-4'-(3-chlorophenyl)-2'-(3-methoxyphenyl)spiro[1H-indole-3,3'-piperidine]-2-one","InChI=1S/C25H22Cl2N2O2/c1-31-19-7-3-5-16(13-19)23-25(21-9-8-18(27)14-22(21)29-24(25)30)20(10-11-28-23)15-4-2-6-17(26)12-15/h2-9,12-14,20,23,28H,10-11H2,1H3,(H,29,30)/t20-,23+,25+/m0/s1",NAOXEAONYYDSHS-QUURXOELSA-N,1,0,0,0,MDM2-Like / P53,5.28,cancer,Inhibition,
318,9803375,367808,7979135,CN1C(=O)N(C(=O)[C@@]1(C)Cc1ccc(Br)cc1)c1cc(Cl)cc(Cl)c1,"(5R)-5-[(4-bromophenyl)methyl]-3-(3,5-dichlorophenyl)-1,5-dimethylimidazolidine-2,4-dione","InChI=1S/C18H15BrCl2N2O2/c1-18(10-11-3-5-12(19)6-4-11)16(24)23(17(25)22(18)2)15-8-13(20)7-14(21)9-15/h3-9H,10H2,1-2H3/t18-/m1/s1",FJNJHZQMQRVZEE-GOSISDBHSA-N,0,1,0,0,LFA / ICAM,7.59,immune system disease,Inhibition,
319,44176177,378030,23271713,Fc1cc(Cl)ccc1CN1[C@@H](c2ccc(Cl)cc2)C(=O)N(CCN2CCOCC2)c2ccc(I)cc2C1=O,"(3S)-4-[(4-chloro-2-fluorophenyl)methyl]-3-(4-chlorophenyl)-7-iodo-1-(2-morpholin-4-ylethyl)-3H-1,4-benzodiazepine-2,5-dione","InChI=1S/C28H25Cl2FIN3O3/c29-20-4-1-18(2-5-20)26-28(37)34(10-9-33-11-13-38-14-12-33)25-8-7-22(32)16-23(25)27(36)35(26)17-19-3-6-21(30)15-24(19)31/h1-8,15-16,26H,9-14,17H2/t26-/m0/s1",SZUZMYZODLFEHY-SANMLTNESA-N,1,0,0,0,MDM2-Like / P53,5.07,cancer,Inhibition,
320,44429175,242339,23291044,CC(C)C[C@@H](C(O)=O)N1C(=S)S\C(=C(\C)c2ccccc2)C1=O,"(2S)-4-methyl-2-[(5Z)-4-oxo-5-(1-phenylethylidene)-2-sulfanylidene-1,3-thiazolidin-3-yl]pentanoic acid","InChI=1S/C17H19NO3S2/c1-10(2)9-13(16(20)21)18-15(19)14(23-17(18)22)11(3)12-7-5-4-6-8-12/h4-8,10,13H,9H2,1-3H3,(H,20,21)/b14-11-/t13-/m0/s1",SCEVCEGSVQEIQX-UROBUVALSA-N,1,0,0,0,BCL2-Like / BAX,4.67,cancer,Inhibition,
321,25138071,519256,24718444,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@H](N2C1=O)C(=O)N[C@@H]1CCc2ccccc12,"(3S,6S,10aS)-N-[(1R)-2,3-dihydro-1H-inden-1-yl]-6-[[(2S)-2-(methylamino)propanoyl]amino]-5-oxo-2,3,6,7,8,9,10,10a-octahydro-1H-pyrrolo[1,2-a]azocine-3-carboxamide","InChI=1S/C24H34N4O3/c1-15(25-2)22(29)27-20-10-6-4-8-17-12-14-21(28(17)24(20)31)23(30)26-19-13-11-16-7-3-5-9-18(16)19/h3,5,7,9,15,17,19-21,25H,4,6,8,10-14H2,1-2H3,(H,26,30)(H,27,29)/t15-,17-,19+,20-,21-/m0/s1",NZBNCCVQVQBULF-VPOJOSCRSA-N,1,0,0,0,XIAP / Smac,7.82,cancer,Inhibition,
322,44176182,380399,23271858,CN1CCN(CCCN2c3ccc(I)cc3C(=O)N(Cc3ccc(Cl)cc3N)[C@@H](c3ccc(Cl)cc3)C2=O)CC1,"4-[(2-amino-4-chlorophenyl)methyl]-3-(4-chlorophenyl)-7-iodo-1-[3-(4-methylpiperazin-1-yl)propyl]-3H-1,4-benzodiazepine-2,5-dione","InChI=1S/C30H32Cl2IN5O2/c1-35-13-15-36(16-14-35)11-2-12-37-27-10-9-24(33)18-25(27)29(39)38(19-21-5-8-23(32)17-26(21)34)28(30(37)40)20-3-6-22(31)7-4-20/h3-10,17-18,28H,2,11-16,19,34H2,1H3/t28-/m0/s1",SZOYOLFYNBXVHW-NDEPHWFRSA-N,1,0,0,0,MDM2-Like / P53,5.27,cancer,Inhibition,
323,168318236,,,Cc1cc2CN(CCc2c(C)c1C(=O)N[C@@H](CNC(=O)c1ccco1)C(O)=O)C(=O)c1ccc(Cl)cc1,,"InChI=1S/C27H26ClN3O6/c1-15-12-18-14-31(26(34)17-5-7-19(28)8-6-17)10-9-20(18)16(2)23(15)25(33)30-21(27(35)36)13-29-24(32)22-4-3-11-37-22/h3-8,11-12,21H,9-10,13-14H2,1-2H3,(H,29,32)(H,30,33)(H,35,36)/t21-/m0/s1",MQJQEUOWHLPSTE-NRFANRHFSA-N,0,1,0,0,LFA / ICAM,7.29,immune system disease,Inhibition,
324,58531683,,,CN(CCc1ccccc1)C(=O)c1ccc(CN(Cc2ccc(F)cc2)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)cc1,"4-[[(3,5-dichloro-2-hydroxyphenyl)sulfonyl-[(4-fluorophenyl)methyl]amino]methyl]-N-methyl-N-(2-phenylethyl)benzamide","InChI=1S/C30H27Cl2FN2O4S/c1-34(16-15-21-5-3-2-4-6-21)30(37)24-11-7-22(8-12-24)19-35(20-23-9-13-26(33)14-10-23)40(38,39)28-18-25(31)17-27(32)29(28)36/h2-14,17-18,36H,15-16,19-20H2,1H3",QNWHKOVECVLONG-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,6.60,cancer,Inhibition,
325,44390619,181138,23246641,OC(=O)[C@@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)Nc2ccccc2C1=O)c1ccc(Cl)cc1,"(2S)-2-(4-chlorophenyl)-2-[(3S)-3-(4-chlorophenyl)-2,5-dioxo-1,3-dihydro-1,4-benzodiazepin-4-yl]acetic acid","InChI=1S/C23H16Cl2N2O4/c24-15-9-5-13(6-10-15)19-21(28)26-18-4-2-1-3-17(18)22(29)27(19)20(23(30)31)14-7-11-16(25)12-8-14/h1-12,19-20H,(H,26,28)(H,30,31)/t19-,20-/m0/s1",ATVQILBXEHQCST-PMACEKPBSA-N,1,0,0,0,MDM2-Like / P53,4.83,cancer,Inhibition,
326,46840790,,,COc1ccc(cc1)-c1sc(nc1C(O)=O)-c1ccc2CCCN(C(=O)Nc3nc4ccccc4s3)c2c1,"2-[1-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-2H-quinolin-7-yl]-5-(4-methoxyphenyl)-1,3-thiazole-4-carboxylic acid","InChI=1S/C28H22N4O4S2/c1-36-19-12-10-17(11-13-19)24-23(26(33)34)30-25(38-24)18-9-8-16-5-4-14-32(21(16)15-18)28(35)31-27-29-20-6-2-3-7-22(20)37-27/h2-3,6-13,15H,4-5,14H2,1H3,(H,33,34)(H,29,31,35)",IUZOFLCDLUXADA-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,8.15,cancer,Inhibition,
327,45137340,,,CN[C@@H](C)C(=O)N[C@@H]([C@@H](C)OC)C(=O)N1CC[C@H]2NC[C@@H]([C@@H]12)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(2S,3R)-1-[(3aR,6S,6aR)-6-(6-fluoro-1H-indol-3-yl)-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,2-b]pyrrol-1-yl]-3-methoxy-1-oxobutan-2-yl]-2-(methylamino)propanamide","InChI=1S/C23H32FN5O3/c1-12(25-3)22(30)28-20(13(2)32-4)23(31)29-8-7-18-21(29)17(11-26-18)16-10-27-19-9-14(24)5-6-15(16)19/h5-6,9-10,12-13,17-18,20-21,25-27H,7-8,11H2,1-4H3,(H,28,30)/t12-,13+,17+,18+,20-,21+/m0/s1",HENNERANMADGEW-LDRJCMAXSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
328,44390668,361168,23246690,OC(=O)[C@@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)Nc2ccc(Cl)cc2C1=O)c1ccc(Cl)cc1,"2-[7-chloro-3-(4-chlorophenyl)-2,5-dioxo-1,3-dihydro-1,4-benzodiazepin-4-yl]-2-(4-chlorophenyl)acetic acid","InChI=1S/C23H15Cl3N2O4/c24-14-5-1-12(2-6-14)19-21(29)27-18-10-9-16(26)11-17(18)22(30)28(19)20(23(31)32)13-3-7-15(25)8-4-13/h1-11,19-20H,(H,27,29)(H,31,32)/t19-,20-/m0/s1",LJWYYGATIFNFFR-PMACEKPBSA-N,1,0,0,0,MDM2-Like / P53,5.82,cancer,Inhibition,
329,168318234,,,Fc1cccc(c1)-n1[nH]c2c3cnn(-c4ccccc4)c3nc(-c3cccc(c3)C(F)(F)F)c2c1=O,,"InChI=1S/C26H15F4N5O/c27-17-8-5-11-19(13-17)35-25(36)21-22(15-6-4-7-16(12-15)26(28,29)30)32-24-20(23(21)33-35)14-31-34(24)18-9-2-1-3-10-18/h1-14,33H",KSWTXHZSEYXKAY-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,6.12,cancer,Inhibition,
330,21906815,360082,10657337,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1cc(ncn1)N1CCOCC1,4-[6-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyrimidin-4-yl]morpholine,"InChI=1S/C24H24F3N3OS/c1-16(2)18-5-3-4-6-21(18)32-22-8-7-17(13-19(22)24(25,26)27)20-14-23(29-15-28-20)30-9-11-31-12-10-30/h3-8,13-16H,9-12H2,1-2H3",SQLPKVCMRLUBJT-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,6.49,immune system disease,Inhibition,
331,45137800,,,CN[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2S(C)(=O)=O)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(2S)-1-[(3aR,6S,6aR)-6-(6-fluoro-1H-indol-3-yl)-4-methylsulfonyl-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-3-hydroxy-1-oxopropan-2-yl]-2-(methylamino)propanamide","InChI=1S/C22H30FN5O5S/c1-12(24-2)21(30)26-18(11-29)22(31)27-7-6-19-20(27)16(10-28(19)34(3,32)33)15-9-25-17-8-13(23)4-5-14(15)17/h4-5,8-9,12,16,18-20,24-25,29H,6-7,10-11H2,1-3H3,(H,26,30)/t12-,16+,18-,19+,20+/m0/s1",UYZBJQURGUZYNO-IVJBOOLNSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
332,25032785,488318,24703742,CC(C)N1CCC(CC1)Nc1cccc(Sc2ccc(\C=C\C(=O)N3CCOCC3)c(c2C(F)(F)F)C(F)(F)F)c1,"(E)-1-morpholin-4-yl-3-[4-[3-[(1-propan-2-ylpiperidin-4-yl)amino]phenyl]sulfanyl-2,3-bis(trifluoromethyl)phenyl]prop-2-en-1-one","InChI=1S/C29H33F6N3O2S/c1-19(2)37-12-10-21(11-13-37)36-22-4-3-5-23(18-22)41-24-8-6-20(7-9-25(39)38-14-16-40-17-15-38)26(28(30,31)32)27(24)29(33,34)35/h3-9,18-19,21,36H,10-17H2,1-2H3/b9-7+",VORCYKUSPCBIIJ-VQHVLOKHSA-N,1,0,0,0,LFA / ICAM,9.46,immune system disease,Inhibition,
333,168316693,,10172888,COc1ccc(CN([C@@H](C(=O)NCc2ccccc2)c2ccc3cc(OCC(=O)OC(C)(C)C)ccc3c2)C(=O)Cc2ccc(OC)cc2)cc1,tert-butyl 2-[6-[2-(benzylamino)-1-[[2-(4-methoxyphenyl)acetyl]-[(4-methoxyphenyl)methyl]amino]-2-oxoethyl]naphthalen-2-yl]oxyacetate,"InChI=1S/C42H44N2O7/c1-42(2,3)51-39(46)28-50-37-22-17-32-24-34(16-15-33(32)25-37)40(41(47)43-26-30-9-7-6-8-10-30)44(27-31-13-20-36(49-5)21-14-31)38(45)23-29-11-18-35(48-4)19-12-29/h6-22,24-25,40H,23,26-28H2,1-5H3,(H,43,47)/t40-/m1/s1",GXEKHLWDVNPDSH-RRHRGVEJSA-N,1,0,0,0,Myc / Max,4.57,cancer,Inhibition,
334,67032194,,,CC(C)(C)OC(=O)Cc1ccc(Cl)c(F)c1-n1c(nc(C(=O)OCc2ccccc2)c1-c1ccc(F)c(Cl)c1)C1CCCCC1,,"InChI=1S/C35H34Cl2F2N2O4/c1-35(2,3)45-28(42)19-24-14-16-25(36)29(39)31(24)41-32(23-15-17-27(38)26(37)18-23)30(40-33(41)22-12-8-5-9-13-22)34(43)44-20-21-10-6-4-7-11-21/h4,6-7,10-11,14-18,22H,5,8-9,12-13,19-20H2,1-3H3",MFQILIFEGXLFNB-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,5.97,cancer,Inhibition,
335,46884084,1093356,24678676,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1nc2c(nc(C)nc2s1)-c1ccccc1,"(2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-(5-methyl-7-phenyl-[1,3]thiazolo[5,4-d]pyrimidin-2-yl)pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C28H36N6O2S/c1-17(29-3)25(35)32-23(20-13-8-5-9-14-20)28(36)34-16-10-15-21(34)26-33-24-22(19-11-6-4-7-12-19)30-18(2)31-27(24)37-26/h4,6-7,11-12,17,20-21,23,29H,5,8-10,13-16H2,1-3H3,(H,32,35)/t17-,21-,23-/m0/s1",LPSXMSKJMIDTCG-HYVJGQCMSA-N,1,0,0,0,XIAP / Smac,7.29,cancer,Inhibition,
336,44580242,446300,24687297,OC(=O)[C@@H]1CC[C@@H](CC1)COc1cccc(c1)Sc1ccc(\C=C\C(=O)N2CCOCC2)c(C(F)(F)F)c1C(F)(F)F,"4-[[3-[4-[(E)-3-morpholin-4-yl-3-oxoprop-1-enyl]-2,3-bis(trifluoromethyl)phenyl]sulfanylphenoxy]methyl]cyclohexane-1-carboxylic acid","InChI=1S/C29H29F6NO5S/c30-28(31,32)25-19(9-11-24(37)36-12-14-40-15-13-36)8-10-23(26(25)29(33,34)35)42-22-3-1-2-21(16-22)41-17-18-4-6-20(7-5-18)27(38)39/h1-3,8-11,16,18,20H,4-7,12-15,17H2,(H,38,39)/b11-9+/t18-,20+",VHJSCKJBRABOFP-VSOCWTRISA-N,1,0,0,0,LFA / ICAM,8.47,immune system disease,Inhibition,
337,24821139,,,CN[C@@H](C)C(=O)Nc1cnc(-c2ccccc2)n(CC(=O)N[C@@H]2CCCc3ccccc23)c1=O,"(2S)-2-(methylamino)-N-[6-oxo-1-[2-oxo-2-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]amino]ethyl]-2-phenylpyrimidin-5-yl]propanamide","InChI=1S/C26H29N5O3/c1-17(27-2)25(33)30-22-15-28-24(19-10-4-3-5-11-19)31(26(22)34)16-23(32)29-21-14-8-12-18-9-6-7-13-20(18)21/h3-7,9-11,13,15,17,21,27H,8,12,14,16H2,1-2H3,(H,29,32)(H,30,33)/t17-,21+/m0/s1",ISIMRBVYDGGLCG-LAUBAEHRSA-N,1,0,0,0,XIAP / Smac,6.00,cancer,Inhibition,
338,71723061,,,CC(C)(C)C[C@H]1N[C@H]([C@H](c2cccc(Cl)c2F)[C@]11C(=O)Nc2cc(Cl)ccc12)C(=O)NCC[C@H](O)CO,"(2'R,3S,3'S,5'R)-6-chloro-3'-(3-chloro-2-fluorophenyl)-N-[(3S)-3,4-dihydroxybutyl]-5'-(2,2-dimethylpropyl)-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide","InChI=1S/C27H32Cl2FN3O4/c1-26(2,3)12-20-27(17-8-7-14(28)11-19(17)32-25(27)37)21(16-5-4-6-18(29)22(16)30)23(33-20)24(36)31-10-9-15(35)13-34/h4-8,11,15,20-21,23,33-35H,9-10,12-13H2,1-3H3,(H,31,36)(H,32,37)/t15-,20+,21-,23+,27+/m0/s1",FYHKPZFIVNTTHR-VAZCYBCOSA-N,2,2,0,0,MDM2-Like / P53,9.22,cancer,Inhibition,
339,44176199,377524,23271177,OC(=O)CCCCN1c2ccc(I)cc2C(=O)N(Cc2ccc(Cl)cc2)[C@@H](c2ccc(Cl)cc2)C1=O,"5-[3-(4-chlorophenyl)-4-[(4-chlorophenyl)methyl]-7-iodo-2,5-dioxo-3H-1,4-benzodiazepin-1-yl]pentanoic acid","InChI=1S/C27H23Cl2IN2O4/c28-19-8-4-17(5-9-19)16-32-25(18-6-10-20(29)11-7-18)27(36)31(14-2-1-3-24(33)34)23-13-12-21(30)15-22(23)26(32)35/h4-13,15,25H,1-3,14,16H2,(H,33,34)/t25-/m0/s1",RIRQVBKIUJQHPL-VWLOTQADSA-N,1,2,0,0,MDM2-Like / P53,5.09,cancer,Inhibition,
340,454878,551288,400537,CC(C)c1c(O)c(O)cc2c(O)c(c(C)cc12)-c1c(C)cc2c(C(C)C)c(O)c(O)cc2c1O,"3-methyl-5-propan-2-yl-2-(1,6,7-trihydroxy-3-methyl-5-propan-2-ylnaphthalen-2-yl)naphthalene-1,6,7-triol","InChI=1S/C28H30O6/c1-11(2)21-15-7-13(5)23(25(31)17(15)9-19(29)27(21)33)24-14(6)8-16-18(26(24)32)10-20(30)28(34)22(16)12(3)4/h7-12,29-34H,1-6H3",PBJKWGWHZVXBGU-UHFFFAOYSA-N,3,0,0,0,BCL2-Like / BAX,5.59,cancer,Inhibition,
341,168318229,,9685673,CCOc1cc(Nc2ccnc3[C@@H](O)CCc23)ccc1NCCc1c[nH]c2cc(OC)ccc12,"4-[3-ethoxy-4-[2-(6-methoxy-1H-indol-3-yl)ethylamino]anilino]-6,7-dihydro-5H-cyclopenta[b]pyridin-7-ol","InChI=1S/C27H30N4O3/c1-3-34-26-14-18(31-22-11-13-29-27-21(22)7-9-25(27)32)4-8-23(26)28-12-10-17-16-30-24-15-19(33-2)5-6-20(17)24/h4-6,8,11,13-16,25,28,30,32H,3,7,9-10,12H2,1-2H3,(H,29,31)/t25-/m0/s1",ISQWPTJWPKDJIZ-VWLOTQADSA-N,1,1,0,0,MDM2-Like / P53,7.50,cancer,Inhibition,
342,168318233,,23271220,COC(=O)[C@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)N(CCCCC(O)=O)c2ccc(I)cc2C1=O)c1ccc(Cl)cc1,"5-[(3S)-3-(4-chlorophenyl)-4-[(1S)-1-(4-chlorophenyl)-2-methoxy-2-oxoethyl]-7-iodo-2,5-dioxo-3H-1,4-benzodiazepin-1-yl]pentanoic acid","InChI=1S/C29H25Cl2IN2O6/c1-40-29(39)26(18-7-11-20(31)12-8-18)34-25(17-5-9-19(30)10-6-17)28(38)33(15-3-2-4-24(35)36)23-14-13-21(32)16-22(23)27(34)37/h5-14,16,25-26H,2-4,15H2,1H3,(H,35,36)/t25-,26+/m0/s1",KXKHVDIJDBRCHO-IZZNHLLZSA-N,1,2,0,0,MDM2-Like / P53,5.55,cancer,Inhibition,
343,45137901,,,CC(C)(C)C[C@@H]1N[C@H]([C@H](c2ccc(F)c(Cl)c2)[C@@]1(C#N)c1ccc(Cl)cc1F)C(=O)NCC[C@H](O)CO,"(2R,3R,4R,5S)-3-(3-chloro-4-fluorophenyl)-4-(4-chloro-2-fluorophenyl)-4-cyano-N-[(3S)-3,4-dihydroxybutyl]-5-(2,2-dimethylpropyl)pyrrolidine-2-carboxamide","InChI=1S/C27H31Cl2F2N3O3/c1-26(2,3)12-22-27(14-32,18-6-5-16(28)11-21(18)31)23(15-4-7-20(30)19(29)10-15)24(34-22)25(37)33-9-8-17(36)13-35/h4-7,10-11,17,22-24,34-36H,8-9,12-13H2,1-3H3,(H,33,37)/t17-,22-,23-,24+,27-/m0/s1",ZDQQHSLVUPTNHS-TZEIZZRTSA-N,1,0,0,0,MDM2-Like / P53,6.72,cancer,Inhibition,
344,46175996,,,CN[C@@H](C)C(=O)N[C@@H](C1CCOCC1)C(=O)N1CCC[C@H]1c1cc2nc(C)nc(-c3ccc(F)cc3)c2[nH]1,"(2S)-N-[(1S)-2-[(2S)-2-[4-(4-fluorophenyl)-2-methyl-5H-pyrrolo[3,2-d]pyrimidin-6-yl]pyrrolidin-1-yl]-1-(oxan-4-yl)-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C28H35FN6O3/c1-16(30-3)27(36)34-25(19-10-13-38-14-11-19)28(37)35-12-4-5-23(35)21-15-22-26(33-21)24(32-17(2)31-22)18-6-8-20(29)9-7-18/h6-9,15-16,19,23,25,30,33H,4-5,10-14H2,1-3H3,(H,34,36)/t16-,23-,25-/m0/s1",LBERDXMISASXGU-KXXXHFJOSA-N,2,0,0,0,XIAP / Smac,7.05,cancer,Inhibition,
345,168318232,,,O[C@H]1CCc2c1nccc2Nc1ccc2N(CCc3c[nH]c4ccccc34)C(=O)COc2c1,"7-[(7-hydroxy-6,7-dihydro-5H-cyclopenta[b]pyridin-4-yl)amino]-4-[2-(1H-indol-3-yl)ethyl]-1,4-benzoxazin-3-one","InChI=1S/C26H24N4O3/c31-23-8-6-19-21(9-11-27-26(19)23)29-17-5-7-22-24(13-17)33-15-25(32)30(22)12-10-16-14-28-20-4-2-1-3-18(16)20/h1-5,7,9,11,13-14,23,28,31H,6,8,10,12,15H2,(H,27,29)/t23-/m0/s1",CVYFYQCFZITENG-QHCPKHFHSA-N,1,1,0,0,MDM2-Like / P53,6.00,cancer,Inhibition,
346,59555740,,,COc1cccc2c(CCNc3ccc(Nc4ccncc4)cc3)c[nH]c12,"1-N-[2-(7-methoxy-1H-indol-3-yl)ethyl]-4-N-pyridin-4-ylbenzene-1,4-diamine","InChI=1S/C22H22N4O/c1-27-21-4-2-3-20-16(15-25-22(20)21)9-14-24-17-5-7-18(8-6-17)26-19-10-12-23-13-11-19/h2-8,10-13,15,24-25H,9,14H2,1H3,(H,23,26)",MAGQZYCMEHHGKS-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,6.10,cancer,Inhibition,
347,59555602,,,COc1ccc2c(CCNc3ccc(Nc4ccnc(CO)c4)cc3OC)c[nH]c2c1,[4-[3-methoxy-4-[2-(6-methoxy-1H-indol-3-yl)ethylamino]anilino]pyridin-2-yl]methanol,"InChI=1S/C24H26N4O3/c1-30-20-4-5-21-16(14-27-23(21)13-20)7-9-26-22-6-3-17(12-24(22)31-2)28-18-8-10-25-19(11-18)15-29/h3-6,8,10-14,26-27,29H,7,9,15H2,1-2H3,(H,25,28)",CAPZRPKPZMPEKQ-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,6.60,cancer,Inhibition,
348,44570043,446480,24686926,CCOC(=O)[C@@H]1Cc2ccccc2CN1C(=O)c1ccccc1-n1nc(cc1C)C(=O)N(c1ccccc1)c1ccccc1,"ethyl (3S)-2-[2-[3-(diphenylcarbamoyl)-5-methylpyrazol-1-yl]benzoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylate","InChI=1S/C36H32N4O4/c1-3-44-36(43)33-23-26-14-10-11-15-27(26)24-38(33)34(41)30-20-12-13-21-32(30)40-25(2)22-31(37-40)35(42)39(28-16-6-4-7-17-28)29-18-8-5-9-19-29/h4-22,33H,3,23-24H2,1-2H3/t33-/m0/s1",ZXTIICGPERGQGI-XIFFEERXSA-N,2,0,0,0,BCL2-Like / BAX,5.25,cancer,Inhibition,
349,58006972,2398343,,CC[C@@H]1CC[C@H](N1C(=O)C1=C(C(C)C)N2[C@H](c3ccc(Cl)cc3)[C@@](C)(N=C2S1)c1ccc(Cl)cc1)C(=O)N(C)C,"(2S,5R)-1-[(5R,6S)-5,6-bis(4-chlorophenyl)-6-methyl-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazole-2-carbonyl]-5-ethyl-N,N-dimethylpyrrolidine-2-carboxamide","InChI=1S/C31H36Cl2N4O2S/c1-7-23-16-17-24(28(38)35(5)6)36(23)29(39)26-25(18(2)3)37-27(19-8-12-21(32)13-9-19)31(4,34-30(37)40-26)20-10-14-22(33)15-11-20/h8-15,18,23-24,27H,7,16-17H2,1-6H3/t23-,24+,27-,31+/m1/s1",KXWDKMJGUISCJZ-LVISKLAHSA-N,1,0,0,0,MDM2-Like / P53,7.85,cancer,Inhibition,
350,168318228,,,CC(=O)Nc1ccc(NC(=O)NC(=O)[C@@H]2[C@@H](OC3([C@@H]2C(O)=O)C(=O)c2ccccc2C3=O)c2ccc(Cl)c(Cl)c2)cc1,,"InChI=1S/C29H21Cl2N3O8/c1-13(35)32-15-7-9-16(10-8-15)33-28(41)34-26(38)21-22(27(39)40)29(24(36)17-4-2-3-5-18(17)25(29)37)42-23(21)14-6-11-19(30)20(31)12-14/h2-12,21-23H,1H3,(H,32,35)(H,39,40)(H2,33,34,38,41)/t21-,22-,23-/m0/s1",HVXMLRLRWSKTQF-VABKMULXSA-N,1,0,0,0,E2 / E1,6.36,human papilloma virus infection,Inhibition,
351,44580573,497358,24708765,FC(F)(F)c1c(Sc2cccc(OC3CCOCC3)c2)ccc(\C=C\C(=O)N2CCOCC2)c1C(F)(F)F,"(E)-1-morpholin-4-yl-3-[4-[3-(oxan-4-yloxy)phenyl]sulfanyl-2,3-bis(trifluoromethyl)phenyl]prop-2-en-1-one","InChI=1S/C26H25F6NO4S/c27-25(28,29)23-17(5-7-22(34)33-10-14-36-15-11-33)4-6-21(24(23)26(30,31)32)38-20-3-1-2-19(16-20)37-18-8-12-35-13-9-18/h1-7,16,18H,8-15H2/b7-5+",AMEPXQRZUIVGBX-FNORWQNLSA-N,1,0,0,0,LFA / ICAM,7.47,immune system disease,Inhibition,
352,11440194,,9615058,CC[C@H](N)C(=O)N[C@H]1CC[C@H]2CC[C@H](N2C1=O)C(=O)NCc1ccccc1,"(3S,6S,8aR)-6-[[(2S)-2-aminobutanoyl]amino]-N-benzyl-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carboxamide","InChI=1S/C20H28N4O3/c1-2-15(21)18(25)23-16-10-8-14-9-11-17(24(14)20(16)27)19(26)22-12-13-6-4-3-5-7-13/h3-7,14-17H,2,8-12,21H2,1H3,(H,22,26)(H,23,25)/t14-,15-,16-,17-/m0/s1",GKPMRGORHINVPF-QAETUUGQSA-N,1,0,0,0,XIAP / Smac,5.85,cancer,Inhibition,
353,46883827,1093598,24669097,CN[C@@H](C)C(=O)N[C@@H](C1CCOCC1)C(=O)N1CCC[C@H]1c1nc(c(s1)C#CCOC)-c1cccc2ccccc12,"(2S)-N-[(1S)-2-[(2S)-2-[5-(3-methoxyprop-1-ynyl)-4-naphthalen-1-yl-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(oxan-4-yl)-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C32H38N4O4S/c1-21(33-2)30(37)34-28(23-15-19-40-20-16-23)32(38)36-17-7-13-26(36)31-35-29(27(41-31)14-8-18-39-3)25-12-6-10-22-9-4-5-11-24(22)25/h4-6,9-12,21,23,26,28,33H,7,13,15-20H2,1-3H3,(H,34,37)/t21-,26-,28-/m0/s1",UIWVKFRRDKWKSL-PTJQVGQKSA-N,1,0,0,0,XIAP / Smac,7.51,cancer,Inhibition,
354,51039416,2322029,,FC(F)(F)S(=O)(=O)c1cc(ccc1N[C@H](CCN1CCOCC1)CSc1ccccc1)S(=O)(=O)Nc1ncnc2CN(Cc12)C1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1,"N-[6-[1-[[2-(4-chlorophenyl)phenyl]methyl]piperidin-4-yl]-5,7-dihydropyrrolo[3,4-d]pyrimidin-4-yl]-4-[[(2R)-4-morpholin-4-yl-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)benzenesulfonamide","InChI=1S/C45H49ClF3N7O5S3/c46-34-12-10-32(11-13-34)39-9-5-4-6-33(39)27-55-20-17-36(18-21-55)56-28-40-42(29-56)50-31-51-44(40)53-64(59,60)38-14-15-41(43(26-38)63(57,58)45(47,48)49)52-35(16-19-54-22-24-61-25-23-54)30-62-37-7-2-1-3-8-37/h1-15,26,31,35-36,52H,16-25,27-30H2,(H,50,51,53)/t35-/m1/s1",MYHAQJLZUQAAHG-PGUFJCEWSA-N,1,0,0,0,BCL2-Like / BAX,6.01,cancer,Inhibition,
355,168318222,,,CC[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(C)(C)C)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1,,"InChI=1S/C45H53ClN6O4S3/c1-5-35(30-57-37-12-7-6-8-13-37)49-41-20-19-38(27-43(41)58(53,54)45(2,3)4)59(55,56)50-44-40-23-26-52(29-42(40)47-31-48-44)36-21-24-51(25-22-36)28-33-11-9-10-14-39(33)32-15-17-34(46)18-16-32/h6-20,27,31,35-36,49H,5,21-26,28-30H2,1-4H3,(H,47,48,50)/t35-/m1/s1",LAJVILUTDLPADN-PGUFJCEWSA-N,1,0,0,0,BCL2-Like / BAX,6.30,cancer,Inhibition,
356,16109149,373631,17266562,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCC(CC1)=Cc1ccccc1F,N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonyl-4-[4-[(2-fluorophenyl)methylidene]piperidin-1-yl]benzamide,"InChI=1S/C37H40FN5O5S2/c1-41(2)21-20-30(26-49-32-9-4-3-5-10-32)39-35-17-16-33(25-36(35)43(45)46)50(47,48)40-37(44)28-12-14-31(15-13-28)42-22-18-27(19-23-42)24-29-8-6-7-11-34(29)38/h3-17,24-25,30,39H,18-23,26H2,1-2H3,(H,40,44)/t30-/m1/s1",APUJKYQKFDVLIU-SSEXGKCCSA-N,2,0,0,0,BCL2-Like / BAX,9.30,cancer,Inhibition,
357,16099367,219963,17257295,C[C@H](O)C(=O)N[C@H]1CCC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,9aS)-N-benzhydryl-6-[[(2S)-2-hydroxypropanoyl]amino]-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C26H31N3O4/c1-17(30)24(31)27-21-14-8-13-20-15-16-22(29(20)26(21)33)25(32)28-23(18-9-4-2-5-10-18)19-11-6-3-7-12-19/h2-7,9-12,17,20-23,30H,8,13-16H2,1H3,(H,27,31)(H,28,32)/t17-,20-,21-,22-/m0/s1",BWLUJLRDIKFWLK-MQGJPIDWSA-N,1,0,0,0,XIAP / Smac,4.54,cancer,Inhibition,
358,59447630,,,CN1CCN(CC1)c1ccc(OCCCc2sc(nc2C(O)=O)N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)cc1,"2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-5-[3-[4-(4-methylpiperazin-1-yl)phenoxy]propyl]-1,3-thiazole-4-carboxylic acid","InChI=1S/C35H36N6O4S2/c1-39-17-19-40(20-18-39)24-11-13-25(14-12-24)45-21-5-10-30-31(33(43)44)37-35(47-30)41-16-15-23-6-4-7-26(27(23)22-41)32(42)38-34-36-28-8-2-3-9-29(28)46-34/h2-4,6-9,11-14H,5,10,15-22H2,1H3,(H,43,44)(H,36,38,42)",UHWCJXRAUBAQPK-UHFFFAOYSA-N,1,0,0,0,BCL2-Like / BAX,6.92,cancer,Inhibition,
359,44564608,454406,23335520,CCCCN(CCCC)C(=O)c1cc(C)n(n1)-c1cccc(C)c1C(=O)N1Cc2ccccc2C[C@H]1CN,"1-[2-[(3S)-3-(aminomethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]-3-methylphenyl]-N,N-dibutyl-5-methylpyrazole-3-carboxamide","InChI=1S/C31H41N5O2/c1-5-7-16-34(17-8-6-2)30(37)27-18-23(4)36(33-27)28-15-11-12-22(3)29(28)31(38)35-21-25-14-10-9-13-24(25)19-26(35)20-32/h9-15,18,26H,5-8,16-17,19-21,32H2,1-4H3/t26-/m0/s1",UYNJORKAXXWQBH-SANMLTNESA-N,1,0,0,0,BCL2-Like / BAX,6.76,cancer,Inhibition,
360,44574956,509472,24713549,OC[C@H]1[C@@H]2Cn3c(cccc3=O)[C@@H]2N(Cc2ccc(Oc3ccccc3)cc2)[C@@H]1C(=O)N1CCC(Cc2ccccc2)CC1,"(2S,3S,3aR,9bR)-2-(4-benzylpiperidine-1-carbonyl)-3-(hydroxymethyl)-1-[(4-phenoxyphenyl)methyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one","InChI=1S/C37H39N3O4/c41-25-32-31-24-39-33(12-7-13-34(39)42)35(31)40(23-28-14-16-30(17-15-28)44-29-10-5-2-6-11-29)36(32)37(43)38-20-18-27(19-21-38)22-26-8-3-1-4-9-26/h1-17,27,31-32,35-36,41H,18-25H2/t31-,32-,35+,36-/m0/s1",UQBOWGUWBXERMG-CXEQJURGSA-N,1,0,0,0,BCL2-Like / BAX,5.28,cancer,Inhibition,
361,58436666,,,C[C@@H](N)c1ccc(o1)C(=O)N1C[C@H](C[C@H]1C(=O)N1CC[C@@H](C1)c1ccccc1)c1ccccc1,"[(2S,4R)-1-[5-(1-aminoethyl)furan-2-carbonyl]-4-phenylpyrrolidin-2-yl]-[(3R)-3-phenylpyrrolidin-1-yl]methanone","InChI=1S/C28H31N3O3/c1-19(29)25-12-13-26(34-25)28(33)31-18-23(21-10-6-3-7-11-21)16-24(31)27(32)30-15-14-22(17-30)20-8-4-2-5-9-20/h2-13,19,22-24H,14-18,29H2,1H3/t19-,22+,23+,24+/m1/s1",VZKONPNTCDVHPC-DLTYFMDKSA-N,1,0,0,0,XIAP / Smac,8.00,cancer,Inhibition,
362,25138058,515848,24717342,CN[C@@H](C)C(=O)N[C@H]1Cc2ccccc2[C@H]2CCC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(4S,7S,12bR)-N-benzhydryl-7-[[(2S)-2-(methylamino)propanoyl]amino]-6-oxo-2,3,4,7,8,12b-hexahydro-1H-pyrido[2,1-a][2]benzazepine-4-carboxamide","InChI=1S/C32H36N4O3/c1-21(33-2)30(37)34-26-20-24-16-9-10-17-25(24)27-18-11-19-28(36(27)32(26)39)31(38)35-29(22-12-5-3-6-13-22)23-14-7-4-8-15-23/h3-10,12-17,21,26-29,33H,11,18-20H2,1-2H3,(H,34,37)(H,35,38)/t21-,26-,27+,28-/m0/s1",JOHHONWRDYKZMW-PSRPIYIESA-N,1,1,0,0,XIAP / Smac,6.16,cancer,Inhibition,
363,11714160,515393,24717330,O=C(O)[C@H]1CC[C@@H](CC1)Nc1cccc(c1)Sc1ccc(\C=C\C(=O)N2CCOCC2)c(C(F)(F)F)c1C(F)(F)F,"4-[3-[4-[(E)-3-morpholin-4-yl-3-oxoprop-1-enyl]-2,3-bis(trifluoromethyl)phenyl]sulfanylanilino]cyclohexane-1-carboxylic acid","InChI=1S/C28H28F6N2O4S/c29-27(30,31)24-17(7-11-23(37)36-12-14-40-15-13-36)6-10-22(25(24)28(32,33)34)41-21-3-1-2-20(16-21)35-19-8-4-18(5-9-19)26(38)39/h1-3,6-7,10-11,16,18-19,35H,4-5,8-9,12-15H2,(H,38,39)/b11-7+/t18-,19-",URZCVPKXOJQTLC-GKWHILSKSA-N,1,0,0,0,LFA / ICAM,8.62,immune system disease,Inhibition,
364,44549893,,,CN1c2ncnn2[C@H](C2=C1c1cc(ccc1O[C@@H]2c1ccc(Br)cc1)C#N)c1ccc(Br)cc1,,"InChI=1S/C26H17Br2N5O/c1-32-24-20-12-15(13-29)2-11-21(20)34-25(17-5-9-19(28)10-6-17)22(24)23(33-26(32)30-14-31-33)16-3-7-18(27)8-4-16/h2-12,14,23,25H,1H3/t23-,25+/m0/s1",XTRRRBPSMDRWKB-UKILVPOCSA-N,1,0,0,0,MDM2-Like / P53,5.51,cancer,Inhibition,
365,44305160,62409,23156063,COc1ccc(Br)c(c1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O,(2S)-2-[(2-bromo-5-methoxybenzoyl)amino]-3-(1H-indol-3-yl)propanoic acid,"InChI=1S/C19H17BrN2O4/c1-26-12-6-7-15(20)14(9-12)18(23)22-17(19(24)25)8-11-10-21-16-5-3-2-4-13(11)16/h2-7,9-10,17,21H,8H2,1H3,(H,22,23)(H,24,25)/t17-/m0/s1",AGQKPFSCDZOPKE-KRWDZBQOSA-N,1,0,0,0,LFA / ICAM,5.05,immune system disease,Inhibition,
366,67031859,,,NC(=O)c1nc(CC2CCCCC2)n(c1-c1ccc(F)c(Cl)c1)-c1cccc(Cl)c1F,,"InChI=1S/C23H21Cl2F2N3O/c24-15-7-4-8-18(20(15)27)30-19(11-13-5-2-1-3-6-13)29-21(23(28)31)22(30)14-9-10-17(26)16(25)12-14/h4,7-10,12-13H,1-3,5-6,11H2,(H2,28,31)",LLWFQSZLYQRZED-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,7.82,cancer,Inhibition,
367,16109157,437148,17266570,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(Cc2ccccc2S(C)(=O)=O)CC1,N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonyl-4-[4-[(2-methylsulfonylphenyl)methyl]piperazin-1-yl]benzamide,"InChI=1S/C37H44N6O7S3/c1-40(2)20-19-30(27-51-32-10-5-4-6-11-32)38-34-18-17-33(25-35(34)43(45)46)53(49,50)39-37(44)28-13-15-31(16-14-28)42-23-21-41(22-24-42)26-29-9-7-8-12-36(29)52(3,47)48/h4-18,25,30,38H,19-24,26-27H2,1-3H3,(H,39,44)/t30-/m1/s1",KAYBFGCVDVUQHJ-SSEXGKCCSA-N,2,0,0,0,BCL2-Like / BAX,9.05,cancer,Inhibition,
368,46884021,1092759,24679177,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1nc2c(cccc2s1)-c1ccc(F)cc1,"(2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorophenyl)-1,3-benzothiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C29H35FN4O2S/c1-18(31-2)27(35)32-25(20-8-4-3-5-9-20)29(36)34-17-7-11-23(34)28-33-26-22(10-6-12-24(26)37-28)19-13-15-21(30)16-14-19/h6,10,12-16,18,20,23,25,31H,3-5,7-9,11,17H2,1-2H3,(H,32,35)/t18-,23-,25-/m0/s1",ZAVJGZJOAOWWTO-WYRQLCSISA-N,1,0,0,0,XIAP / Smac,7.35,cancer,Inhibition,
369,49864525,1222022,25053087,OC(=O)[C@H](CNC(=O)c1cccs1)NC(=O)c1c(Cl)cc2CN(CCc2c1Cl)C(=O)c1ccc(Cl)cc1,"2-[[5,7-dichloro-2-(4-chlorobenzoyl)-3,4-dihydro-1H-isoquinoline-6-carbonyl]amino]-3-(thiophene-2-carbonylamino)propanoic acid","InChI=1S/C25H20Cl3N3O5S/c26-15-5-3-13(4-6-15)24(34)31-8-7-16-14(12-31)10-17(27)20(21(16)28)23(33)30-18(25(35)36)11-29-22(32)19-2-1-9-37-19/h1-6,9-10,18H,7-8,11-12H2,(H,29,32)(H,30,33)(H,35,36)/t18-/m0/s1",OSHCCAHIHYVBQE-SFHVURJKSA-N,1,0,0,0,LFA / ICAM,7.66,immune system disease,Inhibition,
370,45138706,,,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2c1ncccn1)c1c[nH]c2cc(F)ccc12)C(C)(C)C,"(2S)-N-[(2S)-1-[(3aR,6S,6aR)-6-(6-fluoro-1H-indol-3-yl)-4-pyrimidin-2-yl-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]-2-(methylamino)propanamide","InChI=1S/C28H36FN7O2/c1-16(30-5)25(37)34-24(28(2,3)4)26(38)35-12-9-22-23(35)20(15-36(22)27-31-10-6-11-32-27)19-14-33-21-13-17(29)7-8-18(19)21/h6-8,10-11,13-14,16,20,22-24,30,33H,9,12,15H2,1-5H3,(H,34,37)/t16-,20+,22+,23+,24+/m0/s1",RLMAESCRYFPJCI-UQUUVCMPSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
371,44820627,1093339,24678773,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1nc2c(cccc2s1)-c1ccccc1,"(2S)-N-[(1S)-1-cyclohexyl-2-oxo-2-[(2R)-2-(4-phenyl-1,3-benzothiazol-2-yl)pyrrolidin-1-yl]ethyl]-2-(methylamino)propanamide","InChI=1S/C29H36N4O2S/c1-19(30-2)27(34)31-25(21-13-7-4-8-14-21)29(35)33-18-10-16-23(33)28-32-26-22(15-9-17-24(26)36-28)20-11-5-3-6-12-20/h3,5-6,9,11-12,15,17,19,21,23,25,30H,4,7-8,10,13-14,16,18H2,1-2H3,(H,31,34)/t19-,23-,25-/m0/s1",ZMBDQSBUBMMIRB-QXWFJRNPSA-N,1,0,0,0,XIAP / Smac,7.44,cancer,Inhibition,
372,10008291,,8183871,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2cccc(c2)C(=O)NCc2ccc(O)c(O)c2)c1=O,"N-[(3,4-dihydroxyphenyl)methyl]-3-[6-methyl-3-oxo-4-[3-(trifluoromethyl)phenyl]-1H-dipyrazolo[4,3-b:4',5'-e]pyridin-2-yl]benzamide","InChI=1S/C29H21F3N6O4/c1-37-26-20(14-34-37)25-23(24(35-26)16-4-2-6-18(11-16)29(30,31)32)28(42)38(36-25)19-7-3-5-17(12-19)27(41)33-13-15-8-9-21(39)22(40)10-15/h2-12,14,36,39-40H,13H2,1H3,(H,33,41)",GKHXJMVYYWSZAD-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,8.05,cancer,Inhibition,
373,67031944,,,Cc1cccc(c1)-c1nc(C(N)=O)c(-c2cccc(Cl)c2)n1-c1cc(Cl)ccc1C,,"InChI=1S/C24H19Cl2N3O/c1-14-5-3-7-17(11-14)24-28-21(23(27)30)22(16-6-4-8-18(25)12-16)29(24)20-13-19(26)10-9-15(20)2/h3-13H,1-2H3,(H2,27,30)",JJBSUFCYBCXXFO-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,6.07,cancer,Inhibition,
374,66634086,,,Oc1c(Cl)cc(Cl)cc1S(=O)(=O)N(Cc1ccc(cc1)-c1ccccc1)Cc1cccc(CNS(=O)(=O)c2ccc(cc2)C#N)c1,,"InChI=1S/C34H27Cl2N3O5S2/c35-30-18-32(36)34(40)33(19-30)46(43,44)39(22-25-9-13-29(14-10-25)28-7-2-1-3-8-28)23-27-6-4-5-26(17-27)21-38-45(41,42)31-15-11-24(20-37)12-16-31/h1-19,38,40H,21-23H2",NSIWNCVWKFYMMX-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,7.22,cancer,Inhibition,
375,66616535,,,COc1c(Cl)cc(CN(CCn2ccc3ccccc23)S(=O)(=O)c2cc(cc(Cl)c2O)C(=O)NCc2ccccc2)cc1-c1ccc(Cl)cc1,,"InChI=1S/C38H32Cl3N3O5S/c1-49-37-31(27-11-13-30(39)14-12-27)19-26(20-33(37)41)24-44(18-17-43-16-15-28-9-5-6-10-34(28)43)50(47,48)35-22-29(21-32(40)36(35)45)38(46)42-23-25-7-3-2-4-8-25/h2-16,19-22,45H,17-18,23-24H2,1H3,(H,42,46)",QMNVMPBEPOIGTL-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,7.52,cancer,Inhibition,
376,45137950,,,CN[C@@H](C)C(=O)N[C@@H]([C@@H](C)OC)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2S(C)(=O)=O)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(2S,3R)-1-[(3aR,6S,6aR)-6-(6-fluoro-1H-indol-3-yl)-4-methylsulfonyl-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-3-methoxy-1-oxobutan-2-yl]-2-(methylamino)propanamide","InChI=1S/C24H34FN5O5S/c1-13(26-3)23(31)28-21(14(2)35-4)24(32)29-9-8-20-22(29)18(12-30(20)36(5,33)34)17-11-27-19-10-15(25)6-7-16(17)19/h6-7,10-11,13-14,18,20-22,26-27H,8-9,12H2,1-5H3,(H,28,31)/t13-,14+,18+,20+,21-,22+/m0/s1",GUXRETPOEXGXRG-ZVQSEYJXSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
377,168318306,,,O[C@@H]1CCc2c1nccc2Nc1ccc2N(CCc3c[nH]c4ccccc34)CC3(CCCC3)Oc2c1,"4-[[4-[2-(1H-indol-3-yl)ethyl]spiro[3H-1,4-benzoxazine-2,1'-cyclopentane]-7-yl]amino]-6,7-dihydro-5H-cyclopenta[b]pyridin-7-ol","InChI=1S/C30H32N4O2/c35-27-10-8-23-25(11-15-31-29(23)27)33-21-7-9-26-28(17-21)36-30(13-3-4-14-30)19-34(26)16-12-20-18-32-24-6-2-1-5-22(20)24/h1-2,5-7,9,11,15,17-18,27,32,35H,3-4,8,10,12-14,16,19H2,(H,31,33)/t27-/m1/s1",PUKYLBUJJLZQTL-HHHXNRCGSA-N,1,1,0,0,MDM2-Like / P53,5.52,cancer,Inhibition,
378,11351754,181479,9526689,CC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC(c1ccccc1)c1ccccc1,(2S)-1-[(2S)-2-[[(2S)-2-aminobutanoyl]amino]-3-methylbutanoyl]-N-benzhydrylpyrrolidine-2-carboxamide,"InChI=1S/C27H36N4O3/c1-4-21(28)25(32)29-23(18(2)3)27(34)31-17-11-16-22(31)26(33)30-24(19-12-7-5-8-13-19)20-14-9-6-10-15-20/h5-10,12-15,18,21-24H,4,11,16-17,28H2,1-3H3,(H,29,32)(H,30,33)/t21-,22-,23-/m0/s1",ZYQRNUJYGVCLAR-VABKMULXSA-N,1,0,0,0,XIAP / Smac,7.62,cancer,Inhibition,
379,44814408,,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1cc2nc(C)nc(-c3ccc(F)cc3)c2[nH]1,"(2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorophenyl)-2-methyl-5H-pyrrolo[3,2-d]pyrimidin-6-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C29H37FN6O2/c1-17(31-3)28(37)35-26(19-8-5-4-6-9-19)29(38)36-15-7-10-24(36)22-16-23-27(34-22)25(33-18(2)32-23)20-11-13-21(30)14-12-20/h11-14,16-17,19,24,26,31,34H,4-10,15H2,1-3H3,(H,35,37)/t17-,24-,26-/m0/s1",TYDJCKSIBXIJAZ-CIHKJSBTSA-N,2,0,0,0,XIAP / Smac,7.19,cancer,Inhibition,
380,168318305,,,O[C@H]1CCc2c1nccc2Nc1ccc2N(CCc3csc4ccccc34)CCOc2c1,"4-[[4-[2-(1-benzothiophen-3-yl)ethyl]-2,3-dihydro-1,4-benzoxazin-7-yl]amino]-6,7-dihydro-5H-cyclopenta[b]pyridin-7-ol","InChI=1S/C26H25N3O2S/c30-23-8-6-20-21(9-11-27-26(20)23)28-18-5-7-22-24(15-18)31-14-13-29(22)12-10-17-16-32-25-4-2-1-3-19(17)25/h1-5,7,9,11,15-16,23,30H,6,8,10,12-14H2,(H,27,28)/t23-/m0/s1",NJSQJPLMIGQVOH-QHCPKHFHSA-N,1,1,0,0,MDM2-Like / P53,6.52,cancer,Inhibition,
381,44573158,492951,24704784,CC(=O)Oc1cccc2[nH]cc(C(=O)C(=O)N3CCN(CC3)C(=O)c3ccccc3)c12,[3-[2-(4-benzoylpiperazin-1-yl)-2-oxoacetyl]-1H-indol-4-yl] acetate,"InChI=1S/C23H21N3O5/c1-15(27)31-19-9-5-8-18-20(19)17(14-24-18)21(28)23(30)26-12-10-25(11-13-26)22(29)16-6-3-2-4-7-16/h2-9,14,24H,10-13H2,1H3",NQDVNSQWRBXZOV-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,7.61,HIV infectious disease,Inhibition,
382,506241,494225,442072,Fc1ccc(F)c2c(c[nH]c12)C(=O)C(=O)N1CCN(CC1)C(=O)c1ccccc1,"1-(4-benzoylpiperazin-1-yl)-2-(4,7-difluoro-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C21H17F2N3O3/c22-15-6-7-16(23)18-17(15)14(12-24-18)19(27)21(29)26-10-8-25(9-11-26)20(28)13-4-2-1-3-5-13/h1-7,12,24H,8-11H2",IWOHGNFDYTXSAA-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,9.46,HIV infectious disease,Inhibition,
383,24978538,443684,21864722,CC1(C)CCC(=C(CN2CCN(CC2)c2ccc(cc2)C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN3CCOCC3)CSc3ccccc3)c(c2)S(=O)(=O)C(F)(F)F)C1)c1ccc(Cl)cc1,"4-[4-[[2-(4-chlorophenyl)-5,5-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[4-[[(2R)-4-morpholin-4-yl-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylbenzamide","InChI=1S/C47H55ClF3N5O6S3/c1-46(2)20-18-42(34-8-12-37(48)13-9-34)36(31-46)32-55-22-24-56(25-23-55)39-14-10-35(11-15-39)45(57)53-65(60,61)41-16-17-43(44(30-41)64(58,59)47(49,50)51)52-38(19-21-54-26-28-62-29-27-54)33-63-40-6-4-3-5-7-40/h3-17,30,38,52H,18-29,31-33H2,1-2H3,(H,53,57)/t38-/m1/s1",JLYAXFNOILIKPP-KXQOOQHDSA-N,3,0,0,0,BCL2-Like / BAX,9.30,cancer,Inhibition,
384,57809380,,,CCOc1cc(ccc1C1=N[C@H]([C@H](N1C(=O)N1CCNC(=O)C1)c1ccc(Cl)cc1)c1ccc(Cl)cc1)N(C(=O)N1CCNC(=O)C1)S(C)(=O)=O,"N-[4-[(4S,5R)-4,5-bis(4-chlorophenyl)-1-(3-oxopiperazine-1-carbonyl)-4,5-dihydroimidazol-2-yl]-3-ethoxyphenyl]-N-methylsulfonyl-3-oxopiperazine-1-carboxamide","InChI=1S/C34H35Cl2N7O7S/c1-3-50-27-18-25(43(51(2,48)49)34(47)41-17-15-38-29(45)20-41)12-13-26(27)32-39-30(21-4-8-23(35)9-5-21)31(22-6-10-24(36)11-7-22)42(32)33(46)40-16-14-37-28(44)19-40/h4-13,18,30-31H,3,14-17,19-20H2,1-2H3,(H,37,44)(H,38,45)/t30-,31+/m0/s1",UVVCOVRTRJUEEZ-IOWSJCHKSA-N,1,0,0,0,MDM2-Like / P53,6.51,cancer,Inhibition,
385,11952784,377639,10127093,C[C@H](N1[C@H](c2ccc(Cl)cc2)C(=O)N(CCN2CCOCC2)c2ccc(I)cc2C1=O)c1ccc(Cl)cc1N,"4-[1-(2-amino-4-chlorophenyl)ethyl]-3-(4-chlorophenyl)-7-iodo-1-(2-morpholin-4-ylethyl)-3H-1,4-benzodiazepine-2,5-dione","InChI=1S/C29H29Cl2IN4O3/c1-18(23-8-6-21(31)16-25(23)33)36-27(19-2-4-20(30)5-3-19)29(38)35(11-10-34-12-14-39-15-13-34)26-9-7-22(32)17-24(26)28(36)37/h2-9,16-18,27H,10-15,33H2,1H3/t18-,27+/m0/s1",TXTIZPFXYRRDES-XRHLQHRESA-N,1,0,0,0,MDM2-Like / P53,4.88,cancer,Inhibition,
386,25027105,577072,24639653,CNc1nc(NCc2ccc(NC(=O)c3ccc(Cl)nc3)cc2)c2cccc(C)c2n1,6-chloro-N-[4-[[[8-methyl-2-(methylamino)quinazolin-4-yl]amino]methyl]phenyl]pyridine-3-carboxamide,"InChI=1S/C23H21ClN6O/c1-14-4-3-5-18-20(14)29-23(25-2)30-21(18)27-12-15-6-9-17(10-7-15)28-22(31)16-8-11-19(24)26-13-16/h3-11,13H,12H2,1-2H3,(H,28,31)(H2,25,27,29,30)",QSUMUOAPGNILCM-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,6.27,cancer,Inhibition,
387,45487325,571613,24634160,CNC(=O)c1cc(OC)c(O[C@@H](C)C(=O)N2CCN(C[C@H]2C)c2nccc3[nH]ccc23)cn1,"4-methoxy-N-methyl-5-[(2S)-1-[(2R)-2-methyl-4-(1H-pyrrolo[3,2-c]pyridin-4-yl)piperazin-1-yl]-1-oxopropan-2-yl]oxypyridine-2-carboxamide","InChI=1S/C23H28N6O4/c1-14-13-28(21-16-5-7-25-17(16)6-8-26-21)9-10-29(14)23(31)15(2)33-20-12-27-18(22(30)24-3)11-19(20)32-4/h5-8,11-12,14-15,25H,9-10,13H2,1-4H3,(H,24,30)/t14-,15+/m1/s1",IXLOAKYSBRSRLJ-CABCVRRESA-N,0,1,0,0,CD4 / gp120,7.54,HIV infectious disease,Inhibition,
388,168318302,,,CC(C)c1cn(nn1)C(=O)NC[C@H](NC(=O)c1c(Cl)cc2CN(CCc2c1Cl)C(=O)c1ccc(Cl)cc1)C(O)=O,,"InChI=1S/C26H25Cl3N6O5/c1-13(2)20-12-35(33-32-20)26(40)30-10-19(25(38)39)31-23(36)21-18(28)9-15-11-34(8-7-17(15)22(21)29)24(37)14-3-5-16(27)6-4-14/h3-6,9,12-13,19H,7-8,10-11H2,1-2H3,(H,30,40)(H,31,36)(H,38,39)/t19-/m0/s1",SKGPBPZLKJVETD-IBGZPJMESA-N,1,0,0,0,LFA / ICAM,6.51,immune system disease,Inhibition,
389,59447566,,,OC(=O)c1nc(sc1CCNS(=O)(=O)c1cccc(c1)N(=O)=O)N1CCc2cccc(C(=O)Nc3nc4ccccc4s3)c2C1,"2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-5-[2-[(3-nitrophenyl)sulfonylamino]ethyl]-1,3-thiazole-4-carboxylic acid","InChI=1S/C29H24N6O7S3/c36-26(33-28-31-22-9-1-2-10-23(22)43-28)20-8-3-5-17-12-14-34(16-21(17)20)29-32-25(27(37)38)24(44-29)11-13-30-45(41,42)19-7-4-6-18(15-19)35(39)40/h1-10,15,30H,11-14,16H2,(H,37,38)(H,31,33,36)",KNCKAPUPTRJZEZ-UHFFFAOYSA-N,1,0,0,0,BCL2-Like / BAX,6.30,cancer,Inhibition,
390,25051754,,,Fc1ccccc1S(=O)(=O)N1[C@@H]([C@H](c2ccc(Cl)cc2)n2c1ccc(C(=O)N1CCN(CC(=O)N3CCOCC3)CC1)c2=O)c1ccc(Cl)cc1,"(2R,3S)-2,3-bis(4-chlorophenyl)-1-(2-fluorophenyl)sulfonyl-6-[4-(2-morpholin-4-yl-2-oxoethyl)piperazine-1-carbonyl]-2,3-dihydroimidazo[1,2-a]pyridin-5-one","InChI=1S/C36H34Cl2FN5O6S/c37-26-9-5-24(6-10-26)33-34(25-7-11-27(38)12-8-25)44(51(48,49)30-4-2-1-3-29(30)39)31-14-13-28(36(47)43(31)33)35(46)42-17-15-40(16-18-42)23-32(45)41-19-21-50-22-20-41/h1-14,33-34H,15-23H2/t33-,34+/m0/s1",NPEQZLXHTZPLHY-SZAHLOSFSA-N,1,0,0,0,MDM2-Like / P53,6.15,cancer,Inhibition,
391,58531456,,,CC(C)CN(Cc1cc(Cl)cc(CN(CC(C)C)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)c1)C(=O)c1cccc(SC(F)(F)F)c1,"N-[[3-chloro-5-[[(3,5-dichloro-2-hydroxyphenyl)sulfonyl-(2-methylpropyl)amino]methyl]phenyl]methyl]-N-(2-methylpropyl)-3-(trifluoromethylsulfanyl)benzamide","InChI=1S/C30H32Cl3F3N2O4S2/c1-18(2)14-37(29(40)22-6-5-7-25(11-22)43-30(34,35)36)16-20-8-21(10-23(31)9-20)17-38(15-19(3)4)44(41,42)27-13-24(32)12-26(33)28(27)39/h5-13,18-19,39H,14-17H2,1-4H3",GGUWZIYWMOVFAO-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,6.46,cancer,Inhibition,
392,25000812,,,CN1CCN(CC1)C(=O)[C@@H]1N[C@H](CC(C)(C)C)[C@@]2([C@H]1c1ccc(F)c(Cl)c1)C(=O)Nc1cc(Cl)c(F)cc21,"(2'R,3S,4'R,5'R)-6-chloro-4'-(3-chloro-4-fluorophenyl)-2'-(2,2-dimethylpropyl)-5-fluoro-5'-(4-methylpiperazine-1-carbonyl)spiro[1H-indole-3,3'-pyrrolidine]-2-one","InChI=1S/C28H32Cl2F2N4O2/c1-27(2,3)14-22-28(16-12-20(32)18(30)13-21(16)33-26(28)38)23(15-5-6-19(31)17(29)11-15)24(34-22)25(37)36-9-7-35(4)8-10-36/h5-6,11-13,22-24,34H,7-10,14H2,1-4H3,(H,33,38)/t22-,23+,24-,28+/m1/s1",WLXCXBFCRBMECV-PVIBPIFHSA-N,1,3,0,0,MDM2-Like / P53,5.54,cancer,Inhibition,
393,12096170,,11591257,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(cc2)C(=O)Nc2ccc(CCO)cc2)c1=O,"N-[4-(2-hydroxyethyl)phenyl]-4-[6-methyl-3-oxo-4-[3-(trifluoromethyl)phenyl]-1H-dipyrazolo[4,3-b:4',5'-e]pyridin-2-yl]benzamide","InChI=1S/C30H23F3N6O3/c1-38-27-23(16-34-38)26-24(25(36-27)19-3-2-4-20(15-19)30(31,32)33)29(42)39(37-26)22-11-7-18(8-12-22)28(41)35-21-9-5-17(6-10-21)13-14-40/h2-12,15-16,37,40H,13-14H2,1H3,(H,35,41)",QPKMFQMPLJPJNM-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.64,cancer,Inhibition,
394,59452481,,,OCc1cc(Nc2ccc3N(CCc4csc5ccccc45)CCOc3c2)ccn1,"[4-[[4-[2-(1-benzothiophen-3-yl)ethyl]-2,3-dihydro-1,4-benzoxazin-7-yl]amino]pyridin-2-yl]methanol","InChI=1S/C24H23N3O2S/c28-15-20-13-19(7-9-25-20)26-18-5-6-22-23(14-18)29-12-11-27(22)10-8-17-16-30-24-4-2-1-3-21(17)24/h1-7,9,13-14,16,28H,8,10-12,15H2,(H,25,26)",OYVHMDHPWDGGLA-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,5.30,cancer,Inhibition,
395,44579348,486060,24702743,CC(=O)N1CCC(CC1)Nc1cccc(Sc2ccc(\C=C\C(=O)N3CCOCC3)c(c2C(F)(F)F)C(F)(F)F)c1,"(E)-3-[4-[3-[(1-acetylpiperidin-4-yl)amino]phenyl]sulfanyl-2,3-bis(trifluoromethyl)phenyl]-1-morpholin-4-ylprop-2-en-1-one","InChI=1S/C28H29F6N3O3S/c1-18(38)36-11-9-20(10-12-36)35-21-3-2-4-22(17-21)41-23-7-5-19(6-8-24(39)37-13-15-40-16-14-37)25(27(29,30)31)26(23)28(32,33)34/h2-8,17,20,35H,9-16H2,1H3/b8-6+",ZBDUGVCGVJAVEM-SOFGYWHQSA-N,1,0,0,0,LFA / ICAM,8.15,immune system disease,Inhibition,
396,168316115,,,COc1ccccc1C1(CCN(CC1)c1ccc(cc1)C(=O)NS(=O)(=O)c1ccc(N[C@H](CCN(C)C)CSc2ccccc2)c(c1)N(=O)=O)OC,,"InChI=1S/C38H45N5O7S2/c1-41(2)23-20-29(27-51-31-10-6-5-7-11-31)39-34-19-18-32(26-35(34)43(45)46)52(47,48)40-37(44)28-14-16-30(17-15-28)42-24-21-38(50-4,22-25-42)33-12-8-9-13-36(33)49-3/h5-19,26,29,39H,20-25,27H2,1-4H3,(H,40,44)/t29-/m1/s1",SAWXOQHNTGHHPU-GDLZYMKVSA-N,2,0,0,0,BCL2-Like / BAX,8.96,cancer,Inhibition,
397,168318300,,,CC[C@@]1(C)CN(CCc2c[nH]c3ccccc23)c2ccc(Nc3ccnc4[C@H](O)CCc34)cc2O1,"4-[[2-ethyl-4-[2-(1H-indol-3-yl)ethyl]-2-methyl-3H-1,4-benzoxazin-7-yl]amino]-6,7-dihydro-5H-cyclopenta[b]pyridin-7-ol","InChI=1S/C29H32N4O2/c1-3-29(2)18-33(15-13-19-17-31-23-7-5-4-6-21(19)23)25-10-8-20(16-27(25)35-29)32-24-12-14-30-28-22(24)9-11-26(28)34/h4-8,10,12,14,16-17,26,31,34H,3,9,11,13,15,18H2,1-2H3,(H,30,32)/t26-,29+/m1/s1",JSRQFJDQHITLFG-UHSQPCAPSA-N,1,1,0,0,MDM2-Like / P53,6.00,cancer,Inhibition,
398,168318226,,,CN(C)CCNC(=O)c1cc(Cl)cc(c1)-n1c(nc(-c2nnn[nH]2)c1-c1cccc(Cl)c1F)C1CCCCC1,,"InChI=1S/C27H29Cl2FN8O/c1-37(2)12-11-31-27(39)17-13-18(28)15-19(14-17)38-24(20-9-6-10-21(29)22(20)30)23(25-33-35-36-34-25)32-26(38)16-7-4-3-5-8-16/h6,9-10,13-16H,3-5,7-8,11-12H2,1-2H3,(H,31,39)(H,33,34,35,36)",SAMJEZPPNUKOKS-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,7.32,cancer,Inhibition,
399,51042426,,,CN(C)CC[C@H](CSc1ccccc1Cl)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(CC2=C(CC(C)(C)CC2)c2ccc(Cl)cc2)CC1,"N-[7-[1-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperidin-4-yl]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl]-4-[[(2R)-1-(2-chlorophenyl)sulfanyl-4-(dimethylamino)butan-2-yl]amino]-3-(trifluoromethylsulfonyl)benzenesulfonamide","InChI=1S/C46H56Cl2F3N7O4S3/c1-45(2)20-15-32(38(26-45)31-9-11-33(47)12-10-31)27-57-22-17-35(18-23-57)58-24-19-37-41(28-58)52-30-53-44(37)55-65(61,62)36-13-14-40(43(25-36)64(59,60)46(49,50)51)54-34(16-21-56(3)4)29-63-42-8-6-5-7-39(42)48/h5-14,25,30,34-35,54H,15-24,26-29H2,1-4H3,(H,52,53,55)/t34-/m1/s1",MURWMFYCSWNAJE-UUWRZZSWSA-N,1,0,0,0,BCL2-Like / BAX,7.36,cancer,Inhibition,
400,59555638,,,CCOc1cc(Nc2ccncc2)ccc1NCCc1c[nH]c2ccccc12,"2-ethoxy-1-N-[2-(1H-indol-3-yl)ethyl]-4-N-pyridin-4-ylbenzene-1,4-diamine","InChI=1S/C23H24N4O/c1-2-28-23-15-19(27-18-10-12-24-13-11-18)7-8-22(23)25-14-9-17-16-26-21-6-4-3-5-20(17)21/h3-8,10-13,15-16,25-26H,2,9,14H2,1H3,(H,24,27)",SGHWSLZCSBQWOP-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,7.20,cancer,Inhibition,
401,58531699,,,Oc1c(Cl)cc(Cl)cc1S(=O)(=O)N(Cc1ccc(F)cc1)Cc1cccc(c1)-c1ccc(Cl)cc1,"3,5-dichloro-N-[[3-(4-chlorophenyl)phenyl]methyl]-N-[(4-fluorophenyl)methyl]-2-hydroxybenzenesulfonamide","InChI=1S/C26H19Cl3FNO3S/c27-21-8-6-19(7-9-21)20-3-1-2-18(12-20)16-31(15-17-4-10-23(30)11-5-17)35(33,34)25-14-22(28)13-24(29)26(25)32/h1-14,32H,15-16H2",NTKQCBAXLHSLAG-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,7.30,cancer,Inhibition,
402,46883921,1089693,24666717,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1nc2c(cccc2s1)-c1cccnc1,"(2S)-N-[(1S)-1-cyclohexyl-2-oxo-2-[(2R)-2-(4-pyridin-3-yl-1,3-benzothiazol-2-yl)pyrrolidin-1-yl]ethyl]-2-(methylamino)propanamide","InChI=1S/C28H35N5O2S/c1-18(29-2)26(34)31-24(19-9-4-3-5-10-19)28(35)33-16-8-13-22(33)27-32-25-21(12-6-14-23(25)36-27)20-11-7-15-30-17-20/h6-7,11-12,14-15,17-19,22,24,29H,3-5,8-10,13,16H2,1-2H3,(H,31,34)/t18-,22-,24-/m0/s1",UAWQNILLPUUPES-OEOAZWSVSA-N,1,0,0,0,XIAP / Smac,7.30,cancer,Inhibition,
403,168318225,,24632575,CNC(=O)c1ccc(O[C@H](C)C(=O)N2CCN(C[C@H]2C)C(=O)c2ccccc2)c(F)c1,4-[1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-1-oxopropan-2-yl]oxy-3-fluoro-N-methylbenzamide,"InChI=1S/C23H26FN3O4/c1-15-14-26(23(30)17-7-5-4-6-8-17)11-12-27(15)22(29)16(2)31-20-10-9-18(13-19(20)24)21(28)25-3/h4-10,13,15-16H,11-12,14H2,1-3H3,(H,25,28)/t15-,16-/m1/s1",DLVMAUPKVXGJIH-HZPDHXFCSA-N,0,1,0,0,CD4 / gp120,5.70,HIV infectious disease,Inhibition,
404,24847908,,21258227,CC(C)c1c(O)c(O)c(C=O)c2c(O)c(ccc12)-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O,"7-(8-formyl-1,6,7-trihydroxy-5-propan-2-ylnaphthalen-2-yl)-2,3,8-trihydroxy-6-methyl-4-propan-2-ylnaphthalene-1-carbaldehyde","InChI=1S/C29H28O8/c1-11(2)19-14-6-7-15(24(32)22(14)17(9-30)25(33)28(19)36)21-13(5)8-16-20(12(3)4)29(37)26(34)18(10-31)23(16)27(21)35/h6-12,32-37H,1-5H3",NZYNYZXVRKCWAF-UHFFFAOYSA-N,3,0,0,0,BCL2-Like / BAX,6.74,cancer,Inhibition,
405,46884474,1089398,24667567,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1nc(cs1)-c1ccnc2ccccc12,"(2S)-N-[(1S)-1-cyclohexyl-2-oxo-2-[(2S)-2-(4-quinolin-4-yl-1,3-thiazol-2-yl)pyrrolidin-1-yl]ethyl]-2-(methylamino)propanamide","InChI=1S/C28H35N5O2S/c1-18(29-2)26(34)32-25(19-9-4-3-5-10-19)28(35)33-16-8-13-24(33)27-31-23(17-36-27)21-14-15-30-22-12-7-6-11-20(21)22/h6-7,11-12,14-15,17-19,24-25,29H,3-5,8-10,13,16H2,1-2H3,(H,32,34)/t18-,24-,25-/m0/s1",GXPYWYRUTUBCTI-WDNCENIBSA-N,1,0,0,0,XIAP / Smac,7.12,cancer,Inhibition,
406,51042647,,,CN(C)CC[C@H](CSc1ccc(F)cc1)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1,"N-[7-[1-[[2-(4-chlorophenyl)phenyl]methyl]piperidin-4-yl]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl]-4-[[(2R)-4-(dimethylamino)-1-(4-fluorophenyl)sulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)benzenesulfonamide","InChI=1S/C44H48ClF4N7O4S3/c1-54(2)21-17-34(28-61-36-13-11-33(46)12-14-36)52-40-16-15-37(25-42(40)62(57,58)44(47,48)49)63(59,60)53-43-39-20-24-56(27-41(39)50-29-51-43)35-18-22-55(23-19-35)26-31-5-3-4-6-38(31)30-7-9-32(45)10-8-30/h3-16,25,29,34-35,52H,17-24,26-28H2,1-2H3,(H,50,51,53)/t34-/m1/s1",UWPKJKZKRCNBIF-UUWRZZSWSA-N,1,0,0,0,BCL2-Like / BAX,7.24,cancer,Inhibition,
407,168318223,,,OC(=O)[C@H](CNC(=O)c1c[nH]cn1)NC(=O)c1c(Cl)cc2CN(CCc2c1Cl)C(=O)c1ccc(Cl)cc1,,"InChI=1S/C24H20Cl3N5O5/c25-14-3-1-12(2-4-14)23(35)32-6-5-15-13(10-32)7-16(26)19(20(15)27)22(34)31-18(24(36)37)9-29-21(33)17-8-28-11-30-17/h1-4,7-8,11,18H,5-6,9-10H2,(H,28,30)(H,29,33)(H,31,34)(H,36,37)/t18-/m0/s1",ZZMFLGPBCMRCTQ-SFHVURJKSA-N,1,0,0,0,LFA / ICAM,6.37,immune system disease,Inhibition,
408,44424314,1207299,25060503,OC(=O)[C@@H]1[C@@H]([C@@H](OC11C(=O)c2ccccc2C1=O)c1ccc(Cl)c(Cl)c1)C(=O)Nc1ccc2OCOc2c1,"4'-(1,3-benzodioxol-5-ylcarbamoyl)-5'-(3,4-dichlorophenyl)-1,3-dioxospiro[indene-2,2'-oxolane]-3'-carboxylic acid","InChI=1S/C27H17Cl2NO8/c28-16-7-5-12(9-17(16)29)22-20(25(33)30-13-6-8-18-19(10-13)37-11-36-18)21(26(34)35)27(38-22)23(31)14-3-1-2-4-15(14)24(27)32/h1-10,20-22H,11H2,(H,30,33)(H,34,35)/t20-,21-,22-/m0/s1",SCNAEUUVEJJBIN-FKBYEOEOSA-N,2,0,0,0,E2 / E1,6.46,human papilloma virus infection,Inhibition,
409,168318221,,,CC(=O)N(CCSc1ccccc1)c1ccc(cc1S(=O)(=O)C(C)(C)C)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2cc(F)ccc2-c2ccc(Cl)cc2)CC1,,"InChI=1S/C45H50ClFN6O5S3/c1-31(54)53(24-25-59-37-8-6-5-7-9-37)42-17-15-38(27-43(42)60(55,56)45(2,3)4)61(57,58)50-44-40-20-23-52(29-41(40)48-30-49-44)36-18-21-51(22-19-36)28-33-26-35(47)14-16-39(33)32-10-12-34(46)13-11-32/h5-17,26-27,30,36H,18-25,28-29H2,1-4H3,(H,48,49,50)",XDAARKOCPDBNPB-UHFFFAOYSA-N,1,0,0,0,BCL2-Like / BAX,6.12,cancer,Inhibition,
410,168318220,,10172942,CCCCN([C@@H](C(=O)NCc1ccccc1)c1ccc2cc(OCC(=O)OC(C)(C)C)ccc2c1)C(=O)Cc1ccc(OC)cc1,tert-butyl 2-[6-[2-(benzylamino)-1-[butyl-[2-(4-methoxyphenyl)acetyl]amino]-2-oxoethyl]naphthalen-2-yl]oxyacetate,"InChI=1S/C38H44N2O6/c1-6-7-21-40(34(41)22-27-13-18-32(44-5)19-14-27)36(37(43)39-25-28-11-9-8-10-12-28)31-16-15-30-24-33(20-17-29(30)23-31)45-26-35(42)46-38(2,3)4/h8-20,23-24,36H,6-7,21-22,25-26H2,1-5H3,(H,39,43)/t36-/m1/s1",UIACBJJRUPCQMX-PSXMRANNSA-N,1,0,0,0,Myc / Max,4.55,cancer,Inhibition,
411,44390657,361733,23246679,OC(=O)[C@H](Cc1ccccc1)N1[C@@H](c2ccc(Cl)cc2)C(=O)Nc2ccc(I)cc2C1=O,"2-[3-(4-chlorophenyl)-7-iodo-2,5-dioxo-1,3-dihydro-1,4-benzodiazepin-4-yl]-3-phenylpropanoic acid","InChI=1S/C24H18ClIN2O4/c25-16-8-6-15(7-9-16)21-22(29)27-19-11-10-17(26)13-18(19)23(30)28(21)20(24(31)32)12-14-4-2-1-3-5-14/h1-11,13,20-21H,12H2,(H,27,29)(H,31,32)/t20-,21-/m0/s1",KDGSHFIQXUCTKF-SFTDATJTSA-N,1,0,0,0,MDM2-Like / P53,4.92,cancer,Inhibition,
412,88540139,,,CN1CCN(CC[C@H](CSc2ccccc2F)Nc2ccc(cc2S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc2ncnc3CN(CCc23)C2CCN(CC3=C(CC(C)(C)CC3)c3ccc(Cl)cc3)CC2)CC1,,"InChI=1S/C49H61ClF4N8O4S3/c1-48(2)19-14-35(41(29-48)34-8-10-36(50)11-9-34)30-61-21-16-38(17-22-61)62-23-18-40-44(31-62)55-33-56-47(40)58-69(65,66)39-12-13-43(46(28-39)68(63,64)49(52,53)54)57-37(15-20-60-26-24-59(3)25-27-60)32-67-45-7-5-4-6-42(45)51/h4-13,28,33,37-38,57H,14-27,29-32H2,1-3H3,(H,55,56,58)/t37-/m1/s1",BFVYSLPKFAJRAU-DIPNUNPCSA-N,1,0,0,0,BCL2-Like / BAX,7.46,cancer,Inhibition,
413,44432170,232745,23294391,Clc1cc(Cl)cc(c1)C1=C(C#N)[C@]2(Cc3ccc(cc3)C#N)CCCN2C1=O,"8-[(4-cyanophenyl)methyl]-2-(3,5-dichlorophenyl)-3-oxo-6,7-dihydro-5H-pyrrolizine-1-carbonitrile","InChI=1S/C22H15Cl2N3O/c23-17-8-16(9-18(24)10-17)20-19(13-26)22(6-1-7-27(22)21(20)28)11-14-2-4-15(12-25)5-3-14/h2-5,8-10H,1,6-7,11H2/t22-/m1/s1",TZCXQSNBTXDAJG-JOCHJYFZSA-N,0,1,0,0,LFA / ICAM,7.40,immune system disease,Inhibition,
414,11704708,,9879431,CCOc1cc(Nc2ccnc(CO)c2)ccc1NCCc1c[nH]c2cc(OC)ccc12,[4-[3-ethoxy-4-[2-(6-methoxy-1H-indol-3-yl)ethylamino]anilino]pyridin-2-yl]methanol,"InChI=1S/C25H28N4O3/c1-3-32-25-13-18(29-19-9-11-26-20(12-19)16-30)4-7-23(25)27-10-8-17-15-28-24-14-21(31-2)5-6-22(17)24/h4-7,9,11-15,27-28,30H,3,8,10,16H2,1-2H3,(H,26,29)",PPCMBJLWZQUCAN-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,7.00,cancer,Inhibition,
415,45137337,,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2Cc1ccncc1)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(1S)-2-[(3aR,6S,6aR)-6-(6-fluoro-1H-indol-3-yl)-4-(pyridin-4-ylmethyl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-1-cyclohexyl-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C32H41FN6O2/c1-20(34-2)31(40)37-29(22-6-4-3-5-7-22)32(41)39-15-12-28-30(39)26(19-38(28)18-21-10-13-35-14-11-21)25-17-36-27-16-23(33)8-9-24(25)27/h8-11,13-14,16-17,20,22,26,28-30,34,36H,3-7,12,15,18-19H2,1-2H3,(H,37,40)/t20-,26+,28+,29-,30+/m0/s1",SAAALNYUDQENNV-KKQAPILSSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
416,168318219,,24641069,CC(C)C[C@H]1CN(CCN1C(=O)C(=O)c1c[nH]c2cccc(F)c12)C(=O)c1ccccc1,"1-[4-benzoyl-2-(2-methylpropyl)piperazin-1-yl]-2-(4-fluoro-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C25H26FN3O3/c1-16(2)13-18-15-28(24(31)17-7-4-3-5-8-17)11-12-29(18)25(32)23(30)19-14-27-21-10-6-9-20(26)22(19)21/h3-10,14,16,18,27H,11-13,15H2,1-2H3/t18-/m0/s1",KMKYQGQHWZOOBS-SFHVURJKSA-N,0,1,0,0,CD4 / gp120,7.10,HIV infectious disease,Inhibition,
417,44574947,501763,,OC[C@H]1[C@@H]2Cn3c(cccc3=O)[C@H]([C@@H]1C(=O)NCCCN1CCCC1)N2c1nc(c(s1)-c1ccccc1)-c1ccc(Cl)cc1,,"InChI=1S/C34H36ClN5O3S/c35-24-14-12-22(13-15-24)30-32(23-8-2-1-3-9-23)44-34(37-30)40-27-20-39-26(10-6-11-28(39)42)31(40)29(25(27)21-41)33(43)36-16-7-19-38-17-4-5-18-38/h1-3,6,8-15,25,27,29,31,41H,4-5,7,16-21H2,(H,36,43)/t25-,27-,29+,31+/m0/s1",FRVRETVPMVMMPI-FVRFUWMBSA-N,2,0,0,0,BCL2-Like / BAX,5.52,cancer,Inhibition,
418,168318215,,,O[C@H]1CCc2c1nccc2Nc1ccc2N(CCc3c[nH]c4ccccc34)CCCc2c1,"4-[[1-[2-(1H-indol-3-yl)ethyl]-3,4-dihydro-2H-quinolin-6-yl]amino]-6,7-dihydro-5H-cyclopenta[b]pyridin-7-ol","InChI=1S/C27H28N4O/c32-26-10-8-22-24(11-13-28-27(22)26)30-20-7-9-25-18(16-20)4-3-14-31(25)15-12-19-17-29-23-6-2-1-5-21(19)23/h1-2,5-7,9,11,13,16-17,26,29,32H,3-4,8,10,12,14-15H2,(H,28,30)/t26-/m0/s1",JYWFSFZLMQIQOP-SANMLTNESA-N,1,1,0,0,MDM2-Like / P53,7.00,cancer,Inhibition,
419,44573513,494358,24706303,O=C(N1CCN(CC1)C(=O)c1ccccc1)C(=O)c1c[nH]c2c(cccc12)C#N,3-[2-(4-benzoylpiperazin-1-yl)-2-oxoacetyl]-1H-indole-7-carbonitrile,"InChI=1S/C22H18N4O3/c23-13-16-7-4-8-17-18(14-24-19(16)17)20(27)22(29)26-11-9-25(10-12-26)21(28)15-5-2-1-3-6-15/h1-8,14,24H,9-12H2",APWTWFLZDNQNQP-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,8.31,HIV infectious disease,Inhibition,
420,23647742,,,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2SC[C@H](N2C1=O)C(=O)Nc1cc(C)nn1-c1ccccc1,"(3R,6S,9aR)-6-[[(2S)-2-(methylamino)propanoyl]amino]-N-(5-methyl-2-phenylpyrazol-3-yl)-5-oxo-3,6,7,8,9,9a-hexahydro-2H-[1,3]thiazolo[3,2-a]azepine-3-carboxamide","InChI=1S/C23H30N6O3S/c1-14-12-19(29(27-14)16-8-5-4-6-9-16)26-22(31)18-13-33-20-11-7-10-17(23(32)28(18)20)25-21(30)15(2)24-3/h4-6,8-9,12,15,17-18,20,24H,7,10-11,13H2,1-3H3,(H,25,30)(H,26,31)/t15-,17-,18-,20+/m0/s1",YYBUDMKKCZIZQP-TXJVSEOTSA-N,1,0,0,0,XIAP / Smac,6.57,cancer,Inhibition,
421,168315748,,,COC1(CCN(CC1)c1ccc(cc1)C(=O)NS(=O)(=O)c1ccc(N[C@H](CCN(C)C)CSc2ccccc2)c(c1)N(=O)=O)c1ccccc1-c1ccccc1,,"InChI=1S/C43H47N5O6S2/c1-46(2)27-24-34(31-55-36-14-8-5-9-15-36)44-40-23-22-37(30-41(40)48(50)51)56(52,53)45-42(49)33-18-20-35(21-19-33)47-28-25-43(54-3,26-29-47)39-17-11-10-16-38(39)32-12-6-4-7-13-32/h4-23,30,34,44H,24-29,31H2,1-3H3,(H,45,49)/t34-/m1/s1",DYEXZAMWDDJPBR-UUWRZZSWSA-N,2,0,0,0,BCL2-Like / BAX,9.30,cancer,Inhibition,
422,168318218,,,COCCCNC(=O)c1cccc(c1)-n1[nH]c2c3cnn(C)c3nc(-c3cccc(c3)C(F)(F)F)c2c1=O,,"InChI=1S/C26H23F3N6O3/c1-34-23-19(14-31-34)22-20(21(32-23)15-6-3-8-17(12-15)26(27,28)29)25(37)35(33-22)18-9-4-7-16(13-18)24(36)30-10-5-11-38-2/h3-4,6-9,12-14,33H,5,10-11H2,1-2H3,(H,30,36)",LZQIDMUDVORVHD-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,6.74,cancer,Inhibition,
423,46840368,,,CCOc1ccc(cc1)-c1sc(nc1C(O)=O)-c1ccc2CCCN(C(=O)Nc3nc4ccccc4s3)c2c1,"2-[1-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-2H-quinolin-7-yl]-5-(4-ethoxyphenyl)-1,3-thiazole-4-carboxylic acid","InChI=1S/C29H24N4O4S2/c1-2-37-20-13-11-18(12-14-20)25-24(27(34)35)31-26(39-25)19-10-9-17-6-5-15-33(22(17)16-19)29(36)32-28-30-21-7-3-4-8-23(21)38-28/h3-4,7-14,16H,2,5-6,15H2,1H3,(H,34,35)(H,30,32,36)",ZHZAYMPWFBZMHS-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,9.00,cancer,Inhibition,
424,59555730,,,Clc1ccc2c(CCNc3ccc(Nc4ccncc4)cc3)c[nH]c2c1,"1-N-[2-(6-chloro-1H-indol-3-yl)ethyl]-4-N-pyridin-4-ylbenzene-1,4-diamine","InChI=1S/C21H19ClN4/c22-16-1-6-20-15(14-25-21(20)13-16)7-12-24-17-2-4-18(5-3-17)26-19-8-10-23-11-9-19/h1-6,8-11,13-14,24-25H,7,12H2,(H,23,26)",LFDAKAYNDGVZQG-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,7.00,cancer,Inhibition,
425,67032002,,,Nc1nnc(o1)-c1nc(C2CCCCC2)n(c1-c1ccc(F)c(Cl)c1)-c1c(CC(=O)NC2CCCC2)ccc(Cl)c1F,,"InChI=1S/C30H30Cl2F2N6O2/c31-20-12-10-18(15-23(41)36-19-8-4-5-9-19)26(24(20)34)40-27(17-11-13-22(33)21(32)14-17)25(29-38-39-30(35)42-29)37-28(40)16-6-2-1-3-7-16/h10-14,16,19H,1-9,15H2,(H2,35,39)(H,36,41)",KEFPPWIMJAKNQA-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,8.70,cancer,Inhibition,
426,59493252,,,Cc1c(NCCc2c[nH]c3ccccc23)ccc(Nc2ccnc(CO)c2)c1C,"[4-[4-[2-(1H-indol-3-yl)ethylamino]-2,3-dimethylanilino]pyridin-2-yl]methanol","InChI=1S/C24H26N4O/c1-16-17(2)23(28-19-10-12-25-20(13-19)15-29)8-7-22(16)26-11-9-18-14-27-24-6-4-3-5-21(18)24/h3-8,10,12-14,26-27,29H,9,11,15H2,1-2H3,(H,25,28)",DAOSFFINBCOBEQ-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,5.52,cancer,Inhibition,
427,506215,523842,442046,Clc1cccc2[nH]cc(C(=O)C(=O)N3CCN(CC3)C(=O)c3ccccc3)c12,"1-(4-benzoylpiperazin-1-yl)-2-(4-chloro-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C21H18ClN3O3/c22-16-7-4-8-17-18(16)15(13-23-17)19(26)21(28)25-11-9-24(10-12-25)20(27)14-5-2-1-3-6-14/h1-8,13,23H,9-12H2",OYYUWYHGPWDHCN-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,8.37,HIV infectious disease,Inhibition,
428,59555640,,,COc1cc(Nc2ccnc(CO)c2)ccc1NCCc1c[nH]c2ccccc12,[4-[4-[2-(1H-indol-3-yl)ethylamino]-3-methoxyanilino]pyridin-2-yl]methanol,"InChI=1S/C23H24N4O2/c1-29-23-13-17(27-18-9-11-24-19(12-18)15-28)6-7-22(23)25-10-8-16-14-26-21-5-3-2-4-20(16)21/h2-7,9,11-14,25-26,28H,8,10,15H2,1H3,(H,24,27)",RDHLNLYEFWUEKH-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,6.60,cancer,Inhibition,
429,44237055,577824,24638501,CC[C@H](N)C(=O)N[C@H]1[C@@H](CNC(C)=O)CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7R,9aS)-7-(acetamidomethyl)-6-[[(2S)-2-aminobutanoyl]amino]-N-benzhydryl-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C30H39N5O4/c1-3-24(31)28(37)34-27-22(18-32-19(2)36)14-15-23-16-17-25(35(23)30(27)39)29(38)33-26(20-10-6-4-7-11-20)21-12-8-5-9-13-21/h4-13,22-27H,3,14-18,31H2,1-2H3,(H,32,36)(H,33,38)(H,34,37)/t22-,23+,24+,25+,27+/m1/s1",FGVJZVMUQHWRBE-HOIWYFOJSA-N,2,0,0,0,XIAP / Smac,6.53,cancer,Inhibition,
430,46176078,,,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1cc2ccnc(-c3ccccc3)c2[nH]1)c1ccccc1,"(2S)-2-(methylamino)-N-[(1S)-2-oxo-1-phenyl-2-[(2S)-2-(7-phenyl-1H-pyrrolo[2,3-c]pyridin-2-yl)pyrrolidin-1-yl]ethyl]propanamide","InChI=1S/C29H31N5O2/c1-19(30-2)28(35)33-27(21-12-7-4-8-13-21)29(36)34-17-9-14-24(34)23-18-22-15-16-31-25(26(22)32-23)20-10-5-3-6-11-20/h3-8,10-13,15-16,18-19,24,27,30,32H,9,14,17H2,1-2H3,(H,33,35)/t19-,24-,27-/m0/s1",GNHIJPSSTOTMHO-SZJUTTIESA-N,1,0,0,0,XIAP / Smac,7.19,cancer,Inhibition,
431,168318214,,,Cc1cc(Nc2ccnc3[C@H](O)CCc23)c(Cl)cc1NCCc1c[nH]c2c(C)cccc12,"4-[2-chloro-5-methyl-4-[2-(7-methyl-1H-indol-3-yl)ethylamino]anilino]-6,7-dihydro-5H-cyclopenta[b]pyridin-7-ol","InChI=1S/C26H27ClN4O/c1-15-4-3-5-18-17(14-30-25(15)18)8-10-28-22-13-20(27)23(12-16(22)2)31-21-9-11-29-26-19(21)6-7-24(26)32/h3-5,9,11-14,24,28,30,32H,6-8,10H2,1-2H3,(H,29,31)/t24-/m1/s1",VWZIEKKIVSAMHN-XMMPIXPASA-N,1,1,0,0,MDM2-Like / P53,5.45,cancer,Inhibition,
432,44391973,366711,23248057,OC(=O)[C@@H]1CCCN1c1cc(ccn1)-c1ccc(Sc2ccc3OCCOc3c2)c(c1)C(F)(F)F,"(2S)-1-[4-[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfanyl)-3-(trifluoromethyl)phenyl]pyridin-2-yl]pyrrolidine-2-carboxylic acid","InChI=1S/C25H21F3N2O4S/c26-25(27,28)18-12-15(16-7-8-29-23(13-16)30-9-1-2-19(30)24(31)32)3-6-22(18)35-17-4-5-20-21(14-17)34-11-10-33-20/h3-8,12-14,19H,1-2,9-11H2,(H,31,32)/t19-/m0/s1",GERAUBTWBQPHRK-IBGZPJMESA-N,0,1,0,0,LFA / ICAM,6.83,immune system disease,Inhibition,
433,59555637,,,CC(C)(C)OC(=O)N(CCc1cn(C(=O)OC(C)(C)C)c2ccccc12)c1ccc(Nc2ccncc2)cc1,tert-butyl 3-[2-[N-[(2-methylpropan-2-yl)oxycarbonyl]-4-(pyridin-4-ylamino)anilino]ethyl]indole-1-carboxylate,"InChI=1S/C31H36N4O4/c1-30(2,3)38-28(36)34(25-13-11-23(12-14-25)33-24-15-18-32-19-16-24)20-17-22-21-35(29(37)39-31(4,5)6)27-10-8-7-9-26(22)27/h7-16,18-19,21H,17,20H2,1-6H3,(H,32,33)",RZGKBJNYXCKASB-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,5.52,cancer,Inhibition,
434,506415,522665,442246,Cn1cc(C(=O)C(=O)N2CCN(CC2)C(=O)c2ccccc2)c2ccccc12,"1-(4-benzoylpiperazin-1-yl)-2-(1-methylindol-3-yl)ethane-1,2-dione","InChI=1S/C22H21N3O3/c1-23-15-18(17-9-5-6-10-19(17)23)20(26)22(28)25-13-11-24(12-14-25)21(27)16-7-3-2-4-8-16/h2-10,15H,11-14H2,1H3",BQMOORMQCXINHT-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,6.58,HIV infectious disease,Inhibition,
435,45137488,,,CN[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N1CC[C@H]2NC[C@@H]([C@@H]12)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(2S)-1-[(3aR,6S,6aR)-6-(6-fluoro-1H-indol-3-yl)-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,2-b]pyrrol-1-yl]-3-methyl-1-oxobutan-2-yl]-2-(methylamino)propanamide","InChI=1S/C23H32FN5O2/c1-12(2)20(28-22(30)13(3)25-4)23(31)29-8-7-18-21(29)17(11-26-18)16-10-27-19-9-14(24)5-6-15(16)19/h5-6,9-10,12-13,17-18,20-21,25-27H,7-8,11H2,1-4H3,(H,28,30)/t13-,17+,18+,20-,21+/m0/s1",JLPBIZQGXHCWKX-XYRDGILRSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
436,87075791,,,Oc1c(Cl)cc(Cl)cc1S(=O)(=O)NCc1cccc(CN(Cc2ccccc2SC(F)(F)F)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)c1,,"InChI=1S/C28H21Cl4F3N2O6S3/c29-19-9-21(31)26(38)24(11-19)45(40,41)36-13-16-4-3-5-17(8-16)14-37(15-18-6-1-2-7-23(18)44-28(33,34)35)46(42,43)25-12-20(30)10-22(32)27(25)39/h1-12,36,38-39H,13-15H2",USZBTZHBUOCCQI-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,7.02,cancer,Inhibition,
437,506222,493941,442053,Clc1ccc2[nH]cc(C(=O)C(=O)N3CCN(CC3)C(=O)c3ccccc3)c2c1,"1-(4-benzoylpiperazin-1-yl)-2-(5-chloro-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C21H18ClN3O3/c22-15-6-7-18-16(12-15)17(13-23-18)19(26)21(28)25-10-8-24(9-11-25)20(27)14-4-2-1-3-5-14/h1-7,12-13,23H,8-11H2",PPILNZIIFRDGQQ-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,6.40,HIV infectious disease,Inhibition,
438,59555582,,,CCOc1cc(Nc2ccnc3ccccc23)ccc1NCCc1c[nH]c2ccccc12,"2-ethoxy-1-N-[2-(1H-indol-3-yl)ethyl]-4-N-quinolin-4-ylbenzene-1,4-diamine","InChI=1S/C27H26N4O/c1-2-32-27-17-20(31-25-14-16-28-24-10-6-4-8-22(24)25)11-12-26(27)29-15-13-19-18-30-23-9-5-3-7-21(19)23/h3-12,14,16-18,29-30H,2,13,15H2,1H3,(H,28,31)",POMKMFVBUDBRSP-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,7.40,cancer,Inhibition,
439,44305024,293202,23155878,OC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1cccc(Cl)c1Cl,"(2S)-2-[(2,3-dichlorobenzoyl)amino]-3-(1H-indol-3-yl)propanoic acid","InChI=1S/C18H14Cl2N2O3/c19-13-6-3-5-12(16(13)20)17(23)22-15(18(24)25)8-10-9-21-14-7-2-1-4-11(10)14/h1-7,9,15,21H,8H2,(H,22,23)(H,24,25)/t15-/m0/s1",RWSBGHKKZYTJCS-HNNXBMFYSA-N,1,0,0,0,LFA / ICAM,5.20,immune system disease,Inhibition,
440,656967,1161626,571203,Cc1ccc(Nc2nccc(n2)-c2ccnc(c2)N2CCN(CCN)CC2)cc1Cl,4-[2-[4-(2-aminoethyl)piperazin-1-yl]pyridin-4-yl]-N-(3-chloro-4-methylphenyl)pyrimidin-2-amine,"InChI=1S/C22H26ClN7/c1-16-2-3-18(15-19(16)23)27-22-26-8-5-20(28-22)17-4-7-25-21(14-17)30-12-10-29(9-6-24)11-13-30/h2-5,7-8,14-15H,6,9-13,24H2,1H3,(H,26,27,28)",RHOOHUMOHVIXEF-UHFFFAOYSA-N,1,0,0,0,ZipA / ftsZ,4.92,bacterial infectious disease,Inhibition,
441,44818313,577512,24639557,CNc1nc(NCc2ccc(NC(=O)c3ccc(Cl)cc3)cc2)c2ccc(C)cc2n1,4-chloro-N-[4-[[[7-methyl-2-(methylamino)quinazolin-4-yl]amino]methyl]phenyl]benzamide,"InChI=1S/C24H22ClN5O/c1-15-3-12-20-21(13-15)29-24(26-2)30-22(20)27-14-16-4-10-19(11-5-16)28-23(31)17-6-8-18(25)9-7-17/h3-13H,14H2,1-2H3,(H,28,31)(H2,26,27,29,30)",FPGLHUFTBYVZPN-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,6.57,cancer,Inhibition,
442,168318213,,,CCOc1ccc(cc1C1=N[C@H]([C@H](N1C(=O)N1CCNC(=O)C1)c1ccc(Cl)cc1)c1ccc(Cl)cc1)S(=O)(=O)N(CCOC)CCOC,"3-[4,5-bis(4-chlorophenyl)-1-(3-oxopiperazine-1-carbonyl)-4,5-dihydroimidazol-2-yl]-4-ethoxy-N,N-bis(2-methoxyethyl)benzenesulfonamide","InChI=1S/C34H39Cl2N5O7S/c1-4-48-29-14-13-27(49(44,45)40(17-19-46-2)18-20-47-3)21-28(29)33-38-31(23-5-9-25(35)10-6-23)32(24-7-11-26(36)12-8-24)41(33)34(43)39-16-15-37-30(42)22-39/h5-14,21,31-32H,4,15-20,22H2,1-3H3,(H,37,42)/t31-,32+/m0/s1",ANVDFQPCYDUQBK-AJQTZOPKSA-N,1,0,0,0,MDM2-Like / P53,7.24,cancer,Inhibition,
443,168318212,,,CN1CCN(CCNC(=O)[C@@H]2N[C@H](CC(C)(C)C)[C@]3([C@H]2c2cccc(Cl)c2F)C(=O)Nc2cc(Cl)ccc32)CC1,"(2'R,3S,3'S,5'R)-6-chloro-3'-(3-chloro-2-fluorophenyl)-5'-(2,2-dimethylpropyl)-N-[2-(4-methylpiperazin-1-yl)ethyl]-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide","InChI=1S/C30H38Cl2FN5O2/c1-29(2,3)17-23-30(20-9-8-18(31)16-22(20)35-28(30)40)24(19-6-5-7-21(32)25(19)33)26(36-23)27(39)34-10-11-38-14-12-37(4)13-15-38/h5-9,16,23-24,26,36H,10-15,17H2,1-4H3,(H,34,39)(H,35,40)/t23-,24+,26-,30-/m1/s1",BXWXGVCDVQYCNW-AQYJNGKQSA-N,2,2,0,0,MDM2-Like / P53,8.82,cancer,Inhibition,
444,12096167,,,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2cccc(c2)C(=O)NCc2ccccc2)c1=O,,"InChI=1S/C29H21F3N6O2/c1-37-26-22(16-34-37)25-23(24(35-26)18-9-5-11-20(13-18)29(30,31)32)28(40)38(36-25)21-12-6-10-19(14-21)27(39)33-15-17-7-3-2-4-8-17/h2-14,16,36H,15H2,1H3,(H,33,39)",QFPRWIIOUDZHTH-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,6.92,cancer,Inhibition,
445,44574954,470541,24693711,OC[C@@H]1[C@H]2Cn3c(cccc3=O)[C@H]2N(CC2CCCCC2)[C@H]1C(=O)NCc1ccc(Oc2ccccc2)cc1,"(2R,3R,3aS,9bS)-1-(cyclohexylmethyl)-3-(hydroxymethyl)-6-oxo-N-[(4-phenoxyphenyl)methyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide","InChI=1S/C32H37N3O4/c36-21-27-26-20-34-28(12-7-13-29(34)37)30(26)35(19-23-8-3-1-4-9-23)31(27)32(38)33-18-22-14-16-25(17-15-22)39-24-10-5-2-6-11-24/h2,5-7,10-17,23,26-27,30-31,36H,1,3-4,8-9,18-21H2,(H,33,38)/t26-,27-,30+,31-/m1/s1",ARTMKCBBWGSNKB-KTTBDGARSA-N,1,0,0,0,BCL2-Like / BAX,5.08,cancer,Inhibition,
446,46175910,,,CN[C@@H](C)C(=O)N[C@@H](C1CCOCC1)C(=O)N1CCC[C@H]1c1cc2ccnc(-c3ccccc3)c2[nH]1,"(2S)-2-(methylamino)-N-[(1S)-1-(oxan-4-yl)-2-oxo-2-[(2S)-2-(7-phenyl-1H-pyrrolo[2,3-c]pyridin-2-yl)pyrrolidin-1-yl]ethyl]propanamide","InChI=1S/C28H35N5O3/c1-18(29-2)27(34)32-26(20-11-15-36-16-12-20)28(35)33-14-6-9-23(33)22-17-21-10-13-30-24(25(21)31-22)19-7-4-3-5-8-19/h3-5,7-8,10,13,17-18,20,23,26,29,31H,6,9,11-12,14-16H2,1-2H3,(H,32,34)/t18-,23-,26-/m0/s1",IKVUPSWUHVVHKV-WMDMVVLCSA-N,2,0,0,0,XIAP / Smac,7.04,cancer,Inhibition,
447,67031822,,,COc1ccc(Cl)cc1-c1c(nc(-c2ccc(C)c(C)c2)n1-c1cc(Cl)ccc1C)-c1nn[nH]n1,,"InChI=1S/C26H22Cl2N6O/c1-14-5-7-17(11-16(14)3)26-29-23(25-30-32-33-31-25)24(20-12-18(27)9-10-22(20)35-4)34(26)21-13-19(28)8-6-15(21)2/h5-13H,1-4H3,(H,30,31,32,33)",BXCHTLMFBBEGGC-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,6.19,cancer,Inhibition,
448,45137796,,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2C(=O)C(F)(F)F)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(1S)-2-[(3aR,6S,6aR)-6-(6-fluoro-1H-indol-3-yl)-4-(2,2,2-trifluoroacetyl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-1-cyclohexyl-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C28H35F4N5O3/c1-15(33-2)25(38)35-23(16-6-4-3-5-7-16)26(39)36-11-10-22-24(36)20(14-37(22)27(40)28(30,31)32)19-13-34-21-12-17(29)8-9-18(19)21/h8-9,12-13,15-16,20,22-24,33-34H,3-7,10-11,14H2,1-2H3,(H,35,38)/t15-,20+,22+,23-,24+/m0/s1",ZWYOHVUUYAVHLC-KVVBJTDHSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
449,59396832,,,CC1(C)CN(c2ccc(NCCc3c[nH]c4ccccc34)cc12)c1ccncc1,"N-[2-(1H-indol-3-yl)ethyl]-3,3-dimethyl-1-pyridin-4-yl-2H-indol-5-amine","InChI=1S/C25H26N4/c1-25(2)17-29(20-10-12-26-13-11-20)24-8-7-19(15-22(24)25)27-14-9-18-16-28-23-6-4-3-5-21(18)23/h3-8,10-13,15-16,27-28H,9,14,17H2,1-2H3",FYUGVQIGJQQARL-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,6.53,cancer,Inhibition,
450,168318211,,,CCCC[C@H]1CN(CCN1C(=O)C(=O)c1c[nH]c2cccc(F)c12)C(=O)c1ccccc1,,"InChI=1S/C25H26FN3O3/c1-2-3-10-18-16-28(24(31)17-8-5-4-6-9-17)13-14-29(18)25(32)23(30)19-15-27-21-12-7-11-20(26)22(19)21/h4-9,11-12,15,18,27H,2-3,10,13-14,16H2,1H3/t18-/m0/s1",OCOGLIXGSRGDAK-SFHVURJKSA-N,0,1,0,0,CD4 / gp120,6.07,HIV infectious disease,Inhibition,
451,168318210,,,COC(=O)c1ccc(cc1)-n1[nH]c2c3cnn(C)c3nc(-c3cccc(c3)C(F)(F)F)c2c1=O,,"InChI=1S/C23H16F3N5O3/c1-30-20-16(11-27-30)19-17(18(28-20)13-4-3-5-14(10-13)23(24,25)26)21(32)31(29-19)15-8-6-12(7-9-15)22(33)34-2/h3-11,29H,1-2H3",QPXFMWQAORRHBW-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.51,cancer,Inhibition,
452,46884523,1091216,24668280,CN[C@@H](C)C(=O)N[C@@H](C1CCOCC1)C(=O)N1CCC[C@H]1c1nc(c(s1)C#N)-c1cccc2ccccc12,"(2S)-N-[(1S)-2-[(2S)-2-(5-cyano-4-naphthalen-1-yl-1,3-thiazol-2-yl)pyrrolidin-1-yl]-1-(oxan-4-yl)-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C29H33N5O3S/c1-18(31-2)27(35)32-25(20-12-15-37-16-13-20)29(36)34-14-6-11-23(34)28-33-26(24(17-30)38-28)22-10-5-8-19-7-3-4-9-21(19)22/h3-5,7-10,18,20,23,25,31H,6,11-16H2,1-2H3,(H,32,35)/t18-,23-,25-/m0/s1",AHPDFXKGRWZGMR-WYRQLCSISA-N,1,0,0,0,XIAP / Smac,7.49,cancer,Inhibition,
453,12096171,,11591265,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(cc2)C(=O)Nc2cccc(CO)c2)c1=O,"N-[3-(hydroxymethyl)phenyl]-4-[6-methyl-3-oxo-4-[3-(trifluoromethyl)phenyl]-1H-dipyrazolo[4,3-b:4',5'-e]pyridin-2-yl]benzamide","InChI=1S/C29H21F3N6O3/c1-37-26-22(14-33-37)25-23(24(35-26)18-5-3-6-19(13-18)29(30,31)32)28(41)38(36-25)21-10-8-17(9-11-21)27(40)34-20-7-2-4-16(12-20)15-39/h2-14,36,39H,15H2,1H3,(H,34,40)",AGHMWTCIQZXWQO-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.77,cancer,Inhibition,
454,168318208,,,CS(=O)(=O)c1ccc(o1)C(=O)NC[C@H](NC(=O)c1c(Cl)cc2CN(CCc2c1Cl)C(=O)c1ccc2ccoc2c1)C(O)=O,,"InChI=1S/C28H23Cl2N3O9S/c1-43(39,40)22-5-4-20(42-22)25(34)31-12-19(28(37)38)32-26(35)23-18(29)10-16-13-33(8-6-17(16)24(23)30)27(36)15-3-2-14-7-9-41-21(14)11-15/h2-5,7,9-11,19H,6,8,12-13H2,1H3,(H,31,34)(H,32,35)(H,37,38)/t19-/m0/s1",ZAOYBZVWLNWGFV-IBGZPJMESA-N,1,0,0,0,LFA / ICAM,8.92,immune system disease,Inhibition,
455,45138107,,,CN[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2S(C)(=O)=O)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(2S,3R)-1-[(3aR,6S,6aR)-6-(6-fluoro-1H-indol-3-yl)-4-methylsulfonyl-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-3-hydroxy-1-oxobutan-2-yl]-2-(methylamino)propanamide","InChI=1S/C23H32FN5O5S/c1-12(25-3)22(31)27-20(13(2)30)23(32)28-8-7-19-21(28)17(11-29(19)35(4,33)34)16-10-26-18-9-14(24)5-6-15(16)18/h5-6,9-10,12-13,17,19-21,25-26,30H,7-8,11H2,1-4H3,(H,27,31)/t12-,13+,17+,19+,20-,21+/m0/s1",JXUIGLHCEGAMQB-GRTPDYHRSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
456,12158631,389660,23285207,CC(C)Cc1c(O)c(O)c(O)c2c1oc(C)c(-c1ccccc1)c2=O,"5,6,7-trihydroxy-2-methyl-8-(2-methylpropyl)-3-phenylchromen-4-one","InChI=1S/C20H20O5/c1-10(2)9-13-16(21)19(24)18(23)15-17(22)14(11(3)25-20(13)15)12-7-5-4-6-8-12/h4-8,10,21,23-24H,9H2,1-3H3",VOKVHQWUUIPROY-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,6.47,cancer,Inhibition,
457,44237069,4084120,,CC[C@H](NC)C(=O)N[C@H]1[C@@H](CNC(=O)c2ccccc2)CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7R,9aS)-7-(benzamidomethyl)-N-benzhydryl-6-[[(2S)-2-(methylamino)butanoyl]amino]-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C36H43N5O4/c1-3-29(37-2)34(43)40-32-27(23-38-33(42)26-17-11-6-12-18-26)19-20-28-21-22-30(41(28)36(32)45)35(44)39-31(24-13-7-4-8-14-24)25-15-9-5-10-16-25/h4-18,27-32,37H,3,19-23H2,1-2H3,(H,38,42)(H,39,44)(H,40,43)/t27-,28+,29+,30+,32+/m1/s1",OXPBXFHQSIRUSU-HVSNEVFASA-N,1,1,0,0,XIAP / Smac,6.92,cancer,Inhibition,
458,88540211,,,CN(C)CC[C@H](COCc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1,,"InChI=1S/C45H51ClF3N7O5S2/c1-54(2)22-18-36(30-61-29-32-8-4-3-5-9-32)52-41-17-16-38(26-43(41)62(57,58)45(47,48)49)63(59,60)53-44-40-21-25-56(28-42(40)50-31-51-44)37-19-23-55(24-20-37)27-34-10-6-7-11-39(34)33-12-14-35(46)15-13-33/h3-17,26,31,36-37,52H,18-25,27-30H2,1-2H3,(H,50,51,53)/t36-/m1/s1",TXVKIODSSHFXBS-PSXMRANNSA-N,1,0,0,0,BCL2-Like / BAX,6.85,cancer,Inhibition,
459,168318185,,,COc1ccccc1N1CCN([C@@H](C1)C(=O)NCCO)C(=O)[C@@]1(CCCN(C1)C(=O)c1cnccc1C(F)(F)F)Oc1ccc(cc1)C(F)(F)F,N-(2-hydroxyethyl)-4-(2-methoxyphenyl)-1-[3-[4-(trifluoromethyl)phenoxy]-1-[4-(trifluoromethyl)pyridine-3-carbonyl]piperidine-3-carbonyl]piperazine-2-carboxamide,"InChI=1S/C34H35F6N5O6/c1-50-28-6-3-2-5-26(28)43-16-17-45(27(20-43)29(47)42-14-18-46)31(49)32(51-23-9-7-22(8-10-23)33(35,36)37)12-4-15-44(21-32)30(48)24-19-41-13-11-25(24)34(38,39)40/h2-3,5-11,13,19,27,46H,4,12,14-18,20-21H2,1H3,(H,42,47)/t27-,32-/m0/s1",DDSNPBUEIWBYGY-UCGGBYDDSA-N,1,0,0,0,MDM2-Like / P53,6.02,cancer,Inhibition,
460,16109077,374303,17266492,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCC(CC1)=Cc1ccccc1Cl,4-[4-[(2-chlorophenyl)methylidene]piperidin-1-yl]-N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonylbenzamide,"InChI=1S/C37H40ClN5O5S2/c1-41(2)21-20-30(26-49-32-9-4-3-5-10-32)39-35-17-16-33(25-36(35)43(45)46)50(47,48)40-37(44)28-12-14-31(15-13-28)42-22-18-27(19-23-42)24-29-8-6-7-11-34(29)38/h3-17,24-25,30,39H,18-23,26H2,1-2H3,(H,40,44)/t30-/m1/s1",SXJFWYOKAIEGEZ-SSEXGKCCSA-N,2,0,0,0,BCL2-Like / BAX,9.30,cancer,Inhibition,
461,11563403,502512,24711349,OC(=O)[C@@H]1CC[C@@H](CC1)Oc1ccccc1Sc1ccc(\C=C\C(=O)N2CCOCC2)c(C(F)(F)F)c1C(F)(F)F,"4-[2-[4-[(E)-3-morpholin-4-yl-3-oxoprop-1-enyl]-2,3-bis(trifluoromethyl)phenyl]sulfanylphenoxy]cyclohexane-1-carboxylic acid","InChI=1S/C28H27F6NO5S/c29-27(30,31)24-17(8-12-23(36)35-13-15-39-16-14-35)7-11-22(25(24)28(32,33)34)41-21-4-2-1-3-20(21)40-19-9-5-18(6-10-19)26(37)38/h1-4,7-8,11-12,18-19H,5-6,9-10,13-16H2,(H,37,38)/b12-8+/t18-,19+",DZYZAGBAGWPMOE-FWRMUUDVSA-N,1,0,0,0,LFA / ICAM,8.40,immune system disease,Inhibition,
462,25026108,576864,24639861,CNc1nc(NCc2ccc(NC(=O)c3ccc(cc3)C#N)cc2)c2ccccc2n1,4-cyano-N-[4-[[[2-(methylamino)quinazolin-4-yl]amino]methyl]phenyl]benzamide,"InChI=1S/C24H20N6O/c1-26-24-29-21-5-3-2-4-20(21)22(30-24)27-15-17-8-12-19(13-9-17)28-23(31)18-10-6-16(14-25)7-11-18/h2-13H,15H2,1H3,(H,28,31)(H2,26,27,29,30)",BUCKBHOWKWDMMK-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,5.44,cancer,Inhibition,
463,5288250,419362,4450451,COC(=O)[C@H](Cc1ccc(cc1)C#Cc1ccccc1)NC(=O)C[C@H]1CCCN(C1)C(N)=N,methyl 2-[[2-(1-carbamimidoylpiperidin-3-yl)acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate,"InChI=1S/C26H30N4O3/c1-33-25(32)23(29-24(31)17-22-8-5-15-30(18-22)26(27)28)16-21-13-11-20(12-14-21)10-9-19-6-3-2-4-7-19/h2-4,6-7,11-14,22-23H,5,8,15-18H2,1H3,(H3,27,28)(H,29,31)/t22-,23+/m1/s1",MRNGXYMKYHNMLV-PKTZIBPZSA-N,1,0,0,0,IL2 / IL2R,5.52,immune system disease,Inhibition,
464,168318199,,,Clc1ccc(Cn2cnc(c2-c2c([nH]c3cc(Cl)ccc23)C(=O)NCCN2CCN(CC(=O)Nc3cccnc3)CC2)-c2ccccc2)cc1,,"InChI=1S/C38H36Cl2N8O2/c39-28-10-8-26(9-11-28)23-48-25-43-35(27-5-2-1-3-6-27)37(48)34-31-13-12-29(40)21-32(31)45-36(34)38(50)42-15-16-46-17-19-47(20-18-46)24-33(49)44-30-7-4-14-41-22-30/h1-14,21-22,25,45H,15-20,23-24H2,(H,42,50)(H,44,49)",ATGFCJILJGCUMR-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,6.52,cancer,Inhibition,
465,168318197,,,C[C@H](N)c1ncc(o1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O,,"InChI=1S/C20H24N4O5/c1-12(21)18-22-11-16(29-18)19(26)24-9-5-8-15(24)17(25)23-14(20(27)28)10-13-6-3-2-4-7-13/h2-4,6-7,11-12,14-15H,5,8-10,21H2,1H3,(H,23,25)(H,27,28)/t12-,14-,15-/m0/s1",AISXSSFTYZUDTB-QEJZJMRPSA-N,1,0,0,0,XIAP / Smac,4.96,cancer,Inhibition,
466,11258581,181003,9433607,CC(C)[C@H](NC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(=O)NCc1cccs1,(2S)-1-[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-3-methylbutanoyl]-N-(thiophen-2-ylmethyl)pyrrolidine-2-carboxamide,"InChI=1S/C18H28N4O3S/c1-11(2)15(21-16(23)12(3)19)18(25)22-8-4-7-14(22)17(24)20-10-13-6-5-9-26-13/h5-6,9,11-12,14-15H,4,7-8,10,19H2,1-3H3,(H,20,24)(H,21,23)/t12-,14-,15-/m0/s1",OCEUKYZNIXMBLL-QEJZJMRPSA-N,1,0,0,0,XIAP / Smac,6.74,cancer,Inhibition,
467,16109084,373713,17266498,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCC2(CC(=NO2)c2ccccc2)CC1,"N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonyl-4-(3-phenyl-1-oxa-2,8-diazaspiro[4.5]dec-2-en-8-yl)benzamide","InChI=1S/C38H42N6O6S2/c1-42(2)22-19-30(27-51-32-11-7-4-8-12-32)39-34-18-17-33(25-36(34)44(46)47)52(48,49)41-37(45)29-13-15-31(16-14-29)43-23-20-38(21-24-43)26-35(40-50-38)28-9-5-3-6-10-28/h3-18,25,30,39H,19-24,26-27H2,1-2H3,(H,41,45)/t30-/m1/s1",MBESHNJYUQJFTA-SSEXGKCCSA-N,2,0,0,0,BCL2-Like / BAX,8.36,cancer,Inhibition,
468,45485511,585152,24642169,C[C@H]1CN(C[C@@H](C)N1C(=O)c1ccccc1)C(=O)C(=O)c1c[nH]c2cccc(F)c12,"1-(4-benzoyl-3,5-dimethylpiperazin-1-yl)-2-(4-fluoro-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C23H22FN3O3/c1-14-12-26(13-15(2)27(14)22(29)16-7-4-3-5-8-16)23(30)21(28)17-11-25-19-10-6-9-18(24)20(17)19/h3-11,14-15,25H,12-13H2,1-2H3/t14-,15+",XSALDNVGZSFDHK-GASCZTMLSA-N,0,1,0,0,CD4 / gp120,7.32,HIV infectious disease,Inhibition,
469,67980875,,,CC#CCOc1ccccc1CN1CCC(CC1)N1CCc2c(C1)ncnc2NS(=O)(=O)c1ccc(N[C@H](CCN(C)C)CSc2ccccc2)c(c1)S(=O)(=O)C(F)(F)F,,"InChI=1S/C42H50F3N7O5S3/c1-4-5-25-57-39-14-10-9-11-31(39)27-51-22-18-33(19-23-51)52-24-20-36-38(28-52)46-30-47-41(36)49-60(55,56)35-15-16-37(40(26-35)59(53,54)42(43,44)45)48-32(17-21-50(2)3)29-58-34-12-7-6-8-13-34/h6-16,26,30,32-33,48H,17-25,27-29H2,1-3H3,(H,46,47,49)/t32-/m1/s1",OETYXJFKJCPCRN-JGCGQSQUSA-N,1,0,0,0,BCL2-Like / BAX,5.75,cancer,Inhibition,
470,66616817,,,Oc1c(Cl)cc(cc1S(=O)(=O)N(Cc1ccc(F)cc1)Cc1ccc(Oc2ccc(cc2)C(F)(F)F)cc1)C(=O)NCc1ccccc1,,"InChI=1S/C35H27ClF4N2O5S/c36-31-18-26(34(44)41-20-23-4-2-1-3-5-23)19-32(33(31)43)48(45,46)42(21-24-6-12-28(37)13-7-24)22-25-8-14-29(15-9-25)47-30-16-10-27(11-17-30)35(38,39)40/h1-19,43H,20-22H2,(H,41,44)",YJTHLPDZMKYUGL-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,7.40,cancer,Inhibition,
471,155512750,4437666,,Fc1cccc(F)c1N[C@@]1(Cc2cccc(Cl)c2)C(=O)Nc2cc(Cl)ccc12,"6-chloro-3-[(3-chlorophenyl)methyl]-3-(2,6-difluoroanilino)-1H-indol-2-one","InChI=1S/C21H14Cl2F2N2O/c22-13-4-1-3-12(9-13)11-21(27-19-16(24)5-2-6-17(19)25)15-8-7-14(23)10-18(15)26-20(21)28/h1-10,27H,11H2,(H,26,28)/t21-/m1/s1",FUFYOQRYQLCEGB-OAQYLSRUSA-N,1,0,0,0,MDM2-Like / P53,8.93,cancer,Inhibition,
472,25011738,575807,24637364,CC[C@H](N)C(=O)N[C@H]1[C@@H](CN)CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7R,9aS)-6-[[(2S)-2-aminobutanoyl]amino]-7-(aminomethyl)-N-benzhydryl-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C28H37N5O3/c1-2-22(30)26(34)32-25-20(17-29)13-14-21-15-16-23(33(21)28(25)36)27(35)31-24(18-9-5-3-6-10-18)19-11-7-4-8-12-19/h3-12,20-25H,2,13-17,29-30H2,1H3,(H,31,35)(H,32,34)/t20-,21+,22+,23+,25+/m1/s1",XXJHZERDDCOFPK-FCRIMTMASA-N,2,1,0,0,XIAP / Smac,6.01,cancer,Inhibition,
473,168318204,,,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(Cl)c(c2)C(=O)N2CCC[C@H]2C(O)=O)c1=O,"(2R)-1-[2-chloro-5-[6-methyl-3-oxo-4-[3-(trifluoromethyl)phenyl]-1H-dipyrazolo[4,3-b:4',5'-e]pyridin-2-yl]benzoyl]pyrrolidine-2-carboxylic acid","InChI=1S/C27H20ClF3N6O4/c1-35-23-17(12-32-35)22-20(21(33-23)13-4-2-5-14(10-13)27(29,30)31)25(39)37(34-22)15-7-8-18(28)16(11-15)24(38)36-9-3-6-19(36)26(40)41/h2,4-5,7-8,10-12,19,34H,3,6,9H2,1H3,(H,40,41)/t19-/m0/s1",INWWKERXQQCURH-IBGZPJMESA-N,1,0,0,0,CD80 / CD28,7.36,cancer,Inhibition,
474,58894269,,,COc1ccc(C2=N[C@](C)([C@H](N2C(=O)N2CCN(CC2)C(C)=O)c2ccc(Cl)cc2)c2ccc(Cl)cc2)c(OC(C)C)c1,"1-[4-[(4R,5S)-4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-5-methyl-4H-imidazole-3-carbonyl]piperazin-1-yl]ethanone","InChI=1S/C33H36Cl2N4O4/c1-21(2)43-29-20-27(42-5)14-15-28(29)31-36-33(4,24-8-12-26(35)13-9-24)30(23-6-10-25(34)11-7-23)39(31)32(41)38-18-16-37(17-19-38)22(3)40/h6-15,20-21,30H,16-19H2,1-5H3/t30-,33+/m1/s1",KNUFXSLNQSMRKU-NDKRRWIDSA-N,1,0,0,0,MDM2-Like / P53,7.32,cancer,Inhibition,
475,44818132,570656,24633270,CNc1nc(NCc2ccc(NC(=O)c3ccc(F)cc3)cc2)c2cccc(C)c2n1,4-fluoro-N-[4-[[[8-methyl-2-(methylamino)quinazolin-4-yl]amino]methyl]phenyl]benzamide,"InChI=1S/C24H22FN5O/c1-15-4-3-5-20-21(15)29-24(26-2)30-22(20)27-14-16-6-12-19(13-7-16)28-23(31)17-8-10-18(25)11-9-17/h3-13H,14H2,1-2H3,(H,28,31)(H2,26,27,29,30)",SOZJMQJCCKPSJW-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,6.03,cancer,Inhibition,
476,44391966,182333,23248050,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1cc(ncn1)N1CCN(CC1)C(C)=O,1-[4-[6-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyrimidin-4-yl]piperazin-1-yl]ethanone,"InChI=1S/C26H27F3N4OS/c1-17(2)20-6-4-5-7-23(20)35-24-9-8-19(14-21(24)26(27,28)29)22-15-25(31-16-30-22)33-12-10-32(11-13-33)18(3)34/h4-9,14-17H,10-13H2,1-3H3",RNOQFAVOZIQTQB-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,6.70,immune system disease,Inhibition,
477,168318181,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1nnc2CCCN(CCn12)C1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1,,"InChI=1S/C44H52ClF3N8O4S3/c1-53(2)24-20-35(31-61-37-10-4-3-5-11-37)49-40-19-18-38(29-41(40)62(57,58)44(46,47)48)63(59,60)52-43-51-50-42-13-8-23-55(27-28-56(42)43)36-21-25-54(26-22-36)30-33-9-6-7-12-39(33)32-14-16-34(45)17-15-32/h3-7,9-12,14-19,29,35-36,49H,8,13,20-28,30-31H2,1-2H3,(H,51,52)/t35-/m1/s1",AUTRVIRCWHUZPC-PGUFJCEWSA-N,1,0,0,0,BCL2-Like / BAX,7.62,cancer,Inhibition,
478,168318202,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(Cc2ccc(F)cc2)CC1,,"InChI=1S/C36H41FN6O5S2/c1-40(2)19-18-30(26-49-32-6-4-3-5-7-32)38-34-17-16-33(24-35(34)43(45)46)50(47,48)39-36(44)28-10-14-31(15-11-28)42-22-20-41(21-23-42)25-27-8-12-29(37)13-9-27/h3-17,24,30,38H,18-23,25-26H2,1-2H3,(H,39,44)/t30-/m1/s1",BCINWVNNPJMMRO-SSEXGKCCSA-N,2,0,0,0,BCL2-Like / BAX,9.30,cancer,Inhibition,
479,44580725,495518,24706232,FC(F)(F)c1c(Sc2ccccc2OCc2c[nH]cn2)ccc(\C=C\C(=O)N2CCOCC2)c1C(F)(F)F,"(E)-3-[4-[2-(1H-imidazol-5-ylmethoxy)phenyl]sulfanyl-2,3-bis(trifluoromethyl)phenyl]-1-morpholin-4-ylprop-2-en-1-one","InChI=1S/C25H21F6N3O3S/c26-24(27,28)22-16(6-8-21(35)34-9-11-36-12-10-34)5-7-20(23(22)25(29,30)31)38-19-4-2-1-3-18(19)37-14-17-13-32-15-33-17/h1-8,13,15H,9-12,14H2,(H,32,33)/b8-6+",VZSWCQOTQDDSHT-SOFGYWHQSA-N,1,0,0,0,LFA / ICAM,8.02,immune system disease,Inhibition,
480,45138407,,,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2C(C)=O)c1c[nH]c2cc(F)ccc12)C(C)(C)C,"(2S)-N-[(2S)-1-[(3aR,6S,6aR)-4-acetyl-6-(6-fluoro-1H-indol-3-yl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]-2-(methylamino)propanamide","InChI=1S/C26H36FN5O3/c1-14(28-6)24(34)30-23(26(3,4)5)25(35)31-10-9-21-22(31)19(13-32(21)15(2)33)18-12-29-20-11-16(27)7-8-17(18)20/h7-8,11-12,14,19,21-23,28-29H,9-10,13H2,1-6H3,(H,30,34)/t14-,19+,21+,22+,23+/m0/s1",BIWWJVIBSAPJHE-GAVFAVEISA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
481,168318200,,,Cc1cc2CN(CCc2c(C)c1C(=O)N[C@@H](CNC(=O)c1cccs1)C(O)=O)C(=O)c1ccc2ccoc2c1,,"InChI=1S/C29H27N3O6S/c1-16-12-20-15-32(28(35)19-6-5-18-8-10-38-23(18)13-19)9-7-21(20)17(2)25(16)27(34)31-22(29(36)37)14-30-26(33)24-4-3-11-39-24/h3-6,8,10-13,22H,7,9,14-15H2,1-2H3,(H,30,33)(H,31,34)(H,36,37)/t22-/m0/s1",CSENXZJZYBRUFV-QFIPXVFZSA-N,0,1,0,0,LFA / ICAM,8.05,immune system disease,Inhibition,
482,67032012,,,Cc1ccc(cc1C)-c1nc(-c2nnn(C)n2)c(-c2cccc(Cl)c2)n1-c1cc(Cl)ccc1C,,"InChI=1S/C26H22Cl2N6/c1-15-8-10-19(12-17(15)3)26-29-23(25-30-32-33(4)31-25)24(18-6-5-7-20(27)13-18)34(26)22-14-21(28)11-9-16(22)2/h5-14H,1-4H3",LUAKBASMYULHSZ-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,4.90,cancer,Inhibition,
483,67031877,,,COc1ccc(Cl)cc1-c1c(nc(-c2cccc(C)n2)n1-c1cccc(Cl)c1F)-c1nn[nH]n1,,"InChI=1S/C23H16Cl2FN7O/c1-12-5-3-7-16(27-12)23-28-20(22-29-31-32-30-22)21(14-11-13(24)9-10-18(14)34-2)33(23)17-8-4-6-15(25)19(17)26/h3-11H,1-2H3,(H,29,30,31,32)",QXULIAIOWSNMQM-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,7.60,cancer,Inhibition,
484,59555702,,,Clc1cccc2[nH]cc(CCNc3ccc(Nc4ccncc4)cc3)c12,"1-N-[2-(4-chloro-1H-indol-3-yl)ethyl]-4-N-pyridin-4-ylbenzene-1,4-diamine","InChI=1S/C21H19ClN4/c22-19-2-1-3-20-21(19)15(14-25-20)8-13-24-16-4-6-17(7-5-16)26-18-9-11-23-12-10-18/h1-7,9-12,14,24-25H,8,13H2,(H,23,26)",GFVQPVVAPVXIAU-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,6.00,cancer,Inhibition,
485,168318196,,,C[C@H](N1CCC(CC1)N1CCc2c(C1)ncnc2NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(c1)S(=O)(=O)C(F)(F)F)c1ccccc1-c1ccc(Cl)cc1,,"InChI=1S/C47H53ClF3N7O5S3/c1-33(40-9-5-6-10-41(40)34-11-13-35(48)14-12-34)57-22-18-37(19-23-57)58-24-20-42-44(30-58)52-32-53-46(42)55-66(61,62)39-15-16-43(45(29-39)65(59,60)47(49,50)51)54-36(17-21-56-25-27-63-28-26-56)31-64-38-7-3-2-4-8-38/h2-16,29,32-33,36-37,54H,17-28,30-31H2,1H3,(H,52,53,55)/t33-,36+/m0/s1",FMAONFVXGQBHSS-MSEJLTFDSA-N,1,0,0,0,BCL2-Like / BAX,7.01,cancer,Inhibition,
486,59555780,,,Cc1cc(Nc2ccc(NCCc3c[nH]c4ccccc34)cc2)c2ccccc2n1,"1-N-[2-(1H-indol-3-yl)ethyl]-4-N-(2-methylquinolin-4-yl)benzene-1,4-diamine","InChI=1S/C26H24N4/c1-18-16-26(23-7-3-5-9-25(23)29-18)30-21-12-10-20(11-13-21)27-15-14-19-17-28-24-8-4-2-6-22(19)24/h2-13,16-17,27-28H,14-15H2,1H3,(H,29,30)",GSZQGMGRZKJUDO-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,7.90,cancer,Inhibition,
487,88540120,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCC(CC1)=Cc1ccccc1-c1ccc(Cl)cc1,,"InChI=1S/C45H48ClF3N6O4S3/c1-54(2)24-22-35(29-60-37-9-4-3-5-10-37)52-41-21-20-38(27-43(41)61(56,57)45(47,48)49)62(58,59)53-44-40-23-25-55(28-42(40)50-30-51-44)36-18-12-31(13-19-36)26-33-8-6-7-11-39(33)32-14-16-34(46)17-15-32/h3-11,14-17,20-21,26-27,30,35-36,52H,12-13,18-19,22-25,28-29H2,1-2H3,(H,50,51,53)/t35-,36?/m1/s1",LOXPOGRMWCDHGI-RERZGLEZSA-N,1,0,0,0,BCL2-Like / BAX,6.76,cancer,Inhibition,
488,11487643,,9662458,CCC[C@H]1N[C@H]([C@H](c2cccc(Cl)c2)[C@@]11C(=O)Nc2cc(Cl)ccc12)C(=O)N(C)C,"(2'R,3S,3'R,5'R)-6-chloro-3'-(3-chlorophenyl)-N,N-dimethyl-2-oxo-5'-propylspiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide","InChI=1S/C23H25Cl2N3O2/c1-4-6-18-23(16-10-9-15(25)12-17(16)26-22(23)30)19(13-7-5-8-14(24)11-13)20(27-18)21(29)28(2)3/h5,7-12,18-20,27H,4,6H2,1-3H3,(H,26,30)/t18-,19+,20-,23+/m1/s1",JHTSQUJIMVPNCQ-AWWSKVOZSA-N,1,3,0,0,MDM2-Like / P53,6.19,cancer,Inhibition,
489,12109926,,,CNC(=O)[C@H](Cc1ccc2ccccc2c1)N1CCC(=O)N(Cc2ccc3ncccc3c2)[C@@H](CC(C)C)C1=O,"(2S)-N-methyl-2-[(3S)-3-(2-methylpropyl)-2,5-dioxo-4-(quinolin-6-ylmethyl)-1,4-diazepan-1-yl]-3-naphthalen-2-ylpropanamide","InChI=1S/C33H36N4O3/c1-22(2)17-30-33(40)36(29(32(39)34-3)20-23-10-12-25-7-4-5-8-26(25)18-23)16-14-31(38)37(30)21-24-11-13-28-27(19-24)9-6-15-35-28/h4-13,15,18-19,22,29-30H,14,16-17,20-21H2,1-3H3,(H,34,39)/t29-,30-/m0/s1",LPHMXAWJYFROCO-KYJUHHDHSA-N,1,0,0,0,LFA / ICAM,6.89,immune system disease,Inhibition,
490,168318112,,,C[C@H](N1CCC(CC1)N1CCc2c(C1)nc(nc2NS(=O)(=O)c1ccc(N[C@H](CCN(C)C)CSc2ccccc2Cl)c(c1)S(=O)(=O)C(F)(F)F)C(F)(F)F)c1ccccc1-c1ccc(Cl)cc1,,"InChI=1S/C46H49Cl2F6N7O4S3/c1-29(35-8-4-5-9-36(35)30-12-14-31(47)15-13-30)60-23-19-33(20-24-60)61-25-21-37-40(27-61)56-44(45(49,50)51)57-43(37)58-68(64,65)34-16-17-39(42(26-34)67(62,63)46(52,53)54)55-32(18-22-59(2)3)28-66-41-11-7-6-10-38(41)48/h4-17,26,29,32-33,55H,18-25,27-28H2,1-3H3,(H,56,57,58)/t29-,32+/m0/s1",HZLYYRGHNZRNEW-BHDXBOSCSA-N,1,0,0,0,BCL2-Like / BAX,7.00,cancer,Inhibition,
491,506236,492937,442067,Brc1cccc2[nH]cc(C(=O)C(=O)N3CCN(CC3)C(=O)c3ccccc3)c12,"1-(4-benzoylpiperazin-1-yl)-2-(4-bromo-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C21H18BrN3O3/c22-16-7-4-8-17-18(16)15(13-23-17)19(26)21(28)25-11-9-24(10-12-25)20(27)14-5-2-1-3-6-14/h1-8,13,23H,9-12H2",CYIVBPAYCCHZOQ-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,8.35,HIV infectious disease,Inhibition,
492,44391976,180283,23248060,FC(F)(F)c1cc(ccc1Sc1ccc2OCCOc2c1)-c1ccnc(c1)N1CCN(CC1)C=O,"4-[4-[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfanyl)-3-(trifluoromethyl)phenyl]pyridin-2-yl]piperazine-1-carbaldehyde","InChI=1S/C25H22F3N3O3S/c26-25(27,28)20-13-17(18-5-6-29-24(14-18)31-9-7-30(16-32)8-10-31)1-4-23(20)35-19-2-3-21-22(15-19)34-12-11-33-21/h1-6,13-16H,7-12H2",HBXVNIDHYGUGIY-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,6.45,immune system disease,Inhibition,
493,25025707,571994,24635050,CNc1nc(NCc2ccc(NC(=O)c3ccc(Cl)cc3)cc2)c2ccccc2n1,4-chloro-N-[4-[[[2-(methylamino)quinazolin-4-yl]amino]methyl]phenyl]benzamide,"InChI=1S/C23H20ClN5O/c1-25-23-28-20-5-3-2-4-19(20)21(29-23)26-14-15-6-12-18(13-7-15)27-22(30)16-8-10-17(24)11-9-16/h2-13H,14H2,1H3,(H,27,30)(H2,25,26,28,29)",KAMBUPZZPWFSKM-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,6.11,cancer,Inhibition,
494,25049970,,,Clc1ccc(cc1)[C@@H]1[C@H](c2ccc(Cl)cc2)n2c(ccc(C(=O)N3CCOCC3)c2=O)N1S(=O)(=O)c1cccc(c1)C#N,"3-[[(2R,3S)-2,3-bis(4-chlorophenyl)-6-(morpholine-4-carbonyl)-5-oxo-2,3-dihydroimidazo[1,2-a]pyridin-1-yl]sulfonyl]benzonitrile","InChI=1S/C31H24Cl2N4O5S/c32-23-8-4-21(5-9-23)28-29(22-6-10-24(33)11-7-22)37(43(40,41)25-3-1-2-20(18-25)19-34)27-13-12-26(31(39)36(27)28)30(38)35-14-16-42-17-15-35/h1-13,18,28-29H,14-17H2/t28-,29+/m0/s1",DPVKOMKTVZGKLU-URLMMPGGSA-N,1,0,0,0,MDM2-Like / P53,5.80,cancer,Inhibition,
495,25138068,486330,24703250,C[C@H](O)C(=O)N[C@H]1CCCC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,10aS)-N-benzhydryl-6-[[(2S)-2-hydroxypropanoyl]amino]-5-oxo-2,3,6,7,8,9,10,10a-octahydro-1H-pyrrolo[1,2-a]azocine-3-carboxamide","InChI=1S/C27H33N3O4/c1-18(31)25(32)28-22-15-9-8-14-21-16-17-23(30(21)27(22)34)26(33)29-24(19-10-4-2-5-11-19)20-12-6-3-7-13-20/h2-7,10-13,18,21-24,31H,8-9,14-17H2,1H3,(H,28,32)(H,29,33)/t18-,21-,22-,23-/m0/s1",MEIDRYNCEXLIEO-QGQQZZQASA-N,1,1,0,0,XIAP / Smac,5.15,cancer,Inhibition,
496,45138995,,,C[C@H](N)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CC[C@H]2NC[C@@H]([C@@H]12)c1cn(Cc2ccccc2)c2cc(F)ccc12,"(2S)-N-[(1S)-2-[(3aR,6S,6aR)-6-(1-benzyl-6-fluoroindol-3-yl)-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,2-b]pyrrol-1-yl]-1-cyclohexyl-2-oxoethyl]-2-aminopropanamide","InChI=1S/C32H40FN5O2/c1-20(34)31(39)36-29(22-10-6-3-7-11-22)32(40)38-15-14-27-30(38)25(17-35-27)26-19-37(18-21-8-4-2-5-9-21)28-16-23(33)12-13-24(26)28/h2,4-5,8-9,12-13,16,19-20,22,25,27,29-30,35H,3,6-7,10-11,14-15,17-18,34H2,1H3,(H,36,39)/t20-,25+,27+,29-,30+/m0/s1",QWETXBRFEHJDGX-JMNPZEAQSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
497,58531586,,,Oc1c(Cl)cc(Cl)cc1S(=O)(=O)N(Cc1ccc(F)cc1)Cc1ccc(cc1)C(=O)N[C@H]1C[C@@H]1c1ccccc1,"4-[[(3,5-dichloro-2-hydroxyphenyl)sulfonyl-[(4-fluorophenyl)methyl]amino]methyl]-N-[(1S,2R)-2-phenylcyclopropyl]benzamide","InChI=1S/C30H25Cl2FN2O4S/c31-23-14-26(32)29(36)28(15-23)40(38,39)35(18-20-8-12-24(33)13-9-20)17-19-6-10-22(11-7-19)30(37)34-27-16-25(27)21-4-2-1-3-5-21/h1-15,25,27,36H,16-18H2,(H,34,37)/t25-,27+/m1/s1",ZIZYQNAEKNJPSR-VPUSJEBWSA-N,2,0,0,0,BCL2-Like / BAX,6.43,cancer,Inhibition,
498,58531411,2031010,,Oc1c(Cl)cc(Cl)cc1S(=O)(=O)N(Cc1ccc(F)cc1)Cc1ccc(cc1)C(=O)N(Cc1ccc(F)cc1)Cc1cc(Cl)cc(Cl)c1,"4-[[(3,5-dichloro-2-hydroxyphenyl)sulfonyl-[(4-fluorophenyl)methyl]amino]methyl]-N-[(3,5-dichlorophenyl)methyl]-N-[(4-fluorophenyl)methyl]benzamide","InChI=1S/C35H26Cl4F2N2O4S/c36-27-13-25(14-28(37)15-27)19-42(18-22-3-9-30(40)10-4-22)35(45)26-7-1-23(2-8-26)20-43(21-24-5-11-31(41)12-6-24)48(46,47)33-17-29(38)16-32(39)34(33)44/h1-17,44H,18-21H2",KUFRCLRVAYJMCG-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,7.40,cancer,Inhibition,
499,46836723,,,OC(=O)c1nc(sc1CCCOc1ccc(cc1)-c1ncccn1)N1CCc2cccc(C(=O)Nc3nc4ccccc4s3)c2C1,"2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-5-[3-(4-pyrimidin-2-ylphenoxy)propyl]-1,3-thiazole-4-carboxylic acid","InChI=1S/C34H28N6O4S2/c41-31(39-33-37-26-8-1-2-9-27(26)45-33)24-7-3-6-21-15-18-40(20-25(21)24)34-38-29(32(42)43)28(46-34)10-4-19-44-23-13-11-22(12-14-23)30-35-16-5-17-36-30/h1-3,5-9,11-14,16-17H,4,10,15,18-20H2,(H,42,43)(H,37,39,41)",IFTBVCZEUVKFPU-UHFFFAOYSA-N,1,0,0,0,BCL2-Like / BAX,6.96,cancer,Inhibition,
500,168317911,,,COC1(CCN(CC1)c1ccc(cc1)C(=O)NS(=O)(=O)c1ccc(N[C@H](CCN(C)C)CSc2ccccc2)c(c1)N(=O)=O)c1cccc(Cl)c1,,"InChI=1S/C37H42ClN5O6S2/c1-41(2)21-18-30(26-50-32-10-5-4-6-11-32)39-34-17-16-33(25-35(34)43(45)46)51(47,48)40-36(44)27-12-14-31(15-13-27)42-22-19-37(49-3,20-23-42)28-8-7-9-29(38)24-28/h4-17,24-25,30,39H,18-23,26H2,1-3H3,(H,40,44)/t30-/m1/s1",IHYAHFCXVJTLBS-SSEXGKCCSA-N,2,0,0,0,BCL2-Like / BAX,9.30,cancer,Inhibition,
501,44237067,575597,24635903,CC[C@H](N)C(=O)N[C@H]1[C@@H](CCO)CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7R,9aS)-6-[[(2S)-2-aminobutanoyl]amino]-N-benzhydryl-7-(2-hydroxyethyl)-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C29H38N4O4/c1-2-23(30)27(35)32-26-21(17-18-34)13-14-22-15-16-24(33(22)29(26)37)28(36)31-25(19-9-5-3-6-10-19)20-11-7-4-8-12-20/h3-12,21-26,34H,2,13-18,30H2,1H3,(H,31,36)(H,32,35)/t21-,22+,23+,24+,26+/m1/s1",HAMADBKCKRFVNI-VEGWMBEDSA-N,1,1,0,0,XIAP / Smac,6.55,cancer,Inhibition,
502,53316631,1644120,26376093,Cc1cccc2c(cn(c12)S(C)(=O)=O)C(=O)NC[C@H](NC(=O)c1c(Cl)cc2CN(CCc2c1Cl)C(=O)c1ccc(Cl)cc1)C(O)=O,"(2S)-2-[[5,7-dichloro-2-(4-chlorobenzoyl)-3,4-dihydro-1H-isoquinoline-6-carbonyl]amino]-3-[(7-methyl-1-methylsulfonylindole-3-carbonyl)amino]propanoic acid","InChI=1S/C31H27Cl3N4O7S/c1-16-4-3-5-21-22(15-38(27(16)21)46(2,44)45)28(39)35-13-24(31(42)43)36-29(40)25-23(33)12-18-14-37(11-10-20(18)26(25)34)30(41)17-6-8-19(32)9-7-17/h3-9,12,15,24H,10-11,13-14H2,1-2H3,(H,35,39)(H,36,40)(H,42,43)/t24-/m0/s1",JQZDFLNJNAPFDP-DEOSSOPVSA-N,1,0,0,0,LFA / ICAM,6.85,immune system disease,Inhibition,
503,11563403,526564,24720849,OC(=O)[C@H]1CC[C@@H](CC1)Oc1ccccc1Sc1ccc(\C=C\C(=O)N2CCOCC2)c(C(F)(F)F)c1C(F)(F)F,"4-[2-[4-[(E)-3-morpholin-4-yl-3-oxoprop-1-enyl]-2,3-bis(trifluoromethyl)phenyl]sulfanylphenoxy]cyclohexane-1-carboxylic acid","InChI=1S/C28H27F6NO5S/c29-27(30,31)24-17(8-12-23(36)35-13-15-39-16-14-35)7-11-22(25(24)28(32,33)34)41-21-4-2-1-3-20(21)40-19-9-5-18(6-10-19)26(37)38/h1-4,7-8,11-12,18-19H,5-6,9-10,13-16H2,(H,37,38)/b12-8+/t18-,19-",DZYZAGBAGWPMOE-DRXOMFTESA-N,1,0,0,0,LFA / ICAM,8.74,immune system disease,Inhibition,
504,16117417,426608,10657269,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1coc(n1)N1CCCCC1,"2-piperidin-1-yl-4-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]-1,3-oxazole","InChI=1S/C24H25F3N2OS/c1-16(2)18-8-4-5-9-21(18)31-22-11-10-17(14-19(22)24(25,26)27)20-15-30-23(28-20)29-12-6-3-7-13-29/h4-5,8-11,14-16H,3,6-7,12-13H2,1-2H3",BCKMDCAQOKRTLA-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,4.82,immune system disease,Inhibition,
505,10278714,182280,8454191,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1cc(ncn1)N1CCC(CCO)CC1,2-[1-[6-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyrimidin-4-yl]piperidin-4-yl]ethanol,"InChI=1S/C27H30F3N3OS/c1-18(2)21-5-3-4-6-24(21)35-25-8-7-20(15-22(25)27(28,29)30)23-16-26(32-17-31-23)33-12-9-19(10-13-33)11-14-34/h3-8,15-19,34H,9-14H2,1-2H3",OVVILUUFUJVIDC-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,6.64,immune system disease,Inhibition,
506,11556634,,9731412,CCOc1cc(ccc1C1=N[C@H]([C@H](N1C(=O)N1CCN(CCS(C)(=O)=O)CC1)c1ccc(F)cc1)c1ccc(F)cc1)C(C)(C)C,"[(4S,5R)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-fluorophenyl)-4,5-dihydroimidazol-1-yl]-[4-(2-methylsulfonylethyl)piperazin-1-yl]methanone","InChI=1S/C35H42F2N4O4S/c1-6-45-30-23-26(35(2,3)4)11-16-29(30)33-38-31(24-7-12-27(36)13-8-24)32(25-9-14-28(37)15-10-25)41(33)34(42)40-19-17-39(18-20-40)21-22-46(5,43)44/h7-16,23,31-32H,6,17-22H2,1-5H3/t31-,32+/m0/s1",SRKPETVUVPUDNN-AJQTZOPKSA-N,1,0,0,0,MDM2-Like / P53,7.22,cancer,Inhibition,
507,11855425,,10029896,CCOc1cc(ccc1C1=N[C@H]([C@H](N1C(=O)N1CCN(CCO)CC1)c1ccc(Cl)cc1)c1ccc(Cl)cc1)C#N,"4-[(4S,5R)-4,5-bis(4-chlorophenyl)-1-[4-(2-hydroxyethyl)piperazine-1-carbonyl]-4,5-dihydroimidazol-2-yl]-3-ethoxybenzonitrile","InChI=1S/C31H31Cl2N5O3/c1-2-41-27-19-21(20-34)3-12-26(27)30-35-28(22-4-8-24(32)9-5-22)29(23-6-10-25(33)11-7-23)38(30)31(40)37-15-13-36(14-16-37)17-18-39/h3-12,19,28-29,39H,2,13-18H2,1H3/t28-,29+/m0/s1",GMMRNHQJSOKOTD-URLMMPGGSA-N,1,0,0,0,MDM2-Like / P53,8.05,cancer,Inhibition,
508,44390633,359846,23246656,OCc1ccc2NC(=O)[C@@H](N([C@H](C(O)=O)c3ccc(Cl)cc3)C(=O)c2c1)c1ccc(Cl)cc1,"2-(4-chlorophenyl)-2-[3-(4-chlorophenyl)-7-(hydroxymethyl)-2,5-dioxo-1,3-dihydro-1,4-benzodiazepin-4-yl]acetic acid","InChI=1S/C24H18Cl2N2O5/c25-16-6-2-14(3-7-16)20-22(30)27-19-10-1-13(12-29)11-18(19)23(31)28(20)21(24(32)33)15-4-8-17(26)9-5-15/h1-11,20-21,29H,12H2,(H,27,30)(H,32,33)/t20-,21-/m0/s1",OQITXJWQXJJLAN-SFTDATJTSA-N,1,0,0,0,MDM2-Like / P53,5.48,cancer,Inhibition,
509,58531604,,,Oc1c(Cl)cc(Cl)cc1S(=O)(=O)N(Cc1ccc(F)cc1)Cc1ccc(cc1)C(=O)N1CCCCC1,"3,5-dichloro-N-[(4-fluorophenyl)methyl]-2-hydroxy-N-[[4-(piperidine-1-carbonyl)phenyl]methyl]benzenesulfonamide","InChI=1S/C26H25Cl2FN2O4S/c27-21-14-23(28)25(32)24(15-21)36(34,35)31(17-19-6-10-22(29)11-7-19)16-18-4-8-20(9-5-18)26(33)30-12-2-1-3-13-30/h4-11,14-15,32H,1-3,12-13,16-17H2",NJCCLEHEQAKZSF-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,6.08,cancer,Inhibition,
510,59774772,,,CC(C)CC(=C)[C@H]1n2cnnc2C[C@@H](c2cccc(Cl)c2)[C@]11C(=O)Nc2cc(Cl)ccc12,"(3R,5'R,7'S)-6-chloro-7'-(3-chlorophenyl)-5'-(4-methylpent-1-en-2-yl)spiro[1H-indole-3,6'-7,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyridine]-2-one","InChI=1S/C25H24Cl2N4O/c1-14(2)9-15(3)23-25(19-8-7-18(27)11-21(19)29-24(25)32)20(12-22-30-28-13-31(22)23)16-5-4-6-17(26)10-16/h4-8,10-11,13-14,20,23H,3,9,12H2,1-2H3,(H,29,32)/t20-,23+,25-/m0/s1",PEGDNBYYOIBPGK-ZWSUVBHBSA-N,1,0,0,0,MDM2-Like / P53,5.99,cancer,Inhibition,
511,168318194,,9333144,CCOc1cc(ccc1C1=N[C@H]([C@@H](N1C(=O)N1CCC(CC1)C(=O)OC)c1ccc(Cl)cc1)c1ccc(Cl)cc1)C(F)(F)F,"methyl 1-[4,5-bis(4-chlorophenyl)-2-[2-ethoxy-4-(trifluoromethyl)phenyl]-4,5-dihydroimidazole-1-carbonyl]piperidine-4-carboxylate","InChI=1S/C32H30Cl2F3N3O4/c1-3-44-26-18-22(32(35,36)37)8-13-25(26)29-38-27(19-4-9-23(33)10-5-19)28(20-6-11-24(34)12-7-20)40(29)31(42)39-16-14-21(15-17-39)30(41)43-2/h4-13,18,21,27-28H,3,14-17H2,1-2H3/t27-,28-/m0/s1",OCJNCKPZMYMQPW-NSOVKSMOSA-N,1,0,0,0,MDM2-Like / P53,5.76,cancer,Inhibition,
512,45137486,,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2Cc1ccccn1)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(1S)-2-[(3aR,6S,6aR)-6-(6-fluoro-1H-indol-3-yl)-4-(pyridin-2-ylmethyl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-1-cyclohexyl-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C32H41FN6O2/c1-20(34-2)31(40)37-29(21-8-4-3-5-9-21)32(41)39-15-13-28-30(39)26(19-38(28)18-23-10-6-7-14-35-23)25-17-36-27-16-22(33)11-12-24(25)27/h6-7,10-12,14,16-17,20-21,26,28-30,34,36H,3-5,8-9,13,15,18-19H2,1-2H3,(H,37,40)/t20-,26+,28+,29-,30+/m0/s1",LFKAXDARZYQJAV-KKQAPILSSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
513,44580771,496106,24707483,FC(F)(F)c1c(Sc2ccccc2OCc2cccs2)ccc(\C=C\C(=O)N2CCOCC2)c1C(F)(F)F,"(E)-1-morpholin-4-yl-3-[4-[2-(thiophen-2-ylmethoxy)phenyl]sulfanyl-2,3-bis(trifluoromethyl)phenyl]prop-2-en-1-one","InChI=1S/C26H21F6NO3S2/c27-25(28,29)23-17(8-10-22(34)33-11-13-35-14-12-33)7-9-21(24(23)26(30,31)32)38-20-6-2-1-5-19(20)36-16-18-4-3-15-37-18/h1-10,15H,11-14,16H2/b10-8+",PQEXIWGLHFOPDT-CSKARUKUSA-N,1,0,0,0,LFA / ICAM,7.96,immune system disease,Inhibition,
514,59774793,,,COc1ccc(F)cc1[C@H]1NCC[C@@H](c2cccc(Cl)c2)[C@]11C(=O)Nc2cc(Cl)ccc12,"(2'R,3R,4'S)-6-chloro-4'-(3-chlorophenyl)-2'-(5-fluoro-2-methoxyphenyl)spiro[1H-indole-3,3'-piperidine]-2-one","InChI=1S/C25H21Cl2FN2O2/c1-32-22-8-6-17(28)13-18(22)23-25(20-7-5-16(27)12-21(20)30-24(25)31)19(9-10-29-23)14-3-2-4-15(26)11-14/h2-8,11-13,19,23,29H,9-10H2,1H3,(H,30,31)/t19-,23+,25+/m0/s1",LCBVOFKGSFEINI-DNVKUUNQSA-N,1,0,0,0,MDM2-Like / P53,5.64,cancer,Inhibition,
515,44573314,493535,24704858,O=C(N1CCN(CC1)C(=O)c1ccccc1)C(=O)c1c[nH]c2ccc(cc12)N(=O)=O,"1-(4-benzoylpiperazin-1-yl)-2-(5-nitro-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C21H18N4O5/c26-19(17-13-22-18-7-6-15(25(29)30)12-16(17)18)21(28)24-10-8-23(9-11-24)20(27)14-4-2-1-3-5-14/h1-7,12-13,22H,8-11H2",SILJQAATWNVXPP-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,8.42,HIV infectious disease,Inhibition,
516,20791228,494002,19627864,Fc1ccc(Br)c2[nH]cc(C(=O)C(=O)N3CCN(CC3)C(=O)c3ccccc3)c12,"1-(4-benzoylpiperazin-1-yl)-2-(7-bromo-4-fluoro-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C21H17BrFN3O3/c22-15-6-7-16(23)17-14(12-24-18(15)17)19(27)21(29)26-10-8-25(9-11-26)20(28)13-4-2-1-3-5-13/h1-7,12,24H,8-11H2",ZXRJVNXPQCVNJI-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,9.89,HIV infectious disease,Inhibition,
517,46221190,1095148,24669735,CN1C(=O)N(C(=O)[C@]11CN(C[C@H]1c1ccc(cc1)C#N)c1nc2ccc(cc2o1)C(O)=O)c1cc(Cl)cc(Cl)c1,"2-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl]-1,3-benzoxazole-6-carboxylic acid","InChI=1S/C28H19Cl2N5O5/c1-33-27(39)35(20-10-18(29)9-19(30)11-20)25(38)28(33)14-34(13-21(28)16-4-2-15(12-31)3-5-16)26-32-22-7-6-17(24(36)37)8-23(22)40-26/h2-11,21H,13-14H2,1H3,(H,36,37)/t21-,28+/m0/s1",YJPXVQLGBKABGV-RBTNQOKQSA-N,1,0,0,0,LFA / ICAM,8.22,immune system disease,Inhibition,
518,23646346,359465,23247019,C[C@H](N)C(=O)Nc1nc2cc(ccc2[nH]1)C(=O)c1ccccc1,(2S)-2-amino-N-(6-benzoyl-1H-benzimidazol-2-yl)propanamide,"InChI=1S/C17H16N4O2/c1-10(18)16(23)21-17-19-13-8-7-12(9-14(13)20-17)15(22)11-5-3-2-4-6-11/h2-10H,18H2,1H3,(H2,19,20,21,23)/t10-/m0/s1",FEWJFTGPRLQQMU-JTQLQIEISA-N,1,0,0,0,XIAP / Smac,4.52,cancer,Inhibition,
519,126634954,,17249027,OCCCO[C@]1(N(Cc2ccccc2)C(=O)c2ccccc12)c1ccc(Cl)cc1,,"InChI=1S/C24H22ClNO3/c25-20-13-11-19(12-14-20)24(29-16-6-15-27)22-10-5-4-9-21(22)23(28)26(24)17-18-7-2-1-3-8-18/h1-5,7-14,27H,6,15-17H2/t24-/m1/s1",RDFQXKACQGFINF-XMMPIXPASA-N,2,0,0,0,MDM2-Like / P53,4.80,cancer,Inhibition,
520,59542211,,,N[C@H](Cc1ccccc1)C(=O)N[C@H]1[C@@H](CO)CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7S,9aS)-6-[[(2R)-2-amino-3-phenylpropanoyl]amino]-N-benzhydryl-7-(hydroxymethyl)-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C33H38N4O4/c34-27(20-22-10-4-1-5-11-22)31(39)36-30-25(21-38)16-17-26-18-19-28(37(26)33(30)41)32(40)35-29(23-12-6-2-7-13-23)24-14-8-3-9-15-24/h1-15,25-30,38H,16-21,34H2,(H,35,40)(H,36,39)/t25-,26+,27-,28+,30+/m1/s1",PURDXDHIYAYLRT-YQRPSLPTSA-N,1,0,0,0,XIAP / Smac,6.00,cancer,Inhibition,
521,168318191,,,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccccc2F)c1=O,,"InChI=1S/C21H13F4N5O/c1-29-19-13(10-26-29)18-16(20(31)30(28-18)15-8-3-2-7-14(15)22)17(27-19)11-5-4-6-12(9-11)21(23,24)25/h2-10,28H,1H3",RKMNSKWAEKXLLQ-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,6.52,cancer,Inhibition,
522,44574949,502454,,COCCNC(=O)[C@@H]1[C@@H](CO)[C@@H]2Cn3c(cccc3=O)[C@H]1N2c1nc(c(s1)-c1ccccc1)-c1ccc(Cl)cc1,,"InChI=1S/C30H29ClN4O4S/c1-39-15-14-32-29(38)25-21(17-36)23-16-34-22(8-5-9-24(34)37)27(25)35(23)30-33-26(18-10-12-20(31)13-11-18)28(40-30)19-6-3-2-4-7-19/h2-13,21,23,25,27,36H,14-17H2,1H3,(H,32,38)/t21-,23-,25+,27+/m0/s1",TUWXDFQYVJARAO-JZEPBHRJSA-N,1,0,0,0,BCL2-Like / BAX,5.37,cancer,Inhibition,
523,11497354,1089024,9672160,CN[C@@H](C)C(=O)N[C@@H](C1CCOCC1)C(=O)N1CCC[C@H]1c1nc(cs1)-c1ccc(F)c2ccccc12,"(2S)-N-[(1S)-2-[(2S)-2-[4-(4-fluoronaphthalen-1-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(oxan-4-yl)-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C28H33FN4O3S/c1-17(30-2)26(34)32-25(18-11-14-36-15-12-18)28(35)33-13-5-8-24(33)27-31-23(16-37-27)21-9-10-22(29)20-7-4-3-6-19(20)21/h3-4,6-7,9-10,16-18,24-25,30H,5,8,11-15H2,1-2H3,(H,32,34)/t17-,24-,25-/m0/s1",PDPPXLVUFNSPHS-HDBFHEOPSA-N,1,0,0,0,XIAP / Smac,6.85,cancer,Inhibition,
524,44176172,208554,23271887,Nc1cc(Cl)ccc1CN1[C@@H](c2ccc(Cl)cc2)C(=O)N(CCCCC(O)=O)c2ccc(I)cc2C1=O,"5-[(3S)-4-[(2-amino-4-chlorophenyl)methyl]-3-(4-chlorophenyl)-7-iodo-2,5-dioxo-3H-1,4-benzodiazepin-1-yl]pentanoic acid","InChI=1S/C27H24Cl2IN3O4/c28-18-7-4-16(5-8-18)25-27(37)32(12-2-1-3-24(34)35)23-11-10-20(30)14-21(23)26(36)33(25)15-17-6-9-19(29)13-22(17)31/h4-11,13-14,25H,1-3,12,15,31H2,(H,34,35)/t25-/m0/s1",GTYWDSONJKDRTC-VWLOTQADSA-N,1,0,0,0,MDM2-Like / P53,6.09,cancer,Inhibition,
525,168318190,,,COc1cccc(c1)-c1nc2n(C)ncc2c2[nH]n(-c3cccc(F)c3)c(=O)c12,,"InChI=1S/C21H16FN5O2/c1-26-20-16(11-23-26)19-17(18(24-20)12-5-3-8-15(9-12)29-2)21(28)27(25-19)14-7-4-6-13(22)10-14/h3-11,25H,1-2H3",FRWCXXLFEUORIB-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.09,cancer,Inhibition,
526,168318189,,24642819,C[C@H](O)c1ccc2c(NCc3ccc(NC(=O)c4ccc(F)cc4)cc3)nc(nc2c1)N(C)C,N-[4-[[[2-(dimethylamino)-7-(1-hydroxyethyl)quinazolin-4-yl]amino]methyl]phenyl]-4-fluorobenzamide,"InChI=1S/C26H26FN5O2/c1-16(33)19-8-13-22-23(14-19)30-26(32(2)3)31-24(22)28-15-17-4-11-21(12-5-17)29-25(34)18-6-9-20(27)10-7-18/h4-14,16,33H,15H2,1-3H3,(H,29,34)(H,28,30,31)/t16-/m0/s1",DXXURDUATOXHTG-INIZCTEOSA-N,0,1,0,0,Beta-catenin / TCF-4,5.72,cancer,Inhibition,
527,168318187,,,CC(C)c1cn(nn1)C(=O)NC[C@H](NC(=O)c1c(Cl)cc2CN(CCc2c1Cl)C(=O)c1ccc2ccoc2c1)C(O)=O,,"InChI=1S/C28H26Cl2N6O6/c1-14(2)21-13-36(34-33-21)28(41)31-11-20(27(39)40)32-25(37)23-19(29)9-17-12-35(7-5-18(17)24(23)30)26(38)16-4-3-15-6-8-42-22(15)10-16/h3-4,6,8-10,13-14,20H,5,7,11-12H2,1-2H3,(H,31,41)(H,32,37)(H,39,40)/t20-/m0/s1",DKVFEMGBAAXBFO-FQEVSTJZSA-N,1,0,0,0,LFA / ICAM,7.72,immune system disease,Inhibition,
528,168318186,,,Cc1ccc(O[C@]2(CCCN(C2)C(=O)c2cnccc2C(F)(F)F)C(=O)N2CCN(CC2)c2ccccn2)cc1,[3-(4-methylphenoxy)-3-(4-pyridin-2-ylpiperazine-1-carbonyl)piperidin-1-yl]-[4-(trifluoromethyl)pyridin-3-yl]methanone,"InChI=1S/C29H30F3N5O3/c1-21-6-8-22(9-7-21)40-28(27(39)36-17-15-35(16-18-36)25-5-2-3-12-34-25)11-4-14-37(20-28)26(38)23-19-33-13-10-24(23)29(30,31)32/h2-3,5-10,12-13,19H,4,11,14-18,20H2,1H3/t28-/m0/s1",AXHSICWWZKXUKL-NDEPHWFRSA-N,1,0,0,0,MDM2-Like / P53,5.82,cancer,Inhibition,
529,45487328,569385,24631939,CNC(=O)c1ccc(O[C@@H](C)C(=O)N2CCN(C[C@H]2C)C(=O)c2ccccc2)c2ccncc12,5-[(2S)-1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-1-oxopropan-2-yl]oxy-N-methylisoquinoline-8-carboxamide,"InChI=1S/C26H28N4O4/c1-17-16-29(26(33)19-7-5-4-6-8-19)13-14-30(17)25(32)18(2)34-23-10-9-21(24(31)27-3)22-15-28-12-11-20(22)23/h4-12,15,17-18H,13-14,16H2,1-3H3,(H,27,31)/t17-,18+/m1/s1",IFOVLGBERKQOHA-MSOLQXFVSA-N,0,1,0,0,CD4 / gp120,4.67,HIV infectious disease,Inhibition,
530,44570037,516633,24716529,Cc1cc(nn1-c1ccccc1C(=O)N1CCc2ccccc2C1)C(=O)N(C1CCCCC1)c1ccccc1,"N-cyclohexyl-1-[2-(3,4-dihydro-1H-isoquinoline-2-carbonyl)phenyl]-5-methyl-N-phenylpyrazole-3-carboxamide","InChI=1S/C33H34N4O2/c1-24-22-30(33(39)36(27-14-4-2-5-15-27)28-16-6-3-7-17-28)34-37(24)31-19-11-10-18-29(31)32(38)35-21-20-25-12-8-9-13-26(25)23-35/h2,4-5,8-15,18-19,22,28H,3,6-7,16-17,20-21,23H2,1H3",AYRPCROHAVCMHQ-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,5.85,cancer,Inhibition,
531,168318184,,,Cn1ncc2c1nc(-c1cccc(c1)N(=O)=O)c1c2[nH]n(-c2ccc(F)cc2)c1=O,,"InChI=1S/C20H13FN6O3/c1-25-19-15(10-22-25)18-16(17(23-19)11-3-2-4-14(9-11)27(29)30)20(28)26(24-18)13-7-5-12(21)6-8-13/h2-10,24H,1H3",PYLOYQVSTXHVHC-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.30,cancer,Inhibition,
532,44570044,453466,24687996,COC(=O)C[C@@H]1Cc2ccccc2CN1C(=O)c1ccccc1-n1nc(cc1C)C(=O)N(c1ccccc1)c1ccccc1,"methyl 2-[(3S)-2-[2-[3-(diphenylcarbamoyl)-5-methylpyrazol-1-yl]benzoyl]-3,4-dihydro-1H-isoquinolin-3-yl]acetate","InChI=1S/C36H32N4O4/c1-25-21-32(36(43)39(28-15-5-3-6-16-28)29-17-7-4-8-18-29)37-40(25)33-20-12-11-19-31(33)35(42)38-24-27-14-10-9-13-26(27)22-30(38)23-34(41)44-2/h3-21,30H,22-24H2,1-2H3/t30-/m0/s1",CUIQYYXLEMZWRC-PMERELPUSA-N,2,0,0,0,BCL2-Like / BAX,6.55,cancer,Inhibition,
533,44390724,179987,23246747,OCCc1ccc2NC(=O)[C@@H](N([C@H](C(O)=O)c3ccc(Cl)cc3)C(=O)c2c1)c1ccc(Cl)cc1,"2-(4-chlorophenyl)-2-[3-(4-chlorophenyl)-7-(2-hydroxyethyl)-2,5-dioxo-1,3-dihydro-1,4-benzodiazepin-4-yl]acetic acid","InChI=1S/C25H20Cl2N2O5/c26-17-6-2-15(3-7-17)21-23(31)28-20-10-1-14(11-12-30)13-19(20)24(32)29(21)22(25(33)34)16-4-8-18(27)9-5-16/h1-10,13,21-22,30H,11-12H2,(H,28,31)(H,33,34)/t21-,22-/m0/s1",YXOSJUJSWPBSOU-VXKWHMMOSA-N,1,0,0,0,MDM2-Like / P53,5.62,cancer,Inhibition,
534,25218683,458345,24691450,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1CNC(=O)c1cccc2ccccc12)C(C)(C)C,"N-[[(2S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]pyrrolidin-2-yl]methyl]naphthalene-1-carboxamide","InChI=1S/C26H36N4O3/c1-17(27-5)23(31)29-22(26(2,3)4)25(33)30-15-9-12-19(30)16-28-24(32)21-14-8-11-18-10-6-7-13-20(18)21/h6-8,10-11,13-14,17,19,22,27H,9,12,15-16H2,1-5H3,(H,28,32)(H,29,31)/t17-,19-,22+/m0/s1",FPXSXLPIQWNRHT-LQBOVUBWSA-N,1,0,0,0,XIAP / Smac,5.80,cancer,Inhibition,
535,44305282,62991,23156188,Cc1cccc(C)c1C(=O)N[C@@H](Cc1c[nH]cn1)C(O)=O,"(2S)-2-[(2,6-dimethylbenzoyl)amino]-3-(1H-imidazol-5-yl)propanoic acid","InChI=1S/C15H17N3O3/c1-9-4-3-5-10(2)13(9)14(19)18-12(15(20)21)6-11-7-16-8-17-11/h3-5,7-8,12H,6H2,1-2H3,(H,16,17)(H,18,19)(H,20,21)/t12-/m0/s1",RNMFDVJEHLKDQP-LBPRGKRZSA-N,1,0,0,0,LFA / ICAM,5.75,immune system disease,Inhibition,
536,168318178,,,COc1c(Nc2ccnc3[C@@H](O)CCc23)ccc(NCCc2c[nH]c3c(cccc23)C(C)(C)O)c1F,"4-[3-fluoro-4-[2-[7-(2-hydroxypropan-2-yl)-1H-indol-3-yl]ethylamino]-2-methoxyanilino]-6,7-dihydro-5H-cyclopenta[b]pyridin-7-ol","InChI=1S/C28H31FN4O3/c1-28(2,35)19-6-4-5-17-16(15-32-25(17)19)11-13-30-21-8-9-22(27(36-3)24(21)29)33-20-12-14-31-26-18(20)7-10-23(26)34/h4-6,8-9,12,14-15,23,30,32,34-35H,7,10-11,13H2,1-3H3,(H,31,33)/t23-/m0/s1",IITQGAFQGWUZMO-QHCPKHFHSA-N,1,1,0,0,MDM2-Like / P53,7.13,cancer,Inhibition,
537,44305195,65216,23156097,OC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1c(Cl)cccc1Cl,"(2S)-2-[(2,6-dichlorobenzoyl)amino]-3-(1H-indol-3-yl)propanoic acid","InChI=1S/C18H14Cl2N2O3/c19-12-5-3-6-13(20)16(12)17(23)22-15(18(24)25)8-10-9-21-14-7-2-1-4-11(10)14/h1-7,9,15,21H,8H2,(H,22,23)(H,24,25)/t15-/m0/s1",AQVUSOQZBUOAJM-HNNXBMFYSA-N,1,0,0,0,LFA / ICAM,6.22,immune system disease,Inhibition,
538,89857814,,,Clc1ccc(cc1)-c1ccccc1CN1CCC(CC1)N1CCc2c(C1)ncnc2NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(c1)N(=O)=O,,"InChI=1S/C45H51ClN8O5S2/c46-35-12-10-33(11-13-35)40-9-5-4-6-34(40)29-52-21-17-37(18-22-52)53-23-19-41-43(30-53)47-32-48-45(41)50-61(57,58)39-14-15-42(44(28-39)54(55)56)49-36(16-20-51-24-26-59-27-25-51)31-60-38-7-2-1-3-8-38/h1-15,28,32,36-37,49H,16-27,29-31H2,(H,47,48,50)/t36-/m1/s1",VZBFNUHVIOAUFH-PSXMRANNSA-N,1,0,0,0,BCL2-Like / BAX,7.18,cancer,Inhibition,
539,23646361,365059,23252139,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)C(N)=O,N-(1-amino-3-methyl-1-oxopentan-2-yl)-1-[2-(2-aminopropanoylamino)-3-methylbutanoyl]pyrrolidine-2-carboxamide,"InChI=1S/C19H35N5O4/c1-6-11(4)15(16(21)25)23-18(27)13-8-7-9-24(13)19(28)14(10(2)3)22-17(26)12(5)20/h10-15H,6-9,20H2,1-5H3,(H2,21,25)(H,22,26)(H,23,27)/t11-,12-,13-,14-,15-/m0/s1",JHPFUTHPFNABKY-YTFOTSKYSA-N,1,0,0,0,XIAP / Smac,6.24,cancer,Inhibition,
540,44237047,575151,24635872,CC[C@H](N)C(=O)N[C@H]1[C@@H](Cn2cc(nn2)[C@H](O)CC)CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7R,9aS)-6-[[(2S)-2-aminobutanoyl]amino]-N-benzhydryl-7-[[4-[(1R)-1-hydroxypropyl]triazol-1-yl]methyl]-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C33H43N7O4/c1-3-25(34)31(42)36-30-23(19-39-20-26(37-38-39)28(41)4-2)15-16-24-17-18-27(40(24)33(30)44)32(43)35-29(21-11-7-5-8-12-21)22-13-9-6-10-14-22/h5-14,20,23-25,27-30,41H,3-4,15-19,34H2,1-2H3,(H,35,43)(H,36,42)/t23-,24+,25+,27+,28-,30+/m1/s1",BKDHFGCNNIXCGS-KCVLSDOGSA-N,1,0,0,0,XIAP / Smac,6.43,cancer,Inhibition,
541,59555738,,,C(Cc1c[nH]c2ccccc12)Nc1ccc(Nc2ccnc(c2)-c2ccccc2)cc1,"1-N-[2-(1H-indol-3-yl)ethyl]-4-N-(2-phenylpyridin-4-yl)benzene-1,4-diamine","InChI=1S/C27H24N4/c1-2-6-20(7-3-1)27-18-24(15-17-29-27)31-23-12-10-22(11-13-23)28-16-14-21-19-30-26-9-5-4-8-25(21)26/h1-13,15,17-19,28,30H,14,16H2,(H,29,31)",FBGZEIXPJDRALK-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,6.20,cancer,Inhibition,
542,168318177,,,COCCOc1ccccc1N1CCN(CC1)C(=O)[C@@]1(CCCN([C@H]1CC=C)C(=O)c1cnccc1C(F)(F)F)Oc1ccc(cc1)C(F)(F)F,"[(2R,3S)-3-[4-[2-(2-methoxyethoxy)phenyl]piperazine-1-carbonyl]-2-prop-2-enyl-3-[4-(trifluoromethyl)phenoxy]piperidin-1-yl]-[4-(trifluoromethyl)pyridin-3-yl]methanone","InChI=1S/C36H38F6N4O5/c1-3-7-31-34(51-26-12-10-25(11-13-26)35(37,38)39,15-6-17-46(31)32(47)27-24-43-16-14-28(27)36(40,41)42)33(48)45-20-18-44(19-21-45)29-8-4-5-9-30(29)50-23-22-49-2/h3-5,8-14,16,24,31H,1,6-7,15,17-23H2,2H3/t31-,34-/m0/s1",QKOYVKQWXLFSPH-VBTAUBHQSA-N,1,0,0,0,MDM2-Like / P53,7.70,cancer,Inhibition,
543,168318176,,,COCCCNC(=O)c1ccc(cc1)-n1[nH]c2c3cnn(C)c3nc(-c3cccc(c3)C(F)(F)F)c2c1=O,,"InChI=1S/C26H23F3N6O3/c1-34-23-19(14-31-34)22-20(21(32-23)16-5-3-6-17(13-16)26(27,28)29)25(37)35(33-22)18-9-7-15(8-10-18)24(36)30-11-4-12-38-2/h3,5-10,13-14,33H,4,11-12H2,1-2H3,(H,30,36)",CMZPWMJLWIGGLL-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,6.96,cancer,Inhibition,
544,168318175,,17249008,COc1cc(CO[C@]2(N(Cc3ccccc3)C(=O)c3ccccc23)c2ccccc2)cc(OC)c1O,"2-benzyl-3-[(4-hydroxy-3,5-dimethoxyphenyl)methoxy]-3-phenylisoindol-1-one","InChI=1S/C30H27NO5/c1-34-26-17-22(18-27(35-2)28(26)32)20-36-30(23-13-7-4-8-14-23)25-16-10-9-15-24(25)29(33)31(30)19-21-11-5-3-6-12-21/h3-18,32H,19-20H2,1-2H3/t30-/m1/s1",MGACPMHHENLBAT-SSEXGKCCSA-N,2,0,0,0,MDM2-Like / P53,4.75,cancer,Inhibition,
545,59493259,,,COc1ccc2c(CCNc3c(Cl)cc(Nc4ccnc5ccccc45)cc3Cl)c[nH]c2c1,"2,6-dichloro-1-N-[2-(6-methoxy-1H-indol-3-yl)ethyl]-4-N-quinolin-4-ylbenzene-1,4-diamine","InChI=1S/C26H22Cl2N4O/c1-33-18-6-7-19-16(15-31-25(19)14-18)8-10-30-26-21(27)12-17(13-22(26)28)32-24-9-11-29-23-5-3-2-4-20(23)24/h2-7,9,11-15,30-31H,8,10H2,1H3,(H,29,32)",JHGJHKQKFNACAP-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,6.00,cancer,Inhibition,
546,25195478,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(CC1)C(c1ccccc1)c1ccccc1,4-(4-benzhydrylpiperazin-1-yl)-N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonylbenzamide,"InChI=1S/C42H46N6O5S2/c1-45(2)25-24-35(31-54-37-16-10-5-11-17-37)43-39-23-22-38(30-40(39)48(50)51)55(52,53)44-42(49)34-18-20-36(21-19-34)46-26-28-47(29-27-46)41(32-12-6-3-7-13-32)33-14-8-4-9-15-33/h3-23,30,35,41,43H,24-29,31H2,1-2H3,(H,44,49)/t35-/m1/s1",FPGDCWDRXKIVBK-PGUFJCEWSA-N,1,0,0,0,BCL2-Like / BAX,5.30,cancer,Inhibition,
547,168318173,,,CS(=O)(=O)c1nc(c[nH]1)C(=O)NC[C@H](NC(=O)c1c(Cl)cc2CN(CCc2c1Cl)C(=O)c1ccc2ccoc2c1)C(O)=O,,"InChI=1S/C27H23Cl2N5O8S/c1-43(40,41)27-31-10-18(33-27)23(35)30-11-19(26(38)39)32-24(36)21-17(28)8-15-12-34(6-4-16(15)22(21)29)25(37)14-3-2-13-5-7-42-20(13)9-14/h2-3,5,7-10,19H,4,6,11-12H2,1H3,(H,30,35)(H,31,33)(H,32,36)(H,38,39)/t19-/m0/s1",YVXNJRGOHDHQAT-IBGZPJMESA-N,1,0,0,0,LFA / ICAM,7.52,immune system disease,Inhibition,
548,168318172,,,Fc1ccc(cc1)-n1[nH]c2c3cn[nH]c3nc(-c3cccc(c3)C(F)(F)F)c2c1=O,,"InChI=1S/C20H11F4N5O/c21-12-4-6-13(7-5-12)29-19(30)15-16(10-2-1-3-11(8-10)20(22,23)24)26-18-14(9-25-27-18)17(15)28-29/h1-9,28H,(H,25,26,27)",WYPGGKDHKWVSES-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.00,cancer,Inhibition,
549,168318171,,,CCn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(F)cc2)c1=O,,"InChI=1S/C22H15F4N5O/c1-2-30-20-16(11-27-30)19-17(21(32)31(29-19)15-8-6-14(23)7-9-15)18(28-20)12-4-3-5-13(10-12)22(24,25)26/h3-11,29H,2H2,1H3",OEHLCEZIJXZOBM-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,5.82,cancer,Inhibition,
550,25025706,3897459,,CNc1nc(NCc2ccc(NC(=O)c3cccnc3Cl)cc2)c2ccccc2n1,2-chloro-N-[4-[[[2-(methylamino)quinazolin-4-yl]amino]methyl]phenyl]pyridine-3-carboxamide,"InChI=1S/C22H19ClN6O/c1-24-22-28-18-7-3-2-5-16(18)20(29-22)26-13-14-8-10-15(11-9-14)27-21(30)17-6-4-12-25-19(17)23/h2-12H,13H2,1H3,(H,27,30)(H2,24,26,28,29)",CTMSGNYEINNMPK-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,6.22,cancer,Inhibition,
551,44570094,473446,24696186,CCCCN(CCCC)C(=O)c1cc(C)n(n1)-c1ccc(OCC(O)=O)cc1C(=O)N1CCc2ccccc2C1,"2-[4-[3-(dibutylcarbamoyl)-5-methylpyrazol-1-yl]-3-(3,4-dihydro-1H-isoquinoline-2-carbonyl)phenoxy]acetic acid","InChI=1S/C31H38N4O5/c1-4-6-15-33(16-7-5-2)31(39)27-18-22(3)35(32-27)28-13-12-25(40-21-29(36)37)19-26(28)30(38)34-17-14-23-10-8-9-11-24(23)20-34/h8-13,18-19H,4-7,14-17,20-21H2,1-3H3,(H,36,37)",WWVRGDMGTBVQEM-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,8.00,cancer,Inhibition,
552,44818131,569102,24631382,CNc1nc(NCc2ccc(NC(=O)c3ccc(F)cc3)cc2)c2ccccc2n1,4-fluoro-N-[4-[[[2-(methylamino)quinazolin-4-yl]amino]methyl]phenyl]benzamide,"InChI=1S/C23H20FN5O/c1-25-23-28-20-5-3-2-4-19(20)21(29-23)26-14-15-6-12-18(13-7-15)27-22(30)16-8-10-17(24)11-9-16/h2-13H,14H2,1H3,(H,27,30)(H2,25,26,28,29)",WWBNWNFPDKAYDJ-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,6.38,cancer,Inhibition,
553,45485507,578387,24640046,C[C@H]1CN(C[C@@H](C)N1C(=O)C(=O)c1c[nH]c2cccc(F)c12)C(=O)c1ccccc1,"1-(4-benzoyl-2,6-dimethylpiperazin-1-yl)-2-(4-fluoro-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C23H22FN3O3/c1-14-12-26(22(29)16-7-4-3-5-8-16)13-15(2)27(14)23(30)21(28)17-11-25-19-10-6-9-18(24)20(17)19/h3-11,14-15,25H,12-13H2,1-2H3/t14-,15+",VVEQEDUITLOOJH-GASCZTMLSA-N,0,1,0,0,CD4 / gp120,8.48,HIV infectious disease,Inhibition,
554,447945,106187,394894,NC(=N)N[C@H](C1CCCCC1)C(=O)NCC(=O)N1CCC(CC1)c1cc(n[nH]1)-c1cccc(Cl)c1Cl,"(2R)-2-cyclohexyl-2-(diaminomethylideneamino)-N-[2-[4-[3-(2,3-dichlorophenyl)-1H-pyrazol-5-yl]piperidin-1-yl]-2-oxoethyl]acetamide","InChI=1S/C25H33Cl2N7O2/c26-18-8-4-7-17(22(18)27)20-13-19(32-33-20)15-9-11-34(12-10-15)21(35)14-30-24(36)23(31-25(28)29)16-5-2-1-3-6-16/h4,7-8,13,15-16,23H,1-3,5-6,9-12,14H2,(H,30,36)(H,32,33)(H4,28,29,31)/t23-/m1/s1",SSSXBBASYYVGCI-HSZRJFAPSA-N,2,0,0,0,IL2 / IL2R,5.22,immune system disease,Inhibition,
555,45138555,,,CN[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2C(C)=O)c1c[nH]c2ccc(F)cc12,"(2S)-N-[(2S,3R)-1-[(3aR,6S,6aR)-4-acetyl-6-(5-fluoro-1H-indol-3-yl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-3-hydroxy-1-oxobutan-2-yl]-2-(methylamino)propanamide","InChI=1S/C24H32FN5O4/c1-12(26-4)23(33)28-21(13(2)31)24(34)29-8-7-20-22(29)18(11-30(20)14(3)32)17-10-27-19-6-5-15(25)9-16(17)19/h5-6,9-10,12-13,18,20-22,26-27,31H,7-8,11H2,1-4H3,(H,28,33)/t12-,13+,18+,20+,21-,22+/m0/s1",SXVKJGMKGQEWHR-VPZIORFKSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
556,168318170,,,O[C@@H]1CCc2c1nccc2N1CCc2cc(NCCc3c[nH]c4ccccc34)ccc12,"4-[5-[2-(1H-indol-3-yl)ethylamino]-2,3-dihydroindol-1-yl]-6,7-dihydro-5H-cyclopenta[b]pyridin-7-ol","InChI=1S/C26H26N4O/c31-25-8-6-21-24(10-13-28-26(21)25)30-14-11-17-15-19(5-7-23(17)30)27-12-9-18-16-29-22-4-2-1-3-20(18)22/h1-5,7,10,13,15-16,25,27,29,31H,6,8-9,11-12,14H2/t25-/m1/s1",AJCPIVBSLSWYGK-RUZDIDTESA-N,1,1,0,0,MDM2-Like / P53,6.53,cancer,Inhibition,
557,66616678,,,CS(=O)(=O)c1cccc(CN(Cc2cc(CNC(=O)c3cccc(Oc4ccccc4)c3)cc(Oc3ccc(F)cc3)c2)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)c1,,"InChI=1S/C41H33Cl2FN2O8S2/c1-55(49,50)37-12-5-7-27(20-37)25-46(56(51,52)39-23-31(42)22-38(43)40(39)47)26-29-17-28(18-36(19-29)54-34-15-13-32(44)14-16-34)24-45-41(48)30-8-6-11-35(21-30)53-33-9-3-2-4-10-33/h2-23,47H,24-26H2,1H3,(H,45,48)",XBFCJSBMKYKOJY-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,6.88,cancer,Inhibition,
558,46884476,1093692,24676996,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1nc(cs1)-c1coc2ccccc12,"(2S)-N-[(1S)-2-[(2S)-2-[4-(1-benzofuran-3-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-cyclohexyl-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C27H34N4O3S/c1-17(28-2)25(32)30-24(18-9-4-3-5-10-18)27(33)31-14-8-12-22(31)26-29-21(16-35-26)20-15-34-23-13-7-6-11-19(20)23/h6-7,11,13,15-18,22,24,28H,3-5,8-10,12,14H2,1-2H3,(H,30,32)/t17-,22-,24-/m0/s1",ZUMLKIWDRBKBKC-OWSXEPHWSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
559,506235,523702,442066,Clc1cc2[nH]cc(C(=O)C(=O)N3CCN(CC3)C(=O)c3ccccc3)c2cc1Cl,"1-(4-benzoylpiperazin-1-yl)-2-(5,6-dichloro-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C21H17Cl2N3O3/c22-16-10-14-15(12-24-18(14)11-17(16)23)19(27)21(29)26-8-6-25(7-9-26)20(28)13-4-2-1-3-5-13/h1-5,10-12,24H,6-9H2",GYWHJPVBMDREOD-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,6.30,HIV infectious disease,Inhibition,
560,25000808,,,CC(C)(C)C[C@H]1N[C@H]([C@H](c2ccc(F)c(Cl)c2)[C@@]11C(=O)Nc2cc(Cl)c(F)cc12)C(=O)N1CCN(CCO)CC1,"(2'R,3S,4'R,5'R)-6-chloro-4'-(3-chloro-4-fluorophenyl)-2'-(2,2-dimethylpropyl)-5-fluoro-5'-[4-(2-hydroxyethyl)piperazine-1-carbonyl]spiro[1H-indole-3,3'-pyrrolidine]-2-one","InChI=1S/C29H34Cl2F2N4O3/c1-28(2,3)15-23-29(17-13-21(33)19(31)14-22(17)34-27(29)40)24(16-4-5-20(32)18(30)12-16)25(35-23)26(39)37-8-6-36(7-9-37)10-11-38/h4-5,12-14,23-25,35,38H,6-11,15H2,1-3H3,(H,34,40)/t23-,24+,25-,29+/m1/s1",AHOPQGMIYDQMDU-ZTVFFDQVSA-N,1,3,0,0,MDM2-Like / P53,5.71,cancer,Inhibition,
561,46836798,,,OC(=O)c1nc(sc1CCCOc1ccc(OCCN2CCOCC2)cc1)N1CCc2cccc(C(=O)Nc3nc4ccccc4s3)c2C1,"2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-5-[3-[4-(2-morpholin-4-ylethoxy)phenoxy]propyl]-1,3-thiazole-4-carboxylic acid","InChI=1S/C36H37N5O6S2/c42-33(39-35-37-29-7-1-2-8-30(29)48-35)27-6-3-5-24-14-15-41(23-28(24)27)36-38-32(34(43)44)31(49-36)9-4-19-46-25-10-12-26(13-11-25)47-22-18-40-16-20-45-21-17-40/h1-3,5-8,10-13H,4,9,14-23H2,(H,43,44)(H,37,39,42)",QPGMPRVOLFBIAM-UHFFFAOYSA-N,1,0,0,0,BCL2-Like / BAX,6.52,cancer,Inhibition,
562,168318169,,,COCc1cccc(NC(=O)c2ccc(cc2)-n2[nH]c3c4cnn(C)c4nc(-c4cccc(c4)C(F)(F)F)c3c2=O)c1,,"InChI=1S/C30H23F3N6O3/c1-38-27-23(15-34-38)26-24(25(36-27)19-6-4-7-20(14-19)30(31,32)33)29(41)39(37-26)22-11-9-18(10-12-22)28(40)35-21-8-3-5-17(13-21)16-42-2/h3-15,37H,16H2,1-2H3,(H,35,40)",MBVYLWKRXZIQHH-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,6.96,cancer,Inhibition,
563,67980846,,,CN(C)CC[C@H](CSc1ccccc1)Nc1c(F)cc(cc1F)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1,,"InChI=1S/C43H48ClF2N7O2S2/c1-51(2)20-16-33(28-56-35-9-4-3-5-10-35)49-42-39(45)24-36(25-40(42)46)57(54,55)50-43-38-19-23-53(27-41(38)47-29-48-43)34-17-21-52(22-18-34)26-31-8-6-7-11-37(31)30-12-14-32(44)15-13-30/h3-15,24-25,29,33-34,49H,16-23,26-28H2,1-2H3,(H,47,48,50)/t33-/m1/s1",WQHAHUHLZMEJLU-MGBGTMOVSA-N,1,0,0,0,BCL2-Like / BAX,5.51,cancer,Inhibition,
564,46930723,1242922,26351555,CN[C@@H](C)C(=O)N[C@H]1CC[C@H](O)C[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,9R,10aR)-N-benzhydryl-9-hydroxy-6-[[(2S)-2-(methylamino)propanoyl]amino]-5-oxo-2,3,6,7,8,9,10,10a-octahydro-1H-pyrrolo[1,2-a]azocine-3-carboxamide","InChI=1S/C28H36N4O4/c1-18(29-2)26(34)30-23-15-14-22(33)17-21-13-16-24(32(21)28(23)36)27(35)31-25(19-9-5-3-6-10-19)20-11-7-4-8-12-20/h3-12,18,21-25,29,33H,13-17H2,1-2H3,(H,30,34)(H,31,35)/t18-,21+,22-,23-,24-/m0/s1",YSWSPOWPCMUWGP-GXWFBMCDSA-N,2,0,0,0,XIAP / Smac,6.48,cancer,Inhibition,
565,67031837,,,Cc1ccc(cc1C)-c1nc(-c2nnnn2C)c(-c2cccc(Cl)c2)n1-c1cc(Cl)ccc1C,,"InChI=1S/C26H22Cl2N6/c1-15-8-10-19(12-17(15)3)25-29-23(26-30-31-32-33(26)4)24(18-6-5-7-20(27)13-18)34(25)22-14-21(28)11-9-16(22)2/h5-14H,1-4H3",CFBOWKGRGWQTLK-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,4.87,cancer,Inhibition,
566,23644673,180741,23247020,C[C@H](N)C(=O)Nc1nc(cs1)-c1ccc(Cl)c(C)c1,"(2S)-2-amino-N-[4-(4-chloro-3-methylphenyl)-1,3-thiazol-2-yl]propanamide","InChI=1S/C13H14ClN3OS/c1-7-5-9(3-4-10(7)14)11-6-19-13(16-11)17-12(18)8(2)15/h3-6,8H,15H2,1-2H3,(H,16,17,18)/t8-/m0/s1",ZNBPSBVGOOQAMX-QMMMGPOBSA-N,1,0,0,0,XIAP / Smac,4.52,cancer,Inhibition,
567,168318168,,26362484,CN(C)CCC[C@](O)(c1ccccc1)c1ccc(OCCc2ccc(cc2)-c2ccc(cc2)C(O)=O)cc1,4-[4-[2-[4-[4-(dimethylamino)-1-hydroxy-1-phenylbutyl]phenoxy]ethyl]phenyl]benzoic acid,"InChI=1S/C33H35NO4/c1-34(2)23-6-22-33(37,29-7-4-3-5-8-29)30-17-19-31(20-18-30)38-24-21-25-9-11-26(12-10-25)27-13-15-28(16-14-27)32(35)36/h3-5,7-20,37H,6,21-24H2,1-2H3,(H,35,36)/t33-/m0/s1",IBFCGGCXMALXFO-XIFFEERXSA-N,1,0,0,0,BCL2-Like / BAX,4.92,cancer,Inhibition,
568,45487397,565435,24629525,CNC(=O)c1cc(OC)c(O[C@@H](C)C(=O)N2CCN(C[C@H]2C)c2nccc3[nH]cnc23)cn1,"5-[(2S)-1-[(2R)-4-(1H-imidazo[4,5-c]pyridin-4-yl)-2-methylpiperazin-1-yl]-1-oxopropan-2-yl]oxy-4-methoxy-N-methylpyridine-2-carboxamide","InChI=1S/C22H27N7O4/c1-13-11-28(20-19-15(5-6-24-20)26-12-27-19)7-8-29(13)22(31)14(2)33-18-10-25-16(21(30)23-3)9-17(18)32-4/h5-6,9-10,12-14H,7-8,11H2,1-4H3,(H,23,30)(H,26,27)/t13-,14+/m1/s1",XEKOYBDMUHMXBJ-KGLIPLIRSA-N,0,1,0,0,CD4 / gp120,7.62,HIV infectious disease,Inhibition,
569,46883881,1092172,24670174,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1nc2c(C)cccc2s1,"(2S)-N-[(1S)-1-cyclohexyl-2-[(2R)-2-(4-methyl-1,3-benzothiazol-2-yl)pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C24H34N4O2S/c1-15-9-7-13-19-20(15)27-23(31-19)18-12-8-14-28(18)24(30)21(17-10-5-4-6-11-17)26-22(29)16(2)25-3/h7,9,13,16-18,21,25H,4-6,8,10-12,14H2,1-3H3,(H,26,29)/t16-,18-,21-/m0/s1",LDSUSZTYDPJIIM-MDKPJZGXSA-N,1,0,0,0,XIAP / Smac,6.03,cancer,Inhibition,
570,42601768,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCC(CC1)NC(=O)c1ccccc1-c1ccc(Cl)cc1,2-(4-chlorophenyl)-N-[1-[4-[[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonylcarbamoyl]phenyl]piperidin-4-yl]benzamide,"InChI=1S/C43H45ClN6O6S2/c1-48(2)25-22-34(29-57-36-8-4-3-5-9-36)45-40-21-20-37(28-41(40)50(53)54)58(55,56)47-42(51)31-14-18-35(19-15-31)49-26-23-33(24-27-49)46-43(52)39-11-7-6-10-38(39)30-12-16-32(44)17-13-30/h3-21,28,33-34,45H,22-27,29H2,1-2H3,(H,46,52)(H,47,51)/t34-/m1/s1",MDBZEHHWABLHNZ-UUWRZZSWSA-N,1,0,0,0,BCL2-Like / BAX,5.30,cancer,Inhibition,
571,168318142,,10172887,COc1ccc(CN([C@@H](C(=O)NC2CCCCC2)c2ccc3cc(OCC(=O)OC(C)(C)C)ccc3c2)C(=O)Cc2ccc(OC)cc2)cc1,tert-butyl 2-[6-[2-(cyclohexylamino)-1-[[2-(4-methoxyphenyl)acetyl]-[(4-methoxyphenyl)methyl]amino]-2-oxoethyl]naphthalen-2-yl]oxyacetate,"InChI=1S/C41H48N2O7/c1-41(2,3)50-38(45)27-49-36-22-17-30-24-32(16-15-31(30)25-36)39(40(46)42-33-9-7-6-8-10-33)43(26-29-13-20-35(48-5)21-14-29)37(44)23-28-11-18-34(47-4)19-12-28/h11-22,24-25,33,39H,6-10,23,26-27H2,1-5H3,(H,42,46)/t39-/m1/s1",KRVDZRBYXHEEQQ-LDLOPFEMSA-N,1,0,0,0,Myc / Max,4.77,cancer,Inhibition,
572,46883882,1092173,24670348,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1nc2c(cccc2s1)C(C)C,"(2S)-N-[(1S)-1-cyclohexyl-2-oxo-2-[(2R)-2-(4-propan-2-yl-1,3-benzothiazol-2-yl)pyrrolidin-1-yl]ethyl]-2-(methylamino)propanamide","InChI=1S/C26H38N4O2S/c1-16(2)19-12-8-14-21-23(19)29-25(33-21)20-13-9-15-30(20)26(32)22(18-10-6-5-7-11-18)28-24(31)17(3)27-4/h8,12,14,16-18,20,22,27H,5-7,9-11,13,15H2,1-4H3,(H,28,31)/t17-,20-,22-/m0/s1",JGMOCAAMYAMXOV-XJABCFGWSA-N,1,0,0,0,XIAP / Smac,6.72,cancer,Inhibition,
573,168318167,,24634553,CCC[C@H]1CN(CCN1C(=O)c1ccccc1)C(=O)C(=O)c1c[nH]c2cccc(F)c12,"1-(4-benzoyl-3-propylpiperazin-1-yl)-2-(4-fluoro-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C24H24FN3O3/c1-2-7-17-15-27(12-13-28(17)23(30)16-8-4-3-5-9-16)24(31)22(29)18-14-26-20-11-6-10-19(25)21(18)20/h3-6,8-11,14,17,26H,2,7,12-13,15H2,1H3/t17-/m0/s1",OHMAVAINSFOTRQ-KRWDZBQOSA-N,0,1,0,0,CD4 / gp120,8.45,HIV infectious disease,Inhibition,
574,168318140,,,Clc1cc(Cl)cc(c1)N1C(=O)[C@@H]2C[C@@H](CN2C1=O)SCc1ccc(Br)cc1,,"InChI=1S/C19H15BrCl2N2O2S/c20-12-3-1-11(2-4-12)10-27-16-8-17-18(25)24(19(26)23(17)9-16)15-6-13(21)5-14(22)7-15/h1-7,16-17H,8-10H2/t16-,17-/m0/s1",RJWFVUIMPUXLTQ-IRXDYDNUSA-N,0,1,0,0,LFA / ICAM,6.54,immune system disease,Inhibition,
575,44390543,178578,23246568,OC(=O)[C@@H](N1[C@@H](c2ccc(cc2)C(F)(F)F)C(=O)Nc2ccc(I)cc2C1=O)c1ccccc1,"2-[7-iodo-2,5-dioxo-3-[4-(trifluoromethyl)phenyl]-1,3-dihydro-1,4-benzodiazepin-4-yl]-2-phenylacetic acid","InChI=1S/C24H16F3IN2O4/c25-24(26,27)15-8-6-14(7-9-15)19-21(31)29-18-11-10-16(28)12-17(18)22(32)30(19)20(23(33)34)13-4-2-1-3-5-13/h1-12,19-20H,(H,29,31)(H,33,34)/t19-,20-/m0/s1",OUJPKXOGQQVHGA-PMACEKPBSA-N,1,0,0,0,MDM2-Like / P53,5.66,cancer,Inhibition,
576,11474224,,9649054,C[C@H](N)C(=O)N[C@H]1CC[C@H]2CC[C@H](N2C1=O)C(=O)NCCc1ccccc1,"(3S,6S,8aR)-6-[[(2S)-2-aminopropanoyl]amino]-5-oxo-N-(2-phenylethyl)-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carboxamide","InChI=1S/C20H28N4O3/c1-13(21)18(25)23-16-9-7-15-8-10-17(24(15)20(16)27)19(26)22-12-11-14-5-3-2-4-6-14/h2-6,13,15-17H,7-12,21H2,1H3,(H,22,26)(H,23,25)/t13-,15-,16-,17-/m0/s1",YTLXVGUAOHXKBQ-HJWJTTGWSA-N,1,0,0,0,XIAP / Smac,4.65,cancer,Inhibition,
577,168318165,,,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(C(O)=O)c(F)c2)c1=O,,"InChI=1S/C22H13F4N5O3/c1-30-19-14(9-27-30)18-16(17(28-19)10-3-2-4-11(7-10)22(24,25)26)20(32)31(29-18)12-5-6-13(21(33)34)15(23)8-12/h2-9,29H,1H3,(H,33,34)",LSDYSMMYUOXPQK-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,6.68,cancer,Inhibition,
578,21906775,182738,10657285,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1ccnc(c1)N1CCN(CC1)C(C)=O,1-[4-[4-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyridin-2-yl]piperazin-1-yl]ethanone,"InChI=1S/C27H28F3N3OS/c1-18(2)22-6-4-5-7-24(22)35-25-9-8-20(16-23(25)27(28,29)30)21-10-11-31-26(17-21)33-14-12-32(13-15-33)19(3)34/h4-11,16-18H,12-15H2,1-3H3",QSJHFUJBHHSDHO-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,7.03,immune system disease,Inhibition,
579,168318163,,,OC(=O)CCCCN1c2ccc(I)cc2C(=O)N([C@@H](c2ccc(Cl)cc2)C1=O)C1(CC1)c1ccc(Cl)cc1,,"InChI=1S/C29H25Cl2IN2O4/c30-20-8-4-18(5-9-20)26-28(38)33(16-2-1-3-25(35)36)24-13-12-22(32)17-23(24)27(37)34(26)29(14-15-29)19-6-10-21(31)11-7-19/h4-13,17,26H,1-3,14-16H2,(H,35,36)/t26-/m0/s1",KMNROUNLFJMFRG-SANMLTNESA-N,1,0,0,0,MDM2-Like / P53,5.67,cancer,Inhibition,
580,45138852,,,C[C@H](N)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2C(C)=O)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(1S)-2-[(3aR,6S,6aR)-4-acetyl-6-(6-fluoro-1H-indol-3-yl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-1-cyclohexyl-2-oxoethyl]-2-aminopropanamide","InChI=1S/C27H36FN5O3/c1-15(29)26(35)31-24(17-6-4-3-5-7-17)27(36)32-11-10-23-25(32)21(14-33(23)16(2)34)20-13-30-22-12-18(28)8-9-19(20)22/h8-9,12-13,15,17,21,23-25,30H,3-7,10-11,14,29H2,1-2H3,(H,31,35)/t15-,21+,23+,24-,25+/m0/s1",SGPQQIZBCPHNSX-LYYGOLTESA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
581,44237059,584397,24641233,CCNC(=O)NC[C@H]1CC[C@H]2CC[C@H](N2C(=O)[C@H]1NC(=O)[C@@H](N)CC)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7R,9aS)-6-[[(2S)-2-aminobutanoyl]amino]-N-benzhydryl-7-[(ethylcarbamoylamino)methyl]-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C31H42N6O4/c1-3-24(32)28(38)36-27-22(19-34-31(41)33-4-2)15-16-23-17-18-25(37(23)30(27)40)29(39)35-26(20-11-7-5-8-12-20)21-13-9-6-10-14-21/h5-14,22-27H,3-4,15-19,32H2,1-2H3,(H,35,39)(H,36,38)(H2,33,34,41)/t22-,23+,24+,25+,27+/m1/s1",ZOBWRGLXMKGVBQ-HOIWYFOJSA-N,2,0,0,0,XIAP / Smac,6.52,cancer,Inhibition,
582,46884477,1094001,24675717,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1nc(cs1)-c1noc2ccccc12,"(2S)-N-[(1S)-2-[(2S)-2-[4-(1,2-benzoxazol-3-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-cyclohexyl-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C26H33N5O3S/c1-16(27-2)24(32)29-22(17-9-4-3-5-10-17)26(33)31-14-8-12-20(31)25-28-19(15-35-25)23-18-11-6-7-13-21(18)34-30-23/h6-7,11,13,15-17,20,22,27H,3-5,8-10,12,14H2,1-2H3,(H,29,32)/t16-,20-,22-/m0/s1",YNQNHLWGHBFRFI-BUKVSMQUSA-N,1,0,0,0,XIAP / Smac,6.92,cancer,Inhibition,
583,168318155,,,COc1cc(Nc2ccncc2)ccc1NCCc1c[nH]c2cc(C)ccc12,,"InChI=1S/C23H24N4O/c1-16-3-5-20-17(15-26-22(20)13-16)7-12-25-21-6-4-19(14-23(21)28-2)27-18-8-10-24-11-9-18/h3-6,8-11,13-15,25-26H,7,12H2,1-2H3,(H,24,27)",XVVYPVQIPXOKCL-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,6.30,cancer,Inhibition,
584,45138104,,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2C(=O)C1CC1)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(1S)-2-[(3aR,6S,6aR)-4-(cyclopropanecarbonyl)-6-(6-fluoro-1H-indol-3-yl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-1-cyclohexyl-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C30H40FN5O3/c1-17(32-2)28(37)34-26(18-6-4-3-5-7-18)30(39)35-13-12-25-27(35)23(16-36(25)29(38)19-8-9-19)22-15-33-24-14-20(31)10-11-21(22)24/h10-11,14-15,17-19,23,25-27,32-33H,3-9,12-13,16H2,1-2H3,(H,34,37)/t17-,23+,25+,26-,27+/m0/s1",ABXJTNRCANLVHZ-RGRNRJRYSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
585,88572782,,,C[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(CC2=C(CC(C)(C)CC2)c2ccc(Cl)cc2)CC1,,"InChI=1S/C43H50ClF3N6O4S3/c1-29(27-58-34-7-5-4-6-8-34)50-38-14-13-35(23-40(38)59(54,55)43(45,46)47)60(56,57)51-41-36-18-22-53(26-39(36)48-28-49-41)33-16-20-52(21-17-33)25-31-15-19-42(2,3)24-37(31)30-9-11-32(44)12-10-30/h4-14,23,28-29,33,50H,15-22,24-27H2,1-3H3,(H,48,49,51)/t29-/m1/s1",FGFRYAIIXPFFGL-GDLZYMKVSA-N,1,0,0,0,BCL2-Like / BAX,6.44,cancer,Inhibition,
586,59542045,4597431,,CN[C@H](Cc1ccccc1)C(=O)N[C@H]1[C@@H](CCN)CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7R,9aS)-7-(2-aminoethyl)-N-benzhydryl-6-[[(2R)-2-(methylamino)-3-phenylpropanoyl]amino]-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C35H43N5O3/c1-37-29(23-24-11-5-2-6-12-24)33(41)39-32-27(21-22-36)17-18-28-19-20-30(40(28)35(32)43)34(42)38-31(25-13-7-3-8-14-25)26-15-9-4-10-16-26/h2-16,27-32,37H,17-23,36H2,1H3,(H,38,42)(H,39,41)/t27-,28+,29-,30+,32+/m1/s1",SYKRKULUKGSDMB-WVWDVZQYSA-N,1,0,0,0,XIAP / Smac,6.45,cancer,Inhibition,
587,11225031,375349,9400084,CC[C@H](N)C(=O)N[C@H]1CCC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,9aS)-6-[[(2S)-2-aminobutanoyl]amino]-N-benzhydryl-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C27H34N4O3/c1-2-21(28)25(32)29-22-15-9-14-20-16-17-23(31(20)27(22)34)26(33)30-24(18-10-5-3-6-11-18)19-12-7-4-8-13-19/h3-8,10-13,20-24H,2,9,14-17,28H2,1H3,(H,29,32)(H,30,33)/t20-,21-,22-,23-/m0/s1",XWYMWLGPGRAJLM-MLCQCVOFSA-N,4,0,0,0,XIAP / Smac,7.60,cancer,Inhibition,
588,168318162,,,CN(Cc1ccccc1)C(=O)c1cccc(c1)-n1[nH]c2c3cnn(C)c3nc(-c3cccc(c3)C(F)(F)F)c2c1=O,,"InChI=1S/C30H23F3N6O2/c1-37(17-18-8-4-3-5-9-18)28(40)20-11-7-13-22(15-20)39-29(41)24-25(19-10-6-12-21(14-19)30(31,32)33)35-27-23(26(24)36-39)16-34-38(27)2/h3-16,36H,17H2,1-2H3",DIZZXAXAPODBAM-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,6.74,cancer,Inhibition,
589,44390625,179820,23246647,Cc1ccc(cc1)[C@@H]1N([C@H](C(O)=O)c2ccccc2)C(=O)c2cc(I)ccc2NC1=O,"2-[7-iodo-3-(4-methylphenyl)-2,5-dioxo-1,3-dihydro-1,4-benzodiazepin-4-yl]-2-phenylacetic acid","InChI=1S/C24H19IN2O4/c1-14-7-9-16(10-8-14)20-22(28)26-19-12-11-17(25)13-18(19)23(29)27(20)21(24(30)31)15-5-3-2-4-6-15/h2-13,20-21H,1H3,(H,26,28)(H,30,31)/t20-,21-/m0/s1",HMFXZUBOYSHHRF-SFTDATJTSA-N,1,0,0,0,MDM2-Like / P53,4.88,cancer,Inhibition,
590,67980974,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1C#N)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1,,"InChI=1S/C44H49ClN8O2S2/c1-51(2)22-18-36(30-56-38-9-4-3-5-10-38)49-42-17-16-39(26-34(42)27-46)57(54,55)50-44-41-21-25-53(29-43(41)47-31-48-44)37-19-23-52(24-20-37)28-33-8-6-7-11-40(33)32-12-14-35(45)15-13-32/h3-17,26,31,36-37,49H,18-25,28-30H2,1-2H3,(H,47,48,50)/t36-/m1/s1",GKKQUCTYPNTJAE-PSXMRANNSA-N,1,0,0,0,BCL2-Like / BAX,6.76,cancer,Inhibition,
591,46220960,1094431,24668561,CN1C(=O)N(C(=O)[C@]11CN(C[C@H]1c1ccc(cc1)C#N)c1nccc(n1)C(O)=O)c1cc(Cl)cc(Cl)c1,"2-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl]pyrimidine-4-carboxylic acid","InChI=1S/C25H18Cl2N6O4/c1-31-24(37)33(18-9-16(26)8-17(27)10-18)22(36)25(31)13-32(23-29-7-6-20(30-23)21(34)35)12-19(25)15-4-2-14(11-28)3-5-15/h2-10,19H,12-13H2,1H3,(H,34,35)/t19-,25+/m0/s1",CZJWRDKZXNPXHF-UQBPGWFLSA-N,1,0,0,0,LFA / ICAM,7.59,immune system disease,Inhibition,
592,44390620,361770,23246642,OC(=O)[C@@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)Nc2cc(Cl)c(I)cc2C1=O)c1ccc(Cl)cc1,"2-[8-chloro-3-(4-chlorophenyl)-7-iodo-2,5-dioxo-1,3-dihydro-1,4-benzodiazepin-4-yl]-2-(4-chlorophenyl)acetic acid","InChI=1S/C23H14Cl3IN2O4/c24-13-5-1-11(2-6-13)19-21(30)28-18-10-16(26)17(27)9-15(18)22(31)29(19)20(23(32)33)12-3-7-14(25)8-4-12/h1-10,19-20H,(H,28,30)(H,32,33)/t19-,20-/m0/s1",QOQUWWZUQBEUTE-PMACEKPBSA-N,1,0,0,0,MDM2-Like / P53,6.15,cancer,Inhibition,
593,58007468,,,CC(C)C1=C(SC2=N[C@](C)([C@H](N12)c1ccc(Cl)cc1)c1ccc(Cl)cc1)C(=O)N1C[C@@H](F)C[C@H]1C(=O)N1CCOCC1,"[(2S,4S)-1-[(5R,6S)-5,6-bis(4-chlorophenyl)-6-methyl-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazole-2-carbonyl]-4-fluoropyrrolidin-2-yl]-morpholin-4-ylmethanone","InChI=1S/C31H33Cl2FN4O3S/c1-18(2)25-26(29(40)37-17-23(34)16-24(37)28(39)36-12-14-41-15-13-36)42-30-35-31(3,20-6-10-22(33)11-7-20)27(38(25)30)19-4-8-21(32)9-5-19/h4-11,18,23-24,27H,12-17H2,1-3H3/t23-,24-,27+,31-/m0/s1",RZHCIFZMBPMUKF-VLXHMQPOSA-N,1,0,0,0,MDM2-Like / P53,7.10,cancer,Inhibition,
594,506230,495031,442061,Brc1cccc2c(c[nH]c12)C(=O)C(=O)N1CCN(CC1)C(=O)c1ccccc1,"1-(4-benzoylpiperazin-1-yl)-2-(7-bromo-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C21H18BrN3O3/c22-17-8-4-7-15-16(13-23-18(15)17)19(26)21(28)25-11-9-24(10-12-25)20(27)14-5-2-1-3-6-14/h1-8,13,23H,9-12H2",XYDVUUJYNPKXGQ-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,7.76,HIV infectious disease,Inhibition,
595,25000116,,,CC(C)(C)C[C@H]1N(O)[C@H]([C@H](c2ccc(F)c(Cl)c2)[C@@]11C(=O)Nc2cc(Cl)c(F)cc12)C(=O)NCC[C@H](O)CO,"(2'R,3S,3'R,5'R)-6-chloro-3'-(3-chloro-4-fluorophenyl)-N-[(3S)-3,4-dihydroxybutyl]-5'-(2,2-dimethylpropyl)-5-fluoro-1'-hydroxy-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide","InChI=1S/C27H31Cl2F2N3O5/c1-26(2,3)11-21-27(15-9-19(31)17(29)10-20(15)33-25(27)38)22(13-4-5-18(30)16(28)8-13)23(34(21)39)24(37)32-7-6-14(36)12-35/h4-5,8-10,14,21-23,35-36,39H,6-7,11-12H2,1-3H3,(H,32,37)(H,33,38)/t14-,21+,22-,23+,27-/m0/s1",HJKYXPJGHSEQOY-LYAXWJQESA-N,1,3,0,0,MDM2-Like / P53,5.69,cancer,Inhibition,
596,44305129,293826,23156020,OC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1c(F)cccc1F,"(2S)-2-[(2,6-difluorobenzoyl)amino]-3-(1H-indol-3-yl)propanoic acid","InChI=1S/C18H14F2N2O3/c19-12-5-3-6-13(20)16(12)17(23)22-15(18(24)25)8-10-9-21-14-7-2-1-4-11(10)14/h1-7,9,15,21H,8H2,(H,22,23)(H,24,25)/t15-/m0/s1",XIVLZMACKMSZRH-HNNXBMFYSA-N,1,0,0,0,LFA / ICAM,6.34,immune system disease,Inhibition,
597,44549767,,,CN1c2ncnn2[C@H](C2=C1c1cc(Cl)ccc1O[C@@H]2c1ccc(Br)cc1)c1ccc(Br)cc1,,"InChI=1S/C25H17Br2ClN4O/c1-31-23-19-12-18(28)10-11-20(19)33-24(15-4-8-17(27)9-5-15)21(23)22(32-25(31)29-13-30-32)14-2-6-16(26)7-3-14/h2-13,22,24H,1H3/t22-,24+/m0/s1",JPYXUSCSZNXDNP-LADGPHEKSA-N,1,0,0,0,MDM2-Like / P53,5.85,cancer,Inhibition,
598,46836642,,,CC(C)n1cnc2c(ncnc12)-c1ccc(OCCCc2sc(nc2C(O)=O)N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)cc1,"2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-5-[3-[4-(9-propan-2-ylpurin-6-yl)phenoxy]propyl]-1,3-thiazole-4-carboxylic acid","InChI=1S/C38H34N8O4S2/c1-22(2)46-21-41-33-31(39-20-40-34(33)46)24-12-14-25(15-13-24)50-18-6-11-30-32(36(48)49)43-38(52-30)45-17-16-23-7-5-8-26(27(23)19-45)35(47)44-37-42-28-9-3-4-10-29(28)51-37/h3-5,7-10,12-15,20-22H,6,11,16-19H2,1-2H3,(H,48,49)(H,42,44,47)",XZWXJMPHOPTSOA-UHFFFAOYSA-N,1,0,0,0,BCL2-Like / BAX,6.89,cancer,Inhibition,
599,11038945,421412,9214118,COc1ccc(-c2cc(C3CCN(CC3)C(=O)CNC(=O)[C@@H](CC(C)C)NC(N)=N)n(C)n2)c(Cl)c1Cl,"(2R)-2-(diaminomethylideneamino)-N-[2-[4-[5-(2,3-dichloro-4-methoxyphenyl)-2-methylpyrazol-3-yl]piperidin-1-yl]-2-oxoethyl]-4-methylpentanamide","InChI=1S/C25H35Cl2N7O3/c1-14(2)11-18(31-25(28)29)24(36)30-13-21(35)34-9-7-15(8-10-34)19-12-17(32-33(19)3)16-5-6-20(37-4)23(27)22(16)26/h5-6,12,14-15,18H,7-11,13H2,1-4H3,(H,30,36)(H4,28,29,31)/t18-/m1/s1",LOHFCUXSVNYHLN-GOSISDBHSA-N,2,0,0,0,IL2 / IL2R,5.52,immune system disease,Inhibition,
600,25209022,472832,24696174,CN[C@@H](C)C(=O)N[C@H]1C\C=C/C[C@H]2[C@H](C[C@@H](C(=O)N[C@@H]3CCCc4ccccc34)N2C1=O)Cc1ccccc1,"(1S,3S,6S,8Z,10aS)-1-benzyl-6-[[(2S)-2-(methylamino)propanoyl]amino]-5-oxo-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-2,3,6,7,10,10a-hexahydro-1H-pyrrolo[1,2-a]azocine-3-carboxamide","InChI=1S/C32H40N4O3/c1-21(33-2)30(37)35-27-16-8-9-18-28-24(19-22-11-4-3-5-12-22)20-29(36(28)32(27)39)31(38)34-26-17-10-14-23-13-6-7-15-25(23)26/h3-9,11-13,15,21,24,26-29,33H,10,14,16-20H2,1-2H3,(H,34,38)(H,35,37)/b9-8-/t21-,24-,26+,27-,28-,29-/m0/s1",XRNWGSINTQPCAV-IXSUYCQFSA-N,1,1,0,0,XIAP / Smac,7.59,cancer,Inhibition,
601,51354902,1689143,26391781,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)Nc1ncnc2cc(ccc12)N1CCN(CC2=C(CCC(C)(C)C2)c2ccc(Cl)cc2)CC1,"N-[7-[4-[[2-(4-chlorophenyl)-5,5-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]quinazolin-4-yl]-4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrobenzenesulfonamide","InChI=1S/C45H53ClN8O4S2/c1-45(2)20-18-39(32-10-12-34(46)13-11-32)33(28-45)29-52-22-24-53(25-23-52)36-14-16-40-42(26-36)47-31-48-44(40)50-60(57,58)38-15-17-41(43(27-38)54(55)56)49-35(19-21-51(3)4)30-59-37-8-6-5-7-9-37/h5-17,26-27,31,35,49H,18-25,28-30H2,1-4H3,(H,47,48,50)/t35-/m1/s1",JSFKNCWQOKKNFV-PGUFJCEWSA-N,1,0,0,0,BCL2-Like / BAX,8.52,cancer,Inhibition,
602,168318238,,,COCCOCCN1c2ccc(I)cc2C(=O)N([C@H](C)c2ccc(Cl)cc2O)[C@@H](c2ccc(Cl)cc2)C1=O,,"InChI=1S/C28H27Cl2IN2O5/c1-17(22-9-7-20(30)15-25(22)34)33-26(18-3-5-19(29)6-4-18)28(36)32(11-12-38-14-13-37-2)24-10-8-21(31)16-23(24)27(33)35/h3-10,15-17,26,34H,11-14H2,1-2H3/t17-,26+/m1/s1",FGLSZNPQZWOOID-QUGAMOGWSA-N,1,0,0,0,MDM2-Like / P53,5.61,cancer,Inhibition,
603,45139138,,,CN[C@@H](C)C(=O)N[C@@H]([C@@H](C)OC)C(=O)N1CC[C@H]2NC[C@@H]([C@@H]12)c1c[nH]c2ccccc12,"(2S)-N-[(2S,3R)-1-[(3aR,6S,6aR)-6-(1H-indol-3-yl)-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,2-b]pyrrol-1-yl]-3-methoxy-1-oxobutan-2-yl]-2-(methylamino)propanamide","InChI=1S/C23H33N5O3/c1-13(24-3)22(29)27-20(14(2)31-4)23(30)28-10-9-19-21(28)17(12-26-19)16-11-25-18-8-6-5-7-15(16)18/h5-8,11,13-14,17,19-21,24-26H,9-10,12H2,1-4H3,(H,27,29)/t13-,14+,17+,19+,20-,21+/m0/s1",MOIZOMCYPKFWQB-OBJVCPEASA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
604,44429177,242340,23291046,C(C)(C)C[C@@H](C(O)=O)N1C(=S)S\C(C1=O)=C(\c1ccccc1)c1ccc(cc1)-c1ccccc1,"(2S)-4-methyl-2-[(5Z)-4-oxo-5-[phenyl-(4-phenylphenyl)methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]pentanoic acid","InChI=1S/C28H25NO3S2/c1-18(2)17-23(27(31)32)29-26(30)25(34-28(29)33)24(21-11-7-4-8-12-21)22-15-13-20(14-16-22)19-9-5-3-6-10-19/h3-16,18,23H,17H2,1-2H3,(H,31,32)/b25-24-/t23-/m0/s1",VOAXBLPJWRNYKU-KGEYNJJLSA-N,3,0,0,0,BCL2-Like / BAX,5.71,cancer,Inhibition,
605,11326885,,9501837,C[C@H](N)C(=O)N[C@H]1CC[C@H]2CC[C@H](N2C1=O)C(=O)NCc1ccccc1,"(3S,6S,8aR)-6-[[(2S)-2-aminopropanoyl]amino]-N-benzyl-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carboxamide","InChI=1S/C19H26N4O3/c1-12(20)17(24)22-15-9-7-14-8-10-16(23(14)19(15)26)18(25)21-11-13-5-3-2-4-6-13/h2-6,12,14-16H,7-11,20H2,1H3,(H,21,25)(H,22,24)/t12-,14-,15-,16-/m0/s1",HRYYDNAJRUXAJE-TUUVXOQKSA-N,3,0,0,0,XIAP / Smac,5.35,cancer,Inhibition,
606,11590543,,9765306,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(cc2)C(O)=O)c1=O,"4-[6-methyl-3-oxo-4-[3-(trifluoromethyl)phenyl]-1H-dipyrazolo[4,3-b:4',5'-e]pyridin-2-yl]benzoic acid","InChI=1S/C22H14F3N5O3/c1-29-19-15(10-26-29)18-16(17(27-19)12-3-2-4-13(9-12)22(23,24)25)20(31)30(28-18)14-7-5-11(6-8-14)21(32)33/h2-10,28H,1H3,(H,32,33)",HYWGLFWNLHFOSD-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,6.72,cancer,Inhibition,
607,506251,523362,442082,COc1ccc(F)c2c(c[nH]c12)C(=O)C(=O)N1CCN(CC1)C(=O)c1ccccc1,"1-(4-benzoylpiperazin-1-yl)-2-(4-fluoro-7-methoxy-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C22H20FN3O4/c1-30-17-8-7-16(23)18-15(13-24-19(17)18)20(27)22(29)26-11-9-25(10-12-26)21(28)14-5-3-2-4-6-14/h2-8,13,24H,9-12H2,1H3",YAGOLAYHFSZMTF-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,10.22,HIV infectious disease,Inhibition,
608,44580240,524347,24720326,FC(F)(F)c1c(Sc2ccccc2OCc2ccncc2)ccc(\C=C\C(=O)N2CCOCC2)c1C(F)(F)F,"(E)-1-morpholin-4-yl-3-[4-[2-(pyridin-4-ylmethoxy)phenyl]sulfanyl-2,3-bis(trifluoromethyl)phenyl]prop-2-en-1-one","InChI=1S/C27H22F6N2O3S/c28-26(29,30)24-19(6-8-23(36)35-13-15-37-16-14-35)5-7-22(25(24)27(31,32)33)39-21-4-2-1-3-20(21)38-17-18-9-11-34-12-10-18/h1-12H,13-17H2/b8-6+",ONDASBAVURIEBH-SOFGYWHQSA-N,1,0,0,0,LFA / ICAM,8.43,immune system disease,Inhibition,
609,44390649,361559,23246671,CC(C)CC[C@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)Nc2ccc(I)cc2C1=O)C(O)=O,"(2S)-2-[(3S)-3-(4-chlorophenyl)-7-iodo-2,5-dioxo-1,3-dihydro-1,4-benzodiazepin-4-yl]-5-methylhexanoic acid","InChI=1S/C22H22ClIN2O4/c1-12(2)3-10-18(22(29)30)26-19(13-4-6-14(23)7-5-13)20(27)25-17-9-8-15(24)11-16(17)21(26)28/h4-9,11-12,18-19H,3,10H2,1-2H3,(H,25,27)(H,29,30)/t18-,19-/m0/s1",AZLZIZMOHRNCGB-OALUTQOASA-N,1,0,0,0,MDM2-Like / P53,4.92,cancer,Inhibition,
610,168318161,,,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(F)c(Cl)c2)c1=O,,"InChI=1S/C21H12ClF4N5O/c1-30-19-13(9-27-30)18-16(17(28-19)10-3-2-4-11(7-10)21(24,25)26)20(32)31(29-18)12-5-6-15(23)14(22)8-12/h2-9,29H,1H3",BAHLLTKPMRGBDC-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.38,cancer,Inhibition,
611,67175484,,,CC[C@H](NC(=O)[C@H](C)N)C(=O)N1C[C@H](C[C@H]1C(=O)N1C[C@H](C[C@H]1C(=O)NC)c1ccccc1)c1ccccc1,,"InChI=1S/C30H39N5O4/c1-4-24(33-27(36)19(2)31)29(38)35-18-23(21-13-9-6-10-14-21)16-26(35)30(39)34-17-22(15-25(34)28(37)32-3)20-11-7-5-8-12-20/h5-14,19,22-26H,4,15-18,31H2,1-3H3,(H,32,37)(H,33,36)/t19-,22-,23-,24-,25-,26-/m0/s1",IFTWAEHEDFOJGE-KTHKBMNISA-N,1,0,0,0,XIAP / Smac,8.00,cancer,Inhibition,
612,44390685,369321,23246709,OC(=O)[C@@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)Nc2ccc(Br)cc2C1=O)c1ccc(Cl)cc1,"2-[7-bromo-3-(4-chlorophenyl)-2,5-dioxo-1,3-dihydro-1,4-benzodiazepin-4-yl]-2-(4-chlorophenyl)acetic acid","InChI=1S/C23H15BrCl2N2O4/c24-14-5-10-18-17(11-14)22(30)28(20(23(31)32)13-3-8-16(26)9-4-13)19(21(29)27-18)12-1-6-15(25)7-2-12/h1-11,19-20H,(H,27,29)(H,31,32)/t19-,20-/m0/s1",VGGVARMTWYVYGL-PMACEKPBSA-N,1,0,0,0,MDM2-Like / P53,6.01,cancer,Inhibition,
613,67954312,,,OC(=O)Cc1ccc(Cl)c(F)c1-n1c(nc(C(=O)OCc2ccccc2)c1-c1ccc(F)c(Cl)c1)C1CCCCCC1,,"InChI=1S/C32H28Cl2F2N2O4/c33-23-14-12-22(17-26(39)40)29(27(23)36)38-30(21-13-15-25(35)24(34)16-21)28(32(41)42-18-19-8-4-3-5-9-19)37-31(38)20-10-6-1-2-7-11-20/h3-5,8-9,12-16,20H,1-2,6-7,10-11,17-18H2,(H,39,40)",ZFGWXPREFUTQCN-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,7.09,cancer,Inhibition,
614,45136918,,,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2Cc1ccccc1)c1c[nH]c2cc(F)ccc12)C(C)(C)C,"(2S)-N-[(2S)-1-[(3aR,6S,6aR)-4-benzyl-6-(6-fluoro-1H-indol-3-yl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]-2-(methylamino)propanamide","InChI=1S/C31H40FN5O2/c1-19(33-5)29(38)35-28(31(2,3)4)30(39)37-14-13-26-27(37)24(18-36(26)17-20-9-7-6-8-10-20)23-16-34-25-15-21(32)11-12-22(23)25/h6-12,15-16,19,24,26-28,33-34H,13-14,17-18H2,1-5H3,(H,35,38)/t19-,24+,26+,27+,28+/m0/s1",OAVXEGREUOPHCE-IFENCWOESA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
615,28124438,60732,23155975,OC(=O)[C@H](Cc1c[nH]cn1)NC(=O)c1c(F)cccc1F,"(2S)-2-[(2,6-difluorobenzoyl)amino]-3-(1H-imidazol-5-yl)propanoic acid","InChI=1S/C13H11F2N3O3/c14-8-2-1-3-9(15)11(8)12(19)18-10(13(20)21)4-7-5-16-6-17-7/h1-3,5-6,10H,4H2,(H,16,17)(H,18,19)(H,20,21)/t10-/m0/s1",ULKWCLJACWMJSJ-JTQLQIEISA-N,1,0,0,0,LFA / ICAM,6.70,immune system disease,Inhibition,
616,45137056,,,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2C1CCCC1)c1c[nH]c2cc(F)ccc12)C(C)(C)C,"(2S)-N-[(2S)-1-[(3aR,6S,6aR)-4-cyclopentyl-6-(6-fluoro-1H-indol-3-yl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]-2-(methylamino)propanamide","InChI=1S/C29H42FN5O2/c1-17(31-5)27(36)33-26(29(2,3)4)28(37)34-13-12-24-25(34)22(16-35(24)19-8-6-7-9-19)21-15-32-23-14-18(30)10-11-20(21)23/h10-11,14-15,17,19,22,24-26,31-32H,6-9,12-13,16H2,1-5H3,(H,33,36)/t17-,22+,24+,25+,26+/m0/s1",WABVCPDJOMAJJZ-LQKKDMSHSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
617,67034683,,,Nc1nnc(o1)-c1nc(C2CCCCC2)n(c1-c1ccc(F)c(Cl)c1)-c1c(CC(=O)NC2CCOCC2)ccc(Cl)c1F,,"InChI=1S/C30H30Cl2F2N6O3/c31-20-8-6-18(15-23(41)36-19-10-12-42-13-11-19)26(24(20)34)40-27(17-7-9-22(33)21(32)14-17)25(29-38-39-30(35)43-29)37-28(40)16-4-2-1-3-5-16/h6-9,14,16,19H,1-5,10-13,15H2,(H2,35,39)(H,36,41)",OKWDHMRSFRYMAN-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,8.52,cancer,Inhibition,
618,57334231,,,CCOc1cc(Cl)c(cc1C1=N[C@H]([C@H](N1C(=O)N1CCN(CC(=O)N2CCOCC2)CC1)c1ccc(Cl)cc1)c1ccc(Cl)cc1)S(=O)(=O)N1CCCCC1,"2-[4-[(4S,5R)-2-(4-chloro-2-ethoxy-5-piperidin-1-ylsulfonylphenyl)-4,5-bis(4-chlorophenyl)-4,5-dihydroimidazole-1-carbonyl]piperazin-1-yl]-1-morpholin-4-ylethanone","InChI=1S/C39H45Cl3N6O6S/c1-2-54-33-25-32(42)34(55(51,52)47-14-4-3-5-15-47)24-31(33)38-43-36(27-6-10-29(40)11-7-27)37(28-8-12-30(41)13-9-28)48(38)39(50)46-18-16-44(17-19-46)26-35(49)45-20-22-53-23-21-45/h6-13,24-25,36-37H,2-5,14-23,26H2,1H3/t36-,37+/m0/s1",CNMWKOBHJHJQCL-PQQNNWGCSA-N,1,0,0,0,MDM2-Like / P53,8.30,cancer,Inhibition,
619,11685783,,9860511,CCOc1cc(ccc1C1=N[C@H]([C@H](N1C(=O)N1CCNC(=O)C1)c1ccc(F)cc1)c1ccc(F)cc1)C(C)(C)C,"4-[(4S,5R)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-fluorophenyl)-4,5-dihydroimidazole-1-carbonyl]piperazin-2-one","InChI=1S/C32H34F2N4O3/c1-5-41-26-18-22(32(2,3)4)10-15-25(26)30-36-28(20-6-11-23(33)12-7-20)29(21-8-13-24(34)14-9-21)38(30)31(40)37-17-16-35-27(39)19-37/h6-15,18,28-29H,5,16-17,19H2,1-4H3,(H,35,39)/t28-,29+/m0/s1",KKXWSZVFJBNJPC-URLMMPGGSA-N,1,0,0,0,MDM2-Like / P53,5.51,cancer,Inhibition,
620,16109158,375299,17266571,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(Cc2ccccc2N2CCOCC2)CC1,N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonyl-4-[4-[(2-morpholin-4-ylphenyl)methyl]piperazin-1-yl]benzamide,"InChI=1S/C40H49N7O6S2/c1-43(2)19-18-33(30-54-35-9-4-3-5-10-35)41-37-17-16-36(28-39(37)47(49)50)55(51,52)42-40(48)31-12-14-34(15-13-31)45-22-20-44(21-23-45)29-32-8-6-7-11-38(32)46-24-26-53-27-25-46/h3-17,28,33,41H,18-27,29-30H2,1-2H3,(H,42,48)/t33-/m1/s1",ATBNCVGFQYBJBN-MGBGTMOVSA-N,2,0,0,0,BCL2-Like / BAX,9.30,cancer,Inhibition,
621,67238069,,,Fc1ccc(cc1C#N)S(=O)(=O)N1[C@H]([C@@H](c2ccc(Cl)cc2)n2c1cccc2=O)c1ccc(Cl)cc1,"5-[[(2R,3S)-2,3-bis(4-chlorophenyl)-5-oxo-2,3-dihydroimidazo[1,2-a]pyridin-1-yl]sulfonyl]-2-fluorobenzonitrile","InChI=1S/C26H16Cl2FN3O3S/c27-19-8-4-16(5-9-19)25-26(17-6-10-20(28)11-7-17)32(23-2-1-3-24(33)31(23)25)36(34,35)21-12-13-22(29)18(14-21)15-30/h1-14,25-26H/t25-,26+/m1/s1",MBFAQFKAHAKPOL-FTJBHMTQSA-N,1,0,0,0,MDM2-Like / P53,6.66,cancer,Inhibition,
622,168318160,,,C[C@H](N)C(=O)Nc1nc(COCc2ccc3ccccc3c2)c(Cc2ccccc2)s1,,"InChI=1S/C25H25N3O2S/c1-17(26)24(29)28-25-27-22(23(31-25)14-18-7-3-2-4-8-18)16-30-15-19-11-12-20-9-5-6-10-21(20)13-19/h2-13,17H,14-16,26H2,1H3,(H,27,28,29)/t17-/m0/s1",UGFGKWOPNZKTLX-KRWDZBQOSA-N,1,0,0,0,XIAP / Smac,4.85,cancer,Inhibition,
623,24798804,1689139,26327637,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)Nc1ncnc2cc(ccc12)N1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1,N-[7-[4-[[2-(4-chlorophenyl)phenyl]methyl]piperazin-1-yl]quinazolin-4-yl]-4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrobenzenesulfonamide,"InChI=1S/C43H45ClN8O4S2/c1-49(2)21-20-34(29-57-36-9-4-3-5-10-36)47-40-19-17-37(27-42(40)52(53)54)58(55,56)48-43-39-18-16-35(26-41(39)45-30-46-43)51-24-22-50(23-25-51)28-32-8-6-7-11-38(32)31-12-14-33(44)15-13-31/h3-19,26-27,30,34,47H,20-25,28-29H2,1-2H3,(H,45,46,48)/t34-/m1/s1",LLJSSTLCMHGPSB-UUWRZZSWSA-N,1,0,0,0,BCL2-Like / BAX,8.15,cancer,Inhibition,
624,11612373,569621,9787127,CNC(=O)c1cc(OC)c(O[C@@H](C)C(=O)N2CCN(C[C@H]2C)c2nccc3ccccc23)cn1,5-[(2S)-1-[(2R)-4-isoquinolin-1-yl-2-methylpiperazin-1-yl]-1-oxopropan-2-yl]oxy-4-methoxy-N-methylpyridine-2-carboxamide,"InChI=1S/C25H29N5O4/c1-16-15-29(23-19-8-6-5-7-18(19)9-10-27-23)11-12-30(16)25(32)17(2)34-22-14-28-20(24(31)26-3)13-21(22)33-4/h5-10,13-14,16-17H,11-12,15H2,1-4H3,(H,26,31)/t16-,17+/m1/s1",GEOXLESIBVHGGP-SJORKVTESA-N,0,1,0,0,CD4 / gp120,9.54,HIV infectious disease,Inhibition,
625,10142564,360918,8318074,OC(=O)C1CCN(CC1)c1cc(ccn1)-c1ccc(Sc2ccc3OCCOc3c2)c(c1)C(F)(F)F,"1-[4-[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfanyl)-3-(trifluoromethyl)phenyl]pyridin-2-yl]piperidine-4-carboxylic acid","InChI=1S/C26H23F3N2O4S/c27-26(28,29)20-13-17(1-4-23(20)36-19-2-3-21-22(15-19)35-12-11-34-21)18-5-8-30-24(14-18)31-9-6-16(7-10-31)25(32)33/h1-5,8,13-16H,6-7,9-12H2,(H,32,33)",GRRUUHVYLVKVPJ-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,7.15,immune system disease,Inhibition,
626,67980999,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1,,"InChI=1S/C43H49ClN8O4S2/c1-49(2)22-18-34(29-57-36-9-4-3-5-10-36)47-40-17-16-37(26-42(40)52(53)54)58(55,56)48-43-39-21-25-51(28-41(39)45-30-46-43)35-19-23-50(24-20-35)27-32-8-6-7-11-38(32)31-12-14-33(44)15-13-31/h3-17,26,30,34-35,47H,18-25,27-29H2,1-2H3,(H,45,46,48)/t34-/m1/s1",DEMZCGDYHDAZDJ-UUWRZZSWSA-N,1,0,0,0,BCL2-Like / BAX,7.00,cancer,Inhibition,
627,44391925,183295,23248020,CC(=O)N[C@@H]1CCN(C1)c1cc(ccn1)-c1ccc(Sc2ccc3OCCOc3c2)c(c1)C(F)(F)F,"N-[1-[4-[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfanyl)-3-(trifluoromethyl)phenyl]pyridin-2-yl]pyrrolidin-3-yl]acetamide","InChI=1S/C26H24F3N3O3S/c1-16(33)31-19-7-9-32(15-19)25-13-18(6-8-30-25)17-2-5-24(21(12-17)26(27,28)29)36-20-3-4-22-23(14-20)35-11-10-34-22/h2-6,8,12-14,19H,7,9-11,15H2,1H3,(H,31,33)/t19-/m1/s1",JVJJYUVCAROHSN-LJQANCHMSA-N,0,1,0,0,LFA / ICAM,6.95,immune system disease,Inhibition,
628,20792006,,19628818,Cn1ncc2c1nc(-c1cncc(Br)c1)c1c2[nH]n(-c2cccc(F)c2)c1=O,"4-(5-bromopyridin-3-yl)-2-(3-fluorophenyl)-6-methyl-1H-dipyrazolo[4,3-b:4',5'-e]pyridin-3-one","InChI=1S/C19H12BrFN6O/c1-26-18-14(9-23-26)17-15(16(24-18)10-5-11(20)8-22-7-10)19(28)27(25-17)13-4-2-3-12(21)6-13/h2-9,25H,1H3",ZZZLTIZZQSOSDT-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.70,cancer,Inhibition,
629,44176186,382422,23271192,OCCNC(=O)[C@@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)Nc2ccc(I)cc2C1=O)c1ccc(Cl)cc1,"2-(4-chlorophenyl)-2-[3-(4-chlorophenyl)-7-iodo-2,5-dioxo-1,3-dihydro-1,4-benzodiazepin-4-yl]-N-(2-hydroxyethyl)acetamide","InChI=1S/C25H20Cl2IN3O4/c26-16-5-1-14(2-6-16)21(23(33)29-11-12-32)31-22(15-3-7-17(27)8-4-15)24(34)30-20-10-9-18(28)13-19(20)25(31)35/h1-10,13,21-22,32H,11-12H2,(H,29,33)(H,30,34)/t21-,22-/m0/s1",RWPFTTITCVNHHF-VXKWHMMOSA-N,1,0,0,0,MDM2-Like / P53,5.67,cancer,Inhibition,
630,168318158,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(Cc2cccc(Cl)c2)CC1,,"InChI=1S/C36H41ClN6O5S2/c1-40(2)18-17-30(26-49-32-9-4-3-5-10-32)38-34-16-15-33(24-35(34)43(45)46)50(47,48)39-36(44)28-11-13-31(14-12-28)42-21-19-41(20-22-42)25-27-7-6-8-29(37)23-27/h3-16,23-24,30,38H,17-22,25-26H2,1-2H3,(H,39,44)/t30-/m1/s1",DBUSEADEVKSVOU-SSEXGKCCSA-N,2,0,0,0,BCL2-Like / BAX,9.30,cancer,Inhibition,
631,59555686,,,COc1ccc2[nH]cc(CCNc3ccc(Nc4ccnc5ccccc45)cc3)c2c1,"1-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-4-N-quinolin-4-ylbenzene-1,4-diamine","InChI=1S/C26H24N4O/c1-31-21-10-11-25-23(16-21)18(17-29-25)12-14-27-19-6-8-20(9-7-19)30-26-13-15-28-24-5-3-2-4-22(24)26/h2-11,13,15-17,27,29H,12,14H2,1H3,(H,28,30)",MUXQHJINXVJMKL-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,6.80,cancer,Inhibition,
632,12109930,361648,23245172,CNC(=O)[C@H](Cc1ccc2ccccc2c1)N1CCC(=O)N(Cc2cccc(OCc3ccccc3)c2)[C@@H](CC(C)C)C1=O,"(2S)-N-methyl-2-[(3S)-3-(2-methylpropyl)-2,5-dioxo-4-[(3-phenylmethoxyphenyl)methyl]-1,4-diazepan-1-yl]-3-naphthalen-2-ylpropanamide","InChI=1S/C37H41N3O4/c1-26(2)20-34-37(43)39(33(36(42)38-3)23-28-16-17-30-13-7-8-14-31(30)21-28)19-18-35(41)40(34)24-29-12-9-15-32(22-29)44-25-27-10-5-4-6-11-27/h4-17,21-22,26,33-34H,18-20,23-25H2,1-3H3,(H,38,42)/t33-,34-/m0/s1",QSNASQIYKSEJAI-HEVIKAOCSA-N,1,0,0,0,LFA / ICAM,5.18,immune system disease,Inhibition,
633,11562245,219139,9737019,CC[C@H](N(C)C)C(=O)N[C@H]1CCC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,9aS)-N-benzhydryl-6-[[(2S)-2-(dimethylamino)butanoyl]amino]-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C29H38N4O3/c1-4-24(32(2)3)27(34)30-23-17-11-16-22-18-19-25(33(22)29(23)36)28(35)31-26(20-12-7-5-8-13-20)21-14-9-6-10-15-21/h5-10,12-15,22-26H,4,11,16-19H2,1-3H3,(H,30,34)(H,31,35)/t22-,23-,24-,25-/m0/s1",CKOYRIROPKBZLR-QORCZRPOSA-N,2,1,0,0,XIAP / Smac,5.52,cancer,Inhibition,
634,59555735,,,Cc1cccc2c(CCNc3ccc(Nc4ccncc4)cc3)c[nH]c12,"1-N-[2-(7-methyl-1H-indol-3-yl)ethyl]-4-N-pyridin-4-ylbenzene-1,4-diamine","InChI=1S/C22H22N4/c1-16-3-2-4-21-17(15-25-22(16)21)9-14-24-18-5-7-19(8-6-18)26-20-10-12-23-13-11-20/h2-8,10-13,15,24-25H,9,14H2,1H3,(H,23,26)",WQGRCOJNNSBDCR-UHFFFAOYSA-N,2,1,0,0,MDM2-Like / P53,7.52,cancer,Inhibition,
635,44392046,361112,23248117,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1ccnc(c1)N1CCC(CCO)CC1,2-[1-[4-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyridin-2-yl]piperidin-4-yl]ethanol,"InChI=1S/C28H31F3N2OS/c1-19(2)23-5-3-4-6-25(23)35-26-8-7-21(17-24(26)28(29,30)31)22-9-13-32-27(18-22)33-14-10-20(11-15-33)12-16-34/h3-9,13,17-20,34H,10-12,14-16H2,1-2H3",MPPICRKUKRZKSE-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,6.80,immune system disease,Inhibition,
636,11588719,,9763483,C(Cc1c[nH]c2ccccc12)Nc1ccc(Nc2ccnc3CCCc23)cc1,"4-N-(6,7-dihydro-5H-cyclopenta[b]pyridin-4-yl)-1-N-[2-(1H-indol-3-yl)ethyl]benzene-1,4-diamine","InChI=1S/C24H24N4/c1-2-6-22-20(4-1)17(16-27-22)12-14-25-18-8-10-19(11-9-18)28-24-13-15-26-23-7-3-5-21(23)24/h1-2,4,6,8-11,13,15-16,25,27H,3,5,7,12,14H2,(H,26,28)",PVHNQZUDMFOCDT-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,8.00,cancer,Inhibition,
637,168318157,,24632786,C[C@@H](Oc1cccc(-c2ncno2)c1C)C(=O)N1CCN(C[C@H]1C)C(=O)c1ccccc1,"1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-[2-methyl-3-(1,2,4-oxadiazol-5-yl)phenoxy]propan-1-one","InChI=1S/C24H26N4O4/c1-16-14-27(24(30)19-8-5-4-6-9-19)12-13-28(16)23(29)18(3)31-21-11-7-10-20(17(21)2)22-25-15-26-32-22/h4-11,15-16,18H,12-14H2,1-3H3/t16-,18-/m1/s1",UZIFKODROZEAAF-SJLPKXTDSA-N,0,1,0,0,CD4 / gp120,7.12,HIV infectious disease,Inhibition,
638,168318153,,10793081,CNC(=O)CN1c2ccc(I)cc2C(=O)N([C@@H](C(O)=O)c2ccc(Cl)cc2)[C@@H](c2ccc(Cl)cc2)C1=O,"2-(4-chlorophenyl)-2-[3-(4-chlorophenyl)-7-iodo-1-[2-(methylamino)-2-oxoethyl]-2,5-dioxo-3H-1,4-benzodiazepin-4-yl]acetic acid","InChI=1S/C26H20Cl2IN3O5/c1-30-21(33)13-31-20-11-10-18(29)12-19(20)24(34)32(22(25(31)35)14-2-6-16(27)7-3-14)23(26(36)37)15-4-8-17(28)9-5-15/h2-12,22-23H,13H2,1H3,(H,30,33)(H,36,37)/t22-,23+/m0/s1",IRUUIIXRURRPCS-XZOQPEGZSA-N,1,0,0,0,MDM2-Like / P53,5.48,cancer,Inhibition,
639,53325865,1644115,26379288,CS(=O)(=O)n1cc(C(=O)NC[C@H](NC(=O)c2c(Cl)cc3CN(CCc3c2Cl)C(=O)c2ccc(Cl)cc2)C(O)=O)c2ccccc12,"(2S)-2-[[5,7-dichloro-2-(4-chlorobenzoyl)-3,4-dihydro-1H-isoquinoline-6-carbonyl]amino]-3-[(1-methylsulfonylindole-3-carbonyl)amino]propanoic acid","InChI=1S/C30H25Cl3N4O7S/c1-45(43,44)37-15-21(20-4-2-3-5-24(20)37)27(38)34-13-23(30(41)42)35-28(39)25-22(32)12-17-14-36(11-10-19(17)26(25)33)29(40)16-6-8-18(31)9-7-16/h2-9,12,15,23H,10-11,13-14H2,1H3,(H,34,38)(H,35,39)(H,41,42)/t23-/m0/s1",XOXBNFKSIDCMFB-QHCPKHFHSA-N,1,0,0,0,LFA / ICAM,7.00,immune system disease,Inhibition,
640,168318156,,,C[C@@H](NCCCc1ccccc1)c1cc(Nc2ccc(NCCc3c[nH]c4ccccc34)cc2)ccn1,"1-N-[2-(1H-indol-3-yl)ethyl]-4-N-[2-[1-(3-phenylpropylamino)ethyl]pyridin-4-yl]benzene-1,4-diamine","InChI=1S/C32H35N5/c1-24(33-19-7-10-25-8-3-2-4-9-25)32-22-29(18-21-35-32)37-28-15-13-27(14-16-28)34-20-17-26-23-36-31-12-6-5-11-30(26)31/h2-6,8-9,11-16,18,21-24,33-34,36H,7,10,17,19-20H2,1H3,(H,35,37)/t24-/m1/s1",BLCZBSUZAQUBIF-XMMPIXPASA-N,1,1,0,0,MDM2-Like / P53,6.52,cancer,Inhibition,
641,44549892,,,CCc1ccc2O[C@@H](C3=C(N(C)c4ncnn4[C@H]3c3ccc(Br)cc3)c2c1)c1ccc(Br)cc1,,"InChI=1S/C27H22Br2N4O/c1-3-16-4-13-22-21(14-16)25-23(26(34-22)18-7-11-20(29)12-8-18)24(17-5-9-19(28)10-6-17)33-27(32(25)2)30-15-31-33/h4-15,24,26H,3H2,1-2H3/t24-,26+/m0/s1",VBADVYAYXYBYJN-AZGAKELHSA-N,1,0,0,0,MDM2-Like / P53,5.49,cancer,Inhibition,
642,44237052,584396,24641232,CC[C@H](N)C(=O)N[C@H]1[C@@H](CN(CC)Cc2ccccc2)CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7R,9aS)-6-[[(2S)-2-aminobutanoyl]amino]-N-benzhydryl-7-[[benzyl(ethyl)amino]methyl]-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C37H47N5O3/c1-3-31(38)35(43)40-34-29(25-41(4-2)24-26-14-8-5-9-15-26)20-21-30-22-23-32(42(30)37(34)45)36(44)39-33(27-16-10-6-11-17-27)28-18-12-7-13-19-28/h5-19,29-34H,3-4,20-25,38H2,1-2H3,(H,39,44)(H,40,43)/t29-,30+,31+,32+,34+/m1/s1",ZHNPIYLLDWNMTK-UCDLYESDSA-N,2,0,0,0,XIAP / Smac,6.36,cancer,Inhibition,
643,44580070,487496,24704549,FC(F)(F)c1c(Sc2cccc(OCc3ccccn3)c2)ccc(\C=C\C(=O)N2CCOCC2)c1C(F)(F)F,"(E)-1-morpholin-4-yl-3-[4-[3-(pyridin-2-ylmethoxy)phenyl]sulfanyl-2,3-bis(trifluoromethyl)phenyl]prop-2-en-1-one","InChI=1S/C27H22F6N2O3S/c28-26(29,30)24-18(8-10-23(36)35-12-14-37-15-13-35)7-9-22(25(24)27(31,32)33)39-21-6-3-5-20(16-21)38-17-19-4-1-2-11-34-19/h1-11,16H,12-15,17H2/b10-8+",OQGNIEVOYVXSHE-CSKARUKUSA-N,1,0,0,0,LFA / ICAM,7.15,immune system disease,Inhibition,
644,21906802,183570,10657322,OCC1CCN(CC1)c1cc(ccn1)-c1ccc(Sc2ccc3OCCOc3c2)c(c1)C(F)(F)F,"[1-[4-[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfanyl)-3-(trifluoromethyl)phenyl]pyridin-2-yl]piperidin-4-yl]methanol","InChI=1S/C26H25F3N2O3S/c27-26(28,29)21-13-18(19-5-8-30-25(14-19)31-9-6-17(16-32)7-10-31)1-4-24(21)35-20-2-3-22-23(15-20)34-12-11-33-22/h1-5,8,13-15,17,32H,6-7,9-12,16H2",HYBFJADVMPQZEV-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,6.41,immune system disease,Inhibition,
645,168318152,,,CC[C@@H](O)CCNC(=O)[C@@H]1N[C@H](C2CCCC2)[C@@]2([C@H]1c1ccc(F)c(Cl)c1)C(=O)Nc1cc(Cl)c(F)cc21,,"InChI=1S/C28H31Cl2F2N3O3/c1-2-16(36)9-10-33-26(37)24-23(15-7-8-20(31)18(29)11-15)28(25(35-24)14-5-3-4-6-14)17-12-21(32)19(30)13-22(17)34-27(28)38/h7-8,11-14,16,23-25,35-36H,2-6,9-10H2,1H3,(H,33,37)(H,34,38)/t16-,23+,24-,25-,28-/m1/s1",IIMMPSUMBXQAKL-IFEKXBSVSA-N,1,3,0,0,MDM2-Like / P53,6.47,cancer,Inhibition,
646,25138062,487149,24703443,CC[C@H](N)C(=O)N[C@H]1CCCC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,10aS)-6-[[(2S)-2-aminobutanoyl]amino]-N-benzhydryl-5-oxo-2,3,6,7,8,9,10,10a-octahydro-1H-pyrrolo[1,2-a]azocine-3-carboxamide","InChI=1S/C28H36N4O3/c1-2-22(29)26(33)30-23-16-10-9-15-21-17-18-24(32(21)28(23)35)27(34)31-25(19-11-5-3-6-12-19)20-13-7-4-8-14-20/h3-8,11-14,21-25H,2,9-10,15-18,29H2,1H3,(H,30,33)(H,31,34)/t21-,22-,23-,24-/m0/s1",SPMRYEMCEZYTQS-ZJZGAYNASA-N,1,1,0,0,XIAP / Smac,7.41,cancer,Inhibition,
647,44392005,181106,23248084,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1ccnc(c1)N1CC[C@H](C1)NC(C)=O,N-[1-[4-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyridin-2-yl]pyrrolidin-3-yl]acetamide,"InChI=1S/C27H28F3N3OS/c1-17(2)22-6-4-5-7-24(22)35-25-9-8-19(14-23(25)27(28,29)30)20-10-12-31-26(15-20)33-13-11-21(16-33)32-18(3)34/h4-10,12,14-15,17,21H,11,13,16H2,1-3H3,(H,32,34)/t21-/m1/s1",ZIHNRIDMLOHFPP-OAQYLSRUSA-N,0,1,0,0,LFA / ICAM,7.21,immune system disease,Inhibition,
648,46883923,1089695,24676184,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1nc2c(cccc2s1)-c1ccccc1Cl,"(2S)-N-[(1S)-2-[(2R)-2-[4-(2-chlorophenyl)-1,3-benzothiazol-2-yl]pyrrolidin-1-yl]-1-cyclohexyl-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C29H35ClN4O2S/c1-18(31-2)27(35)32-25(19-10-4-3-5-11-19)29(36)34-17-9-15-23(34)28-33-26-21(13-8-16-24(26)37-28)20-12-6-7-14-22(20)30/h6-8,12-14,16,18-19,23,25,31H,3-5,9-11,15,17H2,1-2H3,(H,32,35)/t18-,23-,25-/m0/s1",KNYCQQSDMGDZCG-WYRQLCSISA-N,1,0,0,0,XIAP / Smac,6.80,cancer,Inhibition,
649,168318149,,,Cc1cccc(NC(=O)NC(=O)[C@@H]2[C@@H](OC3([C@@H]2C(O)=O)C(=O)c2ccccc2C3=O)c2ccc(Cl)c(Cl)c2)c1,,"InChI=1S/C28H20Cl2N2O7/c1-13-5-4-6-15(11-13)31-27(38)32-25(35)20-21(26(36)37)28(23(33)16-7-2-3-8-17(16)24(28)34)39-22(20)14-9-10-18(29)19(30)12-14/h2-12,20-22H,1H3,(H,36,37)(H2,31,32,35,38)/t20-,21-,22-/m0/s1",JBVXATRVXYLXNM-FKBYEOEOSA-N,1,0,0,0,E2 / E1,6.13,human papilloma virus infection,Inhibition,
650,44549359,1771706,26336502,CN1c2ncnn2[C@H](C2=C1c1ccccc1O[C@@H]2c1ccc(Br)cc1)c1ccc(Br)cc1,,"InChI=1S/C25H18Br2N4O/c1-30-23-19-4-2-3-5-20(19)32-24(16-8-12-18(27)13-9-16)21(23)22(31-25(30)28-14-29-31)15-6-10-17(26)11-7-15/h2-14,22,24H,1H3/t22-,24+/m0/s1",HPLRNIWPMGIMAW-LADGPHEKSA-N,1,0,0,0,MDM2-Like / P53,5.93,cancer,Inhibition,
651,16109116,385104,17266529,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(CC1)C(=O)c1ccccc1,4-(4-benzoylpiperazin-1-yl)-N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonylbenzamide,"InChI=1S/C36H40N6O6S2/c1-39(2)20-19-29(26-49-31-11-7-4-8-12-31)37-33-18-17-32(25-34(33)42(45)46)50(47,48)38-35(43)27-13-15-30(16-14-27)40-21-23-41(24-22-40)36(44)28-9-5-3-6-10-28/h3-18,25,29,37H,19-24,26H2,1-2H3,(H,38,43)/t29-/m1/s1",ZCOASPBHOFKONX-GDLZYMKVSA-N,2,0,0,0,BCL2-Like / BAX,9.00,cancer,Inhibition,
652,168318145,,,CC(C)n1cnc(c1)C(=O)NC[C@H](NC(=O)c1c(Cl)cc2CN(CCc2c1Cl)C(=O)c1ccc(Cl)cc1)C(O)=O,,"InChI=1S/C27H26Cl3N5O5/c1-14(2)35-12-21(32-13-35)24(36)31-10-20(27(39)40)33-25(37)22-19(29)9-16-11-34(8-7-18(16)23(22)30)26(38)15-3-5-17(28)6-4-15/h3-6,9,12-14,20H,7-8,10-11H2,1-2H3,(H,31,36)(H,33,37)(H,39,40)/t20-/m0/s1",QMDPZLRSRDCFRL-FQEVSTJZSA-N,1,0,0,0,LFA / ICAM,6.77,immune system disease,Inhibition,
653,25050415,,,Clc1ccc(cc1)[C@@H]1[C@H](c2ccc(Cl)cc2)n2c(cccc2=O)N1S(=O)(=O)c1ccsc1,"(2R,3S)-2,3-bis(4-chlorophenyl)-1-thiophen-3-ylsulfonyl-2,3-dihydroimidazo[1,2-a]pyridin-5-one","InChI=1S/C23H16Cl2N2O3S2/c24-17-8-4-15(5-9-17)22-23(16-6-10-18(25)11-7-16)27(20-2-1-3-21(28)26(20)22)32(29,30)19-12-13-31-14-19/h1-14,22-23H/t22-,23+/m0/s1",LFNXLKSEAQYXDT-XZOQPEGZSA-N,1,0,0,0,MDM2-Like / P53,6.15,cancer,Inhibition,
654,44392057,183780,23248127,O[C@@H]1CCN(C1)c1cc(ccn1)-c1ccc(Sc2ccc3OCCOc3c2)c(c1)C(F)(F)F,"(3R)-1-[4-[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfanyl)-3-(trifluoromethyl)phenyl]pyridin-2-yl]pyrrolidin-3-ol","InChI=1S/C24H21F3N2O3S/c25-24(26,27)19-11-15(16-5-7-28-23(12-16)29-8-6-17(30)14-29)1-4-22(19)33-18-2-3-20-21(13-18)32-10-9-31-20/h1-5,7,11-13,17,30H,6,8-10,14H2/t17-/m1/s1",OZDIXXYNNZCRMU-QGZVFWFLSA-N,0,1,0,0,LFA / ICAM,6.90,immune system disease,Inhibition,
655,59555655,,,N#Cc1ccc2nccc(Nc3ccc(NCCc4c[nH]c5ccccc45)cc3)c2c1,4-[4-[2-(1H-indol-3-yl)ethylamino]anilino]quinoline-6-carbonitrile,"InChI=1S/C26H21N5/c27-16-18-5-10-25-23(15-18)26(12-14-29-25)31-21-8-6-20(7-9-21)28-13-11-19-17-30-24-4-2-1-3-22(19)24/h1-10,12,14-15,17,28,30H,11,13H2,(H,29,31)",XGGPULZADQVQNC-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,6.60,cancer,Inhibition,
656,59343750,,,CC(C)(C)C[C@H]1N[C@H]([C@H](c2ccc(F)c(Cl)c2)[C@@]11C(=O)Nc2cc(Cl)c(F)cc12)C(=O)NCCn1ccnc1,"(2'R,3S,3'R,5'R)-6-chloro-3'-(3-chloro-4-fluorophenyl)-5'-(2,2-dimethylpropyl)-5-fluoro-N-(2-imidazol-1-ylethyl)-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide","InChI=1S/C28H29Cl2F2N5O2/c1-27(2,3)13-22-28(16-11-20(32)18(30)12-21(16)35-26(28)39)23(15-4-5-19(31)17(29)10-15)24(36-22)25(38)34-7-9-37-8-6-33-14-37/h4-6,8,10-12,14,22-24,36H,7,9,13H2,1-3H3,(H,34,38)(H,35,39)/t22-,23+,24-,28+/m1/s1",UDNSTTYXSFSVNA-PVIBPIFHSA-N,1,3,0,0,MDM2-Like / P53,6.41,cancer,Inhibition,
657,168318143,,,C[C@H](N)C(=O)N[C@H](C(=O)N1C[C@H](C[C@H]1C(=O)N[C@H]1CCCc2ccccc12)Oc1ccccc1)C(C)(C)C,,"InChI=1S/C30H40N4O4/c1-19(31)27(35)33-26(30(2,3)4)29(37)34-18-22(38-21-13-6-5-7-14-21)17-25(34)28(36)32-24-16-10-12-20-11-8-9-15-23(20)24/h5-9,11,13-15,19,22,24-26H,10,12,16-18,31H2,1-4H3,(H,32,36)(H,33,35)/t19-,22-,24-,25-,26+/m0/s1",QJAIXZOPNXYSAA-FGDDVOGPSA-N,1,0,0,0,XIAP / Smac,8.30,cancer,Inhibition,
658,11752107,183598,9926810,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1ccnc(c1)N1CCC[C@H]1C(O)=O,(2S)-1-[4-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyridin-2-yl]pyrrolidine-2-carboxylic acid,"InChI=1S/C26H25F3N2O2S/c1-16(2)19-6-3-4-8-22(19)34-23-10-9-17(14-20(23)26(27,28)29)18-11-12-30-24(15-18)31-13-5-7-21(31)25(32)33/h3-4,6,8-12,14-16,21H,5,7,13H2,1-2H3,(H,32,33)/t21-/m0/s1",WMECQBYXSNEKHN-NRFANRHFSA-N,0,1,0,0,LFA / ICAM,7.59,immune system disease,Inhibition,
659,24875322,502756,24710186,O=C(O)[C@H]1CC[C@@H](CC1)COc1ccccc1Sc1ccc(\C=C\C(=O)N2CCOCC2)c(C(F)(F)F)c1C(F)(F)F,"4-[[2-[4-[(E)-3-morpholin-4-yl-3-oxoprop-1-enyl]-2,3-bis(trifluoromethyl)phenyl]sulfanylphenoxy]methyl]cyclohexane-1-carboxylic acid","InChI=1S/C29H29F6NO5S/c30-28(31,32)25-19(10-12-24(37)36-13-15-40-16-14-36)9-11-23(26(25)29(33,34)35)42-22-4-2-1-3-21(22)41-17-18-5-7-20(8-6-18)27(38)39/h1-4,9-12,18,20H,5-8,13-17H2,(H,38,39)/b12-10+/t18-,20-",AXSOGTWJBSDWJQ-WDYYSVFXSA-N,1,0,0,0,LFA / ICAM,9.22,immune system disease,Inhibition,
660,51354904,1689145,26393378,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1ncnc2cc(ccc12)N1CCN(CC2=C(CCC(C)(C)C2)c2ccc(Cl)cc2)CC1,"N-[7-[4-[[2-(4-chlorophenyl)-5,5-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]quinazolin-4-yl]-4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)benzenesulfonamide","InChI=1S/C46H53ClF3N7O4S3/c1-45(2)20-18-39(32-10-12-34(47)13-11-32)33(28-45)29-56-22-24-57(25-23-56)36-14-16-40-42(26-36)51-31-52-44(40)54-64(60,61)38-15-17-41(43(27-38)63(58,59)46(48,49)50)53-35(19-21-55(3)4)30-62-37-8-6-5-7-9-37/h5-17,26-27,31,35,53H,18-25,28-30H2,1-4H3,(H,51,52,54)/t35-/m1/s1",GFIQKTNEPGLOBO-PGUFJCEWSA-N,1,0,0,0,BCL2-Like / BAX,8.52,cancer,Inhibition,
661,168317493,,,O=C(O)[C@H](Cc1ccccc1)N1C(=S)S\C(=C/c2ccc(OCOCCOCOc3ccc(cc3)\C=C3/SC(=S)N(C3=O)[C@H](C(=O)O)Cc3ccccc3)cc2)C1=O,,"InChI=1S/C42H36N2O10S4/c45-37-35(57-41(55)43(37)33(39(47)48)21-27-7-3-1-4-8-27)23-29-11-15-31(16-12-29)53-25-51-19-20-52-26-54-32-17-13-30(14-18-32)24-36-38(46)44(42(56)58-36)34(40(49)50)22-28-9-5-2-6-10-28/h1-18,23-24,33-34H,19-22,25-26H2,(H,47,48)(H,49,50)/b35-23-,36-24-/t33-,34-/m0/s1",VIENFBBWIGREAI-YMEGPHBOSA-N,3,0,0,0,BCL2-Like / BAX,5.06,cancer,Inhibition,
662,51354903,1689144,26393163,CC1(C)CCC(=C(CN2CCN(CC2)c2ccc3c(NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(c4)N(=O)=O)ncnc3c2)C1)c1ccc(Cl)cc1,"N-[7-[4-[[2-(4-chlorophenyl)-5,5-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]quinazolin-4-yl]-4-[[(2R)-4-morpholin-4-yl-1-phenylsulfanylbutan-2-yl]amino]-3-nitrobenzenesulfonamide","InChI=1S/C47H55ClN8O5S2/c1-47(2)18-16-41(34-8-10-36(48)11-9-34)35(30-47)31-54-20-22-55(23-21-54)38-12-14-42-44(28-38)49-33-50-46(42)52-63(59,60)40-13-15-43(45(29-40)56(57)58)51-37(17-19-53-24-26-61-27-25-53)32-62-39-6-4-3-5-7-39/h3-15,28-29,33,37,51H,16-27,30-32H2,1-2H3,(H,49,50,52)/t37-/m1/s1",ARWJIYMQTWOIHU-DIPNUNPCSA-N,1,0,0,0,BCL2-Like / BAX,7.52,cancer,Inhibition,
663,44608667,2315847,,COCCN(C)C(=O)[C@@H]1CCCN1C(=O)C1=C(C(C)C)N2[C@H](c3ccc(Cl)cc3)[C@@](C)(N=C2S1)c1ccc(Cl)cc1,"(2S)-1-[(5R,6S)-5,6-bis(4-chlorophenyl)-6-methyl-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazole-2-carbonyl]-N-(2-methoxyethyl)-N-methylpyrrolidine-2-carboxamide","InChI=1S/C31H36Cl2N4O3S/c1-19(2)25-26(29(39)36-16-6-7-24(36)28(38)35(4)17-18-40-5)41-30-34-31(3,21-10-14-23(33)15-11-21)27(37(25)30)20-8-12-22(32)13-9-20/h8-15,19,24,27H,6-7,16-18H2,1-5H3/t24-,27+,31-/m0/s1",AULOEBKRKBIPLR-FDZWRVBXSA-N,1,0,0,0,MDM2-Like / P53,7.64,cancer,Inhibition,
664,140219443,,,CC(C)(C)OC(=O)Cc1ccc(Cl)cc1-n1c(nc(-c2nnc(N)o2)c1-c1ccc(F)c(Cl)c1)C1CCCCC1,,"InChI=1S/C29H30Cl2FN5O3/c1-29(2,3)40-23(38)14-17-9-11-19(30)15-22(17)37-25(18-10-12-21(32)20(31)13-18)24(27-35-36-28(33)39-27)34-26(37)16-7-5-4-6-8-16/h9-13,15-16H,4-8,14H2,1-3H3,(H2,33,36)",VKBKHFQGYDXVDH-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,8.30,cancer,Inhibition,
665,45138409,,,CN[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2C(C)=O)c1c[nH]c2ccc(F)cc12,"(2S)-N-[(2S)-1-[(3aR,6S,6aR)-4-acetyl-6-(5-fluoro-1H-indol-3-yl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-3-methyl-1-oxobutan-2-yl]-2-(methylamino)propanamide","InChI=1S/C25H34FN5O3/c1-13(2)22(29-24(33)14(3)27-5)25(34)30-9-8-21-23(30)19(12-31(21)15(4)32)18-11-28-20-7-6-16(26)10-17(18)20/h6-7,10-11,13-14,19,21-23,27-28H,8-9,12H2,1-5H3,(H,29,33)/t14-,19+,21+,22-,23+/m0/s1",QUMQFRXDVDUPEB-HCLLECIRSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
666,88572771,,,CC1(C)CCC(=C(CN2CCC(CC2)N2CCc3c(C2)ncnc3NS(=O)(=O)c2ccc(N[C@H](CCN3CCOCC3)CSc3ccccc3)c(c2)S(=O)(=O)C(F)(F)F)C1)c1ccc(Cl)cc1,,"InChI=1S/C48H59ClF3N7O5S3/c1-47(2)19-14-41(34-8-10-36(49)11-9-34)35(29-47)30-58-21-16-38(17-22-58)59-23-18-42-44(31-59)53-33-54-46(42)56-67(62,63)40-12-13-43(45(28-40)66(60,61)48(50,51)52)55-37(15-20-57-24-26-64-27-25-57)32-65-39-6-4-3-5-7-39/h3-13,28,33,37-38,55H,14-27,29-32H2,1-2H3,(H,53,54,56)/t37-/m1/s1",BQSDEGQGLGZZSQ-DIPNUNPCSA-N,1,0,0,0,BCL2-Like / BAX,7.12,cancer,Inhibition,
667,59555710,,,OCCNCc1cc(Nc2ccc(NCCc3c[nH]c4ccccc34)cc2)ccn1,2-[[4-[4-[2-(1H-indol-3-yl)ethylamino]anilino]pyridin-2-yl]methylamino]ethanol,"InChI=1S/C24H27N5O/c30-14-13-25-17-22-15-21(10-12-27-22)29-20-7-5-19(6-8-20)26-11-9-18-16-28-24-4-2-1-3-23(18)24/h1-8,10,12,15-16,25-26,28,30H,9,11,13-14,17H2,(H,27,29)",OUUJGTBPKLTNIW-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,5.60,cancer,Inhibition,
668,46884022,1092760,24670728,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1nc2c(ccnc2s1)-c1ccccc1,"(2S)-N-[(1S)-1-cyclohexyl-2-oxo-2-[(2R)-2-(7-phenyl-[1,3]thiazolo[5,4-b]pyridin-2-yl)pyrrolidin-1-yl]ethyl]-2-(methylamino)propanamide","InChI=1S/C28H35N5O2S/c1-18(29-2)25(34)31-23(20-12-7-4-8-13-20)28(35)33-17-9-14-22(33)26-32-24-21(15-16-30-27(24)36-26)19-10-5-3-6-11-19/h3,5-6,10-11,15-16,18,20,22-23,29H,4,7-9,12-14,17H2,1-2H3,(H,31,34)/t18-,22-,23-/m0/s1",CLTARQPEHNOQCG-TZYHBYERSA-N,1,0,0,0,XIAP / Smac,7.39,cancer,Inhibition,
669,21906790,426426,10657302,CCCN1CCN(CC1)c1cc(ccn1)-c1ccc(Sc2ccccc2OC)c(c1)C(F)(F)F,1-[4-[4-(2-methoxyphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyridin-2-yl]-4-propylpiperazine,"InChI=1S/C26H28F3N3OS/c1-3-12-31-13-15-32(16-14-31)25-18-20(10-11-30-25)19-8-9-23(21(17-19)26(27,28)29)34-24-7-5-4-6-22(24)33-2/h4-11,17-18H,3,12-16H2,1-2H3",FDHIKTFGAVFLBW-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,6.05,immune system disease,Inhibition,
670,58531383,,,Oc1c(Cl)cc(Cl)cc1S(=O)(=O)N(Cc1ccc(F)cc1)Cc1cccc(c1)C(=O)N(Cc1ccc(F)cc1)Cc1cc(Cl)cc(Cl)c1,"3-[[(3,5-dichloro-2-hydroxyphenyl)sulfonyl-[(4-fluorophenyl)methyl]amino]methyl]-N-[(3,5-dichlorophenyl)methyl]-N-[(4-fluorophenyl)methyl]benzamide","InChI=1S/C35H26Cl4F2N2O4S/c36-27-13-25(14-28(37)15-27)19-42(18-22-4-8-30(40)9-5-22)35(45)26-3-1-2-24(12-26)21-43(20-23-6-10-31(41)11-7-23)48(46,47)33-17-29(38)16-32(39)34(33)44/h1-17,44H,18-21H2",UPMXAUWQEDKBBP-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,7.15,cancer,Inhibition,
671,24875638,,,OCc1cc(ccn1)N1CCc2cc(NCCc3c[nH]c4ccccc34)ccc12,"[4-[5-[2-(1H-indol-3-yl)ethylamino]-2,3-dihydroindol-1-yl]pyridin-2-yl]methanol","InChI=1S/C24H24N4O/c29-16-20-14-21(8-11-26-20)28-12-9-17-13-19(5-6-24(17)28)25-10-7-18-15-27-23-4-2-1-3-22(18)23/h1-6,8,11,13-15,25,27,29H,7,9-10,12,16H2",JKOCVEDKVVOPLO-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,6.80,cancer,Inhibition,
672,168318136,,,COc1ccc(CN2CCN(CC2)c2ccc(cc2)C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN(C)C)CSc3ccccc3)c(c2)N(=O)=O)cc1,,"InChI=1S/C37H44N6O6S2/c1-40(2)20-19-30(27-50-33-7-5-4-6-8-33)38-35-18-17-34(25-36(35)43(45)46)51(47,48)39-37(44)29-11-13-31(14-12-29)42-23-21-41(22-24-42)26-28-9-15-32(49-3)16-10-28/h4-18,25,30,38H,19-24,26-27H2,1-3H3,(H,39,44)/t30-/m1/s1",LAMGQTLSEAGZMJ-SSEXGKCCSA-N,2,0,0,0,BCL2-Like / BAX,9.30,cancer,Inhibition,
673,168318138,,,C[C@H](N)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1C(=O)N[C@H]1CCCc2ccccc12,,"InChI=1S/C26H38N4O3/c1-17(27)24(31)29-23(19-10-3-2-4-11-19)26(33)30-16-8-15-22(30)25(32)28-21-14-7-12-18-9-5-6-13-20(18)21/h5-6,9,13,17,19,21-23H,2-4,7-8,10-12,14-16,27H2,1H3,(H,28,32)(H,29,31)/t17-,21-,22-,23-/m0/s1",IMFCXNHTXKDVDO-ZMVGRULKSA-N,1,1,0,0,XIAP / Smac,7.80,cancer,Inhibition,
674,44570079,480008,24698359,CN(C(=O)c1cc(C)n(n1)-c1ccccc1C(=O)N1CCc2ccccc2C1)c1ccccc1F,"1-[2-(3,4-dihydro-1H-isoquinoline-2-carbonyl)phenyl]-N-(2-fluorophenyl)-N,5-dimethylpyrazole-3-carboxamide","InChI=1S/C28H25FN4O2/c1-19-17-24(28(35)31(2)26-14-8-6-12-23(26)29)30-33(19)25-13-7-5-11-22(25)27(34)32-16-15-20-9-3-4-10-21(20)18-32/h3-14,17H,15-16,18H2,1-2H3",QKQSYEKLLLWTHO-UHFFFAOYSA-N,1,0,0,0,BCL2-Like / BAX,5.52,cancer,Inhibition,
675,168318135,,,C[C@@H](Oc1cccc(C)c1C)C(=O)N1CCN(C[C@H]1C)C(=O)c1ccccc1,"(2S)-1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-(2,3-dimethylphenoxy)propan-1-one","InChI=1S/C23H28N2O3/c1-16-9-8-12-21(18(16)3)28-19(4)22(26)25-14-13-24(15-17(25)2)23(27)20-10-6-5-7-11-20/h5-12,17,19H,13-15H2,1-4H3/t17-,19-/m1/s1",ZFLYLSQNETWPHM-IEBWSBKVSA-N,0,1,0,0,CD4 / gp120,7.00,HIV infectious disease,Inhibition,
676,25026109,568821,24631904,CN(C)c1nc(NCc2ccc(NC(=O)c3ccc(F)cc3)cc2)c2ccc(cc2n1)C(C)=O,N-[4-[[[7-acetyl-2-(dimethylamino)quinazolin-4-yl]amino]methyl]phenyl]-4-fluorobenzamide,"InChI=1S/C26H24FN5O2/c1-16(33)19-8-13-22-23(14-19)30-26(32(2)3)31-24(22)28-15-17-4-11-21(12-5-17)29-25(34)18-6-9-20(27)10-7-18/h4-14H,15H2,1-3H3,(H,29,34)(H,28,30,31)",KGVIKCUJOCKZNT-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,5.63,cancer,Inhibition,
677,168318137,,10793043,CN1c2ccc(I)cc2C(=O)N([C@@H](C(O)=O)c2ccc(Cl)cc2)[C@@H](c2ccc(Cl)cc2)C1=O,"2-(4-chlorophenyl)-2-[3-(4-chlorophenyl)-7-iodo-1-methyl-2,5-dioxo-3H-1,4-benzodiazepin-4-yl]acetic acid","InChI=1S/C24H17Cl2IN2O4/c1-28-19-11-10-17(27)12-18(19)22(30)29(20(23(28)31)13-2-6-15(25)7-3-13)21(24(32)33)14-4-8-16(26)9-5-14/h2-12,20-21H,1H3,(H,32,33)/t20-,21+/m0/s1",NFQDVKDBCGSJQN-LEWJYISDSA-N,1,0,0,0,MDM2-Like / P53,5.66,cancer,Inhibition,
678,11226364,108470,9401417,COC(=O)[C@H](Cc1ccc(cc1)C#Cc1ccccc1)NC(=O)CNC(=O)[C@@H](CC1CCCCC1)NC(N)=N,methyl (2S)-2-[[2-[[(2R)-3-cyclohexyl-2-(diaminomethylideneamino)propanoyl]amino]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate,"InChI=1S/C30H37N5O4/c1-39-29(38)26(19-24-16-14-22(15-17-24)13-12-21-8-4-2-5-9-21)34-27(36)20-33-28(37)25(35-30(31)32)18-23-10-6-3-7-11-23/h2,4-5,8-9,14-17,23,25-26H,3,6-7,10-11,18-20H2,1H3,(H,33,37)(H,34,36)(H4,31,32,35)/t25-,26+/m1/s1",MCWWAEOCNFUYJG-FTJBHMTQSA-N,1,0,0,0,IL2 / IL2R,6.10,immune system disease,Inhibition,
679,44456365,404899,23324112,O=C(O)[C@H](Cc1ccccc1)N1C(=S)S\C(=C/c2ccc(OCCOc3ccc(cc3)\C=C3/SC(=S)N(C3=O)[C@H](C(=O)O)Cc3ccccc3)cc2)C1=O,"(2S)-2-[(5E)-5-[[4-[2-[4-[(E)-[3-[(1S)-1-carboxy-2-phenylethyl]-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl]phenoxy]ethoxy]phenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-3-phenylpropanoic acid","InChI=1S/C40H32N2O8S4/c43-35-33(53-39(51)41(35)31(37(45)46)21-25-7-3-1-4-8-25)23-27-11-15-29(16-12-27)49-19-20-50-30-17-13-28(14-18-30)24-34-36(44)42(40(52)54-34)32(38(47)48)22-26-9-5-2-6-10-26/h1-18,23-24,31-32H,19-22H2,(H,45,46)(H,47,48)/b33-23-,34-24-/t31-,32-/m0/s1",MEWOLNCWQUCYPM-BOVCXGLBSA-N,3,0,0,0,BCL2-Like / BAX,6.01,cancer,Inhibition,
680,44549763,,,CN1c2ncnn2[C@H](C2=C1c1c(F)cccc1O[C@@H]2c1ccc(Br)cc1)c1ccc(Br)cc1,,"InChI=1S/C25H17Br2FN4O/c1-31-23-20-18(28)3-2-4-19(20)33-24(15-7-11-17(27)12-8-15)21(23)22(32-25(31)29-13-30-32)14-5-9-16(26)10-6-14/h2-13,22,24H,1H3/t22-,24+/m0/s1",UZZAUBNWYYZQJH-LADGPHEKSA-N,1,0,0,0,MDM2-Like / P53,5.76,cancer,Inhibition,
681,58531446,,,CC(C)CN(Cc1cc(CN(Cc2ccc(F)cc2)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)cc(Oc2ccc(F)cc2)c1)S(=O)(=O)c1ccc(C)cc1,"3,5-dichloro-N-[[3-(4-fluorophenoxy)-5-[[(4-methylphenyl)sulfonyl-(2-methylpropyl)amino]methyl]phenyl]methyl]-N-[(4-fluorophenyl)methyl]-2-hydroxybenzenesulfonamide","InChI=1S/C38H36Cl2F2N2O6S2/c1-25(2)21-43(51(46,47)35-14-4-26(3)5-15-35)23-28-16-29(18-34(17-28)50-33-12-10-32(42)11-13-33)24-44(22-27-6-8-31(41)9-7-27)52(48,49)37-20-30(39)19-36(40)38(37)45/h4-20,25,45H,21-24H2,1-3H3",JKFIWXNQQWRMDC-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,8.00,cancer,Inhibition,
682,11236522,,9411567,CC(C)C[C@H]1N[C@H]([C@H](c2cccc(Cl)c2)[C@@]11C(=O)Nc2cc(Cl)ccc12)C(=O)N(C)C,"(2'R,3S,3'R,5'R)-6-chloro-3'-(3-chlorophenyl)-N,N-dimethyl-5'-(2-methylpropyl)-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide","InChI=1S/C24H27Cl2N3O2/c1-13(2)10-19-24(17-9-8-16(26)12-18(17)27-23(24)31)20(14-6-5-7-15(25)11-14)21(28-19)22(30)29(3)4/h5-9,11-13,19-21,28H,10H2,1-4H3,(H,27,31)/t19-,20+,21-,24+/m1/s1",PBDZIMHWKNPOPX-WHLIWEHUSA-N,1,3,0,0,MDM2-Like / P53,6.52,cancer,Inhibition,
683,88540110,,,CN(C)CC[C@H](CSc1ccccc1Cl)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1,,"InChI=1S/C44H48Cl2F3N7O4S3/c1-54(2)21-17-33(28-61-41-10-6-5-9-38(41)46)52-39-16-15-35(25-42(39)62(57,58)44(47,48)49)63(59,60)53-43-37-20-24-56(27-40(37)50-29-51-43)34-18-22-55(23-19-34)26-31-7-3-4-8-36(31)30-11-13-32(45)14-12-30/h3-16,25,29,33-34,52H,17-24,26-28H2,1-2H3,(H,50,51,53)/t33-/m1/s1",GEAINOWYJDLGLH-MGBGTMOVSA-N,1,0,0,0,BCL2-Like / BAX,7.49,cancer,Inhibition,
684,44237057,573787,24638021,CC[C@H](N)C(=O)N[C@H]1[C@@H](CNS(C)(=O)=O)CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7R,9aS)-6-[[(2S)-2-aminobutanoyl]amino]-N-benzhydryl-7-(methanesulfonamidomethyl)-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C29H39N5O5S/c1-3-23(30)27(35)33-26-21(18-31-40(2,38)39)14-15-22-16-17-24(34(22)29(26)37)28(36)32-25(19-10-6-4-7-11-19)20-12-8-5-9-13-20/h4-13,21-26,31H,3,14-18,30H2,1-2H3,(H,32,36)(H,33,35)/t21-,22+,23+,24+,26+/m1/s1",NBFJVEWYOWDDRD-VEGWMBEDSA-N,2,0,0,0,XIAP / Smac,6.44,cancer,Inhibition,
685,25026107,570418,24635083,CNc1nc(NCc2ccc(NC(=O)c3cccc(Cl)c3)cc2)c2ccccc2n1,3-chloro-N-[4-[[[2-(methylamino)quinazolin-4-yl]amino]methyl]phenyl]benzamide,"InChI=1S/C23H20ClN5O/c1-25-23-28-20-8-3-2-7-19(20)21(29-23)26-14-15-9-11-18(12-10-15)27-22(30)16-5-4-6-17(24)13-16/h2-13H,14H2,1H3,(H,27,30)(H2,25,26,28,29)",ITHDRVHVMMIWSS-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,5.56,cancer,Inhibition,
686,168318131,,19174417,CC(C)c1ccccc1Sc1ccc([C@@H]2C[C@H]2C(=O)NCC(O)=O)c(Cl)c1Cl,"2-[[2-[2,3-dichloro-4-(2-propan-2-ylphenyl)sulfanylphenyl]cyclopropanecarbonyl]amino]acetic acid","InChI=1S/C21H21Cl2NO3S/c1-11(2)12-5-3-4-6-16(12)28-17-8-7-13(19(22)20(17)23)14-9-15(14)21(27)24-10-18(25)26/h3-8,11,14-15H,9-10H2,1-2H3,(H,24,27)(H,25,26)/t14-,15+/m0/s1",BODOXPRBLCFXNR-LSDHHAIUSA-N,0,1,0,0,LFA / ICAM,7.92,immune system disease,Inhibition,
687,16109088,439495,17266502,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(CC1)S(=O)(=O)c1ccc(C)cc1,N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonyl-4-[4-(4-methylphenyl)sulfonylpiperazin-1-yl]benzamide,"InChI=1S/C36H42N6O7S3/c1-27-9-15-32(16-10-27)52(48,49)41-23-21-40(22-24-41)30-13-11-28(12-14-30)36(43)38-51(46,47)33-17-18-34(35(25-33)42(44)45)37-29(19-20-39(2)3)26-50-31-7-5-4-6-8-31/h4-18,25,29,37H,19-24,26H2,1-3H3,(H,38,43)/t29-/m1/s1",SVVXHOLCHCAPEW-GDLZYMKVSA-N,2,0,0,0,BCL2-Like / BAX,8.40,cancer,Inhibition,
688,44237040,,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CC[C@H](C)[C@H]1C(=O)Nc1cc(C)nn1-c1ccccc1,"(2S,3S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-3-methyl-N-(5-methyl-2-phenylpyrazol-3-yl)pyrrolidine-2-carboxamide","InChI=1S/C28H40N6O3/c1-18-15-16-33(28(37)24(21-11-7-5-8-12-21)31-26(35)20(3)29-4)25(18)27(36)30-23-17-19(2)32-34(23)22-13-9-6-10-14-22/h6,9-10,13-14,17-18,20-21,24-25,29H,5,7-8,11-12,15-16H2,1-4H3,(H,30,36)(H,31,35)/t18-,20-,24-,25-/m0/s1",IBBHIZXRMBKKII-IYNDAXALSA-N,1,0,0,0,XIAP / Smac,5.62,cancer,Inhibition,
689,59493270,,,C(Cc1c[nH]c2ccccc12)Nc1ccc(Nc2ccncc2)c2ccccc12,"1-N-[2-(1H-indol-3-yl)ethyl]-4-N-pyridin-4-ylnaphthalene-1,4-diamine","InChI=1S/C25H22N4/c1-2-7-22-21(6-1)24(9-10-25(22)29-19-12-14-26-15-13-19)27-16-11-18-17-28-23-8-4-3-5-20(18)23/h1-10,12-15,17,27-28H,11,16H2,(H,26,29)",KSAOWOZEVGCRBQ-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,6.00,cancer,Inhibition,
690,24801008,259034,23326308,Oc1c(O)c(cc(C(=O)c2cccc3ccccc23)c1O)C(=O)c1ccc(Oc2ccccc2)cc1,"(4-phenoxyphenyl)-[2,3,4-trihydroxy-5-(naphthalene-1-carbonyl)phenyl]methanone","InChI=1S/C30H20O6/c31-26(19-13-15-21(16-14-19)36-20-9-2-1-3-10-20)24-17-25(29(34)30(35)28(24)33)27(32)23-12-6-8-18-7-4-5-11-22(18)23/h1-17,33-35H",PZNPHSABNYIWKY-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,6.54,cancer,Inhibition,
691,44570088,481775,24700792,CCCCN(CCCC)C(=O)c1nn(c(C)c1Cl)-c1ccc(N)cc1C(=O)N1CCc2ccccc2C1,"1-[4-amino-2-(3,4-dihydro-1H-isoquinoline-2-carbonyl)phenyl]-N,N-dibutyl-4-chloro-5-methylpyrazole-3-carboxamide","InChI=1S/C29H36ClN5O2/c1-4-6-15-33(16-7-5-2)29(37)27-26(30)20(3)35(32-27)25-13-12-23(31)18-24(25)28(36)34-17-14-21-10-8-9-11-22(21)19-34/h8-13,18H,4-7,14-17,19,31H2,1-3H3",KDMKVTRXOWISMQ-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,7.05,cancer,Inhibition,
692,45138106,,,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2S(C)(=O)=O)c1c[nH]c2cc(F)ccc12)C(C)(C)C,"(2S)-N-[(2S)-1-[(3aR,6S,6aR)-6-(6-fluoro-1H-indol-3-yl)-4-methylsulfonyl-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]-2-(methylamino)propanamide","InChI=1S/C25H36FN5O4S/c1-14(27-5)23(32)29-22(25(2,3)4)24(33)30-10-9-20-21(30)18(13-31(20)36(6,34)35)17-12-28-19-11-15(26)7-8-16(17)19/h7-8,11-12,14,18,20-22,27-28H,9-10,13H2,1-6H3,(H,29,32)/t14-,18+,20+,21+,22+/m0/s1",WPSMOHXKEOMUKM-YRMMABQESA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
693,21906782,182693,10657292,CCCN1CCN(CC1)c1cc(ccn1)-c1ccc(Sc2ccc3OCCOc3c2)c(c1)C(F)(F)F,"1-[4-[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfanyl)-3-(trifluoromethyl)phenyl]pyridin-2-yl]-4-propylpiperazine","InChI=1S/C27H28F3N3O2S/c1-2-9-32-10-12-33(13-11-32)26-17-20(7-8-31-26)19-3-6-25(22(16-19)27(28,29)30)36-21-4-5-23-24(18-21)35-15-14-34-23/h3-8,16-18H,2,9-15H2,1H3",TXMYNHMEJQOXEL-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,6.13,immune system disease,Inhibition,
694,66616554,,,OCC(CO)NCc1ccc(cc1)C(=O)NCc1cccc(CN(Cc2ccc(cc2)-c2ccccc2)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)c1,,"InChI=1S/C38H37Cl2N3O6S/c39-33-18-35(40)37(46)36(19-33)50(48,49)43(22-27-11-13-31(14-12-27)30-7-2-1-3-8-30)23-29-6-4-5-28(17-29)21-42-38(47)32-15-9-26(10-16-32)20-41-34(24-44)25-45/h1-19,34,41,44-46H,20-25H2,(H,42,47)",SGIGHAHEKUKVMI-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,6.82,cancer,Inhibition,
695,44391961,182453,23248046,COc1ccccc1Sc1ccc(cc1C(F)(F)F)-c1ccnc(c1)N1CCC(CC1)C(N)=O,1-[4-[4-(2-methoxyphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyridin-2-yl]piperidine-4-carboxamide,"InChI=1S/C25H24F3N3O2S/c1-33-20-4-2-3-5-22(20)34-21-7-6-17(14-19(21)25(26,27)28)18-8-11-30-23(15-18)31-12-9-16(10-13-31)24(29)32/h2-8,11,14-16H,9-10,12-13H2,1H3,(H2,29,32)",QMCLITAQOBPTQP-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,6.85,immune system disease,Inhibition,
696,46883924,1093708,24677087,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1nc2c(cccc2s1)-c1cccc(Cl)c1,"(2S)-N-[(1S)-2-[(2R)-2-[4-(3-chlorophenyl)-1,3-benzothiazol-2-yl]pyrrolidin-1-yl]-1-cyclohexyl-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C29H35ClN4O2S/c1-18(31-2)27(35)32-25(19-9-4-3-5-10-19)29(36)34-16-8-14-23(34)28-33-26-22(13-7-15-24(26)37-28)20-11-6-12-21(30)17-20/h6-7,11-13,15,17-19,23,25,31H,3-5,8-10,14,16H2,1-2H3,(H,32,35)/t18-,23-,25-/m0/s1",DCNHHLAXABEHQZ-WYRQLCSISA-N,1,0,0,0,XIAP / Smac,7.26,cancer,Inhibition,
697,44570035,469305,24694504,CN(C(=O)c1cc(C)n(n1)-c1ccccc1C(=O)N1CCc2ccccc2C1)c1ccc(F)cc1,"1-[2-(3,4-dihydro-1H-isoquinoline-2-carbonyl)phenyl]-N-(4-fluorophenyl)-N,5-dimethylpyrazole-3-carboxamide","InChI=1S/C28H25FN4O2/c1-19-17-25(28(35)31(2)23-13-11-22(29)12-14-23)30-33(19)26-10-6-5-9-24(26)27(34)32-16-15-20-7-3-4-8-21(20)18-32/h3-14,17H,15-16,18H2,1-2H3",DRFJVMVOQRNXTR-UHFFFAOYSA-N,1,0,0,0,BCL2-Like / BAX,4.97,cancer,Inhibition,
698,46930628,1243385,26351954,CN[C@@H](C)C(=O)N[C@H]1CC[C@@H](O)C[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,9R,10aR)-N-benzhydryl-9-hydroxy-6-[[(2S)-2-(methylamino)propanoyl]amino]-5-oxo-2,3,6,7,8,9,10,10a-octahydro-1H-pyrrolo[1,2-a]azocine-3-carboxamide","InChI=1S/C28H36N4O4/c1-18(29-2)26(34)30-23-15-14-22(33)17-21-13-16-24(32(21)28(23)36)27(35)31-25(19-9-5-3-6-10-19)20-11-7-4-8-12-20/h3-12,18,21-25,29,33H,13-17H2,1-2H3,(H,30,34)(H,31,35)/t18-,21+,22+,23-,24-/m0/s1",YSWSPOWPCMUWGP-IZFXNUPESA-N,2,0,0,0,XIAP / Smac,6.49,cancer,Inhibition,
699,168318133,,26361840,C[C@@](O)(c1ccc(Cl)cc1)c1ccc(Cl)c(CCOc2ccc(cc2)-c2ccc(cc2)C(O)=O)c1,4-[4-[2-[2-chloro-5-[1-(4-chlorophenyl)-1-hydroxyethyl]phenyl]ethoxy]phenyl]benzoic acid,"InChI=1S/C29H24Cl2O4/c1-29(34,23-8-11-25(30)12-9-23)24-10-15-27(31)22(18-24)16-17-35-26-13-6-20(7-14-26)19-2-4-21(5-3-19)28(32)33/h2-15,18,34H,16-17H2,1H3,(H,32,33)/t29-/m1/s1",SNNAEGQGFRLGPM-GDLZYMKVSA-N,1,0,0,0,BCL2-Like / BAX,6.34,cancer,Inhibition,
700,168318127,,,CC[C@H](C)[C@@H](NC(N)=N)C(=O)NCC(=O)N[C@@H](Cc1ccc(cc1)C#Cc1ccccc1)C(=O)OC,"methyl (2S)-2-[[2-[[(2R,3R)-2-(diaminomethylideneamino)-3-methylpentanoyl]amino]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate","InChI=1S/C27H33N5O4/c1-4-18(2)24(32-27(28)29)25(34)30-17-23(33)31-22(26(35)36-3)16-21-14-12-20(13-15-21)11-10-19-8-6-5-7-9-19/h5-9,12-15,18,22,24H,4,16-17H2,1-3H3,(H,30,34)(H,31,33)(H4,28,29,32)/t18-,22-,24+/m0/s1",XGGOZVAZONWKNW-JKFKMHIGSA-N,1,0,0,0,IL2 / IL2R,4.59,immune system disease,Inhibition,
701,168318126,,17249022,CC(=O)NCCN1C(=O)c2ccccc2[C@]1(OCc1ccc(cc1)C(C)(C)C)c1ccccc1,N-[2-[1-[(4-tert-butylphenyl)methoxy]-3-oxo-1-phenylisoindol-2-yl]ethyl]acetamide,"InChI=1S/C29H32N2O3/c1-21(32)30-18-19-31-27(33)25-12-8-9-13-26(25)29(31,24-10-6-5-7-11-24)34-20-22-14-16-23(17-15-22)28(2,3)4/h5-17H,18-20H2,1-4H3,(H,30,32)/t29-/m1/s1",BTICYABAFSUXAA-GDLZYMKVSA-N,2,0,0,0,MDM2-Like / P53,4.85,cancer,Inhibition,
702,87251475,,,CN(C)CC[C@H](CSc1ccc(Cl)c(Cl)c1)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1,,"InChI=1S/C44H47Cl3F3N7O4S3/c1-55(2)19-15-32(27-62-34-11-13-38(46)39(47)23-34)53-40-14-12-35(24-42(40)63(58,59)44(48,49)50)64(60,61)54-43-37-18-22-57(26-41(37)51-28-52-43)33-16-20-56(21-17-33)25-30-5-3-4-6-36(30)29-7-9-31(45)10-8-29/h3-14,23-24,28,32-33,53H,15-22,25-27H2,1-2H3,(H,51,52,54)/t32-/m1/s1",VWZNNBQJFJTWMV-JGCGQSQUSA-N,1,0,0,0,BCL2-Like / BAX,7.39,cancer,Inhibition,
703,168318130,,24611820,C[C@H](NC(=O)c1c(O)c(O)cc2c(O)c(c(C)cc12)-c1c(C)cc2c(C(=O)N[C@@H](C)c3ccc(Cl)cc3)c(O)c(O)cc2c1O)c1ccc(Cl)cc1,"N-[1-(4-chlorophenyl)ethyl]-6-[5-[1-(4-chlorophenyl)ethylcarbamoyl]-1,6,7-trihydroxy-3-methylnaphthalen-2-yl]-2,3,5-trihydroxy-7-methylnaphthalene-1-carboxamide","InChI=1S/C40H34Cl2N2O8/c1-17-13-25-27(15-29(45)37(49)33(25)39(51)43-19(3)21-5-9-23(41)10-6-21)35(47)31(17)32-18(2)14-26-28(36(32)48)16-30(46)38(50)34(26)40(52)44-20(4)22-7-11-24(42)12-8-22/h5-16,19-20,45-50H,1-4H3,(H,43,51)(H,44,52)/t19-,20-/m0/s1",GWXWVWQUYKMTOZ-PMACEKPBSA-N,4,0,0,0,BCL2-Like / BAX,6.64,cancer,Inhibition,
704,506229,495032,442060,Cc1cccc2c(c[nH]c12)C(=O)C(=O)N1CCN(CC1)C(=O)c1ccccc1,"1-(4-benzoylpiperazin-1-yl)-2-(7-methyl-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C22H21N3O3/c1-15-6-5-9-17-18(14-23-19(15)17)20(26)22(28)25-12-10-24(11-13-25)21(27)16-7-3-2-4-8-16/h2-9,14,23H,10-13H2,1H3",GFGMHHHSHWSIIJ-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,7.05,HIV infectious disease,Inhibition,
705,168318128,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(C)(C)C)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(CC2=C(CC(C)(C)CC2)c2ccc(Cl)cc2)CC1,,"InChI=1S/C49H66ClN7O4S3/c1-48(2,3)63(58,59)46-29-41(17-18-44(46)53-38(20-25-55(6)7)33-62-40-11-9-8-10-12-40)64(60,61)54-47-42-23-28-57(32-45(42)51-34-52-47)39-21-26-56(27-22-39)31-36-19-24-49(4,5)30-43(36)35-13-15-37(50)16-14-35/h8-18,29,34,38-39,53H,19-28,30-33H2,1-7H3,(H,51,52,54)/t38-/m1/s1",QFZPSPVEMUQYCP-KXQOOQHDSA-N,1,0,0,0,BCL2-Like / BAX,7.66,cancer,Inhibition,
706,25000117,,,CC(=O)N1[C@H](CC(C)(C)C)[C@@]2([C@H]([C@@H]1C(=O)NCC[C@H](O)CO)c1ccc(F)c(Cl)c1)C(=O)Nc1cc(Cl)c(F)cc21,"(2'R,3S,3'R,5'R)-1'-acetyl-6-chloro-3'-(3-chloro-4-fluorophenyl)-N-[(3S)-3,4-dihydroxybutyl]-5'-(2,2-dimethylpropyl)-5-fluoro-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide","InChI=1S/C29H33Cl2F2N3O5/c1-14(38)36-23(12-28(2,3)4)29(17-10-21(33)19(31)11-22(17)35-27(29)41)24(15-5-6-20(32)18(30)9-15)25(36)26(40)34-8-7-16(39)13-37/h5-6,9-11,16,23-25,37,39H,7-8,12-13H2,1-4H3,(H,34,40)(H,35,41)/t16-,23+,24-,25+,29-/m0/s1",UEVULXUOMVMHDC-CWEXNXMASA-N,1,3,0,0,MDM2-Like / P53,5.49,cancer,Inhibition,
707,67954070,,,NC(=O)Cc1ccc(Cl)cc1-n1c(cc(C(O)=O)c1-c1cccc(Cl)c1)-c1ccccc1,,"InChI=1S/C25H18Cl2N2O3/c26-18-8-4-7-17(11-18)24-20(25(31)32)14-22(15-5-2-1-3-6-15)29(24)21-13-19(27)10-9-16(21)12-23(28)30/h1-11,13-14H,12H2,(H2,28,30)(H,31,32)",OIKVPCXKSBXAOW-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,6.77,cancer,Inhibition,
708,53321871,1644114,26377628,CC(=O)n1cc(C(=O)NC[C@H](NC(=O)c2c(Cl)cc3CN(CCc3c2Cl)C(=O)c2ccc(Cl)cc2)C(O)=O)c2ccccc12,"(2S)-3-[(1-acetylindole-3-carbonyl)amino]-2-[[5,7-dichloro-2-(4-chlorobenzoyl)-3,4-dihydro-1H-isoquinoline-6-carbonyl]amino]propanoic acid","InChI=1S/C31H25Cl3N4O6/c1-16(39)38-15-22(21-4-2-3-5-25(21)38)28(40)35-13-24(31(43)44)36-29(41)26-23(33)12-18-14-37(11-10-20(18)27(26)34)30(42)17-6-8-19(32)9-7-17/h2-9,12,15,24H,10-11,13-14H2,1H3,(H,35,40)(H,36,41)(H,43,44)/t24-/m0/s1",LFXWWGSRHLWXMM-DEOSSOPVSA-N,1,0,0,0,LFA / ICAM,6.09,immune system disease,Inhibition,
709,59555728,,,OCc1cc(Nc2ccc(NCCc3c[nH]c4ccccc34)cc2)cc(CO)n1,[6-(hydroxymethyl)-4-[4-[2-(1H-indol-3-yl)ethylamino]anilino]pyridin-2-yl]methanol,"InChI=1S/C23H24N4O2/c28-14-20-11-19(12-21(15-29)27-20)26-18-7-5-17(6-8-18)24-10-9-16-13-25-23-4-2-1-3-22(16)23/h1-8,11-13,24-25,28-29H,9-10,14-15H2,(H,26,27)",OHXIQWQDHUUGDR-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,6.00,cancer,Inhibition,
710,59555779,,,CCOc1cc(Nc2ccncc2)ccc1NCCc1c[nH]c2cc(OC)ccc12,"2-ethoxy-1-N-[2-(6-methoxy-1H-indol-3-yl)ethyl]-4-N-pyridin-4-ylbenzene-1,4-diamine","InChI=1S/C24H26N4O2/c1-3-30-24-14-19(28-18-9-11-25-12-10-18)4-7-22(24)26-13-8-17-16-27-23-15-20(29-2)5-6-21(17)23/h4-7,9-12,14-16,26-27H,3,8,13H2,1-2H3,(H,25,28)",AMTUIFTVVYRCSB-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,7.30,cancer,Inhibition,
711,44550015,,,COc1c(C)ccc2O[C@@H](C3=C(N(C)c4ncnn4[C@H]3c3ccc(Br)cc3)c12)c1ccc(Br)cc1,,"InChI=1S/C27H22Br2N4O2/c1-15-4-13-20-21(25(15)34-3)24-22(26(35-20)17-7-11-19(29)12-8-17)23(16-5-9-18(28)10-6-16)33-27(32(24)2)30-14-31-33/h4-14,23,26H,1-3H3/t23-,26+/m0/s1",AKTJUOGFAHNFEA-JYFHCDHNSA-N,1,0,0,0,MDM2-Like / P53,5.40,cancer,Inhibition,
712,59555802,,,CCOc1cc(Nc2ccnc(COCCOC)c2)ccc1NCCc1c[nH]c2cc(OC)ccc12,"2-ethoxy-4-N-[2-(2-methoxyethoxymethyl)pyridin-4-yl]-1-N-[2-(6-methoxy-1H-indol-3-yl)ethyl]benzene-1,4-diamine","InChI=1S/C28H34N4O4/c1-4-36-28-16-21(32-22-10-12-29-23(15-22)19-35-14-13-33-2)5-8-26(28)30-11-9-20-18-31-27-17-24(34-3)6-7-25(20)27/h5-8,10,12,15-18,30-31H,4,9,11,13-14,19H2,1-3H3,(H,29,32)",VMNAXQMLIXMEIT-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,5.52,cancer,Inhibition,
713,25138070,481421,24700385,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@H](N2C1=O)C(=O)N[C@H]1CCCc2ccccc12,"(3S,6S,10aS)-6-[[(2S)-2-(methylamino)propanoyl]amino]-5-oxo-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-2,3,6,7,8,9,10,10a-octahydro-1H-pyrrolo[1,2-a]azocine-3-carboxamide","InChI=1S/C25H36N4O3/c1-16(26-2)23(30)28-21-12-6-4-10-18-14-15-22(29(18)25(21)32)24(31)27-20-13-7-9-17-8-3-5-11-19(17)20/h3,5,8,11,16,18,20-22,26H,4,6-7,9-10,12-15H2,1-2H3,(H,27,31)(H,28,30)/t16-,18-,20-,21-,22-/m0/s1",IPIIAWQBJWTGKF-CPNAEOBWSA-N,2,1,0,0,XIAP / Smac,6.68,cancer,Inhibition,
714,88540245,,,CCN1CCN(CC[C@H](CSc2ccccc2)Nc2ccc(cc2S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc2ncnc3CN(CCc23)C2CCN(Cc3ccccc3-c3ccc(Cl)cc3)CC2)CC1,,"InChI=1S/C48H56ClF3N8O4S3/c1-2-57-26-28-58(29-27-57)22-18-38(33-65-40-9-4-3-5-10-40)55-44-17-16-41(30-46(44)66(61,62)48(50,51)52)67(63,64)56-47-43-21-25-60(32-45(43)53-34-54-47)39-19-23-59(24-20-39)31-36-8-6-7-11-42(36)35-12-14-37(49)15-13-35/h3-17,30,34,38-39,55H,2,18-29,31-33H2,1H3,(H,53,54,56)/t38-/m1/s1",PKUWTSLEHNOKOL-KXQOOQHDSA-N,1,0,0,0,BCL2-Like / BAX,7.29,cancer,Inhibition,
715,45139135,,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2C(=O)OCc1ccccc1)c1c[nH]c2cc(F)ccc12,"benzyl (3aR,6S,6aR)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-6-(6-fluoro-1H-indol-3-yl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrole-4-carboxylate","InChI=1S/C34H42FN5O4/c1-21(36-2)32(41)38-30(23-11-7-4-8-12-23)33(42)39-16-15-29-31(39)27(26-18-37-28-17-24(35)13-14-25(26)28)19-40(29)34(43)44-20-22-9-5-3-6-10-22/h3,5-6,9-10,13-14,17-18,21,23,27,29-31,36-37H,4,7-8,11-12,15-16,19-20H2,1-2H3,(H,38,41)/t21-,27+,29+,30-,31+/m0/s1",ZTOGCFIFXCXPFV-USSLBTQDSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
716,168318123,,,CS(=O)(=O)c1ccc(s1)C(=O)NC[C@H](NC(=O)c1c(Cl)cc2CN(CCc2c1Cl)C(=O)c1ccc2ccoc2c1)C(O)=O,,"InChI=1S/C28H23Cl2N3O8S2/c1-43(39,40)22-5-4-21(42-22)25(34)31-12-19(28(37)38)32-26(35)23-18(29)10-16-13-33(8-6-17(16)24(23)30)27(36)15-3-2-14-7-9-41-20(14)11-15/h2-5,7,9-11,19H,6,8,12-13H2,1H3,(H,31,34)(H,32,35)(H,37,38)/t19-/m0/s1",SPVAWNXXAZCMRO-IBGZPJMESA-N,1,0,0,0,LFA / ICAM,6.82,immune system disease,Inhibition,
717,44391959,360487,23248044,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1coc(n1)N1CCOCC1,"4-[4-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]-1,3-oxazol-2-yl]morpholine","InChI=1S/C23H23F3N2O2S/c1-15(2)17-5-3-4-6-20(17)31-21-8-7-16(13-18(21)23(24,25)26)19-14-30-22(27-19)28-9-11-29-12-10-28/h3-8,13-15H,9-12H2,1-2H3",WAVYANGFMBDWEP-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,5.44,immune system disease,Inhibition,
718,44580068,487291,24704544,FC(F)(F)c1c(Sc2cccc(OCc3ccccc3)c2)ccc(\C=C\C(=O)N2CCOCC2)c1C(F)(F)F,"(E)-1-morpholin-4-yl-3-[4-(3-phenylmethoxyphenyl)sulfanyl-2,3-bis(trifluoromethyl)phenyl]prop-2-en-1-one","InChI=1S/C28H23F6NO3S/c29-27(30,31)25-20(10-12-24(36)35-13-15-37-16-14-35)9-11-23(26(25)28(32,33)34)39-22-8-4-7-21(17-22)38-18-19-5-2-1-3-6-19/h1-12,17H,13-16,18H2/b12-10+",UDJIFGWLUPATRA-ZRDIBKRKSA-N,1,0,0,0,LFA / ICAM,6.66,immune system disease,Inhibition,
719,44580239,501166,24711603,FC(F)(F)c1c(Sc2cccc(OCc3cccnc3)c2)ccc(\C=C\C(=O)N2CCOCC2)c1C(F)(F)F,"(E)-1-morpholin-4-yl-3-[4-[3-(pyridin-3-ylmethoxy)phenyl]sulfanyl-2,3-bis(trifluoromethyl)phenyl]prop-2-en-1-one","InChI=1S/C27H22F6N2O3S/c28-26(29,30)24-19(7-9-23(36)35-11-13-37-14-12-35)6-8-22(25(24)27(31,32)33)39-21-5-1-4-20(15-21)38-17-18-3-2-10-34-16-18/h1-10,15-16H,11-14,17H2/b9-7+",BMLUKZUMDLIBNN-VQHVLOKHSA-N,1,0,0,0,LFA / ICAM,7.16,immune system disease,Inhibition,
720,67954139,,,Cc1cccc(n1)-c1nc(C(O)=O)c(-c2cccc(Cl)c2)n1-c1cccc(Cl)c1F,,"InChI=1S/C22H14Cl2FN3O2/c1-12-5-2-9-16(26-12)21-27-19(22(29)30)20(13-6-3-7-14(23)11-13)28(21)17-10-4-8-15(24)18(17)25/h2-11H,1H3,(H,29,30)",CFJZRYBEGOAQIE-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,7.07,cancer,Inhibition,
721,59555649,,,Cc1cc(Nc2ccc(NCCc3c[nH]c4ccccc34)cc2)ccn1,"1-N-[2-(1H-indol-3-yl)ethyl]-4-N-(2-methylpyridin-4-yl)benzene-1,4-diamine","InChI=1S/C22H22N4/c1-16-14-20(11-13-23-16)26-19-8-6-18(7-9-19)24-12-10-17-15-25-22-5-3-2-4-21(17)22/h2-9,11,13-15,24-25H,10,12H2,1H3,(H,23,26)",KLTUCMIFQDYVOZ-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,6.60,cancer,Inhibition,
722,168318122,,,COc1cc(Nc2ccncc2)ccc1NCCc1c[nH]c2ccc(C)cc12,,"InChI=1S/C23H24N4O/c1-16-3-5-21-20(13-16)17(15-26-21)7-12-25-22-6-4-19(14-23(22)28-2)27-18-8-10-24-11-9-18/h3-6,8-11,13-15,25-26H,7,12H2,1-2H3,(H,24,27)",ZTPHZGFQLSBOHQ-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,5.70,cancer,Inhibition,
723,9984227,,8159817,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(cc2)C(=O)N2CCOCC2)c1=O,"6-methyl-2-[4-(morpholine-4-carbonyl)phenyl]-4-[3-(trifluoromethyl)phenyl]-1H-dipyrazolo[4,3-b:4',5'-e]pyridin-3-one","InChI=1S/C26H21F3N6O3/c1-33-23-19(14-30-33)22-20(21(31-23)16-3-2-4-17(13-16)26(27,28)29)25(37)35(32-22)18-7-5-15(6-8-18)24(36)34-9-11-38-12-10-34/h2-8,13-14,32H,9-12H2,1H3",GZWJKFIWMROKEB-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.89,cancer,Inhibition,
724,44595107,,,Oc1c(Cl)cc(Cl)cc1S(=O)(=O)N(Cc1ccc(F)cc1)Cc1cccc(CN(Cc2ccc(F)cc2)S(=O)(=O)c2cc(Cl)cc(Cl)c2)n1,"3,5-dichloro-N-[[6-[[(3,5-dichlorophenyl)sulfonyl-[(4-fluorophenyl)methyl]amino]methyl]pyridin-2-yl]methyl]-N-[(4-fluorophenyl)methyl]-2-hydroxybenzenesulfonamide","InChI=1S/C33H25Cl4F2N3O5S2/c34-23-12-24(35)14-30(13-23)48(44,45)41(17-21-4-8-26(38)9-5-21)19-28-2-1-3-29(40-28)20-42(18-22-6-10-27(39)11-7-22)49(46,47)32-16-25(36)15-31(37)33(32)43/h1-16,43H,17-20H2",LBKDIDGLWUKWLL-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,7.38,cancer,Inhibition,
725,11200722,426052,9375791,CC(C)[C@H](NC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(=O)NCc1ccccc1,(2S)-1-[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-3-methylbutanoyl]-N-benzylpyrrolidine-2-carboxamide,"InChI=1S/C20H30N4O3/c1-13(2)17(23-18(25)14(3)21)20(27)24-11-7-10-16(24)19(26)22-12-15-8-5-4-6-9-15/h4-6,8-9,13-14,16-17H,7,10-12,21H2,1-3H3,(H,22,26)(H,23,25)/t14-,16-,17-/m0/s1",RFCQRRDVLMEWMG-XIRDDKMYSA-N,2,0,0,0,XIAP / Smac,6.54,cancer,Inhibition,
726,57737540,,,C(Cc1c[nH]c2sccc12)Nc1ccc(Nc2ccncc2)cc1,"4-N-pyridin-4-yl-1-N-[2-(6H-thieno[2,3-b]pyrrol-4-yl)ethyl]benzene-1,4-diamine","InChI=1S/C19H18N4S/c1-3-16(23-17-6-9-20-10-7-17)4-2-15(1)21-11-5-14-13-22-19-18(14)8-12-24-19/h1-4,6-10,12-13,21-22H,5,11H2,(H,20,23)",INDIHWFDTZYZKE-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,5.00,cancer,Inhibition,
727,59555700,,,Clc1cc(Nc2ccc(NCCc3c[nH]c4ccccc34)cc2)ccn1,"4-N-(2-chloropyridin-4-yl)-1-N-[2-(1H-indol-3-yl)ethyl]benzene-1,4-diamine","InChI=1S/C21H19ClN4/c22-21-13-18(10-12-24-21)26-17-7-5-16(6-8-17)23-11-9-15-14-25-20-4-2-1-3-19(15)20/h1-8,10,12-14,23,25H,9,11H2,(H,24,26)",UDYLHLAYFIWHCI-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,5.40,cancer,Inhibition,
728,25025911,582809,24641078,CNc1nc(NCc2ccc(NC(=O)c3ccc(cc3)-c3ccccc3)cc2)c2ccccc2n1,N-[4-[[[2-(methylamino)quinazolin-4-yl]amino]methyl]phenyl]-4-phenylbenzamide,"InChI=1S/C29H25N5O/c1-30-29-33-26-10-6-5-9-25(26)27(34-29)31-19-20-11-17-24(18-12-20)32-28(35)23-15-13-22(14-16-23)21-7-3-2-4-8-21/h2-18H,19H2,1H3,(H,32,35)(H2,30,31,33,34)",CICSICZXJDAQLA-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,6.03,cancer,Inhibition,
729,42601767,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCC(CC1)NCc1ccccc1-c1ccc(Cl)cc1,4-[4-[[2-(4-chlorophenyl)phenyl]methylamino]piperidin-1-yl]-N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonylbenzamide,"InChI=1S/C43H47ClN6O5S2/c1-48(2)25-22-36(30-56-38-9-4-3-5-10-38)46-41-21-20-39(28-42(41)50(52)53)57(54,55)47-43(51)32-14-18-37(19-15-32)49-26-23-35(24-27-49)45-29-33-8-6-7-11-40(33)31-12-16-34(44)17-13-31/h3-21,28,35-36,45-46H,22-27,29-30H2,1-2H3,(H,47,51)/t36-/m1/s1",YWIYSRYEKZHYEZ-PSXMRANNSA-N,1,0,0,0,BCL2-Like / BAX,5.30,cancer,Inhibition,
730,168318121,,24635411,CNC(=O)c1ccc(O[C@H](C)C(=O)N2CCN(C[C@H]2C)C(=O)c2ccccc2)cc1OC,4-[1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-1-oxopropan-2-yl]oxy-2-methoxy-N-methylbenzamide,"InChI=1S/C24H29N3O5/c1-16-15-26(24(30)18-8-6-5-7-9-18)12-13-27(16)23(29)17(2)32-19-10-11-20(22(28)25-3)21(14-19)31-4/h5-11,14,16-17H,12-13,15H2,1-4H3,(H,25,28)/t16-,17-/m1/s1",ZBKQANPUWYCEKU-IAGOWNOFSA-N,0,1,0,0,CD4 / gp120,5.57,HIV infectious disease,Inhibition,
731,921795,1230532,804714,OC(=O)Cc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O,2-(6-chloro-2-oxo-4-phenyl-1H-quinolin-3-yl)acetic acid,"InChI=1S/C17H12ClNO3/c18-11-6-7-14-12(8-11)16(10-4-2-1-3-5-10)13(9-15(20)21)17(22)19-14/h1-8H,9H2,(H,19,22)(H,20,21)",SHDUUQWYFNJIAG-UHFFFAOYSA-N,2,0,0,0,LEDGF / IN,4.93,HIV infectious disease,Inhibition,
732,168318120,,,COc1cccc(c1)[C@@H]1C2=C(N=c3s\c(=C/c4ccc(o4)-c4cc(ccc4C)C(O)=O)c(=O)n13)c1ccccc1CC2,,"InChI=1S/C34H26N2O5S/c1-19-10-11-22(33(38)39)17-27(19)28-15-13-24(41-28)18-29-32(37)36-31(21-7-5-8-23(16-21)40-2)26-14-12-20-6-3-4-9-25(20)30(26)35-34(36)42-29/h3-11,13,15-18,31H,12,14H2,1-2H3,(H,38,39)/b29-18-/t31-/m1/s1",YNDUUEXNTXGYTF-IMUCPKNRSA-N,3,0,0,0,BCL2-Like / BAX,5.14,cancer,Inhibition,
733,44549357,,,CN1c2ncnn2[C@H](C2=C1c1ccccc1O[C@@H]2c1ccc(F)cc1)c1ccc(F)cc1,,"InChI=1S/C25H18F2N4O/c1-30-23-19-4-2-3-5-20(19)32-24(16-8-12-18(27)13-9-16)21(23)22(31-25(30)28-14-29-31)15-6-10-17(26)11-7-15/h2-14,22,24H,1H3/t22-,24+/m0/s1",MMTJTCFRHQSHBS-LADGPHEKSA-N,1,0,0,0,MDM2-Like / P53,4.83,cancer,Inhibition,
734,88540488,,,FC(F)(F)S(=O)(=O)c1cc(ccc1N[C@H](CCN1CCOCC1)CSc1ccccc1)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1,,"InChI=1S/C46H51ClF3N7O5S3/c47-35-12-10-33(11-13-35)40-9-5-4-6-34(40)29-56-21-17-37(18-22-56)57-23-19-41-43(30-57)51-32-52-45(41)54-65(60,61)39-14-15-42(44(28-39)64(58,59)46(48,49)50)53-36(16-20-55-24-26-62-27-25-55)31-63-38-7-2-1-3-8-38/h1-15,28,32,36-37,53H,16-27,29-31H2,(H,51,52,54)/t36-/m1/s1",JDBVJFFIOIPKTL-PSXMRANNSA-N,1,0,0,0,BCL2-Like / BAX,6.84,cancer,Inhibition,
735,45137490,,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2C(=O)OC)c1c[nH]c2cc(F)ccc12,"methyl (3aR,6S,6aR)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-6-(6-fluoro-1H-indol-3-yl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrole-4-carboxylate","InChI=1S/C28H38FN5O4/c1-16(30-2)26(35)32-24(17-7-5-4-6-8-17)27(36)33-12-11-23-25(33)21(15-34(23)28(37)38-3)20-14-31-22-13-18(29)9-10-19(20)22/h9-10,13-14,16-17,21,23-25,30-31H,4-8,11-12,15H2,1-3H3,(H,32,35)/t16-,21+,23+,24-,25+/m0/s1",VFUZJGRZTJUNID-STRHDHNLSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
736,168318118,,19174440,FC(F)(F)c1cc(ccc1Sc1ccccc1N1CCCC1)[C@@H]1C[C@H]1C(=O)NCCCN1CCCC1=O,N-[3-(2-oxopyrrolidin-1-yl)propyl]-2-[4-(2-pyrrolidin-1-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]cyclopropane-1-carboxamide,"InChI=1S/C28H32F3N3O2S/c29-28(30,31)22-17-19(20-18-21(20)27(36)32-12-6-16-34-15-5-9-26(34)35)10-11-24(22)37-25-8-2-1-7-23(25)33-13-3-4-14-33/h1-2,7-8,10-11,17,20-21H,3-6,9,12-16,18H2,(H,32,36)/t20-,21+/m0/s1",GVXLMTNNCFPRBM-LEWJYISDSA-N,0,1,0,0,LFA / ICAM,7.49,immune system disease,Inhibition,
737,44390661,180335,23246683,Cc1ccc(cc1)[C@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)Nc2ccc(I)cc2C1=O)C(O)=O,"2-[3-(4-chlorophenyl)-7-iodo-2,5-dioxo-1,3-dihydro-1,4-benzodiazepin-4-yl]-2-(4-methylphenyl)acetic acid","InChI=1S/C24H18ClIN2O4/c1-13-2-4-15(5-3-13)21(24(31)32)28-20(14-6-8-16(25)9-7-14)22(29)27-19-11-10-17(26)12-18(19)23(28)30/h2-12,20-21H,1H3,(H,27,29)(H,31,32)/t20-,21-/m0/s1",RANJWJKEEMFTKN-SFTDATJTSA-N,1,0,0,0,MDM2-Like / P53,5.80,cancer,Inhibition,
738,11527635,376055,9702421,CN(CCCc1ccccc1)S(=O)(=O)c1cc(C(=O)N2CCc3ccc(cc3C2)S(=O)(=O)NCCc2ccccc2)c(O)c(O)c1O,"N-(2-phenylethyl)-2-[2,3,4-trihydroxy-5-[methyl(3-phenylpropyl)sulfamoyl]benzoyl]-3,4-dihydro-1H-isoquinoline-7-sulfonamide","InChI=1S/C34H37N3O8S2/c1-36(19-8-13-24-9-4-2-5-10-24)47(44,45)30-22-29(31(38)33(40)32(30)39)34(41)37-20-17-26-14-15-28(21-27(26)23-37)46(42,43)35-18-16-25-11-6-3-7-12-25/h2-7,9-12,14-15,21-22,35,38-40H,8,13,16-20,23H2,1H3",MSGQUTXPOGRULO-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,7.41,cancer,Inhibition,
739,44392031,180907,23248104,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1ccnc(c1)N1CC[C@H](C1)N(C)C(C)=O,N-methyl-N-[1-[4-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyridin-2-yl]pyrrolidin-3-yl]acetamide,"InChI=1S/C28H30F3N3OS/c1-18(2)23-7-5-6-8-25(23)36-26-10-9-20(15-24(26)28(29,30)31)21-11-13-32-27(16-21)34-14-12-22(17-34)33(4)19(3)35/h5-11,13,15-16,18,22H,12,14,17H2,1-4H3/t22-/m1/s1",UOPLAJAFYJNCFL-JOCHJYFZSA-N,0,1,0,0,LFA / ICAM,6.95,immune system disease,Inhibition,
740,59555598,,,C(CCc1ccccc1)CNCc1cc(Nc2ccc(NCCc3c[nH]c4ccccc34)cc2)ccn1,"1-N-[2-(1H-indol-3-yl)ethyl]-4-N-[2-[(4-phenylbutylamino)methyl]pyridin-4-yl]benzene-1,4-diamine","InChI=1S/C32H35N5/c1-2-8-25(9-3-1)10-6-7-19-33-24-30-22-29(18-21-35-30)37-28-15-13-27(14-16-28)34-20-17-26-23-36-32-12-5-4-11-31(26)32/h1-5,8-9,11-16,18,21-23,33-34,36H,6-7,10,17,19-20,24H2,(H,35,37)",NWDOHPQSIWTMCX-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,6.52,cancer,Inhibition,
741,168318117,,,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(F)c(c2)C(O)=O)c1=O,,"InChI=1S/C22H13F4N5O3/c1-30-19-14(9-27-30)18-16(17(28-19)10-3-2-4-11(7-10)22(24,25)26)20(32)31(29-18)12-5-6-15(23)13(8-12)21(33)34/h2-9,29H,1H3,(H,33,34)",SGCJAUAHBKBIMH-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.15,cancer,Inhibition,
742,11571200,208562,9745970,C[C@@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)N(CCCN2CCN(C)CC2)c2ccc(I)cc2C1=O)c1ccc(Cl)cc1N,"4-[1-(2-amino-4-chlorophenyl)ethyl]-3-(4-chlorophenyl)-7-iodo-1-[3-(4-methylpiperazin-1-yl)propyl]-3H-1,4-benzodiazepine-2,5-dione","InChI=1S/C31H34Cl2IN5O2/c1-20(25-10-8-23(33)18-27(25)35)39-29(21-4-6-22(32)7-5-21)31(41)38(13-3-12-37-16-14-36(2)15-17-37)28-11-9-24(34)19-26(28)30(39)40/h4-11,18-20,29H,3,12-17,35H2,1-2H3/t20-,29+/m1/s1",NUKCQDDVORQLDB-OLILMLBXSA-N,1,0,0,0,MDM2-Like / P53,6.26,cancer,Inhibition,
743,46175993,,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1cc2nc(C)nc(-c3ccccc3)c2[nH]1,"(2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-(2-methyl-4-phenyl-5H-pyrrolo[3,2-d]pyrimidin-6-yl)pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C29H38N6O2/c1-18(30-3)28(36)34-26(21-13-8-5-9-14-21)29(37)35-16-10-15-24(35)22-17-23-27(33-22)25(32-19(2)31-23)20-11-6-4-7-12-20/h4,6-7,11-12,17-18,21,24,26,30,33H,5,8-10,13-16H2,1-3H3,(H,34,36)/t18-,24-,26-/m0/s1",ZVPVIPFQUZCXOZ-SQOVJYTMSA-N,2,0,0,0,XIAP / Smac,7.04,cancer,Inhibition,
744,44570092,450954,24687955,CCCCN(CCCC)C(=O)c1nn(c(C)c1Cl)-c1ccc(NS(=O)(=O)Cc2ccccc2)cc1C(=O)N1CCc2ccccc2C1,"1-[4-(benzylsulfonylamino)-2-(3,4-dihydro-1H-isoquinoline-2-carbonyl)phenyl]-N,N-dibutyl-4-chloro-5-methylpyrazole-3-carboxamide","InChI=1S/C36H42ClN5O4S/c1-4-6-20-40(21-7-5-2)36(44)34-33(37)26(3)42(38-34)32-18-17-30(39-47(45,46)25-27-13-9-8-10-14-27)23-31(32)35(43)41-22-19-28-15-11-12-16-29(28)24-41/h8-18,23,39H,4-7,19-22,24-25H2,1-3H3",TXYIKRKYZPDTCU-UHFFFAOYSA-N,1,0,0,0,BCL2-Like / BAX,6.60,cancer,Inhibition,
745,44579258,491402,24705471,FC(F)(F)c1c(Sc2cccc(NC3CCNCC3)c2)ccc(\C=C\C(=O)N2CCOCC2)c1C(F)(F)F,"(E)-1-morpholin-4-yl-3-[4-[3-(piperidin-4-ylamino)phenyl]sulfanyl-2,3-bis(trifluoromethyl)phenyl]prop-2-en-1-one","InChI=1S/C26H27F6N3O2S/c27-25(28,29)23-17(5-7-22(36)35-12-14-37-15-13-35)4-6-21(24(23)26(30,31)32)38-20-3-1-2-19(16-20)34-18-8-10-33-11-9-18/h1-7,16,18,33-34H,8-15H2/b7-5+",BAHKPHNZYOKPQK-FNORWQNLSA-N,1,0,0,0,LFA / ICAM,8.85,immune system disease,Inhibition,
746,168317854,,24633691,C[C@@H](Oc1cccc(Cl)c1)C(=O)N1CCN(C[C@H]1C)C(=O)c1ccccc1,1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-(3-chlorophenoxy)propan-1-one,"InChI=1S/C21H23ClN2O3/c1-15-14-23(21(26)17-7-4-3-5-8-17)11-12-24(15)20(25)16(2)27-19-10-6-9-18(22)13-19/h3-10,13,15-16H,11-12,14H2,1-2H3/t15-,16-/m1/s1",NAUPLVVOKAWHQB-HZPDHXFCSA-N,0,1,0,0,CD4 / gp120,6.00,HIV infectious disease,Inhibition,
747,59774773,,,FC(F)(F)c1ccccc1[C@H]1NCC[C@@H](c2cccc(Cl)c2)[C@]11C(=O)Nc2cc(Cl)ccc12,"(2'R,3R,4'S)-6-chloro-4'-(3-chlorophenyl)-2'-[2-(trifluoromethyl)phenyl]spiro[1H-indole-3,3'-piperidine]-2-one","InChI=1S/C25H19Cl2F3N2O/c26-15-5-3-4-14(12-15)18-10-11-31-22(17-6-1-2-7-19(17)25(28,29)30)24(18)20-9-8-16(27)13-21(20)32-23(24)33/h1-9,12-13,18,22,31H,10-11H2,(H,32,33)/t18-,22+,24+/m0/s1",KNORKOUJZZOPMZ-KUWBRRTOSA-N,1,0,0,0,MDM2-Like / P53,5.16,cancer,Inhibition,
748,25026713,569682,24633145,CN(C)c1nc(NCc2ccc(NC(=O)c3ccc(F)cc3)cc2)c2ccc(I)cc2n1,N-[4-[[[2-(dimethylamino)-7-iodoquinazolin-4-yl]amino]methyl]phenyl]-4-fluorobenzamide,"InChI=1S/C24H21FIN5O/c1-31(2)24-29-21-13-18(26)9-12-20(21)22(30-24)27-14-15-3-10-19(11-4-15)28-23(32)16-5-7-17(25)8-6-16/h3-13H,14H2,1-2H3,(H,28,32)(H,27,29,30)",ZXEOPBBDKXMHKM-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,5.38,cancer,Inhibition,
749,59555756,,,Brc1ccc2c(CCNc3ccc(Nc4ccncc4)cc3)c[nH]c2c1,"1-N-[2-(6-bromo-1H-indol-3-yl)ethyl]-4-N-pyridin-4-ylbenzene-1,4-diamine","InChI=1S/C21H19BrN4/c22-16-1-6-20-15(14-25-21(20)13-16)7-12-24-17-2-4-18(5-3-17)26-19-8-10-23-11-9-19/h1-6,8-11,13-14,24-25H,7,12H2,(H,23,26)",YJKZQECWPIXXJY-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,6.00,cancer,Inhibition,
750,20792005,,19628817,Cn1ncc2c1nc(-c1cc(Cl)cc(Cl)c1)c1c2[nH]n(-c2cccc(F)c2)c1=O,"4-(3,5-dichlorophenyl)-2-(3-fluorophenyl)-6-methyl-1H-dipyrazolo[4,3-b:4',5'-e]pyridin-3-one","InChI=1S/C20H12Cl2FN5O/c1-27-19-15(9-24-27)18-16(17(25-19)10-5-11(21)7-12(22)6-10)20(29)28(26-18)14-4-2-3-13(23)8-14/h2-9,26H,1H3",OUSADVHOECOJCJ-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.40,cancer,Inhibition,
751,45137640,,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2Cc1cccnc1)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(1S)-2-[(3aR,6S,6aR)-6-(6-fluoro-1H-indol-3-yl)-4-(pyridin-3-ylmethyl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-1-cyclohexyl-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C32H41FN6O2/c1-20(34-2)31(40)37-29(22-8-4-3-5-9-22)32(41)39-14-12-28-30(39)26(19-38(28)18-21-7-6-13-35-16-21)25-17-36-27-15-23(33)10-11-24(25)27/h6-7,10-11,13,15-17,20,22,26,28-30,34,36H,3-5,8-9,12,14,18-19H2,1-2H3,(H,37,40)/t20-,26+,28+,29-,30+/m0/s1",BDJODIRESHTDBJ-KKQAPILSSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
752,59452447,,,CN1CCN(CCc2c[nH]c3ccccc23)c2ccc(Nc3ccnc(CO)c3)cc12,"[4-[[1-[2-(1H-indol-3-yl)ethyl]-4-methyl-2,3-dihydroquinoxalin-6-yl]amino]pyridin-2-yl]methanol","InChI=1S/C25H27N5O/c1-29-12-13-30(11-9-18-16-27-23-5-3-2-4-22(18)23)24-7-6-19(15-25(24)29)28-20-8-10-26-21(14-20)17-31/h2-8,10,14-16,27,31H,9,11-13,17H2,1H3,(H,26,28)",DIZSSTIDZYLNBI-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,5.52,cancer,Inhibition,
753,59555689,,,Clc1ccc2c(CCNc3ccc(Nc4ccnc5ccccc45)cc3)c[nH]c2c1,"1-N-[2-(6-chloro-1H-indol-3-yl)ethyl]-4-N-quinolin-4-ylbenzene-1,4-diamine","InChI=1S/C25H21ClN4/c26-18-5-10-21-17(16-29-25(21)15-18)11-13-27-19-6-8-20(9-7-19)30-24-12-14-28-23-4-2-1-3-22(23)24/h1-10,12,14-16,27,29H,11,13H2,(H,28,30)",XYPIFAUMOGGRIN-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,7.00,cancer,Inhibition,
754,16109162,376409,17266575,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(Cc2ccccc2-c2ccc(cc2)-c2ccccc2)CC1,N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonyl-4-[4-[[2-(4-phenylphenyl)phenyl]methyl]piperazin-1-yl]benzamide,"InChI=1S/C48H50N6O5S2/c1-51(2)28-27-41(35-60-43-14-7-4-8-15-43)49-46-26-25-44(33-47(46)54(56)57)61(58,59)50-48(55)39-21-23-42(24-22-39)53-31-29-52(30-32-53)34-40-13-9-10-16-45(40)38-19-17-37(18-20-38)36-11-5-3-6-12-36/h3-26,33,41,49H,27-32,34-35H2,1-2H3,(H,50,55)/t41-/m1/s1",WFNXNJFAMBCPBZ-VQJSHJPSSA-N,2,0,0,0,BCL2-Like / BAX,9.00,cancer,Inhibition,
755,25138057,458791,24691664,CN[C@@H](C)C(=O)N[C@H]1Cc2ccccc2[C@H]2CC[C@H](N2C1=O)C(=O)N[C@H]1CCCc2ccccc12,"(3S,6S,11bR)-6-[[(2S)-2-(methylamino)propanoyl]amino]-5-oxo-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,3,6,7,11b-hexahydropyrrolo[2,1-a][2]benzazepine-3-carboxamide","InChI=1S/C28H34N4O3/c1-17(29-2)26(33)31-23-16-19-9-4-6-12-21(19)24-14-15-25(32(24)28(23)35)27(34)30-22-13-7-10-18-8-3-5-11-20(18)22/h3-6,8-9,11-12,17,22-25,29H,7,10,13-16H2,1-2H3,(H,30,34)(H,31,33)/t17-,22-,23-,24+,25-/m0/s1",YKDUDNBQXZHFLC-JRCPAZTJSA-N,1,1,0,0,XIAP / Smac,6.40,cancer,Inhibition,
756,44224145,454411,23335573,CCCCN(CCCC)C(=O)c1nn(c(C)c1Cl)-c1cccc(C)c1C(=O)N1Cc2ccccc2C[C@H]1CN,"1-[2-[(3S)-3-(aminomethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]-3-methylphenyl]-N,N-dibutyl-4-chloro-5-methylpyrazole-3-carboxamide","InChI=1S/C31H40ClN5O2/c1-5-7-16-35(17-8-6-2)31(39)29-28(32)22(4)37(34-29)26-15-11-12-21(3)27(26)30(38)36-20-24-14-10-9-13-23(24)18-25(36)19-33/h9-15,25H,5-8,16-20,33H2,1-4H3/t25-/m0/s1",CCUGQOJXLGDWOJ-VWLOTQADSA-N,1,0,0,0,BCL2-Like / BAX,7.38,cancer,Inhibition,
757,45137797,,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2C(=O)c1ccccc1)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(1S)-2-[(3aR,6S,6aR)-4-benzoyl-6-(6-fluoro-1H-indol-3-yl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-1-cyclohexyl-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C33H40FN5O3/c1-20(35-2)31(40)37-29(21-9-5-3-6-10-21)33(42)38-16-15-28-30(38)26(19-39(28)32(41)22-11-7-4-8-12-22)25-18-36-27-17-23(34)13-14-24(25)27/h4,7-8,11-14,17-18,20-21,26,28-30,35-36H,3,5-6,9-10,15-16,19H2,1-2H3,(H,37,40)/t20-,26+,28+,29-,30+/m0/s1",QGAXZHDXCGARPN-KKQAPILSSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
758,23646355,360947,23246915,C[C@H](N)C(=O)Nc1nc(COCc2ccccc2)c(Cc2ccccc2)s1,"(2S)-2-amino-N-[5-benzyl-4-(phenylmethoxymethyl)-1,3-thiazol-2-yl]propanamide","InChI=1S/C21H23N3O2S/c1-15(22)20(25)24-21-23-18(14-26-13-17-10-6-3-7-11-17)19(27-21)12-16-8-4-2-5-9-16/h2-11,15H,12-14,22H2,1H3,(H,23,24,25)/t15-/m0/s1",YBRWIUWQAJGHRM-HNNXBMFYSA-N,1,0,0,0,XIAP / Smac,5.39,cancer,Inhibition,
759,11953137,208999,10127446,C[C@@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)N(CCN2CCOCC2)c2ccc(I)cc2C1=O)c1cc(O)c(Cl)cc1N,"(3S)-4-[(1R)-1-(2-amino-4-chloro-5-hydroxyphenyl)ethyl]-3-(4-chlorophenyl)-7-iodo-1-(2-morpholin-4-ylethyl)-3H-1,4-benzodiazepine-2,5-dione","InChI=1S/C29H29Cl2IN4O4/c1-17(21-15-26(37)23(31)16-24(21)33)36-27(18-2-4-19(30)5-3-18)29(39)35(9-8-34-10-12-40-13-11-34)25-7-6-20(32)14-22(25)28(36)38/h2-7,14-17,27,37H,8-13,33H2,1H3/t17-,27+/m1/s1",CIPUXOASBLBAEP-CRYYWNKWSA-N,1,0,0,0,MDM2-Like / P53,5.57,cancer,Inhibition,
760,44432171,391677,23294392,CC1=C(C(=O)N2CCC[C@@]12Cc1ccc(cc1)C#N)c1cc(Cl)cc(Cl)c1,"4-[[6-(3,5-dichlorophenyl)-7-methyl-5-oxo-2,3-dihydro-1H-pyrrolizin-8-yl]methyl]benzonitrile","InChI=1S/C22H18Cl2N2O/c1-14-20(17-9-18(23)11-19(24)10-17)21(27)26-8-2-7-22(14,26)12-15-3-5-16(13-25)6-4-15/h3-6,9-11H,2,7-8,12H2,1H3/t22-/m1/s1",MTEXZSBIZOFGHW-JOCHJYFZSA-N,0,1,0,0,LFA / ICAM,6.18,immune system disease,Inhibition,
761,42601680,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCC(CC1)N(C)Cc1ccccc1,4-[4-[benzyl(methyl)amino]piperidin-1-yl]-N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonylbenzamide,"InChI=1S/C38H46N6O5S2/c1-41(2)23-20-31(28-50-34-12-8-5-9-13-34)39-36-19-18-35(26-37(36)44(46)47)51(48,49)40-38(45)30-14-16-33(17-15-30)43-24-21-32(22-25-43)42(3)27-29-10-6-4-7-11-29/h4-19,26,31-32,39H,20-25,27-28H2,1-3H3,(H,40,45)/t31-/m1/s1",ZLWZKTPMZXZMEK-WJOKGBTCSA-N,1,0,0,0,BCL2-Like / BAX,5.30,cancer,Inhibition,
762,21300996,,19327154,Clc1cc(Cl)cc(c1)N1C(=O)[C@@H]2C[C@@H](CN2C1=O)NCc1ccc(cc1)C#N,"4-[[[2-(3,5-dichlorophenyl)-1,3-dioxo-5,6,7,7a-tetrahydropyrrolo[1,2-c]imidazol-6-yl]amino]methyl]benzonitrile","InChI=1S/C20H16Cl2N4O2/c21-14-5-15(22)7-17(6-14)26-19(27)18-8-16(11-25(18)20(26)28)24-10-13-3-1-12(9-23)2-4-13/h1-7,16,18,24H,8,10-11H2/t16-,18-/m0/s1",DWXZBHHRZVVWQC-WMZOPIPTSA-N,0,1,0,0,LFA / ICAM,6.76,immune system disease,Inhibition,
763,59452396,,,OCc1cc(Nc2ccc3N(CCc4c[nH]c5ccccc45)C(=O)C(F)(F)Oc3c2)ccn1,"2,2-difluoro-7-[[2-(hydroxymethyl)pyridin-4-yl]amino]-4-[2-(1H-indol-3-yl)ethyl]-1,4-benzoxazin-3-one","InChI=1S/C24H20F2N4O3/c25-24(26)23(32)30(10-8-15-13-28-20-4-2-1-3-19(15)20)21-6-5-16(12-22(21)33-24)29-17-7-9-27-18(11-17)14-31/h1-7,9,11-13,28,31H,8,10,14H2,(H,27,29)",SAXSNPQVWORANT-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,5.00,cancer,Inhibition,
764,16117554,180097,10657311,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1csc(NCCN2CCOCC2)n1,"N-(2-morpholin-4-ylethyl)-4-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]-1,3-thiazol-2-amine","InChI=1S/C25H28F3N3OS2/c1-17(2)19-5-3-4-6-22(19)34-23-8-7-18(15-20(23)25(26,27)28)21-16-33-24(30-21)29-9-10-31-11-13-32-14-12-31/h3-8,15-17H,9-14H2,1-2H3,(H,29,30)",VRRZPNMTWFUQEJ-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,4.92,immune system disease,Inhibition,
765,58006890,,,CCN(C1CN(C1)C(=O)OC(C)(C)C)C(=O)C1=C(C(C)C)N2[C@H](c3ccc(Cl)cc3)[C@@](C)(N=C2S1)c1ccc(Cl)cc1,"tert-butyl 3-[[(5R,6S)-5,6-bis(4-chlorophenyl)-6-methyl-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazole-2-carbonyl]-ethylamino]azetidine-1-carboxylate","InChI=1S/C32H38Cl2N4O3S/c1-8-37(24-17-36(18-24)30(40)41-31(4,5)6)28(39)26-25(19(2)3)38-27(20-9-13-22(33)14-10-20)32(7,35-29(38)42-26)21-11-15-23(34)16-12-21/h9-16,19,24,27H,8,17-18H2,1-7H3/t27-,32+/m1/s1",KJIWVAPUBWVPPA-ZUKKLESISA-N,1,0,0,0,MDM2-Like / P53,7.92,cancer,Inhibition,
766,44549491,,,CN1c2ncnn2[C@H](C2=C1c1ccccc1O[C@@H]2c1ccc(cc1)C#C)c1ccc(Br)cc1,,"InChI=1S/C27H19BrN4O/c1-3-17-8-10-19(11-9-17)26-23-24(18-12-14-20(28)15-13-18)32-27(29-16-30-32)31(2)25(23)21-6-4-5-7-22(21)33-26/h1,4-16,24,26H,2H3/t24-,26+/m0/s1",DHPJTVAVWJRWKL-AZGAKELHSA-N,1,0,0,0,MDM2-Like / P53,5.61,cancer,Inhibition,
767,168318081,,10657245,COc1ccccc1Sc1ccc(cc1C(F)(F)F)-c1ccnc(c1)N1CCC[C@@H](C1)C(O)=O,1-[4-[4-(2-methoxyphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyridin-2-yl]piperidine-3-carboxylic acid,"InChI=1S/C25H23F3N2O3S/c1-33-20-6-2-3-7-22(20)34-21-9-8-16(13-19(21)25(26,27)28)17-10-11-29-23(14-17)30-12-4-5-18(15-30)24(31)32/h2-3,6-11,13-14,18H,4-5,12,15H2,1H3,(H,31,32)/t18-/m0/s1",BPJSFBIYRVIFEZ-SFHVURJKSA-N,0,1,0,0,LFA / ICAM,6.91,immune system disease,Inhibition,
768,506250,524048,442081,Fc1ccc(Br)c2c(c[nH]c12)C(=O)C(=O)N1CCN(CC1)C(=O)c1ccccc1,"1-(4-benzoylpiperazin-1-yl)-2-(4-bromo-7-fluoro-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C21H17BrFN3O3/c22-15-6-7-16(23)18-17(15)14(12-24-18)19(27)21(29)26-10-8-25(9-11-26)20(28)13-4-2-1-3-5-13/h1-7,12,24H,8-11H2",FHPUNKHJTFLQMK-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,8.09,HIV infectious disease,Inhibition,
769,168318080,,,F[C@H]1CN(Cc2ccccc2-c2ccc(Cl)cc2)CC[C@@H]1N1CCc2c(C1)ncnc2NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(c1)S(=O)(=O)C(F)(F)F,,"InChI=1S/C46H50ClF4N7O5S3/c47-34-12-10-32(11-13-34)38-9-5-4-6-33(38)27-57-20-18-43(40(48)28-57)58-21-17-39-42(29-58)52-31-53-45(39)55-66(61,62)37-14-15-41(44(26-37)65(59,60)46(49,50)51)54-35(16-19-56-22-24-63-25-23-56)30-64-36-7-2-1-3-8-36/h1-15,26,31,35,40,43,54H,16-25,27-30H2,(H,52,53,55)/t35-,40+,43+/m1/s1",UKQHIIBGRGLONR-PGSJWCLOSA-N,1,0,0,0,BCL2-Like / BAX,6.74,cancer,Inhibition,
770,11556440,192571,9731218,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCC(C)(C)CC1,"N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonyl-4-(4,4-dimethylpiperidin-1-yl)benzamide","InChI=1S/C32H41N5O5S2/c1-32(2)17-20-36(21-18-32)26-12-10-24(11-13-26)31(38)34-44(41,42)28-14-15-29(30(22-28)37(39)40)33-25(16-19-35(3)4)23-43-27-8-6-5-7-9-27/h5-15,22,25,33H,16-21,23H2,1-4H3,(H,34,38)/t25-/m1/s1",DWEHITNKTMMZBR-RUZDIDTESA-N,2,0,0,0,BCL2-Like / BAX,9.10,cancer,Inhibition,
771,101136468,,,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(F)cc2)c1=O,,"InChI=1S/C21H13F4N5O/c1-29-19-15(10-26-29)18-16(20(31)30(28-18)14-7-5-13(22)6-8-14)17(27-19)11-3-2-4-12(9-11)21(23,24)25/h2-10,28H,1H3",WQKVVTLTCHDAST-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.30,cancer,Inhibition,
772,168318079,,,C[C@@H]1CC(C)(C)N(CCOc2ccc(nc2C(O)=O)-c2ccc3CCCN(C(=O)Nc4nc5ccccc5s4)c3c2)c2cc(C)ccc12,"6-[1-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-2H-quinolin-7-yl]-3-[2-(2,2,4,7-tetramethyl-3,4-dihydroquinolin-1-yl)ethoxy]pyridine-2-carboxylic acid","InChI=1S/C38H39N5O4S/c1-23-11-14-27-24(2)22-38(3,4)43(31(27)20-23)18-19-47-32-16-15-28(39-34(32)35(44)45)26-13-12-25-8-7-17-42(30(25)21-26)37(46)41-36-40-29-9-5-6-10-33(29)48-36/h5-6,9-16,20-21,24H,7-8,17-19,22H2,1-4H3,(H,44,45)(H,40,41,46)/t24-/m1/s1",MFWMERFLBWXVHD-XMMPIXPASA-N,2,0,0,0,BCL2-Like / BAX,9.70,cancer,Inhibition,
773,11532926,,9707709,OC(=O)c1ccc(NC(=O)c2cccc(Cc3cccc(c3)C#N)c2)c(Cc2ccc(cc2)C#N)c1,3-[(4-cyanophenyl)methyl]-4-[[3-[(3-cyanophenyl)methyl]benzoyl]amino]benzoic acid,"InChI=1S/C30H21N3O3/c31-18-21-9-7-20(8-10-21)15-27-17-26(30(35)36)11-12-28(27)33-29(34)25-6-2-4-23(16-25)13-22-3-1-5-24(14-22)19-32/h1-12,14,16-17H,13,15H2,(H,33,34)(H,35,36)",KOAPUGHAYZUHIY-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,4.62,cancer,Inhibition,
774,16109094,374309,17266508,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(Cc2ccccc2-c2ccccc2)CC1,N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonyl-4-[4-[(2-phenylphenyl)methyl]piperazin-1-yl]benzamide,"InChI=1S/C42H46N6O5S2/c1-45(2)24-23-35(31-54-37-14-7-4-8-15-37)43-40-22-21-38(29-41(40)48(50)51)55(52,53)44-42(49)33-17-19-36(20-18-33)47-27-25-46(26-28-47)30-34-13-9-10-16-39(34)32-11-5-3-6-12-32/h3-22,29,35,43H,23-28,30-31H2,1-2H3,(H,44,49)/t35-/m1/s1",MWQLXEGHOOUBPU-PGUFJCEWSA-N,2,0,0,0,BCL2-Like / BAX,9.30,cancer,Inhibition,
775,11417324,444618,9592211,CCC(CC)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C,(2S)-1-[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-3-methylbutanoyl]-N-(2-ethylbutyl)pyrrolidine-2-carboxamide,"InChI=1S/C19H36N4O3/c1-6-14(7-2)11-21-18(25)15-9-8-10-23(15)19(26)16(12(3)4)22-17(24)13(5)20/h12-16H,6-11,20H2,1-5H3,(H,21,25)(H,22,24)/t13-,15-,16-/m0/s1",XEUNZZQOODTMLJ-BPUTZDHNSA-N,1,0,0,0,XIAP / Smac,5.61,cancer,Inhibition,
776,44392073,369774,23248142,OC[C@H]1CCCN1c1cc(ccn1)-c1ccc(Sc2ccc3OCCOc3c2)c(c1)C(F)(F)F,"[(2R)-1-[4-[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfanyl)-3-(trifluoromethyl)phenyl]pyridin-2-yl]pyrrolidin-2-yl]methanol","InChI=1S/C25H23F3N2O3S/c26-25(27,28)20-12-16(17-7-8-29-24(13-17)30-9-1-2-18(30)15-31)3-6-23(20)34-19-4-5-21-22(14-19)33-11-10-32-21/h3-8,12-14,18,31H,1-2,9-11,15H2/t18-/m1/s1",BYQWOSKTUPJKFV-GOSISDBHSA-N,0,1,0,0,LFA / ICAM,6.29,immune system disease,Inhibition,
777,168318039,,24635410,CNC(=O)c1ccc(O[C@H](C)C(=O)N2CCN(C[C@H]2C)C(=O)c2ccccc2)c(C)c1,"4-[1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-1-oxopropan-2-yl]oxy-N,3-dimethylbenzamide","InChI=1S/C24H29N3O4/c1-16-14-20(22(28)25-4)10-11-21(16)31-18(3)23(29)27-13-12-26(15-17(27)2)24(30)19-8-6-5-7-9-19/h5-11,14,17-18H,12-13,15H2,1-4H3,(H,25,28)/t17-,18-/m1/s1",LVHXMRNEIRAIDD-QZTJIDSGSA-N,0,1,0,0,CD4 / gp120,5.54,HIV infectious disease,Inhibition,
778,506244,522175,442075,Cc1ccc(F)c2c(c[nH]c12)C(=O)C(=O)N1CCN(CC1)C(=O)c1ccccc1,"1-(4-benzoylpiperazin-1-yl)-2-(4-fluoro-7-methyl-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C22H20FN3O3/c1-14-7-8-17(23)18-16(13-24-19(14)18)20(27)22(29)26-11-9-25(10-12-26)21(28)15-5-3-2-4-6-15/h2-8,13,24H,9-12H2,1H3",OAXAIXIRIJLMBL-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,9.25,HIV infectious disease,Inhibition,
779,23646345,180747,23247007,CCCCOc1ccc(cc1)-c1nnc(NC(=O)[C@H](C)N)s1,"(2S)-2-amino-N-[5-(4-butoxyphenyl)-1,3,4-thiadiazol-2-yl]propanamide","InChI=1S/C15H20N4O2S/c1-3-4-9-21-12-7-5-11(6-8-12)14-18-19-15(22-14)17-13(20)10(2)16/h5-8,10H,3-4,9,16H2,1-2H3,(H,17,19,20)/t10-/m0/s1",CRVHHAASFSZKST-JTQLQIEISA-N,1,0,0,0,XIAP / Smac,4.60,cancer,Inhibition,
780,44237058,564203,24629959,CC[C@H](N)C(=O)N[C@H]1[C@@H](CNS(=O)(=O)c2ccc(C)cc2)CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7R,9aS)-6-[[(2S)-2-aminobutanoyl]amino]-N-benzhydryl-7-[[(4-methylphenyl)sulfonylamino]methyl]-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C35H43N5O5S/c1-3-29(36)33(41)39-32-26(22-37-46(44,45)28-19-14-23(2)15-20-28)16-17-27-18-21-30(40(27)35(32)43)34(42)38-31(24-10-6-4-7-11-24)25-12-8-5-9-13-25/h4-15,19-20,26-27,29-32,37H,3,16-18,21-22,36H2,1-2H3,(H,38,42)(H,39,41)/t26-,27+,29+,30+,32+/m1/s1",VMODNEWYLILSMS-YSOADSQMSA-N,2,0,0,0,XIAP / Smac,6.45,cancer,Inhibition,
781,44818676,569077,24632763,Cc1ccc2c(NCc3ccc(NC(=O)c4ccc(F)cc4)cc3)nc(nc2c1)N1CCCC1,4-fluoro-N-[4-[[(7-methyl-2-pyrrolidin-1-ylquinazolin-4-yl)amino]methyl]phenyl]benzamide,"InChI=1S/C27H26FN5O/c1-18-4-13-23-24(16-18)31-27(33-14-2-3-15-33)32-25(23)29-17-19-5-11-22(12-6-19)30-26(34)20-7-9-21(28)10-8-20/h4-13,16H,2-3,14-15,17H2,1H3,(H,30,34)(H,29,31,32)",SWHPJPYLDRQPFW-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,6.42,cancer,Inhibition,
782,44570087,481581,24700888,CCCCN(CCCC)C(=O)c1nn(c(C)c1Cl)-c1ccccc1C(=O)N1Cc2ccccc2C[C@H]1CN,"1-[2-[(3S)-3-(aminomethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-N,N-dibutyl-4-chloro-5-methylpyrazole-3-carboxamide","InChI=1S/C30H38ClN5O2/c1-4-6-16-34(17-7-5-2)30(38)28-27(31)21(3)36(33-28)26-15-11-10-14-25(26)29(37)35-20-23-13-9-8-12-22(23)18-24(35)19-32/h8-15,24H,4-7,16-20,32H2,1-3H3/t24-/m0/s1",NCLFJOPXKSMXQY-DEOSSOPVSA-N,2,0,0,0,BCL2-Like / BAX,7.70,cancer,Inhibition,
783,168318077,,8477299,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1cc(ncn1)N1CCC[C@@H](C1)c1nn[nH]n1,4-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]-6-[3-(2H-tetrazol-5-yl)piperidin-1-yl]pyrimidine,"InChI=1S/C26H26F3N7S/c1-16(2)19-7-3-4-8-22(19)37-23-10-9-17(12-20(23)26(27,28)29)21-13-24(31-15-30-21)36-11-5-6-18(14-36)25-32-34-35-33-25/h3-4,7-10,12-13,15-16,18H,5-6,11,14H2,1-2H3,(H,32,33,34,35)/t18-/m0/s1",JLATZOOYNDMRMO-SFHVURJKSA-N,0,1,0,0,LFA / ICAM,7.29,immune system disease,Inhibition,
784,58531503,,,CCCCNC(=O)c1ccc(CN(Cc2ccc(F)cc2)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)cc1,"N-butyl-4-[[(3,5-dichloro-2-hydroxyphenyl)sulfonyl-[(4-fluorophenyl)methyl]amino]methyl]benzamide","InChI=1S/C25H25Cl2FN2O4S/c1-2-3-12-29-25(32)19-8-4-17(5-9-19)15-30(16-18-6-10-21(28)11-7-18)35(33,34)23-14-20(26)13-22(27)24(23)31/h4-11,13-14,31H,2-3,12,15-16H2,1H3,(H,29,32)",HNEBIBZMIHAQOP-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,6.09,cancer,Inhibition,
785,25182592,,,Cc1cc(Nc2ccnc3[C@H](O)CCc23)ccc1NCCc1c[nH]c2c(C)cccc12,"(7S)-4-[3-methyl-4-[2-(7-methyl-1H-indol-3-yl)ethylamino]anilino]-6,7-dihydro-5H-cyclopenta[b]pyridin-7-ol","InChI=1S/C26H28N4O/c1-16-4-3-5-20-18(15-29-25(16)20)10-12-27-22-8-6-19(14-17(22)2)30-23-11-13-28-26-21(23)7-9-24(26)31/h3-6,8,11,13-15,24,27,29,31H,7,9-10,12H2,1-2H3,(H,28,30)/t24-/m1/s1",HMVYHLBCUQWADH-XMMPIXPASA-N,1,0,0,0,MDM2-Like / P53,8.52,cancer,Inhibition,
786,51039625,,,FC(F)(F)c1nc2CN(CCc2c(NS(=O)(=O)c2ccc(N[C@H](CCN3CCOCC3)CSc3ccccc3)c(c2)S(=O)(=O)C(F)(F)F)n1)C1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1,"N-[7-[1-[[2-(4-chlorophenyl)phenyl]methyl]piperidin-4-yl]-2-(trifluoromethyl)-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl]-4-[[(2R)-4-morpholin-4-yl-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)benzenesulfonamide","InChI=1S/C47H50ClF6N7O5S3/c48-34-12-10-32(11-13-34)39-9-5-4-6-33(39)29-60-21-17-36(18-22-60)61-23-19-40-42(30-61)56-45(46(49,50)51)57-44(40)58-69(64,65)38-14-15-41(43(28-38)68(62,63)47(52,53)54)55-35(16-20-59-24-26-66-27-25-59)31-67-37-7-2-1-3-8-37/h1-15,28,35-36,55H,16-27,29-31H2,(H,56,57,58)/t35-/m1/s1",TZLZSMLLOXVZEI-PGUFJCEWSA-N,1,0,0,0,BCL2-Like / BAX,6.63,cancer,Inhibition,
787,168318075,,,CNC(=O)[C@H](Cc1ccc2ccccc2c1)N1CCC(=O)N([C@@H](CC(C)C)C1=O)C(=O)Nc1ccncc1,,"InChI=1S/C29H33N5O4/c1-19(2)16-25-28(37)33(15-12-26(35)34(25)29(38)32-23-10-13-31-14-11-23)24(27(36)30-3)18-20-8-9-21-6-4-5-7-22(21)17-20/h4-11,13-14,17,19,24-25H,12,15-16,18H2,1-3H3,(H,30,36)(H,31,32,38)/t24-,25-/m0/s1",WGQFHLIDARJCHT-DQEYMECFSA-N,1,0,0,0,LFA / ICAM,5.43,immune system disease,Inhibition,
788,168318074,,24642332,C[C@@H](Oc1cccc2n(C)nc(C)c12)C(=O)N1CCN(C[C@H]1C)C(=O)c1ccccc1,"1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-(1,3-dimethylindazol-4-yl)oxypropan-1-one","InChI=1S/C24H28N4O3/c1-16-15-27(24(30)19-9-6-5-7-10-19)13-14-28(16)23(29)18(3)31-21-12-8-11-20-22(21)17(2)25-26(20)4/h5-12,16,18H,13-15H2,1-4H3/t16-,18-/m1/s1",UHTMFBRGCDQTSQ-SJLPKXTDSA-N,0,1,0,0,CD4 / gp120,7.82,HIV infectious disease,Inhibition,
789,45281242,1230654,24603834,CCC[C@H](C(O)=O)c1c(C)nc2ccc(Cl)cc2c1-c1ccccc1,2-(6-chloro-2-methyl-4-phenylquinolin-3-yl)pentanoic acid,"InChI=1S/C21H20ClNO2/c1-3-7-16(21(24)25)19-13(2)23-18-11-10-15(22)12-17(18)20(19)14-8-5-4-6-9-14/h4-6,8-12,16H,3,7H2,1-2H3,(H,24,25)/t16-/m0/s1",XRPUJSGGRFQZPJ-INIZCTEOSA-N,1,0,0,0,LEDGF / IN,5.86,HIV infectious disease,Inhibition,
790,168318067,,23155676,C[C@@H]1CCCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O,(2S)-3-(1H-indol-3-yl)-2-[(2-methylcyclohexanecarbonyl)amino]propanoic acid,"InChI=1S/C19H24N2O3/c1-12-6-2-3-7-14(12)18(22)21-17(19(23)24)10-13-11-20-16-9-5-4-8-15(13)16/h4-5,8-9,11-12,14,17,20H,2-3,6-7,10H2,1H3,(H,21,22)(H,23,24)/t12-,14-,17+/m1/s1",QFJYPNYTGSGPEJ-MRRJBJDNSA-N,1,0,0,0,LFA / ICAM,4.55,immune system disease,Inhibition,
791,168318179,,,Fc1cccc(c1)-n1[nH]c2ccnc(-c3cccc(c3)C(F)(F)F)c2c1=O,,"InChI=1S/C19H11F4N3O/c20-13-5-2-6-14(10-13)26-18(27)16-15(25-26)7-8-24-17(16)11-3-1-4-12(9-11)19(21,22)23/h1-10,25H",ZUICVKRDFXDHDH-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,5.89,cancer,Inhibition,
792,21906788,180092,10657299,COc1ccccc1Sc1ccc(cc1C(F)(F)F)-c1ccnc(c1)N1CCC(O)CC1,1-[4-[4-(2-methoxyphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyridin-2-yl]piperidin-4-ol,"InChI=1S/C24H23F3N2O2S/c1-31-20-4-2-3-5-22(20)32-21-7-6-16(14-19(21)24(25,26)27)17-8-11-28-23(15-17)29-12-9-18(30)10-13-29/h2-8,11,14-15,18,30H,9-10,12-13H2,1H3",NCFNEGXOEYXVOP-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,6.89,immune system disease,Inhibition,
793,168318182,,,C[C@H](N)C(=O)N[C@@H](C1CCCCC1)C(=O)N1C[C@H](C[C@H]1C(=O)N[C@H]1CCCc2ccccc12)Oc1ccccc1,,"InChI=1S/C32H42N4O4/c1-21(33)30(37)35-29(23-12-4-2-5-13-23)32(39)36-20-25(40-24-15-6-3-7-16-24)19-28(36)31(38)34-27-18-10-14-22-11-8-9-17-26(22)27/h3,6-9,11,15-17,21,23,25,27-29H,2,4-5,10,12-14,18-20,33H2,1H3,(H,34,38)(H,35,37)/t21-,25-,27-,28-,29-/m0/s1",ZCNSFDFIIRIJLG-VGUKBLNFSA-N,1,0,0,0,XIAP / Smac,8.22,cancer,Inhibition,
794,44570084,509788,24712931,Cc1c(Br)c(nn1-c1ccccc1C(=O)N1Cc2ccccc2C[C@H]1CO)C(=O)N(c1ccccc1)c1ccccc1,"4-bromo-1-[2-[(3S)-3-(hydroxymethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-5-methyl-N,N-diphenylpyrazole-3-carboxamide","InChI=1S/C34H29BrN4O3/c1-23-31(35)32(34(42)38(26-14-4-2-5-15-26)27-16-6-3-7-17-27)36-39(23)30-19-11-10-18-29(30)33(41)37-21-25-13-9-8-12-24(25)20-28(37)22-40/h2-19,28,40H,20-22H2,1H3/t28-/m0/s1",WMVUQWDTVUNQBN-NDEPHWFRSA-N,2,0,0,0,BCL2-Like / BAX,7.40,cancer,Inhibition,
795,44429173,242126,23291042,CCC\C(c1ccccc1)=C1\SC(=S)N(C1=O)[C@H](C(O)=O)CC(C)C,"(2S)-4-methyl-2-[(5Z)-4-oxo-5-(1-phenylbutylidene)-2-sulfanylidene-1,3-thiazolidin-3-yl]pentanoic acid","InChI=1S/C19H23NO3S2/c1-4-8-14(13-9-6-5-7-10-13)16-17(21)20(19(24)25-16)15(18(22)23)11-12(2)3/h5-7,9-10,12,15H,4,8,11H2,1-3H3,(H,22,23)/b16-14-/t15-/m0/s1",LTESOAGUHITHPM-RIBQPWQFSA-N,2,0,0,0,BCL2-Like / BAX,4.87,cancer,Inhibition,
796,44237041,,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1C(=O)Nc1ccccc1-c1ncccn1,(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(2-pyrimidin-2-ylphenyl)pyrrolidine-2-carboxamide,"InChI=1S/C27H36N6O3/c1-18(28-2)25(34)32-23(19-10-4-3-5-11-19)27(36)33-17-8-14-22(33)26(35)31-21-13-7-6-12-20(21)24-29-15-9-16-30-24/h6-7,9,12-13,15-16,18-19,22-23,28H,3-5,8,10-11,14,17H2,1-2H3,(H,31,35)(H,32,34)/t18-,22-,23-/m0/s1",JVEUWDBVAHOBCS-TZYHBYERSA-N,1,0,0,0,XIAP / Smac,5.30,cancer,Inhibition,
797,16109093,374097,17266507,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(Cc2ccccc2C2CCCCC2)CC1,4-[4-[(2-cyclohexylphenyl)methyl]piperazin-1-yl]-N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonylbenzamide,"InChI=1S/C42H52N6O5S2/c1-45(2)24-23-35(31-54-37-14-7-4-8-15-37)43-40-22-21-38(29-41(40)48(50)51)55(52,53)44-42(49)33-17-19-36(20-18-33)47-27-25-46(26-28-47)30-34-13-9-10-16-39(34)32-11-5-3-6-12-32/h4,7-10,13-22,29,32,35,43H,3,5-6,11-12,23-28,30-31H2,1-2H3,(H,44,49)/t35-/m1/s1",TXEPPGZBOFIRIR-PGUFJCEWSA-N,2,0,0,0,BCL2-Like / BAX,9.30,cancer,Inhibition,
798,45137199,,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2C1CCCCC1)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(1S)-2-[(3aR,6S,6aR)-4-cyclohexyl-6-(6-fluoro-1H-indol-3-yl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-1-cyclohexyl-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C32H46FN5O2/c1-20(34-2)31(39)36-29(21-9-5-3-6-10-21)32(40)37-16-15-28-30(37)26(19-38(28)23-11-7-4-8-12-23)25-18-35-27-17-22(33)13-14-24(25)27/h13-14,17-18,20-21,23,26,28-30,34-35H,3-12,15-16,19H2,1-2H3,(H,36,39)/t20-,26+,28+,29-,30+/m0/s1",AIAKVHUWMBPSCS-KKQAPILSSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
799,68237999,,,CN[C@@H](C)C(=O)N[C@@H](C1CCOCC1)C(=O)N1CCC[C@H]1c1cc2ccnc(-c3ccccc3Cl)c2[nH]1,"(2S)-N-[(1S)-2-[(2R)-2-[7-(2-chlorophenyl)-1H-pyrrolo[2,3-c]pyridin-2-yl]pyrrolidin-1-yl]-1-(oxan-4-yl)-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C28H34ClN5O3/c1-17(30-2)27(35)33-25(18-10-14-37-15-11-18)28(36)34-13-5-8-23(34)22-16-19-9-12-31-26(24(19)32-22)20-6-3-4-7-21(20)29/h3-4,6-7,9,12,16-18,23,25,30,32H,5,8,10-11,13-15H2,1-2H3,(H,33,35)/t17-,23-,25-/m0/s1",VBAQGNWLWUEVKO-XPEQFSOGSA-N,2,0,0,0,XIAP / Smac,6.92,cancer,Inhibition,
800,45136916,,,CN[C@@H](C)C(=O)N[C@@H]([C@@H](C)OC)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2Cc1ccccc1)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(2S,3R)-1-[(3aR,6S,6aR)-4-benzyl-6-(6-fluoro-1H-indol-3-yl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-3-methoxy-1-oxobutan-2-yl]-2-(methylamino)propanamide","InChI=1S/C30H38FN5O3/c1-18(32-3)29(37)34-27(19(2)39-4)30(38)36-13-12-26-28(36)24(17-35(26)16-20-8-6-5-7-9-20)23-15-33-25-14-21(31)10-11-22(23)25/h5-11,14-15,18-19,24,26-28,32-33H,12-13,16-17H2,1-4H3,(H,34,37)/t18-,19+,24+,26+,27-,28+/m0/s1",BQEJJGQMXOLBIV-ZABNDPDXSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
801,67981357,,,CCC[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1,,"InChI=1S/C43H46ClF3N6O4S3/c1-2-8-33(28-58-35-10-4-3-5-11-35)50-39-18-17-36(25-41(39)59(54,55)43(45,46)47)60(56,57)51-42-38-21-24-53(27-40(38)48-29-49-42)34-19-22-52(23-20-34)26-31-9-6-7-12-37(31)30-13-15-32(44)16-14-30/h3-7,9-18,25,29,33-34,50H,2,8,19-24,26-28H2,1H3,(H,48,49,51)/t33-/m1/s1",LLEQODVGXLRWQQ-MGBGTMOVSA-N,1,0,0,0,BCL2-Like / BAX,5.62,cancer,Inhibition,
802,44574955,510828,24714285,OC[C@H]1[C@@H]2Cn3c(cccc3=O)[C@@H]2N(Cc2ccc(Cl)c(Cl)c2)[C@@H]1C(=O)N1CCC(CC1)c1ccc(F)cc1,"(2S,3S,3aR,9bR)-1-[(3,4-dichlorophenyl)methyl]-2-[4-(4-fluorophenyl)piperidine-1-carbonyl]-3-(hydroxymethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one","InChI=1S/C30H30Cl2FN3O3/c31-24-9-4-18(14-25(24)32)15-36-28-22(16-35-26(28)2-1-3-27(35)38)23(17-37)29(36)30(39)34-12-10-20(11-13-34)19-5-7-21(33)8-6-19/h1-9,14,20,22-23,28-29,37H,10-13,15-17H2/t22-,23-,28+,29-/m0/s1",VKAOPIQOKYJYFL-QXRIIVFPSA-N,1,0,0,0,BCL2-Like / BAX,5.66,cancer,Inhibition,
803,11494685,,9669491,C(Cc1c[nH]c2ccccc12)Nc1ccc(Nc2ccnc3CCCCc23)cc1,"1-N-[2-(1H-indol-3-yl)ethyl]-4-N-(5,6,7,8-tetrahydroquinolin-4-yl)benzene-1,4-diamine","InChI=1S/C25H26N4/c1-3-7-23-21(5-1)18(17-28-23)13-15-26-19-9-11-20(12-10-19)29-25-14-16-27-24-8-4-2-6-22(24)25/h1,3,5,7,9-12,14,16-17,26,28H,2,4,6,8,13,15H2,(H,27,29)",WDBZSTIGESHQER-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,7.52,cancer,Inhibition,
804,44390667,180205,23246689,OC(=O)[C@@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)Nc2ccc(I)cc2C1=O)c1ccc(Cl)nc1,"2-[3-(4-chlorophenyl)-7-iodo-2,5-dioxo-1,3-dihydro-1,4-benzodiazepin-4-yl]-2-(6-chloropyridin-3-yl)acetic acid","InChI=1S/C22H14Cl2IN3O4/c23-13-4-1-11(2-5-13)18-20(29)27-16-7-6-14(25)9-15(16)21(30)28(18)19(22(31)32)12-3-8-17(24)26-10-12/h1-10,18-19H,(H,27,29)(H,31,32)/t18-,19-/m0/s1",YJJZWNLWGRTLCM-OALUTQOASA-N,1,0,0,0,MDM2-Like / P53,5.83,cancer,Inhibition,
805,46175913,,,CN[C@@H](C)C(=O)N[C@@H](C1CCOCC1)C(=O)N1CCC[C@H]1c1cc2ncnc(-c3ccccc3)c2[nH]1,"(2S)-2-(methylamino)-N-[(1S)-1-(oxan-4-yl)-2-oxo-2-[(2S)-2-(4-phenyl-5H-pyrrolo[3,2-d]pyrimidin-6-yl)pyrrolidin-1-yl]ethyl]propanamide","InChI=1S/C27H34N6O3/c1-17(28-2)26(34)32-24(19-10-13-36-14-11-19)27(35)33-12-6-9-22(33)20-15-21-25(31-20)23(30-16-29-21)18-7-4-3-5-8-18/h3-5,7-8,15-17,19,22,24,28,31H,6,9-14H2,1-2H3,(H,32,34)/t17-,22-,24-/m0/s1",PPMXNSIFOOMHTN-OWSXEPHWSA-N,2,0,0,0,XIAP / Smac,7.11,cancer,Inhibition,
806,21906794,181271,10657309,OC1CCN(CC1)c1cc(ccn1)-c1ccc(Sc2ccc3OCCOc3c2)c(c1)C(F)(F)F,"1-[4-[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfanyl)-3-(trifluoromethyl)phenyl]pyridin-2-yl]piperidin-4-ol","InChI=1S/C25H23F3N2O3S/c26-25(27,28)20-13-16(17-5-8-29-24(14-17)30-9-6-18(31)7-10-30)1-4-23(20)34-19-2-3-21-22(15-19)33-12-11-32-21/h1-5,8,13-15,18,31H,6-7,9-12H2",JYSZXOVIWSXAMG-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,6.52,immune system disease,Inhibition,
807,168318072,,23271216,CCN(CC)C(=O)[C@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)N(CCCCC(O)=O)c2ccc(I)cc2C1=O)c1ccc(Cl)cc1,"5-[3-(4-chlorophenyl)-4-[1-(4-chlorophenyl)-2-(diethylamino)-2-oxoethyl]-7-iodo-2,5-dioxo-3H-1,4-benzodiazepin-1-yl]pentanoic acid","InChI=1S/C32H32Cl2IN3O5/c1-3-36(4-2)31(42)28(20-8-12-22(33)13-9-20)38-29(21-10-14-23(34)15-11-21)32(43)37(18-6-5-7-27(39)40)26-17-16-24(35)19-25(26)30(38)41/h8-17,19,28-29H,3-7,18H2,1-2H3,(H,39,40)/t28-,29+/m1/s1",MHOPTQKTBICWMN-WDYNHAJCSA-N,1,2,0,0,MDM2-Like / P53,5.67,cancer,Inhibition,
808,11475818,3407578,9650647,CC(C)C[C@H]1N[C@H]([C@H](c2ccccc2)[C@@]11C(=O)Nc2cc(Cl)ccc12)C(=O)N(C)C,"(2'R,3S,3'R,5'R)-6-chloro-N,N-dimethyl-5'-(2-methylpropyl)-2-oxo-3'-phenylspiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide","InChI=1S/C24H28ClN3O2/c1-14(2)12-19-24(17-11-10-16(25)13-18(17)26-23(24)30)20(15-8-6-5-7-9-15)21(27-19)22(29)28(3)4/h5-11,13-14,19-21,27H,12H2,1-4H3,(H,26,30)/t19-,20+,21-,24+/m1/s1",VTKYXKHIEFVJSW-WHLIWEHUSA-N,1,3,0,0,MDM2-Like / P53,5.07,cancer,Inhibition,
809,44574951,467508,24693323,OC[C@@H]1[C@H]2Cn3c(cccc3=O)[C@H]2N(CC2CCCCC2)[C@H]1C(=O)N[C@H]1CCN(Cc2ccccc2)C1,"(2R,3R,3aS,9bS)-N-[(3S)-1-benzylpyrrolidin-3-yl]-1-(cyclohexylmethyl)-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide","InChI=1S/C30H40N4O3/c35-20-25-24-19-33-26(12-7-13-27(33)36)28(24)34(17-22-10-5-2-6-11-22)29(25)30(37)31-23-14-15-32(18-23)16-21-8-3-1-4-9-21/h1,3-4,7-9,12-13,22-25,28-29,35H,2,5-6,10-11,14-20H2,(H,31,37)/t23-,24+,25+,28-,29+/m0/s1",HIGRFICTTRTBSR-CXNNCOGXSA-N,1,0,0,0,BCL2-Like / BAX,5.39,cancer,Inhibition,
810,168318071,,24634717,C[C@@H](Oc1cccc2ccncc12)C(=O)N1CCN(C[C@H]1C)C(=O)c1ccccc1,1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-isoquinolin-8-yloxypropan-1-one,"InChI=1S/C24H25N3O3/c1-17-16-26(24(29)20-7-4-3-5-8-20)13-14-27(17)23(28)18(2)30-22-10-6-9-19-11-12-25-15-21(19)22/h3-12,15,17-18H,13-14,16H2,1-2H3/t17-,18-/m1/s1",GEHLHDMDLCPKIW-QZTJIDSGSA-N,0,1,0,0,CD4 / gp120,6.24,HIV infectious disease,Inhibition,
811,168318012,,,Clc1ccc2c(NC(=O)[C@@]2(Cc2cccc(Cl)c2)NC2CCC2)c1,6-chloro-3-[(3-chlorophenyl)methyl]-3-(cyclobutylamino)-1H-indol-2-one,"InChI=1S/C19H18Cl2N2O/c20-13-4-1-3-12(9-13)11-19(23-15-5-2-6-15)16-8-7-14(21)10-17(16)22-18(19)24/h1,3-4,7-10,15,23H,2,5-6,11H2,(H,22,24)/t19-/m0/s1",DRFZTAQRHZSYTD-IBGZPJMESA-N,1,0,0,0,MDM2-Like / P53,8.60,cancer,Inhibition,
812,59396830,,,COC(=O)c1cc(ccn1)N1CCc2cc(NCCc3c[nH]c4ccccc34)ccc12,"methyl 4-[5-[2-(1H-indol-3-yl)ethylamino]-2,3-dihydroindol-1-yl]pyridine-2-carboxylate","InChI=1S/C25H24N4O2/c1-31-25(30)23-15-20(9-12-27-23)29-13-10-17-14-19(6-7-24(17)29)26-11-8-18-16-28-22-5-3-2-4-21(18)22/h2-7,9,12,14-16,26,28H,8,10-11,13H2,1H3",QSXCRGWSEKGQRW-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,6.52,cancer,Inhibition,
813,506224,492947,442055,Clc1ccc2c(c[nH]c2c1)C(=O)C(=O)N1CCN(CC1)C(=O)c1ccccc1,"1-(4-benzoylpiperazin-1-yl)-2-(6-chloro-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C21H18ClN3O3/c22-15-6-7-16-17(13-23-18(16)12-15)19(26)21(28)25-10-8-24(9-11-25)20(27)14-4-2-1-3-5-14/h1-7,12-13,23H,8-11H2",BESZANVZRKJWLW-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,6.68,HIV infectious disease,Inhibition,
814,168317997,,,C[C@H]1C[C@H](CCN1Cc1ccccc1-c1ccc(Cl)cc1)N1CCc2c(C1)ncnc2NS(=O)(=O)c1ccc(N[C@H](CCN(C)C)CSc2ccccc2)c(c1)S(=O)(=O)C(F)(F)F,"N-[7-[(2S)-1-[[2-(4-chlorophenyl)phenyl]methyl]-2-methylpiperidin-4-yl]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl]-4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)benzenesulfonamide","InChI=1S/C45H51ClF3N7O4S3/c1-31-25-36(20-23-55(31)27-33-9-7-8-12-39(33)32-13-15-34(46)16-14-32)56-24-21-40-42(28-56)50-30-51-44(40)53-63(59,60)38-17-18-41(43(26-38)62(57,58)45(47,48)49)52-35(19-22-54(2)3)29-61-37-10-5-4-6-11-37/h4-18,26,30-31,35-36,52H,19-25,27-29H2,1-3H3,(H,50,51,53)/t31-,35+,36-/m0/s1",ZWWWHJCPYOPUEX-NUHNATIRSA-N,1,0,0,0,BCL2-Like / BAX,7.66,cancer,Inhibition,
815,44818493,583242,24642024,CNc1nc(NCc2ccc(NC(=O)c3ccc(Cl)nc3)cc2)c2ccc(C)cc2n1,6-chloro-N-[4-[[[7-methyl-2-(methylamino)quinazolin-4-yl]amino]methyl]phenyl]pyridine-3-carboxamide,"InChI=1S/C23H21ClN6O/c1-14-3-9-18-19(11-14)29-23(25-2)30-21(18)27-12-15-4-7-17(8-5-15)28-22(31)16-6-10-20(24)26-13-16/h3-11,13H,12H2,1-2H3,(H,28,31)(H2,25,27,29,30)",GXJWTRQQFNHPOC-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,6.38,cancer,Inhibition,
816,45487381,566450,24631774,CNC(=O)c1cc(OC)c(O[C@@H](C)C(=O)N2CCN(C[C@H]2C)c2nccc3[nH]ncc23)cn1,"4-methoxy-N-methyl-5-[(2S)-1-[(2R)-2-methyl-4-(1H-pyrazolo[4,3-c]pyridin-4-yl)piperazin-1-yl]-1-oxopropan-2-yl]oxypyridine-2-carboxamide","InChI=1S/C22H27N7O4/c1-13-12-28(20-15-10-26-27-16(15)5-6-24-20)7-8-29(13)22(31)14(2)33-19-11-25-17(21(30)23-3)9-18(19)32-4/h5-6,9-11,13-14H,7-8,12H2,1-4H3,(H,23,30)(H,26,27)/t13-,14+/m1/s1",CMKHEDIXVQQCOC-KGLIPLIRSA-N,0,1,0,0,CD4 / gp120,7.62,HIV infectious disease,Inhibition,
817,,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1ncnc2CN(CCc12)[C@H]1CC[C@@](O)(Cc2ccccc2-c2ccc(Cl)cc2)CC1,,"InChI=1S/C45H50ClF3N6O5S3/c1-54(2)24-20-34(29-61-36-9-4-3-5-10-36)52-40-17-16-37(26-42(40)62(57,58)45(47,48)49)63(59,60)53-43-39-21-25-55(28-41(39)50-30-51-43)35-18-22-44(56,23-19-35)27-32-8-6-7-11-38(32)31-12-14-33(46)15-13-31/h3-17,26,30,34-35,52,56H,18-25,27-29H2,1-2H3,(H,50,51,53)/t34-,35-,44-/m1/s1",BYJHWFAOZXGAHA-DGHVKXBUSA-N,1,0,0,0,BCL2-Like / BAX,7.15,cancer,Inhibition,
818,50996417,3260812,,Cc1cccc(c1)-c1nc(C(O)=O)c(-c2cccc(Cl)c2)n1-c1cc(Cl)ccc1C,1-(5-chloro-2-methylphenyl)-5-(3-chlorophenyl)-2-(3-methylphenyl)imidazole-4-carboxylic acid,"InChI=1S/C24H18Cl2N2O2/c1-14-5-3-7-17(11-14)23-27-21(24(29)30)22(16-6-4-8-18(25)12-16)28(23)20-13-19(26)10-9-15(20)2/h3-13H,1-2H3,(H,29,30)",UYJZPBBJELZWKZ-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,7.32,cancer,Inhibition,
819,45137951,,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2C(=O)Cc1ccccc1)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(1S)-2-[(3aR,6S,6aR)-6-(6-fluoro-1H-indol-3-yl)-4-(2-phenylacetyl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-1-cyclohexyl-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C34H42FN5O3/c1-21(36-2)33(42)38-31(23-11-7-4-8-12-23)34(43)39-16-15-29-32(39)27(26-19-37-28-18-24(35)13-14-25(26)28)20-40(29)30(41)17-22-9-5-3-6-10-22/h3,5-6,9-10,13-14,18-19,21,23,27,29,31-32,36-37H,4,7-8,11-12,15-17,20H2,1-2H3,(H,38,42)/t21-,27+,29+,31-,32+/m0/s1",NHIPSDOTONPFBI-AQCPNSALSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
820,45138992,,,CN[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2c1ncccn1)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(2S)-1-[(3aR,6S,6aR)-6-(6-fluoro-1H-indol-3-yl)-4-pyrimidin-2-yl-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-3-hydroxy-1-oxopropan-2-yl]-2-(methylamino)propanamide","InChI=1S/C25H30FN7O3/c1-14(27-2)23(35)31-20(13-34)24(36)32-9-6-21-22(32)18(12-33(21)25-28-7-3-8-29-25)17-11-30-19-10-15(26)4-5-16(17)19/h3-5,7-8,10-11,14,18,20-22,27,30,34H,6,9,12-13H2,1-2H3,(H,31,35)/t14-,18+,20-,21+,22+/m0/s1",CVSVGNNDLKTBFQ-JGSCJUMNSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
821,168318069,,,Cc1cc2CN(CCc2c(C)c1C(=O)N[C@@H](CNC(=O)c1cccs1)C(O)=O)C(=O)c1ccccc1,,"InChI=1S/C27H27N3O5S/c1-16-13-19-15-30(26(33)18-7-4-3-5-8-18)11-10-20(19)17(2)23(16)25(32)29-21(27(34)35)14-28-24(31)22-9-6-12-36-22/h3-9,12-13,21H,10-11,14-15H2,1-2H3,(H,28,31)(H,29,32)(H,34,35)/t21-/m0/s1",AHJSZJJPEGELGL-NRFANRHFSA-N,0,1,0,0,LFA / ICAM,7.10,immune system disease,Inhibition,
822,44191694,552287,24620978,Cc1cc2c(C(=O)NCCc3ccccc3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)NCCc3ccccc3)c(O)c(O)cc2c1O,"2,3,5-trihydroxy-7-methyl-N-(2-phenylethyl)-6-[1,6,7-trihydroxy-3-methyl-5-(2-phenylethylcarbamoyl)naphthalen-2-yl]naphthalene-1-carboxamide","InChI=1S/C40H36N2O8/c1-21-17-25-27(19-29(43)37(47)33(25)39(49)41-15-13-23-9-5-3-6-10-23)35(45)31(21)32-22(2)18-26-28(36(32)46)20-30(44)38(48)34(26)40(50)42-16-14-24-11-7-4-8-12-24/h3-12,17-20,43-48H,13-16H2,1-2H3,(H,41,49)(H,42,50)",UZDOVKIBOJKBRO-UHFFFAOYSA-N,4,0,0,0,BCL2-Like / BAX,6.82,cancer,Inhibition,
823,25026111,569098,24631040,CN(C)c1nc(NCc2ccc(NC(=O)c3ccc(F)cc3)cc2)c2ccc(CO)cc2n1,N-[4-[[[2-(dimethylamino)-7-(hydroxymethyl)quinazolin-4-yl]amino]methyl]phenyl]-4-fluorobenzamide,"InChI=1S/C25H24FN5O2/c1-31(2)25-29-22-13-17(15-32)5-12-21(22)23(30-25)27-14-16-3-10-20(11-4-16)28-24(33)18-6-8-19(26)9-7-18/h3-13,32H,14-15H2,1-2H3,(H,28,33)(H,27,29,30)",JXOBVBGRETYJJP-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,6.07,cancer,Inhibition,
824,168318068,,,Cn1ncc2c1nc(-c1cccc(c1)C(N)=O)c1c2[nH]n(-c2cccc(F)c2)c1=O,,"InChI=1S/C21H15FN6O2/c1-27-20-15(10-24-27)18-16(17(25-20)11-4-2-5-12(8-11)19(23)29)21(30)28(26-18)14-7-3-6-13(22)9-14/h2-10,26H,1H3,(H2,23,29)",CLYOOMMYYGDKEO-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,5.82,cancer,Inhibition,
825,44364557,357881,23220601,CC(C)C[C@@H]1N([C@H](C)CCN([C@@H](Cc2ccc3ccccc3c2)C(N)=O)C1=O)C(=O)Cc1ccccc1,"(2S)-2-[(3S,5R)-5-methyl-3-(2-methylpropyl)-2-oxo-4-(2-phenylacetyl)-1,4-diazepan-1-yl]-3-naphthalen-2-ylpropanamide","InChI=1S/C31H37N3O3/c1-21(2)17-28-31(37)33(16-15-22(3)34(28)29(35)20-23-9-5-4-6-10-23)27(30(32)36)19-24-13-14-25-11-7-8-12-26(25)18-24/h4-14,18,21-22,27-28H,15-17,19-20H2,1-3H3,(H2,32,36)/t22-,27+,28+/m1/s1",WBTAHXUCBNIOHJ-WWEDSPNTSA-N,1,0,0,0,LFA / ICAM,6.12,immune system disease,Inhibition,
826,168318066,,442125,OC[C@H]1CN(CCN1C(=O)C(=O)c1c[nH]c2cccc(F)c12)C(=O)c1ccccc1,"1-[4-benzoyl-2-(hydroxymethyl)piperazin-1-yl]-2-(4-fluoro-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C22H20FN3O4/c23-17-7-4-8-18-19(17)16(11-24-18)20(28)22(30)26-10-9-25(12-15(26)13-27)21(29)14-5-2-1-3-6-14/h1-8,11,15,24,27H,9-10,12-13H2/t15-/m1/s1",FBQCBTJQCZMGMN-OAHLLOKOSA-N,0,1,0,0,CD4 / gp120,6.19,HIV infectious disease,Inhibition,
827,25138060,487383,24704292,CC[C@H](O)C(=O)N[C@H]1CCC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,9aS)-N-benzhydryl-6-[[(2S)-2-hydroxybutanoyl]amino]-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C27H33N3O4/c1-2-23(31)26(33)28-21-15-9-14-20-16-17-22(30(20)27(21)34)25(32)29-24(18-10-5-3-6-11-18)19-12-7-4-8-13-19/h3-8,10-13,20-24,31H,2,9,14-17H2,1H3,(H,28,33)(H,29,32)/t20-,21-,22-,23-/m0/s1",HVADKVMBUUALGR-MLCQCVOFSA-N,1,0,0,0,XIAP / Smac,4.54,cancer,Inhibition,
828,45136917,,,CN[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2Cc1ccccc1)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(2S,3R)-1-[(3aR,6S,6aR)-4-benzyl-6-(6-fluoro-1H-indol-3-yl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-3-hydroxy-1-oxobutan-2-yl]-2-(methylamino)propanamide","InChI=1S/C29H36FN5O3/c1-17(31-3)28(37)33-26(18(2)36)29(38)35-12-11-25-27(35)23(16-34(25)15-19-7-5-4-6-8-19)22-14-32-24-13-20(30)9-10-21(22)24/h4-10,13-14,17-18,23,25-27,31-32,36H,11-12,15-16H2,1-3H3,(H,33,37)/t17-,18+,23+,25+,26-,27+/m0/s1",IPIQVYSBOBDVOV-ZXXJXHPYSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
829,44364576,356037,23220629,CC(C)C[C@@H]1N([C@H](C)CCN([C@@H](Cc2ccc3ccccc3c2)C(N)=O)C1=O)C(=O)Cc1ccc(Br)cc1,"(2S)-2-[(3S,5R)-4-[2-(4-bromophenyl)acetyl]-5-methyl-3-(2-methylpropyl)-2-oxo-1,4-diazepan-1-yl]-3-naphthalen-2-ylpropanamide","InChI=1S/C31H36BrN3O3/c1-20(2)16-28-31(38)34(15-14-21(3)35(28)29(36)19-22-9-12-26(32)13-10-22)27(30(33)37)18-23-8-11-24-6-4-5-7-25(24)17-23/h4-13,17,20-21,27-28H,14-16,18-19H2,1-3H3,(H2,33,37)/t21-,27+,28+/m1/s1",YOARGBHUDXYTJE-MHWRTBLVSA-N,1,0,0,0,LFA / ICAM,5.89,immune system disease,Inhibition,
830,44391969,180486,23248053,CN([C@@H]1CCN(C1)c1cc(ccn1)-c1ccc(Sc2ccc3OCCOc3c2)c(c1)C(F)(F)F)C(C)=O,"N-[(3R)-1-[4-[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfanyl)-3-(trifluoromethyl)phenyl]pyridin-2-yl]pyrrolidin-3-yl]-N-methylacetamide","InChI=1S/C27H26F3N3O3S/c1-17(34)32(2)20-8-10-33(16-20)26-14-19(7-9-31-26)18-3-6-25(22(13-18)27(28,29)30)37-21-4-5-23-24(15-21)36-12-11-35-23/h3-7,9,13-15,20H,8,10-12,16H2,1-2H3/t20-/m1/s1",VWDMVVKQHNPLEH-HXUWFJFHSA-N,0,1,0,0,LFA / ICAM,6.77,immune system disease,Inhibition,
831,44818494,569321,24630549,CNc1nc(NCc2ccc(NC(=O)c3ccc(Cl)nc3)cc2)c2cc(C)ccc2n1,6-chloro-N-[4-[[[6-methyl-2-(methylamino)quinazolin-4-yl]amino]methyl]phenyl]pyridine-3-carboxamide,"InChI=1S/C23H21ClN6O/c1-14-3-9-19-18(11-14)21(30-23(25-2)29-19)27-12-15-4-7-17(8-5-15)28-22(31)16-6-10-20(24)26-13-16/h3-11,13H,12H2,1-2H3,(H,28,31)(H2,25,27,29,30)",YQPIBQOIIIQHCV-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,6.32,cancer,Inhibition,
832,168318063,,,CC(=O)c1ccc(NC(=O)NC(=O)[C@@H]2[C@@H](OC3([C@@H]2C(O)=O)C(=O)c2ccccc2C3=O)c2ccc(Cl)c(Cl)c2)cc1,,"InChI=1S/C29H20Cl2N2O8/c1-13(34)14-6-9-16(10-7-14)32-28(40)33-26(37)21-22(27(38)39)29(24(35)17-4-2-3-5-18(17)25(29)36)41-23(21)15-8-11-19(30)20(31)12-15/h2-12,21-23H,1H3,(H,38,39)(H2,32,33,37,40)/t21-,22-,23-/m0/s1",TVLLAOVDRNDJQN-VABKMULXSA-N,1,0,0,0,E2 / E1,6.42,human papilloma virus infection,Inhibition,
833,25138061,487964,24703805,C[C@H](N)C(=O)N[C@H]1CCCC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,10aS)-6-[[(2S)-2-aminopropanoyl]amino]-N-benzhydryl-5-oxo-2,3,6,7,8,9,10,10a-octahydro-1H-pyrrolo[1,2-a]azocine-3-carboxamide","InChI=1S/C27H34N4O3/c1-18(28)25(32)29-22-15-9-8-14-21-16-17-23(31(21)27(22)34)26(33)30-24(19-10-4-2-5-11-19)20-12-6-3-7-13-20/h2-7,10-13,18,21-24H,8-9,14-17,28H2,1H3,(H,29,32)(H,30,33)/t18-,21-,22-,23-/m0/s1",HUNKZBAXZXQBEQ-QGQQZZQASA-N,1,0,0,0,XIAP / Smac,7.85,cancer,Inhibition,
834,44818678,568852,24630681,Cc1ccc2c(NCc3ccc(NC(=O)c4ccc(F)cc4)cc3)nc(nc2c1)N1CCNCC1,4-fluoro-N-[4-[[(7-methyl-2-piperazin-1-ylquinazolin-4-yl)amino]methyl]phenyl]benzamide,"InChI=1S/C27H27FN6O/c1-18-2-11-23-24(16-18)32-27(34-14-12-29-13-15-34)33-25(23)30-17-19-3-9-22(10-4-19)31-26(35)20-5-7-21(28)8-6-20/h2-11,16,29H,12-15,17H2,1H3,(H,31,35)(H,30,32,33)",XDTNFQZQMHHVRT-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,6.49,cancer,Inhibition,
835,168318062,,,CCCCCCCc1ccc(CN(Cc2cccc(Oc3ccc(F)cc3)c2)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)cc1,,"InChI=1S/C33H34Cl2FNO4S/c1-2-3-4-5-6-8-24-11-13-25(14-12-24)22-37(42(39,40)32-21-27(34)20-31(35)33(32)38)23-26-9-7-10-30(19-26)41-29-17-15-28(36)16-18-29/h7,9-21,38H,2-6,8,22-23H2,1H3",QJMJOXKCZROUEE-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,7.40,cancer,Inhibition,
836,21906760,182877,10657264,OCCC1CCN(CC1)c1cc(ccn1)-c1ccc(Sc2ccc3OCCOc3c2)c(c1)C(F)(F)F,"2-[1-[4-[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfanyl)-3-(trifluoromethyl)phenyl]pyridin-2-yl]piperidin-4-yl]ethanol","InChI=1S/C27H27F3N2O3S/c28-27(29,30)22-15-19(1-4-25(22)36-21-2-3-23-24(17-21)35-14-13-34-23)20-5-9-31-26(16-20)32-10-6-18(7-11-32)8-12-33/h1-5,9,15-18,33H,6-8,10-14H2",ZMYOKTHPJKLGOG-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,6.88,immune system disease,Inhibition,
837,46836989,,,CN(C)CCCc1ccc(OCCCc2ccc(nc2C(O)=O)N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)c(F)c1,"6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-[3-[4-[3-(dimethylamino)propyl]-2-fluorophenoxy]propyl]pyridine-2-carboxylic acid","InChI=1S/C37H38FN5O4S/c1-42(2)19-6-8-24-14-16-31(29(38)22-24)47-21-7-10-26-15-17-33(40-34(26)36(45)46)43-20-18-25-9-5-11-27(28(25)23-43)35(44)41-37-39-30-12-3-4-13-32(30)48-37/h3-5,9,11-17,22H,6-8,10,18-21,23H2,1-2H3,(H,45,46)(H,39,41,44)",NACNDXYILJNIHK-UHFFFAOYSA-N,1,0,0,0,BCL2-Like / BAX,6.66,cancer,Inhibition,
838,44818680,569745,24634201,Cc1ccc2c(NCc3ccc(NC(=O)c4ccc(F)cc4)cc3)nc(nc2c1)N1CCNC(C)(C)C1,"N-[4-[[[2-(3,3-dimethylpiperazin-1-yl)-7-methylquinazolin-4-yl]amino]methyl]phenyl]-4-fluorobenzamide","InChI=1S/C29H31FN6O/c1-19-4-13-24-25(16-19)34-28(36-15-14-32-29(2,3)18-36)35-26(24)31-17-20-5-11-23(12-6-20)33-27(37)21-7-9-22(30)10-8-21/h4-13,16,32H,14-15,17-18H2,1-3H3,(H,33,37)(H,31,34,35)",YMPDOPQOELVBID-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,6.25,cancer,Inhibition,
839,168318061,,,Fc1c(Cl)cccc1-n1c(nc(-c2nn[nH]n2)c1-c1cc(Cl)ccc1-c1nnno1)-c1ccccc1,,"InChI=1S/C23H12Cl2FN9O/c24-13-9-10-14(23-30-33-34-36-23)15(11-13)20-19(21-28-31-32-29-21)27-22(12-5-2-1-3-6-12)35(20)17-8-4-7-16(25)18(17)26/h1-11H,(H,28,29,31,32)",JPGZOZFRNJWMQR-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,6.49,cancer,Inhibition,
840,45138993,,,CN[C@@H](C)C(=O)N[C@@H]([C@@H](C)OC)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2c1ncccn1)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(2S,3R)-1-[(3aR,6S,6aR)-6-(6-fluoro-1H-indol-3-yl)-4-pyrimidin-2-yl-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-3-methoxy-1-oxobutan-2-yl]-2-(methylamino)propanamide","InChI=1S/C27H34FN7O3/c1-15(29-3)25(36)33-23(16(2)38-4)26(37)34-11-8-22-24(34)20(14-35(22)27-30-9-5-10-31-27)19-13-32-21-12-17(28)6-7-18(19)21/h5-7,9-10,12-13,15-16,20,22-24,29,32H,8,11,14H2,1-4H3,(H,33,36)/t15-,16+,20+,22+,23-,24+/m0/s1",CMSYQZGHODNIEK-WCBDEGHASA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
841,11351960,378100,9526895,CN(C)C(=O)[C@@H]1N[C@H](CC(C)(C)C)[C@@]2([C@H]1c1cccc(Cl)c1)C(=O)Nc1cc(Cl)ccc21,"(2'R,3S,3'R,5'R)-6-chloro-3'-(3-chlorophenyl)-5'-(2,2-dimethylpropyl)-N,N-dimethyl-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide","InChI=1S/C25H29Cl2N3O2/c1-24(2,3)13-19-25(17-10-9-16(27)12-18(17)28-23(25)32)20(14-7-6-8-15(26)11-14)21(29-19)22(31)30(4)5/h6-12,19-21,29H,13H2,1-5H3,(H,28,32)/t19-,20+,21-,25+/m1/s1",XTJVNDMNVIYGHY-QDMVCWPOSA-N,1,3,0,0,MDM2-Like / P53,7.07,cancer,Inhibition,
842,46884436,1089023,24678343,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1nc(cs1)-c1ccc(F)c2ccccc12,"(2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluoronaphthalen-1-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C29H35FN4O2S/c1-18(31-2)27(35)33-26(19-9-4-3-5-10-19)29(36)34-16-8-13-25(34)28-32-24(17-37-28)22-14-15-23(30)21-12-7-6-11-20(21)22/h6-7,11-12,14-15,17-19,25-26,31H,3-5,8-10,13,16H2,1-2H3,(H,33,35)/t18-,25-,26-/m0/s1",OXVDUVSHCWCOFU-ATANMQQVSA-N,1,0,0,0,XIAP / Smac,7.72,cancer,Inhibition,
843,168318059,,,Cn1cnc(c1)C(=O)NC[C@H](NC(=O)c1c(Cl)cc2CN(CCc2c1Cl)C(=O)c1ccc(Cl)cc1)C(O)=O,,"InChI=1S/C25H22Cl3N5O5/c1-32-11-19(30-12-32)22(34)29-9-18(25(37)38)31-23(35)20-17(27)8-14-10-33(7-6-16(14)21(20)28)24(36)13-2-4-15(26)5-3-13/h2-5,8,11-12,18H,6-7,9-10H2,1H3,(H,29,34)(H,31,35)(H,37,38)/t18-/m0/s1",AFERVRCWFGPNPT-SFHVURJKSA-N,1,0,0,0,LFA / ICAM,6.25,immune system disease,Inhibition,
844,45138261,,,CN[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2C(C)=O)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(2S)-1-[(3aR,6S,6aR)-4-acetyl-6-(6-fluoro-1H-indol-3-yl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-3-hydroxy-1-oxopropan-2-yl]-2-(methylamino)propanamide","InChI=1S/C23H30FN5O4/c1-12(25-3)22(32)27-19(11-30)23(33)28-7-6-20-21(28)17(10-29(20)13(2)31)16-9-26-18-8-14(24)4-5-15(16)18/h4-5,8-9,12,17,19-21,25-26,30H,6-7,10-11H2,1-3H3,(H,27,32)/t12-,17+,19-,20+,21+/m0/s1",VNFFJLBYRHLXBO-PTIDVGSXSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
845,67175528,,,CNC(=O)[C@@H]1C[C@@H](CN1C(=O)[C@@H]1C[C@@H](CN1C(=O)[C@H](Cc1cccc(c1)C#N)NC(=O)[C@H](C)N)c1ccccc1)c1ccccc1,,"InChI=1S/C36H40N6O4/c1-23(38)33(43)40-30(17-24-10-9-11-25(16-24)20-37)35(45)42-22-29(27-14-7-4-8-15-27)19-32(42)36(46)41-21-28(18-31(41)34(44)39-2)26-12-5-3-6-13-26/h3-16,23,28-32H,17-19,21-22,38H2,1-2H3,(H,39,44)(H,40,43)/t23-,28-,29-,30-,31-,32-/m0/s1",TUIZWSRUJKHISI-HUZZHFCNSA-N,1,0,0,0,XIAP / Smac,8.00,cancer,Inhibition,
846,44570082,514298,24715677,C[C@@H]1Cc2ccccc2CN1C(=O)c1ccccc1-n1nc(cc1C)C(=O)N(c1ccccc1)c1ccccc1,"5-methyl-1-[2-[(3R)-3-methyl-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-N,N-diphenylpyrazole-3-carboxamide","InChI=1S/C34H30N4O2/c1-24-21-26-13-9-10-14-27(26)23-36(24)33(39)30-19-11-12-20-32(30)38-25(2)22-31(35-38)34(40)37(28-15-5-3-6-16-28)29-17-7-4-8-18-29/h3-20,22,24H,21,23H2,1-2H3/t24-/m1/s1",DJDZWMABYCHMDB-XMMPIXPASA-N,2,0,0,0,BCL2-Like / BAX,6.96,cancer,Inhibition,
847,168318056,,26362175,CN(C)CCC[C@](O)(c1ccccc1)c1cccc(OCCc2cccc(c2)-c2ccc(cc2)C(O)=O)c1,4-[3-[2-[3-[4-(dimethylamino)-1-hydroxy-1-phenylbutyl]phenoxy]ethyl]phenyl]benzoic acid,"InChI=1S/C33H35NO4/c1-34(2)21-8-20-33(37,29-11-4-3-5-12-29)30-13-7-14-31(24-30)38-22-19-25-9-6-10-28(23-25)26-15-17-27(18-16-26)32(35)36/h3-7,9-18,23-24,37H,8,19-22H2,1-2H3,(H,35,36)/t33-/m0/s1",WFNGHARBPPOEQT-XIFFEERXSA-N,1,0,0,0,BCL2-Like / BAX,5.30,cancer,Inhibition,
848,10279849,183680,8455326,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1cc(ncn1)N1CCC(CC1)c1nn[nH]n1,4-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]-6-[4-(2H-tetrazol-5-yl)piperidin-1-yl]pyrimidine,"InChI=1S/C26H26F3N7S/c1-16(2)19-5-3-4-6-22(19)37-23-8-7-18(13-20(23)26(27,28)29)21-14-24(31-15-30-21)36-11-9-17(10-12-36)25-32-34-35-33-25/h3-8,13-17H,9-12H2,1-2H3,(H,32,33,34,35)",BKXTXBYRPWNSJQ-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,6.97,immune system disease,Inhibition,
849,42601679,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCC(CC1)N(Cc1ccccc1)C(=O)c1ccccc1,4-[4-[benzoyl(benzyl)amino]piperidin-1-yl]-N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonylbenzamide,"InChI=1S/C44H48N6O6S2/c1-47(2)27-24-36(32-57-39-16-10-5-11-17-39)45-41-23-22-40(30-42(41)50(53)54)58(55,56)46-43(51)34-18-20-37(21-19-34)48-28-25-38(26-29-48)49(31-33-12-6-3-7-13-33)44(52)35-14-8-4-9-15-35/h3-23,30,36,38,45H,24-29,31-32H2,1-2H3,(H,46,51)/t36-/m1/s1",RNYUNUOURBEZGA-PSXMRANNSA-N,1,0,0,0,BCL2-Like / BAX,5.30,cancer,Inhibition,
850,25050120,,,Fc1ccc(cc1C#N)S(=O)(=O)N1[C@@H]([C@H](c2ccc(Cl)cc2)n2c1cccc2=O)c1ccc(Cl)cc1,"5-[[(2R,3S)-2,3-bis(4-chlorophenyl)-5-oxo-2,3-dihydroimidazo[1,2-a]pyridin-1-yl]sulfonyl]-2-fluorobenzonitrile","InChI=1S/C26H16Cl2FN3O3S/c27-19-8-4-16(5-9-19)25-26(17-6-10-20(28)11-7-17)32(23-2-1-3-24(33)31(23)25)36(34,35)21-12-13-22(29)18(14-21)15-30/h1-14,25-26H/t25-,26+/m0/s1",MBFAQFKAHAKPOL-IZZNHLLZSA-N,1,0,0,0,MDM2-Like / P53,6.30,cancer,Inhibition,
851,16735541,226678,20567018,CC(C)Cc1c(O)c(O)c(O)c2c1oc(C)cc2=O,"5,6,7-trihydroxy-2-methyl-8-(2-methylpropyl)chromen-4-one","InChI=1S/C14H16O5/c1-6(2)4-8-11(16)13(18)12(17)10-9(15)5-7(3)19-14(8)10/h5-6,16-18H,4H2,1-3H3",ADNKLAAIRXDEOP-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,6.14,cancer,Inhibition,
852,25000448,,,CC(C)(C)C[C@H]1N([C@H]([C@H](c2ccc(F)c(Cl)c2)[C@@]11C(=O)Nc2cc(Cl)c(F)cc12)C(=O)NCC[C@H](O)CO)S(=O)(=O)C(F)(F)F,"(2'R,3S,3'R,5'R)-6-chloro-3'-(3-chloro-4-fluorophenyl)-N-[(3S)-3,4-dihydroxybutyl]-5'-(2,2-dimethylpropyl)-5-fluoro-2-oxo-1'-(trifluoromethylsulfonyl)spiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide","InChI=1S/C28H30Cl2F5N3O6S/c1-26(2,3)11-21-27(15-9-19(32)17(30)10-20(15)37-25(27)42)22(13-4-5-18(31)16(29)8-13)23(24(41)36-7-6-14(40)12-39)38(21)45(43,44)28(33,34)35/h4-5,8-10,14,21-23,39-40H,6-7,11-12H2,1-3H3,(H,36,41)(H,37,42)/t14-,21+,22-,23+,27-/m0/s1",YMVUATWSTDRZRR-LYAXWJQESA-N,1,3,0,0,MDM2-Like / P53,5.55,cancer,Inhibition,
853,44818858,569002,24632092,Cc1ccc2c(NCc3ccc(NC(=O)c4ccc(F)cc4)cc3)nc(nc2c1)N1CCOCC1,4-fluoro-N-[4-[[(7-methyl-2-morpholin-4-ylquinazolin-4-yl)amino]methyl]phenyl]benzamide,"InChI=1S/C27H26FN5O2/c1-18-2-11-23-24(16-18)31-27(33-12-14-35-15-13-33)32-25(23)29-17-19-3-9-22(10-4-19)30-26(34)20-5-7-21(28)8-6-20/h2-11,16H,12-15,17H2,1H3,(H,30,34)(H,29,31,32)",NBQAGLPJFGLCAC-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,6.20,cancer,Inhibition,
854,168318049,,,Cn1ncc2c1nc(-c1cccc(N)c1)c1c2[nH]n(-c2ccc(F)cc2)c1=O,,"InChI=1S/C20H15FN6O/c1-26-19-15(10-23-26)18-16(17(24-19)11-3-2-4-13(22)9-11)20(28)27(25-18)14-7-5-12(21)6-8-14/h2-10,25H,22H2,1H3",YZRQBRVRVKEHSG-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,6.40,cancer,Inhibition,
855,168318053,,,CCN(Cc1ccc(cc1)C#N)[C@H]1C[C@@H]2N(C1)C(=O)N(C2=O)c1cc(Cl)cc(Cl)c1,,"InChI=1S/C22H20Cl2N4O2/c1-2-26(12-15-5-3-14(11-25)4-6-15)19-10-20-21(29)28(22(30)27(20)13-19)18-8-16(23)7-17(24)9-18/h3-9,19-20H,2,10,12-13H2,1H3/t19-,20-/m0/s1",YFMNNQNVKODXCQ-PMACEKPBSA-N,0,1,0,0,LFA / ICAM,6.14,immune system disease,Inhibition,
856,168318047,,,CCOc1ccc(cc1C1=N[C@H]([C@H](N1C(=O)N1CCN(CC(=O)NC)CC1)c1ccc(Cl)cc1)c1ccc(Cl)cc1)S(=O)(=O)N[C@H](C)COC,"2-[4-[4,5-bis(4-chlorophenyl)-2-[2-ethoxy-5-(1-methoxypropan-2-ylsulfamoyl)phenyl]-4,5-dihydroimidazole-1-carbonyl]piperazin-1-yl]-N-methylacetamide","InChI=1S/C35H42Cl2N6O6S/c1-5-49-30-15-14-28(50(46,47)40-23(2)22-48-4)20-29(30)34-39-32(24-6-10-26(36)11-7-24)33(25-8-12-27(37)13-9-25)43(34)35(45)42-18-16-41(17-19-42)21-31(44)38-3/h6-15,20,23,32-33,40H,5,16-19,21-22H2,1-4H3,(H,38,44)/t23-,32+,33-/m1/s1",CEMZGRKTHBDBFV-UMJMCJBLSA-N,1,0,0,0,MDM2-Like / P53,7.24,cancer,Inhibition,
857,44304894,62388,23155725,OC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1cc(Br)ccc1Cl,(2S)-2-[(5-bromo-2-chlorobenzoyl)amino]-3-(1H-indol-3-yl)propanoic acid,"InChI=1S/C18H14BrClN2O3/c19-11-5-6-14(20)13(8-11)17(23)22-16(18(24)25)7-10-9-21-15-4-2-1-3-12(10)15/h1-6,8-9,16,21H,7H2,(H,22,23)(H,24,25)/t16-/m0/s1",FUNKHNLWVFIKCW-INIZCTEOSA-N,1,0,0,0,LFA / ICAM,4.75,immune system disease,Inhibition,
858,44570045,500574,24710782,CN(C)C[C@@H]1Cc2ccccc2CN1C(=O)c1ccccc1-n1nc(cc1C)C(=O)N(c1ccccc1)c1ccccc1,"1-[2-[(3S)-3-[(dimethylamino)methyl]-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-5-methyl-N,N-diphenylpyrazole-3-carboxamide","InChI=1S/C36H35N5O2/c1-26-22-33(36(43)40(29-16-6-4-7-17-29)30-18-8-5-9-19-30)37-41(26)34-21-13-12-20-32(34)35(42)39-24-28-15-11-10-14-27(28)23-31(39)25-38(2)3/h4-22,31H,23-25H2,1-3H3/t31-/m0/s1",KIRNMAGSVAWHCO-HKBQPEDESA-N,2,0,0,0,BCL2-Like / BAX,6.82,cancer,Inhibition,
859,44237049,578000,24639220,CCNC[C@H]1CC[C@H]2CC[C@H](N2C(=O)[C@H]1NC(=O)[C@@H](N)CC)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7R,9aS)-6-[[(2S)-2-aminobutanoyl]amino]-N-benzhydryl-7-(ethylaminomethyl)-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C30H41N5O3/c1-3-24(31)28(36)34-27-22(19-32-4-2)15-16-23-17-18-25(35(23)30(27)38)29(37)33-26(20-11-7-5-8-12-20)21-13-9-6-10-14-21/h5-14,22-27,32H,3-4,15-19,31H2,1-2H3,(H,33,37)(H,34,36)/t22-,23+,24+,25+,27+/m1/s1",DXHHOMHJRYFCHK-HOIWYFOJSA-N,2,1,0,0,XIAP / Smac,6.62,cancer,Inhibition,
860,168318051,,,CC(C)c1cn(nn1)C(=O)NC[C@H](NC(=O)c1c(Cl)cc2CN(CCc2c1Cl)C(=O)c1cc2ccccc2o1)C(O)=O,,"InChI=1S/C28H26Cl2N6O6/c1-14(2)20-13-36(34-33-20)28(41)31-11-19(27(39)40)32-25(37)23-18(29)9-16-12-35(8-7-17(16)24(23)30)26(38)22-10-15-5-3-4-6-21(15)42-22/h3-6,9-10,13-14,19H,7-8,11-12H2,1-2H3,(H,31,41)(H,32,37)(H,39,40)/t19-/m0/s1",GYVWYRULTQYYOJ-IBGZPJMESA-N,1,0,0,0,LFA / ICAM,8.30,immune system disease,Inhibition,
861,168318054,,26363799,CN(C)CCC[C@](O)(c1ccccc1)c1cccc(CCOc2ccc(cc2)-c2ccc(cc2)C(O)=O)c1,4-[4-[2-[3-[4-(dimethylamino)-1-hydroxy-1-phenylbutyl]phenyl]ethoxy]phenyl]benzoic acid,"InChI=1S/C33H35NO4/c1-34(2)22-7-21-33(37,29-9-4-3-5-10-29)30-11-6-8-25(24-30)20-23-38-31-18-16-27(17-19-31)26-12-14-28(15-13-26)32(35)36/h3-6,8-19,24,37H,7,20-23H2,1-2H3,(H,35,36)/t33-/m0/s1",LZQAWDUSDZHIAS-XIFFEERXSA-N,1,0,0,0,BCL2-Like / BAX,5.47,cancer,Inhibition,
862,67954302,,,OC(=O)Cc1ccc(Cl)c(F)c1-n1c(nc(C(=O)OCc2ccccc2)c1-c1ccc(F)c(Cl)c1)C1CCCCC1,,"InChI=1S/C31H26Cl2F2N2O4/c32-22-13-11-21(16-25(38)39)28(26(22)35)37-29(20-12-14-24(34)23(33)15-20)27(36-30(37)19-9-5-2-6-10-19)31(40)41-17-18-7-3-1-4-8-18/h1,3-4,7-8,11-15,19H,2,5-6,9-10,16-17H2,(H,38,39)",NLRHSJVARIXWGQ-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,7.21,cancer,Inhibition,
863,44432173,232747,23294394,Clc1cc(Cl)cc(c1)C1=C(C2CC2)[C@]2(Cc3ccc(Br)cc3)CCCN2C1=O,"8-[(4-bromophenyl)methyl]-1-cyclopropyl-2-(3,5-dichlorophenyl)-6,7-dihydro-5H-pyrrolizin-3-one","InChI=1S/C23H20BrCl2NO/c24-17-6-2-14(3-7-17)13-23-8-1-9-27(23)22(28)20(21(23)15-4-5-15)16-10-18(25)12-19(26)11-16/h2-3,6-7,10-12,15H,1,4-5,8-9,13H2/t23-/m1/s1",NWRRQZMRUZUINI-HSZRJFAPSA-N,0,1,0,0,LFA / ICAM,6.70,immune system disease,Inhibition,
864,12096159,,11591252,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(cc2)S(N)(=O)=O)c1=O,"4-[6-methyl-3-oxo-4-[3-(trifluoromethyl)phenyl]-1H-dipyrazolo[4,3-b:4',5'-e]pyridin-2-yl]benzenesulfonamide","InChI=1S/C21H15F3N6O3S/c1-29-19-15(10-26-29)18-16(17(27-19)11-3-2-4-12(9-11)21(22,23)24)20(31)30(28-18)13-5-7-14(8-6-13)34(25,32)33/h2-10,28H,1H3,(H2,25,32,33)",HYXMPCIQSWHPTK-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,6.82,cancer,Inhibition,
865,168318050,,,C[C@H](N)c1cccc(c1)C(=O)N1C[C@H](C[C@H]1C(=O)N1CC[C@@H](C1)c1ccccc1)c1ccccc1,"[(2S,4R)-1-[3-(1-aminoethyl)benzoyl]-4-phenylpyrrolidin-2-yl]-[(3R)-3-phenylpyrrolidin-1-yl]methanone","InChI=1S/C30H33N3O2/c1-21(31)24-13-8-14-25(17-24)29(34)33-20-27(23-11-6-3-7-12-23)18-28(33)30(35)32-16-15-26(19-32)22-9-4-2-5-10-22/h2-14,17,21,26-28H,15-16,18-20,31H2,1H3/t21-,26-,27-,28-/m0/s1",IXDMKRKRHAHJTH-FYYOVZQQSA-N,1,0,0,0,XIAP / Smac,6.30,cancer,Inhibition,
866,25050420,,,OC(=O)c1cccc(c1)S(=O)(=O)N1[C@@H]([C@H](c2ccc(Cl)cc2)n2c1cccc2=O)c1ccc(Cl)cc1,"3-[[(2R,3S)-2,3-bis(4-chlorophenyl)-5-oxo-2,3-dihydroimidazo[1,2-a]pyridin-1-yl]sulfonyl]benzoic acid","InChI=1S/C26H18Cl2N2O5S/c27-19-11-7-16(8-12-19)24-25(17-9-13-20(28)14-10-17)30(22-5-2-6-23(31)29(22)24)36(34,35)21-4-1-3-18(15-21)26(32)33/h1-15,24-25H,(H,32,33)/t24-,25+/m0/s1",GKOOCADGJMOSAG-LOSJGSFVSA-N,1,0,0,0,MDM2-Like / P53,6.11,cancer,Inhibition,
867,45137798,,,CCOC(=O)CN1C[C@@H]([C@@H]2[C@H]1CCN2C(=O)[C@@H](NC(=O)[C@H](C)NC)C1CCCCC1)c1c[nH]c2cc(F)ccc12,"ethyl 2-[(3aR,6S,6aR)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-6-(6-fluoro-1H-indol-3-yl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-4-yl]acetate","InChI=1S/C30H42FN5O4/c1-4-40-26(37)17-35-16-23(22-15-33-24-14-20(31)10-11-21(22)24)28-25(35)12-13-36(28)30(39)27(19-8-6-5-7-9-19)34-29(38)18(2)32-3/h10-11,14-15,18-19,23,25,27-28,32-33H,4-9,12-13,16-17H2,1-3H3,(H,34,38)/t18-,23+,25+,27-,28+/m0/s1",VCUHEWXBDBSJOB-SXVHJFGSSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
868,66616574,,,OC(=O)c1ccc(cc1)S(=O)(=O)NCc1cccc(CN(Cc2ccc(cc2)-c2ccccc2)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)c1,,"InChI=1S/C34H28Cl2N2O7S2/c35-29-18-31(36)33(39)32(19-29)47(44,45)38(21-23-9-11-27(12-10-23)26-7-2-1-3-8-26)22-25-6-4-5-24(17-25)20-37-46(42,43)30-15-13-28(14-16-30)34(40)41/h1-19,37,39H,20-22H2,(H,40,41)",AWZMUMQGJNSDGL-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,6.69,cancer,Inhibition,
869,168318046,,,OC(=O)[C@@H]1[C@@H]([C@@H](OC11C(=O)c2ccccc2C1=O)c1ccc(Cl)c(Cl)c1)C(=O)NC(=O)Nc1ccc(cc1)-c1csnn1,,"InChI=1S/C29H18Cl2N4O7S/c30-18-10-7-14(11-19(18)31)23-21(22(27(39)40)29(42-23)24(36)16-3-1-2-4-17(16)25(29)37)26(38)33-28(41)32-15-8-5-13(6-9-15)20-12-43-35-34-20/h1-12,21-23H,(H,39,40)(H2,32,33,38,41)/t21-,22-,23-/m0/s1",MXYALQDQBOVGKT-VABKMULXSA-N,1,0,0,0,E2 / E1,6.82,human papilloma virus infection,Inhibition,
870,44390650,182149,23246672,CC(C)c1ccc2NC(=O)[C@@H](N([C@H](C(O)=O)c3ccc(Cl)cc3)C(=O)c2c1)c1ccc(Cl)cc1,"2-(4-chlorophenyl)-2-[3-(4-chlorophenyl)-2,5-dioxo-7-propan-2-yl-1,3-dihydro-1,4-benzodiazepin-4-yl]acetic acid","InChI=1S/C26H22Cl2N2O4/c1-14(2)17-7-12-21-20(13-17)25(32)30(23(26(33)34)16-5-10-19(28)11-6-16)22(24(31)29-21)15-3-8-18(27)9-4-15/h3-14,22-23H,1-2H3,(H,29,31)(H,33,34)/t22-,23-/m0/s1",FSGBJNDTAIPOPY-GOTSBHOMSA-N,1,0,0,0,MDM2-Like / P53,5.99,cancer,Inhibition,
871,45138262,,,CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2C(C)=O)c1c[nH]c2ccc(F)cc12,"(2S)-N-[(2S)-1-[(3aR,6S,6aR)-4-acetyl-6-(5-fluoro-1H-indol-3-yl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-1-oxobutan-2-yl]-2-(methylamino)propanamide","InChI=1S/C24H32FN5O3/c1-5-19(28-23(32)13(2)26-4)24(33)29-9-8-21-22(29)18(12-30(21)14(3)31)17-11-27-20-7-6-15(25)10-16(17)20/h6-7,10-11,13,18-19,21-22,26-27H,5,8-9,12H2,1-4H3,(H,28,32)/t13-,18+,19-,21+,22+/m0/s1",LISDIDPRLJMBPJ-NTFMPISFSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
872,168318044,,,CN(C)CCN(Cc1ccccc1)C(=O)[C@@H](Cc1c[nH]c2ccccc12)Nc1ccc(Nc2ccncc2)cc1,N-benzyl-N-[2-(dimethylamino)ethyl]-3-(1H-indol-3-yl)-2-[4-(pyridin-4-ylamino)anilino]propanamide,"InChI=1S/C33H36N6O/c1-38(2)20-21-39(24-25-8-4-3-5-9-25)33(40)32(22-26-23-35-31-11-7-6-10-30(26)31)37-28-14-12-27(13-15-28)36-29-16-18-34-19-17-29/h3-19,23,32,35,37H,20-22,24H2,1-2H3,(H,34,36)/t32-/m1/s1",GNGOPPXEXLXIFJ-JGCGQSQUSA-N,1,1,0,0,MDM2-Like / P53,7.20,cancer,Inhibition,
873,11585668,,9760433,CCOc1cc(ccc1C1=N[C@H]([C@H](N1C(=O)N1CCN(CCS(C)(=O)=O)CC1)c1ccc(cc1)C#C)c1ccc(cc1)C#C)C(C)(C)C,"[(4S,5R)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-ethynylphenyl)-4,5-dihydroimidazol-1-yl]-[4-(2-methylsulfonylethyl)piperazin-1-yl]methanone","InChI=1S/C39H44N4O4S/c1-8-28-11-15-30(16-12-28)35-36(31-17-13-29(9-2)14-18-31)43(38(44)42-23-21-41(22-24-42)25-26-48(7,45)46)37(40-35)33-20-19-32(39(4,5)6)27-34(33)47-10-3/h1-2,11-20,27,35-36H,10,21-26H2,3-7H3/t35-,36+/m0/s1",ZRQGVPCOWLNSDI-MPQUPPDSSA-N,1,0,0,0,MDM2-Like / P53,7.96,cancer,Inhibition,
874,168318043,,,O[C@@H]1CCc2c1nccc2Nc1ccc2N(CCc3c[nH]c4ccccc34)CC3(CCCCC3)Oc2c1,"4-[[4-[2-(1H-indol-3-yl)ethyl]spiro[3H-1,4-benzoxazine-2,1'-cyclohexane]-7-yl]amino]-6,7-dihydro-5H-cyclopenta[b]pyridin-7-ol","InChI=1S/C31H34N4O2/c36-28-11-9-24-26(12-16-32-30(24)28)34-22-8-10-27-29(18-22)37-31(14-4-1-5-15-31)20-35(27)17-13-21-19-33-25-7-3-2-6-23(21)25/h2-3,6-8,10,12,16,18-19,28,33,36H,1,4-5,9,11,13-15,17,20H2,(H,32,34)/t28-/m1/s1",NGSSANCPKQDBLY-MUUNZHRXSA-N,1,1,0,0,MDM2-Like / P53,5.29,cancer,Inhibition,
875,58007288,,,CC(C)C1=C(SC2=N[C@](C)([C@H](N12)c1ccc(Cl)cc1)c1ccc(Cl)cc1)C(=O)N1CCC[C@H]1c1nnc(C)o1,"[(5R,6S)-5,6-bis(4-chlorophenyl)-6-methyl-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazol-2-yl]-[(2S)-2-(5-methyl-1,3,4-oxadiazol-2-yl)pyrrolidin-1-yl]methanone","InChI=1S/C29H29Cl2N5O2S/c1-16(2)23-24(27(37)35-15-5-6-22(35)26-34-33-17(3)38-26)39-28-32-29(4,19-9-13-21(31)14-10-19)25(36(23)28)18-7-11-20(30)12-8-18/h7-14,16,22,25H,5-6,15H2,1-4H3/t22-,25+,29-/m0/s1",RBSUVUCANRWZSG-HQQGYVGFSA-N,1,0,0,0,MDM2-Like / P53,8.00,cancer,Inhibition,
876,168318041,,24640216,C[C@@H](Oc1cncc2ccccc12)C(=O)N1CCN(C[C@H]1C)C(=O)c1ccccc1,1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-isoquinolin-4-yloxypropan-1-one,"InChI=1S/C24H25N3O3/c1-17-16-26(24(29)19-8-4-3-5-9-19)12-13-27(17)23(28)18(2)30-22-15-25-14-20-10-6-7-11-21(20)22/h3-11,14-15,17-18H,12-13,16H2,1-2H3/t17-,18-/m1/s1",XNONUSSMFODISQ-QZTJIDSGSA-N,0,1,0,0,CD4 / gp120,5.03,HIV infectious disease,Inhibition,
877,168318040,,26364071,CN(C)CCC[C@](O)(c1ccccc1)c1ccc(OCCOc2ccc(cc2)-c2ccc(cc2)C(O)=O)cc1,4-[4-[2-[4-[4-(dimethylamino)-1-hydroxy-1-phenylbutyl]phenoxy]ethoxy]phenyl]benzoic acid,"InChI=1S/C33H35NO5/c1-34(2)22-6-21-33(37,28-7-4-3-5-8-28)29-15-19-31(20-16-29)39-24-23-38-30-17-13-26(14-18-30)25-9-11-27(12-10-25)32(35)36/h3-5,7-20,37H,6,21-24H2,1-2H3,(H,35,36)/t33-/m0/s1",NYJJMCPHLCWNLP-XIFFEERXSA-N,1,0,0,0,BCL2-Like / BAX,6.00,cancer,Inhibition,
878,59555739,,,COc1ccc2nccc(Nc3ccc(NCCc4c[nH]c5ccccc45)cc3)c2c1,"1-N-[2-(1H-indol-3-yl)ethyl]-4-N-(6-methoxyquinolin-4-yl)benzene-1,4-diamine","InChI=1S/C26H24N4O/c1-31-21-10-11-25-23(16-21)26(13-15-28-25)30-20-8-6-19(7-9-20)27-14-12-18-17-29-24-5-3-2-4-22(18)24/h2-11,13,15-17,27,29H,12,14H2,1H3,(H,28,30)",PLMOVNPXWXCUBP-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,8.00,cancer,Inhibition,
879,44580528,495906,24705809,FC(F)(F)c1c(Sc2cccc(OC3CCNCC3)c2)ccc(\C=C\C(=O)N2CCOCC2)c1C(F)(F)F,"(E)-1-morpholin-4-yl-3-[4-(3-piperidin-4-yloxyphenyl)sulfanyl-2,3-bis(trifluoromethyl)phenyl]prop-2-en-1-one","InChI=1S/C26H26F6N2O3S/c27-25(28,29)23-17(5-7-22(35)34-12-14-36-15-13-34)4-6-21(24(23)26(30,31)32)38-20-3-1-2-19(16-20)37-18-8-10-33-11-9-18/h1-7,16,18,33H,8-15H2/b7-5+",LLDYORSLNIEEGL-FNORWQNLSA-N,1,0,0,0,LFA / ICAM,8.41,immune system disease,Inhibition,
880,44580241,501430,24711079,FC(F)(F)c1c(Sc2cccc(OCc3ccncc3)c2)ccc(\C=C\C(=O)N2CCOCC2)c1C(F)(F)F,"(E)-1-morpholin-4-yl-3-[4-[3-(pyridin-4-ylmethoxy)phenyl]sulfanyl-2,3-bis(trifluoromethyl)phenyl]prop-2-en-1-one","InChI=1S/C27H22F6N2O3S/c28-26(29,30)24-19(5-7-23(36)35-12-14-37-15-13-35)4-6-22(25(24)27(31,32)33)39-21-3-1-2-20(16-21)38-17-18-8-10-34-11-9-18/h1-11,16H,12-15,17H2/b7-5+",LUWQOLUBBVTNCZ-FNORWQNLSA-N,1,0,0,0,LFA / ICAM,7.28,immune system disease,Inhibition,
881,11429547,181872,9604423,C[C@H](N)C(=O)Nc1nc(c(s1)-c1ccccc1)-c1ccc(Br)cc1,"(2S)-2-amino-N-[4-(4-bromophenyl)-5-phenyl-1,3-thiazol-2-yl]propanamide","InChI=1S/C18H16BrN3OS/c1-11(20)17(23)22-18-21-15(12-7-9-14(19)10-8-12)16(24-18)13-5-3-2-4-6-13/h2-11H,20H2,1H3,(H,21,22,23)/t11-/m0/s1",LETBSEIOGAQYDW-NSHDSACASA-N,1,0,0,0,XIAP / Smac,6.13,cancer,Inhibition,
882,168318038,,24635106,CC[C@H]1CN(CCN1C(=O)c1ccccc1)C(=O)C(=O)c1c[nH]c2cccc(F)c12,"1-(4-benzoyl-3-ethylpiperazin-1-yl)-2-(4-fluoro-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C23H22FN3O3/c1-2-16-14-26(11-12-27(16)22(29)15-7-4-3-5-8-15)23(30)21(28)17-13-25-19-10-6-9-18(24)20(17)19/h3-10,13,16,25H,2,11-12,14H2,1H3/t16-/m0/s1",JIYDSLCGNMDXBR-INIZCTEOSA-N,0,1,0,0,CD4 / gp120,8.25,HIV infectious disease,Inhibition,
883,45137063,,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2Cc1ccccc1)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(1S)-2-[(3aR,6S,6aR)-4-benzyl-6-(6-fluoro-1H-indol-3-yl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-1-cyclohexyl-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C33H42FN5O2/c1-21(35-2)32(40)37-30(23-11-7-4-8-12-23)33(41)39-16-15-29-31(39)27(20-38(29)19-22-9-5-3-6-10-22)26-18-36-28-17-24(34)13-14-25(26)28/h3,5-6,9-10,13-14,17-18,21,23,27,29-31,35-36H,4,7-8,11-12,15-16,19-20H2,1-2H3,(H,37,40)/t21-,27+,29+,30-,31+/m0/s1",RQFHSZAPAZYHFC-USSLBTQDSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
884,67031670,3260817,,Cc1nnc(o1)-c1nc(C2CCCCC2)n(c1-c1ccc(F)c(Cl)c1)-c1cccc(Cl)c1F,,"InChI=1S/C24H20Cl2F2N4O/c1-13-30-31-24(33-13)21-22(15-10-11-18(27)17(26)12-15)32(19-9-5-8-16(25)20(19)28)23(29-21)14-6-3-2-4-7-14/h5,8-12,14H,2-4,6-7H2,1H3",WSYHJRPECYYALB-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,8.10,cancer,Inhibition,
885,24875322,452882,24688666,O=C(O)[C@@H]1CC[C@@H](CC1)COc1ccccc1Sc1ccc(\C=C\C(=O)N2CCOCC2)c(C(F)(F)F)c1C(F)(F)F,"4-[[2-[4-[(E)-3-morpholin-4-yl-3-oxoprop-1-enyl]-2,3-bis(trifluoromethyl)phenyl]sulfanylphenoxy]methyl]cyclohexane-1-carboxylic acid","InChI=1S/C29H29F6NO5S/c30-28(31,32)25-19(10-12-24(37)36-13-15-40-16-14-36)9-11-23(26(25)29(33,34)35)42-22-4-2-1-3-21(22)41-17-18-5-7-20(8-6-18)27(38)39/h1-4,9-12,18,20H,5-8,13-17H2,(H,38,39)/b12-10+/t18-,20+",AXSOGTWJBSDWJQ-WZEPYWGYSA-N,1,0,0,0,LFA / ICAM,9.40,immune system disease,Inhibition,
886,168318037,,,FC(F)(F)S(=O)(=O)c1cc(ccc1N[C@H](CCN1CCOCC1)CSc1ccccc1)S(=O)(=O)Nc1nnc2CCCN(CCn12)C1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1,,"InChI=1S/C46H54ClF3N8O5S3/c47-36-14-12-34(13-15-36)41-10-5-4-7-35(41)32-56-23-19-38(20-24-56)57-21-6-11-44-52-53-45(58(44)26-25-57)54-66(61,62)40-16-17-42(43(31-40)65(59,60)46(48,49)50)51-37(18-22-55-27-29-63-30-28-55)33-64-39-8-2-1-3-9-39/h1-5,7-10,12-17,31,37-38,51H,6,11,18-30,32-33H2,(H,53,54)/t37-/m1/s1",NLFKRXQLNYARFY-DIPNUNPCSA-N,1,0,0,0,BCL2-Like / BAX,6.71,cancer,Inhibition,
887,11634068,,9808812,OC(=O)c1ccc(NC(=O)c2cccc(Cc3cccc(F)c3)c2)c(Cc2ccc(cc2)C#N)c1,3-[(4-cyanophenyl)methyl]-4-[[3-[(3-fluorophenyl)methyl]benzoyl]amino]benzoic acid,"InChI=1S/C29H21FN2O3/c30-26-6-2-4-22(16-26)13-21-3-1-5-23(15-21)28(33)32-27-12-11-24(29(34)35)17-25(27)14-19-7-9-20(18-31)10-8-19/h1-12,15-17H,13-14H2,(H,32,33)(H,34,35)",GMSVQYDCHDOBPA-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,4.57,cancer,Inhibition,
888,168318035,,,O[C@H]1CCc2c1nccc2Nc1ccc2N(CCc3coc4ccccc34)CCOc2c1,"4-[[4-[2-(1-benzofuran-3-yl)ethyl]-2,3-dihydro-1,4-benzoxazin-7-yl]amino]-6,7-dihydro-5H-cyclopenta[b]pyridin-7-ol","InChI=1S/C26H25N3O3/c30-23-8-6-20-21(9-11-27-26(20)23)28-18-5-7-22-25(15-18)31-14-13-29(22)12-10-17-16-32-24-4-2-1-3-19(17)24/h1-5,7,9,11,15-16,23,30H,6,8,10,12-14H2,(H,27,28)/t23-/m0/s1",DNVCONDEMXUEEB-QHCPKHFHSA-N,1,1,0,0,MDM2-Like / P53,5.19,cancer,Inhibition,
889,506240,493000,442071,Fc1c(F)c(F)c2c(c[nH]c2c1F)C(=O)C(=O)N1CCN(CC1)C(=O)c1ccccc1,"1-(4-benzoylpiperazin-1-yl)-2-(4,5,6,7-tetrafluoro-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C21H15F4N3O3/c22-14-13-12(10-26-18(13)17(25)16(24)15(14)23)19(29)21(31)28-8-6-27(7-9-28)20(30)11-4-2-1-3-5-11/h1-5,10,26H,6-9H2",BDEQBANKDGSIBF-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,8.77,HIV infectious disease,Inhibition,
890,88531111,,,Cc1cccc(c1)-c1nc(C(=O)NO)c(-c2cccc(Cl)c2)n1-c1cc(Cl)ccc1C,,"InChI=1S/C24H19Cl2N3O2/c1-14-5-3-7-17(11-14)23-27-21(24(30)28-31)22(16-6-4-8-18(25)12-16)29(23)20-13-19(26)10-9-15(20)2/h3-13,31H,1-2H3,(H,28,30)",LGJFOXJNHOFDRR-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,6.55,cancer,Inhibition,
891,25181391,517577,24716934,Cc1cc(nn1-c1ccccc1C(=O)N1CCc2ccccc2C1)C(=O)N(c1ccccc1)c1ccccc1,"1-[2-(3,4-dihydro-1H-isoquinoline-2-carbonyl)phenyl]-5-methyl-N,N-diphenylpyrazole-3-carboxamide","InChI=1S/C33H28N4O2/c1-24-22-30(33(39)36(27-14-4-2-5-15-27)28-16-6-3-7-17-28)34-37(24)31-19-11-10-18-29(31)32(38)35-21-20-25-12-8-9-13-26(25)23-35/h2-19,22H,20-21,23H2,1H3",GTQPMXUXXJDUHK-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,6.10,cancer,Inhibition,
892,67032583,,,Fc1ccc(cc1Cl)-c1c(nc(-c2ccc3sccc3c2)n1-c1cccc(Cl)c1F)-c1nn[nH]n1,,"InChI=1S/C24H12Cl2F2N6S/c25-15-2-1-3-18(20(15)28)34-22(13-4-6-17(27)16(26)11-13)21(23-30-32-33-31-23)29-24(34)14-5-7-19-12(10-14)8-9-35-19/h1-11H,(H,30,31,32,33)",BEZWXBGMLGMHSE-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,8.59,cancer,Inhibition,
893,44818312,569962,24633651,CNc1nc(NCc2ccc(NC(=O)c3ccc(Cl)cc3)cc2)c2cccc(C)c2n1,4-chloro-N-[4-[[[8-methyl-2-(methylamino)quinazolin-4-yl]amino]methyl]phenyl]benzamide,"InChI=1S/C24H22ClN5O/c1-15-4-3-5-20-21(15)29-24(26-2)30-22(20)27-14-16-6-12-19(13-7-16)28-23(31)17-8-10-18(25)11-9-17/h3-13H,14H2,1-2H3,(H,28,31)(H2,26,27,29,30)",MHNXYZVWDASRHS-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,6.39,cancer,Inhibition,
894,168318034,,23241103,CN1CCN(CC1)c1ccccc1Sc1ccc(cc1C(F)(F)F)[C@@H]1C[C@H]1C(=O)NCCCN1CCCC1=O,2-[4-[2-(4-methylpiperazin-1-yl)phenyl]sulfanyl-3-(trifluoromethyl)phenyl]-N-[3-(2-oxopyrrolidin-1-yl)propyl]cyclopropane-1-carboxamide,"InChI=1S/C29H35F3N4O2S/c1-34-14-16-35(17-15-34)24-6-2-3-7-26(24)39-25-10-9-20(18-23(25)29(30,31)32)21-19-22(21)28(38)33-11-5-13-36-12-4-8-27(36)37/h2-3,6-7,9-10,18,21-22H,4-5,8,11-17,19H2,1H3,(H,33,38)/t21-,22+/m0/s1",HPSCLHCEPQQJNB-FCHUYYIVSA-N,0,1,0,0,LFA / ICAM,6.70,immune system disease,Inhibition,
895,11146800,108123,9321909,CC(C)C[C@@H](NC(N)=N)C(=O)NCC(=O)N1CCC(CC1)c1cc(nn1C)-c1ccc(OCc2cccc(c2)C(O)=O)c(Cl)c1Cl,"3-[[2,3-dichloro-4-[5-[1-[2-[[(2R)-2-(diaminomethylideneamino)-4-methylpentanoyl]amino]acetyl]piperidin-4-yl]-1-methylpyrazol-3-yl]phenoxy]methyl]benzoic acid","InChI=1S/C32H39Cl2N7O5/c1-18(2)13-24(38-32(35)36)30(43)37-16-27(42)41-11-9-20(10-12-41)25-15-23(39-40(25)3)22-7-8-26(29(34)28(22)33)46-17-19-5-4-6-21(14-19)31(44)45/h4-8,14-15,18,20,24H,9-13,16-17H2,1-3H3,(H,37,43)(H,44,45)(H4,35,36,38)/t24-/m1/s1",DXXSRBULFHQCQV-XMMPIXPASA-N,2,0,0,0,IL2 / IL2R,6.40,immune system disease,Inhibition,
896,42601766,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCC(CC1)NCc1ccccc1,4-[4-(benzylamino)piperidin-1-yl]-N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonylbenzamide,"InChI=1S/C37H44N6O5S2/c1-41(2)22-19-31(27-49-33-11-7-4-8-12-33)39-35-18-17-34(25-36(35)43(45)46)50(47,48)40-37(44)29-13-15-32(16-14-29)42-23-20-30(21-24-42)38-26-28-9-5-3-6-10-28/h3-18,25,30-31,38-39H,19-24,26-27H2,1-2H3,(H,40,44)/t31-/m1/s1",LOPOSFGIOVRMJB-WJOKGBTCSA-N,1,0,0,0,BCL2-Like / BAX,5.30,cancer,Inhibition,
897,50996944,,,CC(C)(CN)NC(=O)Cc1ccc(Cl)c(F)c1-n1c(nc(-c2nnc(N)o2)c1-c1ccc(F)c(Cl)c1)C1CCCCC1,"N-(1-amino-2-methylpropan-2-yl)-2-[2-[4-(5-amino-1,3,4-oxadiazol-2-yl)-5-(3-chloro-4-fluorophenyl)-2-cyclohexylimidazol-1-yl]-4-chloro-3-fluorophenyl]acetamide","InChI=1S/C29H31Cl2F2N7O2/c1-29(2,14-34)37-21(41)13-17-8-10-18(30)22(33)24(17)40-25(16-9-11-20(32)19(31)12-16)23(27-38-39-28(35)42-27)36-26(40)15-6-4-3-5-7-15/h8-12,15H,3-7,13-14,34H2,1-2H3,(H2,35,39)(H,37,41)",TWMRUMHSDWYJTJ-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,7.70,cancer,Inhibition,
898,168318031,,,CC(=O)NC[C@H](NC(=O)c1c(C)cc2CN(CCc2c1C)C(=O)c1ccc(Cl)cc1)C(O)=O,,"InChI=1S/C24H26ClN3O5/c1-13-10-17-12-28(23(31)16-4-6-18(25)7-5-16)9-8-19(17)14(2)21(13)22(30)27-20(24(32)33)11-26-15(3)29/h4-7,10,20H,8-9,11-12H2,1-3H3,(H,26,29)(H,27,30)(H,32,33)/t20-/m0/s1",MTAFOUFERQBSGV-FQEVSTJZSA-N,0,1,0,0,LFA / ICAM,6.21,immune system disease,Inhibition,
899,168318030,,,O[C@H]1CCCN(C1)[C@@]1(Cc2cccc(Cl)c2)C(=O)Nc2cc(Cl)ccc12,6-chloro-3-[(3-chlorophenyl)methyl]-3-(3-hydroxypiperidin-1-yl)-1H-indol-2-one,"InChI=1S/C20H20Cl2N2O2/c21-14-4-1-3-13(9-14)11-20(24-8-2-5-16(25)12-24)17-7-6-15(22)10-18(17)23-19(20)26/h1,3-4,6-7,9-10,16,25H,2,5,8,11-12H2,(H,23,26)/t16-,20+/m0/s1",FPUNOKXIVOUZST-OXJNMPFZSA-N,1,0,0,0,MDM2-Like / P53,8.43,cancer,Inhibition,
900,67031976,,,OC(=O)c1nc(-c2ccccc2F)n(c1-c1cccc(Cl)c1)-c1cccc(Cl)c1,,"InChI=1S/C22H13Cl2FN2O2/c23-14-6-3-5-13(11-14)20-19(22(28)29)26-21(17-9-1-2-10-18(17)25)27(20)16-8-4-7-15(24)12-16/h1-12H,(H,28,29)",XTCHLKUYUTXGDJ-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,5.55,cancer,Inhibition,
901,44392000,182784,23248079,CCOC(=O)N1CCN(CC1)c1cc(ncn1)-c1ccc(Sc2ccccc2C(C)C)c(c1)C(F)(F)F,ethyl 4-[6-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyrimidin-4-yl]piperazine-1-carboxylate,"InChI=1S/C27H29F3N4O2S/c1-4-36-26(35)34-13-11-33(12-14-34)25-16-22(31-17-32-25)19-9-10-24(21(15-19)27(28,29)30)37-23-8-6-5-7-20(23)18(2)3/h5-10,15-18H,4,11-14H2,1-3H3",FRTCDBYRRZDOQQ-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,6.33,immune system disease,Inhibition,
902,168318029,,10657328,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1cc(ncn1)N1CC[C@@H](C1)NC(C)=O,N-[1-[6-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyrimidin-4-yl]pyrrolidin-3-yl]acetamide,"InChI=1S/C26H27F3N4OS/c1-16(2)20-6-4-5-7-23(20)35-24-9-8-18(12-21(24)26(27,28)29)22-13-25(31-15-30-22)33-11-10-19(14-33)32-17(3)34/h4-9,12-13,15-16,19H,10-11,14H2,1-3H3,(H,32,34)/t19-/m0/s1",XGPHRJBZYZFMFD-IBGZPJMESA-N,0,1,0,0,LFA / ICAM,6.66,immune system disease,Inhibition,
903,168318028,,,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(cc2)C(=O)N2CCCC2)c1=O,,"InChI=1S/C26H21F3N6O2/c1-33-23-19(14-30-33)22-20(21(31-23)16-5-4-6-17(13-16)26(27,28)29)25(37)35(32-22)18-9-7-15(8-10-18)24(36)34-11-2-3-12-34/h4-10,13-14,32H,2-3,11-12H2,1H3",WSADUZHNAOLJAB-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,6.96,cancer,Inhibition,
904,94251578,,5008361,OC(=O)c1cccc(c1)-c1ccc(\C=c2/sc3=NC4=C(CCc5ccccc45)[C@@H](c4cccc(F)c4)n3c2=O)o1,,"InChI=1S/C32H21FN2O4S/c33-22-9-4-7-20(16-22)29-25-13-11-18-5-1-2-10-24(18)28(25)34-32-35(29)30(36)27(40-32)17-23-12-14-26(39-23)19-6-3-8-21(15-19)31(37)38/h1-10,12,14-17,29H,11,13H2,(H,37,38)/b27-17-/t29-/m1/s1",CKYGAKWJAJKWCA-USDTVRPUSA-N,3,0,0,0,BCL2-Like / BAX,5.52,cancer,Inhibition,
905,45137799,,,CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2S(C)(=O)=O)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(2S)-1-[(3aR,6S,6aR)-6-(6-fluoro-1H-indol-3-yl)-4-methylsulfonyl-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-1-oxobutan-2-yl]-2-(methylamino)propanamide","InChI=1S/C23H32FN5O4S/c1-5-18(27-22(30)13(2)25-3)23(31)28-9-8-20-21(28)17(12-29(20)34(4,32)33)16-11-26-19-10-14(24)6-7-15(16)19/h6-7,10-11,13,17-18,20-21,25-26H,5,8-9,12H2,1-4H3,(H,27,30)/t13-,17+,18-,20+,21+/m0/s1",VOLJPYJUIDCODI-AAGBKCABSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
906,25138069,481213,24700089,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@H](N2C1=O)C(=O)N[C@@H]1CCCc2ccccc12,"(3S,6S,10aS)-6-[[(2S)-2-(methylamino)propanoyl]amino]-5-oxo-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-2,3,6,7,8,9,10,10a-octahydro-1H-pyrrolo[1,2-a]azocine-3-carboxamide","InChI=1S/C25H36N4O3/c1-16(26-2)23(30)28-21-12-6-4-10-18-14-15-22(29(18)25(21)32)24(31)27-20-13-7-9-17-8-3-5-11-19(17)20/h3,5,8,11,16,18,20-22,26H,4,6-7,9-10,12-15H2,1-2H3,(H,27,31)(H,28,30)/t16-,18-,20+,21-,22-/m0/s1",IPIIAWQBJWTGKF-WVNMJAPOSA-N,2,2,0,0,XIAP / Smac,7.85,cancer,Inhibition,
907,168318027,,,Clc1ccc(CO[C@@H]2C[C@H]3N(C2)C(=O)N(C3=O)c2cc(Cl)cc(Cl)c2)cc1,,"InChI=1S/C19H15Cl3N2O3/c20-12-3-1-11(2-4-12)10-27-16-8-17-18(25)24(19(26)23(17)9-16)15-6-13(21)5-14(22)7-15/h1-7,16-17H,8-10H2/t16-,17-/m1/s1",WCGVNVSWYMVNJA-IAGOWNOFSA-N,0,1,0,0,LFA / ICAM,6.21,immune system disease,Inhibition,
908,168318026,,23248089,CCN(CC)C(=O)[C@H]1CCCN(C1)c1cc(ncn1)-c1ccc(Sc2ccccc2C(C)C)c(c1)C(F)(F)F,"N,N-diethyl-1-[6-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyrimidin-4-yl]piperidine-3-carboxamide","InChI=1S/C30H35F3N4OS/c1-5-36(6-2)29(38)22-10-9-15-37(18-22)28-17-25(34-19-35-28)21-13-14-27(24(16-21)30(31,32)33)39-26-12-8-7-11-23(26)20(3)4/h7-8,11-14,16-17,19-20,22H,5-6,9-10,15,18H2,1-4H3/t22-/m0/s1",SLYGCFGQHBIXPM-QFIPXVFZSA-N,0,1,0,0,LFA / ICAM,6.21,immune system disease,Inhibition,
909,44305212,65611,23156116,OC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1cc(Cl)ccc1Cl,"(2S)-2-[(2,5-dichlorobenzoyl)amino]-3-(1H-indol-3-yl)propanoic acid","InChI=1S/C18H14Cl2N2O3/c19-11-5-6-14(20)13(8-11)17(23)22-16(18(24)25)7-10-9-21-15-4-2-1-3-12(10)15/h1-6,8-9,16,21H,7H2,(H,22,23)(H,24,25)/t16-/m0/s1",OLVHNZUOUNSVFC-INIZCTEOSA-N,1,0,0,0,LFA / ICAM,5.18,immune system disease,Inhibition,
910,44391997,182636,23248078,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1ccnc(c1)N1CCC(CC1)C(N)=O,1-[4-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyridin-2-yl]piperidine-4-carboxamide,"InChI=1S/C27H28F3N3OS/c1-17(2)21-5-3-4-6-23(21)35-24-8-7-19(15-22(24)27(28,29)30)20-9-12-32-25(16-20)33-13-10-18(11-14-33)26(31)34/h3-9,12,15-18H,10-11,13-14H2,1-2H3,(H2,31,34)",KMZGVJHSOHMQRG-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,7.14,immune system disease,Inhibition,
911,20725611,,19528228,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccccc2)c1=O,"6-methyl-2-phenyl-4-[3-(trifluoromethyl)phenyl]-1H-dipyrazolo[4,3-b:4',5'-e]pyridin-3-one","InChI=1S/C21H14F3N5O/c1-28-19-15(11-25-28)18-16(20(30)29(27-18)14-8-3-2-4-9-14)17(26-19)12-6-5-7-13(10-12)21(22,23)24/h2-11,27H,1H3",XZLYIJJVUYWLSG-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,6.70,cancer,Inhibition,
912,44176178,427042,23271734,Nc1cc(ccc1Cl)C1(CC1)N1[C@@H](c2ccc(Cl)cc2)C(=O)N(CCN2CCOCC2)c2ccc(I)cc2C1=O,"4-[1-(3-amino-4-chlorophenyl)cyclopropyl]-3-(4-chlorophenyl)-7-iodo-1-(2-morpholin-4-ylethyl)-3H-1,4-benzodiazepine-2,5-dione","InChI=1S/C30H29Cl2IN4O3/c31-21-4-1-19(2-5-21)27-29(39)36(12-11-35-13-15-40-16-14-35)26-8-6-22(33)18-23(26)28(38)37(27)30(9-10-30)20-3-7-24(32)25(34)17-20/h1-8,17-18,27H,9-16,34H2/t27-/m0/s1",SKDYLCZPJKRLHY-MHZLTWQESA-N,1,0,0,0,MDM2-Like / P53,4.60,cancer,Inhibition,
913,168318023,,24603832,CCC[C@H](C(O)=O)c1c(-c2ccccc2)c2cc(Cl)ccc2n(CCC)c1=O,2-(6-chloro-2-oxo-4-phenyl-1-propylquinolin-3-yl)pentanoic acid,"InChI=1S/C23H24ClNO3/c1-3-8-17(23(27)28)21-20(15-9-6-5-7-10-15)18-14-16(24)11-12-19(18)25(13-4-2)22(21)26/h5-7,9-12,14,17H,3-4,8,13H2,1-2H3,(H,27,28)/t17-/m0/s1",TXCVYBJXPPFXOD-KRWDZBQOSA-N,1,0,0,0,LEDGF / IN,5.03,HIV infectious disease,Inhibition,
914,60108841,,,NC(=O)C1CCN(CC1)c1cc(ccn1)-c1ccc(Sc2ccc3OCCOc3c2)c(c1)C(F)(F)F,"1-[4-[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfanyl)-3-(trifluoromethyl)phenyl]pyridin-2-yl]piperidine-4-carboxamide","InChI=1S/C26H24F3N3O3S/c27-26(28,29)20-13-17(1-4-23(20)36-19-2-3-21-22(15-19)35-12-11-34-21)18-5-8-31-24(14-18)32-9-6-16(7-10-32)25(30)33/h1-5,8,13-16H,6-7,9-12H2,(H2,30,33)",OJHMSKTUQAYMOI-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,6.85,immune system disease,Inhibition,
915,50996419,,,CNC(=O)c1nc(-c2ccccc2)n(c1-c1cccc(Cl)c1)-c1cccc(Cl)c1,"1,5-bis(3-chlorophenyl)-N-methyl-2-phenylimidazole-4-carboxamide","InChI=1S/C23H17Cl2N3O/c1-26-23(29)20-21(16-9-5-10-17(24)13-16)28(19-12-6-11-18(25)14-19)22(27-20)15-7-3-2-4-8-15/h2-14H,1H3,(H,26,29)",KXXHNNPNEGWABI-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,5.63,cancer,Inhibition,
916,168318024,,,COC(=O)[C@@H]1CCCN1C(=O)c1cccc(c1)-n1[nH]c2c3cnn(C)c3nc(-c3cccc(c3)C(F)(F)F)c2c1=O,,"InChI=1S/C28H23F3N6O4/c1-35-24-19(14-32-35)23-21(22(33-24)15-6-3-8-17(12-15)28(29,30)31)26(39)37(34-23)18-9-4-7-16(13-18)25(38)36-11-5-10-20(36)27(40)41-2/h3-4,6-9,12-14,20,34H,5,10-11H2,1-2H3/t20-/m0/s1",LHYNORNDAIPVII-FQEVSTJZSA-N,1,0,0,0,CD80 / CD28,7.70,cancer,Inhibition,
917,168318022,,,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(C(O)=O)c(Cl)c2)c1=O,,"InChI=1S/C22H13ClF3N5O3/c1-30-19-14(9-27-30)18-16(17(28-19)10-3-2-4-11(7-10)22(24,25)26)20(32)31(29-18)12-5-6-13(21(33)34)15(23)8-12/h2-9,29H,1H3,(H,33,34)",RACFPSGQEVIPDO-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.80,cancer,Inhibition,
918,45137643,,,CN[C@@H](C)C(=O)N[C@@H](COC)C(=O)N1CC[C@H]2NC[C@@H]([C@@H]12)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(2S)-1-[(3aR,6S,6aR)-6-(6-fluoro-1H-indol-3-yl)-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,2-b]pyrrol-1-yl]-3-methoxy-1-oxopropan-2-yl]-2-(methylamino)propanamide","InChI=1S/C22H30FN5O3/c1-12(24-2)21(29)27-19(11-31-3)22(30)28-7-6-17-20(28)16(10-25-17)15-9-26-18-8-13(23)4-5-14(15)18/h4-5,8-9,12,16-17,19-20,24-26H,6-7,10-11H2,1-3H3,(H,27,29)/t12-,16+,17+,19-,20+/m0/s1",WLPZHJKMURNGSN-GGSHGAKASA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
919,45138103,,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2C(C)=O)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(1S)-2-[(3aR,6S,6aR)-4-acetyl-6-(6-fluoro-1H-indol-3-yl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-1-cyclohexyl-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C28H38FN5O3/c1-16(30-3)27(36)32-25(18-7-5-4-6-8-18)28(37)33-12-11-24-26(33)22(15-34(24)17(2)35)21-14-31-23-13-19(29)9-10-20(21)23/h9-10,13-14,16,18,22,24-26,30-31H,4-8,11-12,15H2,1-3H3,(H,32,36)/t16-,22+,24+,25-,26+/m0/s1",ZUSTZHLIOFOYHV-ONBGBDQZSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
920,44574943,451196,,CN(C)CCNC(=O)[C@@H]1[C@@H](CO)[C@@H]2Cn3c(cccc3=O)[C@H]1N2c1nc(c(s1)-c1ccccc1)-c1ccc(Cl)cc1,,"InChI=1S/C31H32ClN5O3S/c1-35(2)16-15-33-30(40)26-22(18-38)24-17-36-23(9-6-10-25(36)39)28(26)37(24)31-34-27(19-11-13-21(32)14-12-19)29(41-31)20-7-4-3-5-8-20/h3-14,22,24,26,28,38H,15-18H2,1-2H3,(H,33,40)/t22-,24-,26+,28+/m0/s1",OLLOCGKHFIQEMT-SFNAGVRGSA-N,2,0,0,0,BCL2-Like / BAX,5.70,cancer,Inhibition,
921,67031940,,,Cc1cccc(n1)-c1nc(C(O)=O)c(-c2ccc(F)c(Cl)c2)n1-c1cccc(Cl)c1F,,"InChI=1S/C22H13Cl2F2N3O2/c1-11-4-2-6-16(27-11)21-28-19(22(30)31)20(12-8-9-15(25)14(24)10-12)29(21)17-7-3-5-13(23)18(17)26/h2-10H,1H3,(H,30,31)",LXFOXRXRPQZXOX-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,8.48,cancer,Inhibition,
922,58007451,,,CCN(C1CN(C1)C(=O)CN(C)C)C(=O)C1=C(C(C)C)N2[C@H](c3ccc(Cl)cc3)[C@@](C)(N=C2S1)c1ccc(Cl)cc1,"(5R,6S)-5,6-bis(4-chlorophenyl)-N-[1-[2-(dimethylamino)acetyl]azetidin-3-yl]-N-ethyl-6-methyl-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazole-2-carboxamide","InChI=1S/C31H37Cl2N5O2S/c1-7-37(24-16-36(17-24)25(39)18-35(5)6)29(40)27-26(19(2)3)38-28(20-8-12-22(32)13-9-20)31(4,34-30(38)41-27)21-10-14-23(33)15-11-21/h8-15,19,24,28H,7,16-18H2,1-6H3/t28-,31+/m1/s1",WRSJCNHXAZDPHX-MVSFAKPFSA-N,1,0,0,0,MDM2-Like / P53,7.89,cancer,Inhibition,
923,45487301,571424,24634282,CNC(=O)c1cc(OC)c(O[C@@H](C)C(=O)N2CCN(C[C@H]2C)c2nccn2CC2CC2)cn1,5-[(2S)-1-[(2R)-4-[1-(cyclopropylmethyl)imidazol-2-yl]-2-methylpiperazin-1-yl]-1-oxopropan-2-yl]oxy-4-methoxy-N-methylpyridine-2-carboxamide,"InChI=1S/C23H32N6O4/c1-15-13-28(23-25-7-8-27(23)14-17-5-6-17)9-10-29(15)22(31)16(2)33-20-12-26-18(21(30)24-3)11-19(20)32-4/h7-8,11-12,15-17H,5-6,9-10,13-14H2,1-4H3,(H,24,30)/t15-,16+/m1/s1",CBFBVKRYRFGNRU-CVEARBPZSA-N,0,1,0,0,CD4 / gp120,5.72,HIV infectious disease,Inhibition,
924,44573313,493338,24705332,COc1ccc2[nH]cc(C(=O)C(=O)N3CCN(CC3)C(=O)c3ccccc3)c2c1,"1-(4-benzoylpiperazin-1-yl)-2-(5-methoxy-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C22H21N3O4/c1-29-16-7-8-19-17(13-16)18(14-23-19)20(26)22(28)25-11-9-24(10-12-25)21(27)15-5-3-2-4-6-15/h2-8,13-14,23H,9-12H2,1H3",QXXQFKJYCHTAPB-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,7.68,HIV infectious disease,Inhibition,
925,58531512,,,COC(=O)c1cc(Cl)cc(c1O)S(=O)(=O)N(Cc1ccc(F)cc1)Cc1cccc(c1)-c1ccc(Cl)cc1,methyl 5-chloro-3-[[3-(4-chlorophenyl)phenyl]methyl-[(4-fluorophenyl)methyl]sulfamoyl]-2-hydroxybenzoate,"InChI=1S/C28H22Cl2FNO5S/c1-37-28(34)25-14-23(30)15-26(27(25)33)38(35,36)32(16-18-5-11-24(31)12-6-18)17-19-3-2-4-21(13-19)20-7-9-22(29)10-8-20/h2-15,33H,16-17H2,1H3",FEHCCBFTAICJPK-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,5.64,cancer,Inhibition,
926,91045101,,19174414,CC(C)c1ccccc1Sc1ccc([C@@H]2C[C@H]2C(=O)N2CCC(CC2)C(O)=O)c(Cl)c1Cl,"1-[2-[2,3-dichloro-4-(2-propan-2-ylphenyl)sulfanylphenyl]cyclopropanecarbonyl]piperidine-4-carboxylic acid","InChI=1S/C25H27Cl2NO3S/c1-14(2)16-5-3-4-6-20(16)32-21-8-7-17(22(26)23(21)27)18-13-19(18)24(29)28-11-9-15(10-12-28)25(30)31/h3-8,14-15,18-19H,9-13H2,1-2H3,(H,30,31)/t18-,19+/m0/s1",MEMSOGHDJLMQDL-RBUKOAKNSA-N,0,1,0,0,LFA / ICAM,8.05,immune system disease,Inhibition,
927,21906779,360765,10657289,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1cc(ncn1)N1CCC(O)CC1,1-[6-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyrimidin-4-yl]piperidin-4-ol,"InChI=1S/C25H26F3N3OS/c1-16(2)19-5-3-4-6-22(19)33-23-8-7-17(13-20(23)25(26,27)28)21-14-24(30-15-29-21)31-11-9-18(32)10-12-31/h3-8,13-16,18,32H,9-12H2,1-2H3",JNPJONSHMIUCKC-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,6.64,immune system disease,Inhibition,
928,25026312,583471,24641356,CN(C)c1nc(NCc2ccc(NC(=O)c3ccc(F)cc3)cc2)c2ccc(cc2n1)C#N,N-[4-[[[7-cyano-2-(dimethylamino)quinazolin-4-yl]amino]methyl]phenyl]-4-fluorobenzamide,"InChI=1S/C25H21FN6O/c1-32(2)25-30-22-13-17(14-27)5-12-21(22)23(31-25)28-15-16-3-10-20(11-4-16)29-24(33)18-6-8-19(26)9-7-18/h3-13H,15H2,1-2H3,(H,29,33)(H,28,30,31)",PEHXGTJUEIUPJT-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,5.83,cancer,Inhibition,
929,58006870,,,CC(C)C1=C(SC2=N[C@](C)([C@H](N12)c1ccc(Cl)cc1)c1ccc(Cl)cc1)C(=O)N1[C@H](C)CC[C@H]1C(=O)N1C[C@@H](N)[C@H](F)C1,"[(3R,4R)-3-amino-4-fluoropyrrolidin-1-yl]-[(2S,5R)-1-[(5R,6S)-5,6-bis(4-chlorophenyl)-6-methyl-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazole-2-carbonyl]-5-methylpyrrolidin-2-yl]methanone","InChI=1S/C32H36Cl2FN5O2S/c1-17(2)26-27(30(42)39-18(3)5-14-25(39)29(41)38-15-23(35)24(36)16-38)43-31-37-32(4,20-8-12-22(34)13-9-20)28(40(26)31)19-6-10-21(33)11-7-19/h6-13,17-18,23-25,28H,5,14-16,36H2,1-4H3/t18-,23-,24-,25+,28-,32+/m1/s1",BHEMWZZQBMMKOI-WWZIAFITSA-N,1,0,0,0,MDM2-Like / P53,7.82,cancer,Inhibition,
930,44573759,493172,24705331,O=C(N1CCN(CC1)C(=O)c1ccccc1)C(=O)c1cn(Cc2ccccc2)c2ccccc12,"1-(4-benzoylpiperazin-1-yl)-2-(1-benzylindol-3-yl)ethane-1,2-dione","InChI=1S/C28H25N3O3/c32-26(28(34)30-17-15-29(16-18-30)27(33)22-11-5-2-6-12-22)24-20-31(19-21-9-3-1-4-10-21)25-14-8-7-13-23(24)25/h1-14,20H,15-19H2",MSYGRVOQWPMYBC-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,4.86,HIV infectious disease,Inhibition,
931,1576659,243190,23291040,OC(=O)[C@H](Cc1ccccc1)N1C(=S)S\C(=C/c2ccc(Br)cc2)C1=O,"(2S)-2-[(5Z)-5-[(4-bromophenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-3-phenylpropanoic acid","InChI=1S/C19H14BrNO3S2/c20-14-8-6-13(7-9-14)11-16-17(22)21(19(25)26-16)15(18(23)24)10-12-4-2-1-3-5-12/h1-9,11,15H,10H2,(H,23,24)/b16-11-/t15-/m0/s1",NWNRPXAZPNUBGV-CNYBTUBUSA-N,6,0,0,0,BCL2-Like / BAX,5.28,cancer,Inhibition,
932,168318017,,24632939,CC(C)[C@@H]1CN(CCN1C(=O)c1ccccc1)C(=O)C(=O)c1c[nH]c2cccc(F)c12,"1-(4-benzoyl-3-propan-2-ylpiperazin-1-yl)-2-(4-fluoro-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C24H24FN3O3/c1-15(2)20-14-27(11-12-28(20)23(30)16-7-4-3-5-8-16)24(31)22(29)17-13-26-19-10-6-9-18(25)21(17)19/h3-10,13,15,20,26H,11-12,14H2,1-2H3/t20-/m0/s1",JQDOTZVNBIPURF-FQEVSTJZSA-N,0,1,0,0,CD4 / gp120,7.64,HIV infectious disease,Inhibition,
933,44432169,232555,23294390,COC1=C(C(=O)N2CCC[C@@]12Cc1ccc(cc1)C#N)c1cc(Cl)cc(Cl)c1,"4-[[6-(3,5-dichlorophenyl)-7-methoxy-5-oxo-2,3-dihydro-1H-pyrrolizin-8-yl]methyl]benzonitrile","InChI=1S/C22H18Cl2N2O2/c1-28-20-19(16-9-17(23)11-18(24)10-16)21(27)26-8-2-7-22(20,26)12-14-3-5-15(13-25)6-4-14/h3-6,9-11H,2,7-8,12H2,1H3/t22-/m1/s1",JGDRFWBGECPKHM-JOCHJYFZSA-N,0,1,0,0,LFA / ICAM,6.37,immune system disease,Inhibition,
934,168317918,,24640354,CNC(=O)c1cccc(O[C@H](C)C(=O)N2CCN(C[C@H]2C)C(=O)c2ccccc2)c1C,"3-[1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-1-oxopropan-2-yl]oxy-N,2-dimethylbenzamide","InChI=1S/C24H29N3O4/c1-16-15-26(24(30)19-9-6-5-7-10-19)13-14-27(16)23(29)18(3)31-21-12-8-11-20(17(21)2)22(28)25-4/h5-12,16,18H,13-15H2,1-4H3,(H,25,28)/t16-,18-/m1/s1",PBFRIJWIQVDNNX-SJLPKXTDSA-N,0,1,0,0,CD4 / gp120,4.92,HIV infectious disease,Inhibition,
935,168318019,,26362726,CN(C)CCC[C@](O)(c1ccccc1)c1cccc(OCCOc2ccc(cc2)-c2ccc(cc2)C(O)=O)c1,4-[4-[2-[3-[4-(dimethylamino)-1-hydroxy-1-phenylbutyl]phenoxy]ethoxy]phenyl]benzoic acid,"InChI=1S/C33H35NO5/c1-34(2)21-7-20-33(37,28-8-4-3-5-9-28)29-10-6-11-31(24-29)39-23-22-38-30-18-16-26(17-19-30)25-12-14-27(15-13-25)32(35)36/h3-6,8-19,24,37H,7,20-23H2,1-2H3,(H,35,36)/t33-/m0/s1",ITGAKBXCTVHMME-XIFFEERXSA-N,1,0,0,0,BCL2-Like / BAX,6.00,cancer,Inhibition,
936,24776216,,,CCCCC1(CCN(CC1)c1ccc(cc1)C(=O)NS(=O)(=O)c1ccc(N[C@H](CCN(C)C)CSc2ccccc2)c(c1)N(=O)=O)OC,4-(4-butyl-4-methoxypiperidin-1-yl)-N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonylbenzamide,"InChI=1S/C35H47N5O6S2/c1-5-6-19-35(46-4)20-23-39(24-21-35)29-14-12-27(13-15-29)34(41)37-48(44,45)31-16-17-32(33(25-31)40(42)43)36-28(18-22-38(2)3)26-47-30-10-8-7-9-11-30/h7-17,25,28,36H,5-6,18-24,26H2,1-4H3,(H,37,41)/t28-/m1/s1",PKTRSCZRZRTGKO-MUUNZHRXSA-N,2,0,0,0,BCL2-Like / BAX,8.89,cancer,Inhibition,
937,59555601,,,CN(C)CCNCc1cc(Nc2ccc(NCCc3c[nH]c4ccccc34)cc2)ccn1,"4-N-[2-[[2-(dimethylamino)ethylamino]methyl]pyridin-4-yl]-1-N-[2-(1H-indol-3-yl)ethyl]benzene-1,4-diamine","InChI=1S/C26H32N6/c1-32(2)16-15-27-19-24-17-23(12-14-29-24)31-22-9-7-21(8-10-22)28-13-11-20-18-30-26-6-4-3-5-25(20)26/h3-10,12,14,17-18,27-28,30H,11,13,15-16,19H2,1-2H3,(H,29,31)",NYKWGOOLVPPXBJ-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,6.40,cancer,Inhibition,
938,168318015,,,C[C@@H](N)c1cc(Nc2ccc(NCCc3c[nH]c4ccccc34)cc2)ccn1,"4-N-[2-(1-aminoethyl)pyridin-4-yl]-1-N-[2-(1H-indol-3-yl)ethyl]benzene-1,4-diamine","InChI=1S/C23H25N5/c1-16(24)23-14-20(11-13-26-23)28-19-8-6-18(7-9-19)25-12-10-17-15-27-22-5-3-2-4-21(17)22/h2-9,11,13-16,25,27H,10,12,24H2,1H3,(H,26,28)/t16-/m1/s1",YXESUGBHDSSKHT-MRXNPFEDSA-N,1,1,0,0,MDM2-Like / P53,5.40,cancer,Inhibition,
939,10413083,,8588517,COC(=O)c1ccc(cc1F)-n1[nH]c2c3cnn(C)c3nc(-c3cccc(c3)C(F)(F)F)c2c1=O,"methyl 2-fluoro-4-[6-methyl-3-oxo-4-[3-(trifluoromethyl)phenyl]-1H-dipyrazolo[4,3-b:4',5'-e]pyridin-2-yl]benzoate","InChI=1S/C23H15F4N5O3/c1-31-20-15(10-28-31)19-17(18(29-20)11-4-3-5-12(8-11)23(25,26)27)21(33)32(30-19)13-6-7-14(16(24)9-13)22(34)35-2/h3-10,30H,1-2H3",BWIBVOXTGIARTH-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.92,cancer,Inhibition,
940,16109092,221856,17266506,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(Cc2ccccc2NC2CCCCC2)CC1,4-[4-[[2-(cyclohexylamino)phenyl]methyl]piperazin-1-yl]-N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonylbenzamide,"InChI=1S/C42H53N7O5S2/c1-46(2)24-23-35(31-55-37-14-7-4-8-15-37)44-40-22-21-38(29-41(40)49(51)52)56(53,54)45-42(50)32-17-19-36(20-18-32)48-27-25-47(26-28-48)30-33-11-9-10-16-39(33)43-34-12-5-3-6-13-34/h4,7-11,14-22,29,34-35,43-44H,3,5-6,12-13,23-28,30-31H2,1-2H3,(H,45,50)/t35-/m1/s1",YLMURQOFHMQRRU-PGUFJCEWSA-N,2,0,0,0,BCL2-Like / BAX,9.22,cancer,Inhibition,
941,11417422,510669,9592309,C[C@H](N)C(=O)N[C@H]1CCC[C@H]2CC[C@H](N2C1=O)C(=O)NCc1ccccc1,"(3S,6S,9aS)-6-[[(2S)-2-aminopropanoyl]amino]-N-benzyl-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C20H28N4O3/c1-13(21)18(25)23-16-9-5-8-15-10-11-17(24(15)20(16)27)19(26)22-12-14-6-3-2-4-7-14/h2-4,6-7,13,15-17H,5,8-12,21H2,1H3,(H,22,26)(H,23,25)/t13-,15-,16-,17-/m0/s1",FHZYBAJOAPZBPA-HJWJTTGWSA-N,2,0,0,0,XIAP / Smac,6.82,cancer,Inhibition,
942,45138406,,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2c1nccc(Cl)n1)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(1S)-2-[(3aR,6S,6aR)-4-(4-chloropyrimidin-2-yl)-6-(6-fluoro-1H-indol-3-yl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-1-cyclohexyl-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C30H37ClFN7O2/c1-17(33-2)28(40)37-26(18-6-4-3-5-7-18)29(41)38-13-11-24-27(38)22(16-39(24)30-34-12-10-25(31)36-30)21-15-35-23-14-19(32)8-9-20(21)23/h8-10,12,14-15,17-18,22,24,26-27,33,35H,3-7,11,13,16H2,1-2H3,(H,37,40)/t17-,22+,24+,26-,27+/m0/s1",KPUHMPYXULUJMR-DATVJGKJSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
943,68854914,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(CC1)C(c1ccc(F)cc1)c1ccc(F)cc1,4-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-N-[4-[[(2S)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonylbenzamide,"InChI=1S/C42H44F2N6O5S2/c1-47(2)23-22-35(29-56-37-6-4-3-5-7-37)45-39-21-20-38(28-40(39)50(52)53)57(54,55)46-42(51)32-12-18-36(19-13-32)48-24-26-49(27-25-48)41(30-8-14-33(43)15-9-30)31-10-16-34(44)17-11-31/h3-21,28,35,41,45H,22-27,29H2,1-2H3,(H,46,51)/t35-/m1/s1",NVFSUIUMDIMAMA-PGUFJCEWSA-N,1,0,0,0,BCL2-Like / BAX,5.30,cancer,Inhibition,
944,506248,493738,442079,CCOc1cccc2[nH]cc(C(=O)C(=O)N3CCN(CC3)C(=O)c3ccccc3)c12,"1-(4-benzoylpiperazin-1-yl)-2-(4-ethoxy-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C23H23N3O4/c1-2-30-19-10-6-9-18-20(19)17(15-24-18)21(27)23(29)26-13-11-25(12-14-26)22(28)16-7-4-3-5-8-16/h3-10,15,24H,2,11-14H2,1H3",UVQHGZDUSVOXFT-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,9.35,HIV infectious disease,Inhibition,
945,59343774,,,CC(C)(C)C[C@H]1N[C@H]([C@H](c2ccc(F)c(Cl)c2)[C@@]11C(=O)Nc2cc(Cl)c(F)cc12)C(=O)NCC[C@H](O)CO,"(2'R,3S,3'R,5'R)-6-chloro-3'-(3-chloro-4-fluorophenyl)-N-[(3R)-3,4-dihydroxybutyl]-5'-(2,2-dimethylpropyl)-5-fluoro-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide","InChI=1S/C27H31Cl2F2N3O4/c1-26(2,3)11-21-27(15-9-19(31)17(29)10-20(15)33-25(27)38)22(13-4-5-18(30)16(28)8-13)23(34-21)24(37)32-7-6-14(36)12-35/h4-5,8-10,14,21-23,34-36H,6-7,11-12H2,1-3H3,(H,32,37)(H,33,38)/t14-,21+,22-,23+,27-/m0/s1",SYCGJWKMQNLWAV-LYAXWJQESA-N,1,3,0,0,MDM2-Like / P53,6.43,cancer,Inhibition,
946,11714160,472841,24696358,O=C(O)[C@@H]1CC[C@@H](CC1)Nc1cccc(c1)Sc1ccc(\C=C\C(=O)N2CCOCC2)c(C(F)(F)F)c1C(F)(F)F,"4-[3-[4-[(E)-3-morpholin-4-yl-3-oxoprop-1-enyl]-2,3-bis(trifluoromethyl)phenyl]sulfanylanilino]cyclohexane-1-carboxylic acid","InChI=1S/C28H28F6N2O4S/c29-27(30,31)24-17(7-11-23(37)36-12-14-40-15-13-36)6-10-22(25(24)28(32,33)34)41-21-3-1-2-20(16-21)35-19-8-4-18(5-9-19)26(38)39/h1-3,6-7,10-11,16,18-19,35H,4-5,8-9,12-15H2,(H,38,39)/b11-7+/t18-,19+",URZCVPKXOJQTLC-BZZHFGAJSA-N,1,0,0,0,LFA / ICAM,9.30,immune system disease,Inhibition,
947,11317764,180204,9492730,CC(C)[C@H](NC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(=O)NC(c1ccccc1)c1ccccc1,(2S)-1-[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-3-methylbutanoyl]-N-benzhydrylpyrrolidine-2-carboxamide,"InChI=1S/C26H34N4O3/c1-17(2)22(28-24(31)18(3)27)26(33)30-16-10-15-21(30)25(32)29-23(19-11-6-4-7-12-19)20-13-8-5-9-14-20/h4-9,11-14,17-18,21-23H,10,15-16,27H2,1-3H3,(H,28,31)(H,29,32)/t18-,21-,22-/m0/s1",WKJJKOCFFPMSNU-NYVOZVTQSA-N,1,0,0,0,XIAP / Smac,7.55,cancer,Inhibition,
948,44176188,426321,23271195,OC(=O)CCCCNC(=O)[C@@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)Nc2ccc(I)cc2C1=O)c1ccc(Cl)cc1,,"InChI=1S/C28H24Cl2IN3O5/c29-18-8-4-16(5-9-18)24(26(37)32-14-2-1-3-23(35)36)34-25(17-6-10-19(30)11-7-17)27(38)33-22-13-12-20(31)15-21(22)28(34)39/h4-13,15,24-25H,1-3,14H2,(H,32,37)(H,33,38)(H,35,36)/t24-,25-/m0/s1",ANYUCRJJKHLZON-DQEYMECFSA-N,1,2,0,0,MDM2-Like / P53,6.06,cancer,Inhibition,
949,46883826,1092184,24678569,CN[C@@H](C)C(=O)N[C@@H](C1CCOCC1)C(=O)N1CCC[C@H]1c1nc(c(s1)C#CC)-c1cccc2ccccc12,"(2S)-2-(methylamino)-N-[(1S)-2-[(2S)-2-(4-naphthalen-1-yl-5-prop-1-ynyl-1,3-thiazol-2-yl)pyrrolidin-1-yl]-1-(oxan-4-yl)-2-oxoethyl]propanamide","InChI=1S/C31H36N4O3S/c1-4-9-26-28(24-13-7-11-21-10-5-6-12-23(21)24)34-30(39-26)25-14-8-17-35(25)31(37)27(22-15-18-38-19-16-22)33-29(36)20(2)32-3/h5-7,10-13,20,22,25,27,32H,8,14-19H2,1-3H3,(H,33,36)/t20-,25-,27-/m0/s1",WOZSGFALNANZEC-OICBGKIFSA-N,1,0,0,0,XIAP / Smac,7.42,cancer,Inhibition,
950,46840924,,,OC(=O)c1nc(sc1CCCOc1ccc(cc1)-n1ncc2cncnc12)-c1ccc2CCCN(C(=O)Nc3nc4ccccc4s3)c2c1,"2-[1-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-2H-quinolin-7-yl]-5-[3-(4-pyrazolo[3,4-d]pyrimidin-1-ylphenoxy)propyl]-1,3-thiazole-4-carboxylic acid","InChI=1S/C35H28N8O4S2/c44-33(45)30-29(8-4-16-47-25-13-11-24(12-14-25)43-31-23(19-38-43)18-36-20-37-31)48-32(40-30)22-10-9-21-5-3-15-42(27(21)17-22)35(46)41-34-39-26-6-1-2-7-28(26)49-34/h1-2,6-7,9-14,17-20H,3-5,8,15-16H2,(H,44,45)(H,39,41,46)",KSDFWQKMVJWLGC-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,11.52,cancer,Inhibition,
951,44432175,428898,23294396,CCC1=C(C(=O)N2CCC[C@@]12Cc1ccc(cc1)C#N)c1cc(Cl)cc(Cl)c1,"4-[[6-(3,5-dichlorophenyl)-7-ethyl-5-oxo-2,3-dihydro-1H-pyrrolizin-8-yl]methyl]benzonitrile","InChI=1S/C23H20Cl2N2O/c1-2-20-21(17-10-18(24)12-19(25)11-17)22(28)27-9-3-8-23(20,27)13-15-4-6-16(14-26)7-5-15/h4-7,10-12H,2-3,8-9,13H2,1H3/t23-/m1/s1",GPJFJOUOSHSYHV-HSZRJFAPSA-N,0,1,0,0,LFA / ICAM,7.28,immune system disease,Inhibition,
952,168317935,,,CC(C)C1=C(SC2=N[C@](C)([C@@H](N12)c1ccc(Cl)cc1)c1ccc(Cl)c(N)c1)C(=O)N1CCNC(=O)C1,"4-[6-(3-amino-4-chlorophenyl)-5-(4-chlorophenyl)-6-methyl-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazole-2-carbonyl]piperazin-2-one","InChI=1S/C26H27Cl2N5O2S/c1-14(2)21-22(24(35)32-11-10-30-20(34)13-32)36-25-31-26(3,16-6-9-18(28)19(29)12-16)23(33(21)25)15-4-7-17(27)8-5-15/h4-9,12,14,23H,10-11,13,29H2,1-3H3,(H,30,34)/t23-,26-/m0/s1",PERHLHWIHFPKCQ-OZXSUGGESA-N,1,0,0,0,MDM2-Like / P53,7.54,cancer,Inhibition,
953,168317934,,10793213,OC(=O)CCN1c2ccc(I)cc2C(=O)N([C@@H](C(O)=O)c2ccc(Cl)cc2)[C@@H](c2ccc(Cl)cc2)C1=O,"3-[4-[carboxy-(4-chlorophenyl)methyl]-3-(4-chlorophenyl)-7-iodo-2,5-dioxo-3H-1,4-benzodiazepin-1-yl]propanoic acid","InChI=1S/C26H19Cl2IN2O6/c27-16-5-1-14(2-6-16)22-25(35)30(12-11-21(32)33)20-10-9-18(29)13-19(20)24(34)31(22)23(26(36)37)15-3-7-17(28)8-4-15/h1-10,13,22-23H,11-12H2,(H,32,33)(H,36,37)/t22-,23+/m0/s1",FELRJPIAMHMGEQ-XZOQPEGZSA-N,1,0,0,0,MDM2-Like / P53,5.96,cancer,Inhibition,
954,50996239,,,CCNC(=O)c1nc(-c2ccc(C)c(C)c2)n(c1-c1cccc(Cl)c1)-c1cc(Cl)ccc1C,"1-(5-chloro-2-methylphenyl)-5-(3-chlorophenyl)-2-(3,4-dimethylphenyl)-N-ethylimidazole-4-carboxamide","InChI=1S/C27H25Cl2N3O/c1-5-30-27(33)24-25(19-7-6-8-21(28)14-19)32(23-15-22(29)12-10-17(23)3)26(31-24)20-11-9-16(2)18(4)13-20/h6-15H,5H2,1-4H3,(H,30,33)",DPHDSSWTNTXGEX-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,5.65,cancer,Inhibition,
955,17754801,2386344,,CCOc1cc(ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@](C)(N1C(=O)N1CCN(CCC(F)(F)F)CC1)c1ccc(Cl)cc1)C(C)(C)C,"1-[(4S,5R)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethyl-4,5-dihydro-1H-imidazole-1-carbonyl]-4-(3,3,3-trifluoropropyl)piperazine","InChI=1S/C37H43Cl2F3N4O2/c1-7-48-31-24-27(34(2,3)4)12-17-30(31)32-43-35(5,25-8-13-28(38)14-9-25)36(6,26-10-15-29(39)16-11-26)46(32)33(47)45-22-20-44(21-23-45)19-18-37(40,41)42/h8-17,24H,7,18-23H2,1-6H3/t35-,36+/m0/s1",MVGHTOGJZPPSRC-MPQUPPDSSA-N,2,3,0,0,MDM2-Like / P53,7.66,cancer,Inhibition,
956,44549765,,,CCOc1cccc2O[C@@H](C3=C(N(C)c4ncnn4[C@H]3c3ccc(Br)cc3)c12)c1ccc(Br)cc1,,"InChI=1S/C27H22Br2N4O2/c1-3-34-20-5-4-6-21-22(20)25-23(26(35-21)17-9-13-19(29)14-10-17)24(16-7-11-18(28)12-8-16)33-27(32(25)2)30-15-31-33/h4-15,24,26H,3H2,1-2H3/t24-,26+/m0/s1",KLAAVEAJEAVAOF-AZGAKELHSA-N,1,0,0,0,MDM2-Like / P53,6.04,cancer,Inhibition,
957,59447527,3342197,,CN(C)CC#Cc1ccc(OCCCc2sc(nc2C(O)=O)N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)cc1,"2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-5-[3-[4-[3-(dimethylamino)prop-1-ynyl]phenoxy]propyl]-1,3-thiazole-4-carboxylic acid","InChI=1S/C35H33N5O4S2/c1-39(2)19-6-8-23-14-16-25(17-15-23)44-21-7-13-30-31(33(42)43)37-35(46-30)40-20-18-24-9-5-10-26(27(24)22-40)32(41)38-34-36-28-11-3-4-12-29(28)45-34/h3-5,9-12,14-17H,7,13,18-22H2,1-2H3,(H,42,43)(H,36,38,41)",UBVFEVVNFNKDNY-UHFFFAOYSA-N,1,0,0,0,BCL2-Like / BAX,7.22,cancer,Inhibition,
958,44456362,406312,23324110,O=C(O)[C@H](Cc1ccccc1)N1C(=S)S\C(=C/c2ccc(OCOc3ccc(cc3)\C=C3/SC(=S)N(C3=O)[C@H](C(=O)O)Cc3ccccc3)cc2)C1=O,"(2S)-2-[(5Z)-5-[[4-[[4-[(Z)-[3-[(1S)-1-carboxy-2-phenylethyl]-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl]phenoxy]methoxy]phenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-3-phenylpropanoic acid","InChI=1S/C39H30N2O8S4/c42-34-32(52-38(50)40(34)30(36(44)45)19-24-7-3-1-4-8-24)21-26-11-15-28(16-12-26)48-23-49-29-17-13-27(14-18-29)22-33-35(43)41(39(51)53-33)31(37(46)47)20-25-9-5-2-6-10-25/h1-18,21-22,30-31H,19-20,23H2,(H,44,45)(H,46,47)/b32-21-,33-22-/t30-,31-/m0/s1",KYTPZOARRDNICZ-TWLRFMQXSA-N,3,0,0,0,BCL2-Like / BAX,5.64,cancer,Inhibition,
959,45138408,,,CN[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2C(C)=O)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(2S,3R)-1-[(3aR,6S,6aR)-4-acetyl-6-(6-fluoro-1H-indol-3-yl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-3-hydroxy-1-oxobutan-2-yl]-2-(methylamino)propanamide","InChI=1S/C24H32FN5O4/c1-12(26-4)23(33)28-21(13(2)31)24(34)29-8-7-20-22(29)18(11-30(20)14(3)32)17-10-27-19-9-15(25)5-6-16(17)19/h5-6,9-10,12-13,18,20-22,26-27,31H,7-8,11H2,1-4H3,(H,28,33)/t12-,13+,18+,20+,21-,22+/m0/s1",YTBKJMLXUZPFIZ-VPZIORFKSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
960,9917797,210545,8093444,COCCOCCN1c2ccc(I)cc2C(=O)N([C@H](C)c2ccc(Cl)cc2N)[C@@H](c2ccc(Cl)cc2)C1=O,"(3S)-4-[(1R)-1-(2-amino-4-chlorophenyl)ethyl]-3-(4-chlorophenyl)-7-iodo-1-[2-(2-methoxyethoxy)ethyl]-3H-1,4-benzodiazepine-2,5-dione","InChI=1S/C28H28Cl2IN3O4/c1-17(22-9-7-20(30)15-24(22)32)34-26(18-3-5-19(29)6-4-18)28(36)33(11-12-38-14-13-37-2)25-10-8-21(31)16-23(25)27(34)35/h3-10,15-17,26H,11-14,32H2,1-2H3/t17-,26+/m1/s1",RTYOJEHILRDOMQ-QUGAMOGWSA-N,2,0,0,0,MDM2-Like / P53,6.40,cancer,Inhibition,
961,44424316,1206151,25055700,OC(=O)[C@@H]1[C@@H]([C@@H](OC11C(=O)c2ccccc2C1=O)c1ccc(Cl)c(Cl)c1)C(=O)Nc1ccccc1,"(3'R,4'S,5'R)-5'-(3,4-dichlorophenyl)-1,3-dioxo-4'-(phenylcarbamoyl)spiro[indene-2,2'-oxolane]-3'-carboxylic acid","InChI=1S/C26H17Cl2NO6/c27-17-11-10-13(12-18(17)28)21-19(24(32)29-14-6-2-1-3-7-14)20(25(33)34)26(35-21)22(30)15-8-4-5-9-16(15)23(26)31/h1-12,19-21H,(H,29,32)(H,33,34)/t19-,20-,21-/m0/s1",VOSPXHWNZRLNMS-ACRUOGEOSA-N,1,0,0,0,E2 / E1,6.17,human papilloma virus infection,Inhibition,
962,16109152,221708,17266565,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCC(CC1)=Cc1ccccn1,N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonyl-4-[4-(pyridin-2-ylmethylidene)piperidin-1-yl]benzamide,"InChI=1S/C36H40N6O5S2/c1-40(2)21-19-30(26-48-32-9-4-3-5-10-32)38-34-16-15-33(25-35(34)42(44)45)49(46,47)39-36(43)28-11-13-31(14-12-28)41-22-17-27(18-23-41)24-29-8-6-7-20-37-29/h3-16,20,24-25,30,38H,17-19,21-23,26H2,1-2H3,(H,39,43)/t30-/m1/s1",AXRKKWXXRAOBEV-SSEXGKCCSA-N,2,0,0,0,BCL2-Like / BAX,8.44,cancer,Inhibition,
963,59396839,,,C(Cc1c[nH]c2ccccc12)Nc1ccc2N(CCc2c1)c1ccnc2ccccc12,"N-[2-(1H-indol-3-yl)ethyl]-1-quinolin-4-yl-2,3-dihydroindol-5-amine","InChI=1S/C27H24N4/c1-3-7-24-22(5-1)20(18-30-24)11-14-28-21-9-10-26-19(17-21)13-16-31(26)27-12-15-29-25-8-4-2-6-23(25)27/h1-10,12,15,17-18,28,30H,11,13-14,16H2",CCSQXMRIGXAXDS-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,6.00,cancer,Inhibition,
964,16109090,387142,17266504,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(Cc2ccccc2C)CC1,N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonyl-4-[4-[(2-methylphenyl)methyl]piperazin-1-yl]benzamide,"InChI=1S/C37H44N6O5S2/c1-28-9-7-8-10-30(28)26-41-21-23-42(24-22-41)32-15-13-29(14-16-32)37(44)39-50(47,48)34-17-18-35(36(25-34)43(45)46)38-31(19-20-40(2)3)27-49-33-11-5-4-6-12-33/h4-18,25,31,38H,19-24,26-27H2,1-3H3,(H,39,44)/t31-/m1/s1",SMQYDTWNUNHOFH-WJOKGBTCSA-N,2,0,0,0,BCL2-Like / BAX,8.52,cancer,Inhibition,
965,168317931,,,C[C@H](N)C(=O)N[C@@H](Cc1ccc(cc1)C(N)=O)C(=O)N1C[C@H](C[C@H]1C(=O)N[C@@H]1CCc2ccccc12)c1ccccc1,,"InChI=1S/C33H37N5O4/c1-20(34)31(40)37-28(17-21-11-13-24(14-12-21)30(35)39)33(42)38-19-25(22-7-3-2-4-8-22)18-29(38)32(41)36-27-16-15-23-9-5-6-10-26(23)27/h2-14,20,25,27-29H,15-19,34H2,1H3,(H2,35,39)(H,36,41)(H,37,40)/t20-,25-,27+,28-,29-/m0/s1",RBKCIKMWWXZCQZ-GYNMRXATSA-N,1,0,0,0,XIAP / Smac,8.00,cancer,Inhibition,
966,168317930,,,O[C@@H]1CCc2c1nccc2Nc1ccc2N(CCc3c[nH]c4ccccc34)CC3(CCSCC3)Oc2c1,"4-[[4-[2-(1H-indol-3-yl)ethyl]spiro[3H-1,4-benzoxazine-2,4'-thiane]-7-yl]amino]-6,7-dihydro-5H-cyclopenta[b]pyridin-7-ol","InChI=1S/C30H32N4O2S/c35-27-8-6-23-25(9-13-31-29(23)27)33-21-5-7-26-28(17-21)36-30(11-15-37-16-12-30)19-34(26)14-10-20-18-32-24-4-2-1-3-22(20)24/h1-5,7,9,13,17-18,27,32,35H,6,8,10-12,14-16,19H2,(H,31,33)/t27-/m1/s1",KECPCEYVZZVOGR-HHHXNRCGSA-N,1,1,0,0,MDM2-Like / P53,7.52,cancer,Inhibition,
967,46929436,1241424,26351491,CN[C@@H](C)C(=O)N[C@H]1CC[C@H](C[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1)NC(=O)Cc1ccccc1,"(3S,6S,9R,10aR)-N-benzhydryl-6-[[(2S)-2-(methylamino)propanoyl]amino]-5-oxo-9-[(2-phenylacetyl)amino]-2,3,6,7,8,9,10,10a-octahydro-1H-pyrrolo[1,2-a]azocine-3-carboxamide","InChI=1S/C36H43N5O4/c1-24(37-2)34(43)39-30-20-18-28(38-32(42)22-25-12-6-3-7-13-25)23-29-19-21-31(41(29)36(30)45)35(44)40-33(26-14-8-4-9-15-26)27-16-10-5-11-17-27/h3-17,24,28-31,33,37H,18-23H2,1-2H3,(H,38,42)(H,39,43)(H,40,44)/t24-,28+,29+,30-,31-/m0/s1",KQTBMWSEIIBSGS-KDWADUSMSA-N,2,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
968,44305027,305074,23155881,OC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1cc(Br)ccc1Br,"(2S)-2-[(2,5-dibromobenzoyl)amino]-3-(1H-indol-3-yl)propanoic acid","InChI=1S/C18H14Br2N2O3/c19-11-5-6-14(20)13(8-11)17(23)22-16(18(24)25)7-10-9-21-15-4-2-1-3-12(10)15/h1-6,8-9,16,21H,7H2,(H,22,23)(H,24,25)/t16-/m0/s1",BXGHZRCYCYRJHV-INIZCTEOSA-N,1,0,0,0,LFA / ICAM,4.61,immune system disease,Inhibition,
969,168317929,,,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2cccc(F)c2)c1=O,,"InChI=1S/C21H13F4N5O/c1-29-19-15(10-26-29)18-16(20(31)30(28-18)14-7-3-6-13(22)9-14)17(27-19)11-4-2-5-12(8-11)21(23,24)25/h2-10,28H,1H3",JTXSHJQEOYTUFS-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.70,cancer,Inhibition,
970,506218,493934,442049,Fc1ccc2[nH]cc(C(=O)C(=O)N3CCN(CC3)C(=O)c3ccccc3)c2c1,"1-(4-benzoylpiperazin-1-yl)-2-(5-fluoro-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C21H18FN3O3/c22-15-6-7-18-16(12-15)17(13-23-18)19(26)21(28)25-10-8-24(9-11-25)20(27)14-4-2-1-3-5-14/h1-7,12-13,23H,8-11H2",OXTPRTIEPINELH-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,6.08,HIV infectious disease,Inhibition,
971,88572778,,,FC(F)(F)S(=O)(=O)c1cc(ccc1N[C@H](CCN1CCCCC1)CSc1ccccc1)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1,,"InChI=1S/C47H53ClF3N7O4S3/c48-36-15-13-34(14-16-36)41-12-6-5-9-35(41)30-57-26-20-38(21-27-57)58-28-22-42-44(31-58)52-33-53-46(42)55-65(61,62)40-17-18-43(45(29-40)64(59,60)47(49,50)51)54-37(19-25-56-23-7-2-8-24-56)32-63-39-10-3-1-4-11-39/h1,3-6,9-18,29,33,37-38,54H,2,7-8,19-28,30-32H2,(H,52,53,55)/t37-/m1/s1",RXCPKXVXRYYFSG-DIPNUNPCSA-N,1,0,0,0,BCL2-Like / BAX,6.89,cancer,Inhibition,
972,59343779,,,OC[C@@H](O)CCNC(=O)[C@@H]1N[C@H](C2CCCCC2)[C@@]2([C@H]1c1ccc(F)c(Cl)c1)C(=O)Nc1cc(Cl)c(F)cc21,"(2'R,3S,3'R,5'R)-6-chloro-3'-(3-chloro-4-fluorophenyl)-5'-cyclohexyl-N-[(3S)-3,4-dihydroxybutyl]-5-fluoro-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide","InChI=1S/C28H31Cl2F2N3O4/c29-18-10-15(6-7-20(18)31)23-24(26(38)33-9-8-16(37)13-36)35-25(14-4-2-1-3-5-14)28(23)17-11-21(32)19(30)12-22(17)34-27(28)39/h6-7,10-12,14,16,23-25,35-37H,1-5,8-9,13H2,(H,33,38)(H,34,39)/t16-,23-,24+,25+,28+/m0/s1",DLJFMKLDRBATES-AYOLOSBVSA-N,1,3,0,0,MDM2-Like / P53,6.15,cancer,Inhibition,
973,11952815,210151,23271977,C[C@@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)N(CCCCC(O)=O)c2ccc(I)cc2C1=O)c1ccc(Cl)cc1,"5-[(3S)-3-(4-chlorophenyl)-4-[(1R)-1-(4-chlorophenyl)ethyl]-7-iodo-2,5-dioxo-3H-1,4-benzodiazepin-1-yl]pentanoic acid","InChI=1S/C28H25Cl2IN2O4/c1-17(18-5-9-20(29)10-6-18)33-26(19-7-11-21(30)12-8-19)28(37)32(15-3-2-4-25(34)35)24-14-13-22(31)16-23(24)27(33)36/h5-14,16-17,26H,2-4,15H2,1H3,(H,34,35)/t17-,26+/m1/s1",VLOPNYYNACVDTC-QUGAMOGWSA-N,3,2,0,0,MDM2-Like / P53,6.15,cancer,Inhibition,
974,24800648,270268,23326055,CC(C)c1cc(C(=O)c2ccc(Oc3ccccc3)cc2)c(O)c(O)c1O,"(4-phenoxyphenyl)-(2,3,4-trihydroxy-5-propan-2-ylphenyl)methanone","InChI=1S/C22H20O5/c1-13(2)17-12-18(21(25)22(26)20(17)24)19(23)14-8-10-16(11-9-14)27-15-6-4-3-5-7-15/h3-13,24-26H,1-2H3",BPCUAEBLJFPRKL-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,5.51,cancer,Inhibition,
975,168317928,,,COC(=O)c1cc(ccc1Cl)-n1[nH]c2c3cnn(C)c3nc(-c3cccc(c3)C(F)(F)F)c2c1=O,,"InChI=1S/C23H15ClF3N5O3/c1-31-20-15(10-28-31)19-17(18(29-20)11-4-3-5-12(8-11)23(25,26)27)21(33)32(30-19)13-6-7-16(24)14(9-13)22(34)35-2/h3-10,30H,1-2H3",SEMVYIWHEFVUCL-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,6.92,cancer,Inhibition,
976,44392037,181343,23248109,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1ccnc(c1)N1CCCC1,4-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]-2-pyrrolidin-1-ylpyridine,"InChI=1S/C25H25F3N2S/c1-17(2)20-7-3-4-8-22(20)31-23-10-9-18(15-21(23)25(26,27)28)19-11-12-29-24(16-19)30-13-5-6-14-30/h3-4,7-12,15-17H,5-6,13-14H2,1-2H3",ROTGVBIACJDGCI-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,6.60,immune system disease,Inhibition,
977,51042007,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(CC2=C(CCC(C)(C)C2)c2ccc(Cl)cc2)CC1,"N-[7-[1-[[2-(4-chlorophenyl)-5,5-dimethylcyclohexen-1-yl]methyl]piperidin-4-yl]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl]-4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)benzenesulfonamide","InChI=1S/C46H57ClF3N7O4S3/c1-45(2)21-16-39(32-10-12-34(47)13-11-32)33(27-45)28-56-23-18-36(19-24-56)57-25-20-40-42(29-57)51-31-52-44(40)54-64(60,61)38-14-15-41(43(26-38)63(58,59)46(48,49)50)53-35(17-22-55(3)4)30-62-37-8-6-5-7-9-37/h5-15,26,31,35-36,53H,16-25,27-30H2,1-4H3,(H,51,52,54)/t35-/m1/s1",FRJIPSUXXYFZOO-PGUFJCEWSA-N,1,0,0,0,BCL2-Like / BAX,7.51,cancer,Inhibition,
978,11179874,183272,9354964,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1ccnc(c1)N1CC[C@@H](O)[C@@H](C1)C(O)=O,"(3R,4R)-4-hydroxy-1-[4-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyridin-2-yl]piperidine-3-carboxylic acid","InChI=1S/C27H27F3N2O3S/c1-16(2)19-5-3-4-6-23(19)36-24-8-7-17(13-21(24)27(28,29)30)18-9-11-31-25(14-18)32-12-10-22(33)20(15-32)26(34)35/h3-9,11,13-14,16,20,22,33H,10,12,15H2,1-2H3,(H,34,35)/t20-,22-/m1/s1",QUGRAPNUWRECOX-IFMALSPDSA-N,0,1,0,0,LFA / ICAM,7.37,immune system disease,Inhibition,
979,168317927,,,Cc1cc2CN(CCc2c(C)c1C(=O)N[C@@H](CNC(=O)c1cccs1)C(O)=O)C(=O)\C=C\c1ccco1,,"InChI=1S/C27H27N3O6S/c1-16-13-18-15-30(23(31)8-7-19-5-3-11-36-19)10-9-20(18)17(2)24(16)26(33)29-21(27(34)35)14-28-25(32)22-6-4-12-37-22/h3-8,11-13,21H,9-10,14-15H2,1-2H3,(H,28,32)(H,29,33)(H,34,35)/b8-7+/t21-/m0/s1",RCVCQAKRYGSEMT-CQQBXOTJSA-N,0,1,0,0,LFA / ICAM,7.60,immune system disease,Inhibition,
980,87243621,,,CC(C)CONC(=O)c1nc(-c2cccc(C)c2)n(c1-c1cccc(Cl)c1)-c1cc(Cl)ccc1C,,"InChI=1S/C28H27Cl2N3O2/c1-17(2)16-35-32-28(34)25-26(20-8-6-10-22(29)14-20)33(24-15-23(30)12-11-19(24)4)27(31-25)21-9-5-7-18(3)13-21/h5-15,17H,16H2,1-4H3,(H,32,34)",YXTFBOKCOAWRKS-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,6.02,cancer,Inhibition,
981,58531665,,,CCCCc1ccc(cc1)-c1cccc(CN(Cc2ccc(F)cc2)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)c1,"N-[[3-(4-butylphenyl)phenyl]methyl]-3,5-dichloro-N-[(4-fluorophenyl)methyl]-2-hydroxybenzenesulfonamide","InChI=1S/C30H28Cl2FNO3S/c1-2-3-5-21-8-12-24(13-9-21)25-7-4-6-23(16-25)20-34(19-22-10-14-27(33)15-11-22)38(36,37)29-18-26(31)17-28(32)30(29)35/h4,6-18,35H,2-3,5,19-20H2,1H3",GFRMLPMTFKEXSC-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,6.89,cancer,Inhibition,
982,168317919,,24635087,C[C@@H](Oc1cccc2cnccc12)C(=O)N1CCN(C[C@H]1C)C(=O)c1ccccc1,1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-isoquinolin-5-yloxypropan-1-one,"InChI=1S/C24H25N3O3/c1-17-16-26(24(29)19-7-4-3-5-8-19)13-14-27(17)23(28)18(2)30-22-10-6-9-20-15-25-12-11-21(20)22/h3-12,15,17-18H,13-14,16H2,1-2H3/t17-,18-/m1/s1",QGZBFMRZTJYQSW-QZTJIDSGSA-N,0,1,0,0,CD4 / gp120,6.99,HIV infectious disease,Inhibition,
983,168317926,,23271265,OC(=O)[C@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)N(Cc2ccncc2)c2ccc(I)cc2C1=O)c1ccc(Cl)cc1,"(2S)-2-(4-chlorophenyl)-2-[(3S)-3-(4-chlorophenyl)-7-iodo-2,5-dioxo-1-(pyridin-4-ylmethyl)-3H-1,4-benzodiazepin-4-yl]acetic acid","InChI=1S/C29H20Cl2IN3O4/c30-20-5-1-18(2-6-20)25-28(37)34(16-17-11-13-33-14-12-17)24-10-9-22(32)15-23(24)27(36)35(25)26(29(38)39)19-3-7-21(31)8-4-19/h1-15,25-26H,16H2,(H,38,39)/t25-,26+/m0/s1",GCTUOYWCMFLXSC-IZZNHLLZSA-N,1,0,0,0,MDM2-Like / P53,5.36,cancer,Inhibition,
984,44456329,270646,23324074,O=C(O)[C@H](Cc1ccccc1)N1C(=S)S\C(=C/c2ccc(OCCOCCOc3ccc(cc3)\C=C3/SC(=S)N(C3=O)[C@H](C(=O)O)Cc3ccccc3)cc2)C1=O,"(2S)-2-[(5Z)-5-[[4-[2-[2-[4-[(Z)-[3-[(1S)-1-carboxy-2-phenylethyl]-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl]phenoxy]ethoxy]ethoxy]phenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-3-phenylpropanoic acid","InChI=1S/C42H36N2O9S4/c45-37-35(56-41(54)43(37)33(39(47)48)23-27-7-3-1-4-8-27)25-29-11-15-31(16-12-29)52-21-19-51-20-22-53-32-17-13-30(14-18-32)26-36-38(46)44(42(55)57-36)34(40(49)50)24-28-9-5-2-6-10-28/h1-18,25-26,33-34H,19-24H2,(H,47,48)(H,49,50)/b35-25-,36-26-/t33-,34-/m0/s1",HKIIFTOBMULLCQ-WKAHBFOZSA-N,3,0,0,0,BCL2-Like / BAX,5.66,cancer,Inhibition,
985,168317925,,17249073,CCCN1C(=O)c2ccccc2[C@]1(OCCCO)c1ccc(Cl)cc1,3-(4-chlorophenyl)-3-(3-hydroxypropoxy)-2-propylisoindol-1-one,"InChI=1S/C20H22ClNO3/c1-2-12-22-19(24)17-6-3-4-7-18(17)20(22,25-14-5-13-23)15-8-10-16(21)11-9-15/h3-4,6-11,23H,2,5,12-14H2,1H3/t20-/m1/s1",GMBDGYALRVIIKT-HXUWFJFHSA-N,2,0,0,0,MDM2-Like / P53,4.79,cancer,Inhibition,
986,168317924,,,CNC(=O)[C@H](Cc1ccc2ccccc2c1)N1CCC(=O)N(\C=C\c2ccncc2)[C@@H](CC(C)C)C1=O,,"InChI=1S/C30H34N4O3/c1-21(2)18-27-30(37)34(17-13-28(35)33(27)16-12-22-10-14-32-15-11-22)26(29(36)31-3)20-23-8-9-24-6-4-5-7-25(24)19-23/h4-12,14-16,19,21,26-27H,13,17-18,20H2,1-3H3,(H,31,36)/b16-12+/t26-,27-/m0/s1",SGMLGVXBLSQYDJ-ZNPZAEPOSA-N,1,0,0,0,LFA / ICAM,7.62,immune system disease,Inhibition,
987,168317922,,,Cc1cc2CN(CCc2c(C)c1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O)C(=O)c1ccc(Cl)cc1,,"InChI=1S/C30H28ClN3O4/c1-17-13-21-16-34(29(36)19-7-9-22(31)10-8-19)12-11-23(21)18(2)27(17)28(35)33-26(30(37)38)14-20-15-32-25-6-4-3-5-24(20)25/h3-10,13,15,26,32H,11-12,14,16H2,1-2H3,(H,33,35)(H,37,38)/t26-/m0/s1",WIFCSPALDWRZQS-SANMLTNESA-N,0,1,0,0,LFA / ICAM,6.09,immune system disease,Inhibition,
988,168317920,,,CC(C)c1cccc(c1)C(=O)NC[C@H](NC(=O)c1c(Cl)cc2CN(CCc2c1Cl)C(=O)c1ccc(Cl)cc1)C(O)=O,,"InChI=1S/C30H28Cl3N3O5/c1-16(2)18-4-3-5-19(12-18)27(37)34-14-24(30(40)41)35-28(38)25-23(32)13-20-15-36(11-10-22(20)26(25)33)29(39)17-6-8-21(31)9-7-17/h3-9,12-13,16,24H,10-11,14-15H2,1-2H3,(H,34,37)(H,35,38)(H,40,41)/t24-/m0/s1",ZCYVLWBKTAORHR-DEOSSOPVSA-N,1,0,0,0,LFA / ICAM,8.00,immune system disease,Inhibition,
989,16742546,,20573840,C(Cc1c[nH]c2ccccc12)Nc1ccc2N(CCc2c1)c1ccncc1,"N-[2-(1H-indol-3-yl)ethyl]-1-pyridin-4-yl-2,3-dihydroindol-5-amine","InChI=1S/C23H22N4/c1-2-4-22-21(3-1)18(16-26-22)7-13-25-19-5-6-23-17(15-19)10-14-27(23)20-8-11-24-12-9-20/h1-6,8-9,11-12,15-16,25-26H,7,10,13-14H2",SOSNAFIWRFXNHE-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,8.00,cancer,Inhibition,
990,44570085,460173,24690692,Cc1c(Cl)c(nn1-c1ccccc1C(=O)N1Cc2ccccc2C[C@H]1CO)C(=O)N(c1ccccc1)c1ccccc1,"4-chloro-1-[2-[(3S)-3-(hydroxymethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-5-methyl-N,N-diphenylpyrazole-3-carboxamide","InChI=1S/C34H29ClN4O3/c1-23-31(35)32(34(42)38(26-14-4-2-5-15-26)27-16-6-3-7-17-27)36-39(23)30-19-11-10-18-29(30)33(41)37-21-25-13-9-8-12-24(25)20-28(37)22-40/h2-19,28,40H,20-22H2,1H3/t28-/m0/s1",ITMKSGOOPACEDG-NDEPHWFRSA-N,2,0,0,0,BCL2-Like / BAX,7.30,cancer,Inhibition,
991,44570089,446802,24687308,CCCCN(CCCC)C(=O)c1nn(c(C)c1Cl)-c1ccc(NC(=O)c2ccccc2)cc1C(=O)N1CCc2ccccc2C1,"1-[4-benzamido-2-(3,4-dihydro-1H-isoquinoline-2-carbonyl)phenyl]-N,N-dibutyl-4-chloro-5-methylpyrazole-3-carboxamide","InChI=1S/C36H40ClN5O3/c1-4-6-20-40(21-7-5-2)36(45)33-32(37)25(3)42(39-33)31-18-17-29(38-34(43)27-14-9-8-10-15-27)23-30(31)35(44)41-22-19-26-13-11-12-16-28(26)24-41/h8-18,23H,4-7,19-22,24H2,1-3H3,(H,38,43)",ZSAFZGXHHLMXSO-UHFFFAOYSA-N,1,0,0,0,BCL2-Like / BAX,6.09,cancer,Inhibition,
992,44818859,569230,24630540,CN(C)c1nc(NCc2ccc(NC(=O)c3ccc(F)cc3)cc2)c2ccc(C=C)cc2n1,N-[4-[[[2-(dimethylamino)-7-ethenylquinazolin-4-yl]amino]methyl]phenyl]-4-fluorobenzamide,"InChI=1S/C26H24FN5O/c1-4-17-7-14-22-23(15-17)30-26(32(2)3)31-24(22)28-16-18-5-12-21(13-6-18)29-25(33)19-8-10-20(27)11-9-19/h4-15H,1,16H2,2-3H3,(H,29,33)(H,28,30,31)",WIKFZOQKGJIUSK-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,6.62,cancer,Inhibition,
993,59555821,,,NCc1cc(Nc2ccc(NCCc3c[nH]c4ccccc34)cc2)ccn1,"4-N-[2-(aminomethyl)pyridin-4-yl]-1-N-[2-(1H-indol-3-yl)ethyl]benzene-1,4-diamine","InChI=1S/C22H23N5/c23-14-20-13-19(10-12-25-20)27-18-7-5-17(6-8-18)24-11-9-16-15-26-22-4-2-1-3-21(16)22/h1-8,10,12-13,15,24,26H,9,11,14,23H2,(H,25,27)",ZISSGOYNCACZDI-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,6.52,cancer,Inhibition,
994,24876652,,,C(Cc1cnc2CCCCn12)Nc1ccc(Nc2ccncc2)cc1,"4-N-pyridin-4-yl-1-N-[2-(5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-3-yl)ethyl]benzene-1,4-diamine","InChI=1S/C20H23N5/c1-2-14-25-19(15-23-20(25)3-1)10-13-22-16-4-6-17(7-5-16)24-18-8-11-21-12-9-18/h4-9,11-12,15,22H,1-3,10,13-14H2,(H,21,24)",BUDMKOHZVRWDQQ-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,5.52,cancer,Inhibition,
995,25002081,,,CC(C)(C)C[C@H]1N[C@H]([C@H](c2ccc(F)c(Cl)c2)[C@@]11C(=O)Nc2cc(Cl)c(F)cc12)C(=O)NCC[C@H]1CC[C@@H](O)C1,"(2'R,3S,3'R,5'R)-6-chloro-3'-(3-chloro-4-fluorophenyl)-5'-(2,2-dimethylpropyl)-5-fluoro-N-[2-(3-hydroxycyclopentyl)ethyl]-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide","InChI=1S/C30H35Cl2F2N3O3/c1-29(2,3)14-24-30(18-12-22(34)20(32)13-23(18)36-28(30)40)25(16-5-7-21(33)19(31)11-16)26(37-24)27(39)35-9-8-15-4-6-17(38)10-15/h5,7,11-13,15,17,24-26,37-38H,4,6,8-10,14H2,1-3H3,(H,35,39)(H,36,40)/t15-,17-,24-,25+,26-,30+/m1/s1",XLSHWAWDBJTNLP-LLHAZNGGSA-N,1,3,0,0,MDM2-Like / P53,7.26,cancer,Inhibition,
996,68402895,,,OCCCCNCc1cc(Nc2ccc(NCCc3c[nH]c4ccccc34)cc2)ccn1,,"InChI=1S/C26H31N5O/c32-16-4-3-13-27-19-24-17-23(12-15-29-24)31-22-9-7-21(8-10-22)28-14-11-20-18-30-26-6-2-1-5-25(20)26/h1-2,5-10,12,15,17-18,27-28,30,32H,3-4,11,13-14,16,19H2,(H,29,31)",YWLPUGZLVNRBSU-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,5.52,cancer,Inhibition,
997,58006884,,,CC(C)C1=C(SC2=N[C@](C)([C@H](N12)c1ccc(Cl)cc1)c1ccc(Cl)cc1)C(=O)N1[C@H](C)CC[C@H]1C(=O)N1CCN(CCO)C(C)(C)C1,"[(2S,5R)-1-[(5R,6S)-5,6-bis(4-chlorophenyl)-6-methyl-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazole-2-carbonyl]-5-methylpyrrolidin-2-yl]-[4-(2-hydroxyethyl)-3,3-dimethylpiperazin-1-yl]methanone","InChI=1S/C36H45Cl2N5O3S/c1-22(2)29-30(33(46)42-23(3)7-16-28(42)32(45)40-17-18-41(19-20-44)35(4,5)21-40)47-34-39-36(6,25-10-14-27(38)15-11-25)31(43(29)34)24-8-12-26(37)13-9-24/h8-15,22-23,28,31,44H,7,16-21H2,1-6H3/t23-,28+,31-,36+/m1/s1",HSWCARFRAWSEQL-HNENRWDKSA-N,1,0,0,0,MDM2-Like / P53,8.40,cancer,Inhibition,
998,25000114,,,CC(C)(C)C[C@H]1N[C@H]([C@H](c2ccc(F)c(Cl)c2)[C@@]11C(=O)Nc2cc(Cl)c(F)cc12)C(=O)NCC[C@@H](O)C[C@@H](O)CC(O)=O,"(3R,5R)-7-[[(2'R,3S,3'R,5'R)-6-chloro-3'-(3-chloro-4-fluorophenyl)-5'-(2,2-dimethylpropyl)-5-fluoro-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carbonyl]amino]-3,5-dihydroxyheptanoic acid","InChI=1S/C30H35Cl2F2N3O6/c1-29(2,3)13-23-30(17-11-21(34)19(32)12-22(17)36-28(30)43)25(14-4-5-20(33)18(31)8-14)26(37-23)27(42)35-7-6-15(38)9-16(39)10-24(40)41/h4-5,8,11-12,15-16,23,25-26,37-39H,6-7,9-10,13H2,1-3H3,(H,35,42)(H,36,43)(H,40,41)/t15-,16-,23-,25+,26-,30+/m1/s1",FXOIWZYATMQQKC-BJADBZOVSA-N,1,3,0,0,MDM2-Like / P53,5.45,cancer,Inhibition,
999,88540225,,,CN(C)CC[C@H](CSc1cccc(Cl)c1)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1,,"InChI=1S/C44H48Cl2F3N7O4S3/c1-54(2)20-16-34(28-61-36-8-5-7-33(46)24-36)52-40-15-14-37(25-42(40)62(57,58)44(47,48)49)63(59,60)53-43-39-19-23-56(27-41(39)50-29-51-43)35-17-21-55(22-18-35)26-31-6-3-4-9-38(31)30-10-12-32(45)13-11-30/h3-15,24-25,29,34-35,52H,16-23,26-28H2,1-2H3,(H,50,51,53)/t34-/m1/s1",TXCIYDFKXAEUNM-UUWRZZSWSA-N,1,0,0,0,BCL2-Like / BAX,7.32,cancer,Inhibition,
1000,168318116,,23241104,OC(=O)C1CCN(CC1)c1ccccc1Sc1ccc(cc1C(F)(F)F)[C@@H]1C[C@H]1C(=O)NCCCN1CCCC1=O,1-[2-[4-[2-[3-(2-oxopyrrolidin-1-yl)propylcarbamoyl]cyclopropyl]-2-(trifluoromethyl)phenyl]sulfanylphenyl]piperidine-4-carboxylic acid,"InChI=1S/C30H34F3N3O4S/c31-30(32,33)23-17-20(21-18-22(21)28(38)34-12-4-14-36-13-3-7-27(36)37)8-9-25(23)41-26-6-2-1-5-24(26)35-15-10-19(11-16-35)29(39)40/h1-2,5-6,8-9,17,19,21-22H,3-4,7,10-16,18H2,(H,34,38)(H,39,40)/t21-,22+/m0/s1",BDMKWKGKWYADLX-FCHUYYIVSA-N,0,1,0,0,LFA / ICAM,6.21,immune system disease,Inhibition,
1001,67954232,,,CN(C)CCCN(C)Cc1ccc(Cl)cc1-c1c(nc(-c2ccccc2)n1-c1cccc(Cl)c1F)C(O)=O,,"InChI=1S/C29H29Cl2FN4O2/c1-34(2)15-8-16-35(3)18-20-13-14-21(30)17-22(20)27-26(29(37)38)33-28(19-9-5-4-6-10-19)36(27)24-12-7-11-23(31)25(24)32/h4-7,9-14,17H,8,15-16,18H2,1-3H3,(H,37,38)",ZPAQDYYGSSQCFU-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,6.17,cancer,Inhibition,
1002,16109154,386955,17266567,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCC2(CC(Cc3ccccc3)=NO2)CC1,"4-(3-benzyl-1-oxa-2,8-diazaspiro[4.5]dec-2-en-8-yl)-N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonylbenzamide","InChI=1S/C39H44N6O6S2/c1-43(2)22-19-31(28-52-34-11-7-4-8-12-34)40-36-18-17-35(26-37(36)45(47)48)53(49,50)42-38(46)30-13-15-33(16-14-30)44-23-20-39(21-24-44)27-32(41-51-39)25-29-9-5-3-6-10-29/h3-18,26,31,40H,19-25,27-28H2,1-2H3,(H,42,46)/t31-/m1/s1",WPDFQZLKJJZIJX-WJOKGBTCSA-N,2,0,0,0,BCL2-Like / BAX,8.77,cancer,Inhibition,
1003,44390660,359856,23246682,OC(=O)[C@@H](N1[C@@H](c2ccc(OC(F)(F)F)cc2)C(=O)Nc2ccc(I)cc2C1=O)c1ccccc1,"2-[7-iodo-2,5-dioxo-3-[4-(trifluoromethoxy)phenyl]-1,3-dihydro-1,4-benzodiazepin-4-yl]-2-phenylacetic acid","InChI=1S/C24H16F3IN2O5/c25-24(26,27)35-16-9-6-14(7-10-16)19-21(31)29-18-11-8-15(28)12-17(18)22(32)30(19)20(23(33)34)13-4-2-1-3-5-13/h1-12,19-20H,(H,29,31)(H,33,34)/t19-,20-/m0/s1",VMNOQXOCNDWHJI-PMACEKPBSA-N,1,0,0,0,MDM2-Like / P53,5.88,cancer,Inhibition,
1004,59249652,,,CCC(CC)[C@@H]1N[C@H]([C@H](c2cccc(Cl)c2)[C@@]1(C#N)c1ccc(Cl)cc1)C(=O)NCC[C@H](O)CO,"(2R,3R,4R,5R)-3-(3-chlorophenyl)-4-(4-chlorophenyl)-4-cyano-N-[(3S)-3,4-dihydroxybutyl]-5-pentan-3-ylpyrrolidine-2-carboxamide","InChI=1S/C27H33Cl2N3O3/c1-3-17(4-2)25-27(16-30,19-8-10-20(28)11-9-19)23(18-6-5-7-21(29)14-18)24(32-25)26(35)31-13-12-22(34)15-33/h5-11,14,17,22-25,32-34H,3-4,12-13,15H2,1-2H3,(H,31,35)/t22-,23-,24+,25-,27+/m0/s1",CSOZJVPYDPKXFE-GAYSTUHSSA-N,1,0,0,0,MDM2-Like / P53,6.22,cancer,Inhibition,
1005,45137339,,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CC[C@H]2NC[C@@H]([C@@H]12)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(1S)-2-[(3aR,6S,6aR)-6-(6-fluoro-1H-indol-3-yl)-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,2-b]pyrrol-1-yl]-1-cyclohexyl-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C26H36FN5O2/c1-15(28-2)25(33)31-23(16-6-4-3-5-7-16)26(34)32-11-10-21-24(32)20(14-29-21)19-13-30-22-12-17(27)8-9-18(19)22/h8-9,12-13,15-16,20-21,23-24,28-30H,3-7,10-11,14H2,1-2H3,(H,31,33)/t15-,20+,21+,23-,24+/m0/s1",LFGLZVWZFMNMSV-UJHWWNLFSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
1006,23647740,,,CN[C@@H](C)C(=O)N[C@H]1CCC[C@H]2SC(C)(C)[C@H](N2C1=O)C(=O)Nc1cc(C)nn1-c1ccccc1,"(3R,6R,9aR)-2,2-dimethyl-6-[[(2S)-2-(methylamino)propanoyl]amino]-N-(5-methyl-2-phenylpyrazol-3-yl)-5-oxo-3,6,7,8,9,9a-hexahydro-[1,3]thiazolo[3,2-a]azepine-3-carboxamide","InChI=1S/C25H34N6O3S/c1-15-14-19(31(29-15)17-10-7-6-8-11-17)28-23(33)21-25(3,4)35-20-13-9-12-18(24(34)30(20)21)27-22(32)16(2)26-5/h6-8,10-11,14,16,18,20-21,26H,9,12-13H2,1-5H3,(H,27,32)(H,28,33)/t16-,18-,20+,21+/m0/s1",RBLGKKZTMVKMNE-XIGKFDRGSA-N,1,0,0,0,XIAP / Smac,6.11,cancer,Inhibition,
1007,506288,572013,442119,C[C@@H]1CN(CCN1C(=O)C(=O)c1c[nH]c2cccc(F)c12)C(=O)c1ccccc1,"1-(4-benzoyl-2-methylpiperazin-1-yl)-2-(4-fluoro-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C22H20FN3O3/c1-14-13-25(21(28)15-6-3-2-4-7-15)10-11-26(14)22(29)20(27)16-12-24-18-9-5-8-17(23)19(16)18/h2-9,12,14,24H,10-11,13H2,1H3/t14-/m1/s1",GJIOAZQCBADHSB-CQSZACIVSA-N,0,1,0,0,CD4 / gp120,9.80,HIV infectious disease,Inhibition,
1008,168318111,,26364248,CN(C)CCC[C@](O)(c1ccccc1)c1cccc(OCCc2ccc(cc2)-c2ccc(cc2)C(O)=O)c1,4-[4-[2-[3-[4-(dimethylamino)-1-hydroxy-1-phenylbutyl]phenoxy]ethyl]phenyl]benzoic acid,"InChI=1S/C33H35NO4/c1-34(2)22-7-21-33(37,29-8-4-3-5-9-29)30-10-6-11-31(24-30)38-23-20-25-12-14-26(15-13-25)27-16-18-28(19-17-27)32(35)36/h3-6,8-19,24,37H,7,20-23H2,1-2H3,(H,35,36)/t33-/m0/s1",GXMWGSRSTMANHE-XIFFEERXSA-N,1,0,0,0,BCL2-Like / BAX,5.34,cancer,Inhibition,
1009,168318115,,,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(CO)cc2)c1=O,,"InChI=1S/C22H16F3N5O2/c1-29-20-16(10-26-29)19-17(18(27-20)13-3-2-4-14(9-13)22(23,24)25)21(32)30(28-19)15-7-5-12(11-31)6-8-15/h2-10,28,31H,11H2,1H3",DOCMPTAQFZWREP-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.48,cancer,Inhibition,
1010,67032047,,,CC(C)(C)OC(=O)NCC(C)(C)NC(=O)Cc1ccc(Cl)c(F)c1-n1c(nc(-c2nnc(N)o2)c1-c1ccc(F)c(Cl)c1)C1CCCCC1,,"InChI=1S/C34H39Cl2F2N7O4/c1-33(2,3)49-32(47)40-17-34(4,5)42-24(46)16-20-11-13-21(35)25(38)27(20)45-28(19-12-14-23(37)22(36)15-19)26(30-43-44-31(39)48-30)41-29(45)18-9-7-6-8-10-18/h11-15,18H,6-10,16-17H2,1-5H3,(H2,39,44)(H,40,47)(H,42,46)",NZVXIMLNMVAYQV-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,8.70,cancer,Inhibition,
1011,168318095,,,CN(C)C(=O)C[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(C)(C)C)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1,,"InChI=1S/C47H56ClN7O5S3/c1-47(2,3)62(57,58)44-28-39(19-20-42(44)51-36(27-45(56)53(4)5)31-61-38-12-7-6-8-13-38)63(59,60)52-46-41-23-26-55(30-43(41)49-32-50-46)37-21-24-54(25-22-37)29-34-11-9-10-14-40(34)33-15-17-35(48)18-16-33/h6-20,28,32,36-37,51H,21-27,29-31H2,1-5H3,(H,49,50,52)/t36-/m1/s1",QMBGWJUIXBDJLW-PSXMRANNSA-N,1,0,0,0,BCL2-Like / BAX,7.12,cancer,Inhibition,
1012,168318114,,19174415,OC(=O)[C@H]1CCCN(C1)c1ccccc1Sc1ccc(cc1C(F)(F)F)[C@@H]1C[C@H]1C(=O)NCCCN1CCCC1=O,1-[2-[4-[2-[3-(2-oxopyrrolidin-1-yl)propylcarbamoyl]cyclopropyl]-2-(trifluoromethyl)phenyl]sulfanylphenyl]piperidine-3-carboxylic acid,"InChI=1S/C30H34F3N3O4S/c31-30(32,33)23-16-19(21-17-22(21)28(38)34-12-5-15-35-13-4-9-27(35)37)10-11-25(23)41-26-8-2-1-7-24(26)36-14-3-6-20(18-36)29(39)40/h1-2,7-8,10-11,16,20-22H,3-6,9,12-15,17-18H2,(H,34,38)(H,39,40)/t20-,21-,22+/m0/s1",RDDGVDXVIDYSSC-FDFHNCONSA-N,0,1,0,0,LFA / ICAM,7.30,immune system disease,Inhibition,
1013,11765433,,,Cc1ccc2C(=O)[C@@]3(O[C@H]([C@H]([C@H]3C(O)=O)C(=O)Nc3ccc(cc3)N3CCOCC3)c3ccc(Br)c(Br)c3)C(=O)c2c1,"(2R,3'R,4'S,5'R)-5'-(3,4-dibromophenyl)-5-methyl-4'-[(4-morpholin-4-ylphenyl)carbamoyl]-1,3-dioxospiro[indene-2,2'-oxolane]-3'-carboxylic acid","InChI=1S/C31H26Br2N2O7/c1-16-2-8-20-21(14-16)28(37)31(27(20)36)25(30(39)40)24(26(42-31)17-3-9-22(32)23(33)15-17)29(38)34-18-4-6-19(7-5-18)35-10-12-41-13-11-35/h2-9,14-15,24-26H,10-13H2,1H3,(H,34,38)(H,39,40)/t24-,25-,26-,31+/m0/s1",PSIGPYLZRLKKOO-WJQRCLFPSA-N,1,0,0,0,E2 / E1,7.70,human papilloma virus infection,Inhibition,
1014,50922678,,,Fc1ccc(cc1Cl)-c1c(nc(-c2ccc3cc[nH]c3c2)n1-c1cccc(Cl)c1F)-c1nn[nH]n1,6-[1-(3-chloro-2-fluorophenyl)-5-(3-chloro-4-fluorophenyl)-4-(2H-tetrazol-5-yl)imidazol-2-yl]-1H-indole,"InChI=1S/C24H13Cl2F2N7/c25-15-2-1-3-19(20(15)28)35-22(13-6-7-17(27)16(26)10-13)21(23-31-33-34-32-23)30-24(35)14-5-4-12-8-9-29-18(12)11-14/h1-11,29H,(H,31,32,33,34)",PUDUCJZUDIZXSH-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,8.80,cancer,Inhibition,
1015,23646362,,,CC[C@H](N)C(=O)N[C@H]1CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S)-6-[[(2S)-2-aminobutanoyl]amino]-N-benzhydryl-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carboxamide","InChI=1S/C26H32N4O3/c1-2-20(27)24(31)28-21-15-13-19-14-16-22(30(19)26(21)33)25(32)29-23(17-9-5-3-6-10-17)18-11-7-4-8-12-18/h3-12,19-23H,2,13-16,27H2,1H3,(H,28,31)(H,29,32)/t19-,20-,21-,22-/m0/s1",VWDMCRIMEONDMI-CMOCDZPBSA-N,2,0,0,0,XIAP / Smac,6.46,cancer,Inhibition,
1016,168318109,,,Cc1cc2CN(CCc2c(C)c1C(=O)N[C@@H](CNC(=O)c1cccs1)C(O)=O)C(=O)c1cc2ccccc2o1,,"InChI=1S/C29H27N3O6S/c1-16-12-19-15-32(28(35)23-13-18-6-3-4-7-22(18)38-23)10-9-20(19)17(2)25(16)27(34)31-21(29(36)37)14-30-26(33)24-8-5-11-39-24/h3-8,11-13,21H,9-10,14-15H2,1-2H3,(H,30,33)(H,31,34)(H,36,37)/t21-/m0/s1",ALFPJONYRNTLMZ-NRFANRHFSA-N,0,1,0,0,LFA / ICAM,8.30,immune system disease,Inhibition,
1017,68871011,,,CCOc1cc(Cl)c(cc1C1=N[C@H]([C@H](N1C(=O)N1CCNC(=O)C1)c1ccc(Cl)cc1)c1ccc(Cl)cc1)C#N,,"InChI=1S/C29H24Cl3N5O3/c1-2-40-24-14-23(32)19(15-33)13-22(24)28-35-26(17-3-7-20(30)8-4-17)27(18-5-9-21(31)10-6-18)37(28)29(39)36-12-11-34-25(38)16-36/h3-10,13-14,26-27H,2,11-12,16H2,1H3,(H,34,38)/t26-,27+/m0/s1",IGOYKAALBNCUSJ-RRPNLBNLSA-N,1,0,0,0,MDM2-Like / P53,6.82,cancer,Inhibition,
1018,11166423,,9341519,C[C@H](N)C(=O)N[C@H]1CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,8aS)-6-[[(2S)-2-aminopropanoyl]amino]-N-benzhydryl-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carboxamide","InChI=1S/C25H30N4O3/c1-16(26)23(30)27-20-14-12-19-13-15-21(29(19)25(20)32)24(31)28-22(17-8-4-2-5-9-17)18-10-6-3-7-11-18/h2-11,16,19-22H,12-15,26H2,1H3,(H,27,30)(H,28,31)/t16-,19-,20-,21-/m0/s1",CDMWMGBMHRDILL-FIRPJDEBSA-N,2,0,0,0,XIAP / Smac,5.63,cancer,Inhibition,
1019,46224087,1094753,24670620,CN1C(=O)N(C(=O)[C@]11CN(C[C@H]1c1ccc(cc1)C#N)c1ccc(nc1)C#N)c1cc(Cl)cc(Cl)c1,"5-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl]pyridine-2-carbonitrile","InChI=1S/C26H18Cl2N6O2/c1-32-25(36)34(22-9-18(27)8-19(28)10-22)24(35)26(32)15-33(21-7-6-20(12-30)31-13-21)14-23(26)17-4-2-16(11-29)3-5-17/h2-10,13,23H,14-15H2,1H3/t23-,26+/m0/s1",GUCBJWWAPXRWIV-JYFHCDHNSA-N,1,0,0,0,LFA / ICAM,7.92,immune system disease,Inhibition,
1020,168318085,,,CNc1nc(NCc2ccc(NC(=O)c3cccc(Cl)n3)cc2)c2ccccc2n1,,"InChI=1S/C22H19ClN6O/c1-24-22-28-17-6-3-2-5-16(17)20(29-22)25-13-14-9-11-15(12-10-14)26-21(30)18-7-4-8-19(23)27-18/h2-12H,13H2,1H3,(H,26,30)(H2,24,25,28,29)",DTDHAVMTRCRSNB-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,6.01,cancer,Inhibition,
1021,44580770,496105,24707482,FC(F)(F)c1c(Sc2cccc(OCc3c[nH]cn3)c2)ccc(\C=C\C(=O)N2CCOCC2)c1C(F)(F)F,"(E)-3-[4-[3-(1H-imidazol-5-ylmethoxy)phenyl]sulfanyl-2,3-bis(trifluoromethyl)phenyl]-1-morpholin-4-ylprop-2-en-1-one","InChI=1S/C25H21F6N3O3S/c26-24(27,28)22-16(5-7-21(35)34-8-10-36-11-9-34)4-6-20(23(22)25(29,30)31)38-19-3-1-2-18(12-19)37-14-17-13-32-15-33-17/h1-7,12-13,15H,8-11,14H2,(H,32,33)/b7-5+",XHNFQBYXWHWBKQ-FNORWQNLSA-N,1,0,0,0,LFA / ICAM,7.17,immune system disease,Inhibition,
1022,168318108,,24634716,C[C@@H](Oc1cccc2cccnc12)C(=O)N1CCN(C[C@H]1C)C(=O)c1ccccc1,1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-quinolin-8-yloxypropan-1-one,"InChI=1S/C24H25N3O3/c1-17-16-26(24(29)20-8-4-3-5-9-20)14-15-27(17)23(28)18(2)30-21-12-6-10-19-11-7-13-25-22(19)21/h3-13,17-18H,14-16H2,1-2H3/t17-,18-/m1/s1",PILWBQABZMEXDS-QZTJIDSGSA-N,0,1,0,0,CD4 / gp120,6.36,HIV infectious disease,Inhibition,
1023,44818310,568799,24630680,CNc1nc(NCc2ccc(NC(=O)c3ccc(F)cc3)cc2)c2cc(C)ccc2n1,4-fluoro-N-[4-[[[6-methyl-2-(methylamino)quinazolin-4-yl]amino]methyl]phenyl]benzamide,"InChI=1S/C24H22FN5O/c1-15-3-12-21-20(13-15)22(30-24(26-2)29-21)27-14-16-4-10-19(11-5-16)28-23(31)17-6-8-18(25)9-7-17/h3-13H,14H2,1-2H3,(H,28,31)(H2,26,27,29,30)",UFDQFCNUXSHUFA-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,6.38,cancer,Inhibition,
1024,21906783,181111,10657293,COc1ccccc1Sc1ccc(cc1C(F)(F)F)-c1ccnc(c1)N1CCN(CC1)C(C)=O,1-[4-[4-[4-(2-methoxyphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyridin-2-yl]piperazin-1-yl]ethanone,"InChI=1S/C25H24F3N3O2S/c1-17(32)30-11-13-31(14-12-30)24-16-19(9-10-29-24)18-7-8-22(20(15-18)25(26,27)28)34-23-6-4-3-5-21(23)33-2/h3-10,15-16H,11-14H2,1-2H3",ABFZFLPVUIIHIL-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,6.92,immune system disease,Inhibition,
1025,21906805,360249,10657326,CC(=O)N1CCCN(CC1)c1cc(ccn1)-c1ccc(Sc2ccc3OCCOc3c2)c(c1)C(F)(F)F,"1-[4-[4-[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfanyl)-3-(trifluoromethyl)phenyl]pyridin-2-yl]-1,4-diazepan-1-yl]ethanone","InChI=1S/C27H26F3N3O3S/c1-18(34)32-9-2-10-33(12-11-32)26-16-20(7-8-31-26)19-3-6-25(22(15-19)27(28,29)30)37-21-4-5-23-24(17-21)36-14-13-35-23/h3-8,15-17H,2,9-14H2,1H3",ZFKSCQNGJJUYMW-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,6.44,immune system disease,Inhibition,
1026,168317943,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1ncnc2CN(CCc12)[C@H]1CCN(Cc2ccccc2-c2ccc(Cl)cc2)C[C@@H]1F,,"InChI=1S/C44H48ClF4N7O4S3/c1-54(2)21-18-33(28-61-34-9-4-3-5-10-34)52-39-17-16-35(24-42(39)62(57,58)44(47,48)49)63(59,60)53-43-37-19-23-56(27-40(37)50-29-51-43)41-20-22-55(26-38(41)46)25-31-8-6-7-11-36(31)30-12-14-32(45)15-13-30/h3-17,24,29,33,38,41,52H,18-23,25-28H2,1-2H3,(H,50,51,53)/t33-,38+,41+/m1/s1",DHYJRDDPIRPKOP-DOMFRNPMSA-N,1,0,0,0,BCL2-Like / BAX,7.44,cancer,Inhibition,
1027,58531545,,,CC(C)N(Cc1ccccc1)C(=O)c1ccc(CN(Cc2ccc(F)cc2)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)cc1,"N-benzyl-4-[[(3,5-dichloro-2-hydroxyphenyl)sulfonyl-[(4-fluorophenyl)methyl]amino]methyl]-N-propan-2-ylbenzamide","InChI=1S/C31H29Cl2FN2O4S/c1-21(2)36(20-22-6-4-3-5-7-22)31(38)25-12-8-23(9-13-25)18-35(19-24-10-14-27(34)15-11-24)41(39,40)29-17-26(32)16-28(33)30(29)37/h3-17,21,37H,18-20H2,1-2H3",XFWNQOJWOCJYPU-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,6.32,cancer,Inhibition,
1028,86231919,,,O=N(=O)c1cccc2c(Nc3ccc(NCCc4c[nH]c5ccccc45)cc3)ccnc12,,"InChI=1S/C25H21N5O2/c31-30(32)24-7-3-5-21-23(13-15-27-25(21)24)29-19-10-8-18(9-11-19)26-14-12-17-16-28-22-6-2-1-4-20(17)22/h1-11,13,15-16,26,28H,12,14H2,(H,27,29)",HCGNBPCARQRJNH-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,6.40,cancer,Inhibition,
1029,168318104,,24633845,C[C@@H](Oc1cccc2[nH]c(C)nc12)C(=O)N1CCN(C[C@H]1C)C(=O)c1ccccc1,1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-[(2-methyl-1H-benzimidazol-4-yl)oxy]propan-1-one,"InChI=1S/C23H26N4O3/c1-15-14-26(23(29)18-8-5-4-6-9-18)12-13-27(15)22(28)16(2)30-20-11-7-10-19-21(20)25-17(3)24-19/h4-11,15-16H,12-14H2,1-3H3,(H,24,25)/t15-,16-/m1/s1",NEHXLWBZDUOFAT-HZPDHXFCSA-N,0,1,0,0,CD4 / gp120,6.08,HIV infectious disease,Inhibition,
1030,1101958,3222134,939227,COc1ccc(CNC(=O)c2cc3nc(cc(n3n2)C(F)(F)F)-c2cccs2)cc1,"N-[(4-methoxyphenyl)methyl]-5-thiophen-2-yl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxamide","InChI=1S/C20H15F3N4O2S/c1-29-13-6-4-12(5-7-13)11-24-19(28)15-10-18-25-14(16-3-2-8-30-16)9-17(20(21,22)23)27(18)26-15/h2-10H,11H2,1H3,(H,24,28)",AARUNXNNAZIAQK-UHFFFAOYSA-N,1,0,0,0,Myc / Max,4.60,cancer,Inhibition,
1031,168317445,,,CC[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(C)(C)C)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(CC2=C(CCC(C)(C)C2)c2ccc(Cl)cc2)CC1,,"InChI=1S/C47H61ClN6O4S3/c1-7-36(31-59-38-11-9-8-10-12-38)51-42-18-17-39(27-44(42)60(55,56)46(2,3)4)61(57,58)52-45-41-22-26-54(30-43(41)49-32-50-45)37-20-24-53(25-21-37)29-34-28-47(5,6)23-19-40(34)33-13-15-35(48)16-14-33/h8-18,27,32,36-37,51H,7,19-26,28-31H2,1-6H3,(H,49,50,52)/t36-/m1/s1",RMYSCXJMUWMWJY-PSXMRANNSA-N,1,0,0,0,BCL2-Like / BAX,6.16,cancer,Inhibition,
1032,168318101,,19174412,CC(C)c1ccccc1Sc1ccc([C@@H]2C[C@H]2C(=O)N2CCCC[C@@H]2C(O)=O)c(Cl)c1Cl,"1-[2-[2,3-dichloro-4-(2-propan-2-ylphenyl)sulfanylphenyl]cyclopropanecarbonyl]piperidine-2-carboxylic acid","InChI=1S/C25H27Cl2NO3S/c1-14(2)15-7-3-4-9-20(15)32-21-11-10-16(22(26)23(21)27)17-13-18(17)24(29)28-12-6-5-8-19(28)25(30)31/h3-4,7,9-11,14,17-19H,5-6,8,12-13H2,1-2H3,(H,30,31)/t17-,18+,19+/m0/s1",LBFPLUWTLKUUCU-IPMKNSEASA-N,0,1,0,0,LFA / ICAM,7.89,immune system disease,Inhibition,
1033,44570041,510332,24713792,CC(=O)NC[C@@H]1Cc2ccccc2CN1C(=O)c1ccccc1-n1nc(cc1C)C(=O)N(c1ccccc1)c1ccccc1,"1-[2-[(3S)-3-(acetamidomethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-5-methyl-N,N-diphenylpyrazole-3-carboxamide","InChI=1S/C36H33N5O3/c1-25-21-33(36(44)40(29-15-5-3-6-16-29)30-17-7-4-8-18-30)38-41(25)34-20-12-11-19-32(34)35(43)39-24-28-14-10-9-13-27(28)22-31(39)23-37-26(2)42/h3-21,31H,22-24H2,1-2H3,(H,37,42)/t31-/m0/s1",FPIRBGHECAJMHS-HKBQPEDESA-N,2,0,0,0,BCL2-Like / BAX,6.14,cancer,Inhibition,
1034,44579161,478216,24698846,FC(F)(F)c1c(Sc2cccc(NC3CCCCC3)c2)ccc(\C=C\C(=O)N2CCOCC2)c1C(F)(F)F,"(E)-3-[4-[3-(cyclohexylamino)phenyl]sulfanyl-2,3-bis(trifluoromethyl)phenyl]-1-morpholin-4-ylprop-2-en-1-one","InChI=1S/C27H28F6N2O2S/c28-26(29,30)24-18(10-12-23(36)35-13-15-37-16-14-35)9-11-22(25(24)27(31,32)33)38-21-8-4-7-20(17-21)34-19-5-2-1-3-6-19/h4,7-12,17,19,34H,1-3,5-6,13-16H2/b12-10+",ZTROBKLFMPLYHQ-ZRDIBKRKSA-N,1,0,0,0,LFA / ICAM,7.55,immune system disease,Inhibition,
1035,506196,336293,442027,O=C(N1CCN(CC1)C(=O)c1ccccc1)C(=O)c1c[nH]c2ccccc12,"1-(4-benzoylpiperazin-1-yl)-2-(1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C21H19N3O3/c25-19(17-14-22-18-9-5-4-8-16(17)18)21(27)24-12-10-23(11-13-24)20(26)15-6-2-1-3-7-15/h1-9,14,22H,10-13H2",GCCPYLCLTHXPRB-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,6.82,HIV infectious disease,Inhibition,
1036,168318106,,,Fc1c(Cl)cccc1-c1c(nc(C2CCCCC2)n1-c1cc(Cl)cc(c1)C(=O)NCCN1CCOCC1)-c1nnn[nH]1,,"InChI=1S/C29H31Cl2FN8O2/c30-20-15-19(29(41)33-9-10-39-11-13-42-14-12-39)16-21(17-20)40-26(22-7-4-8-23(31)24(22)32)25(27-35-37-38-36-27)34-28(40)18-5-2-1-3-6-18/h4,7-8,15-18H,1-3,5-6,9-14H2,(H,33,41)(H,35,36,37,38)",OJLITOXVSHHYEN-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,7.49,cancer,Inhibition,
1037,168318105,,,CC(C)(C)C[C@H]1N[C@H]([C@H](c2cccc(Cl)c2)[C@]11C(=O)Nc2cc(Cl)c(F)cc12)C(=O)NCC[C@@H](O)CO,"(2'R,3S,3'R,5'R)-6-chloro-3'-(3-chlorophenyl)-N-[(3S)-3,4-dihydroxybutyl]-5'-(2,2-dimethylpropyl)-5-fluoro-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide","InChI=1S/C27H32Cl2FN3O4/c1-26(2,3)12-21-27(17-10-19(30)18(29)11-20(17)32-25(27)37)22(14-5-4-6-15(28)9-14)23(33-21)24(36)31-8-7-16(35)13-34/h4-6,9-11,16,21-23,33-35H,7-8,12-13H2,1-3H3,(H,31,36)(H,32,37)/t16-,21-,22+,23-,27-/m1/s1",UNXQGBMZYKHQCO-KXFRMMEESA-N,2,2,0,0,MDM2-Like / P53,7.90,cancer,Inhibition,
1038,16109076,385101,17266491,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCC(CC1)=Cc1ccc(F)cc1,N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonyl-4-[4-[(4-fluorophenyl)methylidene]piperidin-1-yl]benzamide,"InChI=1S/C37H40FN5O5S2/c1-41(2)21-20-31(26-49-33-6-4-3-5-7-33)39-35-17-16-34(25-36(35)43(45)46)50(47,48)40-37(44)29-10-14-32(15-11-29)42-22-18-28(19-23-42)24-27-8-12-30(38)13-9-27/h3-17,24-25,31,39H,18-23,26H2,1-2H3,(H,40,44)/t31-/m1/s1",XRDADZJPQLAHCT-WJOKGBTCSA-N,2,0,0,0,BCL2-Like / BAX,9.30,cancer,Inhibition,
1039,59555692,,,COc1ccc2nc(C)cc(Nc3ccc(NCCc4c[nH]c5ccccc45)cc3)c2c1,"1-N-[2-(1H-indol-3-yl)ethyl]-4-N-(6-methoxy-2-methylquinolin-4-yl)benzene-1,4-diamine","InChI=1S/C27H26N4O/c1-18-15-27(24-16-22(32-2)11-12-26(24)30-18)31-21-9-7-20(8-10-21)28-14-13-19-17-29-25-6-4-3-5-23(19)25/h3-12,15-17,28-29H,13-14H2,1-2H3,(H,30,31)",YVYZDZDLQZZNTR-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,7.00,cancer,Inhibition,
1040,67954420,,,NC(=O)c1cc(-c2ccccc2)n(c1-c1ccc(F)c(Cl)c1)-c1cc(Cl)ccc1CCO,,"InChI=1S/C25H19Cl2FN2O2/c26-18-8-6-16(10-11-31)22(13-18)30-23(15-4-2-1-3-5-15)14-19(25(29)32)24(30)17-7-9-21(28)20(27)12-17/h1-9,12-14,31H,10-11H2,(H2,29,32)",RMLMBVSZSCMCDS-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,7.92,cancer,Inhibition,
1041,44237065,572850,24637583,CC[C@H](N)C(=O)N[C@H]1[C@@H](CC#N)CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7R,9aS)-6-[[(2S)-2-aminobutanoyl]amino]-N-benzhydryl-7-(cyanomethyl)-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C29H35N5O3/c1-2-23(31)27(35)33-26-21(17-18-30)13-14-22-15-16-24(34(22)29(26)37)28(36)32-25(19-9-5-3-6-10-19)20-11-7-4-8-12-20/h3-12,21-26H,2,13-17,31H2,1H3,(H,32,36)(H,33,35)/t21-,22+,23+,24+,26+/m1/s1",LHNHJCMAMFMGRA-VEGWMBEDSA-N,2,0,0,0,XIAP / Smac,6.49,cancer,Inhibition,
1042,67031925,,,CCOC(=O)c1nc(CC2CCCCC2)n(c1-c1ccc(F)c(Cl)c1)-c1cccc(Cl)c1F,,"InChI=1S/C25H24Cl2F2N2O2/c1-2-33-25(32)23-24(16-11-12-19(28)18(27)14-16)31(20-10-6-9-17(26)22(20)29)21(30-23)13-15-7-4-3-5-8-15/h6,9-12,14-15H,2-5,7-8,13H2,1H3",VXHVMAGMTBHEMU-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,6.80,cancer,Inhibition,
1043,67032061,,,COc1ccc(Cl)cc1-c1c(nc(-c2ccc(C)c(C)c2)n1-c1cc(Cl)ccc1C)C(N)=O,,"InChI=1S/C26H23Cl2N3O2/c1-14-5-7-17(11-16(14)3)26-30-23(25(29)32)24(20-12-18(27)9-10-22(20)33-4)31(26)21-13-19(28)8-6-15(21)2/h5-13H,1-4H3,(H2,29,32)",UXXXFGQEPGDPLE-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,5.74,cancer,Inhibition,
1044,45137487,,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2Cc1nccn1C)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(1S)-2-[(3aR,6S,6aR)-6-(6-fluoro-1H-indol-3-yl)-4-[(1-methylimidazol-2-yl)methyl]-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-1-cyclohexyl-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C31H42FN7O2/c1-19(33-2)30(40)36-28(20-7-5-4-6-8-20)31(41)39-13-11-26-29(39)24(17-38(26)18-27-34-12-14-37(27)3)23-16-35-25-15-21(32)9-10-22(23)25/h9-10,12,14-16,19-20,24,26,28-29,33,35H,4-8,11,13,17-18H2,1-3H3,(H,36,40)/t19-,24+,26+,28-,29+/m0/s1",PDGSZZPUUBFUSO-UQCFCHBKSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
1045,44176200,207505,23271190,C[C@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)N(CCCCC(O)=O)c2ccc(I)cc2C1=O)c1ccc(Cl)cc1,"5-[(3S)-3-(4-chlorophenyl)-4-[(1R)-1-(4-chlorophenyl)ethyl]-7-iodo-2,5-dioxo-3H-1,4-benzodiazepin-1-yl]pentanoic acid","InChI=1S/C28H25Cl2IN2O4/c1-17(18-5-9-20(29)10-6-18)33-26(19-7-11-21(30)12-8-19)28(37)32(15-3-2-4-25(34)35)24-14-13-22(31)16-23(24)27(33)36/h5-14,16-17,26H,2-4,15H2,1H3,(H,34,35)/t17-,26-/m0/s1",VLOPNYYNACVDTC-QLXKLKPCSA-N,1,0,0,0,MDM2-Like / P53,4.88,cancer,Inhibition,
1046,168318102,,,OC(=O)[C@@H](N1[C@@H](c2cc3ccccc3[nH]2)C(=O)Nc2ccc(I)cc2C1=O)c1ccc(Cl)cc1,,"InChI=1S/C25H17ClIN3O4/c26-15-7-5-13(6-8-15)21(25(33)34)30-22(20-11-14-3-1-2-4-18(14)28-20)23(31)29-19-10-9-16(27)12-17(19)24(30)32/h1-12,21-22,28H,(H,29,31)(H,33,34)/t21-,22-/m0/s1",IUESUTIGQGIGBI-VXKWHMMOSA-N,1,0,0,0,MDM2-Like / P53,5.10,cancer,Inhibition,
1047,67954362,,,COc1ccc(Cl)cc1-c1c(nc(-c2cccc(C)n2)n1-c1cccc(Cl)c1F)C(N)=O,,"InChI=1S/C23H17Cl2FN4O2/c1-12-5-3-7-16(28-12)23-29-20(22(27)31)21(14-11-13(24)9-10-18(14)32-2)30(23)17-8-4-6-15(25)19(17)26/h3-11H,1-2H3,(H2,27,31)",FGYUTAGFGDWHCT-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,6.35,cancer,Inhibition,
1048,44305194,304905,23156096,Cc1cccc(C)c1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O,"(2S)-2-[(2,6-dimethylbenzoyl)amino]-3-(1H-indol-3-yl)propanoic acid","InChI=1S/C20H20N2O3/c1-12-6-5-7-13(2)18(12)19(23)22-17(20(24)25)10-14-11-21-16-9-4-3-8-15(14)16/h3-9,11,17,21H,10H2,1-2H3,(H,22,23)(H,24,25)/t17-/m0/s1",DEGQRJCTRCTPIT-KRWDZBQOSA-N,1,0,0,0,LFA / ICAM,5.96,immune system disease,Inhibition,
1049,44237054,574477,24638262,CC[C@H](N)C(=O)N[C@H]1[C@@H](CNC(=O)CN)CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7R,9aS)-7-[[(2-aminoacetyl)amino]methyl]-6-[[(2S)-2-aminobutanoyl]amino]-N-benzhydryl-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C30H40N6O4/c1-2-23(32)28(38)35-27-21(18-33-25(37)17-31)13-14-22-15-16-24(36(22)30(27)40)29(39)34-26(19-9-5-3-6-10-19)20-11-7-4-8-12-20/h3-12,21-24,26-27H,2,13-18,31-32H2,1H3,(H,33,37)(H,34,39)(H,35,38)/t21-,22+,23+,24+,27+/m1/s1",NITVCSOMZUDMAD-GKPVTSGTSA-N,2,0,0,0,XIAP / Smac,6.37,cancer,Inhibition,
1050,168318100,,,CN1CCN(CC1)C(=O)c1ccc(cc1)-n1[nH]c2c3cnn(C)c3nc(-c3cccc(c3)C(F)(F)F)c2c1=O,,"InChI=1S/C27H24F3N7O2/c1-34-10-12-36(13-11-34)25(38)16-6-8-19(9-7-16)37-26(39)21-22(17-4-3-5-18(14-17)27(28,29)30)32-24-20(23(21)33-37)15-31-35(24)2/h3-9,14-15,33H,10-13H2,1-2H3",HVINNIVOFPHNKC-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,6.30,cancer,Inhibition,
1051,168318099,,,Cn1ncc2c1nc(-c1cccc(c1)C(O)=O)c1c2[nH]n(-c2cccc(F)c2)c1=O,,"InChI=1S/C21H14FN5O3/c1-26-19-15(10-23-26)18-16(17(24-19)11-4-2-5-12(8-11)21(29)30)20(28)27(25-18)14-7-3-6-13(22)9-14/h2-10,25H,1H3,(H,29,30)",TYLLBOCDKUXAKC-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.14,cancer,Inhibition,
1052,21906759,182952,10657263,COc1ccccc1Sc1ccc(cc1C(F)(F)F)-c1ccnc(c1)N1CCCN(CC1)C(C)=O,"1-[4-[4-[4-(2-methoxyphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyridin-2-yl]-1,4-diazepan-1-yl]ethanone","InChI=1S/C26H26F3N3O2S/c1-18(33)31-12-5-13-32(15-14-31)25-17-20(10-11-30-25)19-8-9-23(21(16-19)26(27,28)29)35-24-7-4-3-6-22(24)34-2/h3-4,6-11,16-17H,5,12-15H2,1-2H3",FIOKSZYEWJPCQK-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,6.77,immune system disease,Inhibition,
1053,168318097,,,Cc1ccc(cc1)C(=O)N1CCc2c(C)c(C(=O)N[C@@H](CNC(=O)c3cccs3)C(O)=O)c(C)cc2C1,,"InChI=1S/C28H29N3O5S/c1-16-6-8-19(9-7-16)27(34)31-11-10-21-18(3)24(17(2)13-20(21)15-31)26(33)30-22(28(35)36)14-29-25(32)23-5-4-12-37-23/h4-9,12-13,22H,10-11,14-15H2,1-3H3,(H,29,32)(H,30,33)(H,35,36)/t22-/m0/s1",VCQPPNXFXNJBIB-QFIPXVFZSA-N,0,1,0,0,LFA / ICAM,8.00,immune system disease,Inhibition,
1054,16109153,221805,17266566,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCC(CC1)=Cc1ccccc1-c1ccccc1,N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonyl-4-[4-[(2-phenylphenyl)methylidene]piperidin-1-yl]benzamide,"InChI=1S/C43H45N5O5S2/c1-46(2)26-25-36(31-54-38-14-7-4-8-15-38)44-41-22-21-39(30-42(41)48(50)51)55(52,53)45-43(49)34-17-19-37(20-18-34)47-27-23-32(24-28-47)29-35-13-9-10-16-40(35)33-11-5-3-6-12-33/h3-22,29-30,36,44H,23-28,31H2,1-2H3,(H,45,49)/t36-/m1/s1",KSGOSYWODFBAFN-PSXMRANNSA-N,2,0,0,0,BCL2-Like / BAX,9.30,cancer,Inhibition,
1055,51042006,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2ccccc2-c2ccc(F)cc2)CC1,"4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-N-[7-[1-[[2-(4-fluorophenyl)phenyl]methyl]piperidin-4-yl]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl]-3-(trifluoromethylsulfonyl)benzenesulfonamide","InChI=1S/C44H49F4N7O4S3/c1-53(2)22-18-34(29-60-36-9-4-3-5-10-36)51-40-17-16-37(26-42(40)61(56,57)44(46,47)48)62(58,59)52-43-39-21-25-55(28-41(39)49-30-50-43)35-19-23-54(24-20-35)27-32-8-6-7-11-38(32)31-12-14-33(45)15-13-31/h3-17,26,30,34-35,51H,18-25,27-29H2,1-2H3,(H,49,50,52)/t34-/m1/s1",USXDUYSDVSFPGC-UUWRZZSWSA-N,1,0,0,0,BCL2-Like / BAX,7.60,cancer,Inhibition,
1056,88572781,,,CN(C)CC[C@H](CSc1cc(Cl)cc(Cl)c1)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1,,"InChI=1S/C44H47Cl3F3N7O4S3/c1-55(2)17-13-34(27-62-36-22-32(46)21-33(47)23-36)53-40-12-11-37(24-42(40)63(58,59)44(48,49)50)64(60,61)54-43-39-16-20-57(26-41(39)51-28-52-43)35-14-18-56(19-15-35)25-30-5-3-4-6-38(30)29-7-9-31(45)10-8-29/h3-12,21-24,28,34-35,53H,13-20,25-27H2,1-2H3,(H,51,52,54)/t34-/m1/s1",ZFEAPCUPWIPPAF-UUWRZZSWSA-N,1,0,0,0,BCL2-Like / BAX,6.59,cancer,Inhibition,
1057,21906753,183111,10657257,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1ccnc(c1)N1CCN(CC1)C=O,4-[4-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyridin-2-yl]piperazine-1-carbaldehyde,"InChI=1S/C26H26F3N3OS/c1-18(2)21-5-3-4-6-23(21)34-24-8-7-19(15-22(24)26(27,28)29)20-9-10-30-25(16-20)32-13-11-31(17-33)12-14-32/h3-10,15-18H,11-14H2,1-2H3",HKQSYXSKLFYXEZ-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,6.78,immune system disease,Inhibition,
1058,44237063,578241,24638881,CC[C@H](N)C(=O)N[C@H]1[C@@H](CNC(N)=O)CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7R,9aS)-6-[[(2S)-2-aminobutanoyl]amino]-N-benzhydryl-7-[(carbamoylamino)methyl]-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C29H38N6O4/c1-2-22(30)26(36)34-25-20(17-32-29(31)39)13-14-21-15-16-23(35(21)28(25)38)27(37)33-24(18-9-5-3-6-10-18)19-11-7-4-8-12-19/h3-12,20-25H,2,13-17,30H2,1H3,(H,33,37)(H,34,36)(H3,31,32,39)/t20-,21+,22+,23+,25+/m1/s1",CLNSAWIZKPMBPV-FCRIMTMASA-N,2,0,0,0,XIAP / Smac,6.47,cancer,Inhibition,
1059,58531679,,,CC(C)CN(Cc1cccc(CN(Cc2ccc(cc2)-c2ccc(F)cc2)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)c1)C(=O)c1nc2ccccc2s1,"N-[[3-[[(3,5-dichloro-2-hydroxyphenyl)sulfonyl-[[4-(4-fluorophenyl)phenyl]methyl]amino]methyl]phenyl]methyl]-N-(2-methylpropyl)-1,3-benzothiazole-2-carboxamide","InChI=1S/C39H34Cl2FN3O4S2/c1-25(2)21-44(39(47)38-43-34-8-3-4-9-35(34)50-38)22-27-6-5-7-28(18-27)24-45(51(48,49)36-20-31(40)19-33(41)37(36)46)23-26-10-12-29(13-11-26)30-14-16-32(42)17-15-30/h3-20,25,46H,21-24H2,1-2H3",ADGWCKMQPHRHBI-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,6.96,cancer,Inhibition,
1060,11683381,,9858109,Fc1ccc(cc1)-n1[nH]c2c3ccsc3nc(-c3cccc(c3)C(F)(F)F)c2c1=O,,"InChI=1S/C21H11F4N3OS/c22-13-4-6-14(7-5-13)28-20(29)16-17(11-2-1-3-12(10-11)21(23,24)25)26-19-15(8-9-30-19)18(16)27-28/h1-10,27H",QPWYDVZRXMIKKO-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,6.22,cancer,Inhibition,
1061,58531608,,,Oc1c(Cl)cc(Cl)cc1S(=O)(=O)N(Cc1ccc(Cl)cc1)Cc1cccc(n1)-c1ccc(Cl)cc1,"3,5-dichloro-N-[(4-chlorophenyl)methyl]-N-[[6-(4-chlorophenyl)pyridin-2-yl]methyl]-2-hydroxybenzenesulfonamide","InChI=1S/C25H18Cl4N2O3S/c26-18-8-4-16(5-9-18)14-31(35(33,34)24-13-20(28)12-22(29)25(24)32)15-21-2-1-3-23(30-21)17-6-10-19(27)11-7-17/h1-13,32H,14-15H2",JIZFLSKRZGYCEX-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,6.28,cancer,Inhibition,
1062,44574957,501793,24711897,OC[C@H]1[C@@H]2Cn3c(cccc3=O)[C@@H]2N(Cc2ccc(Oc3ccccc3)cc2)[C@@H]1C(=O)N1CCC(CC1)c1ccc(F)cc1,"(2S,3S,3aR,9bR)-2-[4-(4-fluorophenyl)piperidine-1-carbonyl]-3-(hydroxymethyl)-1-[(4-phenoxyphenyl)methyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one","InChI=1S/C36H36FN3O4/c37-27-13-11-25(12-14-27)26-17-19-38(20-18-26)36(43)35-31(23-41)30-22-39-32(7-4-8-33(39)42)34(30)40(35)21-24-9-15-29(16-10-24)44-28-5-2-1-3-6-28/h1-16,26,30-31,34-35,41H,17-23H2/t30-,31-,34+,35-/m0/s1",URAINBKGINHDBE-VHKMVJEQSA-N,1,0,0,0,BCL2-Like / BAX,5.17,cancer,Inhibition,
1063,46929438,1241425,26352044,CN[C@@H](C)C(=O)N[C@H]1CC[C@@H](C[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1)NC(=O)Cc1ccccc1,"(3S,6S,9R,10aR)-N-benzhydryl-6-[[(2S)-2-(methylamino)propanoyl]amino]-5-oxo-9-[(2-phenylacetyl)amino]-2,3,6,7,8,9,10,10a-octahydro-1H-pyrrolo[1,2-a]azocine-3-carboxamide","InChI=1S/C36H43N5O4/c1-24(37-2)34(43)39-30-20-18-28(38-32(42)22-25-12-6-3-7-13-25)23-29-19-21-31(41(29)36(30)45)35(44)40-33(26-14-8-4-9-15-26)27-16-10-5-11-17-27/h3-17,24,28-31,33,37H,18-23H2,1-2H3,(H,38,42)(H,39,43)(H,40,44)/t24-,28-,29+,30-,31-/m0/s1",KQTBMWSEIIBSGS-SLHNNEBYSA-N,2,0,0,0,XIAP / Smac,6.52,cancer,Inhibition,
1064,44549766,,,CN1c2ncnn2[C@H](C2=C1c1cc(F)ccc1O[C@@H]2c1ccc(Br)cc1)c1ccc(Br)cc1,,"InChI=1S/C25H17Br2FN4O/c1-31-23-19-12-18(28)10-11-20(19)33-24(15-4-8-17(27)9-5-15)21(23)22(32-25(31)29-13-30-32)14-2-6-16(26)7-3-14/h2-13,22,24H,1H3/t22-,24+/m0/s1",XINIOUUODXKWOD-LADGPHEKSA-N,1,0,0,0,MDM2-Like / P53,5.76,cancer,Inhibition,
1065,23646347,362377,23247034,C[C@H](N)C(=O)Nc1nc(Cc2c(C)cc(C)cc2C)c(C)[nH]1,"(2S)-2-amino-N-[5-methyl-4-[(2,4,6-trimethylphenyl)methyl]-1H-imidazol-2-yl]propanamide","InChI=1S/C17H24N4O/c1-9-6-10(2)14(11(3)7-9)8-15-13(5)19-17(20-15)21-16(22)12(4)18/h6-7,12H,8,18H2,1-5H3,(H2,19,20,21,22)/t12-/m0/s1",HAPAZDKFFVFQSG-LBPRGKRZSA-N,1,0,0,0,XIAP / Smac,5.70,cancer,Inhibition,
1066,46236925,1094250,24611428,C[C@@H](CNC(=O)c1c(O)c(O)cc2c(O)c(c(C)cc12)-c1c(C)cc2c(C(=O)NC[C@H](C)c3ccccc3)c(O)c(O)cc2c1O)c1ccccc1,"2,3,5-trihydroxy-7-methyl-N-(2-phenylpropyl)-6-[1,6,7-trihydroxy-3-methyl-5-(2-phenylpropylcarbamoyl)naphthalen-2-yl]naphthalene-1-carboxamide","InChI=1S/C42H40N2O8/c1-21-15-27-29(17-31(45)39(49)35(27)41(51)43-19-23(3)25-11-7-5-8-12-25)37(47)33(21)34-22(2)16-28-30(38(34)48)18-32(46)40(50)36(28)42(52)44-20-24(4)26-13-9-6-10-14-26/h5-18,23-24,45-50H,19-20H2,1-4H3,(H,43,51)(H,44,52)/t23-,24-/m0/s1",RAYNZUHYMMLQQA-ZEQRLZLVSA-N,4,0,0,0,BCL2-Like / BAX,6.55,cancer,Inhibition,
1067,16117549,362178,17274766,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1csc(n1)N1CCN(CC1)C(C)=O,"1-[4-[4-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]piperazin-1-yl]ethanone","InChI=1S/C25H26F3N3OS2/c1-16(2)19-6-4-5-7-22(19)34-23-9-8-18(14-20(23)25(26,27)28)21-15-33-24(29-21)31-12-10-30(11-13-31)17(3)32/h4-9,14-16H,10-13H2,1-3H3",WGYZXTCUEIZSAP-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,5.52,immune system disease,Inhibition,
1068,5326914,446435,4484198,CNC(=O)[C@H](Cc1ccc2ccccc2c1)N1CCC(=O)N(Cc2cnc3ccccc3c2)[C@@H](CC(C)C)C1=O,"(2S)-N-methyl-2-[(3S)-3-(2-methylpropyl)-2,5-dioxo-4-(quinolin-3-ylmethyl)-1,4-diazepan-1-yl]-3-naphthalen-2-ylpropanamide","InChI=1S/C33H36N4O3/c1-22(2)16-30-33(40)36(29(32(39)34-3)19-23-12-13-25-8-4-5-9-26(25)17-23)15-14-31(38)37(30)21-24-18-27-10-6-7-11-28(27)35-20-24/h4-13,17-18,20,22,29-30H,14-16,19,21H2,1-3H3,(H,34,39)/t29-,30-/m0/s1",COVPLULNDBDXTN-KYJUHHDHSA-N,1,0,0,0,LFA / ICAM,7.16,immune system disease,Inhibition,
1069,68051285,,,C[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1,,"InChI=1S/C41H42ClF3N6O4S3/c1-28(26-56-33-8-3-2-4-9-33)48-37-16-15-34(23-39(37)57(52,53)41(43,44)45)58(54,55)49-40-36-19-22-51(25-38(36)46-27-47-40)32-17-20-50(21-18-32)24-30-7-5-6-10-35(30)29-11-13-31(42)14-12-29/h2-16,23,27-28,32,48H,17-22,24-26H2,1H3,(H,46,47,49)/t28-/m1/s1",JEDJRWSFHBODBF-MUUNZHRXSA-N,1,0,0,0,BCL2-Like / BAX,6.63,cancer,Inhibition,
1070,11176734,369736,9351826,CC(C)[C@H](NC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(=O)NCCc1ccccc1,(2S)-1-[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-3-methylbutanoyl]-N-(2-phenylethyl)pyrrolidine-2-carboxamide,"InChI=1S/C21H32N4O3/c1-14(2)18(24-19(26)15(3)22)21(28)25-13-7-10-17(25)20(27)23-12-11-16-8-5-4-6-9-16/h4-6,8-9,14-15,17-18H,7,10-13,22H2,1-3H3,(H,23,27)(H,24,26)/t15-,17-,18-/m0/s1",ZVSVRPUZPIDLBB-SZMVWBNQSA-N,1,0,0,0,XIAP / Smac,6.82,cancer,Inhibition,
1071,44390614,178301,23246638,OC(=O)[C@@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)Nc2ccc(I)cc2C1=O)c1ccc(cc1)C(F)(F)F,"2-[3-(4-chlorophenyl)-7-iodo-2,5-dioxo-1,3-dihydro-1,4-benzodiazepin-4-yl]-2-[4-(trifluoromethyl)phenyl]acetic acid","InChI=1S/C24H15ClF3IN2O4/c25-15-7-3-12(4-8-15)19-21(32)30-18-10-9-16(29)11-17(18)22(33)31(19)20(23(34)35)13-1-5-14(6-2-13)24(26,27)28/h1-11,19-20H,(H,30,32)(H,34,35)/t19-,20-/m0/s1",KMRLDAFNANPYSJ-PMACEKPBSA-N,1,0,0,0,MDM2-Like / P53,6.17,cancer,Inhibition,
1072,10281281,182245,8456758,CNC(=O)[C@H](Cc1ccc2ccccc2c1)N1CCC(=O)N(Cc2ccc(Br)cc2)[C@@H](CC(C)C)C1=O,"(2S)-2-[(3S)-4-[(4-bromophenyl)methyl]-3-(2-methylpropyl)-2,5-dioxo-1,4-diazepan-1-yl]-N-methyl-3-naphthalen-2-ylpropanamide","InChI=1S/C30H34BrN3O3/c1-20(2)16-27-30(37)33(15-14-28(35)34(27)19-21-9-12-25(31)13-10-21)26(29(36)32-3)18-22-8-11-23-6-4-5-7-24(23)17-22/h4-13,17,20,26-27H,14-16,18-19H2,1-3H3,(H,32,36)/t26-,27-/m0/s1",BJSPEWAZMVSCPR-SVBPBHIXSA-N,1,0,0,0,LFA / ICAM,5.53,immune system disease,Inhibition,
1073,168317889,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(Cc2ccc(cc2)C(F)(F)F)CC1,,"InChI=1S/C37H41F3N6O5S2/c1-43(2)19-18-30(26-52-32-6-4-3-5-7-32)41-34-17-16-33(24-35(34)46(48)49)53(50,51)42-36(47)28-10-14-31(15-11-28)45-22-20-44(21-23-45)25-27-8-12-29(13-9-27)37(38,39)40/h3-17,24,30,41H,18-23,25-26H2,1-2H3,(H,42,47)/t30-/m1/s1",OYQCZLSTAXXMNL-SSEXGKCCSA-N,2,0,0,0,BCL2-Like / BAX,9.30,cancer,Inhibition,
1074,41250503,292542,23155777,OC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1ccccc1F,2-[(2-fluorobenzoyl)amino]-3-(1H-indol-3-yl)propanoic acid,"InChI=1S/C18H15FN2O3/c19-14-7-3-1-6-13(14)17(22)21-16(18(23)24)9-11-10-20-15-8-4-2-5-12(11)15/h1-8,10,16,20H,9H2,(H,21,22)(H,23,24)/t16-/m0/s1",NKWCTBQGEYIWFO-INIZCTEOSA-N,1,0,0,0,LFA / ICAM,5.13,immune system disease,Inhibition,
1075,51354614,1689140,26393047,Clc1ccc(cc1)-c1ccccc1CN1CCN(CC1)c1ccc2c(NS(=O)(=O)c3ccc(N[C@H](CCN4CCOCC4)CSc4ccccc4)c(c3)N(=O)=O)ncnc2c1,N-[7-[4-[[2-(4-chlorophenyl)phenyl]methyl]piperazin-1-yl]quinazolin-4-yl]-4-[[(2R)-4-morpholin-4-yl-1-phenylsulfanylbutan-2-yl]amino]-3-nitrobenzenesulfonamide,"InChI=1S/C45H47ClN8O5S2/c46-35-12-10-33(11-13-35)40-9-5-4-6-34(40)30-52-20-22-53(23-21-52)37-14-16-41-43(28-37)47-32-48-45(41)50-61(57,58)39-15-17-42(44(29-39)54(55)56)49-36(18-19-51-24-26-59-27-25-51)31-60-38-7-2-1-3-8-38/h1-17,28-29,32,36,49H,18-27,30-31H2,(H,47,48,50)/t36-/m1/s1",CCTYKFPBYGLUJL-PSXMRANNSA-N,1,0,0,0,BCL2-Like / BAX,7.47,cancer,Inhibition,
1076,25026517,569099,24631203,CN(C)Cc1ccc2c(NCc3ccc(NC(=O)c4ccc(F)cc4)cc3)nc(nc2c1)N(C)C,N-[4-[[[2-(dimethylamino)-7-[(dimethylamino)methyl]quinazolin-4-yl]amino]methyl]phenyl]-4-fluorobenzamide,"InChI=1S/C27H29FN6O/c1-33(2)17-19-7-14-23-24(15-19)31-27(34(3)4)32-25(23)29-16-18-5-12-22(13-6-18)30-26(35)20-8-10-21(28)11-9-20/h5-15H,16-17H2,1-4H3,(H,30,35)(H,29,31,32)",HRJOILGQFVXTGQ-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,5.91,cancer,Inhibition,
1077,168317915,,,Cn1ncc2c1nc(-c1ccc3OCOc3c1)c1c2[nH]n(-c2cccc(F)c2)c1=O,,"InChI=1S/C21H14FN5O3/c1-26-20-14(9-23-26)19-17(21(28)27(25-19)13-4-2-3-12(22)8-13)18(24-20)11-5-6-15-16(7-11)30-10-29-15/h2-9,25H,10H2,1H3",UJJLTAKKBBQNRE-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,6.53,cancer,Inhibition,
1078,46220742,1097733,24673381,CN1C(=O)N(C(=O)[C@]11CN(C[C@H]1c1ccc(cc1)C#N)c1ncc(cn1)C(O)=O)c1cc(Cl)cc(Cl)c1,"2-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl]pyrimidine-5-carboxylic acid","InChI=1S/C25H18Cl2N6O4/c1-31-24(37)33(19-7-17(26)6-18(27)8-19)22(36)25(31)13-32(23-29-10-16(11-30-23)21(34)35)12-20(25)15-4-2-14(9-28)3-5-15/h2-8,10-11,20H,12-13H2,1H3,(H,34,35)/t20-,25+/m0/s1",BOERNFAHPQKHIM-NBGIEHNGSA-N,1,0,0,0,LFA / ICAM,7.96,immune system disease,Inhibition,
1079,44517707,,,Oc1c(Cl)cc(Cl)cc1S(=O)(=O)N(Cc1ccc(F)cc1)Cc1cccc(CN(Cc2ccc(F)cc2)S(=O)(=O)c2cc(Cl)cc(Cl)c2)[n+]1[O-],"3,5-dichloro-N-[[6-[[(3,5-dichlorophenyl)sulfonyl-[(4-fluorophenyl)methyl]amino]methyl]-1-oxidopyridin-1-ium-2-yl]methyl]-N-[(4-fluorophenyl)methyl]-2-hydroxybenzenesulfonamide","InChI=1S/C33H25Cl4F2N3O6S2/c34-23-12-24(35)14-30(13-23)49(45,46)40(17-21-4-8-26(38)9-5-21)19-28-2-1-3-29(42(28)44)20-41(18-22-6-10-27(39)11-7-22)50(47,48)32-16-25(36)15-31(37)33(32)43/h1-16,43H,17-20H2",NWRBQVUBOTZGSE-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,7.34,cancer,Inhibition,
1080,44580529,497978,24709345,FC(F)(F)c1c(Sc2ccccc2OC2CCOCC2)ccc(\C=C\C(=O)N2CCOCC2)c1C(F)(F)F,"(E)-1-morpholin-4-yl-3-[4-[2-(oxan-4-yloxy)phenyl]sulfanyl-2,3-bis(trifluoromethyl)phenyl]prop-2-en-1-one","InChI=1S/C26H25F6NO4S/c27-25(28,29)23-17(6-8-22(34)33-11-15-36-16-12-33)5-7-21(24(23)26(30,31)32)38-20-4-2-1-3-19(20)37-18-9-13-35-14-10-18/h1-8,18H,9-16H2/b8-6+",VQFPBCXPBVPOKI-SOFGYWHQSA-N,1,0,0,0,LFA / ICAM,8.60,immune system disease,Inhibition,
1081,67954182,,,CNc1nnc(o1)-c1nc(C2CCCCC2)n(c1-c1ccc(F)c(Cl)c1)-c1cccc(Cl)c1F,,"InChI=1S/C24H21Cl2F2N5O/c1-29-24-32-31-23(34-24)20-21(14-10-11-17(27)16(26)12-14)33(18-9-5-8-15(25)19(18)28)22(30-20)13-6-3-2-4-7-13/h5,8-13H,2-4,6-7H2,1H3,(H,29,32)",ANDKHKGFXJCTPB-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,8.05,cancer,Inhibition,
1082,11190107,486772,9365189,C[C@H](N)C(=O)N[C@H]1CCC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,9aS)-6-[[(2S)-2-aminopropanoyl]amino]-N-benzhydryl-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C26H32N4O3/c1-17(27)24(31)28-21-14-8-13-20-15-16-22(30(20)26(21)33)25(32)29-23(18-9-4-2-5-10-18)19-11-6-3-7-12-19/h2-7,9-12,17,20-23H,8,13-16,27H2,1H3,(H,28,31)(H,29,32)/t17-,20-,21-,22-/m0/s1",JHJTWSSGXYISJM-MQGJPIDWSA-N,2,0,0,0,XIAP / Smac,7.22,cancer,Inhibition,
1083,168317912,,,C[C@H]1CN([C@H](C)CN1C(=O)C(=O)c1c[nH]c2cccc(F)c12)C(=O)c1ccccc1,"1-(4-benzoyl-2,5-dimethylpiperazin-1-yl)-2-(4-fluoro-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C23H22FN3O3/c1-14-13-27(15(2)12-26(14)22(29)16-7-4-3-5-8-16)23(30)21(28)17-11-25-19-10-6-9-18(24)20(17)19/h3-11,14-15,25H,12-13H2,1-2H3/t14-,15+/m1/s1",VUIHMDOHQFRWLO-CABCVRRESA-N,0,1,0,0,CD4 / gp120,8.33,HIV infectious disease,Inhibition,
1084,44580638,526179,24720606,C[C@H]1CC[C@@H](CC1)Oc1cccc(c1)Sc1ccc(\C=C\C(=O)N2CCOCC2)c(C(F)(F)F)c1C(F)(F)F,"(E)-3-[4-[3-(4-methylcyclohexyl)oxyphenyl]sulfanyl-2,3-bis(trifluoromethyl)phenyl]-1-morpholin-4-ylprop-2-en-1-one","InChI=1S/C28H29F6NO3S/c1-18-5-9-20(10-6-18)38-21-3-2-4-22(17-21)39-23-11-7-19(8-12-24(36)35-13-15-37-16-14-35)25(27(29,30)31)26(23)28(32,33)34/h2-4,7-8,11-12,17-18,20H,5-6,9-10,13-16H2,1H3/b12-8+/t18-,20-",YCBXYRIEXMXDKQ-JVIRHGSHSA-N,1,0,0,0,LFA / ICAM,6.09,immune system disease,Inhibition,
1085,25049968,,,COC(=O)c1cccc(c1)S(=O)(=O)N1[C@@H]([C@H](c2ccc(Cl)cc2)n2c1ccc(C(=O)N1CCN(CCn3ccnc3)CC1)c2=O)c1ccc(Cl)cc1,"methyl 3-[[(2R,3S)-2,3-bis(4-chlorophenyl)-6-[4-(2-imidazol-1-ylethyl)piperazine-1-carbonyl]-5-oxo-2,3-dihydroimidazo[1,2-a]pyridin-1-yl]sulfonyl]benzoate","InChI=1S/C37H34Cl2N6O6S/c1-51-37(48)27-3-2-4-30(23-27)52(49,50)45-32-14-13-31(35(46)43-21-19-41(20-22-43)17-18-42-16-15-40-24-42)36(47)44(32)33(25-5-9-28(38)10-6-25)34(45)26-7-11-29(39)12-8-26/h2-16,23-24,33-34H,17-22H2,1H3/t33-,34+/m0/s1",AHOSULSNRSOOPF-SZAHLOSFSA-N,1,0,0,0,MDM2-Like / P53,6.17,cancer,Inhibition,
1086,23646348,181524,23247043,C[C@H](N)C(=O)Nc1nc(c(C)s1)-c1ccccc1,"(2S)-2-amino-N-(5-methyl-4-phenyl-1,3-thiazol-2-yl)propanamide","InChI=1S/C13H15N3OS/c1-8(14)12(17)16-13-15-11(9(2)18-13)10-6-4-3-5-7-10/h3-8H,14H2,1-2H3,(H,15,16,17)/t8-/m0/s1",YBJRXGCOAGWFHV-QMMMGPOBSA-N,1,0,0,0,XIAP / Smac,4.82,cancer,Inhibition,
1087,168317908,,,CN(Cc1ccc(Br)cc1)[C@H]1C[C@@H]2N(C1)C(=O)N(C2=O)c1cc(Cl)cc(Cl)c1,,"InChI=1S/C20H18BrCl2N3O2/c1-24(10-12-2-4-13(21)5-3-12)17-9-18-19(27)26(20(28)25(18)11-17)16-7-14(22)6-15(23)8-16/h2-8,17-18H,9-11H2,1H3/t17-,18-/m0/s1",GGBKEABHLBXJJE-ROUUACIJSA-N,0,1,0,0,LFA / ICAM,6.76,immune system disease,Inhibition,
1088,168317909,,,C[C@H](N)[C@H]1CCC[C@H](N1)C(=O)N1C[C@H](C[C@H]1C(=O)N1CC[C@@H](C1)c1ccccc1)c1ccccc1,"[(6R)-6-(1-aminoethyl)piperidin-2-yl]-[(2S,4R)-4-phenyl-2-[(3R)-3-phenylpyrrolidine-1-carbonyl]pyrrolidin-1-yl]methanone","InChI=1S/C29H38N4O2/c1-20(30)25-13-8-14-26(31-25)28(34)33-19-24(22-11-6-3-7-12-22)17-27(33)29(35)32-16-15-23(18-32)21-9-4-2-5-10-21/h2-7,9-12,20,23-27,31H,8,13-19,30H2,1H3/t20-,23-,24-,25+,26-,27-/m0/s1",QGKIOJRTXDLQKU-IRDZNAJJSA-N,1,0,0,0,XIAP / Smac,8.00,cancer,Inhibition,
1089,45487341,576074,24639607,CNC(=O)c1cc(OC)c(O[C@@H](C)C(=O)N2CCN(C[C@H]2C)c2ncnc3[nH]cnc23)cn1,4-methoxy-N-methyl-5-[(2S)-1-[(2R)-2-methyl-4-(7H-purin-6-yl)piperazin-1-yl]-1-oxopropan-2-yl]oxypyridine-2-carboxamide,"InChI=1S/C21H26N8O4/c1-12-9-28(19-17-18(25-10-24-17)26-11-27-19)5-6-29(12)21(31)13(2)33-16-8-23-14(20(30)22-3)7-15(16)32-4/h7-8,10-13H,5-6,9H2,1-4H3,(H,22,30)(H,24,25,26,27)/t12-,13+/m1/s1",QECHPDWVPLGWDK-OLZOCXBDSA-N,0,1,0,0,CD4 / gp120,6.53,HIV infectious disease,Inhibition,
1090,168317907,,,CC(C)(C)C[C@H]1N[C@H]([C@H](c2cccc(Cl)c2)[C@]11C(=O)Nc2cc(Cl)c(F)cc12)C(=O)NC[C@H](O)CO,"(2'R,3S,3'R,5'R)-6-chloro-3'-(3-chlorophenyl)-N-[(2S)-2,3-dihydroxypropyl]-5'-(2,2-dimethylpropyl)-5-fluoro-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide","InChI=1S/C26H30Cl2FN3O4/c1-25(2,3)10-20-26(16-8-18(29)17(28)9-19(16)31-24(26)36)21(13-5-4-6-14(27)7-13)22(32-20)23(35)30-11-15(34)12-33/h4-9,15,20-22,32-34H,10-12H2,1-3H3,(H,30,35)(H,31,36)/t15-,20+,21-,22+,26+/m0/s1",BROUFXKDLPNALC-TUWOLIRQSA-N,2,2,0,0,MDM2-Like / P53,7.81,cancer,Inhibition,
1091,11603409,,9720252,O[C@H]1CCc2c1nccc2Nc1ccc(NCCc2c[nH]c3ccccc23)cc1,"4-[4-[2-(1H-indol-3-yl)ethylamino]anilino]-6,7-dihydro-5H-cyclopenta[b]pyridin-7-ol","InChI=1S/C24H24N4O/c29-23-10-9-20-22(12-14-26-24(20)23)28-18-7-5-17(6-8-18)25-13-11-16-15-27-21-4-2-1-3-19(16)21/h1-8,12,14-15,23,25,27,29H,9-11,13H2,(H,26,28)/t23-/m0/s1",FBBUTFVHJKFJIW-QHCPKHFHSA-N,2,1,0,0,MDM2-Like / P53,8.00,cancer,Inhibition,
1092,168317906,,,CN(C)C(=O)c1cc(Cl)cc(c1)-n1c(nc(-c2nnn[nH]2)c1-c1cccc(Cl)c1F)C1CCCCC1,,"InChI=1S/C25H24Cl2FN7O/c1-34(2)25(36)15-11-16(26)13-17(12-15)35-22(18-9-6-10-19(27)20(18)28)21(23-30-32-33-31-23)29-24(35)14-7-4-3-5-8-14/h6,9-14H,3-5,7-8H2,1-2H3,(H,30,31,32,33)",RHBSEYQXCYLYMK-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,7.22,cancer,Inhibition,
1093,25172871,504559,24710510,CN[C@@H](C)C(=O)N[C@H]1CN(CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1)C(=O)Cc1ccccc1,"(5S,8S,10aR)-N-benzhydryl-5-[[(2S)-2-(methylamino)propanoyl]amino]-6-oxo-3-(2-phenylacetyl)-1,2,4,5,8,9,10,10a-octahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide","InChI=1S/C35H41N5O4/c1-24(36-2)33(42)37-29-23-39(31(41)22-25-12-6-3-7-13-25)21-20-28-18-19-30(40(28)35(29)44)34(43)38-32(26-14-8-4-9-15-26)27-16-10-5-11-17-27/h3-17,24,28-30,32,36H,18-23H2,1-2H3,(H,37,42)(H,38,43)/t24-,28+,29-,30-/m0/s1",YBYZHVZWINISJO-XPSCAIQQSA-N,2,0,0,0,XIAP / Smac,6.96,cancer,Inhibition,
1094,44237038,,,CN[C@@H](C)C(=O)N[C@@H](C1CCOCC1)C(=O)N1CCC[C@H]1c1nc2c(nccc2s1)-c1ccccc1Cl,"(2S)-N-[(1S)-2-[(2S)-2-[4-(2-chlorophenyl)-[1,3]thiazolo[4,5-c]pyridin-2-yl]pyrrolidin-1-yl]-1-(oxan-4-yl)-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C27H32ClN5O3S/c1-16(29-2)25(34)31-22(17-10-14-36-15-11-17)27(35)33-13-5-8-20(33)26-32-24-21(37-26)9-12-30-23(24)18-6-3-4-7-19(18)28/h3-4,6-7,9,12,16-17,20,22,29H,5,8,10-11,13-15H2,1-2H3,(H,31,34)/t16-,20-,22-/m0/s1",AVQIBLHJFPCFMB-BUKVSMQUSA-N,1,0,0,0,XIAP / Smac,7.48,cancer,Inhibition,
1095,58191770,,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1cncc(c1)C(=O)c1ccc(F)cc1,(2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[5-(4-fluorobenzoyl)pyridin-3-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide,"InChI=1S/C28H35FN4O3/c1-18(30-2)27(35)32-25(19-7-4-3-5-8-19)28(36)33-14-6-9-24(33)21-15-22(17-31-16-21)26(34)20-10-12-23(29)13-11-20/h10-13,15-19,24-25,30H,3-9,14H2,1-2H3,(H,32,35)/t18-,24-,25-/m0/s1",PLYJYKAWZXEBFC-WDNCENIBSA-N,1,0,0,0,XIAP / Smac,6.00,cancer,Inhibition,
1096,44573279,522010,24718896,Oc1cccc2[nH]cc(C(=O)C(=O)N3CCN(CC3)C(=O)c3ccccc3)c12,"1-(4-benzoylpiperazin-1-yl)-2-(4-hydroxy-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C21H19N3O4/c25-17-8-4-7-16-18(17)15(13-22-16)19(26)21(28)24-11-9-23(10-12-24)20(27)14-5-2-1-3-6-14/h1-8,13,22,25H,9-12H2",APABZECAPAJTQA-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,7.70,HIV infectious disease,Inhibition,
1097,28549459,292064,23156027,OC(=O)[C@H](Cc1c[nH]cn1)NC(=O)c1c(F)cccc1Cl,(2S)-2-[(2-chloro-6-fluorobenzoyl)amino]-3-(1H-imidazol-5-yl)propanoic acid,"InChI=1S/C13H11ClFN3O3/c14-8-2-1-3-9(15)11(8)12(19)18-10(13(20)21)4-7-5-16-6-17-7/h1-3,5-6,10H,4H2,(H,16,17)(H,18,19)(H,20,21)/t10-/m0/s1",BZNCFMHNUSOIAG-JTQLQIEISA-N,1,0,0,0,LFA / ICAM,6.89,immune system disease,Inhibition,
1098,168317905,,23248111,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1cc(ncn1)N1CCC[C@@H](C1)C(N)=O,1-[6-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyrimidin-4-yl]piperidine-3-carboxamide,"InChI=1S/C26H27F3N4OS/c1-16(2)19-7-3-4-8-22(19)35-23-10-9-17(12-20(23)26(27,28)29)21-13-24(32-15-31-21)33-11-5-6-18(14-33)25(30)34/h3-4,7-10,12-13,15-16,18H,5-6,11,14H2,1-2H3,(H2,30,34)/t18-/m0/s1",LNXNIMOXVDAPMR-SFHVURJKSA-N,0,1,0,0,LFA / ICAM,6.47,immune system disease,Inhibition,
1099,67031921,,,OC(=O)c1nc(-c2ccccc2Cl)n(c1-c1cccc(Cl)c1)-c1cccc(Cl)c1,,"InChI=1S/C22H13Cl3N2O2/c23-14-6-3-5-13(11-14)20-19(22(28)29)26-21(17-9-1-2-10-18(17)25)27(20)16-8-4-7-15(24)12-16/h1-12H,(H,28,29)",UBZGNMWMXIONRY-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,4.55,cancer,Inhibition,
1100,168317879,,,COC1(CCN(CC1)c1ccc(cc1)C(=O)NS(=O)(=O)c1ccc(N[C@H](CCN(C)C)CSc2ccccc2)c(c1)N(=O)=O)c1ccccc1Cl,,"InChI=1S/C37H42ClN5O6S2/c1-41(2)22-19-28(26-50-30-9-5-4-6-10-30)39-34-18-17-31(25-35(34)43(45)46)51(47,48)40-36(44)27-13-15-29(16-14-27)42-23-20-37(49-3,21-24-42)32-11-7-8-12-33(32)38/h4-18,25,28,39H,19-24,26H2,1-3H3,(H,40,44)/t28-/m1/s1",FNTVQNGVYYXLQU-MUUNZHRXSA-N,2,0,0,0,BCL2-Like / BAX,9.30,cancer,Inhibition,
1101,11679474,,9854203,CCOc1cc(Cl)c(cc1C1=N[C@H]([C@H](N1C(=O)N1CCN(CCS(C)(=O)=O)CC1)c1ccc(Cl)cc1)c1ccc(Cl)cc1)S(=O)(=O)N1CCCC1,"[(4S,5R)-2-(4-chloro-2-ethoxy-5-pyrrolidin-1-ylsulfonylphenyl)-4,5-bis(4-chlorophenyl)-4,5-dihydroimidazol-1-yl]-[4-(2-methylsulfonylethyl)piperazin-1-yl]methanone","InChI=1S/C35H40Cl3N5O6S2/c1-3-49-30-23-29(38)31(51(47,48)42-14-4-5-15-42)22-28(30)34-39-32(24-6-10-26(36)11-7-24)33(25-8-12-27(37)13-9-25)43(34)35(44)41-18-16-40(17-19-41)20-21-50(2,45)46/h6-13,22-23,32-33H,3-5,14-21H2,1-2H3/t32-,33+/m0/s1",QUNKBKNFZHLFOZ-JHOUSYSJSA-N,1,0,0,0,MDM2-Like / P53,8.30,cancer,Inhibition,
1102,46884409,1089012,24667994,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1nc(cs1)-c1ccccc1,"(2S)-N-[(1S)-1-cyclohexyl-2-oxo-2-[(2S)-2-(4-phenyl-1,3-thiazol-2-yl)pyrrolidin-1-yl]ethyl]-2-(methylamino)propanamide","InChI=1S/C25H34N4O2S/c1-17(26-2)23(30)28-22(19-12-7-4-8-13-19)25(31)29-15-9-14-21(29)24-27-20(16-32-24)18-10-5-3-6-11-18/h3,5-6,10-11,16-17,19,21-22,26H,4,7-9,12-15H2,1-2H3,(H,28,30)/t17-,21-,22-/m0/s1",MMDIHBJNYISZAS-HSQYWUDLSA-N,1,0,0,0,XIAP / Smac,6.72,cancer,Inhibition,
1103,25058143,574027,24638237,CC[C@H](N)C(=O)N[C@H]1[C@@H](CCN)CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7R,9aS)-6-[(2S)-2-aminobutanamido]-7-(2-aminoethyl)-N-(diphenylmethyl)-5-oxo-octahydro-1H-pyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C29H39N5O3/c1-2-23(31)27(35)33-26-21(17-18-30)13-14-22-15-16-24(34(22)29(26)37)28(36)32-25(19-9-5-3-6-10-19)20-11-7-4-8-12-20/h3-12,21-26H,2,13-18,30-31H2,1H3,(H,32,36)(H,33,35)/t21-,22+,23+,24+,26+/m1/s1",KQHWCFZCUNTTCW-VEGWMBEDSA-N,3,0,0,0,XIAP / Smac,8.44,cancer,Inhibition,
1104,44818314,569532,24632612,CNc1nc(NCc2ccc(NC(=O)c3ccc(Cl)cc3)cc2)c2c(C)cccc2n1,4-chloro-N-[4-[[[5-methyl-2-(methylamino)quinazolin-4-yl]amino]methyl]phenyl]benzamide,"InChI=1S/C24H22ClN5O/c1-15-4-3-5-20-21(15)22(30-24(26-2)29-20)27-14-16-6-12-19(13-7-16)28-23(31)17-8-10-18(25)11-9-17/h3-13H,14H2,1-2H3,(H,28,31)(H2,26,27,29,30)",GSIFXTHXPURSBY-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,6.31,cancer,Inhibition,
1105,44176180,378998,23271768,CN(C)CCCCN1c2ccc(I)cc2C(=O)N(Cc2ccc(Cl)cc2N)[C@@H](c2ccc(Cl)cc2)C1=O,"4-[(2-amino-4-chlorophenyl)methyl]-3-(4-chlorophenyl)-1-[4-(dimethylamino)butyl]-7-iodo-3H-1,4-benzodiazepine-2,5-dione","InChI=1S/C28H29Cl2IN4O2/c1-33(2)13-3-4-14-34-25-12-11-22(31)16-23(25)27(36)35(17-19-7-10-21(30)15-24(19)32)26(28(34)37)18-5-8-20(29)9-6-18/h5-12,15-16,26H,3-4,13-14,17,32H2,1-2H3/t26-/m0/s1",JRZMBZBPVQMTFT-SANMLTNESA-N,1,0,0,0,MDM2-Like / P53,5.55,cancer,Inhibition,
1106,44237048,575594,24635723,CC[C@H](N)C(=O)N[C@H]1[C@@H](CNC(N)=N)CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7R,9aS)-6-[[(2S)-2-aminobutanoyl]amino]-N-benzhydryl-7-[(diaminomethylideneamino)methyl]-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C29H39N7O3/c1-2-22(30)26(37)35-25-20(17-33-29(31)32)13-14-21-15-16-23(36(21)28(25)39)27(38)34-24(18-9-5-3-6-10-18)19-11-7-4-8-12-19/h3-12,20-25H,2,13-17,30H2,1H3,(H,34,38)(H,35,37)(H4,31,32,33)/t20-,21+,22+,23+,25+/m1/s1",JXUHBFWPZHCAKE-FCRIMTMASA-N,2,0,0,0,XIAP / Smac,6.66,cancer,Inhibition,
1107,53321366,1644113,26379940,OC(=O)[C@H](CNC(=O)c1c[nH]c2ccccc12)NC(=O)c1c(Cl)cc2CN(CCc2c1Cl)C(=O)c1ccc(Cl)cc1,"(2S)-2-[[5,7-dichloro-2-(4-chlorobenzoyl)-3,4-dihydro-1H-isoquinoline-6-carbonyl]amino]-3-(1H-indole-3-carbonylamino)propanoic acid","InChI=1S/C29H23Cl3N4O5/c30-17-7-5-15(6-8-17)28(39)36-10-9-18-16(14-36)11-21(31)24(25(18)32)27(38)35-23(29(40)41)13-34-26(37)20-12-33-22-4-2-1-3-19(20)22/h1-8,11-12,23,33H,9-10,13-14H2,(H,34,37)(H,35,38)(H,40,41)/t23-/m0/s1",SEEYXMAOXPVGKQ-QHCPKHFHSA-N,1,0,0,0,LFA / ICAM,6.09,immune system disease,Inhibition,
1108,168317903,,,C[C@@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)N(CCCCC(O)=O)c2ccc(I)cc2C1=O)c1ccc(OC(F)(F)F)cc1,,"InChI=1S/C29H25ClF3IN2O5/c1-17(18-7-12-22(13-8-18)41-29(31,32)33)36-26(19-5-9-20(30)10-6-19)28(40)35(15-3-2-4-25(37)38)24-14-11-21(34)16-23(24)27(36)39/h5-14,16-17,26H,2-4,15H2,1H3,(H,37,38)/t17-,26+/m1/s1",OGYFWKKWRVCCCK-QUGAMOGWSA-N,1,2,0,0,MDM2-Like / P53,5.98,cancer,Inhibition,
1109,1354144,,1134527,CCNc1cc(O)c(SSc2cc(C)c(NCC)cc2O)cc1C,5-(ethylamino)-2-[[4-(ethylamino)-2-hydroxy-5-methylphenyl]disulfanyl]-4-methylphenol,"InChI=1S/C18H24N2O2S2/c1-5-19-13-9-15(21)17(7-11(13)3)23-24-18-8-12(4)14(20-6-2)10-16(18)22/h7-10,19-22H,5-6H2,1-4H3",MXZJVGASZOPOCI-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,6.54,cancer,Inhibition,
1110,44305159,304699,23156062,OC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1ccc(cc1Cl)N(=O)=O,(2S)-2-[(2-chloro-4-nitrobenzoyl)amino]-3-(1H-indol-3-yl)propanoic acid,"InChI=1S/C18H14ClN3O5/c19-14-8-11(22(26)27)5-6-13(14)17(23)21-16(18(24)25)7-10-9-20-15-4-2-1-3-12(10)15/h1-6,8-9,16,20H,7H2,(H,21,23)(H,24,25)/t16-/m0/s1",HWKIYEAXHWCEFZ-INIZCTEOSA-N,1,0,0,0,LFA / ICAM,5.28,immune system disease,Inhibition,
1111,44391934,183904,23248024,COc1ccccc1Sc1ccc(cc1C(F)(F)F)-c1ccnc(c1)N1C[C@H](O)C[C@H]1C(O)=O,4-hydroxy-1-[4-[4-(2-methoxyphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyridin-2-yl]pyrrolidine-2-carboxylic acid,"InChI=1S/C24H21F3N2O4S/c1-33-19-4-2-3-5-21(19)34-20-7-6-14(10-17(20)24(25,26)27)15-8-9-28-22(11-15)29-13-16(30)12-18(29)23(31)32/h2-11,16,18,30H,12-13H2,1H3,(H,31,32)/t16-,18+/m1/s1",HQRUSYULBHQARY-AEFFLSMTSA-N,0,1,0,0,LFA / ICAM,6.67,immune system disease,Inhibition,
1112,44392019,183017,23248092,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1ccnc(c1)N1C[C@H](O)C[C@H]1C(O)=O,4-hydroxy-1-[4-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyridin-2-yl]pyrrolidine-2-carboxylic acid,"InChI=1S/C26H25F3N2O3S/c1-15(2)19-5-3-4-6-22(19)35-23-8-7-16(11-20(23)26(27,28)29)17-9-10-30-24(12-17)31-14-18(32)13-21(31)25(33)34/h3-12,15,18,21,32H,13-14H2,1-2H3,(H,33,34)/t18-,21+/m1/s1",KRGAECPDXVSJPY-NQIIRXRSSA-N,0,1,0,0,LFA / ICAM,7.05,immune system disease,Inhibition,
1113,46224088,1098727,24677769,CN1C(=O)N(C(=O)[C@]11CN(C[C@H]1c1ccc(cc1)C#N)c1ccc(cn1)-c1nnn[nH]1)c1cc(Cl)cc(Cl)c1,"4-[(5S,9R)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-7-[5-(2H-tetrazol-5-yl)pyridin-2-yl]-1,3,7-triazaspiro[4.4]nonan-9-yl]benzonitrile","InChI=1S/C26H19Cl2N9O2/c1-35-25(39)37(20-9-18(27)8-19(28)10-20)24(38)26(35)14-36(13-21(26)16-4-2-15(11-29)3-5-16)22-7-6-17(12-30-22)23-31-33-34-32-23/h2-10,12,21H,13-14H2,1H3,(H,31,32,33,34)/t21-,26+/m0/s1",PMZWNDSIHRPMEQ-HFZDXXHNSA-N,1,0,0,0,LFA / ICAM,8.74,immune system disease,Inhibition,
1114,21906773,182589,10657283,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1ccnc(c1)N1CCC(CC1)C(O)=O,1-[4-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyridin-2-yl]piperidine-4-carboxylic acid,"InChI=1S/C27H27F3N2O2S/c1-17(2)21-5-3-4-6-23(21)35-24-8-7-19(15-22(24)27(28,29)30)20-9-12-31-25(16-20)32-13-10-18(11-14-32)26(33)34/h3-9,12,15-18H,10-11,13-14H2,1-2H3,(H,33,34)",BHEGQCULFWMOJE-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,7.38,immune system disease,Inhibition,
1115,51042648,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2ccccc2-c2ccccc2Cl)CC1,"N-[7-[1-[[2-(2-chlorophenyl)phenyl]methyl]piperidin-4-yl]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl]-4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)benzenesulfonamide","InChI=1S/C44H49ClF3N7O4S3/c1-53(2)22-18-32(29-60-34-11-4-3-5-12-34)51-40-17-16-35(26-42(40)61(56,57)44(46,47)48)62(58,59)52-43-38-21-25-55(28-41(38)49-30-50-43)33-19-23-54(24-20-33)27-31-10-6-7-13-36(31)37-14-8-9-15-39(37)45/h3-17,26,30,32-33,51H,18-25,27-29H2,1-2H3,(H,49,50,52)/t32-/m1/s1",XIFJKHNOFQWWQU-JGCGQSQUSA-N,1,0,0,0,BCL2-Like / BAX,7.44,cancer,Inhibition,
1116,16109150,374214,17266563,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCC(CC1)=Cc1ccc(Cl)cc1,4-[4-[(4-chlorophenyl)methylidene]piperidin-1-yl]-N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonylbenzamide,"InChI=1S/C37H40ClN5O5S2/c1-41(2)21-20-31(26-49-33-6-4-3-5-7-33)39-35-17-16-34(25-36(35)43(45)46)50(47,48)40-37(44)29-10-14-32(15-11-29)42-22-18-28(19-23-42)24-27-8-12-30(38)13-9-27/h3-17,24-25,31,39H,18-23,26H2,1-2H3,(H,40,44)/t31-/m1/s1",ICIOZGCFQLUXKY-WJOKGBTCSA-N,2,0,0,0,BCL2-Like / BAX,9.30,cancer,Inhibition,
1117,45137489,,,CN[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CC[C@H]2NC[C@@H]([C@@H]12)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(2S)-1-[(3aR,6S,6aR)-6-(6-fluoro-1H-indol-3-yl)-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,2-b]pyrrol-1-yl]-3-hydroxy-1-oxopropan-2-yl]-2-(methylamino)propanamide","InChI=1S/C21H28FN5O3/c1-11(23-2)20(29)26-18(10-28)21(30)27-6-5-16-19(27)15(9-24-16)14-8-25-17-7-12(22)3-4-13(14)17/h3-4,7-8,11,15-16,18-19,23-25,28H,5-6,9-10H2,1-2H3,(H,26,29)/t11-,15+,16+,18-,19+/m0/s1",WTJGBUUVVFMREW-RJAMUQGESA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
1118,168317902,,10657341,CCN([C@H]1CCN(C1)c1cc(ncn1)-c1ccc(Sc2ccccc2C(C)C)c(c1)C(F)(F)F)C(C)=O,N-ethyl-N-[1-[6-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyrimidin-4-yl]pyrrolidin-3-yl]acetamide,"InChI=1S/C28H31F3N4OS/c1-5-35(19(4)36)21-12-13-34(16-21)27-15-24(32-17-33-27)20-10-11-26(23(14-20)28(29,30)31)37-25-9-7-6-8-22(25)18(2)3/h6-11,14-15,17-18,21H,5,12-13,16H2,1-4H3/t21-/m0/s1",ONGTUAKQYUOWAL-NRFANRHFSA-N,0,1,0,0,LFA / ICAM,6.52,immune system disease,Inhibition,
1119,46830176,1091442,24670329,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1nc2c(ncnc2s1)-c1ccccc1,"(2S)-N-[(1S)-1-cyclohexyl-2-oxo-2-[(2S)-2-(7-phenyl-[1,3]thiazolo[5,4-d]pyrimidin-2-yl)pyrrolidin-1-yl]ethyl]-2-(methylamino)propanamide","InChI=1S/C27H34N6O2S/c1-17(28-2)24(34)31-22(19-12-7-4-8-13-19)27(35)33-15-9-14-20(33)25-32-23-21(18-10-5-3-6-11-18)29-16-30-26(23)36-25/h3,5-6,10-11,16-17,19-20,22,28H,4,7-9,12-15H2,1-2H3,(H,31,34)/t17-,20-,22-/m0/s1",XOMVTFGAOHFQCH-XJABCFGWSA-N,1,0,0,0,XIAP / Smac,6.59,cancer,Inhibition,
1120,45487329,569386,24631940,CNC(=O)c1ccc(O[C@@H](C)C(=O)N2CCN(C[C@H]2C)C(=O)c2ccccc2)c2cccnc12,5-[(2S)-1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-1-oxopropan-2-yl]oxy-N-methylquinoline-8-carboxamide,"InChI=1S/C26H28N4O4/c1-17-16-29(26(33)19-8-5-4-6-9-19)14-15-30(17)25(32)18(2)34-22-12-11-21(24(31)27-3)23-20(22)10-7-13-28-23/h4-13,17-18H,14-16H2,1-3H3,(H,27,31)/t17-,18+/m1/s1",WRUJNGZEAXMDHO-MSOLQXFVSA-N,0,1,0,0,CD4 / gp120,5.90,HIV infectious disease,Inhibition,
1121,168317876,,24603833,OC(=O)[C@@H](CC=C)c1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O,2-(6-chloro-2-oxo-4-phenyl-1H-quinolin-3-yl)pent-4-enoic acid,"InChI=1S/C20H16ClNO3/c1-2-6-14(20(24)25)18-17(12-7-4-3-5-8-12)15-11-13(21)9-10-16(15)22-19(18)23/h2-5,7-11,14H,1,6H2,(H,22,23)(H,24,25)/t14-/m0/s1",VTYFWGGPJJWNMF-AWEZNQCLSA-N,1,0,0,0,LEDGF / IN,4.88,HIV infectious disease,Inhibition,
1122,88540201,,,C[C@H]1Cc2c(CN1C1CCN(Cc3ccccc3-c3ccc(Cl)cc3)CC1)ncnc2NS(=O)(=O)c1ccc(N[C@H](CCN(C)C)CSc2ccccc2)c(c1)S(=O)(=O)C(F)(F)F,,"InChI=1S/C45H51ClF3N7O4S3/c1-31-25-40-42(28-56(31)36-20-23-55(24-21-36)27-33-9-7-8-12-39(33)32-13-15-34(46)16-14-32)50-30-51-44(40)53-63(59,60)38-17-18-41(43(26-38)62(57,58)45(47,48)49)52-35(19-22-54(2)3)29-61-37-10-5-4-6-11-37/h4-18,26,30-31,35-36,52H,19-25,27-29H2,1-3H3,(H,50,51,53)/t31-,35+/m0/s1",BGHYXWAGTHCGIM-MFACQUFMSA-N,1,0,0,0,BCL2-Like / BAX,7.48,cancer,Inhibition,
1123,67954568,,,CC(C)Cc1nc(C(O)=O)c(-c2cccc(Cl)c2)n1-c1cccc(Cl)c1,,"InChI=1S/C20H18Cl2N2O2/c1-12(2)9-17-23-18(20(25)26)19(13-5-3-6-14(21)10-13)24(17)16-8-4-7-15(22)11-16/h3-8,10-12H,9H2,1-2H3,(H,25,26)",NFMWGGXHBIXTQH-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,5.76,cancer,Inhibition,
1124,44305158,292321,23156060,OC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1c(F)cccc1Br,(2S)-2-[(2-bromo-6-fluorobenzoyl)amino]-3-(1H-indol-3-yl)propanoic acid,"InChI=1S/C18H14BrFN2O3/c19-12-5-3-6-13(20)16(12)17(23)22-15(18(24)25)8-10-9-21-14-7-2-1-4-11(10)14/h1-7,9,15,21H,8H2,(H,22,23)(H,24,25)/t15-/m0/s1",GMDRWNJYSVNFBO-HNNXBMFYSA-N,1,0,0,0,LFA / ICAM,6.37,immune system disease,Inhibition,
1125,44570090,449546,24688683,CCCCN(CCCC)C(=O)c1nn(c(C)c1Cl)-c1ccc(NC(=O)Cc2ccccc2)cc1C(=O)N1CCc2ccccc2C1,"N,N-dibutyl-4-chloro-1-[2-(3,4-dihydro-1H-isoquinoline-2-carbonyl)-4-[(2-phenylacetyl)amino]phenyl]-5-methylpyrazole-3-carboxamide","InChI=1S/C37H42ClN5O3/c1-4-6-20-41(21-7-5-2)37(46)35-34(38)26(3)43(40-35)32-18-17-30(39-33(44)23-27-13-9-8-10-14-27)24-31(32)36(45)42-22-19-28-15-11-12-16-29(28)25-42/h8-18,24H,4-7,19-23,25H2,1-3H3,(H,39,44)",MEFONFJTPZVJTA-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,7.40,cancer,Inhibition,
1126,88540127,,,CN(C)CC[C@H](CSc1ccccc1F)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1,,"InChI=1S/C44H48ClF4N7O4S3/c1-54(2)21-17-33(28-61-41-10-6-5-9-38(41)46)52-39-16-15-35(25-42(39)62(57,58)44(47,48)49)63(59,60)53-43-37-20-24-56(27-40(37)50-29-51-43)34-18-22-55(23-19-34)26-31-7-3-4-8-36(31)30-11-13-32(45)14-12-30/h3-16,25,29,33-34,52H,17-24,26-28H2,1-2H3,(H,50,51,53)/t33-/m1/s1",YMIPNIGNZVFRRF-MGBGTMOVSA-N,1,0,0,0,BCL2-Like / BAX,7.60,cancer,Inhibition,
1127,59343740,,,OC[C@@H](O)CCNC(=O)[C@@H]1N[C@H](CC2CCCC2)[C@@]2([C@H]1c1ccc(F)c(Cl)c1)C(=O)Nc1cc(Cl)c(F)cc21,"(2'R,3S,3'R,5'R)-6-chloro-3'-(3-chloro-4-fluorophenyl)-5'-(cyclopentylmethyl)-N-[(3S)-3,4-dihydroxybutyl]-5-fluoro-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide","InChI=1S/C28H31Cl2F2N3O4/c29-18-10-15(5-6-20(18)31)24-25(26(38)33-8-7-16(37)13-36)35-23(9-14-3-1-2-4-14)28(24)17-11-21(32)19(30)12-22(17)34-27(28)39/h5-6,10-12,14,16,23-25,35-37H,1-4,7-9,13H2,(H,33,38)(H,34,39)/t16-,23+,24-,25+,28-/m0/s1",APUHTJQOHHOFMM-CKJCMZDRSA-N,1,2,0,0,MDM2-Like / P53,6.71,cancer,Inhibition,
1128,42601681,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCC(CC1)N(Cc1ccccc1)C(C)=O,4-[4-[acetyl(benzyl)amino]piperidin-1-yl]-N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonylbenzamide,"InChI=1S/C39H46N6O6S2/c1-29(46)44(27-30-10-6-4-7-11-30)34-21-24-43(25-22-34)33-16-14-31(15-17-33)39(47)41-53(50,51)36-18-19-37(38(26-36)45(48)49)40-32(20-23-42(2)3)28-52-35-12-8-5-9-13-35/h4-19,26,32,34,40H,20-25,27-28H2,1-3H3,(H,41,47)/t32-/m1/s1",OYJUANGRJCOMLZ-JGCGQSQUSA-N,1,0,0,0,BCL2-Like / BAX,5.30,cancer,Inhibition,
1129,168317899,,23248069,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1cc(ncn1)N1CC[C@@H](C1)NC(=O)OC(C)(C)C,tert-butyl N-[1-[6-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyrimidin-4-yl]pyrrolidin-3-yl]carbamate,"InChI=1S/C29H33F3N4O2S/c1-18(2)21-8-6-7-9-24(21)39-25-11-10-19(14-22(25)29(30,31)32)23-15-26(34-17-33-23)36-13-12-20(16-36)35-27(37)38-28(3,4)5/h6-11,14-15,17-18,20H,12-13,16H2,1-5H3,(H,35,37)/t20-/m0/s1",OLMNMKWZYAOBIK-FQEVSTJZSA-N,0,1,0,0,LFA / ICAM,6.26,immune system disease,Inhibition,
1130,168317894,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(Cc2ccccc2Cl)CC1,,"InChI=1S/C36H41ClN6O5S2/c1-40(2)19-18-29(26-49-31-9-4-3-5-10-31)38-34-17-16-32(24-35(34)43(45)46)50(47,48)39-36(44)27-12-14-30(15-13-27)42-22-20-41(21-23-42)25-28-8-6-7-11-33(28)37/h3-17,24,29,38H,18-23,25-26H2,1-2H3,(H,39,44)/t29-/m1/s1",RWLBWSRCYSNMQB-GDLZYMKVSA-N,2,0,0,0,BCL2-Like / BAX,9.30,cancer,Inhibition,
1131,168317892,,,COC1(CCN(CC1)c1ccc(cc1)C(=O)NS(=O)(=O)c1ccc(N[C@H](CCN(C)C)CSc2ccccc2)c(c1)N(=O)=O)c1ccccc1C,,"InChI=1S/C38H45N5O6S2/c1-28-10-8-9-13-34(28)38(49-4)21-24-42(25-22-38)31-16-14-29(15-17-31)37(44)40-51(47,48)33-18-19-35(36(26-33)43(45)46)39-30(20-23-41(2)3)27-50-32-11-6-5-7-12-32/h5-19,26,30,39H,20-25,27H2,1-4H3,(H,40,44)/t30-/m1/s1",MVUJDHHTHWIGQU-SSEXGKCCSA-N,2,0,0,0,BCL2-Like / BAX,9.30,cancer,Inhibition,
1132,10383943,302644,8559385,OC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1c(F)cccc1Cl,(2S)-2-[(2-chloro-6-fluorobenzoyl)amino]-3-(1H-indol-3-yl)propanoic acid,"InChI=1S/C18H14ClFN2O3/c19-12-5-3-6-13(20)16(12)17(23)22-15(18(24)25)8-10-9-21-14-7-2-1-4-11(10)14/h1-7,9,15,21H,8H2,(H,22,23)(H,24,25)/t15-/m0/s1",KHHMGBVQNFVSEB-HNNXBMFYSA-N,1,0,0,0,LFA / ICAM,6.60,immune system disease,Inhibition,
1133,59207951,,,CC[C@H](N)C(=O)N[C@H]1CCC[C@H]2CC[C@H](N2C1=O)C(=O)NCc1ccccc1,"(3S,6S,9aS)-6-[[(2S)-2-aminobutanoyl]amino]-N-benzyl-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C21H30N4O3/c1-2-16(22)19(26)24-17-10-6-9-15-11-12-18(25(15)21(17)28)20(27)23-13-14-7-4-3-5-8-14/h3-5,7-8,15-18H,2,6,9-13,22H2,1H3,(H,23,27)(H,24,26)/t15-,16-,17-,18-/m0/s1",VZYBJVVVSXFWMF-XSLAGTTESA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
1134,59493255,,,Cc1[nH]c2ccccc2c1CCNc1c(Cl)cc(Nc2ccnc(CO)c2)cc1Cl,"[4-[3,5-dichloro-4-[2-(2-methyl-1H-indol-3-yl)ethylamino]anilino]pyridin-2-yl]methanol","InChI=1S/C23H22Cl2N4O/c1-14-18(19-4-2-3-5-22(19)28-14)7-9-27-23-20(24)11-16(12-21(23)25)29-15-6-8-26-17(10-15)13-30/h2-6,8,10-12,27-28,30H,7,9,13H2,1H3,(H,26,29)",IRTGHXHKBBVTPC-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,5.52,cancer,Inhibition,
1135,16109137,373577,17266550,COC1(CC(C)C)CCN(CC1)c1ccc(cc1)C(=O)NS(=O)(=O)c1ccc(N[C@H](CCN(C)C)CSc2ccccc2)c(c1)N(=O)=O,N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonyl-4-[4-methoxy-4-(2-methylpropyl)piperidin-1-yl]benzamide,"InChI=1S/C35H47N5O6S2/c1-26(2)24-35(46-5)18-21-39(22-19-35)29-13-11-27(12-14-29)34(41)37-48(44,45)31-15-16-32(33(23-31)40(42)43)36-28(17-20-38(3)4)25-47-30-9-7-6-8-10-30/h6-16,23,26,28,36H,17-22,24-25H2,1-5H3,(H,37,41)/t28-/m1/s1",AGGPTAKEWABCFB-MUUNZHRXSA-N,2,0,0,0,BCL2-Like / BAX,8.21,cancer,Inhibition,
1136,67034825,3260821,,Nc1nnc(o1)-c1nc(C2CCCCC2)n(c1-c1ccc(F)c(Cl)c1)-c1c(CC(=O)NC2CCCCC2)ccc(Cl)c1F,,"InChI=1S/C31H32Cl2F2N6O2/c32-21-13-11-19(16-24(42)37-20-9-5-2-6-10-20)27(25(21)35)41-28(18-12-14-23(34)22(33)15-18)26(30-39-40-31(36)43-30)38-29(41)17-7-3-1-4-8-17/h11-15,17,20H,1-10,16H2,(H2,36,40)(H,37,42)",SMUUKZTVPGSBEE-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,8.52,cancer,Inhibition,
1137,506246,523717,442077,Fc1ccc(OCC(F)(F)F)c2[nH]cc(C(=O)C(=O)N3CCN(CC3)C(=O)c3ccccc3)c12,"1-(4-benzoylpiperazin-1-yl)-2-[4-fluoro-7-(2,2,2-trifluoroethoxy)-1H-indol-3-yl]ethane-1,2-dione","InChI=1S/C23H19F4N3O4/c24-16-6-7-17(34-13-23(25,26)27)19-18(16)15(12-28-19)20(31)22(33)30-10-8-29(9-11-30)21(32)14-4-2-1-3-5-14/h1-7,12,28H,8-11,13H2",JEDLHCTUJDQYBZ-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,9.15,HIV infectious disease,Inhibition,
1138,23647743,,,CN[C@@H](C)C(=O)N[C@H]1CCC[C@@H]2SC[C@H](N2C1=O)C(=O)Nc1cc(C)nn1-c1ccccc1,"(3R,6S,9aR)-6-[[(2S)-2-(methylamino)propanoyl]amino]-N-(5-methyl-2-phenylpyrazol-3-yl)-5-oxo-3,6,7,8,9,9a-hexahydro-2H-[1,3]thiazolo[3,2-a]azepine-3-carboxamide","InChI=1S/C23H30N6O3S/c1-14-12-19(29(27-14)16-8-5-4-6-9-16)26-22(31)18-13-33-20-11-7-10-17(23(32)28(18)20)25-21(30)15(2)24-3/h4-6,8-9,12,15,17-18,20,24H,7,10-11,13H2,1-3H3,(H,25,30)(H,26,31)/t15-,17-,18-,20-/m0/s1",YYBUDMKKCZIZQP-CAIZAGQASA-N,1,0,0,0,XIAP / Smac,5.52,cancer,Inhibition,
1139,168317897,,,CCCn1cc(C(=O)C(=O)N2CCN(CC2)C(=O)c2ccccc2)c2ccccc12,,"InChI=1S/C24H25N3O3/c1-2-12-27-17-20(19-10-6-7-11-21(19)27)22(28)24(30)26-15-13-25(14-16-26)23(29)18-8-4-3-5-9-18/h3-11,17H,2,12-16H2,1H3",UBRAAHQOJHKSBF-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,5.58,HIV infectious disease,Inhibition,
1140,168317893,,,OCCN(Cc1ccccc1)C(=O)[C@@H](Cc1c[nH]c2ccccc12)Nc1ccc(Nc2ccncc2)cc1,N-benzyl-N-(2-hydroxyethyl)-3-(1H-indol-3-yl)-2-[4-(pyridin-4-ylamino)anilino]propanamide,"InChI=1S/C31H31N5O2/c37-19-18-36(22-23-6-2-1-3-7-23)31(38)30(20-24-21-33-29-9-5-4-8-28(24)29)35-26-12-10-25(11-13-26)34-27-14-16-32-17-15-27/h1-17,21,30,33,35,37H,18-20,22H2,(H,32,34)/t30-/m1/s1",SBFQOFMLCZGKMI-SSEXGKCCSA-N,1,0,0,0,MDM2-Like / P53,6.00,cancer,Inhibition,
1141,46883883,1092174,24679764,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1nc2c(Cc3ccccc3)cccc2s1,"(2S)-N-[(1S)-2-[(2R)-2-(4-benzyl-1,3-benzothiazol-2-yl)pyrrolidin-1-yl]-1-cyclohexyl-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C30H38N4O2S/c1-20(31-2)28(35)32-27(22-13-7-4-8-14-22)30(36)34-18-10-16-24(34)29-33-26-23(15-9-17-25(26)37-29)19-21-11-5-3-6-12-21/h3,5-6,9,11-12,15,17,20,22,24,27,31H,4,7-8,10,13-14,16,18-19H2,1-2H3,(H,32,35)/t20-,24-,27-/m0/s1",YVVYRJPRGCJJLO-PPNCUWOSSA-N,1,0,0,0,XIAP / Smac,6.82,cancer,Inhibition,
1142,21906804,183699,10657325,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1cc(ncn1)N1CCC(CC1)C(O)=O,1-[6-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyrimidin-4-yl]piperidine-4-carboxylic acid,"InChI=1S/C26H26F3N3O2S/c1-16(2)19-5-3-4-6-22(19)35-23-8-7-18(13-20(23)26(27,28)29)21-14-24(31-15-30-21)32-11-9-17(10-12-32)25(33)34/h3-8,13-17H,9-12H2,1-2H3,(H,33,34)",ACLVTPBNANYOKG-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,6.92,immune system disease,Inhibition,
1143,168317865,,,OC[C@@H](Cc1c[nH]c2ccccc12)Nc1ccc(Nc2ccncc2)cc1,3-(1H-indol-3-yl)-2-[4-(pyridin-4-ylamino)anilino]propan-1-ol,"InChI=1S/C22H22N4O/c27-15-20(13-16-14-24-22-4-2-1-3-21(16)22)26-18-7-5-17(6-8-18)25-19-9-11-23-12-10-19/h1-12,14,20,24,26-27H,13,15H2,(H,23,25)/t20-/m1/s1",WXMSYCXFTKRFIZ-HXUWFJFHSA-N,1,1,0,0,MDM2-Like / P53,6.80,cancer,Inhibition,
1144,44305025,64189,23155879,OC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1cc(F)ccc1F,"(2S)-2-[(2,5-difluorobenzoyl)amino]-3-(1H-indol-3-yl)propanoic acid","InChI=1S/C18H14F2N2O3/c19-11-5-6-14(20)13(8-11)17(23)22-16(18(24)25)7-10-9-21-15-4-2-1-3-12(10)15/h1-6,8-9,16,21H,7H2,(H,22,23)(H,24,25)/t16-/m0/s1",CZBKPGBZMXDZLB-INIZCTEOSA-N,1,0,0,0,LFA / ICAM,4.94,immune system disease,Inhibition,
1145,16204196,220055,17332494,CC(C)c1cc(C(=O)N2CCc3ccccc3C2)c(O)c(O)c1O,"3,4-dihydro-1H-isoquinolin-2-yl-(2,3,4-trihydroxy-5-propan-2-ylphenyl)methanone","InChI=1S/C19H21NO4/c1-11(2)14-9-15(17(22)18(23)16(14)21)19(24)20-8-7-12-5-3-4-6-13(12)10-20/h3-6,9,11,21-23H,7-8,10H2,1-2H3",BHMAXGYZHGTXAG-UHFFFAOYSA-N,1,0,0,0,BCL2-Like / BAX,5.51,cancer,Inhibition,
1146,44192145,541004,24612258,Cc1cc2c(C(=O)NCC3CCCCC3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)NCC3CCCCC3)c(O)c(O)cc2c1O,"N-(cyclohexylmethyl)-6-[5-(cyclohexylmethylcarbamoyl)-1,6,7-trihydroxy-3-methylnaphthalen-2-yl]-2,3,5-trihydroxy-7-methylnaphthalene-1-carboxamide","InChI=1S/C38H44N2O8/c1-19-13-23-25(15-27(41)35(45)31(23)37(47)39-17-21-9-5-3-6-10-21)33(43)29(19)30-20(2)14-24-26(34(30)44)16-28(42)36(46)32(24)38(48)40-18-22-11-7-4-8-12-22/h13-16,21-22,41-46H,3-12,17-18H2,1-2H3,(H,39,47)(H,40,48)",OQQWENIODLCZHS-UHFFFAOYSA-N,4,0,0,0,BCL2-Like / BAX,6.15,cancer,Inhibition,
1147,11953254,210913,10127562,CC#Cc1ccc2N(CCCCC(O)=O)C(=O)[C@@H](N([C@H](C)c3ccc(Cl)cc3)C(=O)c2c1)c1ccc(Cl)cc1,"5-[(3S)-3-(4-chlorophenyl)-4-[(1R)-1-(4-chlorophenyl)ethyl]-2,5-dioxo-7-prop-1-ynyl-3H-1,4-benzodiazepin-1-yl]pentanoic acid","InChI=1S/C31H28Cl2N2O4/c1-3-6-21-8-17-27-26(19-21)30(38)35(20(2)22-9-13-24(32)14-10-22)29(23-11-15-25(33)16-12-23)31(39)34(27)18-5-4-7-28(36)37/h8-17,19-20,29H,4-5,7,18H2,1-2H3,(H,36,37)/t20-,29+/m1/s1",POKSZIQBBZUBDJ-OLILMLBXSA-N,1,2,0,0,MDM2-Like / P53,5.95,cancer,Inhibition,
1148,45485396,571586,,CNC(=O)c1ccc(O[C@H](C)C(=O)N2CCN(C[C@H]2C)C(=O)c2ccccc2)c(OC)c1,4-[(2S)-1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-1-oxopropan-2-yl]oxy-3-methoxy-N-methylbenzamide,"InChI=1S/C24H29N3O5/c1-16-15-26(24(30)18-8-6-5-7-9-18)12-13-27(16)23(29)17(2)32-20-11-10-19(22(28)25-3)14-21(20)31-4/h5-11,14,16-17H,12-13,15H2,1-4H3,(H,25,28)/t16-,17-/m1/s1",OQRSXFNMNAQFEB-IAGOWNOFSA-N,0,1,0,0,CD4 / gp120,7.77,HIV infectious disease,Inhibition,
1149,46221188,1095137,24669731,CN1C(=O)N(C(=O)[C@]11CN(C[C@H]1c1ccc(cc1)C#N)c1nc(co1)C(O)=O)c1cc(Cl)cc(Cl)c1,"2-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl]-1,3-oxazole-4-carboxylic acid","InChI=1S/C24H17Cl2N5O5/c1-29-23(35)31(17-7-15(25)6-16(26)8-17)21(34)24(29)12-30(22-28-19(11-36-22)20(32)33)10-18(24)14-4-2-13(9-27)3-5-14/h2-8,11,18H,10,12H2,1H3,(H,32,33)/t18-,24+/m0/s1",KYEMYNPDGAAYFU-MHECFPHRSA-N,1,0,0,0,LFA / ICAM,7.24,immune system disease,Inhibition,
1150,168317888,,9823177,CCCN1C(=O)c2ccccc2[C@]1(OCc1cc(OC)c(O)c(OC)c1)c1ccc(Cl)cc1,"3-(4-chlorophenyl)-3-[(4-hydroxy-3,5-dimethoxyphenyl)methoxy]-2-propylisoindol-1-one","InChI=1S/C26H26ClNO5/c1-4-13-28-25(30)20-7-5-6-8-21(20)26(28,18-9-11-19(27)12-10-18)33-16-17-14-22(31-2)24(29)23(15-17)32-3/h5-12,14-15,29H,4,13,16H2,1-3H3/t26-/m1/s1",NDIKZCQEKGERHF-AREMUKBSSA-N,2,0,0,0,MDM2-Like / P53,5.28,cancer,Inhibition,
1151,168317887,,,COC(=O)c1ccc(cc1Cl)-n1[nH]c2c3cnn(C)c3nc(-c3cccc(c3)C(F)(F)F)c2c1=O,,"InChI=1S/C23H15ClF3N5O3/c1-31-20-15(10-28-31)19-17(18(29-20)11-4-3-5-12(8-11)23(25,26)27)21(33)32(30-19)13-6-7-14(16(24)9-13)22(34)35-2/h3-10,30H,1-2H3",SAOYJICYGMWIQD-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.39,cancer,Inhibition,
1152,58007476,2398244,,CC[C@@H]1CC[C@H](N1C(=O)C1=C(C(C)C)N2[C@H](c3ccc(Cl)cc3)[C@@](C)(N=C2S1)c1ccc(Cl)cc1)C(=O)N1CCN(CC1)C(C)=O,"1-[4-[(2S,5R)-1-[(5R,6S)-5,6-bis(4-chlorophenyl)-6-methyl-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazole-2-carbonyl]-5-ethylpyrrolidine-2-carbonyl]piperazin-1-yl]ethanone","InChI=1S/C35H41Cl2N5O3S/c1-6-27-15-16-28(32(44)40-19-17-39(18-20-40)22(4)43)41(27)33(45)30-29(21(2)3)42-31(23-7-11-25(36)12-8-23)35(5,38-34(42)46-30)24-9-13-26(37)14-10-24/h7-14,21,27-28,31H,6,15-20H2,1-5H3/t27-,28+,31-,35+/m1/s1",CSUJXSSOFXILEC-WRDOGMKISA-N,1,0,0,0,MDM2-Like / P53,7.70,cancer,Inhibition,
1153,168317875,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(C)(C)C)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2ccc(F)cc2-c2ccc(Cl)cc2)CC1,,"InChI=1S/C47H57ClFN7O4S3/c1-47(2,3)62(57,58)45-28-40(17-18-43(45)52-37(19-23-54(4)5)31-61-39-9-7-6-8-10-39)63(59,60)53-46-41-22-26-56(30-44(41)50-32-51-46)38-20-24-55(25-21-38)29-34-13-16-36(49)27-42(34)33-11-14-35(48)15-12-33/h6-18,27-28,32,37-38,52H,19-26,29-31H2,1-5H3,(H,50,51,53)/t37-/m1/s1",FAEWHSCRTFYFIU-DIPNUNPCSA-N,1,0,0,0,BCL2-Like / BAX,7.46,cancer,Inhibition,
1154,168317858,,17266528,C[C@H]1OC2(CCN(CC2)c2ccc(cc2)C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN(C)C)CSc3ccccc3)c(c2)N(=O)=O)N(Cc2ccccc2)C1=O,"4-(4-benzyl-2-methyl-3-oxo-1-oxa-4,8-diazaspiro[4.5]decan-8-yl)-N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonylbenzamide","InChI=1S/C40H46N6O7S2/c1-29-39(48)45(27-30-10-6-4-7-11-30)40(53-29)21-24-44(25-22-40)33-16-14-31(15-17-33)38(47)42-55(51,52)35-18-19-36(37(26-35)46(49)50)41-32(20-23-43(2)3)28-54-34-12-8-5-9-13-34/h4-19,26,29,32,41H,20-25,27-28H2,1-3H3,(H,42,47)/t29-,32-/m1/s1",YOWVHFCSBZXUDJ-QLWXXVCSSA-N,2,0,0,0,BCL2-Like / BAX,8.43,cancer,Inhibition,
1155,168317810,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(C)(C)C)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2c(F)cccc2-c2ccc(Cl)cc2)CC1,,"InChI=1S/C47H57ClFN7O4S3/c1-47(2,3)62(57,58)45-28-38(18-19-43(45)52-35(20-24-54(4)5)31-61-37-10-7-6-8-11-37)63(59,60)53-46-40-23-27-56(30-44(40)50-32-51-46)36-21-25-55(26-22-36)29-41-39(12-9-13-42(41)49)33-14-16-34(48)17-15-33/h6-19,28,32,35-36,52H,20-27,29-31H2,1-5H3,(H,50,51,53)/t35-/m1/s1",GWIBQGRPRSORRM-PGUFJCEWSA-N,1,0,0,0,BCL2-Like / BAX,7.52,cancer,Inhibition,
1156,59555642,,,OC(=O)CCNCc1cc(Nc2ccc(NCCc3c[nH]c4ccccc34)cc2)ccn1,3-[[4-[4-[2-(1H-indol-3-yl)ethylamino]anilino]pyridin-2-yl]methylamino]propanoic acid,"InChI=1S/C25H27N5O2/c31-25(32)11-12-26-17-22-15-21(10-14-28-22)30-20-7-5-19(6-8-20)27-13-9-18-16-29-24-4-2-1-3-23(18)24/h1-8,10,14-16,26-27,29H,9,11-13,17H2,(H,28,30)(H,31,32)",RBYMWZBMCJPPIG-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,6.00,cancer,Inhibition,
1157,57809188,,,CCOc1cc(ccc1C1=N[C@H]([C@H](N1C(=O)N1CCN(CC(=O)N2CCOCC2)CC1)c1ccc(Cl)cc1)c1ccc(Cl)cc1)C#CC(C)(C)C,"2-[4-[(4S,5R)-4,5-bis(4-chlorophenyl)-2-[4-(3,3-dimethylbut-1-ynyl)-2-ethoxyphenyl]-4,5-dihydroimidazole-1-carbonyl]piperazin-1-yl]-1-morpholin-4-ylethanone","InChI=1S/C40H45Cl2N5O4/c1-5-51-34-26-28(16-17-40(2,3)4)6-15-33(34)38-43-36(29-7-11-31(41)12-8-29)37(30-9-13-32(42)14-10-30)47(38)39(49)46-20-18-44(19-21-46)27-35(48)45-22-24-50-25-23-45/h6-15,26,36-37H,5,18-25,27H2,1-4H3/t36-,37+/m0/s1",XTGLDCNEZTWBMA-PQQNNWGCSA-N,1,0,0,0,MDM2-Like / P53,6.26,cancer,Inhibition,
1158,44580637,501977,24710159,C[C@H]1CC[C@@H](CC1)Oc1ccccc1Sc1ccc(\C=C\C(=O)N2CCOCC2)c(C(F)(F)F)c1C(F)(F)F,"(E)-3-[4-[2-(4-methylcyclohexyl)oxyphenyl]sulfanyl-2,3-bis(trifluoromethyl)phenyl]-1-morpholin-4-ylprop-2-en-1-one","InChI=1S/C28H29F6NO3S/c1-18-6-10-20(11-7-18)38-21-4-2-3-5-22(21)39-23-12-8-19(9-13-24(36)35-14-16-37-17-15-35)25(27(29,30)31)26(23)28(32,33)34/h2-5,8-9,12-13,18,20H,6-7,10-11,14-17H2,1H3/b13-9+/t18-,20-",IAAIGCGTGAJLIA-FHBFZVEGSA-N,1,0,0,0,LFA / ICAM,7.29,immune system disease,Inhibition,
1159,10208622,179286,8384119,CNC(=O)[C@H](Cc1ccc2ccccc2c1)N1CCC(=O)N(Cc2ccc(cc2)N(C)C)[C@@H](CC(C)C)C1=O,"(2S)-2-[(3S)-4-[[4-(dimethylamino)phenyl]methyl]-3-(2-methylpropyl)-2,5-dioxo-1,4-diazepan-1-yl]-N-methyl-3-naphthalen-2-ylpropanamide","InChI=1S/C32H40N4O3/c1-22(2)18-29-32(39)35(17-16-30(37)36(29)21-23-11-14-27(15-12-23)34(4)5)28(31(38)33-3)20-24-10-13-25-8-6-7-9-26(25)19-24/h6-15,19,22,28-29H,16-18,20-21H2,1-5H3,(H,33,38)/t28-,29-/m0/s1",VHWHPFQFPMRDDY-VMPREFPWSA-N,1,0,0,0,LFA / ICAM,6.10,immune system disease,Inhibition,
1160,68051288,,,FC(F)(F)S(=O)(=O)c1cc(ccc1NCCSc1ccccc1)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1,,"InChI=1S/C40H40ClF3N6O4S3/c41-30-12-10-28(11-13-30)34-9-5-4-6-29(34)25-49-20-16-31(17-21-49)50-22-18-35-37(26-50)46-27-47-39(35)48-57(53,54)33-14-15-36(38(24-33)56(51,52)40(42,43)44)45-19-23-55-32-7-2-1-3-8-32/h1-15,24,27,31,45H,16-23,25-26H2,(H,46,47,48)",HDOYBMDOYXKFRC-UHFFFAOYSA-N,1,0,0,0,BCL2-Like / BAX,5.88,cancer,Inhibition,
1161,11552211,,9726989,OCc1cc(Nc2ccc(NCCc3c[nH]c4ccccc34)cc2)ccn1,[4-[4-[2-(1H-indol-3-yl)ethylamino]anilino]pyridin-2-yl]methanol,"InChI=1S/C22H22N4O/c27-15-20-13-19(10-12-24-20)26-18-7-5-17(6-8-18)23-11-9-16-14-25-22-4-2-1-3-21(16)22/h1-8,10,12-14,23,25,27H,9,11,15H2,(H,24,26)",SECSZGCUWUFWHP-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,6.80,cancer,Inhibition,
1162,11621362,502789,24710987,OC(=O)[C@@H]1CC[C@@H](CC1)Oc1cccc(c1)Sc1ccc(\C=C\C(=O)N2CCOCC2)c(C(F)(F)F)c1C(F)(F)F,"4-[3-[4-[(E)-3-morpholin-4-yl-3-oxoprop-1-enyl]-2,3-bis(trifluoromethyl)phenyl]sulfanylphenoxy]cyclohexane-1-carboxylic acid","InChI=1S/C28H27F6NO5S/c29-27(30,31)24-17(7-11-23(36)35-12-14-39-15-13-35)6-10-22(25(24)28(32,33)34)41-21-3-1-2-20(16-21)40-19-8-4-18(5-9-19)26(37)38/h1-3,6-7,10-11,16,18-19H,4-5,8-9,12-15H2,(H,37,38)/b11-7+/t18-,19+",WBSXKVRTVMHGNY-BZZHFGAJSA-N,1,0,0,0,LFA / ICAM,8.52,immune system disease,Inhibition,
1163,25218666,458742,24690525,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CC[C@H]2CC[C@H](NC(=O)c3c(OC)ccc4ccccc34)[C@@H]12)C(C)(C)C,"N-[(3aR,6S,6aS)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-6-yl]-2-methoxynaphthalene-1-carboxamide","InChI=1S/C29H40N4O4/c1-17(30-5)26(34)32-25(29(2,3)4)28(36)33-16-15-19-11-13-21(24(19)33)31-27(35)23-20-10-8-7-9-18(20)12-14-22(23)37-6/h7-10,12,14,17,19,21,24-25,30H,11,13,15-16H2,1-6H3,(H,31,35)(H,32,34)/t17-,19+,21-,24-,25+/m0/s1",KULASWCGDWKFRQ-WSXGSKLPSA-N,1,0,0,0,XIAP / Smac,6.96,cancer,Inhibition,
1164,46883922,1089694,24666718,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1nc2c(cccc2s1)-c1ccncc1,"(2S)-N-[(1S)-1-cyclohexyl-2-oxo-2-[(2R)-2-(4-pyridin-4-yl-1,3-benzothiazol-2-yl)pyrrolidin-1-yl]ethyl]-2-(methylamino)propanamide","InChI=1S/C28H35N5O2S/c1-18(29-2)26(34)31-24(20-8-4-3-5-9-20)28(35)33-17-7-11-22(33)27-32-25-21(10-6-12-23(25)36-27)19-13-15-30-16-14-19/h6,10,12-16,18,20,22,24,29H,3-5,7-9,11,17H2,1-2H3,(H,31,34)/t18-,22-,24-/m0/s1",WQFARPRDXJNKOW-OEOAZWSVSA-N,1,0,0,0,XIAP / Smac,7.22,cancer,Inhibition,
1165,44580575,496945,24708464,FC(F)(F)c1c(Sc2cccc(OC3CCSCC3)c2)ccc(\C=C\C(=O)N2CCOCC2)c1C(F)(F)F,"(E)-1-morpholin-4-yl-3-[4-[3-(thian-4-yloxy)phenyl]sulfanyl-2,3-bis(trifluoromethyl)phenyl]prop-2-en-1-one","InChI=1S/C26H25F6NO3S2/c27-25(28,29)23-17(5-7-22(34)33-10-12-35-13-11-33)4-6-21(24(23)26(30,31)32)38-20-3-1-2-19(16-20)36-18-8-14-37-15-9-18/h1-7,16,18H,8-15H2/b7-5+",VEYUKVJMTNXXSF-FNORWQNLSA-N,1,0,0,0,LFA / ICAM,8.68,immune system disease,Inhibition,
1166,16090304,214965,17248917,Oc1c(O)c(Cc2ccccc2)cc(C(=O)Nc2ccccc2)c1O,"5-benzyl-2,3,4-trihydroxy-N-phenylbenzamide","InChI=1S/C20H17NO4/c22-17-14(11-13-7-3-1-4-8-13)12-16(18(23)19(17)24)20(25)21-15-9-5-2-6-10-15/h1-10,12,22-24H,11H2,(H,21,25)",QFCGWKILQYTRID-UHFFFAOYSA-N,1,0,0,0,BCL2-Like / BAX,5.08,cancer,Inhibition,
1167,46883992,1091484,24677318,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1nc2c(cccc2s1)-c1ccc(Cl)cc1,"(2S)-N-[(1S)-2-[(2S)-2-[4-(4-chlorophenyl)-1,3-benzothiazol-2-yl]pyrrolidin-1-yl]-1-cyclohexyl-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C29H35ClN4O2S/c1-18(31-2)27(35)32-25(20-8-4-3-5-9-20)29(36)34-17-7-11-23(34)28-33-26-22(10-6-12-24(26)37-28)19-13-15-21(30)16-14-19/h6,10,12-16,18,20,23,25,31H,3-5,7-9,11,17H2,1-2H3,(H,32,35)/t18-,23-,25-/m0/s1",UDSHPTQPAIYZKQ-WYRQLCSISA-N,1,0,0,0,XIAP / Smac,7.24,cancer,Inhibition,
1168,11518327,,9693115,OC(=O)c1ccc(NC(=O)c2cccc(Cc3ccccc3C#N)c2)c(Cc2ccc(F)cc2)c1,4-[[3-[(2-cyanophenyl)methyl]benzoyl]amino]-3-[(4-fluorophenyl)methyl]benzoic acid,"InChI=1S/C29H21FN2O3/c30-26-11-8-19(9-12-26)14-25-17-23(29(34)35)10-13-27(25)32-28(33)22-7-3-4-20(16-22)15-21-5-1-2-6-24(21)18-31/h1-13,16-17H,14-15H2,(H,32,33)(H,34,35)",MUDBDKCNDANQLB-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,4.92,cancer,Inhibition,
1169,46836368,,,OC(=O)c1nc(sc1CCCOc1ccc(cc1)-c1cccnc1C#N)N1CCc2cccc(C(=O)Nc3nc4ccccc4s3)c2C1,"2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-5-[3-[4-(2-cyanopyridin-3-yl)phenoxy]propyl]-1,3-thiazole-4-carboxylic acid","InChI=1S/C36H28N6O4S2/c37-20-29-25(8-4-17-38-29)23-12-14-24(15-13-23)46-19-5-11-31-32(34(44)45)40-36(48-31)42-18-16-22-6-3-7-26(27(22)21-42)33(43)41-35-39-28-9-1-2-10-30(28)47-35/h1-4,6-10,12-15,17H,5,11,16,18-19,21H2,(H,44,45)(H,39,41,43)",IJTBMMJFSGGRLV-UHFFFAOYSA-N,1,0,0,0,BCL2-Like / BAX,6.51,cancer,Inhibition,
1170,506225,492948,442056,COc1ccc2c(c[nH]c2c1)C(=O)C(=O)N1CCN(CC1)C(=O)c1ccccc1,"1-(4-benzoylpiperazin-1-yl)-2-(6-methoxy-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C22H21N3O4/c1-29-16-7-8-17-18(14-23-19(17)13-16)20(26)22(28)25-11-9-24(10-12-25)21(27)15-5-3-2-4-6-15/h2-8,13-14,23H,9-12H2,1H3",WGHIBPXNZYOGFD-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,6.48,HIV infectious disease,Inhibition,
1171,25095168,,,Fc1cc2c(c[nH]c2cc1Cl)-c1c(ncn1Cc1ccc2cc[nH]c2c1)-c1ccccc1,6-chloro-5-fluoro-3-[3-(1H-indol-6-ylmethyl)-5-phenylimidazol-4-yl]-1H-indole,"InChI=1S/C26H18ClFN4/c27-21-12-24-19(11-22(21)28)20(13-30-24)26-25(18-4-2-1-3-5-18)31-15-32(26)14-16-6-7-17-8-9-29-23(17)10-16/h1-13,15,29-30H,14H2",PHMZVBLIEGPMTC-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,5.14,cancer,Inhibition,
1172,44237045,572609,24637200,CC[C@H](N)C(=O)N[C@H]1[C@@H](COC(C)=O)CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"[(3S,6S,7S,9aS)-6-[[(2S)-2-aminobutanoyl]amino]-3-(benzhydrylcarbamoyl)-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepin-7-yl]methyl acetate","InChI=1S/C30H38N4O5/c1-3-24(31)28(36)33-27-22(18-39-19(2)35)14-15-23-16-17-25(34(23)30(27)38)29(37)32-26(20-10-6-4-7-11-20)21-12-8-5-9-13-21/h4-13,22-27H,3,14-18,31H2,1-2H3,(H,32,37)(H,33,36)/t22-,23+,24+,25+,27+/m1/s1",CGTNLNNWWXJERJ-HOIWYFOJSA-N,2,0,0,0,XIAP / Smac,6.48,cancer,Inhibition,
1173,44237064,583950,24641056,CC[C@H](N)C(=O)N[C@H]1[C@@H](CNC(N)=S)CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7R,9aS)-6-[[(2S)-2-aminobutanoyl]amino]-N-benzhydryl-7-[(carbamothioylamino)methyl]-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C29H38N6O3S/c1-2-22(30)26(36)34-25-20(17-32-29(31)39)13-14-21-15-16-23(35(21)28(25)38)27(37)33-24(18-9-5-3-6-10-18)19-11-7-4-8-12-19/h3-12,20-25H,2,13-17,30H2,1H3,(H,33,37)(H,34,36)(H3,31,32,39)/t20-,21+,22+,23+,25+/m1/s1",NOQRYBAHUHKPRC-FCRIMTMASA-N,2,0,0,0,XIAP / Smac,6.66,cancer,Inhibition,
1174,23646338,426055,23246972,CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NCc1ccccc1,(2S)-1-[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-3-methylbutanoyl]-N-benzylpyrrolidine-2-carboxamide,"InChI=1S/C22H34N4O3/c1-14(2)18(23)21(28)25-19(15(3)4)22(29)26-12-8-11-17(26)20(27)24-13-16-9-6-5-7-10-16/h5-7,9-10,14-15,17-19H,8,11-13,23H2,1-4H3,(H,24,27)(H,25,28)/t17-,18-,19-/m0/s1",MSOXVCVBUQCJOZ-FHWLQOOXSA-N,1,0,0,0,XIAP / Smac,5.38,cancer,Inhibition,
1175,67031943,,,CCOC(=O)c1nc(CC(C)(C)C)n(c1-c1ccc(F)c(Cl)c1)-c1cc(Cl)ccc1C,,"InChI=1S/C24H25Cl2FN2O2/c1-6-31-23(30)21-22(15-8-10-18(27)17(26)11-15)29(20(28-21)13-24(3,4)5)19-12-16(25)9-7-14(19)2/h7-12H,6,13H2,1-5H3",OBNJSJFNGXSEFL-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,5.91,cancer,Inhibition,
1176,506233,522372,442064,Fc1cccc2c(c[nH]c12)C(=O)C(=O)N1CCN(CC1)C(=O)c1ccccc1,"1-(4-benzoylpiperazin-1-yl)-2-(7-fluoro-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C21H18FN3O3/c22-17-8-4-7-15-16(13-23-18(15)17)19(26)21(28)25-11-9-24(10-12-25)20(27)14-5-2-1-3-6-14/h1-8,13,23H,9-12H2",ZAYJSFVXCOIZBP-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,8.14,HIV infectious disease,Inhibition,
1177,67035838,,,OC(=O)c1nc(-c2ccccc2)n(c1-c1cccc(Cl)c1)-c1ccc(F)c(Cl)c1,,"InChI=1S/C22H13Cl2FN2O2/c23-15-8-4-7-14(11-15)20-19(22(28)29)26-21(13-5-2-1-3-6-13)27(20)16-9-10-18(25)17(24)12-16/h1-12H,(H,28,29)",OLNJRNLYCSPGQO-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,6.48,cancer,Inhibition,
1178,168317881,,,CC[C@@H]1CC[C@H](N1C(=O)C1=C(C(C)C)N2[C@@H](c3ccc(Cl)cc3)[C@@](C)(N=C2S1)c1ccc(Cl)cc1F)C(=O)N1CCN([C@H](C)C1)C(C)=O,"1-[(2R)-4-[(2S,5R)-1-[(5R,6S)-6-(4-chloro-2-fluorophenyl)-5-(4-chlorophenyl)-6-methyl-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazole-2-carbonyl]-5-ethylpyrrolidine-2-carbonyl]-2-methylpiperazin-1-yl]ethanone","InChI=1S/C36H42Cl2FN5O3S/c1-7-26-13-15-29(33(46)41-16-17-42(22(5)45)21(4)19-41)43(26)34(47)31-30(20(2)3)44-32(23-8-10-24(37)11-9-23)36(6,40-35(44)48-31)27-14-12-25(38)18-28(27)39/h8-12,14,18,20-21,26,29,32H,7,13,15-17,19H2,1-6H3/t21-,26-,29+,32+,36+/m1/s1",QICWGGFYDSEYKR-WLAYAAAPSA-N,1,0,0,0,MDM2-Like / P53,8.00,cancer,Inhibition,
1179,44237061,575154,24635875,CCNC(=S)NC[C@H]1CC[C@H]2CC[C@H](N2C(=O)[C@H]1NC(=O)[C@@H](N)CC)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7R,9aS)-6-[[(2S)-2-aminobutanoyl]amino]-N-benzhydryl-7-[(ethylcarbamothioylamino)methyl]-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C31H42N6O3S/c1-3-24(32)28(38)36-27-22(19-34-31(41)33-4-2)15-16-23-17-18-25(37(23)30(27)40)29(39)35-26(20-11-7-5-8-12-20)21-13-9-6-10-14-21/h5-14,22-27H,3-4,15-19,32H2,1-2H3,(H,35,39)(H,36,38)(H2,33,34,41)/t22-,23+,24+,25+,27+/m1/s1",ICLOIEGJOKLZFR-HOIWYFOJSA-N,2,0,0,0,XIAP / Smac,6.63,cancer,Inhibition,
1180,68809205,,,CN1C(=O)N(C(=O)[C@]11CN(Cc2ccc(cn2)C(O)=O)C[C@H]1c1ccc(cc1)C#N)c1cc(Cl)cc(Cl)c1,"6-[[9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl]methyl]pyridine-3-carboxylic acid","InChI=1S/C27H21Cl2N5O4/c1-32-26(38)34(22-9-19(28)8-20(29)10-22)25(37)27(32)15-33(13-21-7-6-18(12-31-21)24(35)36)14-23(27)17-4-2-16(11-30)3-5-17/h2-10,12,23H,13-15H2,1H3,(H,35,36)/t23-,27+/m0/s1",GEGJPWZJSVQALG-WNCULLNHSA-N,1,0,0,0,LFA / ICAM,8.60,immune system disease,Inhibition,
1181,25138065,487353,24703525,CC[C@H](NC)C(=O)N[C@H]1CCCC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,10aS)-N-benzhydryl-6-[[(2S)-2-(methylamino)butanoyl]amino]-5-oxo-2,3,6,7,8,9,10,10a-octahydro-1H-pyrrolo[1,2-a]azocine-3-carboxamide","InChI=1S/C29H38N4O3/c1-3-23(30-2)27(34)31-24-17-11-10-16-22-18-19-25(33(22)29(24)36)28(35)32-26(20-12-6-4-7-13-20)21-14-8-5-9-15-21/h4-9,12-15,22-26,30H,3,10-11,16-19H2,1-2H3,(H,31,34)(H,32,35)/t22-,23-,24-,25-/m0/s1",NLJQXGSVYYFGHX-QORCZRPOSA-N,1,1,0,0,XIAP / Smac,7.17,cancer,Inhibition,
1182,168317864,,,C[C@H](O)c1cc(Nc2ccc(NCCc3c[nH]c4ccccc34)cc2)ccn1,1-[4-[4-[2-(1H-indol-3-yl)ethylamino]anilino]pyridin-2-yl]ethanol,"InChI=1S/C23H24N4O/c1-16(28)23-14-20(11-13-25-23)27-19-8-6-18(7-9-19)24-12-10-17-15-26-22-5-3-2-4-21(17)22/h2-9,11,13-16,24,26,28H,10,12H2,1H3,(H,25,27)/t16-/m0/s1",WZNVHXQTFHGECE-INIZCTEOSA-N,1,1,0,0,MDM2-Like / P53,5.52,cancer,Inhibition,
1183,44389329,179728,23245271,CNC(=O)[C@H](Cc1ccc2ccccc2c1)N1CC(=O)N(Cc2ccc(Br)cc2)[C@@H](CC(C)C)C1=O,"(2S)-2-[(3S)-4-[(4-bromophenyl)methyl]-3-(2-methylpropyl)-2,5-dioxopiperazin-1-yl]-N-methyl-3-naphthalen-2-ylpropanamide","InChI=1S/C29H32BrN3O3/c1-19(2)14-26-29(36)33(18-27(34)32(26)17-20-9-12-24(30)13-10-20)25(28(35)31-3)16-21-8-11-22-6-4-5-7-23(22)15-21/h4-13,15,19,25-26H,14,16-18H2,1-3H3,(H,31,35)/t25-,26-/m0/s1",YLJIYEKAWCYOEB-UIOOFZCWSA-N,1,0,0,0,LFA / ICAM,5.53,immune system disease,Inhibition,
1184,168317880,,,C[C@@H]1CN(CCc2c[nH]c3ccccc23)c2ccc(Nc3ccnc4[C@H](O)CCc34)cc2O1,"4-[[4-[2-(1H-indol-3-yl)ethyl]-2-methyl-2,3-dihydro-1,4-benzoxazin-7-yl]amino]-6,7-dihydro-5H-cyclopenta[b]pyridin-7-ol","InChI=1S/C27H28N4O2/c1-17-16-31(13-11-18-15-29-22-5-3-2-4-20(18)22)24-8-6-19(14-26(24)33-17)30-23-10-12-28-27-21(23)7-9-25(27)32/h2-6,8,10,12,14-15,17,25,29,32H,7,9,11,13,16H2,1H3,(H,28,30)/t17-,25-/m1/s1",FMEUIQVOTSTQBR-CRICUBBOSA-N,1,1,0,0,MDM2-Like / P53,5.52,cancer,Inhibition,
1185,45138704,,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2c1ncccn1)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(1S)-2-[(3aR,6S,6aR)-6-(6-fluoro-1H-indol-3-yl)-4-pyrimidin-2-yl-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-1-cyclohexyl-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C30H38FN7O2/c1-18(32-2)28(39)36-26(19-7-4-3-5-8-19)29(40)37-14-11-25-27(37)23(17-38(25)30-33-12-6-13-34-30)22-16-35-24-15-20(31)9-10-21(22)24/h6,9-10,12-13,15-16,18-19,23,25-27,32,35H,3-5,7-8,11,14,17H2,1-2H3,(H,36,39)/t18-,23+,25+,26-,27+/m0/s1",JEDNTWBYHJWUQC-BTXMXBEGSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
1186,25218667,456216,24689749,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CC[C@H]2CC[C@H](NC(=O)c3ccc4ccccc4c3)[C@@H]12)C(C)(C)C,"N-[(3aR,6S,6aS)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-6-yl]naphthalene-2-carboxamide","InChI=1S/C28H38N4O3/c1-17(29-5)25(33)31-24(28(2,3)4)27(35)32-15-14-19-12-13-22(23(19)32)30-26(34)21-11-10-18-8-6-7-9-20(18)16-21/h6-11,16-17,19,22-24,29H,12-15H2,1-5H3,(H,30,34)(H,31,33)/t17-,19+,22-,23-,24+/m0/s1",JFFMYRPQVOGSQN-YBAXTEPTSA-N,1,0,0,0,XIAP / Smac,5.92,cancer,Inhibition,
1187,59452421,,,OCc1cc(Nc2ccc3N(CCc4c[nH]c5ccccc45)CCCc3c2)ccn1,"[4-[[1-[2-(1H-indol-3-yl)ethyl]-3,4-dihydro-2H-quinolin-6-yl]amino]pyridin-2-yl]methanol","InChI=1S/C25H26N4O/c30-17-22-15-21(9-11-26-22)28-20-7-8-25-18(14-20)4-3-12-29(25)13-10-19-16-27-24-6-2-1-5-23(19)24/h1-2,5-9,11,14-16,27,30H,3-4,10,12-13,17H2,(H,26,28)",WOMWPSFGPKCCQV-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,5.85,cancer,Inhibition,
1188,168317878,,,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(Cl)c(c2)C(=O)NCc2ccc(O)c(O)c2)c1=O,,"InChI=1S/C29H20ClF3N6O4/c1-38-26-19(13-35-38)25-23(24(36-26)15-3-2-4-16(10-15)29(31,32)33)28(43)39(37-25)17-6-7-20(30)18(11-17)27(42)34-12-14-5-8-21(40)22(41)9-14/h2-11,13,37,40-41H,12H2,1H3,(H,34,42)",UDICXVSXQPGTDV-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.66,cancer,Inhibition,
1189,25218665,514911,24714825,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CC[C@H]2CC[C@H](NC(=O)c3ccc(C)c4ccccc34)[C@@H]12)C(C)(C)C,"N-[(3aR,6S,6aS)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-6-yl]-4-methylnaphthalene-1-carboxamide","InChI=1S/C29H40N4O3/c1-17-11-13-22(21-10-8-7-9-20(17)21)27(35)31-23-14-12-19-15-16-33(24(19)23)28(36)25(29(3,4)5)32-26(34)18(2)30-6/h7-11,13,18-19,23-25,30H,12,14-16H2,1-6H3,(H,31,35)(H,32,34)/t18-,19+,23-,24-,25+/m0/s1",ZDFJYYRBUSKIOX-BVPJHWTISA-N,1,0,0,0,XIAP / Smac,6.72,cancer,Inhibition,
1190,46220743,1098071,24678103,CN1C(=O)N(C(=O)[C@]11CN(C[C@H]1c1ccc(cc1)C#N)c1cnc(cn1)C(O)=O)c1cc(Cl)cc(Cl)c1,"5-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl]pyrazine-2-carboxylic acid","InChI=1S/C25H18Cl2N6O4/c1-31-24(37)33(18-7-16(26)6-17(27)8-18)23(36)25(31)13-32(21-11-29-20(10-30-21)22(34)35)12-19(25)15-4-2-14(9-28)3-5-15/h2-8,10-11,19H,12-13H2,1H3,(H,34,35)/t19-,25+/m0/s1",RCBRCDOPLKJOOW-UQBPGWFLSA-N,1,0,0,0,LFA / ICAM,7.72,immune system disease,Inhibition,
1191,58531610,,,Cc1cccc(CN(Cc2ccc(F)cc2)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)c1,"3,5-dichloro-N-[(4-fluorophenyl)methyl]-2-hydroxy-N-[(3-methylphenyl)methyl]benzenesulfonamide","InChI=1S/C21H18Cl2FNO3S/c1-14-3-2-4-16(9-14)13-25(12-15-5-7-18(24)8-6-15)29(27,28)20-11-17(22)10-19(23)21(20)26/h2-11,26H,12-13H2,1H3",DYFGSTMZEIBNOO-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,6.14,cancer,Inhibition,
1192,44574952,467709,24694329,OC[C@@H]1[C@H]2Cn3c(cccc3=O)[C@H]2N(CC2CCCCC2)[C@H]1C(=O)NC1Cc2ccccc2C1,"(2R,3R,3aS,9bS)-1-(cyclohexylmethyl)-N-(2,3-dihydro-1H-inden-2-yl)-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide","InChI=1S/C28H35N3O3/c32-17-23-22-16-30-24(11-6-12-25(30)33)26(22)31(15-18-7-2-1-3-8-18)27(23)28(34)29-21-13-19-9-4-5-10-20(19)14-21/h4-6,9-12,18,21-23,26-27,32H,1-3,7-8,13-17H2,(H,29,34)/t22-,23-,26+,27-/m1/s1",FOLIXAZTZVFYSM-JUIYCPNDSA-N,1,0,0,0,BCL2-Like / BAX,5.27,cancer,Inhibition,
1193,168317863,,,Cn1ncc2c1nc(-c1ccc3sccc3c1)c1c2[nH]n(-c2cccc(F)c2)c1=O,,"InChI=1S/C22H14FN5OS/c1-27-21-16(11-24-27)20-18(22(29)28(26-20)15-4-2-3-14(23)10-15)19(25-21)13-5-6-17-12(9-13)7-8-30-17/h2-11,26H,1H3",DYAXPQONHBRWGO-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,6.98,cancer,Inhibition,
1194,45487364,571244,24633316,C[C@H](Oc1cccc2nc(ccc12)N(C)C)C(=O)N1CCN(C[C@H]1C)C(=O)c1ccccc1,(2S)-1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-[2-(dimethylamino)quinolin-5-yl]oxypropan-1-one,"InChI=1S/C26H30N4O3/c1-18-17-29(26(32)20-9-6-5-7-10-20)15-16-30(18)25(31)19(2)33-23-12-8-11-22-21(23)13-14-24(27-22)28(3)4/h5-14,18-19H,15-17H2,1-4H3/t18-,19+/m1/s1",RTDHPLYJBCQAII-MOPGFXCFSA-N,0,1,0,0,CD4 / gp120,5.49,HIV infectious disease,Inhibition,
1195,46220964,1096088,24677818,CN1C(=O)N(C(=O)[C@]11CN(C[C@H]1c1ccc(cc1)C#N)c1ncc(s1)C(O)=O)c1cc(Cl)cc(Cl)c1,"2-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl]-1,3-thiazole-5-carboxylic acid","InChI=1S/C24H17Cl2N5O4S/c1-29-23(35)31(17-7-15(25)6-16(26)8-17)21(34)24(29)12-30(22-28-10-19(36-22)20(32)33)11-18(24)14-4-2-13(9-27)3-5-14/h2-8,10,18H,11-12H2,1H3,(H,32,33)/t18-,24+/m0/s1",BFZWHXBQAYWTFR-MHECFPHRSA-N,1,0,0,0,LFA / ICAM,8.30,immune system disease,Inhibition,
1196,45487324,571612,24634159,CNC(=O)c1cc(OC)c(O[C@@H](C)C(=O)N2CCN(C[C@H]2C)c2n[nH]c3ccccc23)cn1,5-[(2S)-1-[(2R)-4-(1H-indazol-3-yl)-2-methylpiperazin-1-yl]-1-oxopropan-2-yl]oxy-4-methoxy-N-methylpyridine-2-carboxamide,"InChI=1S/C23H28N6O4/c1-14-13-28(21-16-7-5-6-8-17(16)26-27-21)9-10-29(14)23(31)15(2)33-20-12-25-18(22(30)24-3)11-19(20)32-4/h5-8,11-12,14-15H,9-10,13H2,1-4H3,(H,24,30)(H,26,27)/t14-,15+/m1/s1",GWUMOYRYGZWMSL-CABCVRRESA-N,0,1,0,0,CD4 / gp120,7.38,HIV infectious disease,Inhibition,
1197,44391965,362260,23248049,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1ccnc(c1)N1CCC[C@H]1CO,[1-[4-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyridin-2-yl]pyrrolidin-2-yl]methanol,"InChI=1S/C26H27F3N2OS/c1-17(2)21-7-3-4-8-23(21)33-24-10-9-18(14-22(24)26(27,28)29)19-11-12-30-25(15-19)31-13-5-6-20(31)16-32/h3-4,7-12,14-15,17,20,32H,5-6,13,16H2,1-2H3/t20-/m0/s1",XIHFTDUKDIRRKY-FQEVSTJZSA-N,0,1,0,0,LFA / ICAM,6.58,immune system disease,Inhibition,
1198,44390632,361220,23246655,OC(=O)[C@@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)Nc2ccc(I)cc2C1=O)c1ccc(O)cc1,"2-[3-(4-chlorophenyl)-7-iodo-2,5-dioxo-1,3-dihydro-1,4-benzodiazepin-4-yl]-2-(4-hydroxyphenyl)acetic acid","InChI=1S/C23H16ClIN2O5/c24-14-5-1-12(2-6-14)19-21(29)26-18-10-7-15(25)11-17(18)22(30)27(19)20(23(31)32)13-3-8-16(28)9-4-13/h1-11,19-20,28H,(H,26,29)(H,31,32)/t19-,20-/m0/s1",RIRUIDHYCYOOFR-PMACEKPBSA-N,1,0,0,0,MDM2-Like / P53,4.78,cancer,Inhibition,
1199,46840524,,,COc1ccc(cc1)-c1sc(nc1C(=O)N(C)C)-c1ccc2CCCN(C(=O)Nc3nc4ccccc4s3)c2c1,"2-[1-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-2H-quinolin-7-yl]-5-(4-methoxyphenyl)-N,N-dimethyl-1,3-thiazole-4-carboxamide","InChI=1S/C30H27N5O3S2/c1-34(2)28(36)25-26(19-12-14-21(38-3)15-13-19)40-27(32-25)20-11-10-18-7-6-16-35(23(18)17-20)30(37)33-29-31-22-8-4-5-9-24(22)39-29/h4-5,8-15,17H,6-7,16H2,1-3H3,(H,31,33,37)",BLYXYYLADZOEON-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,6.18,cancer,Inhibition,
1200,44818677,568800,24630842,Cc1ccc2c(NCc3ccc(NC(=O)c4ccc(F)cc4)cc3)nc(nc2c1)N1CCCCC1,4-fluoro-N-[4-[[(7-methyl-2-piperidin-1-ylquinazolin-4-yl)amino]methyl]phenyl]benzamide,"InChI=1S/C28H28FN5O/c1-19-5-14-24-25(17-19)32-28(34-15-3-2-4-16-34)33-26(24)30-18-20-6-12-23(13-7-20)31-27(35)21-8-10-22(29)11-9-21/h5-14,17H,2-4,15-16,18H2,1H3,(H,31,35)(H,30,32,33)",ZAARNDKEWLKRPI-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,6.54,cancer,Inhibition,
1201,44579257,489362,24703413,FC(F)(F)c1c(Sc2cccc(NC3CCOCC3)c2)ccc(\C=C\C(=O)N2CCOCC2)c1C(F)(F)F,"(E)-1-morpholin-4-yl-3-[4-[3-(oxan-4-ylamino)phenyl]sulfanyl-2,3-bis(trifluoromethyl)phenyl]prop-2-en-1-one","InChI=1S/C26H26F6N2O3S/c27-25(28,29)23-17(5-7-22(35)34-10-14-37-15-11-34)4-6-21(24(23)26(30,31)32)38-20-3-1-2-19(16-20)33-18-8-12-36-13-9-18/h1-7,16,18,33H,8-15H2/b7-5+",DMTPQLIVNVZBPV-FNORWQNLSA-N,1,0,0,0,LFA / ICAM,8.27,immune system disease,Inhibition,
1202,168317873,,,CCC[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(C)(C)C)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(CC2=C(CC(C)(C)CC2)c2ccc(Cl)cc2)CC1,,"InChI=1S/C48H63ClN6O4S3/c1-7-11-37(32-60-39-12-9-8-10-13-39)52-43-19-18-40(28-45(43)61(56,57)47(2,3)4)62(58,59)53-46-41-23-27-55(31-44(41)50-33-51-46)38-21-25-54(26-22-38)30-35-20-24-48(5,6)29-42(35)34-14-16-36(49)17-15-34/h8-10,12-19,28,33,37-38,52H,7,11,20-27,29-32H2,1-6H3,(H,50,51,53)/t37-/m1/s1",SUCMWQBKNHGKJQ-DIPNUNPCSA-N,1,0,0,0,BCL2-Like / BAX,6.24,cancer,Inhibition,
1203,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1203
1204,168317872,,,CC[C@@H]1CC[C@H](N1C(=O)C1=C(C(C)C)N2[C@@H](c3ccc(Cl)cc3)[C@@](C)(N=C2S1)c1ccc(Cl)c(F)c1)C(=O)N1CCN([C@H](C)C1)C(C)=O,"1-[(2R)-4-[(2S,5R)-1-[6-(4-chloro-3-fluorophenyl)-5-(4-chlorophenyl)-6-methyl-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazole-2-carbonyl]-5-ethylpyrrolidine-2-carbonyl]-2-methylpiperazin-1-yl]ethanone","InChI=1S/C36H42Cl2FN5O3S/c1-7-26-13-15-29(33(46)41-16-17-42(22(5)45)21(4)19-41)43(26)34(47)31-30(20(2)3)44-32(23-8-11-25(37)12-9-23)36(6,40-35(44)48-31)24-10-14-27(38)28(39)18-24/h8-12,14,18,20-21,26,29,32H,7,13,15-17,19H2,1-6H3/t21-,26-,29+,32+,36+/m1/s1",AOWBCOTZGSZQOL-WLAYAAAPSA-N,1,0,0,0,MDM2-Like / P53,7.08,cancer,Inhibition,
1205,168317870,,19174439,FC(F)(F)c1cc(ccc1Sc1ccccc1N1CCCCC1)[C@@H]1C[C@H]1C(=O)NCCCN1CCCC1=O,N-[3-(2-oxopyrrolidin-1-yl)propyl]-2-[4-(2-piperidin-1-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]cyclopropane-1-carboxamide,"InChI=1S/C29H34F3N3O2S/c30-29(31,32)23-18-20(21-19-22(21)28(37)33-13-7-17-35-16-6-10-27(35)36)11-12-25(23)38-26-9-3-2-8-24(26)34-14-4-1-5-15-34/h2-3,8-9,11-12,18,21-22H,1,4-7,10,13-17,19H2,(H,33,37)/t21-,22+/m0/s1",TUIWCAJBTHNBBI-FCHUYYIVSA-N,0,1,0,0,LFA / ICAM,7.40,immune system disease,Inhibition,
1206,168317868,,,CC(C)C1=C(SC2=N[C@](C)([C@@H](N12)c1ccc(Cl)cc1)c1ccc(Cl)cc1)C(=O)N1CCN(C)[C@@H](C)C1,"[(5R,6S)-5,6-bis(4-chlorophenyl)-6-methyl-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazol-2-yl]-[(3S)-3,4-dimethylpiperazin-1-yl]methanone","InChI=1S/C28H32Cl2N4OS/c1-17(2)23-24(26(35)33-15-14-32(5)18(3)16-33)36-27-31-28(4,20-8-12-22(30)13-9-20)25(34(23)27)19-6-10-21(29)11-7-19/h6-13,17-18,25H,14-16H2,1-5H3/t18-,25-,28-/m0/s1",AOVRFYLRQBVJAD-QJGUAIBQSA-N,1,0,0,0,MDM2-Like / P53,7.89,cancer,Inhibition,
1207,11952782,377203,10127091,C[C@@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)N(CCN2CCOCC2)c2ccc(I)cc2C1=O)c1ccc(Cl)cc1N,"4-[1-(2-amino-4-chlorophenyl)ethyl]-3-(4-chlorophenyl)-7-iodo-1-(2-morpholin-4-ylethyl)-3H-1,4-benzodiazepine-2,5-dione","InChI=1S/C29H29Cl2IN4O3/c1-18(23-8-6-21(31)16-25(23)33)36-27(19-2-4-20(30)5-3-19)29(38)35(11-10-34-12-14-39-15-13-34)26-9-7-22(32)17-24(26)28(36)37/h2-9,16-18,27H,10-15,33H2,1H3/t18-,27+/m1/s1",TXTIZPFXYRRDES-CLYVBNDRSA-N,2,0,0,0,MDM2-Like / P53,6.44,cancer,Inhibition,
1208,168317866,,,OCc1cc(Nc2ccc3N(CCc4c[nH]c5ccccc45)C[C@H](Oc3c2)c2ccoc2)ccn1,"[4-[[2-(furan-3-yl)-4-[2-(1H-indol-3-yl)ethyl]-2,3-dihydro-1,4-benzoxazin-7-yl]amino]pyridin-2-yl]methanol","InChI=1S/C28H26N4O3/c33-17-23-13-22(7-10-29-23)31-21-5-6-26-27(14-21)35-28(20-9-12-34-18-20)16-32(26)11-8-19-15-30-25-4-2-1-3-24(19)25/h1-7,9-10,12-15,18,28,30,33H,8,11,16-17H2,(H,29,31)/t28-/m0/s1",DNVSEHYTCUBPCJ-NDEPHWFRSA-N,1,1,0,0,MDM2-Like / P53,5.52,cancer,Inhibition,
1209,168317867,,26363119,OC(=O)c1ccc(cc1)-c1ccc(OCCc2cc(ccc2Cl)[C@@](O)(CCN2CCOCC2)c2ccc(Br)cc2)cc1,4-[4-[2-[5-[1-(4-bromophenyl)-1-hydroxy-3-morpholin-4-ylpropyl]-2-chlorophenyl]ethoxy]phenyl]benzoic acid,"InChI=1S/C34H33BrClNO5/c35-30-10-7-28(8-11-30)34(40,16-17-37-18-21-41-22-19-37)29-9-14-32(36)27(23-29)15-20-42-31-12-5-25(6-13-31)24-1-3-26(4-2-24)33(38)39/h1-14,23,40H,15-22H2,(H,38,39)/t34-/m1/s1",BLSOYCQPNQMTPH-UUWRZZSWSA-N,1,0,0,0,BCL2-Like / BAX,6.70,cancer,Inhibition,
1210,25154383,,,Cc1cc(Nc2ccnc3[C@@H](O)CCc23)ccc1NCCc1c[nH]c2c(C)cccc12,"(7S)-4-[3-methyl-4-[2-(7-methyl-1H-indol-3-yl)ethylamino]anilino]-6,7-dihydro-5H-cyclopenta[b]pyridin-7-ol","InChI=1S/C26H28N4O/c1-16-4-3-5-20-18(15-29-25(16)20)10-12-27-22-8-6-19(14-17(22)2)30-23-11-13-28-26-21(23)7-9-24(26)31/h3-6,8,11,13-15,24,27,29,31H,7,9-10,12H2,1-2H3,(H,28,30)/t24-/m0/s1",HMVYHLBCUQWADH-DEOSSOPVSA-N,1,0,0,0,MDM2-Like / P53,8.00,cancer,Inhibition,
1211,44570033,466801,24693013,CN(C(=O)c1cc(C)n(n1)-c1ccccc1C(=O)N1CCc2ccccc2C1)c1ccccc1,"1-[2-(3,4-dihydro-1H-isoquinoline-2-carbonyl)phenyl]-N,5-dimethyl-N-phenylpyrazole-3-carboxamide","InChI=1S/C28H26N4O2/c1-20-18-25(28(34)30(2)23-12-4-3-5-13-23)29-32(20)26-15-9-8-14-24(26)27(33)31-17-16-21-10-6-7-11-22(21)19-31/h3-15,18H,16-17,19H2,1-2H3",NOGQTOFLBRZTMI-UHFFFAOYSA-N,1,0,0,0,BCL2-Like / BAX,5.60,cancer,Inhibition,
1212,16109095,221750,17266509,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(Cc2ccccc2-c2cccnc2)CC1,N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonyl-4-[4-[(2-pyridin-3-ylphenyl)methyl]piperazin-1-yl]benzamide,"InChI=1S/C41H45N7O5S2/c1-45(2)22-20-34(30-54-36-11-4-3-5-12-36)43-39-19-18-37(27-40(39)48(50)51)55(52,53)44-41(49)31-14-16-35(17-15-31)47-25-23-46(24-26-47)29-33-9-6-7-13-38(33)32-10-8-21-42-28-32/h3-19,21,27-28,34,43H,20,22-26,29-30H2,1-2H3,(H,44,49)/t34-/m1/s1",KPJCNJSKWMADIG-UUWRZZSWSA-N,2,0,0,0,BCL2-Like / BAX,9.30,cancer,Inhibition,
1213,168317826,,,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2cccc(c2)C(=O)N2CCc3ccccc3C2)c1=O,,"InChI=1S/C31H23F3N6O2/c1-38-28-24(16-35-38)27-25(26(36-28)19-8-4-10-22(14-19)31(32,33)34)30(42)40(37-27)23-11-5-9-20(15-23)29(41)39-13-12-18-6-2-3-7-21(18)17-39/h2-11,14-16,37H,12-13,17H2,1H3",NZNTXWDUNAYTSK-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,6.52,cancer,Inhibition,
1214,506289,570485,442120,C[C@H]1CN(CCN1C(=O)C(=O)c1c[nH]c2cccc(F)c12)C(=O)c1ccccc1,"1-(4-benzoyl-2-methylpiperazin-1-yl)-2-(4-fluoro-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C22H20FN3O3/c1-14-13-25(21(28)15-6-3-2-4-7-15)10-11-26(14)22(29)20(27)16-12-24-18-9-5-8-17(23)19(16)18/h2-9,12,14,24H,10-11,13H2,1H3/t14-/m0/s1",GJIOAZQCBADHSB-AWEZNQCLSA-N,0,1,0,0,CD4 / gp120,8.86,HIV infectious disease,Inhibition,
1215,46224086,1096040,24673182,CN1C(=O)N(C(=O)[C@]11CN(C[C@H]1c1ccc(cc1)C#N)c1ccc(cc1)C#N)c1cc(Cl)cc(Cl)c1,"4-[(5S,9R)-7-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-9-yl]benzonitrile","InChI=1S/C27H19Cl2N5O2/c1-32-26(36)34(23-11-20(28)10-21(29)12-23)25(35)27(32)16-33(22-8-4-18(14-31)5-9-22)15-24(27)19-6-2-17(13-30)3-7-19/h2-12,24H,15-16H2,1H3/t24-,27+/m0/s1",PJQSUTYJMHQWEE-RPLLCQBOSA-N,1,0,0,0,LFA / ICAM,7.22,immune system disease,Inhibition,
1216,12096165,,,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(cc2)C(=O)NCc2ccccc2)c1=O,,"InChI=1S/C29H21F3N6O2/c1-37-26-22(16-34-37)25-23(24(35-26)19-8-5-9-20(14-19)29(30,31)32)28(40)38(36-25)21-12-10-18(11-13-21)27(39)33-15-17-6-3-2-4-7-17/h2-14,16,36H,15H2,1H3,(H,33,39)",BIZLOZVLTWAKGE-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.10,cancer,Inhibition,
1217,168317824,,,CO[C@@H](C)c1cc(Nc2ccc(NCCc3c[nH]c4ccccc34)cc2)ccn1,"1-N-[2-(1H-indol-3-yl)ethyl]-4-N-[2-(1-methoxyethyl)pyridin-4-yl]benzene-1,4-diamine","InChI=1S/C24H26N4O/c1-17(29-2)24-15-21(12-14-26-24)28-20-9-7-19(8-10-20)25-13-11-18-16-27-23-6-4-3-5-22(18)23/h3-10,12,14-17,25,27H,11,13H2,1-2H3,(H,26,28)/t17-/m0/s1",RWSDBJAREAFEEZ-KRWDZBQOSA-N,1,1,0,0,MDM2-Like / P53,6.00,cancer,Inhibition,
1218,168317823,,24635266,C[C@@H](Oc1ccnc2ccccc12)C(=O)N1CCN(C[C@H]1C)C(=O)c1ccccc1,1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-quinolin-4-yloxypropan-1-one,"InChI=1S/C24H25N3O3/c1-17-16-26(24(29)19-8-4-3-5-9-19)14-15-27(17)23(28)18(2)30-22-12-13-25-21-11-7-6-10-20(21)22/h3-13,17-18H,14-16H2,1-2H3/t17-,18-/m1/s1",WWBXELLGFZCCSS-QZTJIDSGSA-N,0,1,0,0,CD4 / gp120,5.13,HIV infectious disease,Inhibition,
1219,67031917,,,CNC(=O)c1nc(-c2ccccc2)n(c1-c1cccc(Cl)c1)-c1ccc(F)c(Cl)c1,,"InChI=1S/C23H16Cl2FN3O/c1-27-23(30)20-21(15-8-5-9-16(24)12-15)29(17-10-11-19(26)18(25)13-17)22(28-20)14-6-3-2-4-7-14/h2-13H,1H3,(H,27,30)",IQHHILFTQICPRQ-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,5.52,cancer,Inhibition,
1220,44550014,,,CN1c2ncnn2[C@H](C2=C1c1cccc(Cl)c1O[C@@H]2c1ccc(Br)cc1)c1ccc(Br)cc1,,"InChI=1S/C25H17Br2ClN4O/c1-31-22-18-3-2-4-19(28)24(18)33-23(15-7-11-17(27)12-8-15)20(22)21(32-25(31)29-13-30-32)14-5-9-16(26)10-6-14/h2-13,21,23H,1H3/t21-,23+/m0/s1",LPHKLDXZZUEJBX-JTHBVZDNSA-N,1,0,0,0,MDM2-Like / P53,5.46,cancer,Inhibition,
1221,168317822,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1nc(nc2CN(CCc12)[C@H]1CCN(Cc2ccccc2-c2ccc(Cl)cc2)C[C@@H]1F)C(F)(F)F,,"InChI=1S/C45H47ClF7N7O4S3/c1-58(2)21-18-32(28-65-33-9-4-3-5-10-33)54-38-17-16-34(24-41(38)66(61,62)45(51,52)53)67(63,64)57-42-36-19-23-60(27-39(36)55-43(56-42)44(48,49)50)40-20-22-59(26-37(40)47)25-30-8-6-7-11-35(30)29-12-14-31(46)15-13-29/h3-17,24,32,37,40,54H,18-23,25-28H2,1-2H3,(H,55,56,57)/t32-,37+,40+/m1/s1",XYITYONGQARSQX-JOJMXTOGSA-N,1,0,0,0,BCL2-Like / BAX,7.33,cancer,Inhibition,
1222,67032070,,,CNC(=O)Cc1ccc(Cl)cc1-n1c(nc(-c2nnc(N)o2)c1-c1ccc(F)c(Cl)c1)C1CCCCC1,,"InChI=1S/C26H25Cl2FN6O2/c1-31-21(36)12-15-7-9-17(27)13-20(15)35-23(16-8-10-19(29)18(28)11-16)22(25-33-34-26(30)37-25)32-24(35)14-5-3-2-4-6-14/h7-11,13-14H,2-6,12H2,1H3,(H2,30,34)(H,31,36)",BPVCCKVYGYMZKE-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,8.52,cancer,Inhibition,
1223,44608666,,,CC(C)C1=C(SC2=N[C@](C)([C@H](N12)c1ccc(Cl)cc1)c1ccc(Cl)cc1)C(=O)N1C[C@@H](O)C[C@H]1C(=O)N(C)C,"(2S,4S)-1-[(5R,6S)-5,6-bis(4-chlorophenyl)-6-methyl-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazole-2-carbonyl]-4-hydroxy-N,N-dimethylpyrrolidine-2-carboxamide","InChI=1S/C29H32Cl2N4O3S/c1-16(2)23-24(27(38)34-15-21(36)14-22(34)26(37)33(4)5)39-28-32-29(3,18-8-12-20(31)13-9-18)25(35(23)28)17-6-10-19(30)11-7-17/h6-13,16,21-22,25,36H,14-15H2,1-5H3/t21-,22-,25+,29-/m0/s1",BPPGEPCJZCJAAG-PJZGNELNSA-N,1,0,0,0,MDM2-Like / P53,7.74,cancer,Inhibition,
1224,16109078,376254,17266493,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCC(CC1)=Cc1ccccc1C(F)(F)F,N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonyl-4-[4-[[2-(trifluoromethyl)phenyl]methylidene]piperidin-1-yl]benzamide,"InChI=1S/C38H40F3N5O5S2/c1-44(2)21-20-30(26-52-32-9-4-3-5-10-32)42-35-17-16-33(25-36(35)46(48)49)53(50,51)43-37(47)28-12-14-31(15-13-28)45-22-18-27(19-23-45)24-29-8-6-7-11-34(29)38(39,40)41/h3-17,24-25,30,42H,18-23,26H2,1-2H3,(H,43,47)/t30-/m1/s1",RSGYTDGOUIXVMA-SSEXGKCCSA-N,2,0,0,0,BCL2-Like / BAX,9.30,cancer,Inhibition,
1225,168315588,,,COC1(CCN(CC1)c1ccc(cc1)C(=O)NS(=O)(=O)c1ccc(N[C@H](CCN(C)C)CSc2ccccc2)c(c1)N(=O)=O)c1ccccc1Br,,"InChI=1S/C37H42BrN5O6S2/c1-41(2)22-19-28(26-50-30-9-5-4-6-10-30)39-34-18-17-31(25-35(34)43(45)46)51(47,48)40-36(44)27-13-15-29(16-14-27)42-23-20-37(49-3,21-24-42)32-11-7-8-12-33(32)38/h4-18,25,28,39H,19-24,26H2,1-3H3,(H,40,44)/t28-/m1/s1",JKRSSBLDOGFGMP-MUUNZHRXSA-N,2,0,0,0,BCL2-Like / BAX,9.30,cancer,Inhibition,
1226,50996418,,,Clc1cccc(c1)-c1c(nc(-c2ccccc2)n1-c1cccc(Cl)c1)C(=O)NCCN1CCOCC1,"1,5-bis(3-chlorophenyl)-N-(2-morpholin-4-ylethyl)-2-phenylimidazole-4-carboxamide","InChI=1S/C28H26Cl2N4O2/c29-22-9-4-8-21(18-22)26-25(28(35)31-12-13-33-14-16-36-17-15-33)32-27(20-6-2-1-3-7-20)34(26)24-11-5-10-23(30)19-24/h1-11,18-19H,12-17H2,(H,31,35)",HZKJGUYPPGGGEC-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,5.49,cancer,Inhibition,
1227,45487340,577958,24639321,CNc1ccc2c(O[C@@H](C)C(=O)N3CCN(C[C@H]3C)C(=O)c3ccccc3)cccc2n1,(2S)-1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-[2-(methylamino)quinolin-5-yl]oxypropan-1-one,"InChI=1S/C25H28N4O3/c1-17-16-28(25(31)19-8-5-4-6-9-19)14-15-29(17)24(30)18(2)32-22-11-7-10-21-20(22)12-13-23(26-3)27-21/h4-13,17-18H,14-16H2,1-3H3,(H,26,27)/t17-,18+/m1/s1",PZGGIQGQXRBYTL-MSOLQXFVSA-N,0,1,0,0,CD4 / gp120,8.30,HIV infectious disease,Inhibition,
1228,46175912,,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1cc2ccnc(-c3ccccc3)c2[nH]1,"(2S)-N-[(1S)-1-cyclohexyl-2-oxo-2-[(2S)-2-(7-phenyl-1H-pyrrolo[2,3-c]pyridin-2-yl)pyrrolidin-1-yl]ethyl]-2-(methylamino)propanamide","InChI=1S/C29H37N5O2/c1-19(30-2)28(35)33-27(21-12-7-4-8-13-21)29(36)34-17-9-14-24(34)23-18-22-15-16-31-25(26(22)32-23)20-10-5-3-6-11-20/h3,5-6,10-11,15-16,18-19,21,24,27,30,32H,4,7-9,12-14,17H2,1-2H3,(H,33,35)/t19-,24-,27-/m0/s1",SGENREDBXSYLCE-SZJUTTIESA-N,1,0,0,0,XIAP / Smac,7.20,cancer,Inhibition,
1229,44305339,63794,23156240,Cc1ccccc1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O,3-(1H-indol-3-yl)-2-[(2-methylbenzoyl)amino]propanoic acid,"InChI=1S/C19H18N2O3/c1-12-6-2-3-7-14(12)18(22)21-17(19(23)24)10-13-11-20-16-9-5-4-8-15(13)16/h2-9,11,17,20H,10H2,1H3,(H,21,22)(H,23,24)/t17-/m0/s1",XBZGZOGGQFCNHY-KRWDZBQOSA-N,1,0,0,0,LFA / ICAM,5.40,immune system disease,Inhibition,
1230,11250180,359955,9425213,OC(=O)[C@H](N1[C@H](c2ccc(Cl)cc2)C(=O)Nc2ccc(I)cc2C1=O)c1ccc(Cl)cc1,"(2R)-2-(4-chlorophenyl)-2-[(3R)-3-(4-chlorophenyl)-7-iodo-2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-4-yl]acetic acid","InChI=1S/C23H15Cl2IN2O4/c24-14-5-1-12(2-6-14)19-21(29)27-18-10-9-16(26)11-17(18)22(30)28(19)20(23(31)32)13-3-7-15(25)8-4-13/h1-11,19-20H,(H,27,29)(H,31,32)/t19-,20-/m1/s1",HQEQUYKKMMKSSX-WOJBJXKFSA-N,3,0,0,0,MDM2-Like / P53,5.32,cancer,Inhibition,
1231,44432172,232746,23294393,CCC1=C(C(=O)N2CCC[C@@]12Cc1ccc(Br)cc1)c1cc(Cl)cc(Cl)c1,"8-[(4-bromophenyl)methyl]-2-(3,5-dichlorophenyl)-1-ethyl-6,7-dihydro-5H-pyrrolizin-3-one","InChI=1S/C22H20BrCl2NO/c1-2-19-20(15-10-17(24)12-18(25)11-15)21(27)26-9-3-8-22(19,26)13-14-4-6-16(23)7-5-14/h4-7,10-12H,2-3,8-9,13H2,1H3/t22-/m1/s1",LUFQQKMSDLQXPL-JOCHJYFZSA-N,0,1,0,0,LFA / ICAM,6.97,immune system disease,Inhibition,
1232,67032179,,,NC(=O)Cc1ccc(Cl)c(F)c1-n1c(nc(C(N)=O)c1-c1ccc(F)c(Cl)c1)C1CCCCC1,,"InChI=1S/C24H22Cl2F2N4O2/c25-15-8-6-14(11-18(29)33)21(19(15)28)32-22(13-7-9-17(27)16(26)10-13)20(23(30)34)31-24(32)12-4-2-1-3-5-12/h6-10,12H,1-5,11H2,(H2,29,33)(H2,30,34)",LWRWRAQJASZHNS-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,8.15,cancer,Inhibition,
1233,168317820,,,CC(C)c1cc([nH]n1)C(=O)NC[C@H](NC(=O)c1c(Cl)cc2CN(CCc2c1Cl)C(=O)c1ccc(Cl)cc1)C(O)=O,,"InChI=1S/C27H26Cl3N5O5/c1-13(2)19-10-20(34-33-19)24(36)31-11-21(27(39)40)32-25(37)22-18(29)9-15-12-35(8-7-17(15)23(22)30)26(38)14-3-5-16(28)6-4-14/h3-6,9-10,13,21H,7-8,11-12H2,1-2H3,(H,31,36)(H,32,37)(H,33,34)(H,39,40)/t21-/m0/s1",XHKRSCFWMSIKHG-NRFANRHFSA-N,1,0,0,0,LFA / ICAM,6.60,immune system disease,Inhibition,
1234,135445259,105780,23191751,CC(C)C[C@@H](NC(N)=N)C(=O)NCC(=O)N1CCC(CC1)c1cc(nn1C)-c1ccc(O)c(Cl)c1Cl,"(2R)-2-(diaminomethylideneamino)-N-[2-[4-[(5E)-5-(2,3-dichloro-4-oxocyclohexa-2,5-dien-1-ylidene)-2-methyl-1H-pyrazol-3-yl]piperidin-1-yl]-2-oxoethyl]-4-methylpentanamide","InChI=1S/C24H33Cl2N7O3/c1-13(2)10-17(30-24(27)28)23(36)29-12-20(35)33-8-6-14(7-9-33)18-11-16(31-32(18)3)15-4-5-19(34)22(26)21(15)25/h4-5,11,13-14,17,34H,6-10,12H2,1-3H3,(H,29,36)(H4,27,28,30)/t17-/m1/s1",JBUWVUTXZMCPRZ-QGZVFWFLSA-N,1,0,0,0,IL2 / IL2R,5.09,immune system disease,Inhibition,
1235,50996240,,,Cc1ccc(cc1C)-c1nc(-c2nn[nH]n2)c(-c2cccc(Cl)c2)n1-c1cc(Cl)ccc1C,"5-[1-(5-chloro-2-methylphenyl)-5-(3-chlorophenyl)-2-(3,4-dimethylphenyl)imidazol-4-yl]-2H-tetrazole","InChI=1S/C25H20Cl2N6/c1-14-7-9-18(11-16(14)3)25-28-22(24-29-31-32-30-24)23(17-5-4-6-19(26)12-17)33(25)21-13-20(27)10-8-15(21)2/h4-13H,1-3H3,(H,29,30,31,32)",YMXDNHQKJGJSQW-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,6.46,cancer,Inhibition,
1236,11103340,107320,9278481,CC(C)C[C@@H](NC(N)=N)C(=O)NCC(=O)N1CCC(CC1)c1cc(nn1C)-c1cccc(Cl)c1Cl,"(2R)-2-(diaminomethylideneamino)-N-[2-[4-[5-(2,3-dichlorophenyl)-2-methylpyrazol-3-yl]piperidin-1-yl]-2-oxoethyl]-4-methylpentanamide","InChI=1S/C24H33Cl2N7O2/c1-14(2)11-19(30-24(27)28)23(35)29-13-21(34)33-9-7-15(8-10-33)20-12-18(31-32(20)3)16-5-4-6-17(25)22(16)26/h4-6,12,14-15,19H,7-11,13H2,1-3H3,(H,29,35)(H4,27,28,30)/t19-/m1/s1",DHPJTUMPCJVGTJ-LJQANCHMSA-N,2,0,0,0,IL2 / IL2R,5.70,immune system disease,Inhibition,
1237,16090305,217223,17248918,Oc1c(O)c(Cc2ccccc2)cc(C(=O)Nc2ccc(cc2)S(=O)(=O)c2ccccc2)c1O,"N-[4-(benzenesulfonyl)phenyl]-5-benzyl-2,3,4-trihydroxybenzamide","InChI=1S/C26H21NO6S/c28-23-18(15-17-7-3-1-4-8-17)16-22(24(29)25(23)30)26(31)27-19-11-13-21(14-12-19)34(32,33)20-9-5-2-6-10-20/h1-14,16,28-30H,15H2,(H,27,31)",CGSIJNKVBVZVLU-UHFFFAOYSA-N,1,0,0,0,BCL2-Like / BAX,6.03,cancer,Inhibition,
1238,44390731,181148,23246754,OC(=O)[C@@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)Nc2ccc(I)cc2C1=O)c1ccc(Br)cc1,"2-(4-bromophenyl)-2-[3-(4-chlorophenyl)-7-iodo-2,5-dioxo-1,3-dihydro-1,4-benzodiazepin-4-yl]acetic acid","InChI=1S/C23H15BrClIN2O4/c24-14-5-1-13(2-6-14)20(23(31)32)28-19(12-3-7-15(25)8-4-12)21(29)27-18-10-9-16(26)11-17(18)22(28)30/h1-11,19-20H,(H,27,29)(H,31,32)/t19-,20-/m0/s1",KSVJAWNTFXKRKY-PMACEKPBSA-N,1,0,0,0,MDM2-Like / P53,6.21,cancer,Inhibition,
1239,11952566,,10126875,C[C@@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)N(CC(=O)N2CCNCC2)c2ccc(I)cc2C1=O)c1ccc(Cl)cc1N,"(3S)-4-[(1R)-1-(2-amino-4-chlorophenyl)ethyl]-3-(4-chlorophenyl)-7-iodo-1-(2-oxo-2-piperazin-1-ylethyl)-3H-1,4-benzodiazepine-2,5-dione","InChI=1S/C29H28Cl2IN5O3/c1-17(22-8-6-20(31)14-24(22)33)37-27(18-2-4-19(30)5-3-18)29(40)36(16-26(38)35-12-10-34-11-13-35)25-9-7-21(32)15-23(25)28(37)39/h2-9,14-15,17,27,34H,10-13,16,33H2,1H3/t17-,27+/m1/s1",NUGGDLILWIMASB-CRYYWNKWSA-N,1,0,0,0,MDM2-Like / P53,5.81,cancer,Inhibition,
1240,46884410,1091762,24670159,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(cs1)-c1cccc2ccccc12)C(C)(C)C,"(2S)-N-[(2S)-3,3-dimethyl-1-[(2S)-2-(4-naphthalen-1-yl-1,3-thiazol-2-yl)pyrrolidin-1-yl]-1-oxobutan-2-yl]-2-(methylamino)propanamide","InChI=1S/C27H34N4O2S/c1-17(28-5)24(32)30-23(27(2,3)4)26(33)31-15-9-14-22(31)25-29-21(16-34-25)20-13-8-11-18-10-6-7-12-19(18)20/h6-8,10-13,16-17,22-23,28H,9,14-15H2,1-5H3,(H,30,32)/t17-,22-,23+/m0/s1",GYYAJGUBSPVKPD-PDIWNELESA-N,1,0,0,0,XIAP / Smac,7.17,cancer,Inhibition,
1241,168317813,,,COC1(CCN(CC1)c1ccc(cc1)C(=O)NS(=O)(=O)c1ccc(N[C@H](CCN(C)C)CSc2ccccc2)c(c1)N(=O)=O)c1ccc(Cl)cc1,,"InChI=1S/C37H42ClN5O6S2/c1-41(2)22-19-30(26-50-32-7-5-4-6-8-32)39-34-18-17-33(25-35(34)43(45)46)51(47,48)40-36(44)27-9-15-31(16-10-27)42-23-20-37(49-3,21-24-42)28-11-13-29(38)14-12-28/h4-18,25,30,39H,19-24,26H2,1-3H3,(H,40,44)/t30-/m1/s1",SXHSAODSIDBGOK-SSEXGKCCSA-N,2,0,0,0,BCL2-Like / BAX,9.05,cancer,Inhibition,
1242,67954163,,,Cc1cccc(n1)-c1nc(C(O)=O)c(-c2cccc(Cl)c2)n1-c1cc(Cl)ccc1C,,"InChI=1S/C23H17Cl2N3O2/c1-13-9-10-17(25)12-19(13)28-21(15-6-4-7-16(24)11-15)20(23(29)30)27-22(28)18-8-3-5-14(2)26-18/h3-12H,1-2H3,(H,29,30)",IUJRZHJGDURMMO-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,6.92,cancer,Inhibition,
1243,66616502,,,CC(C)CN(Cc1cccc(CN(Cc2ccc(cc2)-c2ccc(F)cc2)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)c1)C(=O)c1ccc2[nH]c(=O)c(=O)[nH]c2c1,,"InChI=1S/C40H35Cl2FN4O6S/c1-24(2)20-46(40(51)30-12-15-34-35(17-30)45-39(50)38(49)44-34)21-26-4-3-5-27(16-26)23-47(54(52,53)36-19-31(41)18-33(42)37(36)48)22-25-6-8-28(9-7-25)29-10-13-32(43)14-11-29/h3-19,24,48H,20-23H2,1-2H3,(H,44,49)(H,45,50)",ZDGCUWGHRIHVNS-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,6.74,cancer,Inhibition,
1244,21060010,207202,19859826,COCCOCCN1c2ccc(I)cc2C(=O)N([C@H](C)c2ccc(Cl)cc2)[C@@H](c2ccc(Cl)cc2)C1=O,"(3S)-3-(4-chlorophenyl)-4-[(1R)-1-(4-chlorophenyl)ethyl]-7-iodo-1-[2-(2-methoxyethoxy)ethyl]-3H-1,4-benzodiazepine-2,5-dione","InChI=1S/C28H27Cl2IN2O4/c1-18(19-3-7-21(29)8-4-19)33-26(20-5-9-22(30)10-6-20)28(35)32(13-14-37-16-15-36-2)25-12-11-23(31)17-24(25)27(33)34/h3-12,17-18,26H,13-16H2,1-2H3/t18-,26+/m1/s1",MDTAPSOLFJDBQB-DWXRJYCRSA-N,1,0,0,0,MDM2-Like / P53,5.62,cancer,Inhibition,
1245,168317817,,,CN1CCC(CCNC(=O)[C@@H]2N[C@H](CC(C)(C)C)[C@]3([C@H]2c2cccc(Cl)c2F)C(=O)Nc2cc(Cl)ccc32)CC1,"(2'R,3S,3'S,5'R)-6-chloro-3'-(3-chloro-2-fluorophenyl)-5'-(2,2-dimethylpropyl)-N-[2-(1-methylpiperidin-4-yl)ethyl]-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide","InChI=1S/C31H39Cl2FN4O2/c1-30(2,3)17-24-31(21-9-8-19(32)16-23(21)36-29(31)40)25(20-6-5-7-22(33)26(20)34)27(37-24)28(39)35-13-10-18-11-14-38(4)15-12-18/h5-9,16,18,24-25,27,37H,10-15,17H2,1-4H3,(H,35,39)(H,36,40)/t24-,25+,27-,31-/m1/s1",COBIADBVPGXSFP-RQJGXFNESA-N,2,2,0,0,MDM2-Like / P53,8.70,cancer,Inhibition,
1246,168317816,,8161098,C[C@H](O)c1cccc(NC(=O)c2ccc(cc2)-n2[nH]c3c4cnn(C)c4nc(-c4cccc(c4)C(F)(F)F)c3c2=O)c1,"N-[3-(1-hydroxyethyl)phenyl]-4-[6-methyl-3-oxo-4-[3-(trifluoromethyl)phenyl]-1H-dipyrazolo[4,3-b:4',5'-e]pyridin-2-yl]benzamide","InChI=1S/C30H23F3N6O3/c1-16(40)18-5-4-8-21(14-18)35-28(41)17-9-11-22(12-10-17)39-29(42)24-25(19-6-3-7-20(13-19)30(31,32)33)36-27-23(26(24)37-39)15-34-38(27)2/h3-16,37,40H,1-2H3,(H,35,41)/t16-/m0/s1",IYUSHWMAMOANFQ-INIZCTEOSA-N,1,0,0,0,CD80 / CD28,8.52,cancer,Inhibition,
1247,3130954,,10891949,Nc1nc(SCC(=O)c2ccc(O)c(O)c2)c(C#N)c(-c2ccc(O)cc2)c1C#N,"2-amino-6-[2-(3,4-dihydroxyphenyl)-2-oxoethyl]sulfanyl-4-(4-oxocyclohexa-2,5-dien-1-ylidene)-1H-pyridine-3,5-dicarbonitrile","InChI=1S/C21H14N4O4S/c22-8-14-19(11-1-4-13(26)5-2-11)15(9-23)21(25-20(14)24)30-10-18(29)12-3-6-16(27)17(28)7-12/h1-7,26-28H,10H2,(H2,24,25)",YBZQMVDFRWVFTH-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,6.96,cancer,Inhibition,
1248,168317814,,,C[C@H](N)C(=O)N[C@H](Cc1cccc(c1)C#N)C(=O)N1C[C@H](C[C@H]1C(=O)N[C@@H]1CCc2ccccc12)c1ccccc1,"(2S,4R)-1-[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-3-(3-cyanophenyl)propanoyl]-N-[(1R)-2,3-dihydro-1H-inden-1-yl]-4-phenylpyrrolidine-2-carboxamide","InChI=1S/C33H35N5O3/c1-21(35)31(39)37-29(17-22-8-7-9-23(16-22)19-34)33(41)38-20-26(24-10-3-2-4-11-24)18-30(38)32(40)36-28-15-14-25-12-5-6-13-27(25)28/h2-13,16,21,26,28-30H,14-15,17-18,20,35H2,1H3,(H,36,40)(H,37,39)/t21-,26-,28+,29+,30-/m0/s1",BEBNOVGRQNMVKD-VTXYRMPVSA-N,1,0,0,0,XIAP / Smac,8.00,cancer,Inhibition,
1249,11609586,2137530,9784341,C(Cc1c[nH]c2ccccc12)Nc1ccc(Nc2ccncc2)cc1,"1-N-[2-(1H-indol-3-yl)ethyl]-4-N-pyridin-4-ylbenzene-1,4-diamine","InChI=1S/C21H20N4/c1-2-4-21-20(3-1)16(15-24-21)9-14-23-17-5-7-18(8-6-17)25-19-10-12-22-13-11-19/h1-8,10-13,15,23-24H,9,14H2,(H,22,25)",CEGSUKYESLWKJP-UHFFFAOYSA-N,2,1,0,0,MDM2-Like / P53,7.00,cancer,Inhibition,
1250,236191,4787881,206135,Nc1ccccc1CC(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,"2-[2,2-bis(1H-indol-3-yl)ethyl]aniline","InChI=1S/C24H21N3/c25-22-10-4-1-7-16(22)13-19(20-14-26-23-11-5-2-8-17(20)23)21-15-27-24-12-6-3-9-18(21)24/h1-12,14-15,19,26-27H,13,25H2",GDGIXKWOJJMLNP-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,5.00,cancer,Inhibition,
1251,15991584,393164,13122517,C[C@H](N)c1nc(co1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O,"(2S)-2-[[(2S)-1-[2-[(1S)-1-aminoethyl]-1,3-oxazole-4-carbonyl]pyrrolidine-2-carbonyl]amino]-3-(1H-indol-3-yl)propanoic acid","InChI=1S/C22H25N5O5/c1-12(23)20-26-17(11-32-20)21(29)27-8-4-7-18(27)19(28)25-16(22(30)31)9-13-10-24-15-6-3-2-5-14(13)15/h2-3,5-6,10-12,16,18,24H,4,7-9,23H2,1H3,(H,25,28)(H,30,31)/t12-,16-,18-/m0/s1",FBRCDLGEWAXPMI-IWEFOYFVSA-N,1,0,0,0,XIAP / Smac,4.52,cancer,Inhibition,
1252,1045911,,897466,FC(F)(Cl)c1cc(nc2cc(nn12)C(=O)Nc1sc2CCCCCc2c1C#N)-c1ccco1,"7-[chloro(difluoro)methyl]-N-(3-cyano-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophen-2-yl)-5-(furan-2-yl)pyrazolo[1,5-a]pyrimidine-2-carboxamide","InChI=1S/C22H16ClF2N5O2S/c23-22(24,25)18-9-14(16-6-4-8-32-16)27-19-10-15(29-30(18)19)20(31)28-21-13(11-26)12-5-2-1-3-7-17(12)33-21/h4,6,8-10H,1-3,5,7H2,(H,28,31)",BAMXBFLPNULUET-UHFFFAOYSA-N,1,0,0,0,Myc / Max,4.55,cancer,Inhibition,
1253,3503,51483,3383,CC(C)c1c(O)c(O)c(C=O)c2c(O)c(c(C)cc12)-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O,"7-(8-formyl-1,6,7-trihydroxy-3-methyl-5-propan-2-ylnaphthalen-2-yl)-2,3,8-trihydroxy-6-methyl-4-propan-2-ylnaphthalene-1-carbaldehyde","InChI=1S/C30H30O8/c1-11(2)19-15-7-13(5)21(27(35)23(15)17(9-31)25(33)29(19)37)22-14(6)8-16-20(12(3)4)30(38)26(34)18(10-32)24(16)28(22)36/h7-12,33-38H,1-6H3",QBKSWRVVCFFDOT-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,6.77,cancer,Inhibition,
1254,46220747,1094116,24678654,CN1C(=O)N(C(=O)[C@]11CN(C[C@H]1c1ccc(cc1)C#N)c1ccnc(c1)C(O)=O)c1cc(Cl)cc(Cl)c1,"4-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl]pyridine-2-carboxylic acid","InChI=1S/C26H19Cl2N5O4/c1-31-25(37)33(20-9-17(27)8-18(28)10-20)24(36)26(31)14-32(19-6-7-30-22(11-19)23(34)35)13-21(26)16-4-2-15(12-29)3-5-16/h2-11,21H,13-14H2,1H3,(H,34,35)/t21-,26+/m0/s1",LWDQQCGEJJMUKY-HFZDXXHNSA-N,1,0,0,0,LFA / ICAM,7.25,immune system disease,Inhibition,
1255,44237062,582975,24642012,CC[C@H](N)C(=O)N[C@H]1[C@@H](CNC(=S)NCc2ccccc2)CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7R,9aS)-6-[[(2R)-2-aminobutanoyl]amino]-N-benzhydryl-7-[(benzylcarbamothioylamino)methyl]-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C36H44N6O3S/c1-2-29(37)33(43)41-32-27(23-39-36(46)38-22-24-12-6-3-7-13-24)18-19-28-20-21-30(42(28)35(32)45)34(44)40-31(25-14-8-4-9-15-25)26-16-10-5-11-17-26/h3-17,27-32H,2,18-23,37H2,1H3,(H,40,44)(H,41,43)(H2,38,39,46)/t27-,28+,29+,30+,32+/m1/s1",BAMKYWPNUMTYIE-HVSNEVFASA-N,2,0,0,0,XIAP / Smac,6.48,cancer,Inhibition,
1256,168317811,,,CC(C)n1cc(nn1)C(=O)NC[C@H](NC(=O)c1c(Cl)cc2CN(CCc2c1Cl)C(=O)c1ccc(Cl)cc1)C(O)=O,,"InChI=1S/C26H25Cl3N6O5/c1-13(2)35-12-20(32-33-35)23(36)30-10-19(26(39)40)31-24(37)21-18(28)9-15-11-34(8-7-17(15)22(21)29)25(38)14-3-5-16(27)6-4-14/h3-6,9,12-13,19H,7-8,10-11H2,1-2H3,(H,30,36)(H,31,37)(H,39,40)/t19-/m0/s1",MTQRDYMEBCVPBA-IBGZPJMESA-N,1,0,0,0,LFA / ICAM,7.23,immune system disease,Inhibition,
1257,44573476,445522,24686302,CCOc1cccc2c(c[nH]c12)C(=O)C(=O)N1CCN(CC1)C(=O)c1ccccc1,"1-(4-benzoylpiperazin-1-yl)-2-(7-ethoxy-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C23H23N3O4/c1-2-30-19-10-6-9-17-18(15-24-20(17)19)21(27)23(29)26-13-11-25(12-14-26)22(28)16-7-4-3-5-8-16/h3-10,15,24H,2,11-14H2,1H3",PHKVQLYMESHOTO-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,9.30,HIV infectious disease,Inhibition,
1258,45136911,,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CC[C@H]2NC[C@@H]([C@@H]12)c1c[nH]c2ccccc12,"(2S)-N-[(1S)-2-[(3aR,6S,6aR)-6-(1H-indol-3-yl)-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,2-b]pyrrol-1-yl]-1-cyclohexyl-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C26H37N5O2/c1-16(27-2)25(32)30-23(17-8-4-3-5-9-17)26(33)31-13-12-22-24(31)20(15-29-22)19-14-28-21-11-7-6-10-18(19)21/h6-7,10-11,14,16-17,20,22-24,27-29H,3-5,8-9,12-13,15H2,1-2H3,(H,30,32)/t16-,20+,22+,23-,24+/m0/s1",YZGDJFGVZYLLIG-JZPZAOSGSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
1259,44237070,,,CC[C@H](NC)C(=O)N[C@H]1[C@@H](CNC(=O)NCc2ccccc2)CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7R,9aS)-N-benzhydryl-7-[(benzylcarbamoylamino)methyl]-6-[[(2S)-2-(methylamino)butanoyl]amino]-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C37H46N6O4/c1-3-30(38-2)34(44)42-33-28(24-40-37(47)39-23-25-13-7-4-8-14-25)19-20-29-21-22-31(43(29)36(33)46)35(45)41-32(26-15-9-5-10-16-26)27-17-11-6-12-18-27/h4-18,28-33,38H,3,19-24H2,1-2H3,(H,41,45)(H,42,44)(H2,39,40,47)/t28-,29+,30+,31+,33+/m1/s1",RSCZGQPLWAYMBU-PIXGQMGXSA-N,1,1,0,0,XIAP / Smac,7.00,cancer,Inhibition,
1260,168318013,,,CCNC(=O)c1nc(CC(C)(C)C)n(c1-c1ccc(Cl)cc1OC)-c1cc(Cl)ccc1C,,"InChI=1S/C25H29Cl2N3O2/c1-7-28-24(31)22-23(18-11-10-17(27)13-20(18)32-6)30(21(29-22)14-25(3,4)5)19-12-16(26)9-8-15(19)2/h8-13H,7,14H2,1-6H3,(H,28,31)",JIJNAFRZEMSILX-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,5.20,cancer,Inhibition,
1261,67224576,,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1cc(Oc2ccc(F)cc2)ccn1,,"InChI=1S/C27H35FN4O3/c1-18(29-2)26(33)31-25(19-7-4-3-5-8-19)27(34)32-16-6-9-24(32)23-17-22(14-15-30-23)35-21-12-10-20(28)11-13-21/h10-15,17-19,24-25,29H,3-9,16H2,1-2H3,(H,31,33)/t18-,24-,25-/m0/s1",RLZDXFUYFJFSIW-WDNCENIBSA-N,1,0,0,0,XIAP / Smac,6.00,cancer,Inhibition,
1262,506242,523864,442073,COc1cccc2[nH]cc(C(=O)C(=O)N3CCN(CC3)C(=O)c3ccccc3)c12,"1-(4-benzoylpiperazin-1-yl)-2-(4-methoxy-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C22H21N3O4/c1-29-18-9-5-8-17-19(18)16(14-23-17)20(26)22(28)25-12-10-24(11-13-25)21(27)15-6-3-2-4-7-15/h2-9,14,23H,10-13H2,1H3",YONWOVYXYCIVNL-UHFFFAOYSA-N,0,2,0,0,CD4 / gp120,9.28,HIV infectious disease,Inhibition,
1263,25195346,511444,24714073,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CC[C@H]2CC[C@H](NC(=O)c3cccc4ccccc34)[C@@H]12)C(C)(C)C,"N-[(3aR,6S,6aS)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-6-yl]naphthalene-1-carboxamide","InChI=1S/C28H38N4O3/c1-17(29-5)25(33)31-24(28(2,3)4)27(35)32-16-15-19-13-14-22(23(19)32)30-26(34)21-12-8-10-18-9-6-7-11-20(18)21/h6-12,17,19,22-24,29H,13-16H2,1-5H3,(H,30,34)(H,31,33)/t17-,19+,22-,23-,24+/m0/s1",FTXKVJPIFDKIID-YBAXTEPTSA-N,1,0,0,0,XIAP / Smac,6.85,cancer,Inhibition,
1264,46884522,1091215,24668279,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1nc(c(Cl)s1)-c1cccc2ccccc12,"(2S)-N-[(1S)-2-[(2S)-2-(5-chloro-4-naphthalen-1-yl-1,3-thiazol-2-yl)pyrrolidin-1-yl]-1-cyclohexyl-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C29H35ClN4O2S/c1-18(31-2)27(35)32-24(20-11-4-3-5-12-20)29(36)34-17-9-16-23(34)28-33-25(26(30)37-28)22-15-8-13-19-10-6-7-14-21(19)22/h6-8,10,13-15,18,20,23-24,31H,3-5,9,11-12,16-17H2,1-2H3,(H,32,35)/t18-,23-,24-/m0/s1",ZQUTYGKFEAAOSB-NWVWQQAFSA-N,1,0,0,0,XIAP / Smac,7.46,cancer,Inhibition,
1265,25025909,570417,24635222,CNc1nc(NCc2ccc(NC(=O)c3ccc(cc3)C(F)(F)F)cc2)c2ccccc2n1,N-[4-[[[2-(methylamino)quinazolin-4-yl]amino]methyl]phenyl]-4-(trifluoromethyl)benzamide,"InChI=1S/C24H20F3N5O/c1-28-23-31-20-5-3-2-4-19(20)21(32-23)29-14-15-6-12-18(13-7-15)30-22(33)16-8-10-17(11-9-16)24(25,26)27/h2-13H,14H2,1H3,(H,30,33)(H2,28,29,31,32)",ISTRBVPLLRSCKS-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,5.98,cancer,Inhibition,
1266,44424318,1207304,25054977,CC(C)(C)NC(=O)[C@@H]1[C@@H](OC2([C@@H]1C(O)=O)C(=O)c1ccccc1C2=O)c1ccc(Cl)c(Cl)c1,"4'-(tert-butylcarbamoyl)-5'-(3,4-dichlorophenyl)-1,3-dioxospiro[indene-2,2'-oxolane]-3'-carboxylic acid","InChI=1S/C24H21Cl2NO6/c1-23(2,3)27-21(30)16-17(22(31)32)24(19(28)12-6-4-5-7-13(12)20(24)29)33-18(16)11-8-9-14(25)15(26)10-11/h4-10,16-18H,1-3H3,(H,27,30)(H,31,32)/t16-,17-,18-/m0/s1",HYVGWFKZIHKIQE-BZSNNMDCSA-N,1,0,0,0,E2 / E1,5.68,human papilloma virus infection,Inhibition,
1267,168318014,,,COC(=O)c1cc(ccc1F)-n1[nH]c2c3cnn(C)c3nc(-c3cccc(c3)C(F)(F)F)c2c1=O,,"InChI=1S/C23H15F4N5O3/c1-31-20-15(10-28-31)19-17(18(29-20)11-4-3-5-12(8-11)23(25,26)27)21(33)32(30-19)13-6-7-16(24)14(9-13)22(34)35-2/h3-10,30H,1-2H3",VIYWIZKMCWHGAG-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.01,cancer,Inhibition,
1268,51039624,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)Nc1nc(nc2CN(CCc12)C1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1)C(F)(F)F,"N-[7-[1-[[2-(4-chlorophenyl)phenyl]methyl]piperidin-4-yl]-2-(trifluoromethyl)-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl]-4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrobenzenesulfonamide","InChI=1S/C44H48ClF3N8O4S2/c1-53(2)22-18-33(29-61-35-9-4-3-5-10-35)49-39-17-16-36(26-41(39)56(57)58)62(59,60)52-42-38-21-25-55(28-40(38)50-43(51-42)44(46,47)48)34-19-23-54(24-20-34)27-31-8-6-7-11-37(31)30-12-14-32(45)15-13-30/h3-17,26,33-34,49H,18-25,27-29H2,1-2H3,(H,50,51,52)/t33-/m1/s1",CAVGCVJHYTXBRI-MGBGTMOVSA-N,1,0,0,0,BCL2-Like / BAX,7.70,cancer,Inhibition,
1269,46175994,,,CN[C@@H](C)C(=O)N[C@@H](C1CCOCC1)C(=O)N1CCC[C@H]1c1cc2nc(C)nc(-c3ccccc3)c2[nH]1,"(2S)-2-(methylamino)-N-[(1S)-2-[(2S)-2-(2-methyl-4-phenyl-5H-pyrrolo[3,2-d]pyrimidin-6-yl)pyrrolidin-1-yl]-1-(oxan-4-yl)-2-oxoethyl]propanamide","InChI=1S/C28H36N6O3/c1-17(29-3)27(35)33-25(20-11-14-37-15-12-20)28(36)34-13-7-10-23(34)21-16-22-26(32-21)24(31-18(2)30-22)19-8-5-4-6-9-19/h4-6,8-9,16-17,20,23,25,29,32H,7,10-15H2,1-3H3,(H,33,35)/t17-,23-,25-/m0/s1",WGKXDYSPPZULLI-XPEQFSOGSA-N,2,0,0,0,XIAP / Smac,6.70,cancer,Inhibition,
1270,44579217,,24713556,CCOC(=O)[C@H]1CC[C@@H](CC1)Nc1cccc(c1)Sc1ccc(\C=C\C(=O)N2CCOCC2)c(C(F)(F)F)c1C(F)(F)F,"ethyl 4-[3-[4-[(E)-3-morpholin-4-yl-3-oxoprop-1-enyl]-2,3-bis(trifluoromethyl)phenyl]sulfanylanilino]cyclohexane-1-carboxylate","InChI=1S/C30H32F6N2O4S/c1-2-42-28(40)20-6-10-21(11-7-20)37-22-4-3-5-23(18-22)43-24-12-8-19(9-13-25(39)38-14-16-41-17-15-38)26(29(31,32)33)27(24)30(34,35)36/h3-5,8-9,12-13,18,20-21,37H,2,6-7,10-11,14-17H2,1H3/b13-9+/t20-,21-",HPLNGZWRFIAXQN-OMPSHEKTSA-N,1,0,0,0,LFA / ICAM,7.35,immune system disease,Inhibition,
1271,44237046,4595839,,CC[C@H](N)C(=O)N[C@H]1[C@@H](COC(=O)c2ccccc2)CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"[(3S,6S,7S,9aS)-6-[[(2S)-2-aminobutanoyl]amino]-3-(benzhydrylcarbamoyl)-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepin-7-yl]methyl benzoate","InChI=1S/C35H40N4O5/c1-2-28(36)32(40)38-31-26(22-44-35(43)25-16-10-5-11-17-25)18-19-27-20-21-29(39(27)34(31)42)33(41)37-30(23-12-6-3-7-13-23)24-14-8-4-9-15-24/h3-17,26-31H,2,18-22,36H2,1H3,(H,37,41)(H,38,40)/t26-,27+,28+,29+,31+/m1/s1",BZEZXJMHLRCUKK-QSXRPSNWSA-N,2,0,0,0,XIAP / Smac,6.59,cancer,Inhibition,
1272,45487396,586038,24642565,CNC(=O)c1cc(OC)c(O[C@@H](C)C(=O)N2CCN(C[C@H]2C)c2ncccn2)cn1,4-methoxy-N-methyl-5-[(2S)-1-[(2R)-2-methyl-4-pyrimidin-2-ylpiperazin-1-yl]-1-oxopropan-2-yl]oxypyridine-2-carboxamide,"InChI=1S/C20H26N6O4/c1-13-12-25(20-22-6-5-7-23-20)8-9-26(13)19(28)14(2)30-17-11-24-15(18(27)21-3)10-16(17)29-4/h5-7,10-11,13-14H,8-9,12H2,1-4H3,(H,21,27)/t13-,14+/m1/s1",QIBJARFLROBPQO-KGLIPLIRSA-N,0,1,0,0,CD4 / gp120,7.15,HIV infectious disease,Inhibition,
1273,59452404,,,CN1CCN(CCc2c[nH]c3ccccc23)c2ccc(Nc3ccncc3)cc12,"1-[2-(1H-indol-3-yl)ethyl]-4-methyl-N-pyridin-4-yl-2,3-dihydroquinoxalin-6-amine","InChI=1S/C24H25N5/c1-28-14-15-29(13-10-18-17-26-22-5-3-2-4-21(18)22)23-7-6-20(16-24(23)28)27-19-8-11-25-12-9-19/h2-9,11-12,16-17,26H,10,13-15H2,1H3,(H,25,27)",YKKORWQPYHIOOA-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,5.48,cancer,Inhibition,
1274,67954192,,,CC1CN(C1)C(=O)Cc1ccc(Cl)c(F)c1-n1c(nc(-c2nnc(N)o2)c1-c1ccc(F)c(Cl)c1)C1CCCCC1,,"InChI=1S/C29H28Cl2F2N6O2/c1-15-13-38(14-15)22(40)12-18-7-9-19(30)23(33)25(18)39-26(17-8-10-21(32)20(31)11-17)24(28-36-37-29(34)41-28)35-27(39)16-5-3-2-4-6-16/h7-11,15-16H,2-6,12-14H2,1H3,(H2,34,37)",QVXWHEYMNIXJPE-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,8.30,cancer,Inhibition,
1275,67954204,,,CN(C)c1cccc(c1)-c1cc(C(O)=O)c(-c2cccc(Cl)c2)n1-c1cccc(Cl)c1F,,"InChI=1S/C25H19Cl2FN2O2/c1-29(2)18-9-4-6-15(13-18)22-14-19(25(31)32)24(16-7-3-8-17(26)12-16)30(22)21-11-5-10-20(27)23(21)28/h3-14H,1-2H3,(H,31,32)",IQKYOCSHFSLZFY-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,6.25,cancer,Inhibition,
1276,25052266,3220437,,COC(=O)c1cccc(c1)S(=O)(=O)N1[C@@H]([C@H](c2ccc(Cl)cc2)n2c1ccc(C(=O)N1CCN(C)CC1)c2=O)c1ccc(Cl)cc1,"methyl 3-[[(2R,3S)-2,3-bis(4-chlorophenyl)-6-(4-methylpiperazine-1-carbonyl)-5-oxo-2,3-dihydroimidazo[1,2-a]pyridin-1-yl]sulfonyl]benzoate","InChI=1S/C33H30Cl2N4O6S/c1-36-16-18-37(19-17-36)31(40)27-14-15-28-38(32(27)41)29(21-6-10-24(34)11-7-21)30(22-8-12-25(35)13-9-22)39(28)46(43,44)26-5-3-4-23(20-26)33(42)45-2/h3-15,20,29-30H,16-19H2,1-2H3/t29-,30+/m0/s1",DMYUYICGWAWUEM-XZWHSSHBSA-N,1,0,0,0,MDM2-Like / P53,6.34,cancer,Inhibition,
1277,44818309,583050,24641416,CNc1nc(NCc2ccc(NC(=O)c3ccc(F)cc3)cc2)c2ccc(C)cc2n1,4-fluoro-N-[4-[[[7-methyl-2-(methylamino)quinazolin-4-yl]amino]methyl]phenyl]benzamide,"InChI=1S/C24H22FN5O/c1-15-3-12-20-21(13-15)29-24(26-2)30-22(20)27-14-16-4-10-19(11-5-16)28-23(31)17-6-8-18(25)9-7-17/h3-13H,14H2,1-2H3,(H,28,31)(H2,26,27,29,30)",YEWKMXVZMMJARV-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,6.52,cancer,Inhibition,
1278,24969086,1236726,25058872,CN(C)CCCN(C)[C@H]1CCN(C1)C(=O)c1[nH]c2cc(Cl)ccc2c1-c1c(ncn1Cc1ccc(Cl)cc1)-c1ccccc1,[6-chloro-3-[3-[(4-chlorophenyl)methyl]-5-phenylimidazol-4-yl]-1H-indol-2-yl]-[(3S)-3-[3-(dimethylamino)propyl-methylamino]pyrrolidin-1-yl]methanone,"InChI=1S/C35H38Cl2N6O/c1-40(2)17-7-18-41(3)28-16-19-42(22-28)35(44)33-31(29-15-14-27(37)20-30(29)39-33)34-32(25-8-5-4-6-9-25)38-23-43(34)21-24-10-12-26(36)13-11-24/h4-6,8-15,20,23,28,39H,7,16-19,21-22H2,1-3H3/t28-/m0/s1",LWWQYOWAPGRPRH-NDEPHWFRSA-N,3,0,0,0,MDM2-Like / P53,7.82,cancer,Inhibition,
1279,135409621,107739,23191524,NC(=N)N[C@H](C1CCCCC1)C(=O)NCC(=O)N1CCC(CC1)c1cc(n[nH]1)-c1ccc(O)cc1Cl,"(2R)-N-[2-[4-[(5E)-5-(2-chloro-4-oxocyclohexa-2,5-dien-1-ylidene)-1,2-dihydropyrazol-3-yl]piperidin-1-yl]-2-oxoethyl]-2-cyclohexyl-2-(diaminomethylideneamino)acetamide","InChI=1S/C25H34ClN7O3/c26-19-12-17(34)6-7-18(19)21-13-20(31-32-21)15-8-10-33(11-9-15)22(35)14-29-24(36)23(30-25(27)28)16-4-2-1-3-5-16/h6-7,12-13,15-16,23,34H,1-5,8-11,14H2,(H,29,36)(H,31,32)(H4,27,28,30)/t23-/m1/s1",XANLXYJFKAWHLL-HSZRJFAPSA-N,1,0,0,0,IL2 / IL2R,4.52,immune system disease,Inhibition,
1280,88540231,,,CN(C)CC[C@H](CSc1ccccc1Cl)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1nc(nc2CN(CCc12)C1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1)C(F)(F)F,,"InChI=1S/C45H47Cl2F6N7O4S3/c1-58(2)21-17-32(28-65-40-10-6-5-9-37(40)47)54-38-16-15-34(25-41(38)66(61,62)45(51,52)53)67(63,64)57-42-36-20-24-60(27-39(36)55-43(56-42)44(48,49)50)33-18-22-59(23-19-33)26-30-7-3-4-8-35(30)29-11-13-31(46)14-12-29/h3-16,25,32-33,54H,17-24,26-28H2,1-2H3,(H,55,56,57)/t32-/m1/s1",FNRCIXMWIGGAPP-JGCGQSQUSA-N,1,0,0,0,BCL2-Like / BAX,7.14,cancer,Inhibition,
1281,168318010,,,C[C@@H]1CN(CCc2c[nH]c3ccccc23)c2c(F)cc(Nc3ccnc4[C@H](O)CCc34)cc2O1,"4-[[5-fluoro-4-[2-(1H-indol-3-yl)ethyl]-2-methyl-2,3-dihydro-1,4-benzoxazin-7-yl]amino]-6,7-dihydro-5H-cyclopenta[b]pyridin-7-ol","InChI=1S/C27H27FN4O2/c1-16-15-32(11-9-17-14-30-22-5-3-2-4-19(17)22)27-21(28)12-18(13-25(27)34-16)31-23-8-10-29-26-20(23)6-7-24(26)33/h2-5,8,10,12-14,16,24,30,33H,6-7,9,11,15H2,1H3,(H,29,31)/t16-,24-/m1/s1",NWOKQSRVTPTGPD-VOIUYBSRSA-N,1,0,0,0,MDM2-Like / P53,5.52,cancer,Inhibition,
1282,25000810,,,CC(C)(C)C[C@H]1N([C@H]([C@H](c2ccc(F)c(Cl)c2)[C@@]11C(=O)Nc2cc(Cl)c(F)cc12)C(=O)NCCN1CCOCC1)S(=O)(=O)C(F)(F)F,"(2'R,3S,3'R,5'R)-6-chloro-3'-(3-chloro-4-fluorophenyl)-5'-(2,2-dimethylpropyl)-5-fluoro-N-(2-morpholin-4-ylethyl)-2-oxo-1'-(trifluoromethylsulfonyl)spiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide","InChI=1S/C30H33Cl2F5N4O5S/c1-28(2,3)15-23-29(17-13-21(34)19(32)14-22(17)39-27(29)43)24(16-4-5-20(33)18(31)12-16)25(41(23)47(44,45)30(35,36)37)26(42)38-6-7-40-8-10-46-11-9-40/h4-5,12-14,23-25H,6-11,15H2,1-3H3,(H,38,42)(H,39,43)/t23-,24+,25-,29+/m1/s1",WGKJNCYFIJVWPL-ZTVFFDQVSA-N,1,3,0,0,MDM2-Like / P53,6.66,cancer,Inhibition,
1283,168317999,,,CN[C@H](C)c1cc(Nc2ccc(NCCc3c[nH]c4ccccc34)cc2)ccn1,"1-N-[2-(1H-indol-3-yl)ethyl]-4-N-[2-[1-(methylamino)ethyl]pyridin-4-yl]benzene-1,4-diamine","InChI=1S/C24H27N5/c1-17(25-2)24-15-21(12-14-27-24)29-20-9-7-19(8-10-20)26-13-11-18-16-28-23-6-4-3-5-22(18)23/h3-10,12,14-17,25-26,28H,11,13H2,1-2H3,(H,27,29)/t17-/m1/s1",ZKSQOOWYDWQKRZ-QGZVFWFLSA-N,1,1,0,0,MDM2-Like / P53,5.52,cancer,Inhibition,
1284,21060011,,19859827,C[C@@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)N(CC(=O)N2CCOCC2)c2ccc(I)cc2C1=O)c1ccc(Cl)cc1,"(3S)-3-(4-chlorophenyl)-4-[(1R)-1-(4-chlorophenyl)ethyl]-7-iodo-1-(2-morpholin-4-yl-2-oxoethyl)-3H-1,4-benzodiazepine-2,5-dione","InChI=1S/C29H26Cl2IN3O4/c1-18(19-2-6-21(30)7-3-19)35-27(20-4-8-22(31)9-5-20)29(38)34(17-26(36)33-12-14-39-15-13-33)25-11-10-23(32)16-24(25)28(35)37/h2-11,16,18,27H,12-15,17H2,1H3/t18-,27+/m1/s1",DFMCKWBGWKZCKJ-CLYVBNDRSA-N,1,0,0,0,MDM2-Like / P53,5.27,cancer,Inhibition,
1285,168318009,,,OCCC[C@H]1CCCCN1C(=O)[C@@H](Cc1c[nH]c2ccccc12)Nc1ccc(Nc2ccncc2)cc1,1-[2-(3-hydroxypropyl)piperidin-1-yl]-3-(1H-indol-3-yl)-2-[4-(pyridin-4-ylamino)anilino]propan-1-one,"InChI=1S/C30H35N5O2/c36-19-5-7-26-6-3-4-18-35(26)30(37)29(20-22-21-32-28-9-2-1-8-27(22)28)34-24-12-10-23(11-13-24)33-25-14-16-31-17-15-25/h1-2,8-17,21,26,29,32,34,36H,3-7,18-20H2,(H,31,33)/t26-,29-/m1/s1",CSIVWAJJCNFKQS-GGXMVOPNSA-N,1,1,0,0,MDM2-Like / P53,6.00,cancer,Inhibition,
1286,168317994,,24633315,C[C@@H](Oc1cccc2nccnc12)C(=O)N1CCN(C[C@H]1C)C(=O)c1ccccc1,1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-quinoxalin-5-yloxypropan-1-one,"InChI=1S/C23H24N4O3/c1-16-15-26(23(29)18-7-4-3-5-8-18)13-14-27(16)22(28)17(2)30-20-10-6-9-19-21(20)25-12-11-24-19/h3-12,16-17H,13-15H2,1-2H3/t16-,17-/m1/s1",RAHAMDOWXJCPRG-IAGOWNOFSA-N,0,1,0,0,CD4 / gp120,6.31,HIV infectious disease,Inhibition,
1287,44391967,181146,23248051,COc1ccccc1Sc1ccc(cc1C(F)(F)F)-c1ccnc(c1)N1CCC[C@H]1C(O)=O,1-[4-[4-(2-methoxyphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyridin-2-yl]pyrrolidine-2-carboxylic acid,"InChI=1S/C24H21F3N2O3S/c1-32-19-6-2-3-7-21(19)33-20-9-8-15(13-17(20)24(25,26)27)16-10-11-28-22(14-16)29-12-4-5-18(29)23(30)31/h2-3,6-11,13-14,18H,4-5,12H2,1H3,(H,30,31)/t18-/m0/s1",VHDWIPLMGLQQHO-SFHVURJKSA-N,0,1,0,0,LFA / ICAM,7.10,immune system disease,Inhibition,
1288,506237,495019,442068,Fc1cc(F)c2c(c[nH]c2c1)C(=O)C(=O)N1CCN(CC1)C(=O)c1ccccc1,"1-(4-benzoylpiperazin-1-yl)-2-(4,6-difluoro-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C21H17F2N3O3/c22-14-10-16(23)18-15(12-24-17(18)11-14)19(27)21(29)26-8-6-25(7-9-26)20(28)13-4-2-1-3-5-13/h1-5,10-12,24H,6-9H2",IRVNUDODBOCUTJ-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,9.38,HIV infectious disease,Inhibition,
1289,168318007,,,C[C@H](O)c1cc(NC(=O)c2ccc(cc2)-n2[nH]c3c4cnn(C)c4nc(-c4cccc(c4)C(F)(F)F)c3c2=O)ccc1Cl,,"InChI=1S/C30H22ClF3N6O3/c1-15(41)21-13-19(8-11-23(21)31)36-28(42)16-6-9-20(10-7-16)40-29(43)24-25(17-4-3-5-18(12-17)30(32,33)34)37-27-22(26(24)38-40)14-35-39(27)2/h3-15,38,41H,1-2H3,(H,36,42)/t15-/m0/s1",ASMPLUBYRPDNGZ-HNNXBMFYSA-N,1,0,0,0,CD80 / CD28,6.26,cancer,Inhibition,
1290,44570042,446607,24687567,Cc1cc(nn1-c1ccccc1C(=O)N1Cc2ccccc2C[C@H]1CNS(C)(=O)=O)C(=O)N(c1ccccc1)c1ccccc1,"1-[2-[(3S)-3-(methanesulfonamidomethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-5-methyl-N,N-diphenylpyrazole-3-carboxamide","InChI=1S/C35H33N5O4S/c1-25-21-32(35(42)39(28-15-5-3-6-16-28)29-17-7-4-8-18-29)37-40(25)33-20-12-11-19-31(33)34(41)38-24-27-14-10-9-13-26(27)22-30(38)23-36-45(2,43)44/h3-21,30,36H,22-24H2,1-2H3/t30-/m0/s1",MRLAQJMSBFEFSW-PMERELPUSA-N,1,0,0,0,BCL2-Like / BAX,5.98,cancer,Inhibition,
1291,168318006,,,CN[C@@H](C)C(=O)N[C@H]1CC[C@H](C[C@H]2CC[C@H](N2C1=O)C(=O)N[C@H]1CCCc2ccccc12)NC(=O)Cc1ccccc1,"(3S,6S,9R,10aR)-6-[[(2S)-2-(methylamino)propanoyl]amino]-5-oxo-9-[(2-phenylacetyl)amino]-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-2,3,6,7,8,9,10,10a-octahydro-1H-pyrrolo[1,2-a]azocine-3-carboxamide","InChI=1S/C33H43N5O4/c1-21(34-2)31(40)37-28-17-15-24(35-30(39)19-22-9-4-3-5-10-22)20-25-16-18-29(38(25)33(28)42)32(41)36-27-14-8-12-23-11-6-7-13-26(23)27/h3-7,9-11,13,21,24-25,27-29,34H,8,12,14-20H2,1-2H3,(H,35,39)(H,36,41)(H,37,40)/t21-,24+,25+,27-,28-,29-/m0/s1",BOOCCBUATVVXCL-CUQYSNLNSA-N,2,0,0,0,XIAP / Smac,7.52,cancer,Inhibition,
1292,656933,361103,571179,OC(=O)[C@@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)Nc2ccc(I)cc2C1=O)c1ccc(Cl)cc1,"(2S)-2-(4-chlorophenyl)-2-[(3S)-3-(4-chlorophenyl)-7-iodo-2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-4-yl]acetic acid","InChI=1S/C23H15Cl2IN2O4/c24-14-5-1-12(2-6-14)19-21(29)27-18-10-9-16(26)11-17(18)22(30)28(19)20(23(31)32)13-3-7-15(25)8-4-13/h1-11,19-20H,(H,27,29)(H,31,32)/t19-,20-/m0/s1",HQEQUYKKMMKSSX-PMACEKPBSA-N,5,3,0,0,MDM2-Like / P53,7.10,cancer,Inhibition,
1293,168318004,,,Cc1cc2CN(CCc2c(C)c1C(=O)N[C@@H](CNC(=O)c1cccs1)C(O)=O)C(=O)c1cccc(Cl)c1,,"InChI=1S/C27H26ClN3O5S/c1-15-11-18-14-31(26(34)17-5-3-6-19(28)12-17)9-8-20(18)16(2)23(15)25(33)30-21(27(35)36)13-29-24(32)22-7-4-10-37-22/h3-7,10-12,21H,8-9,13-14H2,1-2H3,(H,29,32)(H,30,33)(H,35,36)/t21-/m0/s1",HLACBWINZQVIQC-NRFANRHFSA-N,0,1,0,0,LFA / ICAM,7.18,immune system disease,Inhibition,
1294,44595537,,,COc1c(CN(Cc2ccc(F)cc2)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)cccc1-c1ccc(Cl)cc1,"3,5-dichloro-N-[[3-(4-chlorophenyl)-2-methoxyphenyl]methyl]-N-[(4-fluorophenyl)methyl]-2-hydroxybenzenesulfonamide","InChI=1S/C27H21Cl3FNO4S/c1-36-27-19(3-2-4-23(27)18-7-9-20(28)10-8-18)16-32(15-17-5-11-22(31)12-6-17)37(34,35)25-14-21(29)13-24(30)26(25)33/h2-14,33H,15-16H2,1H3",KYBBQEDQJFYYFB-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,6.92,cancer,Inhibition,
1295,168318003,,8360245,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1cc(ncn1)N1CCC[C@H](CO)C1,[1-[6-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyrimidin-4-yl]piperidin-3-yl]methanol,"InChI=1S/C26H28F3N3OS/c1-17(2)20-7-3-4-8-23(20)34-24-10-9-19(12-21(24)26(27,28)29)22-13-25(31-16-30-22)32-11-5-6-18(14-32)15-33/h3-4,7-10,12-13,16-18,33H,5-6,11,14-15H2,1-2H3/t18-/m0/s1",HSSYLIYWARWUTA-SFHVURJKSA-N,0,1,0,0,LFA / ICAM,6.64,immune system disease,Inhibition,
1296,88540244,,,CN(C)CC[C@H](CSc1c(Cl)cccc1Cl)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1,,"InChI=1S/C44H47Cl3F3N7O4S3/c1-55(2)20-16-32(27-62-42-37(46)8-5-9-38(42)47)53-39-15-14-34(24-41(39)63(58,59)44(48,49)50)64(60,61)54-43-36-19-23-57(26-40(36)51-28-52-43)33-17-21-56(22-18-33)25-30-6-3-4-7-35(30)29-10-12-31(45)13-11-29/h3-15,24,28,32-33,53H,16-23,25-27H2,1-2H3,(H,51,52,54)/t32-/m1/s1",FTKWWRIUHLYBBG-JGCGQSQUSA-N,1,0,0,0,BCL2-Like / BAX,7.39,cancer,Inhibition,
1297,51041790,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(CC2=C(CCC(C)(C)C2)c2ccc(Cl)cc2)CC1,"N-[7-[1-[[2-(4-chlorophenyl)-5,5-dimethylcyclohexen-1-yl]methyl]piperidin-4-yl]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl]-4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrobenzenesulfonamide","InChI=1S/C45H57ClN8O4S2/c1-45(2)21-16-39(32-10-12-34(46)13-11-32)33(27-45)28-52-23-18-36(19-24-52)53-25-20-40-42(29-53)47-31-48-44(40)50-60(57,58)38-14-15-41(43(26-38)54(55)56)49-35(17-22-51(3)4)30-59-37-8-6-5-7-9-37/h5-15,26,31,35-36,49H,16-25,27-30H2,1-4H3,(H,47,48,50)/t35-/m1/s1",DKHLWMPARDHZAN-PGUFJCEWSA-N,1,0,0,0,BCL2-Like / BAX,7.51,cancer,Inhibition,
1298,11952735,207364,10127044,CC#Cc1ccc2N(CCN3CCOCC3)C(=O)[C@@H](N([C@H](C)c3ccc(Cl)cc3N)C(=O)c2c1)c1ccc(Cl)cc1,"4-[1-(2-amino-4-chlorophenyl)ethyl]-3-(4-chlorophenyl)-1-(2-morpholin-4-ylethyl)-7-prop-1-ynyl-3H-1,4-benzodiazepine-2,5-dione","InChI=1S/C32H32Cl2N4O3/c1-3-4-22-5-12-29-27(19-22)31(39)38(21(2)26-11-10-25(34)20-28(26)35)30(23-6-8-24(33)9-7-23)32(40)37(29)14-13-36-15-17-41-18-16-36/h5-12,19-21,30H,13-18,35H2,1-2H3/t21-,30+/m1/s1",LQZUTIMEANELKZ-DFXYEROKSA-N,1,0,0,0,MDM2-Like / P53,6.10,cancer,Inhibition,
1299,16090303,214839,17248916,CC(C)c1cc(C(=O)Nc2ccccc2)c(O)c(O)c1O,"2,3,4-trihydroxy-N-phenyl-5-propan-2-ylbenzamide","InChI=1S/C16H17NO4/c1-9(2)11-8-12(14(19)15(20)13(11)18)16(21)17-10-6-4-3-5-7-10/h3-9,18-20H,1-2H3,(H,17,21)",HMVKMSUSFWLQLX-UHFFFAOYSA-N,1,0,0,0,BCL2-Like / BAX,4.62,cancer,Inhibition,
1300,16109064,373712,17266479,COC1(Cc2ccccc2)CCN(CC1)c1ccc(cc1)C(=O)NS(=O)(=O)c1ccc(N[C@H](CCN(C)C)CSc2ccccc2)c(c1)N(=O)=O,4-(4-benzyl-4-methoxypiperidin-1-yl)-N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonylbenzamide,"InChI=1S/C38H45N5O6S2/c1-41(2)23-20-31(28-50-33-12-8-5-9-13-33)39-35-19-18-34(26-36(35)43(45)46)51(47,48)40-37(44)30-14-16-32(17-15-30)42-24-21-38(49-3,22-25-42)27-29-10-6-4-7-11-29/h4-19,26,31,39H,20-25,27-28H2,1-3H3,(H,40,44)/t31-/m1/s1",XMUXSYFVLMWJFR-WJOKGBTCSA-N,2,0,0,0,BCL2-Like / BAX,8.74,cancer,Inhibition,
1301,25022340,2158051,,CN[C@@H](C)C(=O)N[C@H]1CN(CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1)C(=O)CC(C)C,"(5S,8S,10aR)-N-(diphenylmethyl)-5-[(2S)-2-(methylamino)propanamido]-3-(3-methylbutanoyl)-6-oxo-octahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide","InChI=1S/C32H43N5O4/c1-21(2)19-28(38)36-18-17-25-15-16-27(37(25)32(41)26(20-36)34-30(39)22(3)33-4)31(40)35-29(23-11-7-5-8-12-23)24-13-9-6-10-14-24/h5-14,21-22,25-27,29,33H,15-20H2,1-4H3,(H,34,39)(H,35,40)/t22-,25+,26-,27-/m0/s1",LSXUTRRVVSPWDZ-MKKUMYSQSA-N,1,2,0,0,XIAP / Smac,7.18,cancer,Inhibition,
1302,59555586,,,COC(=O)c1cc(Nc2ccc(NCCc3c[nH]c4ccccc34)cc2)cc(n1)C(=O)OC,"dimethyl 4-[4-[2-(1H-indol-3-yl)ethylamino]anilino]pyridine-2,6-dicarboxylate","InChI=1S/C25H24N4O4/c1-32-24(30)22-13-19(14-23(29-22)25(31)33-2)28-18-9-7-17(8-10-18)26-12-11-16-15-27-21-6-4-3-5-20(16)21/h3-10,13-15,26-27H,11-12H2,1-2H3,(H,28,29)",OCQIPBRFVLRAQQ-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,6.00,cancer,Inhibition,
1303,24876653,,,COc1ccc2c(CCNc3ccc(Nc4ccncc4)cc3)coc2c1,"1-N-[2-(6-methoxy-1-benzofuran-3-yl)ethyl]-4-N-pyridin-4-ylbenzene-1,4-diamine","InChI=1S/C22H21N3O2/c1-26-20-6-7-21-16(15-27-22(21)14-20)8-13-24-17-2-4-18(5-3-17)25-19-9-11-23-12-10-19/h2-7,9-12,14-15,24H,8,13H2,1H3,(H,23,25)",FTQGQNXVAYRYQZ-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,5.35,cancer,Inhibition,
1304,67032074,,,COC(CNC(=O)Cc1ccc(Cl)c(F)c1-n1c(nc(-c2nnc(N)o2)c1-c1ccc(F)c(Cl)c1)C1CCCCC1)OC,,"InChI=1S/C29H30Cl2F2N6O4/c1-41-22(42-2)14-35-21(40)13-17-8-10-18(30)23(33)25(17)39-26(16-9-11-20(32)19(31)12-16)24(28-37-38-29(34)43-28)36-27(39)15-6-4-3-5-7-15/h8-12,15,22H,3-7,13-14H2,1-2H3,(H2,34,38)(H,35,40)",SFPAZKCOOUOVBE-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,8.51,cancer,Inhibition,
1305,44237056,584393,24641154,CC[C@H](N)C(=O)N[C@H]1[C@@H](CNC(=O)c2ccccc2)CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7R,9aS)-6-[[(2S)-2-aminobutanoyl]amino]-7-(benzamidomethyl)-N-benzhydryl-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C35H41N5O4/c1-2-28(36)33(42)39-31-26(22-37-32(41)25-16-10-5-11-17-25)18-19-27-20-21-29(40(27)35(31)44)34(43)38-30(23-12-6-3-7-13-23)24-14-8-4-9-15-24/h3-17,26-31H,2,18-22,36H2,1H3,(H,37,41)(H,38,43)(H,39,42)/t26-,27+,28+,29+,31+/m1/s1",BKCCBNUDADJBCR-QSXRPSNWSA-N,2,1,0,0,XIAP / Smac,6.59,cancer,Inhibition,
1306,506226,522687,442057,Clc1cccc2c(c[nH]c12)C(=O)C(=O)N1CCN(CC1)C(=O)c1ccccc1,"1-(4-benzoylpiperazin-1-yl)-2-(7-chloro-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C21H18ClN3O3/c22-17-8-4-7-15-16(13-23-18(15)17)19(26)21(28)25-11-9-24(10-12-25)20(27)14-5-2-1-3-6-14/h1-8,13,23H,9-12H2",GYFMXNLNYOMTAI-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,8.36,HIV infectious disease,Inhibition,
1307,11706629,380214,9881352,C[C@@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)N(CCCCC(O)=O)c2ccc(cc2C1=O)C#C)c1ccc(Cl)cc1,"5-[(3S)-3-(4-chlorophenyl)-4-[(1R)-1-(4-chlorophenyl)ethyl]-7-ethynyl-2,5-dioxo-3H-1,4-benzodiazepin-1-yl]pentanoic acid","InChI=1S/C30H26Cl2N2O4/c1-3-20-7-16-26-25(18-20)29(37)34(19(2)21-8-12-23(31)13-9-21)28(22-10-14-24(32)15-11-22)30(38)33(26)17-5-4-6-27(35)36/h1,7-16,18-19,28H,4-6,17H2,2H3,(H,35,36)/t19-,28+/m1/s1",WRGLVOHNHGTKTI-GDJIYFAZSA-N,1,2,0,0,MDM2-Like / P53,6.15,cancer,Inhibition,
1308,45487380,567504,24631131,CNC(=O)c1ccc2c(O[C@@H](C)C(=O)N3CCN(C[C@H]3C)C(=O)c3ccccc3)cccc2n1,5-[(2S)-1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-1-oxopropan-2-yl]oxy-N-methylquinoline-2-carboxamide,"InChI=1S/C26H28N4O4/c1-17-16-29(26(33)19-8-5-4-6-9-19)14-15-30(17)25(32)18(2)34-23-11-7-10-21-20(23)12-13-22(28-21)24(31)27-3/h4-13,17-18H,14-16H2,1-3H3,(H,27,31)/t17-,18+/m1/s1",QEHBXPIHSWPCHV-MSOLQXFVSA-N,0,1,0,0,CD4 / gp120,7.11,HIV infectious disease,Inhibition,
1309,44237060,582974,24642011,CC[C@H](N)C(=O)N[C@H]1[C@@H](CNC(=O)NCc2ccccc2)CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7R,9aS)-6-[[(2S)-2-aminobutanoyl]amino]-N-benzhydryl-7-[(benzylcarbamoylamino)methyl]-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C36H44N6O4/c1-2-29(37)33(43)41-32-27(23-39-36(46)38-22-24-12-6-3-7-13-24)18-19-28-20-21-30(42(28)35(32)45)34(44)40-31(25-14-8-4-9-15-25)26-16-10-5-11-17-26/h3-17,27-32H,2,18-23,37H2,1H3,(H,40,44)(H,41,43)(H2,38,39,46)/t27-,28+,29+,30+,32+/m1/s1",IHWAHCOLVXAEFK-HVSNEVFASA-N,2,1,0,0,XIAP / Smac,6.62,cancer,Inhibition,
1310,51042646,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2ccccc2-c2ccc(cc2)C(F)(F)F)CC1,"4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-N-[7-[1-[[2-[4-(trifluoromethyl)phenyl]phenyl]methyl]piperidin-4-yl]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl]-3-(trifluoromethylsulfonyl)benzenesulfonamide","InChI=1S/C45H49F6N7O4S3/c1-56(2)22-18-34(29-63-36-9-4-3-5-10-36)54-40-17-16-37(26-42(40)64(59,60)45(49,50)51)65(61,62)55-43-39-21-25-58(28-41(39)52-30-53-43)35-19-23-57(24-20-35)27-32-8-6-7-11-38(32)31-12-14-33(15-13-31)44(46,47)48/h3-17,26,30,34-35,54H,18-25,27-29H2,1-2H3,(H,52,53,55)/t34-/m1/s1",FUPRAOMGGOMPOI-UUWRZZSWSA-N,1,0,0,0,BCL2-Like / BAX,7.43,cancer,Inhibition,
1311,44570081,480010,24698464,CC(C)N(C(=O)c1cc(C)n(n1)-c1ccccc1C(=O)N1CCc2ccccc2C1)c1ccccc1,"1-[2-(3,4-dihydro-1H-isoquinoline-2-carbonyl)phenyl]-5-methyl-N-phenyl-N-propan-2-ylpyrazole-3-carboxamide","InChI=1S/C30H30N4O2/c1-21(2)33(25-13-5-4-6-14-25)30(36)27-19-22(3)34(31-27)28-16-10-9-15-26(28)29(35)32-18-17-23-11-7-8-12-24(23)20-32/h4-16,19,21H,17-18,20H2,1-3H3",AWXPZLJZCHNWOR-UHFFFAOYSA-N,1,0,0,0,BCL2-Like / BAX,5.11,cancer,Inhibition,
1312,168318002,,,CC(C)(CO)C1CCN(CC1)C(=O)[C@@H](Cc1c[nH]c2ccccc12)Nc1ccc(Nc2ccncc2)cc1,,"InChI=1S/C31H37N5O2/c1-31(2,21-37)23-13-17-36(18-14-23)30(38)29(19-22-20-33-28-6-4-3-5-27(22)28)35-25-9-7-24(8-10-25)34-26-11-15-32-16-12-26/h3-12,15-16,20,23,29,33,35,37H,13-14,17-19,21H2,1-2H3,(H,32,34)/t29-/m1/s1",PLGUPWQEYBUOFF-GDLZYMKVSA-N,1,1,0,0,MDM2-Like / P53,5.52,cancer,Inhibition,
1313,88540097,,,C[C@@H]1Cc2c(CN1C1CCN(Cc3ccccc3-c3ccc(Cl)cc3)CC1)ncnc2NS(=O)(=O)c1ccc(N[C@H](CCN(C)C)CSc2ccccc2)c(c1)S(=O)(=O)C(F)(F)F,,"InChI=1S/C45H51ClF3N7O4S3/c1-31-25-40-42(28-56(31)36-20-23-55(24-21-36)27-33-9-7-8-12-39(33)32-13-15-34(46)16-14-32)50-30-51-44(40)53-63(59,60)38-17-18-41(43(26-38)62(57,58)45(47,48)49)52-35(19-22-54(2)3)29-61-37-10-5-4-6-11-37/h4-18,26,30-31,35-36,52H,19-25,27-29H2,1-3H3,(H,50,51,53)/t31-,35-/m1/s1",BGHYXWAGTHCGIM-CYEXUTLASA-N,1,0,0,0,BCL2-Like / BAX,6.45,cancer,Inhibition,
1314,44392036,180653,23248108,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1cc(ncn1)N1CCC(CC1)C(N)=O,1-[6-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyrimidin-4-yl]piperidine-4-carboxamide,"InChI=1S/C26H27F3N4OS/c1-16(2)19-5-3-4-6-22(19)35-23-8-7-18(13-20(23)26(27,28)29)21-14-24(32-15-31-21)33-11-9-17(10-12-33)25(30)34/h3-8,13-17H,9-12H2,1-2H3,(H2,30,34)",UVMBLBJOESBFLX-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,6.64,immune system disease,Inhibition,
1315,11549304,,9724083,CCOc1cc(ccc1C1=N[C@H]([C@H](N1C(=O)N1CCC(CC1)N1CCCC1)c1ccc(Cl)cc1)c1ccc(Cl)cc1)C(C)(C)C,"[(4S,5R)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dihydroimidazol-1-yl]-(4-pyrrolidin-1-ylpiperidin-1-yl)methanone","InChI=1S/C37H44Cl2N4O2/c1-5-45-32-24-27(37(2,3)4)12-17-31(32)35-40-33(25-8-13-28(38)14-9-25)34(26-10-15-29(39)16-11-26)43(35)36(44)42-22-18-30(19-23-42)41-20-6-7-21-41/h8-17,24,30,33-34H,5-7,18-23H2,1-4H3/t33-,34+/m0/s1",MUZXBHMGLOTTHE-SZAHLOSFSA-N,1,0,0,0,MDM2-Like / P53,7.62,cancer,Inhibition,
1316,44580637,524354,24720371,C[C@H]1CC[C@H](CC1)Oc1ccccc1Sc1ccc(\C=C\C(=O)N2CCOCC2)c(C(F)(F)F)c1C(F)(F)F,"(E)-3-[4-[2-(4-methylcyclohexyl)oxyphenyl]sulfanyl-2,3-bis(trifluoromethyl)phenyl]-1-morpholin-4-ylprop-2-en-1-one","InChI=1S/C28H29F6NO3S/c1-18-6-10-20(11-7-18)38-21-4-2-3-5-22(21)39-23-12-8-19(9-13-24(36)35-14-16-37-17-15-35)25(27(29,30)31)26(23)28(32,33)34/h2-5,8-9,12-13,18,20H,6-7,10-11,14-17H2,1H3/b13-9+/t18-,20+",IAAIGCGTGAJLIA-PKCMFLIBSA-N,1,0,0,0,LFA / ICAM,7.74,immune system disease,Inhibition,
1317,,,,CO[C@@]1(Cc2ccccc2-c2ccc(Cl)cc2)CC[C@@H](CC1)N1CCc2c(C1)ncnc2NS(=O)(=O)c1ccc(N[C@H](CCN(C)C)CSc2ccccc2)c(c1)S(=O)(=O)C(F)(F)F,,"InChI=1S/C46H52ClF3N6O5S3/c1-55(2)25-21-35(30-62-37-10-5-4-6-11-37)53-41-18-17-38(27-43(41)63(57,58)46(48,49)50)64(59,60)54-44-40-22-26-56(29-42(40)51-31-52-44)36-19-23-45(61-3,24-20-36)28-33-9-7-8-12-39(33)32-13-15-34(47)16-14-32/h4-18,27,31,35-36,53H,19-26,28-30H2,1-3H3,(H,51,52,54)/t35-,36-,45-/m1/s1",PPXWTTWYTKMGGB-NLXQXZJJSA-N,1,0,0,0,BCL2-Like / BAX,7.20,cancer,Inhibition,
1318,44391957,183485,23248043,COc1ccccc1Sc1ccc(cc1C(F)(F)F)-c1ccnc(c1)N1CC[C@H](C1)N(C)C(C)=O,N-[(3R)-1-[4-[4-(2-methoxyphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyridin-2-yl]pyrrolidin-3-yl]-N-methylacetamide,"InChI=1S/C26H26F3N3O2S/c1-17(33)31(2)20-11-13-32(16-20)25-15-19(10-12-30-25)18-8-9-23(21(14-18)26(27,28)29)35-24-7-5-4-6-22(24)34-3/h4-10,12,14-15,20H,11,13,16H2,1-3H3/t20-/m1/s1",LRABRYURWMXYGU-HXUWFJFHSA-N,0,1,0,0,LFA / ICAM,7.06,immune system disease,Inhibition,
1319,59555798,,,Cc1cc(Nc2ccncc2)ccc1NCCc1c[nH]c2ccccc12,"1-N-[2-(1H-indol-3-yl)ethyl]-2-methyl-4-N-pyridin-4-ylbenzene-1,4-diamine","InChI=1S/C22H22N4/c1-16-14-19(26-18-9-11-23-12-10-18)6-7-21(16)24-13-8-17-15-25-22-5-3-2-4-20(17)22/h2-7,9-12,14-15,24-25H,8,13H2,1H3,(H,23,26)",XCADPRUKAYFVTD-UHFFFAOYSA-N,2,1,0,0,MDM2-Like / P53,6.80,cancer,Inhibition,
1320,44570078,518858,24718615,CN(C(=O)c1cc(C)n(n1)-c1ccccc1C(=O)N1CCc2ccccc2C1)c1cccc(F)c1,"1-[2-(3,4-dihydro-1H-isoquinoline-2-carbonyl)phenyl]-N-(3-fluorophenyl)-N,5-dimethylpyrazole-3-carboxamide","InChI=1S/C28H25FN4O2/c1-19-16-25(28(35)31(2)23-11-7-10-22(29)17-23)30-33(19)26-13-6-5-12-24(26)27(34)32-15-14-20-8-3-4-9-21(20)18-32/h3-13,16-17H,14-15,18H2,1-2H3",ZAESEWQPXNJSNS-UHFFFAOYSA-N,1,0,0,0,BCL2-Like / BAX,5.64,cancer,Inhibition,
1321,168318001,,19174413,CC(C)c1ccccc1Sc1ccc([C@@H]2C[C@H]2C(=O)N2CCC[C@@H](C2)C(O)=O)c(Cl)c1Cl,"1-[2-[2,3-dichloro-4-(2-propan-2-ylphenyl)sulfanylphenyl]cyclopropanecarbonyl]piperidine-3-carboxylic acid","InChI=1S/C25H27Cl2NO3S/c1-14(2)16-7-3-4-8-20(16)32-21-10-9-17(22(26)23(21)27)18-12-19(18)24(29)28-11-5-6-15(13-28)25(30)31/h3-4,7-10,14-15,18-19H,5-6,11-13H2,1-2H3,(H,30,31)/t15-,18-,19+/m0/s1",GKORLDUEXWMZDW-ZYSHUDEJSA-N,0,1,0,0,LFA / ICAM,8.22,immune system disease,Inhibition,
1322,168318000,,,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(OCc3ccccc3)cc2)c1=O,,"InChI=1S/C28H20F3N5O2/c1-35-26-22(15-32-35)25-23(24(33-26)18-8-5-9-19(14-18)28(29,30)31)27(37)36(34-25)20-10-12-21(13-11-20)38-16-17-6-3-2-4-7-17/h2-15,34H,16H2,1H3",QVKDGDDQFFVYHY-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.60,cancer,Inhibition,
1323,11518553,218832,9693341,CC[C@H](NC)C(=O)N[C@H]1CCC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,9aS)-N-benzhydryl-6-[[(2S)-2-(methylamino)butanoyl]amino]-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C28H36N4O3/c1-3-22(29-2)26(33)30-23-16-10-15-21-17-18-24(32(21)28(23)35)27(34)31-25(19-11-6-4-7-12-19)20-13-8-5-9-14-20/h4-9,11-14,21-25,29H,3,10,15-18H2,1-2H3,(H,30,33)(H,31,34)/t21-,22-,23-,24-/m0/s1",UKNQPDHAXSCGKL-ZJZGAYNASA-N,3,2,0,0,XIAP / Smac,7.21,cancer,Inhibition,
1324,23646335,182159,23247039,CC(C)[C@H](NC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1CCCc1ccccc1,(2S)-2-amino-N-[(2S)-3-methyl-1-oxo-1-[(2R)-2-(3-phenylpropyl)pyrrolidin-1-yl]butan-2-yl]propanamide,"InChI=1S/C21H33N3O2/c1-15(2)19(23-20(25)16(3)22)21(26)24-14-8-13-18(24)12-7-11-17-9-5-4-6-10-17/h4-6,9-10,15-16,18-19H,7-8,11-14,22H2,1-3H3,(H,23,25)/t16-,18+,19-/m0/s1",UUZJQDOGNYCTBE-UHOSZYNNSA-N,1,0,0,0,XIAP / Smac,5.92,cancer,Inhibition,
1325,58007244,,,CC(C)C1=C(SC2=N[C@](C)([C@H](N12)c1ccc(Cl)cc1)c1ccc(Cl)cc1)C(=O)N1C[C@H](C[C@H]1C(=O)N1CCOCC1)N(C)C,"[(2S,4S)-1-[(5R,6S)-5,6-bis(4-chlorophenyl)-6-methyl-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazole-2-carbonyl]-4-(dimethylamino)pyrrolidin-2-yl]-morpholin-4-ylmethanone","InChI=1S/C33H39Cl2N5O3S/c1-20(2)27-28(31(42)39-19-25(37(4)5)18-26(39)30(41)38-14-16-43-17-15-38)44-32-36-33(3,22-8-12-24(35)13-9-22)29(40(27)32)21-6-10-23(34)11-7-21/h6-13,20,25-26,29H,14-19H2,1-5H3/t25-,26-,29+,33-/m0/s1",LZYGARLIBBKOAD-CAQQOLQPSA-N,1,0,0,0,MDM2-Like / P53,6.84,cancer,Inhibition,
1326,44580574,496738,24706278,FC(F)(F)c1c(Sc2ccccc2OC2CCSCC2)ccc(\C=C\C(=O)N2CCOCC2)c1C(F)(F)F,"(E)-1-morpholin-4-yl-3-[4-[2-(thian-4-yloxy)phenyl]sulfanyl-2,3-bis(trifluoromethyl)phenyl]prop-2-en-1-one","InChI=1S/C26H25F6NO3S2/c27-25(28,29)23-17(6-8-22(34)33-11-13-35-14-12-33)5-7-21(24(23)26(30,31)32)38-20-4-2-1-3-19(20)36-18-9-15-37-16-10-18/h1-8,18H,9-16H2/b8-6+",ZZSDJBZHPJZXBL-SOFGYWHQSA-N,1,0,0,0,LFA / ICAM,7.26,immune system disease,Inhibition,
1327,44579295,521080,24717887,CCN1CCC(CC1)Nc1cccc(Sc2ccc(\C=C\C(=O)N3CCOCC3)c(c2C(F)(F)F)C(F)(F)F)c1,"(E)-3-[4-[3-[(1-ethylpiperidin-4-yl)amino]phenyl]sulfanyl-2,3-bis(trifluoromethyl)phenyl]-1-morpholin-4-ylprop-2-en-1-one","InChI=1S/C28H31F6N3O2S/c1-2-36-12-10-20(11-13-36)35-21-4-3-5-22(18-21)40-23-8-6-19(7-9-24(38)37-14-16-39-17-15-37)25(27(29,30)31)26(23)28(32,33)34/h3-9,18,20,35H,2,10-17H2,1H3/b9-7+",VDABXUWSEUQIIC-VQHVLOKHSA-N,1,0,0,0,LFA / ICAM,8.85,immune system disease,Inhibition,
1328,25195345,479725,24698454,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CC[C@H]2CC[C@H](NC(=O)C(c3ccccc3)c3ccccc3)[C@@H]12)C(C)(C)C,"(2S)-N-[(2S)-1-[(3aR,6S,6aS)-6-[(2,2-diphenylacetyl)amino]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]-2-(methylamino)propanamide","InChI=1S/C31H42N4O3/c1-20(32-5)28(36)34-27(31(2,3)4)30(38)35-19-18-23-16-17-24(26(23)35)33-29(37)25(21-12-8-6-9-13-21)22-14-10-7-11-15-22/h6-15,20,23-27,32H,16-19H2,1-5H3,(H,33,37)(H,34,36)/t20-,23+,24-,26-,27+/m0/s1",BGWQMUKSEXDJIL-PCVPZPMISA-N,1,0,0,0,XIAP / Smac,6.24,cancer,Inhibition,
1329,506331,583905,442162,COc1cccc2[nH]cc(C(=O)C(=O)N3CCN(C[C@@H]3C)C(=O)c3ccccc3)c12,"1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-(4-methoxy-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C23H23N3O4/c1-15-14-25(22(28)16-7-4-3-5-8-16)11-12-26(15)23(29)21(27)17-13-24-18-9-6-10-19(30-2)20(17)18/h3-10,13,15,24H,11-12,14H2,1-2H3/t15-/m0/s1",YWHUPMDHHBIXPR-HNNXBMFYSA-N,0,1,0,0,CD4 / gp120,8.48,HIV infectious disease,Inhibition,
1330,10174985,104746,8350490,Cn1nc(cc1C1CCN(CC1)C(=O)CNC(=O)[C@H](NC(N)=N)C1CCCCC1)-c1cccc(Cl)c1Cl,"(2R)-2-cyclohexyl-2-(diaminomethylideneamino)-N-[2-[4-[5-(2,3-dichlorophenyl)-2-methylpyrazol-3-yl]piperidin-1-yl]-2-oxoethyl]acetamide","InChI=1S/C26H35Cl2N7O2/c1-34-21(14-20(33-34)18-8-5-9-19(27)23(18)28)16-10-12-35(13-11-16)22(36)15-31-25(37)24(32-26(29)30)17-6-3-2-4-7-17/h5,8-9,14,16-17,24H,2-4,6-7,10-13,15H2,1H3,(H,31,37)(H4,29,30,32)/t24-/m1/s1",OHLPPOJSJOMOGA-XMMPIXPASA-N,1,0,0,0,IL2 / IL2R,4.70,immune system disease,Inhibition,
1331,98468672,,20190372,COc1ccc(cc1)[C@@H]1C2=C(N=c3s\c(=C/c4ccc(o4)-c4cc(C(O)=O)ccc4C)c(=O)n13)c1ccccc1CC2,,"InChI=1S/C34H26N2O5S/c1-19-7-8-22(33(38)39)17-27(19)28-16-14-24(41-28)18-29-32(37)36-31(21-9-12-23(40-2)13-10-21)26-15-11-20-5-3-4-6-25(20)30(26)35-34(36)42-29/h3-10,12-14,16-18,31H,11,15H2,1-2H3,(H,38,39)/b29-18-/t31-/m1/s1",MWEMCUVTSAVODL-IMUCPKNRSA-N,3,0,0,0,BCL2-Like / BAX,5.16,cancer,Inhibition,
1332,12109929,440377,23245214,CNC(=O)[C@H](Cc1ccc2ccccc2c1)N1CCC(=O)N(CCc2cnc3ccccc3c2)[C@@H](CC(C)C)C1=O,"(2S)-N-methyl-2-[(3S)-3-(2-methylpropyl)-2,5-dioxo-4-(2-quinolin-3-ylethyl)-1,4-diazepan-1-yl]-3-naphthalen-2-ylpropanamide","InChI=1S/C34H38N4O3/c1-23(2)18-31-34(41)38(30(33(40)35-3)21-24-12-13-26-8-4-5-9-27(26)19-24)17-15-32(39)37(31)16-14-25-20-28-10-6-7-11-29(28)36-22-25/h4-13,19-20,22-23,30-31H,14-18,21H2,1-3H3,(H,35,40)/t30-,31-/m0/s1",PIDWOXMITGALID-CONSDPRKSA-N,1,0,0,0,LFA / ICAM,6.05,immune system disease,Inhibition,
1333,168317996,,11544251,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1ccnc(c1)N1CCC[C@@H](C1)C(O)=O,1-[4-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyridin-2-yl]piperidine-3-carboxylic acid,"InChI=1S/C27H27F3N2O2S/c1-17(2)21-7-3-4-8-23(21)35-24-10-9-18(14-22(24)27(28,29)30)19-11-12-31-25(15-19)32-13-5-6-20(16-32)26(33)34/h3-4,7-12,14-15,17,20H,5-6,13,16H2,1-2H3,(H,33,34)/t20-/m0/s1",SKCJPAKVOZQNSP-FQEVSTJZSA-N,0,1,0,0,LFA / ICAM,7.37,immune system disease,Inhibition,
1334,11953136,210853,10127445,C[C@@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)N(CCN2CCOCC2)c2ccc(I)cc2C1=O)c1cc(F)c(Cl)cc1N,"(3S)-4-[(1R)-1-(2-amino-4-chloro-5-fluorophenyl)ethyl]-3-(4-chlorophenyl)-7-iodo-1-(2-morpholin-4-ylethyl)-3H-1,4-benzodiazepine-2,5-dione","InChI=1S/C29H28Cl2FIN4O3/c1-17(21-15-24(32)23(31)16-25(21)34)37-27(18-2-4-19(30)5-3-18)29(39)36(9-8-35-10-12-40-13-11-35)26-7-6-20(33)14-22(26)28(37)38/h2-7,14-17,27H,8-13,34H2,1H3/t17-,27+/m1/s1",RETYZFIEVMZHPB-CRYYWNKWSA-N,1,0,0,0,MDM2-Like / P53,5.59,cancer,Inhibition,
1335,168317995,,9402852,CCOc1cc(ccc1C1=N[C@H]([C@@H](N1C(=O)N1CCN(CC1)S(=O)(=O)C(C)C)c1ccc(Cl)cc1)c1ccc(Cl)cc1)C(F)(F)F,"[4,5-bis(4-chlorophenyl)-2-[2-ethoxy-4-(trifluoromethyl)phenyl]-4,5-dihydroimidazol-1-yl]-(4-propan-2-ylsulfonylpiperazin-1-yl)methanone","InChI=1S/C32H33Cl2F3N4O4S/c1-4-45-27-19-23(32(35,36)37)9-14-26(27)30-38-28(21-5-10-24(33)11-6-21)29(22-7-12-25(34)13-8-22)41(30)31(42)39-15-17-40(18-16-39)46(43,44)20(2)3/h5-14,19-20,28-29H,4,15-18H2,1-3H3/t28-,29-/m0/s1",XUMOWPYPPBBYGC-VMPREFPWSA-N,1,0,0,0,MDM2-Like / P53,7.00,cancer,Inhibition,
1336,58894228,,,CCOc1cc(ccc1C1=N[C@](C)([C@H](N1C(=O)N1CCN(CC1)C(C)=O)c1ccc(Cl)cc1)c1ccc(Cl)cc1)C(C)(C)C,"1-[4-[(4R,5S)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-5-methyl-4H-imidazole-3-carbonyl]piperazin-1-yl]ethanone","InChI=1S/C35H40Cl2N4O3/c1-7-44-30-22-26(34(3,4)5)12-17-29(30)32-38-35(6,25-10-15-28(37)16-11-25)31(24-8-13-27(36)14-9-24)41(32)33(43)40-20-18-39(19-21-40)23(2)42/h8-17,22,31H,7,18-21H2,1-6H3/t31-,35+/m1/s1",QMBJAMGUDSEDAM-NQVJXQQZSA-N,1,0,0,0,MDM2-Like / P53,6.97,cancer,Inhibition,
1337,11450670,180306,9625522,CC(C)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C,(2S)-1-[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-3-methylbutanoyl]-N-(2-methylpropyl)pyrrolidine-2-carboxamide,"InChI=1S/C17H32N4O3/c1-10(2)9-19-16(23)13-7-6-8-21(13)17(24)14(11(3)4)20-15(22)12(5)18/h10-14H,6-9,18H2,1-5H3,(H,19,23)(H,20,22)/t12-,13-,14-/m0/s1",TWHNXFZXAMDVAL-IHRRRGAJSA-N,1,0,0,0,XIAP / Smac,4.87,cancer,Inhibition,
1338,58678622,,,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(cs1)-c1coc2ccccc12)C(C)(C)C,"(2S)-N-[(2S)-1-[(2S)-2-[4-(1-benzofuran-3-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]-2-(methylamino)propanamide","InChI=1S/C25H32N4O3S/c1-15(26-5)22(30)28-21(25(2,3)4)24(31)29-12-8-10-19(29)23-27-18(14-33-23)17-13-32-20-11-7-6-9-16(17)20/h6-7,9,11,13-15,19,21,26H,8,10,12H2,1-5H3,(H,28,30)/t15-,19-,21+/m0/s1",AUCLRKHFTGXCEU-PAXLWEDBSA-N,1,0,0,0,XIAP / Smac,6.89,cancer,Inhibition,
1339,44390694,179931,23246717,OC(=O)[C@@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)Nc2ccc(I)cc2C1=O)c1ccccc1Cl,"2-(2-chlorophenyl)-2-[3-(4-chlorophenyl)-7-iodo-2,5-dioxo-1,3-dihydro-1,4-benzodiazepin-4-yl]acetic acid","InChI=1S/C23H15Cl2IN2O4/c24-13-7-5-12(6-8-13)19-21(29)27-18-10-9-14(26)11-16(18)22(30)28(19)20(23(31)32)15-3-1-2-4-17(15)25/h1-11,19-20H,(H,27,29)(H,31,32)/t19-,20-/m0/s1",XRGBLARSTALKEC-PMACEKPBSA-N,1,0,0,0,MDM2-Like / P53,4.70,cancer,Inhibition,
1340,44392017,182126,23248090,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1ccnc(c1)N1CCC(O)CC1,1-[4-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyridin-2-yl]piperidin-4-ol,"InChI=1S/C26H27F3N2OS/c1-17(2)21-5-3-4-6-23(21)33-24-8-7-18(15-22(24)26(27,28)29)19-9-12-30-25(16-19)31-13-10-20(32)11-14-31/h3-9,12,15-17,20,32H,10-11,13-14H2,1-2H3",KQGLUKKEGLGGPO-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,7.12,immune system disease,Inhibition,
1341,11656659,477593,9831397,FC(F)(F)c1c(Sc2cccc(NC3CCC3)c2)ccc(\C=C\C(=O)N2CCOCC2)c1C(F)(F)F,"(E)-3-[4-[3-(cyclobutylamino)phenyl]sulfanyl-2,3-bis(trifluoromethyl)phenyl]-1-morpholin-4-ylprop-2-en-1-one","InChI=1S/C25H24F6N2O2S/c26-24(27,28)22-16(8-10-21(34)33-11-13-35-14-12-33)7-9-20(23(22)25(29,30)31)36-19-6-2-5-18(15-19)32-17-3-1-4-17/h2,5-10,15,17,32H,1,3-4,11-14H2/b10-8+",NPMNYUOXEKFFIQ-CSKARUKUSA-N,1,0,0,0,LFA / ICAM,7.72,immune system disease,Inhibition,
1342,44818497,570902,24633832,CCCNc1nc(NCc2ccc(NC(=O)c3ccc(F)cc3)cc2)c2ccc(C)cc2n1,4-fluoro-N-[4-[[[7-methyl-2-(propylamino)quinazolin-4-yl]amino]methyl]phenyl]benzamide,"InChI=1S/C26H26FN5O/c1-3-14-28-26-31-23-15-17(2)4-13-22(23)24(32-26)29-16-18-5-11-21(12-6-18)30-25(33)19-7-9-20(27)10-8-19/h4-13,15H,3,14,16H2,1-2H3,(H,30,33)(H2,28,29,31,32)",HRAUHIORVNXMMW-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,6.30,cancer,Inhibition,
1343,12096158,,19528229,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2cccc(c2)C(=O)N2CCOCC2)c1=O,"6-methyl-2-[3-(morpholine-4-carbonyl)phenyl]-4-[3-(trifluoromethyl)phenyl]-1H-dipyrazolo[4,3-b:4',5'-e]pyridin-3-one","InChI=1S/C26H21F3N6O3/c1-33-23-19(14-30-33)22-20(21(31-23)15-4-2-6-17(12-15)26(27,28)29)25(37)35(32-22)18-7-3-5-16(13-18)24(36)34-8-10-38-11-9-34/h2-7,12-14,32H,8-11H2,1H3",CMPIUAAHUWOZFB-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.27,cancer,Inhibition,
1344,168317992,,,CC[C@H](N)C(=O)N[C@H]1[C@@H](CN(C)CC)CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,,"InChI=1S/C31H43N5O3/c1-4-25(32)29(37)34-28-23(20-35(3)5-2)16-17-24-18-19-26(36(24)31(28)39)30(38)33-27(21-12-8-6-9-13-21)22-14-10-7-11-15-22/h6-15,23-28H,4-5,16-20,32H2,1-3H3,(H,33,38)(H,34,37)/t23-,24+,25+,26+,28+/m1/s1",YPVSPYAAZXAWKM-VETGFMSWSA-N,1,0,0,0,XIAP / Smac,6.43,cancer,Inhibition,
1345,168317991,,26363182,CC(C)(C)c1ccc(cc1)[C@](O)(CCN1CCOCC1)c1ccc(Cl)c(CCOc2ccc(cc2)-c2ccc(cc2)C(O)=O)c1,4-[4-[2-[5-[1-(4-tert-butylphenyl)-1-hydroxy-3-morpholin-4-ylpropyl]-2-chlorophenyl]ethoxy]phenyl]benzoic acid,"InChI=1S/C38H42ClNO5/c1-37(2,3)31-10-12-32(13-11-31)38(43,19-20-40-21-24-44-25-22-40)33-14-17-35(39)30(26-33)18-23-45-34-15-8-28(9-16-34)27-4-6-29(7-5-27)36(41)42/h4-17,26,43H,18-25H2,1-3H3,(H,41,42)/t38-/m1/s1",DKTLTMZXRUAZAB-KXQOOQHDSA-N,1,0,0,0,BCL2-Like / BAX,6.96,cancer,Inhibition,
1346,168317990,,,C[C@H](N)C(=O)N[C@@H](Cc1cccc(c1)C(N)=O)C(=O)N1C[C@H]([C@@H]1c1ccccc1)C(=O)N[C@H]1CCc2ccccc12,"1-[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-3-(3-carbamoylphenyl)propanoyl]-N-[(1S)-2,3-dihydro-1H-inden-1-yl]-2-phenylazetidine-3-carboxamide","InChI=1S/C32H35N5O4/c1-19(33)30(39)36-27(17-20-8-7-12-23(16-20)29(34)38)32(41)37-18-25(28(37)22-10-3-2-4-11-22)31(40)35-26-15-14-21-9-5-6-13-24(21)26/h2-13,16,19,25-28H,14-15,17-18,33H2,1H3,(H2,34,38)(H,35,40)(H,36,39)/t19-,25+,26-,27-,28-/m0/s1",KIZPRSYGYKLCEQ-FZHCFFITSA-N,1,0,0,0,XIAP / Smac,8.00,cancer,Inhibition,
1347,25218682,457671,24690222,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1CNC(=O)C(c1ccccc1)c1ccccc1)C(C)(C)C,"(2S)-N-[(2S)-1-[(2S)-2-[[(2,2-diphenylacetyl)amino]methyl]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]-2-(methylamino)propanamide","InChI=1S/C29H40N4O3/c1-20(30-5)26(34)32-25(29(2,3)4)28(36)33-18-12-17-23(33)19-31-27(35)24(21-13-8-6-9-14-21)22-15-10-7-11-16-22/h6-11,13-16,20,23-25,30H,12,17-19H2,1-5H3,(H,31,35)(H,32,34)/t20-,23-,25+/m0/s1",PUCIIZPAQVRBTQ-GRYUFTJMSA-N,1,0,0,0,XIAP / Smac,5.52,cancer,Inhibition,
1348,168317989,,,C[C@H](N)C(=O)N[C@@H](Cc1cccc(c1)C(N)=O)C(=O)N1C[C@H](C[C@H]1C(=O)N[C@@H]1CCc2ccccc12)c1ccccc1,"(2S,4R)-1-[(2S)-2-[[(2R)-2-aminopropanoyl]amino]-3-(3-carbamoylphenyl)propanoyl]-N-[(1R)-2,3-dihydro-1H-inden-1-yl]-4-phenylpyrrolidine-2-carboxamide","InChI=1S/C33H37N5O4/c1-20(34)31(40)37-28(17-21-8-7-12-24(16-21)30(35)39)33(42)38-19-25(22-9-3-2-4-10-22)18-29(38)32(41)36-27-15-14-23-11-5-6-13-26(23)27/h2-13,16,20,25,27-29H,14-15,17-19,34H2,1H3,(H2,35,39)(H,36,41)(H,37,40)/t20-,25-,27+,28-,29-/m0/s1",MJRZWEICTYDVRH-GYNMRXATSA-N,1,0,0,0,XIAP / Smac,8.00,cancer,Inhibition,
1349,25026518,569231,24630541,CCc1ccc2c(NCc3ccc(NC(=O)c4ccc(F)cc4)cc3)nc(nc2c1)N(C)C,N-[4-[[[2-(dimethylamino)-7-ethylquinazolin-4-yl]amino]methyl]phenyl]-4-fluorobenzamide,"InChI=1S/C26H26FN5O/c1-4-17-7-14-22-23(15-17)30-26(32(2)3)31-24(22)28-16-18-5-12-21(13-6-18)29-25(33)19-8-10-20(27)11-9-19/h5-15H,4,16H2,1-3H3,(H,29,33)(H,28,30,31)",NGLYERQRYRDLCH-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,6.47,cancer,Inhibition,
1350,16109159,221854,17266572,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(Cc2ccccc2C(F)(F)F)CC1,N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonyl-4-[4-[[2-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]benzamide,"InChI=1S/C37H41F3N6O5S2/c1-43(2)19-18-29(26-52-31-9-4-3-5-10-31)41-34-17-16-32(24-35(34)46(48)49)53(50,51)42-36(47)27-12-14-30(15-13-27)45-22-20-44(21-23-45)25-28-8-6-7-11-33(28)37(38,39)40/h3-17,24,29,41H,18-23,25-26H2,1-2H3,(H,42,47)/t29-/m1/s1",UHIJFHPHVXEEAI-GDLZYMKVSA-N,2,0,0,0,BCL2-Like / BAX,9.30,cancer,Inhibition,
1351,44549489,,,CN1c2ncnn2[C@H](C2=C1c1ccccc1O[C@@H]2c1ccc(C)cc1)c1ccc(Br)cc1,,"InChI=1S/C26H21BrN4O/c1-16-7-9-18(10-8-16)25-22-23(17-11-13-19(27)14-12-17)31-26(28-15-29-31)30(2)24(22)20-5-3-4-6-21(20)32-25/h3-15,23,25H,1-2H3/t23-,25+/m0/s1",RLLRTIHIPONYTN-UKILVPOCSA-N,1,0,0,0,MDM2-Like / P53,5.33,cancer,Inhibition,
1352,506245,494164,442076,Fc1cc2[nH]cc(C(=O)C(=O)N3CCN(CC3)C(=O)c3ccccc3)c2c(F)c1Br,"1-(4-benzoylpiperazin-1-yl)-2-(5-bromo-4,6-difluoro-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C21H16BrF2N3O3/c22-17-14(23)10-15-16(18(17)24)13(11-25-15)19(28)21(30)27-8-6-26(7-9-27)20(29)12-4-2-1-3-5-12/h1-5,10-11,25H,6-9H2",VQHPYJKASGDEHP-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,7.64,HIV infectious disease,Inhibition,
1353,44391981,183506,23248063,COc1ccccc1Sc1ccc(cc1C(F)(F)F)-c1ccnc(c1)N1CC[C@H](C1)NC(C)=O,N-[1-[4-[4-(2-methoxyphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyridin-2-yl]pyrrolidin-3-yl]acetamide,"InChI=1S/C25H24F3N3O2S/c1-16(32)30-19-10-12-31(15-19)24-14-18(9-11-29-24)17-7-8-22(20(13-17)25(26,27)28)34-23-6-4-3-5-21(23)33-2/h3-9,11,13-14,19H,10,12,15H2,1-2H3,(H,30,32)/t19-/m1/s1",ZBALKPBJFFDXAB-LJQANCHMSA-N,0,1,0,0,LFA / ICAM,7.06,immune system disease,Inhibition,
1354,66616453,,,Cc1ccc(cc1)S(=O)(=O)N(Cc1ccc(F)cc1)Cc1cc(CNS(=O)(=O)c2cc(Cl)cc(Cl)c2O)cc(c1)-c1ccc(F)cc1,,"InChI=1S/C34H28Cl2F2N2O5S2/c1-22-2-12-31(13-3-22)47(44,45)40(20-23-4-8-29(37)9-5-23)21-25-14-24(15-27(16-25)26-6-10-30(38)11-7-26)19-39-46(42,43)33-18-28(35)17-32(36)34(33)41/h2-18,39,41H,19-21H2,1H3",LVCRHVFSAGNIEE-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,7.70,cancer,Inhibition,
1355,46220745,1096053,24679906,CN1C(=O)N(C(=O)[C@]11CN(C[C@H]1c1ccc(cc1)C#N)c1ccc(nn1)C(O)=O)c1cc(Cl)cc(Cl)c1,"6-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl]pyridazine-3-carboxylic acid","InChI=1S/C25H18Cl2N6O4/c1-31-24(37)33(18-9-16(26)8-17(27)10-18)23(36)25(31)13-32(21-7-6-20(22(34)35)29-30-21)12-19(25)15-4-2-14(11-28)3-5-15/h2-10,19H,12-13H2,1H3,(H,34,35)/t19-,25+/m0/s1",FUVZQLIZJXPMIS-UQBPGWFLSA-N,1,0,0,0,LFA / ICAM,7.89,immune system disease,Inhibition,
1356,168317988,,9691634,O[C@@H]1CCCc2c(Nc3ccc(NCCc4c[nH]c5ccccc45)cc3)ccnc12,"4-[4-[2-(1H-indol-3-yl)ethylamino]anilino]-5,6,7,8-tetrahydroquinolin-8-ol","InChI=1S/C25H26N4O/c30-24-7-3-5-21-23(13-15-27-25(21)24)29-19-10-8-18(9-11-19)26-14-12-17-16-28-22-6-2-1-4-20(17)22/h1-2,4,6,8-11,13,15-16,24,26,28,30H,3,5,7,12,14H2,(H,27,29)/t24-/m1/s1",YRYJBIZQHGZTTN-XMMPIXPASA-N,1,1,0,0,MDM2-Like / P53,7.10,cancer,Inhibition,
1357,57737535,,,C(Cc1coc2ccccc12)Nc1ccc(Nc2ccncc2)cc1,"1-N-[2-(1-benzofuran-3-yl)ethyl]-4-N-pyridin-4-ylbenzene-1,4-diamine","InChI=1S/C21H19N3O/c1-2-4-21-20(3-1)16(15-25-21)9-14-23-17-5-7-18(8-6-17)24-19-10-12-22-13-11-19/h1-8,10-13,15,23H,9,14H2,(H,22,24)",JTXRVUVVKWTJGN-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,5.49,cancer,Inhibition,
1358,58007010,,,CC(C)C1=C(SC2=N[C@](C)([C@H](N12)c1ccc(Cl)cc1)c1ccc(Cl)cc1)C(=O)N1CCC[C@H]1c1nnn[nH]1,"[(5R,6S)-5,6-bis(4-chlorophenyl)-6-methyl-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazol-2-yl]-[(2S)-2-(2H-tetrazol-5-yl)pyrrolidin-1-yl]methanone","InChI=1S/C27H27Cl2N7OS/c1-15(2)21-22(25(37)35-14-4-5-20(35)24-31-33-34-32-24)38-26-30-27(3,17-8-12-19(29)13-9-17)23(36(21)26)16-6-10-18(28)11-7-16/h6-13,15,20,23H,4-5,14H2,1-3H3,(H,31,32,33,34)/t20-,23+,27-/m0/s1",REHKEFZCVMTLBW-OSADXMDESA-N,1,0,0,0,MDM2-Like / P53,6.71,cancer,Inhibition,
1359,9804074,,7979834,Clc1cc(Cl)cc(c1)N1C(=O)[C@@H]2C[C@@H](CN2C1=O)Oc1ccc(Br)cc1,"(6S,7aS)-6-(4-bromophenoxy)-2-(3,5-dichlorophenyl)-5,6,7,7a-tetrahydropyrrolo[1,2-c]imidazole-1,3-dione","InChI=1S/C18H13BrCl2N2O3/c19-10-1-3-14(4-2-10)26-15-8-16-17(24)23(18(25)22(16)9-15)13-6-11(20)5-12(21)7-13/h1-7,15-16H,8-9H2/t15-,16-/m0/s1",YAIIYQQJBPVSEB-HOTGVXAUSA-N,0,1,0,0,LFA / ICAM,6.32,immune system disease,Inhibition,
1360,44818495,569533,24632613,CNc1nc(NCc2ccc(NC(=O)c3ccc(Cl)nc3)cc2)c2c(C)cccc2n1,6-chloro-N-[4-[[[5-methyl-2-(methylamino)quinazolin-4-yl]amino]methyl]phenyl]pyridine-3-carboxamide,"InChI=1S/C23H21ClN6O/c1-14-4-3-5-18-20(14)21(30-23(25-2)29-18)27-12-15-6-9-17(10-7-15)28-22(31)16-8-11-19(24)26-13-16/h3-11,13H,12H2,1-2H3,(H,28,31)(H2,25,27,29,30)",LLKZNBPLCIOFFO-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,6.33,cancer,Inhibition,
1361,67032257,,,CN1CCN(Cc2ccc(Cl)cc2-c2c(nc(-c3ccccc3)n2-c2cccc(Cl)c2F)C(N)=O)CC1,,"InChI=1S/C28H26Cl2FN5O/c1-34-12-14-35(15-13-34)17-19-10-11-20(29)16-21(19)26-25(27(32)37)33-28(18-6-3-2-4-7-18)36(26)23-9-5-8-22(30)24(23)31/h2-11,16H,12-15,17H2,1H3,(H2,32,37)",ZNPZSEVYHJBEAT-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,7.04,cancer,Inhibition,
1362,11635371,214529,9810115,CN1C(=O)N(C(=O)[C@]11CN(Cc2cc(cs2)C(O)=O)C[C@H]1c1ccc(cc1)C#N)c1cc(Cl)cc(Cl)c1,"5-[[(9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl]methyl]thiophene-3-carboxylic acid","InChI=1S/C26H20Cl2N4O4S/c1-30-25(36)32(20-8-18(27)7-19(28)9-20)24(35)26(30)14-31(11-21-6-17(13-37-21)23(33)34)12-22(26)16-4-2-15(10-29)3-5-16/h2-9,13,22H,11-12,14H2,1H3,(H,33,34)/t22-,26+/m0/s1",NXNKJLOEGWSJGI-BKMJKUGQSA-N,1,0,0,0,LFA / ICAM,7.70,immune system disease,Inhibition,
1363,44305038,303304,23155895,OC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1ccc(Cl)cc1Cl,"2-[(2,4-dichlorobenzoyl)amino]-3-(1H-indol-3-yl)propanoic acid","InChI=1S/C18H14Cl2N2O3/c19-11-5-6-13(14(20)8-11)17(23)22-16(18(24)25)7-10-9-21-15-4-2-1-3-12(10)15/h1-6,8-9,16,21H,7H2,(H,22,23)(H,24,25)/t16-/m0/s1",PSRCDVYHEDLGJM-INIZCTEOSA-N,1,0,0,0,LFA / ICAM,5.08,immune system disease,Inhibition,
1364,67954245,,,COc1ccc(Cl)cc1-c1c(nc(-c2cccc(C)c2)n1-c1cc(Cl)ccc1C)C#N,,"InChI=1S/C25H19Cl2N3O/c1-15-5-4-6-17(11-15)25-29-21(14-28)24(20-12-18(26)9-10-23(20)31-3)30(25)22-13-19(27)8-7-16(22)2/h4-13H,1-3H3",FHYTWNSDJXSZFB-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,5.51,cancer,Inhibition,
1365,168317981,,,Fc1cc(Br)ccc1N[C@@]1(Cc2cccc(Cl)c2)C(=O)Nc2cc(Cl)ccc12,3-(4-bromo-2-fluoroanilino)-6-chloro-3-[(3-chlorophenyl)methyl]-1H-indol-2-one,"InChI=1S/C21H14BrCl2FN2O/c22-13-4-7-18(17(25)9-13)27-21(11-12-2-1-3-14(23)8-12)16-6-5-15(24)10-19(16)26-20(21)28/h1-10,27H,11H2,(H,26,28)/t21-/m1/s1",ZQKRMZWELWIAAB-OAQYLSRUSA-N,1,0,0,0,MDM2-Like / P53,8.43,cancer,Inhibition,
1366,66987559,,,Clc1ccc(Cn2cnc(c2-c2c([nH]c3cc(Cl)ccc23)C(=O)NCCN2CCN(Cc3ccccn3)C2=O)-c2ccccc2)cc1,,"InChI=1S/C36H31Cl2N7O2/c37-26-11-9-24(10-12-26)21-45-23-41-32(25-6-2-1-3-7-25)34(45)31-29-14-13-27(38)20-30(29)42-33(31)35(46)40-16-17-43-18-19-44(36(43)47)22-28-8-4-5-15-39-28/h1-15,20,23,42H,16-19,21-22H2,(H,40,46)",ZBXBXODDPJOMQW-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,6.72,cancer,Inhibition,
1367,12096169,,,CC(=O)c1cccc(NC(=O)c2ccc(cc2)-n2[nH]c3c4cnn(C)c4nc(-c4cccc(c4)C(F)(F)F)c3c2=O)c1,,"InChI=1S/C30H21F3N6O3/c1-16(40)18-5-4-8-21(14-18)35-28(41)17-9-11-22(12-10-17)39-29(42)24-25(19-6-3-7-20(13-19)30(31,32)33)36-27-23(26(24)37-39)15-34-38(27)2/h3-15,37H,1-2H3,(H,35,41)",NZTMTUIICVHLMI-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.36,cancer,Inhibition,
1368,25138064,488796,24704404,CC[C@H](N)C(=O)N[C@H]1CCCC[C@H]2CC[C@H](N2C1=O)C(=O)N[C@@H](c1ccccc1)c1ccc2ccccc2c1,"(3S,6S,10aS)-6-[[(2S)-2-aminobutanoyl]amino]-N-[(R)-naphthalen-2-yl(phenyl)methyl]-5-oxo-2,3,6,7,8,9,10,10a-octahydro-1H-pyrrolo[1,2-a]azocine-3-carboxamide","InChI=1S/C32H38N4O3/c1-2-26(33)30(37)34-27-15-9-8-14-25-18-19-28(36(25)32(27)39)31(38)35-29(22-11-4-3-5-12-22)24-17-16-21-10-6-7-13-23(21)20-24/h3-7,10-13,16-17,20,25-29H,2,8-9,14-15,18-19,33H2,1H3,(H,34,37)(H,35,38)/t25-,26-,27-,28-,29-/m0/s1",MKYCFUQCPNJXDQ-ZIUUJSQJSA-N,1,0,0,0,XIAP / Smac,7.33,cancer,Inhibition,
1369,58436641,,,CNC(=O)[C@@H]1C[C@@H](CN1C(=O)[C@@H]1C[C@@H](CN1C(=O)[C@H](Cc1ccco1)NC(=O)[C@H](C)N)c1ccccc1)c1ccccc1,"(2S,4R)-1-[(2S,4R)-1-[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-3-(furan-2-yl)propanoyl]-4-phenylpyrrolidine-2-carbonyl]-N-methyl-4-phenylpyrrolidine-2-carboxamide","InChI=1S/C33H39N5O5/c1-21(34)30(39)36-27(18-26-14-9-15-43-26)32(41)38-20-25(23-12-7-4-8-13-23)17-29(38)33(42)37-19-24(16-28(37)31(40)35-2)22-10-5-3-6-11-22/h3-15,21,24-25,27-29H,16-20,34H2,1-2H3,(H,35,40)(H,36,39)/t21-,24-,25-,27-,28-,29-/m0/s1",ZQHAPJQAUKHRKR-YGQTVEAASA-N,1,0,0,0,XIAP / Smac,8.00,cancer,Inhibition,
1370,506249,522022,442080,COc1ccc(Br)c2[nH]cc(C(=O)C(=O)N3CCN(CC3)C(=O)c3ccccc3)c12,"1-(4-benzoylpiperazin-1-yl)-2-(7-bromo-4-methoxy-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C22H20BrN3O4/c1-30-17-8-7-16(23)19-18(17)15(13-24-19)20(27)22(29)26-11-9-25(10-12-26)21(28)14-5-3-2-4-6-14/h2-8,13,24H,9-12H2,1H3",NLJKWZBNIWOQAT-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,9.89,HIV infectious disease,Inhibition,
1371,45138405,,,CN[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2C(C)=O)c1c[nH]c2ccc(F)cc12,"(2S)-N-[(2S)-1-[(3aR,6S,6aR)-4-acetyl-6-(5-fluoro-1H-indol-3-yl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-3-hydroxy-1-oxopropan-2-yl]-2-(methylamino)propanamide","InChI=1S/C23H30FN5O4/c1-12(25-3)22(32)27-19(11-30)23(33)28-7-6-20-21(28)17(10-29(20)13(2)31)16-9-26-18-5-4-14(24)8-15(16)18/h4-5,8-9,12,17,19-21,25-26,30H,6-7,10-11H2,1-3H3,(H,27,32)/t12-,17+,19-,20+,21+/m0/s1",KBWGUFLEFLHLMP-PTIDVGSXSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
1372,12096651,,,Clc1cc(Cl)cc(c1)N1C(=O)[C@@H]2C[C@@H](CN2C1=O)OCc1ccc(cc1)C#N,,"InChI=1S/C20H15Cl2N3O3/c21-14-5-15(22)7-16(6-14)25-19(26)18-8-17(10-24(18)20(25)27)28-11-13-3-1-12(9-23)2-4-13/h1-7,17-18H,8,10-11H2/t17-,18-/m0/s1",QONLKJZOZHCOBB-ROUUACIJSA-N,0,1,0,0,LFA / ICAM,6.57,immune system disease,Inhibition,
1373,168317985,,,CNC(=O)c1cc(OC)c(O[C@@H](C)C(=O)N2CCN(C[C@H]2C)c2nccc3cnccc23)cn1,,"InChI=1S/C24H28N6O4/c1-15-14-29(22-18-6-7-26-12-17(18)5-8-27-22)9-10-30(15)24(32)16(2)34-21-13-28-19(23(31)25-3)11-20(21)33-4/h5-8,11-13,15-16H,9-10,14H2,1-4H3,(H,25,31)/t15-,16+/m1/s1",ILRZGXUOQBZBAD-CVEARBPZSA-N,0,1,0,0,CD4 / gp120,7.54,HIV infectious disease,Inhibition,
1374,21060006,378851,19859814,C[C@@H](N1[C@H](c2ccc(Cl)cc2)C(=O)N(CCN2CCOCC2)c2ccc(I)cc2C1=O)c1ccc(Cl)cc1,"(3R)-3-(4-chlorophenyl)-4-[(1R)-1-(4-chlorophenyl)ethyl]-7-iodo-1-(2-morpholin-4-ylethyl)-3H-1,4-benzodiazepine-2,5-dione","InChI=1S/C29H28Cl2IN3O3/c1-19(20-2-6-22(30)7-3-20)35-27(21-4-8-23(31)9-5-21)29(37)34(13-12-33-14-16-38-17-15-33)26-11-10-24(32)18-25(26)28(35)36/h2-11,18-19,27H,12-17H2,1H3/t19-,27-/m1/s1",ATPRYWVAPFXDLB-XHCCPWGMSA-N,1,0,0,0,MDM2-Like / P53,5.20,cancer,Inhibition,
1375,16118979,,17276180,CCOc1cc(ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@](C)(N1C(=O)N1CCN(CC(N)=O)CC1)c1ccc(Cl)cc1)S(=O)(=O)N1CCCC1,"2-[4-[(4S,5R)-4,5-bis(4-chlorophenyl)-2-(2-ethoxy-4-pyrrolidin-1-ylsulfonylphenyl)-4,5-dimethylimidazole-1-carbonyl]piperazin-1-yl]acetamide","InChI=1S/C36H42Cl2N6O5S/c1-4-49-31-23-29(50(47,48)43-17-5-6-18-43)15-16-30(31)33-40-35(2,25-7-11-27(37)12-8-25)36(3,26-9-13-28(38)14-10-26)44(33)34(46)42-21-19-41(20-22-42)24-32(39)45/h7-16,23H,4-6,17-22,24H2,1-3H3,(H2,39,45)/t35-,36+/m0/s1",TZDPSOZRMMPYOY-MPQUPPDSSA-N,1,0,0,0,MDM2-Like / P53,7.77,cancer,Inhibition,
1376,71527971,2322028,,FC(F)(F)S(=O)(=O)c1cc(ccc1N[C@H](CCN1CCOCC1)CSc1ccccc1)S(=O)(=O)Nc1nnc2CN(CCn12)C1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1,,"InChI=1S/C44H50ClF3N8O5S3/c45-34-12-10-32(11-13-34)39-9-5-4-6-33(39)29-54-20-17-36(18-21-54)55-22-23-56-42(30-55)50-51-43(56)52-64(59,60)38-14-15-40(41(28-38)63(57,58)44(46,47)48)49-35(16-19-53-24-26-61-27-25-53)31-62-37-7-2-1-3-8-37/h1-15,28,35-36,49H,16-27,29-31H2,(H,51,52)/t35-/m1/s1",PBAFMRUUBPBFAP-PGUFJCEWSA-N,1,0,0,0,BCL2-Like / BAX,6.39,cancer,Inhibition,
1377,25000455,,,CC(C)(C)C[C@H]1N[C@H]([C@H](c2ccc(F)c(Cl)c2)[C@@]11C(=O)Nc2cc(Cl)c(F)cc12)C(=O)NCC(O)=O,"2-[[(2'R,3S,3'R,5'R)-6-chloro-3'-(3-chloro-4-fluorophenyl)-5'-(2,2-dimethylpropyl)-5-fluoro-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carbonyl]amino]acetic acid","InChI=1S/C25H25Cl2F2N3O4/c1-24(2,3)9-18-25(12-7-16(29)14(27)8-17(12)31-23(25)36)20(11-4-5-15(28)13(26)6-11)21(32-18)22(35)30-10-19(33)34/h4-8,18,20-21,32H,9-10H2,1-3H3,(H,30,35)(H,31,36)(H,33,34)/t18-,20+,21-,25+/m1/s1",PSHPYIYVPCHSIR-XYHMEGALSA-N,1,3,0,0,MDM2-Like / P53,6.46,cancer,Inhibition,
1378,506214,135339,442045,Fc1cccc2[nH]cc(C(=O)C(=O)N3CCN(CC3)C(=O)c3ccccc3)c12,"1-(4-benzoylpiperazin-1-yl)-2-(4-fluoro-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C21H18FN3O3/c22-16-7-4-8-17-18(16)15(13-23-17)19(26)21(28)25-11-9-24(10-12-25)20(27)14-5-2-1-3-6-14/h1-8,13,23H,9-12H2",XTGGYFJUBIZBKW-UHFFFAOYSA-N,0,2,0,0,CD4 / gp120,8.60,HIV infectious disease,Inhibition,
1379,25218664,458540,24691099,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CC[C@H]2CC[C@H](NC(=O)c3ccc(F)c4ccccc34)[C@@H]12)C(C)(C)C,"N-[(3aR,6S,6aS)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-6-yl]-4-fluoronaphthalene-1-carboxamide","InChI=1S/C28H37FN4O3/c1-16(30-5)25(34)32-24(28(2,3)4)27(36)33-15-14-17-10-13-22(23(17)33)31-26(35)20-11-12-21(29)19-9-7-6-8-18(19)20/h6-9,11-12,16-17,22-24,30H,10,13-15H2,1-5H3,(H,31,35)(H,32,34)/t16-,17+,22-,23-,24+/m0/s1",YAJNIUXPYCFLBK-SBWRPUSSSA-N,1,0,0,0,XIAP / Smac,6.68,cancer,Inhibition,
1380,44818498,569004,24632250,Cc1ccc2c(NCc3ccc(NC(=O)c4ccc(F)cc4)cc3)nc(nc2c1)N1CCC1,N-[4-[[[2-(azetidin-1-yl)-7-methylquinazolin-4-yl]amino]methyl]phenyl]-4-fluorobenzamide,"InChI=1S/C26H24FN5O/c1-17-3-12-22-23(15-17)30-26(32-13-2-14-32)31-24(22)28-16-18-4-10-21(11-5-18)29-25(33)19-6-8-20(27)9-7-19/h3-12,15H,2,13-14,16H2,1H3,(H,29,33)(H,28,30,31)",LRLFSSDGEWJOLP-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,6.52,cancer,Inhibition,
1381,168317984,,,CC(C)C1=C(SC2=N[C@](C)([C@@H](N12)c1ccc(Cl)cc1)c1ccc(Cl)cc1)C(=O)N1CC(=O)NC(C)(C)C1,"4-[5,6-bis(4-chlorophenyl)-6-methyl-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazole-2-carbonyl]-6,6-dimethylpiperazin-2-one","InChI=1S/C28H30Cl2N4O2S/c1-16(2)22-23(25(36)33-14-21(35)31-27(3,4)15-33)37-26-32-28(5,18-8-12-20(30)13-9-18)24(34(22)26)17-6-10-19(29)11-7-17/h6-13,16,24H,14-15H2,1-5H3,(H,31,35)/t24-,28-/m0/s1",BNAFYPWGECGENQ-CUBQBAPOSA-N,1,0,0,0,MDM2-Like / P53,7.34,cancer,Inhibition,
1382,168317983,,,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(F)c(c2)C(=O)N2CCOCC2)c1=O,,"InChI=1S/C26H20F4N6O3/c1-34-23-18(13-31-34)22-20(21(32-23)14-3-2-4-15(11-14)26(28,29)30)25(38)36(33-22)16-5-6-19(27)17(12-16)24(37)35-7-9-39-10-8-35/h2-6,11-13,33H,7-10H2,1H3",WSRPYYFLYDRPLH-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,5.62,cancer,Inhibition,
1383,44595254,,,OCCN(Cc1ccc(CN(Cc2ccc(F)cc2)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)cc1)S(=O)(=O)c1cc(Cl)cc(Cl)c1,"3,5-dichloro-N-[[4-[[(3,5-dichlorophenyl)sulfonyl-(2-hydroxyethyl)amino]methyl]phenyl]methyl]-N-[(4-fluorophenyl)methyl]-2-hydroxybenzenesulfonamide","InChI=1S/C29H25Cl4FN2O6S2/c30-22-11-23(31)13-26(12-22)43(39,40)35(9-10-37)16-19-1-3-20(4-2-19)17-36(18-21-5-7-25(34)8-6-21)44(41,42)28-15-24(32)14-27(33)29(28)38/h1-8,11-15,37-38H,9-10,16-18H2",YQBSFCVKPQCGKT-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,6.36,cancer,Inhibition,
1384,44391950,183444,23248036,O[C@@H]1C[C@H](N(C1)c1cc(ccn1)-c1ccc(Sc2ccc3OCCOc3c2)c(c1)C(F)(F)F)C(O)=O,"(2S,4R)-1-[4-[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfanyl)-3-(trifluoromethyl)phenyl]pyridin-2-yl]-4-hydroxypyrrolidine-2-carboxylic acid","InChI=1S/C25H21F3N2O5S/c26-25(27,28)18-9-14(1-4-22(18)36-17-2-3-20-21(12-17)35-8-7-34-20)15-5-6-29-23(10-15)30-13-16(31)11-19(30)24(32)33/h1-6,9-10,12,16,19,31H,7-8,11,13H2,(H,32,33)/t16-,19+/m1/s1",JVFGBZRFEBWUBQ-APWZRJJASA-N,0,1,0,0,LFA / ICAM,6.72,immune system disease,Inhibition,
1385,11431434,,9606309,CC(C)CC[C@H]1N[C@H]([C@H](c2cccc(Cl)c2)[C@@]11C(=O)Nc2cc(Cl)ccc12)C(=O)N(C)C,"(2'R,3S,3'R,5'R)-6-chloro-3'-(3-chlorophenyl)-N,N-dimethyl-5'-(3-methylbutyl)-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide","InChI=1S/C25H29Cl2N3O2/c1-14(2)8-11-20-25(18-10-9-17(27)13-19(18)28-24(25)32)21(15-6-5-7-16(26)12-15)22(29-20)23(31)30(3)4/h5-7,9-10,12-14,20-22,29H,8,11H2,1-4H3,(H,28,32)/t20-,21+,22-,25+/m1/s1",OASBUJMRXJSSMB-FFHOAYQKSA-N,1,3,0,0,MDM2-Like / P53,6.41,cancer,Inhibition,
1386,44818857,568825,24632084,CN1CCN(CC1)c1nc(NCc2ccc(NC(=O)c3ccc(F)cc3)cc2)c2ccc(C)cc2n1,4-fluoro-N-[4-[[[7-methyl-2-(4-methylpiperazin-1-yl)quinazolin-4-yl]amino]methyl]phenyl]benzamide,"InChI=1S/C28H29FN6O/c1-19-3-12-24-25(17-19)32-28(35-15-13-34(2)14-16-35)33-26(24)30-18-20-4-10-23(11-5-20)31-27(36)21-6-8-22(29)9-7-21/h3-12,17H,13-16,18H2,1-2H3,(H,31,36)(H,30,32,33)",JKXMHWLJTNPRNY-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,6.17,cancer,Inhibition,
1387,6481396,573941,4981936,C[C@@H]1CN(CCN1C(=O)C(=O)c1cc2ccccc2[nH]1)C(=O)c1ccccc1,"1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-(1H-indol-2-yl)ethane-1,2-dione","InChI=1S/C22H21N3O3/c1-15-14-24(21(27)16-7-3-2-4-8-16)11-12-25(15)22(28)20(26)19-13-17-9-5-6-10-18(17)23-19/h2-10,13,15,23H,11-12,14H2,1H3/t15-/m1/s1",SGBHMXGRFPBWCM-OAHLLOKOSA-N,0,1,0,0,CD4 / gp120,7.62,HIV infectious disease,Inhibition,
1388,46884521,1090867,24668818,CN[C@@H](C)C(=O)N[C@@H](C1CCOCC1)C(=O)N1CCC[C@H]1c1nc(c(F)s1)-c1cccc2ccccc12,"(2S)-N-[(1S)-2-[(2S)-2-(5-fluoro-4-naphthalen-1-yl-1,3-thiazol-2-yl)pyrrolidin-1-yl]-1-(oxan-4-yl)-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C28H33FN4O3S/c1-17(30-2)26(34)31-23(19-12-15-36-16-13-19)28(35)33-14-6-11-22(33)27-32-24(25(29)37-27)21-10-5-8-18-7-3-4-9-20(18)21/h3-5,7-10,17,19,22-23,30H,6,11-16H2,1-2H3,(H,31,34)/t17-,22-,23-/m0/s1",WPUCUMPNTFVXFM-RTFZILSDSA-N,1,0,0,0,XIAP / Smac,7.62,cancer,Inhibition,
1389,58436648,,,CC[C@H](NC)C(=O)N[C@@H](Cc1cccc(c1)C#N)C(=O)N1C[C@H](C[C@H]1CN1CC[C@@H](C1)c1ccccc1)c1ccccc1,"(2S)-N-[(2S)-3-(3-cyanophenyl)-1-oxo-1-[(2S,4R)-4-phenyl-2-[[(3R)-3-phenylpyrrolidin-1-yl]methyl]pyrrolidin-1-yl]propan-2-yl]-2-(methylamino)butanamide","InChI=1S/C36H43N5O2/c1-3-33(38-2)35(42)39-34(20-26-11-10-12-27(19-26)22-37)36(43)41-24-31(29-15-8-5-9-16-29)21-32(41)25-40-18-17-30(23-40)28-13-6-4-7-14-28/h4-16,19,30-34,38H,3,17-18,20-21,23-25H2,1-2H3,(H,39,42)/t30-,31-,32-,33-,34-/m0/s1",AOGZGXJWHKFYJW-LJADHVKFSA-N,1,0,0,0,XIAP / Smac,8.00,cancer,Inhibition,
1390,44579346,485857,24702611,CCCN1CCC(CC1)Nc1cccc(Sc2ccc(\C=C\C(=O)N3CCOCC3)c(c2C(F)(F)F)C(F)(F)F)c1,"(E)-1-morpholin-4-yl-3-[4-[3-[(1-propylpiperidin-4-yl)amino]phenyl]sulfanyl-2,3-bis(trifluoromethyl)phenyl]prop-2-en-1-one","InChI=1S/C29H33F6N3O2S/c1-2-12-37-13-10-21(11-14-37)36-22-4-3-5-23(19-22)41-24-8-6-20(7-9-25(39)38-15-17-40-18-16-38)26(28(30,31)32)27(24)29(33,34)35/h3-9,19,21,36H,2,10-18H2,1H3/b9-7+",IVAMLBGGCGJJFO-VQHVLOKHSA-N,1,0,0,0,LFA / ICAM,9.05,immune system disease,Inhibition,
1391,44570046,500866,24711061,CNC[C@@H]1Cc2ccccc2CN1C(=O)c1ccccc1-n1nc(cc1C)C(=O)N(c1ccccc1)c1ccccc1,"5-methyl-1-[2-[(3S)-3-(methylaminomethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-N,N-diphenylpyrazole-3-carboxamide","InChI=1S/C35H33N5O2/c1-25-21-32(35(42)39(28-15-5-3-6-16-28)29-17-7-4-8-18-29)37-40(25)33-20-12-11-19-31(33)34(41)38-24-27-14-10-9-13-26(27)22-30(38)23-36-2/h3-21,30,36H,22-24H2,1-2H3/t30-/m0/s1",SMWBVXOIQBMPKQ-PMERELPUSA-N,2,0,0,0,BCL2-Like / BAX,6.85,cancer,Inhibition,
1392,44549625,,,CC#Cc1ccc(cc1)[C@H]1Oc2ccccc2C2=C1[C@H](c1ccc(Br)cc1)n1ncnc1N2C,,"InChI=1S/C28H21BrN4O/c1-3-6-18-9-11-20(12-10-18)27-24-25(19-13-15-21(29)16-14-19)33-28(30-17-31-33)32(2)26(24)22-7-4-5-8-23(22)34-27/h4-5,7-17,25,27H,1-2H3/t25-,27+/m0/s1",LSZNVZOZRGALDO-AHKZPQOWSA-N,1,0,0,0,MDM2-Like / P53,5.04,cancer,Inhibition,
1393,23646350,367347,23246932,C[C@H](N)C(=O)Nc1nc(C)c(s1)-c1ccccc1,"(2S)-2-amino-N-(4-methyl-5-phenyl-1,3-thiazol-2-yl)propanamide","InChI=1S/C13H15N3OS/c1-8(14)12(17)16-13-15-9(2)11(18-13)10-6-4-3-5-7-10/h3-8H,14H2,1-2H3,(H,15,16,17)/t8-/m0/s1",DKYHCWLDOYLCBN-QMMMGPOBSA-N,1,0,0,0,XIAP / Smac,4.82,cancer,Inhibition,
1394,57973947,,,Clc1ccc(cc1)[C@H]1[C@@H](c2ccc(Cl)cc2)n2c(ccc(C(=O)N3CCOCC3)c2=O)N1S(=O)(=O)c1cccc(c1)C#N,"3-[[(2R,3S)-2,3-bis(4-chlorophenyl)-6-(morpholine-4-carbonyl)-5-oxo-2,3-dihydroimidazo[1,2-a]pyridin-1-yl]sulfonyl]benzonitrile","InChI=1S/C31H24Cl2N4O5S/c32-23-8-4-21(5-9-23)28-29(22-6-10-24(33)11-7-22)37(43(40,41)25-3-1-2-20(18-25)19-34)27-13-12-26(31(39)36(27)28)30(38)35-14-16-42-17-15-35/h1-13,18,28-29H,14-17H2/t28-,29+/m1/s1",DPVKOMKTVZGKLU-WDYNHAJCSA-N,1,0,0,0,MDM2-Like / P53,6.16,cancer,Inhibition,
1395,168317979,,8294160,OC(=O)[C@H]1CCCN(C1)c1cc(ccn1)-c1ccc(Sc2ccc3OCCOc3c2)c(c1)C(F)(F)F,"1-[4-[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfanyl)-3-(trifluoromethyl)phenyl]pyridin-2-yl]piperidine-3-carboxylic acid","InChI=1S/C26H23F3N2O4S/c27-26(28,29)20-12-16(3-6-23(20)36-19-4-5-21-22(14-19)35-11-10-34-21)17-7-8-30-24(13-17)31-9-1-2-18(15-31)25(32)33/h3-8,12-14,18H,1-2,9-11,15H2,(H,32,33)/t18-/m0/s1",UTAAVKMLQCWSFT-SFHVURJKSA-N,0,1,0,0,LFA / ICAM,7.12,immune system disease,Inhibition,
1396,23646359,179800,23246942,C[C@H](N)C(=O)Nc1nc2c(ccc3ccccc23)s1,"(2S)-2-amino-N-benzo[e][1,3]benzothiazol-2-ylpropanamide","InChI=1S/C14H13N3OS/c1-8(15)13(18)17-14-16-12-10-5-3-2-4-9(10)6-7-11(12)19-14/h2-8H,15H2,1H3,(H,16,17,18)/t8-/m0/s1",POCGMBFIWVYGJC-QMMMGPOBSA-N,1,0,0,0,XIAP / Smac,5.15,cancer,Inhibition,
1397,168317980,,,CS(=O)(=O)N1CC[C@@H](C1)C(=O)NC[C@H](NC(=O)c1c(Cl)cc2CN(CCc2c1Cl)C(=O)c1ccc2ccoc2c1)C(O)=O,,"InChI=1S/C28H28Cl2N4O8S/c1-43(40,41)34-8-4-17(14-34)25(35)31-12-21(28(38)39)32-26(36)23-20(29)10-18-13-33(7-5-19(18)24(23)30)27(37)16-3-2-15-6-9-42-22(15)11-16/h2-3,6,9-11,17,21H,4-5,7-8,12-14H2,1H3,(H,31,35)(H,32,36)(H,38,39)/t17-,21-/m0/s1",BQWYMLWHRMXUTJ-UWJYYQICSA-N,1,0,0,0,LFA / ICAM,6.00,immune system disease,Inhibition,
1398,168317977,,,C[C@H]1C[C@H](CCN1Cc1ccccc1-c1ccc(Cl)cc1)N1CCn2c(C1)nnc2NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(c1)S(=O)(=O)C(F)(F)F,,"InChI=1S/C45H52ClF3N8O5S3/c1-32-27-37(18-20-55(32)29-34-7-5-6-10-40(34)33-11-13-35(46)14-12-33)56-21-22-57-43(30-56)51-52-44(57)53-65(60,61)39-15-16-41(42(28-39)64(58,59)45(47,48)49)50-36(17-19-54-23-25-62-26-24-54)31-63-38-8-3-2-4-9-38/h2-16,28,32,36-37,50H,17-27,29-31H2,1H3,(H,52,53)/t32-,36+,37-/m0/s1",WAAMDKGZEGUFBD-ZTTBVOJYSA-N,1,0,0,0,BCL2-Like / BAX,6.84,cancer,Inhibition,
1399,45138105,,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2S(C)(=O)=O)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(1S)-2-[(3aR,6S,6aR)-6-(6-fluoro-1H-indol-3-yl)-4-methylsulfonyl-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-1-cyclohexyl-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C27H38FN5O4S/c1-16(29-2)26(34)31-24(17-7-5-4-6-8-17)27(35)32-12-11-23-25(32)21(15-33(23)38(3,36)37)20-14-30-22-13-18(28)9-10-19(20)22/h9-10,13-14,16-17,21,23-25,29-30H,4-8,11-12,15H2,1-3H3,(H,31,34)/t16-,21+,23+,24-,25+/m0/s1",PPYXKCGATRDULW-STRHDHNLSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
1400,168317976,,19174432,FC(F)(F)c1cc(ccc1Sc1ccccc1N1CCOCC1)[C@@H]1C[C@H]1C(=O)NCCCN1CCCC1=O,2-[4-(2-morpholin-4-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]-N-[3-(2-oxopyrrolidin-1-yl)propyl]cyclopropane-1-carboxamide,"InChI=1S/C28H32F3N3O3S/c29-28(30,31)22-17-19(20-18-21(20)27(36)32-10-4-12-34-11-3-7-26(34)35)8-9-24(22)38-25-6-2-1-5-23(25)33-13-15-37-16-14-33/h1-2,5-6,8-9,17,20-21H,3-4,7,10-16,18H2,(H,32,36)/t20-,21+/m0/s1",WZWKDGGJAXYHLC-LEWJYISDSA-N,0,1,0,0,LFA / ICAM,7.82,immune system disease,Inhibition,
1401,25138066,519053,24717736,CC[C@H](N1CCCC1)C(=O)N[C@H]1CCCC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,10aS)-N-benzhydryl-5-oxo-6-[[(2S)-2-pyrrolidin-1-ylbutanoyl]amino]-2,3,6,7,8,9,10,10a-octahydro-1H-pyrrolo[1,2-a]azocine-3-carboxamide","InChI=1S/C32H42N4O3/c1-2-27(35-21-11-12-22-35)30(37)33-26-18-10-9-17-25-19-20-28(36(25)32(26)39)31(38)34-29(23-13-5-3-6-14-23)24-15-7-4-8-16-24/h3-8,13-16,25-29H,2,9-12,17-22H2,1H3,(H,33,37)(H,34,38)/t25-,26-,27-,28-/m0/s1",QERNPHRNQHFRIT-LJWNLINESA-N,1,0,0,0,XIAP / Smac,6.07,cancer,Inhibition,
1402,88572775,,,CCC[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(CC2=C(CC(C)(C)CC2)c2ccc(Cl)cc2)CC1,,"InChI=1S/C45H54ClF3N6O4S3/c1-4-8-34(29-60-36-9-6-5-7-10-36)52-40-16-15-37(25-42(40)61(56,57)45(47,48)49)62(58,59)53-43-38-20-24-55(28-41(38)50-30-51-43)35-18-22-54(23-19-35)27-32-17-21-44(2,3)26-39(32)31-11-13-33(46)14-12-31/h5-7,9-16,25,30,34-35,52H,4,8,17-24,26-29H2,1-3H3,(H,50,51,53)/t34-/m1/s1",BVOUHCBXPGSSCX-UUWRZZSWSA-N,1,0,0,0,BCL2-Like / BAX,6.24,cancer,Inhibition,
1403,168317973,,,C[C@@H](N1CCC(CC1)N1CCc2c(C1)ncnc2NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(c1)S(=O)(=O)C(F)(F)F)C1=C(CC(C)(C)CC1)c1ccc(Cl)cc1,,"InChI=1S/C49H61ClF3N7O5S3/c1-34(41-15-20-48(2,3)30-43(41)35-9-11-36(50)12-10-35)59-22-17-38(18-23-59)60-24-19-42-45(31-60)54-33-55-47(42)57-68(63,64)40-13-14-44(46(29-40)67(61,62)49(51,52)53)56-37(16-21-58-25-27-65-28-26-58)32-66-39-7-5-4-6-8-39/h4-14,29,33-34,37-38,56H,15-28,30-32H2,1-3H3,(H,54,55,57)/t34-,37-/m1/s1",ZYINRAJNDLQUAZ-ZLHGTEGGSA-N,1,0,0,0,BCL2-Like / BAX,7.05,cancer,Inhibition,
1404,16735295,226578,20566777,CC(C)Cc1c(O)c(O)c(O)c2c1oc(C)c(-c1ccc(cc1)-c1c(C)oc3c(CC(C)C)c(O)c(O)c(O)c3c1=O)c2=O,"5,6,7-trihydroxy-2-methyl-8-(2-methylpropyl)-3-[4-[5,6,7-trihydroxy-2-methyl-8-(2-methylpropyl)-4-oxochromen-3-yl]phenyl]chromen-4-one","InChI=1S/C34H34O10/c1-13(2)11-19-25(35)31(41)29(39)23-27(37)21(15(5)43-33(19)23)17-7-9-18(10-8-17)22-16(6)44-34-20(12-14(3)4)26(36)32(42)30(40)24(34)28(22)38/h7-10,13-14,35-36,39-42H,11-12H2,1-6H3",NVRYRFIEVFCEGP-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,7.77,cancer,Inhibition,
1405,44570093,509208,24713969,CCCCN(CCCC)C(=O)c1cc(C)n(n1)-c1ccc(OCC(=O)c2ccccc2)cc1C(=O)N1CCc2ccccc2C1,"N,N-dibutyl-1-[2-(3,4-dihydro-1H-isoquinoline-2-carbonyl)-4-phenacyloxyphenyl]-5-methylpyrazole-3-carboxamide","InChI=1S/C37H42N4O4/c1-4-6-20-39(21-7-5-2)37(44)33-23-27(3)41(38-33)34-18-17-31(45-26-35(42)29-14-9-8-10-15-29)24-32(34)36(43)40-22-19-28-13-11-12-16-30(28)25-40/h8-18,23-24H,4-7,19-22,25-26H2,1-3H3",XIOUWKRWZBNVPX-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,7.70,cancer,Inhibition,
1406,44237042,573309,24637608,CC[C@H](NC)C(=O)N[C@H]1[C@@H](CO)CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7S,9aS)-N-benzhydryl-7-(hydroxymethyl)-6-[[(2S)-2-(methylamino)butanoyl]amino]-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C29H38N4O4/c1-3-23(30-2)27(35)32-26-21(18-34)14-15-22-16-17-24(33(22)29(26)37)28(36)31-25(19-10-6-4-7-11-19)20-12-8-5-9-13-20/h4-13,21-26,30,34H,3,14-18H2,1-2H3,(H,31,36)(H,32,35)/t21-,22+,23+,24+,26+/m1/s1",AYPTYGWZNLNCFL-VEGWMBEDSA-N,2,1,0,0,XIAP / Smac,6.64,cancer,Inhibition,
1407,87251464,,,CN1CCN(CC[C@H](CSc2ccccc2F)Nc2ccc(cc2S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc2ncnc3CN(CCc23)C2CCN(Cc3ccccc3-c3ccc(Cl)cc3)CC2)CC1,,"InChI=1S/C47H53ClF4N8O4S3/c1-57-24-26-58(27-25-57)20-16-36(31-65-44-9-5-4-8-41(44)49)55-42-15-14-38(28-45(42)66(61,62)47(50,51)52)67(63,64)56-46-40-19-23-60(30-43(40)53-32-54-46)37-17-21-59(22-18-37)29-34-6-2-3-7-39(34)33-10-12-35(48)13-11-33/h2-15,28,32,36-37,55H,16-27,29-31H2,1H3,(H,53,54,56)/t36-/m1/s1",YFAUSZFDWXUZEQ-PSXMRANNSA-N,1,0,0,0,BCL2-Like / BAX,7.57,cancer,Inhibition,
1408,45136989,,,CC(C)(C)C[C@@H]1N[C@H]([C@H](c2cccc(Cl)c2)[C@@]1(C#N)c1ccc(Cl)cc1)C(=O)NCCCCO,"(2R,3R,4R,5S)-3-(3-chlorophenyl)-4-(4-chlorophenyl)-4-cyano-5-(2,2-dimethylpropyl)-N-(4-hydroxybutyl)pyrrolidine-2-carboxamide","InChI=1S/C27H33Cl2N3O2/c1-26(2,3)16-22-27(17-30,19-9-11-20(28)12-10-19)23(18-7-6-8-21(29)15-18)24(32-22)25(34)31-13-4-5-14-33/h6-12,15,22-24,32-33H,4-5,13-14,16H2,1-3H3,(H,31,34)/t22-,23-,24+,27-/m0/s1",ICESTUDHXOWBEJ-LUFNOOMBSA-N,1,0,0,0,MDM2-Like / P53,6.51,cancer,Inhibition,
1409,66616638,,,OCCCNC(=O)c1cc(Cl)c(O)c(c1)S(=O)(=O)N(Cc1ccc(F)cc1)Cc1cccc(c1)-c1ccc(Cl)cc1,,"InChI=1S/C30H27Cl2FN2O5S/c31-25-9-7-22(8-10-25)23-4-1-3-21(15-23)19-35(18-20-5-11-26(33)12-6-20)41(39,40)28-17-24(16-27(32)29(28)37)30(38)34-13-2-14-36/h1,3-12,15-17,36-37H,2,13-14,18-19H2,(H,34,38)",XFCKBGXIOAWEFT-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,5.91,cancer,Inhibition,
1410,11192949,427316,9368024,C[C@@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)N(CCCCC(O)=O)C(=CC1=O)c1ccccc1Br)c1ccc(Cl)cc1,"5-[(2S)-5-(2-bromophenyl)-2-(4-chlorophenyl)-1-[(1R)-1-(4-chlorophenyl)ethyl]-3,7-dioxo-2H-1,4-diazepin-4-yl]pentanoic acid","InChI=1S/C30H27BrCl2N2O4/c1-19(20-9-13-22(32)14-10-20)35-27(36)18-26(24-6-2-3-7-25(24)31)34(17-5-4-8-28(37)38)30(39)29(35)21-11-15-23(33)16-12-21/h2-3,6-7,9-16,18-19,29H,4-5,8,17H2,1H3,(H,37,38)/t19-,29+/m1/s1",MPAGIHSKIGKKGZ-XBBWARJSSA-N,1,0,0,0,MDM2-Like / P53,5.44,cancer,Inhibition,
1411,45138703,,,CN[C@@H](C)C(=O)N[C@@H](COC)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2C(C)=O)c1c[nH]c2ccc(F)cc12,"(2S)-N-[(2S)-1-[(3aR,6S,6aR)-4-acetyl-6-(5-fluoro-1H-indol-3-yl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-3-methoxy-1-oxopropan-2-yl]-2-(methylamino)propanamide","InChI=1S/C24H32FN5O4/c1-13(26-3)23(32)28-20(12-34-4)24(33)29-8-7-21-22(29)18(11-30(21)14(2)31)17-10-27-19-6-5-15(25)9-16(17)19/h5-6,9-10,13,18,20-22,26-27H,7-8,11-12H2,1-4H3,(H,28,32)/t13-,18+,20-,21+,22+/m0/s1",OZIABJPOLKJDSR-ACEXNVDFSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
1412,44364712,356393,23220786,CC(C)C[C@@H]1N([C@H](C)CCN([C@@H](Cc2ccc3ccccc3c2)C(N)=O)C1=O)C(=O)Cc1ccncc1,"(2S)-2-[(3S,5R)-5-methyl-3-(2-methylpropyl)-2-oxo-4-(2-pyridin-4-ylacetyl)-1,4-diazepan-1-yl]-3-naphthalen-2-ylpropanamide","InChI=1S/C30H36N4O3/c1-20(2)16-27-30(37)33(15-12-21(3)34(27)28(35)19-22-10-13-32-14-11-22)26(29(31)36)18-23-8-9-24-6-4-5-7-25(24)17-23/h4-11,13-14,17,20-21,26-27H,12,15-16,18-19H2,1-3H3,(H2,31,36)/t21-,26+,27+/m1/s1",KVFXBGFHMNALFK-AIGMYPEUSA-N,1,0,0,0,LFA / ICAM,6.01,immune system disease,Inhibition,
1413,25000115,,,CC(C)(C)C[C@H]1N[C@H]([C@H](c2ccc(F)c(Cl)c2)[C@@]11C(=O)Nc2cc(Cl)c(F)cc12)C(=O)NCC[C@H](O)C(O)=O,"(2S)-4-[[(2'R,3S,3'R,5'R)-6-chloro-3'-(3-chloro-4-fluorophenyl)-5'-(2,2-dimethylpropyl)-5-fluoro-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carbonyl]amino]-2-hydroxybutanoic acid","InChI=1S/C27H29Cl2F2N3O5/c1-26(2,3)11-20-27(13-9-17(31)15(29)10-18(13)33-25(27)39)21(12-4-5-16(30)14(28)8-12)22(34-20)23(36)32-7-6-19(35)24(37)38/h4-5,8-10,19-22,34-35H,6-7,11H2,1-3H3,(H,32,36)(H,33,39)(H,37,38)/t19-,20+,21-,22+,27-/m0/s1",DEPWIBRPLRYIHV-IHVVLDENSA-N,1,3,0,0,MDM2-Like / P53,6.07,cancer,Inhibition,
1414,87243549,,,Cc1cccc(c1)-c1nc(C(=O)NOCc2ccccc2)c(-c2cccc(Cl)c2)n1-c1cc(Cl)ccc1C,,"InChI=1S/C31H25Cl2N3O2/c1-20-8-6-12-24(16-20)30-34-28(31(37)35-38-19-22-9-4-3-5-10-22)29(23-11-7-13-25(32)17-23)36(30)27-18-26(33)15-14-21(27)2/h3-18H,19H2,1-2H3,(H,35,37)",DGJDLWCKEMZPQZ-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,6.09,cancer,Inhibition,
1415,59006916,,,FC(F)(F)c1c(Sc2cccc(NC3CCS(=O)(=O)CC3)c2)ccc(\C=C\C(=O)N2CCOCC2)c1C(F)(F)F,"(E)-3-[4-[3-[(1,1-dioxothian-4-yl)amino]phenyl]sulfanyl-2,3-bis(trifluoromethyl)phenyl]-1-morpholin-4-ylprop-2-en-1-one","InChI=1S/C26H26F6N2O4S2/c27-25(28,29)23-17(5-7-22(35)34-10-12-38-13-11-34)4-6-21(24(23)26(30,31)32)39-20-3-1-2-19(16-20)33-18-8-14-40(36,37)15-9-18/h1-7,16,18,33H,8-15H2/b7-5+",WMEFWYNKCHWYAA-FNORWQNLSA-N,1,0,0,0,LFA / ICAM,8.22,immune system disease,Inhibition,
1416,168317974,,9961525,CCOc1cc(ccc1C1=N[C@H]([C@@H](N1C(=O)N(C)c1ccccn1)c1ccc(Cl)cc1)c1ccc(Cl)cc1)C(F)(F)F,"4,5-bis(4-chlorophenyl)-2-[2-ethoxy-4-(trifluoromethyl)phenyl]-N-methyl-N-pyridin-2-yl-4,5-dihydroimidazole-1-carboxamide","InChI=1S/C31H25Cl2F3N4O2/c1-3-42-25-18-21(31(34,35)36)11-16-24(25)29-38-27(19-7-12-22(32)13-8-19)28(20-9-14-23(33)15-10-20)40(29)30(41)39(2)26-6-4-5-17-37-26/h4-18,27-28H,3H2,1-2H3/t27-,28-/m0/s1",UNKGINWJIXGLGX-NSOVKSMOSA-N,1,0,0,0,MDM2-Like / P53,5.37,cancer,Inhibition,
1417,168317972,,,COCCOCCN1c2ccc(I)cc2C(=O)N([C@H](C)c2ccc(Cl)nc2N)[C@@H](c2ccc(Cl)cc2)C1=O,"4-[1-(2-amino-6-chloropyridin-3-yl)ethyl]-3-(4-chlorophenyl)-7-iodo-1-[2-(2-methoxyethoxy)ethyl]-3H-1,4-benzodiazepine-2,5-dione","InChI=1S/C27H27Cl2IN4O4/c1-16(20-8-10-23(29)32-25(20)31)34-24(17-3-5-18(28)6-4-17)27(36)33(11-12-38-14-13-37-2)22-9-7-19(30)15-21(22)26(34)35/h3-10,15-16,24H,11-14H2,1-2H3,(H2,31,32)/t16-,24+/m1/s1",JQUVOBLYKVLLHK-GYCJOSAFSA-N,1,0,0,0,MDM2-Like / P53,4.94,cancer,Inhibition,
1418,44599354,,,C[C@H](N)c1ccc(o1)C(=O)N1C[C@H](C[C@H]1CN1CC[C@@H](C1)c1ccccc1)c1ccccc1,"[5-(1-aminoethyl)furan-2-yl]-[(2S,4R)-4-phenyl-2-[[(3R)-3-phenylpyrrolidin-1-yl]methyl]pyrrolidin-1-yl]methanone","InChI=1S/C28H33N3O2/c1-20(29)26-12-13-27(33-26)28(32)31-18-24(22-10-6-3-7-11-22)16-25(31)19-30-15-14-23(17-30)21-8-4-2-5-9-21/h2-13,20,23-25H,14-19,29H2,1H3/t20-,23-,24-,25-/m0/s1",KXDVXQIHJJNXFO-VDVKDMFPSA-N,1,0,0,0,XIAP / Smac,6.30,cancer,Inhibition,
1419,58531552,,,CC(C)CN(Cc1ccc(CN(CC(C)C)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)cc1)S(=O)(=O)c1cc(Cl)cc(Cl)c1O,"3,5-dichloro-N-[[4-[[(3,5-dichloro-2-hydroxyphenyl)sulfonyl-(2-methylpropyl)amino]methyl]phenyl]methyl]-2-hydroxy-N-(2-methylpropyl)benzenesulfonamide","InChI=1S/C28H32Cl4N2O6S2/c1-17(2)13-33(41(37,38)25-11-21(29)9-23(31)27(25)35)15-19-5-7-20(8-6-19)16-34(14-18(3)4)42(39,40)26-12-22(30)10-24(32)28(26)36/h5-12,17-18,35-36H,13-16H2,1-4H3",HAGVRVMCIASZFU-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,7.00,cancer,Inhibition,
1420,44573389,492345,24704983,O=C(N1CCN(CC1)C(=O)c1ccccc1)C(=O)c1c[nH]c2ccc(cc12)C#N,3-[2-(4-benzoylpiperazin-1-yl)-2-oxoacetyl]-1H-indole-5-carbonitrile,"InChI=1S/C22H18N4O3/c23-13-15-6-7-19-17(12-15)18(14-24-19)20(27)22(29)26-10-8-25(9-11-26)21(28)16-4-2-1-3-5-16/h1-7,12,14,24H,8-11H2",ARXMSIYPWNHGHD-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,6.92,HIV infectious disease,Inhibition,
1421,11655099,568903,9829837,CNC(=O)c1cc(OC)c(O[C@@H](C)C(=O)N2CCN(C[C@H]2C)C(=O)c2ccccc2)cn1,5-[(2S)-1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-1-oxopropan-2-yl]oxy-4-methoxy-N-methylpyridine-2-carboxamide,"InChI=1S/C23H28N4O5/c1-15-14-26(23(30)17-8-6-5-7-9-17)10-11-27(15)22(29)16(2)32-20-13-25-18(21(28)24-3)12-19(20)31-4/h5-9,12-13,15-16H,10-11,14H2,1-4H3,(H,24,28)/t15-,16+/m1/s1",KVDRFBPETGPOMO-CVEARBPZSA-N,0,2,0,0,CD4 / gp120,7.96,HIV infectious disease,Inhibition,
1422,91497599,,19174434,CC(C)c1ccccc1Sc1ccc([C@@H]2C[C@H]2C(=O)NCCC(O)=O)c(Cl)c1Cl,"3-[[2-[2,3-dichloro-4-(2-propan-2-ylphenyl)sulfanylphenyl]cyclopropanecarbonyl]amino]propanoic acid","InChI=1S/C22H23Cl2NO3S/c1-12(2)13-5-3-4-6-17(13)29-18-8-7-14(20(23)21(18)24)15-11-16(15)22(28)25-10-9-19(26)27/h3-8,12,15-16H,9-11H2,1-2H3,(H,25,28)(H,26,27)/t15-,16+/m0/s1",UAGCAOFGPDUCEN-JKSUJKDBSA-N,0,1,0,0,LFA / ICAM,8.10,immune system disease,Inhibition,
1423,168317950,,,Clc1cc(Cl)cc(c1)N1C(=O)[C@@H]2C[C@H](CN2C1=O)OCc1ccc(Br)cc1,"(6S)-6-[(4-bromophenyl)methoxy]-2-(3,5-dichlorophenyl)-5,6,7,7a-tetrahydropyrrolo[1,2-c]imidazole-1,3-dione","InChI=1S/C19H15BrCl2N2O3/c20-12-3-1-11(2-4-12)10-27-16-8-17-18(25)24(19(26)23(17)9-16)15-6-13(21)5-14(22)7-15/h1-7,16-17H,8-10H2/t16-,17+/m1/s1",XYJWVMMIIYDEBE-SJORKVTESA-N,0,1,0,0,LFA / ICAM,7.07,immune system disease,Inhibition,
1424,44580485,524292,24720283,FC(F)(F)c1c(Sc2cccc(OC3CCCCC3)c2)ccc(\C=C\C(=O)N2CCOCC2)c1C(F)(F)F,"(E)-3-[4-(3-cyclohexyloxyphenyl)sulfanyl-2,3-bis(trifluoromethyl)phenyl]-1-morpholin-4-ylprop-2-en-1-one","InChI=1S/C27H27F6NO3S/c28-26(29,30)24-18(10-12-23(35)34-13-15-36-16-14-34)9-11-22(25(24)27(31,32)33)38-21-8-4-7-20(17-21)37-19-5-2-1-3-6-19/h4,7-12,17,19H,1-3,5-6,13-16H2/b12-10+",JLPFLAVJCXFYQO-ZRDIBKRKSA-N,1,0,0,0,LFA / ICAM,6.28,immune system disease,Inhibition,
1425,58531482,,,Oc1c(Cl)cc(Cl)cc1S(=O)(=O)N(Cc1ccc(F)cc1)Cc1cccc(c1)S(=O)(=O)N(Cc1ccc(F)cc1)Cc1cc(Cl)cc(Cl)c1,"3,5-dichloro-N-[[3-[(3,5-dichlorophenyl)methyl-[(4-fluorophenyl)methyl]sulfamoyl]phenyl]methyl]-N-[(4-fluorophenyl)methyl]-2-hydroxybenzenesulfonamide","InChI=1S/C34H26Cl4F2N2O5S2/c35-26-12-25(13-27(36)15-26)21-41(18-22-4-8-29(39)9-5-22)48(44,45)31-3-1-2-24(14-31)20-42(19-23-6-10-30(40)11-7-23)49(46,47)33-17-28(37)16-32(38)34(33)43/h1-17,43H,18-21H2",KZIVBWWTDLTJFU-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,7.22,cancer,Inhibition,
1426,168317970,,,Cc1cccc(c1)C(=O)N1CCc2c(C)c(C(=O)N[C@@H](CNC(=O)c3cccs3)C(O)=O)c(C)cc2C1,,"InChI=1S/C28H29N3O5S/c1-16-6-4-7-19(12-16)27(34)31-10-9-21-18(3)24(17(2)13-20(21)15-31)26(33)30-22(28(35)36)14-29-25(32)23-8-5-11-37-23/h4-8,11-13,22H,9-10,14-15H2,1-3H3,(H,29,32)(H,30,33)(H,35,36)/t22-/m0/s1",BALWYICOQCIZQD-QFIPXVFZSA-N,0,1,0,0,LFA / ICAM,7.05,immune system disease,Inhibition,
1427,506234,522322,442065,COc1ccc(OC)c2c(c[nH]c12)C(=O)C(=O)N1CCN(CC1)C(=O)c1ccccc1,"1-(4-benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C23H23N3O5/c1-30-17-8-9-18(31-2)20-19(17)16(14-24-20)21(27)23(29)26-12-10-25(11-13-26)22(28)15-6-4-3-5-7-15/h3-9,14,24H,10-13H2,1-2H3",BLZAFNQIOBRKRV-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,9.64,HIV infectious disease,Inhibition,
1428,16109079,376659,17266494,COc1ccccc1C=C1CCN(CC1)c1ccc(cc1)C(=O)NS(=O)(=O)c1ccc(N[C@H](CCN(C)C)CSc2ccccc2)c(c1)N(=O)=O,N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonyl-4-[4-[(2-methoxyphenyl)methylidene]piperidin-1-yl]benzamide,"InChI=1S/C38H43N5O6S2/c1-41(2)22-21-31(27-50-33-10-5-4-6-11-33)39-35-18-17-34(26-36(35)43(45)46)51(47,48)40-38(44)29-13-15-32(16-14-29)42-23-19-28(20-24-42)25-30-9-7-8-12-37(30)49-3/h4-18,25-26,31,39H,19-24,27H2,1-3H3,(H,40,44)/t31-/m1/s1",CIJSMGMCSXMSIU-WJOKGBTCSA-N,2,0,0,0,BCL2-Like / BAX,9.22,cancer,Inhibition,
1429,59555724,,,OCc1cc(Nc2ccc(NCCc3c[nH]c4cc(F)ccc34)cc2)ccn1,[4-[4-[2-(6-fluoro-1H-indol-3-yl)ethylamino]anilino]pyridin-2-yl]methanol,"InChI=1S/C22H21FN4O/c23-16-1-6-21-15(13-26-22(21)11-16)7-9-24-17-2-4-18(5-3-17)27-19-8-10-25-20(12-19)14-28/h1-6,8,10-13,24,26,28H,7,9,14H2,(H,25,27)",VJSDPZZLEHWORY-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,6.00,cancer,Inhibition,
1430,68945800,3913906,,C[C@H]1CN(CCN1)c1nc(NCc2ccc(NC(=O)c3ccc(F)cc3)cc2)c2ccc(C)cc2n1,4-fluoro-N-[4-[[[7-methyl-2-[(3R)-3-methylpiperazin-1-yl]quinazolin-4-yl]amino]methyl]phenyl]benzamide,"InChI=1S/C28H29FN6O/c1-18-3-12-24-25(15-18)33-28(35-14-13-30-19(2)17-35)34-26(24)31-16-20-4-10-23(11-5-20)32-27(36)21-6-8-22(29)9-7-21/h3-12,15,19,30H,13-14,16-17H2,1-2H3,(H,32,36)(H,31,33,34)/t19-/m0/s1",MWXNTFWHXGUHAA-IBGZPJMESA-N,0,1,0,0,Beta-catenin / TCF-4,6.52,cancer,Inhibition,
1431,506216,492938,442047,O=C(N1CCN(CC1)C(=O)c1ccccc1)C(=O)c1c[nH]c2cccc(c12)N(=O)=O,"1-(4-benzoylpiperazin-1-yl)-2-(4-nitro-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C21H18N4O5/c26-19(15-13-22-16-7-4-8-17(18(15)16)25(29)30)21(28)24-11-9-23(10-12-24)20(27)14-5-2-1-3-6-14/h1-8,13,22H,9-12H2",MEXHQKJCAWGZAO-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,6.83,HIV infectious disease,Inhibition,
1432,11475093,182034,9649923,CC(C)[C@H](NC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(=O)NCc1ccco1,(2S)-1-[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-3-methylbutanoyl]-N-(furan-2-ylmethyl)pyrrolidine-2-carboxamide,"InChI=1S/C18H28N4O4/c1-11(2)15(21-16(23)12(3)19)18(25)22-8-4-7-14(22)17(24)20-10-13-6-5-9-26-13/h5-6,9,11-12,14-15H,4,7-8,10,19H2,1-3H3,(H,20,24)(H,21,23)/t12-,14-,15-/m0/s1",ZGNDYHOBUNOWJQ-QEJZJMRPSA-N,1,0,0,0,XIAP / Smac,6.66,cancer,Inhibition,
1433,11244031,,24539359,COC1=CC(=N\C1=C\c1[nH]c(C)cc1C)c1cc2ccccc2[nH]1,"(2E)-2-[(5E)-5-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-4-methoxypyrrol-2-ylidene]indole","InChI=1S/C20H19N3O/c1-12-8-13(2)21-16(12)10-19-20(24-3)11-18(23-19)17-9-14-6-4-5-7-15(14)22-17/h4-11,21-22H,1-3H3/b19-10+",RFTSSZJZXOSICM-VXLYETTFSA-N,3,0,0,0,BCL2-Like / BAX,5.54,cancer,Inhibition,
1434,168318093,,,C[C@H](N1CCC(CC1)N1CCc2c(C1)ncnc2NS(=O)(=O)c1ccc(N[C@H](CCN(C)C)CSc2ccccc2Cl)c(c1)S(=O)(=O)C(F)(F)F)c1ccccc1-c1ccc(Cl)cc1,"N-[7-[1-[1-[2-(4-chlorophenyl)phenyl]ethyl]piperidin-4-yl]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl]-4-[[(2R)-1-(2-chlorophenyl)sulfanyl-4-(dimethylamino)butan-2-yl]amino]-3-(trifluoromethylsulfonyl)benzenesulfonamide","InChI=1S/C45H50Cl2F3N7O4S3/c1-30(36-8-4-5-9-37(36)31-12-14-32(46)15-13-31)56-23-19-34(20-24-56)57-25-21-38-41(27-57)51-29-52-44(38)54-64(60,61)35-16-17-40(43(26-35)63(58,59)45(48,49)50)53-33(18-22-55(2)3)28-62-42-11-7-6-10-39(42)47/h4-17,26,29-30,33-34,53H,18-25,27-28H2,1-3H3,(H,51,52,54)/t30-,33+/m0/s1",CIWKIKZWHSFYHL-BZKUTMRRSA-N,1,0,0,0,BCL2-Like / BAX,7.14,cancer,Inhibition,
1435,44176187,207255,23271193,OC(=O)CCNC(=O)[C@@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)Nc2ccc(I)cc2C1=O)c1ccc(Cl)cc1,"3-[[2-(4-chlorophenyl)-2-[3-(4-chlorophenyl)-7-iodo-2,5-dioxo-1,3-dihydro-1,4-benzodiazepin-4-yl]acetyl]amino]propanoic acid","InChI=1S/C26H20Cl2IN3O5/c27-16-5-1-14(2-6-16)22(24(35)30-12-11-21(33)34)32-23(15-3-7-17(28)8-4-15)25(36)31-20-10-9-18(29)13-19(20)26(32)37/h1-10,13,22-23H,11-12H2,(H,30,35)(H,31,36)(H,33,34)/t22-,23-/m0/s1",MXZSBXTUYOFCRV-GOTSBHOMSA-N,1,0,0,0,MDM2-Like / P53,6.07,cancer,Inhibition,
1436,44390684,179446,23246708,CC(C)c1ccc(cc1)[C@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)Nc2ccc(I)cc2C1=O)C(O)=O,"2-[3-(4-chlorophenyl)-7-iodo-2,5-dioxo-1,3-dihydro-1,4-benzodiazepin-4-yl]-2-(4-propan-2-ylphenyl)acetic acid","InChI=1S/C26H22ClIN2O4/c1-14(2)15-3-5-17(6-4-15)23(26(33)34)30-22(16-7-9-18(27)10-8-16)24(31)29-21-12-11-19(28)13-20(21)25(30)32/h3-14,22-23H,1-2H3,(H,29,31)(H,33,34)/t22-,23-/m0/s1",NECDGFPGXYNUFB-GOTSBHOMSA-N,1,0,0,0,MDM2-Like / P53,5.81,cancer,Inhibition,
1437,25138055,515347,24717256,CN[C@@H](C)C(=O)N[C@H]1Cc2ccccc2[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,11bR)-N-benzhydryl-6-[[(2S)-2-(methylamino)propanoyl]amino]-5-oxo-1,2,3,6,7,11b-hexahydropyrrolo[2,1-a][2]benzazepine-3-carboxamide","InChI=1S/C31H34N4O3/c1-20(32-2)29(36)33-25-19-23-15-9-10-16-24(23)26-17-18-27(35(26)31(25)38)30(37)34-28(21-11-5-3-6-12-21)22-13-7-4-8-14-22/h3-16,20,25-28,32H,17-19H2,1-2H3,(H,33,36)(H,34,37)/t20-,25-,26+,27-/m0/s1",DKSXMHRSKSOZAT-MPPVSAIVSA-N,1,1,0,0,XIAP / Smac,7.52,cancer,Inhibition,
1438,44549358,,,CN1c2ncnn2[C@H](C2=C1c1ccccc1O[C@@H]2c1ccc(Cl)cc1)c1ccc(Cl)cc1,,"InChI=1S/C25H18Cl2N4O/c1-30-23-19-4-2-3-5-20(19)32-24(16-8-12-18(27)13-9-16)21(23)22(31-25(30)28-14-29-31)15-6-10-17(26)11-7-15/h2-14,22,24H,1H3/t22-,24+/m0/s1",TVZQVERUCXVELL-LADGPHEKSA-N,1,0,0,0,MDM2-Like / P53,5.92,cancer,Inhibition,
1439,46224085,1096039,24673181,CN1C(=O)N(C(=O)[C@]11CN(C[C@H]1c1ccc(cc1)C#N)c1ccc(cn1)C#N)c1cc(Cl)cc(Cl)c1,"6-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl]pyridine-3-carbonitrile","InChI=1S/C26H18Cl2N6O2/c1-32-25(36)34(21-9-19(27)8-20(28)10-21)24(35)26(32)15-33(23-7-4-17(12-30)13-31-23)14-22(26)18-5-2-16(11-29)3-6-18/h2-10,13,22H,14-15H2,1H3/t22-,26+/m0/s1",DRNHEYGHOPJSOW-BKMJKUGQSA-N,1,0,0,0,LFA / ICAM,7.96,immune system disease,Inhibition,
1440,44549895,,,CN1c2ncnn2[C@H](C2=C1c1ccc(Cl)cc1O[C@@H]2c1ccc(Br)cc1)c1ccc(Br)cc1,,"InChI=1S/C25H17Br2ClN4O/c1-31-23-19-11-10-18(28)12-20(19)33-24(15-4-8-17(27)9-5-15)21(23)22(32-25(31)29-13-30-32)14-2-6-16(26)7-3-14/h2-13,22,24H,1H3/t22-,24+/m0/s1",QRBDGQPLKRDMBQ-LADGPHEKSA-N,1,0,0,0,MDM2-Like / P53,4.82,cancer,Inhibition,
1441,44390656,359897,23246678,OC(=O)[C@@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)Nc2ccc(cc2C1=O)C#C)c1ccc(Cl)cc1,"2-(4-chlorophenyl)-2-[3-(4-chlorophenyl)-7-ethynyl-2,5-dioxo-1,3-dihydro-1,4-benzodiazepin-4-yl]acetic acid","InChI=1S/C25H16Cl2N2O4/c1-2-14-3-12-20-19(13-14)24(31)29(22(25(32)33)16-6-10-18(27)11-7-16)21(23(30)28-20)15-4-8-17(26)9-5-15/h1,3-13,21-22H,(H,28,30)(H,32,33)/t21-,22-/m0/s1",ZFMQFYUAXREPEG-VXKWHMMOSA-N,1,0,0,0,MDM2-Like / P53,6.06,cancer,Inhibition,
1442,44594963,,,Oc1cc(cc(O)n1)C(=O)NCc1cccc(CN(Cc2ccc(F)cc2)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)c1,"N-[[3-[[(3,5-dichloro-2-hydroxyphenyl)sulfonyl-[(4-fluorophenyl)methyl]amino]methyl]phenyl]methyl]-2-hydroxy-6-oxo-1H-pyridine-4-carboxamide","InChI=1S/C27H22Cl2FN3O6S/c28-20-11-22(29)26(36)23(12-20)40(38,39)33(14-16-4-6-21(30)7-5-16)15-18-3-1-2-17(8-18)13-31-27(37)19-9-24(34)32-25(35)10-19/h1-12,36H,13-15H2,(H,31,37)(H2,32,34,35)",IEAYMLULCYALCJ-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,7.70,cancer,Inhibition,
1443,46175995,,,CN[C@@H](C)C(=O)N[C@@H](C1CCOCC1)C(=O)N1CCC[C@H]1c1cc2ccnc(-c3ccc(F)cc3)c2[nH]1,"(2S)-N-[(1S)-2-[(2S)-2-[7-(4-fluorophenyl)-1H-pyrrolo[2,3-c]pyridin-2-yl]pyrrolidin-1-yl]-1-(oxan-4-yl)-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C28H34FN5O3/c1-17(30-2)27(35)33-26(19-10-14-37-15-11-19)28(36)34-13-3-4-23(34)22-16-20-9-12-31-24(25(20)32-22)18-5-7-21(29)8-6-18/h5-9,12,16-17,19,23,26,30,32H,3-4,10-11,13-15H2,1-2H3,(H,33,35)/t17-,23-,26-/m0/s1",COPJQDWIQBWWSM-RUJAXMSRSA-N,2,0,0,0,XIAP / Smac,7.07,cancer,Inhibition,
1444,58531443,,,NS(=O)(=O)c1ccc(CNC(=O)c2ccc(CN(Cc3ccc(F)cc3)S(=O)(=O)c3cc(Cl)cc(Cl)c3O)cc2)cc1,"4-[[(3,5-dichloro-2-hydroxyphenyl)sulfonyl-[(4-fluorophenyl)methyl]amino]methyl]-N-[(4-sulfamoylphenyl)methyl]benzamide","InChI=1S/C28H24Cl2FN3O6S2/c29-22-13-25(30)27(35)26(14-22)42(39,40)34(17-20-3-9-23(31)10-4-20)16-19-1-7-21(8-2-19)28(36)33-15-18-5-11-24(12-6-18)41(32,37)38/h1-14,35H,15-17H2,(H,33,36)(H2,32,37,38)",MGJKYXSGFHRDCT-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,6.02,cancer,Inhibition,
1445,44191696,541496,24613627,CCc1ccc(CCNC(=O)c2c(O)c(O)cc3c(O)c(c(C)cc23)-c2c(C)cc3c(C(=O)NCCc4ccc(CC)cc4)c(O)c(O)cc3c2O)cc1,"N-[2-(4-ethylphenyl)ethyl]-6-[5-[2-(4-ethylphenyl)ethylcarbamoyl]-1,6,7-trihydroxy-3-methylnaphthalen-2-yl]-2,3,5-trihydroxy-7-methylnaphthalene-1-carboxamide","InChI=1S/C44H44N2O8/c1-5-25-7-11-27(12-8-25)15-17-45-43(53)37-29-19-23(3)35(39(49)31(29)21-33(47)41(37)51)36-24(4)20-30-32(40(36)50)22-34(48)42(52)38(30)44(54)46-18-16-28-13-9-26(6-2)10-14-28/h7-14,19-22,47-52H,5-6,15-18H2,1-4H3,(H,45,53)(H,46,54)",YZSWLOZYXMVNST-UHFFFAOYSA-N,4,0,0,0,BCL2-Like / BAX,6.23,cancer,Inhibition,
1446,168318092,,,COCCOCCNC(=O)[C@@H]1N[C@H](CC(C)(C)C)[C@]2([C@H]1c1cccc(Cl)c1F)C(=O)Nc1cc(Cl)ccc21,"(2'R,3S,3'S,5'R)-6-chloro-3'-(3-chloro-2-fluorophenyl)-5'-(2,2-dimethylpropyl)-N-[2-(2-methoxyethoxy)ethyl]-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide","InChI=1S/C28H34Cl2FN3O4/c1-27(2,3)15-21-28(18-9-8-16(29)14-20(18)33-26(28)36)22(17-6-5-7-19(30)23(17)31)24(34-21)25(35)32-10-11-38-13-12-37-4/h5-9,14,21-22,24,34H,10-13,15H2,1-4H3,(H,32,35)(H,33,36)/t21-,22+,24-,28-/m1/s1",PVSGKYWYWGWPIF-YEPCPMPXSA-N,2,2,0,0,MDM2-Like / P53,9.10,cancer,Inhibition,
1447,168318087,,,O[C@@H]1CCc2c1nccc2Nc1cc(F)c(NCCc2c[nH]c3ccccc23)c(F)c1,"4-[3,5-difluoro-4-[2-(1H-indol-3-yl)ethylamino]anilino]-6,7-dihydro-5H-cyclopenta[b]pyridin-7-ol","InChI=1S/C24H22F2N4O/c25-18-11-15(30-21-8-10-27-23-17(21)5-6-22(23)31)12-19(26)24(18)28-9-7-14-13-29-20-4-2-1-3-16(14)20/h1-4,8,10-13,22,28-29,31H,5-7,9H2,(H,27,30)/t22-/m1/s1",FUHBVHYUQXCKND-JOCHJYFZSA-N,1,1,0,0,MDM2-Like / P53,6.00,cancer,Inhibition,
1448,44390648,362222,23246670,OC(=O)[C@@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)Nc2ccc(I)cc2C1=O)c1ccccc1,"2-[3-(4-chlorophenyl)-7-iodo-2,5-dioxo-1,3-dihydro-1,4-benzodiazepin-4-yl]-2-phenylacetic acid","InChI=1S/C23H16ClIN2O4/c24-15-8-6-14(7-9-15)19-21(28)26-18-11-10-16(25)12-17(18)22(29)27(19)20(23(30)31)13-4-2-1-3-5-13/h1-12,19-20H,(H,26,28)(H,30,31)/t19-,20-/m0/s1",MEFYLJNDZCLFKZ-PMACEKPBSA-N,1,0,0,0,MDM2-Like / P53,5.60,cancer,Inhibition,
1449,132550165,,,CC(C)(C)C[C@H]1N[C@H]([C@H](c2cccc(Cl)c2F)[C@]11C(=O)Nc2cc(Cl)ccc12)C(=O)NCCN1CCOCC1,"(2'R,3S,3'S,5'R)-6-chloro-3'-(3-chloro-2-fluorophenyl)-5'-(2,2-dimethylpropyl)-N-(2-morpholin-4-ylethyl)-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide","InChI=1S/C29H35Cl2FN4O3/c1-28(2,3)16-22-29(19-8-7-17(30)15-21(19)34-27(29)38)23(18-5-4-6-20(31)24(18)32)25(35-22)26(37)33-9-10-36-11-13-39-14-12-36/h4-8,15,22-23,25,35H,9-14,16H2,1-3H3,(H,33,37)(H,34,38)/t22-,23+,25-,29-/m1/s1",YTBYOWZWBDYLQF-WJCHFDDQSA-N,2,2,0,0,MDM2-Like / P53,8.77,cancer,Inhibition,
1450,168318091,,,FC(F)Oc1cccc(N[C@@]2(Cc3cccc(Cl)c3)C(=O)Nc3cc(Cl)ccc23)c1,6-chloro-3-[(3-chlorophenyl)methyl]-3-[3-(difluoromethoxy)anilino]-1H-indol-2-one,"InChI=1S/C22H16Cl2F2N2O2/c23-14-4-1-3-13(9-14)12-22(18-8-7-15(24)10-19(18)27-20(22)29)28-16-5-2-6-17(11-16)30-21(25)26/h1-11,21,28H,12H2,(H,27,29)/t22-/m1/s1",MHLHMGUEMDCLJB-JOCHJYFZSA-N,1,0,0,0,MDM2-Like / P53,8.59,cancer,Inhibition,
1451,168318089,,,C[C@@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)N(CCCCC(O)=O)c2ccc(I)cc2C1=O)c1ccc(cc1)C(F)(F)F,,"InChI=1S/C29H25ClF3IN2O4/c1-17(18-5-9-20(10-6-18)29(31,32)33)36-26(19-7-11-21(30)12-8-19)28(40)35(15-3-2-4-25(37)38)24-14-13-22(34)16-23(24)27(36)39/h5-14,16-17,26H,2-4,15H2,1H3,(H,37,38)/t17-,26+/m1/s1",IKKRLRHFYQHXAU-QUGAMOGWSA-N,1,2,0,0,MDM2-Like / P53,6.01,cancer,Inhibition,
1452,67954298,,,NC(=O)c1nc(-c2ccccc2F)n(c1-c1cccc(Cl)c1)-c1cccc(Cl)c1,,"InChI=1S/C22H14Cl2FN3O/c23-14-6-3-5-13(11-14)20-19(21(26)29)27-22(17-9-1-2-10-18(17)25)28(20)16-8-4-7-15(24)12-16/h1-12H,(H2,26,29)",HACSGRDYTYKDCL-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,4.83,cancer,Inhibition,
1453,168317975,,,FC(F)(F)S(=O)(=O)c1cc(ccc1N[C@H](CCN1CCOCC1)CSc1ccccc1)S(=O)(=O)Nc1nnc2CN(CCn12)[C@@H]1CCCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1,,"InChI=1S/C45H52ClF3N8O5S3/c46-35-14-12-33(13-15-35)40-11-5-4-7-34(40)30-55-20-6-8-37(19-22-55)56-23-24-57-43(31-56)51-52-44(57)53-65(60,61)39-16-17-41(42(29-39)64(58,59)45(47,48)49)50-36(18-21-54-25-27-62-28-26-54)32-63-38-9-2-1-3-10-38/h1-5,7,9-17,29,36-37,50H,6,8,18-28,30-32H2,(H,52,53)/t36-,37-/m1/s1",SXPGTYZKMYKKJU-FZNHDDJXSA-N,1,0,0,0,BCL2-Like / BAX,5.72,cancer,Inhibition,
1454,168318088,,,CCCn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(F)cc2)c1=O,,"InChI=1S/C23H17F4N5O/c1-2-10-31-21-17(12-28-31)20-18(22(33)32(30-20)16-8-6-15(24)7-9-16)19(29-21)13-4-3-5-14(11-13)23(25,26)27/h3-9,11-12,30H,2,10H2,1H3",VEPNSMAUNWTBOX-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.05,cancer,Inhibition,
1455,67032306,,,Nc1nnc(o1)-c1nc(C2CCCCC2)n(c1-c1ccc(F)c(Cl)c1)-c1cc(Cl)ccc1CC(=O)NCc1ccncc1,,"InChI=1S/C31H28Cl2FN7O2/c32-22-8-6-20(15-26(42)37-17-18-10-12-36-13-11-18)25(16-22)41-28(21-7-9-24(34)23(33)14-21)27(30-39-40-31(35)43-30)38-29(41)19-4-2-1-3-5-19/h6-14,16,19H,1-5,15,17H2,(H2,35,40)(H,37,42)",YQJPGYALQFBKJA-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,6.59,cancer,Inhibition,
1456,46175997,,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1cc2ccnc(-c3ccc(F)cc3)c2[nH]1,"(2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[7-(4-fluorophenyl)-1H-pyrrolo[2,3-c]pyridin-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C29H36FN5O2/c1-18(31-2)28(36)34-27(19-7-4-3-5-8-19)29(37)35-16-6-9-24(35)23-17-21-14-15-32-25(26(21)33-23)20-10-12-22(30)13-11-20/h10-15,17-19,24,27,31,33H,3-9,16H2,1-2H3,(H,34,36)/t18-,24-,27-/m0/s1",CIOYSHZYPAWBCS-HNEHEIDXSA-N,2,0,0,0,XIAP / Smac,6.99,cancer,Inhibition,
1457,23646354,180555,23246904,C[C@H](N)C(=O)Nc1nc(COc2ccccc2)c(Cc2ccccc2)s1,"(2S)-2-amino-N-[5-benzyl-4-(phenoxymethyl)-1,3-thiazol-2-yl]propanamide","InChI=1S/C20H21N3O2S/c1-14(21)19(24)23-20-22-17(13-25-16-10-6-3-7-11-16)18(26-20)12-15-8-4-2-5-9-15/h2-11,14H,12-13,21H2,1H3,(H,22,23,24)/t14-/m0/s1",SNMREYXKHOXAHO-AWEZNQCLSA-N,1,0,0,0,XIAP / Smac,5.39,cancer,Inhibition,
1458,5435493,3193644,18298282,CCOc1ccc(cc1)\N=C(/c1nnn[nH]1)c1c(O)c2ccccc2n(C)c1=O,"(3Z)-3-[(4-ethoxyanilino)-(2H-tetrazol-5-yl)methylidene]-1-methylquinoline-2,4-dione","InChI=1S/C20H18N6O3/c1-3-29-13-10-8-12(9-11-13)21-17(19-22-24-25-23-19)16-18(27)14-6-4-5-7-15(14)26(2)20(16)28/h4-11,27H,3H2,1-2H3,(H,22,23,24,25)/b21-17-",LEHNSRJVCJAIDA-FXBPSFAMSA-N,1,0,0,0,LEDGF / IN,4.56,HIV infectious disease,Inhibition,
1459,16109091,221855,17266505,CSc1ccccc1CN1CCN(CC1)c1ccc(cc1)C(=O)NS(=O)(=O)c1ccc(N[C@H](CCN(C)C)CSc2ccccc2)c(c1)N(=O)=O,N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonyl-4-[4-[(2-methylsulfanylphenyl)methyl]piperazin-1-yl]benzamide,"InChI=1S/C37H44N6O5S3/c1-40(2)20-19-30(27-50-32-10-5-4-6-11-32)38-34-18-17-33(25-35(34)43(45)46)51(47,48)39-37(44)28-13-15-31(16-14-28)42-23-21-41(22-24-42)26-29-9-7-8-12-36(29)49-3/h4-18,25,30,38H,19-24,26-27H2,1-3H3,(H,39,44)/t30-/m1/s1",QSDXQZWJLWBNKS-SSEXGKCCSA-N,2,0,0,0,BCL2-Like / BAX,9.30,cancer,Inhibition,
1460,29776138,293220,23155974,NC(=O)C[C@H](NC(=O)c1c(Cl)cccc1Cl)C(O)=O,"(2S)-4-amino-2-[(2,6-dichlorobenzoyl)amino]-4-oxobutanoic acid","InChI=1S/C11H10Cl2N2O4/c12-5-2-1-3-6(13)9(5)10(17)15-7(11(18)19)4-8(14)16/h1-3,7H,4H2,(H2,14,16)(H,15,17)(H,18,19)/t7-/m0/s1",CFGADNMKHAGYEI-ZETCQYMHSA-N,1,0,0,0,LFA / ICAM,6.77,immune system disease,Inhibition,
1461,46884085,1091453,24670860,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1nc2c(nccc2s1)-c1ccccc1,"(2S)-N-[(1S)-1-cyclohexyl-2-oxo-2-[(2S)-2-(4-phenyl-[1,3]thiazolo[4,5-c]pyridin-2-yl)pyrrolidin-1-yl]ethyl]-2-(methylamino)propanamide","InChI=1S/C28H35N5O2S/c1-18(29-2)26(34)31-24(20-12-7-4-8-13-20)28(35)33-17-9-14-21(33)27-32-25-22(36-27)15-16-30-23(25)19-10-5-3-6-11-19/h3,5-6,10-11,15-16,18,20-21,24,29H,4,7-9,12-14,17H2,1-2H3,(H,31,34)/t18-,21-,24-/m0/s1",DAXYGNXUBMFNHC-XZOYJPPVSA-N,1,0,0,0,XIAP / Smac,7.43,cancer,Inhibition,
1462,11455910,217354,9630758,CC(C)c1ccccc1Cc1cc(C(=O)Nc2ccc(cc2)S(=O)(=O)c2ccccc2C(C)(C)C)c(O)c(O)c1O,"N-[4-(2-tert-butylphenyl)sulfonylphenyl]-2,3,4-trihydroxy-5-[(2-propan-2-ylphenyl)methyl]benzamide","InChI=1S/C33H35NO6S/c1-20(2)25-11-7-6-10-21(25)18-22-19-26(30(36)31(37)29(22)35)32(38)34-23-14-16-24(17-15-23)41(39,40)28-13-9-8-12-27(28)33(3,4)5/h6-17,19-20,35-37H,18H2,1-5H3,(H,34,38)",PQAPVTKIEGUPRN-UHFFFAOYSA-N,3,0,0,0,BCL2-Like / BAX,6.59,cancer,Inhibition,
1463,67954178,,,CC(C)C(C)(C)NC(=O)Cc1ccc(Cl)c(F)c1-n1c(nc(-c2nnc(N)o2)c1-c1ccc(F)c(Cl)c1)C1CCCCC1,,"InChI=1S/C31H34Cl2F2N6O2/c1-16(2)31(3,4)38-23(42)15-19-10-12-20(32)24(35)26(19)41-27(18-11-13-22(34)21(33)14-18)25(29-39-40-30(36)43-29)37-28(41)17-8-6-5-7-9-17/h10-14,16-17H,5-9,15H2,1-4H3,(H2,36,40)(H,38,42)",HBNLITKPKDGDHE-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,8.40,cancer,Inhibition,
1464,67954190,,,OC(=O)c1nc(C2CCCCC2)n(c1-c1cc(Cl)c(F)cc1F)-c1cccc(Cl)c1F,,"InChI=1S/C22H17Cl2F3N2O2/c23-13-7-4-8-17(18(13)27)29-20(12-9-14(24)16(26)10-15(12)25)19(22(30)31)28-21(29)11-5-2-1-3-6-11/h4,7-11H,1-3,5-6H2,(H,30,31)",HSGZVPZGXAXHPX-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,8.29,cancer,Inhibition,
1465,25231045,,,OCc1cc(Nc2ccc3N(CCc4c[nH]c5ccccc45)CCOc3c2)ccn1,"[4-[[4-[2-(1H-indol-3-yl)ethyl]-2,3-dihydro-1,4-benzoxazin-7-yl]amino]pyridin-2-yl]methanol","InChI=1S/C24H24N4O2/c29-16-20-13-19(7-9-25-20)27-18-5-6-23-24(14-18)30-12-11-28(23)10-8-17-15-26-22-4-2-1-3-21(17)22/h1-7,9,13-15,26,29H,8,10-12,16H2,(H,25,27)",SJVHAVXPNJDJPK-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,6.00,cancer,Inhibition,
1466,17754800,2386170,,CCOc1cc(ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@](C)(N1C(=O)N1CCCCC1)c1ccc(Cl)cc1)C(C)(C)C,"1-[(4S,5R)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethyl-4,5-dihydro-1H-imidazole-1-carbonyl]piperidine","InChI=1S/C35H41Cl2N3O2/c1-7-42-30-23-26(33(2,3)4)15-20-29(30)31-38-34(5,24-11-16-27(36)17-12-24)35(6,25-13-18-28(37)19-14-25)40(31)32(41)39-21-9-8-10-22-39/h11-20,23H,7-10,21-22H2,1-6H3/t34-,35+/m0/s1",SPEPXXJBZXEJRQ-OIDHKYIRSA-N,2,3,0,0,MDM2-Like / P53,6.68,cancer,Inhibition,
1467,11532891,,9707674,Clc1cc(Cl)cc(c1)N1C(=O)[C@@H]2C[C@@H](CN2C1=O)OCc1ccc(Br)cc1,"(6S)-6-[(4-bromophenyl)methoxy]-2-(3,5-dichlorophenyl)-5,6,7,7a-tetrahydropyrrolo[1,2-c]imidazole-1,3-dione","InChI=1S/C19H15BrCl2N2O3/c20-12-3-1-11(2-4-12)10-27-16-8-17-18(25)24(19(26)23(17)9-16)15-6-13(21)5-14(22)7-15/h1-7,16-17H,8-10H2/t16-,17-/m0/s1",XYJWVMMIIYDEBE-IRXDYDNUSA-N,0,1,0,0,LFA / ICAM,6.03,immune system disease,Inhibition,
1468,168318086,,,CN(C)CCNC(=O)Cc1ccc(Cl)c(F)c1-n1c(nc(-c2nnc(N)o2)c1-c1ccc(F)c(Cl)c1)C1CCCCC1,,"InChI=1S/C29H31Cl2F2N7O2/c1-39(2)13-12-35-22(41)15-18-8-10-19(30)23(33)25(18)40-26(17-9-11-21(32)20(31)14-17)24(28-37-38-29(34)42-28)36-27(40)16-6-4-3-5-7-16/h8-11,14,16H,3-7,12-13,15H2,1-2H3,(H2,34,38)(H,35,41)",QXBRWTLNDSKJLD-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,8.15,cancer,Inhibition,
1469,71025282,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCC(CC1)N(C)Cc1ccccc1-c1ccc(Cl)cc1,4-[4-[[2-(4-chlorophenyl)phenyl]methyl-methylamino]piperidin-1-yl]-N-[4-[[(2S)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonylbenzamide,"InChI=1S/C44H49ClN6O5S2/c1-48(2)26-23-36(31-57-39-10-5-4-6-11-39)46-42-22-21-40(29-43(42)51(53)54)58(55,56)47-44(52)33-15-19-38(20-16-33)50-27-24-37(25-28-50)49(3)30-34-9-7-8-12-41(34)32-13-17-35(45)18-14-32/h4-22,29,36-37,46H,23-28,30-31H2,1-3H3,(H,47,52)/t36-/m1/s1",UDJXGLNJAAKABM-PSXMRANNSA-N,1,0,0,0,BCL2-Like / BAX,5.30,cancer,Inhibition,
1470,25775491,269064,23108078,NC(=O)C[C@H](NC(=O)c1ccccc1Br)C(O)=O,4-amino-2-[(2-bromobenzoyl)amino]-4-oxobutanoic acid,"InChI=1S/C11H11BrN2O4/c12-7-4-2-1-3-6(7)10(16)14-8(11(17)18)5-9(13)15/h1-4,8H,5H2,(H2,13,15)(H,14,16)(H,17,18)/t8-/m0/s1",YAGCWDMDFGMAMA-QMMMGPOBSA-N,1,0,0,0,LFA / ICAM,5.97,immune system disease,Inhibition,
1471,67954327,,,Nc1cccc(c1)-c1cc(C(O)=O)c(-c2cccc(Cl)c2)n1-c1cccc(Cl)c1F,,"InChI=1S/C23H15Cl2FN2O2/c24-15-6-1-5-14(10-15)22-17(23(29)30)12-20(13-4-2-7-16(27)11-13)28(22)19-9-3-8-18(25)21(19)26/h1-12H,27H2,(H,29,30)",UCDNNGNUVQOCEA-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,7.01,cancer,Inhibition,
1472,1046013,,897537,COc1cc(NC(=O)c2cc3nc(cc(n3n2)C(F)(F)Cl)-c2ccco2)c(cc1OC)C(C)=O,"N-(2-acetyl-4,5-dimethoxyphenyl)-7-[chloro(difluoro)methyl]-5-(furan-2-yl)pyrazolo[1,5-a]pyrimidine-2-carboxamide","InChI=1S/C22H17ClF2N4O5/c1-11(30)12-7-17(32-2)18(33-3)8-13(12)27-21(31)15-10-20-26-14(16-5-4-6-34-16)9-19(22(23,24)25)29(20)28-15/h4-10H,1-3H3,(H,27,31)",OETIEACSNLUWLZ-UHFFFAOYSA-N,1,0,0,0,Myc / Max,4.89,cancer,Inhibition,
1473,168317969,,10793086,OC(=O)CN1c2ccc(I)cc2C(=O)N([C@@H](C(O)=O)c2ccc(Cl)cc2)[C@@H](c2ccc(Cl)cc2)C1=O,"2-[1-(carboxymethyl)-3-(4-chlorophenyl)-7-iodo-2,5-dioxo-3H-1,4-benzodiazepin-4-yl]-2-(4-chlorophenyl)acetic acid","InChI=1S/C25H17Cl2IN2O6/c26-15-5-1-13(2-6-15)21-24(34)29(12-20(31)32)19-10-9-17(28)11-18(19)23(33)30(21)22(25(35)36)14-3-7-16(27)8-4-14/h1-11,21-22H,12H2,(H,31,32)(H,35,36)/t21-,22+/m0/s1",NGQMFSXASTVFRU-FCHUYYIVSA-N,1,0,0,0,MDM2-Like / P53,4.99,cancer,Inhibition,
1474,45137954,,,CN[C@@H](C)C(=O)N[C@@H](COC)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2S(C)(=O)=O)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(2S)-1-[(3aR,6S,6aR)-6-(6-fluoro-1H-indol-3-yl)-4-methylsulfonyl-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-3-methoxy-1-oxopropan-2-yl]-2-(methylamino)propanamide","InChI=1S/C23H32FN5O5S/c1-13(25-2)22(30)27-19(12-34-3)23(31)28-8-7-20-21(28)17(11-29(20)35(4,32)33)16-10-26-18-9-14(24)5-6-15(16)18/h5-6,9-10,13,17,19-21,25-26H,7-8,11-12H2,1-4H3,(H,27,30)/t13-,17+,19-,20+,21+/m0/s1",HSCXISVLAJBCNE-JOVVQPSQSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
1475,168317947,,,C1Cc2cc(Nc3ccc(Nc4ccncc4)cc3)ccc2N1,,"InChI=1S/C19H18N4/c1-3-16(4-2-15(1)22-17-8-10-20-11-9-17)23-18-5-6-19-14(13-18)7-12-21-19/h1-6,8-11,13,21,23H,7,12H2,(H,20,22)",SZLLILAILCFIFX-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,6.00,cancer,Inhibition,
1476,506220,494134,442051,Cc1ccc2[nH]cc(C(=O)C(=O)N3CCN(CC3)C(=O)c3ccccc3)c2c1,"1-(4-benzoylpiperazin-1-yl)-2-(5-methyl-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C22H21N3O3/c1-15-7-8-19-17(13-15)18(14-23-19)20(26)22(28)25-11-9-24(10-12-25)21(27)16-5-3-2-4-6-16/h2-8,13-14,23H,9-12H2,1H3",CNNGFFVUIQQOHY-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,5.81,HIV infectious disease,Inhibition,
1477,168317968,,,C[C@H]1C[C@H](CCN1Cc1ccccc1-c1ccc(Cl)cc1)N1CCc2c(C1)ncnc2NS(=O)(=O)c1ccc(N[C@H](CCN(C)C)CSc2ccccc2)c(c1)N(=O)=O,"N-[7-[(2S)-1-[[2-(4-chlorophenyl)phenyl]methyl]-2-methylpiperidin-4-yl]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl]-4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrobenzenesulfonamide","InChI=1S/C44H51ClN8O4S2/c1-31-25-36(20-23-51(31)27-33-9-7-8-12-39(33)32-13-15-34(45)16-14-32)52-24-21-40-42(28-52)46-30-47-44(40)49-59(56,57)38-17-18-41(43(26-38)53(54)55)48-35(19-22-50(2)3)29-58-37-10-5-4-6-11-37/h4-18,26,30-31,35-36,48H,19-25,27-29H2,1-3H3,(H,46,47,49)/t31-,35+,36-/m0/s1",UTJLAPPYABGNIH-NUHNATIRSA-N,1,0,0,0,BCL2-Like / BAX,7.21,cancer,Inhibition,
1478,45137953,,,CN[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2S(C)(=O)=O)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(2S)-1-[(3aR,6S,6aR)-6-(6-fluoro-1H-indol-3-yl)-4-methylsulfonyl-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-3-methyl-1-oxobutan-2-yl]-2-(methylamino)propanamide","InChI=1S/C24H34FN5O4S/c1-13(2)21(28-23(31)14(3)26-4)24(32)29-9-8-20-22(29)18(12-30(20)35(5,33)34)17-11-27-19-10-15(25)6-7-16(17)19/h6-7,10-11,13-14,18,20-22,26-27H,8-9,12H2,1-5H3,(H,28,31)/t14-,18+,20+,21-,22+/m0/s1",DSILWTUYOWCYHB-SWUQHQBRSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
1479,44389263,362072,23245188,CNC(=O)[C@H](Cc1ccc2ccccc2c1)N1CCC(=O)N(Cc2cccc(O)c2)[C@@H](CC(C)C)C1=O,"(2S)-2-[(3S)-4-[(3-hydroxyphenyl)methyl]-3-(2-methylpropyl)-2,5-dioxo-1,4-diazepan-1-yl]-N-methyl-3-naphthalen-2-ylpropanamide","InChI=1S/C30H35N3O4/c1-20(2)15-27-30(37)32(14-13-28(35)33(27)19-22-7-6-10-25(34)17-22)26(29(36)31-3)18-21-11-12-23-8-4-5-9-24(23)16-21/h4-12,16-17,20,26-27,34H,13-15,18-19H2,1-3H3,(H,31,36)/t26-,27-/m0/s1",ZPIMPMCVUHJSCD-SVBPBHIXSA-N,1,0,0,0,LFA / ICAM,5.89,immune system disease,Inhibition,
1480,168317967,,26363582,CC(C)(C)c1ccc(cc1)[C@](O)(CCN1CCCC1)c1ccc(Cl)c(CCOc2ccc(cc2)-c2ccc(cc2)C(O)=O)c1,4-[4-[2-[5-[1-(4-tert-butylphenyl)-1-hydroxy-3-pyrrolidin-1-ylpropyl]-2-chlorophenyl]ethoxy]phenyl]benzoic acid,"InChI=1S/C38H42ClNO4/c1-37(2,3)31-12-14-32(15-13-31)38(43,21-24-40-22-4-5-23-40)33-16-19-35(39)30(26-33)20-25-44-34-17-10-28(11-18-34)27-6-8-29(9-7-27)36(41)42/h6-19,26,43H,4-5,20-25H2,1-3H3,(H,41,42)/t38-/m1/s1",SKKNHOXGOILCBV-KXQOOQHDSA-N,1,0,0,0,BCL2-Like / BAX,7.40,cancer,Inhibition,
1481,168317923,,,C[C@H](N1CCC(CC1)N1CCc2c(C1)ncnc2NS(=O)(=O)c1ccc(N[C@H](CCN(C)C)CSc2ccccc2)c(c1)S(=O)(=O)C(F)(F)F)c1ccccc1-c1ccc(Cl)cc1,,"InChI=1S/C45H51ClF3N7O4S3/c1-31(38-11-7-8-12-39(38)32-13-15-33(46)16-14-32)55-24-20-35(21-25-55)56-26-22-40-42(28-56)50-30-51-44(40)53-63(59,60)37-17-18-41(43(27-37)62(57,58)45(47,48)49)52-34(19-23-54(2)3)29-61-36-9-5-4-6-10-36/h4-18,27,30-31,34-35,52H,19-26,28-29H2,1-3H3,(H,50,51,53)/t31-,34+/m0/s1",SFKFJKZVOGQGAY-AFPLUKJUSA-N,1,0,0,0,BCL2-Like / BAX,7.46,cancer,Inhibition,
1482,10434735,,8610161,COC(=O)c1cccc(c1)-n1[nH]c2c3cnn(C)c3nc(-c3cccc(c3)C(F)(F)F)c2c1=O,"methyl 3-[6-methyl-3-oxo-4-[3-(trifluoromethyl)phenyl]-1H-dipyrazolo[4,3-b:4',5'-e]pyridin-2-yl]benzoate","InChI=1S/C23H16F3N5O3/c1-30-20-16(11-27-30)19-17(18(28-20)12-5-3-7-14(9-12)23(24,25)26)21(32)31(29-19)15-8-4-6-13(10-15)22(33)34-2/h3-11,29H,1-2H3",JNVUMZAHFVUKJB-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,8.10,cancer,Inhibition,
1483,28160607,61015,23155977,NC(=O)C[C@H](NC(=O)c1c(F)cccc1F)C(O)=O,"(2S)-4-amino-2-[(2,6-difluorobenzoyl)amino]-4-oxobutanoic acid","InChI=1S/C11H10F2N2O4/c12-5-2-1-3-6(13)9(5)10(17)15-7(11(18)19)4-8(14)16/h1-3,7H,4H2,(H2,14,16)(H,15,17)(H,18,19)/t7-/m0/s1",XFAPJIVRXVFTKU-ZETCQYMHSA-N,1,0,0,0,LFA / ICAM,6.64,immune system disease,Inhibition,
1484,44580527,521708,24719594,FC(F)(F)c1c(Sc2ccccc2OC2CCNCC2)ccc(\C=C\C(=O)N2CCOCC2)c1C(F)(F)F,"(E)-1-morpholin-4-yl-3-[4-(2-piperidin-4-yloxyphenyl)sulfanyl-2,3-bis(trifluoromethyl)phenyl]prop-2-en-1-one","InChI=1S/C26H26F6N2O3S/c27-25(28,29)23-17(6-8-22(35)34-13-15-36-16-14-34)5-7-21(24(23)26(30,31)32)38-20-4-2-1-3-19(20)37-18-9-11-33-12-10-18/h1-8,18,33H,9-16H2/b8-6+",FZYXWDXHAVNVET-SOFGYWHQSA-N,1,0,0,0,LFA / ICAM,8.70,immune system disease,Inhibition,
1485,11712628,478464,9887349,Nc1cccc(Sc2ccc(\C=C\C(=O)N3CCOCC3)c(c2C(F)(F)F)C(F)(F)F)c1,"(E)-3-[4-(3-aminophenyl)sulfanyl-2,3-bis(trifluoromethyl)phenyl]-1-morpholin-4-ylprop-2-en-1-one","InChI=1S/C21H18F6N2O2S/c22-20(23,24)18-13(5-7-17(30)29-8-10-31-11-9-29)4-6-16(19(18)21(25,26)27)32-15-3-1-2-14(28)12-15/h1-7,12H,8-11,28H2/b7-5+",KLSZVPNVFKKIRD-FNORWQNLSA-N,1,0,0,0,LFA / ICAM,8.77,immune system disease,Inhibition,
1486,2304949,65445,1723289,OC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1ccccc1Cl,(2S)-2-[(2-chlorobenzoyl)amino]-3-(1H-indol-3-yl)propanoic acid,"InChI=1S/C18H15ClN2O3/c19-14-7-3-1-6-13(14)17(22)21-16(18(23)24)9-11-10-20-15-8-4-2-5-12(11)15/h1-8,10,16,20H,9H2,(H,21,22)(H,23,24)/t16-/m0/s1",PIHNVMQBEJPYDL-INIZCTEOSA-N,1,0,0,0,LFA / ICAM,5.82,immune system disease,Inhibition,
1487,46883825,1090770,24677640,CN[C@@H](C)C(=O)N[C@@H](C1CCOCC1)C(=O)N1CCC[C@H]1c1nc(c(s1)C#C)-c1cccc2ccccc12,"(2S)-N-[(1S)-2-[(2S)-2-(5-ethynyl-4-naphthalen-1-yl-1,3-thiazol-2-yl)pyrrolidin-1-yl]-1-(oxan-4-yl)-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C30H34N4O3S/c1-4-25-27(23-12-7-10-20-9-5-6-11-22(20)23)33-29(38-25)24-13-8-16-34(24)30(36)26(21-14-17-37-18-15-21)32-28(35)19(2)31-3/h1,5-7,9-12,19,21,24,26,31H,8,13-18H2,2-3H3,(H,32,35)/t19-,24-,26-/m0/s1",BZDYRZYNAGDZCS-YLORPAJWSA-N,1,0,0,0,XIAP / Smac,7.51,cancer,Inhibition,
1488,46841904,,,OC(=O)c1nc(sc1-c1ccc(cc1)C(O)=O)-c1ccc2OCCN(C(=O)Nc3nc4ccccc4s3)c2c1,"2-[4-(1,3-benzothiazol-2-ylcarbamoyl)-2,3-dihydro-1,4-benzoxazin-6-yl]-5-(4-carboxyphenyl)-1,3-thiazole-4-carboxylic acid","InChI=1S/C27H18N4O6S2/c32-24(33)15-7-5-14(6-8-15)22-21(25(34)35)29-23(39-22)16-9-10-19-18(13-16)31(11-12-37-19)27(36)30-26-28-17-3-1-2-4-20(17)38-26/h1-10,13H,11-12H2,(H,32,33)(H,34,35)(H,28,30,36)",LOHJTCRXLYLPCQ-UHFFFAOYSA-N,1,0,0,0,BCL2-Like / BAX,6.33,cancer,Inhibition,
1489,46840923,,,OC(=O)c1nc(sc1-c1ccc(cc1)-c1ccccc1)-c1ccc2CCCN(C(=O)Nc3nc4ccccc4s3)c2c1,"2-[1-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-2H-quinolin-7-yl]-5-(4-phenylphenyl)-1,3-thiazole-4-carboxylic acid","InChI=1S/C33H24N4O3S2/c38-31(39)28-29(23-15-12-21(13-16-23)20-7-2-1-3-8-20)42-30(35-28)24-17-14-22-9-6-18-37(26(22)19-24)33(40)36-32-34-25-10-4-5-11-27(25)41-32/h1-5,7-8,10-17,19H,6,9,18H2,(H,38,39)(H,34,36,40)",ATYICJLSTAZWCH-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,9.30,cancer,Inhibition,
1490,506330,571578,442161,COc1cccc2[nH]cc(C(=O)C(=O)N3CCN(C[C@H]3C)C(=O)c3ccccc3)c12,"1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-(4-methoxy-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C23H23N3O4/c1-15-14-25(22(28)16-7-4-3-5-8-16)11-12-26(15)23(29)21(27)17-13-24-18-9-6-10-19(30-2)20(17)18/h3-10,13,15,24H,11-12,14H2,1-2H3/t15-/m1/s1",YWHUPMDHHBIXPR-OAHLLOKOSA-N,0,1,0,0,CD4 / gp120,9.03,HIV infectious disease,Inhibition,
1491,44191815,552735,24620663,Cc1cc2c(CCc3ccccc3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(CCc3ccccc3)c(O)c(O)cc2c1O,"3-methyl-5-(2-phenylethyl)-2-[1,6,7-trihydroxy-3-methyl-5-(2-phenylethyl)naphthalen-2-yl]naphthalene-1,6,7-triol","InChI=1S/C38H34O6/c1-21-17-27-25(15-13-23-9-5-3-6-10-23)35(41)31(39)19-29(27)37(43)33(21)34-22(2)18-28-26(16-14-24-11-7-4-8-12-24)36(42)32(40)20-30(28)38(34)44/h3-12,17-20,39-44H,13-16H2,1-2H3",BGXPXERSQBZILH-UHFFFAOYSA-N,4,0,0,0,BCL2-Like / BAX,6.32,cancer,Inhibition,
1492,44364822,145823,23220918,COC(=O)[C@H](Cc1ccc2ccccc2c1)N1CC[C@@H](C)N([C@@H](CC(C)C)C1=O)C(=O)Cc1ccc2ncccc2c1,"methyl (2S)-2-[(3S,5R)-5-methyl-3-(2-methylpropyl)-2-oxo-4-(2-quinolin-6-ylacetyl)-1,4-diazepan-1-yl]-3-naphthalen-2-ylpropanoate","InChI=1S/C35H39N3O4/c1-23(2)18-31-34(40)37(32(35(41)42-4)21-25-11-13-27-8-5-6-9-28(27)19-25)17-15-24(3)38(31)33(39)22-26-12-14-30-29(20-26)10-7-16-36-30/h5-14,16,19-20,23-24,31-32H,15,17-18,21-22H2,1-4H3/t24-,31+,32+/m1/s1",DWKWIQJEGVCEIW-OBVGZQLQSA-N,1,0,0,0,LFA / ICAM,5.59,immune system disease,Inhibition,
1493,168317961,,,OCc1cc(Cl)ccc1Cn1cnc(c1-c1c[nH]c2cc(Cl)c(F)cc12)-c1ccccc1,,"InChI=1S/C25H18Cl2FN3O/c26-18-7-6-16(17(8-18)13-32)12-31-14-30-24(15-4-2-1-3-5-15)25(31)20-11-29-23-10-21(27)22(28)9-19(20)23/h1-11,14,29,32H,12-13H2",CMMPINPDDWCROT-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,6.96,cancer,Inhibition,
1494,7655492,397906,5969867,CC(C)C[C@@H](C(O)=O)N1C(=S)S\C(=C/c2ccc(Br)cc2)C1=O,"2-[5-[(4-bromophenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-4-methylpentanoic acid","InChI=1S/C16H16BrNO3S2/c1-9(2)7-12(15(20)21)18-14(19)13(23-16(18)22)8-10-3-5-11(17)6-4-10/h3-6,8-9,12H,7H2,1-2H3,(H,20,21)/b13-8-/t12-/m0/s1",DZWDQBUUVQBNOI-OEMOTLHWSA-N,2,0,0,0,BCL2-Like / BAX,5.52,cancer,Inhibition,
1495,58007256,,,CC(C)C1=C(SC2=N[C@](C)([C@H](N12)c1ccc(Cl)cc1)c1cccc(Cl)c1)C(=O)N(C)C,"(5R,6S)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-N,N,6-trimethyl-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazole-2-carboxamide","InChI=1S/C24H25Cl2N3OS/c1-14(2)19-20(22(30)28(4)5)31-23-27-24(3,16-7-6-8-18(26)13-16)21(29(19)23)15-9-11-17(25)12-10-15/h6-14,21H,1-5H3/t21-,24+/m1/s1",UWXUHXNGPPREOI-QPPBQGQZSA-N,1,0,0,0,MDM2-Like / P53,7.12,cancer,Inhibition,
1496,168317964,,,OC(=O)[C@@H]1[C@@H]([C@@H](OC11C(=O)c2ccccc2C1=O)c1ccc(Cl)c(Cl)c1)C(=O)NC(=O)Nc1ccc(cc1)N1CCOCC1,,"InChI=1S/C31H25Cl2N3O8/c32-21-10-5-16(15-22(21)33)25-23(24(29(40)41)31(44-25)26(37)19-3-1-2-4-20(19)27(31)38)28(39)35-30(42)34-17-6-8-18(9-7-17)36-11-13-43-14-12-36/h1-10,15,23-25H,11-14H2,(H,40,41)(H2,34,35,39,42)/t23-,24-,25-/m0/s1",DLQFRXVFEKDRNW-SDHOMARFSA-N,1,0,0,0,E2 / E1,7.06,human papilloma virus infection,Inhibition,
1497,46220963,1099103,24673123,CN1C(=O)N(C(=O)[C@]11CN(C[C@H]1c1ccc(cc1)C#N)c1cc(C)c(cn1)C(O)=O)c1cc(Cl)cc(Cl)c1,"6-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl]-4-methylpyridine-3-carboxylic acid","InChI=1S/C27H21Cl2N5O4/c1-15-7-23(31-12-21(15)24(35)36)33-13-22(17-5-3-16(11-30)4-6-17)27(14-33)25(37)34(26(38)32(27)2)20-9-18(28)8-19(29)10-20/h3-10,12,22H,13-14H2,1-2H3,(H,35,36)/t22-,27+/m0/s1",NYIQRNXFPZZFNO-WXVAWEFUSA-N,1,0,0,0,LFA / ICAM,7.96,immune system disease,Inhibition,
1498,10143236,361764,8318745,CNC(=O)[C@H](Cc1ccc2ccccc2c1)N1CCC(=O)N(Cc2ccc(O)c(OC)c2)[C@@H](CC(C)C)C1=O,"(2S)-2-[(3S)-4-[(4-hydroxy-3-methoxyphenyl)methyl]-3-(2-methylpropyl)-2,5-dioxo-1,4-diazepan-1-yl]-N-methyl-3-naphthalen-2-ylpropanamide","InChI=1S/C31H37N3O5/c1-20(2)15-26-31(38)33(14-13-29(36)34(26)19-22-10-12-27(35)28(18-22)39-4)25(30(37)32-3)17-21-9-11-23-7-5-6-8-24(23)16-21/h5-12,16,18,20,25-26,35H,13-15,17,19H2,1-4H3,(H,32,37)/t25-,26-/m0/s1",ASZRMFOYZFBVKS-UIOOFZCWSA-N,1,0,0,0,LFA / ICAM,6.02,immune system disease,Inhibition,
1499,44305319,294355,23156225,OC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1ccccc1I,3-(1H-indol-3-yl)-2-[(2-iodobenzoyl)amino]propanoic acid,"InChI=1S/C18H15IN2O3/c19-14-7-3-1-6-13(14)17(22)21-16(18(23)24)9-11-10-20-15-8-4-2-5-12(11)15/h1-8,10,16,20H,9H2,(H,21,22)(H,23,24)/t16-/m0/s1",MNPPXLIQRYASNB-INIZCTEOSA-N,1,0,0,0,LFA / ICAM,5.05,immune system disease,Inhibition,
1500,23646352,434896,23246889,C[C@H](N)C(=O)Nc1nc(c(s1)-c1ccccc1)-c1ccc(Cc2ccccc2)cc1,"(2S)-2-amino-N-[4-(4-benzylphenyl)-5-phenyl-1,3-thiazol-2-yl]propanamide","InChI=1S/C25H23N3OS/c1-17(26)24(29)28-25-27-22(23(30-25)21-10-6-3-7-11-21)20-14-12-19(13-15-20)16-18-8-4-2-5-9-18/h2-15,17H,16,26H2,1H3,(H,27,28,29)/t17-/m0/s1",NOAPVKQSSCRBKE-KRWDZBQOSA-N,1,0,0,0,XIAP / Smac,5.92,cancer,Inhibition,
1501,44570050,467229,24693644,CCCCN(CCCC)C(=O)c1nn(c(C)c1Cl)-c1ccccc1C(=O)N1Cc2ccccc2C[C@H]1CO,"N,N-dibutyl-4-chloro-1-[2-[(3S)-3-(hydroxymethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide","InChI=1S/C30H37ClN4O3/c1-4-6-16-33(17-7-5-2)30(38)28-27(31)21(3)35(32-28)26-15-11-10-14-25(26)29(37)34-19-23-13-9-8-12-22(23)18-24(34)20-36/h8-15,24,36H,4-7,16-20H2,1-3H3/t24-/m0/s1",CAKOCBPHBFPMRS-DEOSSOPVSA-N,1,0,0,0,BCL2-Like / BAX,7.00,cancer,Inhibition,
1502,45487365,569457,24632429,CNc1nccc2c(O[C@@H](C)C(=O)N3CCN(C[C@H]3C)C(=O)c3ccccc3)cccc12,(2S)-1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-[1-(methylamino)isoquinolin-5-yl]oxypropan-1-one,"InChI=1S/C25H28N4O3/c1-17-16-28(25(31)19-8-5-4-6-9-19)14-15-29(17)24(30)18(2)32-22-11-7-10-21-20(22)12-13-27-23(21)26-3/h4-13,17-18H,14-16H2,1-3H3,(H,26,27)/t17-,18+/m1/s1",BLPQMGAJZGMMOM-MSOLQXFVSA-N,0,1,0,0,CD4 / gp120,7.21,HIV infectious disease,Inhibition,
1503,12109935,369318,23245297,CNC(=O)[C@H](Cc1ccc2ccccc2c1)N1CC(=O)N(Cc2ccc(cc2)-c2cccnc2)[C@@H](CC(C)C)C1=O,"(2S)-N-methyl-2-[(3S)-3-(2-methylpropyl)-2,5-dioxo-4-[(4-pyridin-3-ylphenyl)methyl]piperazin-1-yl]-3-naphthalen-2-ylpropanamide","InChI=1S/C34H36N4O3/c1-23(2)17-31-34(41)38(30(33(40)35-3)19-25-12-15-26-7-4-5-8-28(26)18-25)22-32(39)37(31)21-24-10-13-27(14-11-24)29-9-6-16-36-20-29/h4-16,18,20,23,30-31H,17,19,21-22H2,1-3H3,(H,35,40)/t30-,31-/m0/s1",YKLWYZYISGAXSM-CONSDPRKSA-N,1,0,0,0,LFA / ICAM,4.88,immune system disease,Inhibition,
1504,50939052,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2ccccc2-c2ccc(Br)cc2)CC1,"N-[7-[1-[[2-(4-bromophenyl)phenyl]methyl]piperidin-4-yl]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl]-4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)benzenesulfonamide","InChI=1S/C44H49BrF3N7O4S3/c1-53(2)22-18-34(29-60-36-9-4-3-5-10-36)51-40-17-16-37(26-42(40)61(56,57)44(46,47)48)62(58,59)52-43-39-21-25-55(28-41(39)49-30-50-43)35-19-23-54(24-20-35)27-32-8-6-7-11-38(32)31-12-14-33(45)15-13-31/h3-17,26,30,34-35,51H,18-25,27-29H2,1-2H3,(H,49,50,52)/t34-/m1/s1",BRVCZQZFYSLFCM-UUWRZZSWSA-N,1,0,0,0,BCL2-Like / BAX,7.72,cancer,Inhibition,
1505,44594685,,,CC(C)CN(Cc1cc(Cl)cc(CN(CC(C)C)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)c1)S(=O)(=O)c1cccnc1,"N-[[3-chloro-5-[[(3,5-dichloro-2-hydroxyphenyl)sulfonyl-(2-methylpropyl)amino]methyl]phenyl]methyl]-N-(2-methylpropyl)pyridine-3-sulfonamide","InChI=1S/C27H32Cl3N3O5S2/c1-18(2)14-32(39(35,36)24-6-5-7-31-13-24)16-20-8-21(10-22(28)9-20)17-33(15-19(3)4)40(37,38)26-12-23(29)11-25(30)27(26)34/h5-13,18-19,34H,14-17H2,1-4H3",ULOPBORZMUGTSP-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,8.00,cancer,Inhibition,
1506,168317962,,,CN(C)CCOc1ccc(CN(Cc2cccc(CNS(=O)(=O)c3cc(Cl)cc(Cl)c3O)c2)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)cc1,,"InChI=1S/C31H31Cl4N3O7S2/c1-37(2)10-11-45-25-8-6-20(7-9-25)18-38(47(43,44)29-16-24(33)14-27(35)31(29)40)19-22-5-3-4-21(12-22)17-36-46(41,42)28-15-23(32)13-26(34)30(28)39/h3-9,12-16,36,39-40H,10-11,17-19H2,1-2H3",LWLJNLBPAASNIS-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,6.30,cancer,Inhibition,
1507,9838903,418328,8014623,NC(=O)C[C@H](NC(=O)c1c(F)cccc1Cl)C(O)=O,(2S)-4-amino-2-[(2-chloro-6-fluorobenzoyl)amino]-4-oxobutanoic acid,"InChI=1S/C11H10ClFN2O4/c12-5-2-1-3-6(13)9(5)10(17)15-7(11(18)19)4-8(14)16/h1-3,7H,4H2,(H2,14,16)(H,15,17)(H,18,19)/t7-/m0/s1",RXCDHJANJVJLRC-ZETCQYMHSA-N,1,0,0,0,LFA / ICAM,6.96,immune system disease,Inhibition,
1508,67032664,,,OC(=O)c1nc(CC2CCCC2)n(c1-c1ccc(F)c(Cl)c1)-c1cccc(Cl)c1F,,"InChI=1S/C22H18Cl2F2N2O2/c23-14-6-3-7-17(19(14)26)28-18(10-12-4-1-2-5-12)27-20(22(29)30)21(28)13-8-9-16(25)15(24)11-13/h3,6-9,11-12H,1-2,4-5,10H2,(H,29,30)",PRSMWCYAGRRYIL-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,8.42,cancer,Inhibition,
1509,16204197,219775,17332495,CC(C)c1cc(C(=O)N2CCc3ccc(cc3C2)S(=O)(=O)NCCc2ccccc2)c(O)c(O)c1O,"N-(2-phenylethyl)-2-(2,3,4-trihydroxy-5-propan-2-ylbenzoyl)-3,4-dihydro-1H-isoquinoline-7-sulfonamide","InChI=1S/C27H30N2O6S/c1-17(2)22-15-23(25(31)26(32)24(22)30)27(33)29-13-11-19-8-9-21(14-20(19)16-29)36(34,35)28-12-10-18-6-4-3-5-7-18/h3-9,14-15,17,28,30-32H,10-13,16H2,1-2H3",QDGGZDBYCDBSGQ-UHFFFAOYSA-N,1,0,0,0,BCL2-Like / BAX,6.23,cancer,Inhibition,
1510,506419,493011,442250,CCn1cc(C(=O)C(=O)N2CCN(CC2)C(=O)c2ccccc2)c2ccccc12,"1-(4-benzoylpiperazin-1-yl)-2-(1-ethylindol-3-yl)ethane-1,2-dione","InChI=1S/C23H23N3O3/c1-2-24-16-19(18-10-6-7-11-20(18)24)21(27)23(29)26-14-12-25(13-15-26)22(28)17-8-4-3-5-9-17/h3-11,16H,2,12-15H2,1H3",FRGJEKCSHYOZQT-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,5.84,HIV infectious disease,Inhibition,
1511,12109934,360103,23245282,CNC(=O)[C@H](Cc1ccc2ccccc2c1)N1CC(=O)N(Cc2ccc3ncccc3c2)[C@@H](CC(C)C)C1=O,"(2S)-N-methyl-2-[(3S)-3-(2-methylpropyl)-2,5-dioxo-4-(quinolin-6-ylmethyl)piperazin-1-yl]-3-naphthalen-2-ylpropanamide","InChI=1S/C32H34N4O3/c1-21(2)15-29-32(39)36(20-30(37)35(29)19-23-11-13-27-26(17-23)9-6-14-34-27)28(31(38)33-3)18-22-10-12-24-7-4-5-8-25(24)16-22/h4-14,16-17,21,28-29H,15,18-20H2,1-3H3,(H,33,38)/t28-,29-/m0/s1",NTENNIUZAXAGRB-VMPREFPWSA-N,1,0,0,0,LFA / ICAM,4.61,immune system disease,Inhibition,
1512,59555615,,,C(Cc1c[nH]c2ccccc12)Nc1ccc(cc1)N(c1ccncc1)c1ccncc1,"1-N-[2-(1H-indol-3-yl)ethyl]-4-N,4-N-dipyridin-4-ylbenzene-1,4-diamine","InChI=1S/C26H23N5/c1-2-4-26-25(3-1)20(19-30-26)9-18-29-21-5-7-22(8-6-21)31(23-10-14-27-15-11-23)24-12-16-28-17-13-24/h1-8,10-17,19,29-30H,9,18H2",WTZJEFQSSNZUKZ-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,6.00,cancer,Inhibition,
1513,44549627,,,CN1c2ncnn2[C@H](C2=C1c1ccccc1O[C@@H]2c1ccc(Br)cc1)c1ccc(F)cc1,,"InChI=1S/C25H18BrFN4O/c1-30-23-19-4-2-3-5-20(19)32-24(16-6-10-17(26)11-7-16)21(23)22(31-25(30)28-14-29-31)15-8-12-18(27)13-9-15/h2-14,22,24H,1H3/t22-,24+/m0/s1",SQANGVSPIJUOIT-LADGPHEKSA-N,1,0,0,0,MDM2-Like / P53,5.73,cancer,Inhibition,
1514,88540142,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1nc(nc2CN(CCc12)C1CCN(CC2=C(CCC(C)(C)C2)c2ccc(Cl)cc2)CC1)C(F)(F)F,,"InChI=1S/C47H56ClF6N7O4S3/c1-45(2)21-16-38(31-10-12-33(48)13-11-31)32(27-45)28-60-23-18-35(19-24-60)61-25-20-39-41(29-61)56-44(46(49,50)51)57-43(39)58-68(64,65)37-14-15-40(42(26-37)67(62,63)47(52,53)54)55-34(17-22-59(3)4)30-66-36-8-6-5-7-9-36/h5-15,26,34-35,55H,16-25,27-30H2,1-4H3,(H,56,57,58)/t34-/m1/s1",YDASRQFUAJBBMS-UUWRZZSWSA-N,1,0,0,0,BCL2-Like / BAX,7.29,cancer,Inhibition,
1515,168317960,,,Fc1ccc(cc1)-n1[nH]c2c3cnn(Cc4ccccc4)c3nc(-c3cccc(c3)C(F)(F)F)c2c1=O,,"InChI=1S/C27H17F4N5O/c28-19-9-11-20(12-10-19)36-26(37)22-23(17-7-4-8-18(13-17)27(29,30)31)33-25-21(24(22)34-36)14-32-35(25)15-16-5-2-1-3-6-16/h1-14,34H,15H2",SGHKYMCDSXFGCM-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.15,cancer,Inhibition,
1516,168317959,,24635395,C[C@@H](Oc1cccc2ccccc12)C(=O)N1CCN(C[C@H]1C)C(=O)c1ccccc1,1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-naphthalen-1-yloxypropan-1-one,"InChI=1S/C25H26N2O3/c1-18-17-26(25(29)21-10-4-3-5-11-21)15-16-27(18)24(28)19(2)30-23-14-8-12-20-9-6-7-13-22(20)23/h3-14,18-19H,15-17H2,1-2H3/t18-,19-/m1/s1",WHKQWNUTAKNCOO-RTBURBONSA-N,0,1,0,0,CD4 / gp120,6.91,HIV infectious disease,Inhibition,
1517,168317956,,,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(F)cc2F)c1=O,,"InChI=1S/C21H12F5N5O/c1-30-19-13(9-27-30)18-16(17(28-19)10-3-2-4-11(7-10)21(24,25)26)20(32)31(29-18)15-6-5-12(22)8-14(15)23/h2-9,29H,1H3",QFNNZSZXUULFCW-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,6.00,cancer,Inhibition,
1518,506219,492946,442050,CC(=O)Oc1ccc2[nH]cc(C(=O)C(=O)N3CCN(CC3)C(=O)c3ccccc3)c2c1,[3-[2-(4-benzoylpiperazin-1-yl)-2-oxoacetyl]-1H-indol-5-yl] acetate,"InChI=1S/C23H21N3O5/c1-15(27)31-17-7-8-20-18(13-17)19(14-24-20)21(28)23(30)26-11-9-25(10-12-26)22(29)16-5-3-2-4-6-16/h2-8,13-14,24H,9-12H2,1H3",WHVNHWUDLGRECL-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,6.02,HIV infectious disease,Inhibition,
1519,11605001,566449,9779757,CNC(=O)c1nccc2c(O[C@@H](C)C(=O)N3CCN(C[C@H]3C)C(=O)c3ccccc3)cccc12,5-[(2S)-1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-1-oxopropan-2-yl]oxy-N-methylisoquinoline-1-carboxamide,"InChI=1S/C26H28N4O4/c1-17-16-29(26(33)19-8-5-4-6-9-19)14-15-30(17)25(32)18(2)34-22-11-7-10-21-20(22)12-13-28-23(21)24(31)27-3/h4-13,17-18H,14-16H2,1-3H3,(H,27,31)/t17-,18+/m1/s1",ZZEULHDTBKKLTM-MSOLQXFVSA-N,0,1,0,0,CD4 / gp120,7.68,HIV infectious disease,Inhibition,
1520,168317957,,,CC(C)c1cn(nn1)C(=O)NC[C@H](NC(=O)c1c(Cl)cc2CN(CCc2c1Cl)C(=O)c1cc2ccccn2n1)C(O)=O,,"InChI=1S/C27H26Cl2N8O5/c1-14(2)21-13-37(34-32-21)27(42)30-11-20(26(40)41)31-24(38)22-18(28)9-15-12-35(8-6-17(15)23(22)29)25(39)19-10-16-5-3-4-7-36(16)33-19/h3-5,7,9-10,13-14,20H,6,8,11-12H2,1-2H3,(H,30,42)(H,31,38)(H,40,41)/t20-/m0/s1",PFFMSFNTEGGFIS-FQEVSTJZSA-N,1,0,0,0,LFA / ICAM,8.15,immune system disease,Inhibition,
1521,44818311,584735,24642866,CNc1nc(NCc2ccc(NC(=O)c3ccc(F)cc3)cc2)c2c(C)cccc2n1,4-fluoro-N-[4-[[[5-methyl-2-(methylamino)quinazolin-4-yl]amino]methyl]phenyl]benzamide,"InChI=1S/C24H22FN5O/c1-15-4-3-5-20-21(15)22(30-24(26-2)29-20)27-14-16-6-12-19(13-7-16)28-23(31)17-8-10-18(25)11-9-17/h3-13H,14H2,1-2H3,(H,28,31)(H2,26,27,29,30)",JSCRFRPIEAQXHA-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,5.97,cancer,Inhibition,
1522,46842059,,,OC(=O)c1nc(sc1Oc1ccccc1)-c1ccc2CCCN(C(=O)Nc3nc4ccccc4s3)c2c1,"2-[1-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-2H-quinolin-7-yl]-5-phenoxy-1,3-thiazole-4-carboxylic acid","InChI=1S/C27H20N4O4S2/c32-24(33)22-25(35-18-8-2-1-3-9-18)37-23(29-22)17-13-12-16-7-6-14-31(20(16)15-17)27(34)30-26-28-19-10-4-5-11-21(19)36-26/h1-5,8-13,15H,6-7,14H2,(H,32,33)(H,28,30,34)",XBBJQSQPJIYQNM-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,7.92,cancer,Inhibition,
1523,45138353,,,CC(C)(C)C[C@@H]1N[C@H]([C@H](c2cc(F)cc(Cl)c2)[C@@]1(C#N)c1ccc(Cl)cc1F)C(=O)NCC[C@H](O)CO,"(2R,3R,4R,5S)-3-(3-chloro-5-fluorophenyl)-4-(4-chloro-2-fluorophenyl)-4-cyano-N-[(3S)-3,4-dihydroxybutyl]-5-(2,2-dimethylpropyl)pyrrolidine-2-carboxamide","InChI=1S/C27H31Cl2F2N3O3/c1-26(2,3)12-22-27(14-32,20-5-4-16(28)11-21(20)31)23(15-8-17(29)10-18(30)9-15)24(34-22)25(37)33-7-6-19(36)13-35/h4-5,8-11,19,22-24,34-36H,6-7,12-13H2,1-3H3,(H,33,37)/t19-,22-,23-,24+,27-/m0/s1",BXLKBMGDBRRHRL-QZFLLOCVSA-N,1,0,0,0,MDM2-Like / P53,6.78,cancer,Inhibition,
1524,21906751,183139,10657255,CC(C)c1ccccc1Sc1ccc(cc1C(F)(F)F)-c1cc(NCCCn2ccnc2)ncn1,N-(3-imidazol-1-ylpropyl)-6-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyrimidin-4-amine,"InChI=1S/C26H26F3N5S/c1-18(2)20-6-3-4-7-23(20)35-24-9-8-19(14-21(24)26(27,28)29)22-15-25(33-16-32-22)31-10-5-12-34-13-11-30-17-34/h3-4,6-9,11,13-18H,5,10,12H2,1-2H3,(H,31,32,33)",GKARTWDJGSTNQC-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,6.12,immune system disease,Inhibition,
1525,44549487,,,CN1c2ncnn2[C@H](C2=C1c1ccccc1O[C@@H]2c1ccc(F)cc1)c1ccc(Br)cc1,,"InChI=1S/C25H18BrFN4O/c1-30-23-19-4-2-3-5-20(19)32-24(16-8-12-18(27)13-9-16)21(23)22(31-25(30)28-14-29-31)15-6-10-17(26)11-7-15/h2-14,22,24H,1H3/t22-,24+/m0/s1",GBUBANXKZVPZGW-LADGPHEKSA-N,1,0,0,0,MDM2-Like / P53,5.18,cancer,Inhibition,
1526,11567042,,9741813,C(Cc1c[nH]c2ccccc12)Nc1ccc(Nc2ccnc3ccccc23)cc1,"1-N-[2-(1H-indol-3-yl)ethyl]-4-N-quinolin-4-ylbenzene-1,4-diamine","InChI=1S/C25H22N4/c1-3-7-23-21(5-1)18(17-28-23)13-15-26-19-9-11-20(12-10-19)29-25-14-16-27-24-8-4-2-6-22(24)25/h1-12,14,16-17,26,28H,13,15H2,(H,27,29)",KLWILLOYTRHFFC-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,8.00,cancer,Inhibition,
1527,44573588,522345,24719186,COc1ccc(C#N)c2[nH]cc(C(=O)C(=O)N3CCN(CC3)C(=O)c3ccccc3)c12,3-[2-(4-benzoylpiperazin-1-yl)-2-oxoacetyl]-4-methoxy-1H-indole-7-carbonitrile,"InChI=1S/C23H20N4O4/c1-31-18-8-7-16(13-24)20-19(18)17(14-25-20)21(28)23(30)27-11-9-26(10-12-27)22(29)15-5-3-2-4-6-15/h2-8,14,25H,9-12H2,1H3",RNMYUFIGZVGQLQ-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,11.22,HIV infectious disease,Inhibition,
1528,168317954,,,C[C@H](N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H]1CCc2ccccc12)C(C)(C)C,,"InChI=1S/C23H34N4O3/c1-14(24)20(28)26-19(23(2,3)4)22(30)27-13-7-10-18(27)21(29)25-17-12-11-15-8-5-6-9-16(15)17/h5-6,8-9,14,17-19H,7,10-13,24H2,1-4H3,(H,25,29)(H,26,28)/t14-,17-,18-,19+/m0/s1",MKCLGSSENIHRJB-UDTPNQRGSA-N,1,0,0,0,XIAP / Smac,7.54,cancer,Inhibition,
1529,44570038,444140,24686126,Cc1cc(nn1-c1ccccc1C(=O)N1Cc2ccccc2C[C@H]1CO)C(=O)N(c1ccccc1)c1ccccc1,"1-[2-[(3S)-3-(hydroxymethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-5-methyl-N,N-diphenylpyrazole-3-carboxamide","InChI=1S/C34H30N4O3/c1-24-20-31(34(41)37(27-14-4-2-5-15-27)28-16-6-3-7-17-28)35-38(24)32-19-11-10-18-30(32)33(40)36-22-26-13-9-8-12-25(26)21-29(36)23-39/h2-20,29,39H,21-23H2,1H3/t29-/m0/s1",LHFGEYLRYXCOMA-LJAQVGFWSA-N,1,0,0,0,BCL2-Like / BAX,6.72,cancer,Inhibition,
1530,45137338,,,CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1CC[C@H]2NC[C@@H]([C@@H]12)c1c[nH]c2cc(F)ccc12,"(2S)-N-[(2S)-1-[(3aR,6S,6aR)-6-(6-fluoro-1H-indol-3-yl)-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,2-b]pyrrol-1-yl]-1-oxobutan-2-yl]-2-(methylamino)propanamide","InChI=1S/C22H30FN5O2/c1-4-17(27-21(29)12(2)24-3)22(30)28-8-7-18-20(28)16(11-25-18)15-10-26-19-9-13(23)5-6-14(15)19/h5-6,9-10,12,16-18,20,24-26H,4,7-8,11H2,1-3H3,(H,27,29)/t12-,16+,17-,18+,20+/m0/s1",GJYMSNRRAFJBPY-RSOJTVFVSA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
1531,92160481,,218002,Cc1ccc2ccc([C@H](Nc3ccccc3)c3ccccc3)c(O)c2n1,7-[anilino(phenyl)methyl]-2-methylquinolin-8-ol,"InChI=1S/C23H20N2O/c1-16-12-13-18-14-15-20(23(26)22(18)24-16)21(17-8-4-2-5-9-17)25-19-10-6-3-7-11-19/h2-15,21,25-26H,1H3/t21-/m1/s1",WEENRMPCSWFMTE-OAQYLSRUSA-N,1,0,0,0,MDM2-Like / P53,6.92,cancer,Inhibition,
1532,16109062,221218,17266477,COC1(CC(C)(C)C)CCN(CC1)c1ccc(cc1)C(=O)NS(=O)(=O)c1ccc(N[C@H](CCN(C)C)CSc2ccccc2)c(c1)N(=O)=O,"N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonyl-4-[4-(2,2-dimethylpropyl)-4-methoxypiperidin-1-yl]benzamide","InChI=1S/C36H49N5O6S2/c1-35(2,3)26-36(47-6)19-22-40(23-20-36)29-14-12-27(13-15-29)34(42)38-49(45,46)31-16-17-32(33(24-31)41(43)44)37-28(18-21-39(4)5)25-48-30-10-8-7-9-11-30/h7-17,24,28,37H,18-23,25-26H2,1-6H3,(H,38,42)/t28-/m1/s1",LTNBYBULDRYDLJ-MUUNZHRXSA-N,2,0,0,0,BCL2-Like / BAX,8.34,cancer,Inhibition,
1533,67954486,,,CNC(=O)c1nc(-c2ccccc2F)n(c1-c1cccc(Cl)c1)-c1cccc(Cl)c1,,"InChI=1S/C23H16Cl2FN3O/c1-27-23(30)20-21(14-6-4-7-15(24)12-14)29(17-9-5-8-16(25)13-17)22(28-20)18-10-2-3-11-19(18)26/h2-13H,1H3,(H,27,30)",WHSADHHJSOMISQ-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,4.66,cancer,Inhibition,
1534,59555669,,,COc1ccc2c(CCNc3ccc(Nc4ccnc5ccccc45)cc3)c[nH]c2c1,"1-N-[2-(6-methoxy-1H-indol-3-yl)ethyl]-4-N-quinolin-4-ylbenzene-1,4-diamine","InChI=1S/C26H24N4O/c1-31-21-10-11-22-18(17-29-26(22)16-21)12-14-27-19-6-8-20(9-7-19)30-25-13-15-28-24-5-3-2-4-23(24)25/h2-11,13,15-17,27,29H,12,14H2,1H3,(H,28,30)",YVWLOGFRMMYKGB-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,7.60,cancer,Inhibition,
1535,46841187,,,CN(C)c1cccc(OCCOc2ccc(nc2C(O)=O)-c2ccc3CCCN(C(=O)Nc4nc5ccccc5s4)c3c2)c1,"6-[1-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-2H-quinolin-7-yl]-3-[2-[3-(dimethylamino)phenoxy]ethoxy]pyridine-2-carboxylic acid","InChI=1S/C33H31N5O5S/c1-37(2)23-8-5-9-24(20-23)42-17-18-43-28-15-14-25(34-30(28)31(39)40)22-13-12-21-7-6-16-38(27(21)19-22)33(41)36-32-35-26-10-3-4-11-29(26)44-32/h3-5,8-15,19-20H,6-7,16-18H2,1-2H3,(H,39,40)(H,35,36,41)",ZCJFOMBPZOLDAM-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,9.05,cancer,Inhibition,
1536,45485412,570927,24634969,CNC(=O)c1ccc(O[C@@H](C)C(=O)N2CCN(C[C@H]2C)C(=O)c2ccccc2)c(OC)n1,5-[(2S)-1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-1-oxopropan-2-yl]oxy-6-methoxy-N-methylpyridine-2-carboxamide,"InChI=1S/C23H28N4O5/c1-15-14-26(23(30)17-8-6-5-7-9-17)12-13-27(15)22(29)16(2)32-19-11-10-18(20(28)24-3)25-21(19)31-4/h5-11,15-16H,12-14H2,1-4H3,(H,24,28)/t15-,16+/m1/s1",AOYWRFHEAZOZRH-CVEARBPZSA-N,0,1,0,0,CD4 / gp120,6.59,HIV infectious disease,Inhibition,
1537,67032064,,,Cc1ccc(Cl)cc1-n1c(nc(-c2nn[nH]n2)c1-c1ccc(F)c(Cl)c1)C1CCCCC1,,"InChI=1S/C23H21Cl2FN6/c1-13-7-9-16(24)12-19(13)32-21(15-8-10-18(26)17(25)11-15)20(22-28-30-31-29-22)27-23(32)14-5-3-2-4-6-14/h7-12,14H,2-6H2,1H3,(H,28,29,30,31)",CLXMMKAAHSIGIJ-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,6.91,cancer,Inhibition,
1538,46836436,,,OC(=O)c1nc(sc1CCCOc1ccc(cc1)N1CCNCC1)N1CCc2cccc(C(=O)Nc3nc4ccccc4s3)c2C1,"2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-5-[3-(4-piperazin-1-ylphenoxy)propyl]-1,3-thiazole-4-carboxylic acid","InChI=1S/C34H34N6O4S2/c41-31(38-33-36-27-7-1-2-8-28(27)45-33)25-6-3-5-22-14-17-40(21-26(22)25)34-37-30(32(42)43)29(46-34)9-4-20-44-24-12-10-23(11-13-24)39-18-15-35-16-19-39/h1-3,5-8,10-13,35H,4,9,14-21H2,(H,42,43)(H,36,38,41)",STIJJATXGFUICD-UHFFFAOYSA-N,1,0,0,0,BCL2-Like / BAX,7.05,cancer,Inhibition,
1539,168317952,,,CC1(C)CN(CCc2c[nH]c3ccccc23)c2ccc(Nc3ccnc4[C@@H](O)CCc34)cc2O1,"4-[[4-[2-(1H-indol-3-yl)ethyl]-2,2-dimethyl-3H-1,4-benzoxazin-7-yl]amino]-6,7-dihydro-5H-cyclopenta[b]pyridin-7-ol","InChI=1S/C28H30N4O2/c1-28(2)17-32(14-12-18-16-30-22-6-4-3-5-20(18)22)24-9-7-19(15-26(24)34-28)31-23-11-13-29-27-21(23)8-10-25(27)33/h3-7,9,11,13,15-16,25,30,33H,8,10,12,14,17H2,1-2H3,(H,29,31)/t25-/m0/s1",FXVFQWKPIVYPNN-VWLOTQADSA-N,1,1,0,0,MDM2-Like / P53,5.66,cancer,Inhibition,
1540,506243,523369,442074,Fc1cc(Br)c2[nH]cc(C(=O)C(=O)N3CCN(CC3)C(=O)c3ccccc3)c2c1,"1-(4-benzoylpiperazin-1-yl)-2-(7-bromo-5-fluoro-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C21H17BrFN3O3/c22-17-11-14(23)10-15-16(12-24-18(15)17)19(27)21(29)26-8-6-25(7-9-26)20(28)13-4-2-1-3-5-13/h1-5,10-12,24H,6-9H2",SNDJBVKOLCXWPG-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,7.14,HIV infectious disease,Inhibition,
1541,44237050,584394,24641155,CC[C@H](N)C(=O)N[C@H]1[C@@H](CNCc2ccccc2)CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7R,9aS)-6-[[(2S)-2-aminobutanoyl]amino]-N-benzhydryl-7-[(benzylamino)methyl]-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C35H43N5O3/c1-2-29(36)33(41)39-32-27(23-37-22-24-12-6-3-7-13-24)18-19-28-20-21-30(40(28)35(32)43)34(42)38-31(25-14-8-4-9-15-25)26-16-10-5-11-17-26/h3-17,27-32,37H,2,18-23,36H2,1H3,(H,38,42)(H,39,41)/t27-,28+,29+,30+,32+/m1/s1",AMPOPSQVVNLFPN-HVSNEVFASA-N,2,1,0,0,XIAP / Smac,7.00,cancer,Inhibition,
1542,168317951,,23242420,CCOC(=O)C1CCN(CC1)c1ccccc1Sc1ccc(cc1C(F)(F)F)[C@@H]1C[C@H]1C(=O)NCCCN1CCCC1=O,ethyl 1-[2-[4-[2-[3-(2-oxopyrrolidin-1-yl)propylcarbamoyl]cyclopropyl]-2-(trifluoromethyl)phenyl]sulfanylphenyl]piperidine-4-carboxylate,"InChI=1S/C32H38F3N3O4S/c1-2-42-31(41)21-12-17-37(18-13-21)26-7-3-4-8-28(26)43-27-11-10-22(19-25(27)32(33,34)35)23-20-24(23)30(40)36-14-6-16-38-15-5-9-29(38)39/h3-4,7-8,10-11,19,21,23-24H,2,5-6,9,12-18,20H2,1H3,(H,36,40)/t23-,24+/m0/s1",LFMVROPXFXRDLY-BJKOFHAPSA-N,0,1,0,0,LFA / ICAM,6.94,immune system disease,Inhibition,
1543,10030465,148363,8206036,CC(C)C[C@@H]1N([C@H](C)CCN([C@@H](Cc2ccc3ccccc3c2)C(N)=O)C1=O)C(=O)Cc1ccc2ncccc2c1,"(2S)-2-[(3S,5R)-5-methyl-3-(2-methylpropyl)-2-oxo-4-(2-quinolin-6-ylacetyl)-1,4-diazepan-1-yl]-3-naphthalen-2-ylpropanamide","InChI=1S/C34H38N4O3/c1-22(2)17-31-34(41)37(30(33(35)40)20-24-10-12-26-7-4-5-8-27(26)18-24)16-14-23(3)38(31)32(39)21-25-11-13-29-28(19-25)9-6-15-36-29/h4-13,15,18-19,22-23,30-31H,14,16-17,20-21H2,1-3H3,(H2,35,40)/t23-,30+,31+/m1/s1",MRALGEXHJHNARS-VBDKILDKSA-N,1,0,0,0,LFA / ICAM,6.96,immune system disease,Inhibition,
1544,46220962,1098761,24677959,CN1C(=O)N(C(=O)[C@]11CN(C[C@H]1c1ccc(cc1)C#N)c1ccc(C(O)=O)c(C)n1)c1cc(Cl)cc(Cl)c1,"6-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl]-2-methylpyridine-3-carboxylic acid","InChI=1S/C27H21Cl2N5O4/c1-15-21(24(35)36)7-8-23(31-15)33-13-22(17-5-3-16(12-30)4-6-17)27(14-33)25(37)34(26(38)32(27)2)20-10-18(28)9-19(29)11-20/h3-11,22H,13-14H2,1-2H3,(H,35,36)/t22-,27+/m0/s1",RGINYBTXUVTPLK-WXVAWEFUSA-N,1,0,0,0,LFA / ICAM,7.92,immune system disease,Inhibition,
1545,67032048,,,CC(C)(C)Cc1nc(C(O)=O)c(-c2ccc(F)c(Cl)c2)n1-c1cccc(Cl)c1F,,"InChI=1S/C21H18Cl2F2N2O2/c1-21(2,3)10-16-26-18(20(28)29)19(11-7-8-14(24)13(23)9-11)27(16)15-6-4-5-12(22)17(15)25/h4-9H,10H2,1-3H3,(H,28,29)",XIXMTPFRXZNMDO-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,7.94,cancer,Inhibition,
1546,67031850,,,Nc1nnc(o1)-c1nc(-c2ccsc2)n(c1-c1ccc(F)c(Cl)c1)-c1cccc(Cl)c1F,,"InChI=1S/C21H11Cl2F2N5OS/c22-12-2-1-3-15(16(12)25)30-18(10-4-5-14(24)13(23)8-10)17(20-28-29-21(26)31-20)27-19(30)11-6-7-32-9-11/h1-9H,(H2,26,29)",YOYGDUJRBBUVBT-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,8.57,cancer,Inhibition,
1547,24774889,,,CCOc1nc(ncc1C1=N[C@H]([C@H](N1C(=O)N1CCN(CCS(C)(=O)=O)CC1)c1ccc(Cl)cc1)c1ccc(Cl)cc1)C(F)(F)F,"[(4S,5R)-4,5-bis(4-chlorophenyl)-2-[4-ethoxy-2-(trifluoromethyl)pyrimidin-5-yl]-4,5-dihydroimidazol-1-yl]-[4-(2-methylsulfonylethyl)piperazin-1-yl]methanone","InChI=1S/C30H31Cl2F3N6O4S/c1-3-45-27-23(18-36-28(38-27)30(33,34)35)26-37-24(19-4-8-21(31)9-5-19)25(20-6-10-22(32)11-7-20)41(26)29(42)40-14-12-39(13-15-40)16-17-46(2,43)44/h4-11,18,24-25H,3,12-17H2,1-2H3/t24-,25+/m0/s1",BWARELALGBCBIF-LOSJGSFVSA-N,1,0,0,0,MDM2-Like / P53,5.54,cancer,Inhibition,
1548,59555641,,,COc1cc(Nc2ccncc2)ccc1NCCc1c[nH]c2ccccc12,"1-N-[2-(1H-indol-3-yl)ethyl]-2-methoxy-4-N-pyridin-4-ylbenzene-1,4-diamine","InChI=1S/C22H22N4O/c1-27-22-14-18(26-17-9-11-23-12-10-17)6-7-21(22)24-13-8-16-15-25-20-5-3-2-4-19(16)20/h2-7,9-12,14-15,24-25H,8,13H2,1H3,(H,23,26)",FSBMRSUSLBFNED-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,7.20,cancer,Inhibition,
1549,59555560,,,Oc1cccc2c(Nc3ccc(NCCc4c[nH]c5ccccc45)cc3)ccnc12,4-[4-[2-(1H-indol-3-yl)ethylamino]anilino]quinolin-8-ol,"InChI=1S/C25H22N4O/c30-24-7-3-5-21-23(13-15-27-25(21)24)29-19-10-8-18(9-11-19)26-14-12-17-16-28-22-6-2-1-4-20(17)22/h1-11,13,15-16,26,28,30H,12,14H2,(H,27,29)",NBMGATCQMUQWKK-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,7.10,cancer,Inhibition,
1550,44237068,575805,24637191,CC[C@H](NC)C(=O)N[C@H]1[C@@H](CCO)CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7R,9aS)-N-benzhydryl-7-(2-hydroxyethyl)-6-[[(2S)-2-(methylamino)butanoyl]amino]-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C30H40N4O4/c1-3-24(31-2)28(36)33-27-22(18-19-35)14-15-23-16-17-25(34(23)30(27)38)29(37)32-26(20-10-6-4-7-11-20)21-12-8-5-9-13-21/h4-13,22-27,31,35H,3,14-19H2,1-2H3,(H,32,37)(H,33,36)/t22-,23+,24+,25+,27+/m1/s1",BQFRGLYFTFQIFN-HOIWYFOJSA-N,1,1,0,0,XIAP / Smac,6.89,cancer,Inhibition,
1551,168317949,,,C[C@@H](Oc1cccc(-c2ccn[nH]2)c1C)C(=O)N1CCN(C[C@H]1C)C(=O)c1ccccc1,(2S)-1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-[2-methyl-3-(1H-pyrazol-5-yl)phenoxy]propan-1-one,"InChI=1S/C25H28N4O3/c1-17-16-28(25(31)20-8-5-4-6-9-20)14-15-29(17)24(30)19(3)32-23-11-7-10-21(18(23)2)22-12-13-26-27-22/h4-13,17,19H,14-16H2,1-3H3,(H,26,27)/t17-,19-/m1/s1",HIBFJXIFEVFAMY-IEBWSBKVSA-N,0,1,0,0,CD4 / gp120,7.46,HIV infectious disease,Inhibition,
1552,44390631,182335,23246654,CCCC[C@H](N1[C@@H](c2ccc(Cl)cc2)C(=O)Nc2ccc(I)cc2C1=O)C(O)=O,"(2S)-2-[(3S)-3-(4-chlorophenyl)-7-iodo-2,5-dioxo-1,3-dihydro-1,4-benzodiazepin-4-yl]hexanoic acid","InChI=1S/C21H20ClIN2O4/c1-2-3-4-17(21(28)29)25-18(12-5-7-13(22)8-6-12)19(26)24-16-10-9-14(23)11-15(16)20(25)27/h5-11,17-18H,2-4H2,1H3,(H,24,26)(H,28,29)/t17-,18-/m0/s1",IPMSVNRTKLHFEG-ROUUACIJSA-N,1,0,0,0,MDM2-Like / P53,4.85,cancer,Inhibition,
1553,88540187,,,CN(C)CC[C@H](CSc1ccccc1Cl)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1nc(nc2CN(CCc12)C1CCN(CC2=C(CC(C)(C)CC2)c2ccc(Cl)cc2)CC1)C(F)(F)F,,"InChI=1S/C47H55Cl2F6N7O4S3/c1-45(2)20-15-31(37(26-45)30-9-11-32(48)12-10-30)27-61-22-17-34(18-23-61)62-24-19-36-40(28-62)57-44(46(50,51)52)58-43(36)59-69(65,66)35-13-14-39(42(25-35)68(63,64)47(53,54)55)56-33(16-21-60(3)4)29-67-41-8-6-5-7-38(41)49/h5-14,25,33-34,56H,15-24,26-29H2,1-4H3,(H,57,58,59)/t33-/m1/s1",KSTXEKPHQPXFHY-MGBGTMOVSA-N,1,0,0,0,BCL2-Like / BAX,7.06,cancer,Inhibition,
1554,168317948,,,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(C(=O)N3CCOCC3)c(F)c2)c1=O,,"InChI=1S/C26H20F4N6O3/c1-34-23-18(13-31-34)22-20(21(32-23)14-3-2-4-15(11-14)26(28,29)30)25(38)36(33-22)16-5-6-17(19(27)12-16)24(37)35-7-9-39-10-8-35/h2-6,11-13,33H,7-10H2,1H3",QVLWRKSSWNACPZ-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,6.51,cancer,Inhibition,
1555,44390658,181607,23246680,CC(C)(C)c1ccc2NC(=O)[C@@H](N([C@H](C(O)=O)c3ccc(Cl)cc3)C(=O)c2c1)c1ccc(Cl)cc1,"2-[7-tert-butyl-3-(4-chlorophenyl)-2,5-dioxo-1,3-dihydro-1,4-benzodiazepin-4-yl]-2-(4-chlorophenyl)acetic acid","InChI=1S/C27H24Cl2N2O4/c1-27(2,3)17-8-13-21-20(14-17)25(33)31(23(26(34)35)16-6-11-19(29)12-7-16)22(24(32)30-21)15-4-9-18(28)10-5-15/h4-14,22-23H,1-3H3,(H,30,32)(H,34,35)/t22-,23-/m0/s1",MQOQGSONRZTIDI-GOTSBHOMSA-N,1,0,0,0,MDM2-Like / P53,5.64,cancer,Inhibition,
1556,58678780,,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1nc(cs1)-c1csc2ccccc12,"(2S)-N-[(1S)-2-[(2S)-2-[4-(1-benzothiophen-3-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-cyclohexyl-2-oxoethyl]-2-(methylamino)propanamide","InChI=1S/C27H34N4O2S2/c1-17(28-2)25(32)30-24(18-9-4-3-5-10-18)27(33)31-14-8-12-22(31)26-29-21(16-35-26)20-15-34-23-13-7-6-11-19(20)23/h6-7,11,13,15-18,22,24,28H,3-5,8-10,12,14H2,1-2H3,(H,30,32)/t17-,22-,24-/m0/s1",LUEPEXYWBVELEP-OWSXEPHWSA-N,1,0,0,0,XIAP / Smac,7.33,cancer,Inhibition,
1557,11340134,,9515077,CC(C)C[C@H]1N[C@H]([C@H](c2ccc(Cl)cc2)[C@@]11C(=O)Nc2cc(Cl)ccc12)C(=O)N(C)C,"(2'R,3S,3'R,5'R)-6-chloro-3'-(4-chlorophenyl)-N,N-dimethyl-5'-(2-methylpropyl)-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide","InChI=1S/C24H27Cl2N3O2/c1-13(2)11-19-24(17-10-9-16(26)12-18(17)27-23(24)31)20(14-5-7-15(25)8-6-14)21(28-19)22(30)29(3)4/h5-10,12-13,19-21,28H,11H2,1-4H3,(H,27,31)/t19-,20+,21-,24+/m1/s1",CIAKKMIXEZWILV-WHLIWEHUSA-N,1,3,0,0,MDM2-Like / P53,5.17,cancer,Inhibition,
1558,58006855,,,CC[C@@H]1CC[C@H](N1C(=O)C1=C(C)N2[C@H](c3ccc(Cl)cc3)[C@@](C)(N=C2S1)c1ccc(Cl)cc1)C(=O)N(C)C,"(2S,5R)-1-[(5R,6S)-5,6-bis(4-chlorophenyl)-3,6-dimethyl-5H-imidazo[2,1-b][1,3]thiazole-2-carbonyl]-5-ethyl-N,N-dimethylpyrrolidine-2-carboxamide","InChI=1S/C29H32Cl2N4O2S/c1-6-22-15-16-23(26(36)33(4)5)35(22)27(37)24-17(2)34-25(18-7-11-20(30)12-8-18)29(3,32-28(34)38-24)19-9-13-21(31)14-10-19/h7-14,22-23,25H,6,15-16H2,1-5H3/t22-,23+,25-,29+/m1/s1",RAOMNLQVLIPYJL-BGLPIVGWSA-N,1,0,0,0,MDM2-Like / P53,7.24,cancer,Inhibition,
1559,59555719,,,COCc1cc(Nc2ccc(NCCc3c[nH]c4ccccc34)cc2)ccn1,"1-N-[2-(1H-indol-3-yl)ethyl]-4-N-[2-(methoxymethyl)pyridin-4-yl]benzene-1,4-diamine","InChI=1S/C23H24N4O/c1-28-16-21-14-20(11-13-25-21)27-19-8-6-18(7-9-19)24-12-10-17-15-26-23-5-3-2-4-22(17)23/h2-9,11,13-15,24,26H,10,12,16H2,1H3,(H,25,27)",VGJDQASKXGNVFK-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,6.40,cancer,Inhibition,
1560,67031955,,,CC(C)(C)NC(=O)Cc1ccc(Cl)cc1-n1c(nc(-c2nnc(N)o2)c1-c1ccc(F)c(Cl)c1)C1CCCCC1,,"InChI=1S/C29H31Cl2FN6O2/c1-29(2,3)35-23(39)14-17-9-11-19(30)15-22(17)38-25(18-10-12-21(32)20(31)13-18)24(27-36-37-28(33)40-27)34-26(38)16-7-5-4-6-8-16/h9-13,15-16H,4-8,14H2,1-3H3,(H2,33,37)(H,35,39)",OKXYPJCJFTZRRY-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,8.70,cancer,Inhibition,
1561,168317945,,,COc1cccc2c(CCNc3ccc(Nc4ccnc5[C@@H](O)CCc45)c(OC)c3F)c[nH]c12,"4-[3-fluoro-2-methoxy-4-[2-(7-methoxy-1H-indol-3-yl)ethylamino]anilino]-6,7-dihydro-5H-cyclopenta[b]pyridin-7-ol","InChI=1S/C26H27FN4O3/c1-33-22-5-3-4-16-15(14-30-25(16)22)10-12-28-19-7-8-20(26(34-2)23(19)27)31-18-11-13-29-24-17(18)6-9-21(24)32/h3-5,7-8,11,13-14,21,28,30,32H,6,9-10,12H2,1-2H3,(H,29,31)/t21-/m0/s1",HOVKIGHRDLSJBL-NRFANRHFSA-N,1,1,0,0,MDM2-Like / P53,6.30,cancer,Inhibition,
1562,67032120,,,Nc1nnc(o1)-c1nc(C2CCCCC2)n(c1-c1ccc(F)c(Cl)c1)-c1c(CC(=O)NC2(CO)CC2)ccc(Cl)c1F,,"InChI=1S/C29H28Cl2F2N6O3/c30-18-8-6-17(13-21(41)36-29(14-40)10-11-29)24(22(18)33)39-25(16-7-9-20(32)19(31)12-16)23(27-37-38-28(34)42-27)35-26(39)15-4-2-1-3-5-15/h6-9,12,15,40H,1-5,10-11,13-14H2,(H2,34,38)(H,36,41)",AFUBXOZHFSVZLO-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,8.70,cancer,Inhibition,
1563,67954280,,,Cc1cccc(c1)-c1nc(C(O)=O)c(-c2cc(Cl)ccc2O)n1-c1cc(Cl)ccc1C,,"InChI=1S/C24H18Cl2N2O3/c1-13-4-3-5-15(10-13)23-27-21(24(30)31)22(18-11-16(25)8-9-20(18)29)28(23)19-12-17(26)7-6-14(19)2/h3-12,29H,1-2H3,(H,30,31)",VXPATBDGWWQJBP-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,6.70,cancer,Inhibition,
1564,21906781,183770,10657291,CCN(C)c1cc(ncn1)-c1ccc(Sc2ccccc2C(C)C)c(c1)C(F)(F)F,N-ethyl-N-methyl-6-[4-(2-propan-2-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyrimidin-4-amine,"InChI=1S/C23H24F3N3S/c1-5-29(4)22-13-19(27-14-28-22)16-10-11-21(18(12-16)23(24,25)26)30-20-9-7-6-8-17(20)15(2)3/h6-15H,5H2,1-4H3",VDCWKOMRFTYIHX-UHFFFAOYSA-N,0,1,0,0,LFA / ICAM,6.17,immune system disease,Inhibition,
1565,168317944,,,COC(=O)c1cccc(NC(=O)c2ccc(cc2)-n2[nH]c3c4cnn(C)c4nc(-c4cccc(c4)C(F)(F)F)c3c2=O)c1,,"InChI=1S/C30H21F3N6O4/c1-38-26-22(15-34-38)25-23(24(36-26)17-5-3-7-19(13-17)30(31,32)33)28(41)39(37-25)21-11-9-16(10-12-21)27(40)35-20-8-4-6-18(14-20)29(42)43-2/h3-15,37H,1-2H3,(H,35,40)",GWBOUSAJUKGYBP-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.03,cancer,Inhibition,
1566,25026112,583544,24641694,CN(C)c1nc(NCc2ccc(NC(=O)c3ccc(F)cc3)cc2)c2ccc(C=O)cc2n1,N-[4-[[[2-(dimethylamino)-7-formylquinazolin-4-yl]amino]methyl]phenyl]-4-fluorobenzamide,"InChI=1S/C25H22FN5O2/c1-31(2)25-29-22-13-17(15-32)5-12-21(22)23(30-25)27-14-16-3-10-20(11-4-16)28-24(33)18-6-8-19(26)9-7-18/h3-13,15H,14H2,1-2H3,(H,28,33)(H,27,29,30)",VALDLJHSDBHIOB-UHFFFAOYSA-N,0,1,0,0,Beta-catenin / TCF-4,6.05,cancer,Inhibition,
1567,44392029,183226,23248102,COc1ccccc1Sc1ccc(cc1C(F)(F)F)-c1ccnc(c1)N1CC[C@@H](O)C1,1-[4-[4-(2-methoxyphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyridin-2-yl]pyrrolidin-3-ol,"InChI=1S/C23H21F3N2O2S/c1-30-19-4-2-3-5-21(19)31-20-7-6-15(12-18(20)23(24,25)26)16-8-10-27-22(13-16)28-11-9-17(29)14-28/h2-8,10,12-13,17,29H,9,11,14H2,1H3/t17-/m1/s1",ROCDTGHUIQLNBL-QGZVFWFLSA-N,0,1,0,0,LFA / ICAM,7.11,immune system disease,Inhibition,
1568,66616620,,,CS(=O)(=O)c1ccc(CN(Cc2cccc(CNS(=O)(=O)c3cc(Cl)cc(Cl)c3O)c2)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)cc1,,"InChI=1S/C28H24Cl4N2O8S3/c1-43(37,38)22-7-5-17(6-8-22)15-34(45(41,42)26-13-21(30)11-24(32)28(26)36)16-19-4-2-3-18(9-19)14-33-44(39,40)25-12-20(29)10-23(31)27(25)35/h2-13,33,35-36H,14-16H2,1H3",JAHXXYBXDOSNTN-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,6.83,cancer,Inhibition,
1569,44392063,183597,23248133,COc1ccccc1Sc1ccc(cc1C(F)(F)F)-c1ccnc(c1)N1CCC[C@@H]1CO,[(2R)-1-[4-[4-(2-methoxyphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyridin-2-yl]pyrrolidin-2-yl]methanol,"InChI=1S/C24H23F3N2O2S/c1-31-20-6-2-3-7-22(20)32-21-9-8-16(13-19(21)24(25,26)27)17-10-11-28-23(14-17)29-12-4-5-18(29)15-30/h2-3,6-11,13-14,18,30H,4-5,12,15H2,1H3/t18-/m1/s1",WUFSAKWUUGHJKE-GOSISDBHSA-N,0,1,0,0,LFA / ICAM,6.48,immune system disease,Inhibition,
1570,67954550,,,COc1ccc(Cl)cc1-c1c(nc(-c2cccc(C)c2)n1-c1cc(Cl)ccc1C)-c1nnn[nH]1,,"InChI=1S/C25H20Cl2N6O/c1-14-5-4-6-16(11-14)25-28-22(24-29-31-32-30-24)23(19-12-17(26)9-10-21(19)34-3)33(25)20-13-18(27)8-7-15(20)2/h4-13H,1-3H3,(H,29,30,31,32)",FZMDFJBFQMGJFC-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,6.80,cancer,Inhibition,
1571,44579159,479061,24699504,CNc1cccc(Sc2ccc(\C=C\C(=O)N3CCOCC3)c(c2C(F)(F)F)C(F)(F)F)c1,"(E)-3-[4-[3-(methylamino)phenyl]sulfanyl-2,3-bis(trifluoromethyl)phenyl]-1-morpholin-4-ylprop-2-en-1-one","InChI=1S/C22H20F6N2O2S/c1-29-15-3-2-4-16(13-15)33-17-7-5-14(6-8-18(31)30-9-11-32-12-10-30)19(21(23,24)25)20(17)22(26,27)28/h2-8,13,29H,9-12H2,1H3/b8-6+",BWZVEDBBEOJBAG-SOFGYWHQSA-N,1,0,0,0,LFA / ICAM,8.40,immune system disease,Inhibition,
1572,168317942,,,O[C@H]1CCc2c1nccc2Nc1ccc2N(CCc3c[nH]c4ccccc34)C[C@H](Oc2c1)c1ccoc1,"4-[[2-(furan-3-yl)-4-[2-(1H-indol-3-yl)ethyl]-2,3-dihydro-1,4-benzoxazin-7-yl]amino]-6,7-dihydro-5H-cyclopenta[b]pyridin-7-ol","InChI=1S/C30H28N4O3/c35-27-8-6-23-25(9-12-31-30(23)27)33-21-5-7-26-28(15-21)37-29(20-11-14-36-18-20)17-34(26)13-10-19-16-32-24-4-2-1-3-22(19)24/h1-5,7,9,11-12,14-16,18,27,29,32,35H,6,8,10,13,17H2,(H,31,33)/t27-,29-/m0/s1",NHCDSJWNFXJBOZ-YTMVLYRLSA-N,1,1,0,0,MDM2-Like / P53,6.52,cancer,Inhibition,
1573,168317941,,,CCOc1cc(ccc1C1=N[C@H]([C@@H](N1C(=O)N1CCC(CC1)n1c2ccccc2[nH]c1=O)c1ccc(Cl)cc1)c1ccc(Cl)cc1)C(F)(F)F,"3-[1-[4,5-bis(4-chlorophenyl)-2-[2-ethoxy-4-(trifluoromethyl)phenyl]-4,5-dihydroimidazole-1-carbonyl]piperidin-4-yl]-1H-benzimidazol-2-one","InChI=1S/C37H32Cl2F3N5O3/c1-2-50-31-21-24(37(40,41)42)11-16-28(31)34-44-32(22-7-12-25(38)13-8-22)33(23-9-14-26(39)15-10-23)47(34)36(49)45-19-17-27(18-20-45)46-30-6-4-3-5-29(30)43-35(46)48/h3-16,21,27,32-33H,2,17-20H2,1H3,(H,43,48)/t32-,33-/m0/s1",GBEWNNRCXVTBHZ-LQJZCPKCSA-N,1,0,0,0,MDM2-Like / P53,6.10,cancer,Inhibition,
1574,44191750,541427,24614007,Cc1cc2c(C(=O)NC3Cc4ccccc4C3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)NC3Cc4ccccc4C3)c(O)c(O)cc2c1O,"N-(2,3-dihydro-1H-inden-2-yl)-6-[5-(2,3-dihydro-1H-inden-2-ylcarbamoyl)-1,6,7-trihydroxy-3-methylnaphthalen-2-yl]-2,3,5-trihydroxy-7-methylnaphthalene-1-carboxamide","InChI=1S/C42H36N2O8/c1-19-11-27-29(17-31(45)39(49)35(27)41(51)43-25-13-21-7-3-4-8-22(21)14-25)37(47)33(19)34-20(2)12-28-30(38(34)48)18-32(46)40(50)36(28)42(52)44-26-15-23-9-5-6-10-24(23)16-26/h3-12,17-18,25-26,45-50H,13-16H2,1-2H3,(H,43,51)(H,44,52)",IYKAYCYVRWTIHM-UHFFFAOYSA-N,4,0,0,0,BCL2-Like / BAX,6.46,cancer,Inhibition,
1575,168317937,,,C[C@H](N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H]1CCCc2ccccc12)C(C)(C)C,"(2R)-1-[(2R)-2-[[(2S)-2-aminopropanoyl]amino]-3,3-dimethylbutanoyl]-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]pyrrolidine-2-carboxamide","InChI=1S/C24H36N4O3/c1-15(25)21(29)27-20(24(2,3)4)23(31)28-14-8-13-19(28)22(30)26-18-12-7-10-16-9-5-6-11-17(16)18/h5-6,9,11,15,18-20H,7-8,10,12-14,25H2,1-4H3,(H,26,30)(H,27,29)/t15-,18-,19-,20+/m0/s1",SLOODFCFHRMFEF-MVJPYGJCSA-N,1,1,0,0,XIAP / Smac,7.92,cancer,Inhibition,
1576,67954415,,,CC(C)(CO)NC(=O)Cc1ccc(Cl)c(F)c1-n1c(nc(-c2nnc(N)o2)c1-c1ccc(F)c(Cl)c1)C1CCCCC1,,"InChI=1S/C29H30Cl2F2N6O3/c1-29(2,14-40)36-21(41)13-17-8-10-18(30)22(33)24(17)39-25(16-9-11-20(32)19(31)12-16)23(27-37-38-28(34)42-27)35-26(39)15-6-4-3-5-7-15/h8-12,15,40H,3-7,13-14H2,1-2H3,(H2,34,38)(H,36,41)",NCCFODLJUFCFSX-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,8.30,cancer,Inhibition,
1577,16109081,374941,17266496,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCC(CC1)=Cc1cccnc1,N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonyl-4-[4-(pyridin-3-ylmethylidene)piperidin-1-yl]benzamide,"InChI=1S/C36H40N6O5S2/c1-40(2)20-18-30(26-48-32-8-4-3-5-9-32)38-34-15-14-33(24-35(34)42(44)45)49(46,47)39-36(43)29-10-12-31(13-11-29)41-21-16-27(17-22-41)23-28-7-6-19-37-25-28/h3-15,19,23-25,30,38H,16-18,20-22,26H2,1-2H3,(H,39,43)/t30-/m1/s1",YWPKBEPJHDRETK-SSEXGKCCSA-N,2,0,0,0,BCL2-Like / BAX,8.89,cancer,Inhibition,
1578,168317936,,24632962,C[C@@H](Oc1cccc2ncccc12)C(=O)N1CCN(C[C@H]1C)C(=O)c1ccccc1,1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-quinolin-5-yloxypropan-1-one,"InChI=1S/C24H25N3O3/c1-17-16-26(24(29)19-8-4-3-5-9-19)14-15-27(17)23(28)18(2)30-22-12-6-11-21-20(22)10-7-13-25-21/h3-13,17-18H,14-16H2,1-2H3/t17-,18-/m1/s1",ZMMBSXODONDQLW-QZTJIDSGSA-N,0,1,0,0,CD4 / gp120,7.00,HIV infectious disease,Inhibition,
1579,168317940,,,Fc1cccc2[nH]cc(C(=O)C(=O)N3CCN([C@H](C3)c3ccccc3)C(=O)c3ccccc3)c12,"1-(4-benzoyl-3-phenylpiperazin-1-yl)-2-(4-fluoro-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C27H22FN3O3/c28-21-12-7-13-22-24(21)20(16-29-22)25(32)27(34)30-14-15-31(26(33)19-10-5-2-6-11-19)23(17-30)18-8-3-1-4-9-18/h1-13,16,23,29H,14-15,17H2/t23-/m1/s1",CEVMEMFIXKVVAH-HSZRJFAPSA-N,0,1,0,0,CD4 / gp120,5.47,HIV infectious disease,Inhibition,
1580,168317939,,26362015,OC(=O)c1ccc(cc1)-c1ccc(OCCc2cc(ccc2Cl)[C@](O)(CCN2CCOCC2)c2ccc(Cl)cc2)cc1,4-[4-[2-[2-chloro-5-[1-(4-chlorophenyl)-1-hydroxy-3-morpholin-4-ylpropyl]phenyl]ethoxy]phenyl]benzoic acid,"InChI=1S/C34H33Cl2NO5/c35-30-10-7-28(8-11-30)34(40,16-17-37-18-21-41-22-19-37)29-9-14-32(36)27(23-29)15-20-42-31-12-5-25(6-13-31)24-1-3-26(4-2-24)33(38)39/h1-14,23,40H,15-22H2,(H,38,39)/t34-/m0/s1",CYNBHDONBLRMMT-UMSFTDKQSA-N,1,0,0,0,BCL2-Like / BAX,6.66,cancer,Inhibition,
1581,59555544,,,Cc1cc(Nc2ccc(NCCc3c[nH]c4ccccc34)cc2)c2cc(CO)ccc2n1,[4-[4-[2-(1H-indol-3-yl)ethylamino]anilino]-2-methylquinolin-6-yl]methanol,"InChI=1S/C27H26N4O/c1-18-14-27(24-15-19(17-32)6-11-26(24)30-18)31-22-9-7-21(8-10-22)28-13-12-20-16-29-25-5-3-2-4-23(20)25/h2-11,14-16,28-29,32H,12-13,17H2,1H3,(H,30,31)",CDPGTPPXWYYMLL-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,6.70,cancer,Inhibition,
1582,23646358,359675,23246935,C[C@H](N)C(=O)Nc1nc(COC2Cc3ccccc3C2)c(Cc2ccccc2)s1,"(2S)-2-amino-N-[5-benzyl-4-(2,3-dihydro-1H-inden-2-yloxymethyl)-1,3-thiazol-2-yl]propanamide","InChI=1S/C23H25N3O2S/c1-15(24)22(27)26-23-25-20(21(29-23)11-16-7-3-2-4-8-16)14-28-19-12-17-9-5-6-10-18(17)13-19/h2-10,15,19H,11-14,24H2,1H3,(H,25,26,27)/t15-/m0/s1",NJLCBCUEQWZJFS-HNNXBMFYSA-N,1,0,0,0,XIAP / Smac,4.66,cancer,Inhibition,
1583,10099070,359425,8274604,CC(C)C[C@@H]1N([C@H](C)CCN([C@@H](Cc2ccc3ccccc3c2)C(N)=O)C1=O)C(=O)Cc1cnc2ccccc2c1,"(2S)-2-[(3S,5R)-5-methyl-3-(2-methylpropyl)-2-oxo-4-(2-quinolin-3-ylacetyl)-1,4-diazepan-1-yl]-3-naphthalen-2-ylpropanamide","InChI=1S/C34H38N4O3/c1-22(2)16-31-34(41)37(30(33(35)40)19-24-12-13-26-8-4-5-9-27(26)17-24)15-14-23(3)38(31)32(39)20-25-18-28-10-6-7-11-29(28)36-21-25/h4-13,17-18,21-23,30-31H,14-16,19-20H2,1-3H3,(H2,35,40)/t23-,30+,31+/m1/s1",LGJZQZFSGWSQNO-VBDKILDKSA-N,1,0,0,0,LFA / ICAM,7.15,immune system disease,Inhibition,
1584,44573477,494547,24705980,CCCCOc1cccc2c(c[nH]c12)C(=O)C(=O)N1CCN(CC1)C(=O)c1ccccc1,"1-(4-benzoylpiperazin-1-yl)-2-(7-butoxy-1H-indol-3-yl)ethane-1,2-dione","InChI=1S/C25H27N3O4/c1-2-3-16-32-21-11-7-10-19-20(17-26-22(19)21)23(29)25(31)28-14-12-27(13-15-28)24(30)18-8-5-4-6-9-18/h4-11,17,26H,2-3,12-16H2,1H3",QNAOAJICNOEZDU-UHFFFAOYSA-N,0,1,0,0,CD4 / gp120,9.85,HIV infectious disease,Inhibition,
1585,16072153,242969,17231639,OC(=O)[C@H](Cc1c[nH]c2ccccc12)N1C(=S)S\C(=C/c2ccc(Br)cc2)C1=O,"(2S)-2-[(5Z)-5-[(4-bromophenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-3-(1H-indol-3-yl)propanoic acid","InChI=1S/C21H15BrN2O3S2/c22-14-7-5-12(6-8-14)9-18-19(25)24(21(28)29-18)17(20(26)27)10-13-11-23-16-4-2-1-3-15(13)16/h1-9,11,17,23H,10H2,(H,26,27)/b18-9-/t17-/m0/s1",YWNIWYSIZUOBBC-NBPJVQFTSA-N,1,0,0,0,BCL2-Like / BAX,5.55,cancer,Inhibition,
1586,168317809,,24634517,CNC(=O)c1cccc(O[C@H](C)C(=O)N2CCN(C[C@H]2C)C(=O)c2ccccc2)c1,3-[1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-1-oxopropan-2-yl]oxy-N-methylbenzamide,"InChI=1S/C23H27N3O4/c1-16-15-25(23(29)18-8-5-4-6-9-18)12-13-26(16)22(28)17(2)30-20-11-7-10-19(14-20)21(27)24-3/h4-11,14,16-17H,12-13,15H2,1-3H3,(H,24,27)/t16-,17-/m1/s1",LUSNYUGJESXMCA-IAGOWNOFSA-N,0,1,0,0,CD4 / gp120,5.85,HIV infectious disease,Inhibition,
1587,67033849,,,Cc1ccc(Cl)cc1-n1c(CC(C)(C)C)nc(-c2nn[nH]n2)c1-c1ccc(F)c(Cl)c1,,"InChI=1S/C22H21Cl2FN6/c1-12-5-7-14(23)10-17(12)31-18(11-22(2,3)4)26-19(21-27-29-30-28-21)20(31)13-6-8-16(25)15(24)9-13/h5-10H,11H2,1-4H3,(H,27,28,29,30)",FSTVGPKOIMMQPO-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,7.25,cancer,Inhibition,
1588,44570091,504480,24709962,CCCCN(CCCC)C(=O)c1nn(c(C)c1Cl)-c1ccc(NC(=O)COc2ccccc2)cc1C(=O)N1CCc2ccccc2C1,"N,N-dibutyl-4-chloro-1-[2-(3,4-dihydro-1H-isoquinoline-2-carbonyl)-4-[(2-phenoxyacetyl)amino]phenyl]-5-methylpyrazole-3-carboxamide","InChI=1S/C37H42ClN5O4/c1-4-6-20-41(21-7-5-2)37(46)35-34(38)26(3)43(40-35)32-18-17-29(39-33(44)25-47-30-15-9-8-10-16-30)23-31(32)36(45)42-22-19-27-13-11-12-14-28(27)24-42/h8-18,23H,4-7,19-22,24-25H2,1-3H3,(H,39,44)",JGHBSKWHWQNIKH-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,7.40,cancer,Inhibition,
1589,135741996,258819,23326305,Oc1c(O)c(cc(C(=O)c2ccc(Oc3ccccc3)cc2)c1O)C(=O)c1nc2ccccc2s1,"(6Z)-4-[(Z)-3H-1,3-benzothiazol-2-ylidene(hydroxy)methyl]-6-[hydroxy-(4-phenoxyphenyl)methylidene]cyclohex-4-ene-1,2,3-trione","InChI=1S/C27H17NO6S/c29-22(15-10-12-17(13-11-15)34-16-6-2-1-3-7-16)18-14-19(24(31)26(33)23(18)30)25(32)27-28-20-8-4-5-9-21(20)35-27/h1-14,30-31,33H",CYBLECRKSFPWGB-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,6.77,cancer,Inhibition,
1590,11570828,500859,24710932,OC(=O)[C@@H]1CC[C@@H](CC1)CNc1cccc(c1)Sc1ccc(\C=C\C(=O)N2CCOCC2)c(C(F)(F)F)c1C(F)(F)F,"4-[[3-[4-[(E)-3-morpholin-4-yl-3-oxoprop-1-enyl]-2,3-bis(trifluoromethyl)phenyl]sulfanylanilino]methyl]cyclohexane-1-carboxylic acid","InChI=1S/C29H30F6N2O4S/c30-28(31,32)25-19(9-11-24(38)37-12-14-41-15-13-37)8-10-23(26(25)29(33,34)35)42-22-3-1-2-21(16-22)36-17-18-4-6-20(7-5-18)27(39)40/h1-3,8-11,16,18,20,36H,4-7,12-15,17H2,(H,39,40)/b11-9+/t18-,20+",DMEDNZSJTBCBCR-VSOCWTRISA-N,1,0,0,0,LFA / ICAM,8.49,immune system disease,Inhibition,
1591,44574945,502211,,OC[C@H]1[C@@H]2Cn3c(cccc3=O)[C@H]([C@@H]1C(=O)NCCN1CCCCC1)N2c1nc(c(s1)-c1ccccc1)-c1ccc(Cl)cc1,,"InChI=1S/C34H36ClN5O3S/c35-24-14-12-22(13-15-24)30-32(23-8-3-1-4-9-23)44-34(37-30)40-27-20-39-26(10-7-11-28(39)42)31(40)29(25(27)21-41)33(43)36-16-19-38-17-5-2-6-18-38/h1,3-4,7-15,25,27,29,31,41H,2,5-6,16-21H2,(H,36,43)/t25-,27-,29+,31+/m0/s1",NILBOLZUFRHFHT-FVRFUWMBSA-N,2,0,0,0,BCL2-Like / BAX,5.60,cancer,Inhibition,
1592,44305016,65229,23155866,OC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1cccc(F)c1F,"(2S)-2-[(2,3-difluorobenzoyl)amino]-3-(1H-indol-3-yl)propanoic acid","InChI=1S/C18H14F2N2O3/c19-13-6-3-5-12(16(13)20)17(23)22-15(18(24)25)8-10-9-21-14-7-2-1-4-11(10)14/h1-7,9,15,21H,8H2,(H,22,23)(H,24,25)/t15-/m0/s1",LXIKCJRNYKYYNS-HNNXBMFYSA-N,1,0,0,0,LFA / ICAM,4.67,immune system disease,Inhibition,
1593,25209021,475670,24697394,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2[C@@H](Cc3ccccc3)C[C@H](N2C1=O)C(=O)N[C@@H]1CCCc2ccccc12,"(1S,3S,6S,10aS)-1-benzyl-6-[[(2S)-2-(methylamino)propanoyl]amino]-5-oxo-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-2,3,6,7,8,9,10,10a-octahydro-1H-pyrrolo[1,2-a]azocine-3-carboxamide","InChI=1S/C32H42N4O3/c1-21(33-2)30(37)35-27-16-8-9-18-28-24(19-22-11-4-3-5-12-22)20-29(36(28)32(27)39)31(38)34-26-17-10-14-23-13-6-7-15-25(23)26/h3-7,11-13,15,21,24,26-29,33H,8-10,14,16-20H2,1-2H3,(H,34,38)(H,35,37)/t21-,24-,26+,27-,28-,29-/m0/s1",GSYDLODTKWENBK-UZYJKHRNSA-N,1,1,0,0,XIAP / Smac,8.52,cancer,Inhibition,
1594,67985502,,,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1C(F)(F)F)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1,,"InChI=1S/C44H49ClF3N7O2S2/c1-53(2)22-18-34(29-58-36-9-4-3-5-10-36)51-41-17-16-37(26-40(41)44(46,47)48)59(56,57)52-43-39-21-25-55(28-42(39)49-30-50-43)35-19-23-54(24-20-35)27-32-8-6-7-11-38(32)31-12-14-33(45)15-13-31/h3-17,26,30,34-35,51H,18-25,27-29H2,1-2H3,(H,49,50,52)/t34-/m1/s1",MOTWHKWWKFDYOW-UUWRZZSWSA-N,1,0,0,0,BCL2-Like / BAX,7.18,cancer,Inhibition,
1595,66616596,,,CC(C)NC(=O)c1cc(Cl)c(O)c(c1)S(=O)(=O)N(Cc1ccc(F)cc1)Cc1cccc(c1)-c1ccc(Cl)cc1,,"InChI=1S/C30H27Cl2FN2O4S/c1-19(2)34-30(37)24-15-27(32)29(36)28(16-24)40(38,39)35(17-20-6-12-26(33)13-7-20)18-21-4-3-5-23(14-21)22-8-10-25(31)11-9-22/h3-16,19,36H,17-18H2,1-2H3,(H,34,37)",HFTQHRHBHHIBSA-UHFFFAOYSA-N,2,0,0,0,BCL2-Like / BAX,6.32,cancer,Inhibition,
1596,10051913,,8227475,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2cccc(c2)C(=O)N2CCCC2)c1=O,"6-methyl-2-[3-(pyrrolidine-1-carbonyl)phenyl]-4-[3-(trifluoromethyl)phenyl]-1H-dipyrazolo[4,3-b:4',5'-e]pyridin-3-one","InChI=1S/C26H21F3N6O2/c1-33-23-19(14-30-33)22-20(21(31-23)15-6-4-8-17(12-15)26(27,28)29)25(37)35(32-22)18-9-5-7-16(13-18)24(36)34-10-2-3-11-34/h4-9,12-14,32H,2-3,10-11H2,1H3",SXQDRQOTQPFGRI-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,7.36,cancer,Inhibition,
1597,21340819,358481,19009672,CC(C)C[C@@H]1N([C@H](C)CCN([C@@H](Cc2ccc3ccccc3c2)C(N)=O)C1=O)C(=O)Cc1ccc2ccccc2c1,"(2S)-2-[(3S,5R)-5-methyl-3-(2-methylpropyl)-4-(2-naphthalen-2-ylacetyl)-2-oxo-1,4-diazepan-1-yl]-3-naphthalen-2-ylpropanamide","InChI=1S/C35H39N3O3/c1-23(2)18-32-35(41)37(31(34(36)40)21-25-12-14-27-8-4-6-10-29(27)19-25)17-16-24(3)38(32)33(39)22-26-13-15-28-9-5-7-11-30(28)20-26/h4-15,19-20,23-24,31-32H,16-18,21-22H2,1-3H3,(H2,36,40)/t24-,31+,32+/m1/s1",JUGWPUWQAXJTLD-OBVGZQLQSA-N,1,0,0,0,LFA / ICAM,5.70,immune system disease,Inhibition,
1598,16109080,373544,17266495,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCC(CC1)=Cc1ccccc1C#N,4-[4-[(2-cyanophenyl)methylidene]piperidin-1-yl]-N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonylbenzamide,"InChI=1S/C38H40N6O5S2/c1-42(2)21-20-32(27-50-34-10-4-3-5-11-34)40-36-17-16-35(25-37(36)44(46)47)51(48,49)41-38(45)29-12-14-33(15-13-29)43-22-18-28(19-23-43)24-30-8-6-7-9-31(30)26-39/h3-17,24-25,32,40H,18-23,27H2,1-2H3,(H,41,45)/t32-/m1/s1",VZPPLAMKJVEBAM-JGCGQSQUSA-N,2,0,0,0,BCL2-Like / BAX,9.30,cancer,Inhibition,
1599,168317808,,,Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccccc2C(C)(C)C)c1=O,,"InChI=1S/C25H22F3N5O/c1-24(2,3)17-10-5-6-11-18(17)33-23(34)19-20(14-8-7-9-15(12-14)25(26,27)28)30-22-16(21(19)31-33)13-29-32(22)4/h5-13,31H,1-4H3",SKLGYHOMBPPXCH-UHFFFAOYSA-N,1,0,0,0,CD80 / CD28,6.05,cancer,Inhibition,
1600,45138702,,,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2C(C)=O)c1c[nH]c2ccc(F)cc12)C(C)(C)C,"(2S)-N-[(2S)-1-[(3aR,6S,6aR)-4-acetyl-6-(5-fluoro-1H-indol-3-yl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]-2-(methylamino)propanamide","InChI=1S/C26H36FN5O3/c1-14(28-6)24(34)30-23(26(3,4)5)25(35)31-10-9-21-22(31)19(13-32(21)15(2)33)18-12-29-20-8-7-16(27)11-17(18)20/h7-8,11-12,14,19,21-23,28-29H,9-10,13H2,1-6H3,(H,30,34)/t14-,19+,21+,22+,23+/m0/s1",GJCUTOLOYKMWFU-GAVFAVEISA-N,1,0,0,0,XIAP / Smac,7.00,cancer,Inhibition,
1601,25011737,573550,24638010,CC[C@H](N)C(=O)N[C@H]1[C@@H](CO)CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7S,9aS)-6-[[(2S)-2-aminobutanoyl]amino]-N-benzhydryl-7-(hydroxymethyl)-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C28H36N4O4/c1-2-22(29)26(34)31-25-20(17-33)13-14-21-15-16-23(32(21)28(25)36)27(35)30-24(18-9-5-3-6-10-18)19-11-7-4-8-12-19/h3-12,20-25,33H,2,13-17,29H2,1H3,(H,30,35)(H,31,34)/t20-,21+,22+,23+,25+/m1/s1",WXYVFFGXHFXTLU-FCRIMTMASA-N,2,1,0,0,XIAP / Smac,6.57,cancer,Inhibition,
1602,46907787,1957266,,Cc1nnc2[C@H](CC(=O)OC(C)(C)C)N=C(c3c(C)c(C)sc3-n12)c1ccc(Cl)cc1,"tert-butyl 2-[(9S)-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.0^{2,6}]trideca-2(6),4,7,10,12-pentaen-9-yl]acetate","InChI=1S/C23H25ClN4O2S/c1-12-13(2)31-22-19(12)20(15-7-9-16(24)10-8-15)25-17(11-18(29)30-23(4,5)6)21-27-26-14(3)28(21)22/h7-10,17H,11H2,1-6H3/t17-/m0/s1",DNVXATUJJDPFDM-KRWDZBQOSA-N,12,3,0,0,Bromodomain / Histone,8.40,"cancer, breast cancer",Inhibition,
1603,46943432,1232461,,CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc12,"2-[(7S)-9-(4-chlorophenyl)-12-methoxy-3-methyl-2,4,5,8-tetraazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,8,11,13-hexaen-7-yl]-N-ethylacetamide","InChI=1S/C22H22ClN5O2/c1-4-24-20(29)12-18-22-27-26-13(2)28(22)19-10-9-16(30-3)11-17(19)21(25-18)14-5-7-15(23)8-6-14/h5-11,18H,4,12H2,1-3H3,(H,24,29)/t18-/m0/s1",AAAQFGUYHFJNHI-SFHVURJKSA-N,14,4,0,0,Bromodomain / Histone,7.49,cancer,Inhibition,
1604,52912189,2017291,,COc1cc2c3n([C@H](C)c4ccccn4)c(=O)[nH]c3cnc2cc1-c1c(C)noc1C,"7-(dimethyl-1,2-oxazol-4-yl)-8-methoxy-1-[(1R)-1-(pyridin-2-yl)ethyl]-3H-imidazo[4,5-c]quinolin-2-one","InChI=1S/C23H21N5O3/c1-12-21(14(3)31-27-12)16-9-18-15(10-20(16)30-4)22-19(11-25-18)26-23(29)28(22)13(2)17-7-5-6-8-24-17/h5-11,13H,1-4H3,(H,26,29)/t13-/m1/s1",VUVUVNZRUGEAHB-CYBMUJFWSA-N,5,12,0,0,Bromodomain / Histone,7.82,cancer,Inhibition,
1605,54759170,1950956,,CC(=O)c1cc(-c2ccccn2)c2ccccn12,1-[1-(pyridin-2-yl)indolizin-3-yl]ethanone,"InChI=1S/C15H12N2O/c1-11(18)15-10-12(13-6-2-4-8-16-13)14-7-3-5-9-17(14)15/h2-10H,1H3",WOSGOHDUUBVSBO-UHFFFAOYSA-N,6,1,0,0,Bromodomain / Histone,5.70,cancer,Inhibition,
1606,53054289,2181719,,Cc1noc(C)c1-c1ccc(C)c(c1)S(=O)(=O)NC1CC1,"N-cyclopropyl-5-(dimethyl-1,2-oxazol-4-yl)-2-methylbenzenesulfonamide","InChI=1S/C15H18N2O3S/c1-9-4-5-12(15-10(2)16-20-11(15)3)8-14(9)21(18,19)17-13-6-7-13/h4-5,8,13,17H,6-7H2,1-3H3",DRXUCZBMTLNYCO-UHFFFAOYSA-N,6,1,0,0,Bromodomain / Histone,6.00,cancer,Inhibition,
1607,56950422,2181720,,COc1ccc(cc1S(=O)(=O)NC1CC1)-c1c(C)noc1C,"N-cyclopropyl-5-(dimethyl-1,2-oxazol-4-yl)-2-methoxybenzenesulfonamide","InChI=1S/C15H18N2O4S/c1-9-15(10(2)21-16-9)11-4-7-13(20-3)14(8-11)22(18,19)17-12-5-6-12/h4,7-8,12,17H,5-6H2,1-3H3",JZOMZTBBAILTQJ-UHFFFAOYSA-N,6,1,0,0,Bromodomain / Histone,5.90,cancer,Inhibition,
1608,53054259,2181721,,Cc1noc(C)c1-c1ccc(C)c(c1)S(=O)(=O)NC1CCCC1,"N-cyclopentyl-5-(dimethyl-1,2-oxazol-4-yl)-2-methylbenzenesulfonamide","InChI=1S/C17H22N2O3S/c1-11-8-9-14(17-12(2)18-22-13(17)3)10-16(11)23(20,21)19-15-6-4-5-7-15/h8-10,15,19H,4-7H2,1-3H3",YTFPNQZFSVSZGW-UHFFFAOYSA-N,6,1,0,0,Bromodomain / Histone,6.60,cancer,Inhibition,
1609,53054200,2181722,,COc1ccc(cc1S(=O)(=O)NC1CCCC1)-c1c(C)noc1C,"N-cyclopentyl-5-(dimethyl-1,2-oxazol-4-yl)-2-methoxybenzenesulfonamide","InChI=1S/C17H22N2O4S/c1-11-17(12(2)23-18-11)13-8-9-15(22-3)16(10-13)24(20,21)19-14-6-4-5-7-14/h8-10,14,19H,4-7H2,1-3H3",UVCXALYNQLGUTJ-UHFFFAOYSA-N,6,1,0,0,Bromodomain / Histone,6.00,cancer,Inhibition,
1610,53054258,2181723,,Cc1noc(C)c1-c1ccc(C)c(c1)S(=O)(=O)NC1CCCCC1,"N-cyclohexyl-5-(dimethyl-1,2-oxazol-4-yl)-2-methylbenzenesulfonamide","InChI=1S/C18H24N2O3S/c1-12-9-10-15(18-13(2)19-23-14(18)3)11-17(12)24(21,22)20-16-7-5-4-6-8-16/h9-11,16,20H,4-8H2,1-3H3",PAXZSBFZQIWSKA-UHFFFAOYSA-N,6,1,0,0,Bromodomain / Histone,6.10,cancer,Inhibition,
1611,53054325,2181724,,Cc1noc(C)c1-c1ccc(C)c(c1)S(=O)(=O)Nc1ccccc1,"5-(dimethyl-1,2-oxazol-4-yl)-2-methyl-N-phenylbenzenesulfonamide","InChI=1S/C18H18N2O3S/c1-12-9-10-15(18-13(2)19-23-14(18)3)11-17(12)24(21,22)20-16-7-5-4-6-8-16/h4-11,20H,1-3H3",MVONBAJIJXJZNV-UHFFFAOYSA-N,6,1,0,0,Bromodomain / Histone,6.00,cancer,Inhibition,
1612,53054241,2181725,,COc1ccc(cc1S(=O)(=O)Nc1ccccc1)-c1c(C)noc1C,"5-(dimethyl-1,2-oxazol-4-yl)-2-methoxy-N-phenylbenzenesulfonamide","InChI=1S/C18H18N2O4S/c1-12-18(13(2)24-19-12)14-9-10-16(23-3)17(11-14)25(21,22)20-15-7-5-4-6-8-15/h4-11,20H,1-3H3",QXAPWPVUMQBBCB-UHFFFAOYSA-N,6,1,0,0,Bromodomain / Histone,5.70,cancer,Inhibition,
1613,53054319,2181726,,Cc1noc(C)c1-c1ccc(C)c(c1)S(=O)(=O)Nc1ccccc1Cl,"N-(2-chlorophenyl)-5-(dimethyl-1,2-oxazol-4-yl)-2-methylbenzenesulfonamide","InChI=1S/C18H17ClN2O3S/c1-11-8-9-14(18-12(2)20-24-13(18)3)10-17(11)25(22,23)21-16-7-5-4-6-15(16)19/h4-10,21H,1-3H3",WGMAQYUYNQXUDX-UHFFFAOYSA-N,6,0,0,0,Bromodomain / Histone,5.70,cancer,Inhibition,
1614,53054236,2181727,,COc1ccc(cc1S(=O)(=O)Nc1ccccc1Cl)-c1c(C)noc1C,"N-(2-chlorophenyl)-5-(dimethyl-1,2-oxazol-4-yl)-2-methoxybenzenesulfonamide","InChI=1S/C18H17ClN2O4S/c1-11-18(12(2)25-20-11)13-8-9-16(24-3)17(10-13)26(22,23)21-15-7-5-4-6-14(15)19/h4-10,21H,1-3H3",QQHAEBNIGSWFDN-UHFFFAOYSA-N,6,0,0,0,Bromodomain / Histone,5.40,cancer,Inhibition,
1615,53054251,2181728,,Cc1noc(C)c1-c1ccc(C)c(c1)S(=O)(=O)Nc1cccc(Cl)c1,"N-(3-chlorophenyl)-5-(dimethyl-1,2-oxazol-4-yl)-2-methylbenzenesulfonamide","InChI=1S/C18H17ClN2O3S/c1-11-7-8-14(18-12(2)20-24-13(18)3)9-17(11)25(22,23)21-16-6-4-5-15(19)10-16/h4-10,21H,1-3H3",RCYMFVYTSIXHHI-UHFFFAOYSA-N,6,0,0,0,Bromodomain / Histone,5.70,cancer,Inhibition,
1616,53054252,2181729,,Cc1noc(C)c1-c1ccc(C)c(c1)S(=O)(=O)Nc1ccc(Cl)cc1,"N-(4-chlorophenyl)-5-(dimethyl-1,2-oxazol-4-yl)-2-methylbenzenesulfonamide","InChI=1S/C18H17ClN2O3S/c1-11-4-5-14(18-12(2)20-24-13(18)3)10-17(11)25(22,23)21-16-8-6-15(19)7-9-16/h4-10,21H,1-3H3",UGZJMSVKXJNNSN-UHFFFAOYSA-N,6,0,0,0,Bromodomain / Histone,5.40,cancer,Inhibition,
1617,53054324,2181730,,COc1ccccc1NS(=O)(=O)c1cc(ccc1C)-c1c(C)noc1C,"5-(dimethyl-1,2-oxazol-4-yl)-N-(2-methoxyphenyl)-2-methylbenzenesulfonamide","InChI=1S/C19H20N2O4S/c1-12-9-10-15(19-13(2)20-25-14(19)3)11-18(12)26(22,23)21-16-7-5-6-8-17(16)24-4/h5-11,21H,1-4H3",ZZWKKPJOUHFHRP-UHFFFAOYSA-N,6,0,0,0,Bromodomain / Histone,5.80,cancer,Inhibition,
1618,53054240,2181731,,COc1ccccc1NS(=O)(=O)c1cc(ccc1OC)-c1c(C)noc1C,"5-(dimethyl-1,2-oxazol-4-yl)-2-methoxy-N-(2-methoxyphenyl)benzenesulfonamide","InChI=1S/C19H20N2O5S/c1-12-19(13(2)26-20-12)14-9-10-17(25-4)18(11-14)27(22,23)21-15-7-5-6-8-16(15)24-3/h5-11,21H,1-4H3",QJXGOABVFOATSF-UHFFFAOYSA-N,6,0,0,0,Bromodomain / Histone,5.60,cancer,Inhibition,
1619,53054248,2181732,,COc1cccc(NS(=O)(=O)c2cc(ccc2C)-c2c(C)noc2C)c1,"5-(dimethyl-1,2-oxazol-4-yl)-N-(3-methoxyphenyl)-2-methylbenzenesulfonamide","InChI=1S/C19H20N2O4S/c1-12-8-9-15(19-13(2)20-25-14(19)3)10-18(12)26(22,23)21-16-6-5-7-17(11-16)24-4/h5-11,21H,1-4H3",JSUYLKKHYGOFLO-UHFFFAOYSA-N,6,0,0,0,Bromodomain / Histone,5.70,cancer,Inhibition,
1620,53054190,2181733,,COc1cccc(NS(=O)(=O)c2cc(ccc2OC)-c2c(C)noc2C)c1,"5-(dimethyl-1,2-oxazol-4-yl)-2-methoxy-N-(3-methoxyphenyl)benzenesulfonamide","InChI=1S/C19H20N2O5S/c1-12-19(13(2)26-20-12)14-8-9-17(25-4)18(10-14)27(22,23)21-15-6-5-7-16(11-15)24-3/h5-11,21H,1-4H3",GVZJAPYHAKPDMB-UHFFFAOYSA-N,6,0,0,0,Bromodomain / Histone,5.30,cancer,Inhibition,
1621,53054249,2181734,,COc1ccc(NS(=O)(=O)c2cc(ccc2C)-c2c(C)noc2C)cc1,"5-(dimethyl-1,2-oxazol-4-yl)-N-(4-methoxyphenyl)-2-methylbenzenesulfonamide","InChI=1S/C19H20N2O4S/c1-12-5-6-15(19-13(2)20-25-14(19)3)11-18(12)26(22,23)21-16-7-9-17(24-4)10-8-16/h5-11,21H,1-4H3",AJEBJZBGRXUSEV-UHFFFAOYSA-N,6,0,0,0,Bromodomain / Histone,5.30,cancer,Inhibition,
1622,53054191,2181735,,COc1ccc(NS(=O)(=O)c2cc(ccc2OC)-c2c(C)noc2C)cc1,"5-(dimethyl-1,2-oxazol-4-yl)-2-methoxy-N-(4-methoxyphenyl)benzenesulfonamide","InChI=1S/C19H20N2O5S/c1-12-19(13(2)26-20-12)14-5-10-17(25-4)18(11-14)27(22,23)21-15-6-8-16(24-3)9-7-15/h5-11,21H,1-4H3",CBDNQLWEBDFRNQ-UHFFFAOYSA-N,5,0,0,0,Bromodomain / Histone,4.90,cancer,Inhibition,
1623,53054320,2181736,,Cc1noc(C)c1-c1ccc(C)c(c1)S(=O)(=O)NCc1ccccc1,"N-benzyl-5-(dimethyl-1,2-oxazol-4-yl)-2-methylbenzenesulfonamide","InChI=1S/C19H20N2O3S/c1-13-9-10-17(19-14(2)21-24-15(19)3)11-18(13)25(22,23)20-12-16-7-5-4-6-8-16/h4-11,20H,12H2,1-3H3",WWWXTNNNFFUVPX-UHFFFAOYSA-N,6,0,0,0,Bromodomain / Histone,5.40,cancer,Inhibition,
1624,53054237,2181737,,COc1ccc(cc1S(=O)(=O)NCc1ccccc1)-c1c(C)noc1C,"N-benzyl-5-(dimethyl-1,2-oxazol-4-yl)-2-methoxybenzenesulfonamide","InChI=1S/C19H20N2O4S/c1-13-19(14(2)25-21-13)16-9-10-17(24-3)18(11-16)26(22,23)20-12-15-7-5-4-6-8-15/h4-11,20H,12H2,1-3H3",QKQSHKXIHWMZBP-UHFFFAOYSA-N,6,0,0,0,Bromodomain / Histone,4.90,cancer,Inhibition,
1625,53054291,2181738,,Cc1noc(C)c1-c1ccc(C)c(c1)S(=O)(=O)NCCc1ccccc1,"5-(dimethyl-1,2-oxazol-4-yl)-2-methyl-N-(2-phenylethyl)benzenesulfonamide","InChI=1S/C20H22N2O3S/c1-14-9-10-18(20-15(2)22-25-16(20)3)13-19(14)26(23,24)21-12-11-17-7-5-4-6-8-17/h4-10,13,21H,11-12H2,1-3H3",HUJNTKAIOQIUQI-UHFFFAOYSA-N,6,0,0,0,Bromodomain / Histone,5.50,cancer,Inhibition,
1626,53054274,2181739,,Cc1noc(C)c1-c1ccc(C)c(c1)S(=O)(=O)NCCCc1ccccc1,"5-(dimethyl-1,2-oxazol-4-yl)-2-methyl-N-(3-phenylpropyl)benzenesulfonamide","InChI=1S/C21H24N2O3S/c1-15-11-12-19(21-16(2)23-26-17(21)3)14-20(15)27(24,25)22-13-7-10-18-8-5-4-6-9-18/h4-6,8-9,11-12,14,22H,7,10,13H2,1-3H3",DRGJJHYJRRBMNA-UHFFFAOYSA-N,6,0,0,0,Bromodomain / Histone,5.50,cancer,Inhibition,
1627,56950423,2181740,,COCCNS(=O)(=O)c1cc(ccc1C)-c1c(C)noc1C,"5-(dimethyl-1,2-oxazol-4-yl)-N-(2-methoxyethyl)-2-methylbenzenesulfonamide","InChI=1S/C15H20N2O4S/c1-10-5-6-13(15-11(2)17-21-12(15)3)9-14(10)22(18,19)16-7-8-20-4/h5-6,9,16H,7-8H2,1-4H3",YEJMUBAWJLSIGV-UHFFFAOYSA-N,6,0,0,0,Bromodomain / Histone,5.10,cancer,Inhibition,
1628,56950424,2181741,,Cc1noc(C)c1-c1ccc(C)c(c1)S(=O)(=O)NCCCO,"S-[5-(dimethyl-1,2-oxazol-4-yl)-2-methylphenyl]-3-hydroxypropane-1-sulfonamido","InChI=1S/C15H20N2O4S/c1-10-5-6-13(15-11(2)17-21-12(15)3)9-14(10)22(19,20)16-7-4-8-18/h5-6,9,16,18H,4,7-8H2,1-3H3",CSJAANWZLHJVMP-UHFFFAOYSA-N,6,0,0,0,Bromodomain / Histone,5.40,cancer,Inhibition,
1629,53054250,2181742,,Cc1noc(C)c1-c1ccc(C)c(c1)S(=O)(=O)NC(C)(C)C,"N-tert-butyl-5-(dimethyl-1,2-oxazol-4-yl)-2-methylbenzenesulfonamide","InChI=1S/C16H22N2O3S/c1-10-7-8-13(15-11(2)17-21-12(15)3)9-14(10)22(19,20)18-16(4,5)6/h7-9,18H,1-6H3",ZPZYOXJIFOEOCZ-UHFFFAOYSA-N,6,1,0,0,Bromodomain / Histone,5.80,cancer,Inhibition,
1630,56950425,2181701,,Cc1noc(C)c1-c1ccc(C)c(c1)S(N)(=O)=O,"5-(dimethyl-1,2-oxazol-4-yl)-2-methylbenzenesulfonamide","InChI=1S/C12H14N2O3S/c1-7-4-5-10(6-11(7)18(13,15)16)12-8(2)14-17-9(12)3/h4-6H,1-3H3,(H2,13,15,16)",CRSZBBYHHDCMTP-UHFFFAOYSA-N,6,0,0,0,Bromodomain / Histone,5.10,cancer,Inhibition,
1631,53054297,2181702,,CCNS(=O)(=O)c1cc(ccc1C)-c1c(C)noc1C,"5-(dimethyl-1,2-oxazol-4-yl)-N-ethyl-2-methylbenzenesulfonamide","InChI=1S/C14H18N2O3S/c1-5-15-20(17,18)13-8-12(7-6-9(13)2)14-10(3)16-19-11(14)4/h6-8,15H,5H2,1-4H3",RTJPPXVTEHIEDJ-UHFFFAOYSA-N,6,1,0,0,Bromodomain / Histone,5.80,cancer,Inhibition,
1632,56950426,2181703,,COc1ccc(cc1S(=O)(=O)N(C)C1CCCC1)-c1c(C)noc1C,"N-cyclopentyl-5-(dimethyl-1,2-oxazol-4-yl)-2-methoxy-N-methylbenzenesulfonamide","InChI=1S/C18H24N2O4S/c1-12-18(13(2)24-19-12)14-9-10-16(23-4)17(11-14)25(21,22)20(3)15-7-5-6-8-15/h9-11,15H,5-8H2,1-4H3",ONUKWYBZXUKVSG-UHFFFAOYSA-N,6,1,0,0,Bromodomain / Histone,6.20,cancer,Inhibition,
1633,56950561,2181704,,CCN(C1CCCC1)S(=O)(=O)c1cc(ccc1OC)-c1c(C)noc1C,"N-cyclopentyl-5-(dimethyl-1,2-oxazol-4-yl)-N-ethyl-2-methoxybenzenesulfonamide","InChI=1S/C19H26N2O4S/c1-5-21(16-8-6-7-9-16)26(22,23)18-12-15(10-11-17(18)24-4)19-13(2)20-25-14(19)3/h10-12,16H,5-9H2,1-4H3",HONVADOKRZTBCS-UHFFFAOYSA-N,6,0,0,0,Bromodomain / Histone,6.20,cancer,Inhibition,
1634,168317807,,,COc1ccc(cc1S(=O)(=O)N1CCCC1)-c1c(C)noc1C,"4-[4-methoxy-3-(pyrrolidine-1-sulfonyl)phenyl]-3,5-dimethyl-1,2-oxazole","InChI=1S/C16H20N2O4S/c1-11-16(12(2)22-17-11)13-6-7-14(21-3)15(10-13)23(19,20)18-8-4-5-9-18/h6-7,10H,4-5,8-9H2,1-3H3",JIXMFEDNAVCSIJ-UHFFFAOYSA-N,6,1,0,0,Bromodomain / Histone,6.00,cancer,Inhibition,
1635,168317806,,,COc1ccc(cc1S(=O)(=O)N1CCCCC1)-c1c(C)noc1C,"1-[5-(dimethyl-1,2-oxazol-4-yl)-2-methoxybenzenesulfonyl]piperidine","InChI=1S/C17H22N2O4S/c1-12-17(13(2)23-18-12)14-7-8-15(22-3)16(11-14)24(20,21)19-9-5-4-6-10-19/h7-8,11H,4-6,9-10H2,1-3H3",FQYFUEBMHGUHFN-UHFFFAOYSA-N,6,1,0,0,Bromodomain / Histone,6.10,cancer,Inhibition,
1636,56950563,2181708,,COc1ccc(cc1S(=O)(=O)N1CCNCC1)-c1c(C)noc1C,"1-[5-(dimethyl-1,2-oxazol-4-yl)-2-methoxybenzenesulfonyl]piperazine","InChI=1S/C16H21N3O4S/c1-11-16(12(2)23-18-11)13-4-5-14(22-3)15(10-13)24(20,21)19-8-6-17-7-9-19/h4-5,10,17H,6-9H2,1-3H3",XQWKMFVPDAAVEN-UHFFFAOYSA-N,5,1,0,0,Bromodomain / Histone,5.10,cancer,Inhibition,
1637,56950562,2181707,,Cc1noc(C)c1-c1ccc(C)c(c1)S(=O)(=O)N1CCNCC1,"1-[5-(dimethyl-1,2-oxazol-4-yl)-2-methylbenzenesulfonyl]piperazine","InChI=1S/C16H21N3O3S/c1-11-4-5-14(16-12(2)18-22-13(16)3)10-15(11)23(20,21)19-8-6-17-7-9-19/h4-5,10,17H,6-9H2,1-3H3",HYOQSAJMQNECHX-UHFFFAOYSA-N,4,0,0,0,Bromodomain / Histone,4.90,cancer,Inhibition,
1638,53054238,2181710,,COc1ccc(cc1S(=O)(=O)N1CCOCC1)-c1c(C)noc1C,"4-[5-(dimethyl-1,2-oxazol-4-yl)-2-methoxybenzenesulfonyl]morpholine","InChI=1S/C16H20N2O5S/c1-11-16(12(2)23-17-11)13-4-5-14(21-3)15(10-13)24(19,20)18-6-8-22-9-7-18/h4-5,10H,6-9H2,1-3H3",BMGQMFHTPSJIIW-UHFFFAOYSA-N,6,1,0,0,Bromodomain / Histone,5.50,cancer,Inhibition,
1639,53054322,2181709,,Cc1noc(C)c1-c1ccc(C)c(c1)S(=O)(=O)N1CCOCC1,"4-[5-(dimethyl-1,2-oxazol-4-yl)-2-methylbenzenesulfonyl]morpholine","InChI=1S/C16H20N2O4S/c1-11-4-5-14(16-12(2)17-22-13(16)3)10-15(11)23(19,20)18-6-8-21-9-7-18/h4-5,10H,6-9H2,1-3H3",MLINPHLNCWOFRX-UHFFFAOYSA-N,6,1,0,0,Bromodomain / Histone,5.20,cancer,Inhibition,
1640,56950564,2181711,,Cc1noc(C)c1-c1ccc(C)c(c1)S(=O)(=O)NC1CCNCC1,"5-(dimethyl-1,2-oxazol-4-yl)-2-methyl-N-(piperidin-4-yl)benzenesulfonamide","InChI=1S/C17H23N3O3S/c1-11-4-5-14(17-12(2)19-23-13(17)3)10-16(11)24(21,22)20-15-6-8-18-9-7-15/h4-5,10,15,18,20H,6-9H2,1-3H3",JJMLGJLFFAUARR-UHFFFAOYSA-N,4,1,0,0,Bromodomain / Histone,5.00,cancer,Inhibition,
1641,56950565,2181712,,COc1ccc(cc1S(=O)(=O)NC1CCNCC1)-c1c(C)noc1C,"5-(dimethyl-1,2-oxazol-4-yl)-2-methoxy-N-(piperidin-4-yl)benzenesulfonamide","InChI=1S/C17H23N3O4S/c1-11-17(12(2)24-19-11)13-4-5-15(23-3)16(10-13)25(21,22)20-14-6-8-18-9-7-14/h4-5,10,14,18,20H,6-9H2,1-3H3",VIAPGKPJAXZIMP-UHFFFAOYSA-N,3,0,0,0,Bromodomain / Histone,4.70,cancer,Inhibition,
1642,168317797,,,Cc1noc(C)c1-c1ccc(C)c(c1)S(=O)(=O)N[C@@H]1CCCNC1,"5-(dimethyl-1,2-oxazol-4-yl)-2-methyl-N-[(3R)-piperidin-3-yl]benzenesulfonamide","InChI=1S/C17H23N3O3S/c1-11-6-7-14(17-12(2)19-23-13(17)3)9-16(11)24(21,22)20-15-5-4-8-18-10-15/h6-7,9,15,18,20H,4-5,8,10H2,1-3H3/t15-/m1/s1",MBPQBSOJNLSBMQ-OAHLLOKOSA-N,6,0,0,0,Bromodomain / Histone,5.10,cancer,Inhibition,
1643,168317805,,,COc1ccc(cc1S(=O)(=O)N[C@@H]1CCCNC1)-c1c(C)noc1C,"5-(dimethyl-1,2-oxazol-4-yl)-2-methoxy-N-[(3R)-piperidin-3-yl]benzenesulfonamide","InChI=1S/C17H23N3O4S/c1-11-17(12(2)24-19-11)13-6-7-15(23-3)16(9-13)25(21,22)20-14-5-4-8-18-10-14/h6-7,9,14,18,20H,4-5,8,10H2,1-3H3/t14-/m1/s1",UPPXBXOYPZLBFZ-CQSZACIVSA-N,4,0,0,0,Bromodomain / Histone,5.00,cancer,Inhibition,
1644,56950289,2181715,,Cc1noc(C)c1-c1cccc(c1)S(=O)(=O)NC1CC1,"N-cyclopropyl-3-(dimethyl-1,2-oxazol-4-yl)benzenesulfonamide","InChI=1S/C14H16N2O3S/c1-9-14(10(2)19-15-9)11-4-3-5-13(8-11)20(17,18)16-12-6-7-12/h3-5,8,12,16H,6-7H2,1-2H3",NKCXFZUAZYBPGA-UHFFFAOYSA-N,6,0,0,0,Bromodomain / Histone,5.50,cancer,Inhibition,
1645,71291020,,,Cc1noc(C)c1-c1cccc(c1)S(=O)(=O)NC1CCCC1,"N-cyclopentyl-3-(dimethyl-1,2-oxazol-4-yl)benzenesulfonamide","InChI=1S/C16H20N2O3S/c1-11-16(12(2)21-17-11)13-6-5-9-15(10-13)22(19,20)18-14-7-3-4-8-14/h5-6,9-10,14,18H,3-4,7-8H2,1-2H3",DRZNAVWHBKVASJ-UHFFFAOYSA-N,6,0,0,0,Bromodomain / Histone,5.90,cancer,Inhibition,
1646,56950421,2181717,,Cc1noc(C)c1-c1ccc(OCCN2CCNCC2)c(c1)S(=O)(=O)NC1CCCC1,"N-cyclopentyl-5-(dimethyl-1,2-oxazol-4-yl)-2-[2-(piperazin-1-yl)ethoxy]benzenesulfonamide","InChI=1S/C22H32N4O4S/c1-16-22(17(2)30-24-16)18-7-8-20(29-14-13-26-11-9-23-10-12-26)21(15-18)31(27,28)25-19-5-3-4-6-19/h7-8,15,19,23,25H,3-6,9-14H2,1-2H3",HOSLTVHKUMGQOX-UHFFFAOYSA-N,6,0,0,0,Bromodomain / Histone,5.70,cancer,Inhibition,
1647,56924692,2181718,,Cc1noc(C)c1-c1ccc(OCCCN2CCOCC2)c(c1)S(=O)(=O)NC1CCCC1,"N-cyclopentyl-5-(dimethyl-1,2-oxazol-4-yl)-2-[3-(morpholin-4-yl)propoxy]benzenesulfonamide","InChI=1S/C23H33N3O5S/c1-17-23(18(2)31-24-17)19-8-9-21(30-13-5-10-26-11-14-29-15-12-26)22(16-19)32(27,28)25-20-6-3-4-7-20/h8-9,16,20,25H,3-7,10-15H2,1-2H3",AXHJWOJNGFRTGJ-UHFFFAOYSA-N,8,1,0,0,Bromodomain / Histone,6.00,cancer,Inhibition,
1648,11664437,414662,8184443,COc1ccc(C2=N[C@H]([C@H](N2C(=O)N2CCN(CC2)C(C)=O)c2ccc(Cl)cc2)c2ccc(Cl)cc2)c(OC(C)C)c1,"1-{4-[(4S,5R)-4,5-bis(4-chlorophenyl)-2-(2-isopropoxy-4-methoxyphenyl)-4,5-dihydroimidazole-1-carbonyl]piperazin-1-yl}ethanone","InChI=1S/C32H34Cl2N4O4/c1-20(2)42-28-19-26(41-4)13-14-27(28)31-35-29(22-5-9-24(33)10-6-22)30(23-7-11-25(34)12-8-23)38(31)32(40)37-17-15-36(16-18-37)21(3)39/h5-14,19-20,29-30H,15-18H2,1-4H3/t29-,30+/m0/s1",IYDMGGPKSVWQRT-XZWHSSHBSA-N,1,0,0,0,MDM2-Like / P53,6.59,cancer,Inhibition,
1649,5288631,407632,8253868,CCOc1cc(OC)ccc1C1=N[C@H]([C@H](N1C(=O)N1CCN(CCO)CC1)c1ccc(Br)cc1)c1ccc(Br)cc1,"2-{4-[(4S,5R)-4,5-bis(4-bromophenyl)-2-(2-ethoxy-4-methoxyphenyl)-4,5-dihydroimidazole-1-carbonyl]piperazin-1-yl}ethanol","InChI=1S/C31H34Br2N4O4/c1-3-41-27-20-25(40-2)12-13-26(27)30-34-28(21-4-8-23(32)9-5-21)29(22-6-10-24(33)11-7-22)37(30)31(39)36-16-14-35(15-17-36)18-19-38/h4-13,20,28-29,38H,3,14-19H2,1-2H3/t28-,29+/m0/s1",PVRYEWOXWGDQHA-URLMMPGGSA-N,1,0,0,0,MDM2-Like / P53,6.85,cancer,Inhibition,
1650,11433190,191334,187530,COc1ccc(C2=N[C@H]([C@H](N2C(=O)N2CCNC(=O)C2)c2ccc(Cl)cc2)c2ccc(Cl)cc2)c(OC(C)C)c1,"4-[(4S,5R)-4,5-bis(4-chlorophenyl)-2-[4-methoxy-2-(propan-2-yloxy)phenyl]-4,5-dihydro-1H-imidazole-1-carbonyl]piperazin-2-one","InChI=1S/C30H30Cl2N4O4/c1-18(2)40-25-16-23(39-3)12-13-24(25)29-34-27(19-4-8-21(31)9-5-19)28(20-6-10-22(32)11-7-20)36(29)30(38)35-15-14-33-26(37)17-35/h4-13,16,18,27-28H,14-15,17H2,1-3H3,(H,33,37)/t27-,28+/m0/s1",BDUHCSBCVGXTJM-WUFINQPMSA-N,3,3,0,0,MDM2-Like / P53,7.05,cancer,Inhibition,
1651,2200479,1621063,,CCOc1cc(CNCCO)cc(Br)c1OCc1ccc(Cl)cc1Cl,"2-[({3-bromo-4-[(2,4-dichlorophenyl)methoxy]-5-ethoxyphenyl}methyl)amino]ethanol","InChI=1S/C18H20BrCl2NO3/c1-2-24-17-8-12(10-22-5-6-23)7-15(19)18(17)25-11-13-3-4-14(20)9-16(13)21/h3-4,7-9,22-23H,2,5-6,10-11H2,1H3",LSEBIOJOUZJDNG-UHFFFAOYSA-N,1,0,0,0,NRP / VEGF,4.97,cancer,Inhibition,
1652,1814661,,,COc1cc(CN[C@H](C)c2ccccc2)cc(Br)c1OCc1ccccc1Cl,({3-bromo-4-[(2-chlorophenyl)methoxy]-5-methoxyphenyl}methyl)(1-phenylethyl)amine,"InChI=1S/C23H23BrClNO2/c1-16(18-8-4-3-5-9-18)26-14-17-12-20(24)23(22(13-17)27-2)28-15-19-10-6-7-11-21(19)25/h3-13,16,26H,14-15H2,1-2H3/t16-/m1/s1",GBNFXGVUSNPSHS-MRXNPFEDSA-N,1,0,0,0,NRP / VEGF,5.03,cancer,Inhibition,
1653,2200697,1624864,,COc1cc(CNCCO)cc(Cl)c1OCc1ccc(Cl)cc1Cl,"2-[({3-chloro-4-[(2,4-dichlorophenyl)methoxy]-5-methoxyphenyl}methyl)amino]ethanol","InChI=1S/C17H18Cl3NO3/c1-23-16-7-11(9-21-4-5-22)6-15(20)17(16)24-10-12-2-3-13(18)8-14(12)19/h2-3,6-8,21-22H,4-5,9-10H2,1H3",GZFBOMZAQBAFPC-UHFFFAOYSA-N,1,0,0,0,NRP / VEGF,5.14,cancer,Inhibition,
1654,2217301,3311014,,CCOc1cc(CNCc2ccccc2)cc(Cl)c1OCc1ccccc1Cl,benzyl({3-chloro-4-[(2-chlorophenyl)methoxy]-5-ethoxyphenyl}methyl)amine,"InChI=1S/C23H23Cl2NO2/c1-2-27-22-13-18(15-26-14-17-8-4-3-5-9-17)12-21(25)23(22)28-16-19-10-6-7-11-20(19)24/h3-13,26H,2,14-16H2,1H3",WEBMSXRKAAPFGL-UHFFFAOYSA-N,1,0,0,0,NRP / VEGF,4.95,cancer,Inhibition,
1655,1254374,3322197,,Cc1ccc(cc1NC(=S)NC(=O)c1ccc2OCCOc2c1)-c1nc2ccccc2[nH]1,"3-[5-(1H-1,3-benzodiazol-2-yl)-2-methylphenyl]-1-(2,3-dihydro-1,4-benzodioxine-6-carbonyl)thiourea","InChI=1S/C24H20N4O3S/c1-14-6-7-15(22-25-17-4-2-3-5-18(17)26-22)12-19(14)27-24(32)28-23(29)16-8-9-20-21(13-16)31-11-10-30-20/h2-9,12-13H,10-11H2,1H3,(H,25,26)(H2,27,28,29,32)",BVWHOZYQECWMFG-UHFFFAOYSA-N,1,2,1,0,NRP / VEGF,6.70,cancer,Inhibition,
1656,168317798,,,NC(=N)NCCC[C@@H](NC(=O)c1sccc1CS(=O)(=O)c1cccc2nsnc12)C(O)=O,"2-({3-[(2,1,3-benzothiadiazole-4-sulfonyl)methyl]thiophen-2-yl}formamido)-5-carbamimidamidopentanoic acid","InChI=1S/C18H20N6O5S3/c19-18(20)21-7-2-4-12(17(26)27)22-16(25)15-10(6-8-30-15)9-32(28,29)13-5-1-3-11-14(13)24-31-23-11/h1,3,5-6,8,12H,2,4,7,9H2,(H,22,25)(H,26,27)(H4,19,20,21)/t12-/m1/s1",MANCESMHIBJGHP-GFCCVEGCSA-N,1,0,0,0,NRP / VEGF,4.80,cancer,Inhibition,
1657,63114056,,,CCN(Cc1ccccc1)C(=O)Nc1sccc1C(O)=O,2-{[benzyl(ethyl)carbamoyl]amino}thiophene-3-carboxylic acid,"InChI=1S/C15H16N2O3S/c1-2-17(10-11-6-4-3-5-7-11)15(20)16-13-12(14(18)19)8-9-21-13/h3-9H,2,10H2,1H3,(H,16,20)(H,18,19)",DLHWAOYAWWXEEW-UHFFFAOYSA-N,2,0,0,1,VEGF / VEGFR,5.00,cancer,Inhibition,
1658,55179435,,,COCCCNC(=O)Nc1sccc1C(O)=O,2-{[(3-methoxypropyl)carbamoyl]amino}thiophene-3-carboxylic acid,"InChI=1S/C10H14N2O4S/c1-16-5-2-4-11-10(15)12-8-7(9(13)14)3-6-17-8/h3,6H,2,4-5H2,1H3,(H,13,14)(H2,11,12,15)",FSXGYVHBBBJVIA-UHFFFAOYSA-N,1,0,0,0,VEGF / VEGFR,4.64,cancer,Inhibition,
1659,63113481,,,CCCCN(CC)C(=O)Nc1sccc1C(O)=O,2-{[butyl(ethyl)carbamoyl]amino}thiophene-3-carboxylic acid,"InChI=1S/C12H18N2O3S/c1-3-5-7-14(4-2)12(17)13-10-9(11(15)16)6-8-18-10/h6,8H,3-5,7H2,1-2H3,(H,13,17)(H,15,16)",QCLBVGLQKICMSD-UHFFFAOYSA-N,1,0,0,0,VEGF / VEGFR,4.57,cancer,Inhibition,
1660,168317795,,,C[C@@H]1CCCN(C1)C(=O)Nc1sccc1C(O)=O,2-(3-methylpiperidine-1-carbonylamino)thiophene-3-carboxylic acid,"InChI=1S/C12H16N2O3S/c1-8-3-2-5-14(7-8)12(17)13-10-9(11(15)16)4-6-18-10/h4,6,8H,2-3,5,7H2,1H3,(H,13,17)(H,15,16)/t8-/m1/s1",SAVTWYBICKMDSC-MRVPVSSYSA-N,1,0,0,0,VEGF / VEGFR,4.54,cancer,Inhibition,
1661,25295,1194287,,CN(C)CCN(Cc1ccc(Cl)cc1)c1ccccn1,chloropyramine,"InChI=1S/C16H20ClN3/c1-19(2)11-12-20(16-5-3-4-10-18-16)13-14-6-8-15(17)9-7-14/h3-10H,11-13H2,1-2H3",ICKFFNBDFNZJSX-UHFFFAOYSA-N,1,0,0,0,FAK / VEGFR3,6.24,cancer,Inhibition,
1662,71575835,3265344,,CN(C)CCN(Cc1ccc(Cl)cc1)c1ccc2ccccc2n1,N-[(4-chlorophenyl)methyl]-N-[2-(dimethylamino)ethyl]quinolin-2-amine,"InChI=1S/C20H22ClN3/c1-23(2)13-14-24(15-16-7-10-18(21)11-8-16)20-12-9-17-5-3-4-6-19(17)22-20/h3-12H,13-15H2,1-2H3",KIEHHWYHOAHUOZ-UHFFFAOYSA-N,1,4,0,0,FAK / VEGFR3,7.74,cancer,Inhibition,
1663,78075838,2180472,,Oc1ccc(cc1O)C(=O)C=Cc1ccccc1O,"(2E)-1-(3,4-dihydroxyphenyl)-3-(2-hydroxyphenyl)prop-2-en-1-one","InChI=1S/C15H12O4/c16-12-4-2-1-3-10(12)5-7-13(17)11-6-8-14(18)15(19)9-11/h1-9,16,18-19H",RPPMXVFLYLWWHN-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,5.44,HIV infectious disease,Inhibition,
1664,78074572,2180473,,Oc1cccc(C(=O)C=Cc2ccccc2O)c1O,"(2E)-1-(2,3-dihydroxyphenyl)-3-(2-hydroxyphenyl)prop-2-en-1-one","InChI=1S/C15H12O4/c16-12-6-2-1-4-10(12)8-9-13(17)11-5-3-7-14(18)15(11)19/h1-9,16,18-19H",HVYFGDLINYPWGI-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,5.79,HIV infectious disease,Inhibition,
1665,78073926,2180474,,Oc1cc(O)c(C(=O)C=Cc2ccccc2O)c(O)c1,"(2E)-3-(2-hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)prop-2-en-1-one","InChI=1S/C15H12O5/c16-10-7-13(19)15(14(20)8-10)12(18)6-5-9-3-1-2-4-11(9)17/h1-8,16-17,19-20H",HKQJXIALKSCCKD-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,5.21,HIV infectious disease,Inhibition,
1666,71410143,2180475,,Oc1ccc(C(=O)C=Cc2cccc(O)c2O)c(O)c1,"(2E)-3-(2,3-dihydroxyphenyl)-1-(2,4-dihydroxyphenyl)prop-2-en-1-one","InChI=1S/C15H12O5/c16-10-5-6-11(14(19)8-10)12(17)7-4-9-2-1-3-13(18)15(9)20/h1-8,16,18-20H",IUKUGGBBLOTFNV-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,5.77,HIV infectious disease,Inhibition,
1667,85187066,2180476,,Oc1ccc(C(=O)C=Cc2cc(O)ccc2O)c(O)c1,"(2E)-1-(2,4-dihydroxyphenyl)-3-(2,5-dihydroxyphenyl)prop-2-en-1-one","InChI=1S/C15H12O5/c16-10-3-6-13(18)9(7-10)1-5-14(19)12-4-2-11(17)8-15(12)20/h1-8,16-18,20H",SCYSZHQHDOOZQM-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,5.42,HIV infectious disease,Inhibition,
1668,76522939,1935203,,Oc1ccc(C(=O)C=Cc2ccccc2Cl)c(O)c1,"(2E)-3-(2-chlorophenyl)-1-(2,4-dihydroxyphenyl)prop-2-en-1-one","InChI=1S/C15H11ClO3/c16-13-4-2-1-3-10(13)5-8-14(18)12-7-6-11(17)9-15(12)19/h1-9,17,19H",HUJPOSGMEWSBGX-UHFFFAOYSA-N,1,1,0,1,LEDGF / IN,6.49,HIV infectious disease,Inhibition,
1669,78075839,2180477,,Oc1ccc(C(=O)C=Cc2cc(F)cc(F)c2)c(O)c1,"(2E)-3-(3,5-difluorophenyl)-1-(2,4-dihydroxyphenyl)prop-2-en-1-one","InChI=1S/C15H10F2O3/c16-10-5-9(6-11(17)7-10)1-4-14(19)13-3-2-12(18)8-15(13)20/h1-8,18,20H",LHTJCEJXRYTIIW-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,5.76,HIV infectious disease,Inhibition,
1670,75026045,243619,,Oc1cc(O)c(C(=O)C=Cc2cccc(O)c2O)c(O)c1,"(2E)-3-(2,3-dihydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)prop-2-en-1-one","InChI=1S/C15H12O6/c16-9-6-12(19)14(13(20)7-9)10(17)5-4-8-2-1-3-11(18)15(8)21/h1-7,16,18-21H",QKOLNBKUBWORFA-UHFFFAOYSA-N,1,1,0,1,LEDGF / IN,6.59,HIV infectious disease,Inhibition,
1671,71453834,2180478,,Oc1cc(OCc2ccccc2)ccc1C(=O)NCc1cccc(c1)N(=O)=O,4-(benzyloxy)-2-hydroxy-N-[(3-nitrophenyl)methyl]benzamide,"InChI=1S/C21H18N2O5/c24-20-12-18(28-14-15-5-2-1-3-6-15)9-10-19(20)21(25)22-13-16-7-4-8-17(11-16)23(26)27/h1-12,24H,13-14H2,(H,22,25)",BMGQFBABFVSNBK-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,5.42,HIV infectious disease,Inhibition,
1672,168317478,,,CC1(C)C[C@@H](CCCCC(=O)N[C@H](Cc2ccccc2Cl)C(O)=O)[C@@H]2CC[C@]3(C)C(=CC[C@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]2C1,"2-{5-[(4R,6aS,6bR,10S,12aR)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-3,4,4a,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1H-picen-4-yl]pentanamido}-3-(2-chlorophenyl)propanoic acid","InChI=1S/C43H64ClNO4/c1-39(2)25-28(13-9-11-15-37(47)45-33(38(48)49)24-27-12-8-10-14-32(27)44)29-18-22-42(6)31(30(29)26-39)16-17-35-41(5)21-20-36(46)40(3,4)34(41)19-23-43(35,42)7/h8,10,12,14,16,28-30,33-36,46H,9,11,13,15,17-26H2,1-7H3,(H,45,47)(H,48,49)/t28-,29+,30+,33-,34+,35+,36+,41+,42-,43-/m1/s1",UWAYDLHTSUTKMO-MLPJIECTSA-N,1,0,0,1,LEDGF / IN,6.19,HIV infectious disease,Inhibition,
1673,168317529,,,COc1ccccc1C[C@@H](NC(=O)CCCC[C@@H]1CC(C)(C)C[C@H]2[C@H]1CC[C@]1(C)C2=CC[C@H]2[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@@]12C)C(O)=O,"2-{5-[(4R,6aS,6bR,10S,12aR)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-3,4,4a,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1H-picen-4-yl]pentanamido}-3-(2-methoxyphenyl)propanoic acid","InChI=1S/C44H67NO5/c1-40(2)26-29(14-10-12-16-38(47)45-33(39(48)49)25-28-13-9-11-15-34(28)50-8)30-19-23-43(6)32(31(30)27-40)17-18-36-42(5)22-21-37(46)41(3,4)35(42)20-24-44(36,43)7/h9,11,13,15,17,29-31,33,35-37,46H,10,12,14,16,18-27H2,1-8H3,(H,45,47)(H,48,49)/t29-,30+,31+,33-,35+,36+,37+,42+,43-,44-/m1/s1",KUWNLWWPFRHDPT-WPIXJAPTSA-N,1,0,0,0,LEDGF / IN,5.34,HIV infectious disease,Inhibition,
1674,168317517,,,COc1cc(C[C@@H](NC(=O)CCCC[C@@H]2CC(C)(C)C[C@H]3[C@H]2CC[C@]2(C)C3=CC[C@H]3[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@@]23C)C(O)=O)cc(OC)c1,"2-{5-[(4R,6aS,6bR,10S,12aR)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-3,4,4a,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1H-picen-4-yl]pentanamido}-3-(3,5-dimethoxyphenyl)propanoic acid","InChI=1S/C45H69NO6/c1-41(2)26-29(12-10-11-13-39(48)46-35(40(49)50)24-28-22-30(51-8)25-31(23-28)52-9)32-16-20-44(6)34(33(32)27-41)14-15-37-43(5)19-18-38(47)42(3,4)36(43)17-21-45(37,44)7/h14,22-23,25,29,32-33,35-38,47H,10-13,15-21,24,26-27H2,1-9H3,(H,46,48)(H,49,50)/t29-,32+,33+,35-,36+,37+,38+,43+,44-,45-/m1/s1",XSJXQKVZYNLQLQ-GMFIZRRESA-N,1,0,0,0,LEDGF / IN,5.90,HIV infectious disease,Inhibition,
1675,168317800,,,COc1cccc(C[C@@H](NC(=O)CCCC[C@@H]2CC(C)(C)C[C@H]3[C@H]2CC[C@]2(C)C3=CC[C@H]3[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@@]23C)C(O)=O)c1OC,"2-{5-[(4R,6aS,6bR,10S,12aR)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-3,4,4a,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1H-picen-4-yl]pentanamido}-3-(2,3-dimethoxyphenyl)propanoic acid","InChI=1S/C45H69NO6/c1-41(2)26-29(13-10-11-16-38(48)46-33(40(49)50)25-28-14-12-15-34(51-8)39(28)52-9)30-19-23-44(6)32(31(30)27-41)17-18-36-43(5)22-21-37(47)42(3,4)35(43)20-24-45(36,44)7/h12,14-15,17,29-31,33,35-37,47H,10-11,13,16,18-27H2,1-9H3,(H,46,48)(H,49,50)/t29-,30+,31+,33-,35+,36+,37+,43+,44-,45-/m1/s1",LBIDLFPQRQTJIB-HNDICMBSSA-N,1,0,0,0,LEDGF / IN,5.49,HIV infectious disease,Inhibition,
1676,168317803,,,CC1(C)CC[C@@]2(CC[C@]3(C)C(=CC[C@H]4[C@@]5(C)CC[C@H](OC(=O)C(O)=O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]2C1)C(O)=O,"(4aS,6aS,6bR,10S,12aR)-10-[(carboxycarbonyl)oxy]-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid","InChI=1S/C32H48O6/c1-27(2)14-16-32(26(36)37)17-15-30(6)19(20(32)18-27)8-9-22-29(5)12-11-23(38-25(35)24(33)34)28(3,4)21(29)10-13-31(22,30)7/h8,20-23H,9-18H2,1-7H3,(H,33,34)(H,36,37)/t20-,21+,22+,23+,29+,30-,31-,32+/m1/s1",LXIFWYMDNHORHK-OAGBFDATSA-N,1,0,0,0,LEDGF / IN,5.00,HIV infectious disease,Inhibition,
1677,168317802,,,CC1(C)CC[C@@]2(CC[C@]3(C)C(=CC[C@H]4[C@@]5(C)CC[C@H](OCc6cccc(c6)C(O)=O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]2C1)C(O)=O,"(4aS,6aS,6bR,10S,12aR)-10-[(3-carboxyphenyl)methoxy]-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid","InChI=1S/C38H54O5/c1-33(2)17-19-38(32(41)42)20-18-36(6)26(27(38)22-33)11-12-29-35(5)15-14-30(34(3,4)28(35)13-16-37(29,36)7)43-23-24-9-8-10-25(21-24)31(39)40/h8-11,21,27-30H,12-20,22-23H2,1-7H3,(H,39,40)(H,41,42)/t27-,28+,29+,30+,35+,36-,37-,38+/m1/s1",PGQYDENFZPYITQ-ONMLTPRLSA-N,1,0,0,0,LEDGF / IN,5.94,HIV infectious disease,Inhibition,
1678,168317799,,,CC(C)(CC(=O)O[C@H]1CC[C@@]2(C)[C@@H](CC[C@]3(C)[C@H]2CC=C2[C@H]4CC(C)(C)CC[C@@]4(CC[C@@]32C)C(O)=O)C1(C)C)C(O)=O,"(4aS,6aS,6bR,10S,12aR)-10-[(3-carboxy-3,3-dimethylpropanoyl)oxy]-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid","InChI=1S/C36H56O6/c1-30(2)16-18-36(29(40)41)19-17-34(8)22(23(36)20-30)10-11-25-33(7)14-13-26(42-27(37)21-31(3,4)28(38)39)32(5,6)24(33)12-15-35(25,34)9/h10,23-26H,11-21H2,1-9H3,(H,38,39)(H,40,41)/t23-,24+,25+,26+,33+,34-,35-,36+/m1/s1",CILDPQKNQAUATK-QFWWUMFUSA-N,1,0,0,0,LEDGF / IN,5.26,HIV infectious disease,Inhibition,
1679,168317796,,,CC1(C)CC[C@@]2(CC[C@]3(C)C(=CC[C@H]4[C@@]5(C)CC[C@H](OCc6ccccc6)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]2C1)C(O)=O,"(4aS,6aS,6bR,10S,12aR)-10-(benzyloxy)-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid","InChI=1S/C37H54O3/c1-32(2)19-21-37(31(38)39)22-20-35(6)26(27(37)23-32)13-14-29-34(5)17-16-30(40-24-25-11-9-8-10-12-25)33(3,4)28(34)15-18-36(29,35)7/h8-13,27-30H,14-24H2,1-7H3,(H,38,39)/t27-,28+,29+,30+,34+,35-,36-,37+/m1/s1",QCMGXAOSRFIWAU-RCOHTFALSA-N,1,0,0,0,LEDGF / IN,6.15,HIV infectious disease,Inhibition,
1680,65035,2111558,,OC(=O)[C@@H](Cc1ccc(O)c(O)c1)OC(=O)C=Cc1ccc(O)c(O)c1,rosmarinic acid,"InChI=1S/C18H16O8/c19-12-4-1-10(7-14(12)21)3-6-17(23)26-16(18(24)25)9-11-2-5-13(20)15(22)8-11/h1-8,16,19-22H,9H2,(H,24,25)/t16-/m1/s1",DOUMFZQKYFQNTF-MRXNPFEDSA-N,1,0,0,0,LEDGF / IN,6.26,HIV infectious disease,Inhibition,
1681,242591,602784,,Oc1ccc(C=NNC(=O)c2ccncc2)c(O)c1,"N'-[(1E)-(2,4-dihydroxyphenyl)methylidene]pyridine-4-carbohydrazide","InChI=1S/C13H11N3O3/c17-11-2-1-10(12(18)7-11)8-15-16-13(19)9-3-5-14-6-4-9/h1-8,17-18H,(H,16,19)",CKBWTRSIUARPEC-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,5.40,HIV infectious disease,Inhibition,
1682,356436,200144,,Oc1ccc(Br)cc1C=NNC(=O)c1cccnc1,N'-[(1E)-(5-bromo-2-hydroxyphenyl)methylidene]pyridine-3-carbohydrazide,"InChI=1S/C13H10BrN3O2/c14-11-3-4-12(18)10(6-11)8-16-17-13(19)9-2-1-5-15-7-9/h1-8,18H,(H,17,19)",DBMMBUWTQUXOCE-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,5.40,HIV infectious disease,Inhibition,
1683,1138366,2311867,,COc1cc(Br)cc(C=NNC(=O)c2ccccn2)c1O,N'-[(1E)-(5-bromo-2-hydroxy-3-methoxyphenyl)methylidene]pyridine-2-carbohydrazide,"InChI=1S/C14H12BrN3O3/c1-21-12-7-10(15)6-9(13(12)19)8-17-18-14(20)11-4-2-3-5-16-11/h2-8,19H,1H3,(H,18,20)",ZMECOPHBTSLPQS-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,5.89,HIV infectious disease,Inhibition,
1684,760529,569410,,Oc1ccccc1C=NNC(=O)c1cnccn1,N'-[(1E)-(2-hydroxyphenyl)methylidene]pyrazine-2-carbohydrazide,"InChI=1S/C12H10N4O2/c17-11-4-2-1-3-9(11)7-15-16-12(18)10-8-13-5-6-14-10/h1-8,17H,(H,16,18)",FNOAOFIHRVSHJT-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,6.40,HIV infectious disease,Inhibition,
1685,4491,1698529,,Oc1ccc2ccccc2c1C=NNC(=O)c1ccncc1,N'-[(1E)-(2-hydroxynaphthalen-1-yl)methylidene]pyridine-4-carbohydrazide,"InChI=1S/C17H13N3O2/c21-16-6-5-12-3-1-2-4-14(12)15(16)11-19-20-17(22)13-7-9-18-10-8-13/h1-11,21H,(H,20,22)",WQSHHAVECQJKLX-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,5.22,HIV infectious disease,Inhibition,
1686,744899,2311872,,CCOc1cccc(C=NNC(=O)c2n[nH]c3CCCc23)c1O,"N'-[(1E)-(3-ethoxy-2-hydroxyphenyl)methylidene]-1H,4H,5H,6H-cyclopenta[c]pyrazole-3-carbohydrazide","InChI=1S/C16H18N4O3/c1-2-23-13-8-3-5-10(15(13)21)9-17-20-16(22)14-11-6-4-7-12(11)18-19-14/h3,5,8-9,21H,2,4,6-7H2,1H3,(H,18,19)(H,20,22)",IGRPXAZQJGUXPW-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,5.70,HIV infectious disease,Inhibition,
1687,1097668,,,Oc1ccc(Br)cc1C=NNC(=O)c1n[nH]c2CCCCc12,"N'-[(1E)-(5-bromo-2-hydroxyphenyl)methylidene]-4,5,6,7-tetrahydro-1H-indazole-3-carbohydrazide","InChI=1S/C15H15BrN4O2/c16-10-5-6-13(21)9(7-10)8-17-20-15(22)14-11-3-1-2-4-12(11)18-19-14/h5-8,21H,1-4H2,(H,18,19)(H,20,22)",UJGFXGRNERDLJE-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,5.40,HIV infectious disease,Inhibition,
1688,744800,2311874,,Oc1ccc2ccccc2c1C=NNC(=O)c1n[nH]c2CCCc12,"N'-[(1E)-(2-hydroxynaphthalen-1-yl)methylidene]-1H,4H,5H,6H-cyclopenta[c]pyrazole-3-carbohydrazide","InChI=1S/C18H16N4O2/c23-16-9-8-11-4-1-2-5-12(11)14(16)10-19-22-18(24)17-13-6-3-7-15(13)20-21-17/h1-2,4-5,8-10,23H,3,6-7H2,(H,20,21)(H,22,24)",DXALFAYOYMDQMC-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,5.40,HIV infectious disease,Inhibition,
1689,774351,,,Oc1ccc2ccccc2c1C=NNC(=O)c1ccn[nH]1,N'-[(1E)-(2-hydroxynaphthalen-1-yl)methylidene]-2H-pyrazole-3-carbohydrazide,"InChI=1S/C15H12N4O2/c20-14-6-5-10-3-1-2-4-11(10)12(14)9-17-19-15(21)13-7-8-16-18-13/h1-9,20H,(H,16,18)(H,19,21)",KMDHNWTYSTVILC-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,5.15,HIV infectious disease,Inhibition,
1690,826430,1597979,,CCNc1nc(NCC)nc(n1)C(=O)NN,"bis(ethylamino)-1,3,5-triazine-2-carbohydrazide","InChI=1S/C8H15N7O/c1-3-10-7-12-5(6(16)15-9)13-8(14-7)11-4-2/h3-4,9H2,1-2H3,(H,15,16)(H2,10,11,12,13,14)",DJFDYAHDZXILCI-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,5.22,HIV infectious disease,Inhibition,
1691,1088144,1489980,,CCNc1nc(NCC)nc(n1)C(=O)Nc1ccccc1,"4,6-bis(ethylamino)-N-phenyl-1,3,5-triazine-2-carboxamide","InChI=1S/C14H18N6O/c1-3-15-13-18-11(19-14(20-13)16-4-2)12(21)17-10-8-6-5-7-9-10/h5-9H,3-4H2,1-2H3,(H,17,21)(H2,15,16,18,19,20)",ZDOXKFXSDLMDMZ-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,4.68,HIV infectious disease,Inhibition,
1692,6839194,2311881,,Cc1occc1C(=O)NNC=C1C(=O)N(C(=O)c2ccccc12)c1ccccc1Cl,"N'-{[(4E)-2-(2-chlorophenyl)-1,3-dioxoisoquinolin-4-ylidene]methyl}-2-methylfuran-3-carbohydrazide","InChI=1S/C22H16ClN3O4/c1-13-14(10-11-30-13)20(27)25-24-12-17-15-6-2-3-7-16(15)21(28)26(22(17)29)19-9-5-4-8-18(19)23/h2-12,24H,1H3,(H,25,27)",BMHRBAYCUDJCDU-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,5.10,HIV infectious disease,Inhibition,
1693,44482610,2311882,,COCCN1C(=S)NC(=O)C(=CNNC(=O)c2cc(Cl)ccc2O)C1=O,"5-chloro-2-hydroxy-N'-{[(5Z)-1-(2-methoxyethyl)-4,6-dioxo-2-sulfanylidene-1,3-diazinan-5-ylidene]methyl}benzohydrazide","InChI=1S/C15H15ClN4O5S/c1-25-5-4-20-14(24)10(12(22)18-15(20)26)7-17-19-13(23)9-6-8(16)2-3-11(9)21/h2-3,6-7,17,21H,4-5H2,1H3,(H,19,23)(H,18,22,26)",NHZOSAMEQCKTAP-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,4.89,HIV infectious disease,Inhibition,
1694,71596892,2311885,,Cc1nnc(NN)c2c3ccccc3[nH]c12,"1-hydrazinyl-4-methyl-5H-pyridazino[4,5-b]indole","InChI=1S/C11H11N5/c1-6-10-9(11(14-12)16-15-6)7-4-2-3-5-8(7)13-10/h2-5,13H,12H2,1H3,(H,14,16)",DEKPGHJYVZOHKE-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,5.30,HIV infectious disease,Inhibition,
1695,3092704,2311887,,Cc1sc2ncnc(NN=Cc3c(O)ccc4ccccc34)c2c1C,"1-[(1E)-(2-{5,6-dimethylthieno[2,3-d]pyrimidin-4-yl}hydrazin-1-ylidene)methyl]naphthalen-2-ol","InChI=1S/C19H16N4OS/c1-11-12(2)25-19-17(11)18(20-10-21-19)23-22-9-15-14-6-4-3-5-13(14)7-8-16(15)24/h3-10,24H,1-2H3,(H,20,21,23)",ZHLIBGVCPIYWGR-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,5.22,HIV infectious disease,Inhibition,
1696,135931232,,,CC(=N/Nc1ccc(cc1N(=O)=O)S(=O)(=O)Nc1ccccc1)c1cc(O)ccc1O,"4-[(E)-2-[1-(2,5-dihydroxyphenyl)ethylidene]hydrazin-1-yl]-3-nitro-N-phenylbenzenesulfonamide","InChI=1S/C20H18N4O6S/c1-13(17-11-15(25)7-10-20(17)26)21-22-18-9-8-16(12-19(18)24(27)28)31(29,30)23-14-5-3-2-4-6-14/h2-12,22-23,25-26H,1H3",KRYPLSSHPYCPNV-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,4.89,HIV infectious disease,Inhibition,
1697,4257193,,,COc1ccccc1NS(=O)(=O)c1ccc(NN=C(/C)c2ccccc2Br)c(c1)N(=O)=O,4-[(E)-2-[1-(2-bromophenyl)ethylidene]hydrazin-1-yl]-N-(2-methoxyphenyl)-3-nitrobenzenesulfonamide,"InChI=1S/C21H19BrN4O5S/c1-14(16-7-3-4-8-17(16)22)23-24-18-12-11-15(13-20(18)26(27)28)32(29,30)25-19-9-5-6-10-21(19)31-2/h3-13,24-25H,1-2H3",XCXBZMQZXKZSPX-UHFFFAOYSA-N,1,1,0,0,LEDGF / IN,5.22,HIV infectious disease,Inhibition,
1698,4129285,1516329,,COc1cc(C=NNc2ccc(cc2N(=O)=O)S(=O)(=O)Nc2ccccc2C(O)=O)ccc1O,2-{4-[(E)-2-[(4-hydroxy-3-methoxyphenyl)methylidene]hydrazin-1-yl]-3-nitrobenzenesulfonamido}benzoic acid,"InChI=1S/C21H18N4O8S/c1-33-20-10-13(6-9-19(20)26)12-22-23-17-8-7-14(11-18(17)25(29)30)34(31,32)24-16-5-3-2-4-15(16)21(27)28/h2-12,23-24,26H,1H3,(H,27,28)",LZJWACDYXIPMKB-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,4.60,HIV infectious disease,Inhibition,
1699,6804940,,,Cc1nn(c(O)c1C=NNc1ccc(cc1)N(=O)=O)-c1ccccc1,5-methyl-4-[(1E)-[2-(4-nitrophenyl)hydrazin-1-ylidene]methyl]-2-phenylpyrazol-3-ol,"InChI=1S/C17H15N5O3/c1-12-16(17(23)21(20-12)14-5-3-2-4-6-14)11-18-19-13-7-9-15(10-8-13)22(24)25/h2-11,19,23H,1H3",KUXWLNJLTHELNO-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,5.22,HIV infectious disease,Inhibition,
1700,3528394,2311893,,CCN(CC)c1ccc(C=C2/CCC(C=NN=Cc3cccnc3)=C2N2CCOCC2)cc1,"N,N-diethyl-4-{[(1E)-2-(morpholin-4-yl)-3-[(1E)-[(E)-2-(pyridin-3-ylmethylidene)hydrazin-1-ylidene]methyl]cyclopent-2-en-1-ylidene]methyl}aniline","InChI=1S/C27H33N5O/c1-3-31(4-2)26-11-7-22(8-12-26)18-24-9-10-25(27(24)32-14-16-33-17-15-32)21-30-29-20-23-6-5-13-28-19-23/h5-8,11-13,18-21H,3-4,9-10,14-17H2,1-2H3",IFUPFELSZJZFLF-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,5.52,HIV infectious disease,Inhibition,
1701,68274,2311896,,N(N=C(N=Nc1ccccc1)/c1ccccc1)c1ccccc1,"(NE,E)-N'-(phenylamino)-N-(phenylimino)benzene-1-carboximidamide","InChI=1S/C19H16N4/c1-4-10-16(11-5-1)19(22-20-17-12-6-2-7-13-17)23-21-18-14-8-3-9-15-18/h1-15,20H",BEIHVSJTPTXQGB-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,4.70,HIV infectious disease,Inhibition,
1702,17226,2311897,,CN(C)c1ccc(cc1)N=Nc1ccc(Cl)cc1,"4-[(E)-2-(4-chlorophenyl)diazen-1-yl]-N,N-dimethylaniline","InChI=1S/C14H14ClN3/c1-18(2)14-9-7-13(8-10-14)17-16-12-5-3-11(15)4-6-12/h3-10H,1-2H3",WQWHNMIYCHFRJK-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,5.70,HIV infectious disease,Inhibition,
1703,3531695,2365875,,CC(=O)c1ccc(cc1)N=Nc1ccc(C[P+](c2ccccc2)(c2ccccc2)c2ccccc2)cc1,({4-[(E)-2-(4-acetylphenyl)diazen-1-yl]phenyl}methyl)triphenylphosphanium,"InChI=1S/C33H28N2OP/c1-26(36)28-19-23-30(24-20-28)35-34-29-21-17-27(18-22-29)25-37(31-11-5-2-6-12-31,32-13-7-3-8-14-32)33-15-9-4-10-16-33/h2-24H,25H2,1H3/q+1",ODFAZBKZTCKCPR-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,4.92,HIV infectious disease,Inhibition,
1704,6154471,2311902,,OC1=Cc2ccccc2C(=N/Nc2ccc(Cl)cc2)C1=O,(1E)-1-[2-(4-chlorophenyl)hydrazin-1-ylidene]-3-hydroxynaphthalen-2-one,"InChI=1S/C16H11ClN2O2/c17-11-5-7-12(8-6-11)18-19-15-13-4-2-1-3-10(13)9-14(20)16(15)21/h1-9,18,20H",MACZXHASJQIUCK-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,5.52,HIV infectious disease,Inhibition,
1705,6802170,2311903,,Cc1ccc(NN=C2/Sc3ccccc3C2=O)cc1,(2Z)-2-[2-(4-methylphenyl)hydrazin-1-ylidene]-1-benzothiophen-3-one,"InChI=1S/C15H12N2OS/c1-10-6-8-11(9-7-10)16-17-15-14(18)12-4-2-3-5-13(12)19-15/h2-9,16H,1H3",YFMADDFFVFAOSW-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,5.22,HIV infectious disease,Inhibition,
1706,1552523,,,O=N(=O)c1ccccc1C=NN1CCN(Cc2ccccc2)CC1,(NE)-4-benzyl-N-[(2-nitrophenyl)methylidene]piperazin-1-amine,"InChI=1S/C18H20N4O2/c23-22(24)18-9-5-4-8-17(18)14-19-21-12-10-20(11-13-21)15-16-6-2-1-3-7-16/h1-9,14H,10-13,15H2",VKBQZSAOIDUDJG-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,4.62,HIV infectious disease,Inhibition,
1707,1184893,,,CC(=N/N1CCN(Cc2ccccc2Cl)CC1)c1ccc(cc1)N(=O)=O,(NE)-4-[(2-chlorophenyl)methyl]-N-[1-(4-nitrophenyl)ethylidene]piperazin-1-amine,"InChI=1S/C19H21ClN4O2/c1-15(16-6-8-18(9-7-16)24(25)26)21-23-12-10-22(11-13-23)14-17-4-2-3-5-19(17)20/h2-9H,10-14H2,1H3",GKDCYDHTHCBRLI-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,4.72,HIV infectious disease,Inhibition,
1708,761597,2094513,,Oc1ccc(C=NN2CCN(CC2)c2ccccc2)cc1O,"4-[(E)-N-(4-phenylpiperazin-1-yl)carboximidoyl]benzene-1,2-diol","InChI=1S/C17H19N3O2/c21-16-7-6-14(12-17(16)22)13-18-20-10-8-19(9-11-20)15-4-2-1-3-5-15/h1-7,12-13,21-22H,8-11H2",SVDSQTDJNMFDDT-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,4.80,HIV infectious disease,Inhibition,
1709,1369071,,,COc1ccccc1N1CCN(CC1)N=Cc1ccc(Cl)c(c1)N(=O)=O,(NE)-N-[(4-chloro-3-nitrophenyl)methylidene]-4-(2-methoxyphenyl)piperazin-1-amine,"InChI=1S/C18H19ClN4O3/c1-26-18-5-3-2-4-16(18)21-8-10-22(11-9-21)20-13-14-6-7-15(19)17(12-14)23(24)25/h2-7,12-13H,8-11H2,1H3",PDICYFOXVGFINZ-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,4.68,HIV infectious disease,Inhibition,
1710,2455881,2311910,,COCCN=c1/scc(-c2cccs2)n1N=Cc1cc(Br)c(O)c(OC)c1,"2-bromo-6-methoxy-4-[(E)-N-[(2E)-2-[(2-methoxyethyl)imino]-4-(thiophen-2-yl)-1,3-thiazol-3-yl]carboximidoyl]phenol","InChI=1S/C18H18BrN3O3S2/c1-24-6-5-20-18-22(14(11-27-18)16-4-3-7-26-16)21-10-12-8-13(19)17(23)15(9-12)25-2/h3-4,7-11,23H,5-6H2,1-2H3",SKPUUEBMTHFTRP-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,4.85,HIV infectious disease,Inhibition,
1711,5145260,2311911,,CCN=c1/scc(-c2cc(OC)ccc2OC)n1N=C(/C)c1ccco1,"(NE,2E)-4-(2,5-dimethoxyphenyl)-2-(ethylimino)-N-[1-(furan-2-yl)ethylidene]-1,3-thiazol-3-amine","InChI=1S/C19H21N3O3S/c1-5-20-19-22(21-13(2)17-7-6-10-25-17)16(12-26-19)15-11-14(23-3)8-9-18(15)24-4/h6-12H,5H2,1-4H3",YEOMQAMBEFCHPQ-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,5.10,HIV infectious disease,Inhibition,
1712,2471634,2311912,,Brc1ccccc1-c1csc(=N/CC=C)n1N=Cc1ccccn1,"(NE,2E)-4-(2-bromophenyl)-2-(prop-2-en-1-ylimino)-N-(pyridin-2-ylmethylidene)-1,3-thiazol-3-amine","InChI=1S/C18H15BrN4S/c1-2-10-21-18-23(22-12-14-7-5-6-11-20-14)17(13-24-18)15-8-3-4-9-16(15)19/h2-9,11-13H,1,10H2",XGYNUNWQRPKZBS-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,4.64,HIV infectious disease,Inhibition,
1713,564859,1414893,,OC(=O)c1[nH]cnc1C(=O)Nc1ccccc1,5-(phenylcarbamoyl)-3H-imidazole-4-carboxylic acid,"InChI=1S/C11H9N3O3/c15-10(14-7-4-2-1-3-5-7)8-9(11(16)17)13-6-12-8/h1-6H,(H,12,13)(H,14,15)(H,16,17)",JRYSJLPNUUHTER-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,5.22,HIV infectious disease,Inhibition,
1714,784642,1703922,,OC(=O)c1[nH]cnc1C(=O)Nc1ccc(F)cc1,5-[(4-fluorophenyl)carbamoyl]-3H-imidazole-4-carboxylic acid,"InChI=1S/C11H8FN3O3/c12-6-1-3-7(4-2-6)15-10(16)8-9(11(17)18)14-5-13-8/h1-5H,(H,13,14)(H,15,16)(H,17,18)",VRQZJKLTBLHHHP-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,5.00,HIV infectious disease,Inhibition,
1715,564988,2419623,,OC(=O)c1[nH]cnc1C(=O)Nc1ccccn1,5-[(pyridin-2-yl)carbamoyl]-3H-imidazole-4-carboxylic acid,"InChI=1S/C10H8N4O3/c15-9(14-6-3-1-2-4-11-6)7-8(10(16)17)13-5-12-7/h1-5H,(H,12,13)(H,16,17)(H,11,14,15)",CXVUEKICGYNMBG-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,4.89,HIV infectious disease,Inhibition,
1716,565699,2419624,,OC(=O)c1[nH]cnc1C(=O)Nc1ccc(cc1)N(=O)=O,5-[(4-nitrophenyl)carbamoyl]-3H-imidazole-4-carboxylic acid,"InChI=1S/C11H8N4O5/c16-10(8-9(11(17)18)13-5-12-8)14-6-1-3-7(4-2-6)15(19)20/h1-5H,(H,12,13)(H,14,16)(H,17,18)",YJUBHURCCLOHSI-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,5.28,HIV infectious disease,Inhibition,
1717,3132734,2419625,,Nc1ccc(NC(=O)c2nc[nH]c2C(O)=O)cc1,5-[(4-aminophenyl)carbamoyl]-3H-imidazole-4-carboxylic acid,"InChI=1S/C11H10N4O3/c12-6-1-3-7(4-2-6)15-10(16)8-9(11(17)18)14-5-13-8/h1-5H,12H2,(H,13,14)(H,15,16)(H,17,18)",HQARDVLSJLCFBA-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,6.00,HIV infectious disease,Inhibition,
1718,823571,1534378,,Cc1ccc(NC(=O)c2nc[nH]c2C(=O)NN)cc1,5-(hydrazinecarbonyl)-N-(4-methylphenyl)-1H-imidazole-4-carboxamide,"InChI=1S/C12H13N5O2/c1-7-2-4-8(5-3-7)16-11(18)9-10(12(19)17-13)15-6-14-9/h2-6H,13H2,1H3,(H,14,15)(H,16,18)(H,17,19)",MBISWCGGLARJBA-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,4.80,HIV infectious disease,Inhibition,
1719,565801,1312820,,NNC(=O)c1[nH]cnc1C(=O)Nc1ccccn1,5-(hydrazinecarbonyl)-N-(pyridin-2-yl)-1H-imidazole-4-carboxamide,"InChI=1S/C10H10N6O2/c11-16-10(18)8-7(13-5-14-8)9(17)15-6-3-1-2-4-12-6/h1-5H,11H2,(H,13,14)(H,16,18)(H,12,15,17)",JRPSMMVOCVGVPN-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,6.40,HIV infectious disease,Inhibition,
1720,5280343,50,,Oc1cc(O)c2c(c1)oc(-c1ccc(O)c(O)c1)c(O)c2=O,quercetin,"InChI=1S/C15H10O7/c16-7-4-10(19)12-11(5-7)22-15(14(21)13(12)20)6-1-2-8(17)9(18)3-6/h1-5,16-19,21H",REFJWTPEDVJJIY-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,6.22,HIV infectious disease,Inhibition,
1721,168317755,,,Oc1ccc(cc1O)-c1oc2cc(Oc3ccc(F)cc3)cc(O)c2c(=O)c1O,"2-(3,4-dihydroxyphenyl)-7-(4-fluorophenoxy)-3,5-dihydroxychromen-4-one","InChI=1S/C21H13FO7/c22-11-2-4-12(5-3-11)28-13-8-16(25)18-17(9-13)29-21(20(27)19(18)26)10-1-6-14(23)15(24)7-10/h1-9,23-25,27H",UMPDGKHSOYXYQV-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,6.03,HIV infectious disease,Inhibition,
1722,90643992,3288713,,Oc1ccc(cc1O)-c1oc2cc(cc(O)c2c(=O)c1O)N1CCOCC1,"2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7-(morpholin-4-yl)chromen-4-one","InChI=1S/C19H17NO7/c21-12-2-1-10(7-13(12)22)19-18(25)17(24)16-14(23)8-11(9-15(16)27-19)20-3-5-26-6-4-20/h1-2,7-9,21-23,25H,3-6H2",QRVYTBLYTRAQEA-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,6.01,HIV infectious disease,Inhibition,
1723,5281605,8260,,Oc1cc2oc(cc(=O)c2c(O)c1O)-c1ccccc1,baicalein,"InChI=1S/C15H10O5/c16-9-6-11(8-4-2-1-3-5-8)20-12-7-10(17)14(18)15(19)13(9)12/h1-7,17-19H",FXNFHKRTJBSTCS-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,5.57,HIV infectious disease,Inhibition,
1724,5280445,151,,Oc1cc(O)c2c(c1)oc(cc2=O)-c1ccc(O)c(O)c1,luteolin,"InChI=1S/C15H10O6/c16-8-4-11(19)15-12(20)6-13(21-14(15)5-8)7-1-2-9(17)10(18)3-7/h1-6,16-19H",IQPNAANSBPBGFQ-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,6.35,HIV infectious disease,Inhibition,
1725,90643989,3288945,,Oc1ccc(cc1O)-c1cc(=O)c2c(O)cc(cc2o1)N1CCOCC1,"2-(3,4-dihydroxyphenyl)-5-hydroxy-7-(morpholin-4-yl)chromen-4-one","InChI=1S/C19H17NO6/c21-13-2-1-11(7-14(13)22)17-10-16(24)19-15(23)8-12(9-18(19)26-17)20-3-5-25-6-4-20/h1-2,7-10,21-23H,3-6H2",JXEJTHPNNOJYJU-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,5.80,HIV infectious disease,Inhibition,
1726,5280443,28,,Oc1ccc(cc1)-c1cc(=O)c2c(O)cc(O)cc2o1,chamomile,"InChI=1S/C15H10O5/c16-9-3-1-8(2-4-9)13-7-12(19)15-11(18)5-10(17)6-14(15)20-13/h1-7,16-18H",KZNIFHPLKGYRTM-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,5.82,HIV infectious disease,Inhibition,
1727,90643979,3288948,,Oc1ccc(cc1)-c1cc(=O)c2c(O)cc(cc2o1)N1CCOCC1,5-hydroxy-2-(4-hydroxyphenyl)-7-(morpholin-4-yl)chromen-4-one,"InChI=1S/C19H17NO5/c21-14-3-1-12(2-4-14)17-11-16(23)19-15(22)9-13(10-18(19)25-17)20-5-7-24-8-6-20/h1-4,9-11,21-22H,5-8H2",LZGFSHUZJKAICY-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,5.77,HIV infectious disease,Inhibition,
1728,5281607,117,,Oc1cc(O)c2c(c1)oc(cc2=O)-c1ccccc1,chrysin,"InChI=1S/C15H10O4/c16-10-6-11(17)15-12(18)8-13(19-14(15)7-10)9-4-2-1-3-5-9/h1-8,16-17H",RTIXKCRFFJGDFG-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,5.85,HIV infectious disease,Inhibition,
1729,439246,9352,,Oc1ccc(cc1)[C@@H]1CC(=O)c2c(O)cc(O)cc2O1,asahina,"InChI=1S/C15H12O5/c16-9-3-1-8(2-4-9)13-7-12(19)15-11(18)5-10(17)6-14(15)20-13/h1-6,13,16-18H,7H2/t13-/m0/s1",FTVWIRXFELQLPI-ZDUSSCGKSA-N,1,0,0,0,LEDGF / IN,5.77,HIV infectious disease,Inhibition,
1730,5280961,44,,Oc1ccc(cc1)-c1coc2cc(O)cc(O)c2c1=O,genistein,"InChI=1S/C15H10O5/c16-9-3-1-8(2-4-9)11-7-20-13-6-10(17)5-12(18)14(13)15(11)19/h1-7,16-18H",TZBJGXHYKVUXJN-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,5.96,HIV infectious disease,Inhibition,
1731,86291005,3288956,,Oc1ccc(cc1)-c1coc2cc(cc(O)c2c1=O)N1CCOCC1,5-hydroxy-3-(4-hydroxyphenyl)-7-(morpholin-4-yl)chromen-4-one,"InChI=1S/C19H17NO5/c21-14-3-1-12(2-4-14)15-11-25-17-10-13(20-5-7-24-8-6-20)9-16(22)18(17)19(15)23/h1-4,9-11,21-22H,5-8H2",DQIWDDWTTROUFW-UHFFFAOYSA-N,1,0,0,0,LEDGF / IN,5.77,HIV infectious disease,Inhibition,
1732,92208905,3621951,,C[C@H]1C[C@H](C)CN(C1)c1cc(Nc2ccccc2C(O)=O)c2C(=O)c3ccccc3-c3onc1c23,"2-({12-[(3S,5S)-3,5-dimethylpiperidin-1-yl]-8-oxo-15-oxa-14-azatetracyclo[7.6.1.0²,?.0¹³,¹?]hexadeca-1(16),2,4,6,9,11,13-heptaen-10-yl}amino)benzoic acid","InChI=1S/C28H25N3O4/c1-15-11-16(2)14-31(13-15)22-12-21(29-20-10-6-5-9-19(20)28(33)34)23-24-25(22)30-35-27(24)18-8-4-3-7-17(18)26(23)32/h3-10,12,15-16,29H,11,13-14H2,1-2H3,(H,33,34)/t15-,16-/m0/s1",HQQHYDSAYJUPSU-HOTGVXAUSA-N,3,1,0,0,UPAR / UPA,6.85,cancer,Inhibition,
1733,92174699,,,C[C@H]1C[C@H](C)CN(C1)c1cc(NCCC(O)=O)c2C(=O)c3ccccc3-c3onc1c23,"3-({12-[(3S,5S)-3,5-dimethylpiperidin-1-yl]-8-oxo-15-oxa-14-azatetracyclo[7.6.1.0²,?.0¹³,¹?]hexadeca-1(16),2,4,6,9,11,13-heptaen-10-yl}amino)propanoic acid","InChI=1S/C24H25N3O4/c1-13-9-14(2)12-27(11-13)18-10-17(25-8-7-19(28)29)20-21-22(18)26-31-24(21)16-6-4-3-5-15(16)23(20)30/h3-6,10,13-14,25H,7-9,11-12H2,1-2H3,(H,28,29)/t13-,14-/m0/s1",UHNFSUXPSFACER-KBPBESRZSA-N,2,0,0,0,UPAR / UPA,4.70,cancer,Inhibition,
1734,3675673,2206359,,OC(=O)c1cccc(Nc2cc(N3CCCCCC3)c3noc4-c5ccccc5C(=O)c2c34)c1,,"InChI=1S/C27H23N3O4/c31-25-18-10-3-4-11-19(18)26-23-22(25)20(28-17-9-7-8-16(14-17)27(32)33)15-21(24(23)29-34-26)30-12-5-1-2-6-13-30/h3-4,7-11,14-15,28H,1-2,5-6,12-13H2,(H,32,33)",UAEULQWANHYLGJ-UHFFFAOYSA-N,3,1,2,0,UPAR / UPA,6.72,cancer,Inhibition,
1735,3273507,,,CC1CCN(CC1)c1cc(Nc2ccc(cc2)C(O)=O)c2C(=O)c3ccccc3-c3onc1c23,"4-{[12-(4-methylpiperidin-1-yl)-8-oxo-15-oxa-14-azatetracyclo[7.6.1.0²,?.0¹³,¹?]hexadeca-1(16),2,4,6,9,11,13-heptaen-10-yl]amino}benzoic acid","InChI=1S/C27H23N3O4/c1-15-10-12-30(13-11-15)21-14-20(28-17-8-6-16(7-9-17)27(32)33)22-23-24(21)29-34-26(23)19-5-3-2-4-18(19)25(22)31/h2-9,14-15,28H,10-13H2,1H3,(H,32,33)",BCSSTWMTOBZCRD-UHFFFAOYSA-N,1,0,0,0,UPAR / UPA,4.52,cancer,Inhibition,
1736,92208914,,,C[C@H]1CCCN(C1)c1cc(Nc2ccc(cc2)C(O)=O)c2C(=O)c3ccccc3-c3onc1c23,,"InChI=1S/C27H23N3O4/c1-15-5-4-12-30(14-15)21-13-20(28-17-10-8-16(9-11-17)27(32)33)22-23-24(21)29-34-26(23)19-7-3-2-6-18(19)25(22)31/h2-3,6-11,13,15,28H,4-5,12,14H2,1H3,(H,32,33)/t15-/m0/s1",SIAIFDRREMUXFO-HNNXBMFYSA-N,0,1,0,0,UPAR / UPA,4.52,cancer,Inhibition,
1737,2517991,1438422,,O[C@@H](COc1ccc(cc1)C#N)CN1CCC(CC1)C(O)(c1ccccc1)c1ccccc1,4-{2-hydroxy-3-[4-(hydroxydiphenylmethyl)piperidin-1-yl]propoxy}benzonitrile,"InChI=1S/C28H30N2O3/c29-19-22-11-13-27(14-12-22)33-21-26(31)20-30-17-15-25(16-18-30)28(32,23-7-3-1-4-8-23)24-9-5-2-6-10-24/h1-14,25-26,31-32H,15-18,20-21H2/t26-/m1/s1",FUXZYKBZWQNXAX-AREMUKBSSA-N,1,0,0,0,MENIN / MLL,4.89,cancer,Inhibition,
1738,44543700,3126202,,OC(C1CCN(CCCOc2ccc(cc2)C#N)CC1)(c1ccccc1)c1ccccc1,4-{3-[4-(hydroxydiphenylmethyl)piperidin-1-yl]propoxy}benzonitrile,"InChI=1S/C28H30N2O2/c29-22-23-12-14-27(15-13-23)32-21-7-18-30-19-16-26(17-20-30)28(31,24-8-3-1-4-9-24)25-10-5-2-6-11-25/h1-6,8-15,26,31H,7,16-21H2",PFDYBDSSCPZQSF-UHFFFAOYSA-N,1,0,0,0,MENIN / MLL,4.97,cancer,Inhibition,
1739,168317754,3126181,,CCCC[C@@](O)(C1CCN(CCCOc2ccc(cc2)C#N)CC1)c1ccccc1,4-{3-[4-(1-hydroxy-1-phenylpentyl)piperidin-1-yl]propoxy}benzonitrile,"InChI=1S/C26H34N2O2/c1-2-3-16-26(29,23-8-5-4-6-9-23)24-14-18-28(19-15-24)17-7-20-30-25-12-10-22(21-27)11-13-25/h4-6,8-13,24,29H,2-3,7,14-20H2,1H3/t26-/m0/s1",JJAPANZDGHTBJO-SANMLTNESA-N,1,0,0,0,MENIN / MLL,4.82,cancer,Inhibition,
1740,168317753,3126182,,O[C@](C1CC1)(C1CCN(CCCOc2ccc(cc2)C#N)CC1)c1ccccc1,4-(3-{4-[cyclopropyl(hydroxy)benzyl]piperidin-1-yl}propoxy)benzonitrile,"InChI=1S/C25H30N2O2/c26-19-20-7-11-24(12-8-20)29-18-4-15-27-16-13-23(14-17-27)25(28,22-9-10-22)21-5-2-1-3-6-21/h1-3,5-8,11-12,22-23,28H,4,9-10,13-18H2/t25-/m1/s1",SZRJACHFBPNVHW-RUZDIDTESA-N,1,0,0,0,MENIN / MLL,4.95,cancer,Inhibition,
1741,168317752,3126183,,CC(C)[C@@](O)(C1CCN(CCCOc2ccc(cc2)C#N)CC1)c1ccccc1,4-{3-[4-(1-hydroxy-2-methyl-1-phenylpropyl)piperidin-1-yl]propoxy}benzonitrile,"InChI=1S/C25H32N2O2/c1-20(2)25(28,22-7-4-3-5-8-22)23-13-16-27(17-14-23)15-6-18-29-24-11-9-21(19-26)10-12-24/h3-5,7-12,20,23,28H,6,13-18H2,1-2H3/t25-/m0/s1",GYIRGZHIMDCFEY-VWLOTQADSA-N,1,0,0,0,MENIN / MLL,5.39,cancer,Inhibition,
1742,168317745,3126184,,O[C@@](C1CCC1)(C1CCN(CCCOc2ccc(cc2)C#N)CC1)c1ccccc1,4-(3-{4-[cyclobutyl(hydroxy)benzyl]piperidin-1-yl}propoxy)benzonitrile,"InChI=1S/C26H32N2O2/c27-20-21-10-12-25(13-11-21)30-19-5-16-28-17-14-24(15-18-28)26(29,23-8-4-9-23)22-6-2-1-3-7-22/h1-3,6-7,10-13,23-24,29H,4-5,8-9,14-19H2/t26-/m0/s1",WNMLKDFEBXLYRH-SANMLTNESA-N,1,0,0,0,MENIN / MLL,5.40,cancer,Inhibition,
1743,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1743
1744,49791890,3126187,,O[C@](C1CCCC1)(C1CCN(CCCOc2ccc(cc2)C#N)CC1)c1ccccc1,4-(3-{4-[(R)-cyclopentyl(hydroxy)benzyl]piperidin-1-yl}propoxy)benzonitrile,"InChI=1S/C27H34N2O2/c28-21-22-11-13-26(14-12-22)31-20-6-17-29-18-15-25(16-19-29)27(30,24-9-4-5-10-24)23-7-2-1-3-8-23/h1-3,7-8,11-14,24-25,30H,4-6,9-10,15-20H2/t27-/m1/s1",QBITUTDDFZQXDO-HHHXNRCGSA-N,2,3,0,0,MENIN / MLL,6.57,cancer,Inhibition,
1745,49791889,3124953,,O[C@@](C1CCCC1)(C1CCN(CCCOc2ccc(cc2)C#N)CC1)c1ccccc1,4-(3-{4-[(S)-cyclopentyl(hydroxy)benzyl]piperidin-1-yl}propoxy)benzonitrile,"InChI=1S/C27H34N2O2/c28-21-22-11-13-26(14-12-22)31-20-6-17-29-18-15-25(16-19-29)27(30,24-9-4-5-10-24)23-7-2-1-3-8-23/h1-3,7-8,11-14,24-25,30H,4-6,9-10,15-20H2/t27-/m0/s1",QBITUTDDFZQXDO-MHZLTWQESA-N,2,0,0,0,MENIN / MLL,6.28,cancer,Inhibition,
1746,49791888,3126186,,O[C@](C1CCCCC1)(C1CCN(CCCOc2ccc(cc2)C#N)CC1)c1ccccc1,4-(3-{4-[cyclohexyl(hydroxy)benzyl]piperidin-1-yl}propoxy)benzonitrile,"InChI=1S/C28H36N2O2/c29-22-23-12-14-27(15-13-23)32-21-7-18-30-19-16-26(17-20-30)28(31,24-8-3-1-4-9-24)25-10-5-2-6-11-25/h1,3-4,8-9,12-15,25-26,31H,2,5-7,10-11,16-21H2/t28-/m1/s1",LBGOREZSMURYIQ-MUUNZHRXSA-N,1,0,0,0,MENIN / MLL,5.77,cancer,Inhibition,
1747,168317751,3126188,,O[C@@](C1CCCC1)(C1CCN(CCCOc2ccc(cc2)C#N)CC1)c1cccc(F)c1,4-(3-{4-[cyclopentyl(3-fluorophenyl)hydroxymethyl]piperidin-1-yl}propoxy)benzonitrile,"InChI=1S/C27H33FN2O2/c28-25-8-3-7-24(19-25)27(31,22-5-1-2-6-22)23-13-16-30(17-14-23)15-4-18-32-26-11-9-21(20-29)10-12-26/h3,7-12,19,22-23,31H,1-2,4-6,13-18H2/t27-/m0/s1",FTSMDZBUBLYVKI-MHZLTWQESA-N,1,0,0,0,MENIN / MLL,6.71,cancer,Inhibition,
1748,168317750,3126189,,O[C@@](C1CCCC1)(C1CCN(CCCOc2ccc(cc2)C#N)CC1)c1cc(F)cc(F)c1,"4-(3-{4-[cyclopentyl(3,5-difluorophenyl)hydroxymethyl]piperidin-1-yl}propoxy)benzonitrile","InChI=1S/C27H32F2N2O2/c28-24-16-23(17-25(29)18-24)27(32,21-4-1-2-5-21)22-10-13-31(14-11-22)12-3-15-33-26-8-6-20(19-30)7-9-26/h6-9,16-18,21-22,32H,1-5,10-15H2/t27-/m0/s1",OAOHJPWUVQFOCX-MHZLTWQESA-N,1,0,0,0,MENIN / MLL,6.36,cancer,Inhibition,
1749,168317749,3126190,,O[C@@](C1CCCC1)(C1CCN(CCCOc2ccc(cc2)C#N)CC1)c1cccc(Cl)c1,4-(3-{4-[(3-chlorophenyl)(cyclopentyl)hydroxymethyl]piperidin-1-yl}propoxy)benzonitrile,"InChI=1S/C27H33ClN2O2/c28-25-8-3-7-24(19-25)27(31,22-5-1-2-6-22)23-13-16-30(17-14-23)15-4-18-32-26-11-9-21(20-29)10-12-26/h3,7-12,19,22-23,31H,1-2,4-6,13-18H2/t27-/m0/s1",DRGVYVUPPVUATJ-MHZLTWQESA-N,1,0,0,0,MENIN / MLL,6.65,cancer,Inhibition,
1750,71777739,3126201,,O[C@@](C1CCCC1)(C1CCN(CCCOc2ccc(cc2)C#N)CC1)c1ccccn1,4-(3-{4-[cyclopentyl(hydroxy)pyridin-2-ylmethyl]piperidin-1-yl}propoxy)benzonitrile,"InChI=1S/C26H33N3O2/c27-20-21-9-11-24(12-10-21)31-19-5-16-29-17-13-23(14-18-29)26(30,22-6-1-2-7-22)25-8-3-4-15-28-25/h3-4,8-12,15,22-23,30H,1-2,5-7,13-14,16-19H2/t26-/m0/s1",CXFJNJZPBYIKCK-SANMLTNESA-N,1,0,0,0,MENIN / MLL,6.52,cancer,Inhibition,
1751,168317748,3126192,,O[C@@](C1CCCC1)(C1CCN(CCCOc2ccc(cc2)C#N)CC1)c1nccs1,"4-(3-{4-[cyclopentyl(hydroxy)1,3-thiazol-2-ylmethyl]piperidin-1-yl}propoxy)benzonitrile","InChI=1S/C24H31N3O2S/c25-18-19-6-8-22(9-7-19)29-16-3-13-27-14-10-21(11-15-27)24(28,20-4-1-2-5-20)23-26-12-17-30-23/h6-9,12,17,20-21,28H,1-5,10-11,13-16H2/t24-/m0/s1",INLKZOGWBUSMOY-DEOSSOPVSA-N,1,0,0,0,MENIN / MLL,6.62,cancer,Inhibition,
1752,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1752
1753,71777738,3126194,,O[C@](C1CCN(CCCOc2ccc(cc2)C#N)CC1)(c1cccc(F)c1)c1ccccn1,4-(3-{4-[(R)-(3-fluorophenyl)(hydroxy)pyridin-2-ylmethyl]piperidin-1-yl}propoxy)benzonitrile,"InChI=1S/C27H28FN3O2/c28-24-6-3-5-23(19-24)27(32,26-7-1-2-14-30-26)22-12-16-31(17-13-22)15-4-18-33-25-10-8-21(20-29)9-11-25/h1-3,5-11,14,19,22,32H,4,12-13,15-18H2/t27-/m1/s1",YLADDJNCJBCBJE-HHHXNRCGSA-N,1,0,0,0,MENIN / MLL,7.05,cancer,Inhibition,
1754,71777745,3126195,,O[C@@](C1CCN(CCCOc2ccc(cc2)C#N)CC1)(c1cccc(F)c1)c1ccccn1,4-(3-{4-[(S)-(3-fluorophenyl)(hydroxy)pyridin-2-ylmethyl]piperidin-1-yl}propoxy)benzonitrile,"InChI=1S/C27H28FN3O2/c28-24-6-3-5-23(19-24)27(32,26-7-1-2-14-30-26)22-12-16-31(17-13-22)15-4-18-33-25-10-8-21(20-29)9-11-25/h1-3,5-11,14,19,22,32H,4,12-13,15-18H2/t27-/m0/s1",YLADDJNCJBCBJE-MHZLTWQESA-N,1,0,0,0,MENIN / MLL,5.85,cancer,Inhibition,
1755,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1755
1756,71777747,3126198,,N[C@](C1CCCC1)(C1CCN(CCCOc2ccc(cc2)C#N)CC1)c1ccccc1,4-(3-{4-[(R)-amino(cyclopentyl)benzyl]piperidin-1-yl}propoxy)benzonitrile,"InChI=1S/C27H35N3O/c28-21-22-11-13-26(14-12-22)31-20-6-17-30-18-15-25(16-19-30)27(29,24-9-4-5-10-24)23-7-2-1-3-8-23/h1-3,7-8,11-14,24-25H,4-6,9-10,15-20,29H2/t27-/m1/s1",AUWUGRCKTQSGJY-HHHXNRCGSA-N,2,0,0,0,MENIN / MLL,7.25,cancer,Inhibition,
1757,71777746,3126197,,N[C@@](C1CCCC1)(C1CCN(CCCOc2ccc(cc2)C#N)CC1)c1ccccc1,4-(3-{4-[(S)-amino(cyclopentyl)benzyl]piperidin-1-yl}propoxy)benzonitrile,"InChI=1S/C27H35N3O/c28-21-22-11-13-26(14-12-22)31-20-6-17-30-18-15-25(16-19-30)27(29,24-9-4-5-10-24)23-7-2-1-3-8-23/h1-3,7-8,11-14,24-25H,4-6,9-10,15-20,29H2/t27-/m0/s1",AUWUGRCKTQSGJY-MHZLTWQESA-N,1,0,0,0,MENIN / MLL,7.09,cancer,Inhibition,
1758,73010398,3126199,,NS(=O)(=O)c1ccc(OCCCN2CCC(CC2)[C@@](O)(C2CCCC2)c2ccccn2)cc1,4-(3-{4-[cyclopentyl(hydroxy)pyridin-2-ylmethyl]piperidin-1-yl}propoxy)benzenesulfonamide,"InChI=1S/C25H35N3O4S/c26-33(30,31)23-11-9-22(10-12-23)32-19-5-16-28-17-13-21(14-18-28)25(29,20-6-1-2-7-20)24-8-3-4-15-27-24/h3-4,8-12,15,20-21,29H,1-2,5-7,13-14,16-19H2,(H2,26,30,31)/t25-/m0/s1",NQXVDDGKDJESCO-VWLOTQADSA-N,1,0,0,0,MENIN / MLL,6.94,cancer,Inhibition,
1759,168317744,3126200,,NS(=O)(=O)c1ccc(OCCCN2CCC(CC2)[C@@](O)(c2cccc(F)c2)c2ccccn2)cc1,4-(3-{4-[(3-fluorophenyl)(hydroxy)pyridin-2-ylmethyl]piperidin-1-yl}propoxy)benzenesulfonamide,"InChI=1S/C26H30FN3O4S/c27-22-6-3-5-21(19-22)26(31,25-7-1-2-14-29-25)20-12-16-30(17-13-20)15-4-18-34-23-8-10-24(11-9-23)35(28,32)33/h1-3,5-11,14,19-20,31H,4,12-13,15-18H2,(H2,28,32,33)/t26-/m1/s1",INGQKBOOCCZMBG-AREMUKBSSA-N,1,0,0,0,MENIN / MLL,6.83,cancer,Inhibition,
1760,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1760
1761,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1761
1762,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1762
1763,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1763
1764,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1764
1765,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1765
1766,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1766
1767,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1767
1768,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1768
1769,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1769
1770,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1770
1771,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1771
1772,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1772
1773,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1773
1774,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1774
1775,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1775
1776,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1776
1777,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1777
1778,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1778
1779,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1779
1780,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1780
1781,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1781
1782,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1782
1783,606347,5271824,,NC(=O)c1ccc2nc(N)sc2c1,"2-amino-1,3-benzothiazole-6-carboxamide","InChI=1S/C8H7N3OS/c9-7(12)4-1-2-5-6(3-4)13-8(10)11-5/h1-3H,(H2,9,12)(H2,10,11)",HPRLVAQRFQEQPF-UHFFFAOYSA-N,1,0,0,0,Bromodomain / Histone,4.63,"hepatocellular clear cell carcinoma, non-small cell lung carcinoma (disease)",Inhibition,
1784,11839197,,,COC(=O)c1ccc(N)cc1Cl,methyl 4-amino-2-chlorobenzoate,"InChI=1S/C8H8ClNO2/c1-12-8(11)6-3-2-5(10)4-7(6)9/h2-4H,10H2,1H3",DSHBGNPOIBSIOQ-UHFFFAOYSA-N,1,0,0,0,Bromodomain / Histone,4.22,"hepatocellular clear cell carcinoma, non-small cell lung carcinoma (disease)",Inhibition,
1785,5324572,,,Brc1cn[nH]c1-c1ccccc1,4-bromo-5-phenyl-1H-pyrazole,"InChI=1S/C9H7BrN2/c10-8-6-11-12-9(8)7-4-2-1-3-5-7/h1-6H,(H,11,12)",ZJFUSLGMGSYTRY-UHFFFAOYSA-N,1,0,0,0,Bromodomain / Histone,3.52,"hepatocellular clear cell carcinoma, non-small cell lung carcinoma (disease)",Inhibition,
1786,29893086,,,Nc1cc(ccc1F)-n1cnnc1,"2-fluoro-5-(4H-1,2,4-triazol-4-yl)aniline","InChI=1S/C8H7FN4/c9-7-2-1-6(3-8(7)10)13-4-11-12-5-13/h1-5H,10H2",WXILGCWARVMDQB-UHFFFAOYSA-N,1,0,0,0,Bromodomain / Histone,3.33,"hepatocellular clear cell carcinoma, non-small cell lung carcinoma (disease)",Inhibition,
1787,1477766,,,C1Oc2ccc(cc2O1)-c1cc[nH]n1,"3-(2H-1,3-benzodioxol-5-yl)-1H-pyrazole","InChI=1S/C10H8N2O2/c1-2-9-10(14-6-13-9)5-7(1)8-3-4-11-12-8/h1-5H,6H2,(H,11,12)",LOPAFWMOCZGHFX-UHFFFAOYSA-N,1,0,0,0,Bromodomain / Histone,3.54,"hepatocellular clear cell carcinoma, non-small cell lung carcinoma (disease)",Inhibition,
1788,91827372,3753082,,CC(C)CS(=O)(=O)N[C@H]1CCC(=O)N([C@@H]1c1ccc(Cl)cc1)c1ccc2c(C)cc(=O)n(C)c2c1,"N-[(2R,3S)-2-(4-chlorophenyl)-1-(1,4-dimethyl-2-oxo-1,2-dihydroquinolin-7-yl)-6-oxopiperidin-3-yl]-2-methylpropane-1-sulfonamide","InChI=1S/C26H30ClN3O4S/c1-16(2)15-35(33,34)28-22-11-12-24(31)30(26(22)18-5-7-19(27)8-6-18)20-9-10-21-17(3)13-25(32)29(4)23(21)14-20/h5-10,13-14,16,22,26,28H,11-12,15H2,1-4H3/t22-,26+/m0/s1",LVDRREOUMKACNJ-BKMJKUGQSA-N,1,0,0,0,Bromodomain / Histone,7.00,"hepatocellular clear cell carcinoma, non-small cell lung carcinoma (disease)",Inhibition,
1789,91668541,3769507,,CCn1cc(-c2cccc(c2)C(F)(F)F)c2sc(cc2c1=O)C(=N)NC1CCS(=O)(=O)CC1,"N-(1,1-dioxo-1lambda6-thian-4-yl)-5-ethyl-4-oxo-7-[3-(trifluoromethyl)phenyl]-4H,5H-thieno[3,2-c]pyridine-2-carboximidamide","InChI=1S/C22H22F3N3O3S2/c1-2-28-12-17(13-4-3-5-14(10-13)22(23,24)25)19-16(21(28)29)11-18(32-19)20(26)27-15-6-8-33(30,31)9-7-15/h3-5,10-12,15H,2,6-9H2,1H3,(H2,26,27)",WRUWGLUCNBMGPS-UHFFFAOYSA-N,3,0,0,0,Bromodomain / Histone,8.70,"hepatocellular clear cell carcinoma, non-small cell lung carcinoma (disease), cancer",Inhibition,
1790,127038798,3740819,,CC(=O)c1cc(-c2cccc3nccn23)c2cc(ccn12)N1CCOCC1,"1-(1-{imidazo[1,2-a]pyridin-5-yl}-7-(morpholin-4-yl)indolizin-3-yl)ethan-1-one","InChI=1S/C21H20N4O2/c1-15(26)19-14-17(18-3-2-4-21-22-6-8-25(18)21)20-13-16(5-7-24(19)20)23-9-11-27-12-10-23/h2-8,13-14H,9-12H2,1H3",LBUBPCSKFDKKFO-UHFFFAOYSA-N,1,0,0,0,Bromodomain / Histone,7.17,"hepatocellular clear cell carcinoma, non-small cell lung carcinoma (disease)",Inhibition,
1791,76310219,3108801,,Cc1nnc2c3ccccc3c(nn12)-c1ccc(N2CCOCC2)c(NS(=O)(=O)c2ccccc2Cl)c1,"2-chloro-N-(5-{3-methyl-[1,2,4]triazolo[3,4-a]phthalazin-6-yl}-2-(morpholin-4-yl)phenyl)benzene-1-sulfonamide","InChI=1S/C26H23ClN6O3S/c1-17-28-29-26-20-7-3-2-6-19(20)25(30-33(17)26)18-10-11-23(32-12-14-36-15-13-32)22(16-18)31-37(34,35)24-9-5-4-8-21(24)27/h2-11,16,31H,12-15H2,1H3",WLUMGCPGWDQOSB-UHFFFAOYSA-N,5,0,0,0,Bromodomain / Histone,6.80,"hepatocellular clear cell carcinoma, non-small cell lung carcinoma (disease), inflammatory disease",Inhibition,
1792,,,,CC[C@H](N1[C@@H]([C@H](C[C@H](CC(O)=O)C1=O)c2cccc(Cl)c2)c3ccc(Cl)cc3)C(=O)OC(C)(C)C,,,,1,1,0,0,MDM2-Like / P53,8.37,cancer,Inhibition,
1793,56965957,2059435,,CC[C@@H]([C@H](C)O)N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)c1cccc(Cl)c1)c1ccc(Cl)cc1,"2-[(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-[(2S,3S)-2-hydroxypentan-3-yl]-3-methyl-2-oxopiperidin-3-yl]acetic acid","InChI=1S/C25H29Cl2NO4/c1-4-21(15(2)29)28-23(16-8-10-18(26)11-9-16)20(17-6-5-7-19(27)12-17)13-25(3,24(28)32)14-22(30)31/h5-12,15,20-21,23,29H,4,13-14H2,1-3H3,(H,30,31)/t15-,20+,21-,23+,25+/m0/s1",YUALYRLIFVPOHL-VPLUBSIMSA-N,2,2,2,0,MDM2-Like / P53,8.96,cancer,Inhibition,
1794,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1794
1795,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1795
1796,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1796
1797,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1797
1798,49846579,3137309,,CC1(C)CCC(CN2CCN(CC2)c2ccc(C(=O)NS(=O)(=O)c3ccc(NCC4CCOCC4)c(c3)[N+]([O-])=O)c(Oc3cnc4[nH]ccc4c3)c2)=C(C1)c1ccc(Cl)cc1,"4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-(3-nitro-4-{[(oxan-4-yl)methyl]amino}benzenesulfonyl)-2-{1H-pyrrolo[2,3-b]pyridin-5-yloxy}benzamide","InChI=1S/C45H50ClN7O7S/c1-45(2)15-11-33(39(26-45)31-3-5-34(46)6-4-31)29-51-17-19-52(20-18-51)35-7-9-38(42(24-35)60-36-23-32-12-16-47-43(32)49-28-36)44(54)50-61(57,58)37-8-10-40(41(25-37)53(55)56)48-27-30-13-21-59-22-14-30/h3-10,12,16,23-25,28,30,48H,11,13-15,17-22,26-27,29H2,1-2H3,(H,47,49)(H,50,54)",LQBVNQSMGBZMKD-UHFFFAOYSA-N,1,0,0,0,BCL2-Like / BAX,10.57,cancer,Inhibition,
1799,11228183,376408,,CN(C)CC[C@H](CSc1ccccc1)Nc2ccc(cc2[N+](=O)[O-])S(=O)(=O)NC(=O)c3ccc(cc3)N4CCN(CC4)Cc5ccccc5c6ccc(cc6)Cl,,"InChI=1S/C42H45ClN6O5S2/c1-46(2)23-22-35(30-55-37-9-4-3-5-10-37)44-40-21-20-38(28-41(40)49(51)52)56(53,54)45-42(50)32-14-18-36(19-15-32)48-26-24-47(25-27-48)29-33-8-6-7-11-39(33)31-12-16-34(43)17-13-31/h3-21,28,35,44H,22-27,29-30H2,1-2H3,(H,45,50)/t35-/m1/s1",HPLNQCPCUACXLM-PGUFJCEWSA-N,,,,,,,,,
1800,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1800
1801,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1801
1802,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1802
1803,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1803
1804,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1804
1805,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1805
1806,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1806
1807,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1807
1808,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1808
1809,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1809
1810,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/1810
1811,39791103,1828978,,CN1Cc2cc(ccc2NC1=O)-c1c(C)noc1C,"6-(3,5-dimethyl-1,2-oxazol-4-yl)-3-methyl-1,2,3,4-tetrahydroquinazolin-2-one","InChI=1S/C14H15N3O2/c1-8-13(9(2)19-16-8)10-4-5-12-11(6-10)7-17(3)14(18)15-12/h4-6H,7H2,1-3H3,(H,15,18)",DRKGLYHLBGWKHL-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,5.47,breast cancer,Inhibition,
1812,5325760,1828979,,Cc1noc(C)c1-c1ccccc1,"3,5-dimethyl-4-phenyl-1,2-oxazole","InChI=1S/C11H11NO/c1-8-11(9(2)13-12-8)10-6-4-3-5-7-10/h3-7H,1-2H3",BHAXDAUULXCVEK-UHFFFAOYSA-N,3,0,0,0,Bromodomain / Histone,4.46,breast cancer,Inhibition,
1813,44243549,1828980,,CC(=O)c1cccc(c1)-c1c(C)noc1C,"1-[3-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]ethan-1-one","InChI=1S/C13H13NO2/c1-8-13(10(3)16-14-8)12-6-4-5-11(7-12)9(2)15/h4-7H,1-3H3",PQDJCPDVQWLFCE-UHFFFAOYSA-N,3,0,0,0,Bromodomain / Histone,5.22,breast cancer,Inhibition,
1814,54757749,1828981,,CCOc1cccc(c1)-c1c(C)noc1C,"4-(3-ethoxyphenyl)-3,5-dimethyl-1,2-oxazole","InChI=1S/C13H15NO2/c1-4-15-12-7-5-6-11(8-12)13-9(2)14-16-10(13)3/h5-8H,4H2,1-3H3",WXDQJUHQGQVRKB-UHFFFAOYSA-N,3,0,0,0,Bromodomain / Histone,5.13,breast cancer,Inhibition,
1815,54757750,1828982,,CC(O)c1cccc(c1)-c1c(C)noc1C,"1-[3-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]ethan-1-ol","InChI=1S/C13H15NO2/c1-8-13(10(3)16-14-8)12-6-4-5-11(7-12)9(2)15/h4-7,9,15H,1-3H3",FXWIWZBTSLATJR-UHFFFAOYSA-N,3,0,0,0,Bromodomain / Histone,5.38,breast cancer,Inhibition,
1816,54757751,1828983,,CCOC(=O)c1cc(OCC)cc(c1)-c1c(C)noc1C,"ethyl 3-(3,5-dimethyl-1,2-oxazol-4-yl)-5-ethoxybenzoate","InChI=1S/C16H19NO4/c1-5-19-14-8-12(15-10(3)17-21-11(15)4)7-13(9-14)16(18)20-6-2/h7-9H,5-6H2,1-4H3",JIXMVLQGJGPIIG-UHFFFAOYSA-N,3,0,0,0,Bromodomain / Histone,5.48,breast cancer,Inhibition,
1817,53308655,1828984,,CCOc1cc(cc(c1)-c1c(C)noc1C)C(O)=O,"3-(3,5-dimethyl-1,2-oxazol-4-yl)-5-ethoxybenzoic acid","InChI=1S/C14H15NO4/c1-4-18-12-6-10(5-11(7-12)14(16)17)13-8(2)15-19-9(13)3/h5-7H,4H2,1-3H3,(H,16,17)",GAMMHRRBGXCHRX-UHFFFAOYSA-N,3,0,0,1,Bromodomain / Histone,4.55,breast cancer,Inhibition,
1818,54757752,1828985,,CCOc1cc(cc(c1)-c1c(C)noc1C)C(C)=O,"1-[3-(3,5-dimethyl-1,2-oxazol-4-yl)-5-ethoxyphenyl]ethan-1-one","InChI=1S/C15H17NO3/c1-5-18-14-7-12(10(3)17)6-13(8-14)15-9(2)16-19-11(15)4/h6-8H,5H2,1-4H3",MFVHCTKKQRFPQC-UHFFFAOYSA-N,3,0,0,0,Bromodomain / Histone,5.64,breast cancer,Inhibition,
1819,54669868,1828986,,CCOc1cc(cc(c1)-c1c(C)noc1C)C(C)O,"1-[3-(3,5-dimethyl-1,2-oxazol-4-yl)-5-ethoxyphenyl]ethan-1-ol","InChI=1S/C15H19NO3/c1-5-18-14-7-12(10(3)17)6-13(8-14)15-9(2)16-19-11(15)4/h6-8,10,17H,5H2,1-4H3",AONNGYBECNOVTK-UHFFFAOYSA-N,3,0,0,1,Bromodomain / Histone,5.80,breast cancer,Inhibition,
1820,76317442,3108800,,Cc1nnc2c3ccccc3c(nn12)-c1ccc(N2CCOCC2)c(NS(C)(=O)=O)c1,"N-(5-{3-methyl-[1,2,4]triazolo[3,4-a]phthalazin-6-yl}-2-(morpholin-4-yl)phenyl)methanesulfonamide","InChI=1S/C21H22N6O3S/c1-14-22-23-21-17-6-4-3-5-16(17)20(24-27(14)21)15-7-8-19(26-9-11-30-12-10-26)18(13-15)25-31(2,28)29/h3-8,13,25H,9-12H2,1-2H3",MYFFGZYMLKZBPZ-UHFFFAOYSA-N,4,0,0,0,Bromodomain / Histone,6.80,inflammatory disease,Inhibition,
1821,76310219,3108801,,c1(c(cccc1)Cl)S(=O)(=O)Nc1c(ccc(c1)c1nn2c(c3ccccc13)nnc2C)N1CCOCC1,,"InChI=1S/C26H23ClN6O3S/c1-17-28-29-26-20-7-3-2-6-19(20)25(30-33(17)26)18-10-11-23(32-12-14-36-15-13-32)22(16-18)31-37(34,35)24-9-5-4-8-21(24)27/h2-11,16,31H,12-15H2,1H3",WLUMGCPGWDQOSB-UHFFFAOYSA-N,,,,,,,,,
1822,76335637,3108803,,Cc1nnc2c3ccccc3c(nn12)-c1ccc(N2CCOCC2)c(NS(=O)(=O)c2ccc(Cl)cc2)c1,"4-chloro-N-(5-{3-methyl-[1,2,4]triazolo[3,4-a]phthalazin-6-yl}-2-(morpholin-4-yl)phenyl)benzene-1-sulfonamide","InChI=1S/C26H23ClN6O3S/c1-17-28-29-26-22-5-3-2-4-21(22)25(30-33(17)26)18-6-11-24(32-12-14-36-15-13-32)23(16-18)31-37(34,35)20-9-7-19(27)8-10-20/h2-11,16,31H,12-15H2,1H3",RHPSSUMJYGAMNR-UHFFFAOYSA-N,4,0,0,0,Bromodomain / Histone,6.20,inflammatory disease,Inhibition,
1823,76328466,3110353,,COc1ccc(cc1)S(=O)(=O)Nc1cc(ccc1N1CCN(C)CC1)-c1nn2c(C)nnc2c2ccccc12,"4-methoxy-N-(5-{3-methyl-[1,2,4]triazolo[3,4-a]phthalazin-6-yl}-2-(4-methylpiperazin-1-yl)phenyl)benzene-1-sulfonamide","InChI=1S/C28H29N7O3S/c1-19-29-30-28-24-7-5-4-6-23(24)27(31-35(19)28)20-8-13-26(34-16-14-33(2)15-17-34)25(18-20)32-39(36,37)22-11-9-21(38-3)10-12-22/h4-13,18,32H,14-17H2,1-3H3",APJDTDALQSVARU-UHFFFAOYSA-N,4,0,0,0,Bromodomain / Histone,6.20,inflammatory disease,Inhibition,
1824,137640560,4073738,,CCCc1cc2c(nc([nH]c2=O)-c2ccc(O)cc2)s1,"2-(4-hydroxyphenyl)-6-propyl-3H,4H-thieno[2,3-d]pyrimidin-4-one","InChI=1S/C15H14N2O2S/c1-2-3-11-8-12-14(19)16-13(17-15(12)20-11)9-4-6-10(18)7-5-9/h4-8,18H,2-3H2,1H3,(H,16,17,19)",HJADADKAVZTDTB-UHFFFAOYSA-N,1,1,0,0,Bromodomain / Histone,5.07,breast cancer,Inhibition,
1825,82104608,,,COc1ccccc1-c1nc2sc3CCCc3c2c(=O)[nH]1,"10-(2-methoxyphenyl)-7-thia-9,11-diazatricyclo[6.4.0.0^{2,6}]dodeca-1(8),2(6),9-trien-12-one","InChI=1S/C16H14N2O2S/c1-20-11-7-3-2-5-9(11)14-17-15(19)13-10-6-4-8-12(10)21-16(13)18-14/h2-3,5,7H,4,6,8H2,1H3,(H,17,18,19)",RIUGPDPZJZNVIZ-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,6.11,breast cancer,Inhibition,
1826,137650788,4078743,,FC(F)(F)c1ccc(cc1)-c1nc2sc3CCCc3c2c(=O)[nH]1,"10-[4-(trifluoromethyl)phenyl]-7-thia-9,11-diazatricyclo[6.4.0.0^{2,6}]dodeca-1(8),2(6),9-trien-12-one","InChI=1S/C16H11F3N2OS/c17-16(18,19)9-6-4-8(5-7-9)13-20-14(22)12-10-2-1-3-11(10)23-15(12)21-13/h4-7H,1-3H2,(H,20,21,22)",RQRGABXMLLGLLU-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,5.82,breast cancer,Inhibition,
1827,2371015,4069975,,Brc1ccc(cc1)-c1nc2sc3CCCc3c2c(=O)[nH]1,"10-(4-bromophenyl)-7-thia-9,11-diazatricyclo[6.4.0.0^{2,6}]dodeca-1(8),2(6),9-trien-12-one","InChI=1S/C15H11BrN2OS/c16-9-6-4-8(5-7-9)13-17-14(19)12-10-2-1-3-11(10)20-15(12)18-13/h4-7H,1-3H2,(H,17,18,19)",SGKVRQFNFNNAJG-UHFFFAOYSA-N,1,1,0,0,Bromodomain / Histone,5.05,breast cancer,Inhibition,
1828,136577469,4080510,,Cc1cc(cc(C)c1O)-c1nc2sc3CCCc3c2c(=O)[nH]1,"10-(4-hydroxy-3,5-dimethylphenyl)-7-thia-9,11-diazatricyclo[6.4.0.0^{2,6}]dodeca-1(8),2(6),9-trien-12-one","InChI=1S/C17H16N2O2S/c1-8-6-10(7-9(2)14(8)20)15-18-16(21)13-11-4-3-5-12(11)22-17(13)19-15/h6-7,20H,3-5H2,1-2H3,(H,18,19,21)",SJSIKYDYHSSABB-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,5.20,breast cancer,Inhibition,
1829,137643679,4088370,,FC(F)(F)c1ccc(cc1)-c1nc2sc3CCCCc3c2c(=O)[nH]1,"5-[4-(trifluoromethyl)phenyl]-8-thia-4,6-diazatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),5-trien-3-one","InChI=1S/C17H13F3N2OS/c18-17(19,20)10-7-5-9(6-8-10)14-21-15(23)13-11-3-1-2-4-12(11)24-16(13)22-14/h5-8H,1-4H2,(H,21,22,23)",CTNLHRVALUSOPO-UHFFFAOYSA-N,0,1,0,0,Bromodomain / Histone,4.55,breast cancer,Inhibition,
1830,714750,265438,,Oc1ccc(cc1)-c1nc2sc3CCCCc3c2c(=O)[nH]1,"5-(4-hydroxyphenyl)-8-thia-4,6-diazatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),5-trien-3-one","InChI=1S/C16H14N2O2S/c19-10-7-5-9(6-8-10)14-17-15(20)13-11-3-1-2-4-12(11)21-16(13)18-14/h5-8,19H,1-4H2,(H,17,18,20)",OJQGZRUBLIAVFY-UHFFFAOYSA-N,1,1,0,0,Bromodomain / Histone,5.14,breast cancer,Inhibition,
1831,137640120,4069813,,Cc1cc(cc(C)c1O)-c1nc2sc3CCCCc3c2c(=O)[nH]1,"5-(4-hydroxy-3,5-dimethylphenyl)-8-thia-4,6-diazatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),5-trien-3-one","InChI=1S/C18H18N2O2S/c1-9-7-11(8-10(2)15(9)21)16-19-17(22)14-12-5-3-4-6-13(12)23-18(14)20-16/h7-8,21H,3-6H2,1-2H3,(H,19,20,22)",ICGSKBBQBPYFGC-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,5.16,breast cancer,Inhibition,
1832,1015929,4080969,,Brc1cccc(c1)-c1nc2sc3CCCCCc3c2c(=O)[nH]1,"5-(3-bromophenyl)-8-thia-4,6-diazatricyclo[7.5.0.0^{2,7}]tetradeca-1(9),2(7),5-trien-3-one","InChI=1S/C17H15BrN2OS/c18-11-6-4-5-10(9-11)15-19-16(21)14-12-7-2-1-3-8-13(12)22-17(14)20-15/h4-6,9H,1-3,7-8H2,(H,19,20,21)",PIIYXVDVTHQQPW-UHFFFAOYSA-N,1,1,0,0,Bromodomain / Histone,5.24,breast cancer,Inhibition,
1833,124429951,4098993,,Oc1cccc(c1)-c1nc2sc3CCCCCc3c2c(=O)[nH]1,"5-(3-hydroxyphenyl)-8-thia-4,6-diazatricyclo[7.5.0.0^{2,7}]tetradeca-1(9),2(7),5-trien-3-one","InChI=1S/C17H16N2O2S/c20-11-6-4-5-10(9-11)15-18-16(21)14-12-7-2-1-3-8-13(12)22-17(14)19-15/h4-6,9,20H,1-3,7-8H2,(H,18,19,21)",XQXAYMMIDCTMLV-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,5.40,breast cancer,Inhibition,
1834,136242352,2397398,,Oc1ccc(cc1)-c1nc2sc3CCCCCc3c2c(=O)[nH]1,"5-(4-hydroxyphenyl)-8-thia-4,6-diazatricyclo[7.5.0.0^{2,7}]tetradeca-1(9),2(7),5-trien-3-one","InChI=1S/C17H16N2O2S/c20-11-8-6-10(7-9-11)15-18-16(21)14-12-4-2-1-3-5-13(12)22-17(14)19-15/h6-9,20H,1-5H2,(H,18,19,21)",HIPCDHDMFWCRML-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,6.25,breast cancer,Inhibition,
1835,137654107,4096544,,Cc1cc(cc(C)c1O)-c1nc2sc3CCCCCc3c2c(=O)[nH]1,"5-(4-hydroxy-3,5-dimethylphenyl)-8-thia-4,6-diazatricyclo[7.5.0.0^{2,7}]tetradeca-1(9),2(7),5-trien-3-one","InChI=1S/C19H20N2O2S/c1-10-8-12(9-11(2)16(10)22)17-20-18(23)15-13-6-4-3-5-7-14(13)24-19(15)21-17/h8-9,22H,3-7H2,1-2H3,(H,20,21,23)",UNXACKFLOUYIKN-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,6.31,breast cancer,Inhibition,
1836,24156462,4069308,,O=c1[nH]c(Cc2ccccc2)nc2sc3CCCCCc3c12,"5-benzyl-8-thia-4,6-diazatricyclo[7.5.0.0^{2,7}]tetradeca-1(9),2(7),5-trien-3-one","InChI=1S/C18H18N2OS/c21-17-16-13-9-5-2-6-10-14(13)22-18(16)20-15(19-17)11-12-7-3-1-4-8-12/h1,3-4,7-8H,2,5-6,9-11H2,(H,19,20,21)",XMZDRVVDEKXTRX-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,6.09,breast cancer,Inhibition,
1837,53268718,4087922,,CC1CCc2c(C1)sc1nc([nH]c(=O)c21)-c1cccc(Br)c1,"5-(3-bromophenyl)-11-methyl-8-thia-4,6-diazatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),5-trien-3-one","InChI=1S/C17H15BrN2OS/c1-9-5-6-12-13(7-9)22-17-14(12)16(21)19-15(20-17)10-3-2-4-11(18)8-10/h2-4,8-9H,5-7H2,1H3,(H,19,20,21)",MZUXWDRHTXHNFF-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,5.99,breast cancer,Inhibition,
1838,136212224,4066449,,CC1CCc2c(C1)sc1nc([nH]c(=O)c21)-c1ccc(O)cc1,"5-(4-hydroxyphenyl)-11-methyl-8-thia-4,6-diazatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),5-trien-3-one","InChI=1S/C17H16N2O2S/c1-9-2-7-12-13(8-9)22-17-14(12)16(21)18-15(19-17)10-3-5-11(20)6-4-10/h3-6,9,20H,2,7-8H2,1H3,(H,18,19,21)",TZWSGFZJLUMAJN-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,5.37,breast cancer,Inhibition,
1839,137653732,4093043,,CC1CCc2c(C1)sc1nc([nH]c(=O)c21)-c1cc(C)c(O)c(C)c1,"5-(4-hydroxy-3,5-dimethylphenyl)-11-methyl-8-thia-4,6-diazatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),5-trien-3-one","InChI=1S/C19H20N2O2S/c1-9-4-5-13-14(6-9)24-19-15(13)18(23)20-17(21-19)12-7-10(2)16(22)11(3)8-12/h7-9,22H,4-6H2,1-3H3,(H,20,21,23)",OSEHKWOJUNJWCM-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,5.49,breast cancer,Inhibition,
1840,168317743,,,COc1ccccc1-c1nc2sc3CN(C)CCc3c2c(=O)[nH]1,"5-(2-methoxyphenyl)-11-methyl-8-thia-4,6,11-triazatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),5-trien-3-one","InChI=1S/C17H17N3O2S/c1-20-8-7-11-13(9-20)23-17-14(11)16(21)18-15(19-17)10-5-3-4-6-12(10)22-2/h3-6H,7-9H2,1-2H3,(H,18,19,21)",BTZWCXUVGSWERN-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,5.61,breast cancer,Inhibition,
1841,137650944,4077019,,CN1CCc2c(C1)sc1nc([nH]c(=O)c21)-c1cccc(Br)c1,"5-(3-bromophenyl)-11-methyl-8-thia-4,6,11-triazatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),5-trien-3-one","InChI=1S/C16H14BrN3OS/c1-20-6-5-11-12(8-20)22-16-13(11)15(21)18-14(19-16)9-3-2-4-10(17)7-9/h2-4,7H,5-6,8H2,1H3,(H,18,19,21)",HAJDFRQHCCXQCE-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,5.98,breast cancer,Inhibition,
1842,168317742,,,CN1CCC2=C(Cc3nc([nH]c(=O)c23)-c2ccc(O)cc2)C1,"5-(4-hydroxyphenyl)-11-methyl-4,6,11-triazatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),5-trien-3-one","InChI=1S/C17H17N3O2/c1-20-7-6-13-11(9-20)8-14-15(13)17(22)19-16(18-14)10-2-4-12(21)5-3-10/h2-5,21H,6-9H2,1H3,(H,18,19,22)",UNDJGGZQEYCWJS-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,6.14,breast cancer,Inhibition,
1843,135567026,4077274,,CN1CCc2c(C1)sc1nc([nH]c(=O)c21)-c1cc(C)c(O)c(C)c1,"5-(4-hydroxy-3,5-dimethylphenyl)-11-methyl-8-thia-4,6,11-triazatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),5-trien-3-one","InChI=1S/C18H19N3O2S/c1-9-6-11(7-10(2)15(9)22)16-19-17(23)14-12-4-5-21(3)8-13(12)24-18(14)20-16/h6-7,22H,4-5,8H2,1-3H3,(H,19,20,23)",PXJZRFLBUBYEPV-UHFFFAOYSA-N,8,2,2,0,Bromodomain / Histone,6.37,breast cancer,Inhibition,
1844,137650878,4075573,,Oc1ccc(cc1)-c1nc2sc3CN(Cc4ccccc4)CCc3c2c(=O)[nH]1,"11-benzyl-5-(4-hydroxyphenyl)-8-thia-4,6,11-triazatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),5-trien-3-one","InChI=1S/C22H19N3O2S/c26-16-8-6-15(7-9-16)20-23-21(27)19-17-10-11-25(12-14-4-2-1-3-5-14)13-18(17)28-22(19)24-20/h1-9,26H,10-13H2,(H,23,24,27)",DPYKFGGHEFSUEG-UHFFFAOYSA-N,1,1,0,0,Bromodomain / Histone,5.20,breast cancer,Inhibition,
1845,46907787,1957266,,Cc3nnc4[C@H](CC(=O)OC(C)(C)C)/N=C(c1ccc(Cl)cc1)\c2c(C)c(C)sc2n34,,"InChI=1S/C23H25ClN4O2S/c1-12-13(2)31-22-19(12)20(15-7-9-16(24)10-8-15)25-17(11-18(29)30-23(4,5)6)21-27-26-14(3)28(21)22/h7-10,17H,11H2,1-6H3/t17-/m0/s1",DNVXATUJJDPFDM-KRWDZBQOSA-N,,,,,,,,,
1846,24871506,2393130,,COc1cc(OC)c2c(c1)nc([nH]c2=O)-c1cc(C)c(OCCO)c(C)c1,"2-[4-(2-hydroxyethoxy)-3,5-dimethylphenyl]-5,7-dimethoxy-3,4-dihydroquinazolin-4-one","InChI=1S/C20H22N2O5/c1-11-7-13(8-12(2)18(11)27-6-5-23)19-21-15-9-14(25-3)10-16(26-4)17(15)20(24)22-19/h7-10,23H,5-6H2,1-4H3,(H,21,22,24)",NETXMUIMUZJUTB-UHFFFAOYSA-N,0,2,0,0,Bromodomain / Histone,3.85,breast cancer,Inhibition,
1847,86299506,4073935,,Cc1[nH]c(cc1C(N)=O)-c1ccccc1N,5-(2-aminophenyl)-2-methyl-1H-pyrrole-3-carboxamide,"InChI=1S/C12H13N3O/c1-7-9(12(14)16)6-11(15-7)8-4-2-3-5-10(8)13/h2-6,15H,13H2,1H3,(H2,14,16)",UBOQKPCXNYZXEW-UHFFFAOYSA-N,1,0,0,0,Bromodomain / Histone,4.66,cancer,Inhibition,
1848,71811952,4096256,,Cc1[nH]c(c2CCCC(=O)c12)-c1ccccc1N,"1-(2-aminophenyl)-3-methyl-4,5,6,7-tetrahydro-2H-isoindol-4-one","InChI=1S/C15H16N2O/c1-9-14-11(6-4-8-13(14)18)15(17-9)10-5-2-3-7-12(10)16/h2-3,5,7,17H,4,6,8,16H2,1H3",IPQGUMYPDJKXTB-UHFFFAOYSA-N,1,1,0,0,Bromodomain / Histone,5.15,cancer,Inhibition,
1849,86299086,4086753,,Cc1[nH]c(cc1C(N)=O)-c1ccccc1Nc1ccccc1,2-methyl-5-[2-(phenylamino)phenyl]-1H-pyrrole-3-carboxamide,"InChI=1S/C18H17N3O/c1-12-15(18(19)22)11-17(20-12)14-9-5-6-10-16(14)21-13-7-3-2-4-8-13/h2-11,20-21H,1H3,(H2,19,22)",UBFGQVREMCMKPU-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,6.35,cancer,Inhibition,
1850,86299218,4065327,,Cc1[nH]c(cc1C(N)=O)-c1ccccc1Oc1ccccc1,2-methyl-5-(2-phenoxyphenyl)-1H-pyrrole-3-carboxamide,"InChI=1S/C18H16N2O2/c1-12-15(18(19)21)11-16(20-12)14-9-5-6-10-17(14)22-13-7-3-2-4-8-13/h2-11,20H,1H3,(H2,19,21)",GIOFUGBJPWWPNJ-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,6.57,cancer,Inhibition,
1851,90413480,4098863,,Cc1[nH]c(cc1C(N)=O)-c1ccccc1Oc1ccc(Cl)cc1,5-[2-(4-chlorophenoxy)phenyl]-2-methyl-1H-pyrrole-3-carboxamide,"InChI=1S/C18H15ClN2O2/c1-11-15(18(20)22)10-16(21-11)14-4-2-3-5-17(14)23-13-8-6-12(19)7-9-13/h2-10,21H,1H3,(H2,20,22)",VYHWNVJEEBHTKR-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,6.55,cancer,Inhibition,
1852,86299220,4080820,,Cc1[nH]c(cc1C(N)=O)-c1c(N)cccc1Oc1ccccc1,5-(2-amino-6-phenoxyphenyl)-2-methyl-1H-pyrrole-3-carboxamide,"InChI=1S/C18H17N3O2/c1-11-13(18(20)22)10-15(21-11)17-14(19)8-5-9-16(17)23-12-6-3-2-4-7-12/h2-10,21H,19H2,1H3,(H2,20,22)",HMGRPWXRXLIZEW-UHFFFAOYSA-N,1,1,0,0,Bromodomain / Histone,5.80,cancer,Inhibition,
1853,90413429,4088536,,Cc1[nH]c(cc1C(N)=O)-c1cc(N)ccc1Oc1ccccc1,5-(5-amino-2-phenoxyphenyl)-2-methyl-1H-pyrrole-3-carboxamide,"InChI=1S/C18H17N3O2/c1-11-14(18(20)22)10-16(21-11)15-9-12(19)7-8-17(15)23-13-5-3-2-4-6-13/h2-10,21H,19H2,1H3,(H2,20,22)",CUUGHSOYWQABPW-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,6.38,cancer,Inhibition,
1854,90415492,4060309,,Cc1[nH]c(cc1C(N)=O)-c1cc(NS(C)(=O)=O)ccc1Oc1ccccc1,5-(5-methanesulfonamido-2-phenoxyphenyl)-2-methyl-1H-pyrrole-3-carboxamide,"InChI=1S/C19H19N3O4S/c1-12-15(19(20)23)11-17(21-12)16-10-13(22-27(2,24)25)8-9-18(16)26-14-6-4-3-5-7-14/h3-11,21-22H,1-2H3,(H2,20,23)",ZZTOGTBTPJGXNS-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,6.55,cancer,Inhibition,
1855,71811973,4068988,,Cc1[nH]c(c2CCCC(=O)c12)-c1ccccc1Oc1ccccc1,"3-methyl-1-(2-phenoxyphenyl)-4,5,6,7-tetrahydro-2H-isoindol-4-one","InChI=1S/C21H19NO2/c1-14-20-17(11-7-12-18(20)23)21(22-14)16-10-5-6-13-19(16)24-15-8-3-2-4-9-15/h2-6,8-10,13,22H,7,11-12H2,1H3",KLYIVVNLQIHWNI-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,6.55,cancer,Inhibition,
1856,71812048,4069994,,Cc1[nH]c(c2CCCC(=O)c12)-c1cc(N)ccc1Oc1ccccc1,"1-(5-amino-2-phenoxyphenyl)-3-methyl-4,5,6,7-tetrahydro-2H-isoindol-4-one","InChI=1S/C21H20N2O2/c1-13-20-16(8-5-9-18(20)24)21(23-13)17-12-14(22)10-11-19(17)25-15-6-3-2-4-7-15/h2-4,6-7,10-12,23H,5,8-9,22H2,1H3",WEJMCQNBCYFALA-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,6.68,cancer,Inhibition,
1857,71760902,4063051,,Cc1[nH]c(c2CCCC(=O)c12)-c1cc(NS(C)(=O)=O)ccc1Oc1ccccc1,"N-[3-(3-methyl-4-oxo-4,5,6,7-tetrahydro-2H-isoindol-1-yl)-4-phenoxyphenyl]methanesulfonamide","InChI=1S/C22H22N2O4S/c1-14-21-17(9-6-10-19(21)25)22(23-14)18-13-15(24-29(2,26)27)11-12-20(18)28-16-7-4-3-5-8-16/h3-5,7-8,11-13,23-24H,6,9-10H2,1-2H3",GZFJPALDEYOFHA-UHFFFAOYSA-N,1,2,2,0,Bromodomain / Histone,7.48,cancer,Inhibition,
1858,71812065,4080666,,COC(=O)c1ccc(Oc2ccccc2)c(c1)-c1[nH]c(C)c2c1CCCC2=O,"methyl 3-(3-methyl-4-oxo-4,5,6,7-tetrahydro-2H-isoindol-1-yl)-4-phenoxybenzoate","InChI=1S/C23H21NO4/c1-14-21-17(9-6-10-19(21)25)22(24-14)18-13-15(23(26)27-2)11-12-20(18)28-16-7-4-3-5-8-16/h3-5,7-8,11-13,24H,6,9-10H2,1-2H3",NPKQOBAGAPKRFP-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,7.04,cancer,Inhibition,
1859,71812067,4098709,,CCNC(=O)c1ccc(Oc2ccccc2)c(c1)-c1[nH]c(C)c2c1CCCC2=O,"N-ethyl-3-(3-methyl-4-oxo-4,5,6,7-tetrahydro-2H-isoindol-1-yl)-4-phenoxybenzamide","InChI=1S/C24H24N2O3/c1-3-25-24(28)16-12-13-21(29-17-8-5-4-6-9-17)19(14-16)23-18-10-7-11-20(27)22(18)15(2)26-23/h4-6,8-9,12-14,26H,3,7,10-11H2,1-2H3,(H,25,28)",UYVKPTPDSHKJCN-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,6.60,cancer,Inhibition,
1860,137651591,4074891,,Cc1[nH]c(cc1C(N)=O)-c1cc(NS(C)(=O)=O)ccc1Oc1ccc(F)cc1F,"5-[2-(2,4-difluorophenoxy)-5-methanesulfonamidophenyl]-2-methyl-1H-pyrrole-3-carboxamide","InChI=1S/C19H17F2N3O4S/c1-10-13(19(22)25)9-16(23-10)14-8-12(24-29(2,26)27)4-6-17(14)28-18-5-3-11(20)7-15(18)21/h3-9,23-24H,1-2H3,(H2,22,25)",JFZJRGWCQQBHCT-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,6.43,cancer,Inhibition,
1861,137653121,4095330,,Cc1[nH]c(cc1C(N)=O)-c1cc(ccc1Oc1ccc(F)cc1F)S(C)(=O)=O,"5-[2-(2,4-difluorophenoxy)-5-methanesulfonylphenyl]-2-methyl-1H-pyrrole-3-carboxamide","InChI=1S/C19H16F2N2O4S/c1-10-13(19(22)24)9-16(23-10)14-8-12(28(2,25)26)4-6-17(14)27-18-5-3-11(20)7-15(18)21/h3-9,23H,1-2H3,(H2,22,24)",HEBJGQDORMSDGL-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,5.66,cancer,Inhibition,
1862,71812037,4097227,,Cc1[nH]c(c2CCCC(=O)c12)-c1cc(NS(C)(=O)=O)ccc1Oc1ccc(F)cc1F,"N-[4-(2,4-difluorophenoxy)-3-(3-methyl-4-oxo-4,5,6,7-tetrahydro-2H-isoindol-1-yl)phenyl]methanesulfonamide","InChI=1S/C22H20F2N2O4S/c1-12-21-15(4-3-5-18(21)27)22(25-12)16-11-14(26-31(2,28)29)7-9-19(16)30-20-8-6-13(23)10-17(20)24/h6-11,25-26H,3-5H2,1-2H3",PLXPCRHHULAZDG-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,7.12,cancer,Inhibition,
1863,137651043,4079208,,Cc1[nH]c(c2CCCC(=O)c12)-c1cc(ccc1Oc1ccc(F)cc1F)S(C)(=O)=O,"1-[2-(2,4-difluorophenoxy)-5-methanesulfonylphenyl]-3-methyl-4,5,6,7-tetrahydro-2H-isoindol-4-one","InChI=1S/C22H19F2NO4S/c1-12-21-15(4-3-5-18(21)26)22(25-12)16-11-14(30(2,27)28)7-9-19(16)29-20-8-6-13(23)10-17(20)24/h6-11,25H,3-5H2,1-2H3",RFRKNJZNTDDXFX-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,6.34,cancer,Inhibition,
1864,86271752,4104934,,Cc1[nH]c(c2CCNC(=O)c12)-c1ccccc1Oc1ccccc1,"3-methyl-1-(2-phenoxyphenyl)-2H,4H,5H,6H,7H-pyrrolo[3,4-c]pyridin-4-one","InChI=1S/C20H18N2O2/c1-13-18-16(11-12-21-20(18)23)19(22-13)15-9-5-6-10-17(15)24-14-7-3-2-4-8-14/h2-10,22H,11-12H2,1H3,(H,21,23)",QZKKZCIZIUWXFK-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,6.72,cancer,Inhibition,
1865,90387291,4087079,,Cc1[nH]c(c2CCNC(=O)c12)-c1cc(NS(C)(=O)=O)ccc1Oc1ccccc1,"N-(3-{3-methyl-4-oxo-2H,4H,5H,6H,7H-pyrrolo[3,4-c]pyridin-1-yl}-4-phenoxyphenyl)methanesulfonamide","InChI=1S/C21H21N3O4S/c1-13-19-16(10-11-22-21(19)25)20(23-13)17-12-14(24-29(2,26)27)8-9-18(17)28-15-6-4-3-5-7-15/h3-9,12,23-24H,10-11H2,1-2H3,(H,22,25)",ZGNLBROTMZIJBB-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,7.39,cancer,Inhibition,
1866,86271751,4067320,,Cc1[nH]c(c2CCNC(=O)c12)-c1cc(NS(C)(=O)=O)ccc1Oc1ccc(F)cc1F,"N-[4-(2,4-difluorophenoxy)-3-{3-methyl-4-oxo-2H,4H,5H,6H,7H-pyrrolo[3,4-c]pyridin-1-yl}phenyl]methanesulfonamide","InChI=1S/C21H19F2N3O4S/c1-11-19-14(7-8-24-21(19)27)20(25-11)15-10-13(26-31(2,28)29)4-6-17(15)30-18-5-3-12(22)9-16(18)23/h3-6,9-10,25-26H,7-8H2,1-2H3,(H,24,27)",MLNOGJLNUKUYDQ-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,7.08,cancer,Inhibition,
1867,77843982,3786012,,Cc1[nH]c(c2CCNC(=O)c12)-c1cc(ccc1Oc1ccc(F)cc1F)S(C)(=O)=O,"1-[2-(2,4-difluorophenoxy)-5-methanesulfonylphenyl]-3-methyl-2H,4H,5H,6H,7H-pyrrolo[3,4-c]pyridin-4-one","InChI=1S/C21H18F2N2O4S/c1-11-19-14(7-8-24-21(19)26)20(25-11)15-10-13(30(2,27)28)4-6-17(15)29-18-5-3-12(22)9-16(18)23/h3-6,9-10,25H,7-8H2,1-2H3,(H,24,26)",QNOJAPBYTXGBLX-UHFFFAOYSA-N,1,2,2,0,Bromodomain / Histone,6.54,cancer,Inhibition,
1868,86270617,4078245,,Cc1[nH]c(-c2ccccc2Oc2ccccc2)c2cc[nH]c(=O)c12,"3-methyl-1-(2-phenoxyphenyl)-2H,4H,5H-pyrrolo[3,4-c]pyridin-4-one","InChI=1S/C20H16N2O2/c1-13-18-16(11-12-21-20(18)23)19(22-13)15-9-5-6-10-17(15)24-14-7-3-2-4-8-14/h2-12,22H,1H3,(H,21,23)",ZVBYYZLLHHAMEC-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,6.66,cancer,Inhibition,
1869,136387526,4102516,,Cc1[nH]c(-c2ccccc2Oc2ccccc2)c2cn[nH]c(=O)c12,"7-methyl-5-(2-phenoxyphenyl)-1H,2H,6H-pyrrolo[3,4-d]pyridazin-1-one","InChI=1S/C19H15N3O2/c1-12-17-15(11-20-22-19(17)23)18(21-12)14-9-5-6-10-16(14)24-13-7-3-2-4-8-13/h2-11,21H,1H3,(H,22,23)",QCLURBBHYMMOOB-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,7.43,cancer,Inhibition,
1870,136387525,4086135,,Cc1[nH]c(-c2cc(NS(C)(=O)=O)ccc2Oc2ccccc2)c2cn[nH]c(=O)c12,"N-(3-{7-methyl-1-oxo-1H,2H,6H-pyrrolo[3,4-d]pyridazin-5-yl}-4-phenoxyphenyl)methanesulfonamide","InChI=1S/C20H18N4O4S/c1-12-18-16(11-21-23-20(18)25)19(22-12)15-10-13(24-29(2,26)27)8-9-17(15)28-14-6-4-3-5-7-14/h3-11,22,24H,1-2H3,(H,23,25)",LPQIHHHQRDWFRN-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,7.52,cancer,Inhibition,
1871,135567317,4064625,,CCS(=O)(=O)Nc1ccc(Oc2ccccc2)c(c1)-c1[nH]c(C)c2c1cn[nH]c2=O,"N-(3-{7-methyl-1-oxo-1H,2H,6H-pyrrolo[3,4-d]pyridazin-5-yl}-4-phenoxyphenyl)ethane-1-sulfonamide","InChI=1S/C21H20N4O4S/c1-3-30(27,28)25-14-9-10-18(29-15-7-5-4-6-8-15)16(11-14)20-17-12-22-24-21(26)19(17)13(2)23-20/h4-12,23,25H,3H2,1-2H3,(H,24,26)",YYFWVXHZOKCWDD-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,8.00,cancer,Inhibition,
1872,136387543,4074813,,Cc1[nH]c(-c2cc(NS(C)(=O)=O)ccc2Oc2ccc(F)cc2F)c2cn[nH]c(=O)c12,"N-[4-(2,4-difluorophenoxy)-3-{7-methyl-1-oxo-1H,2H,6H-pyrrolo[3,4-d]pyridazin-5-yl}phenyl]methanesulfonamide","InChI=1S/C20H16F2N4O4S/c1-10-18-14(9-23-25-20(18)27)19(24-10)13-8-12(26-31(2,28)29)4-6-16(13)30-17-5-3-11(21)7-15(17)22/h3-9,24,26H,1-2H3,(H,25,27)",CWVAUKGWAKGWBJ-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,7.80,cancer,Inhibition,
1873,136387545,4095264,,Cc1[nH]c(-c2cc(ccc2Oc2ccc(F)cc2F)S(C)(=O)=O)c2cn[nH]c(=O)c12,"5-[2-(2,4-difluorophenoxy)-5-methanesulfonylphenyl]-7-methyl-1H,2H,6H-pyrrolo[3,4-d]pyridazin-1-one","InChI=1S/C20H15F2N3O4S/c1-10-18-14(9-23-25-20(18)26)19(24-10)13-8-12(30(2,27)28)4-6-16(13)29-17-5-3-11(21)7-15(17)22/h3-9,24H,1-2H3,(H,25,26)",XXDVOJXVRUJACY-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,7.11,cancer,Inhibition,
1874,86271653,4076251,,Cc1[nH]c(-c2ccccc2Oc2ccccc2)c2nc[nH]c(=O)c12,"5-methyl-7-(2-phenoxyphenyl)-3H,4H,6H-pyrrolo[3,4-d]pyrimidin-4-one","InChI=1S/C19H15N3O2/c1-12-16-18(20-11-21-19(16)23)17(22-12)14-9-5-6-10-15(14)24-13-7-3-2-4-8-13/h2-11,22H,1H3,(H,20,21,23)",GBBSZTYFIKCEPZ-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,5.96,cancer,Inhibition,
1875,86271750,4080682,,Cc1[nH]c(-c2cc(NS(C)(=O)=O)ccc2Oc2ccccc2)c2nc[nH]c(=O)c12,"N-(3-{5-methyl-4-oxo-3H,4H,6H-pyrrolo[3,4-d]pyrimidin-7-yl}-4-phenoxyphenyl)methanesulfonamide","InChI=1S/C20H18N4O4S/c1-12-17-19(21-11-22-20(17)25)18(23-12)15-10-13(24-29(2,26)27)8-9-16(15)28-14-6-4-3-5-7-14/h3-11,23-24H,1-2H3,(H,21,22,25)",JFLBWMRPEABFBV-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,6.82,cancer,Inhibition,
1876,86287687,4103937,,Cn1cc(-c2ccccc2Oc2ccccc2)c2cc[nH]c(=O)c12,"1-methyl-3-(2-phenoxyphenyl)-1H,6H,7H-pyrrolo[2,3-c]pyridin-7-one","InChI=1S/C20H16N2O2/c1-22-13-17(16-11-12-21-20(23)19(16)22)15-9-5-6-10-18(15)24-14-7-3-2-4-8-14/h2-13H,1H3,(H,21,23)",LXTIJBUYZHCORC-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,6.92,cancer,Inhibition,
1877,86287688,4079684,,Cn1cc(-c2cc(NS(C)(=O)=O)ccc2Oc2ccc(F)cc2F)c2cc[nH]c(=O)c12,"N-[4-(2,4-difluorophenoxy)-3-{1-methyl-7-oxo-1H,6H,7H-pyrrolo[2,3-c]pyridin-3-yl}phenyl]methanesulfonamide","InChI=1S/C21H17F2N3O4S/c1-26-11-16(14-7-8-24-21(27)20(14)26)15-10-13(25-31(2,28)29)4-6-18(15)30-19-5-3-12(22)9-17(19)23/h3-11,25H,1-2H3,(H,24,27)",WUAHSMFJJJYZOF-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,7.77,cancer,Inhibition,
1878,86287690,4096183,,CCS(=O)(=O)Nc1ccc(Oc2ccc(F)cc2F)c(c1)-c1cn(C)c2c1cc[nH]c2=O,"N-[4-(2,4-difluorophenoxy)-3-{1-methyl-7-oxo-1H,6H,7H-pyrrolo[2,3-c]pyridin-3-yl}phenyl]ethane-1-sulfonamide","InChI=1S/C22H19F2N3O4S/c1-3-32(29,30)26-14-5-7-19(31-20-6-4-13(23)10-18(20)24)16(11-14)17-12-27(2)21-15(17)8-9-25-22(21)28/h4-12,26H,3H2,1-2H3,(H,25,28)",RWDOZZPKEZJESZ-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,7.96,cancer,Inhibition,
1879,90417643,4068902,,Cn1cc(-c2cc(ccc2Oc2ccccc2)S(C)(=O)=O)c2cc[nH]c(=O)c12,"3-(5-methanesulfonyl-2-phenoxyphenyl)-1-methyl-1H,6H,7H-pyrrolo[2,3-c]pyridin-7-one","InChI=1S/C21H18N2O4S/c1-23-13-18(16-10-11-22-21(24)20(16)23)17-12-15(28(2,25)26)8-9-19(17)27-14-6-4-3-5-7-14/h3-13H,1-2H3,(H,22,24)",YCCIGZDTXLSNIN-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,7.77,cancer,Inhibition,
1880,78319129,4088466,,Cn1cc(-c2cc(ccc2Oc2ccc(F)cc2F)S(C)(=O)=O)c2cc[nH]c(=O)c12,"3-[2-(2,4-difluorophenoxy)-5-methanesulfonylphenyl]-1-methyl-1H,6H,7H-pyrrolo[2,3-c]pyridin-7-one","InChI=1S/C21H16F2N2O4S/c1-25-11-16(14-7-8-24-21(26)20(14)25)15-10-13(30(2,27)28)4-6-18(15)29-19-5-3-12(22)9-17(19)23/h3-11H,1-2H3,(H,24,26)",JGGBFOUTSJEGRT-UHFFFAOYSA-N,1,2,2,0,Bromodomain / Histone,7.01,cancer,Inhibition,
1881,86287755,4064089,,CCS(=O)(=O)Nc1ccc(Oc2ccc(F)cc2)c(c1)-c1cn(C)c2c1cc[nH]c2=O,"N-[4-(4-fluorophenoxy)-3-{1-methyl-7-oxo-1H,6H,7H-pyrrolo[2,3-c]pyridin-3-yl}phenyl]ethane-1-sulfonamide","InChI=1S/C22H20FN3O4S/c1-3-31(28,29)25-15-6-9-20(30-16-7-4-14(23)5-8-16)18(12-15)19-13-26(2)21-17(19)10-11-24-22(21)27/h4-13,25H,3H2,1-2H3,(H,24,27)",AITMUTNEKRWIEC-UHFFFAOYSA-N,1,2,2,0,Bromodomain / Histone,8.26,cancer,Inhibition,
1882,86287958,4097720,,Cn1cc(-c2cc(CS(C)(=O)=O)ccc2Oc2ccc(F)cc2F)c2cc[nH]c(=O)c12,"3-[2-(2,4-difluorophenoxy)-5-(methanesulfonylmethyl)phenyl]-1-methyl-1H,6H,7H-pyrrolo[2,3-c]pyridin-7-one","InChI=1S/C22H18F2N2O4S/c1-26-11-17(15-7-8-25-22(27)21(15)26)16-9-13(12-31(2,28)29)3-5-19(16)30-20-6-4-14(23)10-18(20)24/h3-11H,12H2,1-2H3,(H,25,27)",LUILGIUVLRKZHB-UHFFFAOYSA-N,1,2,0,0,Bromodomain / Histone,7.96,cancer,Inhibition,
1883,2766364,4077137,,CNC(=O)c1cc(Br)c[nH]1,4-bromo-N-methyl-1H-pyrrole-2-carboxamide,"InChI=1S/C6H7BrN2O/c1-8-6(10)5-2-4(7)3-9-5/h2-3,9H,1H3,(H,8,10)",HQGRBJIXXLIGLE-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,5.40,cancer,Inhibition,
1884,12564532,4087272,,COC(=O)c1ccc2[nH]c(=O)oc2c1,"methyl 2-oxo-2,3-dihydro-1,3-benzoxazole-6-carboxylate","InChI=1S/C9H7NO4/c1-13-8(11)5-2-3-6-7(4-5)14-9(12)10-6/h2-4H,1H3,(H,10,12)",FUJBKRLYHYJMNF-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,4.07,cancer,Inhibition,
1885,56684144,3108881,,Cc1cc(CC(=O)N2C[C@H](O)C[C@H]2C(=O)NCc2ccc(cc2)-c2cnco2)on1,"(2S,4R)-4-hydroxy-1-[2-(3-methyl-1,2-oxazol-5-yl)acetyl]-N-{[4-(1,3-oxazol-5-yl)phenyl]methyl}pyrrolidine-2-carboxamide","InChI=1S/C21H22N4O5/c1-13-6-17(30-24-13)8-20(27)25-11-16(26)7-18(25)21(28)23-9-14-2-4-15(5-3-14)19-10-22-12-29-19/h2-6,10,12,16,18,26H,7-9,11H2,1H3,(H,23,28)/t16-,18+/m1/s1",HFCLIEBJTGJKSV-AEFFLSMTSA-N,2,0,0,0,VHL / HIF1α,5.27,,Inhibition,
1886,10797632,3108877,,CNC(=O)[C@@H]1C[C@@H](O)CN1C(C)=O,"(2S,4R)-1-acetyl-4-hydroxy-N-methylpyrrolidine-2-carboxamide","InChI=1S/C8H14N2O3/c1-5(11)10-4-6(12)3-7(10)8(13)9-2/h6-7,12H,3-4H2,1-2H3,(H,9,13)/t6-,7+/m1/s1",XAZYBLFYZNUKHD-RQJHMYQMSA-N,1,0,0,0,VHL / HIF1α,2.00,,Inhibition,
1887,57381962,3108879,,CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)Cc1cc(C)no1,"(2S,4R)-4-hydroxy-N-methyl-1-[2-(3-methyl-1,2-oxazol-5-yl)acetyl]pyrrolidine-2-carboxamide","InChI=1S/C12H17N3O4/c1-7-3-9(19-14-7)5-11(17)15-6-8(16)4-10(15)12(18)13-2/h3,8,10,16H,4-6H2,1-2H3,(H,13,18)/t8-,10+/m1/s1",RKIBNEDMQYMQFM-SCZZXKLOSA-N,2,0,0,0,VHL / HIF1α,3.62,,Inhibition,
1888,168317739,,,COC(=O)c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(C)=O)cc1,"methyl 4-({[(2S,4R)-1-acetyl-4-hydroxypyrrolidin-2-yl]formamido}methyl)benzoate","InChI=1S/C16H20N2O5/c1-10(19)18-9-13(20)7-14(18)15(21)17-8-11-3-5-12(6-4-11)16(22)23-2/h3-6,13-14,20H,7-9H2,1-2H3,(H,17,21)/t13-,14+/m1/s1",MUSUFVXQGAUCQU-KGLIPLIRSA-N,2,0,0,0,VHL / HIF1α,3.82,,Inhibition,
1889,57381963,,,Cc1cc(CC(=O)N2C[C@H](O)C[C@H]2C(=O)NCc2ccccc2)on1,"(2S,4R)-N-benzyl-4-hydroxy-1-[2-(3-methyl-1,2-oxazol-5-yl)acetyl]pyrrolidine-2-carboxamide","InChI=1S/C18H21N3O4/c1-12-7-15(25-20-12)9-17(23)21-11-14(22)8-16(21)18(24)19-10-13-5-3-2-4-6-13/h2-7,14,16,22H,8-11H2,1H3,(H,19,24)/t14-,16+/m1/s1",FRDGWEKFMQWGHF-ZBFHGGJFSA-N,2,0,0,0,VHL / HIF1α,3.53,,Inhibition,
1890,168317737,5266076,,COC(=O)c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)CC(C)(C)C)cc1,"methyl 4-({[(2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxypyrrolidin-2-yl]formamido}methyl)benzoate","InChI=1S/C20H28N2O5/c1-20(2,3)10-17(24)22-12-15(23)9-16(22)18(25)21-11-13-5-7-14(8-6-13)19(26)27-4/h5-8,15-16,23H,9-12H2,1-4H3,(H,21,25)/t15-,16+/m1/s1",LUXKEEIMLQRZAH-CVEARBPZSA-N,2,0,0,0,VHL / HIF1α,4.34,,Inhibition,
1891,168317735,,,COC(=O)c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)Cc2ccccc2)cc1,"methyl 4-({[(2S,4R)-4-hydroxy-1-(2-phenylacetyl)pyrrolidin-2-yl]formamido}methyl)benzoate","InChI=1S/C22H24N2O5/c1-29-22(28)17-9-7-16(8-10-17)13-23-21(27)19-12-18(25)14-24(19)20(26)11-15-5-3-2-4-6-15/h2-10,18-19,25H,11-14H2,1H3,(H,23,27)/t18-,19+/m1/s1",VASXINJOAFUQTM-MOPGFXCFSA-N,2,0,0,0,VHL / HIF1α,3.78,,Inhibition,
1892,168317733,,,COC(=O)c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)Cc2cccnc2)cc1,"methyl 4-({[(2S,4R)-4-hydroxy-1-[2-(pyridin-3-yl)acetyl]pyrrolidin-2-yl]formamido}methyl)benzoate","InChI=1S/C21H23N3O5/c1-29-21(28)16-6-4-14(5-7-16)12-23-20(27)18-10-17(25)13-24(18)19(26)9-15-3-2-8-22-11-15/h2-8,11,17-18,25H,9-10,12-13H2,1H3,(H,23,27)/t17-,18+/m1/s1",XQDGZZLLOQRQIG-MSOLQXFVSA-N,2,0,0,0,VHL / HIF1α,3.24,,Inhibition,
1893,57382396,,,COC(=O)c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)Cc2cc(C)no2)cc1,"methyl 4-({[(2S,4R)-4-hydroxy-1-[2-(3-methyl-1,2-oxazol-5-yl)acetyl]pyrrolidin-2-yl]formamido}methyl)benzoate","InChI=1S/C20H23N3O6/c1-12-7-16(29-22-12)9-18(25)23-11-15(24)8-17(23)19(26)21-10-13-3-5-14(6-4-13)20(27)28-2/h3-7,15,17,24H,8-11H2,1-2H3,(H,21,26)/t15-,17+/m1/s1",HMFSOBWOOWBCBL-WBVHZDCISA-N,2,0,0,0,VHL / HIF1α,4.06,,Inhibition,
1894,168317731,,,Cc1cc(CC(=O)N2C[C@H](O)C[C@H]2C(=O)NCC(C)(C)C)on1,"(2S,4R)-N-(2,2-dimethylpropyl)-4-hydroxy-1-[2-(3-methyl-1,2-oxazol-5-yl)acetyl]pyrrolidine-2-carboxamide","InChI=1S/C16H25N3O4/c1-10-5-12(23-18-10)7-14(21)19-8-11(20)6-13(19)15(22)17-9-16(2,3)4/h5,11,13,20H,6-9H2,1-4H3,(H,17,22)/t11-,13+/m1/s1",ANQLICZLSWSFDR-YPMHNXCESA-N,1,0,0,0,VHL / HIF1α,2.96,,Inhibition,
1895,89701841,,,Cc1cc(CC(=O)N2C[C@H](O)C[C@H]2C(=O)NCc2cccnc2)on1,"(2S,4R)-4-hydroxy-1-[2-(3-methyl-1,2-oxazol-5-yl)acetyl]-N-[(pyridin-3-yl)methyl]pyrrolidine-2-carboxamide","InChI=1S/C17H20N4O4/c1-11-5-14(25-20-11)7-16(23)21-10-13(22)6-15(21)17(24)19-9-12-3-2-4-18-8-12/h2-5,8,13,15,22H,6-7,9-10H2,1H3,(H,19,24)/t13-,15+/m1/s1",SFCHWXVGACXSRN-HIFRSBDPSA-N,2,0,0,0,VHL / HIF1α,3.36,,Inhibition,
1896,168317727,,,Cc1cc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)Cc2cc(C)no2)on1,"(2S,4R)-4-hydroxy-1-[2-(3-methyl-1,2-oxazol-5-yl)acetyl]-N-[(3-methyl-1,2-oxazol-5-yl)methyl]pyrrolidine-2-carboxamide","InChI=1S/C16H20N4O5/c1-9-3-12(24-18-9)6-15(22)20-8-11(21)5-14(20)16(23)17-7-13-4-10(2)19-25-13/h3-4,11,14,21H,5-8H2,1-2H3,(H,17,23)/t11-,14+/m1/s1",PUSJPNCTJBLVKQ-RISCZKNCSA-N,2,0,0,0,VHL / HIF1α,3.46,,Inhibition,
1897,57382182,,,Cc1cc(CC(=O)N2C[C@H](O)C[C@H]2C(=O)NCc2ccc(cc2)C(C)(C)C)on1,"(2S,4R)-N-[(4-tert-butylphenyl)methyl]-4-hydroxy-1-[2-(3-methyl-1,2-oxazol-5-yl)acetyl]pyrrolidine-2-carboxamide","InChI=1S/C22H29N3O4/c1-14-9-18(29-24-14)11-20(27)25-13-17(26)10-19(25)21(28)23-12-15-5-7-16(8-6-15)22(2,3)4/h5-9,17,19,26H,10-13H2,1-4H3,(H,23,28)/t17-,19+/m1/s1",KNHJXPMXMZCZAE-MJGOQNOKSA-N,1,0,0,0,VHL / HIF1α,3.09,,Inhibition,
1898,57519703,,,Cc1cc(CC(=O)N2C[C@H](O)C[C@H]2C(=O)NCc2ccc(cc2)-c2ccccc2)on1,"(2S,4R)-N-({[1,1'-biphenyl]-4-yl}methyl)-4-hydroxy-1-[2-(3-methyl-1,2-oxazol-5-yl)acetyl]pyrrolidine-2-carboxamide","InChI=1S/C24H25N3O4/c1-16-11-21(31-26-16)13-23(29)27-15-20(28)12-22(27)24(30)25-14-17-7-9-19(10-8-17)18-5-3-2-4-6-18/h2-11,20,22,28H,12-15H2,1H3,(H,25,30)/t20-,22+/m1/s1",NRELVQVYPBFBDC-IRLDBZIGSA-N,1,0,0,0,VHL / HIF1α,4.56,,Inhibition,
1899,72734413,,,Cc1cc(CC(=O)N2C[C@H](O)C[C@H]2C(=O)NCc2ccc(cc2)-c2cccnc2)on1,"(2S,4R)-4-hydroxy-1-[2-(3-methyl-1,2-oxazol-5-yl)acetyl]-N-{[4-(pyridin-3-yl)phenyl]methyl}pyrrolidine-2-carboxamide","InChI=1S/C23H24N4O4/c1-15-9-20(31-26-15)11-22(29)27-14-19(28)10-21(27)23(30)25-12-16-4-6-17(7-5-16)18-3-2-8-24-13-18/h2-9,13,19,21,28H,10-12,14H2,1H3,(H,25,30)/t19-,21+/m1/s1",DVDQPUMVGPRXPB-CTNGQTDRSA-N,2,0,0,0,VHL / HIF1α,4.83,,Inhibition,
1900,71608568,,,Cc1cc(CC(=O)N2C[C@H](O)C[C@H]2C(=O)NCc2ccc(cc2)-c2ocnc2C)on1,"(2S,4R)-4-hydroxy-1-[2-(3-methyl-1,2-oxazol-5-yl)acetyl]-N-{[4-(4-methyl-1,3-oxazol-5-yl)phenyl]methyl}pyrrolidine-2-carboxamide","InChI=1S/C22H24N4O5/c1-13-7-18(31-25-13)9-20(28)26-11-17(27)8-19(26)22(29)23-10-15-3-5-16(6-4-15)21-14(2)24-12-30-21/h3-7,12,17,19,27H,8-11H2,1-2H3,(H,23,29)/t17-,19+/m1/s1",ATLFUVSBWFVMCI-MJGOQNOKSA-N,2,0,0,0,VHL / HIF1α,5.44,,Inhibition,
1901,3827663,5209443,,Cc1ccc(NC(=S)NNc2c(cc(cc2N(=O)=O)C(F)(F)F)N(=O)=O)cc1Cl,"1-(3-chloro-4-methylphenyl)-3-{[2,6-dinitro-4-(trifluoromethyl)phenyl]amino}thiourea","InChI=1S/C15H11ClF3N5O4S/c1-7-2-3-9(6-10(7)16)20-14(29)22-21-13-11(23(25)26)4-8(15(17,18)19)5-12(13)24(27)28/h2-6,21H,1H3,(H2,20,22,29)",KSJVAYBCXSURMQ-UHFFFAOYSA-N,2,2,1,0,H-Ras / SOS1,6.30,,Inhibition,
1902,4369988,,,Fc1ccc(NC(=S)NNc2ccc(cc2N(=O)=O)N(=O)=O)cc1,"3-[(2,4-dinitrophenyl)amino]-1-(4-fluorophenyl)thiourea","InChI=1S/C13H10FN5O4S/c14-8-1-3-9(4-2-8)15-13(24)17-16-11-6-5-10(18(20)21)7-12(11)19(22)23/h1-7,16H,(H2,15,17,24)",XAWWYTYFOCONCK-UHFFFAOYSA-N,1,0,0,0,H-Ras / SOS1,3.11,,Inhibition,
1903,3827738,5280849,,Fc1ccc(NC(=S)NNc2c(cc(cc2N(=O)=O)C(F)(F)F)N(=O)=O)cc1,"3-{[2,6-dinitro-4-(trifluoromethyl)phenyl]amino}-1-(4-fluorophenyl)thiourea","InChI=1S/C14H9F4N5O4S/c15-8-1-3-9(4-2-8)19-13(28)21-20-12-10(22(24)25)5-7(14(16,17)18)6-11(12)23(26)27/h1-6,20H,(H2,19,21,28)",NNPBSITXCGPXJC-UHFFFAOYSA-N,2,2,0,0,H-Ras / SOS1,5.85,,Inhibition,
1904,149432195,,,OC(=O)[C@@H](NC(=O)c1cc(cc(n1)C(=O)N1CCC[C@H]1CN1CCCC1)-c1cc(nc(c1)C(=O)N1CCC[C@H]1CN1CCCC1)C(=O)NCc1cccc(c1)-c1ccccc1)C1CCCCC1,"(2S)-2-({2'-[({[1,1'-biphenyl]-3-yl}methyl)carbamoyl]-6,6'-bis[(2S)-2-[(pyrrolidin-1-yl)methyl]pyrrolidine-1-carbonyl]-[4,4'-bipyridin]-2-yl}formamido)-2-cyclohexylacetic acid","InChI=1S/C53H64N8O6/c62-49(54-33-36-14-11-19-39(28-36)37-15-3-1-4-16-37)44-29-40(31-46(55-44)51(64)60-26-12-20-42(60)34-58-22-7-8-23-58)41-30-45(50(63)57-48(53(66)67)38-17-5-2-6-18-38)56-47(32-41)52(65)61-27-13-21-43(61)35-59-24-9-10-25-59/h1,3-4,11,14-16,19,28-32,38,42-43,48H,2,5-10,12-13,17-18,20-27,33-35H2,(H,54,62)(H,57,63)(H,66,67)/t42-,43-,48-/m0/s1",WJYLSDLKLWXYML-CHQPKSDDSA-N,1,0,0,0,CD40L-trimer,4.60,lupus nephritis,Stabilization,
1905,1073725,2402207,,COc1ccc(cc1)S(=O)(=O)Nc1ccc(NS(=O)(=O)c2ccc(OC)cc2)c2ccccc12,4-methoxy-N-[4-(4-methoxybenzenesulfonamido)naphthalen-1-yl]benzene-1-sulfonamide,"InChI=1S/C24H22N2O6S2/c1-31-17-7-11-19(12-8-17)33(27,28)25-23-15-16-24(22-6-4-3-5-21(22)23)26-34(29,30)20-13-9-18(32-2)10-14-20/h3-16,25-26H,1-2H3",XLLVCULLOGKYOO-UHFFFAOYSA-N,2,0,0,0,Keap1 / Nrf2,5.84,"cancer, candidemia",Inhibition,
1906,73330369,3237245,,COc1ccc(cc1)S(=O)(=O)N(CC(O)=O)c1ccc(N(CC(O)=O)S(=O)(=O)c2ccc(OC)cc2)c2ccccc12,2-(N-{4-[N-(carboxymethyl)4-methoxybenzenesulfonamido]naphthalen-1-yl}4-methoxybenzenesulfonamido)acetic acid,"InChI=1S/C28H26N2O10S2/c1-39-19-7-11-21(12-8-19)41(35,36)29(17-27(31)32)25-15-16-26(24-6-4-3-5-23(24)25)30(18-28(33)34)42(37,38)22-13-9-20(40-2)10-14-22/h3-16H,17-18H2,1-2H3,(H,31,32)(H,33,34)",KWSIQJUNYMMCTB-UHFFFAOYSA-N,2,0,0,0,Keap1 / Nrf2,8.44,"cancer, candidemia",Inhibition,
1907,2118,661,,Cc1nnc2CN=C(c3ccccc3)c3cc(Cl)ccc3-n12,"12-chloro-3-methyl-9-phenyl-2,4,5,8-tetraazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,8,11,13-hexaene","InChI=1S/C17H13ClN4/c1-11-20-21-16-10-19-17(12-5-3-2-4-6-12)14-9-13(18)7-8-15(14)22(11)16/h2-9H,10H2,1H3",VREFGVBLTWBCJP-UHFFFAOYSA-N,1,0,0,0,Bromodomain / Histone,5.61,cancer,Inhibition,
1908,4192,655,,Cc1ncc2CN=C(c3ccccc3F)c3cc(Cl)ccc3-n12,"12-chloro-9-(2-fluorophenyl)-3-methyl-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,8,11,13-hexaene","InChI=1S/C18H13ClFN3/c1-11-21-9-13-10-22-18(14-4-2-3-5-16(14)20)15-8-12(19)6-7-17(15)23(11)13/h2-9H,10H2,1H3",DDLIGBOFAVUZHB-UHFFFAOYSA-N,0,0,0,0,,,,,
1909,20350618,1958337,,CN1N=C(c2ccccc2)c2cc(Cl)ccc2-n2c(C)nnc12,"12-chloro-3,7-dimethyl-9-phenyl-2,4,5,7,8-pentaazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,8,11,13-hexaene","InChI=1S/C17H14ClN5/c1-11-19-20-17-22(2)21-16(12-6-4-3-5-7-12)14-10-13(18)8-9-15(14)23(11)17/h3-10H,1-2H3",UYIVCPRWMLOCSB-UHFFFAOYSA-N,1,0,0,0,Bromodomain / Histone,6.19,cancer,Inhibition,
1910,4310,,,OC(=O)c1cccc2N(c3cccc(c3)C(F)(F)F)c3cccc(C(O)=O)c3Oc12,"10-[3-(trifluoromethyl)phenyl]-10H-phenoxazine-4,6-dicarboxylic acid","InChI=1S/C21H12F3NO5/c22-21(23,24)11-4-1-5-12(10-11)25-15-8-2-6-13(19(26)27)17(15)30-18-14(20(28)29)7-3-9-16(18)25/h1-10H,(H,26,27)(H,28,29)",NQOOJFXBGLOGTC-UHFFFAOYSA-N,2,0,0,0,TTR,7.10,amyloidosis (disease),Stabilization,
1911,3371,23588,,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F,2-{[3-(trifluoromethyl)phenyl]amino}benzoic acid,"InChI=1S/C14H10F3NO2/c15-14(16,17)9-4-3-5-10(8-9)18-12-7-2-1-6-11(12)13(19)20/h1-8,18H,(H,19,20)",LPEPZBJOKDYZAD-UHFFFAOYSA-N,2,0,0,0,TTR,7.52,amyloidosis (disease),Stabilization,
1912,5819,1624,,N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(O)=O,"(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid","InChI=1S/C15H11I4NO4/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23/h1-2,4-5,12,21H,3,20H2,(H,22,23)/t12-/m0/s1",XUIIKFGFIJCVMT-LBPRGKRZSA-N,2,0,0,0,TTR,7.00,amyloidosis (disease),Stabilization,
1913,8730,559,,N[C@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O,,"InChI=1S/C15H11I4NO4/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23/h1-2,4-5,12,21H,3,20H2,(H,22,23)/t12-/m1/s1",XUIIKFGFIJCVMT-GFCCVEGCSA-N,1,0,0,0,TTR,7.80,,Stabilization,
1914,5920,1544,,N[C@@H](Cc1cc(c(Oc2cc(c(O)cc2)I)c(c1)I)I)C(=O)O,,"InChI=1S/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H,21,22)/t12-/m0/s1",AUYYCJSJGJYCDS-LBPRGKRZSA-N,1,0,0,0,TTR,6.22,,Stabilization,
1915,644280,1743304,,N[C@@H](Cc1cc(c(Oc2cc(c(O)c(c2)I)I)cc1)I)C(=O)O,,"InChI=1S/C15H12I3NO4/c16-9-3-7(4-12(19)15(21)22)1-2-13(9)23-8-5-10(17)14(20)11(18)6-8/h1-3,5-6,12,20H,4,19H2,(H,21,22)/t12-/m0/s1",HZCBWYNLGPIQRK-LBPRGKRZSA-N,1,0,0,0,TTR,7.36,,Stabilization,
1916,168317728,,,N[C@@H](Cc1cc(I)c(c2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O,,"InChI=1S/C15H11I4NO3/c16-8-1-6(3-12(20)15(22)23)2-9(17)13(8)7-4-10(18)14(21)11(19)5-7/h1-2,4-5,12,21H,3,20H2,(H,22,23)/t12-/m0/s1",QHDLYNFVNBCOFT-LBPRGKRZSA-N,1,0,0,0,TTR,8.52,,Stabilization,
1917,185131,160726,,OC(=O)c1cc(I)c(c2cc(I)c(O)c(I)c2)c(I)c1,,"InChI=1S/C13H6I4O3/c14-7-3-6(13(19)20)4-8(15)11(7)5-1-9(16)12(18)10(17)2-5/h1-4,18H,(H,19,20)",DRIBUDGRSYYVRU-UHFFFAOYSA-N,1,0,0,0,TTR,10.00,,Stabilization,
1918,7095,14092,,c1ccccc1c1ccccc1,,InChI=1S/C12H10/c1-3-7-11(8-4-1)12-9-5-2-6-10-12/h1-10H,ZUOUZKKEUPVFJK-UHFFFAOYSA-N,0,0,0,0,,,,,
1919,27588,82258,,c1(cccc(c1c1c(cccc1Cl)Cl)Cl)Cl,,InChI=1S/C12H6Cl4/c13-7-3-1-4-8(14)11(7)12-9(15)5-2-6-10(12)16/h1-6H,PXAGFNRKXSYIHU-UHFFFAOYSA-N,0,0,0,0,,,,,
1920,36400,160213,,c1c(cc(cc1c1cc(cc(c1)Cl)Cl)Cl)Cl,,InChI=1S/C12H6Cl4/c13-9-1-7(2-10(14)5-9)8-3-11(15)6-12(16)4-8/h1-6H,UTMWFJSRHLYRPY-UHFFFAOYSA-N,0,0,0,0,,,,,
1921,36231,14658,,c1c(c(c(cc1c1cc(c(c(c1)Cl)Cl)Cl)Cl)Cl)Cl,,InChI=1S/C12H4Cl6/c13-7-1-5(2-8(14)11(7)17)6-3-9(15)12(18)10(16)4-6/h1-4H,ZHLICBPIXDOFFG-UHFFFAOYSA-N,0,0,0,0,,,,,
1922,70820,83669,,c1ccccc1c1cc(c(c(c1)Cl)O)Cl,,"InChI=1S/C12H8Cl2O/c13-10-6-9(7-11(14)12(10)15)8-4-2-1-3-5-8/h1-7,15H",HHFXDKAXCKUSIV-UHFFFAOYSA-N,0,0,0,0,,,,,
1923,21419,79701,,c1ccccc1c1c(c(cc(c1)Cl)Cl)O,,"InChI=1S/C12H8Cl2O/c13-9-6-10(12(15)11(14)7-9)8-4-2-1-3-5-8/h1-7,15H",AFXPPGXJWHJULD-UHFFFAOYSA-N,0,0,0,0,,,,,
1924,105036,79850,,c1cc(ccc1c1c(cc(cc1Cl)Cl)Cl)O,,"InChI=1S/C12H7Cl3O/c13-8-5-10(14)12(11(15)6-8)7-1-3-9(16)4-2-7/h1-6,16H",LTQJFLVGNGVJCX-UHFFFAOYSA-N,0,0,0,0,,,,,
1925,78111,82312,,c1cc(ccc1c1cc(c(c(c1)Cl)O)Cl)Cl,,"InChI=1S/C12H7Cl3O/c13-9-3-1-7(2-4-9)8-5-10(14)12(16)11(15)6-8/h1-6,16H",OICMUGIRBDYVOV-UHFFFAOYSA-N,0,0,0,0,,,,,
1926,105101,311000,,c1cc(ccc1c1c(c(c(c(c1)Cl)Cl)Cl)Cl)O,,"InChI=1S/C12H6Cl4O/c13-9-5-8(10(14)12(16)11(9)15)6-1-3-7(17)4-2-6/h1-5,17H",RESKVBRHSNTJNG-UHFFFAOYSA-N,0,0,0,0,,,,,
1927,180912,352220,,c1cc(ccc1c1c(c(c(c(c1Cl)Cl)O)Cl)Cl)O,,"InChI=1S/C12H6Cl4O2/c13-8-7(5-1-3-6(17)4-2-5)9(14)11(16)12(18)10(8)15/h1-4,17-18H",ZTJLKJPIKUPJIB-UHFFFAOYSA-N,0,0,0,0,,,,,
1928,97032,83116,,c1c(c(c(cc1c1cc(c(c(c1)Cl)O)Cl)Cl)O)Cl,,"InChI=1S/C12H6Cl4O2/c13-7-1-5(2-8(14)11(7)17)6-3-9(15)12(18)10(16)4-6/h1-4,17-18H",YCYDXOVJXVALHY-UHFFFAOYSA-N,0,0,0,0,,,,,
1929,6454632,160172,,c1c(c(c(cc1c1c(c(c(c(c1)Cl)Cl)Cl)O)Cl)Cl)Cl,,"InChI=1S/C12H4Cl6O/c13-6-1-4(2-7(14)9(6)16)5-3-8(15)10(17)11(18)12(5)19/h1-3,19H",SASAWKFCSDRAGD-UHFFFAOYSA-N,0,0,0,0,,,,,
1930,115196,,,CC(C)[C@H](C)[C@@H](O)[C@H](O)[C@@H](C)[C@H]1CC[C@H]2[C@@H]3COC(=O)[C@H]4C[C@H](O)[C@H](O)C[C@]4(C)[C@H]3CC[C@]12C,"(1S,2R,4R,5S,7S,11S,12S,15R,16S)-15-[(2S,3R,4R,5S)-3,4-dihydroxy-5,6-dimethylheptan-2-yl]-4,5-dihydroxy-2,16-dimethyl-9-oxatetracyclo[9.7.0.0^{2,7}.0^{12,16}]octadecan-8-one","InChI=1S/C28H48O6/c1-14(2)15(3)24(31)25(32)16(4)18-7-8-19-17-13-34-26(33)21-11-22(29)23(30)12-28(21,6)20(17)9-10-27(18,19)5/h14-25,29-32H,7-13H2,1-6H3/t15-,16-,17-,18+,19-,20-,21+,22-,23+,24+,25+,27+,28+/m0/s1",IXVMHGVQKLDRKH-KNBKMWSGSA-N,3,0,0,0,BRI1,7.97,,Stabilization,
1931,133534,,,CC(C)[C@H](C)[C@@H](O)[C@H](O)[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC(=O)[C@H]4C[C@H](O)[C@H](O)C[C@]4(C)[C@H]3CC[C@]12C,"(1R,3aS,3bS,5aS,7S,8R,9aR,9bS,11aS)-1-[(2S,3R,4R,5S)-3,4-dihydroxy-5,6-dimethylheptan-2-yl]-7,8-dihydroxy-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-5-one","InChI=1S/C28H48O5/c1-14(2)15(3)25(32)26(33)16(4)18-7-8-19-17-11-22(29)21-12-23(30)24(31)13-28(21,6)20(17)9-10-27(18,19)5/h14-21,23-26,30-33H,7-13H2,1-6H3/t15-,16-,17-,18+,19-,20-,21+,23-,24+,25+,26+,27+,28+/m0/s1",VYUIKSFYFRVQLF-YLNAYWRASA-N,1,0,0,0,BRI1,6.47,,Stabilization,
1932,3059,898,,OC(=O)c1cc(ccc1O)-c1ccc(F)cc1F,"2',4'-difluoro-4-hydroxy-[1,1'-biphenyl]-3-carboxylic acid","InChI=1S/C13H8F2O3/c14-8-2-3-9(11(15)6-8)7-1-4-12(16)10(5-7)13(17)18/h1-6,16H,(H,17,18)",HUPFGZXOMWLGNK-UHFFFAOYSA-N,2,0,0,0,TTR,7.12,amyloidosis (disease),Stabilization,
1933,5288193,432234,,OC(=O)c1ccc(cc1)-c1cc(F)cc(F)c1,"3',5'-difluoro-[1,1'-biphenyl]-4-carboxylic acid","InChI=1S/C13H8F2O2/c14-11-5-10(6-12(15)7-11)8-1-3-9(4-2-8)13(16)17/h1-7H,(H,16,17)",VCEFNMHMLWBFNV-UHFFFAOYSA-N,1,0,0,0,TTR,8.05,amyloidosis (disease),Stabilization,
1934,11276360,331526,,OC(=O)c1cccc(c1)-c1c(F)cccc1F,"2',6'-difluoro-[1,1'-biphenyl]-3-carboxylic acid","InChI=1S/C13H8F2O2/c14-10-5-2-6-11(15)12(10)8-3-1-4-9(7-8)13(16)17/h1-7H,(H,16,17)",ZTPVDMLBKGVDLV-UHFFFAOYSA-N,2,0,0,0,TTR,7.10,amyloidosis (disease),Stabilization,
1935,5287495,123154,,OC(=O)c1cc(ccc1O)-c1ccc(Cl)cc1Cl,"2',4'-dichloro-4-hydroxy-[1,1'-biphenyl]-3-carboxylic acid","InChI=1S/C13H8Cl2O3/c14-8-2-3-9(11(15)6-8)7-1-4-12(16)10(5-7)13(17)18/h1-6,16H,(H,17,18)",SKAFZYDMDHPPJM-UHFFFAOYSA-N,1,0,0,0,TTR,5.89,amyloidosis (disease),Stabilization,
1936,97032,83116,,Oc1c(Cl)cc(cc1Cl)-c1cc(Cl)c(O)c(Cl)c1,"3,3',5,5'-tetrachloro-[1,1'-biphenyl]-4,4'-diol","InChI=1S/C12H6Cl4O2/c13-7-1-5(2-8(14)11(7)17)6-3-9(15)12(18)10(16)4-6/h1-4,17-18H",YCYDXOVJXVALHY-UHFFFAOYSA-N,2,0,0,0,TTR,8.49,,Stabilization,
1937,5327044,255489,,CN(CCN(C)Cc1coc2cc(C)c(C)cc2c1=O)Cc1cn(-c2cccc(c2)C(F)(F)F)c2ccccc12,"6,7-dimethyl-3-{[methyl({2-[methyl({1-[3-(trifluoromethyl)phenyl]-1H-indol-3-yl}methyl)amino]ethyl})amino]methyl}-4H-chromen-4-one","InChI=1S/C32H32F3N3O2/c1-21-14-28-30(15-22(21)2)40-20-24(31(28)39)18-37(4)13-12-36(3)17-23-19-38(29-11-6-5-10-27(23)29)26-9-7-8-25(16-26)32(33,34)35/h5-11,14-16,19-20H,12-13,17-18H2,1-4H3",JZNXLPPJRFFECJ-UHFFFAOYSA-N,2,1,0,0,TNF trimer,5.34,rheumatoid arthritis,Stabilization,
1938,1235170,391586,,Oc1ccc(Br)cc1-c1cc(-c2ccccc2)c(C#N)c(=O)[nH]1,"6-(5-bromo-2-hydroxyphenyl)-2-oxo-4-phenyl-1,2-dihydropyridine-3-carbonitrile","InChI=1S/C18H11BrN2O2/c19-12-6-7-17(22)14(8-12)16-9-13(11-4-2-1-3-5-11)15(10-20)18(23)21-16/h1-9,22H,(H,21,23)",SVSYJTYGPLVUOZ-UHFFFAOYSA-N,3,0,0,0,Survivin dimer,5.30,cancer,Stabilization,
1939,775716,233218,,Clc1ccc(cc1)-n1ccc2ccccc12,1-(4-chlorophenyl)-1H-indole,InChI=1S/C14H10ClN/c15-12-5-7-13(8-6-12)16-10-9-11-3-1-2-4-14(11)16/h1-10H,KHYIDGIPLSNPHO-UHFFFAOYSA-N,1,0,0,0,Survivin dimer,5.30,cancer,Stabilization,
1940,79528,395633,,Clc1cccc(Nc2ccc3ccccc3c2)c1,N-(3-chlorophenyl)naphthalen-2-amine,"InChI=1S/C16H12ClN/c17-14-6-3-7-15(11-14)18-16-9-8-12-4-1-2-5-13(12)10-16/h1-11,18H",XEYHIIBYEOWKLL-UHFFFAOYSA-N,1,0,0,0,Survivin dimer,5.00,cancer,Stabilization,
1941,75027038,,,CC1(C)NC(=O)N(CC(COc2ccc(cc2)-c2ccc(OC(F)(F)F)cc2)=NO)C1=O,"3-[2-(hydroxyimino)-3-{[4'-(trifluoromethoxy)-[1,1'-biphenyl]-4-yl]oxy}propyl]-5,5-dimethylimidazolidine-2,4-dione","InChI=1S/C21H20F3N3O5/c1-20(2)18(28)27(19(29)25-20)11-15(26-30)12-31-16-7-3-13(4-8-16)14-5-9-17(10-6-14)32-21(22,23)24/h3-10,30H,11-12H2,1-2H3,(H,25,29)",XRXOKKLROFIKEH-UHFFFAOYSA-N,1,0,0,0,Survivin dimer,5.00,cancer,Stabilization,
1942,19889421,397092,,Brc1cccc(c1)-c1cnc2ccccc2c1,3-(3-bromophenyl)quinoline,InChI=1S/C15H10BrN/c16-14-6-3-5-11(9-14)13-8-12-4-1-2-7-15(12)17-10-13/h1-10H,IZZKXRUCFMLTKZ-UHFFFAOYSA-N,1,0,0,0,Survivin dimer,5.00,cancer,Stabilization,
1943,6237,232201,,CCc1oc2ccccc2c1C(=O)c1cc(I)c(O)c(I)c1,"4-(2-ethyl-1-benzofuran-3-carbonyl)-2,6-diiodophenol","InChI=1S/C17H12I2O3/c1-2-13-15(10-5-3-4-6-14(10)22-13)16(20)9-7-11(18)17(21)12(19)8-9/h3-8,21H,2H2,1H3",CZCHIEJNWPNBDE-UHFFFAOYSA-N,1,0,0,0,Survivin dimer,5.10,cancer,Stabilization,
1944,26790864,277554,,Cc1ccnc(NC(=O)C2CCNCC2)c1,N-(4-methylpyridin-2-yl)piperidine-4-carboxamide,"InChI=1S/C12H17N3O/c1-9-2-7-14-11(8-9)15-12(16)10-3-5-13-6-4-10/h2,7-8,10,13H,3-6H2,1H3,(H,14,15,16)",IWLKNRXWKYRFCK-UHFFFAOYSA-N,0,0,0,0,,,,,
1945,23770859,441913,,Oc1ccccc1-c1cc(-c2ccccc2)c(C#N)c(=O)[nH]1,"6-(2-hydroxyphenyl)-2-oxo-4-phenyl-1,2-dihydropyridine-3-carbonitrile","InChI=1S/C18H12N2O2/c19-11-15-14(12-6-2-1-3-7-12)10-16(20-18(15)22)13-8-4-5-9-17(13)21/h1-10,21H,(H,20,22)",LLBAPJVAKZDUIA-UHFFFAOYSA-N,1,0,0,0,Survivin dimer,4.12,cancer,Stabilization,
1946,44431543,391106,,Oc1ccc(cc1-c1cc(-c2cc(Cl)ccc2Cl)c(C#N)c(=O)[nH]1)-c1ccccc1,"4-(2,5-dichlorophenyl)-6-{4-hydroxy-[1,1'-biphenyl]-3-yl}-2-oxo-1,2-dihydropyridine-3-carbonitrile","InChI=1S/C24H14Cl2N2O2/c25-16-7-8-21(26)18(11-16)17-12-22(28-24(30)20(17)13-27)19-10-15(6-9-23(19)29)14-4-2-1-3-5-14/h1-12,29H,(H,28,30)",LWJXZHBKKRIBDK-UHFFFAOYSA-N,1,0,0,0,Survivin dimer,6.15,cancer,Stabilization,
1947,44431544,232402,,Oc1ccc(cc1-c1cc(-c2cc(Cl)ccc2Cl)c(C#N)c(=O)[nH]1)C1CCCC1,"6-(5-cyclopentyl-2-hydroxyphenyl)-4-(2,5-dichlorophenyl)-2-oxo-1,2-dihydropyridine-3-carbonitrile","InChI=1S/C23H18Cl2N2O2/c24-15-6-7-20(25)17(10-15)16-11-21(27-23(29)19(16)12-26)18-9-14(5-8-22(18)28)13-3-1-2-4-13/h5-11,13,28H,1-4H2,(H,27,29)",LDKWIJMNHXVJGA-UHFFFAOYSA-N,1,0,0,0,Survivin dimer,6.29,cancer,Stabilization,
1948,44431549,399196,,CC(C)Cc1ccc(O)c(c1)-c1cc(-c2cc(Cl)ccc2Cl)c(C#N)c(=O)[nH]1,"4-(2,5-dichlorophenyl)-6-[2-hydroxy-5-(2-methylpropyl)phenyl]-2-oxo-1,2-dihydropyridine-3-carbonitrile","InChI=1S/C22H18Cl2N2O2/c1-12(2)7-13-3-6-21(27)17(8-13)20-10-15(18(11-25)22(28)26-20)16-9-14(23)4-5-19(16)24/h3-6,8-10,12,27H,7H2,1-2H3,(H,26,28)",DLKAUSIPGLKJRN-UHFFFAOYSA-N,1,0,0,0,Survivin dimer,5.12,cancer,Stabilization,
1949,44431550,234852,,Oc1ccc(cc1-c1cc(-c2cc(Cl)ccc2Cl)c(C#N)c(=O)[nH]1)C1CCCCC1,"6-(5-cyclohexyl-2-hydroxyphenyl)-4-(2,5-dichlorophenyl)-2-oxo-1,2-dihydropyridine-3-carbonitrile","InChI=1S/C24H20Cl2N2O2/c25-16-7-8-21(26)18(11-16)17-12-22(28-24(30)20(17)13-27)19-10-15(6-9-23(19)29)14-4-2-1-3-5-14/h6-12,14,29H,1-5H2,(H,28,30)",NJHITNNANZJYHI-UHFFFAOYSA-N,1,0,0,0,Survivin dimer,5.53,cancer,Stabilization,
1950,44431552,391681,,Cc1ccc(c(C)c1)-c1cc([nH]c(=O)c1C#N)-c1cc(Br)ccc1O,"6-(5-bromo-2-hydroxyphenyl)-4-(2,4-dimethylphenyl)-2-oxo-1,2-dihydropyridine-3-carbonitrile","InChI=1S/C20H15BrN2O2/c1-11-3-5-14(12(2)7-11)15-9-18(23-20(25)17(15)10-22)16-8-13(21)4-6-19(16)24/h3-9,24H,1-2H3,(H,23,25)",ZAQHRTWFTFLZHD-UHFFFAOYSA-N,1,0,0,0,Survivin dimer,6.15,cancer,Stabilization,
1951,44431556,236829,,Cc1ccc(C)c(c1)-c1cc([nH]c(=O)c1C#N)-c1cc(Br)ccc1O,"6-(5-bromo-2-hydroxyphenyl)-4-(2,5-dimethylphenyl)-2-oxo-1,2-dihydropyridine-3-carbonitrile","InChI=1S/C20H15BrN2O2/c1-11-3-4-12(2)14(7-11)15-9-18(23-20(25)17(15)10-22)16-8-13(21)5-6-19(16)24/h3-9,24H,1-2H3,(H,23,25)",XTBKZJJSYXEQSS-UHFFFAOYSA-N,1,0,0,0,Survivin dimer,5.93,cancer,Stabilization,
1952,44431558,393124,,Oc1ccc(Br)cc1-c1cc(-c2cc(Cl)ccc2Cl)c(C#N)c(=O)[nH]1,"6-(5-bromo-2-hydroxyphenyl)-4-(2,5-dichlorophenyl)-2-oxo-1,2-dihydropyridine-3-carbonitrile","InChI=1S/C18H9BrCl2N2O2/c19-9-1-4-17(24)13(5-9)16-7-11(14(8-22)18(25)23-16)12-6-10(20)2-3-15(12)21/h1-7,24H,(H,23,25)",OZBHFRZALVOEJM-UHFFFAOYSA-N,1,0,0,0,Survivin dimer,6.09,cancer,Stabilization,
1953,168317725,,,Oc1ccc(Br)cc1-c1cc(-c2cc(ccc2Cl)C(Cl)(Cl)Cl)c(C#N)c(=O)[nH]1,"6-(5-bromo-2-hydroxyphenyl)-4-[2-chloro-5-(trichloromethyl)phenyl]-2-oxo-1,2-dihydropyridine-3-carbonitrile","InChI=1S/C19H9BrCl4N2O2/c20-10-2-4-17(27)13(6-10)16-7-11(14(8-25)18(28)26-16)12-5-9(19(22,23)24)1-3-15(12)21/h1-7,27H,(H,26,28)",AZISUMNPHJQFRC-UHFFFAOYSA-N,1,0,0,0,Survivin dimer,6.31,cancer,Stabilization,
1954,44431561,236620,,Oc1ccc(Cl)cc1-c1cc(-c2cc(ccc2Cl)C(F)(F)F)c(C#N)c(=O)[nH]1,"6-(5-chloro-2-hydroxyphenyl)-4-[2-chloro-5-(trifluoromethyl)phenyl]-2-oxo-1,2-dihydropyridine-3-carbonitrile","InChI=1S/C19H9Cl2F3N2O2/c20-10-2-4-17(27)13(6-10)16-7-11(14(8-25)18(28)26-16)12-5-9(19(22,23)24)1-3-15(12)21/h1-7,27H,(H,26,28)",HDKUBJYDFUJSOG-UHFFFAOYSA-N,1,0,0,0,Survivin dimer,6.28,cancer,Stabilization,
1955,44431572,392065,,Oc1ccc(Br)cc1-c1cc(-c2cc(ccc2Cl)-c2ccccc2)c(C#N)c(=O)[nH]1,"6-(5-bromo-2-hydroxyphenyl)-4-{4-chloro-[1,1'-biphenyl]-3-yl}-2-oxo-1,2-dihydropyridine-3-carbonitrile","InChI=1S/C24H14BrClN2O2/c25-16-7-9-23(29)19(11-16)22-12-17(20(13-27)24(30)28-22)18-10-15(6-8-21(18)26)14-4-2-1-3-5-14/h1-12,29H,(H,28,30)",MLWSADJBOPYABB-UHFFFAOYSA-N,1,0,0,0,Survivin dimer,5.37,cancer,Stabilization,
1956,44431578,392285,,CN(Cc1cc(Cl)cc(c1O)-c1cc(-c2cc(ccc2Cl)C(F)(F)F)c(C#N)c(=O)[nH]1)C(=O)C1CCCCC1,"N-[(5-chloro-3-{4-[2-chloro-5-(trifluoromethyl)phenyl]-5-cyano-6-oxo-1,6-dihydropyridin-2-yl}-2-hydroxyphenyl)methyl]-N-methylcyclohexanecarboxamide","InChI=1S/C28H24Cl2F3N3O3/c1-36(27(39)15-5-3-2-4-6-15)14-16-9-18(29)11-21(25(16)37)24-12-19(22(13-34)26(38)35-24)20-10-17(28(31,32)33)7-8-23(20)30/h7-12,15,37H,2-6,14H2,1H3,(H,35,38)",LVGRTPCFTGPHEC-UHFFFAOYSA-N,1,0,0,0,Survivin dimer,6.21,cancer,Stabilization,
1957,44431579,234608,,Oc1c(CNC(=O)C2CCCCC2)cc(Cl)cc1-c1cc(-c2cc(ccc2Cl)C(F)(F)F)c(C#N)c(=O)[nH]1,"N-[(5-chloro-3-{4-[2-chloro-5-(trifluoromethyl)phenyl]-5-cyano-6-oxo-1,6-dihydropyridin-2-yl}-2-hydroxyphenyl)methyl]cyclohexanecarboxamide","InChI=1S/C27H22Cl2F3N3O3/c28-17-8-15(13-34-25(37)14-4-2-1-3-5-14)24(36)20(10-17)23-11-18(21(12-33)26(38)35-23)19-9-16(27(30,31)32)6-7-22(19)29/h6-11,14,36H,1-5,13H2,(H,34,37)(H,35,38)",GQDRYADBJIAZGH-UHFFFAOYSA-N,1,0,0,0,Survivin dimer,6.06,cancer,Stabilization,
1958,44431580,232404,,CN(Cc1cc(Cl)cc(c1O)-c1cc(-c2cc(ccc2Cl)C(F)(F)F)c(C#N)c(=O)[nH]1)C(=O)C1CCN(CC1)C(C)=O,"1-acetyl-N-[(5-chloro-3-{4-[2-chloro-5-(trifluoromethyl)phenyl]-5-cyano-6-oxo-1,6-dihydropyridin-2-yl}-2-hydroxyphenyl)methyl]-N-methylpiperidine-4-carboxamide","InChI=1S/C29H25Cl2F3N4O4/c1-15(39)38-7-5-16(6-8-38)28(42)37(2)14-17-9-19(30)11-22(26(17)40)25-12-20(23(13-35)27(41)36-25)21-10-18(29(32,33)34)3-4-24(21)31/h3-4,9-12,16,40H,5-8,14H2,1-2H3,(H,36,41)",RUSBNYWHSZATPZ-UHFFFAOYSA-N,1,0,0,0,Survivin dimer,7.07,cancer,Stabilization,
1959,44431582,233848,,CC(=O)N1CCC(CC1)C(=O)NCc1cc(Cl)cc(c1O)-c1cc(-c2cc(ccc2Cl)C(F)(F)F)c(C#N)c(=O)[nH]1,"1-acetyl-N-[(5-chloro-3-{4-[2-chloro-5-(trifluoromethyl)phenyl]-5-cyano-6-oxo-1,6-dihydropyridin-2-yl}-2-hydroxyphenyl)methyl]piperidine-4-carboxamide","InChI=1S/C28H23Cl2F3N4O4/c1-14(38)37-6-4-15(5-7-37)26(40)35-13-16-8-18(29)10-21(25(16)39)24-11-19(22(12-34)27(41)36-24)20-9-17(28(31,32)33)2-3-23(20)30/h2-3,8-11,15,39H,4-7,13H2,1H3,(H,35,40)(H,36,41)",HDCCFRZARJMJEW-UHFFFAOYSA-N,1,0,0,0,Survivin dimer,7.32,cancer,Stabilization,
1960,44431583,428195,,CN(Cc1cc(Cl)cc(c1O)-c1cc(-c2cc(ccc2Cl)C(F)(F)F)c(C#N)c(=O)[nH]1)C(=O)CCN1CCCC1,"N-[(5-chloro-3-{4-[2-chloro-5-(trifluoromethyl)phenyl]-5-cyano-6-oxo-1,6-dihydropyridin-2-yl}-2-hydroxyphenyl)methyl]-N-methyl-3-(pyrrolidin-1-yl)propanamide","InChI=1S/C28H25Cl2F3N4O3/c1-36(25(38)6-9-37-7-2-3-8-37)15-16-10-18(29)12-21(26(16)39)24-13-19(22(14-34)27(40)35-24)20-11-17(28(31,32)33)4-5-23(20)30/h4-5,10-13,39H,2-3,6-9,15H2,1H3,(H,35,40)",JJLLLNSQFXKXDY-UHFFFAOYSA-N,1,0,0,0,Survivin dimer,7.36,cancer,Stabilization,
1961,44431585,234040,,CN(Cc1cc(Cl)cc(c1O)-c1cc(-c2cc(ccc2Cl)C(F)(F)F)c(C#N)c(=O)[nH]1)C(=O)CCN1CCOCC1,"N-[(5-chloro-3-{4-[2-chloro-5-(trifluoromethyl)phenyl]-5-cyano-6-oxo-1,6-dihydropyridin-2-yl}-2-hydroxyphenyl)methyl]-N-methyl-3-(morpholin-4-yl)propanamide","InChI=1S/C28H25Cl2F3N4O4/c1-36(25(38)4-5-37-6-8-41-9-7-37)15-16-10-18(29)12-21(26(16)39)24-13-19(22(14-34)27(40)35-24)20-11-17(28(31,32)33)2-3-23(20)30/h2-3,10-13,39H,4-9,15H2,1H3,(H,35,40)",XRIKNQGWIFGWFZ-UHFFFAOYSA-N,1,0,0,0,Survivin dimer,7.12,cancer,Stabilization,
1962,44431588,234041,,COC1CCC(CC1)C(=O)N(C)Cc1cc(Cl)cc(c1O)-c1cc(-c2cc(ccc2Cl)C(F)(F)F)c(C#N)c(=O)[nH]1,"N-[(5-chloro-3-{4-[2-chloro-5-(trifluoromethyl)phenyl]-5-cyano-6-oxo-1,6-dihydropyridin-2-yl}-2-hydroxyphenyl)methyl]-4-methoxy-N-methylcyclohexane-1-carboxamide","InChI=1S/C29H26Cl2F3N3O4/c1-37(28(40)15-3-6-19(41-2)7-4-15)14-16-9-18(30)11-22(26(16)38)25-12-20(23(13-35)27(39)36-25)21-10-17(29(32,33)34)5-8-24(21)31/h5,8-12,15,19,38H,3-4,6-7,14H2,1-2H3,(H,36,39)",PCMHZCSKRGSJMA-UHFFFAOYSA-N,1,0,0,0,Survivin dimer,6.70,cancer,Stabilization,
1963,44431592,394046,,CN(Cc1cc(Cl)cc(c1O)-c1cc(-c2cc(ccc2Cl)C(F)(F)F)c(C#N)c(=O)[nH]1)C(=O)C1CCN(CC1)C(=O)OC(C)(C)C,"tert-butyl 4-{[(5-chloro-3-{4-[2-chloro-5-(trifluoromethyl)phenyl]-5-cyano-6-oxo-1,6-dihydropyridin-2-yl}-2-hydroxyphenyl)methyl](methyl)carbamoyl}piperidine-1-carboxylate","InChI=1S/C32H31Cl2F3N4O5/c1-31(2,3)46-30(45)41-9-7-17(8-10-41)29(44)40(4)16-18-11-20(33)13-23(27(18)42)26-14-21(24(15-38)28(43)39-26)22-12-19(32(35,36)37)5-6-25(22)34/h5-6,11-14,17,42H,7-10,16H2,1-4H3,(H,39,43)",ARNVETFRRGWWOB-UHFFFAOYSA-N,1,0,0,0,Survivin dimer,6.59,cancer,Stabilization,
1964,44431593,392286,,CN(Cc1cc(Cl)cc(c1O)-c1cc(-c2cc(ccc2Cl)C(F)(F)F)c(C#N)c(=O)[nH]1)C(=O)C1CCNCC1,"N-[(5-chloro-3-{4-[2-chloro-5-(trifluoromethyl)phenyl]-5-cyano-6-oxo-1,6-dihydropyridin-2-yl}-2-hydroxyphenyl)methyl]-N-methylpiperidine-4-carboxamide","InChI=1S/C27H23Cl2F3N4O3/c1-36(26(39)14-4-6-34-7-5-14)13-15-8-17(28)10-20(24(15)37)23-11-18(21(12-33)25(38)35-23)19-9-16(27(30,31)32)2-3-22(19)29/h2-3,8-11,14,34,37H,4-7,13H2,1H3,(H,35,38)",QHEKGIRBBMPYLJ-UHFFFAOYSA-N,1,0,0,0,Survivin dimer,6.28,cancer,Stabilization,
1965,44431596,234330,,COCC(=O)N1CCC(CC1)C(=O)N(C)Cc1cc(Cl)cc(c1O)-c1cc(-c2cc(ccc2Cl)C(F)(F)F)c(C#N)c(=O)[nH]1,"N-[(5-chloro-3-{4-[2-chloro-5-(trifluoromethyl)phenyl]-5-cyano-6-oxo-1,6-dihydropyridin-2-yl}-2-hydroxyphenyl)methyl]-1-(2-methoxyacetyl)-N-methylpiperidine-4-carboxamide","InChI=1S/C30H27Cl2F3N4O5/c1-38(29(43)16-5-7-39(8-6-16)26(40)15-44-2)14-17-9-19(31)11-22(27(17)41)25-12-20(23(13-36)28(42)37-25)21-10-18(30(33,34)35)3-4-24(21)32/h3-4,9-12,16,41H,5-8,14-15H2,1-2H3,(H,37,42)",XXQDQNLYFCJEPH-UHFFFAOYSA-N,1,0,0,0,Survivin dimer,7.19,cancer,Stabilization,
1966,16747688,272921,,CCCC(=O)N1CCC(CC1)C(=O)N(C)Cc1cc(Cl)cc(c1O)-c1cc(-c2cc(ccc2Cl)C(F)(F)F)c(C#N)c(=O)[nH]1,"1-butanoyl-N-[(5-chloro-3-{4-[2-chloro-5-(trifluoromethyl)phenyl]-5-cyano-6-oxo-1,6-dihydropyridin-2-yl}-2-hydroxyphenyl)methyl]-N-methylpiperidine-4-carboxamide","InChI=1S/C31H29Cl2F3N4O4/c1-3-4-27(41)40-9-7-17(8-10-40)30(44)39(2)16-18-11-20(32)13-23(28(18)42)26-14-21(24(15-37)29(43)38-26)22-12-19(31(34,35)36)5-6-25(22)33/h5-6,11-14,17,42H,3-4,7-10,16H2,1-2H3,(H,38,43)",WGLORHLIIYUIIF-UHFFFAOYSA-N,1,0,0,0,Survivin dimer,7.22,cancer,Stabilization,
1967,44431598,234421,,CN(Cc1cc(Cl)cc(c1O)-c1cc(-c2cc(ccc2Cl)C(F)(F)F)c(C#N)c(=O)[nH]1)C(=O)C1CCN(CC1)C(=O)C1CCCCC1,"N-[(5-chloro-3-{4-[2-chloro-5-(trifluoromethyl)phenyl]-5-cyano-6-oxo-1,6-dihydropyridin-2-yl}-2-hydroxyphenyl)methyl]-1-cyclohexanecarbonyl-N-methylpiperidine-4-carboxamide","InChI=1S/C34H33Cl2F3N4O4/c1-42(32(46)20-9-11-43(12-10-20)33(47)19-5-3-2-4-6-19)18-21-13-23(35)15-26(30(21)44)29-16-24(27(17-40)31(45)41-29)25-14-22(34(37,38)39)7-8-28(25)36/h7-8,13-16,19-20,44H,2-6,9-12,18H2,1H3,(H,41,45)",XYNFLQKEZVDXRD-UHFFFAOYSA-N,1,0,0,0,Survivin dimer,7.00,cancer,Stabilization,
1968,44431600,234358,,CCCN1CCC(CC1)C(=O)N(C)Cc1cc(Cl)cc(c1O)-c1cc(-c2cc(ccc2Cl)C(F)(F)F)c(C#N)c(=O)[nH]1,"N-[(5-chloro-3-{4-[2-chloro-5-(trifluoromethyl)phenyl]-5-cyano-6-oxo-1,6-dihydropyridin-2-yl}-2-hydroxyphenyl)methyl]-N-methyl-1-propylpiperidine-4-carboxamide","InChI=1S/C30H29Cl2F3N4O3/c1-3-8-39-9-6-17(7-10-39)29(42)38(2)16-18-11-20(31)13-23(27(18)40)26-14-21(24(15-36)28(41)37-26)22-12-19(30(33,34)35)4-5-25(22)32/h4-5,11-14,17,40H,3,6-10,16H2,1-2H3,(H,37,41)",IJBUJUGLLLXHLL-UHFFFAOYSA-N,1,0,0,0,Survivin dimer,7.43,cancer,Stabilization,
1969,44431603,396856,,CCCCCN1CCC(CC1)C(=O)N(C)Cc1cc(Cl)cc(c1O)-c1cc(-c2cc(ccc2Cl)C(F)(F)F)c(C#N)c(=O)[nH]1,"N-[(5-chloro-3-{4-[2-chloro-5-(trifluoromethyl)phenyl]-5-cyano-6-oxo-1,6-dihydropyridin-2-yl}-2-hydroxyphenyl)methyl]-N-methyl-1-pentylpiperidine-4-carboxamide","InChI=1S/C32H33Cl2F3N4O3/c1-3-4-5-10-41-11-8-19(9-12-41)31(44)40(2)18-20-13-22(33)15-25(29(20)42)28-16-23(26(17-38)30(43)39-28)24-14-21(32(35,36)37)6-7-27(24)34/h6-7,13-16,19,42H,3-5,8-12,18H2,1-2H3,(H,39,43)",VXJHBGJLIFZTRS-UHFFFAOYSA-N,1,0,0,0,Survivin dimer,6.66,cancer,Stabilization,
1970,5564,849,,Oc1cc(Cl)ccc1Oc1ccc(Cl)cc1Cl,"5-chloro-2-(2,4-dichlorophenoxy)phenol","InChI=1S/C12H7Cl3O2/c13-7-1-3-11(9(15)5-7)17-12-4-2-8(14)6-10(12)16/h1-6,16H",XEFQLINVKFYRCS-UHFFFAOYSA-N,3,0,0,0,TTR,6.72,amyloidosis (disease),Stabilization,
1971,23656594,240804,,Oc1cc(C=O)ccc1Oc1ccc(Cl)cc1Cl,"4-(2,4-dichlorophenoxy)-3-hydroxybenzaldehyde","InChI=1S/C13H8Cl2O3/c14-9-2-4-12(10(15)6-9)18-13-3-1-8(7-16)5-11(13)17/h1-7,17H",GKHZEXMYTPRFKV-UHFFFAOYSA-N,3,0,0,0,TTR,7.86,amyloidosis (disease),Stabilization,
1972,23656591,240805,,Oc1cc(CCl)ccc1Oc1ccc(Cl)cc1Cl,"5-(chloromethyl)-2-(2,4-dichlorophenoxy)phenol","InChI=1S/C13H9Cl3O2/c14-7-8-1-3-13(11(17)5-8)18-12-4-2-9(15)6-10(12)16/h1-6,17H,7H2",XVCALTYAVXDHNO-UHFFFAOYSA-N,3,0,0,0,TTR,8.24,amyloidosis (disease),Stabilization,
1973,23656595,240806,,OCc1ccc(Oc2ccc(Cl)cc2Cl)c(O)c1,"2-(2,4-dichlorophenoxy)-5-(hydroxymethyl)phenol","InChI=1S/C13H10Cl2O3/c14-9-2-4-12(10(15)6-9)18-13-3-1-8(7-16)5-11(13)17/h1-6,16-17H,7H2",GILJPGZIIDINED-UHFFFAOYSA-N,3,0,0,0,TTR,9.52,amyloidosis (disease),Stabilization,
1974,23656592,240807,,COc1cc(CCl)ccc1Oc1ccc(Cl)cc1Cl,"2,4-dichloro-1-[4-(chloromethyl)-2-methoxyphenoxy]benzene","InChI=1S/C14H11Cl3O2/c1-18-14-6-9(8-15)2-4-13(14)19-12-5-3-10(16)7-11(12)17/h2-7H,8H2,1H3",KGFZDWAEBKKPMK-UHFFFAOYSA-N,1,0,0,0,TTR,5.50,amyloidosis (disease),Stabilization,
1975,23656596,438498,,COc1cc(ccc1Oc1ccc(Cl)cc1Cl)C(O)=O,"4-(2,4-dichlorophenoxy)-3-methoxybenzoic acid","InChI=1S/C14H10Cl2O4/c1-19-13-6-8(14(17)18)2-4-12(13)20-11-5-3-9(15)7-10(11)16/h2-7H,1H3,(H,17,18)",MRLRZVCXQWUIBP-UHFFFAOYSA-N,3,0,0,0,TTR,9.70,amyloidosis (disease),Stabilization,
1976,23656593,240808,,OC(=O)c1ccc(Oc2ccc(Cl)cc2Cl)c(O)c1,"4-(2,4-dichlorophenoxy)-3-hydroxybenzoic acid","InChI=1S/C13H8Cl2O4/c14-8-2-4-11(9(15)6-8)19-12-3-1-7(13(17)18)5-10(12)16/h1-6,16H,(H,17,18)",KUJXLYCFJYCPHN-UHFFFAOYSA-N,3,0,0,0,TTR,8.52,amyloidosis (disease),Stabilization,
1977,23656754,241025,,COc1cc(CCl)ccc1Oc1ccccc1,4-(chloromethyl)-2-methoxy-1-phenoxybenzene,"InChI=1S/C14H13ClO2/c1-16-14-9-11(10-15)7-8-13(14)17-12-5-3-2-4-6-12/h2-9H,10H2,1H3",MFZKFMUYNLFXKY-UHFFFAOYSA-N,1,0,0,0,TTR,5.71,amyloidosis (disease),Stabilization,
1978,18433807,241453,,COc1cc(C=O)ccc1Oc1ccccc1,3-methoxy-4-phenoxybenzaldehyde,"InChI=1S/C14H12O3/c1-16-14-9-11(10-15)7-8-13(14)17-12-5-3-2-4-6-12/h2-10H,1H3",AARAIFZDFDNWOI-UHFFFAOYSA-N,2,0,0,0,TTR,7.06,amyloidosis (disease),Stabilization,
1979,22133420,241454,,OC(=O)c1ccc(Oc2ccccc2)c(O)c1,3-hydroxy-4-phenoxybenzoic acid,"InChI=1S/C13H10O4/c14-11-8-9(13(15)16)6-7-12(11)17-10-4-2-1-3-5-10/h1-8,14H,(H,15,16)",KCIALBPOCOGYNE-UHFFFAOYSA-N,3,0,0,0,TTR,7.57,amyloidosis (disease),Stabilization,
1980,693308,240165,,Oc1ccccc1-c1nnc(S)o1,"2-(5-sulfanyl-1,3,4-oxadiazol-2-yl)phenol","InChI=1S/C8H6N2O2S/c11-6-4-2-1-3-5(6)7-9-10-8(13)12-7/h1-4,11H,(H,10,13)",HMIBKGQKYCFESO-UHFFFAOYSA-N,3,0,0,0,TTR,7.38,amyloidosis (disease),Stabilization,
1981,659923,394034,,Clc1ccc(Cl)c(C(=O)Nc2nnc[nH]2)c1Cl,"2,3,6-trichloro-N-(4H-1,2,4-triazol-3-yl)benzamide","InChI=1S/C9H5Cl3N4O/c10-4-1-2-5(11)7(12)6(4)8(17)15-9-13-3-14-16-9/h1-3H,(H2,13,14,15,16,17)",KBDDCRNUQDKWIA-UHFFFAOYSA-N,2,0,0,0,TTR,6.92,amyloidosis (disease),Stabilization,
1982,8730,559,,N[C@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(O)=O,"(2R)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid","InChI=1S/C15H11I4NO4/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23/h1-2,4-5,12,21H,3,20H2,(H,22,23)/t12-/m1/s1",XUIIKFGFIJCVMT-GFCCVEGCSA-N,1,0,0,0,TTR,5.14,amyloidosis (disease),Stabilization,
1983,16358,60569,,CN1C(=O)C(=O)c2ccccc12,"1-methyl-2,3-dihydro-1H-indole-2,3-dione","InChI=1S/C9H7NO2/c1-10-7-5-3-2-4-6(7)8(11)9(10)12/h2-5H,1H3",VCYBVWFTGAZHGH-UHFFFAOYSA-N,1,0,0,0,TTR,5.20,amyloidosis (disease),Stabilization,
1984,11218587,,,CN1C(=O)C(=Nc2ccccc2)c2ccccc12,"1-methyl-3-(phenylimino)-2,3-dihydro-1H-indol-2-one","InChI=1S/C15H12N2O/c1-17-13-10-6-5-9-12(13)14(15(17)18)16-11-7-3-2-4-8-11/h2-10H,1H3",LUEXNLDVPSVDKD-UHFFFAOYSA-N,1,0,0,0,TTR,4.96,amyloidosis (disease),Stabilization,
1985,2816035,,,CN1C(=O)C(=Nc2ccc(C)cc2)c2ccccc12,"1-methyl-3-[(4-methylphenyl)imino]-2,3-dihydro-1H-indol-2-one","InChI=1S/C16H14N2O/c1-11-7-9-12(10-8-11)17-15-13-5-3-4-6-14(13)18(2)16(15)19/h3-10H,1-2H3",ISVODKXPQNTMCZ-UHFFFAOYSA-N,1,0,0,0,TTR,5.20,amyloidosis (disease),Stabilization,
1986,489554,378695,,COc1ccc(cc1)N=C1C(=O)Nc2ccccc12,"3-[(4-methoxyphenyl)imino]-2,3-dihydro-1H-indol-2-one","InChI=1S/C15H12N2O2/c1-19-11-8-6-10(7-9-11)16-14-12-4-2-3-5-13(12)17-15(14)18/h2-9H,1H3,(H,16,17,18)",PXSATUQXASGWQE-UHFFFAOYSA-N,1,0,0,0,TTR,5.09,amyloidosis (disease),Stabilization,
1987,4313553,,,COc1ccc(cc1)N=C1C(=O)N(C)c2ccccc12,"3-[(4-methoxyphenyl)imino]-1-methyl-2,3-dihydro-1H-indol-2-one","InChI=1S/C16H14N2O2/c1-18-14-6-4-3-5-13(14)15(16(18)19)17-11-7-9-12(20-2)10-8-11/h3-10H,1-2H3",JWDGSAISZIKHKI-UHFFFAOYSA-N,1,0,0,0,TTR,5.11,amyloidosis (disease),Stabilization,
1988,554870,570013,,O=C1Nc2ccccc2C1=Nc1ccc(cc1)N(=O)=O,"3-[(4-nitrophenyl)imino]-2,3-dihydro-1H-indol-2-one","InChI=1S/C14H9N3O3/c18-14-13(11-3-1-2-4-12(11)16-14)15-9-5-7-10(8-6-9)17(19)20/h1-8H,(H,15,16,18)",HVXOHQAYPDOUFI-UHFFFAOYSA-N,1,0,0,0,TTR,5.55,amyloidosis (disease),Stabilization,
1989,24020163,,,CN1C(=O)C(=Nc2ccc(cc2)N(=O)=O)c2ccccc12,"1-methyl-3-[(4-nitrophenyl)imino]-2,3-dihydro-1H-indol-2-one","InChI=1S/C15H11N3O3/c1-17-13-5-3-2-4-12(13)14(15(17)19)16-10-6-8-11(9-7-10)18(20)21/h2-9H,1H3",PYLUXVAFFHTNRU-UHFFFAOYSA-N,1,0,0,0,TTR,5.20,amyloidosis (disease),Stabilization,
1990,11862,81721,,Oc1c(I)cc(I)cc1I,"2,4,6-triiodophenol","InChI=1S/C6H3I3O/c7-3-1-4(8)6(10)5(9)2-3/h1-2,10H",VAPDZNUFNKUROY-UHFFFAOYSA-N,1,0,0,0,TTR,5.49,amyloidosis (disease),Stabilization,
1991,1549065,,,[O-]S(=O)(=O)c1cccc2cccc(Nc3ccccc3)c12,8-(phenylamino)naphthalene-1-sulfonate,"InChI=1S/C16H13NO3S/c18-21(19,20)15-11-5-7-12-6-4-10-14(16(12)15)17-13-8-2-1-3-9-13/h1-11,17H,(H,18,19,20)/p-1",FWEOQOXTVHGIFQ-UHFFFAOYSA-M,3,0,0,0,TTR,5.37,amyloidosis (disease),Stabilization,
1992,6793,589370,,Nc1cccc2c(cccc12)S(O)(=O)=O,5-aminonaphthalene-1-sulfonic acid,"InChI=1S/C10H9NO3S/c11-9-5-1-4-8-7(9)3-2-6-10(8)15(12,13)14/h1-6H,11H2,(H,12,13,14)",DQNAQOYOSRJXFZ-UHFFFAOYSA-N,3,0,0,0,TTR,4.19,amyloidosis (disease),Stabilization,
1993,3033,139,,OC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl,"2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid","InChI=1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)",DCOPUUMXTXDBNB-UHFFFAOYSA-N,0,0,0,0,,,,,
1994,71308204,,,COC[C@H]1CC[C@H]2[C@@H](C)[C@@H](O)[C@H](O[C@H]3O[C@H](COC(C)(C)C=C)[C@@H](O)[C@H](OC(C)=O)[C@H]3O)C3=C(C[C@H](O)[C@]3(C)C=C12)[C@H](C)COC(C)=O,"(2S)-2-[(3R,4S,8R,9R,10R,11S,14S)-8-{[(2S,3R,4S,5R,6R)-4-(acetyloxy)-3,5-dihydroxy-6-{[(2-methylbut-3-en-2-yl)oxy]methyl}oxan-2-yl]oxy}-4,9-dihydroxy-14-(methoxymethyl)-3,10-dimethyltricyclo[9.3.0.0^{3,7}]tetradeca-1,6-dien-6-yl]propyl acetate","InChI=1S/C36H56O12/c1-10-35(6,7)45-17-26-30(41)33(46-21(5)38)31(42)34(47-26)48-32-28-24(18(2)15-44-20(4)37)13-27(39)36(28,8)14-25-22(16-43-9)11-12-23(25)19(3)29(32)40/h10,14,18-19,22-23,26-27,29-34,39-42H,1,11-13,15-17H2,2-9H3/t18-,19-,22-,23+,26-,27+,29-,30-,31-,32-,33+,34-,36+/m1/s1",KXTYBXCEQOANSX-HPVXDZOISA-N,3,0,0,0,14-3-3 / PMA2,8.29,,Stabilization,
1995,9995423,90621,,CC(C)C[C@H](NC(=O)[C@H](O)[C@H](N)Cc1ccccc1)C(O)=O,"(2S)-2-[(2R,3R)-3-amino-2-hydroxy-4-phenylbutanamido]-4-methylpentanoic acid","InChI=1S/C16H24N2O4/c1-10(2)8-13(16(21)22)18-15(20)14(19)12(17)9-11-6-4-3-5-7-11/h3-7,10,12-14,19H,8-9,17H2,1-2H3,(H,18,20)(H,21,22)/t12-,13+,14-/m1/s1",VGGGPCQERPFHOB-HZSPNIEDSA-N,1,0,0,0,14-3-3 / PMA2,5.73,,Stabilization,
1996,,1236913,,OC(=O)c1cc(ccc1O)N1[C@H](C(C(=O)c2ccccc2)=C(O)C1=O)c1ccc(cc1)N(=O)=O,"5-[(2S)-3-benzoyl-4-hydroxy-2-(4-nitrophenyl)-5-oxo-2,5-dihydro-1H-pyrrol-1-yl]-2-hydroxybenzoic acid","InChI=1S/C24H16N2O8/c27-18-11-10-16(12-17(18)24(31)32)25-20(13-6-8-15(9-7-13)26(33)34)19(22(29)23(25)30)21(28)14-4-2-1-3-5-14/h1-12,20,27,29H,(H,31,32)/t20-/m0/s1",SHWIONPIUOUFNT-FQEVSTJZSA-N,1,0,0,0,14-3-3 / PMA2,4.10,,Stabilization,
1997,91681,,,CC[C@H]1C[C@@]1(NC(=O)C1=C[C@H](CC)C[C@H]2[C@@H]1CCC2=O)C(O)=O,"(1S,2S)-1-[(3aS,6R,7aS)-6-ethyl-1-oxo-2,3,3a,6,7,7a-hexahydro-1H-indene-4-amido]-2-ethylcyclopropane-1-carboxylic acid","InChI=1S/C18H25NO4/c1-3-10-7-13-12(5-6-15(13)20)14(8-10)16(21)19-18(17(22)23)9-11(18)4-2/h8,10-13H,3-7,9H2,1-2H3,(H,19,21)(H,22,23)/t10-,11+,12+,13+,18+/m1/s1",FMGBNISRFNDECK-CZSBRECXSA-N,2,0,0,0,COI1 / JAZ1,7.32,,Stabilization,
1998,168317722,,,CCC=CC[C@H]1[C@@H](CC(=O)N[C@@H]([C@@H](C)CC)C(O)=O)CCC1=O,"(2S,3S)-3-methyl-2-{2-[(1R,2S)-3-oxo-2-(pent-2-en-1-yl)cyclopentyl]acetamido}pentanoic acid","InChI=1S/C18H29NO4/c1-4-6-7-8-14-13(9-10-15(14)20)11-16(21)19-17(18(22)23)12(3)5-2/h6-7,12-14,17H,4-5,8-11H2,1-3H3,(H,19,21)(H,22,23)/t12-,13+,14-,17-/m0/s1",IBZYPBGPOGJMBF-LOUJCGABSA-N,1,0,0,0,COI1 / JAZ1,5.74,,Stabilization,
1999,644079,,,CCC=CC[C@@H]1[C@@H](CC(=O)N[C@@H]([C@@H](C)CC)C(O)=O)CCC1=O,"(2S,3S)-3-methyl-2-{2-[(1R,2R)-3-oxo-2-(pent-2-en-1-yl)cyclopentyl]acetamido}pentanoic acid","InChI=1S/C18H29NO4/c1-4-6-7-8-14-13(9-10-15(14)20)11-16(21)19-17(18(22)23)12(3)5-2/h6-7,12-14,17H,4-5,8-11H2,1-3H3,(H,19,21)(H,22,23)/t12-,13+,14+,17-/m0/s1",IBZYPBGPOGJMBF-CFAJVAMVSA-N,1,0,0,0,COI1 / JAZ1,4.74,,Stabilization,
2000,2863945,2032324,,Cc1onc(c1C(=O)N1CCN(CC1)c1ccc(cc1Cl)N(=O)=O)-c1ccccc1,"1-(2-chloro-4-nitrophenyl)-4-(5-methyl-3-phenyl-1,2-oxazole-4-carbonyl)piperazine","InChI=1S/C21H19ClN4O4/c1-14-19(20(23-30-14)15-5-3-2-4-6-15)21(27)25-11-9-24(10-12-25)18-8-7-16(26(28)29)13-17(18)22/h2-8,13H,9-12H2,1H3",OWXBJAPOSQSWAO-UHFFFAOYSA-N,1,3,0,0,Influenza NP,6.82,influenza,Stabilization,
2001,2866163,5415752,,Cc1onc(c1C(=O)N1CCN(CC1)c1ccc(cc1Cl)N(=O)=O)-c1ccccc1Cl,"1-(2-chloro-4-nitrophenyl)-4-[3-(2-chlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]piperazine","InChI=1S/C21H18Cl2N4O4/c1-13-19(20(24-31-13)15-4-2-3-5-16(15)22)21(28)26-10-8-25(9-11-26)18-7-6-14(27(29)30)12-17(18)23/h2-7,12H,8-11H2,1H3",MVZDVDKOXKQGDM-UHFFFAOYSA-N,1,3,0,0,Influenza NP,7.22,influenza,Stabilization,
2002,53361971,,,COc1ccccc1-c1noc(C)c1C(=O)N1CCN(CC1)c1ccc(cc1Cl)N(=O)=O,"1-(2-chloro-4-nitrophenyl)-4-[3-(2-methoxyphenyl)-5-methyl-1,2-oxazole-4-carbonyl]piperazine","InChI=1S/C22H21ClN4O5/c1-14-20(21(24-32-14)16-5-3-4-6-19(16)31-2)22(28)26-11-9-25(10-12-26)18-8-7-15(27(29)30)13-17(18)23/h3-8,13H,9-12H2,1-2H3",OQYUKAFYGKRXTK-UHFFFAOYSA-N,1,4,0,0,Influenza NP,7.40,influenza,Stabilization,
2003,56949213,,,Cc1onc(c1C(=O)N1CCN(CC1)c1ccc(cc1Cl)N(=O)=O)-c1cccnc1Cl,"1-(2-chloro-4-nitrophenyl)-4-[3-(2-chloropyridin-3-yl)-5-methyl-1,2-oxazole-4-carbonyl]piperazine","InChI=1S/C20H17Cl2N5O4/c1-12-17(18(24-31-12)14-3-2-6-23-19(14)22)20(28)26-9-7-25(8-10-26)16-5-4-13(27(29)30)11-15(16)21/h2-6,11H,7-10H2,1H3",OVZFTYKFOMVVNQ-UHFFFAOYSA-N,1,3,0,0,Influenza NP,7.15,influenza,Stabilization,
2004,56949089,,,COc1ccccc1-c1nnn(C)c1C(=O)N1CCN(CC1)c1ccc(cc1Cl)N(=O)=O,"1-(2-chloro-4-nitrophenyl)-4-[4-(2-methoxyphenyl)-1-methyl-1H-1,2,3-triazole-5-carbonyl]piperazine","InChI=1S/C21H21ClN6O4/c1-25-20(19(23-24-25)15-5-3-4-6-18(15)32-2)21(29)27-11-9-26(10-12-27)17-8-7-14(28(30)31)13-16(17)22/h3-8,13H,9-12H2,1-2H3",AKYFFCZJOVDFGF-UHFFFAOYSA-N,1,3,2,0,Influenza NP,7.40,influenza,Stabilization,
2005,831824,,,Cc1ccsc1C(=O)NN=Cc1ccc2ccccc2c1O,N'-[(1-hydroxynaphthalen-2-yl)methylidene]-3-methylthiophene-2-carbohydrazide,"InChI=1S/C17H14N2O2S/c1-11-8-9-22-16(11)17(21)19-18-10-13-7-6-12-4-2-3-5-14(12)15(13)20/h2-10,20H,1H3,(H,19,21)",NZWTWRNHYZNWNW-UHFFFAOYSA-N,2,22,0,0,PCNA trimer,9.74,,Stabilization,
2006,168317556,,,Oc1c(C=NNC(=O)c2ccn[nH]2)ccc2ccccc12,N'-[(1-hydroxynaphthalen-2-yl)methylidene]-1H-pyrazole-5-carbohydrazide,"InChI=1S/C15H12N4O2/c20-14-11(6-5-10-3-1-2-4-12(10)14)9-17-19-15(21)13-7-8-16-18-13/h1-9,20H,(H,16,18)(H,19,21)",YMJZTJJCMOKSAP-UHFFFAOYSA-N,0,6,0,0,PCNA trimer,6.25,,Stabilization,
2007,692756,,,Oc1c(C=NNC(=O)c2cccc(Cl)c2)ccc2ccccc12,3-chloro-N'-[(1-hydroxynaphthalen-2-yl)methylidene]benzohydrazide,"InChI=1S/C18H13ClN2O2/c19-15-6-3-5-13(10-15)18(23)21-20-11-14-9-8-12-4-1-2-7-16(12)17(14)22/h1-11,22H,(H,21,23)",NUIXWYJEHWJXCG-UHFFFAOYSA-N,1,2,0,0,PCNA trimer,6.77,,Stabilization,
2008,1087428,,,Oc1c(C(=O)NNS(=O)(=O)c2ccc(Br)cc2)c(=O)[nH]c2ccccc12,"N'-(4-bromobenzenesulfonyl)-4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carbohydrazide","InChI=1S/C16H12BrN3O5S/c17-9-5-7-10(8-6-9)26(24,25)20-19-16(23)13-14(21)11-3-1-2-4-12(11)18-15(13)22/h1-8,20H,(H,19,23)(H2,18,21,22)",OCPSHQZXGYIEAT-UHFFFAOYSA-N,0,2,0,0,PCNA trimer,6.17,,Stabilization,
2009,1087426,,,Oc1c(C(=O)NNS(=O)(=O)c2ccc(Cl)cc2)c(=O)[nH]c2ccccc12,"N'-(4-chlorobenzenesulfonyl)-4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carbohydrazide","InChI=1S/C16H12ClN3O5S/c17-9-5-7-10(8-6-9)26(24,25)20-19-16(23)13-14(21)11-3-1-2-4-12(11)18-15(13)22/h1-8,20H,(H,19,23)(H2,18,21,22)",RCPRMNUWCYQCHP-UHFFFAOYSA-N,0,0,0,0,,,,,
2010,3575400,,,Cc1ccc2[nH]c(=O)c(C=NNC(=O)c3ccccc3)c(O)c2c1,"N'-[(4-hydroxy-6-methyl-2-oxo-1,2-dihydroquinolin-3-yl)methylidene]benzohydrazide","InChI=1S/C18H15N3O3/c1-11-7-8-15-13(9-11)16(22)14(18(24)20-15)10-19-21-17(23)12-5-3-2-4-6-12/h2-10H,1H3,(H,21,23)(H2,20,22,24)",JRBBXIJONXOZOV-UHFFFAOYSA-N,0,0,0,0,,,,,
2011,168317791,,,Cc1c(sc2ccccc12)C(=O)NN=Cc1ccc2ccccc2c1O,N'-[(1-hydroxynaphthalen-2-yl)methylidene]-3-methyl-1-benzothiophene-2-carbohydrazide,"InChI=1S/C21H16N2O2S/c1-13-16-7-4-5-9-18(16)26-20(13)21(25)23-22-12-15-11-10-14-6-2-3-8-17(14)19(15)24/h2-12,24H,1H3,(H,23,25)",NFKBPLWMLKWNNL-UHFFFAOYSA-N,0,2,0,0,PCNA trimer,5.66,,Stabilization,
2012,168317746,,,CC(=NNC(=O)c1cccc(C)c1)c1ccc2ccccc2c1O,N'-[1-(1-hydroxynaphthalen-2-yl)ethylidene]-3-methylbenzohydrazide,"InChI=1S/C20H18N2O2/c1-13-6-5-8-16(12-13)20(24)22-21-14(2)17-11-10-15-7-3-4-9-18(15)19(17)23/h3-12,23H,1-2H3,(H,22,24)",DIVLPCLMTPHBCQ-UHFFFAOYSA-N,0,2,0,0,PCNA trimer,6.17,,Stabilization,
2013,689179,,,CC(=NNC(=O)c1ccccc1O)c1ccc2ccccc2c1O,2-hydroxy-N'-[1-(1-hydroxynaphthalen-2-yl)ethylidene]benzohydrazide,"InChI=1S/C19H16N2O3/c1-12(20-21-19(24)16-8-4-5-9-17(16)22)14-11-10-13-6-2-3-7-15(13)18(14)23/h2-11,22-23H,1H3,(H,21,24)",LJGDTCIGYKNKQN-UHFFFAOYSA-N,0,2,0,0,PCNA trimer,6.15,,Stabilization,
2014,3115951,241596,,Oc1c(C(=O)NNC(=O)c2ccccc2N(=O)=O)c(=O)[nH]c2ccccc12,"N'-(4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carbonyl)-2-nitrobenzohydrazide","InChI=1S/C17H12N4O6/c22-14-9-5-1-3-7-11(9)18-16(24)13(14)17(25)20-19-15(23)10-6-2-4-8-12(10)21(26)27/h1-8H,(H,19,23)(H,20,25)(H2,18,22,24)",TYYRCNXSLCGOHA-UHFFFAOYSA-N,0,1,0,0,PCNA trimer,5.66,,Stabilization,
2015,19588850,,,OC(=O)c1ccc(cc1)N1C(c2c([nH]nc2-c2ccccc2)C1=O)c1ccc(cc1)N(=O)=O,"4-[4-(4-nitrophenyl)-6-oxo-3-phenyl-1H,4H,5H,6H-pyrrolo[3,4-c]pyrazol-5-yl]benzoic acid","InChI=1S/C24H16N4O5/c29-23-21-19(20(25-26-21)14-4-2-1-3-5-14)22(15-6-12-18(13-7-15)28(32)33)27(23)17-10-8-16(9-11-17)24(30)31/h1-13,22H,(H,25,26)(H,30,31)",FAPWESYGTXHTQV-UHFFFAOYSA-N,1,0,0,0,14-3-3 / PMA2,3.42,,Stabilization,
2016,59052369,,,Brc1ccc(cc1)-c1n[nH]c2C(=O)N(C(c12)c1ccc(cc1)N(=O)=O)c1cccc(c1)-c1nnn[nH]1,"3-(4-bromophenyl)-4-(4-nitrophenyl)-5-[3-(1H-1,2,3,4-tetrazol-5-yl)phenyl]-1H,4H,5H,6H-pyrrolo[3,4-c]pyrazol-6-one","InChI=1S/C24H15BrN8O3/c25-16-8-4-13(5-9-16)20-19-21(27-26-20)24(34)32(22(19)14-6-10-17(11-7-14)33(35)36)18-3-1-2-15(12-18)23-28-30-31-29-23/h1-12,22H,(H,26,27)(H,28,29,30,31)",XHFWXANQTJGHAF-UHFFFAOYSA-N,1,0,0,0,14-3-3 / PMA2,4.48,,Stabilization,
2017,11001318,2103837,,OC(=O)c1ccc2nc(oc2c1)-c1cc(Cl)cc(Cl)c1,"2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid","InChI=1S/C14H7Cl2NO3/c15-9-3-8(4-10(16)6-9)13-17-11-2-1-7(14(18)19)5-12(11)20-13/h1-6H,(H,18,19)",TXEIIPDJKFWEEC-UHFFFAOYSA-N,5,0,0,0,TTR,8.70,amyloidosis (disease),Stabilization,
2018,,,,Cc1c(Cl)ccc2c(C=C3NC(=O)N(Cc4ccc(F)c(F)c4)C3=O)c[nH]c12,"5-[(6-chloro-7-methyl-1H-indol-3-yl)methylidene]-3-[(3,4-difluorophenyl)methyl]imidazolidine-2,4-dione","InChI=1S/C20H14ClF2N3O2/c1-10-14(21)4-3-13-12(8-24-18(10)13)7-17-19(27)26(20(28)25-17)9-11-2-5-15(22)16(23)6-11/h2-8,24H,9H2,1H3,(H,25,28)",OEXMEVPQEPHTAQ-UHFFFAOYSA-N,3,0,0,0,MDM2-like dimer,7.48,cancer,Stabilization,
2019,72681826,,,Cc1c(Cl)ccc2c(C=C3NC(=O)N(C(C(=O)NC(CO)CO)c4ccc(F)c(F)c4)C3=O)c[nH]c12,"2-{4-[(6-chloro-7-methyl-1H-indol-3-yl)methylidene]-2,5-dioxoimidazolidin-1-yl}-2-(3,4-difluorophenyl)-N-(1,3-dihydroxypropan-2-yl)acetamide","InChI=1S/C24H21ClF2N4O5/c1-11-16(25)4-3-15-13(8-28-20(11)15)7-19-23(35)31(24(36)30-19)21(22(34)29-14(9-32)10-33)12-2-5-17(26)18(27)6-12/h2-8,14,21,28,32-33H,9-10H2,1H3,(H,29,34)(H,30,36)",ZFYQBPVMECJUBO-UHFFFAOYSA-N,2,0,0,0,MDM2-like dimer,7.76,cancer,Stabilization,
2020,11433190,191334,,C1(=O)CN(CCN1)C(=O)N1C(=N[C@H]([C@H]1c1ccc(cc1)Cl)c1ccc(cc1)Cl)c1c(cc(cc1)OC)OC(C)C,,"InChI=1S/C30H30Cl2N4O4/c1-18(2)40-25-16-23(39-3)12-13-24(25)29-34-27(19-4-8-21(31)9-5-19)28(20-6-10-22(32)11-7-20)36(29)30(38)35-15-14-33-26(37)17-35/h4-13,16,18,27-28H,14-15,17H2,1-3H3,(H,33,37)/t27-,28+/m0/s1",BDUHCSBCVGXTJM-WUFINQPMSA-N,,,,,,,,,
2021,82320,452887,,CCn1c2ccccc2[nH]c1=O,"1-ethyl-2,3-dihydro-1H-1,3-benzodiazol-2-one","InChI=1S/C9H10N2O/c1-2-11-8-6-4-3-5-7(8)10-9(11)12/h3-6H,2H2,1H3,(H,10,12)",CXUCKELNYMZTRT-UHFFFAOYSA-N,0,1,0,0,CaM / CaMBD2,3.40,schizophrenia (disease),Stabilization,
2022,6145,168445,,NC(=O)Nc1ccccc1,phenylurea,"InChI=1S/C7H8N2O/c8-7(10)9-6-4-2-1-3-5-6/h1-5H,(H3,8,9,10)",LUBJCRLGQSPQNN-UHFFFAOYSA-N,0,1,0,0,CaM / CaMBD2,2.79,schizophrenia (disease),Stabilization,
2023,11637204,499968,,ON=C1C(=O)Nc2c1ccc(Cl)c2Cl,"6,7-dichloro-3-(hydroxyimino)-2,3-dihydro-1H-indol-2-one","InChI=1S/C8H4Cl2N2O2/c9-4-2-1-3-6(5(4)10)11-8(13)7(3)12-14/h1-2,14H,(H,11,12,13)",CVOUSAVHMDXCKG-UHFFFAOYSA-N,0,1,0,0,CaM / CaMBD2,6.36,schizophrenia (disease),Stabilization,
2024,52929826,,,COC[C@H]1CC[C@@H]2C1C[C@@]1(C)[C@@H](O)CC([C@H](C)COC(C)=O)=C1[C@@H](O[C@H]1O[C@H](OCC(C)(C)C=C)C(O)C(OC(C)=O)C1O)[C@H](O)[C@@H]2C,"(2S)-2-[(3R,4S,8R,9R,10R,11R,14S)-8-{[(2S,6S)-4-(acetyloxy)-6-[(2,2-dimethylbut-3-en-1-yl)oxy]-3,5-dihydroxyoxan-2-yl]oxy}-4,9-dihydroxy-14-(methoxymethyl)-3,10-dimethyltricyclo[9.3.0.0^{3,7}]tetradec-6-en-6-yl]propyl acetate","InChI=1S/C36H58O12/c1-10-35(6,7)17-45-33-29(41)32(46-21(5)38)30(42)34(48-33)47-31-27-24(18(2)15-44-20(4)37)13-26(39)36(27,8)14-25-22(16-43-9)11-12-23(25)19(3)28(31)40/h10,18-19,22-23,25-26,28-34,39-42H,1,11-17H2,2-9H3/t18-,19-,22-,23+,25?,26+,28-,29?,30?,31-,32?,33+,34+,36+/m1/s1",PNWRSESCMBPWCI-CXISALMZSA-N,2,0,0,0,14-3-3 / TASK-like,5.72,cancer,Stabilization,
2025,168317793,,,COC[C@H]1CC[C@H]2[C@@H](C)[C@@H](O)[C@H](O)C3=C(C[C@H](O)[C@]3(C)C=C12)[C@H](C)COC(C)=O,"(2S)-2-[(3R,4S,8R,9R,10R,11S,14S)-4,8,9-trihydroxy-14-(methoxymethyl)-3,10-dimethyltricyclo[9.3.0.0^{3,7}]tetradeca-1,6-dien-6-yl]propyl acetate","InChI=1S/C23H36O6/c1-12(10-29-14(3)24)17-8-19(25)23(4)9-18-15(11-28-5)6-7-16(18)13(2)21(26)22(27)20(17)23/h9,12-13,15-16,19,21-22,25-27H,6-8,10-11H2,1-5H3/t12-,13-,15-,16+,19+,21-,22-,23+/m1/s1",JWXDGEQLSBXQMO-KJYHUIMWSA-N,2,0,0,0,14-3-3 / TASK-like,3.68,cancer,Stabilization,
2026,168317794,,,COC[C@H]1CC[C@H]2[C@@H](C)[C@@H](O)[C@H](O)C3=C(C[C@H](O)[C@]3(C)C=C12)C(C)C,"(3R,4S,8R,9R,10R,11S,14S)-14-(methoxymethyl)-3,10-dimethyl-6-(propan-2-yl)tricyclo[9.3.0.0^{3,7}]tetradeca-1,6-diene-4,8,9-triol","InChI=1S/C21H34O4/c1-11(2)15-8-17(22)21(4)9-16-13(10-25-5)6-7-14(16)12(3)19(23)20(24)18(15)21/h9,11-14,17,19-20,22-24H,6-8,10H2,1-5H3/t12-,13-,14+,17+,19-,20-,21+/m1/s1",YZZBBYUVOSVRJT-XIQBLEEISA-N,2,0,0,0,14-3-3 / TASK-like,3.58,cancer,Stabilization,
2027,442028,,,CC(C)C1=C2[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H](C)[C@@H]3CC[C@H](CO)C3=C[C@@]2(C)CC1,"(2S,3R,4S,5S,6R)-2-{[(3R,8R,9R,10R,11S,14S)-9-hydroxy-14-(hydroxymethyl)-3,10-dimethyl-6-(propan-2-yl)tricyclo[9.3.0.0^{3,7}]tetradeca-1,6-dien-8-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol","InChI=1S/C26H42O8/c1-12(2)15-7-8-26(4)9-17-14(10-27)5-6-16(17)13(3)20(29)24(19(15)26)34-25-23(32)22(31)21(30)18(11-28)33-25/h9,12-14,16,18,20-25,27-32H,5-8,10-11H2,1-4H3/t13-,14-,16+,18-,20-,21-,22+,23-,24-,25-,26-/m1/s1",FQPATHNUIPAADA-RLGUMQDJSA-N,2,0,0,0,14-3-3 / TASK-like,3.73,cancer,Stabilization,
2028,168323003,,,COC[C@H]1CC[C@H]2[C@@H](C)[C@@H](O)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C3=C(CC[C@]3(C)C=C12)C(C)C,"(2S,3R,4S,5S,6R)-2-{[(3R,8R,9R,10R,11S,14S)-9-hydroxy-14-(methoxymethyl)-3,10-dimethyl-6-(propan-2-yl)tricyclo[9.3.0.0^{3,7}]tetradeca-1,6-dien-8-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol","InChI=1S/C27H44O8/c1-13(2)16-8-9-27(4)10-18-15(12-33-5)6-7-17(18)14(3)21(29)25(20(16)27)35-26-24(32)23(31)22(30)19(11-28)34-26/h10,13-15,17,19,21-26,28-32H,6-9,11-12H2,1-5H3/t14-,15-,17+,19-,21-,22-,23+,24-,25-,26-,27-/m1/s1",ZKINNMSFCCOPQI-RXNGSEETSA-N,2,0,0,0,14-3-3 / TASK-like,5.21,cancer,Stabilization,
2029,168318016,,,COC[C@H]1CC[C@H]2[C@@H](C)[C@@H](O)[C@H](O[C@H]3O[C@@H]4COC(C)(C)O[C@H]4[C@H](O)[C@H]3O)C3=C(C(C)C)[C@@H]4CCO[C@@H]4[C@]3(C)C=C12,"(4aR,6S,7R,8R,8aS)-6-{[(1R,4S,7S,8R,9R,10R,13S,17S)-9-hydroxy-4-(methoxymethyl)-1,8-dimethyl-12-(propan-2-yl)-16-oxatetracyclo[9.6.0.0^{3,7}.0^{13,17}]heptadeca-2,11-dien-10-yl]oxy}-2,2-dimethyl-hexahydro-2H-pyrano[3,2-d][1,3]dioxine-7,8-diol","InChI=1S/C32H50O9/c1-15(2)22-19-10-11-37-29(19)32(6)12-20-17(13-36-7)8-9-18(20)16(3)24(33)28(23(22)32)40-30-26(35)25(34)27-21(39-30)14-38-31(4,5)41-27/h12,15-19,21,24-30,33-35H,8-11,13-14H2,1-7H3/t16-,17-,18+,19+,21-,24-,25-,26-,27-,28-,29+,30-,32-/m1/s1",VVWLHUXTBJWIOB-JLTRQRTNSA-N,3,0,0,0,14-3-3 / TASK-like,4.91,cancer,Stabilization,
2030,71308204,,,COC[C@H]/1CC[C@H]2[C@@H](C)[C@@H](O)[C@H](O[C@H]3O[C@H](COC(C)(C)C=C)[C@@H](O)[C@H](OC(C)=O)[C@H]3O)C4=C(C[C@H](O)[C@]4(C)\C=C/12)[C@H](C)COC(C)=O,,"InChI=1S/C36H56O12/c1-10-35(6,7)45-17-26-30(41)33(46-21(5)38)31(42)34(47-26)48-32-28-24(18(2)15-44-20(4)37)13-27(39)36(28,8)14-25-22(16-43-9)11-12-23(25)19(3)29(32)40/h10,14,18-19,22-23,26-27,29-34,39-42H,1,11-13,15-17H2,2-9H3/t18-,19-,22-,23+,26-,27+,29-,30-,31-,32-,33+,34-,36+/m1/s1",KXTYBXCEQOANSX-HPVXDZOISA-N,,,,,,,,,
2031,118080305,4203897,,CNC(=O)c1cccc(c1)-c1ccc2N([C@@H](C)CN(C(=O)c3ccco3)c2c1)C(C)=O,"3-[(2S)-1-acetyl-4-(furan-2-carbonyl)-2-methyl-1,2,3,4-tetrahydroquinoxalin-6-yl]-N-methylbenzamide","InChI=1S/C24H23N3O4/c1-15-14-26(24(30)22-8-5-11-31-22)21-13-18(9-10-20(21)27(15)16(2)28)17-6-4-7-19(12-17)23(29)25-3/h4-13,15H,14H2,1-3H3,(H,25,29)/t15-/m0/s1",BNLUHUAAWOCZIZ-HNNXBMFYSA-N,1,1,0,0,Bromodomain / Histone,6.11,cancer,Inhibition,
2032,118079489,4217059,,C[C@H]1CN(C(=O)c2ccco2)c2cc(ccc2N1C(C)=O)-c1cnn(C)c1,"1-[(2S)-4-(furan-2-carbonyl)-2-methyl-6-(1-methyl-1H-pyrazol-4-yl)-1,2,3,4-tetrahydroquinoxalin-1-yl]ethan-1-one","InChI=1S/C20H20N4O3/c1-13-11-23(20(26)19-5-4-8-27-19)18-9-15(16-10-21-22(3)12-16)6-7-17(18)24(13)14(2)25/h4-10,12-13H,11H2,1-3H3/t13-/m0/s1",ZAAQDDYAHFDBQN-ZDUSSCGKSA-N,1,1,0,0,Bromodomain / Histone,6.68,cancer,Inhibition,
2033,118078887,4208315,,C[C@H]1CN(C(=O)C2CC2)c2cc(ccc2N1C(C)=O)-c1ccc(cc1)C(=O)N1CCNCC1,"1-[(2S)-4-cyclopropanecarbonyl-2-methyl-6-[4-(piperazine-1-carbonyl)phenyl]-1,2,3,4-tetrahydroquinoxalin-1-yl]ethan-1-one","InChI=1S/C26H30N4O3/c1-17-16-29(26(33)21-7-8-21)24-15-22(9-10-23(24)30(17)18(2)31)19-3-5-20(6-4-19)25(32)28-13-11-27-12-14-28/h3-6,9-10,15,17,21,27H,7-8,11-14,16H2,1-2H3/t17-/m0/s1",QKBAGTPAMDGHFQ-KRWDZBQOSA-N,1,1,0,0,Bromodomain / Histone,6.92,cancer,Inhibition,
2034,118079235,4203456,,C[C@H]1CN(C(=O)C2CC2)c2cc(ccc2N1C(C)=O)-c1cnn(c1)C1CNC1,"1-[(2S)-6-[1-(azetidin-3-yl)-1H-pyrazol-4-yl]-4-cyclopropanecarbonyl-2-methyl-1,2,3,4-tetrahydroquinoxalin-1-yl]ethan-1-one","InChI=1S/C21H25N5O2/c1-13-11-24(21(28)15-3-4-15)20-7-16(5-6-19(20)26(13)14(2)27)17-8-23-25(12-17)18-9-22-10-18/h5-8,12-13,15,18,22H,3-4,9-11H2,1-2H3/t13-/m0/s1",CNZQNIGFBSQECU-ZDUSSCGKSA-N,1,1,0,0,Bromodomain / Histone,7.22,cancer,Inhibition,
2035,118078985,4205343,,C[C@H]1CN(C(=O)c2ccco2)c2cc(ccc2N1C(C)=O)-c1ccc(cc1)S(C)(=O)=O,"1-[(2S)-4-(furan-2-carbonyl)-6-(4-methanesulfonylphenyl)-2-methyl-1,2,3,4-tetrahydroquinoxalin-1-yl]ethan-1-one","InChI=1S/C23H22N2O5S/c1-15-14-24(23(27)22-5-4-12-30-22)21-13-18(8-11-20(21)25(15)16(2)26)17-6-9-19(10-7-17)31(3,28)29/h4-13,15H,14H2,1-3H3/t15-/m0/s1",WVSGMQZUVMAABV-HNNXBMFYSA-N,1,1,0,0,Bromodomain / Histone,6.40,cancer,Inhibition,
2036,118080263,4208254,,C[C@H]1CN(C(=O)c2ccco2)c2ccccc2N1C(C)=O,"1-[(2S)-4-(furan-2-carbonyl)-2-methyl-1,2,3,4-tetrahydroquinoxalin-1-yl]ethan-1-one","InChI=1S/C16H16N2O3/c1-11-10-17(16(20)15-8-5-9-21-15)13-6-3-4-7-14(13)18(11)12(2)19/h3-9,11H,10H2,1-2H3/t11-/m0/s1",PQZDVDAGCKDFQI-NSHDSACASA-N,1,0,0,0,Bromodomain / Histone,4.85,cancer,Inhibition,
2037,118079690,4207530,,C[C@H]1CN(C(=O)c2ccco2)c2cc(ccc2N1C(C)=O)-c1ccccc1,"1-[(2S)-4-(furan-2-carbonyl)-2-methyl-6-phenyl-1,2,3,4-tetrahydroquinoxalin-1-yl]ethan-1-one","InChI=1S/C22H20N2O3/c1-15-14-23(22(26)21-9-6-12-27-21)20-13-18(17-7-4-3-5-8-17)10-11-19(20)24(15)16(2)25/h3-13,15H,14H2,1-2H3/t15-/m0/s1",KNFQVRRKTXLXDN-HNNXBMFYSA-N,1,1,0,0,Bromodomain / Histone,6.46,cancer,Inhibition,
2038,118079652,4206854,,CC(C)n1cc(cn1)-c1ccc2N([C@@H](C)CN(C(=O)C3CC3)c2c1)C(C)=O,"1-[(2S)-4-cyclopropanecarbonyl-2-methyl-6-[1-(propan-2-yl)-1H-pyrazol-4-yl]-1,2,3,4-tetrahydroquinoxalin-1-yl]ethan-1-one","InChI=1S/C21H26N4O2/c1-13(2)24-12-18(10-22-24)17-7-8-19-20(9-17)23(21(27)16-5-6-16)11-14(3)25(19)15(4)26/h7-10,12-14,16H,5-6,11H2,1-4H3/t14-/m0/s1",OCYHSSHUJWVLMA-AWEZNQCLSA-N,1,1,0,0,Bromodomain / Histone,6.38,cancer,Inhibition,
2039,146340782,,,CCC(=O)N1C(C)CN(C(=O)c2ccco2)c2cc(ccc12)-c1ccc(cc1)S(C)(=O)=O,"1-[4-(furan-2-carbonyl)-6-(4-methanesulfonylphenyl)-2-methyl-1,2,3,4-tetrahydroquinoxalin-1-yl]propan-1-one","InChI=1S/C24H24N2O5S/c1-4-23(27)26-16(2)15-25(24(28)22-6-5-13-31-22)21-14-18(9-12-20(21)26)17-7-10-19(11-8-17)32(3,29)30/h5-14,16H,4,15H2,1-3H3",QKPQTHQXGQUXRX-UHFFFAOYSA-N,1,1,0,0,Bromodomain / Histone,6.26,cancer,Inhibition,
2040,118079501,4215658,,C[C@H]1CN(C(=O)C2CC2)c2cc(ccc2N1C(C)=O)-c1ccc(cc1)N1CCS(=O)(=O)CC1,"4-{4-[(2S)-1-acetyl-4-cyclopropanecarbonyl-2-methyl-1,2,3,4-tetrahydroquinoxalin-6-yl]phenyl}-1lambda6-thiomorpholine-1,1-dione","InChI=1S/C25H29N3O4S/c1-17-16-27(25(30)20-3-4-20)24-15-21(7-10-23(24)28(17)18(2)29)19-5-8-22(9-6-19)26-11-13-33(31,32)14-12-26/h5-10,15,17,20H,3-4,11-14,16H2,1-2H3/t17-/m0/s1",BRFIYWZYWCKGBC-KRWDZBQOSA-N,1,1,1,0,Bromodomain / Histone,7.00,cancer,Inhibition,
2041,118080153,4216188,,C[C@H]1CN(C(=O)C2CC2)c2cc(ccc2N1C(C)=O)-c1ccc(cc1)S(C)(=O)=O,"1-[(2S)-4-cyclopropanecarbonyl-6-(4-methanesulfonylphenyl)-2-methyl-1,2,3,4-tetrahydroquinoxalin-1-yl]ethan-1-one","InChI=1S/C22H24N2O4S/c1-14-13-23(22(26)17-4-5-17)21-12-18(8-11-20(21)24(14)15(2)25)16-6-9-19(10-7-16)29(3,27)28/h6-12,14,17H,4-5,13H2,1-3H3/t14-/m0/s1",GRNBUOALSCLXHX-AWEZNQCLSA-N,1,1,0,0,Bromodomain / Histone,6.08,cancer,Inhibition,
2042,118080085,4214127,,C[C@H]1CN(C(=O)c2ccco2)c2cc(ccc2N1C(=O)C1CC1)-c1ccc(cc1)S(C)(=O)=O,"(2S)-1-cyclopropanecarbonyl-4-(furan-2-carbonyl)-6-(4-methanesulfonylphenyl)-2-methyl-1,2,3,4-tetrahydroquinoxaline","InChI=1S/C25H24N2O5S/c1-16-15-26(25(29)23-4-3-13-32-23)22-14-19(17-7-10-20(11-8-17)33(2,30)31)9-12-21(22)27(16)24(28)18-5-6-18/h3-4,7-14,16,18H,5-6,15H2,1-2H3/t16-/m0/s1",SNISVGQABMWICJ-INIZCTEOSA-N,1,1,0,0,Bromodomain / Histone,6.55,cancer,Inhibition,
2043,118317783,4209209,,COC(=O)N1[C@@H](C)CN(C(=O)c2ccco2)c2cc(ccc12)-c1ccc(cc1)S(C)(=O)=O,"methyl (2S)-4-(furan-2-carbonyl)-6-(4-methanesulfonylphenyl)-2-methyl-1,2,3,4-tetrahydroquinoxaline-1-carboxylate","InChI=1S/C23H22N2O6S/c1-15-14-24(22(26)21-5-4-12-31-21)20-13-17(8-11-19(20)25(15)23(27)30-2)16-6-9-18(10-7-16)32(3,28)29/h4-13,15H,14H2,1-3H3/t15-/m0/s1",FNGHABKDXSWAPR-HNNXBMFYSA-N,1,1,0,0,Bromodomain / Histone,6.49,cancer,Inhibition,
2044,118078912,4211756,,C[C@H]1CN(C(=O)C2CCCC2)c2ccccc2N1C(C)=O,"1-[(2S)-4-cyclopentanecarbonyl-2-methyl-1,2,3,4-tetrahydroquinoxalin-1-yl]ethan-1-one","InChI=1S/C17H22N2O2/c1-12-11-18(17(21)14-7-3-4-8-14)15-9-5-6-10-16(15)19(12)13(2)20/h5-6,9-10,12,14H,3-4,7-8,11H2,1-2H3/t12-/m0/s1",BUJVVMBJKZVXOR-LBPRGKRZSA-N,1,0,0,0,Bromodomain / Histone,4.37,cancer,Inhibition,
2045,118078883,4211739,,C[C@H]1CN(C(=O)C2CC2)c2cc(ccc2N1C(C)=O)-c1cnn(c1)C1COC1,"1-[(2S)-4-cyclopropanecarbonyl-2-methyl-6-[1-(oxetan-3-yl)-1H-pyrazol-4-yl]-1,2,3,4-tetrahydroquinoxalin-1-yl]ethan-1-one","InChI=1S/C21H24N4O3/c1-13-9-23(21(27)15-3-4-15)20-7-16(5-6-19(20)25(13)14(2)26)17-8-22-24(10-17)18-11-28-12-18/h5-8,10,13,15,18H,3-4,9,11-12H2,1-2H3/t13-/m0/s1",IZGKRXAIBAPJKA-ZDUSSCGKSA-N,1,1,0,0,Bromodomain / Histone,6.43,cancer,Inhibition,
2046,118080562,4211224,,CC(C)OC(=O)N1C[C@H](C)N(C(C)=O)c2ccc(cc12)-c1ccc(cc1)S(C)(=O)=O,"propan-2-yl (3S)-4-acetyl-7-(4-methanesulfonylphenyl)-3-methyl-1,2,3,4-tetrahydroquinoxaline-1-carboxylate","InChI=1S/C22H26N2O5S/c1-14(2)29-22(26)23-13-15(3)24(16(4)25)20-11-8-18(12-21(20)23)17-6-9-19(10-7-17)30(5,27)28/h6-12,14-15H,13H2,1-5H3/t15-/m0/s1",LLPZDFFDKXBSEA-HNNXBMFYSA-N,1,1,0,0,Bromodomain / Histone,6.59,cancer,Inhibition,
2047,118079722,4217584,,C[C@H]1CN(C(=O)c2ccco2)c2cc(ccc2N1C=O)-c1ccc(cc1)S(C)(=O)=O,"(2S)-4-(furan-2-carbonyl)-6-(4-methanesulfonylphenyl)-2-methyl-1,2,3,4-tetrahydroquinoxaline-1-carbaldehyde","InChI=1S/C22H20N2O5S/c1-15-13-23(22(26)21-4-3-11-29-21)20-12-17(7-10-19(20)24(15)14-25)16-5-8-18(9-6-16)30(2,27)28/h3-12,14-15H,13H2,1-2H3/t15-/m0/s1",HDWZYYBGRVSDHC-HNNXBMFYSA-N,0,0,0,0,,,,,
2048,118079985,4206870,,CC(C)CC(=O)N1C[C@H](C)N(C(C)=O)c2ccccc12,"1-[(3S)-4-acetyl-3-methyl-1,2,3,4-tetrahydroquinoxalin-1-yl]-3-methylbutan-1-one","InChI=1S/C16H22N2O2/c1-11(2)9-16(20)17-10-12(3)18(13(4)19)15-8-6-5-7-14(15)17/h5-8,11-12H,9-10H2,1-4H3/t12-/m0/s1",MQVJOGMUDIEXSD-LBPRGKRZSA-N,0,0,0,0,,,,,
2049,118079664,4213180,,C[C@H]1CN(C(=O)c2ccccc2)c2ccccc2N1C(C)=O,"1-[(2S)-4-benzoyl-2-methyl-1,2,3,4-tetrahydroquinoxalin-1-yl]ethan-1-one","InChI=1S/C18H18N2O2/c1-13-12-19(18(22)15-8-4-3-5-9-15)16-10-6-7-11-17(16)20(13)14(2)21/h3-11,13H,12H2,1-2H3/t13-/m0/s1",XISWKHNXRRASFZ-ZDUSSCGKSA-N,0,0,0,0,,,,,
2050,71717128,2347397,,CC(C)N[C@@H]1CC[C@@H]([C@@H](C1)c1ccc(Cl)cc1)c1ccc(Cl)cc1,"(1R,3R,4S)-3,4-bis(4-chlorophenyl)-N-(propan-2-yl)cyclohexan-1-amine","InChI=1S/C21H25Cl2N/c1-14(2)24-19-11-12-20(15-3-7-17(22)8-4-15)21(13-19)16-5-9-18(23)10-6-16/h3-10,14,19-21,24H,11-13H2,1-2H3/t19-,20-,21+/m1/s1",GYVSDGRZPBXQQE-NJYVYQBISA-N,1,0,0,0,MDM2-Like / P53,4.85,cancer,Inhibition,
2051,71663150,2347398,,CN1[C@@H]([C@@H](OCC1=O)c1ccc(Br)cc1)c1ccc(Br)cc1,"(5R,6S)-5,6-bis(4-bromophenyl)-4-methylmorpholin-3-one","InChI=1S/C17H15Br2NO2/c1-20-15(21)10-22-17(12-4-8-14(19)9-5-12)16(20)11-2-6-13(18)7-3-11/h2-9,16-17H,10H2,1H3/t16-,17+/m1/s1",OUTBUVLNDIYGFF-SJORKVTESA-N,1,0,0,0,MDM2-Like / P53,5.27,cancer,Inhibition,
2052,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/2052
2053,71305071,2347401,,CN1[C@@H]([C@@H](O[C@@H](Cc2ccccc2)C1=O)c1ccc(Cl)cc1)c1ccc(Cl)cc1,"(2S,5R,6S)-2-benzyl-5,6-bis(4-chlorophenyl)-4-methylmorpholin-3-one","InChI=1S/C24H21Cl2NO2/c1-27-22(17-7-11-19(25)12-8-17)23(18-9-13-20(26)14-10-18)29-21(24(27)28)15-16-5-3-2-4-6-16/h2-14,21-23H,15H2,1H3/t21-,22+,23-/m0/s1",NFFXQTHZDQEVMP-ZRBLBEILSA-N,1,0,0,0,MDM2-Like / P53,5.74,cancer,Inhibition,
2054,71305070,2347399,,CN1[C@@H]([C@@H](O[C@@H](Cc2ccccc2)C1=O)c1ccc(Br)cc1)c1ccc(Br)cc1,"(2S,5R,6S)-2-benzyl-5,6-bis(4-bromophenyl)-4-methylmorpholin-3-one","InChI=1S/C24H21Br2NO2/c1-27-22(17-7-11-19(25)12-8-17)23(18-9-13-20(26)14-10-18)29-21(24(27)28)15-16-5-3-2-4-6-16/h2-14,21-23H,15H2,1H3/t21-,22+,23-/m0/s1",YYVYIVSNIAMIER-ZRBLBEILSA-N,1,0,0,0,MDM2-Like / P53,6.00,cancer,Inhibition,
2055,71663333,2347403,,CN1[C@@H]([C@@H](O[C@@H](Cc2ccc(Br)cc2)C1=O)c1ccc(Br)cc1)c1ccc(Br)cc1,"(2S,5R,6S)-5,6-bis(4-bromophenyl)-2-[(4-bromophenyl)methyl]-4-methylmorpholin-3-one","InChI=1S/C24H20Br3NO2/c1-28-22(16-4-10-19(26)11-5-16)23(17-6-12-20(27)13-7-17)30-21(24(28)29)14-15-2-8-18(25)9-3-15/h2-13,21-23H,14H2,1H3/t21-,22+,23-/m0/s1",RHWGELPEQKFUHE-ZRBLBEILSA-N,1,0,0,0,MDM2-Like / P53,5.82,cancer,Inhibition,
2056,71663334,2347380,,CN1[C@@H]([C@@H](O[C@@H](Cc2ccc(F)cc2)C1=O)c1ccc(Br)cc1)c1ccc(Br)cc1,"(2S,5R,6S)-5,6-bis(4-bromophenyl)-2-[(4-fluorophenyl)methyl]-4-methylmorpholin-3-one","InChI=1S/C24H20Br2FNO2/c1-28-22(16-4-8-18(25)9-5-16)23(17-6-10-19(26)11-7-17)30-21(24(28)29)14-15-2-12-20(27)13-3-15/h2-13,21-23H,14H2,1H3/t21-,22+,23-/m0/s1",ZOPUXVMFTFLAOX-ZRBLBEILSA-N,1,0,0,0,MDM2-Like / P53,5.74,cancer,Inhibition,
2057,71663335,2347381,,COc1ccc(C[C@@H]2O[C@H]([C@H](N(C)C2=O)c2ccc(Br)cc2)c2ccc(Br)cc2)cc1,"(2S,5R,6S)-5,6-bis(4-bromophenyl)-2-[(4-methoxyphenyl)methyl]-4-methylmorpholin-3-one","InChI=1S/C25H23Br2NO3/c1-28-23(17-5-9-19(26)10-6-17)24(18-7-11-20(27)12-8-18)31-22(25(28)29)15-16-3-13-21(30-2)14-4-16/h3-14,22-24H,15H2,1-2H3/t22-,23+,24-/m0/s1",JQFPMGMYKYPPLI-VXNXHJTFSA-N,1,0,0,0,MDM2-Like / P53,5.72,cancer,Inhibition,
2058,71663336,2347382,,COc1cccc(C[C@@H]2O[C@H]([C@H](N(C)C2=O)c2ccc(Br)cc2)c2ccc(Br)cc2)c1,"(2S,5R,6S)-5,6-bis(4-bromophenyl)-2-[(3-methoxyphenyl)methyl]-4-methylmorpholin-3-one","InChI=1S/C25H23Br2NO3/c1-28-23(17-6-10-19(26)11-7-17)24(18-8-12-20(27)13-9-18)31-22(25(28)29)15-16-4-3-5-21(14-16)30-2/h3-14,22-24H,15H2,1-2H3/t22-,23+,24-/m0/s1",FCOPQZKTHYVUEK-VXNXHJTFSA-N,1,0,0,0,MDM2-Like / P53,5.68,cancer,Inhibition,
2059,71305072,2347383,,CCC[C@@H](N1[C@@H]([C@@H](O[C@@H](Cc2ccc(F)cc2)C1=O)c1ccc(Cl)cc1)c1ccc(Cl)cc1)C(O)=O,"(2R)-2-[(2S,3R,6S)-2,3-bis(4-chlorophenyl)-6-[(4-fluorophenyl)methyl]-5-oxomorpholin-4-yl]pentanoic acid","InChI=1S/C28H26Cl2FNO4/c1-2-3-23(28(34)35)32-25(18-6-10-20(29)11-7-18)26(19-8-12-21(30)13-9-19)36-24(27(32)33)16-17-4-14-22(31)15-5-17/h4-15,23-26H,2-3,16H2,1H3,(H,34,35)/t23-,24+,25-,26+/m1/s1",BPTXICQAEGSTHS-ZJSPYRCASA-N,1,1,0,0,MDM2-Like / P53,5.54,cancer,Inhibition,
2060,71663525,2347384,,CN1[C@@H]([C@@H](OCC1=O)c1cccc(Cl)c1)c1ccc(Cl)cc1,"(5R,6S)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-4-methylmorpholin-3-one","InChI=1S/C17H15Cl2NO2/c1-20-15(21)10-22-17(12-3-2-4-14(19)9-12)16(20)11-5-7-13(18)8-6-11/h2-9,16-17H,10H2,1H3/t16-,17+/m1/s1",ZUYDNBDMQAEZPD-SJORKVTESA-N,1,0,0,0,MDM2-Like / P53,5.74,cancer,Inhibition,
2061,71663526,2347385,,Clc1ccc(cc1)[C@@H]1[C@@H](OCC(=O)N1CC1CC1)c1cccc(Cl)c1,"(5R,6S)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-4-(cyclopropylmethyl)morpholin-3-one","InChI=1S/C20H19Cl2NO2/c21-16-8-6-14(7-9-16)19-20(15-2-1-3-17(22)10-15)25-12-18(24)23(19)11-13-4-5-13/h1-3,6-10,13,19-20H,4-5,11-12H2/t19-,20+/m1/s1",USNQYGDSTBFBSK-UXHICEINSA-N,1,0,0,0,MDM2-Like / P53,5.74,cancer,Inhibition,
2062,71663528,2347387,,Clc1ccc(cc1)[C@@H]1[C@@H](O[C@@H](CC=C)C(=O)N1CC1CC1)c1cccc(Cl)c1,"(2S,5R,6S)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-4-(cyclopropylmethyl)-2-(prop-2-en-1-yl)morpholin-3-one","InChI=1S/C23H23Cl2NO2/c1-2-4-20-23(27)26(14-15-7-8-15)21(16-9-11-18(24)12-10-16)22(28-20)17-5-3-6-19(25)13-17/h2-3,5-6,9-13,15,20-22H,1,4,7-8,14H2/t20-,21+,22-/m0/s1",GYOAZTPSRBBAKY-BDTNDASRSA-N,1,0,0,0,MDM2-Like / P53,6.52,cancer,Inhibition,
2063,71663529,2347388,,OCC[C@@H]1O[C@H]([C@H](N(CC2CC2)C1=O)c1ccc(Cl)cc1)c1cccc(Cl)c1,"(2S,5R,6S)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-4-(cyclopropylmethyl)-2-(2-hydroxyethyl)morpholin-3-one","InChI=1S/C22H23Cl2NO3/c23-17-8-6-15(7-9-17)20-21(16-2-1-3-18(24)12-16)28-19(10-11-26)22(27)25(20)13-14-4-5-14/h1-3,6-9,12,14,19-21,26H,4-5,10-11,13H2/t19-,20+,21-/m0/s1",BTFDOQOPNARQSS-HBMCJLEFSA-N,1,0,0,0,MDM2-Like / P53,6.06,cancer,Inhibition,
2064,71663697,2347390,,CNCC[C@@H]1O[C@H]([C@H](N(CC2CC2)C1=O)c1ccc(Cl)cc1)c1cccc(Cl)c1,"(2S,5R,6S)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-4-(cyclopropylmethyl)-2-[2-(methylamino)ethyl]morpholin-3-one","InChI=1S/C23H26Cl2N2O2/c1-26-12-11-20-23(28)27(14-15-5-6-15)21(16-7-9-18(24)10-8-16)22(29-20)17-3-2-4-19(25)13-17/h2-4,7-10,13,15,20-22,26H,5-6,11-12,14H2,1H3/t20-,21+,22-/m0/s1",FODTWMGUVKCBDV-BDTNDASRSA-N,1,0,0,0,MDM2-Like / P53,5.00,cancer,Inhibition,
2065,71663698,2347391,,OC(=O)CC[C@@H]1O[C@H]([C@H](N(CC2CC2)C1=O)c1ccc(Cl)cc1)c1cccc(Cl)c1,"3-[(2S,5R,6S)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-4-(cyclopropylmethyl)-3-oxomorpholin-2-yl]propanoic acid","InChI=1S/C23H23Cl2NO4/c24-17-8-6-15(7-9-17)21-22(16-2-1-3-18(25)12-16)30-19(10-11-20(27)28)23(29)26(21)13-14-4-5-14/h1-3,6-9,12,14,19,21-22H,4-5,10-11,13H2,(H,27,28)/t19-,21+,22-/m0/s1",RTDZBLVTLREENZ-NNWRFLSQSA-N,1,0,0,0,MDM2-Like / P53,5.89,cancer,Inhibition,
2066,71663699,2347392,,OC(=O)C[C@H]1O[C@@H]([C@@H](N(CC2CC2)C1=O)c1ccc(Cl)cc1)c1cccc(Cl)c1,"2-[(2R,5S,6R)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-4-(cyclopropylmethyl)-3-oxomorpholin-2-yl]acetic acid","InChI=1S/C22H21Cl2NO4/c23-16-8-6-14(7-9-16)20-21(15-2-1-3-17(24)10-15)29-18(11-19(26)27)22(28)25(20)12-13-4-5-13/h1-3,6-10,13,18,20-21H,4-5,11-12H2,(H,26,27)/t18-,20+,21-/m1/s1",PLSLYOZGYCPTIL-HLAWJBBLSA-N,1,0,0,0,MDM2-Like / P53,5.13,cancer,Inhibition,
2067,71663696,2347389,,OC(=O)C[C@@H]1O[C@H]([C@H](N(CC2CC2)C1=O)c1ccc(Cl)cc1)c1cccc(Cl)c1,"2-[(2S,5R,6S)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-4-(cyclopropylmethyl)-3-oxomorpholin-2-yl]acetic acid","InChI=1S/C22H21Cl2NO4/c23-16-8-6-14(7-9-16)20-21(15-2-1-3-17(24)10-15)29-18(11-19(26)27)22(28)25(20)12-13-4-5-13/h1-3,6-10,13,18,20-21H,4-5,11-12H2,(H,26,27)/t18-,20+,21-/m0/s1",PLSLYOZGYCPTIL-TYPHKJRUSA-N,1,1,2,0,MDM2-Like / P53,7.00,cancer,Inhibition,
2068,71305074,2347393,,CC[C@@H](CO)N1[C@@H]([C@@H](O[C@@H](CC(O)=O)C1=O)c1cccc(Cl)c1)c1ccc(Cl)cc1,"2-[(2S,5R,6S)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-4-[(2S)-1-hydroxybutan-2-yl]-3-oxomorpholin-2-yl]acetic acid","InChI=1S/C22H23Cl2NO5/c1-2-17(12-26)25-20(13-6-8-15(23)9-7-13)21(14-4-3-5-16(24)10-14)30-18(22(25)29)11-19(27)28/h3-10,17-18,20-21,26H,2,11-12H2,1H3,(H,27,28)/t17-,18-,20+,21-/m0/s1",GOJFTLJDUNFYCJ-MMKMLUHNSA-N,1,0,0,0,MDM2-Like / P53,6.21,cancer,Inhibition,
2069,71663864,2347376,,OC(=O)C[C@H]1O[C@@H]([C@H](N(CC2CC2)C1=O)c1ccc(Cl)cc1)c1cccc(Cl)c1,"2-[(2R,5R,6R)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-4-(cyclopropylmethyl)-3-oxomorpholin-2-yl]acetic acid","InChI=1S/C22H21Cl2NO4/c23-16-8-6-14(7-9-16)20-21(15-2-1-3-17(24)10-15)29-18(11-19(26)27)22(28)25(20)12-13-4-5-13/h1-3,6-10,13,18,20-21H,4-5,11-12H2,(H,26,27)/t18-,20-,21-/m1/s1",PLSLYOZGYCPTIL-HMXCVIKNSA-N,1,1,0,0,MDM2-Like / P53,6.54,cancer,Inhibition,
2070,71544022,2347377,,OC(=O)C[C@@H]1O[C@@H]([C@H](N(CC2CC2)C1=O)c1ccc(Cl)cc1)c1cccc(Cl)c1,"2-[(2S,5R,6R)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-4-(cyclopropylmethyl)-3-oxomorpholin-2-yl]acetic acid","InChI=1S/C22H21Cl2NO4/c23-16-8-6-14(7-9-16)20-21(15-2-1-3-17(24)10-15)29-18(11-19(26)27)22(28)25(20)12-13-4-5-13/h1-3,6-10,13,18,20-21H,4-5,11-12H2,(H,26,27)/t18-,20+,21+/m0/s1",PLSLYOZGYCPTIL-CEWLAPEOSA-N,1,1,0,0,MDM2-Like / P53,6.85,cancer,Inhibition,
2071,60154111,2059299,,OC(=O)C[C@@H]1C[C@H]([C@H](N(CC2CC2)C1=O)c1ccc(Cl)cc1)c1cccc(Cl)c1,"2-[(3S,5S,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-(cyclopropylmethyl)-2-oxopiperidin-3-yl]acetic acid","InChI=1S/C23H23Cl2NO3/c24-18-8-6-15(7-9-18)22-20(16-2-1-3-19(25)10-16)11-17(12-21(27)28)23(29)26(22)13-14-4-5-14/h1-3,6-10,14,17,20,22H,4-5,11-13H2,(H,27,28)/t17-,20-,22+/m0/s1",OMAPWASVHLHIRY-RBDMOPTHSA-N,1,0,0,0,MDM2-Like / P53,5.62,cancer,Inhibition,
2072,56591348,2177203,,OC(=O)C[C@@H]1C[C@@H]([C@H](N(CC2CC2)C1=O)c1ccc(Cl)cc1)c1cccc(Cl)c1,"2-[(3S,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-(cyclopropylmethyl)-2-oxopiperidin-3-yl]acetic acid","InChI=1S/C23H23Cl2NO3/c24-18-8-6-15(7-9-18)22-20(16-2-1-3-19(25)10-16)11-17(12-21(27)28)23(29)26(22)13-14-4-5-14/h1-3,6-10,14,17,20,22H,4-5,11-13H2,(H,27,28)/t17-,20+,22+/m0/s1",OMAPWASVHLHIRY-UCNVEGJOSA-N,1,1,0,0,MDM2-Like / P53,7.12,cancer,Inhibition,
2073,71716517,2347378,,OC(=O)C[C@H]1C[C@H]([C@@H](N(CC2CC2)C1=O)c1ccc(Cl)cc1)c1cccc(Cl)c1,"2-[(3R,5S,6R)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-(cyclopropylmethyl)-2-oxopiperidin-3-yl]acetic acid","InChI=1S/C23H23Cl2NO3/c24-18-8-6-15(7-9-18)22-20(16-2-1-3-19(25)10-16)11-17(12-21(27)28)23(29)26(22)13-14-4-5-14/h1-3,6-10,14,17,20,22H,4-5,11-13H2,(H,27,28)/t17-,20+,22+/m1/s1",OMAPWASVHLHIRY-AGHHOFFYSA-N,1,0,0,0,MDM2-Like / P53,5.54,cancer,Inhibition,
2074,71717127,2347379,,OC(=O)C[C@@H]1C[C@H]([C@@H](N(CC2CC2)C1=O)c1ccc(Cl)cc1)c1cccc(Cl)c1,"2-[(3S,5S,6R)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-(cyclopropylmethyl)-2-oxopiperidin-3-yl]acetic acid","InChI=1S/C23H23Cl2NO3/c24-18-8-6-15(7-9-18)22-20(16-2-1-3-19(25)10-16)11-17(12-21(27)28)23(29)26(22)13-14-4-5-14/h1-3,6-10,14,17,20,22H,4-5,11-13H2,(H,27,28)/t17-,20-,22-/m0/s1",OMAPWASVHLHIRY-XJABCFGWSA-N,1,0,0,0,MDM2-Like / P53,5.09,cancer,Inhibition,
2075,56591370,2177813,,OC(=O)C[C@H]1C[C@@H]([C@H](N(CC2CC2)C1=O)c1ccc(Cl)cc1)c1cccc(Cl)c1,"2-[(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-(cyclopropylmethyl)-2-oxopiperidin-3-yl]acetic acid","InChI=1S/C23H23Cl2NO3/c24-18-8-6-15(7-9-18)22-20(16-2-1-3-19(25)10-16)11-17(12-21(27)28)23(29)26(22)13-14-4-5-14/h1-3,6-10,14,17,20,22H,4-5,11-13H2,(H,27,28)/t17-,20-,22-/m1/s1",OMAPWASVHLHIRY-NQSCKRDGSA-N,1,1,0,0,MDM2-Like / P53,7.47,cancer,Inhibition,
2076,,,,,,,,,,,,,,,,404 Client Error: Not Found for url: https://ippidb.pasteur.fr/compounds/2076
2077,44596256,575256,,CC[C@H](NC)C(=O)N[C@H]1[C@@H](CCNCc2ccccc2)CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c1ccccc1)c1ccccc1,"(3S,6S,7R,9aS)-7-[2-(benzylamino)ethyl]-N-(diphenylmethyl)-6-[(2S)-2-(methylamino)butanamido]-5-oxo-octahydro-1H-pyrrolo[1,2-a]azepine-3-carboxamide","InChI=1S/C37H47N5O3/c1-3-31(38-2)35(43)41-34-29(23-24-39-25-26-13-7-4-8-14-26)19-20-30-21-22-32(42(30)37(34)45)36(44)40-33(27-15-9-5-10-16-27)28-17-11-6-12-18-28/h4-18,29-34,38-39H,3,19-25H2,1-2H3,(H,40,44)(H,41,43)/t29-,30+,31+,32+,34+/m1/s1",NVNDSZWHCFDEAR-UCDLYESDSA-N,0,0,0,0,,,,,
2078,58137842,3039743,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1C[C@H]2C[C@@H]3C[C@@H]3N2C[C@H]1C(=O)N[C@@H]1CCOc2ccccc12,"(2S,4S,6R,9S)-8-[(2S)-2-cyclohexyl-2-[(2S)-2-(methylamino)propanamido]acetyl]-N-[(4R)-3,4-dihydro-2H-1-benzopyran-4-yl]-1,8-diazatricyclo[4.4.0.0^{2,4}]decane-9-carboxamide","InChI=1S/C30H43N5O4/c1-18(31-2)28(36)33-27(19-8-4-3-5-9-19)30(38)35-16-21-14-20-15-24(20)34(21)17-25(35)29(37)32-23-12-13-39-26-11-7-6-10-22(23)26/h6-7,10-11,18-21,23-25,27,31H,3-5,8-9,12-17H2,1-2H3,(H,32,37)(H,33,36)/t18-,20+,21+,23+,24-,25-,27-/m0/s1",OGTGKCOHYGILPQ-BBAYRLSSSA-N,2,1,0,0,XIAP / Smac,7.55,cancer,Inhibition,
2079,50913340,2365533,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1C[C@H]2CCCN2C[C@H]1C(=O)N[C@@H]1CCOc2ccccc12,"(3S,8aR)-2-[(2S)-2-cyclohexyl-2-[(2S)-2-(methylamino)propanamido]acetyl]-N-[(4R)-3,4-dihydro-2H-1-benzopyran-4-yl]-octahydropyrrolo[1,2-a]pyrazine-3-carboxamide","InChI=1S/C29H43N5O4/c1-19(30-2)27(35)32-26(20-9-4-3-5-10-20)29(37)34-17-21-11-8-15-33(21)18-24(34)28(36)31-23-14-16-38-25-13-7-6-12-22(23)25/h6-7,12-13,19-21,23-24,26,30H,3-5,8-11,14-18H2,1-2H3,(H,31,36)(H,32,35)/t19-,21+,23+,24-,26-/m0/s1",GIAUJOMDUOPYLU-XFCBJTKFSA-N,2,1,0,0,XIAP / Smac,8.46,cancer,Inhibition,
2080,168317786,,,CNC(C)C(=O)NC(C1CCCCC1)C(=O)N1C[C@H]2CCCN2CC1C(=O)NC1CCOc2ccccc12,"(8aR)-2-{2-cyclohexyl-2-[2-(methylamino)propanamido]acetyl}-N-(3,4-dihydro-2H-1-benzopyran-4-yl)-octahydropyrrolo[1,2-a]pyrazine-3-carboxamide","InChI=1S/C29H43N5O4/c1-19(30-2)27(35)32-26(20-9-4-3-5-10-20)29(37)34-17-21-11-8-15-33(21)18-24(34)28(36)31-23-14-16-38-25-13-7-6-12-22(23)25/h6-7,12-13,19-21,23-24,26,30H,3-5,8-11,14-18H2,1-2H3,(H,31,36)(H,32,35)/t19?,21-,23?,24?,26?/m1/s1",GIAUJOMDUOPYLU-SAVXELPKSA-N,2,1,0,0,XIAP / Smac,8.68,cancer,Inhibition,
2081,168317784,,,COC(=O)C(Cc1ccc(cc1)C#CC1CC=CC=C1)NC(=O)CC1CCCN(C1)C(N)=N,"methyl 2-[2-(1-carbamimidoylpiperidin-3-yl)acetamido]-3-{4-[2-(cyclohexa-2,4-dien-1-yl)ethynyl]phenyl}propanoate","InChI=1S/C26H32N4O3/c1-33-25(32)23(29-24(31)17-22-8-5-15-30(18-22)26(27)28)16-21-13-11-20(12-14-21)10-9-19-6-3-2-4-7-19/h2-4,6,11-14,19,22-23H,5,7-8,15-18H2,1H3,(H3,27,28)(H,29,31)",HXLSYRJONXTZMI-UHFFFAOYSA-N,1,0,0,0,IL2 / IL2R,5.09,cancer,Inhibition,
2082,123132228,4065484,,CS(=O)(=O)c1ccc(cc1)-c1cnc(NCc2ccco2)n2cnnc12,"N-[(furan-2-yl)methyl]-8-(4-methanesulfonylphenyl)-[1,2,4]triazolo[4,3-c]pyrimidin-5-amine","InChI=1S/C17H15N5O3S/c1-26(23,24)14-6-4-12(5-7-14)15-10-19-17(22-11-20-21-16(15)22)18-9-13-3-2-8-25-13/h2-8,10-11H,9H2,1H3,(H,18,19)",DYIRSNMPIZZNBK-UHFFFAOYSA-N,6,0,0,0,WD40 / H3,7.70,lymphoma,Inhibition,
2083,95854757,,,COc1ccccc1CN1C[C@H]([C@@H](C1)c1cn(C)c2ccccc12)N(C)C,"(3S,4R)-1-[(2-methoxyphenyl)methyl]-N,N-dimethyl-4-(1-methyl-1H-indol-3-yl)pyrrolidin-3-amine","InChI=1S/C23H29N3O/c1-24(2)22-16-26(13-17-9-5-8-12-23(17)27-4)15-20(22)19-14-25(3)21-11-7-6-10-18(19)21/h5-12,14,20,22H,13,15-16H2,1-4H3/t20-,22+/m0/s1",CXQQECCQTKSQKN-RBBKRZOGSA-N,1,0,0,0,WD40 / H3,5.92,lymphoma,Inhibition,
2084,126962003,4085428,,CN(C)[C@H]1CN(Cc2c(C)cccc2F)C[C@@H]1c1cn(C)c2ccccc12,"(3R,4S)-1-[(2-fluoro-6-methylphenyl)methyl]-N,N-dimethyl-4-(1-methyl-1H-indol-3-yl)pyrrolidin-3-amine","InChI=1S/C23H28FN3/c1-16-8-7-10-21(24)18(16)13-27-14-20(23(15-27)25(2)3)19-12-26(4)22-11-6-5-9-17(19)22/h5-12,20,23H,13-15H2,1-4H3/t20-,23+/m1/s1",MJNFUMWCOKCILM-OFNKIYASSA-N,1,3,0,0,WD40 / H3,8.40,lymphoma,Inhibition,
2085,123132216,4080018,,CN(C)[C@H]1CN(C[C@@H]1c1cn(C)c2ccccc12)[C@H]1CCc2cccc(F)c12,"(3R,4S)-1-[(1S)-7-fluoro-2,3-dihydro-1H-inden-1-yl]-N,N-dimethyl-4-(1-methyl-1H-indol-3-yl)pyrrolidin-3-amine","InChI=1S/C24H28FN3/c1-26(2)23-15-28(22-12-11-16-7-6-9-20(25)24(16)22)14-19(23)18-13-27(3)21-10-5-4-8-17(18)21/h4-10,13,19,22-23H,11-12,14-15H2,1-3H3/t19-,22+,23+/m1/s1",XAWMNFFOVCNWGF-OIBXWCBGSA-N,1,3,0,0,WD40 / H3,9.00,lymphoma,Inhibition,
2086,123132213,4104741,,CN(C)[C@H]1CN(C[C@@H]1c1ccc(cc1)N1CCN(CC1)S(C)(=O)=O)C1CCc2cccc(F)c12,"(3R,4S)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-4-[4-(4-methanesulfonylpiperazin-1-yl)phenyl]-N,N-dimethylpyrrolidin-3-amine","InChI=1S/C26H35FN4O2S/c1-28(2)25-18-30(24-12-9-20-5-4-6-23(27)26(20)24)17-22(25)19-7-10-21(11-8-19)29-13-15-31(16-14-29)34(3,32)33/h4-8,10-11,22,24-25H,9,12-18H2,1-3H3/t22-,24?,25+/m1/s1",REVJNSVNICWODC-KIDMSAQOSA-N,4,3,0,0,WD40 / H3,9.40,lymphoma,Inhibition,
2087,123132222,,,CN(C)[C@@H]1CN(Cc2ccccc2)C[C@H]1c1ccc(cc1)N1CCN(CC1)S(C)(=O)=O,"(3S,4R)-1-benzyl-4-[4-(4-methanesulfonylpiperazin-1-yl)phenyl]-N,N-dimethylpyrrolidin-3-amine","InChI=1S/C24H34N4O2S/c1-25(2)24-19-26(17-20-7-5-4-6-8-20)18-23(24)21-9-11-22(12-10-21)27-13-15-28(16-14-27)31(3,29)30/h4-12,23-24H,13-19H2,1-3H3/t23-,24+/m0/s1",VEABDKBNQNHHCB-BJKOFHAPSA-N,2,0,0,0,WD40 / H3,5.88,lymphoma,Inhibition,
2088,168317474,,,COC(=O)c1ccc(NC(=O)c2ccc(NC(=O)c3ccc(c(OCc4ccccc4)n3)N(=O)=O)c(OCc3ccccc3)n2)c(OCCCN)n1,methyl 6-(3-aminopropoxy)-5-[6-(benzyloxy)-5-[6-(benzyloxy)-5-nitropyridine-2-amido]pyridine-2-amido]pyridine-2-carboxylate,"InChI=1S/C36H33N7O9/c1-49-36(46)29-16-15-27(33(42-29)50-20-8-19-37)38-31(44)25-13-14-28(34(40-25)51-21-23-9-4-2-5-10-23)39-32(45)26-17-18-30(43(47)48)35(41-26)52-22-24-11-6-3-7-12-24/h2-7,9-18H,8,19-22,37H2,1H3,(H,38,44)(H,39,45)",CZDOMMMFTOYYPZ-UHFFFAOYSA-N,2,0,0,0,WD40 / H3,6.12,lymphoma,Inhibition,
2089,53356803,3799591,,CCC(CC)(NC(=O)C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NC1(CCCC1)C(=O)NC(c1ccccc1)c1ccccc1,1-[(2S)-5-carbamimidamido-2-[2-ethyl-2-(2-methylpropanamido)butanamido]pentanamido]-N-(diphenylmethyl)cyclopentane-1-carboxamide,"InChI=1S/C35H51N7O4/c1-5-34(6-2,41-29(43)24(3)4)31(45)39-27(20-15-23-38-33(36)37)30(44)42-35(21-13-14-22-35)32(46)40-28(25-16-9-7-10-17-25)26-18-11-8-12-19-26/h7-12,16-19,24,27-28H,5-6,13-15,20-23H2,1-4H3,(H,39,45)(H,40,46)(H,41,43)(H,42,44)(H4,36,37,38)/t27-/m0/s1",BCIPILGGOSCOMC-MHZLTWQESA-N,3,0,0,0,WDR5/MLL,9.00,lymphoid leukemia (disease),Inhibition,
2090,71586081,3798088,,CC[C@@H]1NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@](C)(CCCCNC(=O)[C@H](NC1=O)c1ccccc1)NC(=O)C(C)C,"N-[(3R,6S,9S,12R)-9-(3-carbamimidamidopropyl)-6-ethyl-12-methyl-2,5,8,11-tetraoxo-3-phenyl-1,4,7,10-tetraazacyclohexadecan-12-yl]-2-methylpropanamide","InChI=1S/C29H46N8O5/c1-5-20-24(39)36-22(19-12-7-6-8-13-19)26(41)32-16-10-9-15-29(4,37-23(38)18(2)3)27(42)35-21(25(40)34-20)14-11-17-33-28(30)31/h6-8,12-13,18,20-22H,5,9-11,14-17H2,1-4H3,(H,32,41)(H,34,40)(H,35,42)(H,36,39)(H,37,38)(H4,30,31,33)/t20-,21-,22+,29+/m0/s1",SILRGLDFBXVGOQ-ZMROOPMESA-N,3,2,0,0,WDR5/MLL,9.05,lymphoid leukemia (disease),Inhibition,
2091,71586084,4116319,,CC[C@@H]1NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@](C)(CCCCN(C)C(=O)[C@H](NC1=O)c1ccccc1)NC(=O)C(C)C,"N-[(3R,6S,9S,12R)-9-(3-carbamimidamidopropyl)-6-ethyl-1,12-dimethyl-2,5,8,11-tetraoxo-3-phenyl-1,4,7,10-tetraazacyclohexadecan-12-yl]-2-methylpropanamide","InChI=1S/C30H48N8O5/c1-6-21-25(40)36-23(20-13-8-7-9-14-20)27(42)38(5)18-11-10-16-30(4,37-24(39)19(2)3)28(43)35-22(26(41)34-21)15-12-17-33-29(31)32/h7-9,13-14,19,21-23H,6,10-12,15-18H2,1-5H3,(H,34,41)(H,35,43)(H,36,40)(H,37,39)(H4,31,32,33)/t21-,22-,23+,30+/m0/s1",JBLHDYOCJVQGEP-CXDLDTBJSA-N,3,0,0,0,WDR5/MLL,9.00,lymphoid leukemia (disease),Inhibition,
2092,71586179,4117068,,CC[C@@H]1NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@](C)(CCCCN(C)C(=O)[C@H](NC1=O)c1ccc(F)cc1)NC(=O)C(C)C,"N-[(3R,6S,9S,12R)-9-(3-carbamimidamidopropyl)-6-ethyl-3-(4-fluorophenyl)-1,12-dimethyl-2,5,8,11-tetraoxo-1,4,7,10-tetraazacyclohexadecan-12-yl]-2-methylpropanamide","InChI=1S/C30H47FN8O5/c1-6-21-25(41)37-23(19-11-13-20(31)14-12-19)27(43)39(5)17-8-7-15-30(4,38-24(40)18(2)3)28(44)36-22(26(42)35-21)10-9-16-34-29(32)33/h11-14,18,21-23H,6-10,15-17H2,1-5H3,(H,35,42)(H,36,44)(H,37,41)(H,38,40)(H4,32,33,34)/t21-,22-,23+,30+/m0/s1",JGIIYJOEBDGPQO-CXDLDTBJSA-N,3,3,0,0,WDR5/MLL,9.00,lymphoid leukemia (disease),Inhibition,
2093,71585983,4116506,,CC[C@@H]1NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@](C)(CCCCN(C)C(=O)[C@H](NC1=O)c1ccc(Cl)cc1)NC(=O)C(C)C,"N-[(3R,6S,9S,12R)-9-(3-carbamimidamidopropyl)-3-(4-chlorophenyl)-6-ethyl-1,12-dimethyl-2,5,8,11-tetraoxo-1,4,7,10-tetraazacyclohexadecan-12-yl]-2-methylpropanamide","InChI=1S/C30H47ClN8O5/c1-6-21-25(41)37-23(19-11-13-20(31)14-12-19)27(43)39(5)17-8-7-15-30(4,38-24(40)18(2)3)28(44)36-22(26(42)35-21)10-9-16-34-29(32)33/h11-14,18,21-23H,6-10,15-17H2,1-5H3,(H,35,42)(H,36,44)(H,37,41)(H,38,40)(H4,32,33,34)/t21-,22-,23+,30+/m0/s1",KXYGAIVJVQJFDQ-CXDLDTBJSA-N,3,0,0,0,WDR5/MLL,9.00,lymphoid leukemia (disease),Inhibition,
2094,89610270,4116090,,CC[C@@H]1NC(=O)[C@H](CCCNC(=N)NC)NC(=O)[C@@](C)(CCCCNC(=O)[C@H](NC1=O)c1ccccc1)NC(=O)C(C)C,"N-[(3R,6S,9S,12R)-6-ethyl-12-methyl-9-[3-(N'-methylcarbamimidamido)propyl]-2,5,8,11-tetraoxo-3-phenyl-1,4,7,10-tetraazacyclohexadecan-12-yl]-2-methylpropanamide","InChI=1S/C30H48N8O5/c1-6-21-25(40)37-23(20-13-8-7-9-14-20)27(42)33-17-11-10-16-30(4,38-24(39)19(2)3)28(43)36-22(26(41)35-21)15-12-18-34-29(31)32-5/h7-9,13-14,19,21-23H,6,10-12,15-18H2,1-5H3,(H,33,42)(H,35,41)(H,36,43)(H,37,40)(H,38,39)(H3,31,32,34)/t21-,22-,23+,30+/m0/s1",SUXNCBRCYTZFPW-CXDLDTBJSA-N,3,2,0,0,WDR5/MLL,9.00,lymphoid leukemia (disease),Inhibition,
2095,89610269,4116682,,CC[C@@H]1NC(=O)[C@H](CCCNC(NC)=NC)NC(=O)[C@@](C)(CCCCNC(=O)[C@H](NC1=O)c1ccccc1)NC(=O)C(C)C,"N-[(3R,6S,9S,12R)-9-[3-(N',N''-dimethylcarbamimidamido)propyl]-6-ethyl-12-methyl-2,5,8,11-tetraoxo-3-phenyl-1,4,7,10-tetraazacyclohexadecan-12-yl]-2-methylpropanamide","InChI=1S/C31H50N8O5/c1-7-22-26(41)38-24(21-14-9-8-10-15-21)28(43)34-18-12-11-17-31(4,39-25(40)20(2)3)29(44)37-23(27(42)36-22)16-13-19-35-30(32-5)33-6/h8-10,14-15,20,22-24H,7,11-13,16-19H2,1-6H3,(H,34,43)(H,36,42)(H,37,44)(H,38,41)(H,39,40)(H2,32,33,35)/t22-,23-,24+,31+/m0/s1",DAOYDPRFSPLOQX-UBWFJNMSSA-N,3,3,0,0,WDR5/MLL,9.00,lymphoid leukemia (disease),Inhibition,
2096,89610953,4086690,,CC[C@H]1NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@](C)(CCCCNC(=O)[C@@H](NC1=O)c1ccccc1)NC(=O)C(C)C,"N-[(3S,6R,9R,12S)-9-(3-carbamimidamidopropyl)-6-ethyl-12-methyl-2,5,8,11-tetraoxo-3-phenyl-1,4,7,10-tetraazacyclohexadecan-12-yl]-2-methylpropanamide","InChI=1S/C29H46N8O5/c1-5-20-24(39)36-22(19-12-7-6-8-13-19)26(41)32-16-10-9-15-29(4,37-23(38)18(2)3)27(42)35-21(25(40)34-20)14-11-17-33-28(30)31/h6-8,12-13,18,20-22H,5,9-11,14-17H2,1-4H3,(H,32,41)(H,34,40)(H,35,42)(H,36,39)(H,37,38)(H4,30,31,33)/t20-,21-,22+,29+/m1/s1",SILRGLDFBXVGOQ-WWJNNCHVSA-N,0,0,0,0,,,,,
2097,137630040,4116447,,CC[C@@H]1NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CNC(=O)[C@H](NC1=O)c1ccccc1)NC(=O)C(C)C,"N-[(3R,6S,9S,12R)-9-(3-carbamimidamidopropyl)-6-ethyl-2,5,8,11-tetraoxo-3-phenyl-1,4,7,10-tetraazacyclotridecan-12-yl]-2-methylpropanamide","InChI=1S/C25H38N8O5/c1-4-16-21(35)33-19(15-9-6-5-7-10-15)24(38)29-13-18(32-20(34)14(2)3)23(37)31-17(22(36)30-16)11-8-12-28-25(26)27/h5-7,9-10,14,16-19H,4,8,11-13H2,1-3H3,(H,29,38)(H,30,36)(H,31,37)(H,32,34)(H,33,35)(H4,26,27,28)/t16-,17-,18+,19+/m0/s1",HITKRNXBNHCNTJ-INDMIFKZSA-N,2,0,0,0,WDR5/MLL,6.62,lymphoid leukemia (disease),Inhibition,
2098,168317782,,,CC[C@@H]1NC(=O)[C@H](CCCNC(N)=N)NC(=O)C(CCNC(=O)[C@H](NC1=O)c1ccccc1)NC(=O)C(C)C,"N-[(3R,6S,9S)-9-(3-carbamimidamidopropyl)-6-ethyl-2,5,8,11-tetraoxo-3-phenyl-1,4,7,10-tetraazacyclotetradecan-12-yl]-2-methylpropanamide","InChI=1S/C26H40N8O5/c1-4-17-22(36)34-20(16-9-6-5-7-10-16)25(39)29-14-12-19(32-21(35)15(2)3)24(38)33-18(23(37)31-17)11-8-13-30-26(27)28/h5-7,9-10,15,17-20H,4,8,11-14H2,1-3H3,(H,29,39)(H,31,37)(H,32,35)(H,33,38)(H,34,36)(H4,27,28,30)/t17-,18-,19?,20+/m0/s1",XPDKPUAGAKXLIS-QFJIIPRISA-N,3,2,0,0,WDR5/MLL,9.10,lymphoid leukemia (disease),Inhibition,
2099,137630010,4116408,,CC[C@@H]1NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCNC(=O)[C@H](NC1=O)c1ccccc1)NC(=O)C(C)C,"N-[(3R,6S,9S,12R)-9-(3-carbamimidamidopropyl)-6-ethyl-2,5,8,11-tetraoxo-3-phenyl-1,4,7,10-tetraazacyclopentadecan-12-yl]-2-methylpropanamide","InChI=1S/C27H42N8O5/c1-4-18-23(37)35-21(17-10-6-5-7-11-17)26(40)30-14-8-12-19(33-22(36)16(2)3)25(39)34-20(24(38)32-18)13-9-15-31-27(28)29/h5-7,10-11,16,18-21H,4,8-9,12-15H2,1-3H3,(H,30,40)(H,32,38)(H,33,36)(H,34,39)(H,35,37)(H4,28,29,31)/t18-,19+,20-,21+/m0/s1",TYRJPXXEXDBARQ-JSXRDJHFSA-N,2,0,0,0,WDR5/MLL,7.48,lymphoid leukemia (disease),Inhibition,
2100,137630583,4116915,,CC[C@@H]1NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](NC1=O)c1ccccc1)NC(=O)C(C)C,"N-[(3R,6S,9S,12R)-9-(3-carbamimidamidopropyl)-6-ethyl-2,5,8,11-tetraoxo-3-phenyl-1,4,7,10-tetraazacyclohexadecan-12-yl]-2-methylpropanamide","InChI=1S/C28H44N8O5/c1-4-19-24(38)36-22(18-11-6-5-7-12-18)27(41)31-15-9-8-13-20(34-23(37)17(2)3)26(40)35-21(25(39)33-19)14-10-16-32-28(29)30/h5-7,11-12,17,19-22H,4,8-10,13-16H2,1-3H3,(H,31,41)(H,33,39)(H,34,37)(H,35,40)(H,36,38)(H4,29,30,32)/t19-,20+,21-,22+/m0/s1",PYARBFPEJRKODC-LNRXMEIDSA-N,2,0,0,0,WDR5/MLL,7.22,lymphoid leukemia (disease),Inhibition,
2101,135381590,4117123,,CC[C@@H]1NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@](C)(CCNC(=O)[C@H](NC1=O)c1ccccc1)NC(=O)C(C)C,"N-[(3R,6S,9S,12R)-9-(3-carbamimidamidopropyl)-6-ethyl-12-methyl-2,5,8,11-tetraoxo-3-phenyl-1,4,7,10-tetraazacyclotetradecan-12-yl]-2-methylpropanamide","InChI=1S/C27H42N8O5/c1-5-18-22(37)34-20(17-10-7-6-8-11-17)24(39)30-15-13-27(4,35-21(36)16(2)3)25(40)33-19(23(38)32-18)12-9-14-31-26(28)29/h6-8,10-11,16,18-20H,5,9,12-15H2,1-4H3,(H,30,39)(H,32,38)(H,33,40)(H,34,37)(H,35,36)(H4,28,29,31)/t18-,19-,20+,27+/m0/s1",NNIBWLKDWXOMEW-UDOOFANFSA-N,3,3,0,0,WDR5/MLL,9.00,lymphoid leukemia (disease),Inhibition,
2102,135382165,4117723,,CC[C@@H]1NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@](C)(CCCNC(=O)[C@H](NC1=O)c1ccccc1)NC(=O)C(C)C,"N-[(3R,6S,9S,12R)-9-(3-carbamimidamidopropyl)-6-ethyl-12-methyl-2,5,8,11-tetraoxo-3-phenyl-1,4,7,10-tetraazacyclopentadecan-12-yl]-2-methylpropanamide","InChI=1S/C28H44N8O5/c1-5-19-23(38)35-21(18-11-7-6-8-12-18)25(40)31-16-10-14-28(4,36-22(37)17(2)3)26(41)34-20(24(39)33-19)13-9-15-32-27(29)30/h6-8,11-12,17,19-21H,5,9-10,13-16H2,1-4H3,(H,31,40)(H,33,39)(H,34,41)(H,35,38)(H,36,37)(H4,29,30,32)/t19-,20-,21+,28+/m0/s1",PRAJCBYVBKZLED-LDFBIXNTSA-N,3,3,0,0,WDR5/MLL,9.01,lymphoid leukemia (disease),Inhibition,
2103,168317776,,,CC[C@@H]1NC(=O)C(CCCNC(N)=N)NC(=O)[C@@](C)(CCCCCNC(=O)[C@H](NC1=O)c1ccccc1)NC(=O)C(C)C,"N-[(3R,6S,12R)-9-(3-carbamimidamidopropyl)-6-ethyl-12-methyl-2,5,8,11-tetraoxo-3-phenyl-1,4,7,10-tetraazacycloheptadecan-12-yl]-2-methylpropanamide","InChI=1S/C30H48N8O5/c1-5-21-25(40)37-23(20-13-8-6-9-14-20)27(42)33-17-11-7-10-16-30(4,38-24(39)19(2)3)28(43)36-22(26(41)35-21)15-12-18-34-29(31)32/h6,8-9,13-14,19,21-23H,5,7,10-12,15-18H2,1-4H3,(H,33,42)(H,35,41)(H,36,43)(H,37,40)(H,38,39)(H4,31,32,34)/t21-,22?,23+,30+/m0/s1",NFWMDBLMPSEJGD-PVFVZEHHSA-N,3,2,0,0,WDR5/MLL,9.00,lymphoid leukemia (disease),Inhibition,
2104,71586082,,,CC[C@@H]1NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@](C)(CCCCCCNC(=O)[C@H](NC1=O)c1ccccc1)NC(=O)C(C)C,"N-[(3R,6S,9S,12R)-9-(3-carbamimidamidopropyl)-6-ethyl-12-methyl-2,5,8,11-tetraoxo-3-phenyl-1,4,7,10-tetraazacyclooctadecan-12-yl]-2-methylpropanamide","InChI=1S/C31H50N8O5/c1-5-22-26(41)38-24(21-14-9-8-10-15-21)28(43)34-18-12-7-6-11-17-31(4,39-25(40)20(2)3)29(44)37-23(27(42)36-22)16-13-19-35-30(32)33/h8-10,14-15,20,22-24H,5-7,11-13,16-19H2,1-4H3,(H,34,43)(H,36,42)(H,37,44)(H,38,41)(H,39,40)(H4,32,33,35)/t22-,23-,24+,31+/m0/s1",OFICXTRETNQZCW-UBWFJNMSSA-N,3,3,0,0,WDR5/MLL,9.00,lymphoid leukemia (disease),Inhibition,
2105,,,,CC[C@@H]1NC(=O)C([CH]CCNC(N)=N)NC(=O)[C@@](C)(CCCCCCCCNC(=O)[C@H](NC1=O)c1ccccc1)NC(=O)C(C)C,"3-carbamimidamido-1-[(5S,8R,19R)-5-ethyl-19-methyl-19-(2-methylpropanamido)-3,6,9,20-tetraoxo-8-phenyl-1,4,7,10-tetraazacycloicosan-2-yl]propyl","InChI=1S/C33H53N8O5/c1-5-24-28(43)40-26(23-16-11-10-12-17-23)30(45)36-20-14-9-7-6-8-13-19-33(4,41-27(42)22(2)3)31(46)39-25(29(44)38-24)18-15-21-37-32(34)35/h10-12,16-18,22,24-26H,5-9,13-15,19-21H2,1-4H3,(H,36,45)(H,38,44)(H,39,46)(H,40,43)(H,41,42)(H4,34,35,37)/t24-,25?,26+,33+/m0/s1",PWVZQWAQCMDYLO-FGWOXDHBSA-N,3,2,0,0,WDR5/MLL,9.00,lymphoid leukemia (disease),Inhibition,
2106,129010138,4116919,,CC[C@@H]1NC(=O)[C@H](CCCNC(=N)NC)NC(=O)[C@@](C)(CCNC(=O)[C@H](NC1=O)c1ccccc1)NC(=O)C(C)C,"N-[(3R,6S,9S,12R)-6-ethyl-12-methyl-9-[3-(N'-methylcarbamimidamido)propyl]-2,5,8,11-tetraoxo-3-phenyl-1,4,7,10-tetraazacyclotetradecan-12-yl]-2-methylpropanamide","InChI=1S/C28H44N8O5/c1-6-19-23(38)35-21(18-11-8-7-9-12-18)25(40)31-16-14-28(4,36-22(37)17(2)3)26(41)34-20(24(39)33-19)13-10-15-32-27(29)30-5/h7-9,11-12,17,19-21H,6,10,13-16H2,1-5H3,(H,31,40)(H,33,39)(H,34,41)(H,35,38)(H,36,37)(H3,29,30,32)/t19-,20-,21+,28+/m0/s1",ZAIPJVQTYUSDTG-LDFBIXNTSA-N,3,3,0,0,WDR5/MLL,9.05,lymphoid leukemia (disease),Inhibition,
2107,137630163,4116579,,CC[C@@H]1NC(=O)[C@H](CCCNC(=N)NC)NC(=O)[C@@](C)(CCNC(=O)[C@@H](NC1=O)c1ccccc1)NC(=O)C(C)C,"N-[(3S,6S,9S,12R)-6-ethyl-12-methyl-9-[3-(N'-methylcarbamimidamido)propyl]-2,5,8,11-tetraoxo-3-phenyl-1,4,7,10-tetraazacyclotetradecan-12-yl]-2-methylpropanamide","InChI=1S/C28H44N8O5/c1-6-19-23(38)35-21(18-11-8-7-9-12-18)25(40)31-16-14-28(4,36-22(37)17(2)3)26(41)34-20(24(39)33-19)13-10-15-32-27(29)30-5/h7-9,11-12,17,19-21H,6,10,13-16H2,1-5H3,(H,31,40)(H,33,39)(H,34,41)(H,35,38)(H,36,37)(H3,29,30,32)/t19-,20-,21-,28+/m0/s1",ZAIPJVQTYUSDTG-MLWROCFZSA-N,3,2,0,0,WDR5/MLL,9.00,lymphoid leukemia (disease),Inhibition,
2108,,3601398,,COc1cc2CC(=O)N([C@@H](c3ccc(Cl)cc3)c2cc1OC(C)C)c1ccc(cc1)N(C)C[C@H]1CC[C@@H](CC1)N1CCN(C)C(=O)C1,"(1S)-1-(4-chlorophenyl)-6-methoxy-2-{4-[methyl({[(1r,4r)-4-(4-methyl-3-oxopiperazin-1-yl)cyclohexyl]methyl})amino]phenyl}-7-(propan-2-yloxy)-1,2,3,4-tetrahydroisoquinolin-3-one","InChI=1S/C38H47ClN4O4/c1-25(2)47-35-22-33-28(20-34(35)46-5)21-36(44)43(38(33)27-8-10-29(39)11-9-27)32-16-14-30(15-17-32)41(4)23-26-6-12-31(13-7-26)42-19-18-40(3)37(45)24-42/h8-11,14-17,20,22,25-26,31,38H,6-7,12-13,18-19,21,23-24H2,1-5H3/t26-,31-,38-/m0/s1",CLRSLRWKONPSRQ-IIPSPAQQSA-N,2,2,0,0,MDM2-Like / P53,8.77,cancer,Inhibition,
2109,58437867,3601317,,CC[C@@H](C)Oc1cc2[C@@H](N(C(=O)Cc2cc1OC)c1ccc(cc1)N(C)Cc1ccncc1)c1ccc(Cl)cc1,"(1S)-7-[(2R)-butan-2-yloxy]-1-(4-chlorophenyl)-6-methoxy-2-(4-{methyl[(pyridin-4-yl)methyl]amino}phenyl)-1,2,3,4-tetrahydroisoquinolin-3-one","InChI=1S/C33H34ClN3O3/c1-5-22(2)40-31-20-29-25(18-30(31)39-4)19-32(38)37(33(29)24-6-8-26(34)9-7-24)28-12-10-27(11-13-28)36(3)21-23-14-16-35-17-15-23/h6-18,20,22,33H,5,19,21H2,1-4H3/t22-,33+/m1/s1",RNOXGLRIZIHGIA-NBLPZQPVSA-N,1,1,0,0,MDM2-Like / P53,8.10,cancer,Inhibition,
2110,91668542,3769979,,COc1ccc(cc1OC)-c1cn(C)c(=O)c2cc(sc12)C(=O)N1CCN(CC1)S(C)(=O)=O,"7-(3,4-dimethoxyphenyl)-2-(4-methanesulfonylpiperazine-1-carbonyl)-5-methyl-4H,5H-thieno[3,2-c]pyridin-4-one","InChI=1S/C22H25N3O6S2/c1-23-13-16(14-5-6-17(30-2)18(11-14)31-3)20-15(21(23)26)12-19(32-20)22(27)24-7-9-25(10-8-24)33(4,28)29/h5-6,11-13H,7-10H2,1-4H3",BEIFGZXXCPXAAY-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,6.70,cancer,Inhibition,
2111,127025980,3771218,,COc1ccc(cc1OC)-c1cn(C)c(=O)c2cc(sc12)C(=O)N1CCCCC1,"7-(3,4-dimethoxyphenyl)-5-methyl-2-(piperidine-1-carbonyl)-4H,5H-thieno[3,2-c]pyridin-4-one","InChI=1S/C22H24N2O4S/c1-23-13-16(14-7-8-17(27-2)18(11-14)28-3)20-15(21(23)25)12-19(29-20)22(26)24-9-5-4-6-10-24/h7-8,11-13H,4-6,9-10H2,1-3H3",TWNMJRDGUZTHLI-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,5.40,cancer,Inhibition,
2112,127025981,3771308,,COc1ccc(cc1OC)-c1cn(C)c(=O)c2cc(sc12)C(=O)N(C)C,"7-(3,4-dimethoxyphenyl)-N,N,5-trimethyl-4-oxo-4H,5H-thieno[3,2-c]pyridine-2-carboxamide","InChI=1S/C19H20N2O4S/c1-20(2)19(23)16-9-12-17(26-16)13(10-21(3)18(12)22)11-6-7-14(24-4)15(8-11)25-5/h6-10H,1-5H3",BHBYXNDWTCOCCG-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,5.30,cancer,Inhibition,
2113,127025982,3770039,,CNC(=O)c1cc2c(s1)c(cn(C)c2=O)-c1ccc(OC)c(OC)c1,"7-(3,4-dimethoxyphenyl)-N,5-dimethyl-4-oxo-4H,5H-thieno[3,2-c]pyridine-2-carboxamide","InChI=1S/C18H18N2O4S/c1-19-17(21)15-8-11-16(25-15)12(9-20(2)18(11)22)10-5-6-13(23-3)14(7-10)24-4/h5-9H,1-4H3,(H,19,21)",NMMSMXOCHXLFTJ-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,6.90,cancer,Inhibition,
2114,91668539,3769688,,COc1ccc(cc1OC)-c1cn(C)c(=O)c2cc(sc12)C(=O)NC1CCS(=O)(=O)CC1,"7-(3,4-dimethoxyphenyl)-N-(1,1-dioxo-1lambda6-thian-4-yl)-5-methyl-4-oxo-4H,5H-thieno[3,2-c]pyridine-2-carboxamide","InChI=1S/C22H24N2O6S2/c1-24-12-16(13-4-5-17(29-2)18(10-13)30-3)20-15(22(24)26)11-19(31-20)21(25)23-14-6-8-32(27,28)9-7-14/h4-5,10-12,14H,6-9H2,1-3H3,(H,23,25)",ZJDRXPZROJHILR-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,7.90,cancer,Inhibition,
2115,127025419,3770367,,CNC(=N)c1cc2c(s1)c(cn(C)c2=O)-c1ccc(OC)c(OC)c1,"7-(3,4-dimethoxyphenyl)-N,5-dimethyl-4-oxo-4H,5H-thieno[3,2-c]pyridine-2-carboximidamide","InChI=1S/C18H19N3O3S/c1-20-17(19)15-8-11-16(25-15)12(9-21(2)18(11)22)10-5-6-13(23-3)14(7-10)24-4/h5-9H,1-4H3,(H2,19,20)",OWJKWJIJOSMALG-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,7.10,cancer,Inhibition,
2116,127025420,3770188,,COc1ccc(cc1OC)-c1cn(C)c(=O)c2cc(sc12)C(=N)NC1CCS(=O)(=O)CC1,"7-(3,4-dimethoxyphenyl)-N-(1,1-dioxo-1lambda6-thian-4-yl)-5-methyl-4-oxo-4H,5H-thieno[3,2-c]pyridine-2-carboximidamide","InChI=1S/C22H25N3O5S2/c1-25-12-16(13-4-5-17(29-2)18(10-13)30-3)20-15(22(25)26)11-19(31-20)21(23)24-14-6-8-32(27,28)9-7-14/h4-5,10-12,14H,6-9H2,1-3H3,(H2,23,24)",KCZMLIMZGLNMQN-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,8.10,cancer,Inhibition,
2117,127026594,3769509,,Cn1cc(-c2ccccc2)c2sc(cc2c1=O)C(=N)NC1CCS(=O)(=O)CC1,"N-(1,1-dioxo-1lambda6-thian-4-yl)-5-methyl-4-oxo-7-phenyl-4H,5H-thieno[3,2-c]pyridine-2-carboximidamide","InChI=1S/C20H21N3O3S2/c1-23-12-16(13-5-3-2-4-6-13)18-15(20(23)24)11-17(27-18)19(21)22-14-7-9-28(25,26)10-8-14/h2-6,11-12,14H,7-10H2,1H3,(H2,21,22)",TTYKSANGMNELCB-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,7.40,cancer,Inhibition,
2118,127026595,3769855,,COc1cccc(c1)-c1cn(C)c(=O)c2cc(sc12)C(=N)NC1CCS(=O)(=O)CC1,"N-(1,1-dioxo-1lambda6-thian-4-yl)-7-(3-methoxyphenyl)-5-methyl-4-oxo-4H,5H-thieno[3,2-c]pyridine-2-carboximidamide","InChI=1S/C21H23N3O4S2/c1-24-12-17(13-4-3-5-15(10-13)28-2)19-16(21(24)25)11-18(29-19)20(22)23-14-6-8-30(26,27)9-7-14/h3-5,10-12,14H,6-9H2,1-2H3,(H2,22,23)",TWAMSFSFBGEKAM-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,7.90,cancer,Inhibition,
2119,127025697,3769944,,CN(C)c1cccc(c1)-c1cn(C)c(=O)c2cc(sc12)C(=N)NC1CCS(=O)(=O)CC1,"7-[3-(dimethylamino)phenyl]-N-(1,1-dioxo-1lambda6-thian-4-yl)-5-methyl-4-oxo-4H,5H-thieno[3,2-c]pyridine-2-carboximidamide","InChI=1S/C22H26N4O3S2/c1-25(2)16-6-4-5-14(11-16)18-13-26(3)22(27)17-12-19(30-20(17)18)21(23)24-15-7-9-31(28,29)10-8-15/h4-6,11-13,15H,7-10H2,1-3H3,(H2,23,24)",MOYOGONDTNZILF-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,8.00,cancer,Inhibition,
2120,127025979,3769628,,Cn1cc(-c2cccc(c2)C#N)c2sc(cc2c1=O)C(=N)NC1CCS(=O)(=O)CC1,"7-(3-cyanophenyl)-N-(1,1-dioxo-1lambda6-thian-4-yl)-5-methyl-4-oxo-4H,5H-thieno[3,2-c]pyridine-2-carboximidamide","InChI=1S/C21H20N4O3S2/c1-25-12-17(14-4-2-3-13(9-14)11-22)19-16(21(25)26)10-18(29-19)20(23)24-15-5-7-30(27,28)8-6-15/h2-4,9-10,12,15H,5-8H2,1H3,(H2,23,24)",DJOZNJRNLBIYQT-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,7.40,cancer,Inhibition,
2121,91668540,3770949,,Cn1cc(-c2cccc(c2)C(F)(F)F)c2sc(cc2c1=O)C(N)=NC1CCS(=O)(=O)CC1,"N'-(1,1-dioxo-1lambda6-thian-4-yl)-5-methyl-4-oxo-7-[3-(trifluoromethyl)phenyl]-4H,5H-thieno[3,2-c]pyridine-2-carboximidamide","InChI=1S/C21H20F3N3O3S2/c1-27-11-16(12-3-2-4-13(9-12)21(22,23)24)18-15(20(27)28)10-17(31-18)19(25)26-14-5-7-32(29,30)8-6-14/h2-4,9-11,14H,5-8H2,1H3,(H2,25,26)",UCISVEKCUIGBJX-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,7.80,cancer,Inhibition,
2122,,,,n1(c(=O)c2c(c(c1)c1cc(ccc1)C(F)(F)F)sc(c2)C(=N)NC1CCS(=O)(=O)CC1)CC,,,,,,,,,,,,
2123,127026593,3770716,,CC(C)n1cc(-c2cccc(c2)C(F)(F)F)c2sc(cc2c1=O)C(=N)NC1CCS(=O)(=O)CC1,"N-(1,1-dioxo-1lambda6-thian-4-yl)-4-oxo-5-(propan-2-yl)-7-[3-(trifluoromethyl)phenyl]-4H,5H-thieno[3,2-c]pyridine-2-carboximidamide","InChI=1S/C23H24F3N3O3S2/c1-13(2)29-12-18(14-4-3-5-15(10-14)23(24,25)26)20-17(22(29)30)11-19(33-20)21(27)28-16-6-8-34(31,32)9-7-16/h3-5,10-13,16H,6-9H2,1-2H3,(H2,27,28)",LXOSYHIAUKYCPF-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,5.50,cancer,Inhibition,
2124,118439587,4776839,,OC(=O)c1ccc(cc1)[C@H]1C[C@H]2[C@@H](N1)[C@H](c1cccc(Cl)c1F)[C@@]1(N2CC2CC2)C(=O)Nc2cc(Cl)ccc12,"4-[(3S,3'S,3'aS,5'R,6'aS)-6-chloro-3'-(3-chloro-2-fluorophenyl)-1'-(cyclopropylmethyl)-2-oxo-1,2,3',3'a,4',5',6',6'a-octahydro-1'H-spiro[indole-3,2'-pyrrolo[3,2-b]pyrrol]-5'-yl]benzoic acid","InChI=1S/C30H26Cl2FN3O3/c31-18-10-11-20-23(12-18)35-29(39)30(20)25(19-2-1-3-21(32)26(19)33)27-24(36(30)14-15-4-5-15)13-22(34-27)16-6-8-17(9-7-16)28(37)38/h1-3,6-12,15,22,24-25,27,34H,4-5,13-14H2,(H,35,39)(H,37,38)/t22-,24+,25+,27-,30-/m1/s1",CCPUFNJKOGKOOG-AFKAWQRRSA-N,1,1,0,0,MDM2-Like / P53,8.40,cancer,Inhibition,
2125,122198471,4785458,,CC(C)(C)CN1C[C@@H](N)[C@H](c2cccc(Cl)c2)[C@]11C(=O)Nc2cc(Cl)ccc12,"(3S,3'S,4'S)-4'-amino-6-chloro-3'-(3-chlorophenyl)-1'-(2,2-dimethylpropyl)-1,2-dihydrospiro[indole-3,2'-pyrrolidin]-2-one","InChI=1S/C22H25Cl2N3O/c1-21(2,3)12-27-11-17(25)19(13-5-4-6-14(23)9-13)22(27)16-8-7-15(24)10-18(16)26-20(22)28/h4-10,17,19H,11-12,25H2,1-3H3,(H,26,28)/t17-,19+,22-/m1/s1",CWDGHXCEKKZGEC-ZWCUEREDSA-N,1,0,0,0,MDM2-Like / P53,7.47,cancer,Inhibition,
2126,122198472,4756922,,CCOc1cccc(CN2[C@@H](C)[C@@H](N)[C@H](c3cccc(Cl)c3F)[C@]22C(=O)Nc3cc(Cl)ccc23)c1,"(3S,3'S,4'S,5'S)-4'-amino-6-chloro-3'-(3-chloro-2-fluorophenyl)-1'-[(3-ethoxyphenyl)methyl]-5'-methyl-1,2-dihydrospiro[indole-3,2'-pyrrolidin]-2-one","InChI=1S/C27H26Cl2FN3O2/c1-3-35-18-7-4-6-16(12-18)14-33-15(2)25(31)23(19-8-5-9-21(29)24(19)30)27(33)20-11-10-17(28)13-22(20)32-26(27)34/h4-13,15,23,25H,3,14,31H2,1-2H3,(H,32,34)/t15-,23-,25+,27+/m0/s1",VTZPRLPCZBTKSH-VFICKSILSA-N,1,0,0,0,MDM2-Like / P53,6.09,cancer,Inhibition,
2127,118439641,4739921,,OC(=O)CN1CC[C@H]2[C@@H]1[C@H](c1cccc(Cl)c1)[C@@]1(N2CC2CC2)C(=O)Nc2cc(Cl)ccc12,"2-[(3S,3'S,3'aS,6'aS)-6-chloro-3'-(3-chlorophenyl)-1'-(cyclopropylmethyl)-2-oxo-1,2,3',3'a,4',5',6',6'a-octahydro-1'H-spiro[indole-3,2'-pyrrolo[3,2-b]pyrrol]-4'-yl]acetic acid","InChI=1S/C25H25Cl2N3O3/c26-16-3-1-2-15(10-16)22-23-20(8-9-29(23)13-21(31)32)30(12-14-4-5-14)25(22)18-7-6-17(27)11-19(18)28-24(25)33/h1-3,6-7,10-11,14,20,22-23H,4-5,8-9,12-13H2,(H,28,33)(H,31,32)/t20-,22-,23+,25+/m0/s1",PECRYANCKVXSRI-FDHFVPJWSA-N,1,0,0,0,MDM2-Like / P53,7.10,cancer,Inhibition,
2128,135566877,2436013,,Cc1cccnc1-n1nc(nc1-c1c[nH]c(=O)c(Cl)c1)-c1ccccc1,"3-chloro-5-[1-(3-methylpyridin-2-yl)-3-phenyl-1H-1,2,4-triazol-5-yl]-1,2-dihydropyridin-2-one","InChI=1S/C19H14ClN5O/c1-12-6-5-9-21-17(12)25-18(14-10-15(20)19(26)22-11-14)23-16(24-25)13-7-3-2-4-8-13/h2-11H,1H3,(H,22,26)",NVMAHFDIMUFGEC-UHFFFAOYSA-N,1,0,0,0,Bromodomain / Histone,5.33,cancer,Inhibition,
2129,2782959,2436014,,Cc1noc(N)c1-c1cccc(c1)C(F)(F)F,"3-methyl-4-[3-(trifluoromethyl)phenyl]-1,2-oxazol-5-amine","InChI=1S/C11H9F3N2O/c1-6-9(10(15)17-16-6)7-3-2-4-8(5-7)11(12,13)14/h2-5H,15H2,1H3",RCAOVLVIOVBPIB-UHFFFAOYSA-N,1,0,0,0,Bromodomain / Histone,4.09,cancer,Inhibition,
2130,9328193,2436015,,CN(Cc1ccc(C)cc1)c1cc(C)nc2ncnn12,"N,5-dimethyl-N-[(4-methylphenyl)methyl]-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine","InChI=1S/C15H17N5/c1-11-4-6-13(7-5-11)9-19(3)14-8-12(2)18-15-16-10-17-20(14)15/h4-8,10H,9H2,1-3H3",JAEVUMCKPBRDAJ-UHFFFAOYSA-N,0,0,0,0,,,,,
2131,975713,1421650,,Cc1cc(-c2ccccc2)n2nc(N)nc2n1,"5-methyl-7-phenyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine","InChI=1S/C12H11N5/c1-8-7-10(9-5-3-2-4-6-9)17-12(14-8)15-11(13)16-17/h2-7H,1H3,(H2,13,16)",ZCOHGHCESYZASH-UHFFFAOYSA-N,0,0,0,0,,,,,
2132,39796783,2436016,,CC(=O)Nc1cccc(c1)-c1cc(C)nc2ccccc12,N-[3-(2-methylquinolin-4-yl)phenyl]acetamide,"InChI=1S/C18H16N2O/c1-12-10-17(16-8-3-4-9-18(16)19-12)14-6-5-7-15(11-14)20-13(2)21/h3-11H,1-2H3,(H,20,21)",UMONOEYUBSYABK-UHFFFAOYSA-N,0,0,0,0,,,,,
2133,52908295,2436001,,Cn1ccc2cc[nH]c(=O)c12,"1-methyl-1H,6H,7H-pyrrolo[2,3-c]pyridin-7-one","InChI=1S/C8H8N2O/c1-10-5-3-6-2-4-9-8(11)7(6)10/h2-5H,1H3,(H,9,11)",MKLDTQZQFAGIBR-UHFFFAOYSA-N,0,0,0,0,,,,,
2134,136060436,2436002,,CC(C)c1nc(-c2c[nH]c(=O)c(Cl)c2)n(n1)-c1ccncc1C,"3-chloro-5-[1-(3-methylpyridin-4-yl)-3-(propan-2-yl)-1H-1,2,4-triazol-5-yl]-1,2-dihydropyridin-2-one","InChI=1S/C16H16ClN5O/c1-9(2)14-20-15(11-6-12(17)16(23)19-8-11)22(21-14)13-4-5-18-7-10(13)3/h4-9H,1-3H3,(H,19,23)",YLAJZDPZPGZQBG-UHFFFAOYSA-N,0,0,0,0,,,,,
2135,136244604,2436003,,CC(C)Cc1nc(-c2c[nH]c(=O)c(Cl)c2)n(n1)-c1cccc2OCCOc12,"3-chloro-5-[1-(2,3-dihydro-1,4-benzodioxin-5-yl)-3-(2-methylpropyl)-1H-1,2,4-triazol-5-yl]-1,2-dihydropyridin-2-one","InChI=1S/C19H19ClN4O3/c1-11(2)8-16-22-18(12-9-13(20)19(25)21-10-12)24(23-16)14-4-3-5-15-17(14)27-7-6-26-15/h3-5,9-11H,6-8H2,1-2H3,(H,21,25)",ADJRVHQGKHBURM-UHFFFAOYSA-N,1,0,0,0,Bromodomain / Histone,4.11,cancer,Inhibition,
2136,136014790,2436004,,Cc1nc(-c2c[nH]c(=O)c(Cl)c2)n(n1)-c1ccc(F)cc1,"3-chloro-5-[1-(4-fluorophenyl)-3-methyl-1H-1,2,4-triazol-5-yl]-1,2-dihydropyridin-2-one","InChI=1S/C14H10ClFN4O/c1-8-18-13(9-6-12(15)14(21)17-7-9)20(19-8)11-4-2-10(16)3-5-11/h2-7H,1H3,(H,17,21)",ZALGEOPJUDTSFF-UHFFFAOYSA-N,0,0,0,0,,,,,
2137,2295889,1333793,,Cc1cc(-c2ccccc2)n2ncnc2n1,"5-methyl-7-phenyl-[1,2,4]triazolo[1,5-a]pyrimidine","InChI=1S/C12H10N4/c1-9-7-11(10-5-3-2-4-6-10)16-12(15-9)13-8-14-16/h2-8H,1H3",DTGGUFCUGLHNTE-UHFFFAOYSA-N,0,0,0,0,,,,,
2138,17481591,2436005,,CN(Cc1ccc(Cl)s1)c1cc(C)nc2ncnn12,"N-[(5-chlorothiophen-2-yl)methyl]-N,5-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine","InChI=1S/C12H12ClN5S/c1-8-5-11(18-12(16-8)14-7-15-18)17(2)6-9-3-4-10(13)19-9/h3-5,7H,6H2,1-2H3",XPXXKLPLYCUUND-UHFFFAOYSA-N,1,0,0,0,Bromodomain / Histone,4.62,cancer,Inhibition,
2139,72713634,2436006,,CN(Cc1ccc(C)cc1)c1cc(C)nc2nc(N)nn12,"5,N7-dimethyl-N7-[(4-methylphenyl)methyl]-[1,2,4]triazolo[1,5-a]pyrimidine-2,7-diamine","InChI=1S/C15H18N6/c1-10-4-6-12(7-5-10)9-20(3)13-8-11(2)17-15-18-14(16)19-21(13)15/h4-8H,9H2,1-3H3,(H2,16,19)",UFBCIQRXVIIFKB-UHFFFAOYSA-N,1,0,0,0,Bromodomain / Histone,4.18,cancer,Inhibition,
2140,72713635,2436007,,Cc1ccc(CNc2cc(C)nc3nc(N)nn23)cc1,"5-methyl-N7-[(4-methylphenyl)methyl]-[1,2,4]triazolo[1,5-a]pyrimidine-2,7-diamine","InChI=1S/C14H16N6/c1-9-3-5-11(6-4-9)8-16-12-7-10(2)17-14-18-13(15)19-20(12)14/h3-7,16H,8H2,1-2H3,(H2,15,19)",RHQVLDPPUVPKNZ-UHFFFAOYSA-N,1,0,0,0,Bromodomain / Histone,4.13,cancer,Inhibition,
2141,72713636,2436008,,CN(Cc1ccc(Cl)s1)c1cc(C)nc2nc(N)nn12,"N7-[(5-chlorothiophen-2-yl)methyl]-5,N7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidine-2,7-diamine","InChI=1S/C12H13ClN6S/c1-7-5-10(19-12(15-7)16-11(14)17-19)18(2)6-8-3-4-9(13)20-8/h3-5H,6H2,1-2H3,(H2,14,17)",BWYATFCHPWUVFE-UHFFFAOYSA-N,1,0,0,0,Bromodomain / Histone,4.55,cancer,Inhibition,
2142,72713637,2436009,,CC(=O)Nc1cccc(c1)-c1cc(C)[n+]([O-])c2ccccc12,4-(3-acetamidophenyl)-2-methylquinolin-1-ium-1-olate,"InChI=1S/C18H16N2O2/c1-12-10-17(16-8-3-4-9-18(16)20(12)22)14-6-5-7-15(11-14)19-13(2)21/h3-11H,1-2H3,(H,19,21)",YSGOTUAMXVUKOD-UHFFFAOYSA-N,1,0,0,0,Bromodomain / Histone,4.38,cancer,Inhibition,
2143,49815116,2436010,,Cc1ccc(cc1)-c1cn(C)c2c1nc[nH]c2=O,"5-methyl-7-(4-methylphenyl)-3H,4H,5H-pyrrolo[3,2-d]pyrimidin-4-one","InChI=1S/C14H13N3O/c1-9-3-5-10(6-4-9)11-7-17(2)13-12(11)15-8-16-14(13)18/h3-8H,1-2H3,(H,15,16,18)",LEKQTUGFPHVMTN-UHFFFAOYSA-N,1,0,0,0,Bromodomain / Histone,4.51,cancer,Inhibition,
2144,49815111,2436011,,Cn1cc(-c2ccc(F)cc2)c2nc[nH]c(=O)c12,"7-(4-fluorophenyl)-5-methyl-3H,4H,5H-pyrrolo[3,2-d]pyrimidin-4-one","InChI=1S/C13H10FN3O/c1-17-6-10(8-2-4-9(14)5-3-8)11-12(17)13(18)16-7-15-11/h2-7H,1H3,(H,15,16,18)",PZQHTGGMJXMIDR-UHFFFAOYSA-N,1,0,0,0,Bromodomain / Histone,4.80,cancer,Inhibition,
2145,135566302,,,Cc1cc(N=Nc2cc(c(C)cc2C)S(O)(=O)=O)c(N)cc1O,"5-[2-(2-amino-4-hydroxy-5-methylphenyl)diazen-1-yl]-2,4-dimethylbenzene-1-sulfonic acid","InChI=1S/C15H17N3O4S/c1-8-4-10(3)15(23(20,21)22)7-12(8)17-18-13-5-9(2)14(19)6-11(13)16/h4-7,19H,16H2,1-3H3,(H,20,21,22)",UUECJWRVDTUDCB-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,4.96,cancer,Inhibition,
2146,136226498,,,Cc1cc(cc(C)c1O)N=Nc1cc(c(C)cc1C)S(O)(=O)=O,"5-[2-(4-hydroxy-3,5-dimethylphenyl)diazen-1-yl]-2,4-dimethylbenzene-1-sulfonic acid","InChI=1S/C16H18N2O4S/c1-9-5-10(2)15(23(20,21)22)8-14(9)18-17-13-6-11(3)16(19)12(4)7-13/h5-8,19H,1-4H3,(H,20,21,22)",JZUHAWDNVURDFI-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,5.31,cancer,Inhibition,
2147,136226499,,,Cc1cc(cc(C)c1O)N=Nc1cccc(c1)S(=O)(=O)Nc1ccccn1,"3-[2-(4-hydroxy-3,5-dimethylphenyl)diazen-1-yl]-N-(pyridin-2-yl)benzene-1-sulfonamide","InChI=1S/C19H18N4O3S/c1-13-10-16(11-14(2)19(13)24)22-21-15-6-5-7-17(12-15)27(25,26)23-18-8-3-4-9-20-18/h3-12,24H,1-2H3,(H,20,23)",AXNRGDLGWUFGKG-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,5.22,cancer,Inhibition,
2148,135566898,,,Cc1cc(cc(C)c1O)N=Nc1ccc(cc1)S(=O)(=O)Nc1ccccn1,"4-[2-(4-hydroxy-3,5-dimethylphenyl)diazen-1-yl]-N-(pyridin-2-yl)benzene-1-sulfonamide","InChI=1S/C19H18N4O3S/c1-13-11-16(12-14(2)19(13)24)22-21-15-6-8-17(9-7-15)27(25,26)23-18-5-3-4-10-20-18/h3-12,24H,1-2H3,(H,20,23)",UPZISPNEBVCTRN-UHFFFAOYSA-N,4,2,0,1,Bromodomain / Histone,6.04,cancer,Inhibition,
2149,168317767,,,Cc1cc(cc(C)c1O)N=Nc1ccc(cc1)S(=O)(=O)NC(c1ccccc1)C(F)(F)F,"4-[2-(4-hydroxy-3,5-dimethylphenyl)diazen-1-yl]-N-(2,2,2-trifluoro-1-phenylethyl)benzene-1-sulfonamide","InChI=1S/C22H20F3N3O3S/c1-14-12-18(13-15(2)20(14)29)27-26-17-8-10-19(11-9-17)32(30,31)28-21(22(23,24)25)16-6-4-3-5-7-16/h3-13,21,28-29H,1-2H3",XDFDLEALOQAOOB-UHFFFAOYSA-N,0,0,0,0,,,,,
2150,136226501,,,CN(c1ccccn1)S(=O)(=O)c1ccc(cc1)N=Nc1cc(C)c(O)c(C)c1,"4-[2-(4-hydroxy-3,5-dimethylphenyl)diazen-1-yl]-N-methyl-N-(pyridin-2-yl)benzene-1-sulfonamide","InChI=1S/C20H20N4O3S/c1-14-12-17(13-15(2)20(14)25)23-22-16-7-9-18(10-8-16)28(26,27)24(3)19-6-4-5-11-21-19/h4-13,25H,1-3H3",BZNOQPWEFIWTQI-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,5.15,cancer,Inhibition,
2151,136226502,,,Cc1cc(cc(C)c1O)N=Nc1ccc(cc1)S(=O)(=O)Nc1cccc(c1)C(F)(F)F,"4-[2-(4-hydroxy-3,5-dimethylphenyl)diazen-1-yl]-N-[3-(trifluoromethyl)phenyl]benzene-1-sulfonamide","InChI=1S/C21H18F3N3O3S/c1-13-10-18(11-14(2)20(13)28)26-25-16-6-8-19(9-7-16)31(29,30)27-17-5-3-4-15(12-17)21(22,23)24/h3-12,27-28H,1-2H3",JOBJAZOZNJODIF-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,5.21,cancer,Inhibition,
2152,136226503,,,Cc1cc(cc(C)c1O)N=Nc1ccc(cc1)S(=O)(=O)Nc1cc(Cl)ccn1,"N-(4-chloropyridin-2-yl)-4-[2-(4-hydroxy-3,5-dimethylphenyl)diazen-1-yl]benzene-1-sulfonamide","InChI=1S/C19H17ClN4O3S/c1-12-9-16(10-13(2)19(12)25)23-22-15-3-5-17(6-4-15)28(26,27)24-18-11-14(20)7-8-21-18/h3-11,25H,1-2H3,(H,21,24)",NWRSZGDBXDGLBP-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,6.05,cancer,Inhibition,
2153,136226504,,,Cc1cc(cc(C)c1O)N=Nc1ccc(cc1)S(=O)(=O)Nc1ccc(cn1)C(O)=O,"6-{4-[2-(4-hydroxy-3,5-dimethylphenyl)diazen-1-yl]benzenesulfonamido}pyridine-3-carboxylic acid","InChI=1S/C20H18N4O5S/c1-12-9-16(10-13(2)19(12)25)23-22-15-4-6-17(7-5-15)30(28,29)24-18-8-3-14(11-21-18)20(26)27/h3-11,25H,1-2H3,(H,21,24)(H,26,27)",WJHLTPMNRRALNX-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,6.49,cancer,Inhibition,
2154,136226505,,,Cc1cc(cc(C)c1O)N=Nc1ccc(cc1)S(=O)(=O)Nc1ccc(Cl)cn1,"N-(5-chloropyridin-2-yl)-4-[2-(4-hydroxy-3,5-dimethylphenyl)diazen-1-yl]benzene-1-sulfonamide","InChI=1S/C19H17ClN4O3S/c1-12-9-16(10-13(2)19(12)25)23-22-15-4-6-17(7-5-15)28(26,27)24-18-8-3-14(20)11-21-18/h3-11,25H,1-2H3,(H,21,24)",WNCKBBYSIBZELD-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,6.14,cancer,Inhibition,
2155,136226506,,,Cc1cc(cc(C)c1O)N=Nc1ccc(cc1)S(=O)(=O)Nc1ccc(Br)cn1,"N-(5-bromopyridin-2-yl)-4-[2-(4-hydroxy-3,5-dimethylphenyl)diazen-1-yl]benzene-1-sulfonamide","InChI=1S/C19H17BrN4O3S/c1-12-9-16(10-13(2)19(12)25)23-22-15-4-6-17(7-5-15)28(26,27)24-18-8-3-14(20)11-21-18/h3-11,25H,1-2H3,(H,21,24)",HLZXDZBEEGLJKL-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,5.18,cancer,Inhibition,
2156,136174610,,,COc1ccc(NS(=O)(=O)c2ccc(cc2)N=Nc2cc(C)c(O)c(C)c2)nc1,"4-[2-(4-hydroxy-3,5-dimethylphenyl)diazen-1-yl]-N-(5-methoxypyridin-2-yl)benzene-1-sulfonamide","InChI=1S/C20H20N4O4S/c1-13-10-16(11-14(2)20(13)25)23-22-15-4-7-18(8-5-15)29(26,27)24-19-9-6-17(28-3)12-21-19/h4-12,25H,1-3H3,(H,21,24)",DPZYMTMUTWSZOW-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,6.30,cancer,Inhibition,
2157,136174597,,,COc1ccc(NS(=O)(=O)c2ccc(cc2)N=Nc2cc(C)c(O)c(C)c2)cc1,"4-[2-(4-hydroxy-3,5-dimethylphenyl)diazen-1-yl]-N-(4-methoxyphenyl)benzene-1-sulfonamide","InChI=1S/C21H21N3O4S/c1-14-12-18(13-15(2)21(14)25)23-22-16-6-10-20(11-7-16)29(26,27)24-17-4-8-19(28-3)9-5-17/h4-13,24-25H,1-3H3",HFLAYZFLAUGYSL-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,5.19,cancer,Inhibition,
2158,136174618,,,Cc1cc(cc(C)c1O)N=Nc1ccc(cc1)S(=O)(=O)Nc1ccc(cc1)C(F)(F)F,"4-[2-(4-hydroxy-3,5-dimethylphenyl)diazen-1-yl]-N-[4-(trifluoromethyl)phenyl]benzene-1-sulfonamide","InChI=1S/C21H18F3N3O3S/c1-13-11-18(12-14(2)20(13)28)26-25-16-7-9-19(10-8-16)31(29,30)27-17-5-3-15(4-6-17)21(22,23)24/h3-12,27-28H,1-2H3",TXXXOOBUYYCCJA-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,5.15,cancer,Inhibition,
2159,136226507,,,Cc1cc(cc(C)c1O)N=Nc1ccc(cc1)S(=O)(=O)Nc1ccc(cc1)C(N)=O,"4-{4-[2-(4-hydroxy-3,5-dimethylphenyl)diazen-1-yl]benzenesulfonamido}benzamide","InChI=1S/C21H20N4O4S/c1-13-11-18(12-14(2)20(13)26)24-23-16-7-9-19(10-8-16)30(28,29)25-17-5-3-15(4-6-17)21(22)27/h3-12,25-26H,1-2H3,(H2,22,27)",VNVJHLJKSREUHH-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,5.02,cancer,Inhibition,
2160,136226508,,,Cc1cc(cc(C)c1O)N=Nc1ccc(cc1)S(=O)(=O)Nc1ccc(F)cn1,"N-(5-fluoropyridin-2-yl)-4-[2-(4-hydroxy-3,5-dimethylphenyl)diazen-1-yl]benzene-1-sulfonamide","InChI=1S/C19H17FN4O3S/c1-12-9-16(10-13(2)19(12)25)23-22-15-4-6-17(7-5-15)28(26,27)24-18-8-3-14(20)11-21-18/h3-11,25H,1-2H3,(H,21,24)",STBJKDXYORRTEM-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,5.89,cancer,Inhibition,
2161,136226509,,,Cc1cc(cc(C)c1O)N=Nc1ccc(cc1)S(=O)(=O)Nc1ccc(F)cc1,"N-(4-fluorophenyl)-4-[2-(4-hydroxy-3,5-dimethylphenyl)diazen-1-yl]benzene-1-sulfonamide","InChI=1S/C20H18FN3O3S/c1-13-11-18(12-14(2)20(13)25)23-22-16-7-9-19(10-8-16)28(26,27)24-17-5-3-15(21)4-6-17/h3-12,24-25H,1-2H3",PYVCDUXKORLXIT-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,5.74,cancer,Inhibition,
2162,136226510,,,COc1cc(ccc1S(=O)(=O)Nc1ccccn1)N=Nc1cc(C)c(O)c(C)c1,"4-[2-(4-hydroxy-3,5-dimethylphenyl)diazen-1-yl]-2-methoxy-N-(pyridin-2-yl)benzene-1-sulfonamide","InChI=1S/C20H20N4O4S/c1-13-10-16(11-14(2)20(13)25)23-22-15-7-8-18(17(12-15)28-3)29(26,27)24-19-6-4-5-9-21-19/h4-12,25H,1-3H3,(H,21,24)",ZQLWHZAQJSYSRK-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,5.50,cancer,Inhibition,
2163,136174604,,,Oc1c(Cl)cc(cc1Cl)N=Nc1ccc(cc1)S(=O)(=O)Nc1ccccn1,"4-[2-(3,5-dichloro-4-hydroxyphenyl)diazen-1-yl]-N-(pyridin-2-yl)benzene-1-sulfonamide","InChI=1S/C17H12Cl2N4O3S/c18-14-9-12(10-15(19)17(14)24)22-21-11-4-6-13(7-5-11)27(25,26)23-16-3-1-2-8-20-16/h1-10,24H,(H,20,23)",GSVATAACOLMIIC-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,5.90,cancer,Inhibition,
2164,136174611,,,Cc1cc(cc(Br)c1O)N=Nc1ccc(cc1)S(=O)(=O)Nc1ccccn1,4-[2-(3-bromo-4-hydroxy-5-methylphenyl)diazen-1-yl]-N-(pyridin-2-yl)benzene-1-sulfonamide,"InChI=1S/C18H15BrN4O3S/c1-12-10-14(11-16(19)18(12)24)22-21-13-5-7-15(8-6-13)27(25,26)23-17-4-2-3-9-20-17/h2-11,24H,1H3,(H,20,23)",KCSFRNPOIBUWHU-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,5.55,cancer,Inhibition,
2165,136174612,,,Cc1cc(cc(Cl)c1O)N=Nc1ccc(cc1)S(=O)(=O)Nc1ccccn1,4-[2-(3-chloro-4-hydroxy-5-methylphenyl)diazen-1-yl]-N-(pyridin-2-yl)benzene-1-sulfonamide,"InChI=1S/C18H15ClN4O3S/c1-12-10-14(11-16(19)18(12)24)22-21-13-5-7-15(8-6-13)27(25,26)23-17-4-2-3-9-20-17/h2-11,24H,1H3,(H,20,23)",KBKXBABMPWUUOW-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,5.85,cancer,Inhibition,
2166,136174605,,,Oc1ccc(cc1Br)N=Nc1ccc(cc1)S(=O)(=O)Nc1ccccn1,4-[2-(3-bromo-4-hydroxyphenyl)diazen-1-yl]-N-(pyridin-2-yl)benzene-1-sulfonamide,"InChI=1S/C17H13BrN4O3S/c18-15-11-13(6-9-16(15)23)21-20-12-4-7-14(8-5-12)26(24,25)22-17-3-1-2-10-19-17/h1-11,23H,(H,19,22)",PDMOYKGLCNMRHK-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,5.33,cancer,Inhibition,
2167,136174603,,,Oc1ccc(cc1Cl)N=Nc1ccc(cc1)S(=O)(=O)Nc1ccccn1,4-[2-(3-chloro-4-hydroxyphenyl)diazen-1-yl]-N-(pyridin-2-yl)benzene-1-sulfonamide,"InChI=1S/C17H13ClN4O3S/c18-15-11-13(6-9-16(15)23)21-20-12-4-7-14(8-5-12)26(24,25)22-17-3-1-2-10-19-17/h1-11,23H,(H,19,22)",XNYCWWRRJOIVBY-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,5.89,cancer,Inhibition,
2168,136002815,,,Cc1cc(ccc1O)N=Nc1ccc(cc1)S(=O)(=O)Nc1ccccn1,4-[2-(4-hydroxy-3-methylphenyl)diazen-1-yl]-N-(pyridin-2-yl)benzene-1-sulfonamide,"InChI=1S/C18H16N4O3S/c1-13-12-15(7-10-17(13)23)21-20-14-5-8-16(9-6-14)26(24,25)22-18-4-2-3-11-19-18/h2-12,23H,1H3,(H,19,22)",BRMQUCUHSDODTM-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,5.19,cancer,Inhibition,
2169,136174601,,,Oc1c(Br)cc(cc1Br)N=Nc1ccc(cc1)S(=O)(=O)Nc1ccccn1,"4-[2-(3,5-dibromo-4-hydroxyphenyl)diazen-1-yl]-N-(pyridin-2-yl)benzene-1-sulfonamide","InChI=1S/C17H12Br2N4O3S/c18-14-9-12(10-15(19)17(14)24)22-21-11-4-6-13(7-5-11)27(25,26)23-16-3-1-2-8-20-16/h1-10,24H,(H,20,23)",FSXCIDJKULZKSB-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,6.28,cancer,Inhibition,
2170,136174600,,,Oc1ccc(cc1C(F)(F)F)N=Nc1ccc(cc1)S(=O)(=O)Nc1ccccn1,4-{2-[4-hydroxy-3-(trifluoromethyl)phenyl]diazen-1-yl}-N-(pyridin-2-yl)benzene-1-sulfonamide,"InChI=1S/C18H13F3N4O3S/c19-18(20,21)15-11-13(6-9-16(15)26)24-23-12-4-7-14(8-5-12)29(27,28)25-17-3-1-2-10-22-17/h1-11,26H,(H,22,25)",ISBRQZZVZNNMKS-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,5.17,cancer,Inhibition,
2171,135566899,,,Cc1cc(N=Nc2ccc(cc2)S(=O)(=O)Nc2ccccn2)c(N)cc1O,4-[2-(2-amino-4-hydroxy-5-methylphenyl)diazen-1-yl]-N-(pyridin-2-yl)benzene-1-sulfonamide,"InChI=1S/C18H17N5O3S/c1-12-10-16(15(19)11-17(12)24)22-21-13-5-7-14(8-6-13)27(25,26)23-18-4-2-3-9-20-18/h2-11,24H,19H2,1H3,(H,20,23)",DZTGIRNXWSZBIM-UHFFFAOYSA-N,4,2,0,1,Bromodomain / Histone,7.07,cancer,Inhibition,
2172,135566900,,,Cc1cc(N=Nc2ccc(cc2)S(=O)(=O)Nc2ccccn2)c(N)c(C)c1O,"4-[2-(2-amino-4-hydroxy-3,5-dimethylphenyl)diazen-1-yl]-N-(pyridin-2-yl)benzene-1-sulfonamide","InChI=1S/C19H19N5O3S/c1-12-11-16(18(20)13(2)19(12)25)23-22-14-6-8-15(9-7-14)28(26,27)24-17-5-3-4-10-21-17/h3-11,25H,20H2,1-2H3,(H,21,24)",PJXWUXARDBIOKJ-UHFFFAOYSA-N,4,2,0,1,Bromodomain / Histone,6.82,cancer,Inhibition,
2173,136226511,,,Cc1cc(N=Nc2ccc(cc2)S(=O)(=O)Nc2ccccn2)c(N)c(Cl)c1O,4-[2-(2-amino-3-chloro-4-hydroxy-5-methylphenyl)diazen-1-yl]-N-(pyridin-2-yl)benzene-1-sulfonamide,"InChI=1S/C18H16ClN5O3S/c1-11-10-14(17(20)16(19)18(11)25)23-22-12-5-7-13(8-6-12)28(26,27)24-15-4-2-3-9-21-15/h2-10,25H,20H2,1H3,(H,21,24)",NPQKWPKFRWMJFA-UHFFFAOYSA-N,4,2,0,1,Bromodomain / Histone,6.77,cancer,Inhibition,
2174,136224170,,,COc1cc(N=Nc2ccc(cc2)S(=O)(=O)Nc2ccccn2)c(N)cc1O,4-[2-(2-amino-4-hydroxy-5-methoxyphenyl)diazen-1-yl]-N-(pyridin-2-yl)benzene-1-sulfonamide,"InChI=1S/C18H17N5O4S/c1-27-17-11-15(14(19)10-16(17)24)22-21-12-5-7-13(8-6-12)28(25,26)23-18-4-2-3-9-20-18/h2-11,24H,19H2,1H3,(H,20,23)",ZWOSMSLARGAJPG-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,5.89,cancer,Inhibition,
2175,136224171,,,Cc1cc(N=Nc2ccc(cc2)S(=O)(=O)Nc2ccccn2)nc(C)c1O,"4-[2-(5-hydroxy-4,6-dimethylpyridin-2-yl)diazen-1-yl]-N-(pyridin-2-yl)benzene-1-sulfonamide","InChI=1S/C18H17N5O3S/c1-12-11-17(20-13(2)18(12)24)22-21-14-6-8-15(9-7-14)27(25,26)23-16-5-3-4-10-19-16/h3-11,24H,1-2H3,(H,19,23)",PZRYRGCGKZCRRU-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,5.64,cancer,Inhibition,
2176,136226512,,,Cc1nc(N=Nc2ccc(cc2)S(=O)(=O)Nc2ccccn2)c(C)c(C)c1O,"4-[2-(5-hydroxy-3,4,6-trimethylpyridin-2-yl)diazen-1-yl]-N-(pyridin-2-yl)benzene-1-sulfonamide","InChI=1S/C19H19N5O3S/c1-12-13(2)19(21-14(3)18(12)25)23-22-15-7-9-16(10-8-15)28(26,27)24-17-6-4-5-11-20-17/h4-11,25H,1-3H3,(H,20,24)",PRFAPNBSAKGDHK-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,5.22,cancer,Inhibition,
2177,136226513,,,Cc1cc(cc(O)c1O)N=Nc1ccc(cc1)S(=O)(=O)Nc1ccccn1,"4-[2-(3,4-dihydroxy-5-methylphenyl)diazen-1-yl]-N-(pyridin-2-yl)benzene-1-sulfonamide","InChI=1S/C18H16N4O4S/c1-12-10-14(11-16(23)18(12)24)21-20-13-5-7-15(8-6-13)27(25,26)22-17-4-2-3-9-19-17/h2-11,23-24H,1H3,(H,19,22)",UWZXCLGIJGVSCA-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,5.62,cancer,Inhibition,
2178,136226514,,,Oc1ccc(cc1O)N=Nc1ccc(cc1)S(=O)(=O)Nc1ccccn1,"4-[2-(3,4-dihydroxyphenyl)diazen-1-yl]-N-(pyridin-2-yl)benzene-1-sulfonamide","InChI=1S/C17H14N4O4S/c22-15-9-6-13(11-16(15)23)20-19-12-4-7-14(8-5-12)26(24,25)21-17-3-1-2-10-18-17/h1-11,22-23H,(H,18,21)",CBORMFPBQPCDNJ-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,5.41,cancer,Inhibition,
2179,136226516,,,Cc1cc(ccc1O)N=Nc1ccc(cc1)S(=O)(=O)NCc1ccc(cc1)C(F)(F)F,4-[2-(4-hydroxy-3-methylphenyl)diazen-1-yl]-N-{[4-(trifluoromethyl)phenyl]methyl}benzene-1-sulfonamide,"InChI=1S/C21H18F3N3O3S/c1-14-12-18(8-11-20(14)28)27-26-17-6-9-19(10-7-17)31(29,30)25-13-15-2-4-16(5-3-15)21(22,23)24/h2-12,25,28H,13H2,1H3",RSPQAGQXUHEGEP-UHFFFAOYSA-N,0,0,0,0,,,,,
2180,136226517,,,Cc1cc(N=Nc2ccc(cc2)S(=O)(=O)NCc2ccc(cc2)C(F)(F)F)c(N)cc1O,4-[2-(2-amino-4-hydroxy-5-methylphenyl)diazen-1-yl]-N-{[4-(trifluoromethyl)phenyl]methyl}benzene-1-sulfonamide,"InChI=1S/C21H19F3N4O3S/c1-13-10-19(18(25)11-20(13)29)28-27-16-6-8-17(9-7-16)32(30,31)26-12-14-2-4-15(5-3-14)21(22,23)24/h2-11,26,29H,12,25H2,1H3",GPIHVSHWLRRCHX-UHFFFAOYSA-N,0,0,0,0,,,,,
2181,72735611,,,COc1c(C)cc(cc1C)N=Nc1ccc(cc1)S(=O)(=O)Nc1ccccn1,"4-[2-(4-methoxy-3,5-dimethylphenyl)diazen-1-yl]-N-(pyridin-2-yl)benzene-1-sulfonamide","InChI=1S/C20H20N4O3S/c1-14-12-17(13-15(2)20(14)27-3)23-22-16-7-9-18(10-8-16)28(25,26)24-19-6-4-5-11-21-19/h4-13H,1-3H3,(H,21,24)",XSXTVZGIXAQCCK-UHFFFAOYSA-N,0,0,0,0,,,,,
2182,72735612,,,CC(=O)Nc1c(C)cc(cc1C)N=Nc1ccc(cc1)S(=O)(=O)Nc1ccccn1,"N-[2,6-dimethyl-4-(2-{4-[(pyridin-2-yl)sulfamoyl]phenyl}diazen-1-yl)phenyl]acetamide","InChI=1S/C21H21N5O3S/c1-14-12-18(13-15(2)21(14)23-16(3)27)25-24-17-7-9-19(10-8-17)30(28,29)26-20-6-4-5-11-22-20/h4-13H,1-3H3,(H,22,26)(H,23,27)",ZMYFPFRPLKSMIX-UHFFFAOYSA-N,0,0,0,0,,,,,
2183,136174606,,,CC(C)c1cc(ccc1O)N=Nc1ccc(cc1)S(=O)(=O)Nc1ccccn1,4-{2-[4-hydroxy-3-(propan-2-yl)phenyl]diazen-1-yl}-N-(pyridin-2-yl)benzene-1-sulfonamide,"InChI=1S/C20H20N4O3S/c1-14(2)18-13-16(8-11-19(18)25)23-22-15-6-9-17(10-7-15)28(26,27)24-20-5-3-4-12-21-20/h3-14,25H,1-2H3,(H,21,24)",JNIDFULPZRYKQL-UHFFFAOYSA-N,0,0,0,0,,,,,
2184,136174613,,,CC(C)(C)c1cc(ccc1O)N=Nc1ccc(cc1)S(=O)(=O)Nc1ccccn1,4-[2-(3-tert-butyl-4-hydroxyphenyl)diazen-1-yl]-N-(pyridin-2-yl)benzene-1-sulfonamide,"InChI=1S/C21H22N4O3S/c1-21(2,3)18-14-16(9-12-19(18)26)24-23-15-7-10-17(11-8-15)29(27,28)25-20-6-4-5-13-22-20/h4-14,26H,1-3H3,(H,22,25)",GHJZVYRLWMOWDD-UHFFFAOYSA-N,0,0,0,0,,,,,
2185,136174602,,,CC(C)c1cc(cc(C(C)C)c1O)N=Nc1ccc(cc1)S(=O)(=O)Nc1ccccn1,"4-{2-[4-hydroxy-3,5-bis(propan-2-yl)phenyl]diazen-1-yl}-N-(pyridin-2-yl)benzene-1-sulfonamide","InChI=1S/C23H26N4O3S/c1-15(2)20-13-18(14-21(16(3)4)23(20)28)26-25-17-8-10-19(11-9-17)31(29,30)27-22-7-5-6-12-24-22/h5-16,28H,1-4H3,(H,24,27)",IOJCEXBEZVPCCG-UHFFFAOYSA-N,0,0,0,0,,,,,
2186,136226518,,,CC(C)(C)c1cc(cc(c1O)C(C)(C)C)N=Nc1ccc(cc1)S(=O)(=O)Nc1ccccn1,"4-[2-(3,5-di-tert-butyl-4-hydroxyphenyl)diazen-1-yl]-N-(pyridin-2-yl)benzene-1-sulfonamide","InChI=1S/C25H30N4O3S/c1-24(2,3)20-15-18(16-21(23(20)30)25(4,5)6)28-27-17-10-12-19(13-11-17)33(31,32)29-22-9-7-8-14-26-22/h7-16,30H,1-6H3,(H,26,29)",DWACTAZCSLCJCE-UHFFFAOYSA-N,0,0,0,0,,,,,
2187,136240256,,,Oc1ccc(N=Nc2ccc(cc2)S(=O)(=O)Nc2ccccn2)c2ccccc12,4-[2-(4-hydroxynaphthalen-1-yl)diazen-1-yl]-N-(pyridin-2-yl)benzene-1-sulfonamide,"InChI=1S/C21H16N4O3S/c26-20-13-12-19(17-5-1-2-6-18(17)20)24-23-15-8-10-16(11-9-15)29(27,28)25-21-7-3-4-14-22-21/h1-14,26H,(H,22,25)",BKKIAVKYDURMCC-UHFFFAOYSA-N,0,0,0,0,,,,,
2188,136226519,,,Oc1ccc(N=Nc2ccc(cc2)S(=O)(=O)Nc2ccccn2)c2CCCCc12,"4-[2-(4-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)diazen-1-yl]-N-(pyridin-2-yl)benzene-1-sulfonamide","InChI=1S/C21H20N4O3S/c26-20-13-12-19(17-5-1-2-6-18(17)20)24-23-15-8-10-16(11-9-15)29(27,28)25-21-7-3-4-14-22-21/h3-4,7-14,26H,1-2,5-6H2,(H,22,25)",RBJRQPQNCNYSPX-UHFFFAOYSA-N,0,0,0,0,,,,,
2189,136226520,,,Oc1ccc(N=Nc2ccc(cc2)S(=O)(=O)Nc2ccccn2)c2NCCCc12,"4-[2-(5-hydroxy-1,2,3,4-tetrahydroquinolin-8-yl)diazen-1-yl]-N-(pyridin-2-yl)benzene-1-sulfonamide","InChI=1S/C20H19N5O3S/c26-18-11-10-17(20-16(18)4-3-13-22-20)24-23-14-6-8-15(9-7-14)29(27,28)25-19-5-1-2-12-21-19/h1-2,5-12,22,26H,3-4,13H2,(H,21,25)",QJNLYWKQIWYVJF-UHFFFAOYSA-N,0,0,0,0,,,,,
2190,136226521,,,CC1(C)Cc2c(O1)c(O)ccc2N=Nc1ccc(cc1)S(=O)(=O)Nc1ccccn1,"4-[2-(7-hydroxy-2,2-dimethyl-2,3-dihydro-1-benzofuran-4-yl)diazen-1-yl]-N-(pyridin-2-yl)benzene-1-sulfonamide","InChI=1S/C21H20N4O4S/c1-21(2)13-16-17(10-11-18(26)20(16)29-21)24-23-14-6-8-15(9-7-14)30(27,28)25-19-5-3-4-12-22-19/h3-12,26H,13H2,1-2H3,(H,22,25)",YRAMXKSTCNZPJJ-UHFFFAOYSA-N,0,0,0,0,,,,,
2191,136226522,,,Cc1nc(N=Nc2ccc(cc2)S(=O)(=O)Nc2ccccn2)c(CO)c(C)c1O,"4-{2-[5-hydroxy-3-(hydroxymethyl)-4,6-dimethylpyridin-2-yl]diazen-1-yl}-N-(pyridin-2-yl)benzene-1-sulfonamide","InChI=1S/C19H19N5O4S/c1-12-16(11-25)19(21-13(2)18(12)26)23-22-14-6-8-15(9-7-14)29(27,28)24-17-5-3-4-10-20-17/h3-10,25-26H,11H2,1-2H3,(H,20,24)",OJAXMILUMBFGAG-UHFFFAOYSA-N,0,0,0,0,,,,,
2192,136226523,,,Cc1nc(N=Nc2ccc(cc2)S(=O)(=O)Nc2ccccn2)c(CO)c(CN)c1O,4-{2-[4-(aminomethyl)-5-hydroxy-3-(hydroxymethyl)-6-methylpyridin-2-yl]diazen-1-yl}-N-(pyridin-2-yl)benzene-1-sulfonamide,"InChI=1S/C19H20N6O4S/c1-12-18(27)15(10-20)16(11-26)19(22-12)24-23-13-5-7-14(8-6-13)30(28,29)25-17-4-2-3-9-21-17/h2-9,26-27H,10-11,20H2,1H3,(H,21,25)",JMEWMEDRHFOMPK-UHFFFAOYSA-N,0,0,0,0,,,,,
2193,136226524,,,Cc1nc(N=Nc2ccc(cc2)S(=O)(=O)Nc2ccccn2)c(CO)c(C=O)c1O,4-{2-[4-formyl-5-hydroxy-3-(hydroxymethyl)-6-methylpyridin-2-yl]diazen-1-yl}-N-(pyridin-2-yl)benzene-1-sulfonamide,"InChI=1S/C19H17N5O5S/c1-12-18(27)15(10-25)16(11-26)19(21-12)23-22-13-5-7-14(8-6-13)30(28,29)24-17-4-2-3-9-20-17/h2-10,26-27H,11H2,1H3,(H,20,24)",PSSHCGWNDRDLCQ-UHFFFAOYSA-N,0,0,0,0,,,,,
2194,136174615,,,COc1cc(ccc1O)N=Nc1ccc(cc1)S(=O)(=O)Nc1ccccn1,4-[2-(4-hydroxy-3-methoxyphenyl)diazen-1-yl]-N-(pyridin-2-yl)benzene-1-sulfonamide,"InChI=1S/C18H16N4O4S/c1-26-17-12-14(7-10-16(17)23)21-20-13-5-8-15(9-6-13)27(24,25)22-18-4-2-3-11-19-18/h2-12,23H,1H3,(H,19,22)",NNVWBPGOBVMGDY-UHFFFAOYSA-N,0,0,0,0,,,,,
2195,168317859,,,Cc1cc(N=Nc2cccc(c2)S(=O)(=O)Nc2ccccn2)c(N)cc1O,3-[2-(2-amino-4-hydroxy-5-methylphenyl)diazen-1-yl]-N-(pyridin-2-yl)benzene-1-sulfonamide,"InChI=1S/C18H17N5O3S/c1-12-9-16(15(19)11-17(12)24)22-21-13-5-4-6-14(10-13)27(25,26)23-18-7-2-3-8-20-18/h2-11,24H,19H2,1H3,(H,20,23)",JZTICAHMECMHKG-UHFFFAOYSA-N,0,0,0,0,,,,,
2196,704120,3262776,,CC(=O)c1ccc(OCc2c(C)noc2C)cc1,"1-{4-[(3,5-dimethyl-1,2-oxazol-4-yl)methoxy]phenyl}ethan-1-one","InChI=1S/C14H15NO3/c1-9-14(11(3)18-15-9)8-17-13-6-4-12(5-7-13)10(2)16/h4-7H,8H2,1-3H3",SFDGUZHAGIATHW-UHFFFAOYSA-N,0,0,0,0,,,,,
2197,11128828,3262777,,CCc1cc2c(CCCC2=O)n1Cc1ccccc1,"1-benzyl-2-ethyl-4,5,6,7-tetrahydro-1H-indol-4-one","InChI=1S/C17H19NO/c1-2-14-11-15-16(9-6-10-17(15)19)18(14)12-13-7-4-3-5-8-13/h3-5,7-8,11H,2,6,9-10,12H2,1H3",WAZKIRPFJTZRDA-UHFFFAOYSA-N,1,0,0,0,Bromodomain / Histone,5.15,cancer,Inhibition,
2198,2824992,1620811,,CN1c2ccccc2NC(CC1=O)c1ccccc1,"1-methyl-4-phenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-2-one","InChI=1S/C16H16N2O/c1-18-15-10-6-5-9-13(15)17-14(11-16(18)19)12-7-3-2-4-8-12/h2-10,14,17H,11H2,1H3",FHOSJKIPIAZPJP-UHFFFAOYSA-N,1,0,0,0,Bromodomain / Histone,5.12,cancer,Inhibition,
2199,3016,12,,CN1c2ccc(Cl)cc2C(=NCC1=O)c1ccccc1,"7-chloro-1-methyl-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one","InChI=1S/C16H13ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h2-9H,10H2,1H3",AAOVKJBEBIDNHE-UHFFFAOYSA-N,0,0,0,0,,,,,
2200,57406853,2386346,,CCOc1cc(ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@](C)(N1C(=O)N1CCN(CCCS(C)(=O)=O)CC1)c1ccc(Cl)cc1)C(C)(C)C,"1-[(4S,5R)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethyl-4,5-dihydro-1H-imidazole-1-carbonyl]-4-(3-methanesulfonylpropyl)piperazine","InChI=1S/C38H48Cl2N4O4S/c1-8-48-33-26-29(36(2,3)4)14-19-32(33)34-41-37(5,27-10-15-30(39)16-11-27)38(6,28-12-17-31(40)18-13-28)44(34)35(45)43-23-21-42(22-24-43)20-9-25-49(7,46)47/h10-19,26H,8-9,20-25H2,1-7H3/t37-,38+/m0/s1",QBGKPEROWUKSBK-QPPIDDCLSA-N,3,4,1,0,MDM2-Like / P53,7.97,cancer,Inhibition,
2201,16265714,4104179,,CCn1c2NC3=C(C(c4ccc(C)cc4)c2c(=O)[nH]c1=O)C(=O)OC3,"13-ethyl-8-(4-methylphenyl)-5-oxa-2,11,13-triazatricyclo[7.4.0.0^{3,7}]trideca-1(9),3(7)-diene-6,10,12-trione","InChI=1S/C18H17N3O4/c1-3-21-15-14(16(22)20-18(21)24)12(10-6-4-9(2)5-7-10)13-11(19-15)8-25-17(13)23/h4-7,12,19H,3,8H2,1-2H3,(H,20,22,24)",MUOCQMZJLRQTRD-UHFFFAOYSA-N,5,0,0,0,Bromodomain / Histone,6.43,cancer,Inhibition,
2202,137643147,4086263,,COc1ccc(cc1)C1C2=C(COC2=O)Nc2c1c(=O)[nH]c(=O)n2C,"8-(4-methoxyphenyl)-13-methyl-5-oxa-2,11,13-triazatricyclo[7.4.0.0^{3,7}]trideca-1(9),3(7)-diene-6,10,12-trione","InChI=1S/C17H15N3O5/c1-20-14-13(15(21)19-17(20)23)11(8-3-5-9(24-2)6-4-8)12-10(18-14)7-25-16(12)22/h3-6,11,18H,7H2,1-2H3,(H,19,21,23)",RDJWSVQIOXAMKF-UHFFFAOYSA-N,0,0,0,0,,,,,
2203,16251975,4066490,,Cn1c2NC3=C(C(c4ccccc4)c2c(=O)[nH]c1=O)C(=O)OC3,"13-methyl-8-phenyl-5-oxa-2,11,13-triazatricyclo[7.4.0.0^{3,7}]trideca-1(9),3(7)-diene-6,10,12-trione","InChI=1S/C16H13N3O4/c1-19-13-12(14(20)18-16(19)22)10(8-5-3-2-4-6-8)11-9(17-13)7-23-15(11)21/h2-6,10,17H,7H2,1H3,(H,18,20,22)",LDRPHFMYAJCBFM-UHFFFAOYSA-N,0,0,0,0,,,,,
2204,4800411,4094028,,CCn1c2NC3=C(C(c4ccccc4)c2c(=O)[nH]c1=O)C(=O)OC3,"13-ethyl-8-phenyl-5-oxa-2,11,13-triazatricyclo[7.4.0.0^{3,7}]trideca-1(9),3(7)-diene-6,10,12-trione","InChI=1S/C17H15N3O4/c1-2-20-14-13(15(21)19-17(20)23)11(9-6-4-3-5-7-9)12-10(18-14)8-24-16(12)22/h3-7,11,18H,2,8H2,1H3,(H,19,21,23)",WMTVHKOJALQDKD-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,6.46,cancer,Inhibition,
2205,16258758,4088746,,CCCn1c2NC3=C(C(c4ccccc4)c2c(=O)[nH]c1=O)C(=O)OC3,"8-phenyl-13-propyl-5-oxa-2,11,13-triazatricyclo[7.4.0.0^{3,7}]trideca-1(9),3(7)-diene-6,10,12-trione","InChI=1S/C18H17N3O4/c1-2-8-21-15-14(16(22)20-18(21)24)12(10-6-4-3-5-7-10)13-11(19-15)9-25-17(13)23/h3-7,12,19H,2,8-9H2,1H3,(H,20,22,24)",JXTZQNJRSYNAJR-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,5.92,cancer,Inhibition,
2206,4794457,4060512,,Cc1ccc(cc1)C1C2=C(COC2=O)Nc2c1c(=O)n(C)c(=O)n2C,"11,13-dimethyl-8-(4-methylphenyl)-5-oxa-2,11,13-triazatricyclo[7.4.0.0^{3,7}]trideca-1(9),3(7)-diene-6,10,12-trione","InChI=1S/C18H17N3O4/c1-9-4-6-10(7-5-9)12-13-11(8-25-17(13)23)19-15-14(12)16(22)21(3)18(24)20(15)2/h4-7,12,19H,8H2,1-3H3",AVGOOVXJYOSRNE-UHFFFAOYSA-N,0,0,0,0,,,,,
2207,4541508,4102160,,COc1ccc(cc1)C1C2=C(COC2=O)Nc2c1c(=O)n(C)c(=O)n2C,"8-(4-methoxyphenyl)-11,13-dimethyl-5-oxa-2,11,13-triazatricyclo[7.4.0.0^{3,7}]trideca-1(9),3(7)-diene-6,10,12-trione","InChI=1S/C18H17N3O5/c1-20-15-14(16(22)21(2)18(20)24)12(9-4-6-10(25-3)7-5-9)13-11(19-15)8-26-17(13)23/h4-7,12,19H,8H2,1-3H3",PWGGLSDTFYJKIA-UHFFFAOYSA-N,0,0,0,0,,,,,
2208,16822024,4077905,,CCn1c2NC3=C(C(c4ccc(Cl)cc4)c2c(=O)[nH]c1=O)C(=O)OC3,"8-(4-chlorophenyl)-13-ethyl-5-oxa-2,11,13-triazatricyclo[7.4.0.0^{3,7}]trideca-1(9),3(7)-diene-6,10,12-trione","InChI=1S/C17H14ClN3O4/c1-2-21-14-13(15(22)20-17(21)24)11(8-3-5-9(18)6-4-8)12-10(19-14)7-25-16(12)23/h3-6,11,19H,2,7H2,1H3,(H,20,22,24)",SLWPFZUDYLJXOB-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,6.52,cancer,Inhibition,
2209,137655200,4094424,,CCn1c2NC3=C(C(c4ccc(cc4)C(F)(F)F)c2c(=O)[nH]c1=O)C(=O)OC3,"13-ethyl-8-[4-(trifluoromethyl)phenyl]-5-oxa-2,11,13-triazatricyclo[7.4.0.0^{3,7}]trideca-1(9),3(7)-diene-6,10,12-trione","InChI=1S/C18H14F3N3O4/c1-2-24-14-13(15(25)23-17(24)27)11(12-10(22-14)7-28-16(12)26)8-3-5-9(6-4-8)18(19,20)21/h3-6,11,22H,2,7H2,1H3,(H,23,25,27)",GSQMKFKPHLJZSN-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,5.82,cancer,Inhibition,
2210,137632087,4066935,,Cc1ccc(cc1)C1C2=C(COC2=O)Nc2c1c(=O)[nH]c(=O)n2C1CC1,"13-cyclopropyl-8-(4-methylphenyl)-5-oxa-2,11,13-triazatricyclo[7.4.0.0^{3,7}]trideca-1(9),3(7)-diene-6,10,12-trione","InChI=1S/C19H17N3O4/c1-9-2-4-10(5-3-9)13-14-12(8-26-18(14)24)20-16-15(13)17(23)21-19(25)22(16)11-6-7-11/h2-5,11,13,20H,6-8H2,1H3,(H,21,23,25)",ZEFGFAQVPMQFOV-UHFFFAOYSA-N,0,0,0,0,,,,,
2211,137639306,4072799,,Cc1ccc(cc1)C1C2=C(COC2=O)Nc2c1c(=O)[nH]c(=O)n2CC(F)(F)F,"8-(4-methylphenyl)-13-(2,2,2-trifluoroethyl)-5-oxa-2,11,13-triazatricyclo[7.4.0.0^{3,7}]trideca-1(9),3(7)-diene-6,10,12-trione","InChI=1S/C18H14F3N3O4/c1-8-2-4-9(5-3-8)11-12-10(6-28-16(12)26)22-14-13(11)15(25)23-17(27)24(14)7-18(19,20)21/h2-5,11,22H,6-7H2,1H3,(H,23,25,27)",JNPLKPXUKXLWKV-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,6.80,cancer,Inhibition,
2212,137654718,4093510,,CCn1c2NC3=C(C(c4ccc(C)cc4)c2c(=O)[nH]c1=O)C(=O)CC3,"13-ethyl-8-(4-methylphenyl)-2,11,13-triazatricyclo[7.4.0.0^{3,7}]trideca-1(9),3(7)-diene-6,10,12-trione","InChI=1S/C19H19N3O3/c1-3-22-17-16(18(24)21-19(22)25)14(11-6-4-10(2)5-7-11)15-12(20-17)8-9-13(15)23/h4-7,14,20H,3,8-9H2,1-2H3,(H,21,24,25)",GFYQCHZFSLHBOA-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,5.00,cancer,Inhibition,
2213,137636712,4064204,,CCn1c2NC3=C(C(c4ccc(C)cc4)c2c(=O)[nH]c1=O)C(=O)N(C)C3,"13-ethyl-5-methyl-8-(4-methylphenyl)-2,5,11,13-tetraazatricyclo[7.4.0.0^{3,7}]trideca-1(9),3(7)-diene-6,10,12-trione","InChI=1S/C19H20N4O3/c1-4-23-16-15(17(24)21-19(23)26)13(11-7-5-10(2)6-8-11)14-12(20-16)9-22(3)18(14)25/h5-8,13,20H,4,9H2,1-3H3,(H,21,24,26)",XBNYMTXJOBYHMR-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,5.60,cancer,Inhibition,
2214,137643820,4085767,,CCn1c2NC3=C(C(c4ccc(C)cc4)c2c(=O)n(C)c1=O)C(=O)OC3,"13-ethyl-11-methyl-8-(4-methylphenyl)-5-oxa-2,11,13-triazatricyclo[7.4.0.0^{3,7}]trideca-1(9),3(7)-diene-6,10,12-trione","InChI=1S/C19H19N3O4/c1-4-22-16-15(17(23)21(3)19(22)25)13(11-7-5-10(2)6-8-11)14-12(20-16)9-26-18(14)24/h5-8,13,20H,4,9H2,1-3H3",UVXLCDRWDGHQDE-UHFFFAOYSA-N,0,0,0,0,,,,,
2215,137632690,4067951,,CCn1c2nc3COC(=O)c3c(-c3ccc(C)cc3)c2c(=O)[nH]c1=O,"13-ethyl-8-(4-methylphenyl)-5-oxa-2,11,13-triazatricyclo[7.4.0.0^{3,7}]trideca-1(9),2,7-triene-6,10,12-trione","InChI=1S/C18H15N3O4/c1-3-21-15-14(16(22)20-18(21)24)12(10-6-4-9(2)5-7-10)13-11(19-15)8-25-17(13)23/h4-7H,3,8H2,1-2H3,(H,20,22,24)",XQIVSOWGERBFQG-UHFFFAOYSA-N,0,0,0,0,,,,,
2216,137644677,4089152,,CCn1c2NC3=C(C(c4ccc(C)cc4)c2c(=O)[nH]c1=O)C(=O)N(CC=C)C3,"13-ethyl-8-(4-methylphenyl)-5-(prop-2-en-1-yl)-2,5,11,13-tetraazatricyclo[7.4.0.0^{3,7}]trideca-1(9),3(7)-diene-6,10,12-trione","InChI=1S/C21H22N4O3/c1-4-10-24-11-14-16(20(24)27)15(13-8-6-12(3)7-9-13)17-18(22-14)25(5-2)21(28)23-19(17)26/h4,6-9,15,22H,1,5,10-11H2,2-3H3,(H,23,26,28)",SGYUNIXZZZQROD-UHFFFAOYSA-N,1,0,0,0,Bromodomain / Histone,4.85,cancer,Inhibition,
2217,137632577,4065286,,CCn1c2NC3=C(C(c4ccc(C)cc4)c2c(=O)[nH]c1=O)C(=O)N(Cc1ccccc1)C3,"5-benzyl-13-ethyl-8-(4-methylphenyl)-2,5,11,13-tetraazatricyclo[7.4.0.0^{3,7}]trideca-1(9),3(7)-diene-6,10,12-trione","InChI=1S/C25H24N4O3/c1-3-29-22-21(23(30)27-25(29)32)19(17-11-9-15(2)10-12-17)20-18(26-22)14-28(24(20)31)13-16-7-5-4-6-8-16/h4-12,19,26H,3,13-14H2,1-2H3,(H,27,30,32)",ZBRDRGVJFCJFQS-UHFFFAOYSA-N,2,1,0,0,Bromodomain / Histone,6.72,cancer,Inhibition,
2218,137653484,4092949,,CCn1c2NC3=C(C(c4ccc(C)cc4)c2c(=O)[nH]c1=O)C(=O)N(CCc1ccccc1)C3,"13-ethyl-8-(4-methylphenyl)-5-(2-phenylethyl)-2,5,11,13-tetraazatricyclo[7.4.0.0^{3,7}]trideca-1(9),3(7)-diene-6,10,12-trione","InChI=1S/C26H26N4O3/c1-3-30-23-22(24(31)28-26(30)33)20(18-11-9-16(2)10-12-18)21-19(27-23)15-29(25(21)32)14-13-17-7-5-4-6-8-17/h4-12,20,27H,3,13-15H2,1-2H3,(H,28,31,33)",DQFBZYXAVHHSEQ-UHFFFAOYSA-N,2,1,0,0,Bromodomain / Histone,6.85,cancer,Inhibition,
2219,137657448,4103140,,CCn1c2NC3=C(C(c4ccc(C)cc4)c2c(=O)[nH]c1=O)C(=O)N(CCc1ccc(OC)cc1)C3,"13-ethyl-5-[2-(4-methoxyphenyl)ethyl]-8-(4-methylphenyl)-2,5,11,13-tetraazatricyclo[7.4.0.0^{3,7}]trideca-1(9),3(7)-diene-6,10,12-trione","InChI=1S/C27H28N4O4/c1-4-31-24-23(25(32)29-27(31)34)21(18-9-5-16(2)6-10-18)22-20(28-24)15-30(26(22)33)14-13-17-7-11-19(35-3)12-8-17/h5-12,21,28H,4,13-15H2,1-3H3,(H,29,32,34)",MWNUDTXWOMXGKW-UHFFFAOYSA-N,2,1,0,0,Bromodomain / Histone,7.00,cancer,Inhibition,
2220,137648257,4085204,,CCn1c2NC3=C(C(c4ccc(C)cc4)c2c(=O)[nH]c1=O)C(=O)N(CCc1ccc(O)cc1)C3,"13-ethyl-5-[2-(4-hydroxyphenyl)ethyl]-8-(4-methylphenyl)-2,5,11,13-tetraazatricyclo[7.4.0.0^{3,7}]trideca-1(9),3(7)-diene-6,10,12-trione","InChI=1S/C26H26N4O4/c1-3-30-23-22(24(32)28-26(30)34)20(17-8-4-15(2)5-9-17)21-19(27-23)14-29(25(21)33)13-12-16-6-10-18(31)11-7-16/h4-11,20,27,31H,3,12-14H2,1-2H3,(H,28,32,34)",VLSYQVCLFAZVNI-UHFFFAOYSA-N,2,1,0,0,Bromodomain / Histone,6.96,cancer,Inhibition,
2221,137650388,4074955,,CCn1c2NC(C)=C(C(c3ccc(C)cc3)c2c(=O)[nH]c1=O)C(=O)OC,"methyl 1-ethyl-7-methyl-5-(4-methylphenyl)-2,4-dioxo-1H,2H,3H,4H,5H,8H-pyrido[2,3-d]pyrimidine-6-carboxylate","InChI=1S/C19H21N3O4/c1-5-22-16-15(17(23)21-19(22)25)14(12-8-6-10(2)7-9-12)13(11(3)20-16)18(24)26-4/h6-9,14,20H,5H2,1-4H3,(H,21,23,25)",HUNYLEOCQMWUJR-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,6.13,cancer,Inhibition,
2222,137643860,4086644,,CCn1c2NC(C)=C(C(c3ccc(C)cc3)c2c(=O)[nH]c1=O)C(=O)OCc1ccccc1,"benzyl 1-ethyl-7-methyl-5-(4-methylphenyl)-2,4-dioxo-1H,2H,3H,4H,5H,8H-pyrido[2,3-d]pyrimidine-6-carboxylate","InChI=1S/C25H25N3O4/c1-4-28-22-21(23(29)27-25(28)31)20(18-12-10-15(2)11-13-18)19(16(3)26-22)24(30)32-14-17-8-6-5-7-9-17/h5-13,20,26H,4,14H2,1-3H3,(H,27,29,31)",RVYKPIDWJIKYLX-UHFFFAOYSA-N,1,0,0,0,Bromodomain / Histone,6.60,cancer,Inhibition,
2223,137657907,4104541,,CCn1c2NC(C)=C(C(c3ccc(C)cc3)c2c(=O)[nH]c1=O)C(=O)OCC=C,"prop-2-en-1-yl 1-ethyl-7-methyl-5-(4-methylphenyl)-2,4-dioxo-1H,2H,3H,4H,5H,8H-pyrido[2,3-d]pyrimidine-6-carboxylate","InChI=1S/C21H23N3O4/c1-5-11-28-20(26)15-13(4)22-18-17(19(25)23-21(27)24(18)6-2)16(15)14-9-7-12(3)8-10-14/h5,7-10,16,22H,1,6,11H2,2-4H3,(H,23,25,27)",WWSMMSQOAGMCFL-UHFFFAOYSA-N,2,0,0,0,Bromodomain / Histone,6.25,cancer,Inhibition,
2224,2767362,4059728,,CONC=Nc1nc2nccc(-c3cccnc3)n2n1,"N-methoxy-N'-[7-(pyridin-3-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]methanimidamide","InChI=1S/C12H11N7O/c1-20-16-8-15-11-17-12-14-6-4-10(19(12)18-11)9-3-2-5-13-7-9/h2-8H,1H3,(H,15,16,18)",OWJDQIQTYCDUAA-UHFFFAOYSA-N,1,0,0,0,Bromodomain / Histone,3.92,cancer,Inhibition,
2225,16457178,,,CN1c2ccc(Cl)cc2C(=NCCC1=O)c1ccc(Cl)cc1,"8-chloro-6-(4-chlorophenyl)-1-methyl-1,2,3,4-tetrahydro-1,5-benzodiazocin-2-one","InChI=1S/C17H14Cl2N2O/c1-21-15-7-6-13(19)10-14(15)17(20-9-8-16(21)22)11-2-4-12(18)5-3-11/h2-7,10H,8-9H2,1H3",RYFVPWCSBPISQS-UHFFFAOYSA-N,1,0,0,0,Bromodomain / Histone,3.66,cancer,Inhibition,
2226,719444,4098168,,CN=c1[nH]c2n(C)c(=O)[nH]c(=O)c2n1Cc1ccc(F)cc1,"7-[(4-fluorophenyl)methyl]-3-methyl-8-(methylimino)-2,3,6,7,8,9-hexahydro-1H-purine-2,6-dione","InChI=1S/C14H14FN5O2/c1-16-13-17-11-10(12(21)18-14(22)19(11)2)20(13)7-8-3-5-9(15)6-4-8/h3-6H,7H2,1-2H3,(H,16,17)(H,18,21,22)",URPANXUHEDIZOO-UHFFFAOYSA-N,1,0,0,0,Bromodomain / Histone,4.17,cancer,Inhibition,
2227,16414715,4080143,,O=c1[nH]c(=O)c2c(ccnc2n1CC1CCCO1)-c1ccco1,"5-(furan-2-yl)-1-[(oxolan-2-yl)methyl]-1H,2H,3H,4H-pyrido[2,3-d]pyrimidine-2,4-dione","InChI=1S/C16H15N3O4/c20-15-13-11(12-4-2-8-23-12)5-6-17-14(13)19(16(21)18-15)9-10-3-1-7-22-10/h2,4-6,8,10H,1,3,7,9H2,(H,18,20,21)",OIEHAXQSKYVIJF-UHFFFAOYSA-N,1,0,0,0,Bromodomain / Histone,3.89,cancer,Inhibition,
2228,3152866,,,Cn1c2[nH]c(=NCCO)n(Cc3cccc4ccccc34)c2c(=O)[nH]c1=O,"8-[(2-hydroxyethyl)imino]-3-methyl-7-[(naphthalen-1-yl)methyl]-2,3,6,7,8,9-hexahydro-1H-purine-2,6-dione","InChI=1S/C19H19N5O3/c1-23-16-15(17(26)22-19(23)27)24(18(21-16)20-9-10-25)11-13-7-4-6-12-5-2-3-8-14(12)13/h2-8,25H,9-11H2,1H3,(H,20,21)(H,22,26,27)",PTHWZJAUVFQPGI-UHFFFAOYSA-N,1,0,0,0,Bromodomain / Histone,4.06,cancer,Inhibition,
2229,4271628,1471174,,CCC1(C)Cc2ccccc2-c2ncnc(O)c12,"5-ethyl-5-methyl-5H,6H-benzo[h]quinazolin-4-ol","InChI=1S/C15H16N2O/c1-3-15(2)8-10-6-4-5-7-11(10)13-12(15)14(18)17-9-16-13/h4-7,9H,3,8H2,1-2H3,(H,16,17,18)",UTJRGNCYPLAFDJ-UHFFFAOYSA-N,1,0,0,0,Bromodomain / Histone,3.66,cancer,Inhibition,
2230,6484105,4094383,,CCn1c2ccc(C=O)cc2n(CC)c1=O,"1,3-diethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazole-5-carbaldehyde","InChI=1S/C12H14N2O2/c1-3-13-10-6-5-9(8-15)7-11(10)14(4-2)12(13)16/h5-8H,3-4H2,1-2H3",JZPXIWMYTZXPIF-UHFFFAOYSA-N,1,0,0,0,Bromodomain / Histone,3.85,cancer,Inhibition,
2231,6490828,,,CCCN1C(c2c(C)[nH]nc2C1=O)c1cc(OC)ccc1OC,"4-(2,5-dimethoxyphenyl)-3-methyl-5-propyl-2H,4H,5H,6H-pyrrolo[3,4-c]pyrazol-6-one","InChI=1S/C17H21N3O3/c1-5-8-20-16(14-10(2)18-19-15(14)17(20)21)12-9-11(22-3)6-7-13(12)23-4/h6-7,9,16H,5,8H2,1-4H3,(H,18,19)",BVJZNCYAAPLDEH-UHFFFAOYSA-N,1,0,0,0,Bromodomain / Histone,4.17,cancer,Inhibition,
2232,168317724,,,Nc1nccn1NCCCOc1ccc(Cl)cc1Cl,"N1-[3-(2,4-dichlorophenoxy)propyl]-1H-imidazole-1,2-diamine","InChI=1S/C12H14Cl2N4O/c13-9-2-3-11(10(14)8-9)19-7-1-4-17-18-6-5-16-12(18)15/h2-3,5-6,8,17H,1,4,7H2,(H2,15,16)",JOKJIZLKSTZFLF-UHFFFAOYSA-N,1,0,0,0,WDR5/MLL,4.18,Leukemia,Inhibition,
2233,146370875,5175404,,CC(NC(=O)c1cccc(CNC2=NCCN2)c1)c1cccc(Cl)c1,"N-[1-(3-chlorophenyl)ethyl]-3-{[(4,5-dihydro-1H-imidazol-2-yl)amino]methyl}benzamide","InChI=1S/C19H21ClN4O/c1-13(15-5-3-7-17(20)11-15)24-18(25)16-6-2-4-14(10-16)12-23-19-21-8-9-22-19/h2-7,10-11,13H,8-9,12H2,1H3,(H,24,25)(H2,21,22,23)",ZHGJIKXLESXIHK-UHFFFAOYSA-N,2,0,0,0,WDR5/MLL,7.65,Leukemia,Inhibition,
2234,138753248,5172311,,COc1cc(CNC(=O)c2ccc(F)c(CNC3=NCCN3)c2)cc(OC)c1,"3-{[(4,5-dihydro-1H-imidazol-2-yl)amino]methyl}-N-[(3,5-dimethoxyphenyl)methyl]-4-fluorobenzamide","InChI=1S/C20H23FN4O3/c1-27-16-7-13(8-17(10-16)28-2)11-24-19(26)14-3-4-18(21)15(9-14)12-25-20-22-5-6-23-20/h3-4,7-10H,5-6,11-12H2,1-2H3,(H,24,26)(H2,22,23,25)",VDAMWMOTTUWVPR-UHFFFAOYSA-N,4,2,0,0,WDR5/MLL,9.10,Leukemia,Inhibition,
2235,146371031,,,COc1cc(CNC(=O)c2cccc(CNC3=NCCN3)c2F)cc(OC)c1,"3-{[(4,5-dihydro-1H-imidazol-2-yl)amino]methyl}-N-[(3,5-dimethoxyphenyl)methyl]-2-fluorobenzamide","InChI=1S/C20H23FN4O3/c1-27-15-8-13(9-16(10-15)28-2)11-24-19(26)17-5-3-4-14(18(17)21)12-25-20-22-6-7-23-20/h3-5,8-10H,6-7,11-12H2,1-2H3,(H,24,26)(H2,22,23,25)",QDOLMNUEDRBING-UHFFFAOYSA-N,2,0,0,0,WDR5/MLL,7.46,Leukemia,Inhibition,
2236,3154177,5198324,,OC(=O)c1ccc(Cn2ccnc2)o1,5-[(1H-imidazol-1-yl)methyl]furan-2-carboxylic acid,"InChI=1S/C9H8N2O3/c12-9(13)8-2-1-7(14-8)5-11-4-3-10-6-11/h1-4,6H,5H2,(H,12,13)",NNJVURHBCVIUHK-UHFFFAOYSA-N,1,0,0,0,WDR5/MLL,3.82,Leukemia,Inhibition,
2237,137530077,5176836,,Clc1cc(Cl)cc(CNC(=O)c2cccc(Cn3ccnc3)c2)c1,"N-[(3,5-dichlorophenyl)methyl]-3-[(1H-imidazol-1-yl)methyl]benzamide","InChI=1S/C18H15Cl2N3O/c19-16-7-14(8-17(20)9-16)10-22-18(24)15-3-1-2-13(6-15)11-23-5-4-21-12-23/h1-9,12H,10-11H2,(H,22,24)",JZXCLJKOXUVFTA-UHFFFAOYSA-N,1,0,0,0,WDR5/MLL,6.17,Leukemia,Inhibition,
2238,138319680,4441671,,Cc1nc(F)ccc1-c1cc(Cn2ccn(C)c2=N)cc(c1)C(=O)NCc1ccc(Cl)c(Cl)c1,"N-[(3,4-dichlorophenyl)methyl]-3-(6-fluoro-2-methylpyridin-3-yl)-5-[(2-imino-3-methyl-2,3-dihydro-1H-imidazol-1-yl)methyl]benzamide","InChI=1S/C25H22Cl2FN5O/c1-15-20(4-6-23(28)31-15)18-9-17(14-33-8-7-32(2)25(33)29)10-19(12-18)24(34)30-13-16-3-5-21(26)22(27)11-16/h3-12,29H,13-14H2,1-2H3,(H,30,34)",ZPVQIJIWGMKMQN-UHFFFAOYSA-N,6,2,0,0,WDR5/MLL,12.00,Leukemia,Inhibition,
2239,168317855,,,Cc1nc(F)ccc1-c1cc(ccc1Cn1ccn(C)c1=N)C(=O)NCc1ccc(Cl)c(Cl)c1,"N-[(3,4-dichlorophenyl)methyl]-3-(6-fluoro-2-methylpyridin-3-yl)-4-[(2-imino-3-methyl-2,3-dihydro-1H-imidazol-1-yl)methyl]benzamide","InChI=1S/C25H22Cl2FN5O/c1-15-19(6-8-23(28)31-15)20-12-17(4-5-18(20)14-33-10-9-32(2)25(33)29)24(34)30-13-16-3-7-21(26)22(27)11-16/h3-12,29H,13-14H2,1-2H3,(H,30,34)",BZKKPZJFHSBRJA-UHFFFAOYSA-N,0,0,0,0,,,,,
2240,91623360,3798846,,CN1CCN(CC1)c1ccc(cc1NC(=O)c1c[nH]c(=O)cc1C(F)(F)F)-c1cccc(CN2CCOCC2)c1,"N-[4-(4-methylpiperazin-1-yl)-3'-[(morpholin-4-yl)methyl]-[1,1'-biphenyl]-3-yl]-6-oxo-4-(trifluoromethyl)-1,6-dihydropyridine-3-carboxamide","InChI=1S/C29H32F3N5O3/c1-35-7-9-37(10-8-35)26-6-5-22(21-4-2-3-20(15-21)19-36-11-13-40-14-12-36)16-25(26)34-28(39)23-18-33-27(38)17-24(23)29(30,31)32/h2-6,15-18H,7-14,19H2,1H3,(H,33,38)(H,34,39)",DJOVLOYCGXNVPI-UHFFFAOYSA-N,4,0,0,0,WDR5/MLL,7.19,myeloid leukemia,Inhibition,
2241,6484689,5408148,,COC(=O)c1ccc(cc1)C(=O)Nc1ccc2[nH]c(CN3CCCCC3)nc2c1,"methyl 4-({2-[(piperidin-1-yl)methyl]-1H-1,3-benzodiazol-5-yl}carbamoyl)benzoate","InChI=1S/C22H24N4O3/c1-29-22(28)16-7-5-15(6-8-16)21(27)23-17-9-10-18-19(13-17)25-20(24-18)14-26-11-3-2-4-12-26/h5-10,13H,2-4,11-12,14H2,1H3,(H,23,27)(H,24,25)",UVAMTJLXRMVTBI-UHFFFAOYSA-N,1,0,0,0,MLLT1 / H3,5.68,myeloid leukemia,Inhibition,
2242,145979206,4280015,,Clc1ccc(cc1Cl)C(=O)Nc1ccc2[nH]c(CN3CCCCC3)nc2c1,"3,4-dichloro-N-{2-[(piperidin-1-yl)methyl]-1H-1,3-benzodiazol-5-yl}benzamide","InChI=1S/C20H20Cl2N4O/c21-15-6-4-13(10-16(15)22)20(27)23-14-5-7-17-18(11-14)25-19(24-17)12-26-8-2-1-3-9-26/h4-7,10-11H,1-3,8-9,12H2,(H,23,27)(H,24,25)",WCGKVETXIRUCNS-UHFFFAOYSA-N,1,0,0,0,MLLT1 / H3,5.35,myeloid leukemia,Inhibition,
2243,168317853,,,Cc1ccc(cc1C)C(=O)Nc1ccc2[nH]c(CN3CCCCC3)nc2c1,"3,4-dimethyl-N-{2-[(piperidin-1-yl)methyl]-1H-1,3-benzodiazol-5-yl}benzamide","InChI=1S/C22H26N4O/c1-15-6-7-17(12-16(15)2)22(27)23-18-8-9-19-20(13-18)25-21(24-19)14-26-10-4-3-5-11-26/h6-9,12-13H,3-5,10-11,14H2,1-2H3,(H,23,27)(H,24,25)",OGMDMHTXYJWOFY-UHFFFAOYSA-N,1,0,0,0,MLLT1 / H3,5.26,myeloid leukemia,Inhibition,
2244,139592540,4290656,,Clc1ccc(cc1)C(=O)Nc1ccc2[nH]c(CN3CCCCC3)nc2c1,"4-chloro-N-{2-[(piperidin-1-yl)methyl]-1H-1,3-benzodiazol-5-yl}benzamide","InChI=1S/C20H21ClN4O/c21-15-6-4-14(5-7-15)20(26)22-16-8-9-17-18(12-16)24-19(23-17)13-25-10-2-1-3-11-25/h4-9,12H,1-3,10-11,13H2,(H,22,26)(H,23,24)",BKSMGCKPKGVUHS-UHFFFAOYSA-N,1,0,0,0,MLLT1 / H3,5.33,myeloid leukemia,Inhibition,
2245,168317852,,,COc1ccc(cc1)C(=O)Nc1ccc2[nH]c(CN3CCCCC3)nc2c1,"4-methoxy-N-{2-[(piperidin-1-yl)methyl]-1H-1,3-benzodiazol-5-yl}benzamide","InChI=1S/C21H24N4O2/c1-27-17-8-5-15(6-9-17)21(26)22-16-7-10-18-19(13-16)24-20(23-18)14-25-11-3-2-4-12-25/h5-10,13H,2-4,11-12,14H2,1H3,(H,22,26)(H,23,24)",UBZJCXABCHMMKH-UHFFFAOYSA-N,1,0,0,0,MLLT1 / H3,5.19,myeloid leukemia,Inhibition,
2246,168317851,,,O=C(Nc1ccc2[nH]c(CN3CCCCC3)nc2c1)c1ccc2ncccc2c1,"N-{2-[(piperidin-1-yl)methyl]-1H-1,3-benzodiazol-5-yl}quinoline-6-carboxamide","InChI=1S/C23H23N5O/c29-23(17-6-8-19-16(13-17)5-4-10-24-19)25-18-7-9-20-21(14-18)27-22(26-20)15-28-11-2-1-3-12-28/h4-10,13-14H,1-3,11-12,15H2,(H,25,29)(H,26,27)",QUTRNVZMYIGFEF-UHFFFAOYSA-N,1,0,0,0,MLLT1 / H3,5.92,myeloid leukemia,Inhibition,
2247,168317850,,,O=C(Nc1ccc2[nH]c(CN3CCCCC3)nc2c1)c1ccc(cc1)-n1ccnc1,"4-(1H-imidazol-1-yl)-N-{2-[(piperidin-1-yl)methyl]-1H-1,3-benzodiazol-5-yl}benzamide","InChI=1S/C23H24N6O/c30-23(17-4-7-19(8-5-17)29-13-10-24-16-29)25-18-6-9-20-21(14-18)27-22(26-20)15-28-11-2-1-3-12-28/h4-10,13-14,16H,1-3,11-12,15H2,(H,25,30)(H,26,27)",OCMUSOQFGRNIJE-UHFFFAOYSA-N,1,0,0,0,MLLT1 / H3,6.00,myeloid leukemia,Inhibition,
2248,168317849,,,Cn1ncc2ccc(cc12)C(=O)Nc1ccc2[nH]c(CN3CCCCC3)nc2c1,"1-methyl-N-{2-[(piperidin-1-yl)methyl]-1H-1,3-benzodiazol-5-yl}-1H-indazole-6-carboxamide","InChI=1S/C22H24N6O/c1-27-20-11-15(5-6-16(20)13-23-27)22(29)24-17-7-8-18-19(12-17)26-21(25-18)14-28-9-3-2-4-10-28/h5-8,11-13H,2-4,9-10,14H2,1H3,(H,24,29)(H,25,26)",PHMHELWDYJYWSO-UHFFFAOYSA-N,1,0,0,0,MLLT1 / H3,5.68,myeloid leukemia,Inhibition,
2249,168317848,,,Cn1ncc2cc(ccc12)C(=O)Nc1ccc2[nH]c(CN3CCCCC3)nc2c1,"1-methyl-N-{2-[(piperidin-1-yl)methyl]-1H-1,3-benzodiazol-5-yl}-1H-indazole-5-carboxamide","InChI=1S/C22H24N6O/c1-27-20-8-5-15(11-16(20)13-23-27)22(29)24-17-6-7-18-19(12-17)26-21(25-18)14-28-9-3-2-4-10-28/h5-8,11-13H,2-4,9-10,14H2,1H3,(H,24,29)(H,25,26)",XWQJWKNEMNPJNB-UHFFFAOYSA-N,1,0,0,0,MLLT1 / H3,5.80,myeloid leukemia,Inhibition,
2250,168317846,,,C[C@H]1C[C@@H](C)CN(Cc2nc3cc(NC(=O)c4ccc5n(C)ncc5c4)ccc3[nH]2)C1,"N-(2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]methyl}-1H-1,3-benzodiazol-5-yl)-1-methyl-1H-indazole-5-carboxamide","InChI=1S/C24H28N6O/c1-15-8-16(2)13-30(12-15)14-23-27-20-6-5-19(10-21(20)28-23)26-24(31)17-4-7-22-18(9-17)11-25-29(22)3/h4-7,9-11,15-16H,8,12-14H2,1-3H3,(H,26,31)(H,27,28)/t15-,16+",TZKBYUXIHFAKIW-IYBDPMFKSA-N,1,0,0,0,MLLT1 / H3,5.24,myeloid leukemia,Inhibition,
2251,139269581,,,CC1CCCN1Cc1nc2cc(NC(=O)c3ccc4n(C)ncc4c3)ccc2[nH]1,"1-methyl-N-{2-[(2-methylpyrrolidin-1-yl)methyl]-1H-1,3-benzodiazol-5-yl}-1H-indazole-5-carboxamide","InChI=1S/C22H24N6O/c1-14-4-3-9-28(14)13-21-25-18-7-6-17(11-19(18)26-21)24-22(29)15-5-8-20-16(10-15)12-23-27(20)2/h5-8,10-12,14H,3-4,9,13H2,1-2H3,(H,24,29)(H,25,26)",QGNDVASWIHEXCL-UHFFFAOYSA-N,1,0,0,0,MLLT1 / H3,6.48,myeloid leukemia,Inhibition,
2252,168317845,,,Cn1ncc2cc(ccc12)C(=O)Nc1ccc2[nH]c(CN3CC4CC4C3)nc2c1,"N-[2-({3-azabicyclo[3.1.0]hexan-3-yl}methyl)-1H-1,3-benzodiazol-5-yl]-1-methyl-1H-indazole-5-carboxamide","InChI=1S/C22H22N6O/c1-27-20-5-2-13(6-14(20)9-23-27)22(29)24-17-3-4-18-19(8-17)26-21(25-18)12-28-10-15-7-16(15)11-28/h2-6,8-9,15-16H,7,10-12H2,1H3,(H,24,29)(H,25,26)",IGZWGTGHJXYZKT-UHFFFAOYSA-N,1,0,0,0,MLLT1 / H3,5.85,myeloid leukemia,Inhibition,
2253,167039420,,,CCC1CCCN1Cc1nc2cc(NC(=O)c3ccc4n(C)ncc4c3)ccc2[nH]1,"N-{2-[(2-ethylpyrrolidin-1-yl)methyl]-1H-1,3-benzodiazol-5-yl}-1-methyl-1H-indazole-5-carboxamide","InChI=1S/C23H26N6O/c1-3-18-5-4-10-29(18)14-22-26-19-8-7-17(12-20(19)27-22)25-23(30)15-6-9-21-16(11-15)13-24-28(21)2/h6-9,11-13,18H,3-5,10,14H2,1-2H3,(H,25,30)(H,26,27)",HJALFHDMZVSLEG-UHFFFAOYSA-N,1,0,0,0,MLLT1 / H3,6.52,myeloid leukemia,Inhibition,
2254,168317844,,,COCC1CCCN1Cc1nc2cc(NC(=O)c3ccc4n(C)ncc4c3)ccc2[nH]1,"N-(2-{[2-(methoxymethyl)pyrrolidin-1-yl]methyl}-1H-1,3-benzodiazol-5-yl)-1-methyl-1H-indazole-5-carboxamide","InChI=1S/C23H26N6O2/c1-28-21-8-5-15(10-16(21)12-24-28)23(30)25-17-6-7-19-20(11-17)27-22(26-19)13-29-9-3-4-18(29)14-31-2/h5-8,10-12,18H,3-4,9,13-14H2,1-2H3,(H,25,30)(H,26,27)",JJVHEEXCVCFCQC-UHFFFAOYSA-N,1,0,0,0,MLLT1 / H3,6.01,myeloid leukemia,Inhibition,
2255,168317843,,,C[C@H]1CCN(Cc2nc3cc(NC(=O)c4ccc5n(C)ncc5c4)ccc3[nH]2)C1,"1-methyl-N-(2-{[(3S)-3-methylpyrrolidin-1-yl]methyl}-1H-1,3-benzodiazol-5-yl)-1H-indazole-5-carboxamide","InChI=1S/C22H24N6O/c1-14-7-8-28(12-14)13-21-25-18-5-4-17(10-19(18)26-21)24-22(29)15-3-6-20-16(9-15)11-23-27(20)2/h3-6,9-11,14H,7-8,12-13H2,1-2H3,(H,24,29)(H,25,26)/t14-/m0/s1",RFYBIIKRBMJDNX-AWEZNQCLSA-N,1,0,0,0,MLLT1 / H3,6.22,myeloid leukemia,Inhibition,
2256,168317841,,,C[C@@H]1CCN(Cc2nc3cc(NC(=O)c4ccc5n(C)ncc5c4)ccc3[nH]2)C1,"1-methyl-N-(2-{[(3R)-3-methylpyrrolidin-1-yl]methyl}-1H-1,3-benzodiazol-5-yl)-1H-indazole-5-carboxamide","InChI=1S/C22H24N6O/c1-14-7-8-28(12-14)13-21-25-18-5-4-17(10-19(18)26-21)24-22(29)15-3-6-20-16(9-15)11-23-27(20)2/h3-6,9-11,14H,7-8,12-13H2,1-2H3,(H,24,29)(H,25,26)/t14-/m1/s1",RFYBIIKRBMJDNX-CQSZACIVSA-N,1,0,0,0,MLLT1 / H3,6.14,myeloid leukemia,Inhibition,
2257,137701957,,,C[C@@H]1CCCN1Cc1nc2cc(NC(=O)c3ccc4n(C)ncc4c3)ccc2[nH]1,"1-methyl-N-(2-{[(2R)-2-methylpyrrolidin-1-yl]methyl}-1H-1,3-benzodiazol-5-yl)-1H-indazole-5-carboxamide","InChI=1S/C22H24N6O/c1-14-4-3-9-28(14)13-21-25-18-7-6-17(11-19(18)26-21)24-22(29)15-5-8-20-16(10-15)12-23-27(20)2/h5-8,10-12,14H,3-4,9,13H2,1-2H3,(H,24,29)(H,25,26)/t14-/m1/s1",QGNDVASWIHEXCL-CQSZACIVSA-N,3,1,0,0,MLLT1 / H3,6.27,myeloid leukemia,Inhibition,
2258,134820948,4552313,,C[C@H]1CCCN1Cc1nc2cc(NC(=O)c3ccc4n(C)ncc4c3)ccc2[nH]1,"1-methyl-N-(2-{[(2S)-2-methylpyrrolidin-1-yl]methyl}-1H-1,3-benzodiazol-5-yl)-1H-indazole-5-carboxamide","InChI=1S/C22H24N6O/c1-14-4-3-9-28(14)13-21-25-18-7-6-17(11-19(18)26-21)24-22(29)15-5-8-20-16(10-15)12-23-27(20)2/h5-8,10-12,14H,3-4,9,13H2,1-2H3,(H,24,29)(H,25,26)/t14-/m0/s1",QGNDVASWIHEXCL-AWEZNQCLSA-N,3,1,0,0,MLLT1 / H3,7.11,myeloid leukemia,Inhibition,
2259,134820947,,,C[C@H]1CCCN1Cc1nc2cc(NC(=O)c3ccc4n(ncc4c3)C3CC3)ccc2[nH]1,"1-cyclopropyl-N-(2-{[(2S)-2-methylpyrrolidin-1-yl]methyl}-1H-1,3-benzodiazol-5-yl)-1H-indazole-5-carboxamide","InChI=1S/C24H26N6O/c1-15-3-2-10-29(15)14-23-27-20-8-5-18(12-21(20)28-23)26-24(31)16-4-9-22-17(11-16)13-25-30(22)19-6-7-19/h4-5,8-9,11-13,15,19H,2-3,6-7,10,14H2,1H3,(H,26,31)(H,27,28)/t15-/m0/s1",FTNYJPRHIRILOI-HNNXBMFYSA-N,1,0,0,0,MLLT1 / H3,7.24,myeloid leukemia,Inhibition,
2260,638578,4553271,,Cn1ccc2cc[nH]c2c1=O,"6-methyl-1H,6H,7H-pyrrolo[2,3-c]pyridin-7-one","InChI=1S/C8H8N2O/c1-10-5-3-6-2-4-9-7(6)8(10)11/h2-5,9H,1H3",ZLKWLYKVKAVOMD-UHFFFAOYSA-N,7,0,0,0,Bromodomain / Histone,5.12,cancer,Inhibition,
2261,119081692,4436408,,CN(C)C(=O)c1cccc(c1)-c1cn(C)c(=O)c2[nH]ccc12,"N,N-dimethyl-3-{6-methyl-7-oxo-1H,6H,7H-pyrrolo[2,3-c]pyridin-4-yl}benzamide","InChI=1S/C17H17N3O2/c1-19(2)16(21)12-6-4-5-11(9-12)14-10-20(3)17(22)15-13(14)7-8-18-15/h4-10,18H,1-3H3",YHMNROQTPUKNLA-UHFFFAOYSA-N,7,0,0,0,Bromodomain / Histone,7.23,cancer,Inhibition,
2262,121335281,4460783,,CN(C)C(=O)c1cccc(c1)-c1cn(CC=C)c(=O)c2[nH]ccc12,"N,N-dimethyl-3-[7-oxo-6-(prop-2-en-1-yl)-1H,6H,7H-pyrrolo[2,3-c]pyridin-4-yl]benzamide","InChI=1S/C19H19N3O2/c1-4-10-22-12-16(15-8-9-20-17(15)19(22)24)13-6-5-7-14(11-13)18(23)21(2)3/h4-9,11-12,20H,1,10H2,2-3H3",SPSRAFOXVSNAJA-UHFFFAOYSA-N,6,0,0,0,Bromodomain / Histone,6.77,cancer,Inhibition,
2263,145767868,,,CC=CCn1cc(-c2cccc(c2)C(=O)N(C)C)c2cc[nH]c2c1=O,"3-[6-(but-2-en-1-yl)-7-oxo-1H,6H,7H-pyrrolo[2,3-c]pyridin-4-yl]-N,N-dimethylbenzamide","InChI=1S/C20H21N3O2/c1-4-5-11-23-13-17(16-9-10-21-18(16)20(23)25)14-7-6-8-15(12-14)19(24)22(2)3/h4-10,12-13,21H,11H2,1-3H3",RJEMCUZKQLRUIS-UHFFFAOYSA-N,5,0,0,0,Bromodomain / Histone,6.80,cancer,Inhibition,
2264,119081691,4436158,,CN(C)C(=O)c1cccc(c1)-c1cn(CCC=C)c(=O)c2[nH]ccc12,"3-[6-(but-3-en-1-yl)-7-oxo-1H,6H,7H-pyrrolo[2,3-c]pyridin-4-yl]-N,N-dimethylbenzamide","InChI=1S/C20H21N3O2/c1-4-5-11-23-13-17(16-9-10-21-18(16)20(23)25)14-7-6-8-15(12-14)19(24)22(2)3/h4,6-10,12-13,21H,1,5,11H2,2-3H3",VNCNIMOILJQAGJ-UHFFFAOYSA-N,5,0,0,0,Bromodomain / Histone,7.34,cancer,Inhibition,
2265,121334655,,,CCn1cc(-c2cccc(c2)C(=O)N(C)C)c2cc[nH]c2c1=O,"3-{6-ethyl-7-oxo-1H,6H,7H-pyrrolo[2,3-c]pyridin-4-yl}-N,N-dimethylbenzamide","InChI=1S/C18H19N3O2/c1-4-21-11-15(14-8-9-19-16(14)18(21)23)12-6-5-7-13(10-12)17(22)20(2)3/h5-11,19H,4H2,1-3H3",KPQRLIXAHFIOKV-UHFFFAOYSA-N,7,0,0,0,Bromodomain / Histone,6.30,cancer,Inhibition,
2266,121334591,,,CCCn1cc(-c2cccc(c2)C(=O)N(C)C)c2cc[nH]c2c1=O,"N,N-dimethyl-3-{7-oxo-6-propyl-1H,6H,7H-pyrrolo[2,3-c]pyridin-4-yl}benzamide","InChI=1S/C19H21N3O2/c1-4-10-22-12-16(15-8-9-20-17(15)19(22)24)13-6-5-7-14(11-13)18(23)21(2)3/h5-9,11-12,20H,4,10H2,1-3H3",XNKHNWJEUXDDEI-UHFFFAOYSA-N,5,0,0,0,Bromodomain / Histone,6.17,cancer,Inhibition,
2267,121335285,,,CCCCn1cc(-c2cccc(c2)C(=O)N(C)C)c2cc[nH]c2c1=O,"3-{6-butyl-7-oxo-1H,6H,7H-pyrrolo[2,3-c]pyridin-4-yl}-N,N-dimethylbenzamide","InChI=1S/C20H23N3O2/c1-4-5-11-23-13-17(16-9-10-21-18(16)20(23)25)14-7-6-8-15(12-14)19(24)22(2)3/h6-10,12-13,21H,4-5,11H2,1-3H3",ASBIUJSKYAKZEN-UHFFFAOYSA-N,5,0,0,0,Bromodomain / Histone,6.13,cancer,Inhibition,
2268,121335227,,,COCCn1cc(-c2cccc(c2)C(=O)N(C)C)c2cc[nH]c2c1=O,"3-[6-(2-methoxyethyl)-7-oxo-1H,6H,7H-pyrrolo[2,3-c]pyridin-4-yl]-N,N-dimethylbenzamide","InChI=1S/C19H21N3O3/c1-21(2)18(23)14-6-4-5-13(11-14)16-12-22(9-10-25-3)19(24)17-15(16)7-8-20-17/h4-8,11-12,20H,9-10H2,1-3H3",CWTVPBWGTIZPKC-UHFFFAOYSA-N,5,0,0,0,Bromodomain / Histone,5.72,cancer,Inhibition,
2269,86277842,3769729,,COC(=O)[C@H](C)[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc12,"methyl (2R)-2-[(7S)-9-(4-chlorophenyl)-12-methoxy-3-methyl-2,4,5,8-tetraazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,8,11,13-hexaen-7-yl]propanoate","InChI=1S/C22H21ClN4O3/c1-12(22(28)30-4)19-21-26-25-13(2)27(21)18-10-9-16(29-3)11-17(18)20(24-19)14-5-7-15(23)8-6-14/h5-12,19H,1-4H3/t12-,19+/m1/s1",FENXDXHDXYVGRJ-BLVKFPJESA-N,2,0,0,0,Bromodomain / Histone,5.83,cancer,Inhibition,
2270,118121364,3770576,,COC(=O)CC1N=C(c2cc(OC)ccc2-n2c(C)nnc12)c1cccc2[nH]ccc12,"methyl 2-[9-(1H-indol-4-yl)-12-methoxy-3-methyl-2,4,5,8-tetraazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,8,11,13-hexaen-7-yl]acetate","InChI=1S/C23H21N5O3/c1-13-26-27-23-19(12-21(29)31-3)25-22(16-5-4-6-18-15(16)9-10-24-18)17-11-14(30-2)7-8-20(17)28(13)23/h4-11,19,24H,12H2,1-3H3",RARZHTSXOQRRPR-UHFFFAOYSA-N,4,0,0,0,Bromodomain / Histone,7.35,cancer,Inhibition,
2271,46274030,,,O=C(CCn1c2ncccc2n2cccc2c1=O)NCCCN1CCCC1,"3-{7-oxo-2,8,10-triazatricyclo[7.4.0.0^{2,6}]trideca-1(9),3,5,10,12-pentaen-8-yl}-N-[3-(pyrrolidin-1-yl)propyl]propanamide","InChI=1S/C20H25N5O2/c26-18(21-10-5-13-23-11-1-2-12-23)8-15-25-19-16(6-3-9-22-19)24-14-4-7-17(24)20(25)27/h3-4,6-7,9,14H,1-2,5,8,10-13,15H2,(H,21,26)",UBCAQWPZFSHSQM-UHFFFAOYSA-N,1,0,0,0,Pygo PHD / H3,2.46,colorectal cancer,Inhibition,
2272,319954,98406,,Nc1nc2ccc(F)cc2s1,"6-fluoro-1,3-benzothiazol-2-amine","InChI=1S/C7H5FN2S/c8-4-1-2-5-6(3-4)11-7(9)10-5/h1-3H,(H2,9,10)",CJLUXPZQUXVJNF-UHFFFAOYSA-N,1,0,0,0,Pygo PHD / H3,2.51,colorectal cancer,Inhibition,
2273,15630,97797,,COc1ccc2nc(N)sc2c1,"6-methoxy-1,3-benzothiazol-2-amine","InChI=1S/C8H8N2OS/c1-11-5-2-3-6-7(4-5)12-8(9)10-6/h2-4H,1H3,(H2,9,10)",KZHGPDSVHSDCMX-UHFFFAOYSA-N,1,0,0,0,Pygo PHD / H3,2.60,colorectal cancer,Inhibition,
2274,595193,464157,,CCn1c(N)nc2ccccc12,"1-ethyl-1H-1,3-benzodiazol-2-amine","InChI=1S/C9H11N3/c1-2-12-8-6-4-3-5-7(8)11-9(12)10/h3-6H,2H2,1H3,(H2,10,11)",AQOCOHSUICOLQL-UHFFFAOYSA-N,1,0,0,0,Pygo PHD / H3,2.14,colorectal cancer,Inhibition,
2275,745066,1876240,,CN(C)CCn1c(N)nc2ccccc12,"1-[2-(dimethylamino)ethyl]-1H-1,3-benzodiazol-2-amine","InChI=1S/C11H16N4/c1-14(2)7-8-15-10-6-4-3-5-9(10)13-11(15)12/h3-6H,7-8H2,1-2H3,(H2,12,13)",ZILUPJDRTVRYTK-UHFFFAOYSA-N,1,0,0,0,Pygo PHD / H3,1.83,colorectal cancer,Inhibition,
2276,8706,329785,,Nc1nc2ccccc2s1,"1,3-benzothiazol-2-amine","InChI=1S/C7H6N2S/c8-7-9-5-3-1-2-4-6(5)10-7/h1-4H,(H2,8,9)",UHGULLIUJBCTEF-UHFFFAOYSA-N,1,0,0,0,Pygo PHD / H3,2.34,colorectal cancer,Inhibition,
2277,7192,565755,,CCOc1ccc2nc(N)sc2c1,"6-ethoxy-1,3-benzothiazol-2-amine","InChI=1S/C9H10N2OS/c1-2-12-6-3-4-7-8(5-6)13-9(10)11-7/h3-5H,2H2,1H3,(H2,10,11)",KOYJWFGMEBETBU-UHFFFAOYSA-N,1,0,0,0,Pygo PHD / H3,2.37,colorectal cancer,Inhibition,
2278,771615,1236743,,Nc1nc2cc3OCCOc3cc2s1,"10,13-dioxa-4-thia-6-azatricyclo[7.4.0.0^{3,7}]trideca-1(9),2,5,7-tetraen-5-amine","InChI=1S/C9H8N2O2S/c10-9-11-5-3-6-7(4-8(5)14-9)13-2-1-12-6/h3-4H,1-2H2,(H2,10,11)",IURPFIBKOPUBIT-UHFFFAOYSA-N,1,0,0,0,Pygo PHD / H3,2.54,colorectal cancer,Inhibition,
2279,13953710,2153434,,Cc1nnc2C(NC(=O)OCc3ccccc3)N=C(c3ccccc3)c3ccccc3-n12,"benzyl N-{3-methyl-9-phenyl-2,4,5,8-tetraazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,8,11,13-hexaen-7-yl}carbamate","InChI=1S/C25H21N5O2/c1-17-28-29-24-23(27-25(31)32-16-18-10-4-2-5-11-18)26-22(19-12-6-3-7-13-19)20-14-8-9-15-21(20)30(17)24/h2-15,23H,16H2,1H3,(H,27,31)",TUWDLUFFAHHNEF-UHFFFAOYSA-N,7,1,0,0,Bromodomain / Histone,7.81,cancer,Inhibition,
2280,156471534,,,CCC(C(C)OC)N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)c1cccc(Cl)c1)c1ccc(Cl)cc1,"2-[(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-(2-methoxypentan-3-yl)-3-methyl-2-oxopiperidin-3-yl]acetic acid","InChI=1S/C26H31Cl2NO4/c1-5-22(16(2)33-4)29-24(17-9-11-19(27)12-10-17)21(18-7-6-8-20(28)13-18)14-26(3,25(29)32)15-23(30)31/h6-13,16,21-22,24H,5,14-15H2,1-4H3,(H,30,31)/t16?,21-,22?,24-,26-/m1/s1",RJULIFZYUVRMFB-MRZXJGQFSA-N,1,1,0,0,MDM2-Like / P53,8.70,cancer,Inhibition,
2281,153267395,,,CCC(C1CCCO1)N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)c1cccc(Cl)c1)c1ccc(Cl)cc1,"2-[(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxo-1-[1-(oxolan-2-yl)propyl]piperidin-3-yl]acetic acid","InChI=1S/C27H31Cl2NO4/c1-3-22(23-8-5-13-34-23)30-25(17-9-11-19(28)12-10-17)21(18-6-4-7-20(29)14-18)15-27(2,26(30)33)16-24(31)32/h4,6-7,9-12,14,21-23,25H,3,5,8,13,15-16H2,1-2H3,(H,31,32)/t21-,22?,23?,25-,27-/m1/s1",WWKWPSAIEAMHPQ-PWGYGSINSA-N,1,1,0,0,MDM2-Like / P53,9.00,cancer,Inhibition,
2282,168317838,,,CCC(N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)c1cccc(Cl)c1)c1ccc(Cl)cc1)c1cnco1,"2-[(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-[1-(1,3-oxazol-5-yl)propyl]-2-oxopiperidin-3-yl]acetic acid","InChI=1S/C26H26Cl2N2O4/c1-3-21(22-14-29-15-34-22)30-24(16-7-9-18(27)10-8-16)20(17-5-4-6-19(28)11-17)12-26(2,25(30)33)13-23(31)32/h4-11,14-15,20-21,24H,3,12-13H2,1-2H3,(H,31,32)/t20-,21?,24-,26-/m1/s1",PJXXNGIVMUTKHE-XAQHNUDOSA-N,1,1,0,0,MDM2-Like / P53,8.10,cancer,Inhibition,
2283,168317836,,,CCC(N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)c1cccc(Cl)c1)c1ccc(Cl)cc1)c1nccs1,"2-[(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxo-1-[1-(1,3-thiazol-2-yl)propyl]piperidin-3-yl]acetic acid","InChI=1S/C26H26Cl2N2O3S/c1-3-21(24-29-11-12-34-24)30-23(16-7-9-18(27)10-8-16)20(17-5-4-6-19(28)13-17)14-26(2,25(30)33)15-22(31)32/h4-13,20-21,23H,3,14-15H2,1-2H3,(H,31,32)/t20-,21?,23-,26-/m1/s1",QJFFJYFEPPYZSQ-OQHZZKOESA-N,1,1,0,0,MDM2-Like / P53,8.22,cancer,Inhibition,
2284,168317835,,,CCC(N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)c1cccc(Cl)c1)c1ccc(Cl)cc1)c1ccccn1,"2-[(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxo-1-[1-(pyridin-2-yl)propyl]piperidin-3-yl]acetic acid","InChI=1S/C28H28Cl2N2O3/c1-3-24(23-9-4-5-14-31-23)32-26(18-10-12-20(29)13-11-18)22(19-7-6-8-21(30)15-19)16-28(2,27(32)35)17-25(33)34/h4-15,22,24,26H,3,16-17H2,1-2H3,(H,33,34)/t22-,24?,26-,28-/m1/s1",WGSOZDLVXMXSND-URNXRWCWSA-N,1,1,0,0,MDM2-Like / P53,8.52,cancer,Inhibition,
2285,168317834,,,CCC(N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)c1cccc(Cl)c1)c1ccc(Cl)cc1)c1ncccn1,"2-[(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxo-1-[1-(pyrimidin-2-yl)propyl]piperidin-3-yl]acetic acid","InChI=1S/C27H27Cl2N3O3/c1-3-22(25-30-12-5-13-31-25)32-24(17-8-10-19(28)11-9-17)21(18-6-4-7-20(29)14-18)15-27(2,26(32)35)16-23(33)34/h4-14,21-22,24H,3,15-16H2,1-2H3,(H,33,34)/t21-,22?,24-,27-/m1/s1",YKFHMVNLZCJNBT-HDDMYPJUSA-N,1,1,0,0,MDM2-Like / P53,8.15,cancer,Inhibition,
2286,168317833,,,CCC(N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)c1cccc(Cl)c1)c1ccc(Cl)cc1)c1ccncc1,"2-[(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxo-1-[1-(pyridin-4-yl)propyl]piperidin-3-yl]acetic acid","InChI=1S/C28H28Cl2N2O3/c1-3-24(18-11-13-31-14-12-18)32-26(19-7-9-21(29)10-8-19)23(20-5-4-6-22(30)15-20)16-28(2,27(32)35)17-25(33)34/h4-15,23-24,26H,3,16-17H2,1-2H3,(H,33,34)/t23-,24?,26-,28-/m1/s1",YQWBAIDBNDOTEM-PDVAZQOOSA-N,1,1,0,0,MDM2-Like / P53,8.05,cancer,Inhibition,
2287,168317832,,,CCC(N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)c1cccc(Cl)c1)c1ccc(Cl)cc1)c1cccnc1,"2-[(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxo-1-[1-(pyridin-3-yl)propyl]piperidin-3-yl]acetic acid","InChI=1S/C28H28Cl2N2O3/c1-3-24(20-7-5-13-31-17-20)32-26(18-9-11-21(29)12-10-18)23(19-6-4-8-22(30)14-19)15-28(2,27(32)35)16-25(33)34/h4-14,17,23-24,26H,3,15-16H2,1-2H3,(H,33,34)/t23-,24?,26-,28-/m1/s1",FYBDUDQVIFLRNC-PDVAZQOOSA-N,1,1,0,0,MDM2-Like / P53,7.82,cancer,Inhibition,
2288,168317830,,,CC(N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)c1cccc(Cl)c1)c1ccc(Cl)cc1)c1ccccn1,"2-[(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxo-1-[1-(pyridin-2-yl)ethyl]piperidin-3-yl]acetic acid","InChI=1S/C27H26Cl2N2O3/c1-17(23-8-3-4-13-30-23)31-25(18-9-11-20(28)12-10-18)22(19-6-5-7-21(29)14-19)15-27(2,26(31)34)16-24(32)33/h3-14,17,22,25H,15-16H2,1-2H3,(H,32,33)/t17?,22-,25-,27-/m1/s1",CSKRARILUKCETF-GQDLCPBOSA-N,1,1,0,0,MDM2-Like / P53,8.00,cancer,Inhibition,
2289,168317829,,,CC(C)C(N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)c1cccc(Cl)c1)c1ccc(Cl)cc1)c1ccccn1,"2-[(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-[2-methyl-1-(pyridin-2-yl)propyl]-2-oxopiperidin-3-yl]acetic acid","InChI=1S/C29H30Cl2N2O3/c1-18(2)26(24-9-4-5-14-32-24)33-27(19-10-12-21(30)13-11-19)23(20-7-6-8-22(31)15-20)16-29(3,28(33)36)17-25(34)35/h4-15,18,23,26-27H,16-17H2,1-3H3,(H,34,35)/t23-,26?,27-,29-/m1/s1",WELWVRMWMNQKHD-BUIQNHJTSA-N,1,1,0,0,MDM2-Like / P53,8.70,cancer,Inhibition,
2290,129153270,,,C[C@]1(CC(O)=O)C[C@@H]([C@H](N(C(C2CC2)c2ccccn2)C1=O)c1ccc(Cl)cc1)c1cccc(Cl)c1,"2-[(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-[cyclopropyl(pyridin-2-yl)methyl]-3-methyl-2-oxopiperidin-3-yl]acetic acid","InChI=1S/C29H28Cl2N2O3/c1-29(17-25(34)35)16-23(20-5-4-6-22(31)15-20)26(18-10-12-21(30)13-11-18)33(28(29)36)27(19-8-9-19)24-7-2-3-14-32-24/h2-7,10-15,19,23,26-27H,8-9,16-17H2,1H3,(H,34,35)/t23-,26-,27?,29-/m1/s1",GIOQOKPBDIEPRR-IBLZCCCQSA-N,1,1,0,0,MDM2-Like / P53,8.70,cancer,Inhibition,
2291,168317828,,,CCCC(N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)c1cccc(Cl)c1)c1ccc(Cl)cc1)c1ccccn1,"2-[(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxo-1-[1-(pyridin-2-yl)butyl]piperidin-3-yl]acetic acid","InChI=1S/C29H30Cl2N2O3/c1-3-7-25(24-10-4-5-15-32-24)33-27(19-11-13-21(30)14-12-19)23(20-8-6-9-22(31)16-20)17-29(2,28(33)36)18-26(34)35/h4-6,8-16,23,25,27H,3,7,17-18H2,1-2H3,(H,34,35)/t23-,25?,27-,29-/m1/s1",RACLIYFAUNFBQY-RDKBUKGGSA-N,1,1,0,0,MDM2-Like / P53,8.22,cancer,Inhibition,
2292,168317825,,,CCC(N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)c1cccc(Cl)c1)c1ccc(Cl)cc1)c1cccc(C)n1,"2-[(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-[1-(6-methylpyridin-2-yl)propyl]-2-oxopiperidin-3-yl]acetic acid","InChI=1S/C29H30Cl2N2O3/c1-4-25(24-10-5-7-18(2)32-24)33-27(19-11-13-21(30)14-12-19)23(20-8-6-9-22(31)15-20)16-29(3,28(33)36)17-26(34)35/h5-15,23,25,27H,4,16-17H2,1-3H3,(H,34,35)/t23-,25?,27-,29-/m1/s1",JHXLHQAKIVJSCF-RDKBUKGGSA-N,1,1,0,0,MDM2-Like / P53,8.70,cancer,Inhibition,
2293,168317827,,,CCC(N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)c1cccc(Cl)c1)c1ccc(Cl)cc1)c1cccc(Cl)n1,"2-[(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-[1-(6-chloropyridin-2-yl)propyl]-3-methyl-2-oxopiperidin-3-yl]acetic acid","InChI=1S/C28H27Cl3N2O3/c1-3-23(22-8-5-9-24(31)32-22)33-26(17-10-12-19(29)13-11-17)21(18-6-4-7-20(30)14-18)15-28(2,27(33)36)16-25(34)35/h4-14,21,23,26H,3,15-16H2,1-2H3,(H,34,35)/t21-,23?,26-,28-/m1/s1",GJFWBOZSLJZUTC-WKQHMMEZSA-N,1,1,0,0,MDM2-Like / P53,9.15,cancer,Inhibition,
2294,168317765,,,CCC(N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)c1cccc(Cl)c1)c1ccc(Cl)cc1)c1cccc(n1)C1CC1,"2-[(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-[1-(6-cyclopropylpyridin-2-yl)propyl]-3-methyl-2-oxopiperidin-3-yl]acetic acid","InChI=1S/C31H32Cl2N2O3/c1-3-27(26-9-5-8-25(34-26)19-10-11-19)35-29(20-12-14-22(32)15-13-20)24(21-6-4-7-23(33)16-21)17-31(2,30(35)38)18-28(36)37/h4-9,12-16,19,24,27,29H,3,10-11,17-18H2,1-2H3,(H,36,37)/t24-,27?,29-,31-/m1/s1",QHQNRLZCHQCYRC-RRLYSDIYSA-N,1,1,0,0,MDM2-Like / P53,8.30,cancer,Inhibition,
2295,168317763,,,CCC(N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)c1cccc(Cl)c1)c1ccc(Cl)cc1)c1ccc(C)cn1,"2-[(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-[1-(5-methylpyridin-2-yl)propyl]-2-oxopiperidin-3-yl]acetic acid","InChI=1S/C29H30Cl2N2O3/c1-4-25(24-13-8-18(2)17-32-24)33-27(19-9-11-21(30)12-10-19)23(20-6-5-7-22(31)14-20)15-29(3,28(33)36)16-26(34)35/h5-14,17,23,25,27H,4,15-16H2,1-3H3,(H,34,35)/t23-,25?,27-,29-/m1/s1",ACEPRGXMVXFNRW-RDKBUKGGSA-N,1,1,0,0,MDM2-Like / P53,8.30,cancer,Inhibition,
2296,168317761,,,CCC(N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)c1cccc(Cl)c1)c1ccc(Cl)cc1)c1cc(C)ccn1,"2-[(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-[1-(4-methylpyridin-2-yl)propyl]-2-oxopiperidin-3-yl]acetic acid","InChI=1S/C29H30Cl2N2O3/c1-4-25(24-14-18(2)12-13-32-24)33-27(19-8-10-21(30)11-9-19)23(20-6-5-7-22(31)15-20)16-29(3,28(33)36)17-26(34)35/h5-15,23,25,27H,4,16-17H2,1-3H3,(H,34,35)/t23-,25?,27-,29-/m1/s1",XXXAJZYALKYVBF-RDKBUKGGSA-N,1,1,0,0,MDM2-Like / P53,8.22,cancer,Inhibition,
2297,168317759,,,CCC(N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)c1cccc(Cl)c1)c1ccc(Cl)cc1)c1ncccc1C,"2-[(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-[1-(3-methylpyridin-2-yl)propyl]-2-oxopiperidin-3-yl]acetic acid","InChI=1S/C29H30Cl2N2O3/c1-4-24(26-18(2)7-6-14-32-26)33-27(19-10-12-21(30)13-11-19)23(20-8-5-9-22(31)15-20)16-29(3,28(33)36)17-25(34)35/h5-15,23-24,27H,4,16-17H2,1-3H3,(H,34,35)/t23-,24?,27-,29-/m1/s1",JJKWOYOQGGSZFQ-VQUVJIPASA-N,1,1,0,0,MDM2-Like / P53,8.30,cancer,Inhibition,
2298,118712500,3329618,,C[C@]1(CC(O)=O)C[C@@H]([C@H](N(C1=O)c1ccccn1)c1ccc(Cl)cc1)c1cccc(Cl)c1,"2-[(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxo-1-(pyridin-2-yl)piperidin-3-yl]acetic acid","InChI=1S/C25H22Cl2N2O3/c1-25(15-22(30)31)14-20(17-5-4-6-19(27)13-17)23(16-8-10-18(26)11-9-16)29(24(25)32)21-7-2-3-12-28-21/h2-13,20,23H,14-15H2,1H3,(H,30,31)/t20-,23-,25-/m1/s1",UJBDJALBAHAARE-QFZRFWILSA-N,1,0,0,0,MDM2-Like / P53,7.89,cancer,Inhibition,
2299,118712501,3329619,,C[C@]1(CC(O)=O)C[C@@H]([C@H](N(C1=O)c1ccccc1)c1ccc(Cl)cc1)c1cccc(Cl)c1,"2-[(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxo-1-phenylpiperidin-3-yl]acetic acid","InChI=1S/C26H23Cl2NO3/c1-26(16-23(30)31)15-22(18-6-5-7-20(28)14-18)24(17-10-12-19(27)13-11-17)29(25(26)32)21-8-3-2-4-9-21/h2-14,22,24H,15-16H2,1H3,(H,30,31)/t22-,24-,26-/m1/s1",QWXGVOTXWSFORI-QIGHUWCUSA-N,1,0,0,0,MDM2-Like / P53,8.40,cancer,Inhibition,
2300,56591137,2177190,,CCC(CC)N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)c1cccc(Cl)c1)c1ccc(Cl)cc1,"2-[(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxo-1-(pentan-3-yl)piperidin-3-yl]acetic acid","InChI=1S/C25H29Cl2NO3/c1-4-20(5-2)28-23(16-9-11-18(26)12-10-16)21(17-7-6-8-19(27)13-17)14-25(3,24(28)31)15-22(29)30/h6-13,20-21,23H,4-5,14-15H2,1-3H3,(H,29,30)/t21-,23-,25-/m1/s1",YZXCLRHTZJADSX-GZGNHOFSSA-N,1,1,2,0,MDM2-Like / P53,8.52,cancer,Inhibition,
2301,56591135,3329620,,CC(C)N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)c1cccc(Cl)c1)c1ccc(Cl)cc1,"2-[(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxo-1-(propan-2-yl)piperidin-3-yl]acetic acid","InChI=1S/C23H25Cl2NO3/c1-14(2)26-21(15-7-9-17(24)10-8-15)19(16-5-4-6-18(25)11-16)12-23(3,22(26)29)13-20(27)28/h4-11,14,19,21H,12-13H2,1-3H3,(H,27,28)/t19-,21-,23-/m1/s1",BAKOCZVLYDLEAG-KJXAQDMKSA-N,1,1,2,0,MDM2-Like / P53,8.05,cancer,Inhibition,
2302,,,,OC(=O)[C@@H](N1[C@H](C(=O)Nc2ccc(I)cc2C1=O)c1ccc(Cl)cc1)c1ccc(Cl)cc1,,,,,,,,,,,,
2303,,,,OC(=O)[C@H](N1[C@@H](C(=O)Nc2ccc(I)cc2C1=O)c1ccc(Cl)cc1)c1ccc(Cl)cc1,,,,,,,,,,,,
2304,179897,4589188,,Nc1nc2ncccc2[nH]1,"1H-imidazo[4,5-b]pyridin-2-amine","InChI=1S/C6H6N4/c7-6-9-4-2-1-3-8-5(4)10-6/h1-3H,(H3,7,8,9,10)",KXQPVJRJUJJWQJ-UHFFFAOYSA-N,2,0,0,0,BAZ2-like PHD / H3,3.05,prostate cancer,Inhibition,
2305,38282,3298755,,OC1(CCNCC1)c1ccc(Cl)cc1,4-(4-chlorophenyl)piperidin-4-ol,"InChI=1S/C11H14ClNO/c12-10-3-1-9(2-4-10)11(14)5-7-13-8-6-11/h1-4,13-14H,5-8H2",LZAYOZUFUAMFLD-UHFFFAOYSA-N,1,0,0,0,BAZ2-like PHD / H3,2.33,prostate cancer,Inhibition,
2306,734502,3410012,,Nc1nc2ccc(cc2s1)S(N)(=O)=O,"2-amino-1,3-benzothiazole-6-sulfonamide","InChI=1S/C7H7N3O2S2/c8-7-10-5-2-1-4(14(9,11)12)3-6(5)13-7/h1-3H,(H2,8,10)(H2,9,11,12)",CGJUKQLMOOVGOC-UHFFFAOYSA-N,2,0,0,0,BAZ2-like PHD / H3,3.22,prostate cancer,Inhibition,
2307,126801668,,,CC(N)C(C)C(=O)NCC1CCCN(C)C1c1cccs1,3-amino-2-methyl-N-{[1-methyl-2-(thiophen-2-yl)piperidin-3-yl]methyl}butanamide,"InChI=1S/C16H27N3OS/c1-11(12(2)17)16(20)18-10-13-6-4-8-19(3)15(13)14-7-5-9-21-14/h5,7,9,11-13,15H,4,6,8,10,17H2,1-3H3,(H,18,20)",JKXBBCKRWYIBCE-UHFFFAOYSA-N,2,0,0,0,BAZ2-like PHD / H3,2.47,prostate cancer,Inhibition,
2308,16770323,,,NCC(=O)N1CCc2sccc2C1,"2-amino-1-{4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}ethan-1-one","InChI=1S/C9H12N2OS/c10-5-9(12)11-3-1-8-7(6-11)2-4-13-8/h2,4H,1,3,5-6,10H2",NRRHFNCSXNXKHA-UHFFFAOYSA-N,1,0,0,0,BAZ2-like PHD / H3,2.03,prostate cancer,Inhibition,
2309,127266493,,,NC(=O)NCC(=O)NCc1csc2ccccc12,N-[(1-benzothiophen-3-yl)methyl]-2-(carbamoylamino)acetamide,"InChI=1S/C12H13N3O2S/c13-12(17)15-6-11(16)14-5-8-7-18-10-4-2-1-3-9(8)10/h1-4,7H,5-6H2,(H,14,16)(H3,13,15,17)",HAVSKPTVGCVYLJ-UHFFFAOYSA-N,2,0,0,0,BAZ2-like PHD / H3,2.64,prostate cancer,Inhibition,
2310,2801474,,,Cc1ccc(C(N)=O)c(N)c1,2-amino-4-methylbenzamide,"InChI=1S/C8H10N2O/c1-5-2-3-6(8(10)11)7(9)4-5/h2-4H,9H2,1H3,(H2,10,11)",RUHKZVAPXHIWJH-UHFFFAOYSA-N,2,0,0,0,BAZ2-like PHD / H3,3.30,prostate cancer,Inhibition,
2311,19048,,,O=C1CCSc2ccccc12,"3,4-dihydro-2H-1-benzothiopyran-4-one","InChI=1S/C9H8OS/c10-8-5-6-11-9-4-2-1-3-7(8)9/h1-4H,5-6H2",CVQSWZMJOGOPAV-UHFFFAOYSA-N,0,0,0,0,,,,,
2312,50989214,,,COc1ncnc2CCNCc12,"4-methoxy-5H,6H,7H,8H-pyrido[4,3-d]pyrimidine","InChI=1S/C8H11N3O/c1-12-8-6-4-9-3-2-7(6)10-5-11-8/h5,9H,2-4H2,1H3",FAQYDZRQALQEDF-UHFFFAOYSA-N,3,0,0,0,BAZ2-like PHD / H3,3.30,prostate cancer,Inhibition,
2313,412561,,,NCC(=O)Nc1ccc(O)cc1,2-amino-N-(4-hydroxyphenyl)acetamide,"InChI=1S/C8H10N2O2/c9-5-8(12)10-6-1-3-7(11)4-2-6/h1-4,11H,5,9H2,(H,10,12)",KSHDSWRHTYVABI-UHFFFAOYSA-N,2,0,0,0,BAZ2-like PHD / H3,1.95,prostate cancer,Inhibition,
2314,20558664,,,NCC(=O)Nc1nccs1,"2-amino-N-(1,3-thiazol-2-yl)acetamide","InChI=1S/C5H7N3OS/c6-3-4(9)8-5-7-1-2-10-5/h1-2H,3,6H2,(H,7,8,9)",JVRRHVNPKGSGSX-UHFFFAOYSA-N,2,0,0,0,BAZ2-like PHD / H3,2.47,prostate cancer,Inhibition,
2315,21263335,,,NCC(=O)Nc1ccc(N)cc1,2-amino-N-(4-aminophenyl)acetamide,"InChI=1S/C8H11N3O/c9-5-8(12)11-7-3-1-6(10)2-4-7/h1-4H,5,9-10H2,(H,11,12)",DKCWGVIARWBMDV-UHFFFAOYSA-N,4,0,0,0,BAZ2-like PHD / H3,4.00,prostate cancer,Inhibition,
2316,12289977,,,CNCC(=O)Nc1nccs1,"2-(methylamino)-N-(1,3-thiazol-2-yl)acetamide","InChI=1S/C6H9N3OS/c1-7-4-5(10)9-6-8-2-3-11-6/h2-3,7H,4H2,1H3,(H,8,9,10)",SRTCQOIADFBXBK-UHFFFAOYSA-N,2,0,0,0,BAZ2-like PHD / H3,2.15,prostate cancer,Inhibition,
2317,46224516,1231795,,COc1cc2c(NC3CCN(CC3)C(C)C)nc(nc2cc1OCCCN1CCCC1)C1CCCCC1,2-cyclohexyl-6-methoxy-N-[1-(propan-2-yl)piperidin-4-yl]-7-[3-(pyrrolidin-1-yl)propoxy]quinazolin-4-amine,"InChI=1S/C30H47N5O2/c1-22(2)35-17-12-24(13-18-35)31-30-25-20-27(36-3)28(37-19-9-16-34-14-7-8-15-34)21-26(25)32-29(33-30)23-10-5-4-6-11-23/h20-24H,4-19H2,1-3H3,(H,31,32,33)",QOECJCJVIMVJGX-UHFFFAOYSA-N,2,0,0,0,SPIN1 / H3,5.49,ovarian cancer,Inhibition,
2318,155567242,4588285,,COc1c(CN)cc(CN)cc1OCCCN1CCCC1,1-[3-(aminomethyl)-4-methoxy-5-[3-(pyrrolidin-1-yl)propoxy]phenyl]methanamine,"InChI=1S/C16H27N3O2/c1-20-16-14(12-18)9-13(11-17)10-15(16)21-8-4-7-19-5-2-3-6-19/h9-10H,2-8,11-12,17-18H2,1H3",RKANOIFOWDBVSH-UHFFFAOYSA-N,3,0,0,0,SPIN1 / H3,6.47,ovarian cancer,Inhibition,
2319,138455182,4552020,,COc1c(CN)cc(CN)cc1OCCCN1Cc2ccccc2C1,"1-[3-(aminomethyl)-5-[3-(2,3-dihydro-1H-isoindol-2-yl)propoxy]-4-methoxyphenyl]methanamine","InChI=1S/C20H27N3O2/c1-24-20-18(12-22)9-15(11-21)10-19(20)25-8-4-7-23-13-16-5-2-3-6-17(16)14-23/h2-3,5-6,9-10H,4,7-8,11-14,21-22H2,1H3",XQQZNYFJATXWON-UHFFFAOYSA-N,6,1,0,3,SPIN1 / H3,7.11,ovarian cancer,Inhibition,
2320,76285486,3109630,,COc1cc2c(cc1OCCCN1CCCC1)N=C(N)C21CCC1,"5'-methoxy-6'-[3-(pyrrolidin-1-yl)propoxy]spiro[cyclobutane-1,3'-indol]-2'-amine","InChI=1S/C19H27N3O2/c1-23-16-12-14-15(21-18(20)19(14)6-4-7-19)13-17(16)24-11-5-10-22-8-2-3-9-22/h12-13H,2-11H2,1H3,(H2,20,21)",BKCDJTRMYWSXMC-UHFFFAOYSA-N,8,0,0,0,SPIN1 / H3,7.14,"ovarian cancer, cancer",Inhibition,
2321,76468394,,,COc1cc(ccc1NC(=O)C1NC(CC(C)(C)C)C2(C1c1cccc(Cl)c1F)C(=O)Nc1ccncc21)C(O)=O,"4-{[4-(3-chloro-2-fluorophenyl)-2-(2,2-dimethylpropyl)-2'-oxo-1',2'-dihydrospiro[pyrrolidine-3,3'-pyrrolo[3,2-c]pyridin]-5-yl]amido}-3-methoxybenzoic acid","InChI=1S/C30H30ClFN4O5/c1-29(2,3)13-22-30(17-14-33-11-10-19(17)35-28(30)40)23(16-6-5-7-18(31)24(16)32)25(36-22)26(37)34-20-9-8-15(27(38)39)12-21(20)41-4/h5-12,14,22-23,25,36H,13H2,1-4H3,(H,34,37)(H,35,40)(H,38,39)",ITTQHYXUPNVUBV-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,7.28,cancer,Inhibition,
2322,66760052,,,COc1cc(ccc1NC(=O)C1NC(CC(C)(C)C)C2(C1c1cccc(Cl)c1F)C(=O)Nc1ccncc21)C(N)=O,"N-(4-carbamoyl-2-methoxyphenyl)-4-(3-chloro-2-fluorophenyl)-2-(2,2-dimethylpropyl)-2'-oxo-1',2'-dihydrospiro[pyrrolidine-3,3'-pyrrolo[3,2-c]pyridine]-5-carboxamide","InChI=1S/C30H31ClFN5O4/c1-29(2,3)13-22-30(17-14-34-11-10-19(17)36-28(30)40)23(16-6-5-7-18(31)24(16)32)25(37-22)27(39)35-20-9-8-15(26(33)38)12-21(20)41-4/h5-12,14,22-23,25,37H,13H2,1-4H3,(H2,33,38)(H,35,39)(H,36,40)",JZJSBNKVPGNXHW-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,6.85,cancer,Inhibition,
2323,76468559,,,COc1cc(ccc1NC(=O)C1NC(CC(C)(C)C)C2(C1c1cccc(Cl)c1F)C(=O)Nc1cc(Cl)ncc21)C(O)=O,"4-{[6'-chloro-4-(3-chloro-2-fluorophenyl)-2-(2,2-dimethylpropyl)-2'-oxo-1',2'-dihydrospiro[pyrrolidine-3,3'-pyrrolo[3,2-c]pyridin]-5-yl]amido}-3-methoxybenzoic acid","InChI=1S/C30H29Cl2FN4O5/c1-29(2,3)12-21-30(16-13-34-22(32)11-19(16)36-28(30)41)23(15-6-5-7-17(31)24(15)33)25(37-21)26(38)35-18-9-8-14(27(39)40)10-20(18)42-4/h5-11,13,21,23,25,37H,12H2,1-4H3,(H,35,38)(H,36,41)(H,39,40)",HHZBIQDQELBELB-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,7.37,cancer,Inhibition,
2324,76332045,3109051,,COc1cc(ccc1NC(=O)C1NC(CC(C)(C)C)C2(C1c1cccc(Cl)c1F)C(=O)Nc1cc(Cl)ncc21)C(N)=O,"N-(4-carbamoyl-2-methoxyphenyl)-6'-chloro-4-(3-chloro-2-fluorophenyl)-2-(2,2-dimethylpropyl)-2'-oxo-1',2'-dihydrospiro[pyrrolidine-3,3'-pyrrolo[3,2-c]pyridine]-5-carboxamide","InChI=1S/C30H30Cl2FN5O4/c1-29(2,3)12-21-30(16-13-35-22(32)11-19(16)37-28(30)41)23(15-6-5-7-17(31)24(15)33)25(38-21)27(40)36-18-9-8-14(26(34)39)10-20(18)42-4/h5-11,13,21,23,25,38H,12H2,1-4H3,(H2,34,39)(H,36,40)(H,37,41)",CGCOPBXAGSCZNX-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,7.85,cancer,Inhibition,
2325,76468442,,,COc1cc(ccc1NC(=O)C1NC(CC(C)(C)C)C2(C1c1cccc(Cl)c1F)C(=O)Nc1ncccc21)C(O)=O,"4-{[4-(3-chloro-2-fluorophenyl)-2-(2,2-dimethylpropyl)-2'-oxo-1',2'-dihydrospiro[pyrrolidine-3,3'-pyrrolo[2,3-b]pyridin]-5-yl]amido}-3-methoxybenzoic acid","InChI=1S/C30H30ClFN4O5/c1-29(2,3)14-21-30(17-8-6-12-33-25(17)36-28(30)40)22(16-7-5-9-18(31)23(16)32)24(35-21)26(37)34-19-11-10-15(27(38)39)13-20(19)41-4/h5-13,21-22,24,35H,14H2,1-4H3,(H,34,37)(H,38,39)(H,33,36,40)",QLORRPOWHCOBMY-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,7.28,cancer,Inhibition,
2326,76468672,,,COc1cc(ccc1NC(=O)C1NC(CC(C)(C)C)C2(C1c1cccc(Cl)c1F)C(=O)Nc1nc(Cl)ccc21)C(O)=O,"4-{[6'-chloro-4-(3-chloro-2-fluorophenyl)-2-(2,2-dimethylpropyl)-2'-oxo-1',2'-dihydrospiro[pyrrolidine-3,3'-pyrrolo[2,3-b]pyridin]-5-yl]amido}-3-methoxybenzoic acid","InChI=1S/C30H29Cl2FN4O5/c1-29(2,3)13-20-30(16-9-11-21(32)36-25(16)37-28(30)41)22(15-6-5-7-17(31)23(15)33)24(35-20)26(38)34-18-10-8-14(27(39)40)12-19(18)42-4/h5-12,20,22,24,35H,13H2,1-4H3,(H,34,38)(H,39,40)(H,36,37,41)",CNODLALQBVKLIV-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,7.74,cancer,Inhibition,
2327,76468506,,,COc1cc(ccc1NC(=O)C1NC(CC(C)(C)C)C2(C1c1cccc(Cl)c1F)C(=O)Nc1nc(Cl)ccc21)C(N)=O,"N-(4-carbamoyl-2-methoxyphenyl)-6'-chloro-4-(3-chloro-2-fluorophenyl)-2-(2,2-dimethylpropyl)-2'-oxo-1',2'-dihydrospiro[pyrrolidine-3,3'-pyrrolo[2,3-b]pyridine]-5-carboxamide","InChI=1S/C30H30Cl2FN5O4/c1-29(2,3)13-20-30(16-9-11-21(32)37-26(16)38-28(30)41)22(15-6-5-7-17(31)23(15)33)24(36-20)27(40)35-18-10-8-14(25(34)39)12-19(18)42-4/h5-12,20,22,24,36H,13H2,1-4H3,(H2,34,39)(H,35,40)(H,37,38,41)",BXAYHKKPWXVTLG-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,7.96,cancer,Inhibition,
2328,76468674,,,COc1cc(ccc1NC(=O)C1NC(CC(C)(C)C)C2(C1c1cccc(Cl)c1F)C(=O)Nc1cc(Cl)cnc21)C(O)=O,"4-{[6'-chloro-4-(3-chloro-2-fluorophenyl)-2-(2,2-dimethylpropyl)-2'-oxo-1',2'-dihydrospiro[pyrrolidine-3,3'-pyrrolo[3,2-b]pyridin]-5-yl]amido}-3-methoxybenzoic acid","InChI=1S/C30H29Cl2FN4O5/c1-29(2,3)12-21-30(25-19(36-28(30)41)11-15(31)13-34-25)22(16-6-5-7-17(32)23(16)33)24(37-21)26(38)35-18-9-8-14(27(39)40)10-20(18)42-4/h5-11,13,21-22,24,37H,12H2,1-4H3,(H,35,38)(H,36,41)(H,39,40)",IJIGMWANDSKYOG-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,7.34,cancer,Inhibition,
2329,66761262,,,COc1cc(ccc1NC(=O)C1NC(CC(C)(C)C)C2(C1c1cccc(Cl)c1F)C(=O)Nc1cc(Cl)cnc21)C(N)=O,"N-(4-carbamoyl-2-methoxyphenyl)-6'-chloro-4-(3-chloro-2-fluorophenyl)-2-(2,2-dimethylpropyl)-2'-oxo-1',2'-dihydrospiro[pyrrolidine-3,3'-pyrrolo[3,2-b]pyridine]-5-carboxamide","InChI=1S/C30H30Cl2FN5O4/c1-29(2,3)12-21-30(25-19(37-28(30)41)11-15(31)13-35-25)22(16-6-5-7-17(32)23(16)33)24(38-21)27(40)36-18-9-8-14(26(34)39)10-20(18)42-4/h5-11,13,21-22,24,38H,12H2,1-4H3,(H2,34,39)(H,36,40)(H,37,41)",ACHCLOSSNAELCR-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,7.38,cancer,Inhibition,
2330,76468239,,,COc1cc(ccc1NC(=O)C1NC(CC(C)(C)C)C2(C1c1cccc(Cl)c1F)C(=O)Nc1nc(Cl)ncc21)C(O)=O,"4-{[2'-chloro-4-(3-chloro-2-fluorophenyl)-2-(2,2-dimethylpropyl)-6'-oxo-6',7'-dihydrospiro[pyrrolidine-3,5'-pyrrolo[2,3-d]pyrimidin]-5-yl]amido}-3-methoxybenzoic acid","InChI=1S/C29H28Cl2FN5O5/c1-28(2,3)11-19-29(15-12-33-27(31)37-23(15)36-26(29)41)20(14-6-5-7-16(30)21(14)32)22(35-19)24(38)34-17-9-8-13(25(39)40)10-18(17)42-4/h5-10,12,19-20,22,35H,11H2,1-4H3,(H,34,38)(H,39,40)(H,33,36,37,41)",JMUOXYBXFJQWPT-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,7.60,cancer,Inhibition,
2331,76468288,,,COc1cc(ccc1NC(=O)C1NC(CC(C)(C)C)C2(C1c1cccc(Cl)c1F)C(=O)Nc1nc(Cl)ncc21)C(N)=O,"N-(4-carbamoyl-2-methoxyphenyl)-2'-chloro-4-(3-chloro-2-fluorophenyl)-2-(2,2-dimethylpropyl)-6'-oxo-6',7'-dihydrospiro[pyrrolidine-3,5'-pyrrolo[2,3-d]pyrimidine]-5-carboxamide","InChI=1S/C29H29Cl2FN6O4/c1-28(2,3)11-19-29(15-12-34-27(31)38-24(15)37-26(29)41)20(14-6-5-7-16(30)21(14)32)22(36-19)25(40)35-17-9-8-13(23(33)39)10-18(17)42-4/h5-10,12,19-20,22,36H,11H2,1-4H3,(H2,33,39)(H,35,40)(H,34,37,38,41)",ORCGOHBRBKYLAQ-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,7.35,cancer,Inhibition,
2332,76328371,3109044,,COc1cc(ccc1NC(=O)C1NC(CC(C)(C)C)C2(C1c1cccc(Cl)c1F)C(=O)Nc1cc(Cl)sc21)C(O)=O,"4-{[2'-chloro-4-(3-chloro-2-fluorophenyl)-2-(2,2-dimethylpropyl)-5'-oxo-4',5'-dihydrospiro[pyrrolidine-3,6'-thieno[3,2-b]pyrrol]-5-yl]amido}-3-methoxybenzoic acid","InChI=1S/C29H28Cl2FN3O5S/c1-28(2,3)12-19-29(24-17(34-27(29)39)11-20(31)41-24)21(14-6-5-7-15(30)22(14)32)23(35-19)25(36)33-16-9-8-13(26(37)38)10-18(16)40-4/h5-11,19,21,23,35H,12H2,1-4H3,(H,33,36)(H,34,39)(H,37,38)",YXQHJKFKRZDXHV-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,8.05,cancer,Inhibition,
2333,66760186,3109043,,COc1cc(ccc1NC(=O)C1NC(CC(C)(C)C)C2(C1c1cccc(Cl)c1F)C(=O)Nc1cc(Cl)sc21)C(N)=O,"N-(4-carbamoyl-2-methoxyphenyl)-2'-chloro-4-(3-chloro-2-fluorophenyl)-2-(2,2-dimethylpropyl)-5'-oxo-4',5'-dihydrospiro[pyrrolidine-3,6'-thieno[3,2-b]pyrrole]-5-carboxamide","InChI=1S/C29H29Cl2FN4O4S/c1-28(2,3)12-19-29(24-17(35-27(29)39)11-20(31)41-24)21(14-6-5-7-15(30)22(14)32)23(36-19)26(38)34-16-9-8-13(25(33)37)10-18(16)40-4/h5-11,19,21,23,36H,12H2,1-4H3,(H2,33,37)(H,34,38)(H,35,39)",UOVSZRTTWLJPHE-UHFFFAOYSA-N,1,1,0,0,MDM2-Like / P53,7.96,cancer,Inhibition,
2334,56942527,3109039,,COc1cc(ccc1NC(=O)[C@H]1N[C@H](CC(C)(C)C)[C@@]2([C@@H]1c1cccc(Cl)c1F)C(=O)Nc1cc(Cl)ncc21)C(N)=O,"(2R,3S,4R,5S)-N-(4-carbamoyl-2-methoxyphenyl)-6'-chloro-4-(3-chloro-2-fluorophenyl)-2-(2,2-dimethylpropyl)-2'-oxo-1',2'-dihydrospiro[pyrrolidine-3,3'-pyrrolo[3,2-c]pyridine]-5-carboxamide","InChI=1S/C30H30Cl2FN5O4/c1-29(2,3)12-21-30(16-13-35-22(32)11-19(16)37-28(30)41)23(15-6-5-7-17(31)24(15)33)25(38-21)27(40)36-18-9-8-14(26(34)39)10-20(18)42-4/h5-11,13,21,23,25,38H,12H2,1-4H3,(H2,34,39)(H,36,40)(H,37,41)/t21-,23-,25+,30+/m1/s1",CGCOPBXAGSCZNX-JLEYQQFFSA-N,1,1,1,0,MDM2-Like / P53,8.22,cancer,Inhibition,
2335,56941233,3109041,,COc1cc(ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@]2([C@H]1c1cccc(Cl)c1F)C(=O)Nc1cc(Cl)sc21)C(O)=O,"4-{[(2S,3R,4R,5R)-2'-chloro-4-(3-chloro-2-fluorophenyl)-2-(2,2-dimethylpropyl)-5'-oxo-4',5'-dihydrospiro[pyrrolidine-3,6'-thieno[3,2-b]pyrrol]-5-yl]amido}-3-methoxybenzoic acid","InChI=1S/C29H28Cl2FN3O5S/c1-28(2,3)12-19-29(24-17(34-27(29)39)11-20(31)41-24)21(14-6-5-7-15(30)22(14)32)23(35-19)25(36)33-16-9-8-13(26(37)38)10-18(16)40-4/h5-11,19,21,23,35H,12H2,1-4H3,(H,33,36)(H,34,39)(H,37,38)/t19-,21-,23+,29+/m0/s1",YXQHJKFKRZDXHV-HNXAPSNLSA-N,1,1,1,0,MDM2-Like / P53,8.52,cancer,Inhibition,
2336,56649312,3109040,,COc1cc(ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@]2([C@H]1c1cccc(Cl)c1F)C(=O)Nc1cc(Cl)sc21)C(N)=O,"(2S,3R,4R,5R)-N-(4-carbamoyl-2-methoxyphenyl)-2'-chloro-4-(3-chloro-2-fluorophenyl)-2-(2,2-dimethylpropyl)-5'-oxo-4',5'-dihydrospiro[pyrrolidine-3,6'-thieno[3,2-b]pyrrole]-5-carboxamide","InChI=1S/C29H29Cl2FN4O4S/c1-28(2,3)12-19-29(24-17(35-27(29)39)11-20(31)41-24)21(14-6-5-7-15(30)22(14)32)23(36-19)26(38)34-16-9-8-13(25(33)37)10-18(16)40-4/h5-11,19,21,23,36H,12H2,1-4H3,(H2,33,37)(H,34,38)(H,35,39)/t19-,21-,23+,29+/m0/s1",UOVSZRTTWLJPHE-HNXAPSNLSA-N,1,1,1,0,MDM2-Like / P53,8.15,cancer,Inhibition,
2337,56941948,3109042,,COc1cc(ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@]2([C@H]1c1cccc(Cl)c1F)C(=O)Nc1cc(Cl)ncc21)C(N)=O,"(2S,3R,4S,5R)-N-(4-carbamoyl-2-methoxyphenyl)-6'-chloro-4-(3-chloro-2-fluorophenyl)-2-(2,2-dimethylpropyl)-2'-oxo-1',2'-dihydrospiro[pyrrolidine-3,3'-pyrrolo[3,2-c]pyridine]-5-carboxamide","InChI=1S/C30H30Cl2FN5O4/c1-29(2,3)12-21-30(16-13-35-22(32)11-19(16)37-28(30)41)23(15-6-5-7-17(31)24(15)33)25(38-21)27(40)36-18-9-8-14(26(34)39)10-20(18)42-4/h5-11,13,21,23,25,38H,12H2,1-4H3,(H2,34,39)(H,36,40)(H,37,41)/t21-,23-,25+,30+/m0/s1",CGCOPBXAGSCZNX-FNQJWKMRSA-N,1,0,0,0,MDM2-Like / P53,5.24,cancer,Inhibition,
2338,66760762,3109038,,COc1cc(ccc1NC(=O)[C@H]1N[C@H](CC(C)(C)C)[C@@]2([C@@H]1c1cccc(Cl)c1F)C(=O)Nc1cc(Cl)sc21)C(O)=O,"4-{[(2R,3S,4S,5S)-2'-chloro-4-(3-chloro-2-fluorophenyl)-2-(2,2-dimethylpropyl)-5'-oxo-4',5'-dihydrospiro[pyrrolidine-3,6'-thieno[3,2-b]pyrrol]-5-yl]amido}-3-methoxybenzoic acid","InChI=1S/C29H28Cl2FN3O5S/c1-28(2,3)12-19-29(24-17(34-27(29)39)11-20(31)41-24)21(14-6-5-7-15(30)22(14)32)23(35-19)25(36)33-16-9-8-13(26(37)38)10-18(16)40-4/h5-11,19,21,23,35H,12H2,1-4H3,(H,33,36)(H,34,39)(H,37,38)/t19-,21-,23+,29+/m1/s1",YXQHJKFKRZDXHV-RPMQLHGRSA-N,1,1,0,0,MDM2-Like / P53,7.24,cancer,Inhibition,
2339,66764524,3109037,,COc1cc(ccc1NC(=O)[C@H]1N[C@H](CC(C)(C)C)[C@@]2([C@@H]1c1cccc(Cl)c1F)C(=O)Nc1cc(Cl)sc21)C(N)=O,"(2R,3S,4S,5S)-N-(4-carbamoyl-2-methoxyphenyl)-2'-chloro-4-(3-chloro-2-fluorophenyl)-2-(2,2-dimethylpropyl)-5'-oxo-4',5'-dihydrospiro[pyrrolidine-3,6'-thieno[3,2-b]pyrrole]-5-carboxamide","InChI=1S/C29H29Cl2FN4O4S/c1-28(2,3)12-19-29(24-17(35-27(29)39)11-20(31)41-24)21(14-6-5-7-15(30)22(14)32)23(36-19)26(38)34-16-9-8-13(25(33)37)10-18(16)40-4/h5-11,19,21,23,36H,12H2,1-4H3,(H2,33,37)(H,34,38)(H,35,39)/t19-,21-,23+,29+/m1/s1",UOVSZRTTWLJPHE-RPMQLHGRSA-N,1,1,0,0,MDM2-Like / P53,6.75,cancer,Inhibition,
2340,126480585,,,O=C(N1CCC(CCN2CCCC2)CC1)c1ccc(C(=O)N2CCC(CCN3CCCC3)CC2)c(Nc2ccccc2)c1,"N-phenyl-2,5-bis({4-[2-(pyrrolidin-1-yl)ethyl]piperidine-1-carbonyl})aniline","InChI=1S/C36H51N5O2/c42-35(40-24-14-29(15-25-40)12-22-38-18-4-5-19-38)31-10-11-33(34(28-31)37-32-8-2-1-3-9-32)36(43)41-26-16-30(17-27-41)13-23-39-20-6-7-21-39/h1-3,8-11,28-30,37H,4-7,12-27H2",MJSAAVJPPGYWEY-UHFFFAOYSA-N,4,0,0,0,SPIN1 / H3,4.96,cancer,Inhibition,
2341,126480597,4476514,,O=C(N1CCC(CCN2CCCC2)CC1)c1ccc(C(=O)N2CCC(CCN3CCCC3)CC2)c(Nc2ccc(OCN3CCCC3)cc2)c1,"2,5-bis({4-[2-(pyrrolidin-1-yl)ethyl]piperidine-1-carbonyl})-N-{4-[(pyrrolidin-1-yl)methoxy]phenyl}aniline","InChI=1S/C41H60N6O3/c48-40(46-27-15-33(16-28-46)13-25-43-19-1-2-20-43)35-7-12-38(41(49)47-29-17-34(18-30-47)14-26-44-21-3-4-22-44)39(31-35)42-36-8-10-37(11-9-36)50-32-45-23-5-6-24-45/h7-12,31,33-34,42H,1-6,13-30,32H2",LPCWQWNRCGWRFC-UHFFFAOYSA-N,4,0,0,0,SPIN1 / H3,5.41,cancer,Inhibition,
2342,126480596,,,O=C(N1CCC(CCN2CCCC2)CC1)c1ccc(C(=O)N2CCC(CCN3CCCC3)CC2)c(Nc2ccc(CCN3CCCC3)cc2)c1,"N-{4-[2-(pyrrolidin-1-yl)ethyl]phenyl}-2,5-bis({4-[2-(pyrrolidin-1-yl)ethyl]piperidine-1-carbonyl})aniline","InChI=1S/C42H62N6O2/c49-41(47-29-16-35(17-30-47)14-27-45-22-3-4-23-45)37-9-12-39(42(50)48-31-18-36(19-32-48)15-28-46-24-5-6-25-46)40(33-37)43-38-10-7-34(8-11-38)13-26-44-20-1-2-21-44/h7-12,33,35-36,43H,1-6,13-32H2",UJLVEHPJYLSVOB-UHFFFAOYSA-N,4,0,0,0,SPIN1 / H3,5.14,cancer,Inhibition,
2343,126480594,,,O=C(N1CCC(CCN2CCCC2)CC1)c1ccc(C(=O)N2CCC(CCN3CCCC3)CC2)c(Nc2cccc(CCN3CCCC3)c2)c1,"N-{3-[2-(pyrrolidin-1-yl)ethyl]phenyl}-2,5-bis({4-[2-(pyrrolidin-1-yl)ethyl]piperidine-1-carbonyl})aniline","InChI=1S/C42H62N6O2/c49-41(47-28-15-34(16-29-47)12-25-44-19-1-2-20-44)37-10-11-39(42(50)48-30-17-35(18-31-48)13-26-45-21-3-4-22-45)40(33-37)43-38-9-7-8-36(32-38)14-27-46-23-5-6-24-46/h7-11,32-35,43H,1-6,12-31H2",HXPPYTDIFBBGQX-UHFFFAOYSA-N,4,0,0,0,SPIN1 / H3,5.72,cancer,Inhibition,
2344,57339144,2426364,,O=C(N1CCC(CC1)N1CCCC1)c1ccc(C(=O)N2CCC(CC2)N2CCCC2)c(Nc2ccccc2)c1,"N-phenyl-2,5-bis[4-(pyrrolidin-1-yl)piperidine-1-carbonyl]aniline","InChI=1S/C32H43N5O2/c38-31(36-20-12-27(13-21-36)34-16-4-5-17-34)25-10-11-29(30(24-25)33-26-8-2-1-3-9-26)32(39)37-22-14-28(15-23-37)35-18-6-7-19-35/h1-3,8-11,24,27-28,33H,4-7,12-23H2",PQOOIERVZAXHBP-UHFFFAOYSA-N,5,0,0,0,SPIN1 / H3,6.30,cancer,Inhibition,
2345,56941384,3911184,,CC(C)CC(NC(C(=O)NCc1ccccc1)c1c([nH]c2cc(Cl)ccc12)C(=O)NO)C(=O)NO,3-[(benzylcarbamoyl)({[1-(hydroxycarbamoyl)-3-methylbutyl]amino})methyl]-6-chloro-N-hydroxy-1H-indole-2-carboxamide,"InChI=1S/C24H28ClN5O5/c1-13(2)10-18(22(31)29-34)28-20(23(32)26-12-14-6-4-3-5-7-14)19-16-9-8-15(25)11-17(16)27-21(19)24(33)30-35/h3-9,11,13,18,20,27-28,34-35H,10,12H2,1-2H3,(H,26,32)(H,29,31)(H,30,33)",VRQFWSWBTGHUMK-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,5.92,cancer,Inhibition,
2346,90656494,3260849,,CC(C)(C)NC(=O)C(N(Cc1ccc(OCc2ccc(Cl)cc2)cc1)C=O)c1c([nH]c2cc(Cl)ccc12)C(O)=O,3-[(tert-butylcarbamoyl)[N-({4-[(4-chlorophenyl)methoxy]phenyl}methyl)formamido]methyl]-6-chloro-1H-indole-2-carboxylic acid,"InChI=1S/C30H29Cl2N3O5/c1-30(2,3)34-28(37)27(25-23-13-10-21(32)14-24(23)33-26(25)29(38)39)35(17-36)15-18-6-11-22(12-7-18)40-16-19-4-8-20(31)9-5-19/h4-14,17,27,33H,15-16H2,1-3H3,(H,34,37)(H,38,39)",PESUUIPTWNTJKA-UHFFFAOYSA-N,1,0,0,0,MDM2-Like / P53,6.22,cancer,Inhibition,
2347,90654510,3233588,,COCCOc1ccccc1N1CCN(CC1)C(=O)[C@@]1(CCCN(C1)C(=O)c1cnccc1C(F)(F)F)Oc1ccc(cc1)C(F)(F)F,1-[2-(2-methoxyethoxy)phenyl]-4-[(3S)-3-[4-(trifluoromethyl)phenoxy]-1-[4-(trifluoromethyl)pyridine-3-carbonyl]piperidine-3-carbonyl]piperazine,"InChI=1S/C33H34F6N4O5/c1-46-19-20-47-28-6-3-2-5-27(28)41-15-17-42(18-16-41)30(45)31(48-24-9-7-23(8-10-24)32(34,35)36)12-4-14-43(22-31)29(44)25-21-40-13-11-26(25)33(37,38)39/h2-3,5-11,13,21H,4,12,14-20,22H2,1H3/t31-/m0/s1",CRIWMVCCGZFDSF-HKBQPEDESA-N,1,1,0,0,MDM2-Like / P53,6.77,cancer,Inhibition,
2348,23642310,3233018,,COCCOc1ccccc1N1CCN(CC1)C(=O)[C@@]1(CCCN([C@@H]1CC=C)C(=O)c1cnccc1C(F)(F)F)Oc1ccc(cc1)C(F)(F)F,"1-[2-(2-methoxyethoxy)phenyl]-4-[(2R,3S)-2-(prop-2-en-1-yl)-3-[4-(trifluoromethyl)phenoxy]-1-[4-(trifluoromethyl)pyridine-3-carbonyl]piperidine-3-carbonyl]piperazine","InChI=1S/C36H38F6N4O5/c1-3-7-31-34(51-26-12-10-25(11-13-26)35(37,38)39,15-6-17-46(31)32(47)27-24-43-16-14-28(27)36(40,41)42)33(48)45-20-18-44(19-21-45)29-8-4-5-9-30(29)50-23-22-49-2/h3-5,8-14,16,24,31H,1,6-7,15,17-23H2,2H3/t31-,34+/m1/s1",QKOYVKQWXLFSPH-FJQKOURKSA-N,1,1,0,0,MDM2-Like / P53,7.39,cancer,Inhibition,
2349,24966258,3304544,,CCC[C@H]1N(CCC[C@@]1(Oc1ccc(cc1)C(F)(F)F)C(=O)N1CCN(CC1)c1ccccc1OCCOC)C(=O)c1cnccc1C(F)(F)F,"1-[2-(2-methoxyethoxy)phenyl]-4-[(2R,3S)-2-propyl-3-[4-(trifluoromethyl)phenoxy]-1-[4-(trifluoromethyl)pyridine-3-carbonyl]piperidine-3-carbonyl]piperazine","InChI=1S/C36H40F6N4O5/c1-3-7-31-34(51-26-12-10-25(11-13-26)35(37,38)39,15-6-17-46(31)32(47)27-24-43-16-14-28(27)36(40,41)42)33(48)45-20-18-44(19-21-45)29-8-4-5-9-30(29)50-23-22-49-2/h4-5,8-14,16,24,31H,3,6-7,15,17-23H2,1-2H3/t31-,34+/m1/s1",WAKAOKPIMUQSES-FJQKOURKSA-N,1,1,0,0,MDM2-Like / P53,7.62,cancer,Inhibition,
2350,24967335,3304678,,COCCOc1ccccc1N1CCN(CC1)C(=O)[C@@]1(CCCN([C@@H]1CC(O)CO)C(=O)c1cnccc1C(F)(F)F)Oc1ccc(cc1)C(F)(F)F,"3-[(2R,3S)-3-{4-[2-(2-methoxyethoxy)phenyl]piperazine-1-carbonyl}-3-[4-(trifluoromethyl)phenoxy]-1-[4-(trifluoromethyl)pyridine-3-carbonyl]piperidin-2-yl]propane-1,2-diol","InChI=1S/C36H40F6N4O7/c1-51-19-20-52-30-6-3-2-5-29(30)44-15-17-45(18-16-44)33(50)34(53-26-9-7-24(8-10-26)35(37,38)39)12-4-14-46(31(34)21-25(48)23-47)32(49)27-22-43-13-11-28(27)36(40,41)42/h2-3,5-11,13,22,25,31,47-48H,4,12,14-21,23H2,1H3/t25?,31-,34+/m1/s1",VIVLZPBBGBMFDQ-UJJIYMDQSA-N,1,1,0,0,MDM2-Like / P53,7.62,cancer,Inhibition,
2351,86302516,3305317,,COCCOc1ccccc1N1CCN(CC1)C(=O)[C@@]1(CCCN([C@@H]1CCO)C(=O)c1cnccc1C(F)(F)F)Oc1ccc(cc1)C(F)(F)F,"2-[(2R,3S)-3-{4-[2-(2-methoxyethoxy)phenyl]piperazine-1-carbonyl}-3-[4-(trifluoromethyl)phenoxy]-1-[4-(trifluoromethyl)pyridine-3-carbonyl]piperidin-2-yl]ethan-1-ol","InChI=1S/C35H38F6N4O6/c1-49-21-22-50-29-6-3-2-5-28(29)43-16-18-44(19-17-43)32(48)33(51-25-9-7-24(8-10-25)34(36,37)38)13-4-15-45(30(33)12-20-46)31(47)26-23-42-14-11-27(26)35(39,40)41/h2-3,5-11,14,23,30,46H,4,12-13,15-22H2,1H3/t30-,33+/m1/s1",GOOKVWRPGSXHEA-NDKRRWIDSA-N,1,1,0,0,MDM2-Like / P53,7.62,cancer,Inhibition,
2352,,,,c1c(c(cc2c1C1(C(=N2)N)CCC1)OCCCN1CCCC1)OC,,,,,,,,,,,,
2353,,,,CCOc1cc2c(cc1OCCCN1CCCC1)N=C(N)C21CCCC1,"5'-ethoxy-6'-[3-(pyrrolidin-1-yl)propoxy]spiro[cyclopentane-1,3'-indol]-2'-amine",,,1,0,0,0,SPIN1 / H3,5.67,cancer,Inhibition,
2354,,,,CC(C)Oc1cc2c(cc1OCCCN1CCCC1)N=C(N)C21CCCC1,"5'-(propan-2-yloxy)-6'-[3-(pyrrolidin-1-yl)propoxy]spiro[cyclopentane-1,3'-indol]-2'-amine",,,1,0,0,0,SPIN1 / H3,5.05,cancer,Inhibition,
2355,,,,NC1=Nc2cc(OCCCN3CCCC3)c(OCC3CC3)cc2C11CCCC1,"5'-(cyclopropylmethoxy)-6'-[3-(pyrrolidin-1-yl)propoxy]spiro[cyclopentane-1,3'-indol]-2'-amine",,,1,0,0,0,SPIN1 / H3,5.95,cancer,Inhibition,
2356,,,,COc1cc2c(cc1OCCCN1CCCC1)N=C(N)C21CCCC1,"5'-methoxy-6'-[3-(pyrrolidin-1-yl)propoxy]spiro[cyclopentane-1,3'-indol]-2'-amine",,,1,0,0,0,SPIN1 / H3,6.12,cancer,Inhibition,
2357,,,,COc1cc2c(cc1OCCCN1Cc3ccccc3C1)N=C(N)C21CCCC1,"6'-[3-(2,3-dihydro-1H-isoindol-2-yl)propoxy]-5'-methoxyspiro[cyclopentane-1,3'-indol]-2'-amine",,,1,0,0,0,SPIN1 / H3,6.18,cancer,Inhibition,
2358,,,,COc1cccc2CN(CCCOc3cc4N=C(N)C5(CCCC5)c4cc3OC)Cc12,"5'-methoxy-6'-[3-(4-methoxy-2,3-dihydro-1H-isoindol-2-yl)propoxy]spiro[cyclopentane-1,3'-indol]-2'-amine",,,1,0,0,0,SPIN1 / H3,5.18,cancer,Inhibition,
2359,,,,COc1ccc2CN(CCCOc3cc4N=C(N)C5(CCCC5)c4cc3OC)Cc2c1,"5'-methoxy-6'-[3-(5-methoxy-2,3-dihydro-1H-isoindol-2-yl)propoxy]spiro[cyclopentane-1,3'-indol]-2'-amine",,,1,0,0,0,SPIN1 / H3,6.22,cancer,Inhibition,
2360,,,,COc1ccc2CN(CCCOc3cc4N=C(N)C5(CCCC5)c4cc3OCC3CC3)Cc2c1,"5'-(cyclopropylmethoxy)-6'-[3-(5-methoxy-2,3-dihydro-1H-isoindol-2-yl)propoxy]spiro[cyclopentane-1,3'-indol]-2'-amine",,,1,0,0,0,SPIN1 / H3,6.47,cancer,Inhibition,
2361,,,,NC1=Nc2cc(OCCCN3Cc4ccccc4C3)c(OCC3CC3)cc2C11CCCC1,"5'-(cyclopropylmethoxy)-6'-[3-(2,3-dihydro-1H-isoindol-2-yl)propoxy]spiro[cyclopentane-1,3'-indol]-2'-amine",,,1,0,0,1,SPIN1 / H3,6.41,cancer,Inhibition,
2362,,,,NC1=Nc2cc(OCCCCN3Cc4ccccc4C3)c(OCC3CC3)cc2C11CCCC1,"5'-(cyclopropylmethoxy)-6'-[4-(2,3-dihydro-1H-isoindol-2-yl)butoxy]spiro[cyclopentane-1,3'-indol]-2'-amine",,,1,0,0,1,SPIN1 / H3,5.21,cancer,Inhibition,
2363,,,,CC1(C)C(N)=Nc2cc(OCCCN3Cc4ccccc4C3)c(OCC3CC3)cc12,"5-(cyclopropylmethoxy)-6-[3-(2,3-dihydro-1H-isoindol-2-yl)propoxy]-3,3-dimethyl-3H-indol-2-amine",,,3,0,0,1,SPIN1 / H3,7.81,cancer,Inhibition,
2364,,,,CC1(C)C(N)=Nc2cc(OCCCCN3Cc4ccccc4C3)c(OCC3CC3)cc12,"5-(cyclopropylmethoxy)-6-[4-(2,3-dihydro-1H-isoindol-2-yl)butoxy]-3,3-dimethyl-3H-indol-2-amine",,,1,0,0,1,SPIN1 / H3,5.16,cancer,Inhibition,
2365,,,,C(=O)(Cn1nnc(c1)COc1ccc2CN(Cc2c1)CCCOc1c(cc2C(C(=Nc2c1)N)(C)C)OCC1CC1)N1CCC(CC1)CCN1CCCC1,,,,3,0,0,0,SPIN1 / H3,7.22,cancer,Inhibition,
2366,,,,CC1(C)C(N)=Nc2cc(OCCCN3Cc4ccc(OCCc5cn(CC(=O)N6CCC(CCN7CCCC7)CC6)nn5)cc4C3)c(OCC3CC3)cc12,"2-[4-(2-{[2-(3-{[2-amino-5-(cyclopropylmethoxy)-3,3-dimethyl-3H-indol-6-yl]oxy}propyl)-2,3-dihydro-1H-isoindol-5-yl]oxy}ethyl)-1H-1,2,3-triazol-1-yl]-1-{4-[2-(pyrrolidin-1-yl)ethyl]piperidin-1-yl}ethan-1-one",,,10,0,0,1,SPIN1 / H3,8.00,cancer,Inhibition,
2367,,,,C(=O)(CCn1nnc(c1)COc1ccc2CN(Cc2c1)CCCOc1c(cc2C(C(=Nc2c1)N)(C)C)OCC1CC1)N1CCC(CC1)CCN1CCCC1,,,,3,0,0,0,SPIN1 / H3,8.18,cancer,Inhibition,
2368,,,,C(=O)(CCn1nnc(c1)CCOc1ccc2CN(Cc2c1)CCCOc1c(cc2C(C(=Nc2c1)N)(C)C)OCC1CC1)N1CCC(CC1)CCN1CCCC1,,,,3,0,0,0,SPIN1 / H3,8.00,cancer,Inhibition,
2369,,,,C(=O)(Cn1nnc(c1)COc1ccc2CN(Cc2c1)CCCCOc1c(cc2C(C(=Nc2c1)N)(C)C)OCC1CC1)N1CCC(CC1)CCN1CCCC1,,,,5,0,0,1,SPIN1 / H3,5.89,cancer,Inhibition,
2370,16011141,2141272,,CCN(CC)CCCNC(=O)Cn1nc(C)n2c3ccsc3cc2c1=O,"N-[3-(diethylamino)propyl]-2-{12-methyl-9-oxo-5-thia-1,10,11-triazatricyclo[6.4.0.0^{2,6}]dodeca-2(6),3,7,11-tetraen-10-yl}acetamide","InChI=1S/C18H25N5O2S/c1-4-21(5-2)9-6-8-19-17(24)12-22-18(25)15-11-16-14(7-10-26-16)23(15)13(3)20-22/h7,10-11H,4-6,8-9,12H2,1-3H3,(H,19,24)",DRDIHUMOFDGYRJ-UHFFFAOYSA-N,2,0,0,0,UHRF1 / H3,5.28,breast cancer,Inhibition,
2371,168317717,,,CCN(CC)CCCNC(=O)Cn1nc(C)n2c3ccsc3c(Br)c2c1=O,"2-{7-bromo-12-methyl-9-oxo-5-thia-1,10,11-triazatricyclo[6.4.0.0^{2,6}]dodeca-2(6),3,7,11-tetraen-10-yl}-N-[3-(diethylamino)propyl]acetamide","InChI=1S/C18H24BrN5O2S/c1-4-22(5-2)9-6-8-20-14(25)11-23-18(26)16-15(19)17-13(7-10-27-17)24(16)12(3)21-23/h7,10H,4-6,8-9,11H2,1-3H3,(H,20,25)",XZJKMCMRBQLRNX-UHFFFAOYSA-N,2,0,0,0,UHRF1 / H3,5.51,breast cancer,Inhibition,
2372,139291004,,,CCN(CC)CCCNC(=O)Cn1nc(C)n2c3ccsc3c(C)c2c1=O,"N-[3-(diethylamino)propyl]-2-{7,12-dimethyl-9-oxo-5-thia-1,10,11-triazatricyclo[6.4.0.0^{2,6}]dodeca-2(6),3,7,11-tetraen-10-yl}acetamide","InChI=1S/C19H27N5O2S/c1-5-22(6-2)10-7-9-20-16(25)12-23-19(26)17-13(3)18-15(8-11-27-18)24(17)14(4)21-23/h8,11H,5-7,9-10,12H2,1-4H3,(H,20,25)",KNZQAVKYBBYDKV-UHFFFAOYSA-N,2,0,0,0,UHRF1 / H3,5.62,breast cancer,Inhibition,
2373,168317721,,,CCN(CC)CCCNC(=O)Cn1nc(C)n2c3ccccc3cc2c1=O,"N-[3-(diethylamino)propyl]-2-{4-methyl-1-oxo-1H,2H-[1,2,4]triazino[4,5-a]indol-2-yl}acetamide","InChI=1S/C20H27N5O2/c1-4-23(5-2)12-8-11-21-19(26)14-24-20(27)18-13-16-9-6-7-10-17(16)25(18)15(3)22-24/h6-7,9-10,13H,4-5,8,11-12,14H2,1-3H3,(H,21,26)",NEJWKRXFJLZCRA-UHFFFAOYSA-N,1,0,0,0,UHRF1 / H3,4.82,breast cancer,Inhibition,
2374,168317720,,,CCN(CC)CCCNC(=O)Cn1nc(C)n2c3ccccc3c(Br)c2c1=O,"2-{10-bromo-4-methyl-1-oxo-1H,2H-[1,2,4]triazino[4,5-a]indol-2-yl}-N-[3-(diethylamino)propyl]acetamide","InChI=1S/C20H26BrN5O2/c1-4-24(5-2)12-8-11-22-17(27)13-25-20(28)19-18(21)15-9-6-7-10-16(15)26(19)14(3)23-25/h6-7,9-10H,4-5,8,11-13H2,1-3H3,(H,22,27)",ZXVVXFDFZKBBSI-UHFFFAOYSA-N,1,0,0,0,UHRF1 / H3,5.17,breast cancer,Inhibition,
2375,168317719,,,CCN(CC)CCCNC(=O)Cn1nc(C)n2c(cc3c(F)cccc23)c1=O,"N-[3-(diethylamino)propyl]-2-{9-fluoro-4-methyl-1-oxo-1H,2H-[1,2,4]triazino[4,5-a]indol-2-yl}acetamide","InChI=1S/C20H26FN5O2/c1-4-24(5-2)11-7-10-22-19(27)13-25-20(28)18-12-15-16(21)8-6-9-17(15)26(18)14(3)23-25/h6,8-9,12H,4-5,7,10-11,13H2,1-3H3,(H,22,27)",VMWVNBGFGFTYOQ-UHFFFAOYSA-N,1,0,0,0,UHRF1 / H3,4.26,breast cancer,Inhibition,
2376,168317718,,,CCN(CC)CCCNC(=O)Cn1nc(C)n2c3cccc(F)c3c(Br)c2c1=O,"2-{10-bromo-9-fluoro-4-methyl-1-oxo-1H,2H-[1,2,4]triazino[4,5-a]indol-2-yl}-N-[3-(diethylamino)propyl]acetamide","InChI=1S/C20H25BrFN5O2/c1-4-25(5-2)11-7-10-23-16(28)12-26-20(29)19-18(21)17-14(22)8-6-9-15(17)27(19)13(3)24-26/h6,8-9H,4-5,7,10-12H2,1-3H3,(H,23,28)",CPXHLXIACCDEDI-UHFFFAOYSA-N,2,0,0,0,UHRF1 / H3,5.27,breast cancer,Inhibition,
2377,688344,4538578,,CC(C)(C)NC(=O)[C@@H]1Cc2ccccc2CN1,"(3S)-N-tert-butyl-1,2,3,4-tetrahydroisoquinoline-3-carboxamide","InChI=1S/C14H20N2O/c1-14(2,3)16-13(17)12-8-10-6-4-5-7-11(10)9-15-12/h4-7,12,15H,8-9H2,1-3H3,(H,16,17)/t12-/m0/s1",DMJXRYSGXCLCFP-LBPRGKRZSA-N,0,0,0,0,,,,,
2378,58923143,4587486,,Cc1nnc2COCc3ccccc3-n12,"3-methyl-8-oxa-2,4,5-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,11,13-pentaene","InChI=1S/C11H11N3O/c1-8-12-13-11-7-15-6-9-4-2-3-5-10(9)14(8)11/h2-5H,6-7H2,1H3",HEEIZXCFEVISIX-UHFFFAOYSA-N,0,0,0,0,,,,,
2379,7631344,,,O=C(NCc1ccco1)C1CCN(CC1)C(=O)[C@@H]1Cc2ccccc2CN1,"N-[(furan-2-yl)methyl]-1-[(3S)-1,2,3,4-tetrahydroisoquinoline-3-carbonyl]piperidine-4-carboxamide","InChI=1S/C21H25N3O3/c25-20(23-14-18-6-3-11-27-18)15-7-9-24(10-8-15)21(26)19-12-16-4-1-2-5-17(16)13-22-19/h1-6,11,15,19,22H,7-10,12-14H2,(H,23,25)/t19-/m0/s1",CHWQZRDDUSGKFB-IBGZPJMESA-N,0,0,0,0,,,,,
2380,131633051,4576037,,CC(=O)NCc1ccccc1-n1c(C)nnc1C,"N-{[2-(3,5-dimethyl-4H-1,2,4-triazol-4-yl)phenyl]methyl}acetamide","InChI=1S/C13H16N4O/c1-9-15-16-10(2)17(9)13-7-5-4-6-12(13)8-14-11(3)18/h4-7H,8H2,1-3H3,(H,14,18)",FLTCDBPTYKZRMD-UHFFFAOYSA-N,1,0,0,0,SETDB1 / H3,2.46,cancer,Inhibition,
2381,155550980,4542222,,CC(=O)NCc1cc(Br)ccc1-n1c(C)nnc1C,"N-{[5-bromo-2-(3,5-dimethyl-4H-1,2,4-triazol-4-yl)phenyl]methyl}acetamide","InChI=1S/C13H15BrN4O/c1-8-16-17-9(2)18(8)13-5-4-12(14)6-11(13)7-15-10(3)19/h4-6H,7H2,1-3H3,(H,15,19)",GMAJOKNXUXTWNC-UHFFFAOYSA-N,1,0,0,0,SETDB1 / H3,2.57,cancer,Inhibition,
2382,155524696,4455427,,CC(=O)NCc1cc(Cl)ccc1-n1c(C)nnc1C,"N-{[5-chloro-2-(3,5-dimethyl-4H-1,2,4-triazol-4-yl)phenyl]methyl}acetamide","InChI=1S/C13H15ClN4O/c1-8-16-17-9(2)18(8)13-5-4-12(14)6-11(13)7-15-10(3)19/h4-6H,7H2,1-3H3,(H,15,19)",HQUQIZCPRFKLBL-UHFFFAOYSA-N,1,0,0,0,SETDB1 / H3,2.60,cancer,Inhibition,
2383,155521990,4451286,,CC(=O)NCc1cc(ccc1-n1c(C)nnc1C)C#N,"N-{[5-cyano-2-(3,5-dimethyl-4H-1,2,4-triazol-4-yl)phenyl]methyl}acetamide","InChI=1S/C14H15N5O/c1-9-17-18-10(2)19(9)14-5-4-12(7-15)6-13(14)8-16-11(3)20/h4-6H,8H2,1-3H3,(H,16,20)",BWHKMEKOONHNHJ-UHFFFAOYSA-N,1,0,0,0,SETDB1 / H3,2.00,cancer,Inhibition,
2384,155568129,4589361,,CC(=O)NCc1cc(C)ccc1-n1c(C)nnc1C,"N-{[2-(3,5-dimethyl-4H-1,2,4-triazol-4-yl)-5-methylphenyl]methyl}acetamide","InChI=1S/C14H18N4O/c1-9-5-6-14(13(7-9)8-15-12(4)19)18-10(2)16-17-11(18)3/h5-7H,8H2,1-4H3,(H,15,19)",YOOWACTYJKDGHI-UHFFFAOYSA-N,1,0,0,0,SETDB1 / H3,2.11,cancer,Inhibition,
2385,,,,CCOc1cc(ccc1C2=N[C@@](C)(c3ccc(Cl)cc3)[C@](C)(N2C(=O)N4CCN(CCC[S](C)(=O)=O)CC4)c5ccc(Cl)cc5)C(C)(C)C,,,,,,,,,,,,
2386,71655426,2386168,,CCOc1cc(ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@](C)(N1C(=O)N1CCNC(=O)C1)c1ccc(Cl)cc1)C(C)(C)C,"4-[(4S,5R)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethyl-4,5-dihydro-1H-imidazole-1-carbonyl]piperazin-2-one","InChI=1S/C34H38Cl2N4O3/c1-7-43-28-20-24(32(2,3)4)12-17-27(28)30-38-33(5,22-8-13-25(35)14-9-22)34(6,23-10-15-26(36)16-11-23)40(30)31(42)39-19-18-37-29(41)21-39/h8-17,20H,7,18-19,21H2,1-6H3,(H,37,41)/t33-,34+/m0/s1",ZZRODNWWALHZAJ-SZAHLOSFSA-N,1,3,0,0,MDM2-Like / P53,7.28,cancer,Inhibition,
2387,17754546,2386169,,CCOc1cc(ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@](C)(N1C(=O)N1CCNCC1)c1ccc(Cl)cc1)C(C)(C)C,"1-[(4S,5R)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethyl-4,5-dihydro-1H-imidazole-1-carbonyl]piperazine","InChI=1S/C34H40Cl2N4O2/c1-7-42-29-22-25(32(2,3)4)12-17-28(29)30-38-33(5,23-8-13-26(35)14-9-23)34(6,24-10-15-27(36)16-11-24)40(30)31(41)39-20-18-37-19-21-39/h8-17,22,37H,7,18-21H2,1-6H3/t33-,34+/m0/s1",HPHUDNTXCKTLNK-SZAHLOSFSA-N,1,3,0,0,MDM2-Like / P53,7.52,cancer,Inhibition,
2388,,,,c1(C2=N[C@@](C)(c3ccc(Cl)cc3)[C@](C)(N2C(=O)N2CCCCC2)c2ccc(Cl)cc2)ccc(cc1OCC)C(C)(C)C,,,,,,,,,,,,
2389,17754588,2386343,,CCOc1cc(ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@](C)(N1C(=O)N1CCN(CC1)C(C)=O)c1ccc(Cl)cc1)C(C)(C)C,"1-{4-[(4S,5R)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethyl-4,5-dihydro-1H-imidazole-1-carbonyl]piperazin-1-yl}ethan-1-one","InChI=1S/C36H42Cl2N4O3/c1-8-45-31-23-27(34(3,4)5)13-18-30(31)32-39-35(6,25-9-14-28(37)15-10-25)36(7,26-11-16-29(38)17-12-26)42(32)33(44)41-21-19-40(20-22-41)24(2)43/h9-18,23H,8,19-22H2,1-7H3/t35-,36+/m0/s1",OHBOYVVVTREVDA-MPQUPPDSSA-N,1,3,1,0,MDM2-Like / P53,7.64,cancer,Inhibition,
2390,,,,c1(C2=N[C@@](C)(c3ccc(Cl)cc3)[C@](C)(N2C(=O)N2CCN(CC2)CCC(F)(F)F)c2ccc(Cl)cc2)ccc(cc1OCC)C(C)(C)C,,,,,,,,,,,,
2391,17754846,2386345,,CCOc1cc(ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@](C)(N1C(=O)N1CCN(CCO)CC1)c1ccc(Cl)cc1)C(C)(C)C,"2-{4-[(4S,5R)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethyl-4,5-dihydro-1H-imidazole-1-carbonyl]piperazin-1-yl}ethan-1-ol","InChI=1S/C36H44Cl2N4O3/c1-7-45-31-24-27(34(2,3)4)12-17-30(31)32-39-35(5,25-8-13-28(37)14-9-25)36(6,26-10-15-29(38)16-11-26)42(32)33(44)41-20-18-40(19-21-41)22-23-43/h8-17,24,43H,7,18-23H2,1-6H3/t35-,36+/m0/s1",QEHAAELBCKBEBS-MPQUPPDSSA-N,1,3,0,0,MDM2-Like / P53,7.59,cancer,Inhibition,
2392,17754845,2386347,,CCOc1cc(ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@](C)(N1C(=O)N1CCN(CCNS(C)(=O)=O)CC1)c1ccc(Cl)cc1)C(C)(C)C,"N-(2-{4-[(4S,5R)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethyl-4,5-dihydro-1H-imidazole-1-carbonyl]piperazin-1-yl}ethyl)methanesulfonamide","InChI=1S/C37H47Cl2N5O4S/c1-8-48-32-25-28(35(2,3)4)13-18-31(32)33-41-36(5,26-9-14-29(38)15-10-26)37(6,27-11-16-30(39)17-12-27)44(33)34(45)43-23-21-42(22-24-43)20-19-40-49(7,46)47/h9-18,25,40H,8,19-24H2,1-7H3/t36-,37+/m0/s1",RLVHIMZOZMLGIX-PQQNNWGCSA-N,1,3,0,0,MDM2-Like / P53,7.34,cancer,Inhibition,
2393,17754844,2386348,,CCOc1cc(ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@](C)(N1C(=O)N1CCN(CCNC(C)=O)CC1)c1ccc(Cl)cc1)C(C)(C)C,"N-(2-{4-[(4S,5R)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethyl-4,5-dihydro-1H-imidazole-1-carbonyl]piperazin-1-yl}ethyl)acetamide","InChI=1S/C38H47Cl2N5O3/c1-8-48-33-25-29(36(3,4)5)13-18-32(33)34-42-37(6,27-9-14-30(39)15-10-27)38(7,28-11-16-31(40)17-12-28)45(34)35(47)44-23-21-43(22-24-44)20-19-41-26(2)46/h9-18,25H,8,19-24H2,1-7H3,(H,41,46)/t37-,38+/m0/s1",WOJXNSCIVSUSTO-QPPIDDCLSA-N,1,3,1,0,MDM2-Like / P53,7.48,cancer,Inhibition,
2394,168317715,,,CCOc1cc(ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@](C)(N1C(=O)N1CCN(CCN2CCCC2)CC1)c1ccc(Cl)cc1)C(C)(C)C,"1-[(4S,5R)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethyl-4,5-dihydro-1H-imidazole-1-carbonyl]-4-[2-(pyrrolidin-1-yl)ethyl]piperazine","InChI=1S/C40H51Cl2N5O2/c1-7-49-35-28-31(38(2,3)4)14-19-34(35)36-43-39(5,29-10-15-32(41)16-11-29)40(6,30-12-17-33(42)18-13-30)47(36)37(48)46-26-24-45(25-27-46)23-22-44-20-8-9-21-44/h10-19,28H,7-9,20-27H2,1-6H3/t39-,40+/m0/s1",LYFXBWPPIOGFJD-IOLBBIBUSA-N,1,3,1,0,MDM2-Like / P53,7.85,cancer,Inhibition,
2395,168317713,,,CCOc1cc(ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@](C)(N1C(=O)N1CCN(CCN2CCOCC2)CC1)c1ccc(Cl)cc1)C(C)(C)C,"4-(2-{4-[(4S,5R)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethyl-4,5-dihydro-1H-imidazole-1-carbonyl]piperazin-1-yl}ethyl)morpholine","InChI=1S/C40H51Cl2N5O3/c1-7-50-35-28-31(38(2,3)4)12-17-34(35)36-43-39(5,29-8-13-32(41)14-9-29)40(6,30-10-15-33(42)16-11-30)47(36)37(48)46-22-20-44(21-23-46)18-19-45-24-26-49-27-25-45/h8-17,28H,7,18-27H2,1-6H3/t39-,40+/m0/s1",XUEOXZKPFBXPIS-IOLBBIBUSA-N,1,3,0,0,MDM2-Like / P53,7.74,cancer,Inhibition,
2396,59595061,2386351,,CCOc1cc(ccc1C1=N[C@@](CC)(c2ccc(Cl)cc2)[C@](CC)(N1C(=O)N1CCN(CCCS(C)(=O)=O)CC1)c1ccc(Cl)cc1)C(C)(C)C,"1-[(4S,5R)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-diethyl-4,5-dihydro-1H-imidazole-1-carbonyl]-4-(3-methanesulfonylpropyl)piperazine","InChI=1S/C40H52Cl2N4O4S/c1-8-39(29-12-17-32(41)18-13-29)40(9-2,30-14-19-33(42)20-15-30)46(37(47)45-25-23-44(24-26-45)22-11-27-51(7,48)49)36(43-39)34-21-16-31(38(4,5)6)28-35(34)50-10-3/h12-21,28H,8-11,22-27H2,1-7H3/t39-,40+/m0/s1",JSZMEICPYDYNJQ-IOLBBIBUSA-N,1,3,0,0,MDM2-Like / P53,5.66,cancer,Inhibition,
2397,58894294,2386167,,CCOc1cc(ccc1C1=N[C@](C)([C@H](N1C(=O)N1CCN(CCCS(C)(=O)=O)CC1)c1ccc(Cl)cc1)c1ccc(Cl)cc1)C(C)(C)C,"1-[(4S,5R)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4-methyl-4,5-dihydro-1H-imidazole-1-carbonyl]-4-(3-methanesulfonylpropyl)piperazine","InChI=1S/C37H46Cl2N4O4S/c1-7-47-32-25-28(36(2,3)4)13-18-31(32)34-40-37(5,27-11-16-30(39)17-12-27)33(26-9-14-29(38)15-10-26)43(34)35(44)42-22-20-41(21-23-42)19-8-24-48(6,45)46/h9-18,25,33H,7-8,19-24H2,1-6H3/t33-,37+/m1/s1",HJAIBUOZTNJPKT-GOJCVTOHSA-N,1,3,0,0,MDM2-Like / P53,6.63,cancer,Inhibition,
2398,78673861,4172977,,CC(C)(C)NCCCNC(=O)c1cccc(Br)c1,3-bromo-N-[3-(tert-butylamino)propyl]benzamide,"InChI=1S/C14H21BrN2O/c1-14(2,3)17-9-5-8-16-13(18)11-6-4-7-12(15)10-11/h4,6-7,10,17H,5,8-9H2,1-3H3,(H,16,18)",XUFUVCIZFNREBI-UHFFFAOYSA-N,3,0,0,1,53BP1 / H4,4.66,,Inhibition,
2399,8699243,4160535,,CC(C)(C)NCCCNC(=O)c1cccc(I)c1,N-[3-(tert-butylamino)propyl]-3-iodobenzamide,"InChI=1S/C14H21IN2O/c1-14(2,3)17-9-5-8-16-13(18)11-6-4-7-12(15)10-11/h4,6-7,10,17H,5,8-9H2,1-3H3,(H,16,18)",YKQSWTFGSUNNEI-UHFFFAOYSA-N,1,0,0,0,53BP1 / H4,4.89,,Inhibition,
2400,91970648,4170666,,CC(C)c1cccc(c1)C(=O)NCCCNC(C)(C)C,N-[3-(tert-butylamino)propyl]-3-(propan-2-yl)benzamide,"InChI=1S/C17H28N2O/c1-13(2)14-8-6-9-15(12-14)16(20)18-10-7-11-19-17(3,4)5/h6,8-9,12-13,19H,7,10-11H2,1-5H3,(H,18,20)",CNTJLQUUYDXEFL-UHFFFAOYSA-N,1,0,0,0,53BP1 / H4,4.85,,Inhibition,
2401,91970649,4164098,,CC(C)(C)NCCCNC(=O)c1cccc(c1)C(F)(F)F,N-[3-(tert-butylamino)propyl]-3-(trifluoromethyl)benzamide,"InChI=1S/C15H21F3N2O/c1-14(2,3)20-9-5-8-19-13(21)11-6-4-7-12(10-11)15(16,17)18/h4,6-7,10,20H,5,8-9H2,1-3H3,(H,19,21)",UTBTYWGTMLPLJP-UHFFFAOYSA-N,1,0,0,0,53BP1 / H4,4.66,,Inhibition,
2402,284708,1450586,,NCC(=O)Nc1ccc(Cl)cc1C(=O)c1ccc[nH]1,2-amino-N-[4-chloro-2-(1H-pyrrole-2-carbonyl)phenyl]acetamide,"InChI=1S/C13H12ClN3O2/c14-8-3-4-10(17-12(18)7-15)9(6-8)13(19)11-2-1-5-16-11/h1-6,16H,7,15H2,(H,17,18)",HEMNVSCJOZIBEQ-UHFFFAOYSA-N,2,0,0,0,RUNX1 / CBFb,5.46,acute lymphoblastic leukemia (disease),Inhibition,
2403,768985,1566002,,NC(=O)N(CCC(O)=O)c1ccccc1,3-[carbamoyl(phenyl)amino]propanoic acid,"InChI=1S/C10H12N2O3/c11-10(15)12(7-6-9(13)14)8-4-2-1-3-5-8/h1-5H,6-7H2,(H2,11,15)(H,13,14)",FFQLMOLDTSZBCK-UHFFFAOYSA-N,2,0,0,0,RUNX1 / CBFb,5.46,acute lymphoblastic leukemia (disease),Inhibition,
2404,2772042,1410186,,CC(Cc1c[nH]c2ccccc12)C(O)=O,3-(1H-indol-3-yl)-2-methylpropanoic acid,"InChI=1S/C12H13NO2/c1-8(12(14)15)6-9-7-13-11-5-3-2-4-10(9)11/h2-5,7-8,13H,6H2,1H3,(H,14,15)",JDZNIWUNOASRIK-UHFFFAOYSA-N,2,0,0,0,RUNX1 / CBFb,5.46,acute lymphoblastic leukemia (disease),Inhibition,
2405,64983,91609,,Clc1ccc2NC(=O)CN=C(c3ccc[nH]3)c2c1,"7-chloro-5-(1H-pyrrol-2-yl)-2,3-dihydro-1H-1,4-benzodiazepin-2-one","InChI=1S/C13H10ClN3O/c14-8-3-4-10-9(6-8)13(11-2-1-5-15-11)16-7-12(18)17-10/h1-6,15H,7H2,(H,17,18)",XWNMORIHKRROGW-UHFFFAOYSA-N,0,5,1,0,RUNX1 / CBFb,5.96,acute lymphoblastic leukemia (disease),Inhibition,
2406,24941262,549695,,C[C@@H](NC(=O)c1cc(N)ccc1C)c1cccc2ccccc12,5-amino-2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]benzamide,"InChI=1S/C20H20N2O/c1-13-10-11-16(21)12-19(13)20(23)22-14(2)17-9-5-7-15-6-3-4-8-18(15)17/h3-12,14H,21H2,1-2H3,(H,22,23)/t14-/m1/s1",UVERBUNNCOKGNZ-CQSZACIVSA-N,2,1,0,0,PLpro-SARS-CoV2 / ISG15,5.68,COVID-19,Inhibition,
2407,,,,c1(c(ccc(c1)N)C)C(=O)N[C@H](C)c1c2ccccc2ccc1,,,,,,,,,,,,
2408,44235889,551592,,C[C@@H](NC(=O)c1cc(NC(C)=O)ccc1C)c1cccc2ccccc12,5-acetamido-2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]benzamide,"InChI=1S/C22H22N2O2/c1-14-11-12-18(24-16(3)25)13-21(14)22(26)23-15(2)19-10-6-8-17-7-4-5-9-20(17)19/h4-13,15H,1-3H3,(H,23,26)(H,24,25)/t15-/m1/s1",KGPYBLOBHQLIET-OAHLLOKOSA-N,1,0,0,0,PLpro-SARS-CoV2 / ISG15,4.96,COVID-19,Inhibition,
2409,153835400,4741088,,CC(C)(C)CC[C@H](NC(=O)c1cc(Cl)cc(Cl)c1)C(O)=O,"(2S)-2-[(3,5-dichlorophenyl)formamido]-5,5-dimethylhexanoic acid","InChI=1S/C15H19Cl2NO3/c1-15(2,3)5-4-12(14(20)21)18-13(19)9-6-10(16)8-11(17)7-9/h6-8,12H,4-5H2,1-3H3,(H,18,19)(H,20,21)/t12-/m0/s1",GTMNLKRWZVHZAV-LBPRGKRZSA-N,1,1,0,0,Sortilin / Progranulin,6.77,"Huntington disease, Alzheimer disease, familial early-onset, with coexisting amyloid and prion pathology, parkinson disease 3, autosomal dominant, parkinson disease 12",Inhibition,
2410,162651172,4751566,,CC(C)(C)CC[C@H](NC(=O)c1cc(Cl)c[nH]1)C(O)=O,"(2S)-2-[(4-chloro-1H-pyrrol-2-yl)formamido]-5,5-dimethylhexanoic acid","InChI=1S/C13H19ClN2O3/c1-13(2,3)5-4-9(12(18)19)16-11(17)10-6-8(14)7-15-10/h6-7,9,15H,4-5H2,1-3H3,(H,16,17)(H,18,19)/t9-/m0/s1",YQXNFQSYQSGCSK-VIFPVBQESA-N,1,1,0,0,Sortilin / Progranulin,7.05,"Huntington disease, Alzheimer disease, familial early-onset, with coexisting amyloid and prion pathology, parkinson disease 3, autosomal dominant, parkinson disease 12",Inhibition,
2411,162653277,4752312,,CC(C)(C)CC[C@H](NC(=O)c1ccc(Oc2ccccc2)nc1)C(O)=O,"(2S)-5,5-dimethyl-2-[(6-phenoxypyridin-3-yl)formamido]hexanoic acid","InChI=1S/C20H24N2O4/c1-20(2,3)12-11-16(19(24)25)22-18(23)14-9-10-17(21-13-14)26-15-7-5-4-6-8-15/h4-10,13,16H,11-12H2,1-3H3,(H,22,23)(H,24,25)/t16-/m0/s1",OWESOSHRVQOBOS-INIZCTEOSA-N,1,1,0,0,Sortilin / Progranulin,7.70,"Huntington disease, Alzheimer disease, familial early-onset, with coexisting amyloid and prion pathology, parkinson disease 3, autosomal dominant, parkinson disease 12",Inhibition,
2412,2744515,4748685,,CC(C)(C)c1cc(C(O)=O)n(Cc2ccccc2)n1,1-benzyl-3-tert-butyl-1H-pyrazole-5-carboxylic acid,"InChI=1S/C15H18N2O2/c1-15(2,3)13-9-12(14(18)19)17(16-13)10-11-7-5-4-6-8-11/h4-9H,10H2,1-3H3,(H,18,19)",IJXYLILRNVOJNF-UHFFFAOYSA-N,1,0,0,0,Sortilin / Progranulin,5.70,"Huntington disease, Alzheimer disease, familial early-onset, with coexisting amyloid and prion pathology, parkinson disease 3, autosomal dominant, parkinson disease 12",Inhibition,
2413,153835401,4751985,,CC(C)(C)C[C@H](NC(=O)c1ccc(Oc2ccccc2)nc1)C(O)=O,"(2S)-4,4-dimethyl-2-[(6-phenoxypyridin-3-yl)formamido]pentanoic acid","InChI=1S/C19H22N2O4/c1-19(2,3)11-15(18(23)24)21-17(22)13-9-10-16(20-12-13)25-14-7-5-4-6-8-14/h4-10,12,15H,11H2,1-3H3,(H,21,22)(H,23,24)/t15-/m0/s1",DASSWHWKVPKLEB-HNNXBMFYSA-N,1,0,0,0,Sortilin / Progranulin,7.19,"Huntington disease, Alzheimer disease, familial early-onset, with coexisting amyloid and prion pathology, parkinson disease 3, autosomal dominant, parkinson disease 12",Inhibition,
2414,142449697,,,COC(=O)[C@@H]1CCCN(N1)C(=O)[C@H](Cc1cccc(O)c1)NC(=O)[C@@H](NC(C)=O)C(C)C,"methyl (3S)-1-[(2S)-2-[(2S)-2-acetamido-3-methylbutanamido]-3-(3-hydroxyphenyl)propanoyl]-1,2-diazinane-3-carboxylate","InChI=1S/C22H32N4O6/c1-13(2)19(23-14(3)27)20(29)24-18(12-15-7-5-8-16(28)11-15)21(30)26-10-6-9-17(25-26)22(31)32-4/h5,7-8,11,13,17-19,25,28H,6,9-10,12H2,1-4H3,(H,23,27)(H,24,29)/t17-,18-,19-/m0/s1",IUZKEOQGDGPKJY-FHWLQOOXSA-N,1,0,0,0,CYPA /,4.52,,Inhibition,
2415,146171284,,,CC(C)[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H]1Cc2cccc(OCCCCOC(=O)[C@@H]3CCCN(N3)C1=O)c2,"tert-butyl N-[(1S)-1-{[(3S,17S)-2,16-dioxo-10,15-dioxa-1,21-diazatricyclo[15.3.1.1^{5,9}]docosa-5(22),6,8-trien-3-yl]carbamoyl}-2-methylpropyl]carbamate","InChI=1S/C28H42N4O7/c1-18(2)23(30-27(36)39-28(3,4)5)24(33)29-22-17-19-10-8-11-20(16-19)37-14-6-7-15-38-26(35)21-12-9-13-32(31-21)25(22)34/h8,10-11,16,18,21-23,31H,6-7,9,12-15,17H2,1-5H3,(H,29,33)(H,30,36)/t21-,22-,23-/m0/s1",BZQRBTRFLXZFDJ-VABKMULXSA-N,1,0,0,0,CYPA /,5.00,,Inhibition,
2416,71225383,,,CC(C)[C@@H]1NC(=O)CCCCC=CC=CCCOC(=O)[C@@H]2CCCN(N2)C(=O)[C@H](Cc2cccc(O)c2)NC1=O,"(3S,6S,21S)-3-[(3-hydroxyphenyl)methyl]-6-(propan-2-yl)-19-oxa-1,4,7,25-tetraazabicyclo[19.3.1]pentacosa-13,15-diene-2,5,8,20-tetrone","InChI=1S/C30H42N4O6/c1-21(2)27-28(37)31-25(20-22-13-11-14-23(35)19-22)29(38)34-17-12-15-24(33-34)30(39)40-18-10-8-6-4-3-5-7-9-16-26(36)32-27/h3-4,6,8,11,13-14,19,21,24-25,27,33,35H,5,7,9-10,12,15-18,20H2,1-2H3,(H,31,37)(H,32,36)/t24-,25-,27-/m0/s1",ZXIFDXMZMTULOX-KLJDGLGGSA-N,1,0,0,0,CYPA /,5.59,,Inhibition,
2417,71225272,,,CO[C@H]1C=CC=CCCOC(=O)[C@@H]2CCCN(N2)C(=O)[C@H](Cc2cccc(O)c2)NC(=O)[C@@H](NC(=O)[C@H](C)[C@H](OC)[C@H]1C)C(C)C,"(3S,6S,9R,10R,11S,12S,21S)-3-[(3-hydroxyphenyl)methyl]-10,12-dimethoxy-9,11-dimethyl-6-(propan-2-yl)-19-oxa-1,4,7,25-tetraazabicyclo[19.3.1]pentacosa-13,15-diene-2,5,8,20-tetrone","InChI=1S/C34H50N4O8/c1-21(2)29-32(41)35-27(20-24-13-11-14-25(39)19-24)33(42)38-17-12-15-26(37-38)34(43)46-18-10-8-7-9-16-28(44-5)22(3)30(45-6)23(4)31(40)36-29/h7-9,11,13-14,16,19,21-23,26-30,37,39H,10,12,15,17-18,20H2,1-6H3,(H,35,41)(H,36,40)/t22-,23+,26-,27-,28-,29-,30+/m0/s1",NEMOPOKMUVPNPN-XUYKKRNYSA-N,1,0,0,0,CYPA /,7.60,,Inhibition,
2418,71225243,,,CO[C@@H]1CCC=Cc2cccc(c2)[C@@H](C)OC(=O)[C@@H]2CCCN(N2)C(=O)[C@H](Cc2cccc(O)c2)NC(=O)[C@@H](NC(=O)[C@@H]1C)C(C)C,"(2R,5S,11S,14S,17R,18R)-11-[(3-hydroxyphenyl)methyl]-18-methoxy-2,17-dimethyl-14-(propan-2-yl)-3-oxa-9,12,15,28-tetraazatricyclo[21.3.1.1^{5,9}]octacosa-1(27),21,23,25-tetraene-4,10,13,16-tetrone","InChI=1S/C36H48N4O7/c1-22(2)32-34(43)37-30(21-26-13-9-15-28(41)20-26)35(44)40-18-10-16-29(39-40)36(45)47-24(4)27-14-8-12-25(19-27)11-6-7-17-31(46-5)23(3)33(42)38-32/h6,8-9,11-15,19-20,22-24,29-32,39,41H,7,10,16-18,21H2,1-5H3,(H,37,43)(H,38,42)/t23-,24-,29+,30+,31-,32+/m1/s1",SDVRVWXKFPHKSR-UGAJPKFTSA-N,1,0,0,0,CYPA /,8.00,,Inhibition,
2419,,,,CO[C@@H]1CCC=Cc2cccc(c2)[C@@H](C)OC(=O)[C@@H]2CCCN(N2)C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]1C)C(C)C,"(2R,5S,11S,14S,17R,18R)-18-methoxy-2,11,17-trimethyl-14-(propan-2-yl)-3-oxa-9,12,15,28-tetraazatricyclo[21.3.1.1^{5,9}]octacosa-1(27),21,23,25-tetraene-4,10,13,16-tetrone","InChI=1S/C30H44N4O6/c1-18(2)26-28(36)31-20(4)29(37)34-16-10-14-24(33-34)30(38)40-21(5)23-13-9-12-22(17-23)11-7-8-15-25(39-6)19(3)27(35)32-26/h7,9,11-13,17-21,24-26,33H,8,10,14-16H2,1-6H3,(H,31,36)(H,32,35)/t19-,20+,21-,24+,25-,26+/m1/s1",BSBCQRNFTUWDHR-WXWOAPRPSA-N,1,0,0,0,CYPA /,7.70,,Inhibition,
2420,123855490,,,CC(C)[C@@H]1NC(=O)CC=Cc2cc3cc(ccc3cn2)[C@@H](C)OC(=O)[C@@H]2CCCN(N2)C(=O)[C@H](C)NC1=O,"(2R,5S,11S,14S)-2,11-dimethyl-14-(propan-2-yl)-3-oxa-9,12,15,21,29-pentaazatetracyclo[18.5.3.1^{5,9}.0^{23,27}]nonacosa-1(26),18,20(28),21,23(27),24-hexaene-4,10,13,16-tetrone","InChI=1S/C28H35N5O5/c1-16(2)25-26(35)30-17(3)27(36)33-12-6-8-23(32-33)28(37)38-18(4)19-10-11-20-15-29-22(14-21(20)13-19)7-5-9-24(34)31-25/h5,7,10-11,13-18,23,25,32H,6,8-9,12H2,1-4H3,(H,30,35)(H,31,34)/t17-,18+,23-,25-/m0/s1",MGYHGMOTCTUOQS-PJCFOSJUSA-N,1,0,0,0,CYPA /,8.00,,Inhibition,
2421,123851289,,,CC(C)[C@@H]1NC(=O)C(C)(C)C=Cc2ccc3ccc(nc3c2)[C@@H](C)OC(=O)[C@@H]2CCCN(N2)C(=O)[C@H](C)NC1=O,"(2R,5S,11S,14S)-2,11,17,17-tetramethyl-14-(propan-2-yl)-3-oxa-9,12,15,26,29-pentaazatetracyclo[18.5.3.1^{5,9}.0^{23,27}]nonacosa-1(26),18,20(28),21,23(27),24-hexaene-4,10,13,16-tetrone","InChI=1S/C30H39N5O5/c1-17(2)25-26(36)31-18(3)27(37)35-15-7-8-23(34-35)28(38)40-19(4)22-12-11-21-10-9-20(16-24(21)32-22)13-14-30(5,6)29(39)33-25/h9-14,16-19,23,25,34H,7-8,15H2,1-6H3,(H,31,36)(H,33,39)/t18-,19+,23-,25-/m0/s1",XCZDYKRNHKYRTQ-IMVQFDEQSA-N,1,0,0,0,CYPA /,8.40,,Inhibition,
2422,123442632,,,CC(C)[C@@H]1OC(=O)C(C)(C)C=Cc2ccc3ccc(nc3c2)[C@@H](C)NC(=O)[C@@H]2CCCN(N2)C(=O)[C@H](C)NC1=O,"(2R,5S,11S,14S)-2,11,17,17-tetramethyl-14-(propan-2-yl)-15-oxa-3,9,12,26,29-pentaazatetracyclo[18.5.3.1^{5,9}.0^{23,27}]nonacosa-1(26),18,20(28),21,23(27),24-hexaene-4,10,13,16-tetrone","InChI=1S/C30H39N5O5/c1-17(2)25-27(37)32-19(4)28(38)35-15-7-8-23(34-35)26(36)31-18(3)22-12-11-21-10-9-20(16-24(21)33-22)13-14-30(5,6)29(39)40-25/h9-14,16-19,23,25,34H,7-8,15H2,1-6H3,(H,31,36)(H,32,37)/t18-,19+,23+,25+/m1/s1",YVBYTKCYPFMUBG-ICSRYVJKSA-N,1,0,0,0,CYPA /,7.85,,Inhibition,
2423,123717232,,,C[C@H]1NC(=O)[C@@H]2CCCN(N2)C(=O)[C@H](C)NC(=O)[C@@H](OC(=O)C(C)(C)C=Cc2ccc3ccc1nc3c2)C1CCC1,"(2R,5S,11S,14S)-14-cyclobutyl-2,11,17,17-tetramethyl-15-oxa-3,9,12,26,29-pentaazatetracyclo[18.5.3.1^{5,9}.0^{23,27}]nonacosa-1(26),18,20(28),21,23(27),24-hexaene-4,10,13,16-tetrone","InChI=1S/C31H39N5O5/c1-18-23-13-12-21-11-10-20(17-25(21)34-23)14-15-31(3,4)30(40)41-26(22-7-5-8-22)28(38)33-19(2)29(39)36-16-6-9-24(35-36)27(37)32-18/h10-15,17-19,22,24,26,35H,5-9,16H2,1-4H3,(H,32,37)(H,33,38)/t18-,19+,24+,26+/m1/s1",KKULOCXHXDLVMI-SLDDBXMOSA-N,1,0,0,0,CYPA /,8.05,,Inhibition,
2424,156016407,4641424,,Nc1cc(ccn1)-c1cc(Cl)cc2CC(Oc12)C(=O)N1CCNCC1,"4-[5-chloro-2-(piperazine-1-carbonyl)-2,3-dihydro-1-benzofuran-7-yl]pyridin-2-amine","InChI=1S/C18H19ClN4O2/c19-13-7-12-8-15(18(24)23-5-3-21-4-6-23)25-17(12)14(10-13)11-1-2-22-16(20)9-11/h1-2,7,9-10,15,21H,3-6,8H2,(H2,20,22)",JGHCITCCEQEXTL-UHFFFAOYSA-N,1,0,0,0,USP7 / Ubiquitin,5.25,cancer,Inhibition,
2425,156016018,4641014,,Clc1cc2CC(Oc2c(c1)-c1ccnc2[nH]ccc12)C(=O)N1CCNCC1,"1-(5-chloro-7-{1H-pyrrolo[2,3-b]pyridin-4-yl}-2,3-dihydro-1-benzofuran-2-carbonyl)piperazine","InChI=1S/C20H19ClN4O2/c21-13-9-12-10-17(20(26)25-7-5-22-6-8-25)27-18(12)16(11-13)14-1-3-23-19-15(14)2-4-24-19/h1-4,9,11,17,22H,5-8,10H2,(H,23,24)",HOYXFXCLPCBVPO-UHFFFAOYSA-N,1,0,0,0,USP7 / Ubiquitin,6.03,cancer,Inhibition,
2426,156015131,4641037,,Clc1cc2C[C@@H](Oc2c(c1)-c1ccnc2[nH]ccc12)C(=O)N1CCNCC1,"1-[(2R)-5-chloro-7-{1H-pyrrolo[2,3-b]pyridin-4-yl}-2,3-dihydro-1-benzofuran-2-carbonyl]piperazine","InChI=1S/C20H19ClN4O2/c21-13-9-12-10-17(20(26)25-7-5-22-6-8-25)27-18(12)16(11-13)14-1-3-23-19-15(14)2-4-24-19/h1-4,9,11,17,22H,5-8,10H2,(H,23,24)/t17-/m1/s1",HOYXFXCLPCBVPO-QGZVFWFLSA-N,1,0,0,0,USP7 / Ubiquitin,6.35,cancer,Inhibition,
2427,156013784,4636266,,Clc1cc2C[C@@H](Oc2c(c1)-c1ccnc2ccsc12)C(=O)N1CCNCC1,"1-[(2R)-5-chloro-7-{thieno[3,2-b]pyridin-7-yl}-2,3-dihydro-1-benzofuran-2-carbonyl]piperazine","InChI=1S/C20H18ClN3O2S/c21-13-9-12-10-17(20(25)24-6-4-22-5-7-24)26-18(12)15(11-13)14-1-3-23-16-2-8-27-19(14)16/h1-3,8-9,11,17,22H,4-7,10H2/t17-/m1/s1",SSIWAASKJNDWDE-QGZVFWFLSA-N,1,0,0,0,USP7 / Ubiquitin,7.05,cancer,Inhibition,
2428,156018892,4643218,,Cc1cc2nccc(-c3cc(Cl)cc4C[C@@H](Oc34)C(=O)N3CCNCC3)c2s1,"1-[(2R)-5-chloro-7-{2-methylthieno[3,2-b]pyridin-7-yl}-2,3-dihydro-1-benzofuran-2-carbonyl]piperazine","InChI=1S/C21H20ClN3O2S/c1-12-8-17-20(28-12)15(2-3-24-17)16-11-14(22)9-13-10-18(27-19(13)16)21(26)25-6-4-23-5-7-25/h2-3,8-9,11,18,23H,4-7,10H2,1H3/t18-/m1/s1",KJLOQQLOFNVZKL-GOSISDBHSA-N,1,0,0,0,USP7 / Ubiquitin,6.89,cancer,Inhibition,
2429,156018905,4643800,,OCc1cc2nccc(-c3cc(Cl)cc4C[C@@H](Oc34)C(=O)N3CCNCC3)c2s1,"{7-[(2R)-5-chloro-2-(piperazine-1-carbonyl)-2,3-dihydro-1-benzofuran-7-yl]thieno[3,2-b]pyridin-2-yl}methanol","InChI=1S/C21H20ClN3O3S/c22-13-7-12-8-18(21(27)25-5-3-23-4-6-25)28-19(12)16(9-13)15-1-2-24-17-10-14(11-26)29-20(15)17/h1-2,7,9-10,18,23,26H,3-6,8,11H2/t18-/m1/s1",YCGQVRKPSRARFT-GOSISDBHSA-N,1,0,0,0,USP7 / Ubiquitin,7.37,cancer,Inhibition,
2430,156019926,4645724,,OC1(COC1)c1cc2nccc(-c3cc(Cl)cc4C[C@@H](Oc34)C(=O)N3CCNCC3)c2s1,"3-{7-[(2R)-5-chloro-2-(piperazine-1-carbonyl)-2,3-dihydro-1-benzofuran-7-yl]thieno[3,2-b]pyridin-2-yl}oxetan-3-ol","InChI=1S/C23H22ClN3O4S/c24-14-7-13-8-18(22(28)27-5-3-25-4-6-27)31-20(13)16(9-14)15-1-2-26-17-10-19(32-21(15)17)23(29)11-30-12-23/h1-2,7,9-10,18,25,29H,3-6,8,11-12H2/t18-/m1/s1",DGJJTXHQKRHFGA-GOSISDBHSA-N,1,0,0,0,USP7 / Ubiquitin,7.14,cancer,Inhibition,
2431,156021670,4646914,,OCC(O)(CCl)c1cc2nccc(-c3cc(Cl)cc4C[C@@H](Oc34)C(=O)N3CCNCC3)c2s1,"3-chloro-2-{7-[(2R)-5-chloro-2-(piperazine-1-carbonyl)-2,3-dihydro-1-benzofuran-7-yl]thieno[3,2-b]pyridin-2-yl}propane-1,2-diol","InChI=1S/C23H23Cl2N3O4S/c24-11-23(31,12-29)19-10-17-21(33-19)15(1-2-27-17)16-9-14(25)7-13-8-18(32-20(13)16)22(30)28-5-3-26-4-6-28/h1-2,7,9-10,18,26,29,31H,3-6,8,11-12H2/t18-,23?/m1/s1",QPYNPPDGRISUAE-FKSKYRLFSA-N,1,0,0,0,USP7 / Ubiquitin,8.05,cancer,Inhibition,
2432,156009874,4633562,,Clc1cc2C[C@@H](Oc2c(c1)-c1ccnc2cc(Cn3cnccc3=O)sc12)C(=O)N1CCNCC1,"3-({7-[(2R)-5-chloro-2-(piperazine-1-carbonyl)-2,3-dihydro-1-benzofuran-7-yl]thieno[3,2-b]pyridin-2-yl}methyl)-3,4-dihydropyrimidin-4-one","InChI=1S/C25H22ClN5O3S/c26-16-9-15-10-21(25(33)30-7-5-27-6-8-30)34-23(15)19(11-16)18-1-4-29-20-12-17(35-24(18)20)13-31-14-28-3-2-22(31)32/h1-4,9,11-12,14,21,27H,5-8,10,13H2/t21-/m1/s1",SFXAEXHJQAFFCR-OAQYLSRUSA-N,1,0,0,0,USP7 / Ubiquitin,7.57,cancer,Inhibition,
2433,156017346,4641488,,CC(=O)NCc1cc2nccc(-c3cc(Cl)cc4C[C@@H](Oc34)C(=O)N3CCNCC3)c2s1,"N-({7-[(2R)-5-chloro-2-(piperazine-1-carbonyl)-2,3-dihydro-1-benzofuran-7-yl]thieno[3,2-b]pyridin-2-yl}methyl)acetamide","InChI=1S/C23H23ClN4O3S/c1-13(29)27-12-16-11-19-22(32-16)17(2-3-26-19)18-10-15(24)8-14-9-20(31-21(14)18)23(30)28-6-4-25-5-7-28/h2-3,8,10-11,20,25H,4-7,9,12H2,1H3,(H,27,29)/t20-/m1/s1",DSUSTNYBVVVKEK-HXUWFJFHSA-N,1,0,0,0,USP7 / Ubiquitin,7.60,cancer,Inhibition,
2434,156017229,4642553,,Clc1cc2C[C@@H](Oc2c(c1)-c1ccnc2cc(CN3CCCC3=O)sc12)C(=O)N1CCNCC1,"1-({7-[(2R)-5-chloro-2-(piperazine-1-carbonyl)-2,3-dihydro-1-benzofuran-7-yl]thieno[3,2-b]pyridin-2-yl}methyl)pyrrolidin-2-one","InChI=1S/C25H25ClN4O3S/c26-16-10-15-11-21(25(32)29-8-5-27-6-9-29)33-23(15)19(12-16)18-3-4-28-20-13-17(34-24(18)20)14-30-7-1-2-22(30)31/h3-4,10,12-13,21,27H,1-2,5-9,11,14H2/t21-/m1/s1",NAFSZOAFHRPSHA-OAQYLSRUSA-N,1,0,0,0,USP7 / Ubiquitin,7.59,cancer,Inhibition,
2435,146672986,4640002,,Clc1cc2C[C@@H](Oc2c(c1)-c1ccnc2cc(CN3C(=O)CCC3=O)sc12)C(=O)N1CCNCC1,"1-({7-[(2R)-5-chloro-2-(piperazine-1-carbonyl)-2,3-dihydro-1-benzofuran-7-yl]thieno[3,2-b]pyridin-2-yl}methyl)pyrrolidine-2,5-dione","InChI=1S/C25H23ClN4O4S/c26-15-9-14-10-20(25(33)29-7-5-27-6-8-29)34-23(14)18(11-15)17-3-4-28-19-12-16(35-24(17)19)13-30-21(31)1-2-22(30)32/h3-4,9,11-12,20,27H,1-2,5-8,10,13H2/t20-/m1/s1",HDYYKIHPDVFOOZ-HXUWFJFHSA-N,1,0,0,0,USP7 / Ubiquitin,9.74,cancer,Inhibition,
2436,156016803,4642308,,Clc1cc2C[C@@H](Oc2c(c1)-c1ccnc2cc(CN3C(=O)CCC3=O)sc12)c1ocnc1CN1CCC1,"1-({7-[(2R)-2-{4-[(azetidin-1-yl)methyl]-1,3-oxazol-5-yl}-5-chloro-2,3-dihydro-1-benzofuran-7-yl]thieno[3,2-b]pyridin-2-yl}methyl)pyrrolidine-2,5-dione","InChI=1S/C27H23ClN4O4S/c28-16-8-15-9-22(26-21(30-14-35-26)13-31-6-1-7-31)36-25(15)19(10-16)18-4-5-29-20-11-17(37-27(18)20)12-32-23(33)2-3-24(32)34/h4-5,8,10-11,14,22H,1-3,6-7,9,12-13H2/t22-/m1/s1",ZUAACQXOFSMOEP-JOCHJYFZSA-N,1,0,0,0,USP7 / Ubiquitin,7.89,cancer,Inhibition,
2437,156018073,4643330,,Clc1cc2C[C@@H](Oc2c(c1)-c1ccnc2cc(CN3C(=O)CCC3=O)sc12)c1onc2CCNCc12,"1-({7-[(2R)-5-chloro-2-{4H,5H,6H,7H-[1,2]oxazolo[4,3-c]pyridin-3-yl}-2,3-dihydro-1-benzofuran-7-yl]thieno[3,2-b]pyridin-2-yl}methyl)pyrrolidine-2,5-dione","InChI=1S/C26H21ClN4O4S/c27-14-7-13-8-21(25-18-11-28-5-4-19(18)30-35-25)34-24(13)17(9-14)16-3-6-29-20-10-15(36-26(16)20)12-31-22(32)1-2-23(31)33/h3,6-7,9-10,21,28H,1-2,4-5,8,11-12H2/t21-/m1/s1",BNCPGZNISCICGU-OAQYLSRUSA-N,1,0,0,0,USP7 / Ubiquitin,9.42,cancer,Inhibition,
2438,156020731,4648116,,Cn1nc2CCNCc2c1[C@H]1Cc2cc(Cl)cc(c2O1)-c1ccnc2cc(CN3C(=O)CCC3=O)sc12,"1-({7-[(2R)-5-chloro-2-{2-methyl-2H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-3-yl}-2,3-dihydro-1-benzofuran-7-yl]thieno[3,2-b]pyridin-2-yl}methyl)pyrrolidine-2,5-dione","InChI=1S/C27H24ClN5O3S/c1-32-25(19-12-29-6-5-20(19)31-32)22-9-14-8-15(28)10-18(26(14)36-22)17-4-7-30-21-11-16(37-27(17)21)13-33-23(34)2-3-24(33)35/h4,7-8,10-11,22,29H,2-3,5-6,9,12-13H2,1H3/t22-/m1/s1",PPORELYPKPTZHG-JOCHJYFZSA-N,1,0,0,0,USP7 / Ubiquitin,8.96,cancer,Inhibition,
2439,138610279,4647687,,F[C@H]1CNC[C@H]1Oc1ccc(Cl)cc1-c1ccnc2cc(CN3C(=O)CCC3=O)sc12,"1-{[7-(5-chloro-2-{[(3R,4S)-4-fluoropyrrolidin-3-yl]oxy}phenyl)thieno[3,2-b]pyridin-2-yl]methyl}pyrrolidine-2,5-dione","InChI=1S/C22H19ClFN3O3S/c23-12-1-2-18(30-19-10-25-9-16(19)24)15(7-12)14-5-6-26-17-8-13(31-22(14)17)11-27-20(28)3-4-21(27)29/h1-2,5-8,16,19,25H,3-4,9-11H2/t16-,19+/m0/s1",JJPFTAGLDCWDFZ-QFBILLFUSA-N,1,0,0,0,USP7 / Ubiquitin,6.68,cancer,Inhibition,
2440,138610287,4641569,,Cc1cc(Cl)cc(c1O[C@@H]1CNC[C@@H]1F)-c1ccnc2cc(CN3C(=O)CCC3=O)sc12,"1-{[7-(5-chloro-2-{[(3R,4S)-4-fluoropyrrolidin-3-yl]oxy}-3-methylphenyl)thieno[3,2-b]pyridin-2-yl]methyl}pyrrolidine-2,5-dione","InChI=1S/C23H21ClFN3O3S/c1-12-6-13(24)7-16(22(12)31-19-10-26-9-17(19)25)15-4-5-27-18-8-14(32-23(15)18)11-28-20(29)2-3-21(28)30/h4-8,17,19,26H,2-3,9-11H2,1H3/t17-,19+/m0/s1",SWLBIOVQZDSJKD-PKOBYXMFSA-N,1,1,0,0,USP7 / Ubiquitin,8.92,cancer,Inhibition,
2441,138610177,4635798,,Cc1cc(Cl)cc(c1O[C@H]1CCCNC1)-c1ccnc2cc(CN3C(=O)CCC3=O)sc12,"1-[(7-{5-chloro-3-methyl-2-[(3S)-piperidin-3-yloxy]phenyl}thieno[3,2-b]pyridin-2-yl)methyl]pyrrolidine-2,5-dione","InChI=1S/C24H24ClN3O3S/c1-14-9-15(25)10-19(23(14)31-16-3-2-7-26-12-16)18-6-8-27-20-11-17(32-24(18)20)13-28-21(29)4-5-22(28)30/h6,8-11,16,26H,2-5,7,12-13H2,1H3/t16-/m0/s1",PYEXJMBGOSOZHC-INIZCTEOSA-N,1,1,0,0,USP7 / Ubiquitin,8.34,cancer,Inhibition,
2442,138609780,4632475,,Cc1cc(Cl)cc(c1OC1CCNCC1)-c1ccnc2cc(CN3C(=O)CCC3=O)sc12,"1-({7-[5-chloro-3-methyl-2-(piperidin-4-yloxy)phenyl]thieno[3,2-b]pyridin-2-yl}methyl)pyrrolidine-2,5-dione","InChI=1S/C24H24ClN3O3S/c1-14-10-15(25)11-19(23(14)31-16-4-7-26-8-5-16)18-6-9-27-20-12-17(32-24(18)20)13-28-21(29)2-3-22(28)30/h6,9-12,16,26H,2-5,7-8,13H2,1H3",AQRAUIQQBINJNH-UHFFFAOYSA-N,1,1,0,0,USP7 / Ubiquitin,8.10,cancer,Inhibition,
2443,138610564,4633860,,Cc1cc(Cl)cc(c1OCC1(F)CNC1)-c1ccnc2cc(CN3C(=O)CCC3=O)sc12,"1-[(7-{5-chloro-2-[(3-fluoroazetidin-3-yl)methoxy]-3-methylphenyl}thieno[3,2-b]pyridin-2-yl)methyl]pyrrolidine-2,5-dione","InChI=1S/C23H21ClFN3O3S/c1-13-6-14(24)7-17(21(13)31-12-23(25)10-26-11-23)16-4-5-27-18-8-15(32-22(16)18)9-28-19(29)2-3-20(28)30/h4-8,26H,2-3,9-12H2,1H3",LBPLUUDMTWXBMU-UHFFFAOYSA-N,1,1,0,0,USP7 / Ubiquitin,8.82,cancer,Inhibition,
2444,,,,N[C@H]1C[C@@H](C1)Oc1ccc(Cl)cc1-c1ccnc2cc(CN3C(=O)CCC3=O)sc12,"1-[(7-{5-chloro-2-[(1r,3r)-3-aminocyclobutoxy]phenyl}thieno[3,2-b]pyridin-2-yl)methyl]pyrrolidine-2,5-dione","InChI=1S/C22H20ClN3O3S/c23-12-1-2-19(29-14-8-13(24)9-14)17(7-12)16-5-6-25-18-10-15(30-22(16)18)11-26-20(27)3-4-21(26)28/h1-2,5-7,10,13-14H,3-4,8-9,11,24H2/t13-,14-",XZSBOJKUOQCRSY-HDJSIYSDSA-N,1,1,0,0,USP7 / Ubiquitin,8.47,cancer,Inhibition,
2445,138609916,4644317,,C[C@H]1CNCC[C@H]1Oc1c(C)cc(Cl)cc1-c1ccnc2cc(CN3C(=O)CCC3=O)sc12,"1-{[7-(5-chloro-3-methyl-2-{[(3S,4R)-3-methylpiperidin-4-yl]oxy}phenyl)thieno[3,2-b]pyridin-2-yl]methyl}pyrrolidine-2,5-dione","InChI=1S/C25H26ClN3O3S/c1-14-9-16(26)10-19(24(14)32-21-6-7-27-12-15(21)2)18-5-8-28-20-11-17(33-25(18)20)13-29-22(30)3-4-23(29)31/h5,8-11,15,21,27H,3-4,6-7,12-13H2,1-2H3/t15-,21+/m0/s1",TZRCZTLMNKIMSY-YCRPNKLZSA-N,1,1,0,0,USP7 / Ubiquitin,8.68,cancer,Inhibition,
2446,138610344,4638573,,C[C@H]1CNCC[C@H]1Oc1c(C)cc(Cl)cc1-c1ccnc2cc(CN3C(=O)C4CC4C3=O)sc12,"3-{[7-(5-chloro-3-methyl-2-{[(3S,4R)-3-methylpiperidin-4-yl]oxy}phenyl)thieno[3,2-b]pyridin-2-yl]methyl}-3-azabicyclo[3.1.0]hexane-2,4-dione","InChI=1S/C26H26ClN3O3S/c1-13-7-15(27)8-18(23(13)33-22-4-5-28-11-14(22)2)17-3-6-29-21-9-16(34-24(17)21)12-30-25(31)19-10-20(19)26(30)32/h3,6-9,14,19-20,22,28H,4-5,10-12H2,1-2H3/t14-,19?,20?,22+/m0/s1",TWVAGLKFJBPJEZ-VPMRZTOHSA-N,1,1,0,0,USP7 / Ubiquitin,8.96,cancer,Inhibition,
2447,138609936,4635160,,C[C@H]1CNCC[C@H]1Oc1c(C)cc(Cl)cc1-c1ccnc2cc(CN3C(=O)C4C(C3=O)C4(C)C)sc12,"3-{[7-(5-chloro-3-methyl-2-{[(3S,4R)-3-methylpiperidin-4-yl]oxy}phenyl)thieno[3,2-b]pyridin-2-yl]methyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2,4-dione","InChI=1S/C28H30ClN3O3S/c1-14-9-16(29)10-19(24(14)35-21-6-7-30-12-15(21)2)18-5-8-31-20-11-17(36-25(18)20)13-32-26(33)22-23(27(32)34)28(22,3)4/h5,8-11,15,21-23,30H,6-7,12-13H2,1-4H3/t15-,21+,22?,23?/m0/s1",LSPPODQSTNTKTE-AAORLSLPSA-N,1,1,0,0,USP7 / Ubiquitin,9.74,cancer,Inhibition,
2448,138610213,4649132,,C[C@H]1CNCC[C@H]1Oc1c(C)cc(Cl)cc1-c1ccnc2cc(Cn3c(=O)ccn(CC(F)(F)F)c3=O)sc12,"3-{[7-(5-chloro-3-methyl-2-{[(3S,4R)-3-methylpiperidin-4-yl]oxy}phenyl)thieno[3,2-b]pyridin-2-yl]methyl}-1-(2,2,2-trifluoroethyl)-1,2,3,4-tetrahydropyrimidine-2,4-dione","InChI=1S/C27H26ClF3N4O3S/c1-15-9-17(28)10-20(24(15)38-22-4-6-32-12-16(22)2)19-3-7-33-21-11-18(39-25(19)21)13-35-23(36)5-8-34(26(35)37)14-27(29,30)31/h3,5,7-11,16,22,32H,4,6,12-14H2,1-2H3/t16-,22+/m0/s1",AAWWECJHPHXAGX-KSFYIVLOSA-N,1,1,0,0,USP7 / Ubiquitin,9.59,cancer,Inhibition,
2449,156016684,4642862,,Cc1cc(Cl)cc(c1OC1CCCNC1)-c1ccnc2cc(CN3C(=O)C4C(C3=O)C4(C)C)sc12,"3-({7-[5-chloro-3-methyl-2-(piperidin-3-yloxy)phenyl]thieno[3,2-b]pyridin-2-yl}methyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2,4-dione","InChI=1S/C27H28ClN3O3S/c1-14-9-15(28)10-19(23(14)34-16-5-4-7-29-12-16)18-6-8-30-20-11-17(35-24(18)20)13-31-25(32)21-22(26(31)33)27(21,2)3/h6,8-11,16,21-22,29H,4-5,7,12-13H2,1-3H3",MHUASFFQYUOBDL-UHFFFAOYSA-N,1,1,0,0,USP7 / Ubiquitin,8.62,cancer,Inhibition,
2450,156013528,4638998,,Cc1cc(Cl)cc(c1NC1CCCNC1)-c1ccnc2cc(CN3C(=O)C4C(C3=O)C4(C)C)sc12,"3-[(7-{5-chloro-3-methyl-2-[(piperidin-3-yl)amino]phenyl}thieno[3,2-b]pyridin-2-yl)methyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2,4-dione","InChI=1S/C27H29ClN4O2S/c1-14-9-15(28)10-19(23(14)31-16-5-4-7-29-12-16)18-6-8-30-20-11-17(35-24(18)20)13-32-25(33)21-22(26(32)34)27(21,2)3/h6,8-11,16,21-22,29,31H,4-5,7,12-13H2,1-3H3",UEAPPVUIFDAOQU-UHFFFAOYSA-N,1,1,0,0,USP7 / Ubiquitin,9.11,cancer,Inhibition,
2451,156018246,4643112,,Cc1cc(Cl)cc(c1CC1CCCNC1)-c1ccnc2cc(CN3C(=O)C4C(C3=O)C4(C)C)sc12,"3-[(7-{5-chloro-3-methyl-2-[(piperidin-3-yl)methyl]phenyl}thieno[3,2-b]pyridin-2-yl)methyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2,4-dione","InChI=1S/C28H30ClN3O2S/c1-15-9-17(29)11-21(20(15)10-16-5-4-7-30-13-16)19-6-8-31-22-12-18(35-25(19)22)14-32-26(33)23-24(27(32)34)28(23,2)3/h6,8-9,11-12,16,23-24,30H,4-5,7,10,13-14H2,1-3H3",XXQHINVMIVHNET-UHFFFAOYSA-N,1,1,0,0,USP7 / Ubiquitin,8.89,cancer,Inhibition,
2452,146445185,4638960,,Cc1cc(Cl)cc(c1CN1CCNCC1)-c1ccnc2cc(CN3C(=O)CCC3=O)sc12,"1-[(7-{5-chloro-3-methyl-2-[(piperazin-1-yl)methyl]phenyl}thieno[3,2-b]pyridin-2-yl)methyl]pyrrolidine-2,5-dione","InChI=1S/C24H25ClN4O2S/c1-15-10-16(25)11-19(20(15)14-28-8-6-26-7-9-28)18-4-5-27-21-12-17(32-24(18)21)13-29-22(30)2-3-23(29)31/h4-5,10-12,26H,2-3,6-9,13-14H2,1H3",MJVNKLYUWIPXLC-UHFFFAOYSA-N,1,1,0,0,USP7 / Ubiquitin,7.49,cancer,Inhibition,
2453,146445073,4638688,,C[C@H]1CNCCN1Cc1c(C)cc(Cl)cc1-c1ccnc2cc(CN3C(=O)CCC3=O)sc12,"1-{[7-(5-chloro-3-methyl-2-{[(2S)-2-methylpiperazin-1-yl]methyl}phenyl)thieno[3,2-b]pyridin-2-yl]methyl}pyrrolidine-2,5-dione","InChI=1S/C25H27ClN4O2S/c1-15-9-17(26)10-20(21(15)14-29-8-7-27-12-16(29)2)19-5-6-28-22-11-18(33-25(19)22)13-30-23(31)3-4-24(30)32/h5-6,9-11,16,27H,3-4,7-8,12-14H2,1-2H3/t16-/m0/s1",LHLPOHUMAFQMLG-INIZCTEOSA-N,1,1,0,0,USP7 / Ubiquitin,8.18,cancer,Inhibition,
2454,146445360,4638458,,C[C@H]1CNC[C@H](C)N1Cc1c(C)cc(Cl)cc1-c1ccnc2cc(CN3C(=O)CCC3=O)sc12,"1-{[7-(5-chloro-2-{[(2S,6S)-2,6-dimethylpiperazin-1-yl]methyl}-3-methylphenyl)thieno[3,2-b]pyridin-2-yl]methyl}pyrrolidine-2,5-dione","InChI=1S/C26H29ClN4O2S/c1-15-8-18(27)9-21(22(15)14-30-16(2)11-28-12-17(30)3)20-6-7-29-23-10-19(34-26(20)23)13-31-24(32)4-5-25(31)33/h6-10,16-17,28H,4-5,11-14H2,1-3H3/t16-,17-/m0/s1",ZPKJNNBGFQUARW-IRXDYDNUSA-N,1,1,0,0,USP7 / Ubiquitin,9.49,cancer,Inhibition,
2455,146445219,4634092,,Cc1cc(Cl)cc(c1C[C@@H]1CNCCO1)-c1ccnc2cc(CN3C(=O)C4CC4C3=O)sc12,"3-{[7-(5-chloro-3-methyl-2-{[(2R)-morpholin-2-yl]methyl}phenyl)thieno[3,2-b]pyridin-2-yl]methyl}-3-azabicyclo[3.1.0]hexane-2,4-dione","InChI=1S/C25H24ClN3O3S/c1-13-6-14(26)7-19(18(13)8-15-11-27-4-5-32-15)17-2-3-28-22-9-16(33-23(17)22)12-29-24(30)20-10-21(20)25(29)31/h2-3,6-7,9,15,20-21,27H,4-5,8,10-12H2,1H3/t15-,20?,21?/m1/s1",VUGIWFWUHWWOHW-TVRCVXMWSA-N,1,1,0,0,USP7 / Ubiquitin,9.80,cancer,Inhibition,
2456,146445064,4648623,,C[C@H]1NCCO[C@@H]1Cc1c(C)cc(Cl)cc1-c1ccnc2cc(CN3C(=O)C4CC4C3=O)sc12,"3-{[7-(5-chloro-3-methyl-2-{[(2R,3R)-3-methylmorpholin-2-yl]methyl}phenyl)thieno[3,2-b]pyridin-2-yl]methyl}-3-azabicyclo[3.1.0]hexane-2,4-dione","InChI=1S/C26H26ClN3O3S/c1-13-7-15(27)8-19(18(13)11-23-14(2)28-5-6-33-23)17-3-4-29-22-9-16(34-24(17)22)12-30-25(31)20-10-21(20)26(30)32/h3-4,7-9,14,20-21,23,28H,5-6,10-12H2,1-2H3/t14-,20?,21?,23-/m1/s1",QANIPMSZUGTHAV-IHDNSLFNSA-N,1,1,0,0,USP7 / Ubiquitin,8.82,cancer,Inhibition,
2457,146445370,4640729,,C[C@@H]1CNC[C@@H](Cc2c(C)cc(Cl)cc2-c2ccnc3cc(CN4C(=O)C5CC5C4=O)sc23)O1,"3-{[7-(5-chloro-3-methyl-2-{[(2R,6R)-6-methylmorpholin-2-yl]methyl}phenyl)thieno[3,2-b]pyridin-2-yl]methyl}-3-azabicyclo[3.1.0]hexane-2,4-dione","InChI=1S/C26H26ClN3O3S/c1-13-5-15(27)6-20(19(13)7-16-11-28-10-14(2)33-16)18-3-4-29-23-8-17(34-24(18)23)12-30-25(31)21-9-22(21)26(30)32/h3-6,8,14,16,21-22,28H,7,9-12H2,1-2H3/t14-,16-,21?,22?/m1/s1",JLPZIAGJKHDMOQ-SYJVCXSYSA-N,1,1,0,0,USP7 / Ubiquitin,9.41,cancer,Inhibition,
2458,146445055,4647217,,Cc1cc(Cl)cc(c1C[C@@H]1CNCCO1)-c1ccnc2cc(CN3C(=O)C4C(C3=O)C4(C)C)sc12,"3-{[7-(5-chloro-3-methyl-2-{[(2R)-morpholin-2-yl]methyl}phenyl)thieno[3,2-b]pyridin-2-yl]methyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2,4-dione","InChI=1S/C27H28ClN3O3S/c1-14-8-15(28)9-20(19(14)10-16-12-29-6-7-34-16)18-4-5-30-21-11-17(35-24(18)21)13-31-25(32)22-23(26(31)33)27(22,2)3/h4-5,8-9,11,16,22-23,29H,6-7,10,12-13H2,1-3H3/t16-,22?,23?/m1/s1",DUAGQCVAGBJSHT-ZUTUBDCJSA-N,1,1,1,0,USP7 / Ubiquitin,9.36,cancer,Inhibition,
2459,139570937,4649151,,COc1ccc(cc1)S(=O)(=O)N(CC(O)=O)c1ccc(CCC(O)=O)c2ccccc12,3-{4-[N-(carboxymethyl)4-methoxybenzenesulfonamido]naphthalen-1-yl}propanoic acid,"InChI=1S/C22H21NO7S/c1-30-16-8-10-17(11-9-16)31(28,29)23(14-22(26)27)20-12-6-15(7-13-21(24)25)18-4-2-3-5-19(18)20/h2-6,8-12H,7,13-14H2,1H3,(H,24,25)(H,26,27)",PYWHLXAIQCJQKR-UHFFFAOYSA-N,1,0,0,0,Keap1 / Nrf2,5.03,"chronic obstructive pulmonary disease, multiple sclerosis, chronic kidney disease",Inhibition,
2460,,,,COc1ccc(cc1)S(=O)(=O)N(CC(O)=O)c1ccc(C=CC(O)=O)c2ccccc12,3-{4-[N-(carboxymethyl)4-methoxybenzenesulfonamido]naphthalen-1-yl}prop-2-enoic acid,"InChI=1S/C22H19NO7S/c1-30-16-8-10-17(11-9-16)31(28,29)23(14-22(26)27)20-12-6-15(7-13-21(24)25)18-4-2-3-5-19(18)20/h2-13H,14H2,1H3,(H,24,25)(H,26,27)",ILNONRRNTOXPKM-UHFFFAOYSA-N,1,0,0,0,Keap1 / Nrf2,4.89,"chronic obstructive pulmonary disease, multiple sclerosis, chronic kidney disease",Inhibition,
2461,139561295,4635294,,COc1ccc(CCc2ccc(N(CC(O)=O)S(=O)(=O)c3ccc(OC)cc3)c3ccccc23)cc1,2-(N-{4-[2-(4-methoxyphenyl)ethyl]naphthalen-1-yl}4-methoxybenzenesulfonamido)acetic acid,"InChI=1S/C28H27NO6S/c1-34-22-12-8-20(9-13-22)7-10-21-11-18-27(26-6-4-3-5-25(21)26)29(19-28(30)31)36(32,33)24-16-14-23(35-2)15-17-24/h3-6,8-9,11-18H,7,10,19H2,1-2H3,(H,30,31)",HJRHEYQUTCNSLR-UHFFFAOYSA-N,1,0,0,0,Keap1 / Nrf2,5.82,"chronic obstructive pulmonary disease, multiple sclerosis, chronic kidney disease",Inhibition,
2462,139559795,4634673,,COc1ccc(cc1)S(=O)(=O)Cc1ccc(N(CC(O)=O)S(=O)(=O)c2ccc(OC)cc2)c2ccccc12,2-(N-{4-[(4-methoxybenzenesulfonyl)methyl]naphthalen-1-yl}4-methoxybenzenesulfonamido)acetic acid,"InChI=1S/C27H25NO8S2/c1-35-20-8-12-22(13-9-20)37(31,32)18-19-7-16-26(25-6-4-3-5-24(19)25)28(17-27(29)30)38(33,34)23-14-10-21(36-2)11-15-23/h3-16H,17-18H2,1-2H3,(H,29,30)",ZPWOSQULANINNR-UHFFFAOYSA-N,1,0,0,0,Keap1 / Nrf2,6.17,"chronic obstructive pulmonary disease, multiple sclerosis, chronic kidney disease",Inhibition,
2463,139559717,4634320,,COc1ccc(cc1)S(=O)(=O)Cc1ccc(NS(=O)(=O)c2ccc(OC)cc2)c2ccccc12,4-methoxy-N-{4-[(4-methoxybenzenesulfonyl)methyl]naphthalen-1-yl}benzene-1-sulfonamide,"InChI=1S/C25H23NO6S2/c1-31-19-8-12-21(13-9-19)33(27,28)17-18-7-16-25(24-6-4-3-5-23(18)24)26-34(29,30)22-14-10-20(32-2)11-15-22/h3-16,26H,17H2,1-2H3",UAQWWYCFJATMOR-UHFFFAOYSA-N,1,0,0,0,Keap1 / Nrf2,5.52,"chronic obstructive pulmonary disease, multiple sclerosis, chronic kidney disease",Inhibition,
2464,,,,COc1ccc(cc1)S(=O)(=O)Nc1ccc(N([C@@H](C)C(O)=O)S(=O)(=O)c2ccc(OC)cc2)c2ccccc12,(2S)-2-{N-[4-(4-methoxybenzenesulfonamido)naphthalen-1-yl]4-methoxybenzenesulfonamido}propanoic acid,"InChI=1S/C27H26N2O8S2/c1-18(27(30)31)29(39(34,35)22-14-10-20(37-3)11-15-22)26-17-16-25(23-6-4-5-7-24(23)26)28-38(32,33)21-12-8-19(36-2)9-13-21/h4-18,28H,1-3H3,(H,30,31)/t18-/m0/s1",GSPXMSUWDWFXCY-SFHVURJKSA-N,1,0,0,0,Keap1 / Nrf2,6.90,"chronic obstructive pulmonary disease, multiple sclerosis, chronic kidney disease",Inhibition,
2465,,,,COc1ccc(cc1)S(=O)(=O)Nc1ccc(N(C(C(O)=O)c2ccccc2)S(=O)(=O)c2ccc(OC)cc2)c2ccccc12,2-{N-[4-(4-methoxybenzenesulfonamido)naphthalen-1-yl]4-methoxybenzenesulfonamido}-2-phenylacetic acid,"InChI=1S/C32H28N2O8S2/c1-41-23-12-16-25(17-13-23)43(37,38)33-29-20-21-30(28-11-7-6-10-27(28)29)34(31(32(35)36)22-8-4-3-5-9-22)44(39,40)26-18-14-24(42-2)15-19-26/h3-21,31,33H,1-2H3,(H,35,36)",USIBQXRXGBYQQP-UHFFFAOYSA-N,1,0,0,0,Keap1 / Nrf2,4.85,"chronic obstructive pulmonary disease, multiple sclerosis, chronic kidney disease",Inhibition,
2466,139559930,4647946,,COc1ccc(cc1)S(=O)(=O)Cc1ccc(N([C@@H](C)C(O)=O)S(=O)(=O)c2ccc(OC)cc2)c2ccccc12,(2S)-2-(N-{4-[(4-methoxybenzenesulfonyl)methyl]naphthalen-1-yl}4-methoxybenzenesulfonamido)propanoic acid,"InChI=1S/C28H27NO8S2/c1-19(28(30)31)29(39(34,35)24-15-11-22(37-3)12-16-24)27-17-8-20(25-6-4-5-7-26(25)27)18-38(32,33)23-13-9-21(36-2)10-14-23/h4-17,19H,18H2,1-3H3,(H,30,31)/t19-/m0/s1",ZGCAXGWKZBFCEZ-IBGZPJMESA-N,1,0,0,0,Keap1 / Nrf2,6.62,"chronic obstructive pulmonary disease, multiple sclerosis, chronic kidney disease",Inhibition,
2467,156010955,4632722,,COc1ccc(cc1)S(=O)(=O)Cc1ccc(N([C@H](C)C(O)=O)S(=O)(=O)c2ccc(OC)cc2)c2ccccc12,(2R)-2-(N-{4-[(4-methoxybenzenesulfonyl)methyl]naphthalen-1-yl}4-methoxybenzenesulfonamido)propanoic acid,"InChI=1S/C28H27NO8S2/c1-19(28(30)31)29(39(34,35)24-15-11-22(37-3)12-16-24)27-17-8-20(25-6-4-5-7-26(25)27)18-38(32,33)23-13-9-21(36-2)10-14-23/h4-17,19H,18H2,1-3H3,(H,30,31)/t19-/m1/s1",ZGCAXGWKZBFCEZ-LJQANCHMSA-N,1,0,0,0,Keap1 / Nrf2,6.82,"chronic obstructive pulmonary disease, multiple sclerosis, chronic kidney disease",Inhibition,
2468,736494,3951007,,OC(=O)c1ccc(s1)-c1ccccc1,5-phenylthiophene-2-carboxylic acid,"InChI=1S/C11H8O2S/c12-11(13)10-7-6-9(14-10)8-4-2-1-3-5-8/h1-7H,(H,12,13)",QGMFBCDNJUZQBZ-UHFFFAOYSA-N,2,0,0,0,RTA / 60S ribosomal subunit,3.74,toxin,Inhibition,
2469,20038987,,,OC(=O)c1ccc(Cc2cccs2)cc1,4-[(thiophen-2-yl)methyl]benzoic acid,"InChI=1S/C12H10O2S/c13-12(14)10-5-3-9(4-6-10)8-11-2-1-7-15-11/h1-7H,8H2,(H,13,14)",OAIBKSRZDOMJKZ-UHFFFAOYSA-N,2,0,0,0,RTA / 60S ribosomal subunit,6.39,toxin,Inhibition,
2470,297677,5219398,,NC(=O)c1cccc2C(=O)c3ccccc3-c12,9-oxo-9H-fluorene-4-carboxamide,"InChI=1S/C14H9NO2/c15-14(17)11-7-3-6-10-12(11)8-4-1-2-5-9(8)13(10)16/h1-7H,(H2,15,17)",PRROCNFTWSJBTJ-UHFFFAOYSA-N,1,0,0,0,RTA / 60S ribosomal subunit,3.82,toxin,Inhibition,
